Citrus Sinensis ID: 039819
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 534 | 2.2.26 [Sep-21-2011] | |||||||
| Q0WVM4 | 634 | Probable LRR receptor-lik | yes | no | 0.953 | 0.802 | 0.669 | 0.0 | |
| Q8VYT3 | 648 | Probable LRR receptor-lik | no | no | 0.964 | 0.794 | 0.670 | 0.0 | |
| Q9LFS4 | 638 | Protein NSP-INTERACTING K | no | no | 0.928 | 0.777 | 0.588 | 0.0 | |
| Q8RY65 | 635 | Protein NSP-INTERACTING K | no | no | 0.928 | 0.781 | 0.582 | 0.0 | |
| Q93ZS4 | 632 | Protein NSP-INTERACTING K | no | no | 0.930 | 0.786 | 0.523 | 1e-152 | |
| C0LGU5 | 614 | Probable LRR receptor-lik | no | no | 0.895 | 0.778 | 0.500 | 1e-139 | |
| Q94AG2 | 625 | Somatic embryogenesis rec | no | no | 0.842 | 0.72 | 0.506 | 1e-131 | |
| Q9SKG5 | 620 | Somatic embryogenesis rec | no | no | 0.861 | 0.741 | 0.499 | 1e-128 | |
| Q94F62 | 615 | BRASSINOSTEROID INSENSITI | no | no | 0.867 | 0.752 | 0.498 | 1e-124 | |
| Q8LPS5 | 601 | Somatic embryogenesis rec | no | no | 0.855 | 0.760 | 0.490 | 1e-121 |
| >sp|Q0WVM4|Y2239_ARATH Probable LRR receptor-like serine/threonine-protein kinase At2g23950 OS=Arabidopsis thaliana GN=At2g23950 PE=2 SV=1 | Back alignment and function desciption |
|---|
Score = 761 bits (1965), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 397/593 (66%), Positives = 447/593 (75%), Gaps = 84/593 (14%)
Query: 1 MITCSPENLVIGLGAPSQSLSGTLSGSIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQT 60
MI+CS +NLVIGLGAPSQSLSGTLSGSIGNLTNLRQV LQNNNISG IPP++ SLPKLQT
Sbjct: 67 MISCSSDNLVIGLGAPSQSLSGTLSGSIGNLTNLRQVSLQNNNISGKIPPEICSLPKLQT 126
Query: 61 LDLSNNRLSGVIPALLFLSIWLPRKWDKRKCSGVDQGLLRLNNNSLSGAFPVFLAKISEL 120
LDLSNNR SG IP + + S + LRLNNNSLSG FP L++I L
Sbjct: 127 LDLSNNRFSGEIPGSV------------NQLSNLQ--YLRLNNNSLSGPFPASLSQIPHL 172
Query: 121 AFLDLSYNNLSGPVPKFPARTFNVAGNPLICGSSSTNVCSGSANSVPLSFSLNSSP---- 176
+FLDLSYNNL GPVPKFPARTFNVAGNPLIC +S +CSGS ++ PLS SL SS
Sbjct: 173 SFLDLSYNNLRGPVPKFPARTFNVAGNPLICKNSLPEICSGSISASPLSVSLRSSSGRRT 232
Query: 177 ---------------------------------------DKQEEGLISLGNLRNFTFREL 197
DKQEEGL+ LGNLR+FTFREL
Sbjct: 233 NILAVALGVSLGFAVSVILSLGFIWYRKKQRRLTMLRISDKQEEGLLGLGNLRSFTFREL 292
Query: 198 QQATENFSSKNILGAGGFGNVYKGKLGDGTVLAVKRLKD---------------MISLAV 242
AT+ FSSK+ILGAGGFGNVY+GK GDGTV+AVKRLKD MISLAV
Sbjct: 293 HVATDGFSSKSILGAGGFGNVYRGKFGDGTVVAVKRLKDVNGTSGNSQFRTELEMISLAV 352
Query: 243 HRNLLRLIGYCATPTERLLVYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHE 302
HRNLLRLIGYCA+ +ERLLVYPYMSNGSVASRL+ KPALDWNTRK+IAIGAARGL YLHE
Sbjct: 353 HRNLLRLIGYCASSSERLLVYPYMSNGSVASRLKAKPALDWNTRKKIAIGAARGLFYLHE 412
Query: 303 QCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGHIAPEYLST 362
QCDPKIIHRDVKAAN+LLD++ EA+VGDFGLAKLL+H DSHVTTAVRGTVGHIAPEYLST
Sbjct: 413 QCDPKIIHRDVKAANILLDEYFEAVVGDFGLAKLLNHEDSHVTTAVRGTVGHIAPEYLST 472
Query: 363 GQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELG 422
GQSSEKTDVFGFGILLLELITGMRALEFGKS++QKGAMLEWV+K+ +E KVE LVDRELG
Sbjct: 473 GQSSEKTDVFGFGILLLELITGMRALEFGKSVSQKGAMLEWVRKLHKEMKVEELVDRELG 532
Query: 423 SNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLEGDGLAEKWAAAHNHTNPTMNNFH 482
+ YDRIEVGE+LQVALLCTQ+LP HRPKMSEVV+MLEGDGLAE+WAA+H+H+ + +H
Sbjct: 533 TTYDRIEVGEMLQVALLCTQFLPAHRPKMSEVVQMLEGDGLAERWAASHDHS----HFYH 588
Query: 483 TNTKKSTSCPTSAPKHDHEEKNDQSSMFGTAVDEDDDD-HSLDSYAMELSGPR 534
N T T N +FG++ ED+DD +LDS+AMELSGPR
Sbjct: 589 ANMSYRTITSTDG-------NNQTKHLFGSSGFEDEDDNQALDSFAMELSGPR 634
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q8VYT3|Y4052_ARATH Probable LRR receptor-like serine/threonine-protein kinase At4g30520 OS=Arabidopsis thaliana GN=At4g30520 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 744 bits (1922), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 401/598 (67%), Positives = 445/598 (74%), Gaps = 83/598 (13%)
Query: 1 MITCSPENLVIGLGAPSQSLSGTLSGSIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQT 60
MITCSP+NLVIGLGAPSQSLSG LS SIGNLTNLRQV LQNNNISG IPP+LG LPKLQT
Sbjct: 70 MITCSPDNLVIGLGAPSQSLSGGLSESIGNLTNLRQVSLQNNNISGKIPPELGFLPKLQT 129
Query: 61 LDLSNNRLSGVIPALLFLSIWLPRKWDKRKCSGVDQ----GLLRLNNNSLSGAFPVFLAK 116
LDLSNNR SG IP +DQ LRLNNNSLSG FP L++
Sbjct: 130 LDLSNNRFSGDIPV------------------SIDQLSSLQYLRLNNNSLSGPFPASLSQ 171
Query: 117 ISELAFLDLSYNNLSGPVPKFPARTFNVAGNPLICGSSSTNVCSGSAN------------ 164
I L+FLDLSYNNLSGPVPKFPARTFNVAGNPLIC S+ +CSGS N
Sbjct: 172 IPHLSFLDLSYNNLSGPVPKFPARTFNVAGNPLICRSNPPEICSGSINASPLSVSLSSSS 231
Query: 165 -------SVPLSFSLNSSP-------------------------DKQEEGLISLGNLRNF 192
++ LS SL S DKQEEGL LGNLR+F
Sbjct: 232 GRRSNRLAIALSVSLGSVVILVLALGSFCWYRKKQRRLLILNLNDKQEEGLQGLGNLRSF 291
Query: 193 TFRELQQATENFSSKNILGAGGFGNVYKGKLGDGTVLAVKRLKD---------------M 237
TFREL T+ FSSKNILGAGGFGNVY+GKLGDGT++AVKRLKD M
Sbjct: 292 TFRELHVYTDGFSSKNILGAGGFGNVYRGKLGDGTMVAVKRLKDINGTSGDSQFRMELEM 351
Query: 238 ISLAVHRNLLRLIGYCATPTERLLVYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGL 297
ISLAVH+NLLRLIGYCAT ERLLVYPYM NGSVAS+L+ KPALDWN RKRIAIGAARGL
Sbjct: 352 ISLAVHKNLLRLIGYCATSGERLLVYPYMPNGSVASKLKSKPALDWNMRKRIAIGAARGL 411
Query: 298 LYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGHIAP 357
LYLHEQCDPKIIHRDVKAAN+LLD+ EA+VGDFGLAKLL+H+DSHVTTAVRGTVGHIAP
Sbjct: 412 LYLHEQCDPKIIHRDVKAANILLDECFEAVVGDFGLAKLLNHADSHVTTAVRGTVGHIAP 471
Query: 358 EYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLV 417
EYLSTGQSSEKTDVFGFGILLLELITG+RALEFGK+++QKGAMLEWV+K+ +E KVE L+
Sbjct: 472 EYLSTGQSSEKTDVFGFGILLLELITGLRALEFGKTVSQKGAMLEWVRKLHEEMKVEELL 531
Query: 418 DRELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLEGDGLAEKWAAAHNHTNPT 477
DRELG+NYD+IEVGE+LQVALLCTQYLP HRPKMSEVV MLEGDGLAE+WAA+HNH++
Sbjct: 532 DRELGTNYDKIEVGEMLQVALLCTQYLPAHRPKMSEVVLMLEGDGLAERWAASHNHSHFY 591
Query: 478 MNNFHTNTKKSTSCPTSAPKHDHEEKNDQSSMFGTAVDEDDDDHS-LDSYAMELSGPR 534
N T S S TS + D + MFG++ +DDDDH LDS+AMELSGPR
Sbjct: 592 HANISFKTISSLST-TSVSRLDAHCNDPTYQMFGSSAFDDDDDHQPLDSFAMELSGPR 648
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LFS4|NIK1_ARATH Protein NSP-INTERACTING KINASE 1 OS=Arabidopsis thaliana GN=NIK1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 650 bits (1676), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 355/603 (58%), Positives = 411/603 (68%), Gaps = 107/603 (17%)
Query: 1 MITCSPENLVIGLGAPSQSLSGTLSGSIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQT 60
M+TCS EN VIGLG PSQ+LSGTLS SI NLTNLR VLLQNNNI G IP ++G L +L+T
Sbjct: 74 MVTCSSENFVIGLGTPSQNLSGTLSPSITNLTNLRIVLLQNNNIKGKIPAEIGRLTRLET 133
Query: 61 LDLSNNRLSGVIPALLFLSIWLPRKWDKRKCSGVDQGL--LRLNNNSLSGAFPVFLAKIS 118
LDLS+N G IP S+ G Q L LRLNNNSLSG FP+ L+ ++
Sbjct: 134 LDLSDNFFHGEIP----FSV------------GYLQSLQYLRLNNNSLSGVFPLSLSNMT 177
Query: 119 ELAFLDLSYNNLSGPVPKFPARTFNVAGNPLICGSSSTNVCSGSANSVPLSFSLNSS--- 175
+LAFLDLSYNNLSGPVP+F A+TF++ GNPLIC + + C+G+ +P+S +LN +
Sbjct: 178 QLAFLDLSYNNLSGPVPRFAAKTFSIVGNPLICPTGTEPDCNGTT-LIPMSMNLNQTGVP 236
Query: 176 -----------------------------------------------PDKQEEGLISLGN 188
D +SLGN
Sbjct: 237 LYAGGSRNHKMAIAVGSSVGTVSLIFIAVGLFLWWRQRHNQNTFFDVKDGNHHEEVSLGN 296
Query: 189 LRNFTFRELQQATENFSSKNILGAGGFGNVYKGKLGDGTVLAVKRLKD------------ 236
LR F FRELQ AT NFSSKN+LG GG+GNVYKG LGD TV+AVKRLKD
Sbjct: 297 LRRFGFRELQIATNNFSSKNLLGKGGYGNVYKGILGDSTVVAVKRLKDGGALGGEIQFQT 356
Query: 237 ---MISLAVHRNLLRLIGYCATPTERLLVYPYMSNGSVASRLREKPALDWNTRKRIAIGA 293
MISLAVHRNLLRL G+C T TE+LLVYPYMSNGSVASR++ KP LDW+ RKRIAIGA
Sbjct: 357 EVEMISLAVHRNLLRLYGFCITQTEKLLVYPYMSNGSVASRMKAKPVLDWSIRKRIAIGA 416
Query: 294 ARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVG 353
ARGL+YLHEQCDPKIIHRDVKAAN+LLDD+CEA+VGDFGLAKLLDH DSHVTTAVRGTVG
Sbjct: 417 ARGLVYLHEQCDPKIIHRDVKAANILLDDYCEAVVGDFGLAKLLDHQDSHVTTAVRGTVG 476
Query: 354 HIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKV 413
HIAPEYLSTGQSSEKTDVFGFGILLLEL+TG RA EFGK+ NQKG ML+WVKKI QEKK+
Sbjct: 477 HIAPEYLSTGQSSEKTDVFGFGILLLELVTGQRAFEFGKAANQKGVMLDWVKKIHQEKKL 536
Query: 414 EVLVDREL--GSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLEGDGLAEKWAAAH 471
E+LVD+EL +YD IE+ E+++VALLCTQYLP HRPKMSEVVRMLEGDGLAEKW A+
Sbjct: 537 ELLVDKELLKKKSYDEIELDEMVRVALLCTQYLPGHRPKMSEVVRMLEGDGLAEKWEASQ 596
Query: 472 NHTNPTMNNFHTNTKKSTSCPTSAPKHDHEEKNDQSSMFGTAVDEDDDDHSLDSYAMELS 531
+ + + N S+S D+ S + DD SL AMELS
Sbjct: 597 RSDSVSKCSNRINELMSSS--------------DRYS-------DLTDDSSLLVQAMELS 635
Query: 532 GPR 534
GPR
Sbjct: 636 GPR 638
|
Involved in defense response to geminivirus infection via regulation of the nuclear trafficking of RPL10A. Phosphorylates RPL10A in vitro. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8RY65|NIK2_ARATH Protein NSP-INTERACTING KINASE 2 OS=Arabidopsis thaliana GN=NIK2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 641 bits (1653), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 349/599 (58%), Positives = 405/599 (67%), Gaps = 103/599 (17%)
Query: 1 MITCSPENLVIGLGAPSQSLSGTLSGSIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQT 60
MITCS + VI L APSQ+LSGTLS SIGNLTNL+ VLLQNN I+G IP ++G L KL+T
Sbjct: 75 MITCS-DGFVIRLEAPSQNLSGTLSSSIGNLTNLQTVLLQNNYITGNIPHEIGKLMKLKT 133
Query: 61 LDLSNNRLSGVIPALLFLSIWLPRKWDKRKCSGVDQGLLRLNNNSLSGAFPVFLAKISEL 120
LDLS N +G IP L S L LR+NNNSL+G P LA +++L
Sbjct: 134 LDLSTNNFTGQIPFTLSYSKNLQ--------------YLRVNNNSLTGTIPSSLANMTQL 179
Query: 121 AFLDLSYNNLSGPVPKFPARTFNVAGNPLICGSSSTNVCSGSANSVPLSFSLNSSPDKQE 180
FLDLSYNNLSGPVP+ A+TFNV GN IC + + C+G+ P+S +LNSS +K
Sbjct: 180 TFLDLSYNNLSGPVPRSLAKTFNVMGNSQICPTGTEKDCNGTQPK-PMSITLNSSQNKSS 238
Query: 181 EG--------------------------------------------------LISLGNLR 190
+G + LGNLR
Sbjct: 239 DGGTKNRKIAVVFGVSLTCVCLLIIGFGFLLWWRRRHNKQVLFFDINEQNKEEMCLGNLR 298
Query: 191 NFTFRELQQATENFSSKNILGAGGFGNVYKGKLGDGTVLAVKRLKD-------------- 236
F F+ELQ AT NFSSKN++G GGFGNVYKG L DG+++AVKRLKD
Sbjct: 299 RFNFKELQSATSNFSSKNLVGKGGFGNVYKGCLHDGSIIAVKRLKDINNGGGEVQFQTEL 358
Query: 237 -MISLAVHRNLLRLIGYCATPTERLLVYPYMSNGSVASRLREKPALDWNTRKRIAIGAAR 295
MISLAVHRNLLRL G+C T +ERLLVYPYMSNGSVASRL+ KP LDW TRKRIA+GA R
Sbjct: 359 EMISLAVHRNLLRLYGFCTTSSERLLVYPYMSNGSVASRLKAKPVLDWGTRKRIALGAGR 418
Query: 296 GLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGHI 355
GLLYLHEQCDPKIIHRDVKAAN+LLDD+ EA+VGDFGLAKLLDH +SHVTTAVRGTVGHI
Sbjct: 419 GLLYLHEQCDPKIIHRDVKAANILLDDYFEAVVGDFGLAKLLDHEESHVTTAVRGTVGHI 478
Query: 356 APEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEV 415
APEYLSTGQSSEKTDVFGFGILLLELITG+RALEFGK+ NQ+GA+L+WVKK+QQEKK+E
Sbjct: 479 APEYLSTGQSSEKTDVFGFGILLLELITGLRALEFGKAANQRGAILDWVKKLQQEKKLEQ 538
Query: 416 LVDRELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLEGDGLAEKWAAAHNHTN 475
+VD++L SNYDRIEV E++QVALLCTQYLP+HRPKMSEVVRMLEGDGL EKW A+
Sbjct: 539 IVDKDLKSNYDRIEVEEMVQVALLCTQYLPIHRPKMSEVVRMLEGDGLVEKWEASSQ--- 595
Query: 476 PTMNNFHTNTKKSTSCPTSAPKHDHEEKNDQSSMFGTAVDEDDDDHSLDSYAMELSGPR 534
T +S S P E +D + DD S+ AMELSGPR
Sbjct: 596 ------RAETNRSYSKPNEFS--SSERYSDLT-----------DDSSVLVQAMELSGPR 635
|
Involved in defense response to geminivirus infection (By similarity). Phosphorylates RPL10A in vitro. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q93ZS4|NIK3_ARATH Protein NSP-INTERACTING KINASE 3 OS=Arabidopsis thaliana GN=NIK3 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 539 bits (1389), Expect = e-152, Method: Compositional matrix adjust.
Identities = 315/602 (52%), Positives = 386/602 (64%), Gaps = 105/602 (17%)
Query: 1 MITCSPENLVIGLGAPSQSLSGTLSGSIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQT 60
M++C+ + V L PSQSLSGTLS IGNLT L+ V+LQNN I+G IP +G L KLQ+
Sbjct: 68 MVSCT-DGYVSSLDLPSQSLSGTLSPRIGNLTYLQSVVLQNNAITGPIPETIGRLEKLQS 126
Query: 61 LDLSNNRLSGVIPALLFLSIWLPRKWDKRKCSGVDQGLLRLNNNSLSGAFPVFLAKISEL 120
LDLSNN +G IPA L + LRLNNNSL G P L+KI L
Sbjct: 127 LDLSNNSFTGEIPASL--------------GELKNLNYLRLNNNSLIGTCPESLSKIEGL 172
Query: 121 AFLDLSYNNLSGPVPKFPARTFNVAGNPLICGSSSTNVCSGSANSVPLSFSL-NSSPDK- 178
+D+SYNNLSG +PK ARTF V GN LICG + + CS +VP +L PD+
Sbjct: 173 TLVDISYNNLSGSLPKVSARTFKVIGNALICGPKAVSNCS----AVPEPLTLPQDGPDES 228
Query: 179 -----------------------------------------------QEEGLISLGNLRN 191
Q + +SLG+L+
Sbjct: 229 GTRTNGHHVALAFAASFSAAFFVFFTSGMFLWWRYRRNKQIFFDVNEQYDPEVSLGHLKR 288
Query: 192 FTFRELQQATENFSSKNILGAGGFGNVYKGKLGDGTVLAVKRLKD--------------- 236
+TF+EL+ AT +F+SKNILG GG+G VYKG L DGT++AVKRLKD
Sbjct: 289 YTFKELRSATNHFNSKNILGRGGYGIVYKGHLNDGTLVAVKRLKDCNIAGGEVQFQTEVE 348
Query: 237 MISLAVHRNLLRLIGYCATPTERLLVYPYMSNGSVASRLRE----KPALDWNTRKRIAIG 292
ISLA+HRNLLRL G+C++ ER+LVYPYM NGSVASRL++ +PALDW+ RK+IA+G
Sbjct: 349 TISLALHRNLLRLRGFCSSNQERILVYPYMPNGSVASRLKDNIRGEPALDWSRRKKIAVG 408
Query: 293 AARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTV 352
ARGL+YLHEQCDPKIIHRDVKAAN+LLD+ EA+VGDFGLAKLLDH DSHVTTAVRGTV
Sbjct: 409 TARGLVYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTV 468
Query: 353 GHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKK 412
GHIAPEYLSTGQSSEKTDVFGFGILLLELITG +AL+FG+S +QKG ML+WVKK+ QE K
Sbjct: 469 GHIAPEYLSTGQSSEKTDVFGFGILLLELITGQKALDFGRSAHQKGVMLDWVKKLHQEGK 528
Query: 413 VEVLVDRELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLEGDGLAEKWAAAHN 472
++ L+D++L +DR+E+ EI+QVALLCTQ+ P HRPKMSEV++MLEGDGLAE+W A N
Sbjct: 529 LKQLIDKDLNDKFDRVELEEIVQVALLCTQFNPSHRPKMSEVMKMLEGDGLAERWEATQN 588
Query: 473 HTNPTMNNFHTNTKKSTSCPTSAPKHDHEEKNDQSSMFGTAVDEDDDDHSLDSYAMELSG 532
T H +S+P+ + Q S SL A+ELSG
Sbjct: 589 GTGE-----HQPPPLPPGMVSSSPRVRYYSDYIQES-------------SLVVEAIELSG 630
Query: 533 PR 534
PR
Sbjct: 631 PR 632
|
Involved in defense response to geminivirus infection. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGU5|Y5457_ARATH Probable LRR receptor-like serine/threonine-protein kinase At5g45780 OS=Arabidopsis thaliana GN=At5g45780 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 494 bits (1271), Expect = e-139, Method: Compositional matrix adjust.
Identities = 277/553 (50%), Positives = 354/553 (64%), Gaps = 75/553 (13%)
Query: 1 MITCSPENLVIGLGAPSQSLSGTLSGSIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQT 60
M+ CS E V+ L S+ LSG LS SIG LT+L +LLQNN ++G IP +LG L +L+T
Sbjct: 72 MVGCSSEGFVVSLEMASKGLSGILSTSIGELTHLHTLLLQNNQLTGPIPSELGQLSELET 131
Query: 61 LDLSNNRLSGVIPALL-FLSIWLPRKWDKRKCSGVDQGLLRLNNNSLSGAFPVFLAKISE 119
LDLS NR SG IPA L FL+ LRL+ N LSG P +A +S
Sbjct: 132 LDLSGNRFSGEIPASLGFLT---------------HLNYLRLSRNLLSGQVPHLVAGLSG 176
Query: 120 LAFLDLSYNNLSGPVPKFPARTFNVAGNPLICGSSSTNVCSGSA---------------- 163
L+FLDLS+NNLSGP P A+ + + GN +CG +S +CS +
Sbjct: 177 LSFLDLSFNNLSGPTPNISAKDYRIVGNAFLCGPASQELCSDATPVRNATGLSEKDNSKH 236
Query: 164 NSVPLSFSLN-----------------------SSPDKQEEGLISLGNLRNFTFRELQQA 200
+S+ LSF+ S Q++ +G+L+ F+FRE+Q A
Sbjct: 237 HSLVLSFAFGIVVAFIISLMFLFFWVLWHRSRLSRSHVQQDYEFEIGHLKRFSFREIQTA 296
Query: 201 TENFSSKNILGAGGFGNVYKGKLGDGTVLAVKRLKD--------------MISLAVHRNL 246
T NFS KNILG GGFG VYKG L +GTV+AVKRLKD MI LAVHRNL
Sbjct: 297 TSNFSPKNILGQGGFGMVYKGYLPNGTVVAVKRLKDPIYTGEVQFQTEVEMIGLAVHRNL 356
Query: 247 LRLIGYCATPTERLLVYPYMSNGSVASRLR----EKPALDWNTRKRIAIGAARGLLYLHE 302
LRL G+C TP ER+LVYPYM NGSVA RLR EKP+LDWN R IA+GAARGL+YLHE
Sbjct: 357 LRLFGFCMTPEERMLVYPYMPNGSVADRLRDNYGEKPSLDWNRRISIALGAARGLVYLHE 416
Query: 303 QCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGHIAPEYLST 362
QC+PKIIHRDVKAAN+LLD+ EAIVGDFGLAKLLD DSHVTTAVRGT+GHIAPEYLST
Sbjct: 417 QCNPKIIHRDVKAANILLDESFEAIVGDFGLAKLLDQRDSHVTTAVRGTIGHIAPEYLST 476
Query: 363 GQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELG 422
GQSSEKTDVFGFG+L+LELITG + ++ G +KG +L WV+ ++ EK+ +VDR+L
Sbjct: 477 GQSSEKTDVFGFGVLILELITGHKMIDQGNGQVRKGMILSWVRTLKAEKRFAEMVDRDLK 536
Query: 423 SNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLEGDGLAEKWAAAHNHTNPTMNNFH 482
+D + + E++++ALLCTQ P RP+MS+V+++LE GL E+ + P+++ +
Sbjct: 537 GEFDDLVLEEVVELALLCTQPHPNLRPRMSQVLKVLE--GLVEQCEGGYEARAPSVSRNY 594
Query: 483 TNTKKSTSCPTSA 495
+N + S A
Sbjct: 595 SNGHEEQSFIIEA 607
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q94AG2|SERK1_ARATH Somatic embryogenesis receptor kinase 1 OS=Arabidopsis thaliana GN=SERK1 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 470 bits (1209), Expect = e-131, Method: Compositional matrix adjust.
Identities = 273/539 (50%), Positives = 341/539 (63%), Gaps = 89/539 (16%)
Query: 2 ITCSPENLVIGLGAPSQSLSGTLSGSIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTL 61
+TC+ EN VI + + LSG L +G L NL+ + L +NNI+G IP LG+L L +L
Sbjct: 63 VTCNNENSVIRVDLGNAELSGHLVPELGVLKNLQYLELYSNNITGPIPSNLGNLTNLVSL 122
Query: 62 DLSNNRLSGVIPALLFLSIWLPRKWDKRKCSGVDQGLLRLNNNSLSGAFPVFLAKISELA 121
DL N SG IP L K K + LRLNNNSL+G+ P+ L I+ L
Sbjct: 123 DLYLNSFSGPIPESL-------GKLSKLR-------FLRLNNNSLTGSIPMSLTNITTLQ 168
Query: 122 FLDLSYNNLSGPVP---KFPART-FNVAGNPLICGSSSTN-------------------V 158
LDLS N LSG VP F T + A N +CG +++ V
Sbjct: 169 VLDLSNNRLSGSVPDNGSFSLFTPISFANNLDLCGPVTSHPCPGSPPFSPPPPFIQPPPV 228
Query: 159 CSGSANSV------------------------------PLSFSLNSSPDKQEEGLISLGN 188
+ S + PL + ++ E + LG
Sbjct: 229 STPSGYGITGAIAGGVAAGAALLFAAPAIAFAWWRRRKPLDIFFDVPAEEDPE--VHLGQ 286
Query: 189 LRNFTFRELQQATENFSSKNILGAGGFGNVYKGKLGDGTVLAVKRLK------------- 235
L+ F+ RELQ A++ FS+KNILG GGFG VYKG+L DGT++AVKRLK
Sbjct: 287 LKRFSLRELQVASDGFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTPGGELQFQT 346
Query: 236 --DMISLAVHRNLLRLIGYCATPTERLLVYPYMSNGSVASRLREK----PALDWNTRKRI 289
+MIS+AVHRNLLRL G+C TPTERLLVYPYM+NGSVAS LRE+ P LDW TRKRI
Sbjct: 347 EVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQPPLDWPTRKRI 406
Query: 290 AIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVR 349
A+G+ARGL YLH+ CDPKIIHRDVKAAN+LLD+ EA+VGDFGLAKL+D+ D+HVTTAVR
Sbjct: 407 ALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVR 466
Query: 350 GTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAM-LEWVKKIQ 408
GT+GHIAPEYLSTG+SSEKTDVFG+GI+LLELITG RA + + N M L+WVK +
Sbjct: 467 GTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLL 526
Query: 409 QEKKVEVLVDRELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLEGDGLAEKW 467
+EKK+E+LVD +L +NY+ E+ +++QVALLCTQ P+ RPKMSEVVRMLEGDGLAEKW
Sbjct: 527 KEKKLEMLVDPDLQTNYEERELEQVIQVALLCTQGSPMERPKMSEVVRMLEGDGLAEKW 585
|
Dual specificity kinase acting on both serine/threonine-and tyrosine-containing substrates. Phosphorylates BRI1 on 'Ser-887' and CDC48 on at least one threonine residue and on 'Ser-41'. Confers embryogenic competence. Acts redundantly with SERK2 as a control point for sporophytic development controlling male gametophyte production. Involved in the brassinolide signaling pathway. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SKG5|SERK4_ARATH Somatic embryogenesis receptor kinase 4 OS=Arabidopsis thaliana GN=SERK4 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 459 bits (1182), Expect = e-128, Method: Compositional matrix adjust.
Identities = 266/533 (49%), Positives = 337/533 (63%), Gaps = 73/533 (13%)
Query: 2 ITCSPENLVIGLGAPSQSLSGTLSGSIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTL 61
+TC+PEN V + + LSG L +G L NL+ + L +NNI+G IP +LG L +L +L
Sbjct: 69 VTCNPENKVTRVDLGNAKLSGKLVPELGQLLNLQYLELYSNNITGEIPEELGDLVELVSL 128
Query: 62 DLSNNRLSGVIPALLFLSIWLPRKWDKRKCSGVDQGLLRLNNNSLSGAFPVFLAKISELA 121
DL N +SG IP+ L K K + LRLNNNSLSG P+ L + +L
Sbjct: 129 DLYANSISGPIPSSL-------GKLGKLR-------FLRLNNNSLSGEIPMTLTSV-QLQ 173
Query: 122 FLDLSYNNLSGPVP---KFPART-FNVAGNPLI-----------------CGSSSTNVCS 160
LD+S N LSG +P F T + A N L G T +
Sbjct: 174 VLDISNNRLSGDIPVNGSFSLFTPISFANNSLTDLPEPPPTSTSPTPPPPSGGQMTAAIA 233
Query: 161 G----------SANSVPLSFSLNSSPDK-------QEEGLISLGNLRNFTFRELQQATEN 203
G + ++ ++ L P +E+ + LG L+ FT REL AT+N
Sbjct: 234 GGVAAGAALLFAVPAIAFAWWLRRKPQDHFFDVPAEEDPEVHLGQLKRFTLRELLVATDN 293
Query: 204 FSSKNILGAGGFGNVYKGKLGDGTVLAVKRLKD---------------MISLAVHRNLLR 248
FS+KN+LG GGFG VYKG+L DG ++AVKRLK+ MIS+AVHRNLLR
Sbjct: 294 FSNKNVLGRGGFGKVYKGRLADGNLVAVKRLKEERTKGGELQFQTEVEMISMAVHRNLLR 353
Query: 249 LIGYCATPTERLLVYPYMSNGSVASRLREKP----ALDWNTRKRIAIGAARGLLYLHEQC 304
L G+C TPTERLLVYPYM+NGSVAS LRE+P ALDW RK IA+G+ARGL YLH+ C
Sbjct: 354 LRGFCMTPTERLLVYPYMANGSVASCLRERPEGNPALDWPKRKHIALGSARGLAYLHDHC 413
Query: 305 DPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGHIAPEYLSTGQ 364
D KIIHRDVKAAN+LLD+ EA+VGDFGLAKL++++DSHVTTAVRGT+GHIAPEYLSTG+
Sbjct: 414 DQKIIHRDVKAANILLDEEFEAVVGDFGLAKLMNYNDSHVTTAVRGTIGHIAPEYLSTGK 473
Query: 365 SSEKTDVFGFGILLLELITGMRALEFGKSINQKGAM-LEWVKKIQQEKKVEVLVDRELGS 423
SSEKTDVFG+G++LLELITG +A + + N M L+WVK++ +EKK+E LVD EL
Sbjct: 474 SSEKTDVFGYGVMLLELITGQKAFDLARLANDDDIMLLDWVKEVLKEKKLESLVDAELEG 533
Query: 424 NYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLEGDGLAEKWAAAHNHTNP 476
Y EV +++Q+ALLCTQ + RPKMSEVVRMLEGDGLAE+W P
Sbjct: 534 KYVETEVEQLIQMALLCTQSSAMERPKMSEVVRMLEGDGLAERWEEWQKEEMP 586
|
Dual specificity kinase acting on both serine/threonine-and tyrosine-containing substrates. Positively regulates the BR-dependent plant growth pathway and negatively regulates the BR-independent cell-death pathway. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q94F62|BAK1_ARATH BRASSINOSTEROID INSENSITIVE 1-associated receptor kinase 1 OS=Arabidopsis thaliana GN=BAK1 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 447 bits (1149), Expect = e-124, Method: Compositional matrix adjust.
Identities = 256/514 (49%), Positives = 330/514 (64%), Gaps = 51/514 (9%)
Query: 2 ITCSPENLVIGLGAPSQSLSGTLSGSIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTL 61
+TC+ +N V + + +LSG L +G L NL+ + L +NNI+G IP QLG+L +L +L
Sbjct: 62 VTCNSDNSVTRVDLGNANLSGQLVMQLGQLPNLQYLELYSNNITGTIPEQLGNLTELVSL 121
Query: 62 DLSNNRLSGVIPALL-------FLSI---WLPRKWDKRKCSGVDQGLLRLNNNSLSGAFP 111
DL N LSG IP+ L FL + L + + + + +L L+NN L+G P
Sbjct: 122 DLYLNNLSGPIPSTLGRLKKLRFLRLNNNSLSGEIPRSLTAVLTLQVLDLSNNPLTGDIP 181
Query: 112 VFLAKISELAFLDLSYNNLSGPVPKFPARTFNVAGNPLICGSSSTNVCSG---------- 161
V S F +S+ N P GS+
Sbjct: 182 V---NGSFSLFTPISFANTKLTPLPASPPPPISPTPPSPAGSNRITGAIAGGVAAGAALL 238
Query: 162 -SANSVPLSFSLNSSPDK-------QEEGLISLGNLRNFTFRELQQATENFSSKNILGAG 213
+ ++ L++ P +E+ + LG L+ F+ RELQ A++NFS+KNILG G
Sbjct: 239 FAVPAIALAWWRRKKPQDHFFDVPAEEDPEVHLGQLKRFSLRELQVASDNFSNKNILGRG 298
Query: 214 GFGNVYKGKLGDGTVLAVKRLKD---------------MISLAVHRNLLRLIGYCATPTE 258
GFG VYKG+L DGT++AVKRLK+ MIS+AVHRNLLRL G+C TPTE
Sbjct: 299 GFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTE 358
Query: 259 RLLVYPYMSNGSVASRLREKPA----LDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVK 314
RLLVYPYM+NGSVAS LRE+P LDW R+RIA+G+ARGL YLH+ CDPKIIHRDVK
Sbjct: 359 RLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVK 418
Query: 315 AANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGF 374
AAN+LLD+ EA+VGDFGLAKL+D+ D+HVTTAVRGT+GHIAPEYLSTG+SSEKTDVFG+
Sbjct: 419 AANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGY 478
Query: 375 GILLLELITGMRALEFGKSINQKGAM-LEWVKKIQQEKKVEVLVDRELGSNYDRIEVGEI 433
G++LLELITG RA + + N M L+WVK + +EKK+E LVD +L NY EV ++
Sbjct: 479 GVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQL 538
Query: 434 LQVALLCTQYLPVHRPKMSEVVRMLEGDGLAEKW 467
+QVALLCTQ P+ RPKMSEVVRMLEGDGLAE+W
Sbjct: 539 IQVALLCTQSSPMERPKMSEVVRMLEGDGLAERW 572
|
Dual specificity kinase acting on both serine/threonine-and tyrosine-containing substrates. Controls the expression of genes associated with innate immunity in the absence of pathogens or elicitors. Involved in brassinosteroid (BR) signal transduction. Phosphorylates BRI1. May be involved in changing the equilibrium between plasma membrane-located BRI1 homodimers and endocytosed BRI1-BAK1 heterodimers. Interaction with MSBP1 stimulates the endocytosis of BAK1 and suppresses brassinosteroid signaling. Acts in pathogen-associated molecular pattern (PAMP)-triggered immunity (PTI) via its interaction with FLS2 and the phosphorylation of BIK1. Involved in programmed cell death (PCD) control. Positively regulates the BR-dependent plant growth pathway and negatively regulates the BR-independent cell-death pathway. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8LPS5|SERK5_ARATH Somatic embryogenesis receptor kinase 5 OS=Arabidopsis thaliana GN=SERK5 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 436 bits (1122), Expect = e-121, Method: Compositional matrix adjust.
Identities = 256/522 (49%), Positives = 323/522 (61%), Gaps = 65/522 (12%)
Query: 2 ITCSPENLVIGLGAPSQSLSGTLSGSIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTL 61
+TC+ EN V L S +LSG L + L NL+ + L NNNI+G IP +LG L +L +L
Sbjct: 64 VTCNTENSVTRLDLGSANLSGELVPQLAQLPNLQYLELFNNNITGEIPEELGDLMELVSL 123
Query: 62 DLSNNRLSGVIPALLFLSIWLPRKWDKRKCSGVDQGLLRLNNNSLSGAFPVFLAKISELA 121
DL N +SG IP+ L K K + LRL NNSLSG P L + L
Sbjct: 124 DLFANNISGPIPSSL-------GKLGKLR-------FLRLYNNSLSGEIPRSLTALP-LD 168
Query: 122 FLDLSYNNLSGPVP------KFPARTFNVAGNPL---------------------ICGSS 154
LD+S N LSG +P +F + +F A N L + +
Sbjct: 169 VLDISNNRLSGDIPVNGSFSQFTSMSF--ANNKLRPRPASPSPSPSGTSAAIVVGVAAGA 226
Query: 155 STNVCSGSANSVPLSFSLNSSPDKQEEGLISLGNLRNFTFRELQQATENFSSKNILGAGG 214
+ L P +E+ + LG + F+ REL ATE FS +N+LG G
Sbjct: 227 ALLFALAWWLRRKLQGHFLDVP-AEEDPEVYLGQFKRFSLRELLVATEKFSKRNVLGKGR 285
Query: 215 FGNVYKGKLGDGTVLAVKRLKD---------------MISLAVHRNLLRLIGYCATPTER 259
FG +YKG+L D T++AVKRL + MIS+AVHRNLLRL G+C TPTER
Sbjct: 286 FGILYKGRLADDTLVAVKRLNEERTKGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTER 345
Query: 260 LLVYPYMSNGSVASRLREKP----ALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKA 315
LLVYPYM+NGSVAS LRE+P ALDW RK IA+G+ARGL YLH+ CD KIIH DVKA
Sbjct: 346 LLVYPYMANGSVASCLRERPEGNPALDWPKRKHIALGSARGLAYLHDHCDQKIIHLDVKA 405
Query: 316 ANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFG 375
AN+LLD+ EA+VGDFGLAKL++++DSHVTTAVRGT+GHIAPEYLSTG+SSEKTDVFG+G
Sbjct: 406 ANILLDEEFEAVVGDFGLAKLMNYNDSHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYG 465
Query: 376 ILLLELITGMRALEFGKSINQKGAM-LEWVKKIQQEKKVEVLVDRELGSNYDRIEVGEIL 434
++LLELITG +A + + N M L+WVK++ +EKK+E LVD EL Y EV +++
Sbjct: 466 VMLLELITGQKAFDLARLANDDDIMLLDWVKEVLKEKKLESLVDAELEGKYVETEVEQLI 525
Query: 435 QVALLCTQYLPVHRPKMSEVVRMLEGDGLAEKWAAAHNHTNP 476
Q+ALLCTQ + RPKMSEVVRMLEGDGLAE+W P
Sbjct: 526 QMALLCTQSSAMERPKMSEVVRMLEGDGLAERWEEWQKEEMP 567
|
Serine/threonine-kinase of unknown function. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 534 | ||||||
| 224091851 | 640 | predicted protein [Populus trichocarpa] | 0.970 | 0.809 | 0.743 | 0.0 | |
| 359484816 | 640 | PREDICTED: probable LRR receptor-like se | 0.971 | 0.810 | 0.743 | 0.0 | |
| 356498787 | 638 | PREDICTED: probable LRR receptor-like se | 0.970 | 0.811 | 0.713 | 0.0 | |
| 147779544 | 640 | hypothetical protein VITISV_040285 [Viti | 0.971 | 0.810 | 0.741 | 0.0 | |
| 449457957 | 639 | PREDICTED: probable LRR receptor-like se | 0.971 | 0.812 | 0.717 | 0.0 | |
| 224143880 | 637 | serine/threonine protein kinase [Populus | 0.966 | 0.810 | 0.724 | 0.0 | |
| 356562533 | 642 | PREDICTED: probable LRR receptor-like se | 0.970 | 0.806 | 0.700 | 0.0 | |
| 357479941 | 640 | Somatic embryogenesis receptor-like kina | 0.970 | 0.809 | 0.685 | 0.0 | |
| 42569274 | 634 | putative LRR receptor-like serine/threon | 0.953 | 0.802 | 0.669 | 0.0 | |
| 297825303 | 641 | leucine-rich repeat family protein [Arab | 0.956 | 0.797 | 0.666 | 0.0 |
| >gi|224091851|ref|XP_002309372.1| predicted protein [Populus trichocarpa] gi|222855348|gb|EEE92895.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 850 bits (2197), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 443/596 (74%), Positives = 469/596 (78%), Gaps = 78/596 (13%)
Query: 1 MITCSPENLVIGLGAPSQSLSGTLSGSIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQT 60
MITCSP+NLVI LGAPSQSLSGTLSG+IGNLTNLRQVLLQNNNISG IPP+LG+L KLQT
Sbjct: 61 MITCSPDNLVICLGAPSQSLSGTLSGAIGNLTNLRQVLLQNNNISGQIPPELGTLSKLQT 120
Query: 61 LDLSNNRLSGVIPALLFLSIWLPRKWDKRKCSGVDQGL--LRLNNNSLSGAFPVFLAKIS 118
LDLSNNR S V+P L G L LRLNNNSLSG FPV +AKIS
Sbjct: 121 LDLSNNRFSSVVPDSL----------------GQLNSLQYLRLNNNSLSGPFPVSVAKIS 164
Query: 119 ELAFLDLSYNNLSGPVPKFPARTFNVAGNPLICGSSSTNVCSGSANSVPLSFSLNSSP-- 176
+L FLDLSYNNLSGPVPK PARTFNVAGNPLICGSSST CSGSAN PLSFSL +SP
Sbjct: 165 QLVFLDLSYNNLSGPVPKSPARTFNVAGNPLICGSSSTEGCSGSANVGPLSFSLVTSPGK 224
Query: 177 ------------------------------------------DKQEEGLISLGNLRNFTF 194
DKQEEGLI LGNLRNFTF
Sbjct: 225 HKSKKLALALGLSLSLVSLFLLALGILWLRRKQKGHMMLNVSDKQEEGLIRLGNLRNFTF 284
Query: 195 RELQQATENFSSKNILGAGGFGNVYKGKLGDGTVLAVKRLKD---------------MIS 239
RELQ AT+NF SKNILG GGFGNVYKGKLGD T++AVKRLKD MIS
Sbjct: 285 RELQIATDNFCSKNILGTGGFGNVYKGKLGDRTMVAVKRLKDLTGTSGESQFRTELEMIS 344
Query: 240 LAVHRNLLRLIGYCATPTERLLVYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLY 299
LAVHRNLLRLIGYCAT ERLLVYPYMSNGSVASRLR KPALDWNTRKRIAIGAARGLLY
Sbjct: 345 LAVHRNLLRLIGYCATSNERLLVYPYMSNGSVASRLRGKPALDWNTRKRIAIGAARGLLY 404
Query: 300 LHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGHIAPEY 359
LHEQCDPKIIHRDVKAANVLLD+FCEA+VGDFGLAKLLDH+DSHVTTAVRGTVGHIAPEY
Sbjct: 405 LHEQCDPKIIHRDVKAANVLLDEFCEAVVGDFGLAKLLDHADSHVTTAVRGTVGHIAPEY 464
Query: 360 LSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDR 419
LSTGQSSEKTDVFGFGILL+ELITGMRALEFGK++NQKGAMLEWVKKIQQEKKV+ LVD+
Sbjct: 465 LSTGQSSEKTDVFGFGILLIELITGMRALEFGKTVNQKGAMLEWVKKIQQEKKVDELVDK 524
Query: 420 ELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLEGDGLAEKWAAAHNHTNPTMN 479
ELGSNYD IEV E+LQVALLCTQYLP HRPKMSEVVRMLEGDGLAEKWA +HNH+NPTMN
Sbjct: 525 ELGSNYDWIEVEEMLQVALLCTQYLPAHRPKMSEVVRMLEGDGLAEKWAVSHNHSNPTMN 584
Query: 480 NFH-TNTKKSTSCPTSAPKHDHEEKNDQSSMFGTAVDEDDDDHSLDSYAMELSGPR 534
H N +ST PT+A KHD N SSMFGT +DEDDD+ SLDSYAMELSGPR
Sbjct: 585 LSHPKNANRSTFYPTTASKHDESGHNRSSSMFGTTMDEDDDERSLDSYAMELSGPR 640
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359484816|ref|XP_003633168.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At2g23950-like [Vitis vinifera] gi|297743709|emb|CBI36592.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 822 bits (2124), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 443/596 (74%), Positives = 477/596 (80%), Gaps = 77/596 (12%)
Query: 1 MITCSPENLVIGLGAPSQSLSGTLSGSIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQT 60
MITCS ENLV GLGAPSQSLSG+LSG IGNLTNL+QVLLQNNNISG IP +LG+LP+LQT
Sbjct: 60 MITCSTENLVTGLGAPSQSLSGSLSGMIGNLTNLKQVLLQNNNISGPIPTELGTLPRLQT 119
Query: 61 LDLSNNRLSGVIPALLFLSIWLPRKWDKRKCSGVDQGLLRLNNNSLSGAFPVFLAKISEL 120
LDLSNNR +G +PA L + S + LRLNNNSLSGAFPV LAKI +L
Sbjct: 120 LDLSNNRFAGAVPASL------------GQLSNLH--YLRLNNNSLSGAFPVSLAKIPQL 165
Query: 121 AFLDLSYNNLSGPVPKFPARTFNVAGNPLICGSSSTNVCSGSANSVPLSFSLNSSP---- 176
AFLDLSYNNLSGPVPKFPARTFNV GNPLIC +SST+ CSGSAN+VPLS SLNSS
Sbjct: 166 AFLDLSYNNLSGPVPKFPARTFNVVGNPLICEASSTDGCSGSANAVPLSISLNSSTGKPK 225
Query: 177 -----------------------------------------DKQEEGLISLGNLRNFTFR 195
D QEEGLISLGNLRNFT R
Sbjct: 226 SKKVAIALGVSLSIVSLILLALGYLICQRRKQRNQTILNINDHQEEGLISLGNLRNFTLR 285
Query: 196 ELQQATENFSSKNILGAGGFGNVYKGKLGDGTVLAVKRLKD---------------MISL 240
ELQ AT+NFS+KNILG+GGFGNVYKGKLGDGT++AVKRLKD MISL
Sbjct: 286 ELQLATDNFSTKNILGSGGFGNVYKGKLGDGTMVAVKRLKDVTGTAGESQFRTELEMISL 345
Query: 241 AVHRNLLRLIGYCATPTERLLVYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYL 300
AVHRNLLRLIGYCATP ERLL+YPYMSNGSVASRLR KPALDWNTRKRIAIGAARGLLYL
Sbjct: 346 AVHRNLLRLIGYCATPNERLLIYPYMSNGSVASRLRGKPALDWNTRKRIAIGAARGLLYL 405
Query: 301 HEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGHIAPEYL 360
HEQCDPKIIHRDVKAANVLLDD+CEAIVGDFGLAKLLDHSDSHVTTAVRGTVGHIAPEYL
Sbjct: 406 HEQCDPKIIHRDVKAANVLLDDYCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGHIAPEYL 465
Query: 361 STGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRE 420
STGQSSEKTDVFGFGILLLELITGMRALEFGK++NQKGAMLEWVKKIQQEKKVEVLVDRE
Sbjct: 466 STGQSSEKTDVFGFGILLLELITGMRALEFGKTVNQKGAMLEWVKKIQQEKKVEVLVDRE 525
Query: 421 LGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLEGDGLAEKWAAAHNHTNPTMNN 480
LG NYDRI+VGE+LQVALLCTQYLP HRPKMSEVVRMLEGDGLAEKWAA+HNH N
Sbjct: 526 LGCNYDRIDVGEMLQVALLCTQYLPAHRPKMSEVVRMLEGDGLAEKWAASHNHNNNNPTP 585
Query: 481 F--HTNTKKSTSCPTSAPKHDHEEKNDQSSMFGTAVDEDDDDHSLDSYAMELSGPR 534
H N+ KST PT+A KHD+ + +D SSMFGT +DE+DDDHSLD++AMELSGPR
Sbjct: 586 NISHFNSHKSTWRPTTASKHDNID-HDGSSMFGTMMDEEDDDHSLDAHAMELSGPR 640
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356498787|ref|XP_003518230.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At2g23950-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 820 bits (2118), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 423/593 (71%), Positives = 467/593 (78%), Gaps = 75/593 (12%)
Query: 1 MITCSPENLVIGLGAPSQSLSGTLSGSIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQT 60
MITCS + LVIGLGAPSQSLSGTLS SIGNLTNLRQVLLQNNNISG IPP LG+LPKLQT
Sbjct: 62 MITCSSDYLVIGLGAPSQSLSGTLSPSIGNLTNLRQVLLQNNNISGNIPPALGNLPKLQT 121
Query: 61 LDLSNNRLSGVIPALLFLSIWLPRKWDKRKCSGVDQGLLRLNNNSLSGAFPVFLAKISEL 120
LDLSNNR SG+IPA L L L LRLNNN+LSG+FPV LAK +L
Sbjct: 122 LDLSNNRFSGLIPASLSLLNSLQ--------------YLRLNNNNLSGSFPVSLAKTPQL 167
Query: 121 AFLDLSYNNLSGPVPKFPARTFNVAGNPLICGSSSTNVCSGSANSVPLSFSLNSS----- 175
AFLDLSYNNLSGP+PKFPAR+FN+ GNPL+CGSS+T CSGSA +P+SFS SS
Sbjct: 168 AFLDLSYNNLSGPLPKFPARSFNIVGNPLVCGSSTTEGCSGSATLMPISFSQVSSEGKHK 227
Query: 176 ---------------------------------------PDKQEEGLISLGNLRNFTFRE 196
D +EEG++SLGNL+NF+FRE
Sbjct: 228 SKRLAIALGVSLSCASLILLLFGLLWYRKKRQHGAMLYISDCKEEGVLSLGNLKNFSFRE 287
Query: 197 LQQATENFSSKNILGAGGFGNVYKGKLGDGTVLAVKRLKD---------------MISLA 241
L AT+NFSSKNILGAGGFGNVY+GKLGDGT++AVKRLKD MISLA
Sbjct: 288 LLHATDNFSSKNILGAGGFGNVYRGKLGDGTMVAVKRLKDVNGSAGESQFQTELEMISLA 347
Query: 242 VHRNLLRLIGYCATPTERLLVYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLH 301
VHRNLLRLIGYCATP E+LLVYPYMSNGSVASRLR KPALDWNTRKRIAIGAARGLLYLH
Sbjct: 348 VHRNLLRLIGYCATPNEKLLVYPYMSNGSVASRLRGKPALDWNTRKRIAIGAARGLLYLH 407
Query: 302 EQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGHIAPEYLS 361
EQCDPKIIHRDVKAANVLLDD+CEA+VGDFGLAKLLDH+DSHVTTAVRGTVGHIAPEYLS
Sbjct: 408 EQCDPKIIHRDVKAANVLLDDYCEAVVGDFGLAKLLDHADSHVTTAVRGTVGHIAPEYLS 467
Query: 362 TGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDREL 421
TGQSSEKTDVFGFGILLLELITGM ALEFGK++NQKGAMLEWV+KI EK+V VLVD+EL
Sbjct: 468 TGQSSEKTDVFGFGILLLELITGMTALEFGKTVNQKGAMLEWVRKILHEKRVAVLVDKEL 527
Query: 422 GSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLEGDGLAEKWAAAHNHTNPTMNNF 481
G NYDRIEVGE+LQVALLCTQYL HRPKMSEVVRMLEGDGLAEKWA++HN+ N MN
Sbjct: 528 GDNYDRIEVGEMLQVALLCTQYLTAHRPKMSEVVRMLEGDGLAEKWASSHNYGNQDMNPS 587
Query: 482 HTNTKKSTSCPTSAPKHDHEEKNDQSSMFGTAVDEDDDDHSLDSYAMELSGPR 534
H N ++S PTSA KHD ++ +D+SSMFG +D DDD+ SL+SYAMELSGPR
Sbjct: 588 HGNNSNTSSRPTSASKHD-DDVHDRSSMFGMTMD-DDDEQSLESYAMELSGPR 638
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147779544|emb|CAN63294.1| hypothetical protein VITISV_040285 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 820 bits (2118), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 442/596 (74%), Positives = 476/596 (79%), Gaps = 77/596 (12%)
Query: 1 MITCSPENLVIGLGAPSQSLSGTLSGSIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQT 60
MITCS ENLV GLGAPSQSLSG+LSG IGNLTNL+QVLLQNNNISG IP +LG+LP+LQT
Sbjct: 60 MITCSTENLVTGLGAPSQSLSGSLSGMIGNLTNLKQVLLQNNNISGPIPTELGTLPRLQT 119
Query: 61 LDLSNNRLSGVIPALLFLSIWLPRKWDKRKCSGVDQGLLRLNNNSLSGAFPVFLAKISEL 120
LDLSNNR +G +PA L + S + LRLNNNSLSGAFPV LAKI +L
Sbjct: 120 LDLSNNRFAGAVPASL------------GQLSNLH--YLRLNNNSLSGAFPVSLAKIPQL 165
Query: 121 AFLDLSYNNLSGPVPKFPARTFNVAGNPLICGSSSTNVCSGSANSVPLSFSLNSSP---- 176
AFLDLSYNNLSGPVPKFPARTFNV GNPLIC +SST+ CSGSAN+VPLS SLNSS
Sbjct: 166 AFLDLSYNNLSGPVPKFPARTFNVVGNPLICEASSTDGCSGSANAVPLSISLNSSTGKPK 225
Query: 177 -----------------------------------------DKQEEGLISLGNLRNFTFR 195
D QEEGLISLGNLRNFT R
Sbjct: 226 SKKVAIALGVSLSIVSLILLALGYLICQRRKQRNLTILNINDHQEEGLISLGNLRNFTLR 285
Query: 196 ELQQATENFSSKNILGAGGFGNVYKGKLGDGTVLAVKRLKD---------------MISL 240
ELQ AT+NFS+KNILG+GGFGNVYKGKLGDGT++AVKRLKD MISL
Sbjct: 286 ELQLATDNFSTKNILGSGGFGNVYKGKLGDGTMVAVKRLKDVTGTAGESQFRTELEMISL 345
Query: 241 AVHRNLLRLIGYCATPTERLLVYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYL 300
AVHRNLLRLIGYCATP ERLL+YPYMSNGSVASRLR KPALDWNTRKRIAIGAARGLLYL
Sbjct: 346 AVHRNLLRLIGYCATPNERLLIYPYMSNGSVASRLRGKPALDWNTRKRIAIGAARGLLYL 405
Query: 301 HEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGHIAPEYL 360
HEQCDPKIIHRDVKAANVLLDD+CEAIVGDFGLAKLLDHSDSHVTTAVRGTVGHIAPEYL
Sbjct: 406 HEQCDPKIIHRDVKAANVLLDDYCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGHIAPEYL 465
Query: 361 STGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRE 420
STGQSSEKTDVFGFGILLLELITGMRALEFGK++NQKGAMLEWVKKIQQEKKVEVLVDRE
Sbjct: 466 STGQSSEKTDVFGFGILLLELITGMRALEFGKTVNQKGAMLEWVKKIQQEKKVEVLVDRE 525
Query: 421 LGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLEGDGLAEKWAAAHNHTNPTMNN 480
LG NYDRI+VGE+LQVALLCTQYLP HRPKMSEVVRMLEGDGLAEKWAA+HNH N
Sbjct: 526 LGCNYDRIDVGEMLQVALLCTQYLPAHRPKMSEVVRMLEGDGLAEKWAASHNHNNNNPTP 585
Query: 481 FHT--NTKKSTSCPTSAPKHDHEEKNDQSSMFGTAVDEDDDDHSLDSYAMELSGPR 534
N+ KST PT+A KHD+ + +D SSMFGT +DE+DDDHSLD++AMELSGPR
Sbjct: 586 NIPHFNSHKSTWRPTTASKHDNID-HDGSSMFGTMMDEEDDDHSLDAHAMELSGPR 640
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449457957|ref|XP_004146714.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At2g23950-like [Cucumis sativus] gi|449524716|ref|XP_004169367.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At2g23950-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 807 bits (2084), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 427/595 (71%), Positives = 468/595 (78%), Gaps = 76/595 (12%)
Query: 1 MITCSPENLVIGLGAPSQSLSGTLSGSIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQT 60
MITCSPENLVIGLGAPSQSLSG+L+G+IGNLTNLRQVLLQNNNISG IP +LG+LP LQT
Sbjct: 60 MITCSPENLVIGLGAPSQSLSGSLAGAIGNLTNLRQVLLQNNNISGPIPIELGTLPLLQT 119
Query: 61 LDLSNNRLSGVIPALLFLSIWLPRKWDKRKCSGVDQGLLRLNNNSLSGAFPVFLAKISEL 120
LDLSNNR SG IP + +G+ LRLNNNSLSG FP+ LAKI +L
Sbjct: 120 LDLSNNRFSGPIPTSF------------AQLNGLRY--LRLNNNSLSGPFPLSLAKIPQL 165
Query: 121 AFLDLSYNNLSGPVPKFPARTFNVAGNPLICGSSSTNVCSGSANSVPLSFSLNSSPDK-- 178
AFLDLS+NNLSGPVP F ARTFNV GNP+ICGSS CSGSAN+VPLSFSL SSP +
Sbjct: 166 AFLDLSFNNLSGPVPVFSARTFNVVGNPMICGSSPNEGCSGSANAVPLSFSLESSPGRLR 225
Query: 179 -------------------------------------------QEEGLISLGNLRNFTFR 195
E GL+ LGNLRNFTF+
Sbjct: 226 SKRIAVALGVSLSCAFLILLALGILWRRRNQKTKTILDINVHNHEVGLVRLGNLRNFTFK 285
Query: 196 ELQQATENFSSKNILGAGGFGNVYKGKLGDGTVLAVKRLKD---------------MISL 240
ELQ AT++FSSKNILGAGGFGNVYKGKLGDGT++AVKRLKD MISL
Sbjct: 286 ELQLATDHFSSKNILGAGGFGNVYKGKLGDGTMVAVKRLKDVTGTTGESQFRTELEMISL 345
Query: 241 AVHRNLLRLIGYCATPTERLLVYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYL 300
AVHRNLLRLIGYCAT ERLLVYPYMSNGSVASRLR KPALDWNTRKRIAIGAARGLLYL
Sbjct: 346 AVHRNLLRLIGYCATSHERLLVYPYMSNGSVASRLRGKPALDWNTRKRIAIGAARGLLYL 405
Query: 301 HEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGHIAPEYL 360
HEQCDPKIIHRDVKAANVLLDD+CEA+VGDFGLAKLLDH+DSHVTTAVRGTVGHIAPEYL
Sbjct: 406 HEQCDPKIIHRDVKAANVLLDDYCEAVVGDFGLAKLLDHADSHVTTAVRGTVGHIAPEYL 465
Query: 361 STGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRE 420
STGQSSEKTDVFGFGILL+ELITGMRALEFGK+INQKGAMLEWVKKIQQEKKVE+LVDRE
Sbjct: 466 STGQSSEKTDVFGFGILLIELITGMRALEFGKTINQKGAMLEWVKKIQQEKKVELLVDRE 525
Query: 421 LGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLEGDGLAEKWAAAHNHTNPTMNN 480
LG+NYD+IEVGE+LQVALLCTQYLP HRPKMSEVVRMLEGDGL EKWAAAH H + +N
Sbjct: 526 LGNNYDQIEVGEMLQVALLCTQYLPAHRPKMSEVVRMLEGDGLVEKWAAAHTHNDLHVNL 585
Query: 481 FHT-NTKKSTSCPTSAPKHDHEEKNDQSSMFGTAVDEDDDDHSLDSYAMELSGPR 534
FH+ N+ KST PT+ K++ E+ + SSM +D+DDD+ SLDSYAMELSGPR
Sbjct: 586 FHSRNSCKSTYNPTNVLKNNGNER-EHSSMLSLTMDDDDDERSLDSYAMELSGPR 639
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224143880|ref|XP_002325107.1| serine/threonine protein kinase [Populus trichocarpa] gi|222866541|gb|EEF03672.1| serine/threonine protein kinase [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 802 bits (2072), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 431/595 (72%), Positives = 463/595 (77%), Gaps = 79/595 (13%)
Query: 1 MITCSPENLVIGLGAPSQSLSGTLSGSIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQT 60
MITCSPENLVIG GAPSQSLSG+LSG+IGNLTNLRQVLLQNNNISG IPP+LG+L KLQT
Sbjct: 61 MITCSPENLVIGFGAPSQSLSGSLSGTIGNLTNLRQVLLQNNNISGQIPPELGTLSKLQT 120
Query: 61 LDLSNNRLSGVIPALLFLSIWLPRKWDKRKCSGVDQGL--LRLNNNSLSGAFPVFLAKIS 118
LDLSNNR SGV+P L G L LRLNNNSL G FPV LAKI
Sbjct: 121 LDLSNNRFSGVVPESL----------------GQLNSLQYLRLNNNSLFGPFPVSLAKIP 164
Query: 119 ELAFLDLSYNNLSGPVPKFPARTFNVAGNPLICGSSSTNVCSGSANSV------------ 166
+LAFLDLSYNNLSG VPK PARTFNVAGNPLICGS ST CSGSAN+
Sbjct: 165 QLAFLDLSYNNLSGHVPKSPARTFNVAGNPLICGSGSTEGCSGSANAGPLSFSLSSSPGK 224
Query: 167 ----PLSFSLNSS----------------------------PDKQEEGLISLGNLRNFTF 194
L+ +L S D QEE ISLGNLRNFTF
Sbjct: 225 HKPKKLAIALGVSLSLVSLFLLALGILWLRGKQKGQMILNISDNQEEERISLGNLRNFTF 284
Query: 195 RELQQATENFSSKNILGAGGFGNVYKGKLGDGTVLAVKRLKD---------------MIS 239
RELQ AT+NF SKNILGAGGFGNVYKGKLGDGT++AVKRLKD MIS
Sbjct: 285 RELQIATDNFCSKNILGAGGFGNVYKGKLGDGTMMAVKRLKDLTGTAGESQFRTELEMIS 344
Query: 240 LAVHRNLLRLIGYCATPTERLLVYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLY 299
LAVHRNLLRLIGYCA+ ERLLVYPYMSNGSVASRLR KPALDWNTRKRIAIG ARGLLY
Sbjct: 345 LAVHRNLLRLIGYCASHNERLLVYPYMSNGSVASRLRVKPALDWNTRKRIAIGTARGLLY 404
Query: 300 LHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGHIAPEY 359
LHEQC+PKIIHRDVKAANVLLD+FCEA+VGDFGLAKLLDH+DSHVTTAVRGTVGHIAPEY
Sbjct: 405 LHEQCNPKIIHRDVKAANVLLDEFCEAVVGDFGLAKLLDHADSHVTTAVRGTVGHIAPEY 464
Query: 360 LSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDR 419
LSTGQSSEKTDVFGFGILL+ELITGMRALEFGK++NQKGAMLEWVKK+QQEKK+E LVD+
Sbjct: 465 LSTGQSSEKTDVFGFGILLIELITGMRALEFGKTVNQKGAMLEWVKKVQQEKKMEELVDK 524
Query: 420 ELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLEGDGLAEKWAAAHNHTNPTMN 479
ELGSN+ RIEVGE+LQVALLCTQ+LP HRPKMSEVVRMLEGDGLAEKWAAAH+H NPTM+
Sbjct: 525 ELGSNFCRIEVGEMLQVALLCTQFLPAHRPKMSEVVRMLEGDGLAEKWAAAHSHCNPTMS 584
Query: 480 NFHTNTKKSTSCPTSAPKHDHEEKNDQSSMFGTAVDEDDDDHSLDSYAMELSGPR 534
H N ++ TSA KHD N SSMFGT +DEDDD+HSLDSYAMELSGPR
Sbjct: 585 LSHPNNNNKST--TSASKHDESGPNRSSSMFGTTMDEDDDEHSLDSYAMELSGPR 637
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356562533|ref|XP_003549524.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At2g23950-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 795 bits (2054), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 418/597 (70%), Positives = 466/597 (78%), Gaps = 79/597 (13%)
Query: 1 MITCSPENLVIGLGAPSQSLSGTLSGSIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQT 60
MITCS + LVIGLGAPSQSLSGTLS +I NLTNLRQVLLQNNNISG IPP+LG+LPKLQT
Sbjct: 62 MITCSSDYLVIGLGAPSQSLSGTLSPAIENLTNLRQVLLQNNNISGNIPPELGNLPKLQT 121
Query: 61 LDLSNNRLSGVIPALLFLSIWLPRKWDKRKCSGVDQGLLRLNNNSLSGAFPVFLAKISEL 120
LDLSNNR SG+IPA L L LRLNNN+LSG+FPV LAK +L
Sbjct: 122 LDLSNNRFSGLIPASLSQLNSLQ--------------YLRLNNNNLSGSFPVSLAKTPQL 167
Query: 121 AFLDLSYNNLSGPVPKFPARTFNVAGNPLICGSSSTNVCSGSANSVPLSFSLNSS----- 175
AFLDLSYNNLSGP+PKFPAR+FN+ GNPL+CGSS+T CSGSA +P+SFS SS
Sbjct: 168 AFLDLSYNNLSGPLPKFPARSFNIVGNPLVCGSSTTEGCSGSATLMPISFSQVSSEGKHK 227
Query: 176 ---------------------------------------PDKQEEGLISLGNLRNFTFRE 196
D +EEG++SLGNL+ FTFRE
Sbjct: 228 SKRLAIAFGVSLGCASLILLLFGLLWYRKKRQHGVILYISDYKEEGVLSLGNLKKFTFRE 287
Query: 197 LQQATENFSSKNILGAGGFGNVYKGKLGDGTVLAVKRLKD---------------MISLA 241
L AT+NFSSKNILGAGGFGNVY+GKLGDGT++AVKRLKD MISLA
Sbjct: 288 LLHATDNFSSKNILGAGGFGNVYRGKLGDGTMVAVKRLKDVNGSAGESQFQTELEMISLA 347
Query: 242 VHRNLLRLIGYCATPTERLLVYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLH 301
VHRNLLRLIGYCAT +E+LLVYPYMSNGSVASRLR KPALDWNTRKRIAIGAARGLLYLH
Sbjct: 348 VHRNLLRLIGYCATSSEKLLVYPYMSNGSVASRLRGKPALDWNTRKRIAIGAARGLLYLH 407
Query: 302 EQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGHIAPEYLS 361
EQCDPKIIHRDVKAANVLLDD+CEA+VGDFGLAKLLDH+DSHVTTAVRGTVGHIAPEYLS
Sbjct: 408 EQCDPKIIHRDVKAANVLLDDYCEAVVGDFGLAKLLDHADSHVTTAVRGTVGHIAPEYLS 467
Query: 362 TGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDREL 421
TGQSSEKTDVFGFGILLLELITGM ALEFGK++NQKGAMLEWV+KI EK+V VLVD+EL
Sbjct: 468 TGQSSEKTDVFGFGILLLELITGMTALEFGKTVNQKGAMLEWVRKILHEKRVAVLVDKEL 527
Query: 422 GSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLEGDGLAEKWAAAHNHTNPTMNNF 481
G NYDRIEVGE+LQVALLCTQYL HRPKMSEVVRMLEGDGLAEKWA++HN+ N MN+
Sbjct: 528 GDNYDRIEVGEMLQVALLCTQYLTAHRPKMSEVVRMLEGDGLAEKWASSHNYGNQDMNSS 587
Query: 482 HTNTKKSTSC----PTSAPKHDHEEKNDQSSMFGTAVDEDDDDHSLDSYAMELSGPR 534
H+++ + S PTSA KHD ++ ND+SSM G +D DDD+ SL+SYAMELSGPR
Sbjct: 588 HSHSNSNNSNTSSRPTSASKHD-DDVNDRSSMLGMTMD-DDDEQSLESYAMELSGPR 642
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357479941|ref|XP_003610256.1| Somatic embryogenesis receptor-like kinase [Medicago truncatula] gi|308154496|gb|ADO15295.1| somatic embryogenesis receptor kinase-like protein 1 [Medicago truncatula] gi|355511311|gb|AES92453.1| Somatic embryogenesis receptor-like kinase [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 763 bits (1969), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 408/595 (68%), Positives = 460/595 (77%), Gaps = 77/595 (12%)
Query: 1 MITCSPENLVIGLGAPSQSLSGTLSGSIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQT 60
MITCS ++ VIGLGAPSQSLSGTLS SI NLTNL+QVLLQNNNISG IPP+LG+LPKLQT
Sbjct: 62 MITCSSDSFVIGLGAPSQSLSGTLSSSIANLTNLKQVLLQNNNISGKIPPELGNLPKLQT 121
Query: 61 LDLSNNRLSGVIPALLFLSIWLPRKWDKRKCSGVDQGLLRLNNNSLSGAFPVFLAKISEL 120
LDLSNNR SG IP+ L + + + +RLNNNSLSG FPV L+ I++L
Sbjct: 122 LDLSNNRFSGFIPSSL------------NQLNSLQ--YMRLNNNSLSGPFPVSLSNITQL 167
Query: 121 AFLDLSYNNLSGPVPKFPARTFNVAGNPLICGSSSTNVCSGSANSVPLSFS--------- 171
AFLDLS+NNL+GP+PKFPAR+FN+ GNPLIC S+S CSGS +P+ FS
Sbjct: 168 AFLDLSFNNLTGPLPKFPARSFNIVGNPLICVSTSIEGCSGSVTLMPVPFSQAILQGKHK 227
Query: 172 -----------------------------------LNSSPDKQEEGLISLGNLRNFTFRE 196
+ D +EE ++SLGNL++F FRE
Sbjct: 228 SKKLAIALGVSFSCVSLIVLFLGLFWYRKKRQHGAILYIGDYKEEAVVSLGNLKHFGFRE 287
Query: 197 LQQATENFSSKNILGAGGFGNVYKGKLGDGTVLAVKRLKD---------------MISLA 241
LQ AT++FSSKNILGAGGFGNVY+GKLGDGT++AVKRLKD MISLA
Sbjct: 288 LQHATDSFSSKNILGAGGFGNVYRGKLGDGTLVAVKRLKDVNGSAGELQFQTELEMISLA 347
Query: 242 VHRNLLRLIGYCATPTERLLVYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLH 301
VHRNLLRLIGYCATP +++LVYPYMSNGSVASRLR KPALDWNTRKRIAIGAARGLLYLH
Sbjct: 348 VHRNLLRLIGYCATPNDKILVYPYMSNGSVASRLRGKPALDWNTRKRIAIGAARGLLYLH 407
Query: 302 EQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGHIAPEYLS 361
EQCDPKIIHRDVKAANVLLDD EAIVGDFGLAKLLDH+DSHVTTAVRGTVGHIAPEYLS
Sbjct: 408 EQCDPKIIHRDVKAANVLLDDDYEAIVGDFGLAKLLDHADSHVTTAVRGTVGHIAPEYLS 467
Query: 362 TGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDREL 421
TGQSSEKTDVFGFGILLLELITGM ALEFGK++NQKGAMLEWVKKIQQEKKVEVLVD+EL
Sbjct: 468 TGQSSEKTDVFGFGILLLELITGMTALEFGKTLNQKGAMLEWVKKIQQEKKVEVLVDKEL 527
Query: 422 GSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLEGDGLAEKWAAAHNHTNPTMNNF 481
GSNYDRIEVGE+LQVALLCTQY+ HRPKMSEVVRMLEGDGLAEKWA+ HN+ + ++
Sbjct: 528 GSNYDRIEVGEMLQVALLCTQYMTAHRPKMSEVVRMLEGDGLAEKWASTHNYGSNCWSHS 587
Query: 482 HTNTKKSTSC--PTSAPKHDHEEKNDQSSMFGTAVDEDDDDHSLDSYAMELSGPR 534
H+N S S PT+ KHD E +D+SSMFG + +DDDD SLDSYAMELSGPR
Sbjct: 588 HSNNSSSNSSSRPTTTSKHD-ENFHDRSSMFGMTM-DDDDDQSLDSYAMELSGPR 640
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|42569274|ref|NP_179973.2| putative LRR receptor-like serine/threonine-protein kinase [Arabidopsis thaliana] gi|122223928|sp|Q0WVM4.1|Y2239_ARATH RecName: Full=Probable LRR receptor-like serine/threonine-protein kinase At2g23950; Flags: Precursor gi|110741758|dbj|BAE98824.1| putative LRR receptor protein kinase [Arabidopsis thaliana] gi|224589519|gb|ACN59293.1| leucine-rich repeat receptor-like protein kinase [Arabidopsis thaliana] gi|330252413|gb|AEC07507.1| putative LRR receptor-like serine/threonine-protein kinase [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 761 bits (1965), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 397/593 (66%), Positives = 447/593 (75%), Gaps = 84/593 (14%)
Query: 1 MITCSPENLVIGLGAPSQSLSGTLSGSIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQT 60
MI+CS +NLVIGLGAPSQSLSGTLSGSIGNLTNLRQV LQNNNISG IPP++ SLPKLQT
Sbjct: 67 MISCSSDNLVIGLGAPSQSLSGTLSGSIGNLTNLRQVSLQNNNISGKIPPEICSLPKLQT 126
Query: 61 LDLSNNRLSGVIPALLFLSIWLPRKWDKRKCSGVDQGLLRLNNNSLSGAFPVFLAKISEL 120
LDLSNNR SG IP + + S + LRLNNNSLSG FP L++I L
Sbjct: 127 LDLSNNRFSGEIPGSV------------NQLSNLQ--YLRLNNNSLSGPFPASLSQIPHL 172
Query: 121 AFLDLSYNNLSGPVPKFPARTFNVAGNPLICGSSSTNVCSGSANSVPLSFSLNSSP---- 176
+FLDLSYNNL GPVPKFPARTFNVAGNPLIC +S +CSGS ++ PLS SL SS
Sbjct: 173 SFLDLSYNNLRGPVPKFPARTFNVAGNPLICKNSLPEICSGSISASPLSVSLRSSSGRRT 232
Query: 177 ---------------------------------------DKQEEGLISLGNLRNFTFREL 197
DKQEEGL+ LGNLR+FTFREL
Sbjct: 233 NILAVALGVSLGFAVSVILSLGFIWYRKKQRRLTMLRISDKQEEGLLGLGNLRSFTFREL 292
Query: 198 QQATENFSSKNILGAGGFGNVYKGKLGDGTVLAVKRLKD---------------MISLAV 242
AT+ FSSK+ILGAGGFGNVY+GK GDGTV+AVKRLKD MISLAV
Sbjct: 293 HVATDGFSSKSILGAGGFGNVYRGKFGDGTVVAVKRLKDVNGTSGNSQFRTELEMISLAV 352
Query: 243 HRNLLRLIGYCATPTERLLVYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHE 302
HRNLLRLIGYCA+ +ERLLVYPYMSNGSVASRL+ KPALDWNTRK+IAIGAARGL YLHE
Sbjct: 353 HRNLLRLIGYCASSSERLLVYPYMSNGSVASRLKAKPALDWNTRKKIAIGAARGLFYLHE 412
Query: 303 QCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGHIAPEYLST 362
QCDPKIIHRDVKAAN+LLD++ EA+VGDFGLAKLL+H DSHVTTAVRGTVGHIAPEYLST
Sbjct: 413 QCDPKIIHRDVKAANILLDEYFEAVVGDFGLAKLLNHEDSHVTTAVRGTVGHIAPEYLST 472
Query: 363 GQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELG 422
GQSSEKTDVFGFGILLLELITGMRALEFGKS++QKGAMLEWV+K+ +E KVE LVDRELG
Sbjct: 473 GQSSEKTDVFGFGILLLELITGMRALEFGKSVSQKGAMLEWVRKLHKEMKVEELVDRELG 532
Query: 423 SNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLEGDGLAEKWAAAHNHTNPTMNNFH 482
+ YDRIEVGE+LQVALLCTQ+LP HRPKMSEVV+MLEGDGLAE+WAA+H+H+ + +H
Sbjct: 533 TTYDRIEVGEMLQVALLCTQFLPAHRPKMSEVVQMLEGDGLAERWAASHDHS----HFYH 588
Query: 483 TNTKKSTSCPTSAPKHDHEEKNDQSSMFGTAVDEDDDD-HSLDSYAMELSGPR 534
N T T N +FG++ ED+DD +LDS+AMELSGPR
Sbjct: 589 ANMSYRTITSTDG-------NNQTKHLFGSSGFEDEDDNQALDSFAMELSGPR 634
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297825303|ref|XP_002880534.1| leucine-rich repeat family protein [Arabidopsis lyrata subsp. lyrata] gi|297326373|gb|EFH56793.1| leucine-rich repeat family protein [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 759 bits (1961), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 395/593 (66%), Positives = 450/593 (75%), Gaps = 82/593 (13%)
Query: 1 MITCSPENLVIGLGAPSQSLSGTLSGSIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQT 60
MITCSP+NLV GLGAPSQSLSGTLSGSIGNLTNL+QVLLQNNNISG IPP+L SLPKLQT
Sbjct: 72 MITCSPDNLVTGLGAPSQSLSGTLSGSIGNLTNLQQVLLQNNNISGKIPPELCSLPKLQT 131
Query: 61 LDLSNNRLSGVIPALLFLSIWLPRKWDKRKCSGVDQGLLRLNNNSLSGAFPVFLAKISEL 120
LDLSNNR SG IP + + S ++ LRLNNNSLSG FP L++I L
Sbjct: 132 LDLSNNRFSGEIPGSV------------NQLSNLE--YLRLNNNSLSGPFPASLSQIPHL 177
Query: 121 AFLDLSYNNLSGPVPKFPARTFNVAGNPLICGSSSTNVCSGSANSVPLSFSLNSSP---- 176
+FLDLSYNNL GPV KFPARTFNVAGNPLIC +S +CSGS N+ PLS SL SS
Sbjct: 178 SFLDLSYNNLRGPVSKFPARTFNVAGNPLICKNSPPEICSGSINASPLSVSLRSSSGRRT 237
Query: 177 ---------------------------------------DKQEEGLISLGNLRNFTFREL 197
DKQEEGL+ LGNLR+FTFREL
Sbjct: 238 NILAVALGVSLGFAVSVILSLGLIWYRRKQRRLTMLRISDKQEEGLLGLGNLRSFTFREL 297
Query: 198 QQATENFSSKNILGAGGFGNVYKGKLGDGTVLAVKRLKD---------------MISLAV 242
AT+ FS K+ILGAGGFGNVY+GKL DGT++AVKRLKD MISLAV
Sbjct: 298 HVATDGFSYKSILGAGGFGNVYRGKLVDGTMVAVKRLKDVNGTSGNSQFRTELEMISLAV 357
Query: 243 HRNLLRLIGYCATPTERLLVYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHE 302
HRNLLRLIGYCA+ +ERLLVYPYMSNGSVASRL+ KPALDWNTRK+IAIGAARGL YLHE
Sbjct: 358 HRNLLRLIGYCASSSERLLVYPYMSNGSVASRLKAKPALDWNTRKKIAIGAARGLFYLHE 417
Query: 303 QCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGHIAPEYLST 362
QCDPKIIHRDVKAAN+LLD++ EA+VGDFGLAKLL+H DSHVTTAVRGTVGHIAPEYLST
Sbjct: 418 QCDPKIIHRDVKAANILLDEYFEAVVGDFGLAKLLNHEDSHVTTAVRGTVGHIAPEYLST 477
Query: 363 GQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELG 422
GQSSEKTDVFGFGILLLELITGMRALEFGKS++QKGAMLEWV+K+ +E KVE LVDRELG
Sbjct: 478 GQSSEKTDVFGFGILLLELITGMRALEFGKSVSQKGAMLEWVRKLHKEMKVEELVDRELG 537
Query: 423 SNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLEGDGLAEKWAAAHNHTNPTMNNFH 482
+ YDRIEVGE+LQVALLCTQ+LP HRPKMSEVV+MLEGDGLAE+WAA+H+H+ + +H
Sbjct: 538 TTYDRIEVGEMLQVALLCTQFLPAHRPKMSEVVQMLEGDGLAERWAASHDHS----HFYH 593
Query: 483 TNTKKSTSCPTSAPKHDHEEKNDQSSMFGTA-VDEDDDDHSLDSYAMELSGPR 534
N T T D N +FG++ ++++D++ +LDS+AMELSGPR
Sbjct: 594 ANMSYRTITST-----DANGNNQTKHLFGSSGLEDEDENQALDSFAMELSGPR 641
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 534 | ||||||
| TAIR|locus:2118811 | 648 | SARK "SENESCENCE-ASSOCIATED RE | 0.668 | 0.550 | 0.716 | 6.5e-188 | |
| TAIR|locus:2061466 | 634 | AT2G23950 [Arabidopsis thalian | 0.649 | 0.547 | 0.708 | 2.9e-185 | |
| TAIR|locus:2146102 | 638 | NIK1 "NSP-interacting kinase 1 | 0.574 | 0.481 | 0.706 | 3.3e-159 | |
| TAIR|locus:2036636 | 632 | NIK3 "NSP-interacting kinase 3 | 0.447 | 0.378 | 0.703 | 1.5e-122 | |
| TAIR|locus:2040461 | 620 | SERK4 "somatic embryogenesis r | 0.434 | 0.374 | 0.654 | 2.5e-121 | |
| TAIR|locus:2171973 | 614 | AT5G45780 [Arabidopsis thalian | 0.473 | 0.412 | 0.594 | 2.7e-107 | |
| TAIR|locus:2040471 | 601 | SERK5 "somatic embryogenesis r | 0.434 | 0.386 | 0.649 | 3.2e-104 | |
| TAIR|locus:2013021 | 625 | SERK1 "somatic embryogenesis r | 0.434 | 0.371 | 0.679 | 4.4e-103 | |
| TAIR|locus:2026097 | 628 | SERK2 "somatic embryogenesis r | 0.434 | 0.369 | 0.666 | 7.1e-101 | |
| TAIR|locus:2145407 | 613 | AT5G10290 [Arabidopsis thalian | 0.455 | 0.396 | 0.612 | 1.5e-89 |
| TAIR|locus:2118811 SARK "SENESCENCE-ASSOCIATED RECEPTOR-LIKE KINASE" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1313 (467.3 bits), Expect = 6.5e-188, Sum P(2) = 6.5e-188
Identities = 268/374 (71%), Positives = 297/374 (79%)
Query: 177 DKQEEGLISLGNLRNFTFRELQQATENFSSKNILGAGGFGNVYKGKLGDGTVLAVKRLKD 236
DKQEEGL LGNLR+FTFREL T+ FSSKNILGAGGFGNVY+GKLGDGT++AVKRLKD
Sbjct: 276 DKQEEGLQGLGNLRSFTFRELHVYTDGFSSKNILGAGGFGNVYRGKLGDGTMVAVKRLKD 335
Query: 237 ---------------MISLAVHRNLLRLIGYCATPTERLLVYPYMSNGSVASRLREKPAL 281
MISLAVH+NLLRLIGYCAT ERLLVYPYM NGSVAS+L+ KPAL
Sbjct: 336 INGTSGDSQFRMELEMISLAVHKNLLRLIGYCATSGERLLVYPYMPNGSVASKLKSKPAL 395
Query: 282 DWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSD 341
DWN RKRIAIGAARGLLYLHEQCDPKIIHRDVKAAN+LLD+ EA+VGDFGLAKLL+H+D
Sbjct: 396 DWNMRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANILLDECFEAVVGDFGLAKLLNHAD 455
Query: 342 SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAML 401
SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITG+RALEFGK+++QKGAML
Sbjct: 456 SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGLRALEFGKTVSQKGAML 515
Query: 402 EWXXXXXXXXXXXXXXDRELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLEGD 461
EW DRELG+NYD+IEVGE+LQVALLCTQYLP HRPKMSEVV MLEGD
Sbjct: 516 EWVRKLHEEMKVEELLDRELGTNYDKIEVGEMLQVALLCTQYLPAHRPKMSEVVLMLEGD 575
Query: 462 GLAEKWAAAHNHTNPTMNNFHTNTKKSTSCPTSAPKHDHEEKNDQSSMFGTAVXXXXXXH 521
GLAE+WAA+HNH++ N T S S TS + D + MFG++ H
Sbjct: 576 GLAERWAASHNHSHFYHANISFKTISSLST-TSVSRLDAHCNDPTYQMFGSSAFDDDDDH 634
Query: 522 S-LDSYAMELSGPR 534
LDS+AMELSGPR
Sbjct: 635 QPLDSFAMELSGPR 648
|
|
| TAIR|locus:2061466 AT2G23950 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1304 (464.1 bits), Expect = 2.9e-185, Sum P(2) = 2.9e-185
Identities = 265/374 (70%), Positives = 297/374 (79%)
Query: 177 DKQEEGLISLGNLRNFTFRELQQATENFSSKNILGAGGFGNVYKGKLGDGTVLAVKRLKD 236
DKQEEGL+ LGNLR+FTFREL AT+ FSSK+ILGAGGFGNVY+GK GDGTV+AVKRLKD
Sbjct: 272 DKQEEGLLGLGNLRSFTFRELHVATDGFSSKSILGAGGFGNVYRGKFGDGTVVAVKRLKD 331
Query: 237 ---------------MISLAVHRNLLRLIGYCATPTERLLVYPYMSNGSVASRLREKPAL 281
MISLAVHRNLLRLIGYCA+ +ERLLVYPYMSNGSVASRL+ KPAL
Sbjct: 332 VNGTSGNSQFRTELEMISLAVHRNLLRLIGYCASSSERLLVYPYMSNGSVASRLKAKPAL 391
Query: 282 DWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSD 341
DWNTRK+IAIGAARGL YLHEQCDPKIIHRDVKAAN+LLD++ EA+VGDFGLAKLL+H D
Sbjct: 392 DWNTRKKIAIGAARGLFYLHEQCDPKIIHRDVKAANILLDEYFEAVVGDFGLAKLLNHED 451
Query: 342 SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAML 401
SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKS++QKGAML
Sbjct: 452 SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSVSQKGAML 511
Query: 402 EWXXXXXXXXXXXXXXDRELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLEGD 461
EW DRELG+ YDRIEVGE+LQVALLCTQ+LP HRPKMSEVV+MLEGD
Sbjct: 512 EWVRKLHKEMKVEELVDRELGTTYDRIEVGEMLQVALLCTQFLPAHRPKMSEVVQMLEGD 571
Query: 462 GLAEKWAAAHNHTNPTMNNFHTNTKKSTSCPTSAPKHDHEEKNDQSSMFGTA-VXXXXXX 520
GLAE+WAA+H+H++ +H N T T N +FG++
Sbjct: 572 GLAERWAASHDHSH----FYHANMSYRTITSTDG-------NNQTKHLFGSSGFEDEDDN 620
Query: 521 HSLDSYAMELSGPR 534
+LDS+AMELSGPR
Sbjct: 621 QALDSFAMELSGPR 634
|
|
| TAIR|locus:2146102 NIK1 "NSP-interacting kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1140 (406.4 bits), Expect = 3.3e-159, Sum P(3) = 3.3e-159
Identities = 229/324 (70%), Positives = 256/324 (79%)
Query: 184 ISLGNLRNFTFRELQQATENFSSKNILGAGGFGNVYKGKLGDGTVLAVKRLKD------- 236
+SLGNLR F FRELQ AT NFSSKN+LG GG+GNVYKG LGD TV+AVKRLKD
Sbjct: 292 VSLGNLRRFGFRELQIATNNFSSKNLLGKGGYGNVYKGILGDSTVVAVKRLKDGGALGGE 351
Query: 237 --------MISLAVHRNLLRLIGYCATPTERLLVYPYMSNGSVASRLREKPALDWNTRKR 288
MISLAVHRNLLRL G+C T TE+LLVYPYMSNGSVASR++ KP LDW+ RKR
Sbjct: 352 IQFQTEVEMISLAVHRNLLRLYGFCITQTEKLLVYPYMSNGSVASRMKAKPVLDWSIRKR 411
Query: 289 IAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAV 348
IAIGAARGL+YLHEQCDPKIIHRDVKAAN+LLDD+CEA+VGDFGLAKLLDH DSHVTTAV
Sbjct: 412 IAIGAARGLVYLHEQCDPKIIHRDVKAANILLDDYCEAVVGDFGLAKLLDHQDSHVTTAV 471
Query: 349 RGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWXXXXX 408
RGTVGHIAPEYLSTGQSSEKTDVFGFGILLLEL+TG RA EFGK+ NQKG ML+W
Sbjct: 472 RGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELVTGQRAFEFGKAANQKGVMLDWVKKIH 531
Query: 409 XXXXXXXXXDREL--GSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLEGDGLAEK 466
D+EL +YD IE+ E+++VALLCTQYLP HRPKMSEVVRMLEGDGLAEK
Sbjct: 532 QEKKLELLVDKELLKKKSYDEIELDEMVRVALLCTQYLPGHRPKMSEVVRMLEGDGLAEK 591
Query: 467 WAAAHNHTNPTMNNFHTNTKKSTS 490
W A+ + + + N S+S
Sbjct: 592 WEASQRSDSVSKCSNRINELMSSS 615
|
|
| TAIR|locus:2036636 NIK3 "NSP-interacting kinase 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 897 (320.8 bits), Expect = 1.5e-122, Sum P(3) = 1.5e-122
Identities = 171/243 (70%), Positives = 202/243 (83%)
Query: 236 DMISLAVHRNLLRLIGYCATPTERLLVYPYMSNGSVASRLRE----KPALDWNTRKRIAI 291
+ ISLA+HRNLLRL G+C++ ER+LVYPYM NGSVASRL++ +PALDW+ RK+IA+
Sbjct: 348 ETISLALHRNLLRLRGFCSSNQERILVYPYMPNGSVASRLKDNIRGEPALDWSRRKKIAV 407
Query: 292 GAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGT 351
G ARGL+YLHEQCDPKIIHRDVKAAN+LLD+ EA+VGDFGLAKLLDH DSHVTTAVRGT
Sbjct: 408 GTARGLVYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGT 467
Query: 352 VGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWXXXXXXXX 411
VGHIAPEYLSTGQSSEKTDVFGFGILLLELITG +AL+FG+S +QKG ML+W
Sbjct: 468 VGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQKALDFGRSAHQKGVMLDWVKKLHQEG 527
Query: 412 XXXXXXDRELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLEGDGLAEKWAAAH 471
D++L +DR+E+ EI+QVALLCTQ+ P HRPKMSEV++MLEGDGLAE+W A
Sbjct: 528 KLKQLIDKDLNDKFDRVELEEIVQVALLCTQFNPSHRPKMSEVMKMLEGDGLAERWEATQ 587
Query: 472 NHT 474
N T
Sbjct: 588 NGT 590
|
|
| TAIR|locus:2040461 SERK4 "somatic embryogenesis receptor-like kinase 4" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 792 (283.9 bits), Expect = 2.5e-121, Sum P(2) = 2.5e-121
Identities = 155/237 (65%), Positives = 185/237 (78%)
Query: 236 DMISLAVHRNLLRLIGYCATPTERLLVYPYMSNGSVASRLREKP----ALDWNTRKRIAI 291
+MIS+AVHRNLLRL G+C TPTERLLVYPYM+NGSVAS LRE+P ALDW RK IA+
Sbjct: 341 EMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPEGNPALDWPKRKHIAL 400
Query: 292 GAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGT 351
G+ARGL YLH+ CD KIIHRDVKAAN+LLD+ EA+VGDFGLAKL++++DSHVTTAVRGT
Sbjct: 401 GSARGLAYLHDHCDQKIIHRDVKAANILLDEEFEAVVGDFGLAKLMNYNDSHVTTAVRGT 460
Query: 352 VGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAML-EWXXXXXXX 410
+GHIAPEYLSTG+SSEKTDVFG+G++LLELITG +A + + N ML +W
Sbjct: 461 IGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQKAFDLARLANDDDIMLLDWVKEVLKE 520
Query: 411 XXXXXXXDRELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLEGDGLAEKW 467
D EL Y EV +++Q+ALLCTQ + RPKMSEVVRMLEGDGLAE+W
Sbjct: 521 KKLESLVDAELEGKYVETEVEQLIQMALLCTQSSAMERPKMSEVVRMLEGDGLAERW 577
|
|
| TAIR|locus:2171973 AT5G45780 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 774 (277.5 bits), Expect = 2.7e-107, Sum P(2) = 2.7e-107
Identities = 154/259 (59%), Positives = 192/259 (74%)
Query: 236 DMISLAVHRNLLRLIGYCATPTERLLVYPYMSNGSVASRLR----EKPALDWNTRKRIAI 291
+MI LAVHRNLLRL G+C TP ER+LVYPYM NGSVA RLR EKP+LDWN R IA+
Sbjct: 346 EMIGLAVHRNLLRLFGFCMTPEERMLVYPYMPNGSVADRLRDNYGEKPSLDWNRRISIAL 405
Query: 292 GAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGT 351
GAARGL+YLHEQC+PKIIHRDVKAAN+LLD+ EAIVGDFGLAKLLD DSHVTTAVRGT
Sbjct: 406 GAARGLVYLHEQCNPKIIHRDVKAANILLDESFEAIVGDFGLAKLLDQRDSHVTTAVRGT 465
Query: 352 VGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWXXXXXXXX 411
+GHIAPEYLSTGQSSEKTDVFGFG+L+LELITG + ++ G +KG +L W
Sbjct: 466 IGHIAPEYLSTGQSSEKTDVFGFGVLILELITGHKMIDQGNGQVRKGMILSWVRTLKAEK 525
Query: 412 XXXXXXDRELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLEGDGLAEKWAAAH 471
DR+L +D + + E++++ALLCTQ P RP+MS+V+++LEG L E+ +
Sbjct: 526 RFAEMVDRDLKGEFDDLVLEEVVELALLCTQPHPNLRPRMSQVLKVLEG--LVEQCEGGY 583
Query: 472 NHTNPTMNNFHTNTKKSTS 490
P+++ ++N + S
Sbjct: 584 EARAPSVSRNYSNGHEEQS 602
|
|
| TAIR|locus:2040471 SERK5 "somatic embryogenesis receptor-like kinase 5" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 785 (281.4 bits), Expect = 3.2e-104, Sum P(2) = 3.2e-104
Identities = 154/237 (64%), Positives = 184/237 (77%)
Query: 236 DMISLAVHRNLLRLIGYCATPTERLLVYPYMSNGSVASRLREKP----ALDWNTRKRIAI 291
+MIS+AVHRNLLRL G+C TPTERLLVYPYM+NGSVAS LRE+P ALDW RK IA+
Sbjct: 322 EMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPEGNPALDWPKRKHIAL 381
Query: 292 GAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGT 351
G+ARGL YLH+ CD KIIH DVKAAN+LLD+ EA+VGDFGLAKL++++DSHVTTAVRGT
Sbjct: 382 GSARGLAYLHDHCDQKIIHLDVKAANILLDEEFEAVVGDFGLAKLMNYNDSHVTTAVRGT 441
Query: 352 VGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAML-EWXXXXXXX 410
+GHIAPEYLSTG+SSEKTDVFG+G++LLELITG +A + + N ML +W
Sbjct: 442 IGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQKAFDLARLANDDDIMLLDWVKEVLKE 501
Query: 411 XXXXXXXDRELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLEGDGLAEKW 467
D EL Y EV +++Q+ALLCTQ + RPKMSEVVRMLEGDGLAE+W
Sbjct: 502 KKLESLVDAELEGKYVETEVEQLIQMALLCTQSSAMERPKMSEVVRMLEGDGLAERW 558
|
|
| TAIR|locus:2013021 SERK1 "somatic embryogenesis receptor-like kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 827 (296.2 bits), Expect = 4.4e-103, Sum P(3) = 4.4e-103
Identities = 161/237 (67%), Positives = 190/237 (80%)
Query: 236 DMISLAVHRNLLRLIGYCATPTERLLVYPYMSNGSVASRLREKPA----LDWNTRKRIAI 291
+MIS+AVHRNLLRL G+C TPTERLLVYPYM+NGSVAS LRE+P LDW TRKRIA+
Sbjct: 349 EMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQPPLDWPTRKRIAL 408
Query: 292 GAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGT 351
G+ARGL YLH+ CDPKIIHRDVKAAN+LLD+ EA+VGDFGLAKL+D+ D+HVTTAVRGT
Sbjct: 409 GSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGT 468
Query: 352 VGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAML-EWXXXXXXX 410
+GHIAPEYLSTG+SSEKTDVFG+GI+LLELITG RA + + N ML +W
Sbjct: 469 IGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKE 528
Query: 411 XXXXXXXDRELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLEGDGLAEKW 467
D +L +NY+ E+ +++QVALLCTQ P+ RPKMSEVVRMLEGDGLAEKW
Sbjct: 529 KKLEMLVDPDLQTNYEERELEQVIQVALLCTQGSPMERPKMSEVVRMLEGDGLAEKW 585
|
|
| TAIR|locus:2026097 SERK2 "somatic embryogenesis receptor-like kinase 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 810 (290.2 bits), Expect = 7.1e-101, Sum P(3) = 7.1e-101
Identities = 158/237 (66%), Positives = 188/237 (79%)
Query: 236 DMISLAVHRNLLRLIGYCATPTERLLVYPYMSNGSVASRLREKPA----LDWNTRKRIAI 291
+MIS+AVHRNLLRL G+C TPTERLLVYPYM+NGSVAS LRE+P L W+ R++IA+
Sbjct: 352 EMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLAWSIRQQIAL 411
Query: 292 GAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGT 351
G+ARGL YLH+ CDPKIIHRDVKAAN+LLD+ EA+VGDFGLA+L+D+ D+HVTTAVRGT
Sbjct: 412 GSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLARLMDYKDTHVTTAVRGT 471
Query: 352 VGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAML-EWXXXXXXX 410
+GHIAPEYLSTG+SSEKTDVFG+GI+LLELITG RA + + N ML +W
Sbjct: 472 IGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKE 531
Query: 411 XXXXXXXDRELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLEGDGLAEKW 467
D +L SNY EV +++QVALLCTQ P+ RPKMSEVVRMLEGDGLAEKW
Sbjct: 532 KKLEMLVDPDLQSNYTEAEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGLAEKW 588
|
|
| TAIR|locus:2145407 AT5G10290 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 739 (265.2 bits), Expect = 1.5e-89, Sum P(2) = 1.5e-89
Identities = 152/248 (61%), Positives = 183/248 (73%)
Query: 230 AVKRLKDMISLAVHRNLLRLIGYCATPTERLLVYPYMSNGSVASRLRE----KPALDWNT 285
A +R +MIS+AVHRNLLRLIG+C T TERLLVYP+M N S+A RLRE P LDW T
Sbjct: 331 AFQREVEMISVAVHRNLLRLIGFCTTQTERLLVYPFMQNLSLAHRLREIKAGDPVLDWET 390
Query: 286 RKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVT 345
RKRIA+GAARG YLHE C+PKIIHRDVKAANVLLD+ EA+VGDFGLAKL+D ++VT
Sbjct: 391 RKRIALGAARGFEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRRTNVT 450
Query: 346 TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAML-EWX 404
T VRGT+GHIAPEYLSTG+SSE+TDVFG+GI+LLEL+TG RA++F + + +L +
Sbjct: 451 TQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHV 510
Query: 405 XXXXXXXXXXXXXDRELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLEGDGLA 464
D+ L Y + EV ++QVALLCTQ P RP MSEVVRMLEG+GLA
Sbjct: 511 KKLEREKRLGAIVDKNLDGEYIKEEVEMMIQVALLCTQGSPEDRPVMSEVVRMLEGEGLA 570
Query: 465 EKWAAAHN 472
E+W N
Sbjct: 571 ERWEEWQN 578
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q0WVM4 | Y2239_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.6694 | 0.9531 | 0.8028 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | 0.921 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 534 | |||
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 8e-43 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 9e-42 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 2e-41 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 3e-41 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 4e-39 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 2e-38 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 4e-37 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 5e-37 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 3e-29 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 1e-27 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 1e-25 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 5e-24 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 3e-23 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 8e-23 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 1e-22 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 3e-22 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 9e-22 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 6e-21 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 7e-21 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 1e-20 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 2e-20 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 2e-20 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 2e-20 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 2e-20 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 2e-20 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 4e-20 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 5e-20 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 6e-20 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 2e-19 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 3e-19 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 8e-19 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 2e-18 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 4e-18 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 5e-18 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 9e-18 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 1e-17 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 1e-17 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 1e-17 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 2e-17 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 2e-17 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 2e-17 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 3e-17 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 4e-17 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 5e-17 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 7e-17 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 7e-17 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 9e-17 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 6e-16 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 6e-16 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 8e-16 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 8e-16 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 9e-16 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-15 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 1e-15 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 1e-15 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 2e-15 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 4e-15 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 5e-15 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 5e-15 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 7e-15 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 8e-15 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 9e-15 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 1e-14 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 1e-14 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 1e-14 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 2e-14 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 2e-14 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 2e-14 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 2e-14 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 2e-14 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 3e-14 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 3e-14 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 3e-14 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 4e-14 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 6e-14 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 6e-14 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 9e-14 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 9e-14 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 9e-14 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 1e-13 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 1e-13 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-13 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 2e-13 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 2e-13 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 2e-13 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 3e-13 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 3e-13 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 4e-13 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 4e-13 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 8e-13 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 9e-13 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 9e-13 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 1e-12 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 1e-12 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 1e-12 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 2e-12 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 2e-12 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 2e-12 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 2e-12 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 3e-12 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 3e-12 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 3e-12 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 4e-12 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 4e-12 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 4e-12 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 4e-12 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 4e-12 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 4e-12 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 5e-12 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 5e-12 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 5e-12 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 6e-12 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 7e-12 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 8e-12 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 9e-12 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 1e-11 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 1e-11 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 1e-11 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 1e-11 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 1e-11 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 2e-11 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 2e-11 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 3e-11 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 3e-11 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 4e-11 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 4e-11 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 4e-11 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 4e-11 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 4e-11 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 5e-11 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 6e-11 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 6e-11 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 6e-11 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 6e-11 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 7e-11 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 8e-11 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 9e-11 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 9e-11 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 1e-10 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 1e-10 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 1e-10 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 2e-10 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 2e-10 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 2e-10 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 2e-10 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 2e-10 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 2e-10 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 2e-10 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 2e-10 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-10 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 3e-10 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 3e-10 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 4e-10 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 4e-10 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 4e-10 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 4e-10 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 4e-10 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 4e-10 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 5e-10 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 6e-10 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 7e-10 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 8e-10 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 8e-10 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 9e-10 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 9e-10 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 1e-09 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 1e-09 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 1e-09 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 1e-09 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 1e-09 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 1e-09 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 1e-09 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 2e-09 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 2e-09 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 2e-09 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 2e-09 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-09 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 3e-09 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 3e-09 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 3e-09 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 3e-09 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 4e-09 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 4e-09 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 4e-09 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 4e-09 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 4e-09 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 4e-09 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 4e-09 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 6e-09 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 7e-09 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 9e-09 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 1e-08 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 1e-08 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 1e-08 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 1e-08 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 1e-08 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 1e-08 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 1e-08 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 2e-08 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 2e-08 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 2e-08 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 2e-08 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-08 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 3e-08 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 3e-08 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 3e-08 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 3e-08 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 3e-08 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 4e-08 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 4e-08 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 5e-08 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 5e-08 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 5e-08 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 7e-08 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 7e-08 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 7e-08 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 8e-08 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 9e-08 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 2e-07 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 2e-07 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 2e-07 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 3e-07 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 3e-07 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 3e-07 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 3e-07 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 3e-07 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 5e-07 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 5e-07 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 5e-07 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 6e-07 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 6e-07 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 6e-07 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 6e-07 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 6e-07 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 7e-07 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 8e-07 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 8e-07 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 9e-07 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 1e-06 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 1e-06 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 1e-06 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 1e-06 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 1e-06 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 2e-06 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 2e-06 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 2e-06 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 2e-06 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 2e-06 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 2e-06 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 3e-06 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 4e-06 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 4e-06 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 4e-06 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 4e-06 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 6e-06 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 6e-06 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 1e-05 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 1e-05 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 2e-05 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 2e-05 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 2e-05 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 2e-05 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 2e-05 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 3e-05 | |
| pfam12799 | 43 | pfam12799, LRR_4, Leucine Rich repeats (2 copies) | 3e-05 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 3e-05 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 3e-05 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 3e-05 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 4e-05 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 4e-05 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 5e-05 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 5e-05 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 5e-05 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 5e-05 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 5e-05 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 6e-05 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 6e-05 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 6e-05 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 7e-05 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 7e-05 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 7e-05 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 9e-05 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 1e-04 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 2e-04 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 2e-04 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 2e-04 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 3e-04 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 4e-04 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 4e-04 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 6e-04 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 7e-04 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 8e-04 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 8e-04 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 0.001 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 0.001 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 0.001 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 0.001 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 0.002 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 0.003 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 0.003 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 0.004 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 0.004 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 153 bits (388), Expect = 8e-43
Identities = 81/273 (29%), Positives = 120/273 (43%), Gaps = 40/273 (14%)
Query: 207 KNILGAGGFGNVYKGKL----GDGTVL-AVKRLKDMISLAV---------------HRNL 246
LG G FG VYKGKL G V AVK LK+ S H N+
Sbjct: 4 GKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNV 63
Query: 247 LRLIGYCATPTERLLVYPYMSNGSVASRLRE-KPALDWNTRKRIAIGAARGLLYLHEQCD 305
++L+G C +V YM G + S LR+ +P L + A+ ARG+ YL +
Sbjct: 64 VKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLESK-- 121
Query: 306 PKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGHIAPEYLSTGQS 365
IHRD+ A N L+ + + DFGL++ L D + + + +APE L G+
Sbjct: 122 -NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPESLKEGKF 180
Query: 366 SEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELGSNY 425
+ K+DV+ FG+LL E+ T G S + +LE++K + +
Sbjct: 181 TSKSDVWSFGVLLWEIFTLGEQPYPGMSNEE---VLEYLKNGYRLPQPPNCPP------- 230
Query: 426 DRIEVGEILQVALLCTQYLPVHRPKMSEVVRML 458
E+ + L C P RP SE+V +L
Sbjct: 231 ------ELYDLMLQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 150 bits (380), Expect = 9e-42
Identities = 79/272 (29%), Positives = 117/272 (43%), Gaps = 41/272 (15%)
Query: 209 ILGAGGFGNVYKGKL----GDGTVL-AVKRLKDMISLAV---------------HRNLLR 248
LG G FG VYKG L V AVK LK+ S H N+++
Sbjct: 6 KLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVK 65
Query: 249 LIGYCATPTERLLVYPYMSNGSVASRLR--EKPALDWNTRKRIAIGAARGLLYLHEQCDP 306
L+G C ++V YM G + LR L + A+ ARG+ YL +
Sbjct: 66 LLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESK--- 122
Query: 307 KIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGHIAPEYLSTGQSS 366
IHRD+ A N L+ + + DFGL++ L D + + + +APE L G+ +
Sbjct: 123 NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPESLKEGKFT 182
Query: 367 EKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELGSNYD 426
K+DV+ FG+LL E+ T G S + +LE++KK + K
Sbjct: 183 SKSDVWSFGVLLWEIFTLGEEPYPGMSNAE---VLEYLKKGYRLPKPPNCPP-------- 231
Query: 427 RIEVGEILQVALLCTQYLPVHRPKMSEVVRML 458
E+ ++ L C P RP SE+V +L
Sbjct: 232 -----ELYKLMLQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 147 bits (374), Expect = 2e-41
Identities = 65/192 (33%), Positives = 91/192 (47%), Gaps = 25/192 (13%)
Query: 210 LGAGGFGNVYKGK-LGDGTVLAVKRLKD----------------MISLAVHRNLLRLIGY 252
LG GGFG VY + G +A+K +K + L H N+++L G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLN-HPNIVKLYGV 59
Query: 253 CATPTERLLVYPYMSNGSVASRLREKPA-LDWNTRKRIAIGAARGLLYLHEQCDPKIIHR 311
LV Y GS+ L+E L + RI + GL YLH IIHR
Sbjct: 60 FEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSN---GIIHR 116
Query: 312 DVKAANVLLDDFC-EAIVGDFGLAKLLDHSDSHVTTAVRGTVGHIAPEYLSTGQS-SEKT 369
D+K N+LLD + + DFGL+KLL S + T + GT ++APE L SEK+
Sbjct: 117 DLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKT-IVGTPAYMAPEVLLGKGYYSEKS 175
Query: 370 DVFGFGILLLEL 381
D++ G++L EL
Sbjct: 176 DIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 148 bits (377), Expect = 3e-41
Identities = 88/293 (30%), Positives = 121/293 (41%), Gaps = 72/293 (24%)
Query: 208 NILGAGGFGNVYKGKL--GDGTVL--AVKRLKD----------------MISLAVHRNLL 247
LG G FG VYKGKL DG AVK LK+ M L H N++
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLG-HPNVV 59
Query: 248 RLIGYCATPTERLLVYPYMSNGSVASRLRE---------KPALDWNTRKRIAIGAARGLL 298
RL+G C LV YM G + LR+ K L AI A+G+
Sbjct: 60 RLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGME 119
Query: 299 YLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGHI--- 355
YL + K +HRD+ A N L+ + + DFGL++ + D + G I
Sbjct: 120 YLASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKK--TGGKLPIRWM 174
Query: 356 APEYLSTGQSSEKTDVFGFGILLLELIT-------GMRALEFGKSINQKGAMLEWVKKIQ 408
APE L G + K+DV+ FG+LL E+ T G+ E +LE+++K
Sbjct: 175 APESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEE----------VLEYLRK-- 222
Query: 409 QEKKVEVLVDRELGSNYDRIEV--GEILQVALLCTQYLPVHRPKMSEVVRMLE 459
G + E E+ ++ L C Q P RP SE+V LE
Sbjct: 223 -------------GYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 143 bits (362), Expect = 4e-39
Identities = 75/194 (38%), Positives = 96/194 (49%), Gaps = 22/194 (11%)
Query: 209 ILGAGGFGNVYKGK-LGDGTVLAVKRLK--------DMISLA--------VHRNLLRLIG 251
LG+G FG VYK K G G ++AVK LK D + H N++RLI
Sbjct: 6 KLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLID 65
Query: 252 YCATPTERLLVYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHR 311
LV Y G + L L + K+IA+ RGL YLH IIHR
Sbjct: 66 AFEDKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLHSN---GIIHR 122
Query: 312 DVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGHIAPEYLSTGQ-SSEKTD 370
D+K N+LLD+ + DFGLAK L S S +TT V GT ++APE L G K D
Sbjct: 123 DLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFV-GTPWYMAPEVLLGGNGYGPKVD 181
Query: 371 VFGFGILLLELITG 384
V+ G++L EL+TG
Sbjct: 182 VWSLGVILYELLTG 195
|
Length = 260 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 141 bits (357), Expect = 2e-38
Identities = 80/281 (28%), Positives = 123/281 (43%), Gaps = 61/281 (21%)
Query: 210 LGAGGFGNVYKGKL-----GDGTVLAVKRLKD----------------MISLAVHRNLLR 248
LG G FG VYKG L G T +AVK LK+ M L+ H N++R
Sbjct: 7 LGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLS-HPNIVR 65
Query: 249 LIGYCATPTERLLVYPYMSNGSVASRLRE-KPALDWNTRKRIAIGAARGLLYLHEQCDPK 307
L+G C +V YM G + LR+ L ++A+ A+G+ YL +
Sbjct: 66 LLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLESK---N 122
Query: 308 IIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTA-----VRGTVGHIAPEYLST 362
+HRD+ A N L+ + + DFGL++ + D + ++ APE L
Sbjct: 123 FVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWM----APESLKD 178
Query: 363 GQSSEKTDVFGFGILLLELITGMRALEFGKS-----INQKGAMLEWVKKIQQEKKVEVLV 417
G+ + K+DV+ FG+LL E+ T G+ N++ +LE ++ + + E
Sbjct: 179 GKFTSKSDVWSFGVLLWEIFT------LGEQPYPGMSNEE--VLELLEDGYRLPRPE-NC 229
Query: 418 DRELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRML 458
EL Y+ + L C Y P RP SE+V L
Sbjct: 230 PDEL---YE---------LMLQCWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 137 bits (347), Expect = 4e-37
Identities = 56/197 (28%), Positives = 89/197 (45%), Gaps = 21/197 (10%)
Query: 204 FSSKNILGAGGFGNVYKGK-LGDGTVLAVKRLK---------------DMISLAVHRNLL 247
+ LG G FG VY + G ++A+K +K ++ H N++
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60
Query: 248 RLIGYCATPTERLLVYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPK 307
RL + LV Y G + L+++ L + + L YLH +
Sbjct: 61 RLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYLHSK---G 117
Query: 308 IIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGHIAPEYLSTGQSSE 367
I+HRD+K N+LLD+ + DFGLA+ L +TT V GT ++APE L +
Sbjct: 118 IVHRDLKPENILLDEDGHVKLADFGLARQL-DPGEKLTTFV-GTPEYMAPEVLLGKGYGK 175
Query: 368 KTDVFGFGILLLELITG 384
D++ G++L EL+TG
Sbjct: 176 AVDIWSLGVILYELLTG 192
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 146 bits (369), Expect = 5e-37
Identities = 136/492 (27%), Positives = 228/492 (46%), Gaps = 81/492 (16%)
Query: 20 LSGTLSGSIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFLS 79
SG + +G+L+ L Q+ L N +SG IP +L S KL +LDLS+N+LSG IPA
Sbjct: 487 FSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEM 546
Query: 80 IWLPRKWDKRKCSGVDQGLLRLNNNSLSGAFPVFLAKISELAFLDLSYNNLSGPVPKFPA 139
L L L+ N LSG P L + L +++S+N+L G +P A
Sbjct: 547 PVL--------------SQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGA 592
Query: 140 ----RTFNVAGNPLICGSSSTN--------------------------VCSGSANSVPLS 169
VAGN +CG +T+ V + A
Sbjct: 593 FLAINASAVAGNIDLCGGDTTSGLPPCKRVRKTPSWWFYITCTLGAFLVLALVAFGFVFI 652
Query: 170 FSLNSSPDKQEEGLISLGNLRNFTFRELQQATEN--FSSK---NILGAGGFGNVYKGK-L 223
N+ K+ E L+ F + + T N SS N++ G G YKGK +
Sbjct: 653 RGRNNLELKRVENEDGTWELQFFDSKVSKSITINDILSSLKEENVISRGKKGASYKGKSI 712
Query: 224 GDGTVLAVKRLKDMISLAV----------HRNLLRLIGYCATPTERLLVYPYMSNGSVAS 273
+G VK + D+ S+ H N+++LIG C + L++ Y+ +++
Sbjct: 713 KNGMQFVVKEINDVNSIPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSE 772
Query: 274 RLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLD--DFCEAIVGDF 331
LR L W R++IAIG A+ L +LH +C P ++ ++ +++D D +
Sbjct: 773 VLR---NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLRLSLP 829
Query: 332 GLAKLLDHSDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRA--LE 389
GL L + +++A ++APE T +EK+D++GFG++L+EL+TG E
Sbjct: 830 GL--LCTDTKCFISSA------YVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAE 881
Query: 390 FGKSINQKGAMLEWVKKIQQEKKVEVLVDRELGSN--YDRIEVGEILQVALLCTQYLPVH 447
FG G+++EW + + +++ +D + + ++ E+ E++ +AL CT P
Sbjct: 882 FGVH----GSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTA 937
Query: 448 RPKMSEVVRMLE 459
RP ++V++ LE
Sbjct: 938 RPCANDVLKTLE 949
|
Length = 968 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 115 bits (291), Expect = 3e-29
Identities = 58/197 (29%), Positives = 93/197 (47%), Gaps = 23/197 (11%)
Query: 208 NILGAGGFGNVYKGKLGD-GTVLAVKRLK----------------DMISLAVHRNLLRLI 250
+LG G FG+VY D G ++AVK ++ ++S H N++R
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65
Query: 251 GYCATPTER-LLVY-PYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKI 308
G + L ++ Y+S GS++S L++ L ++ GL YLH I
Sbjct: 66 GSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSN---GI 122
Query: 309 IHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSD-SHVTTAVRGTVGHIAPEYLSTGQSSE 367
+HRD+K AN+L+D + DFG AK L + T +VRGT +APE + +
Sbjct: 123 VHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGR 182
Query: 368 KTDVFGFGILLLELITG 384
D++ G ++E+ TG
Sbjct: 183 AADIWSLGCTVIEMATG 199
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 1e-27
Identities = 75/275 (27%), Positives = 114/275 (41%), Gaps = 53/275 (19%)
Query: 207 KNILGAGGFGNVYKGKLGDGTVLAVKRLKD--------------MISLAVHRNLLRLIGY 252
+G G FG+V G V AVK LKD M +L H NL++L+G
Sbjct: 11 GATIGKGEFGDVMLGDYRGQKV-AVKCLKDDSTAAQAFLAEASVMTTLR-HPNLVQLLGV 68
Query: 253 CATPTERLLVYPYMSNGSVAS--RLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIH 310
+V YM+ GS+ R R + + + A+ G+ YL E+ +H
Sbjct: 69 VLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEK---NFVH 125
Query: 311 RDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAV-RGTVGHIAPEYLSTGQSSEKT 369
RD+ A NVL+ + A V DFGLAK ++ + V APE L + S K+
Sbjct: 126 RDLAARNVLVSEDLVAKVSDFGLAK-----EASQGQDSGKLPVKWTAPEALREKKFSTKS 180
Query: 370 DVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELGSNYDRIE 429
DV+ FGILL E+ + FG+ + + + V ++ Y R+E
Sbjct: 181 DVWSFGILLWEIYS------FGRVPYPRIPLKDVVPHVE--------------KGY-RME 219
Query: 430 V-----GEILQVALLCTQYLPVHRPKMSEVVRMLE 459
E+ +V C + P RP ++ L
Sbjct: 220 APEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLA 254
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 1e-25
Identities = 61/216 (28%), Positives = 92/216 (42%), Gaps = 33/216 (15%)
Query: 210 LGAGGFGNVYKGK-LGDGTVLAVKRLKDMISLAVHRNL--LRLIGYCATP---------- 256
+G GGFG VYK + G +A+K +K + + ++++ C P
Sbjct: 8 IGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYL 67
Query: 257 --TERLLVYPYMSNGSVASRLREKPA-LDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDV 313
E +V + S GS+ L+ L + + +GL YLH IIHRD+
Sbjct: 68 KKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSN---GIIHRDI 124
Query: 314 KAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFG 373
KAAN+LL E + DFGL+ L + + T GT +APE ++ K D++
Sbjct: 125 KAANILLTSDGEVKLIDFGLSAQLSDTKARNTMV--GTPYWMAPEVINGKPYDYKADIWS 182
Query: 374 FGILLLELITG---------MRALEFGKSINQKGAM 400
GI +EL G M+AL I G
Sbjct: 183 LGITAIELAEGKPPYSELPPMKALFK---IATNGPP 215
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 5e-24
Identities = 59/201 (29%), Positives = 97/201 (48%), Gaps = 25/201 (12%)
Query: 203 NFSSKNILGAGGFGNVYKG-KLGDGTVLAVKRLK-------DMISLAV---------HRN 245
N+ +++G G FG VYKG L G +A+K++ + S+ H N
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60
Query: 246 LLRLIGYCATPTERLLVYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCD 305
+++ IG T ++ Y NGS+ +++ + +GL YLHEQ
Sbjct: 61 IVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQ-- 118
Query: 306 PKIIHRDVKAANVLL--DDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGHIAPEYLSTG 363
+IHRD+KAAN+L D + + DFG+A L+ S +V GT +APE +
Sbjct: 119 -GVIHRDIKAANILTTKDGVVK--LADFGVATKLN-DVSKDDASVVGTPYWMAPEVIEMS 174
Query: 364 QSSEKTDVFGFGILLLELITG 384
+S +D++ G ++EL+TG
Sbjct: 175 GASTASDIWSLGCTVIELLTG 195
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 98.9 bits (247), Expect = 3e-23
Identities = 59/190 (31%), Positives = 90/190 (47%), Gaps = 20/190 (10%)
Query: 210 LGAGGFGNVYKGKLGDGTVLAVKRLKD--------------MISLAVHRNLLRLIGYCAT 255
LGAG FG V+ G T +AVK LK M L H L++L C+
Sbjct: 14 LGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEAFLQEAQIMKKLR-HDKLVQLYAVCSE 72
Query: 256 PTERLLVYPYMSNGSVASRLREKPALDWNTRKRIAIGA--ARGLLYLHEQCDPKIIHRDV 313
+V YMS GS+ L+ + + + A A G+ YL + IHRD+
Sbjct: 73 EEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESR---NYIHRDL 129
Query: 314 KAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFG 373
A N+L+ + + DFGLA+L++ + + + APE + G+ + K+DV+
Sbjct: 130 AARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTAPEAANYGRFTIKSDVWS 189
Query: 374 FGILLLELIT 383
FGILL E++T
Sbjct: 190 FGILLTEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 98.2 bits (245), Expect = 8e-23
Identities = 73/285 (25%), Positives = 120/285 (42%), Gaps = 46/285 (16%)
Query: 208 NILGAGGFGNVYKGK---LGDGT--VLAVKRLKDMISLAV---------------HRNLL 247
LG G FG V + LGD T +AVK L H N++
Sbjct: 10 KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIV 69
Query: 248 RLIGYCATPTER--LLVYPYMSNGSVASRLRE-KPALDWNTRKRIAIGAARGLLYLHEQC 304
+ G C P R L+ Y+ +GS+ L+ + ++ + +G+ YL Q
Sbjct: 70 KYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQ- 128
Query: 305 DPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGT--VGHIAPEYLST 362
+ IHRD+ A N+L++ + DFGLAK+L + G + APE L T
Sbjct: 129 --RYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRT 186
Query: 363 GQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELG 422
+ S +DV+ FG+ L EL T S + L + Q + V L+ EL
Sbjct: 187 SKFSSASDVWSFGVTLYELFTYGD-----PSQSPPAEFLRMIGIAQGQMIVTRLL--ELL 239
Query: 423 SNYDRI--------EVGEILQVALLCTQYLPVHRPKMSEVVRMLE 459
+R+ EV ++++ LC + P RP ++++ +++
Sbjct: 240 KEGERLPRPPSCPDEVYDLMK---LCWEAEPQDRPSFADLILIVD 281
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 97.1 bits (242), Expect = 1e-22
Identities = 63/198 (31%), Positives = 96/198 (48%), Gaps = 20/198 (10%)
Query: 202 ENFSSKNILGAGGFGNVYKGKLGDGTVLAVKRLK-------DMISLAV-------HRNLL 247
E F+ + LG+G FG V++G + +A+K LK V H++L+
Sbjct: 6 EEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLI 65
Query: 248 RLIGYCATPTERLLVYPYMSNGSVASRLR--EKPALDWNTRKRIAIGAARGLLYLHEQCD 305
L C+ ++ M GS+ + LR E L + +A A G+ YL EQ
Sbjct: 66 SLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQ-- 123
Query: 306 PKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGHIAPEYLSTGQS 365
IHRD+ A N+L+ + V DFGLA+L+ D ++++ + APE S G
Sbjct: 124 -NSIHRDLAARNILVGEDLVCKVADFGLARLIK-EDVYLSSDKKIPYKWTAPEAASHGTF 181
Query: 366 SEKTDVFGFGILLLELIT 383
S K+DV+ FGILL E+ T
Sbjct: 182 STKSDVWSFGILLYEMFT 199
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 95.6 bits (238), Expect = 3e-22
Identities = 75/275 (27%), Positives = 117/275 (42%), Gaps = 52/275 (18%)
Query: 210 LGAGGFGNVYKGKLGDGTVLAVK--RLKDMISLAV-------------HRNLLRLIGYCA 254
+G G FG+VYKG L T +AVK R L H N+++LIG C
Sbjct: 3 IGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCV 62
Query: 255 TPTERLLVYPYMSNGSVASRLR-EKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDV 313
+V + GS+ + LR +K L ++++ AA G+ YL + IHRD+
Sbjct: 63 QKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKN---CIHRDL 119
Query: 314 KAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGT----VGHIAPEYLSTGQSSEKT 369
A N L+ + + DFG+++ + + T G + APE L+ G+ + ++
Sbjct: 120 AARNCLVGENNVLKISDFGMSR---EEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSES 176
Query: 370 DVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELGSNYDRIE 429
DV+ +GILL E + G S Q +E S Y R+
Sbjct: 177 DVWSYGILLWETFSLGDTPYPGMSNQQTRERIE--------------------SGY-RMP 215
Query: 430 V-----GEILQVALLCTQYLPVHRPKMSEVVRMLE 459
EI ++ L C Y P +RP SE+ L+
Sbjct: 216 APQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 96.7 bits (239), Expect = 9e-22
Identities = 72/283 (25%), Positives = 112/283 (39%), Gaps = 40/283 (14%)
Query: 203 NFSSKNILGAGGFGNVYKGKLGDGTVLAVKRLKD------------------MISLAVHR 244
++ LG G FG VY + D ++A+K L + SL
Sbjct: 1 SYRILRKLGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58
Query: 245 NLLRLIGYCATPTERLLVYPYMSNGSVASRLREKP---ALDWNTRKRIAIGAARGLLYLH 301
N+++L + LV Y+ GS+ L++ L + I L YLH
Sbjct: 59 NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH 118
Query: 302 EQCDPKIIHRDVKAANVLLDDF-CEAIVGDFGLAKLLDHSDSHV-----TTAVRGTVGHI 355
+ IIHRD+K N+LLD + DFGLAKLL S + GT G++
Sbjct: 119 SKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYM 175
Query: 356 APEYL---STGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKK 412
APE L S +S +D++ GI L EL+TG+ E K+ + L+ + ++
Sbjct: 176 APEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSL 235
Query: 413 VEVLVDRELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVV 455
L ++L+ L P +R S +
Sbjct: 236 ASPLSPSNPELISKAAS--DLLKKLL---AKDPKNRLSSSSDL 273
|
Length = 384 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 92.2 bits (230), Expect = 6e-21
Identities = 66/269 (24%), Positives = 114/269 (42%), Gaps = 57/269 (21%)
Query: 210 LGAGGFGNVYKGK-LGDGTVLAVKR--LKDMIS------------LAV--HRNLLRLIGY 252
+G G FG VY + DG + +K L +M L H N+++
Sbjct: 8 IGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYES 67
Query: 253 CATPTERLLVYPYMSNGSVASRLR----------EKPALDWNTRKRIAIGAARGLLYLHE 302
+ +V Y G ++ +++ E+ LDW + + + L YLH
Sbjct: 68 FEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQ--LCLA----LKYLHS 121
Query: 303 QCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGHIAPEYLST 362
+ KI+HRD+K N+ L +GDFG++K+L + T V GT +++PE L
Sbjct: 122 R---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVV-GTPYYLSPE-LCQ 176
Query: 363 GQS-SEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEV------ 415
+ + K+D++ G +L EL T E G++ +LE KI + + +
Sbjct: 177 NKPYNYKSDIWSLGCVLYELCTLKHPFE-GEN------LLELALKILKGQYPPIPSQYSS 229
Query: 416 ----LVDRELGSN-YDRIEVGEILQVALL 439
LV L + +R + +ILQ +
Sbjct: 230 ELRNLVSSLLQKDPEERPSIAQILQSPFI 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 92.1 bits (229), Expect = 7e-21
Identities = 60/189 (31%), Positives = 87/189 (46%), Gaps = 18/189 (9%)
Query: 210 LGAGGFGNVYKGKLGDGTVLAVKRLK-------DMISLAV------HRNLLRLIGYCATP 256
LGAG FG V++G + T +AVK LK D ++ A H L++L C
Sbjct: 14 LGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTLE 73
Query: 257 TERLLVYPYMSNGSVASRLREKPALDWNTRKRIAIGA--ARGLLYLHEQCDPKIIHRDVK 314
+V M GS+ L+ + I + A A G+ YL Q IHRD+
Sbjct: 74 EPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQ---NYIHRDLA 130
Query: 315 AANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGF 374
A NVL+ + V DFGLA+++ + + APE + S K+DV+ F
Sbjct: 131 ARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSF 190
Query: 375 GILLLELIT 383
GILL E++T
Sbjct: 191 GILLTEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 91.2 bits (227), Expect = 1e-20
Identities = 60/206 (29%), Positives = 95/206 (46%), Gaps = 34/206 (16%)
Query: 208 NILGAGGFGNVYKG-KLGDGTVLAVKRLK----------------DMISLAVHRNLLRLI 250
N +G G FG VY L G ++AVK ++ ++ L H NL++
Sbjct: 6 NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVK-- 63
Query: 251 GYCATPTERLLVYPYM---SNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPK 307
Y R VY +M S G++ L LD + + + GL YLH
Sbjct: 64 -YYGVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSH---G 119
Query: 308 IIHRDVKAANVLLDDFCEAI-VGDFGLAKLL-DHSDSHVTT--AVRGTVGHIAPEYLSTG 363
I+HRD+K AN+ L D I +GDFG A L +++ + ++ GT ++APE ++ G
Sbjct: 120 IVHRDIKPANIFL-DHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGG 178
Query: 364 QSSEK---TDVFGFGILLLELITGMR 386
+ D++ G ++LE+ TG R
Sbjct: 179 KGKGHGRAADIWSLGCVVLEMATGKR 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 91.1 bits (226), Expect = 2e-20
Identities = 59/190 (31%), Positives = 93/190 (48%), Gaps = 21/190 (11%)
Query: 210 LGAGGFGNVYKGKLGDGTVLAVKRLKD--------------MISLAVHRNLLRLIGYCAT 255
LGAG FG V+ G T +A+K LK M L H L+RL T
Sbjct: 14 LGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQ-HPRLVRLYA-VVT 71
Query: 256 PTERLLVYPYMSNGSVASRLREKPALDWNTRKRIAIGA--ARGLLYLHEQCDPKIIHRDV 313
++ YM NGS+ L+ + K I + A A G+ ++ + IHRD+
Sbjct: 72 QEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERK---NYIHRDL 128
Query: 314 KAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFG 373
+AAN+L+ + + DFGLA+L++ ++ + + APE ++ G + K+DV+
Sbjct: 129 RAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWS 188
Query: 374 FGILLLELIT 383
FGILL E++T
Sbjct: 189 FGILLTEIVT 198
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 91.3 bits (227), Expect = 2e-20
Identities = 61/224 (27%), Positives = 104/224 (46%), Gaps = 36/224 (16%)
Query: 209 ILGAGGFGNVYKG---KLGDGTVL--AVKRLKD----------------MISLAVHRNLL 247
+LG+G FG VYKG G+ + A+K L++ M S+ H +++
Sbjct: 14 VLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVD-HPHVV 72
Query: 248 RLIGYCATPTERLLVYPYMSNGSVASRLRE-KPALDWNTRKRIAIGAARGLLYLHEQCDP 306
RL+G C + L+ M G + +R K + + A+G+ YL E+
Sbjct: 73 RLLGICLSSQ-VQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEK--- 128
Query: 307 KIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHV-TTAVRGTVGHIAPEYLSTGQS 365
+++HRD+ A NVL+ + DFGLAKLLD + + + +A E +
Sbjct: 129 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIY 188
Query: 366 SEKTDVFGFGILLLELIT-------GMRALEFGKSINQKGAMLE 402
+ K+DV+ +G+ + EL+T G+ A+E + +KG L
Sbjct: 189 THKSDVWSYGVTVWELMTFGAKPYEGIPAVEI-PDLLEKGERLP 231
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 90.9 bits (226), Expect = 2e-20
Identities = 73/278 (26%), Positives = 124/278 (44%), Gaps = 50/278 (17%)
Query: 208 NILGAGGFGNVYKGKLG----DGTVLAVKRLK---------DMISLAV------HRNLLR 248
++G G FG V +G+L +A+K LK D ++ A H N++R
Sbjct: 10 KVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIR 69
Query: 249 LIGYCATPTERLLVYPYMSNGSVASRLREKPA-LDWNTRKRIAIGAARGLLYLHEQCDPK 307
L G +++ YM NGS+ LRE + G A G+ YL E
Sbjct: 70 LEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMN--- 126
Query: 308 IIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTA-----VRGTVGHIAPEYLST 362
+HRD+ A N+L++ V DFGL++ L+ S++ TT +R T APE ++
Sbjct: 127 YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWT----APEAIAY 182
Query: 363 GQSSEKTDVFGFGILLLELIT-GMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDREL 421
+ + +DV+ FGI++ E+++ G R + NQ + +K ++ ++ +D
Sbjct: 183 RKFTSASDVWSFGIVMWEVMSYGERP--YWDMSNQ-----DVIKAVEDGYRLPPPMDCPS 235
Query: 422 GSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLE 459
+ Q+ L C Q RP S++V L+
Sbjct: 236 A----------LYQLMLDCWQKDRNERPTFSQIVSTLD 263
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 90.4 bits (224), Expect = 2e-20
Identities = 76/270 (28%), Positives = 125/270 (46%), Gaps = 43/270 (15%)
Query: 209 ILGAGGFGNVYKGKLGDGTVLAVKRLKD---------------MISLAVHRNLLRLIGYC 253
+LG G FG V+KG L D T +AVK K+ ++ H N+++LIG C
Sbjct: 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVC 61
Query: 254 ATPTERLLVYPYM---SNGSVASRLREKPALDWNTRK--RIAIGAARGLLYLHEQCDPKI 308
T+R +Y M G S LR+K + T++ + A+ AA G+ YL +
Sbjct: 62 ---TQRQPIYIVMELVPGGDFLSFLRKKKD-ELKTKQLVKFALDAAAGMAYLESK---NC 114
Query: 309 IHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGHIAPEYLSTGQSSEK 368
IHRD+ A N L+ + + DFG+++ D + + + APE L+ G+ S +
Sbjct: 115 IHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSE 174
Query: 369 TDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELGSNYDRI 428
+DV+ +GILL E + + + NQ+ + Q EK + ++
Sbjct: 175 SDVWSYGILLWETFS-LGVCPYPGMTNQQA-------REQVEKGYRMSCPQKCPD----- 221
Query: 429 EVGEILQVALLCTQYLPVHRPKMSEVVRML 458
++ +V C Y P +RPK SE+ + L
Sbjct: 222 ---DVYKVMQRCWDYKPENRPKFSELQKEL 248
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 90.5 bits (225), Expect = 2e-20
Identities = 81/276 (29%), Positives = 119/276 (43%), Gaps = 47/276 (17%)
Query: 210 LGAGGFGNVYKG--KLGDGTVL--AVKRLKD----------------MISLAVHRNLLRL 249
LG G FG+V KG + G + AVK LK M L H ++RL
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLD-HPCIVRL 61
Query: 250 IGYCATPTERLLVYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKII 309
IG C +LV G + L+++ + + K +A A G+ YL + +
Sbjct: 62 IGVCKGEP-LMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESK---HFV 117
Query: 310 HRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSH--VTTAVRGTVGHIAPEYLSTGQSSE 367
HRD+ A NVLL + +A + DFG+++ L + TTA R + APE ++ G+ S
Sbjct: 118 HRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKFSS 177
Query: 368 KTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELGSNYDR 427
K+DV+ +G+ L E A +G K + K EV+ E G R
Sbjct: 178 KSDVWSYGVTLWE------AFSYGA------------KPYGEMKGAEVIAMLESGERLPR 219
Query: 428 IEV--GEILQVALLCTQYLPVHRPKMSEVVRMLEGD 461
E EI + L C +Y P RP SE+ D
Sbjct: 220 PEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD 255
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 89.8 bits (223), Expect = 4e-20
Identities = 67/202 (33%), Positives = 100/202 (49%), Gaps = 31/202 (15%)
Query: 208 NILGAGGFGNVYKGKL----GDGTVLAVK---RLKDMISLAV------------HRNLLR 248
++G G FG VY G L G AVK R+ D+ + H N+L
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLS 60
Query: 249 LIGYCATPTE--RLLVYPYMSNGSVASRLREKPALDWNTRKRIAIG--AARGLLYLHEQC 304
L+G C P+E L+V PYM +G + + +R + + I G A+G+ YL +
Sbjct: 61 LLGIC-LPSEGSPLVVLPYMKHGDLRNFIR-SETHNPTVKDLIGFGLQVAKGMEYLASK- 117
Query: 305 DPKIIHRDVKAANVLLDDFCEAIVGDFGLAK-LLD--HSDSHVTTAVRGTVGHIAPEYLS 361
K +HRD+ A N +LD+ V DFGLA+ + D + H T + V +A E L
Sbjct: 118 --KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQ 175
Query: 362 TGQSSEKTDVFGFGILLLELIT 383
T + + K+DV+ FG+LL EL+T
Sbjct: 176 TQKFTTKSDVWSFGVLLWELMT 197
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.1 bits (222), Expect = 5e-20
Identities = 60/195 (30%), Positives = 86/195 (44%), Gaps = 26/195 (13%)
Query: 210 LGAGGFGNVYK-GKLGDGTVLAVKRL-----------------KDMISLAVHRNLLRLIG 251
LG G FG V K G + A+K L ++++S H +++L
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKL-- 58
Query: 252 YCATPT-ERL-LVYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKII 309
+ A T E+L LV Y G + S L ++ + A L YLH II
Sbjct: 59 HYAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSL---GII 115
Query: 310 HRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGHIAPEYLSTGQSSEKT 369
+RD+K N+LLD + DFGLAK L S T GT ++APE L +
Sbjct: 116 YRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFC-GTPEYLAPEVLLGKGYGKAV 174
Query: 370 DVFGFGILLLELITG 384
D + G+LL E++TG
Sbjct: 175 DWWSLGVLLYEMLTG 189
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 89.2 bits (222), Expect = 6e-20
Identities = 54/199 (27%), Positives = 90/199 (45%), Gaps = 19/199 (9%)
Query: 202 ENFSSKNILGAGGFGNVYKGKL-GDGTVLAVKRLK---------------DMISLAVHRN 245
+ +LG G G VYK + G + A+K++ +
Sbjct: 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPY 60
Query: 246 LLRLIGYCATPTERLLVYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCD 305
+++ G E +V YM GS+A L++ + IA +GL YLH
Sbjct: 61 VVKCYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHT--K 118
Query: 306 PKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGHIAPEYLSTGQS 365
IIHRD+K +N+L++ E + DFG++K+L+++ T V GTV +++PE +
Sbjct: 119 RHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFV-GTVTYMSPERIQGESY 177
Query: 366 SEKTDVFGFGILLLELITG 384
S D++ G+ LLE G
Sbjct: 178 SYAADIWSLGLTLLECALG 196
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 2e-19
Identities = 57/189 (30%), Positives = 92/189 (48%), Gaps = 18/189 (9%)
Query: 210 LGAGGFGNVYKGKLGDGTVLAVKRLK-------------DMISLAVHRNLLRLIGYCATP 256
LGAG FG V+ G + T +AVK LK +++ H L+RL
Sbjct: 14 LGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTKE 73
Query: 257 TERLLVYPYMSNGSVASRLREKPALDWNTRKRIAIGA--ARGLLYLHEQCDPKIIHRDVK 314
++ YM+ GS+ L+ K I A A G+ Y+ + IHRD++
Sbjct: 74 EPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERK---NYIHRDLR 130
Query: 315 AANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGF 374
AANVL+ + + DFGLA++++ ++ + + APE ++ G + K+DV+ F
Sbjct: 131 AANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSF 190
Query: 375 GILLLELIT 383
GILL E++T
Sbjct: 191 GILLYEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 87.2 bits (216), Expect = 3e-19
Identities = 62/197 (31%), Positives = 98/197 (49%), Gaps = 22/197 (11%)
Query: 207 KNILGAGGFGNVYKG--KLGDGTVLAVKRLK-DMISL-------AV-----HRNLLRLIG 251
K+ LG G +G VY+G K TV AVK LK D + + AV H NL++L+G
Sbjct: 11 KHKLGGGQYGEVYEGVWKKYSLTV-AVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLG 69
Query: 252 YCATPTERLLVYPYMSNGSVASRLRE--KPALDWNTRKRIAIGAARGLLYLHEQCDPKII 309
C ++ +M+ G++ LRE + ++ +A + + YL ++ I
Sbjct: 70 VCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK---NFI 126
Query: 310 HRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGHIAPEYLSTGQSSEKT 369
HRD+ A N L+ + V DFGL++L+ + + APE L+ + S K+
Sbjct: 127 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKS 186
Query: 370 DVFGFGILLLELIT-GM 385
DV+ FG+LL E+ T GM
Sbjct: 187 DVWAFGVLLWEIATYGM 203
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 8e-19
Identities = 70/278 (25%), Positives = 132/278 (47%), Gaps = 43/278 (15%)
Query: 205 SSKNILGAGGFGNVYKGKLG----DGTVLAVKRLK---------DMISLA------VHRN 245
+ + ++GAG FG V++G L +A+K LK D +S A H N
Sbjct: 8 TKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHN 67
Query: 246 LLRLIGYCATPTERLLVYPYMSNGSVASRLREKPALDWNTRKRIAI--GAARGLLYLHEQ 303
++RL G +++ YM NG++ LR+ ++++ + + + G A G+ YL
Sbjct: 68 IIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDG-EFSSYQLVGMLRGIAAGMKYL--- 123
Query: 304 CDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLL--DHSDSHVTTAVRGTVGHIAPEYLS 361
D +HRD+ A N+L++ E V DFGL+++L D ++ T+ + + APE ++
Sbjct: 124 SDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIA 183
Query: 362 TGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDREL 421
+ + +DV+ FGI++ E+++ FG+ + E +K I ++ +D
Sbjct: 184 YRKFTSASDVWSFGIVMWEVMS------FGERPYWDMSNHEVMKAINDGFRLPAPMDCP- 236
Query: 422 GSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLE 459
+ Q+ L C Q RP+ ++V +L+
Sbjct: 237 ---------SAVYQLMLQCWQQDRARRPRFVDIVNLLD 265
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 84.7 bits (210), Expect = 2e-18
Identities = 61/192 (31%), Positives = 99/192 (51%), Gaps = 22/192 (11%)
Query: 210 LGAGGFGNVYKGK-LGDGTVLAVKRLKDMISLAVHRNLLR------------LIGY---C 253
LGAG G V K G ++AVK ++ I+ A+ + +LR ++G+
Sbjct: 9 LGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAF 68
Query: 254 ATPTERLLVYPYMSNGSVASRLRE-KPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRD 312
+ + YM GS+ L+E + + +IA+ +GL YLHE+ KIIHRD
Sbjct: 69 YNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKH--KIIHRD 126
Query: 313 VKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVF 372
VK +N+L++ + + DFG++ L +S T V GT ++APE + S K+D++
Sbjct: 127 VKPSNILVNSRGQIKLCDFGVSGQL--VNSLAKTFV-GTSSYMAPERIQGNDYSVKSDIW 183
Query: 373 GFGILLLELITG 384
G+ L+EL TG
Sbjct: 184 SLGLSLIELATG 195
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 84.4 bits (209), Expect = 4e-18
Identities = 62/214 (28%), Positives = 94/214 (43%), Gaps = 42/214 (19%)
Query: 209 ILGAGGFGNVYKG------KLGDGTVLAVKRLKD----------------MISLAVHRNL 246
LG G FG V K + + +AVK LKD M + H+N+
Sbjct: 19 PLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNI 78
Query: 247 LRLIGYCATPTERLLVYPYMSNGSVASRLR--------EKPALDWNTRKRI--------A 290
+ L+G C +V Y ++G++ LR P + + A
Sbjct: 79 INLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFA 138
Query: 291 IGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSH-VTTAVR 349
ARG+ +L + K IHRD+ A NVL+ + + DFGLA+ + H D + TT R
Sbjct: 139 YQVARGMEFLASK---KCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGR 195
Query: 350 GTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT 383
V +APE L + ++DV+ FG+LL E+ T
Sbjct: 196 LPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 83.9 bits (208), Expect = 5e-18
Identities = 73/284 (25%), Positives = 120/284 (42%), Gaps = 55/284 (19%)
Query: 210 LGAGGFGNVYKGKL-------GDGTVLAVKRLKDMISLAVHRNLL--------------- 247
LG G FG VY+G + V A+K + + S+ L
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRV-AIKTVNENASMRERIEFLNEASVMKEFNCHHVV 72
Query: 248 RLIGYCATPTERLLVYPYMSNGSVASRLREK-------PALDWNTRKRI---AIGAARGL 297
RL+G +T L+V M+ G + S LR + P L T ++ A A G+
Sbjct: 73 RLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGM 132
Query: 298 LYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSH-VTTAVRGTVGHIA 356
YL + K +HRD+ A N ++ + +GDFG+ + + +D + V +A
Sbjct: 133 AYLAAK---KFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMA 189
Query: 357 PEYLSTGQSSEKTDVFGFGILLLELITGMRALEF-GKSINQKGAMLEWVKKIQQEKKVEV 415
PE L G + K+DV+ FG++L E+ T + + G S + +L++V E
Sbjct: 190 PESLKDGVFTTKSDVWSFGVVLWEMAT-LAEQPYQGLSNEE---VLKFVIDGGHLDLPEN 245
Query: 416 LVDRELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLE 459
D+ +L++ +C QY P RP E+V L+
Sbjct: 246 CPDK-------------LLELMRMCWQYNPKMRPTFLEIVSSLK 276
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 82.8 bits (205), Expect = 9e-18
Identities = 81/281 (28%), Positives = 114/281 (40%), Gaps = 60/281 (21%)
Query: 210 LGAGGFGNVYKGK----LGDGTVLAVKRLKD----------------MISLAVHRNLLRL 249
LG G FG V +G+ G +AVK LK M SL H NL+RL
Sbjct: 3 LGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLD-HENLIRL 61
Query: 250 IGYCATPTERLLVYPYMSNGSVASRLREKPALDWNTRKRI---AIGAARGLLYLHEQCDP 306
G T ++V GS+ RLR K AL + A+ A G+ YL +
Sbjct: 62 YGVVLTHP-LMMVTELAPLGSLLDRLR-KDALGHFLISTLCDYAVQIANGMRYLESK--- 116
Query: 307 KIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTV--GHIAPEYLSTGQ 364
+ IHRD+ A N+LL + +GDFGL + L ++ H V APE L T
Sbjct: 117 RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRT 176
Query: 365 SSEKTDVFGFGILLLELIT-------GMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLV 417
S +DV+ FG+ L E+ T G+ + K I+++G LE + Q
Sbjct: 177 FSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLERPEACPQ-------- 228
Query: 418 DRELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRML 458
+I V L C + P RP + + L
Sbjct: 229 --------------DIYNVMLQCWAHNPADRPTFAALREFL 255
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.0 bits (206), Expect = 1e-17
Identities = 59/207 (28%), Positives = 86/207 (41%), Gaps = 36/207 (17%)
Query: 210 LGAGGFGNVYKG-KLGDGTVLAVKRL------KDMISLAVHRNLLRLIGYCATP------ 256
+G G FG VYK V+A+K + ++ + L C +P
Sbjct: 9 IGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQ---CRSPYITKYY 65
Query: 257 ------TERLLVYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIH 310
++ ++ Y GS L+ LD I GL YLHE+ IH
Sbjct: 66 GSFLKGSKLWIIMEYCGGGSCLDLLKPGK-LDETYIAFILREVLLGLEYLHEE---GKIH 121
Query: 311 RDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGHIAPEYLSTGQSSEKTD 370
RD+KAAN+LL + + + DFG++ L + S T V GT +APE + EK D
Sbjct: 122 RDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFV-GTPFWMAPEVIKQSGYDEKAD 180
Query: 371 VFGFGILLLELITG---------MRAL 388
++ GI +EL G MR L
Sbjct: 181 IWSLGITAIELAKGEPPLSDLHPMRVL 207
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 82.3 bits (204), Expect = 1e-17
Identities = 64/218 (29%), Positives = 96/218 (44%), Gaps = 43/218 (19%)
Query: 202 ENFSSKNILGAGGFGNVYKG-KLGDGTVLAVK---------RLKDMISL---AVHRNLLR 248
E F LG G +G+VYK G V+A+K + IS+ +++
Sbjct: 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEIIKEISILKQCDSPYIVK 62
Query: 249 LIGYCATPTERLLVYPYMSNGSVAS--RLREKPALDWNTRKRIAI---GAARGLLYLHEQ 303
G T+ +V Y GSV+ ++ K T + IA +GL YLH
Sbjct: 63 YYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTL----TEEEIAAILYQTLKGLEYLHSN 118
Query: 304 CDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTV-G---HIAPEY 359
K IHRD+KA N+LL++ +A + DFG++ L T A R TV G +APE
Sbjct: 119 ---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTD-----TMAKRNTVIGTPFWMAPEV 170
Query: 360 LSTGQSSEKTDVFGFGILLLELITG---------MRAL 388
+ + K D++ GI +E+ G MRA+
Sbjct: 171 IQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAI 208
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 82.6 bits (204), Expect = 1e-17
Identities = 63/208 (30%), Positives = 98/208 (47%), Gaps = 36/208 (17%)
Query: 209 ILGAGGFGNVYKGKLG--DGTVL--AVKRLK----------DMISLAV------HRNLLR 248
ILG G FG+V +G+L DG+ L AVK +K + +S A H N+++
Sbjct: 6 ILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMK 65
Query: 249 LIGYCATPTER------LLVYPYMSNGSV-----ASRLREKPA-LDWNTRKRIAIGAARG 296
LIG C + +++ P+M +G + SRL P L T + + A G
Sbjct: 66 LIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALG 125
Query: 297 LLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTT-AVRGTVGHI 355
+ YL + IHRD+ A N +L + V DFGL+K + D + + V I
Sbjct: 126 MEYLSNR---NFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWI 182
Query: 356 APEYLSTGQSSEKTDVFGFGILLLELIT 383
A E L+ + K+DV+ FG+ + E+ T
Sbjct: 183 AIESLADRVYTSKSDVWAFGVTMWEIAT 210
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 81.9 bits (203), Expect = 2e-17
Identities = 57/204 (27%), Positives = 86/204 (42%), Gaps = 28/204 (13%)
Query: 208 NILGAGGFGNVYKGK-LGDGTVLAVKRL---------KDMISLAV-------HRNLLRLI 250
+G G FG V K + DG +L K + K + V H N++R
Sbjct: 6 ETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYY 65
Query: 251 GYCATPTERLLVYPYM---SNGSVASRL----REKPALDWNTRKRIAIGAARGLLYLH-- 301
+ + L Y M G +A + +E+ ++ RI L H
Sbjct: 66 DRIIDRSNQTL-YIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNR 124
Query: 302 EQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGHIAPEYLS 361
++HRD+K AN+ LD +GDFGLAK+L H S T V GT +++PE L+
Sbjct: 125 SDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYV-GTPYYMSPEQLN 183
Query: 362 TGQSSEKTDVFGFGILLLELITGM 385
EK+D++ G L+ EL
Sbjct: 184 HMSYDEKSDIWSLGCLIYELCALS 207
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 2e-17
Identities = 62/224 (27%), Positives = 102/224 (45%), Gaps = 30/224 (13%)
Query: 203 NFSSKNILGAGGFGNVYKG-KLGDGTVLAVKRLK-------------DMISLAVHRNLLR 248
+F N +G G FG V+K + D V A+K++ D + +
Sbjct: 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSY 60
Query: 249 LIGYCATPTERLLVY---PYMSNGSVASRLR--EKPALDWNTRKRIAIGAARGLLYLHEQ 303
+I Y + ++ + Y NG + L+ L + R I GL +LH +
Sbjct: 61 IIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSK 120
Query: 304 CDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGHIAPEYLSTG 363
KI+HRD+K+ N+ LD + +GD G+AKLL + + T V GT +++PE
Sbjct: 121 ---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIV-GTPYYLSPELCEDK 176
Query: 364 QSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKI 407
+EK+DV+ G++L E TG + N +GA+ + KI
Sbjct: 177 PYNEKSDVWALGVVLYECCTGKHPFD----ANNQGAL---ILKI 213
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 82.2 bits (203), Expect = 2e-17
Identities = 57/207 (27%), Positives = 96/207 (46%), Gaps = 33/207 (15%)
Query: 209 ILGAGGFGNVYKG-KLGDGTVLAVK--------------RLKDMISLAV----------- 242
++G G +G VY + G ++AVK R KDM+ A+
Sbjct: 8 LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVK-ALRSEIETLKDLD 66
Query: 243 HRNLLRLIGYCATPTERLLVYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHE 302
H N+++ +G+ T + Y+ GS+ S LR + + GL YLH
Sbjct: 67 HLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHS 126
Query: 303 QCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHS-DSHVTTAVRGTVGHIAPEYLS 361
+ I+HRD+KA N+L+D + DFG++K D D+ +++G+V +APE +
Sbjct: 127 K---GILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIH 183
Query: 362 TGQS--SEKTDVFGFGILLLELITGMR 386
+ S K D++ G ++LE+ G R
Sbjct: 184 SYSQGYSAKVDIWSLGCVVLEMFAGRR 210
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 81.9 bits (203), Expect = 3e-17
Identities = 56/222 (25%), Positives = 93/222 (41%), Gaps = 43/222 (19%)
Query: 202 ENFSSKNILGAGGFGNVYKGKL-GDGTVLAVKRL-----------------KDMIS-LAV 242
++F I+G G F V K A+K L K++++ L
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNG 60
Query: 243 HRNLLRLIGYCATPTERL-LVYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLH 301
H +++L Y E L V Y NG + +R+ +LD + A L YLH
Sbjct: 61 HPGIIKLY-YTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLH 119
Query: 302 EQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVR------------ 349
+ IIHRD+K N+LLD + DFG AK+LD + S +
Sbjct: 120 SK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNR 176
Query: 350 -------GTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITG 384
GT +++PE L+ + + +D++ G ++ +++TG
Sbjct: 177 RRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTG 218
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 4e-17
Identities = 58/197 (29%), Positives = 91/197 (46%), Gaps = 33/197 (16%)
Query: 210 LGAGGFGNVYKGKLGDGTVLAVKRLKD--------------MISLAVHRNLLRLIGYCAT 255
LG+G FG V+ GK +A+K +++ M+ L+ H NL++L G C
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMIREGAMSEDDFIEEAKVMMKLS-HPNLVQLYGVCTK 70
Query: 256 PTERLLVYPYMSNGSVASRLREKPALDWNTRKRIAIGAA----RGLLYLHEQCDPKIIHR 311
+V YM+NG + + LRE+ + + YL IHR
Sbjct: 71 QRPIFIVTEYMANGCLLNYLRERKGK---LGTEWLLDMCSDVCEAMEYLESNG---FIHR 124
Query: 312 DVKAANVLLDDFCEAIVGDFGLAK-LLDHSDSHVTTAVRGT---VGHIAPEYLSTGQSSE 367
D+ A N L+ + V DFGLA+ +LD D + T+ +GT V PE + S
Sbjct: 125 DLAARNCLVGEDNVVKVSDFGLARYVLD--DQY--TSSQGTKFPVKWAPPEVFDYSRFSS 180
Query: 368 KTDVFGFGILLLELITG 384
K+DV+ FG+L+ E+ +
Sbjct: 181 KSDVWSFGVLMWEVFSE 197
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 80.9 bits (200), Expect = 5e-17
Identities = 55/207 (26%), Positives = 92/207 (44%), Gaps = 48/207 (23%)
Query: 210 LGAGGFGNVYKG-KLGDGTVLAVKRLK-------------------DMISLAVHRNLLRL 249
LG+G FG+VY+G L DG AVK + ++S H N+++
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 250 IGYCATPTERLLVY-PYMSNGSVASRLREKPALDWN-----TRKRIAIGAARGLLYLHEQ 303
+G + L ++ + GS+A L++ + TR+ + GL YLH++
Sbjct: 68 LG-TEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILL-----GLEYLHDR 121
Query: 304 CDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTT-----AVRGTVGHIAPE 358
+HRD+K AN+L+D + DFG+AK V + +G+ +APE
Sbjct: 122 ---NTVHRDIKGANILVDTNGVVKLADFGMAK-------QVVEFSFAKSFKGSPYWMAPE 171
Query: 359 YL-STGQSSEKTDVFGFGILLLELITG 384
+ G D++ G +LE+ TG
Sbjct: 172 VIAQQGGYGLAADIWSLGCTVLEMATG 198
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 7e-17
Identities = 71/267 (26%), Positives = 116/267 (43%), Gaps = 37/267 (13%)
Query: 210 LGAGGFGNVYKGKL-GDGTVLAVKRLKD---------------MISLAVHRNLLRLIGYC 253
+G G FG V+ G+L D T +AVK ++ ++ H N++RLIG C
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62
Query: 254 ATPTERLLVYPYMSNGSVASRLR-EKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRD 312
+V + G + LR E P L ++ AA G+ YL + IHRD
Sbjct: 63 TQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKH---CIHRD 119
Query: 313 VKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGT-VGHIAPEYLSTGQSSEKTDV 371
+ A N L+ + + DFG+++ + T ++ V APE L+ G+ S ++DV
Sbjct: 120 LAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSESDV 179
Query: 372 FGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELGSNYDRIEVG 431
+ FGILL E + + A+ + NQ+ E + E+ V +
Sbjct: 180 WSFGILLWEAFS-LGAVPYANLSNQQ--TREAI-----EQGVRLPCPELCPD-------- 223
Query: 432 EILQVALLCTQYLPVHRPKMSEVVRML 458
+ ++ C +Y P RP S V + L
Sbjct: 224 AVYRLMERCWEYDPGQRPSFSTVHQEL 250
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 7e-17
Identities = 49/189 (25%), Positives = 90/189 (47%), Gaps = 19/189 (10%)
Query: 210 LGAGGFGNVYKGKLGDGTVLAVKRLKD--------------MISLAVHRNLLRLIGYCAT 255
+G+G FG V+ G + +A+K +++ M+ L+ H L++L G C
Sbjct: 12 IGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEEDFIEEAQVMMKLS-HPKLVQLYGVCTE 70
Query: 256 PTERLLVYPYMSNGSVASRLR-EKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVK 314
+ LV+ +M +G ++ LR ++ T + + G+ YL +IHRD+
Sbjct: 71 RSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSN---VIHRDLA 127
Query: 315 AANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGF 374
A N L+ + V DFG+ + + +T + V +PE S + S K+DV+ F
Sbjct: 128 ARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSF 187
Query: 375 GILLLELIT 383
G+L+ E+ +
Sbjct: 188 GVLMWEVFS 196
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.9 bits (197), Expect = 9e-17
Identities = 64/203 (31%), Positives = 94/203 (46%), Gaps = 25/203 (12%)
Query: 203 NFSSKNILGAGGFGNVYKGKLGD-GTVLAVKRL----------KDMISLAVHRNLL---- 247
N+ +LG G FG VY D G LAVK++ K++ +L LL
Sbjct: 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQ 62
Query: 248 --RLIGY--CATPTERLLVY-PYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHE 302
R++ Y C E L ++ YM GSV +L+ AL ++ G+ YLH
Sbjct: 63 HERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLH- 121
Query: 303 QCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVT--TAVRGTVGHIAPEYL 360
I+HRD+K AN+L D +GDFG +K L S T +V GT ++PE +
Sbjct: 122 --SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVI 179
Query: 361 STGQSSEKTDVFGFGILLLELIT 383
S K DV+ G ++E++T
Sbjct: 180 SGEGYGRKADVWSVGCTVVEMLT 202
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 6e-16
Identities = 62/193 (32%), Positives = 93/193 (48%), Gaps = 21/193 (10%)
Query: 210 LGAGGFGNVYKGKLGDGTVLAVKRLK-------------DMISLAVHRNLLRLIGYCATP 256
LG G FG V+ G T +AVK LK ++ H L++L Y
Sbjct: 14 LGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQL--YAVVS 71
Query: 257 TERL-LVYPYMSNGSVASRLR--EKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDV 313
E + +V YMS GS+ L+ E AL +A A G+ Y+ IHRD+
Sbjct: 72 EEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERM---NYIHRDL 128
Query: 314 KAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFG 373
++AN+L+ D + DFGLA+L++ ++ + + APE G+ + K+DV+
Sbjct: 129 RSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWS 188
Query: 374 FGILLLELITGMR 386
FGILL EL+T R
Sbjct: 189 FGILLTELVTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 6e-16
Identities = 64/206 (31%), Positives = 100/206 (48%), Gaps = 35/206 (16%)
Query: 210 LGAGGFGNVYKGKLG-DGTVL--AVKRLK----------DMISLAV------HRNLLRLI 250
LG G FG+V +G+L D ++L AVK +K D +S AV H N++RLI
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 251 GYCATPTER------LLVYPYMSNGSVAS-----RLREKPA-LDWNTRKRIAIGAARGLL 298
G C E +++ P+M +G + S RL + P L + A G+
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126
Query: 299 YLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAV-RGTVGHIAP 357
YL + IHRD+ A N +L++ V DFGL+K + + D + + + V IA
Sbjct: 127 YLSSK---SFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAI 183
Query: 358 EYLSTGQSSEKTDVFGFGILLLELIT 383
E L+ + K+DV+ FG+ + E+ T
Sbjct: 184 ESLADRVYTTKSDVWSFGVTMWEIAT 209
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 77.0 bits (190), Expect = 8e-16
Identities = 54/220 (24%), Positives = 85/220 (38%), Gaps = 25/220 (11%)
Query: 203 NFSSKNILGAGGFGNVYKGKLGD-GTVLAVK--RLKDMISLAVHRNLLR----------- 248
+F ++G G FG V + D + A+K + + RN+L
Sbjct: 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHP 60
Query: 249 -LIGYCATPTER---LLVYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQC 304
L+ + + LV + G + L +K K L YLH +
Sbjct: 61 FLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSK- 119
Query: 305 DPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGHIAPEYLSTGQ 364
IIHRD+K N+LLD+ + DF +A + + +TT+ GT G++APE L
Sbjct: 120 --GIIHRDIKPDNILLDEQGHVHITDFNIATKV--TPDTLTTSTSGTPGYMAPEVLCRQG 175
Query: 365 SSEKTDVFGFGILLLELITGMRALEF--GKSINQKGAMLE 402
S D + G+ E + G R +Q A E
Sbjct: 176 YSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQE 215
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 8e-16
Identities = 67/267 (25%), Positives = 115/267 (43%), Gaps = 39/267 (14%)
Query: 210 LGAGGFGNVYKGKLGDGTVLAVKRLK-------------DMISLAVHRNLLRLIGYCATP 256
LGAG FG V+ T +AVK +K +++ H L++L T
Sbjct: 14 LGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKL-HAVVTK 72
Query: 257 TERLLVYPYMSNGSVASRLREKPALDWNTRKRIAIGA--ARGLLYLHEQCDPKIIHRDVK 314
++ +M+ GS+ L+ K I A A G+ ++ ++ IHRD++
Sbjct: 73 EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLR 129
Query: 315 AANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGF 374
AAN+L+ + DFGLA++++ ++ + + APE ++ G + K+DV+ F
Sbjct: 130 AANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSF 189
Query: 375 GILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELGSNYDRIEV--GE 432
GILL+E++T R G S EV+ E G R E E
Sbjct: 190 GILLMEIVTYGRIPYPGMS------------------NPEVIRALERGYRMPRPENCPEE 231
Query: 433 ILQVALLCTQYLPVHRPKMSEVVRMLE 459
+ + + C + P RP + +L+
Sbjct: 232 LYNIMMRCWKNRPEERPTFEYIQSVLD 258
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 9e-16
Identities = 60/204 (29%), Positives = 93/204 (45%), Gaps = 34/204 (16%)
Query: 209 ILGAGGFGNVYKGK-LGDGTVLAVKR-----------------LKDMISLAV---HRNLL 247
LG G F + Y+ + + GT++AVK+ L+ I L H +++
Sbjct: 7 QLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHII 66
Query: 248 RLIGYCATPTERLLVYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPK 307
R++G + L +M+ GSV+ L + A RGL YLHE +
Sbjct: 67 RMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHEN---Q 123
Query: 308 IIHRDVKAANVLLDDFCEAI-VGDFGLAKLLDHSDSHVTTA------VRGTVGHIAPEYL 360
IIHRDVK AN+L+D + + + DFG A L + T A + GT+ +APE L
Sbjct: 124 IIHRDVKGANLLIDSTGQRLRIADFGAAARL---AAKGTGAGEFQGQLLGTIAFMAPEVL 180
Query: 361 STGQSSEKTDVFGFGILLLELITG 384
Q DV+ G +++E+ T
Sbjct: 181 RGEQYGRSCDVWSVGCVIIEMATA 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 79.9 bits (197), Expect = 1e-15
Identities = 51/127 (40%), Positives = 68/127 (53%), Gaps = 10/127 (7%)
Query: 19 SLSGTLSGSIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALL-- 76
+L+G + S+GNL NL+ + L N +SG IPP + SL KL +LDLS+N LSG IP L+
Sbjct: 247 NLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQ 306
Query: 77 --------FLSIWLPRKWDKRKCSGVDQGLLRLNNNSLSGAFPVFLAKISELAFLDLSYN 128
S K S +L+L +N SG P L K + L LDLS N
Sbjct: 307 LQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTN 366
Query: 129 NLSGPVP 135
NL+G +P
Sbjct: 367 NLTGEIP 373
|
Length = 968 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 77.0 bits (190), Expect = 1e-15
Identities = 49/155 (31%), Positives = 68/155 (43%), Gaps = 10/155 (6%)
Query: 237 MISLAVHRNLLRLIGYCATPTERLLVYPYMSNGSVASRLREKPALDWNTRKRIAI---GA 293
+S H N+++ E LV PY+S GS+ ++ IA
Sbjct: 52 AMSQCNHPNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEV 111
Query: 294 ARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGL-AKLLDHSD--SHVTTAVRG 350
+GL YLH IHRD+KA N+LL + + DFG+ A L D D V G
Sbjct: 112 LKGLEYLHSN---GQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVG 168
Query: 351 TVGHIAPEYLSTGQS-SEKTDVFGFGILLLELITG 384
T +APE + K D++ FGI +EL TG
Sbjct: 169 TPCWMAPEVMEQVHGYDFKADIWSFGITAIELATG 203
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 1e-15
Identities = 64/214 (29%), Positives = 100/214 (46%), Gaps = 44/214 (20%)
Query: 208 NILGAGGFGNVYKGK----LGDGT---VLAVKRLKD---------------MISLAVHRN 245
N LG+G FG VY+G LG G+ +AVK L+ ++S H N
Sbjct: 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPN 60
Query: 246 LLRLIGYCATPTERLLVYPYMSNGSVASRLREK-------PALDWNTRKRIAIGAARGLL 298
+++L+G C + ++ M G + S LR+ P L I + A+G +
Sbjct: 61 IVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCV 120
Query: 299 YLHEQCDPKIIHRDVKAANVLL---DDFCEAIV--GDFGLAKLLDHSDSHVTTAVRGT-- 351
YL IHRD+ A N L+ + +V GDFGLA+ + SD + G
Sbjct: 121 YLE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYY---RKEGEGL 174
Query: 352 --VGHIAPEYLSTGQSSEKTDVFGFGILLLELIT 383
V +APE L G+ + ++DV+ FG+L+ E++T
Sbjct: 175 LPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILT 208
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 2e-15
Identities = 58/206 (28%), Positives = 102/206 (49%), Gaps = 34/206 (16%)
Query: 209 ILGAGGFGNVYKG-KLGDGTVLAVKR--------------------LKDMISLA---VHR 244
++G+G FG+VY G G ++AVK+ L I+L H
Sbjct: 7 LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66
Query: 245 NLLRLIGYCATPTERLLVY-PYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQ 303
N+++ +G + + L ++ Y+ GSVA+ L A + + +GL YLH +
Sbjct: 67 NIVQYLG-SSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNR 125
Query: 304 CDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTT-----AVRGTVGHIAPE 358
IIHRD+K AN+L+D+ + DFG++K L+ + T +++G+V +APE
Sbjct: 126 ---GIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPE 182
Query: 359 YLSTGQSSEKTDVFGFGILLLELITG 384
+ + K D++ G L++E++TG
Sbjct: 183 VVKQTSYTRKADIWSLGCLVVEMLTG 208
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 75.3 bits (185), Expect = 4e-15
Identities = 69/276 (25%), Positives = 128/276 (46%), Gaps = 45/276 (16%)
Query: 209 ILGAGGFGNVYKGKLG----DGTVLAVKRLK---------DMISLAV------HRNLLRL 249
++GAG FG V +G+L +A+K LK D +S A H N++ L
Sbjct: 11 VIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHL 70
Query: 250 IGYCATPTERLLVYPYMSNGSVASRLREKPALDWNTRKRIAI--GAARGLLYLHEQCDPK 307
G +++ +M NG++ S LR+ + + + + G A G+ YL E
Sbjct: 71 EGVVTKSRPVMIITEFMENGALDSFLRQNDG-QFTVIQLVGMLRGIAAGMKYLSEM---N 126
Query: 308 IIHRDVKAANVLLDDFCEAIVGDFGLAKLL--DHSDSHVTTAVRGT--VGHIAPEYLSTG 363
+HRD+ A N+L++ V DFGL++ L D SD T+++ G + APE ++
Sbjct: 127 YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYR 186
Query: 364 QSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELGS 423
+ + +DV+ +GI++ E+++ +G+ + + + I+Q+ ++ +D
Sbjct: 187 KFTSASDVWSYGIVMWEVMS------YGERPYWDMSNQDVINAIEQDYRLPPPMDCPTA- 239
Query: 424 NYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLE 459
+ Q+ L C Q RPK ++V L+
Sbjct: 240 ---------LHQLMLDCWQKDRNARPKFGQIVSTLD 266
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 74.9 bits (184), Expect = 5e-15
Identities = 70/269 (26%), Positives = 118/269 (43%), Gaps = 45/269 (16%)
Query: 210 LGAGGFGNVYKGKLGDGTVLAVKRL--------------KDMISLAVHRNLLRLIGYCAT 255
LG+G FG V+ GK +A+K + K M+ L+ H L++L G C
Sbjct: 12 LGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEEDFIEEAKVMMKLS-HPKLVQLYGVCTQ 70
Query: 256 PTERLLVYPYMSNGSVASRLREKPALDWNTRKRIAIGAAR----GLLYLHEQCDPKIIHR 311
+V +M NG + + LR++ K + + + G+ YL IHR
Sbjct: 71 QKPLYIVTEFMENGCLLNYLRQRQG---KLSKDMLLSMCQDVCEGMEYLERN---SFIHR 124
Query: 312 DVKAANVLLDDFCEAIVGDFGLAK-LLDHSDSHVTTA-VRGTVGHIAPEYLSTGQSSEKT 369
D+ A N L+ V DFG+ + +LD D + +++ + V PE + + S K+
Sbjct: 125 DLAARNCLVSSTGVVKVSDFGMTRYVLD--DEYTSSSGAKFPVKWSPPEVFNFSKYSSKS 182
Query: 370 DVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELGSNYDRIE 429
DV+ FG+L+ E+ T + + F K N E V+ I + + L +L S
Sbjct: 183 DVWSFGVLMWEVFTEGK-MPFEKKSN-----YEVVEMISRGFR---LYRPKLASMT---- 229
Query: 430 VGEILQVALLCTQYLPVHRPKMSEVVRML 458
+ +V C P RP +E++R +
Sbjct: 230 ---VYEVMYSCWHEKPEGRPTFAELLRAI 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 5e-15
Identities = 58/193 (30%), Positives = 92/193 (47%), Gaps = 21/193 (10%)
Query: 210 LGAGGFGNVYKGKLGDGTVLAVKRLK-------------DMISLAVHRNLLRLIGYCATP 256
LG G FG V+ G T +A+K LK ++ H L++L Y
Sbjct: 14 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQL--YAVVS 71
Query: 257 TERL-LVYPYMSNGSVASRLREKPALDWNTRKRIAIGA--ARGLLYLHEQCDPKIIHRDV 313
E + +V YMS GS+ L+ + + + + A A G+ Y+ +HRD+
Sbjct: 72 EEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDL 128
Query: 314 KAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFG 373
+AAN+L+ + V DFGLA+L++ ++ + + APE G+ + K+DV+
Sbjct: 129 RAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWS 188
Query: 374 FGILLLELITGMR 386
FGILL EL T R
Sbjct: 189 FGILLTELTTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 7e-15
Identities = 51/202 (25%), Positives = 87/202 (43%), Gaps = 28/202 (13%)
Query: 208 NILGAGGFGNVYKGKLGDGTVLAVKRLK--------------------DMISLAVHRNLL 247
+LG G +G VY G G ++AVK+++ D++ H N++
Sbjct: 6 EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65
Query: 248 RLIGYCATPTERLLVYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPK 307
+ +G C + ++ GS++S L L + G+ YLH C
Sbjct: 66 QYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNC--- 122
Query: 308 IIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVT-----TAVRGTVGHIAPEYLST 362
++HRD+K NV+L + DFG A+ L H T ++ GT +APE ++
Sbjct: 123 VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINE 182
Query: 363 GQSSEKTDVFGFGILLLELITG 384
K+D++ G + E+ TG
Sbjct: 183 SGYGRKSDIWSIGCTVFEMATG 204
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.5 bits (184), Expect = 8e-15
Identities = 49/217 (22%), Positives = 87/217 (40%), Gaps = 55/217 (25%)
Query: 204 FSSKNILGAGGFGNVYKGK-LGDGTVLAVKR--------------------LKDMISLAV 242
+ +G G +G VYK + G ++A+K+ L+ +
Sbjct: 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLR---- 56
Query: 243 HRNLLRLIGYCATPTERL-----LVYPYMSNGSVASRLREKPALDWNTRKRIAIGAAR-- 295
H N++RL T + +V+ YM + + L + + +
Sbjct: 57 HPNIVRLKEIV---TSKGKGSIYMVFEYMDH-DLTGLLD-------SPEVKFTESQIKCY 105
Query: 296 ------GLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVR 349
GL YLH I+HRD+K +N+L+++ + DFGLA+ +S T
Sbjct: 106 MKQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRV 162
Query: 350 GTVGHIAPEYL--STGQSSEKTDVFGFGILLLELITG 384
T+ + PE L +T + + D++ G +L EL G
Sbjct: 163 ITLWYRPPELLLGAT-RYGPEVDMWSVGCILAELFLG 198
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 9e-15
Identities = 57/208 (27%), Positives = 92/208 (44%), Gaps = 40/208 (19%)
Query: 202 ENFSSKNILGAGGFGNVYKGKL-GDGTVLAVKRLKDMISLAVHRNLLRLIGY---CATP- 256
E + LG G G+V K +L G + A+K + + + + +LR + C +P
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPY 60
Query: 257 -------------TERLLVYPYMSNGSVAS----------RLREKPALDWNTRKRIAIGA 293
+ + Y GS+ S R+ EK +IA
Sbjct: 61 IVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLG------KIAESV 114
Query: 294 ARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVG 353
+GL YLH + KIIHRD+K +N+LL + + DFG++ L +S + T GT
Sbjct: 115 LKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTFT---GTSF 168
Query: 354 HIAPEYLSTGQSSEKTDVFGFGILLLEL 381
++APE + S +DV+ G+ LLE+
Sbjct: 169 YMAPERIQGKPYSITSDVWSLGLTLLEV 196
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 73.8 bits (181), Expect = 1e-14
Identities = 60/193 (31%), Positives = 99/193 (51%), Gaps = 23/193 (11%)
Query: 209 ILGAGGFGNVYKGKLGDGTVLAVKRLK-DMISLAV-----------HRNLLRLIGYCATP 256
I+G G FG V +G+ G +AVK +K D+ + A H+NL+RL+G
Sbjct: 13 IIGEGEFGAVLQGEY-TGQKVAVKNIKCDVTAQAFLEETAVMTKLHHKNLVRLLG-VILH 70
Query: 257 TERLLVYPYMSNGSVASRLREKPALDWNTRK--RIAIGAARGLLYLHEQCDPKIIHRDVK 314
+V MS G++ + LR + + + + ++ A G+ YL + K++HRD+
Sbjct: 71 NGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESK---KLVHRDLA 127
Query: 315 AANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGF 374
A N+L+ + A V DFGLA++ + V+ T APE L + S K+DV+ +
Sbjct: 128 ARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVKWT----APEALKHKKFSSKSDVWSY 183
Query: 375 GILLLELITGMRA 387
G+LL E+ + RA
Sbjct: 184 GVLLWEVFSYGRA 196
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 1e-14
Identities = 67/215 (31%), Positives = 98/215 (45%), Gaps = 44/215 (20%)
Query: 210 LGAGGFGNVY--------KGKLGDGTVLAVKRLKD----------------MISLAVHRN 245
LG G FG V K K +AVK LKD M + H+N
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79
Query: 246 LLRLIGYCATPTERLLVYPYMSNGSVASRLREK--PALDWN-----------TRKRI--- 289
++ L+G C ++ Y S G++ LR + P +D++ T K +
Sbjct: 80 IINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSC 139
Query: 290 AIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSH-VTTAV 348
A ARG+ YL Q K IHRD+ A NVL+ + + DFGLA+ + + D + TT
Sbjct: 140 AYQVARGMEYLASQ---KCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNG 196
Query: 349 RGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT 383
R V +APE L + ++DV+ FG+LL E+ T
Sbjct: 197 RLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 1e-14
Identities = 55/195 (28%), Positives = 78/195 (40%), Gaps = 25/195 (12%)
Query: 210 LGAGGFGNVY------KGKLGDGTVLAVKRLK------------DMISLAVHRNLLRLIG 251
LG GGFG V GK+ L KRLK ++ R ++ L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 252 YCATPTERLLVYPYMSNGSVASRLRE--KPALDWNTRKRIAIGAARGLLYLHEQCDPKII 309
T + LV M+ G + + +P A GL +LH++ +I+
Sbjct: 61 AFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQR---RIV 117
Query: 310 HRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGHIAPEYLSTGQSSEKT 369
+RD+K NVLLDD + D GLA ++ GT G++APE L
Sbjct: 118 YRDLKPENVLLDDHGNVRISDLGLA--VELKGGKKIKGRAGTPGYMAPEVLQGEVYDFSV 175
Query: 370 DVFGFGILLLELITG 384
D F G L E+I G
Sbjct: 176 DWFALGCTLYEMIAG 190
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 73.6 bits (180), Expect = 2e-14
Identities = 58/193 (30%), Positives = 91/193 (47%), Gaps = 21/193 (10%)
Query: 210 LGAGGFGNVYKGKLGDGTVLAVKRLK-------------DMISLAVHRNLLRLIGYCATP 256
LG G FG V+ G T +A+K LK ++ H L+ L Y
Sbjct: 14 LGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPL--YAVVS 71
Query: 257 TERL-LVYPYMSNGSVASRLREKPALDWNTRKRIAIGA--ARGLLYLHEQCDPKIIHRDV 313
E + +V +M GS+ L+E + + + A A G+ Y+ IHRD+
Sbjct: 72 EEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERM---NYIHRDL 128
Query: 314 KAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFG 373
+AAN+L+ D + DFGLA+L++ ++ + + APE G+ + K+DV+
Sbjct: 129 RAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWS 188
Query: 374 FGILLLELITGMR 386
FGILL EL+T R
Sbjct: 189 FGILLTELVTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 73.6 bits (181), Expect = 2e-14
Identities = 75/281 (26%), Positives = 122/281 (43%), Gaps = 42/281 (14%)
Query: 210 LGAGGFGNVYKGK---LGDGT--VLAVKRLK--------------DMISLAVHRNLLRLI 250
LG G FG+V + L D T V+AVK+L+ +++ H N+++
Sbjct: 12 LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYK 71
Query: 251 GYCATPTER--LLVYPYMSNGSVASRL-REKPALDWNTRKRIAIGAARGLLYLHEQCDPK 307
G C + R LV Y+ GS+ L + + LD A +G+ YL + +
Sbjct: 72 GVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSK---R 128
Query: 308 IIHRDVKAANVLLDDFCEAIVGDFGLAKLL--DHSDSHVTTAVRGTVGHIAPEYLSTGQS 365
+HRD+ N+L++ +GDFGL K+L D V + APE L+ +
Sbjct: 129 YVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESKF 188
Query: 366 SEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDR--ELGS 423
S +DV+ FG++L EL F S E+++ + +K+ +++V EL
Sbjct: 189 SVASDVWSFGVVLYEL--------FTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLK 240
Query: 424 NYDRIEV-----GEILQVALLCTQYLPVHRPKMSEVVRMLE 459
N R+ EI + C P RP SE+ +E
Sbjct: 241 NNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVE 281
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 73.4 bits (181), Expect = 2e-14
Identities = 61/228 (26%), Positives = 90/228 (39%), Gaps = 43/228 (18%)
Query: 201 TENFSSKNILGAGGFGNVYKGK-LGDGTVLAVKRL---KDMISLAV----------HRNL 246
E + + +G G G VYK G +A+K++ K L + H N+
Sbjct: 18 RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNI 77
Query: 247 LRLIGYCATPTERLLVYPYMSNGSVASRLREKPALDWN----TRKRIAIGAA---RGLLY 299
+ E +V YM GS+ + N +IA +GL Y
Sbjct: 78 VDYYDSYLVGDELWVVMEYMDGGSLTD------IITQNFVRMNEPQIAYVCREVLQGLEY 131
Query: 300 LHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGHIAPEY 359
LH Q +IHRD+K+ N+LL + DFG A L S + V GT +APE
Sbjct: 132 LHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVV-GTPYWMAPEV 187
Query: 360 LSTGQSSEKTDVFGFGILLLELITG---------MRALEFGKSINQKG 398
+ K D++ GI+ +E+ G +RAL I KG
Sbjct: 188 IKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRAL---FLITTKG 232
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 73.2 bits (180), Expect = 2e-14
Identities = 63/222 (28%), Positives = 96/222 (43%), Gaps = 47/222 (21%)
Query: 198 QQATENFSSKNILGAGGFGNVYKGKL----GDGTVL--AVKRLKDM-------------- 237
+ ++ + LG G FG VY+G GD L AVK L +
Sbjct: 2 EVPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEAL 61
Query: 238 -ISLAVHRNLLRLIGYCATPTERLLVYPYMSNGSVASRLRE-KPALDWNTRKR------I 289
+S H+N++RLIG R ++ M+ G + S LRE +P + +
Sbjct: 62 IMSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFC 121
Query: 290 AIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCE-----AIVGDFGLAKLLDHSDSHV 344
A A+G YL E IHRD+ A N LL C+ A + DFG+A+ + + +
Sbjct: 122 ARDVAKGCKYLEEN---HFIHRDIAARNCLLT--CKGPGRVAKIADFGMARDIYRASYY- 175
Query: 345 TTAVRG-----TVGHIAPEYLSTGQSSEKTDVFGFGILLLEL 381
+G + + PE G + KTDV+ FG+LL E+
Sbjct: 176 ---RKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEI 214
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 72.6 bits (178), Expect = 2e-14
Identities = 74/274 (27%), Positives = 116/274 (42%), Gaps = 53/274 (19%)
Query: 210 LGAGGFGNVYKGKLGDGTVLAVKRLKD--------------MISLAVHRNLLRLIGYCAT 255
LG G FG V GK +A+K +K+ M+ L+ H L++L G C
Sbjct: 12 LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMKLS-HEKLVQLYGVCTK 70
Query: 256 PTERLLVYPYMSNGSVASRLREKPALDWNTRKRIAIG--------AARGLLYLHEQCDPK 307
+V YMSNG + + LRE KR G+ YL + +
Sbjct: 71 QRPIYIVTEYMSNGCLLNYLRE-------HGKRFQPSQLLEMCKDVCEGMAYLESK---Q 120
Query: 308 IIHRDVKAANVLLDDFCEAIVGDFGLAK-LLDHSDSHVTT-AVRGTVGHIAPEYLSTGQS 365
IHRD+ A N L+DD V DFGL++ +LD D + ++ + V PE L +
Sbjct: 121 FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLD--DEYTSSVGSKFPVRWSPPEVLLYSKF 178
Query: 366 SEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELGSNY 425
S K+DV+ FG+L+ E+ + GK ++ E V+K+ Q + L L S
Sbjct: 179 SSKSDVWAFGVLMWEVYS------LGKMPYERFNNSETVEKVSQGLR---LYRPHLASE- 228
Query: 426 DRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLE 459
++ + C RP +++ +E
Sbjct: 229 ------KVYAIMYSCWHEKAEERPTFQQLLSSIE 256
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 3e-14
Identities = 61/211 (28%), Positives = 92/211 (43%), Gaps = 36/211 (17%)
Query: 202 ENFSSKNILGAGGFGNVYK------GKLGDGTVLAVKRLKD----------------MIS 239
N S LGAG FG V + K +AVK LK M
Sbjct: 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSH 94
Query: 240 LAVHRNLLRLIGYCATPTERLLVYPYMSNGSVASRLREKPA--LDWNTRKRIAIGAARGL 297
L H N++ L+G C L++ Y G + + LR K L + A+G+
Sbjct: 95 LGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGM 154
Query: 298 LYL-HEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGT----V 352
+L + C IHRD+ A NVLL + DFGLA+ + + ++V V+G V
Sbjct: 155 AFLASKNC----IHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYV---VKGNARLPV 207
Query: 353 GHIAPEYLSTGQSSEKTDVFGFGILLLELIT 383
+APE + + ++DV+ +GILL E+ +
Sbjct: 208 KWMAPESIFNCVYTFESDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 3e-14
Identities = 66/215 (30%), Positives = 96/215 (44%), Gaps = 44/215 (20%)
Query: 210 LGAGGFGNVY--------KGKLGDGTVLAVKRLK---------DMIS-------LAVHRN 245
LG G FG V K K T +AVK LK D+IS + H+N
Sbjct: 26 LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85
Query: 246 LLRLIGYCATPTERLLVYPYMSNGSVAS--RLREKPALDWNTRK--------------RI 289
++ L+G C ++ Y S G++ R R P +++
Sbjct: 86 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSC 145
Query: 290 AIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSH-VTTAV 348
A ARG+ YL + K IHRD+ A NVL+ + + DFGLA+ + H D + TT
Sbjct: 146 AYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 202
Query: 349 RGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT 383
R V +APE L + ++DV+ FG+LL E+ T
Sbjct: 203 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 3e-14
Identities = 62/221 (28%), Positives = 98/221 (44%), Gaps = 49/221 (22%)
Query: 209 ILGAGGFGNVYKGK------LGDGTVLAVKRLKD---------------MISLAVHRNLL 247
LG G FG V K T +AVK LK+ ++ H +++
Sbjct: 7 TLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVI 66
Query: 248 RLIGYCATPTERLLVYPYMSNGSVASRLRE----------------KPALDWNTRKRIAI 291
+L G C+ LL+ Y GS+ S LRE LD + + +
Sbjct: 67 KLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTM 126
Query: 292 G--------AARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSH 343
G +RG+ YL E K++HRD+ A NVL+ + + + DFGL++ + DS+
Sbjct: 127 GDLISFAWQISRGMQYLAEM---KLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSY 183
Query: 344 VTTAV-RGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT 383
V + R V +A E L + ++DV+ FG+LL E++T
Sbjct: 184 VKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 224
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 4e-14
Identities = 50/197 (25%), Positives = 99/197 (50%), Gaps = 26/197 (13%)
Query: 209 ILGAGGFGNVYKGK-LGDGTVL----AVKRLKD-------------MISLAV--HRNLLR 248
+LG+G FG V+KG + +G + A+K ++D M+++ H ++R
Sbjct: 14 LLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVR 73
Query: 249 LIGYCATPTERLLVYPYMSNGSVASRLRE-KPALDWNTRKRIAIGAARGLLYLHEQCDPK 307
L+G C + +L V GS+ +R+ + +LD + A+G+ YL E
Sbjct: 74 LLGICPGASLQL-VTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHR--- 129
Query: 308 IIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSD-SHVTTAVRGTVGHIAPEYLSTGQSS 366
++HR++ A N+LL + DFG+A LL D + + + + +A E + G+ +
Sbjct: 130 MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYT 189
Query: 367 EKTDVFGFGILLLELIT 383
++DV+ +G+ + E+++
Sbjct: 190 HQSDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 6e-14
Identities = 58/205 (28%), Positives = 91/205 (44%), Gaps = 27/205 (13%)
Query: 203 NFSSKNILGAGGFGNVYKGKLGD-GTVLAVKRLK-------------------DMISLAV 242
N+ +LG G FG VY D G LAVK+++ ++ +
Sbjct: 3 NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLL 62
Query: 243 HRNLLRLIGYCATPTERLL--VYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYL 300
H +++ G P ER L +M GS+ +L+ AL N ++ G+ YL
Sbjct: 63 HERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYL 122
Query: 301 HEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVT--TAVRGTVGHIAPE 358
H I+HRD+K AN+L D +GDFG +K L T +V GT ++PE
Sbjct: 123 HSN---MIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPE 179
Query: 359 YLSTGQSSEKTDVFGFGILLLELIT 383
+S K D++ G ++E++T
Sbjct: 180 VISGEGYGRKADIWSVGCTVVEMLT 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 6e-14
Identities = 65/231 (28%), Positives = 104/231 (45%), Gaps = 35/231 (15%)
Query: 202 ENFSSKNILGAGGFGNVYKGKLGD--GTVLAVKRLKD-------------MISLAVHRNL 246
+ +G G FG+V LGD G +AVK +K+ M L H NL
Sbjct: 6 KELKLLQTIGKGEFGDVM---LGDYRGNKVAVKCIKNDATAQAFLAEASVMTQLR-HSNL 61
Query: 247 LRLIGYCATPTERL-LVYPYMSNGSVASRLREK--PALDWNTRKRIAIGAARGLLYLHEQ 303
++L+G L +V YM+ GS+ LR + L + + ++ + YL
Sbjct: 62 VQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEAN 121
Query: 304 CDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGHIAPEYLSTG 363
+HRD+ A NVL+ + A V DFGL K + V+ T APE L
Sbjct: 122 ---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT----APEALREK 174
Query: 364 QSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVE 414
+ S K+DV+ FGILL E+ + FG+ + + + V ++++ K++
Sbjct: 175 KFSTKSDVWSFGILLWEIYS------FGRVPYPRIPLKDVVPRVEKGYKMD 219
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.5 bits (176), Expect = 9e-14
Identities = 65/233 (27%), Positives = 95/233 (40%), Gaps = 47/233 (20%)
Query: 197 LQQATENFSSKNILGAGGFGNVYKGKLGD-GTVLAVKRL------KDMISLAV------- 242
L T F ++G G +G VYK + G ++A+K + ++ I
Sbjct: 1 LPDPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYS 60
Query: 243 -HRNLLRLIG--YCATPT----ERLLVYPYMSNGSVASRLREKPALDWNTRKR------I 289
H N+ G P + LV GSV + L K R + I
Sbjct: 61 NHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSV-TDL-VKGLRKKGKRLKEEWIAYI 118
Query: 290 AIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVR 349
RGL YLHE K+IHRD+K N+LL E + DFG++ LD + T +
Sbjct: 119 LRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFI- 174
Query: 350 GTVGHIAPEYLSTGQSSEKT-----DVFGFGILLLELITG---------MRAL 388
GT +APE ++ + + + DV+ GI +EL G MRAL
Sbjct: 175 GTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRAL 227
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 71.1 bits (174), Expect = 9e-14
Identities = 72/275 (26%), Positives = 130/275 (47%), Gaps = 45/275 (16%)
Query: 209 ILGAGGFGNVYKGKL---GDGTV-LAVKRLK---------DMISLAV------HRNLLRL 249
++GAG FG V G+L G + +A+K LK D +S A H N++ L
Sbjct: 11 VIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHL 70
Query: 250 IGYCATPTERLLVYPYMSNGSVASRLREKPALDWNTRKRIAI--GAARGLLYLHEQCDPK 307
G ++V YM NGS+ + LR+ + + + + G A G+ YL D
Sbjct: 71 EGVVTKSKPVMIVTEYMENGSLDAFLRKHDG-QFTVIQLVGMLRGIASGMKYL---SDMG 126
Query: 308 IIHRDVKAANVLLDDFCEAIVGDFGLAKLL--DHSDSHVTTAVRGTVGHIAPEYLSTGQS 365
+HRD+ A N+L++ V DFGL+++L D ++ T + + APE ++ +
Sbjct: 127 YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKF 186
Query: 366 SEKTDVFGFGILLLELIT-GMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELGSN 424
+ +DV+ +GI++ E+++ G R + + NQ + +K I++ ++ +D
Sbjct: 187 TSASDVWSYGIVMWEVMSYGERP--YWEMSNQ-----DVIKAIEEGYRLPAPMDCPAA-- 237
Query: 425 YDRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLE 459
+ Q+ L C Q RPK ++V +L+
Sbjct: 238 --------LHQLMLDCWQKDRNERPKFEQIVSILD 264
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 9e-14
Identities = 53/215 (24%), Positives = 99/215 (46%), Gaps = 35/215 (16%)
Query: 196 ELQQATENFSSKNILGAGGFGNVYKGKLGDGTV-LAVKRL--KDM---------ISL--- 240
E + + + +LG G +G VY + V +A+K + +D I+L
Sbjct: 2 EYEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSY 61
Query: 241 AVHRNLLRLIGYCATPTERLLVYPYMSNGSVASRLREK--------PALDWNTRKRIAIG 292
HRN+++ +G + + + GS+++ LR K + + T++ +
Sbjct: 62 LKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQIL--- 118
Query: 293 AARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAI-VGDFGLAKLLDHSDSHVTTAVRGT 351
GL YLH+ +I+HRD+K NVL++ + + + DFG +K L + T GT
Sbjct: 119 --EGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINP-CTETFTGT 172
Query: 352 VGHIAPEYLSTGQS--SEKTDVFGFGILLLELITG 384
+ ++APE + G D++ G ++E+ TG
Sbjct: 173 LQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATG 207
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.8 bits (174), Expect = 1e-13
Identities = 56/220 (25%), Positives = 94/220 (42%), Gaps = 42/220 (19%)
Query: 202 ENFSSKNILGAGGFGNVYKGK-LGDGTVLAVKRLK--------------DMISLAVHRNL 246
E++ +G+G +G+VYK + + G ++A+K +K M+ H N+
Sbjct: 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNI 62
Query: 247 LRLIGYCATPTERLLVYPYMSNGSVA---SRLR---EKPALDWNTRKRIAIGAARGLLYL 300
+ G + +V Y GS+ R + + + R+ +GL YL
Sbjct: 63 VAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRE-----TLKGLAYL 117
Query: 301 HEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGHIAPEYL 360
HE IHRD+K AN+LL + + + DFG++ L + + + + GT +APE
Sbjct: 118 HET---GKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFI-GTPYWMAPEVA 173
Query: 361 ---STGQSSEKTDVFGFGILLLELITG---------MRAL 388
G K D++ GI +EL MRAL
Sbjct: 174 AVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRAL 213
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 1e-13
Identities = 80/293 (27%), Positives = 126/293 (43%), Gaps = 64/293 (21%)
Query: 210 LGAGGFGNVY--------KGKLGDGTVLAVKRLKD----------------MISLAVHRN 245
LG G FG V K K + +AVK LKD M + H+N
Sbjct: 23 LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82
Query: 246 LLRLIGYCATPTERLLVYPYMSNGSVASRLREK--PALDWN-----------TRKRI--- 289
++ L+G C ++ Y S G++ LR + P ++++ T K +
Sbjct: 83 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSC 142
Query: 290 AIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSH-VTTAV 348
ARG+ YL Q K IHRD+ A NVL+ + + DFGLA+ +++ D + TT
Sbjct: 143 TYQVARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNG 199
Query: 349 RGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQ 408
R V +APE L + ++DV+ FG+L+ E+ T G S G +E + K+
Sbjct: 200 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT------LGGS-PYPGIPVEELFKLL 252
Query: 409 QEKKVEVLVDRELGSNYDRIE--VGEILQVALLCTQYLPVHRPKMSEVVRMLE 459
+E G D+ E+ + C +P HRP ++V L+
Sbjct: 253 KE-----------GHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLD 294
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 2e-13
Identities = 48/148 (32%), Positives = 58/148 (39%), Gaps = 32/148 (21%)
Query: 12 GLGAPSQSLSGTLSGSIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGV 71
GLG +Q L G + I L +L+ + L N+I G IPP LGS+ L+ LDLS N +G
Sbjct: 422 GLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGS 481
Query: 72 IPALLFLSIWLPRKWDKRKCSGVDQGLLRLNNNSLSGAFPVFLAKISELAFLDLSYNNLS 131
IP L L L LN NSLSG P L
Sbjct: 482 IPESLGQLTSLRI--------------LNLNGNSLSGRVPAAL----------------- 510
Query: 132 GPVPKFPARTFNVAGNPLICGSSSTNVC 159
G A FN N +CG C
Sbjct: 511 GGRLLHRAS-FNFTDNAGLCGIPGLRAC 537
|
Length = 623 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 2e-13
Identities = 57/225 (25%), Positives = 97/225 (43%), Gaps = 51/225 (22%)
Query: 207 KNILGAGGFGNVYKGKL------GDGTVLAVKRLKDMIS-------------LAV--HRN 245
K LG G FG V+ G+ D ++AVK LK+ S L H N
Sbjct: 10 KRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHEN 69
Query: 246 LLRLIGYCATPTERLLVYPYMSNGSVASRLR--------------EKPALDWNTRKRIAI 291
+++ G C ++V+ YM +G + LR L + +IA+
Sbjct: 70 IVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAV 129
Query: 292 GAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGT 351
A G++YL Q +HRD+ N L+ +GDFG+++ + +D + V G
Sbjct: 130 QIASGMVYLASQ---HFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYY---RVGGH 183
Query: 352 ----VGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGK 392
+ + PE + + + ++DV+ FG++L E+ T +GK
Sbjct: 184 TMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFT------YGK 222
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 70.3 bits (172), Expect = 2e-13
Identities = 59/202 (29%), Positives = 96/202 (47%), Gaps = 30/202 (14%)
Query: 202 ENFSSKNILGAGGFGNVYKG-KLGDGTVLAVKRLKDMISLAVHRNL---LRLIGYCATP- 256
++ + ILG G G VYK L +LAVK + I++ + + + L ++ C +P
Sbjct: 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPY 60
Query: 257 ----------TERL-LVYPYMSNGS--VASRLREKPALDWNTRKRIAIGAARGLLYLHEQ 303
R+ + +M GS V ++ E L RIA+ +GL YL
Sbjct: 61 IIGFYGAFFVENRISICTEFMDGGSLDVYRKIPE-HVLG-----RIAVAVVKGLTYLWSL 114
Query: 304 CDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGHIAPEYLSTG 363
KI+HRDVK +N+L++ + + DFG++ L +S + GT ++APE +S
Sbjct: 115 ---KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS---IAKTYVGTNAYMAPERISGE 168
Query: 364 QSSEKTDVFGFGILLLELITGM 385
Q +DV+ GI +EL G
Sbjct: 169 QYGIHSDVWSLGISFMELALGR 190
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 2e-13
Identities = 61/206 (29%), Positives = 92/206 (44%), Gaps = 27/206 (13%)
Query: 202 ENFSSKNILGAGGFGNVYKGKLGD-GTVLAVKRL----------KDMISLAVHRNLLRLI 250
N+ +LG G FG VY D G LAVK++ K++ +L LL+ +
Sbjct: 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNL 61
Query: 251 ---------GYCATPTERLL--VYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLY 299
G P E+ L YM GS+ +L+ AL N +R +G+ Y
Sbjct: 62 RHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSY 121
Query: 300 LHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVT--TAVRGTVGHIAP 357
LH I+HRD+K AN+L D +GDFG +K + T +V GT ++P
Sbjct: 122 LHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSP 178
Query: 358 EYLSTGQSSEKTDVFGFGILLLELIT 383
E +S K DV+ ++E++T
Sbjct: 179 EVISGEGYGRKADVWSVACTVVEMLT 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 3e-13
Identities = 46/134 (34%), Positives = 66/134 (49%), Gaps = 9/134 (6%)
Query: 290 AIGAARGLL----YLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLA-KLLDHSDSHV 344
AI R LL YLH + IIHRDVK N+ LD+ A++GDFG A KL H D+
Sbjct: 187 AITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQ 243
Query: 345 TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWV 404
GT+ +PE L+ KTD++ G++L E+ L FGK + + L +
Sbjct: 244 CYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTL-FGKQVKSSSSQLRSI 302
Query: 405 KKIQQEKKVEVLVD 418
+ Q +E +
Sbjct: 303 IRCMQVHPLEFPQN 316
|
Length = 392 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 70.3 bits (172), Expect = 3e-13
Identities = 58/200 (29%), Positives = 88/200 (44%), Gaps = 23/200 (11%)
Query: 209 ILGAGGFGNVYKGKL-GDGTVLAVKRLK-DMI----------------SLAVHRNLLRLI 250
+LG G FG V +L G + AVK LK D+I SLA + L +
Sbjct: 2 VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQL 61
Query: 251 GYCATPTERLL-VYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKII 309
C +RL V +++ G + +++ D + A L++LH++ II
Sbjct: 62 YCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDK---GII 118
Query: 310 HRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGHIAPEYLSTGQSSEKT 369
+RD+K NVLLD + DFG+ K + T+ GT +IAPE L
Sbjct: 119 YRDLKLDNVLLDHEGHCKLADFGMCKEGIF-NGKTTSTFCGTPDYIAPEILQEMLYGPSV 177
Query: 370 DVFGFGILLLELITGMRALE 389
D + G+LL E++ G E
Sbjct: 178 DWWAMGVLLYEMLCGHAPFE 197
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 4e-13
Identities = 44/117 (37%), Positives = 62/117 (52%), Gaps = 14/117 (11%)
Query: 19 SLSGTLSGSIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFL 78
+LSG + IG LT+L + L NN++G IP LG+L LQ L L N+LSG IP +F
Sbjct: 223 NLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIF- 281
Query: 79 SIWLPRKWDKRKCSGVDQGLLRLNNNSLSGAFPVFLAKISELAFLDLSYNNLSGPVP 135
+K +D L++NSLSG P + ++ L L L NN +G +P
Sbjct: 282 --------SLQKLISLD-----LSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIP 325
|
Length = 968 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 69.2 bits (170), Expect = 4e-13
Identities = 58/204 (28%), Positives = 89/204 (43%), Gaps = 34/204 (16%)
Query: 210 LGAGGFGNVY---KGKLGDGTVLAVKRLK--DMI------SLAVHRN-LLRLIG------ 251
+ G +G V+ K GD + A+K +K DMI + R+ L +
Sbjct: 1 ISKGAYGRVFLAKKKSTGD--IYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKL 58
Query: 252 YCATPTER--LLVYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKII 309
Y + ++ LV Y+ G +AS L +LD + + L YLH II
Sbjct: 59 YYSFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSN---GII 115
Query: 310 HRDVKAANVLLDDFCEAIVGDFGLAK-------LLDHSDSHVTTAVRGTVGHIAPEYLST 362
HRD+K N+L+D + DFGL+K + + D + GT +IAPE +
Sbjct: 116 HRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVI-L 174
Query: 363 GQSSEKT-DVFGFGILLLELITGM 385
GQ KT D + G +L E + G+
Sbjct: 175 GQGHSKTVDWWSLGCILYEFLVGI 198
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 8e-13
Identities = 56/200 (28%), Positives = 96/200 (48%), Gaps = 33/200 (16%)
Query: 209 ILGAGGFGNVYKGK-LGDGTVLAVK------------------RLKDMISLAVHRNLLRL 249
++G G +G VY+GK + G V+A+K L + + N+ +
Sbjct: 8 LIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKY 67
Query: 250 IGYCATPTERLLVYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLL----YLHEQCD 305
G ++ Y GSV + ++ P K I++ R +L Y+H+
Sbjct: 68 YGSYLKGPRLWIIMEYAEGGSVRTLMKAGPI----AEKYISV-IIREVLVALKYIHKV-- 120
Query: 306 PKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGHIAPEYLSTGQS 365
+IHRD+KAAN+L+ + + DFG+A LL+ + S +T V GT +APE ++ G+
Sbjct: 121 -GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFV-GTPYWMAPEVITEGKY 178
Query: 366 SE-KTDVFGFGILLLELITG 384
+ K D++ GI + E+ TG
Sbjct: 179 YDTKADIWSLGITIYEMATG 198
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 9e-13
Identities = 50/133 (37%), Positives = 69/133 (51%), Gaps = 19/133 (14%)
Query: 17 SQSLSGTLSGSIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVI---- 72
S SL G + S+G +LR+V LQ+N+ SG +P + LP + LD+SNN L G I
Sbjct: 389 SNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRK 448
Query: 73 ---PALLFLSIW-------LPRKWDKRKCSGVDQGLLRLNNNSLSGAFPVFLAKISELAF 122
P+L LS+ LP + ++ +D L+ N SGA P L +SEL
Sbjct: 449 WDMPSLQMLSLARNKFFGGLPDSFGSKRLENLD-----LSRNQFSGAVPRKLGSLSELMQ 503
Query: 123 LDLSYNNLSGPVP 135
L LS N LSG +P
Sbjct: 504 LKLSENKLSGEIP 516
|
Length = 968 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 68.4 bits (167), Expect = 9e-13
Identities = 62/213 (29%), Positives = 99/213 (46%), Gaps = 36/213 (16%)
Query: 204 FSSKNILGAGGFGNVYKGKL----GDGTVLAVKRLKDMISLAV----------------H 243
F+ +LG G FG+V + +L G +AVK LK I + H
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60
Query: 244 RNLLRLIGYC--ATPTERL----LVYPYMSNGSV-----ASRLREKP-ALDWNTRKRIAI 291
N+++LIG + RL ++ P+M +G + SR+ E+P L T R I
Sbjct: 61 PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMI 120
Query: 292 GAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVT-TAVRG 350
A G+ YL + IHRD+ A N +L++ V DFGL+K + D + A +
Sbjct: 121 DIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKL 177
Query: 351 TVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT 383
V +A E L+ + +DV+ FG+ + E++T
Sbjct: 178 PVKWLALESLADNVYTTHSDVWAFGVTMWEIMT 210
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 1e-12
Identities = 61/215 (28%), Positives = 103/215 (47%), Gaps = 49/215 (22%)
Query: 209 ILGAGGFGNVYKGK-LGDG----TVLAVKRLKDMISLAVHRNLL---------------R 248
+LG+G FG VYKG + DG +A+K L++ S ++ +L R
Sbjct: 14 VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCR 73
Query: 249 LIGYCATPTERLLVYPYMSNGSVASRLRE-------KPALDWNTRKRIAIGAARGLLYLH 301
L+G C T T +L V M G + +RE + L+W + A+G+ YL
Sbjct: 74 LLGICLTSTVQL-VTQLMPYGCLLDYVRENKDRIGSQDLLNW------CVQIAKGMSYLE 126
Query: 302 EQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLD------HSDSHVTTAVRGTVGHI 355
E +++HRD+ A NVL+ + DFGLA+LLD H+D + + +
Sbjct: 127 EV---RLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGG-----KVPIKWM 178
Query: 356 APEYLSTGQSSEKTDVFGFGILLLELIT-GMRALE 389
A E + + + ++DV+ +G+ + EL+T G + +
Sbjct: 179 ALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYD 213
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 1e-12
Identities = 60/195 (30%), Positives = 89/195 (45%), Gaps = 23/195 (11%)
Query: 209 ILGAGGFGNVYKGKL-GDGTVLAVKRLK--------DMISLAVHRNLLRLIG-------- 251
+LG G FG V +L G G AVK LK D+ V + +L L
Sbjct: 2 VLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHL 61
Query: 252 YCATPTERLL--VYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKII 309
YC T+ L V +++ G + +++K D A GL +LH + II
Sbjct: 62 YCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSK---GII 118
Query: 310 HRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGHIAPEYLSTGQSSEKT 369
+RD+K NV+LD + DFG+ K D+ +T GT +IAPE L + +
Sbjct: 119 YRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFC-GTPDYIAPEILQGLKYTFSV 177
Query: 370 DVFGFGILLLELITG 384
D + FG+LL E++ G
Sbjct: 178 DWWSFGVLLYEMLIG 192
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 1e-12
Identities = 61/208 (29%), Positives = 95/208 (45%), Gaps = 37/208 (17%)
Query: 203 NFSSKNILGAGGFGNVYKGK-LGDGTVLAVKRLKDMISLAVHR-----NLLRLIGYCATP 256
+F LG G +G+VYK K L D A+K + D+ S++ N +R++ P
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEV-DLGSMSQKEREDAVNEIRILASVNHP 59
Query: 257 T-----------ERL-LVYPYMSNGSVASRLREKPALD--------WNTRKRIAIGAARG 296
+L +V Y G ++ + ++ W RI I RG
Sbjct: 60 NIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIW----RIFIQLLRG 115
Query: 297 LLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGHIA 356
L LHEQ KI+HRD+K+AN+LL +GD G++K+L ++ GT ++A
Sbjct: 116 LQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVL---KKNMAKTQIGTPHYMA 169
Query: 357 PEYLSTGQSSEKTDVFGFGILLLELITG 384
PE S K+D++ G LL E+ T
Sbjct: 170 PEVWKGRPYSYKSDIWSLGCLLYEMATF 197
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 2e-12
Identities = 57/218 (26%), Positives = 99/218 (45%), Gaps = 42/218 (19%)
Query: 202 ENFSSKNILGAGGFGNVYKG---KLGDGTVLAVKRLKDMIS----------------LAV 242
E+ ++++G G FG V + K G A+K LK+ S L
Sbjct: 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGH 61
Query: 243 HRNLLRLIGYCATPTERLLVYPYMSNGSVASRLREKPALDWN--------------TRK- 287
H N++ L+G C + Y G++ LR+ L+ + +++
Sbjct: 62 HPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQL 121
Query: 288 -RIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHV-T 345
+ A A G+ YL E+ + IHRD+ A NVL+ + + + DFGL++ + +V
Sbjct: 122 LQFASDVATGMQYLSEK---QFIHRDLAARNVLVGENLASKIADFGLSR---GEEVYVKK 175
Query: 346 TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT 383
T R V +A E L+ + K+DV+ FG+LL E+++
Sbjct: 176 TMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 67.8 bits (165), Expect = 2e-12
Identities = 55/203 (27%), Positives = 102/203 (50%), Gaps = 38/203 (18%)
Query: 209 ILGAGGFGNVYKGK-LGDGTVL----AVKRLKD---------------MISLAVHRNLLR 248
+LG+G FG VYKG + +G + A+K L + +++ H +L+R
Sbjct: 14 VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVR 73
Query: 249 LIGYCATPTERLLVYPYMSNGSVASRLRE-------KPALDWNTRKRIAIGAARGLLYLH 301
L+G C +PT +L V M +G + + E + L+W + A+G++YL
Sbjct: 74 LLGVCLSPTIQL-VTQLMPHGCLLDYVHEHKDNIGSQLLLNW------CVQIAKGMMYLE 126
Query: 302 EQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTT-AVRGTVGHIAPEYL 360
E+ +++HRD+ A NVL+ + DFGLA+LL+ + + + +A E +
Sbjct: 127 ER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECI 183
Query: 361 STGQSSEKTDVFGFGILLLELIT 383
+ + ++DV+ +G+ + EL+T
Sbjct: 184 HYRKFTHQSDVWSYGVTIWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 2e-12
Identities = 57/200 (28%), Positives = 97/200 (48%), Gaps = 21/200 (10%)
Query: 202 ENFSSKNILGAGGFGNVYKGK-LGDGTVLAVKRLKDMISLAVHRNLLR---LIGYCATP- 256
++F LGAG G V K G ++A K + I A+ ++R ++ C +P
Sbjct: 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPY 60
Query: 257 -----------TERLLVYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCD 305
E + +M GS+ L++ + N +I+I RGL YL E+
Sbjct: 61 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREK-- 118
Query: 306 PKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGHIAPEYLSTGQS 365
KI+HRDVK +N+L++ E + DFG++ L DS + V GT +++PE L
Sbjct: 119 HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL--IDSMANSFV-GTRSYMSPERLQGTHY 175
Query: 366 SEKTDVFGFGILLLELITGM 385
+ ++D++ G+ L+E+ G
Sbjct: 176 TVQSDIWSLGLSLVEMAIGR 195
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 2e-12
Identities = 73/293 (24%), Positives = 134/293 (45%), Gaps = 62/293 (21%)
Query: 207 KNILGAGGFGNVYKGKL-GDGTVL--AVKRLKDMIS----------------LAVHRNLL 247
++++G G FG V K ++ DG + A+KR+K+ S L H N++
Sbjct: 12 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 71
Query: 248 RLIGYCATPTERLLVYPYMSNGSVASRLREKPALD--------------WNTRKRIAIGA 293
L+G C L Y +G++ LR+ L+ ++++ + A
Sbjct: 72 NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 131
Query: 294 --ARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHV-TTAVRG 350
ARG+ YL ++ + IHRD+ A N+L+ + A + DFGL++ + +V T R
Sbjct: 132 DVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKTMGRL 185
Query: 351 TVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQE 410
V +A E L+ + +DV+ +G+LL E+++ G + E +K+ Q
Sbjct: 186 PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS------LGGTPYCGMTCAELYEKLPQG 239
Query: 411 KKVEVLVDRELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVV----RMLE 459
++E + N D EV ++++ C + P RP ++++ RMLE
Sbjct: 240 YRLEKPL------NCDD-EVYDLMR---QCWREKPYERPSFAQILVSLNRMLE 282
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.9 bits (164), Expect = 3e-12
Identities = 73/287 (25%), Positives = 119/287 (41%), Gaps = 60/287 (20%)
Query: 208 NILGAGGFGNVYKGK-LGDGTVLAVKRLK-----DMISLAV--------------HRNLL 247
+G G +G VYK + L G +A+K+++ + I L+ H N++
Sbjct: 5 AEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIV 64
Query: 248 RLIGYCATP-TER----LLVYP--------YMSNGSVASRLREKPALDWNTRKRIAIGAA 294
RL+ C P T+R LV+ Y+S KP L T K +
Sbjct: 65 RLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCP-------KPGLPPETIKDLMRQLL 117
Query: 295 RGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGH 354
RG+ +LH I+HRD+K N+L+ + + DFGLA++ + +T+ V T+ +
Sbjct: 118 RGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLARIYS-FEMALTSVVV-TLWY 172
Query: 355 IAPEYLSTGQSSEKT--DVFGFGILLLELITGMRALEFGKS-INQKGAMLEWV-KKIQQE 410
APE L QSS T D++ G + EL R L G S +Q + + + ++E
Sbjct: 173 RAPEVLL--QSSYATPVDMWSVGCIFAELFR-RRPLFRGTSEADQLDKIFDVIGLPSEEE 229
Query: 411 KKVEVLVDRELGSNYDRIEVGEILQ------VALL--CTQYLPVHRP 449
V + R +Y + + LL + P R
Sbjct: 230 WPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRI 276
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 3e-12
Identities = 61/209 (29%), Positives = 99/209 (47%), Gaps = 40/209 (19%)
Query: 204 FSSKNILGAGGFGNVYKG---KLGDGTVL--AVKRLKDMISLAVHRNLL----------- 247
F +LG+G FG VYKG G+ + A+K L++ S ++ +L
Sbjct: 9 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 68
Query: 248 ----RLIGYCATPTERLLVYPYMSNGSVASRLRE-------KPALDWNTRKRIAIGAARG 296
RL+G C T T +L + M G + +RE + L+W + A+G
Sbjct: 69 PHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKG 121
Query: 297 LLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTV--GH 354
+ YL E+ +++HRD+ A NVL+ + DFGLAKLL +D A G V
Sbjct: 122 MNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLG-ADEKEYHAEGGKVPIKW 177
Query: 355 IAPEYLSTGQSSEKTDVFGFGILLLELIT 383
+A E + + ++DV+ +G+ + EL+T
Sbjct: 178 MALESILHRIYTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.7 bits (164), Expect = 3e-12
Identities = 63/223 (28%), Positives = 95/223 (42%), Gaps = 46/223 (20%)
Query: 204 FSSKNILGAGGFGNVYKGK-LGDGTVLAVKRLK-DM------------ISL---AVHRNL 246
+ LG G +G VYK + G ++A+K+++ D ISL H N+
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNI 60
Query: 247 LRLIGYCATPTERLLVYPYMSNGSVASRLRE-----KPALDWNTRKRIAIGAARGLLYLH 301
++L+ T + LV+ Y L++ L N K I RGL Y H
Sbjct: 61 VKLLDVIHTERKLYLVFEYCDMD-----LKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCH 115
Query: 302 EQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAV-----RGTVGHIA 356
+I+HRD+K N+L++ + DFGLA+ T V R A
Sbjct: 116 SH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVVTLWYR------A 166
Query: 357 PEYL--STGQSSEKTDVFGFGILLLELITGMRALEFGKS-INQ 396
PE L S S+ D++ G + E+ITG + L G S I+Q
Sbjct: 167 PEILLGSKHYSTA-VDIWSVGCIFAEMITG-KPLFPGDSEIDQ 207
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 4e-12
Identities = 49/160 (30%), Positives = 74/160 (46%), Gaps = 41/160 (25%)
Query: 2 ITCSPENLVIGLGAPSQSLSGTLSGSIGNLTNLRQVLLQNNNISGGIPPQL--------- 52
ITC+ + V+ + +++SG +S +I L ++ + L NN +SG IP +
Sbjct: 63 ITCNNSSRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRY 122
Query: 53 ---------GSLPK-----LQTLDLSNNRLSGVIPALL--FLSIWLPRKWDKRKCSGVDQ 96
GS+P+ L+TLDLSNN LSG IP + F S+
Sbjct: 123 LNLSNNNFTGSIPRGSIPNLETLDLSNNMLSGEIPNDIGSFSSL---------------- 166
Query: 97 GLLRLNNNSLSGAFPVFLAKISELAFLDLSYNNLSGPVPK 136
+L L N L G P L ++ L FL L+ N L G +P+
Sbjct: 167 KVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPR 206
|
Length = 968 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 4e-12
Identities = 70/299 (23%), Positives = 123/299 (41%), Gaps = 64/299 (21%)
Query: 207 KNILGAGGFGNVYKGK------LGDGTVLAVKRLKD--------------MISLAVHRNL 246
K LG G FG V+ + D ++AVK LKD +++ H ++
Sbjct: 10 KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHI 69
Query: 247 LRLIGYCATPTERLLVYPYMSNGSVASRLR----------------EKPALDWNTRKRIA 290
++ G C ++V+ YM +G + LR K L + IA
Sbjct: 70 VKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIA 129
Query: 291 IGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSD-----SHVT 345
A G++YL Q +HRD+ N L+ +GDFG+++ + +D H
Sbjct: 130 SQIASGMVYLASQ---HFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTM 186
Query: 346 TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVK 405
+R + PE + + + ++DV+ FG++L E+ T +GK + + E ++
Sbjct: 187 LPIR----WMPPESIMYRKFTTESDVWSFGVILWEIFT------YGKQPWFQLSNTEVIE 236
Query: 406 KIQQEKKVEVLVDRELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLEGDGLA 464
I Q + +E R+ E+ + L C Q P R + E+ ++L G A
Sbjct: 237 CITQGRVLE----------RPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKA 285
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 4e-12
Identities = 67/285 (23%), Positives = 119/285 (41%), Gaps = 54/285 (18%)
Query: 202 ENFSSKNILGAGGFGNVYKG----KLGDGTVLAVKRLKDMISLAV--------------- 242
E+ + +G G FG+VY+G + +AVK K+ S +V
Sbjct: 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFD 65
Query: 243 HRNLLRLIGYCATPTERLL--VYPYMSNGSVASRL-REKPALDWNTRKRIAIGAARGLLY 299
H ++++LIG ++ + P G + S L K +LD + + + L Y
Sbjct: 66 HPHIVKLIGVITENPVWIVMELAPL---GELRSYLQVNKYSLDLASLILYSYQLSTALAY 122
Query: 300 LHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGHIAPEY 359
L + + +HRD+ A NVL+ +GDFGL++ L+ + + + + +APE
Sbjct: 123 LESK---RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPES 179
Query: 360 LSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDR 419
++ + + +DV+ FG+ + E+ L G VK Q K +V+
Sbjct: 180 INFRRFTSASDVWMFGVCMWEI------LMLG------------VKPFQGVKNNDVIGRI 221
Query: 420 ELGSNYDRIEVGEILQVAL-----LCTQYLPVHRPKMSEVVRMLE 459
E G +R+ + L C Y P RP+ +E+ L
Sbjct: 222 ENG---ERLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLS 263
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 4e-12
Identities = 57/199 (28%), Positives = 98/199 (49%), Gaps = 21/199 (10%)
Query: 202 ENFSSKNILGAGGFGNVYKGK-LGDGTVLAVKRLKDMISLAVHRNLLR---LIGYCATP- 256
++F + LGAG G V K + G ++A K + I A+ ++R ++ C +P
Sbjct: 5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 64
Query: 257 -----------TERLLVYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCD 305
E + +M GS+ L+E + +++I RGL YL E+
Sbjct: 65 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREK-- 122
Query: 306 PKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGHIAPEYLSTGQS 365
+I+HRDVK +N+L++ E + DFG++ L DS + V GT +++PE L
Sbjct: 123 HQIMHRDVKPSNILVNSRGEIKLCDFGVSGQL--IDSMANSFV-GTRSYMSPERLQGTHY 179
Query: 366 SEKTDVFGFGILLLELITG 384
S ++D++ G+ L+EL G
Sbjct: 180 SVQSDIWSMGLSLVELAIG 198
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 4e-12
Identities = 63/215 (29%), Positives = 97/215 (45%), Gaps = 44/215 (20%)
Query: 210 LGAGGFGNVYKGKL-------GDGTV-LAVKRLKD----------------MISLAVHRN 245
LG G FG V + + D TV +AVK LKD M + H+N
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79
Query: 246 LLRLIGYCATPTERLLVYPYMSNGSVASRLREK--PALDWN---TRK-----------RI 289
++ L+G C ++ Y + G++ LR + P D+ T+
Sbjct: 80 IINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSC 139
Query: 290 AIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSH-VTTAV 348
A ARG+ YL + + IHRD+ A NVL+ + + DFGLA+ + D + T+
Sbjct: 140 AYQVARGMEYLESR---RCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNG 196
Query: 349 RGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT 383
R V +APE L + ++DV+ FGIL+ E+ T
Sbjct: 197 RLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 4e-12
Identities = 56/198 (28%), Positives = 92/198 (46%), Gaps = 28/198 (14%)
Query: 209 ILGAGGFGNVYKGKLGD-GTVLAVK-------RLKDMISLAVH-RNLLRLI--GYCA--- 254
I+G GGFG VY + D G + A+K ++K +LA++ R +L L+ G C
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60
Query: 255 -------TPTERLLVYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPK 307
TP + + M+ G + L + + A GL ++H +
Sbjct: 61 CMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRF--- 117
Query: 308 IIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGHIAPEYLSTGQSSE 367
+++RD+K AN+LLD+ + D GLA H + GT G++APE L G + +
Sbjct: 118 VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMAPEVLQKGTAYD 174
Query: 368 KT-DVFGFGILLLELITG 384
+ D F G +L +L+ G
Sbjct: 175 SSADWFSLGCMLFKLLRG 192
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 5e-12
Identities = 42/116 (36%), Positives = 61/116 (52%), Gaps = 14/116 (12%)
Query: 20 LSGTLSGSIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFLS 79
LSG + IG+ ++L+ + L N + G IP L +L L+ L L++N+L G IP L
Sbjct: 152 LSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQM 211
Query: 80 IWLPRKWDKRKCSGVDQGLLRLNNNSLSGAFPVFLAKISELAFLDLSYNNLSGPVP 135
L KW + L N+LSG P + ++ L LDL YNNL+GP+P
Sbjct: 212 KSL--KW------------IYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIP 253
|
Length = 968 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 5e-12
Identities = 58/206 (28%), Positives = 96/206 (46%), Gaps = 42/206 (20%)
Query: 210 LGAGGFGNVYKGK-LGDGTVLAVKRLKDMISLAVHRNLLRLIGYCATPTERLLVYPYMSN 268
LG G +G V K + + GT++AVKR++ ++ + LL + R + PY
Sbjct: 9 LGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISM----RSVDCPYTVT 64
Query: 269 --GSVASRLRE----------KPALDWNTRK--------------RIAIGAARGLLYLHE 302
G++ RE +LD +K +IA+ + L YLH
Sbjct: 65 FYGAL---FREGDVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHS 121
Query: 303 QCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGHIAPEYLST 362
+ +IHRDVK +NVL++ + + DFG++ L DS T G ++APE ++
Sbjct: 122 KL--SVIHRDVKPSNVLINRNGQVKLCDFGISGYL--VDSVAKTIDAGCKPYMAPERINP 177
Query: 363 GQSSE----KTDVFGFGILLLELITG 384
+ + K+DV+ GI ++EL TG
Sbjct: 178 ELNQKGYDVKSDVWSLGITMIELATG 203
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 66.3 bits (161), Expect = 5e-12
Identities = 59/202 (29%), Positives = 90/202 (44%), Gaps = 27/202 (13%)
Query: 202 ENFSSKNILGAGGFGNVYKG------KLGDGTVLAVKRLKDMISLAVHRNLLRLIGYCAT 255
E F+ +G G FG V+KG K+ ++ ++ +D I + ++ C +
Sbjct: 4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQE--ITVLSQCDS 61
Query: 256 P------------TERLLVYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQ 303
P T+ ++ Y+ GS L P LD I +GL YLH +
Sbjct: 62 PYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP-LDETQIATILREILKGLDYLHSE 120
Query: 304 CDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVT-TAVRGTVGHIAPEYLST 362
K IHRD+KAANVLL + E + DFG+A L +D+ + GT +APE +
Sbjct: 121 ---KKIHRDIKAANVLLSEHGEVKLADFGVAGQL--TDTQIKRNTFVGTPFWMAPEVIKQ 175
Query: 363 GQSSEKTDVFGFGILLLELITG 384
K D++ GI +EL G
Sbjct: 176 SAYDSKADIWSLGITAIELAKG 197
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 66.1 bits (161), Expect = 6e-12
Identities = 62/198 (31%), Positives = 87/198 (43%), Gaps = 28/198 (14%)
Query: 210 LGAGGFGNV--YK---GKLGDGTVLAVKRLK---------------DMISLAVHRNLLRL 249
LG G FG V Y G G ++AVK LK +++ H N+++
Sbjct: 12 LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKY 71
Query: 250 IGYCATPTER--LLVYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPK 307
G C+ + L+ Y+ GS+ L K L+ A G+ YLH Q
Sbjct: 72 KGCCSEQGGKGLQLIMEYVPLGSLRDYL-PKHKLNLAQLLLFAQQICEGMAYLHSQ---H 127
Query: 308 IIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGT--VGHIAPEYLSTGQS 365
IHRD+ A NVLLD+ +GDFGLAK + + G V A E L +
Sbjct: 128 YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKF 187
Query: 366 SEKTDVFGFGILLLELIT 383
S +DV+ FG+ L EL+T
Sbjct: 188 SYASDVWSFGVTLYELLT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 7e-12
Identities = 52/191 (27%), Positives = 93/191 (48%), Gaps = 21/191 (10%)
Query: 210 LGAGGFGNVYKGK-LGDGTVLAVKRLKDMISLAVHRNLLRLIG---YCATP--------- 256
LGAG G+V K K + GTV+A K + +V + +LR + C +P
Sbjct: 13 LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAF 72
Query: 257 ---TERLLVYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDV 313
+ +M GS+ ++ + +IA+ GL YL+ +I+HRD+
Sbjct: 73 LNENNICMCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNV--HRIMHRDI 130
Query: 314 KAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFG 373
K +N+L++ + + DFG++ L +S + GT +++PE + G+ + K+DV+
Sbjct: 131 KPSNILVNSRGQIKLCDFGVSGELINS---IADTFVGTSTYMSPERIQGGKYTVKSDVWS 187
Query: 374 FGILLLELITG 384
GI ++EL G
Sbjct: 188 LGISIIELALG 198
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 8e-12
Identities = 72/287 (25%), Positives = 129/287 (44%), Gaps = 57/287 (19%)
Query: 210 LGAGGFGNVYKGKLGD------GTVLAVKRLKDMISL----------AVHR-----NLLR 248
LG G FG VY+G D T +AVK + + SL +V + +++R
Sbjct: 14 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 73
Query: 249 LIGYCATPTERLLVYPYMSNGSVASRLRE-KPALDWNT-------RKRIAIGA--ARGLL 298
L+G + L+V M++G + S LR +P + N ++ I + A A G+
Sbjct: 74 LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 133
Query: 299 YLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRG--TVGHIA 356
YL+ + K +HRD+ A N ++ +GDFG+ + + +D + +G V +A
Sbjct: 134 YLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETD-YYRKGGKGLLPVRWMA 189
Query: 357 PEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVL 416
PE L G + +D++ FG++L E+ + G S E+ ++ +
Sbjct: 190 PESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLS---------------NEQVLKFV 234
Query: 417 VDRELGSNYDRIEVGE--ILQVALLCTQYLPVHRPKMSEVVRMLEGD 461
+D G D+ + + + +C Q+ P RP E+V +L+ D
Sbjct: 235 MD---GGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD 278
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 9e-12
Identities = 46/162 (28%), Positives = 73/162 (45%), Gaps = 25/162 (15%)
Query: 299 YLHEQCDPKIIHRDVKAANVLL--DDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGHIA 356
Y+H+ I+HRD+K N+ L + +GDFG++K+L S T V GT +++
Sbjct: 116 YIHKA---GILHRDIKTLNIFLTKAGLIK--LGDFGISKILGSEYSMAETVV-GTPYYMS 169
Query: 357 PEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVL 416
PE + + K+D++ G +L EL+T R + + N L V KI Q V+
Sbjct: 170 PELCQGVKYNFKSDIWALGCVLYELLTLKRTFD---ATNP----LNLVVKIVQGNYTPVV 222
Query: 417 VDRELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRML 458
S Y E++ + Q P RP EV+
Sbjct: 223 ------SVYSS----ELISLVHSLLQQDPEKRPTADEVLDQP 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 66.1 bits (161), Expect = 1e-11
Identities = 33/88 (37%), Positives = 51/88 (57%), Gaps = 5/88 (5%)
Query: 295 RGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGH 354
GL YLH Q +IIHRDVK N+ ++D + +GD G A+ + + + A GTV
Sbjct: 168 EGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLGLA--GTVET 222
Query: 355 IAPEYLSTGQSSEKTDVFGFGILLLELI 382
APE L+ + + K D++ GI+L E++
Sbjct: 223 NAPEVLARDKYNSKADIWSAGIVLFEML 250
|
Length = 357 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 65.3 bits (159), Expect = 1e-11
Identities = 63/198 (31%), Positives = 82/198 (41%), Gaps = 32/198 (16%)
Query: 210 LGAGGFGNVY------KGKLGDGTVLAVKRLKD-----------MISLAVHRNLLRLIGY 252
LG GGFG V GKL L KRLK I VH + + Y
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60
Query: 253 C-ATPTERLLVYPYMSNGSVASRL----REKPALDWNTRKRIAIGAAR---GLLYLHEQC 304
T T+ LV M+ G + + E P R A+ GL +LH++
Sbjct: 61 AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFP---EPRACFYTAQIISGLEHLHQR- 116
Query: 305 DPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGHIAPEYLSTGQ 364
+II+RD+K NVLLD+ + D GLA L S T GT G +APE L +
Sbjct: 117 --RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK-TKGYAGTPGFMAPELLQGEE 173
Query: 365 SSEKTDVFGFGILLLELI 382
D F G+ L E+I
Sbjct: 174 YDFSVDYFALGVTLYEMI 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 1e-11
Identities = 60/197 (30%), Positives = 87/197 (44%), Gaps = 27/197 (13%)
Query: 209 ILGAGGFGNVYKGKL-GDGTVLAVKRLK--------DMISLAVHRNLLRLIG-------- 251
+LG G FG V +L G + AVK LK D+ + +L L G
Sbjct: 2 VLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQL 61
Query: 252 YCATPT-ERL-LVYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKII 309
+ T +RL V Y++ G + ++ D + A GL +LHE+ II
Sbjct: 62 HSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHER---GII 118
Query: 310 HRDVKAANVLLDDFCEAIVGDFGLAK--LLDHSDSHVTTAVRGTVGHIAPEYLSTGQSSE 367
+RD+K NVLLD + DFG+ K +L T+ GT +IAPE LS
Sbjct: 119 YRDLKLDNVLLDSEGHIKIADFGMCKEGILG---GVTTSTFCGTPDYIAPEILSYQPYGP 175
Query: 368 KTDVFGFGILLLELITG 384
D + G+LL E++ G
Sbjct: 176 AVDWWALGVLLYEMLAG 192
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 65.3 bits (159), Expect = 1e-11
Identities = 56/198 (28%), Positives = 92/198 (46%), Gaps = 28/198 (14%)
Query: 209 ILGAGGFGNVYKGKLGD-GTVLAVK-------RLKDMISLAVH-RNLLRLI--GYCA--- 254
I+G GGFG VY + D G + A+K ++K +LA++ R +L L+ G C
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60
Query: 255 -------TPTERLLVYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPK 307
TP + + M+ G + L + + A GL ++H +
Sbjct: 61 CMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRF--- 117
Query: 308 IIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGHIAPEYLSTGQSSE 367
+++RD+K AN+LLD+ + D GLA H + GT G++APE L G + +
Sbjct: 118 VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMAPEVLQKGVAYD 174
Query: 368 KT-DVFGFGILLLELITG 384
+ D F G +L +L+ G
Sbjct: 175 SSADWFSLGCMLFKLLRG 192
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 1e-11
Identities = 60/202 (29%), Positives = 93/202 (46%), Gaps = 27/202 (13%)
Query: 202 ENFSSKNILGAGGFGNVYKGKLGDGT--VLAVKRL-----KDMISLAVHRNLLRLIGYCA 254
E F+ +G G FG V+KG + + T V+A+K + +D I + ++ C
Sbjct: 4 ELFTKLERIGKGSFGEVFKG-IDNRTQQVVAIKIIDLEEAEDEIEDIQQE--ITVLSQCD 60
Query: 255 TP------------TERLLVYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHE 302
+P T+ ++ Y+ GS LR P ++ + +GL YLH
Sbjct: 61 SPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLK-EILKGLDYLHS 119
Query: 303 QCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGHIAPEYLST 362
+ K IHRD+KAANVLL + + + DFG+A L + T V GT +APE +
Sbjct: 120 E---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIQQ 175
Query: 363 GQSSEKTDVFGFGILLLELITG 384
K D++ GI +EL G
Sbjct: 176 SAYDSKADIWSLGITAIELAKG 197
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 2e-11
Identities = 38/96 (39%), Positives = 50/96 (52%), Gaps = 11/96 (11%)
Query: 289 IAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAV 348
I GA +GL YLH IHRD+KA N+LL + + DFG A L+ ++S V
Sbjct: 120 ICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASLVSPANSFV---- 172
Query: 349 RGTVGHIAPEY---LSTGQSSEKTDVFGFGILLLEL 381
GT +APE + GQ K DV+ GI +EL
Sbjct: 173 -GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 2e-11
Identities = 58/209 (27%), Positives = 91/209 (43%), Gaps = 43/209 (20%)
Query: 210 LGAGGFGNVYK--GKLGDGTVLAVKRL------------------KDMIS-LAVHRNLLR 248
LG+G FG VYK K +LA+K + D++S + + + LR
Sbjct: 8 LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67
Query: 249 ---LIGYCATPTERLLVYPYM------SNGSVASRLREK-----PALDWNTRKRIAIGAA 294
++ Y T E +Y M G + L+EK WN I +
Sbjct: 68 HPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWN----IFVQMV 123
Query: 295 RGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGH 354
L YLH++ +I+HRD+ N++L + + + DFGLAK T+V GT+ +
Sbjct: 124 LALRYLHKE--KRIVHRDLTPNNIMLGEDDKVTITDFGLAK--QKQPESKLTSVVGTILY 179
Query: 355 IAPEYLSTGQSSEKTDVFGFGILLLELIT 383
PE + EK DV+ FG +L ++ T
Sbjct: 180 SCPEIVKNEPYGEKADVWAFGCILYQMCT 208
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 3e-11
Identities = 60/198 (30%), Positives = 89/198 (44%), Gaps = 29/198 (14%)
Query: 209 ILGAGGFGNVYKGKLGDGT-VLAVKRLK--------DMISLAVHRNLLRLIG-------- 251
+LG G FG V +L A+K LK D+ V R +L L
Sbjct: 2 VLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHL 61
Query: 252 YCATPTERLL--VYPYMSNGSVASRLREKPALDWNTRKRIAIGAAR---GLLYLHEQCDP 306
+C T+ L V Y++ G + ++ D R AA GL +LH++
Sbjct: 62 FCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFD---EARARFYAAEIICGLQFLHKK--- 115
Query: 307 KIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGHIAPEYLSTGQSS 366
II+RD+K NVLLD + DFG+ K + + +T GT +IAPE L + +
Sbjct: 116 GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFC-GTPDYIAPEILKGQKYN 174
Query: 367 EKTDVFGFGILLLELITG 384
E D + FG+LL E++ G
Sbjct: 175 ESVDWWSFGVLLYEMLIG 192
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 3e-11
Identities = 59/222 (26%), Positives = 99/222 (44%), Gaps = 43/222 (19%)
Query: 197 LQQATENFSSKNILGAGGFGNVYKGKLGDGT------VLAVKRLKDMISL---------- 240
+ + + + ++L G FG ++ G L D V VK +KD S
Sbjct: 1 IAISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVF-VKTVKDHASEIQVTLLLQES 59
Query: 241 -----AVHRNLLRLIGYCATPTERLLV-YPYMSNGSVASRLREKPALDWNTRKRI----- 289
H+N+L ++ C E V YPYM+ G++ L++ + N + +
Sbjct: 60 CLLYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQL 119
Query: 290 ---AIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTT 346
AI A G+ YLH++ +IH+D+ A N ++D+ + + D L++ L D H
Sbjct: 120 VHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCL- 175
Query: 347 AVRGT-----VGHIAPEYLSTGQSSEKTDVFGFGILLLELIT 383
G V +A E L + S +DV+ FG+LL EL+T
Sbjct: 176 ---GDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMT 214
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 4e-11
Identities = 51/206 (24%), Positives = 82/206 (39%), Gaps = 36/206 (17%)
Query: 210 LGAGGFGNVYKGKLGDGTVLA---VKRLKDMIS---------------LAVHRNLLRLIG 251
+G G FG V G+ G A VK L+ + H N+L+ +G
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62
Query: 252 YCATPTERLLVYPYMSNGSVASRLR-----EKPALDWNTRKRIAIGAARGLLYLHEQCDP 306
C LLV + G + + LR + +R+A A GLL+LH+
Sbjct: 63 QCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA--- 119
Query: 307 KIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVG--HIAPEYLSTGQ 364
IH D+ N L +GD+GLA L + + + T V +APE +
Sbjct: 120 DFIHSDLALRNCQLTADLSVKIGDYGLA-LEQYPEDYYITKDCHAVPLRWLAPELVEIRG 178
Query: 365 S-------SEKTDVFGFGILLLELIT 383
++K++++ G+ + EL T
Sbjct: 179 QDLLPKDQTKKSNIWSLGVTMWELFT 204
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 4e-11
Identities = 57/214 (26%), Positives = 94/214 (43%), Gaps = 49/214 (22%)
Query: 210 LGAGGFGNVYKGKL------GDGTVLAVKRLKDMISLAV---------------HRNLLR 248
LG G FG VYKG+L T +A+K LK+ V H N++
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72
Query: 249 LIGYCATPTERLLVYPYMSNGSVASRL-REKP---------------ALDWNTRKRIAIG 292
L+G C +++ Y+++G + L R P +LD + IAI
Sbjct: 73 LLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQ 132
Query: 293 AARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSD-----SHVTTA 347
A G+ YL +HRD+ A N L+ + + DFGL++ + +D S
Sbjct: 133 IAAGMEYLSSH---HFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLP 189
Query: 348 VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLEL 381
VR + PE + G+ + ++D++ FG++L E+
Sbjct: 190 VR----WMPPEAILYGKFTTESDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 4e-11
Identities = 60/199 (30%), Positives = 89/199 (44%), Gaps = 21/199 (10%)
Query: 202 ENFSSKNILGAGGFGNVYKG-KLGDGTVLAVK---------RLKDM------ISLAVHRN 245
E F+ +G G FG VYKG V+A+K ++D+ +S
Sbjct: 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 63
Query: 246 LLRLIGYCATPTERLLVYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCD 305
+ R G T+ ++ Y+ GS L+ P L+ I +GL YLH +
Sbjct: 64 ITRYYGSYLKGTKLWIIMEYLGGGSALDLLKPGP-LEETYIATILREILKGLDYLHSE-- 120
Query: 306 PKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGHIAPEYLSTGQS 365
+ IHRD+KAANVLL + + + DFG+A L + T V GT +APE +
Sbjct: 121 -RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIKQSAY 178
Query: 366 SEKTDVFGFGILLLELITG 384
K D++ GI +EL G
Sbjct: 179 DFKADIWSLGITAIELAKG 197
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 4e-11
Identities = 54/206 (26%), Positives = 90/206 (43%), Gaps = 27/206 (13%)
Query: 203 NFSSKNILGAGGFGNVY---------KGKLGDGTVLA----VKRLKDMISLAVHRNLLRL 249
NF +LG G +G V+ GKL VL V++ K + RN+L
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60
Query: 250 IGYC----------ATPTERLLVYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLY 299
+ T + L+ Y+S G + + L ++ D + + + +L
Sbjct: 61 VRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQR---DNFSEDEVRFYSGEIILA 117
Query: 300 LHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGHIAPEY 359
L I++RD+K N+LLD ++ DFGL+K + T + GT+ ++APE
Sbjct: 118 LEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEI 177
Query: 360 L-STGQSSEKTDVFGFGILLLELITG 384
+ G + D + GIL+ EL+TG
Sbjct: 178 IRGKGGHGKAVDWWSLGILIFELLTG 203
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 4e-11
Identities = 56/208 (26%), Positives = 92/208 (44%), Gaps = 30/208 (14%)
Query: 203 NFSSKNILGAGGFGNVY----KGKLGDGTVLAVKRLKDMISL-----AVH----RNLLRL 249
NF +LG G +G V+ G G + A+K LK + A H R +L
Sbjct: 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEA 60
Query: 250 IGYC----------ATPTERLLVYPYMSNGSVASRLREKPALDWNTRKRIAIGA-ARGLL 298
+ C T T+ L+ Y++ G + + L ++ + R+ I L
Sbjct: 61 VRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFT-ESEVRVYIAEIVLALD 119
Query: 299 YLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGHIAPE 358
+LH+ II+RD+K N+LLD ++ DFGL+K + + GT+ ++APE
Sbjct: 120 HLHQL---GIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPE 176
Query: 359 YLSTGQS--SEKTDVFGFGILLLELITG 384
+ G + D + G+L EL+TG
Sbjct: 177 VIRGGSGGHDKAVDWWSLGVLTFELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 63.5 bits (155), Expect = 5e-11
Identities = 56/198 (28%), Positives = 93/198 (46%), Gaps = 29/198 (14%)
Query: 210 LGAGGFGNVYKGK-LGDGTVLAVKR-------------LKDM-ISLAVHR--NLLRLIGY 252
+G+G G VYK + G V+AVK+ L D+ + L H +++ GY
Sbjct: 23 IGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGY 82
Query: 253 CATPTERLLVYPYMSNGSVASRL--REKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIH 310
T ++ + MS + +L R + + + ++ + + L YL E+ +IH
Sbjct: 83 FITDSDVFICMELMS--TCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEK--HGVIH 138
Query: 311 RDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGHIAPEYLSTGQSSEK-- 368
RDVK +N+LLD + DFG++ L S + +A G ++APE + + K
Sbjct: 139 RDVKPSNILLDASGNVKLCDFGISGRLVDSKAKTRSA--GCAAYMAPERIDPPDPNPKYD 196
Query: 369 --TDVFGFGILLLELITG 384
DV+ GI L+EL TG
Sbjct: 197 IRADVWSLGISLVELATG 214
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 62.8 bits (152), Expect = 6e-11
Identities = 58/206 (28%), Positives = 91/206 (44%), Gaps = 29/206 (14%)
Query: 203 NFSSKNILGAGGFGNVYKG-KLGDGTVLAVKRL----------KDMISLAVHRNLL---- 247
N+ +LG G FG VY + G LA K++ K++ +L LL
Sbjct: 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQ 62
Query: 248 --RLIGYCATPTER-----LLVYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYL 300
R++ Y +R + YM GSV +L+ AL + ++ G+ YL
Sbjct: 63 HERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYL 122
Query: 301 HEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGH---IAP 357
H I+HRD+K AN+L D +GDFG +K L + T +R G ++P
Sbjct: 123 HSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRL-QTICMSGTGIRSVTGTPYWMSP 178
Query: 358 EYLSTGQSSEKTDVFGFGILLLELIT 383
E +S K DV+ G ++E++T
Sbjct: 179 EVISGEGYGRKADVWSLGCTVVEMLT 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 6e-11
Identities = 59/215 (27%), Positives = 101/215 (46%), Gaps = 29/215 (13%)
Query: 209 ILGAGGFGNVY--KGKLGD--GTVLAVKRLK-------DMISLAVHRNLLRLIGY----- 252
+LG G FG V+ + G G + A+K LK D + + R++L + +
Sbjct: 3 VLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVK 62
Query: 253 ----CATPTERLLVYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKI 308
T + L+ ++ G + +RL ++ K A L +LH I
Sbjct: 63 LHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSL---GI 119
Query: 309 IHRDVKAANVLLDDFCEAIVGDFGLAK-LLDHSDSHVTTAVRGTVGHIAPEYLSTGQSSE 367
I+RD+K N+LLD+ + DFGL+K +DH + GTV ++APE ++ ++
Sbjct: 120 IYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKK--AYSFCGTVEYMAPEVVNRRGHTQ 177
Query: 368 KTDVFGFGILLLELITGMRALEF-GKSINQKGAML 401
D + FG+L+ E++TG +L F GK + M+
Sbjct: 178 SADWWSFGVLMFEMLTG--SLPFQGKDRKETMTMI 210
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 63.3 bits (155), Expect = 6e-11
Identities = 37/112 (33%), Positives = 59/112 (52%), Gaps = 20/112 (17%)
Query: 295 RGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSH--------VTT 346
RGL YLH +IHRD+K +N+L++ C+ + DFGLA+ +D + VT
Sbjct: 114 RGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTR 170
Query: 347 AVRGTVGHIAPE-YLSTGQSSEKTDVFGFGILLLELITGMRALEFGKS-INQ 396
R APE LS+ + ++ D++ G + EL+T + L G+ I+Q
Sbjct: 171 WYR------APELLLSSSRYTKAIDIWSVGCIFAELLTR-KPLFPGRDYIDQ 215
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 6e-11
Identities = 57/204 (27%), Positives = 88/204 (43%), Gaps = 31/204 (15%)
Query: 204 FSSKNILGAGGFGNV------YKGKLGDGTVLAVKRLKDMISLAVHRNLLRLIGYCATPT 257
F +LG GGFG V GK+ L KR+K A+ N +++ +
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 61
Query: 258 ERLLVYPY------------MSNGSVASRLRE--KPALDWNTRKRIAIGAAR---GLLYL 300
L Y Y M+ G + + P D +R AA GL L
Sbjct: 62 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFD---EERAVFYAAEITCGLEDL 118
Query: 301 HEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGHIAPEYL 360
H + +I++RD+K N+LLDD+ + D GLA ++ + GTVG++APE +
Sbjct: 119 HRE---RIVYRDLKPENILLDDYGHIRISDLGLA--VEIPEGETIRGRVGTVGYMAPEVV 173
Query: 361 STGQSSEKTDVFGFGILLLELITG 384
+ + D +G G L+ E+I G
Sbjct: 174 KNERYTFSPDWWGLGCLIYEMIEG 197
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 7e-11
Identities = 57/195 (29%), Positives = 86/195 (44%), Gaps = 23/195 (11%)
Query: 209 ILGAGGFGNVYKGKL-GDGTVLAVKRLK--------DMISLAVHRNLLRLIG-------- 251
+LG G FG V+ +L G A+K LK D+ V + +L L
Sbjct: 2 MLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHL 61
Query: 252 YCATPTERLL--VYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKII 309
YC T+ L V Y++ G + ++ D A GL +LH + I+
Sbjct: 62 YCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSK---GIV 118
Query: 310 HRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGHIAPEYLSTGQSSEKT 369
+RD+K N+LLD + DFG+ K D+ T GT +IAPE L + +
Sbjct: 119 YRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFC-GTPDYIAPEILLGQKYNTSV 177
Query: 370 DVFGFGILLLELITG 384
D + FG+LL E++ G
Sbjct: 178 DWWSFGVLLYEMLIG 192
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 8e-11
Identities = 53/224 (23%), Positives = 100/224 (44%), Gaps = 52/224 (23%)
Query: 210 LGAGGFGNVYKGK-LG-----DGTVLAVKRLKDMISLAV---------------HRNLLR 248
+G G FG V++ + G T++AVK LK+ S + H N+++
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72
Query: 249 LIGYCATPTERLLVYPYMSNGSVASRLREK--------------------PALDWNTRKR 288
L+G CA L++ YM+ G + LR + L + ++
Sbjct: 73 LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132
Query: 289 IAIGA--ARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAK---LLDHSDSH 343
+ I A G+ YL E+ K +HRD+ N L+ + + DFGL++ D+ +
Sbjct: 133 LCIAKQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKAS 189
Query: 344 VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GMR 386
A+ + + PE + + + ++DV+ +G++L E+ + GM+
Sbjct: 190 ENDAI--PIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQ 231
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 9e-11
Identities = 54/212 (25%), Positives = 91/212 (42%), Gaps = 33/212 (15%)
Query: 202 ENFSSKNILGAGGFGNVYKGKL------GDGTVLAVKRLK---------------DMISL 240
N LG G FG V+ K G T++ VK L+ DM
Sbjct: 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRK 64
Query: 241 AVHRNLLRLIGYCATPTERLLVYPYMSNGSVASRLR-EKPALDW------NTRKRIAIGA 293
H+N++RL+G C ++ Y G + LR K + +T++++A+
Sbjct: 65 LSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCT 124
Query: 294 --ARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGT 351
A G+ +L + +HRD+ A N L+ E V L+K + +S+ +
Sbjct: 125 QIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIP 181
Query: 352 VGHIAPEYLSTGQSSEKTDVFGFGILLLELIT 383
+ +APE + S K+DV+ FG+L+ E+ T
Sbjct: 182 LRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFT 213
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 9e-11
Identities = 55/199 (27%), Positives = 98/199 (49%), Gaps = 21/199 (10%)
Query: 202 ENFSSKNILGAGGFGNVYK-GKLGDGTVLAVKRLKDMISLAVHRNLLR---LIGYCATP- 256
++F + LGAG G V+K G ++A K + I A+ ++R ++ C +P
Sbjct: 5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 64
Query: 257 -----------TERLLVYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCD 305
E + +M GS+ L++ + +++I +GL YL E+
Sbjct: 65 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK-- 122
Query: 306 PKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGHIAPEYLSTGQS 365
KI+HRDVK +N+L++ E + DFG++ L DS + V GT +++PE L
Sbjct: 123 HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL--IDSMANSFV-GTRSYMSPERLQGTHY 179
Query: 366 SEKTDVFGFGILLLELITG 384
S ++D++ G+ L+E+ G
Sbjct: 180 SVQSDIWSMGLSLVEMAIG 198
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 1e-10
Identities = 62/227 (27%), Positives = 112/227 (49%), Gaps = 33/227 (14%)
Query: 210 LGAGGFGNVYKG--KLGDGTV-LAVKRLK---------DMISLA--VHR----NLLRLIG 251
LG+G FG V KG K+ + +A+K LK +M+ A +H+ ++R+IG
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62
Query: 252 YCATPTERLLVYPYMSNGSVASRL--REKPALDWNTRKRIAIGAARGLLYLHEQCDPKII 309
C E L++ M++G ++ +K + + + + G+ YL + +
Sbjct: 63 VCEA--EALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGK---NFV 117
Query: 310 HRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVT--TAVRGTVGHIAPEYLSTGQSSE 367
HRD+ A NVLL + A + DFGL+K L DS+ +A + + APE ++ + S
Sbjct: 118 HRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFSS 177
Query: 368 KTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVE 414
++DV+ +GI + E A +G+ +K E + I+Q K+++
Sbjct: 178 RSDVWSYGITMWE------AFSYGQKPYKKMKGPEVMSFIEQGKRLD 218
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 1e-10
Identities = 60/212 (28%), Positives = 92/212 (43%), Gaps = 35/212 (16%)
Query: 203 NFSSKNILGAGGFGNVYKG-KLGDGTVLAVKRLK--------DMISLAVHRNLLRLIG-- 251
+F+ +LG G FG V + G + A+K LK D+ V + +L L G
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKP 60
Query: 252 -------YCATPTERL-LVYPYMSNGSV------ASRLREKPALDWNTRKRIAIGAARGL 297
C +RL V Y++ G + R +E A+ + I GL
Sbjct: 61 PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAI------GL 114
Query: 298 LYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGHIAP 357
+LH + II+RD+K NV+LD + DFG+ K + D T GT +IAP
Sbjct: 115 FFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKE-NMWDGVTTKTFCGTPDYIAP 170
Query: 358 EYLSTGQSSEKTDVFGFGILLLELITGMRALE 389
E ++ + D + FG+LL E++ G E
Sbjct: 171 EIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFE 202
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 62.3 bits (152), Expect = 1e-10
Identities = 38/108 (35%), Positives = 61/108 (56%), Gaps = 11/108 (10%)
Query: 295 RGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSD----SHVTTAVRG 350
RGL Y+H +IHRD+K +N+L+++ CE +GDFG+A+ L S +T V
Sbjct: 118 RGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYV-A 173
Query: 351 TVGHIAPE-YLSTGQSSEKTDVFGFGILLLELITGMRALEFGKS-INQ 396
T + APE LS + + D++ G + E++ G R L GK+ ++Q
Sbjct: 174 TRWYRAPELLLSLPEYTTAIDMWSVGCIFAEML-GRRQLFPGKNYVHQ 220
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 2e-10
Identities = 56/212 (26%), Positives = 100/212 (47%), Gaps = 42/212 (19%)
Query: 208 NILGAGGFGNVYKGKLG-DGTVL--AVKRLKDMIS----------------LAVHRNLLR 248
+++G G FG V K ++ DG + A+KR+K+ S L H N++
Sbjct: 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 60
Query: 249 LIGYCATPTERLLVYPYMSNGSVASRLREKPALD--------------WNTRK--RIAIG 292
L+G C L Y +G++ LR+ L+ ++++ A
Sbjct: 61 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 120
Query: 293 AARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHV-TTAVRGT 351
ARG+ YL ++ + IHRD+ A N+L+ + A + DFGL++ + +V T R
Sbjct: 121 VARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKTMGRLP 174
Query: 352 VGHIAPEYLSTGQSSEKTDVFGFGILLLELIT 383
V +A E L+ + +DV+ +G+LL E+++
Sbjct: 175 VRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 61.5 bits (150), Expect = 2e-10
Identities = 49/194 (25%), Positives = 82/194 (42%), Gaps = 23/194 (11%)
Query: 210 LGAGGFGNVYKGK-LGDGTVLAVK-----RLKDMISLAV-----------HRNLLRLIGY 252
+G G G V+K K G +A+K RL+ I H +++L+
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDV 67
Query: 253 CATPTERLLVYPYMSNGSVASRLREKPA-LDWNTRKRIAIGAARGLLYLHEQCDPKIIHR 311
+ +LV YM ++ LR++ L K +G+ Y+H I+HR
Sbjct: 68 FPHGSGFVLVMEYMP-SDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHAN---GIMHR 123
Query: 312 DVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGHIAPEYLSTGQS-SEKTD 370
D+K AN+L+ + DFGLA+L + + + T + APE L + D
Sbjct: 124 DLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARKYDPGVD 183
Query: 371 VFGFGILLLELITG 384
++ G + EL+ G
Sbjct: 184 LWAVGCIFAELLNG 197
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 61.9 bits (151), Expect = 2e-10
Identities = 49/162 (30%), Positives = 70/162 (43%), Gaps = 44/162 (27%)
Query: 210 LGAGGFGNVYKG-KLGDGTVLAVKRL-----KD-----------MISLAVHRNLLRLI-- 250
LG G FG VYK ++ G V+A+K++ KD ++ H N++ LI
Sbjct: 16 LGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDM 75
Query: 251 ------GYCATPTERLLVYPYM--------SNGSVASRLREKPALDWNTRKRIAIGAARG 296
+V PYM N SV +L E K + G
Sbjct: 76 AVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSV--KLTESQI------KCYMLQLLEG 127
Query: 297 LLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLD 338
+ YLHE I+HRD+KAAN+L+D+ + DFGLA+ D
Sbjct: 128 INYLHEN---HILHRDIKAANILIDNQGILKIADFGLARPYD 166
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 2e-10
Identities = 63/200 (31%), Positives = 93/200 (46%), Gaps = 31/200 (15%)
Query: 209 ILGAGGFGNVY--KGKLGDGTVLAVKRL--------KDMISLAVHRNLLR-------LIG 251
++G G FG V K K DG AVK L K+ + RN+L L+G
Sbjct: 2 VIGKGSFGKVLLAKHKA-DGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVG 60
Query: 252 --YCATPTERL-LVYPYMSNGSVASRL-REKPALDWNTRKRIA-IGAARGLLYLHEQCDP 306
Y ++L V Y++ G + L RE+ + R A I +A G YLH
Sbjct: 61 LHYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALG--YLHSL--- 115
Query: 307 KIIHRDVKAANVLLDDFCEAIVGDFGLAKL-LDHSDSHVTTAVRGTVGHIAPEYLSTGQS 365
II+RD+K N+LLD ++ DFGL K ++HS + T+ GT ++APE L
Sbjct: 116 NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKT--TSTFCGTPEYLAPEVLRKQPY 173
Query: 366 SEKTDVFGFGILLLELITGM 385
D + G +L E++ G+
Sbjct: 174 DRTVDWWCLGAVLYEMLYGL 193
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 61.6 bits (150), Expect = 2e-10
Identities = 57/216 (26%), Positives = 89/216 (41%), Gaps = 52/216 (24%)
Query: 203 NFSSKNILGAGGFGNVYKGK-LGDGTVLAVKRL-----KDMISLAV-----------HRN 245
F N +G G +G VY+ + G ++A+K++ +D I ++ H N
Sbjct: 8 EFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPN 67
Query: 246 LLRL---------------IGYCATPTERLLVYPYMSNGSVASRLREKPALDWNTRKRIA 290
++ L + YC LL M S++ K +
Sbjct: 68 IVELKEVVVGKHLDSIFLVMEYCEQDLASLL--DNMPTPFSESQV-----------KCLM 114
Query: 291 IGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRG 350
+ RGL YLHE IIHRD+K +N+LL D + DFGLA+ +T V
Sbjct: 115 LQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVV- 170
Query: 351 TVGHIAPEYL--STGQSSEKTDVFGFGILLLELITG 384
T+ + APE L T + D++ G +L EL+
Sbjct: 171 TLWYRAPELLLGCTTY-TTAIDMWAVGCILAELLAH 205
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 2e-10
Identities = 61/234 (26%), Positives = 97/234 (41%), Gaps = 40/234 (17%)
Query: 204 FSSKNILGAGGFGNVYKGKL-GDGTVLAVKRL-----------------KDMISLAVHRN 245
F +LG GGFG V ++ G + A KRL K ++ +
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61
Query: 246 LLRLIGYCATPTERLLVYPYMSNGSVASRLRE--KPALDWNTRKRIAIGAAR---GLLYL 300
++ L T LV M+ G + + P + +R AA GL L
Sbjct: 62 VVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFE---EERALFYAAEILCGLEDL 118
Query: 301 HEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGHIAPEYL 360
H + ++RD+K N+LLDD+ + D GLA + +S GTVG++APE L
Sbjct: 119 HRE---NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES--IRGRVGTVGYMAPEVL 173
Query: 361 STGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVE 414
+ + + D +G G L+ E+I G K E VK+ + +++V
Sbjct: 174 NNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRK---------EKVKREEVDRRVL 218
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 60.7 bits (148), Expect = 2e-10
Identities = 54/197 (27%), Positives = 81/197 (41%), Gaps = 29/197 (14%)
Query: 210 LGAGGFGNVYKGKL-GDGTVLAVKRL-----------------KDMISLAVHRNLLRLIG 251
LG GGFG V K+ A+K + K+++ H +++L
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLY- 59
Query: 252 YCATPTERLLVY---PYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKI 308
T ++ +Y Y G + + LR++ D T + YLH + I
Sbjct: 60 --RTFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNR---GI 114
Query: 309 IHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGHIAPEYLSTGQSSEK 368
I+RD+K N+LLD + DFG AK L T GT ++APE +
Sbjct: 115 IYRDLKPENLLLDSNGYVKLVDFGFAKKL--KSGQKTWTFCGTPEYVAPEIILNKGYDFS 172
Query: 369 TDVFGFGILLLELITGM 385
D + GILL EL+TG
Sbjct: 173 VDYWSLGILLYELLTGR 189
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 2e-10
Identities = 59/200 (29%), Positives = 92/200 (46%), Gaps = 31/200 (15%)
Query: 204 FSSKNILGAGGFGNVYKGK-LGDGTVLAVKRL-----------KDMISLAV------HRN 245
FS +G G FG VY + + + V+A+K++ +D+I H N
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 246 LLRLIG-YCATPTERLLVYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQC 304
++ G Y T L++ + + S + +KP + + GA +GL YLH
Sbjct: 77 TIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAA-VTHGALQGLAYLHSH- 134
Query: 305 DPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGHIAPEY---LS 361
+IHRDVKA N+LL + +GDFG A ++ ++ V GT +APE +
Sbjct: 135 --NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFV-----GTPYWMAPEVILAMD 187
Query: 362 TGQSSEKTDVFGFGILLLEL 381
GQ K DV+ GI +EL
Sbjct: 188 EGQYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 3e-10
Identities = 40/122 (32%), Positives = 57/122 (46%), Gaps = 24/122 (19%)
Query: 20 LSGTLSGSIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFLS 79
L G + S+ NLT+L + L +N + G IP +LG + L+ + L N LSG IP +
Sbjct: 176 LVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEI--- 232
Query: 80 IWLPRKWDKRKCSGVDQGLLRLNN-----NSLSGAFPVFLAKISELAFLDLSYNNLSGPV 134
GL LN+ N+L+G P L + L +L L N LSGP+
Sbjct: 233 ----------------GGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPI 276
Query: 135 PK 136
P
Sbjct: 277 PP 278
|
Length = 968 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.2 bits (149), Expect = 3e-10
Identities = 50/204 (24%), Positives = 83/204 (40%), Gaps = 26/204 (12%)
Query: 210 LGAGGFGNVYKGKLGD-GTVLAVKRLKD----------------MISLAVHRNLLRLIGY 252
+G G +G V K + G ++A+K+ K+ ++ H N++ L
Sbjct: 9 VGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEA 68
Query: 253 CATPTERLLVYPYMSNGSVASRLREKPA-LDWNTRKRIAIGAARGLLYLHEQCDPKIIHR 311
LV+ Y+ ++ L P L + + + + Y H IIHR
Sbjct: 69 FRRKGRLYLVFEYVER-TLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSH---NIIHR 124
Query: 312 DVKAANVLLDDFCEAIVGDFGLAKLL-DHSDSHVTTAVRGTVGHIAPEYL-STGQSSEKT 369
D+K N+L+ + + DFG A+ L S +T V T + APE L +
Sbjct: 125 DIKPENILVSESGVLKLCDFGFARALRARPASPLTDYV-ATRWYRAPELLVGDTNYGKPV 183
Query: 370 DVFGFGILLLELITGMRALEFGKS 393
DV+ G ++ EL+ G L G S
Sbjct: 184 DVWAIGCIMAELLDG-EPLFPGDS 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 3e-10
Identities = 54/215 (25%), Positives = 94/215 (43%), Gaps = 28/215 (13%)
Query: 201 TENFSSKNILGAGGFGNVYKGK-LGDGTVLAVKRLKDMISLAV----------------H 243
T + +G G FG V + G +A+K++ S V H
Sbjct: 9 TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRH 68
Query: 244 RNLLRLIGYCATPTERLLVYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQ 303
N++ L +P E + + + L +P L+ + RGL Y+H
Sbjct: 69 ENIISLSDIFISPLEDIYFVTELLGTDLHRLLTSRP-LEKQFIQYFLYQILRGLKYVHSA 127
Query: 304 CDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGHIAPEYLSTG 363
++HRD+K +N+L+++ C+ + DFGLA++ D +T V T + APE + T
Sbjct: 128 ---GVVHRDLKPSNILINENCDLKICDFGLARIQDP---QMTGYV-STRYYRAPEIMLTW 180
Query: 364 QS-SEKTDVFGFGILLLELITGMRALEFGKS-INQ 396
Q + D++ G + E++ G + L GK +NQ
Sbjct: 181 QKYDVEVDIWSAGCIFAEMLEG-KPLFPGKDHVNQ 214
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 4e-10
Identities = 56/200 (28%), Positives = 93/200 (46%), Gaps = 30/200 (15%)
Query: 210 LGAGGFGNV----YKGKLGD--GTVLAVKRLK---------------DMISLAVHRNLLR 248
LG G FG V Y + GD G +AVK LK +++ H N+++
Sbjct: 12 LGEGHFGKVELCRYDPE-GDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVK 70
Query: 249 LIGYCATPTER--LLVYPYMSNGSVASRL-REKPALDWNTRKRIAIGAARGLLYLHEQCD 305
G C L+ ++ +GS+ L R K ++ + + A+ +G+ YL +
Sbjct: 71 YKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSR-- 128
Query: 306 PKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTA--VRGTVGHIAPEYLSTG 363
+ +HRD+ A NVL++ + +GDFGL K ++ + T + V APE L
Sbjct: 129 -QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQS 187
Query: 364 QSSEKTDVFGFGILLLELIT 383
+ +DV+ FG+ L EL+T
Sbjct: 188 KFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 60.5 bits (146), Expect = 4e-10
Identities = 63/225 (28%), Positives = 100/225 (44%), Gaps = 47/225 (20%)
Query: 204 FSSKNILGAGGFGNVYKGK-LGDGTVLAVK----------RLKDMISL----AVHRNLLR 248
F ++G G +G VYKG+ + G + A+K +K I++ + HRN+
Sbjct: 8 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIAT 67
Query: 249 LIGYC------ATPTERLLVYPYMSNGSVASRLREKPALDWNTRKR-----IAIGAARGL 297
G + LV + GSV ++ NT K I RGL
Sbjct: 68 YYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKG---NTLKEEWIAYICREILRGL 124
Query: 298 LYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGHIAP 357
+LH+ K+IHRD+K NVLL + E + DFG++ LD + T + GT +AP
Sbjct: 125 SHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-GTPYWMAP 180
Query: 358 EYLSTGQSSE-----KTDVFGFGILLLELITG---------MRAL 388
E ++ ++ + K+D++ GI +E+ G MRAL
Sbjct: 181 EVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRAL 225
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.5 bits (147), Expect = 4e-10
Identities = 48/194 (24%), Positives = 84/194 (43%), Gaps = 27/194 (13%)
Query: 210 LGAGGFGNVYKGKLGDGTVL-AVKRLK--------------DMISLAVHRNLLRLIGYCA 254
LG G FG VYK + + + A K ++ D++S H N++ L
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72
Query: 255 TPTERLLVYPYMSNGSVASRLR--EKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRD 312
+ ++ + G++ S + E+ L + + L +LH K+IHRD
Sbjct: 73 YENKLWILIEFCDGGALDSIMLELERG-LTEPQIRYVCRQMLEALNFLHSH---KVIHRD 128
Query: 313 VKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGHIAPEYLSTGQSSE----- 367
+KA N+LL + + DFG++ + T + GT +APE ++ +
Sbjct: 129 LKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFI-GTPYWMAPEVVACETFKDNPYDY 187
Query: 368 KTDVFGFGILLLEL 381
K D++ GI L+EL
Sbjct: 188 KADIWSLGITLIEL 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 4e-10
Identities = 56/200 (28%), Positives = 86/200 (43%), Gaps = 23/200 (11%)
Query: 209 ILGAGGFGNVYKGKL-GDGTVLAVKRL-KDMI----------------SLAVHRNLLRLI 250
+LG G FG V +L G V A+K L KD+I +LA L +
Sbjct: 2 VLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTAL 61
Query: 251 GYCATPTERLL-VYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKII 309
C +RL V Y++ G + +++ D + A L++LH +I
Sbjct: 62 HCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRH---GVI 118
Query: 310 HRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGHIAPEYLSTGQSSEKT 369
+RD+K N+LLD + DFG+ K + TT GT +IAPE L +
Sbjct: 119 YRDLKLDNILLDAEGHCKLADFGMCK-EGILNGVTTTTFCGTPDYIAPEILQELEYGPSV 177
Query: 370 DVFGFGILLLELITGMRALE 389
D + G+L+ E++ G E
Sbjct: 178 DWWALGVLMYEMMAGQPPFE 197
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 4e-10
Identities = 60/204 (29%), Positives = 85/204 (41%), Gaps = 40/204 (19%)
Query: 209 ILGAGGFGNV----YKGKLGDGTVLAVKRLK--DMIS--------------LAV----HR 244
+LG G FG V YK G + A+K LK D+I+ H
Sbjct: 6 VLGRGHFGKVLLAEYKKT---GELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHP 62
Query: 245 NLLRLIGYCATPTERLLVYPYMSNGSVASRLREKPALDWNTRKRIAIGAAR---GLLYLH 301
L+ L T V Y + G + + D + R AA GL YLH
Sbjct: 63 FLVNLFACFQTEDHVCFVMEYAAGGDLMMHIHT----DVFSEPRAVFYAACVVLGLQYLH 118
Query: 302 EQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKL-LDHSDSHVTTAVRGTVGHIAPEYL 360
E KI++RD+K N+LLD + DFGL K + D T+ GT +APE L
Sbjct: 119 EN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDR--TSTFCGTPEFLAPEVL 173
Query: 361 STGQSSEKTDVFGFGILLLELITG 384
+ + D +G G+L+ E++ G
Sbjct: 174 TETSYTRAVDWWGLGVLIYEMLVG 197
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 4e-10
Identities = 64/229 (27%), Positives = 97/229 (42%), Gaps = 29/229 (12%)
Query: 204 FSSKNILGAGGFGNV------YKGKLGDGTVLAVKRLKD-----------MISLAVHRNL 246
F +LG GGFG V GK+ L KR+K I V+
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRF 61
Query: 247 LRLIGYCATPTERL-LVYPYMSNGSVASRLREKPALDWNTRKRIAIGAAR---GLLYLHE 302
+ + Y + L LV M+ G + + + R AA GL LH+
Sbjct: 62 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFE-EGRAVFYAAEICCGLEDLHQ 120
Query: 303 QCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVR-GTVGHIAPEYLS 361
+ +I++RD+K N+LLDD + D GLA H T R GTVG++APE +
Sbjct: 121 E---RIVYRDLKPENILLDDHGHIRISDLGLAV---HVPEGQTIKGRVGTVGYMAPEVVK 174
Query: 362 TGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQE 410
+ + D + G LL E+I G + K ++ + VK++Q+E
Sbjct: 175 NERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEE 223
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 5e-10
Identities = 48/179 (26%), Positives = 79/179 (44%), Gaps = 17/179 (9%)
Query: 231 VKRLKDMISLAV---HRNLLRLIGYCATPTERLL-VYPYMSNGSVASRLREKPALDWNTR 286
R + +L H N++ L+ P L V+ Y+ ++ L AL
Sbjct: 22 RARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVPGRTLREVLAADGALPAGET 81
Query: 287 KRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLL---DDFCEAIVGDFGLAKLL-DHSDS 342
R+ + L H Q I+HRD+K N+++ A V DFG+ LL D+
Sbjct: 82 GRLMLQVLDALACAHNQ---GIVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLLPGVRDA 138
Query: 343 HVTTAVR-----GTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQ 396
V T R GT + APE L + +D++ +G++ LE +TG R ++ G S+ +
Sbjct: 139 DVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFLECLTGQRVVQ-GASVAE 196
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 6e-10
Identities = 58/196 (29%), Positives = 87/196 (44%), Gaps = 23/196 (11%)
Query: 209 ILGAGGFGNVYKGKLG-DGTVLAVKRLKDMISL--------AVHRNLLR-------LIG- 251
++G G FG V K DG AVK L+ I L RN+L L+G
Sbjct: 2 VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGL 61
Query: 252 -YCATPTERL-LVYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKII 309
Y TE+L V +++ G + L+ + + + A A L YLH I+
Sbjct: 62 HYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSI---NIV 118
Query: 310 HRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGHIAPEYLSTGQSSEKT 369
+RD+K N+LLD ++ DFGL K + S TT GT ++APE +
Sbjct: 119 YRDLKPENILLDSQGHVVLTDFGLCK-EGIAQSDTTTTFCGTPEYLAPEVIRKQPYDNTV 177
Query: 370 DVFGFGILLLELITGM 385
D + G +L E++ G+
Sbjct: 178 DWWCLGAVLYEMLYGL 193
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.6 bits (145), Expect = 7e-10
Identities = 51/203 (25%), Positives = 89/203 (43%), Gaps = 25/203 (12%)
Query: 210 LGAGGFGNVYKGK-LGDGTVLAVKRLK----------------DMISLAVHRNLLRLIGY 252
+G G +G VYK + G ++A+K++K ++ H N+++L+
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDV 66
Query: 253 CATPTERLLVYPYM-SNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHR 311
+ LV+ +M ++ + R++ L + K +GL + H I+HR
Sbjct: 67 FRHKGDLYLVFEFMDTDLYKLIKDRQRG-LPESLIKSYLYQLLQGLAFCHSH---GILHR 122
Query: 312 DVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGHIAPEYLST-GQSSEKTD 370
D+K N+L++ + DFGLA+ S T T + APE L S D
Sbjct: 123 DLKPENLLINTEGVLKLADFGLARSFG-SPVRPYTHYVVTRWYRAPELLLGDKGYSTPVD 181
Query: 371 VFGFGILLLELITGMRALEFGKS 393
++ G + EL++ R L GKS
Sbjct: 182 IWSVGCIFAELLSR-RPLFPGKS 203
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 8e-10
Identities = 46/127 (36%), Positives = 60/127 (47%), Gaps = 14/127 (11%)
Query: 10 VIGLGAPSQSLSGTLSGSIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLS 69
+I L SLSG + + L NL + L +NN +G IP L SLP+LQ L L +N+ S
Sbjct: 286 LISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFS 345
Query: 70 GVIPALLFLSIWLPRKWDKRKCSGVDQGLLRLNNNSLSGAFPVFLAKISELAFLDLSYNN 129
G IP L K V L L+ N+L+G P L L L L N+
Sbjct: 346 GEIPKNL----------GKHNNLTV----LDLSTNNLTGEIPEGLCSSGNLFKLILFSNS 391
Query: 130 LSGPVPK 136
L G +PK
Sbjct: 392 LEGEIPK 398
|
Length = 968 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 60.4 bits (147), Expect = 8e-10
Identities = 63/239 (26%), Positives = 105/239 (43%), Gaps = 53/239 (22%)
Query: 210 LGAGGFGNVYKGKL-GDGTVLAVKR--------------------LKDMISLAVHRNLLR 248
+G+G +G V G +A+K+ LK M H N++
Sbjct: 23 VGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHM----DHENVIG 78
Query: 249 LIGYCATPTERL-------LVYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLH 301
L+ TP L LV M G+ + + + L + + + RGL Y+H
Sbjct: 79 LLD-VFTPASSLEDFQDVYLVTHLM--GADLNNIVKCQKLSDDHIQFLVYQILRGLKYIH 135
Query: 302 EQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGHIAPE-YL 360
IIHRD+K +N+ +++ CE + DFGLA+ H+D +T V T + APE L
Sbjct: 136 SA---GIIHRDLKPSNIAVNEDCELKILDFGLAR---HTDDEMTGYV-ATRWYRAPEIML 188
Query: 361 STGQSSEKTDVFGFGILLLELITGMRALEFGK-SINQKGAML--------EWVKKIQQE 410
+ ++ D++ G ++ EL+TG + L G I+Q ++ E ++KI E
Sbjct: 189 NWMHYNQTVDIWSVGCIMAELLTG-KTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSE 246
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 9e-10
Identities = 62/225 (27%), Positives = 98/225 (43%), Gaps = 47/225 (20%)
Query: 204 FSSKNILGAGGFGNVYKGK-LGDGTVLAVKRL------KDMISLAV--------HRNLLR 248
F ++G G +G VYKG+ + G + A+K + ++ I L + HRN+
Sbjct: 18 FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIAT 77
Query: 249 LIGYCATPT------ERLLVYPYMSNGSVASRLREKPALDWNTRKRIAIG-----AARGL 297
G + + LV + GSV ++ N K I RGL
Sbjct: 78 YYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKG---NALKEDWIAYICREILRGL 134
Query: 298 LYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGHIAP 357
+LH K+IHRD+K NVLL + E + DFG++ LD + T + GT +AP
Sbjct: 135 AHLHAH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-GTPYWMAP 190
Query: 358 EYLSTGQSSEKT-----DVFGFGILLLELITG---------MRAL 388
E ++ ++ + T D++ GI +E+ G MRAL
Sbjct: 191 EVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRAL 235
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 9e-10
Identities = 63/250 (25%), Positives = 114/250 (45%), Gaps = 53/250 (21%)
Query: 194 FRELQQATENFSSKNILGAGGFGNV-YKGKLGDGTVLAVKRL-----KDMISLAVHRNLL 247
+R+L+Q +G+G +G V G +A+K+L ++ + +R L
Sbjct: 17 YRDLKQ----------VGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYREL- 65
Query: 248 RLIGYCA-----------TPTERL-------LVYPYMSNGSVASRLREKPALDWNTRKRI 289
RL+ + TP L LV P+M G+ +L + L + + +
Sbjct: 66 RLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFM--GTDLGKLMKHEKLSEDRIQFL 123
Query: 290 AIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVR 349
+GL Y+H IIHRD+K N+ +++ CE + DFGLA+ +DS +T V
Sbjct: 124 VYQMLKGLKYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLAR---QTDSEMTGYVV 177
Query: 350 GTVGHIAPEY-LSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAML------- 401
T + APE L+ ++ D++ G ++ E++TG + ++Q ++
Sbjct: 178 -TRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPS 236
Query: 402 -EWVKKIQQE 410
E+V+K+Q E
Sbjct: 237 KEFVQKLQSE 246
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 1e-09
Identities = 56/215 (26%), Positives = 98/215 (45%), Gaps = 27/215 (12%)
Query: 203 NFSSKNILGAGGFGNVY--KGKLGDGTVLAVKRL--------------KDMISLA--VHR 244
+ +G G FG +Y K K D +K + K++I LA H
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAKS-DSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHP 59
Query: 245 NLLRLIGYCATPTERLLVYPYMSNGSVASRLREKPALDWNTRKRIA--IGAARGLLYLHE 302
N++ +V Y G + R+ + + ++ + ++ + + GL ++H
Sbjct: 60 NIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIH- 118
Query: 303 QCDPKIIHRDVKAANVLLD-DFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGHIAPEYLS 361
D KI+HRD+K+ N+ L + A +GDFG+A+ L+ S T V GT +++PE
Sbjct: 119 --DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCV-GTPYYLSPEICQ 175
Query: 362 TGQSSEKTDVFGFGILLLELITGMRALEFGKSINQ 396
+ KTD++ G +L EL T E G +++Q
Sbjct: 176 NRPYNNKTDIWSLGCVLYELCTLKHPFE-GNNLHQ 209
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 1e-09
Identities = 54/199 (27%), Positives = 79/199 (39%), Gaps = 33/199 (16%)
Query: 210 LGAGGFGNV---------------------YKGKLGDGTVLAVKRLKDMISLAVHRNLLR 248
LG GGFG V K K G+ L K + + ++ NL
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNL-- 58
Query: 249 LIGYC-ATPTERLLVYPYMSNGSVASRLRE--KPALDWNTRKRIAIGAARGLLYLHEQCD 305
Y + T LV M+ G + + + L+ + G+L+LH
Sbjct: 59 --AYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSM-- 114
Query: 306 PKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGHIAPEYLSTGQS 365
I++RD+K NVLLDD + D GLA ++ D T GT G++APE L
Sbjct: 115 -DIVYRDMKPENVLLDDQGNCRLSDLGLA--VELKDGKTITQRAGTNGYMAPEILKEEPY 171
Query: 366 SEKTDVFGFGILLLELITG 384
S D F G + E++ G
Sbjct: 172 SYPVDWFAMGCSIYEMVAG 190
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 1e-09
Identities = 60/193 (31%), Positives = 87/193 (45%), Gaps = 27/193 (13%)
Query: 210 LGAGGFGNVYKG----KLGDGTVLAVKRLK-DMISLAVHRNLL---------------RL 249
LG+G FG V KG K + TV AVK LK D A+ LL R+
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTV-AVKILKNDNNDPALKDELLREANVMQQLDNPYIVRM 61
Query: 250 IGYCATPTERLLVYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKII 309
IG C + +LV G + L++ + + + G+ YL E +
Sbjct: 62 IGICEAES-WMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEET---NFV 117
Query: 310 HRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGT--VGHIAPEYLSTGQSSE 367
HRD+ A NVLL A + DFGL+K L +++ G V APE ++ + S
Sbjct: 118 HRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFSS 177
Query: 368 KTDVFGFGILLLE 380
K+DV+ FG+L+ E
Sbjct: 178 KSDVWSFGVLMWE 190
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 1e-09
Identities = 51/182 (28%), Positives = 84/182 (46%), Gaps = 27/182 (14%)
Query: 275 LREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLA 334
L E ++W + A L YLHE+ I+HRD+K NV L VGD G+A
Sbjct: 99 LPENQVVEW------FVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIA 149
Query: 335 KLLDHSDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSI 394
++L++ +T + GT +++PE S + K+DV+ G + E+ T A
Sbjct: 150 RVLENQCDMASTLI-GTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAF------ 202
Query: 395 NQKGAMLEWVKKIQQEKKVEVLVDRELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEV 454
N K M V +I + K + +Y E+GE++ +L + P RP + +
Sbjct: 203 NAKD-MNSLVYRIIEGKL------PPMPKDYSP-ELGELIA-TMLSKR--PEKRPSVKSI 251
Query: 455 VR 456
+R
Sbjct: 252 LR 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 1e-09
Identities = 59/208 (28%), Positives = 93/208 (44%), Gaps = 37/208 (17%)
Query: 203 NFSSKNILGAGGFGNVYKG-KLGDGTVLAVKRLK--------DMISLAVHRNLLRLIG-- 251
+F+ +LG G FG V + G + A+K LK D+ V + +L L G
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKP 60
Query: 252 -------YCATPTERL-LVYPYMSNGSV------ASRLREKPALDWNTRKRIAIGAARGL 297
C +RL V Y++ G + + +E A+ + A A GL
Sbjct: 61 PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFY------AAEIAIGL 114
Query: 298 LYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVR-GTVGHIA 356
+LH + II+RD+K NV+LD + DFG+ K ++ TT GT +IA
Sbjct: 115 FFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCK--ENIFGGKTTRTFCGTPDYIA 169
Query: 357 PEYLSTGQSSEKTDVFGFGILLLELITG 384
PE ++ + D + FG+LL E++ G
Sbjct: 170 PEIIAYQPYGKSVDWWAFGVLLYEMLAG 197
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 58.9 bits (143), Expect = 1e-09
Identities = 59/210 (28%), Positives = 85/210 (40%), Gaps = 50/210 (23%)
Query: 210 LGAGGFGNVYKGKLGD-GTVLAVKRL------KDMISL-----AVHR-----NLLRLIGY 252
+G G FG V K GT++AVKR+ K+ L V R +++ Y
Sbjct: 12 IGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKF--Y 69
Query: 253 CATPTE---------------RLLVYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGL 297
A E + Y Y K + +IA+ + L
Sbjct: 70 GALFREGDCWICMELMDISLDKFYKYVYE---------VLKSVIPEEILGKIAVATVKAL 120
Query: 298 LYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGHIAP 357
YL E + KIIHRDVK +N+LLD + DFG++ L DS T G ++AP
Sbjct: 121 NYLKE--ELKIIHRDVKPSNILLDRNGNIKLCDFGISGQL--VDSIAKTRDAGCRPYMAP 176
Query: 358 EYLSTGQSSE---KTDVFGFGILLLELITG 384
E + ++DV+ GI L E+ TG
Sbjct: 177 ERIDPSARDGYDVRSDVWSLGITLYEVATG 206
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 1e-09
Identities = 57/204 (27%), Positives = 90/204 (44%), Gaps = 27/204 (13%)
Query: 201 TENFSSKNILGAGGFGNVYKGKL-GDGTVLAVKRLK--------DMISLAVHRNLLRL-- 249
NF +LG G FG V + G + A+K LK D+ V + +L L
Sbjct: 1 DFNFLM--VLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQD 58
Query: 250 -------IGYCATPTERL-LVYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLH 301
+ C +RL V Y++ G + +++ A + GL +LH
Sbjct: 59 KPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLH 118
Query: 302 EQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVR-GTVGHIAPEYL 360
+ II+RD+K NV+LD + DFG+ K +H VTT GT +IAPE +
Sbjct: 119 RR---GIIYRDLKLDNVMLDSEGHIKIADFGMCK--EHMVDGVTTRTFCGTPDYIAPEII 173
Query: 361 STGQSSEKTDVFGFGILLLELITG 384
+ + D + +G+LL E++ G
Sbjct: 174 AYQPYGKSVDWWAYGVLLYEMLAG 197
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 2e-09
Identities = 37/96 (38%), Positives = 50/96 (52%), Gaps = 11/96 (11%)
Query: 289 IAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAV 348
I GA +GL YLH +IHRD+KA N+LL + + + DFG A ++S V
Sbjct: 126 ITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSSPANSFV---- 178
Query: 349 RGTVGHIAPEY---LSTGQSSEKTDVFGFGILLLEL 381
GT +APE + GQ K DV+ GI +EL
Sbjct: 179 -GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 213
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 2e-09
Identities = 29/88 (32%), Positives = 51/88 (57%), Gaps = 4/88 (4%)
Query: 296 GLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGHI 355
G+ ++HE+ +++HRD+K+ N+ L + +GDFG A+LL ++ T V GT ++
Sbjct: 112 GVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYV-GTPYYV 167
Query: 356 APEYLSTGQSSEKTDVFGFGILLLELIT 383
PE + K+D++ G +L EL T
Sbjct: 168 PPEIWENMPYNNKSDIWSLGCILYELCT 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 2e-09
Identities = 50/219 (22%), Positives = 92/219 (42%), Gaps = 45/219 (20%)
Query: 203 NFSSKNILGAGGFGNVYKGKL------GDGTVLAVKRLKD--------------MISLAV 242
N K LG G FG V+ + D ++AVK LKD +++
Sbjct: 6 NIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQ 65
Query: 243 HRNLLRLIGYCATPTERLLVYPYMSNGSVASRLRE-----------KPALDWNTRKRIAI 291
H ++++ G C ++V+ YM +G + LR + + + I
Sbjct: 66 HEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHI 125
Query: 292 GA--ARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSD-----SHV 344
A G++YL Q +HRD+ N L+ + +GDFG+++ + +D H
Sbjct: 126 AQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHT 182
Query: 345 TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT 383
+R + PE + + + ++DV+ G++L E+ T
Sbjct: 183 MLPIR----WMPPESIMYRKFTTESDVWSLGVVLWEIFT 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 2e-09
Identities = 52/207 (25%), Positives = 88/207 (42%), Gaps = 28/207 (13%)
Query: 203 NFSSKNILGAGGFGNVY---------KGKLGDGTVLA----VKRLKDMISLAVHRNLLRL 249
NF +LG G +G V+ GKL VL V++ K R +L
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60
Query: 250 IGYC----------ATPTERLLVYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLY 299
I T T+ L+ Y++ G + + L ++ + + I + +L
Sbjct: 61 IRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERF---KEQEVQIYSGEIVLA 117
Query: 300 LHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGHIAPEY 359
L II+RD+K N+LLD ++ DFGL+K + + GT+ ++AP+
Sbjct: 118 LEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDI 177
Query: 360 LSTGQS--SEKTDVFGFGILLLELITG 384
+ G + D + G+L+ EL+TG
Sbjct: 178 VRGGDGGHDKAVDWWSMGVLMYELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 3e-09
Identities = 42/126 (33%), Positives = 62/126 (49%), Gaps = 20/126 (15%)
Query: 30 NLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFLSIWLPRKWDKR 89
N + + + L NISG I + LP +QT++LSNN+LSG IP +F +
Sbjct: 67 NSSRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTT---------- 116
Query: 90 KCSGVDQGLLRLNNNSLSGAFPVFLAKISELAFLDLSYNNLSGPVPK-----FPARTFNV 144
S + L L+NN+ +G+ P I L LDLS N LSG +P + ++
Sbjct: 117 -SSSLR--YLNLSNNNFTGSIPR--GSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDL 171
Query: 145 AGNPLI 150
GN L+
Sbjct: 172 GGNVLV 177
|
Length = 968 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 3e-09
Identities = 35/91 (38%), Positives = 50/91 (54%), Gaps = 1/91 (1%)
Query: 297 LLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDS-HVTTAVRGTVGHI 355
LL +H +IHRD+K+AN+LL +GDFG +K+ + S V GT ++
Sbjct: 153 LLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYV 212
Query: 356 APEYLSTGQSSEKTDVFGFGILLLELITGMR 386
APE S+K D+F G+LL EL+T R
Sbjct: 213 APEIWRRKPYSKKADMFSLGVLLYELLTLKR 243
|
Length = 496 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 58.2 bits (140), Expect = 3e-09
Identities = 56/205 (27%), Positives = 92/205 (44%), Gaps = 21/205 (10%)
Query: 210 LGAGGFGNVYKGKLG-DGTVLAVK--RLKD-------------MISLAVHRNLLRLIGYC 253
LG G + VYKGK +G ++A+K RL++ ++ H N++ L
Sbjct: 13 LGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDII 72
Query: 254 ATPTERLLVYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDV 313
T LV+ Y+ + L K RGL Y+H++ I+HRD+
Sbjct: 73 HTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQR---YILHRDL 129
Query: 314 KAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGHIAPE-YLSTGQSSEKTDVF 372
K N+L+ D E + DFGLA+ SH + T+ + P+ L + + S D++
Sbjct: 130 KPQNLLISDTGELKLADFGLAR-AKSVPSHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMW 188
Query: 373 GFGILLLELITGMRALEFGKSINQK 397
G G + +E+I G+ A K I +
Sbjct: 189 GVGCIFVEMIQGVAAFPGMKDIQDQ 213
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 3e-09
Identities = 70/290 (24%), Positives = 124/290 (42%), Gaps = 55/290 (18%)
Query: 200 ATENFSSKNILGAGGFGNVYKGKLGDGTV-------LAVKRLKDMISLAVH--------- 243
A E + LG G FG VY+G + G V +A+K + + S+
Sbjct: 4 AREKITMSRELGQGSFGMVYEG-IAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 62
Query: 244 ------RNLLRLIGYCATPTERLLVYPYMSNGSVASRLRE-KPALDWNT-------RKRI 289
+++RL+G + L++ M+ G + S LR +P ++ N +K I
Sbjct: 63 MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMI 122
Query: 290 AIGA--ARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTA 347
+ A G+ YL+ K +HRD+ A N ++ + +GDFG+ + + +D +
Sbjct: 123 QMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETD-YYRKG 178
Query: 348 VRG--TVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVK 405
+G V ++PE L G + +DV+ FG++L E+ T G S Q +L +V
Sbjct: 179 GKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQ---VLRFVM 235
Query: 406 KIQQEKKVEVLVDRELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVV 455
+ K + D + ++ +C QY P RP E++
Sbjct: 236 EGGLLDKPDNCPDM-------------LFELMRMCWQYNPKMRPSFLEII 272
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 3e-09
Identities = 54/197 (27%), Positives = 88/197 (44%), Gaps = 33/197 (16%)
Query: 210 LGAGGFGNVYKGKLGDGTVLAVKRLKD----------MISLAV-----HRNLLRLIGYCA 254
LG G FG VYK + + VLA ++ D M+ + + H N+++L+
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 72
Query: 255 TPTERLLVYPYMSNGSV-ASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDV 313
++ + + G+V A L + L + + L YLHE KIIHRD+
Sbjct: 73 YENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHEN---KIIHRDL 129
Query: 314 KAANVLLDDFCEAIVGDFGLA----KLLDHSDSHVTTAVRGTVGHIAPEYLSTGQSSE-- 367
KA N+L + + DFG++ + + DS + GT +APE + S +
Sbjct: 130 KAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI-----GTPYWMAPEVVMCETSKDRP 184
Query: 368 ---KTDVFGFGILLLEL 381
K DV+ GI L+E+
Sbjct: 185 YDYKADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 4e-09
Identities = 55/241 (22%), Positives = 104/241 (43%), Gaps = 45/241 (18%)
Query: 210 LGAGGFGNVYKGKLG------DGTVLAVKRLKD--------------MISLAVHRNLLRL 249
LG G FG V+ + D ++AVK LK+ ++++ H++++R
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72
Query: 250 IGYCATPTERLLVYPYMSNGSVASRLREK---------------PALDWNTRKRIAIGAA 294
G C L+V+ YM +G + LR L IA A
Sbjct: 73 YGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIA 132
Query: 295 RGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSH-VTTAVRGTVG 353
G++YL +HRD+ N L+ +GDFG+++ + +D + V +
Sbjct: 133 SGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 189
Query: 354 HIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKV 413
+ PE + + + ++D++ FG++L E+ T +GK + + E ++ I Q +++
Sbjct: 190 WMPPESILYRKFTTESDIWSFGVVLWEIFT------YGKQPWYQLSNTEAIECITQGREL 243
Query: 414 E 414
E
Sbjct: 244 E 244
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 57.2 bits (138), Expect = 4e-09
Identities = 37/94 (39%), Positives = 54/94 (57%), Gaps = 3/94 (3%)
Query: 297 LLYLHEQCDPKIIHRDVKAANVLLDDFCEAI-VGDFGLAKLLDHSDSHVTTAVRGTVGHI 355
LL LH I+HRD+K N+LLD + +GDFG++K+L S S T V GT +I
Sbjct: 111 LLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILS-SKSKAYTVV-GTPCYI 168
Query: 356 APEYLSTGQSSEKTDVFGFGILLLELITGMRALE 389
+PE ++K+D++ G +L EL + RA E
Sbjct: 169 SPELCEGKPYNQKSDIWALGCVLYELASLKRAFE 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 4e-09
Identities = 60/207 (28%), Positives = 90/207 (43%), Gaps = 37/207 (17%)
Query: 204 FSSKNILGAGGFGNV------YKGKLGDGTVLAVKRLKDMISLAVHRNLLRLI------- 250
F +LG GGFG V GK+ L KR+K A+ N R++
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRF 61
Query: 251 ----GYCATPTERL-LVYPYMSNGSVASRLRE--KPALDWNTRKRIAIGAAR---GLLYL 300
Y + L LV M+ G + + P D +R AA GL L
Sbjct: 62 VVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFD---EQRAIFYAAELCCGLEDL 118
Query: 301 HEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRG---TVGHIAP 357
+ +I++RD+K N+LLDD + D GLA + ++ VRG TVG++AP
Sbjct: 119 QRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET-----VRGRVGTVGYMAP 170
Query: 358 EYLSTGQSSEKTDVFGFGILLLELITG 384
E ++ + + D +G G L+ E+I G
Sbjct: 171 EVINNEKYTFSPDWWGLGCLIYEMIQG 197
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 57.8 bits (140), Expect = 4e-09
Identities = 55/203 (27%), Positives = 91/203 (44%), Gaps = 25/203 (12%)
Query: 210 LGAGGFGNVYKGKLGD-GTVLAVKRLKD----------------MISLAVHRNLLRLIGY 252
+G G +G V+K + + G ++A+K+ + M+ H NL+ LI
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEV 68
Query: 253 CATPTERLLVYPYMSNGSVASRLREKP-ALDWNTRKRIAIGAARGLLYLHEQCDPKIIHR 311
+ LV+ Y + +V + L + P + + K+I + + + H+ IHR
Sbjct: 69 FRRKRKLHLVFEYCDH-TVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKH---NCIHR 124
Query: 312 DVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGHIAPEYL-STGQSSEKTD 370
DVK N+L+ + + DFG A++L T V T + APE L Q D
Sbjct: 125 DVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYV-ATRWYRAPELLVGDTQYGPPVD 183
Query: 371 VFGFGILLLELITGMRALEFGKS 393
V+ G + EL+TG + L GKS
Sbjct: 184 VWAIGCVFAELLTG-QPLWPGKS 205
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.0 bits (140), Expect = 4e-09
Identities = 55/198 (27%), Positives = 90/198 (45%), Gaps = 28/198 (14%)
Query: 210 LGAGGFGNVYKGKLGD-GTVLAVKRL--------KDMISLAVHRNLLR---------LIG 251
+G G FG VY+ + D + A+K L K++ RN+L ++G
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 252 Y---CATPTERLLVYPYMSNGSVASRLREKPALDWNTRKRIAIGA-ARGLLYLHEQCDPK 307
T ++ LV YMS G + L+++ R + I L +LH+
Sbjct: 61 LKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFS-EDRAKFYIAELVLALEHLHKY---D 116
Query: 308 IIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGHIAPEYLSTGQSSE 367
I++RD+K N+LLD + DFGL+K + +D+ T GT ++APE L +
Sbjct: 117 IVYRDLKPENILLDATGHIALCDFGLSK-ANLTDNKTTNTFCGTTEYLAPEVLLDEKGYT 175
Query: 368 K-TDVFGFGILLLELITG 384
K D + G+L+ E+ G
Sbjct: 176 KHVDFWSLGVLVFEMCCG 193
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 4e-09
Identities = 62/280 (22%), Positives = 118/280 (42%), Gaps = 46/280 (16%)
Query: 203 NFSSKNILGAGGFGNVYKGK-LGDGTVLAVKRLK-----------------DMISLAVHR 244
NF + +G G F VY+ L DG +A+K+++ D++ H
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62
Query: 245 NLLRLIGYCATPTERLLVYPYMSNGSVASRLR----EKPALDWNTRKRIAIGAARGLLYL 300
N+++ E +V G ++ ++ +K + T + + L ++
Sbjct: 63 NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHM 122
Query: 301 HEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVG---HIAP 357
H + +++HRD+K ANV + +GD GL + S TTA VG +++P
Sbjct: 123 HSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFF----SSKTTAAHSLVGTPYYMSP 175
Query: 358 EYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLV 417
E + + K+D++ G LL E+ +++ +G +N + KKI+Q +
Sbjct: 176 ERIHENGYNFKSDIWSLGCLLYEM-AALQSPFYGDKMN----LYSLCKKIEQCDYPPLPS 230
Query: 418 DRELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRM 457
D +Y E+ Q+ +C P RP ++ V +
Sbjct: 231 D-----HYSE----ELRQLVNMCINPDPEKRPDITYVYDV 261
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 57.4 bits (139), Expect = 4e-09
Identities = 52/202 (25%), Positives = 88/202 (43%), Gaps = 24/202 (11%)
Query: 202 ENFSSKNILGAGGFGNVYKGKLGD-GTVLAVKRLKD----------------MISLAVHR 244
E + + ++G G +G V K K + G ++A+K+ + M+ H
Sbjct: 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHE 60
Query: 245 NLLRLIGYCATPTERLLVYPYMSNGSVASRLREKP-ALDWNTRKRIAIGAARGLLYLHEQ 303
NL+ LI LV+ ++ + +V L + P LD + ++ RG+ + H
Sbjct: 61 NLVNLIEVFRRKKRLYLVFEFVDH-TVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSH 119
Query: 304 CDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGHIAPEYLSTG 363
IIHRD+K N+L+ + DFG A+ L T V T + APE L
Sbjct: 120 ---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYV-ATRWYRAPELLVGD 175
Query: 364 QSSEK-TDVFGFGILLLELITG 384
+ D++ G L+ E++TG
Sbjct: 176 TKYGRAVDIWAVGCLVTEMLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 6e-09
Identities = 37/96 (38%), Positives = 51/96 (53%), Gaps = 11/96 (11%)
Query: 289 IAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAV 348
I GA +GL YLH +IHRD+KA N+LL + + + DFG A + ++S V
Sbjct: 130 ITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASIASPANSFV---- 182
Query: 349 RGTVGHIAPEY---LSTGQSSEKTDVFGFGILLLEL 381
GT +APE + GQ K DV+ GI +EL
Sbjct: 183 -GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 217
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 7e-09
Identities = 56/200 (28%), Positives = 87/200 (43%), Gaps = 26/200 (13%)
Query: 207 KNILGAGGFGNVYKGKLGDGT----VLAVKRL---------KDMISLAVHRNLLR----- 248
+LG GG+G V++ + G + A+K L KD RN+L
Sbjct: 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHP 60
Query: 249 ----LIGYCATPTERLLVYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQC 304
LI T + L+ Y+S G + L + +T + L +LH+Q
Sbjct: 61 FIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQ- 119
Query: 305 DPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGHIAPEYLSTGQ 364
II+RD+K N+LLD + DFGL K H + VT GT+ ++APE L
Sbjct: 120 --GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT-VTHTFCGTIEYMAPEILMRSG 176
Query: 365 SSEKTDVFGFGILLLELITG 384
+ D + G L+ +++TG
Sbjct: 177 HGKAVDWWSLGALMYDMLTG 196
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 9e-09
Identities = 57/237 (24%), Positives = 103/237 (43%), Gaps = 44/237 (18%)
Query: 210 LGAGGFGNVYKGKL-----GDGTVLAVKRLKD---------------MISLAVHRNLLRL 249
LG FG +YKG L ++A+K LKD +++ H N++ L
Sbjct: 13 LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCL 72
Query: 250 IGYCATPTERLLVYPYMSNGSVASRL-----------------REKPALDWNTRKRIAIG 292
+G +++ Y++ G + L K +LD IAI
Sbjct: 73 LGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQ 132
Query: 293 AARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSH-VTTAVRGT 351
A G+ YL +H+D+ A N+L+ + + D GL++ + +D + V
Sbjct: 133 IAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLP 189
Query: 352 VGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQ 408
+ + PE + G+ S +D++ FG++L E+ + +G S NQ+ ++E V+K Q
Sbjct: 190 IRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFS-NQE--VIEMVRKRQ 243
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 1e-08
Identities = 57/224 (25%), Positives = 102/224 (45%), Gaps = 55/224 (24%)
Query: 209 ILGAGGFGNVYKGKLGDGTV----LAVKRL-KDMISLA-VHRNLLR-------LIGYCAT 255
++G GG G VY L V +A+K++ +D+ + + LR LI
Sbjct: 9 LIGKGGMGEVY---LAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIV 65
Query: 256 P-----TERLLVY---PYMSNGSVASRLR---EKPALDWNTRKRIAIGA--------ARG 296
P ++ VY PY+ ++ S L+ +K +L ++ ++GA
Sbjct: 66 PVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICAT 125
Query: 297 LLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAK--------LLD---------H 339
+ Y+H + ++HRD+K N+LL F E ++ D+G A LLD +
Sbjct: 126 IEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICY 182
Query: 340 SDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT 383
S + + GT ++APE L +SE TD++ G++L +++T
Sbjct: 183 SSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLT 226
|
Length = 932 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 1e-08
Identities = 46/156 (29%), Positives = 75/156 (48%), Gaps = 11/156 (7%)
Query: 255 TPTERLLVYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVK 314
+P + LV +++ G + L+ + D +R R A L L +I+RD+K
Sbjct: 64 SPEKLYLVLAFINGGELFHHLQREGRFD-LSRARFYT--AELLCALENLHKFNVIYRDLK 120
Query: 315 AANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGF 374
N+LLD + DFGL KL + D T GT ++APE L ++ D +
Sbjct: 121 PENILLDYQGHIALCDFGLCKL-NMKDDDKTNTFCGTPEYLAPELLLGHGYTKAVDWWTL 179
Query: 375 GILLLELITGMRALEFGKSINQKGAMLEWVKKIQQE 410
G+LL E++TG+ + +++N E +KI QE
Sbjct: 180 GVLLYEMLTGLPPF-YDENVN------EMYRKILQE 208
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 1e-08
Identities = 37/120 (30%), Positives = 60/120 (50%), Gaps = 16/120 (13%)
Query: 291 IGAARGLLYLHEQ--------C-------DPKIIHRDVKAANVLLDDFCEAIVGDFGLAK 335
I A RG+L+ +Q C D KI+HRD+K+ N+ L +GDFG+A+
Sbjct: 90 INAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIAR 149
Query: 336 LLDHSDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSIN 395
+L+ + T + GT +++PE + K+D++ G +L E+ T A E G N
Sbjct: 150 VLNSTVELARTCI-GTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKN 208
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 1e-08
Identities = 55/199 (27%), Positives = 92/199 (46%), Gaps = 33/199 (16%)
Query: 210 LGAGGFGNVYKGK-LGDGTVLAVKRLK-----DMISLAV--------------HRNLLRL 249
+G G +G VYK + G +A+K ++ D + L+ H N++RL
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67
Query: 250 IGYCAT-----PTERLLVYPYMSNGSVASRLREKPA--LDWNTRKRIAIGAARGLLYLHE 302
+ CAT T+ LV+ ++ + + L + P L T K + RGL +LH
Sbjct: 68 MDVCATSRTDRETKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHA 126
Query: 303 QCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGHIAPEYLST 362
C I+HRD+K N+L+ + + DFGLA++ +S T V T+ + APE L
Sbjct: 127 NC---IVHRDLKPENILVTSGGQVKLADFGLARI--YSCQMALTPVVVTLWYRAPEVLLQ 181
Query: 363 GQSSEKTDVFGFGILLLEL 381
+ D++ G + E+
Sbjct: 182 STYATPVDMWSVGCIFAEM 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 1e-08
Identities = 52/198 (26%), Positives = 86/198 (43%), Gaps = 31/198 (15%)
Query: 213 GGFGNVYKG-KLGDGTVLAVKRLK--DMIS------LAVHRNLLRLIGYCATP-TERL-- 260
G FG+VY K G A+K LK DMI+ + R ++ + G +P +L
Sbjct: 7 GAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGE--SPYVAKLYY 64
Query: 261 ---------LVYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHR 311
LV Y++ G AS ++ L + K+ G+ LH++ IIHR
Sbjct: 65 SFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQR---GIIHR 121
Query: 312 DVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDV 371
D+K N+L+D + DFGL++ + V GT ++APE + + +D
Sbjct: 122 DIKPENLLIDQTGHLKLTDFGLSRNGLENKKFV-----GTPDYLAPETILGVGDDKMSDW 176
Query: 372 FGFGILLLELITGMRALE 389
+ G ++ E + G
Sbjct: 177 WSLGCVIFEFLFGYPPFH 194
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 55.6 bits (135), Expect = 1e-08
Identities = 54/204 (26%), Positives = 83/204 (40%), Gaps = 31/204 (15%)
Query: 202 ENFSSKNILGAGGFGNVYKGKLGD-GTVLAVKRL-----------------KDMISLAVH 243
++F LG G FG V + G A+K L K ++ H
Sbjct: 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRH 60
Query: 244 RNLLRLIGYCATPTERLLVYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQ 303
L+ L G + LV Y+ G + S LR+ + A L YLH
Sbjct: 61 PFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSL 120
Query: 304 CDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGHIAPEYLST- 362
I++RD+K N+LLD + DFG AK + T + GT ++APE + +
Sbjct: 121 ---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR----TYTLCGTPEYLAPEIILSK 173
Query: 363 --GQSSEKTDVFGFGILLLELITG 384
G++ D + GIL+ E++ G
Sbjct: 174 GYGKAV---DWWALGILIYEMLAG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 1e-08
Identities = 61/198 (30%), Positives = 88/198 (44%), Gaps = 27/198 (13%)
Query: 209 ILGAGGFGNVYKGKL-GDGTVLAVKRL--------KDMISLAVHRNLLR-------LIG- 251
++G G FG V K DG+ AVK L K+ + RN+L L+G
Sbjct: 2 VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGL 61
Query: 252 -YCATPTERL-LVYPYMSNGSVASRL-REKPALDWNTRKRI-AIGAARGLLYLHEQCDPK 307
Y E+L V Y++ G + L RE+ L+ R R A A + YLH
Sbjct: 62 HYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLE--PRARFYAAEVASAIGYLHSL---N 116
Query: 308 IIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGHIAPEYLSTGQSSE 367
II+RD+K N+LLD ++ DFGL K T+ GT ++APE L
Sbjct: 117 IIYRDLKPENILLDSQGHVVLTDFGLCK-EGVEPEETTSTFCGTPEYLAPEVLRKEPYDR 175
Query: 368 KTDVFGFGILLLELITGM 385
D + G +L E++ G+
Sbjct: 176 TVDWWCLGAVLYEMLYGL 193
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 2e-08
Identities = 58/206 (28%), Positives = 95/206 (46%), Gaps = 33/206 (16%)
Query: 203 NFSSKNILGAGGFGNVYKGK-LGDGTVLAVKRLK------------DMISLA---VHRNL 246
NF LG G + VYKG+ G ++A+K + ISL H N+
Sbjct: 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENI 60
Query: 247 LRLIGYCATPTERLLVYPYMSNGSVASRLR-------EKPALDWNTRKRIAIGAARGLLY 299
+RL T + +LV+ YM L+ + ALD NT K +G+ +
Sbjct: 61 VRLHDVIHTENKLMLVFEYMDKD-----LKKYMDTHGVRGALDPNTVKSFTYQLLKGIAF 115
Query: 300 LHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGHIAPEY 359
HE +++HRD+K N+L++ E + DFGLA+ + + V T+ + AP+
Sbjct: 116 CHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV-TLWYRAPDV 171
Query: 360 LSTGQS-SEKTDVFGFGILLLELITG 384
L ++ S D++ G ++ E+ITG
Sbjct: 172 LLGSRTYSTSIDIWSVGCIMAEMITG 197
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 2e-08
Identities = 34/111 (30%), Positives = 54/111 (48%), Gaps = 11/111 (9%)
Query: 286 RKRIAI--------GAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLL 337
++ IAI R + YLHE +IIHRD+KA N+ ++ + +GDFG A
Sbjct: 176 KRNIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFP 232
Query: 338 DHSDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRAL 388
+++ GT+ APE L+ D++ GI+L E+ T +L
Sbjct: 233 VDINANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSL 283
|
Length = 391 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 2e-08
Identities = 28/88 (31%), Positives = 43/88 (48%), Gaps = 4/88 (4%)
Query: 297 LLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGHIA 356
L YLH +++RD+K N++LD + DFGL K SD GT ++A
Sbjct: 108 LGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCK-EGISDGATMKTFCGTPEYLA 163
Query: 357 PEYLSTGQSSEKTDVFGFGILLLELITG 384
PE L D +G G+++ E++ G
Sbjct: 164 PEVLEDNDYGRAVDWWGLGVVMYEMMCG 191
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 2e-08
Identities = 53/223 (23%), Positives = 99/223 (44%), Gaps = 34/223 (15%)
Query: 210 LGAGGFGNVYKGK--LGDGTVLAVKRLKDMIS-----------LAV--------HRNLLR 248
+G G +G V+K + G +A+KR++ +AV H N++R
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68
Query: 249 LIGYCATP-----TERLLVYPYMSNGSVASRLRE--KPALDWNTRKRIAIGAARGLLYLH 301
L C T+ LV+ ++ + + L + +P + T K + RGL +LH
Sbjct: 69 LFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH 127
Query: 302 EQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGHIAPEYLS 361
+++HRD+K N+L+ + + DFGLA++ +S T+V T+ + APE L
Sbjct: 128 SH---RVVHRDLKPQNILVTSSGQIKLADFGLARI--YSFQMALTSVVVTLWYRAPEVLL 182
Query: 362 TGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWV 404
+ D++ G + E+ ++Q G +L+ +
Sbjct: 183 QSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVI 225
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 3e-08
Identities = 41/116 (35%), Positives = 53/116 (45%), Gaps = 14/116 (12%)
Query: 17 SQSLSGTLSGSIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALL 76
S SG + ++G NL + L NN++G IP L S L L L +N L G IP L
Sbjct: 341 SNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSL 400
Query: 77 FLSIWLPRKWDKRKCSGVDQGLLRLNNNSLSGAFPVFLAKISELAFLDLSYNNLSG 132
L R +RL +NS SG P K+ + FLD+S NNL G
Sbjct: 401 GACRSLRR--------------VRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQG 442
|
Length = 968 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 3e-08
Identities = 38/111 (34%), Positives = 60/111 (54%), Gaps = 8/111 (7%)
Query: 295 RGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGH 354
RGL Y+H IIHRD+K +N+ +++ CE + DFGLA+ H+D +T V T +
Sbjct: 131 RGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGYV-ATRWY 183
Query: 355 IAPE-YLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWV 404
APE L+ ++ D++ G ++ EL+TG I+Q +L V
Sbjct: 184 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 234
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 3e-08
Identities = 57/220 (25%), Positives = 94/220 (42%), Gaps = 42/220 (19%)
Query: 195 RELQQATENFSSKNILGAGGFGNVYKGK-LGDGTVLAVKRL-----------------KD 236
R+LQ E++ ++G G FG V + V A+K L +D
Sbjct: 36 RKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERD 95
Query: 237 MISLAVHRNLLRLIGYCATPTERLL--VYPYMSNGSVASRLR-----EKPALDWNTRKRI 289
+++ A +++L +CA ++ L V YM G + + + EK A + +
Sbjct: 96 IMAFANSPWVVQL--FCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVL 153
Query: 290 AIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDS-HVTTAV 348
A+ A + +IHRDVK N+LLD + DFG +D + TAV
Sbjct: 154 ALDAIHSM---------GLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAV 204
Query: 349 RGTVGHIAPEYLST----GQSSEKTDVFGFGILLLELITG 384
GT +I+PE L + G + D + G+ L E++ G
Sbjct: 205 -GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 3e-08
Identities = 50/200 (25%), Positives = 90/200 (45%), Gaps = 30/200 (15%)
Query: 210 LGAGGFGNVYKGK-LGDGTVLAVKRLKDMISLAVHRNLLR---LIGYCATP--------- 256
LG G +G+VYK G +A+K ++ + + ++ ++ +P
Sbjct: 9 LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAF 68
Query: 257 TERLLVY---PYMSNGSVASRLREKPA---LDWNTRKRIAIGAARGLLYLHEQCDPKIIH 310
VY YM GS+ A + + +RI +GL +L E+ + IIH
Sbjct: 69 FIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN--IIH 126
Query: 311 RDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGHIAPEYLSTGQSSE--- 367
RDVK NVL++ + + DFG++ L S + G ++APE + +G ++
Sbjct: 127 RDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTNI---GCQSYMAPERIKSGGPNQNPT 183
Query: 368 ---KTDVFGFGILLLELITG 384
++DV+ G+ +LE+ G
Sbjct: 184 YTVQSDVWSLGLSILEMALG 203
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 3e-08
Identities = 66/217 (30%), Positives = 93/217 (42%), Gaps = 33/217 (15%)
Query: 197 LQQATENFSSKNILGAGGFGNVYK-GKLGDGTVLAVKRL---KDM-----------ISLA 241
L T+ + +G G +G VYK DG++ AVK L D+ SL
Sbjct: 17 LGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLP 76
Query: 242 VHRNLLRLIG--YCA---TPTERLLVYPYMSNGSVASR----LREKPALDWNTRKRIAIG 292
H N+++ G Y A + LV + GSV L LD I G
Sbjct: 77 NHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYG 136
Query: 293 AARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTV 352
A GL +LH +IIHRDVK N+LL + DFG++ L + T+V GT
Sbjct: 137 ALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV-GTP 192
Query: 353 GHIAPEYLSTGQSSE-----KTDVFGFGILLLELITG 384
+APE ++ Q + + DV+ GI +EL G
Sbjct: 193 FWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDG 229
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 55.9 bits (134), Expect = 3e-08
Identities = 44/158 (27%), Positives = 76/158 (48%), Gaps = 10/158 (6%)
Query: 228 VLAVKRLKDMISLAVHRNLLRLIGYCATPTERLL--VYPYMSNGSVASRLREKPALDWNT 285
+LA+ RL L + +LR T++ +Y +M + A +++P L T
Sbjct: 214 ILALGRLNHENILKI-EEILRSEANTYMITQKYDFDLYSFMYDE--AFDWKDRPLL-KQT 269
Query: 286 RKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVT 345
R I + Y+H D K+IHRD+K N+ L+ + ++GDFG A +
Sbjct: 270 R-AIMKQLLCAVEYIH---DKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREAFD 325
Query: 346 TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT 383
GTV +PE L+ E TD++ G++LL++++
Sbjct: 326 YGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLS 363
|
Length = 501 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 4e-08
Identities = 56/203 (27%), Positives = 85/203 (41%), Gaps = 34/203 (16%)
Query: 210 LGAGGFGNVYKGKLGDG---TVLAVKRLKDMISLA---------------VHRNLLRLIG 251
+G G FG V G++ G + VK L+ S+ H NLL+ +G
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62
Query: 252 YCATPTERLLVYPYMSNGSVASRLR-----EKPALDWNTRKRIAIGAARGLLYLHEQCDP 306
C T LLV + G + LR E D T +R+A A GLL+LH+
Sbjct: 63 QCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN--- 119
Query: 307 KIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGT-VGHIAPEYLSTGQS 365
IH D+ N LL +GD+GL+ D +VT + IAPE +
Sbjct: 120 NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHG 179
Query: 366 -------SEKTDVFGFGILLLEL 381
+++++V+ G+ + EL
Sbjct: 180 NLLVVDQTKESNVWSLGVTIWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 4e-08
Identities = 55/197 (27%), Positives = 85/197 (43%), Gaps = 33/197 (16%)
Query: 210 LGAGGFGNVYKGKLGDGTVLAVKRLKD----------MISLAV-----HRNLLRLIGYCA 254
LG G FG VYK K + LA ++ + M+ + + H +++L+G
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY 79
Query: 255 TPTERLLVYPYMSNGSV-ASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDV 313
+ ++ + G+V A L L + I L YLH KIIHRD+
Sbjct: 80 WDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSM---KIIHRDL 136
Query: 314 KAANVLLDDFCEAIVGDFGLA----KLLDHSDSHVTTAVRGTVGHIAPEYLSTGQSSE-- 367
KA NVLL + + DFG++ K L DS + GT +APE + +
Sbjct: 137 KAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFI-----GTPYWMAPEVVMCETMKDTP 191
Query: 368 ---KTDVFGFGILLLEL 381
K D++ GI L+E+
Sbjct: 192 YDYKADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 5e-08
Identities = 52/202 (25%), Positives = 89/202 (44%), Gaps = 27/202 (13%)
Query: 202 ENFSSKNILGAGGFGNVYKGK-LGDGTVLAVKRLK--DMISLA----VH--RNLLRLIG- 251
++ +G G FG V+ + A+K + ++I L VH + +L+ +
Sbjct: 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSH 60
Query: 252 ------YCATPTERLL--VYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQ 303
+ +R L + Y+ G + S LR +T A L YLH +
Sbjct: 61 PFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSK 120
Query: 304 CDPKIIHRDVKAANVLLDDFCEAIVGDFGLAK-LLDHSDSHVTTAVRGTVGHIAPEYLST 362
+I++RD+K N+LLD + DFG AK L D T + GT ++APE + +
Sbjct: 121 ---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR-----TWTLCGTPEYLAPEVIQS 172
Query: 363 GQSSEKTDVFGFGILLLELITG 384
++ D + GIL+ E++ G
Sbjct: 173 KGHNKAVDWWALGILIYEMLVG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 5e-08
Identities = 53/200 (26%), Positives = 85/200 (42%), Gaps = 25/200 (12%)
Query: 203 NFSSKNILGAGGFGNVYKGKL-GDGTVLAVK--------RLKDMISLAVHRNLLRLIG-- 251
+F LG G FG V K G G A+K ++K + +A +++L +
Sbjct: 19 DFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHP 78
Query: 252 -----YCATPTERLL--VYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQC 304
C+ E + + ++ G + + LR+ + K YLH
Sbjct: 79 FIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHS-K 137
Query: 305 DPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGHIAPEYLSTGQ 364
D II+RD+K N+LLD+ V DFG AK + T + GT ++APE + +
Sbjct: 138 D--IIYRDLKPENLLLDNKGHVKVTDFGFAKKV----PDRTFTLCGTPEYLAPEVIQSKG 191
Query: 365 SSEKTDVFGFGILLLELITG 384
+ D + G+LL E I G
Sbjct: 192 HGKAVDWWTMGVLLYEFIAG 211
|
Length = 329 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 5e-08
Identities = 52/207 (25%), Positives = 91/207 (43%), Gaps = 34/207 (16%)
Query: 201 TENFSSKNILGAGGFGNVYKGK-LGDGTVLAVKRLK-----------------DMISLAV 242
NF + +G G F VYK L DG V+A+K+++ D++
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60
Query: 243 HRNLLRLIGYCATPTERLLVYPYMSNGSVASRL-----REKPALDWNTRKRIAIGAARGL 297
H N+++ + E +V G + SR+ ++K + T + + L
Sbjct: 61 HPNVIKYLASFIENNELNIVLELADAGDL-SRMIKHFKKQKRLIPERTIWKYFVQLCSAL 119
Query: 298 LYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVG---H 354
++H + +I+HRD+K ANV + +GD GL + S TTA VG +
Sbjct: 120 EHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFF----SSKTTAAHSLVGTPYY 172
Query: 355 IAPEYLSTGQSSEKTDVFGFGILLLEL 381
++PE + + K+D++ G LL E+
Sbjct: 173 MSPERIHENGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 53.9 bits (130), Expect = 7e-08
Identities = 67/314 (21%), Positives = 120/314 (38%), Gaps = 52/314 (16%)
Query: 177 DKQEEGLISLGNLRNFTFRELQQATENFSSKNILGAGGFGNVYKGKLGDGTVL-AVKRLK 235
+ + L + L F E+ E ++ N D VL AVK L+
Sbjct: 1 EFPRQPLNFVEKLGEGQFGEVHLC-EADGLQDFSEKAFAENDNA----DAPVLVAVKVLR 55
Query: 236 D----------------MISLAVHRNLLRLIGYCATPTERLLVYPYMSNGSVASRLRE-- 277
+ L+ N+ RL+G C ++ YM NG + L++
Sbjct: 56 PDASDNAREDFLKEVKILSRLS-DPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHV 114
Query: 278 ---------KPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIV 328
+L ++T +A A G+ YL +HRD+ N L+ +
Sbjct: 115 AETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRDLATRNCLVGKNYTIKI 171
Query: 329 GDFGLAKLLDHSDSHVTTAVRG-TVGHI---APEYLSTGQSSEKTDVFGFGILLLELITG 384
DFG+++ L SD + V+G I A E + G+ + K+DV+ FG+ L E++T
Sbjct: 172 ADFGMSRNLYSSDYY---RVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTL 228
Query: 385 MRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELGSNYDRIEVGEILQVALLCTQYL 444
R + +Q+ ++E ++ ++ + R +I ++ L C +
Sbjct: 229 CREQPYEHLTDQQ--VIENAGHFFRDDGRQIYLPRPPNCP------KDIYELMLECWRRD 280
Query: 445 PVHRPKMSEVVRML 458
RP E+ L
Sbjct: 281 EEDRPTFREIHLFL 294
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 53.3 bits (129), Expect = 7e-08
Identities = 49/185 (26%), Positives = 77/185 (41%), Gaps = 22/185 (11%)
Query: 213 GGFGNVY--KGKLGDGTVLAVKRLKDM----ISLAVH------RNLLRLIGYCATPTERL 260
G FG V K K + K +K I VH N ++L T +
Sbjct: 27 GKFGKVSVLKHK-PTQKLFVQKIIKAKNFNAIEPMVHQLMKDNPNFIKLYYSVTTLKGHV 85
Query: 261 LVYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLL 320
L+ Y+ +G + L+++ L K+I L LH+ IIH D+K NVL
Sbjct: 86 LIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLENVLY 142
Query: 321 DDFCEAI-VGDFGLAKLLDHSDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLL 379
D + I + D+GL K++ + GT+ + +PE + D + G+L
Sbjct: 143 DRAKDRIYLCDYGLCKIIGTPSCY-----DGTLDYFSPEKIKGHNYDVSFDWWAVGVLTY 197
Query: 380 ELITG 384
EL+TG
Sbjct: 198 ELLTG 202
|
Length = 267 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 54.1 bits (131), Expect = 7e-08
Identities = 36/109 (33%), Positives = 58/109 (53%), Gaps = 12/109 (11%)
Query: 295 RGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVR----G 350
+ L Y+H +IHRD+K +N+LL+ C + DFGLA+ L + + V
Sbjct: 118 KALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVA 174
Query: 351 TVGHIAPEYL--STGQSSEKTDVFGFGILLLELITGMRALEFGKS-INQ 396
T + APE L ST + ++ D++ G +L E++ G + L G S +NQ
Sbjct: 175 TRWYRAPEILLGST-RYTKGVDMWSVGCILGEMLLG-KPLFPGTSTLNQ 221
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 8e-08
Identities = 57/257 (22%), Positives = 110/257 (42%), Gaps = 50/257 (19%)
Query: 165 SVPLSFSLNSSPDKQEEGLISLGNLRNFTFRELQQATENFSS---KNILGAGGFGNVYK- 220
+VPL SS + G+ A ++ S N +G+G G VYK
Sbjct: 42 AVPLPLPPPSSSSSSSSSSSASGSA--------PSAAKSLSELERVNRIGSGAGGTVYKV 93
Query: 221 -----GKLGDGTVL------AVKR--------LKDMISLAVHRNLLRLIGYCATPTERLL 261
G+L V+ V+R L+D H N+++ E +
Sbjct: 94 IHRPTGRLYALKVIYGNHEDTVRRQICREIEILRD----VNHPNVVKCHDMFDHNGEIQV 149
Query: 262 VYPYMSNGSV-ASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLL 320
+ +M GS+ + + ++ L R+ ++ G+ YLH + I+HRD+K +N+L+
Sbjct: 150 LLEFMDGGSLEGTHIADEQFLADVARQILS-----GIAYLHRR---HIVHRDIKPSNLLI 201
Query: 321 DDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGHIAPEYLSTGQSSEK-----TDVFGFG 375
+ + DFG++++L + ++V GT+ +++PE ++T + D++ G
Sbjct: 202 NSAKNVKIADFGVSRILAQTMDPCNSSV-GTIAYMSPERINTDLNHGAYDGYAGDIWSLG 260
Query: 376 ILLLELITGMRALEFGK 392
+ +LE G G+
Sbjct: 261 VSILEFYLGRFPFGVGR 277
|
Length = 353 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 53.3 bits (129), Expect = 9e-08
Identities = 53/205 (25%), Positives = 83/205 (40%), Gaps = 47/205 (22%)
Query: 210 LGAGGFGNVYKGK-LGDGTVLAVKRLK--------DMISLAV-----------HRNLLRL 249
LG G + VYK + G ++A+K++K D I+ H N++ L
Sbjct: 8 LGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGL 67
Query: 250 IGYCATPTERLLVYPYMSNGSVASRLREKPALDWNTR------KRIAIGAARGLLYLHEQ 303
+ + LV+ +M + L EK D + K + RGL YLH
Sbjct: 68 LDVFGHKSNINLVFEFME-----TDL-EKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSN 121
Query: 304 CDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGHIAPEYL--- 360
I+HRD+K N+L+ + DFGLA+ + +T V T + APE L
Sbjct: 122 ---WILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVV-TRWYRAPELLFGA 177
Query: 361 ---STGQSSEKTDVFGFGILLLELI 382
G D++ G + EL+
Sbjct: 178 RHYGVG-----VDMWSVGCIFAELL 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 2e-07
Identities = 50/174 (28%), Positives = 85/174 (48%), Gaps = 20/174 (11%)
Query: 294 ARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTT-AVRGTV 352
ARG+ +L + K IHRD+ A N+LL + + DFGLA+ + +V + R +
Sbjct: 184 ARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPL 240
Query: 353 GHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKK 412
+APE + + ++DV+ FG+LL E+ + + G IN+ E+ ++++ +
Sbjct: 241 KWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINE-----EFCQRLKDGTR 295
Query: 413 VEVLVDRELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLEGDGLAEK 466
+ E + EI ++ L C Q P RP S +V +L GD L E
Sbjct: 296 MRA---PENAT-------PEIYRIMLACWQGDPKERPTFSALVEIL-GDLLQEN 338
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 2e-07
Identities = 30/91 (32%), Positives = 47/91 (51%), Gaps = 4/91 (4%)
Query: 295 RGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGH 354
RGL YLH I+HRD+K N+L++ C + DFGLA++ + +S T T +
Sbjct: 114 RGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYY 170
Query: 355 IAPEYLSTGQS-SEKTDVFGFGILLLELITG 384
APE L + + D++ G + EL+
Sbjct: 171 RAPEILMGSRHYTSAVDIWSVGCIFAELLGR 201
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 2e-07
Identities = 40/127 (31%), Positives = 65/127 (51%), Gaps = 9/127 (7%)
Query: 295 RGLLYLHEQCDPKIIHRDVKAANVLL--DDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTV 352
RGL Y+H ++HRD+K ANV + +D I GDFGLA+++D SH G V
Sbjct: 125 RGLKYIHSA---NVLHRDLKPANVFINTEDLVLKI-GDFGLARIVDPHYSHKGYLSEGLV 180
Query: 353 G--HIAPE-YLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQ 409
+ +P LS ++ D++ G + E++TG + Q +LE V +++
Sbjct: 181 TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVRE 240
Query: 410 EKKVEVL 416
E + E+L
Sbjct: 241 EDRNELL 247
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 52.4 bits (125), Expect = 3e-07
Identities = 43/163 (26%), Positives = 76/163 (46%), Gaps = 7/163 (4%)
Query: 255 TPTERLLVYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVK 314
T + V Y++ G + ++ + L + + + L YLHE+ II+RD+K
Sbjct: 67 TESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHER---GIIYRDLK 123
Query: 315 AANVLLDDFCEAIVGDFGLAKL-LDHSDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFG 373
NVLLD + D+G+ K L D+ T+ GT +IAPE L D +
Sbjct: 124 LDNVLLDSEGHIKLTDYGMCKEGLRPGDT--TSTFCGTPNYIAPEILRGEDYGFSVDWWA 181
Query: 374 FGILLLELITGMRALEF-GKSINQKGAMLEWVKKIQQEKKVEV 415
G+L+ E++ G + G S N +++ ++ EK++ +
Sbjct: 182 LGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRI 224
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 3e-07
Identities = 64/280 (22%), Positives = 115/280 (41%), Gaps = 56/280 (20%)
Query: 210 LGAGGFGNVYKGK---LGDG-----TVLAVKRLK--------------DMISLAVHRNLL 247
LG G F ++KG +GD T + +K L M+S H++L+
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 248 RLIGYCATPTERLLVYPYMSNGSVASRLRE-KPALDWNTRKRIAIGAARGLLYLHEQCDP 306
G C E ++V Y+ GS+ + L++ K ++ + + +A A L +L ++
Sbjct: 63 LNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDK--- 119
Query: 307 KIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGT------VGHIAPEYL 360
+ H +V A NVLL + G+ KL SD ++ V + + PE +
Sbjct: 120 GLTHGNVCAKNVLLIREEDRKTGNPPFIKL---SDPGISITVLPKEILLERIPWVPPECI 176
Query: 361 STGQS-SEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQ-QEKKVEVLVD 418
Q+ S D + FG L E+ +G ++ + L+ KK+Q E + ++
Sbjct: 177 ENPQNLSLAADKWSFGTTLWEIFSG---------GDKPLSALDSQKKLQFYEDRHQLPAP 227
Query: 419 RELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRML 458
+ E+ ++ C Y P RP ++R L
Sbjct: 228 K-------WTELANLINQ---CMDYEPDFRPSFRAIIRDL 257
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 3e-07
Identities = 34/93 (36%), Positives = 54/93 (58%), Gaps = 5/93 (5%)
Query: 297 LLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDS---HVTTAVRGTVG 353
+L L E K++HRD+K+AN+ L +GDFG +K +SDS V ++ GT
Sbjct: 179 VLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSK--QYSDSVSLDVASSFCGTPY 236
Query: 354 HIAPEYLSTGQSSEKTDVFGFGILLLELITGMR 386
++APE + S+K D++ G++L EL+T R
Sbjct: 237 YLAPELWERKRYSKKADMWSLGVILYELLTLHR 269
|
Length = 478 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 3e-07
Identities = 34/91 (37%), Positives = 53/91 (58%), Gaps = 4/91 (4%)
Query: 294 ARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAK-LLDHSDSHVTTAVRGTV 352
A+G+ +L + IHRDV A NVLL D A + DFGLA+ +++ S+ V R V
Sbjct: 222 AQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLPV 278
Query: 353 GHIAPEYLSTGQSSEKTDVFGFGILLLELIT 383
+APE + + ++DV+ +GILL E+ +
Sbjct: 279 KWMAPESIFDCVYTVQSDVWSYGILLWEIFS 309
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 3e-07
Identities = 31/86 (36%), Positives = 51/86 (59%), Gaps = 5/86 (5%)
Query: 296 GLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGHI 355
G+ Y+H++ +I+HRD+KA N+ L + I GDFG+++LL S TT GT ++
Sbjct: 118 GVHYMHQR---RILHRDLKAKNIFLKNNLLKI-GDFGVSRLLMGSCDLATT-FTGTPYYM 172
Query: 356 APEYLSTGQSSEKTDVFGFGILLLEL 381
+PE L K+D++ G +L E+
Sbjct: 173 SPEALKHQGYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 5e-07
Identities = 55/197 (27%), Positives = 86/197 (43%), Gaps = 27/197 (13%)
Query: 209 ILGAGGFGNVYKG--KLGDGTVL--AVKRLKDMIS-------LAV--------HRNLLRL 249
ILG G FG + +G KL L A+ L+ S LA H N++RL
Sbjct: 12 ILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRL 71
Query: 250 IGYCATPTERLLVYPYMSNGSVASRLREKPA-LDWNTRKRIAIGAARGLLYLHEQCDPKI 308
G ++V YMSNG++ S LR+ L + G A G+ YL E
Sbjct: 72 EGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEM---GY 128
Query: 309 IHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRG--TVGHIAPEYLSTGQSS 366
+H+ + A VL++ + F +L + + T + G V APE + S
Sbjct: 129 VHKGLAAHKVLVNSDLVCKISGFR--RLQEDKSEAIYTTMSGKSPVLWAAPEAIQYHHFS 186
Query: 367 EKTDVFGFGILLLELIT 383
+DV+ FGI++ E+++
Sbjct: 187 SASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 5e-07
Identities = 47/190 (24%), Positives = 85/190 (44%), Gaps = 20/190 (10%)
Query: 210 LGAGGFGNVYKG-KLGDGTVLAVKRL-------KDMISLAV-------HRNLLRLIGYCA 254
+G G G VY + G +A+K++ K++I + H N++ +
Sbjct: 27 IGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYL 86
Query: 255 TPTERLLVYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVK 314
E +V Y++ GS+ + E +D + + L +LH ++IHRD+K
Sbjct: 87 VGDELWVVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIK 142
Query: 315 AANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGF 374
+ N+LL + DFG + S +T V GT +APE ++ K D++
Sbjct: 143 SDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKVDIWSL 201
Query: 375 GILLLELITG 384
GI+ +E++ G
Sbjct: 202 GIMAIEMVEG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 5e-07
Identities = 57/220 (25%), Positives = 92/220 (41%), Gaps = 42/220 (19%)
Query: 195 RELQQATENFSSKNILGAGGFGNVYKGKLGDG-TVLAVKRLK--DMIS------------ 239
+L+ E+F ++G G FG V + V A+K L +MI
Sbjct: 36 TKLRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERD 95
Query: 240 LAVHRN---LLRLIGYCATPTERLL--VYPYMSNGSVASRLR-----EKPALDWNTRKRI 289
+ H N +++L + A ++ L V YM G + + + EK A + +
Sbjct: 96 IMAHANSEWIVQL--HYAFQDDKYLYMVMEYMPGGDLVNLMSNYDIPEKWARFYTAEVVL 153
Query: 290 AIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDS-HVTTAV 348
A+ A + + IHRDVK N+LLD + DFG +D + TAV
Sbjct: 154 ALDAIHSMGF---------IHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAV 204
Query: 349 RGTVGHIAPEYLST----GQSSEKTDVFGFGILLLELITG 384
GT +I+PE L + G + D + G+ L E++ G
Sbjct: 205 -GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 51.2 bits (123), Expect = 6e-07
Identities = 33/92 (35%), Positives = 48/92 (52%), Gaps = 9/92 (9%)
Query: 295 RGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGH 354
RGL Y+H ++HRD+K +N+LL+ C+ + DFGLA+ +T V T +
Sbjct: 119 RGLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVV-TRWY 174
Query: 355 IAPEYLSTGQSSEKT---DVFGFGILLLELIT 383
APE L SE T DV+ G + EL+
Sbjct: 175 RAPELLLN--CSEYTTAIDVWSVGCIFAELLG 204
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 50.9 bits (121), Expect = 6e-07
Identities = 48/190 (25%), Positives = 86/190 (45%), Gaps = 20/190 (10%)
Query: 210 LGAGGFGNVYKG-KLGDGTVLAVKRL-------KDMI--SLAVHR-----NLLRLIGYCA 254
+G G G VY + G +A+K++ K++I + V R N++ +
Sbjct: 27 IGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 86
Query: 255 TPTERLLVYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVK 314
E +V Y++ GS+ + E +D + + L +LH ++IHRD+K
Sbjct: 87 VGDELWVVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALDFLHSN---QVIHRDIK 142
Query: 315 AANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGF 374
+ N+LL + DFG + S +T V GT +APE ++ K D++
Sbjct: 143 SDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKVDIWSL 201
Query: 375 GILLLELITG 384
GI+ +E++ G
Sbjct: 202 GIMAIEMVEG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 6e-07
Identities = 32/91 (35%), Positives = 53/91 (58%), Gaps = 8/91 (8%)
Query: 295 RGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGH 354
GL Y+H IIHRD+K N+ +++ CE + DFGLA+ H+D+ +T V T +
Sbjct: 128 CGLKYIHSA---GIIHRDLKPGNLAVNEDCELKILDFGLAR---HADAEMTGYVV-TRWY 180
Query: 355 IAPEY-LSTGQSSEKTDVFGFGILLLELITG 384
APE L+ ++ D++ G ++ E++TG
Sbjct: 181 RAPEVILNWMHYNQTVDIWSVGCIMAEMLTG 211
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.8 bits (122), Expect = 6e-07
Identities = 32/98 (32%), Positives = 52/98 (53%), Gaps = 17/98 (17%)
Query: 295 RGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAK---LLDHSDSH--VTTAVR 349
RGL Y H++ +++HRD+K N+L+ + E + DFGLA+ + + S+ VT R
Sbjct: 114 RGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEVVTLWYR 170
Query: 350 GTVGHIAPEYL--STGQSSEKTDVFGFGILLLELITGM 385
P+ L ST S+ D++G G + E+ TG
Sbjct: 171 ------PPDVLLGSTEYSTS-LDMWGVGCIFYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 6e-07
Identities = 42/134 (31%), Positives = 65/134 (48%), Gaps = 7/134 (5%)
Query: 253 CATPTERL-LVYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHR 311
C T RL LV Y++ G + ++ + L + A L +LHE+ II+R
Sbjct: 64 CFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHER---GIIYR 120
Query: 312 DVKAANVLLDDFCEAIVGDFGLAKL-LDHSDSHVTTAVRGTVGHIAPEYLSTGQSSEKTD 370
D+K NVLLD + D+G+ K L D+ T+ GT +IAPE L + D
Sbjct: 121 DLKLDNVLLDADGHIKLTDYGMCKEGLGPGDT--TSTFCGTPNYIAPEILRGEEYGFSVD 178
Query: 371 VFGFGILLLELITG 384
+ G+L+ E++ G
Sbjct: 179 WWALGVLMFEMMAG 192
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 50.9 bits (121), Expect = 7e-07
Identities = 41/157 (26%), Positives = 72/157 (45%), Gaps = 12/157 (7%)
Query: 228 VLAVKRLKDMISLAVHRNLLRLIGYCATPTERLLVYPYMSNGSVASRLREKPALDWNTRK 287
+L +K LK+ N++ + E +V Y++ GS+ + E +D
Sbjct: 67 ILVMKELKN-------PNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTET-CMDEAQIA 118
Query: 288 RIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTA 347
+ + L +LH ++IHRD+K+ NVLL + DFG + S +T
Sbjct: 119 AVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTM 175
Query: 348 VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITG 384
V GT +APE ++ K D++ GI+ +E++ G
Sbjct: 176 V-GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 8e-07
Identities = 49/190 (25%), Positives = 83/190 (43%), Gaps = 22/190 (11%)
Query: 210 LGAGGFGNVYKG-KLGDGTVLAVKRLK--------------DMISLAVHRNLLRLIGYCA 254
+G+G +G+VYK L G + AVK +K M+ H N++ G
Sbjct: 17 VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYL 76
Query: 255 TPTERLLVYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVK 314
+ + + Y GS+ L + +GL YLH + +HRD+K
Sbjct: 77 SREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGK---MHRDIK 133
Query: 315 AANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGHIAPEYLS---TGQSSEKTDV 371
AN+LL D + + DFG+A + + + + + GT +APE + G ++ D+
Sbjct: 134 GANILLTDNGDVKLADFGVAAKITATIAKRKSFI-GTPYWMAPEVAAVEKNGGYNQLCDI 192
Query: 372 FGFGILLLEL 381
+ GI +EL
Sbjct: 193 WAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.8 bits (122), Expect = 8e-07
Identities = 30/93 (32%), Positives = 53/93 (56%), Gaps = 6/93 (6%)
Query: 295 RGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLD--HSDSHVTTAVRGTV 352
RGL Y+H ++HRD+K +N+LL+ C+ + DFGLA++ D H + T T
Sbjct: 117 RGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATR 173
Query: 353 GHIAPE-YLSTGQSSEKTDVFGFGILLLELITG 384
+ APE L++ ++ D++ G +L E+++
Sbjct: 174 WYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSN 206
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 9e-07
Identities = 54/214 (25%), Positives = 94/214 (43%), Gaps = 24/214 (11%)
Query: 202 ENFSSKNILGAGGFGNVYKG--KLGDGTVLAVKRLK---------------DMISLAVHR 244
E + + LG G + VYKG KL D V A+K ++ ++ H
Sbjct: 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLV-ALKEIRLEHEEGAPCTAIREVSLLKDLKHA 64
Query: 245 NLLRLIGYCATPTERLLVYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQC 304
N++ L T LV+ Y+ +++ + K RGL Y H +
Sbjct: 65 NIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRR- 123
Query: 305 DPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGHIAPE-YLSTG 363
K++HRD+K N+L+++ E + DFGLA+ + V T+ + P+ L +
Sbjct: 124 --KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVV-TLWYRPPDILLGST 180
Query: 364 QSSEKTDVFGFGILLLELITGMRALEFGKSINQK 397
S + D++G G + E+ TG R L G ++ ++
Sbjct: 181 DYSTQIDMWGVGCIFYEMSTG-RPLFPGSTVEEQ 213
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 50.5 bits (120), Expect = 1e-06
Identities = 51/194 (26%), Positives = 81/194 (41%), Gaps = 22/194 (11%)
Query: 209 ILGAGGFGNVYKGK-LGDGTVLAVKRLKDMISLA------------VHRN----LLRLIG 251
+LG G FG V + G A+K LK + +A V +N L +
Sbjct: 2 LLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLK 61
Query: 252 YCATPTERL-LVYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIH 310
Y +RL V Y++ G + L + + + L YLH KI++
Sbjct: 62 YSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSG---KIVY 118
Query: 311 RDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGHIAPEYLSTGQSSEKTD 370
RD+K N++LD + DFGL K +D+ GT ++APE L D
Sbjct: 119 RDLKLENLMLDKDGHIKITDFGLCK-EGITDAATMKTFCGTPEYLAPEVLEDNDYGRAVD 177
Query: 371 VFGFGILLLELITG 384
+G G+++ E++ G
Sbjct: 178 WWGLGVVMYEMMCG 191
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 1e-06
Identities = 41/169 (24%), Positives = 78/169 (46%), Gaps = 23/169 (13%)
Query: 231 VKRLKDMISLAVHRNLLRLIGYCATPTERLLVYPYMSNGSVASRLREK------------ 278
+K +K M L + N++RL+G C + ++ YM NG + L ++
Sbjct: 65 LKEIKIMSRLK-NPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNI 123
Query: 279 PALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLD 338
P++ +A+ A G+ YL +HRD+ N L+ + + DFG+++ L
Sbjct: 124 PSVSIANLLYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLY 180
Query: 339 HSDSHVTTAVRG----TVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT 383
D + ++G + +A E + G+ + +DV+ FG+ L E+ T
Sbjct: 181 SGDYY---RIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 1e-06
Identities = 41/125 (32%), Positives = 63/125 (50%), Gaps = 16/125 (12%)
Query: 295 RGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGH 354
RGL Y+H IIHRD+K +NV +++ CE + DFGLA+ +D +T V T +
Sbjct: 129 RGLKYIHSA---GIIHRDLKPSNVAVNEDCELRILDFGLAR---QADDEMTGYV-ATRWY 181
Query: 355 IAPE-YLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWV--------K 405
APE L+ ++ D++ G ++ EL+ G I+Q ++E V K
Sbjct: 182 RAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLK 241
Query: 406 KIQQE 410
KI E
Sbjct: 242 KISSE 246
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 1e-06
Identities = 50/232 (21%), Positives = 101/232 (43%), Gaps = 37/232 (15%)
Query: 203 NFSSKNILGAGGFGNVYKGK-LGDGTVLAVKRLK-----------------DMISLAVHR 244
NF + +G G F VY+ L D +A+K+++ D++ H
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62
Query: 245 NLLRLIGYCATPTERLLVYPYMSNGSVASRL----REKPALDWNTRKRIAIGAARGLLYL 300
N+++ + E +V G ++ + ++K + T + + + ++
Sbjct: 63 NVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHM 122
Query: 301 HEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVG---HIAP 357
H + +++HRD+K ANV + +GD GL + S TTA VG +++P
Sbjct: 123 HSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFF----SSKTTAAHSLVGTPYYMSP 175
Query: 358 EYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQ 409
E + + K+D++ G LL E+ +++ +G +N + +KI+Q
Sbjct: 176 ERIHENGYNFKSDIWSLGCLLYEM-AALQSPFYGDKMN----LFSLCQKIEQ 222
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 1e-06
Identities = 57/199 (28%), Positives = 92/199 (46%), Gaps = 29/199 (14%)
Query: 209 ILGAGGFGNVYKGK-LGDGTVLAVKRL--------KDMISLAVHRNLLR-------LIG- 251
++G G FG V + + AVK L K+ + RN+L L+G
Sbjct: 2 VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 61
Query: 252 -YCATPTERL-LVYPYMSNGSVASRL-REKPALDWNTRKRIA-IGAARGLLYLHEQCDPK 307
+ ++L V Y++ G + L RE+ L+ R A I +A G YLH
Sbjct: 62 HFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALG--YLHSL---N 116
Query: 308 IIHRDVKAANVLLDDFCEAIVGDFGLAKL-LDHSDSHVTTAVRGTVGHIAPEYLSTGQSS 366
I++RD+K N+LLD ++ DFGL K ++H+ + T+ GT ++APE L
Sbjct: 117 IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGT--TSTFCGTPEYLAPEVLHKQPYD 174
Query: 367 EKTDVFGFGILLLELITGM 385
D + G +L E++ G+
Sbjct: 175 RTVDWWCLGAVLYEMLYGL 193
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.6 bits (119), Expect = 2e-06
Identities = 40/164 (24%), Positives = 67/164 (40%), Gaps = 45/164 (27%)
Query: 211 GAGGFGNVYKGKL---GDGTVLAVKRLK------DMISLAV-----------HRNLLRLI 250
G G +G VYK K DG A+K+ K IS + H N++ L+
Sbjct: 9 GRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLV 68
Query: 251 GYCATPTERL--LVYPYMSNGSVAS----------RLREKPALDWNTRKRIAIGAARGLL 298
++ L++ Y A R ++ ++ + K + G+
Sbjct: 69 EVFLEHADKSVYLLFDY------AEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVH 122
Query: 299 YLHEQCDPKIIHRDVKAANVLL--DDFCEAIV--GDFGLAKLLD 338
YLH ++HRD+K AN+L+ + +V GD GLA+L +
Sbjct: 123 YLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFN 163
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 2e-06
Identities = 44/166 (26%), Positives = 79/166 (47%), Gaps = 19/166 (11%)
Query: 294 ARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTA-VRGTV 352
A+G+ +L + K IHRD+ A N+LL + + DFGLA+ + +V R +
Sbjct: 189 AKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPL 245
Query: 353 GHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKK 412
+APE + + ++DV+ FG+LL E+ + + G I++ E+ +++++ +
Sbjct: 246 KWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE-----EFCRRLKEGTR 300
Query: 413 VEVLVDRELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRML 458
+ +Y E+ Q L C P RP SE+V L
Sbjct: 301 MR-------APDY---TTPEMYQTMLDCWHGEPSQRPTFSELVEHL 336
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 49.1 bits (118), Expect = 2e-06
Identities = 35/104 (33%), Positives = 55/104 (52%), Gaps = 7/104 (6%)
Query: 295 RGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGH 354
G+ +LH+ I+HRD+K +N+LL++ + DFGLA+ T V T+ +
Sbjct: 117 SGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVV-TLWY 172
Query: 355 IAPE-YLSTGQSSEKTDVFGFGILLLELITGMRALEFGKS-INQ 396
APE L + S D++ G + EL+T + L GKS I+Q
Sbjct: 173 RAPELLLGAKEYSTAIDMWSVGCIFAELLT-KKPLFPGKSEIDQ 215
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 2e-06
Identities = 47/198 (23%), Positives = 87/198 (43%), Gaps = 22/198 (11%)
Query: 202 ENFSSKNILGAGGFGNVYKGK-LGDGTVLAVKRLK--------------DMISLAVHRNL 246
E+F +G+G +G+VYK + + G + A+K +K M+ H N+
Sbjct: 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNI 68
Query: 247 LRLIGYCATPTERLLVYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDP 306
+ G + + + GS+ L + ++ +GL YLH +
Sbjct: 69 VAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGK- 127
Query: 307 KIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGHIAPEYLST---G 363
+HRD+K AN+LL D + DFG++ + + + + + GT +APE + G
Sbjct: 128 --MHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFI-GTPYWMAPEVAAVERKG 184
Query: 364 QSSEKTDVFGFGILLLEL 381
++ D++ GI +EL
Sbjct: 185 GYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 49.3 bits (118), Expect = 2e-06
Identities = 45/161 (27%), Positives = 70/161 (43%), Gaps = 44/161 (27%)
Query: 208 NILGAGGFGNVYKGK-LGDGTVLAVKRLK----------------DMISLAVHRNLLRLI 250
+G G FG V+K + ++A+K++ ++ L H N++ LI
Sbjct: 18 AKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLI 77
Query: 251 GYC---ATPTER-----LLVYPY--------MSNGSVASRLREKPALDWNTRKRIAIGAA 294
C ATP R LV+ + +SN +V L E K++
Sbjct: 78 EICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEI--------KKVMKMLL 129
Query: 295 RGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAK 335
GL Y+H KI+HRD+KAAN+L+ + DFGLA+
Sbjct: 130 NGLYYIHRN---KILHRDMKAANILITKDGILKLADFGLAR 167
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 2e-06
Identities = 50/173 (28%), Positives = 82/173 (47%), Gaps = 20/173 (11%)
Query: 294 ARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTA-VRGTV 352
ARG+ +L + K IHRD+ A N+LL + + DFGLA+ + +V R +
Sbjct: 183 ARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPL 239
Query: 353 GHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKK 412
+APE + + ++DV+ FG+LL E+ + + G I++ E+ +++++
Sbjct: 240 KWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE-----EFCRRLKEGT- 293
Query: 413 VEVLVDRELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLEGDGLAE 465
R Y EI + L C P RP SE+V +L GD L E
Sbjct: 294 ------RMRAPEY---ATPEIYSIMLDCWHNNPEDRPTFSELVEIL-GDLLQE 336
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.9 bits (117), Expect = 3e-06
Identities = 51/195 (26%), Positives = 84/195 (43%), Gaps = 29/195 (14%)
Query: 210 LGAGGFGNVYKGKLGD-GTVLAVKRLK-----------------DMISLAVHRNLLRLIG 251
+G GG+G V+ K D G ++A+KR+K D+++ L++L+
Sbjct: 9 VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLL- 67
Query: 252 YCATPTERL-LVYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIH 310
Y E L L Y+ G + L L + + + LHE IH
Sbjct: 68 YAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHEL---GYIH 124
Query: 311 RDVKAANVLLDDFCEAIVGDFGLAK-LLDHSDSHVTTAVRGTVGHIAPEYLSTGQSSEKT 369
RD+K N L+D + DFGL+K ++ +++S V G+ ++APE L
Sbjct: 125 RDLKPENFLIDASGHIKLTDFGLSKGIVTYANSVV-----GSPDYMAPEVLRGKGYDFTV 179
Query: 370 DVFGFGILLLELITG 384
D + G +L E + G
Sbjct: 180 DYWSLGCMLYEFLCG 194
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 48.6 bits (115), Expect = 4e-06
Identities = 48/190 (25%), Positives = 86/190 (45%), Gaps = 20/190 (10%)
Query: 210 LGAGGFGNVYKG-KLGDGTVLAVKRL-------KDMI--SLAVHR-----NLLRLIGYCA 254
+G G G VY + G +A++++ K++I + V R N++ +
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 255 TPTERLLVYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVK 314
E +V Y++ GS+ + E +D + + L +LH ++IHRD+K
Sbjct: 88 VGDELWVVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIK 143
Query: 315 AANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGF 374
+ N+LL + DFG + S +T V GT +APE ++ K D++
Sbjct: 144 SDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKVDIWSL 202
Query: 375 GILLLELITG 384
GI+ +E+I G
Sbjct: 203 GIMAIEMIEG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 4e-06
Identities = 31/91 (34%), Positives = 51/91 (56%), Gaps = 5/91 (5%)
Query: 295 RGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGH 354
RGL Y H++ KI+HRD+K N+L+++ E + DFGLA+ + V T+ +
Sbjct: 114 RGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVV-TLWY 169
Query: 355 IAPE-YLSTGQSSEKTDVFGFGILLLELITG 384
P+ L + + S D++G G +L E+ TG
Sbjct: 170 RPPDVLLGSTEYSTPIDMWGVGCILYEMATG 200
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 4e-06
Identities = 59/234 (25%), Positives = 102/234 (43%), Gaps = 39/234 (16%)
Query: 204 FSSKNILGAGGFGNVYKGKLGD-GTVLAVKRLK----------------DMISLAVHRNL 246
F +G G +G VYK + D G ++A+K+++ ++ HRN+
Sbjct: 9 FDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNI 68
Query: 247 LRLIGYCATPTERL----------LVYPYMSNGSVASRLREKPALDWNTR--KRIAIGAA 294
+ L + L LV+ YM + + L E + ++ K
Sbjct: 69 VNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMG--LLESGLVHFSEDHIKSFMKQLL 126
Query: 295 RGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGH 354
GL Y H++ +HRD+K +N+LL++ + + DFGLA+L + +S T T+ +
Sbjct: 127 EGLNYCHKK---NFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVITLWY 183
Query: 355 IAPE-YLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKI 407
PE L + DV+ G +L EL T + F NQ+ A LE + ++
Sbjct: 184 RPPELLLGEERYGPAIDVWSCGCILGELFT--KKPIF--QANQELAQLELISRL 233
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 48.0 bits (115), Expect = 4e-06
Identities = 50/202 (24%), Positives = 77/202 (38%), Gaps = 42/202 (20%)
Query: 210 LGAGGFGNVYKGK-LGDGTVLAVKRLKD----------------MISLAVHRNLLRLIGY 252
+G G F V K + G A+K +K + L+ H N+LRLI
Sbjct: 7 IGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEV 66
Query: 253 C-ATPTERL-LV--------YPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHE 302
T RL LV Y + R++P L K + L ++H
Sbjct: 67 LFDRKTGRLALVFELMDMNLYELIKG-------RKRP-LPEKRVKSYMYQLLKSLDHMHR 118
Query: 303 QCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGHIAPE-YLS 361
I HRD+K N+L+ D + DFG + + T T + APE L+
Sbjct: 119 N---GIFHRDIKPENILIKDDILKL-ADFGSCRGIY--SKPPYTEYISTRWYRAPECLLT 172
Query: 362 TGQSSEKTDVFGFGILLLELIT 383
G K D++ G + E+++
Sbjct: 173 DGYYGPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 6e-06
Identities = 58/218 (26%), Positives = 90/218 (41%), Gaps = 30/218 (13%)
Query: 202 ENFSSKNILGAGGFGNVY--KGKLGDGTVLAVKRLKDMISLAVH--------RNLLRL-- 249
++F K+++G G FG V + K G + A+K +K + LA R++L +
Sbjct: 1 KDFDVKSLVGRGHFGEVQVVREK-ATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISN 59
Query: 250 ------IGYCATPTERL-LVYPYMSNGSVASRL-REKPALDWNTRKRIAIGAARGLLYLH 301
+ Y + L LV Y G + S L R + D + A +L +H
Sbjct: 60 SPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDM---AQFYLAELVLAIH 116
Query: 302 EQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGHIAPEYLS 361
+HRD+K NVL+D + DFG A L + + GT +IAPE L+
Sbjct: 117 SVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLT 176
Query: 362 TGQSSEKT------DVFGFGILLLELITGMRALEFGKS 393
T K D + G++ E+I G G S
Sbjct: 177 TMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTS 214
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 6e-06
Identities = 55/212 (25%), Positives = 87/212 (41%), Gaps = 32/212 (15%)
Query: 195 RELQQATENFSSKNILGAGGFGNVY--KGKLGDGTVLAVKRL-----------------K 235
R+ + E+F+ LG G FG V K D +A+KR +
Sbjct: 23 RKNKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSER 82
Query: 236 DMISLAVHRNLLRLIGYCATPTERLLVYPYMSNGSVASRLREKPALDWNTRKRIAIG--- 292
+++ H + L G + LV ++ G + LR N R +G
Sbjct: 83 KILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRR------NKRFPNDVGCFY 136
Query: 293 AARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTV 352
AA+ +L I++RD+K N+LLD + DFG AK++D T + GT
Sbjct: 137 AAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR----TYTLCGTP 192
Query: 353 GHIAPEYLSTGQSSEKTDVFGFGILLLELITG 384
+IAPE L + D + GI + E++ G
Sbjct: 193 EYIAPEILLNVGHGKAADWWTLGIFIYEILVG 224
|
Length = 340 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 1e-05
Identities = 35/130 (26%), Positives = 59/130 (45%), Gaps = 4/130 (3%)
Query: 255 TPTERLLVYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVK 314
T + V ++S G + ++ + L + + + L +LHE+ II+RD+K
Sbjct: 67 TESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHER---GIIYRDLK 123
Query: 315 AANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGF 374
NVLLD + D+G+ K T+ GT +IAPE L D +
Sbjct: 124 LDNVLLDAEGHIKLTDYGMCKE-GIRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWAL 182
Query: 375 GILLLELITG 384
G+L+ E++ G
Sbjct: 183 GVLMFEMMAG 192
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 1e-05
Identities = 41/168 (24%), Positives = 75/168 (44%), Gaps = 28/168 (16%)
Query: 231 VKRLKDMISLAVHRNLLRLIGYCATPTERLLVYPYMSNGSV---ASRLR--------EKP 279
+ RLKD N++RL+ C T ++ YM NG + SR +
Sbjct: 73 MSRLKD-------PNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVV 125
Query: 280 ALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDH 339
+ ++T +A A G+ YL +HRD+ N L+ + DFG+++ L
Sbjct: 126 TISYSTLIFMATQIASGMKYLSSL---NFVHRDLATRNCLVGKNYTIKIADFGMSRNLYS 182
Query: 340 SDSHVTTAVRG----TVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT 383
D + ++G + ++ E + G+ + +DV+ FG+ L E++T
Sbjct: 183 GDYY---RIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.4 bits (111), Expect = 2e-05
Identities = 55/201 (27%), Positives = 89/201 (44%), Gaps = 31/201 (15%)
Query: 210 LGAGGFGNVYKGK-LGDGTVLAVKRLKD----------------MISLAVHRNLLRLIGY 252
LG G FG+VY + G ++A+K++K + L H N+++L
Sbjct: 7 LGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEV 66
Query: 253 CATPTERLLVYPYMSNGSVAS--RLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIH 310
E V+ YM G++ + R+ + + I +GL ++H+ H
Sbjct: 67 FRENDELYFVFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKH---GFFH 122
Query: 311 RDVKAANVLL-DDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGHIAPEYL--STGQSSE 367
RD+K N+L+ I DFGLA+ + + T V T + APE L ST SS
Sbjct: 123 RDLKPENLLVSGPEVVKI-ADFGLAREIRSRPPY-TDYV-STRWYRAPEILLRSTSYSS- 178
Query: 368 KTDVFGFGILLLELITGMRAL 388
D++ G ++ EL T +R L
Sbjct: 179 PVDIWALGCIMAELYT-LRPL 198
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 2e-05
Identities = 28/88 (31%), Positives = 44/88 (50%), Gaps = 4/88 (4%)
Query: 297 LLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGHIA 356
L YLH + +++RD+K N++LD + DFGL K SD GT ++A
Sbjct: 108 LEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCK-EGISDGATMKTFCGTPEYLA 163
Query: 357 PEYLSTGQSSEKTDVFGFGILLLELITG 384
PE L D +G G+++ E++ G
Sbjct: 164 PEVLEDNDYGRAVDWWGLGVVMYEMMCG 191
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 2e-05
Identities = 55/229 (24%), Positives = 95/229 (41%), Gaps = 49/229 (21%)
Query: 196 ELQQATENFSSKNILGAGGFGNVYKGKL-----GDGT-VLAVKRLKDMISLAV------- 242
E+ +T F + LG FG VYKG L G+ T +A+K LKD +
Sbjct: 1 EINLSTVRFMEE--LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHE 58
Query: 243 --------HRNLLRLIG-------------YCA-TPTERLLVY--PYMSNGSVASRLREK 278
H N++ L+G YC+ + LV P+ GS K
Sbjct: 59 AMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVK 118
Query: 279 PALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLD 338
L+ I A G+ +L ++H+D+ NVL+ D + D GL + +
Sbjct: 119 STLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKLNVKISDLGLFREVY 175
Query: 339 HSDSHVTTAVRGT----VGHIAPEYLSTGQSSEKTDVFGFGILLLELIT 383
+D + + G + ++PE + G+ S +D++ +G++L E+ +
Sbjct: 176 AADYY---KLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 2e-05
Identities = 52/194 (26%), Positives = 85/194 (43%), Gaps = 25/194 (12%)
Query: 210 LGAGGFGNVYKG-KLGDGTVLAVK---------------RLKDMISLAVHRNLLRLIGYC 253
LG G + VYKG +G ++A+K R ++ H N++ L
Sbjct: 13 LGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDII 72
Query: 254 ATPTERLLVYPYMSNGSVASRLREKPA-LDWNTRKRIAIGAARGLLYLHEQCDPKIIHRD 312
T V+ YM +A + + P L + RGL Y+H Q I+HRD
Sbjct: 73 HTKETLTFVFEYMHT-DLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQ---HILHRD 128
Query: 313 VKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGHIAPEYL--STGQSSEKTD 370
+K N+L+ E + DFGLA+ S ++ T+ + P+ L +T SS D
Sbjct: 129 LKPQNLLISYLGELKLADFGLAR-AKSIPSQTYSSEVVTLWYRPPDVLLGATDYSSA-LD 186
Query: 371 VFGFGILLLELITG 384
++G G + +E++ G
Sbjct: 187 IWGAGCIFIEMLQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 2e-05
Identities = 55/215 (25%), Positives = 95/215 (44%), Gaps = 27/215 (12%)
Query: 203 NFSSKNILGAGGFGNVYKGK-LGDGTVLAVKRLK-DMISLAV---------------HRN 245
NF +G G +G VYK + G V+A+K+++ D + V H N
Sbjct: 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 60
Query: 246 LLRLIGYCATPTERLLVYPYMSNGSVASRLREKPA--LDWNTRKRIAIGAARGLLYLHEQ 303
+++L+ T + LV+ ++ + + + P + K +GL + H
Sbjct: 61 IVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSH 119
Query: 304 CDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGHIAPE-YLST 362
+++HRD+K N+L++ + DFGLA+ T V T+ + APE L
Sbjct: 120 ---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPEILLGC 175
Query: 363 GQSSEKTDVFGFGILLLELITGMRALEFGKS-INQ 396
S D++ G + E++T RAL G S I+Q
Sbjct: 176 KYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQ 209
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 3e-05
Identities = 37/153 (24%), Positives = 64/153 (41%), Gaps = 40/153 (26%)
Query: 210 LGAGGFGNVYKGK-LGDGTVLAVKRLK------DMISLAV----------HRNLLRLIGY 252
+G G +G V+K K ++A+KR++ + S A+ H+N++RL
Sbjct: 8 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDV 67
Query: 253 CATPTERLLVYPYMS----------NGSVASRLREKPALDWNTRKRIAIGAARGLLYLHE 302
+ + LV+ Y NG + D K +GL + H
Sbjct: 68 LHSDKKLTLVFEYCDQDLKKYFDSCNGDI----------DPEIVKSFMFQLLKGLAFCHS 117
Query: 303 QCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAK 335
++HRD+K N+L++ E + DFGLA+
Sbjct: 118 H---NVLHRDLKPQNLLINKNGELKLADFGLAR 147
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|205079 pfam12799, LRR_4, Leucine Rich repeats (2 copies) | Back alignment and domain information |
|---|
Score = 40.9 bits (97), Expect = 3e-05
Identities = 19/38 (50%), Positives = 27/38 (71%), Gaps = 2/38 (5%)
Query: 32 TNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLS 69
TNL + L NN I+ +PP L +LP L+TLDLS N+++
Sbjct: 1 TNLETLDLSNNQITD-LPP-LSNLPNLETLDLSGNKIT 36
|
Leucine rich repeats are short sequence motifs present in a number of proteins with diverse functions and cellular locations. These repeats are usually involved in protein-protein interactions. Each Leucine Rich Repeat is composed of a beta-alpha unit. These units form elongated non-globular structures. Leucine Rich Repeats are often flanked by cysteine rich domains. Length = 43 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 3e-05
Identities = 29/96 (30%), Positives = 48/96 (50%), Gaps = 4/96 (4%)
Query: 289 IAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAV 348
+ + R L YLH Q +IHRD+K+ ++LL + DFG + + V
Sbjct: 123 VCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLV 179
Query: 349 RGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITG 384
GT +APE +S + D++ GI+++E+I G
Sbjct: 180 -GTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDG 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 3e-05
Identities = 34/129 (26%), Positives = 61/129 (47%), Gaps = 16/129 (12%)
Query: 262 VYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLD 321
+ + + E PAL + + A G+ +L + +HRD+ A NVL+
Sbjct: 217 LPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK---NCVHRDLAARNVLI- 272
Query: 322 DFCEAI---VGDFGLAKLLDHSDSHVTTAVRGT----VGHIAPEYLSTGQSSEKTDVFGF 374
CE + DFGLA+ + ++++ +G+ + +APE + + +DV+ F
Sbjct: 273 --CEGKLVKICDFGLARDIMRDSNYIS---KGSTFLPLKWMAPESIFNNLYTTLSDVWSF 327
Query: 375 GILLLELIT 383
GILL E+ T
Sbjct: 328 GILLWEIFT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 3e-05
Identities = 61/242 (25%), Positives = 96/242 (39%), Gaps = 52/242 (21%)
Query: 190 RNFTFRELQQATENFSSKNILGAGGFGNVYK-GKLGDGTVLAVKRLKD------------ 236
+ F ++ + +G G +G V+K +G+ AVK L
Sbjct: 6 KTIIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEY 65
Query: 237 --MISLAVHRNLLRLIGY-----CATPTERLLVYPYMSNGSVASRLR---------EKPA 280
+ +L+ H N+++ G + LV + GSV ++ E+P
Sbjct: 66 NILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPI 125
Query: 281 LDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHS 340
+ + I A GL +LH K IHRDVK N+LL + DFG++ L +
Sbjct: 126 IAY-----ILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTST 177
Query: 341 DSHVTTAVRGTVGHIAPEYLSTGQS-----SEKTDVFGFGILLLELITG---------MR 386
T+V GT +APE ++ Q + DV+ GI +EL G MR
Sbjct: 178 RLRRNTSV-GTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMR 236
Query: 387 AL 388
AL
Sbjct: 237 AL 238
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 45.1 bits (107), Expect = 4e-05
Identities = 47/194 (24%), Positives = 86/194 (44%), Gaps = 24/194 (12%)
Query: 210 LGAGGFGNVYKGK-LGDGTVLAVKRLK------DMISLAV----------HRNLLRLIGY 252
+G G +G VYKG+ G ++A+K+++ + S A+ H N++ L
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDV 67
Query: 253 CATPTERLLVYPYMSNG--SVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIH 310
+ L++ ++S L + +D K +G+L+ H + +++H
Sbjct: 68 LMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSR---RVLH 124
Query: 311 RDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGHIAPEYLSTGQS-SEKT 369
RD+K N+L+D+ + DFGLA+ V T T+ + APE L S
Sbjct: 125 RDLKPQNLLIDNKGVIKLADFGLARAFG-IPVRVYTHEVVTLWYRAPEVLLGSPRYSTPV 183
Query: 370 DVFGFGILLLELIT 383
D++ G + E+ T
Sbjct: 184 DIWSIGTIFAEMAT 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 4e-05
Identities = 51/210 (24%), Positives = 86/210 (40%), Gaps = 49/210 (23%)
Query: 210 LGAGGFGNVYKGKLGDGTVLA---VKRLK---------------DMISLAVHRNLLRLIG 251
+G G FG V ++ T +A VK LK D + H N+L+ +G
Sbjct: 3 IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLG 62
Query: 252 YCATPTERLLVYPYMSNGSVASRLREKPALDWNTR-------KRIAIGAARGLLYLHEQC 304
C LLV+ Y G + S L ++ W+ R +R+A A G+ ++H+
Sbjct: 63 QCVEAIPYLLVFEYCELGDLKSYLSQE---QWHRRNSQLLLLQRMACEIAAGVTHMHKH- 118
Query: 305 DPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTT------AVRGTVGHIAPE 358
+H D+ N L VGD+G+ + + ++ T +R APE
Sbjct: 119 --NFLHSDLALRNCFLTSDLTVKVGDYGIG-PSRYKEDYIETEDDKCVPLRWL----APE 171
Query: 359 YLSTGQ----SSEKT---DVFGFGILLLEL 381
+ ++E+T +V+ G+ L EL
Sbjct: 172 LVGEFHGGLITAEQTKPSNVWALGVTLWEL 201
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 5e-05
Identities = 48/201 (23%), Positives = 85/201 (42%), Gaps = 23/201 (11%)
Query: 202 ENFSSKNILGAGGFGNVYKG--KLGDGTVLAVKRLK---------------DMISLAVHR 244
E + LG G + V+KG KL + V A+K ++ ++ H
Sbjct: 6 ETYIKLEKLGEGTYATVFKGRSKLTENLV-ALKEIRLEHEEGAPCTAIREVSLLKDLKHA 64
Query: 245 NLLRLIGYCATPTERLLVYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQC 304
N++ L T LV+ Y+ + + K RGL Y H +
Sbjct: 65 NIVTLHDIVHTDKSLTLVFEYLDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRR- 123
Query: 305 DPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGHIAPE-YLSTG 363
K++HRD+K N+L+++ E + DFGLA+ + V T+ + P+ L +
Sbjct: 124 --KVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVV-TLWYRPPDVLLGSS 180
Query: 364 QSSEKTDVFGFGILLLELITG 384
+ S + D++G G + E+ +G
Sbjct: 181 EYSTQIDMWGVGCIFFEMASG 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 5e-05
Identities = 31/94 (32%), Positives = 52/94 (55%), Gaps = 10/94 (10%)
Query: 294 ARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGT-- 351
ARG+ +L + +HRD+ A NVLL + DFGLA+ + H ++V+ +G+
Sbjct: 247 ARGMEFLASK---NCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVS---KGSTF 300
Query: 352 --VGHIAPEYLSTGQSSEKTDVFGFGILLLELIT 383
V +APE + + +DV+ +GILL E+ +
Sbjct: 301 LPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 5e-05
Identities = 50/194 (25%), Positives = 78/194 (40%), Gaps = 21/194 (10%)
Query: 209 ILGAGGFGNVYKGK-LGDGTVLAVKRLKDMISLA------------VHRN----LLRLIG 251
+LG G FG V K G A+K LK + +A V +N L +
Sbjct: 2 LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK 61
Query: 252 YCATPTERL-LVYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIH 310
Y +RL V Y + G + L + + + L YLH + +++
Sbjct: 62 YSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSE--KNVVY 119
Query: 311 RDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGHIAPEYLSTGQSSEKTD 370
RD+K N++LD + DFGL K D GT ++APE L D
Sbjct: 120 RDLKLENLMLDKDGHIKITDFGLCK-EGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVD 178
Query: 371 VFGFGILLLELITG 384
+G G+++ E++ G
Sbjct: 179 WWGLGVVMYEMMCG 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 44.7 bits (106), Expect = 5e-05
Identities = 25/90 (27%), Positives = 47/90 (52%), Gaps = 4/90 (4%)
Query: 295 RGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGH 354
+ L +LH Q +IHRD+K+ ++LL + DFG + + ++ GT
Sbjct: 126 KALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVS-KEVPRRKSLVGTPYW 181
Query: 355 IAPEYLSTGQSSEKTDVFGFGILLLELITG 384
+APE +S + D++ GI+++E++ G
Sbjct: 182 MAPEVISRLPYGTEVDIWSLGIMVIEMVDG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 5e-05
Identities = 33/114 (28%), Positives = 54/114 (47%), Gaps = 11/114 (9%)
Query: 296 GLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGHI 355
G+ +LH IIHRD+K +N+++ C + DFGLA+ + + T T +
Sbjct: 135 GIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA--CTNFMMTPYVVTRYYR 189
Query: 356 APEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQ 409
APE + E D++ G ++ EL+ G + I+Q W K I+Q
Sbjct: 190 APEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQ------WNKVIEQ 237
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 45.1 bits (107), Expect = 6e-05
Identities = 32/95 (33%), Positives = 49/95 (51%), Gaps = 9/95 (9%)
Query: 295 RGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLD----HSDSHVTTAVRG 350
GL Y+H ++HRD+K N+L++ CE + DFGLA+ + +T V
Sbjct: 116 CGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYV-A 171
Query: 351 TVGHIAPEYLSTGQSSEKT-DVFGFGILLLELITG 384
T + APE + + QS K DV+ G +L EL+
Sbjct: 172 TRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGR 206
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 6e-05
Identities = 42/149 (28%), Positives = 63/149 (42%), Gaps = 19/149 (12%)
Query: 252 YCATPTERLL--VYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKII 309
+C+ T+R L V Y+ G A+ L+ AL + + L YLH I+
Sbjct: 67 FCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNY---GIV 123
Query: 310 HRDVKAANVLLDDFCEAIVGDFGLAK---------LLDHSDSHVT-----TAVRGTVGHI 355
HRD+K N+L+ + DFGL+K L + T V GT +I
Sbjct: 124 HRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYI 183
Query: 356 APEYLSTGQSSEKTDVFGFGILLLELITG 384
APE + + D + GI+L E + G
Sbjct: 184 APEVILRQGYGKPVDWWAMGIILYEFLVG 212
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 6e-05
Identities = 33/95 (34%), Positives = 48/95 (50%), Gaps = 14/95 (14%)
Query: 294 ARGLL----YLHEQCDPKIIHRDVKAANVLL---DDFCEAIVGDFGLAKLLDHS-DSHVT 345
AR LL Y+H + IIHRD+K NVL+ +D C +GDFG A S +
Sbjct: 266 ARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDIC---LGDFGAACFARGSWSTPFH 319
Query: 346 TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLE 380
+ GTV APE L+ + D++ G+++ E
Sbjct: 320 YGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 7e-05
Identities = 43/167 (25%), Positives = 80/167 (47%), Gaps = 19/167 (11%)
Query: 294 ARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTA-VRGTV 352
A+G+ +L + IHRD+ A N+LL + DFGLA+ + + ++V R V
Sbjct: 224 AKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLPV 280
Query: 353 GHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKK 412
+APE + + ++DV+ +GILL E+ + + G ++ K + K I++
Sbjct: 281 KWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSK-----FYKMIKEGY- 334
Query: 413 VEVLVDRELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLE 459
R L E+ +I++ C P+ RP ++V+++E
Sbjct: 335 ------RMLSPECAPSEMYDIMKS---CWDADPLKRPTFKQIVQLIE 372
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 7e-05
Identities = 27/90 (30%), Positives = 47/90 (52%), Gaps = 4/90 (4%)
Query: 295 RGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGH 354
+ L YLH Q +IHRD+K+ ++LL + DFG + D ++ GT
Sbjct: 128 QALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQIS-KDVPKRKSLVGTPYW 183
Query: 355 IAPEYLSTGQSSEKTDVFGFGILLLELITG 384
+APE +S + D++ GI+++E++ G
Sbjct: 184 MAPEVISRTPYGTEVDIWSLGIMVIEMVDG 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 44.6 bits (106), Expect = 7e-05
Identities = 61/229 (26%), Positives = 87/229 (37%), Gaps = 63/229 (27%)
Query: 210 LGAGGFGNVYKGKL-GDGTVLAVKRL--KDMI---------------SLAVHRNLLRLIG 251
LG G G V+ +L G G + A+K L K+MI + H L L
Sbjct: 9 LGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYA 68
Query: 252 YCATPTERLLVYPYMSNGSVASRLREKPALDWNTRKRIAIGAAR--------GLLYLHEQ 303
T T LV Y G + L+ +P K ++ AR L YLH
Sbjct: 69 SFQTETYLCLVMDYCPGGELFRLLQRQP------GKCLSEEVARFYAAEVLLALEYLHLL 122
Query: 304 CDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVR-------------- 349
I++RD+K N+LL + ++ DF L+K D V+ A+R
Sbjct: 123 ---GIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSE 179
Query: 350 --------------GTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITG 384
GT +IAPE +S D + GILL E++ G
Sbjct: 180 TFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYG 228
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 9e-05
Identities = 43/183 (23%), Positives = 82/183 (44%), Gaps = 36/183 (19%)
Query: 233 RLKDMISLAVHRNLLRLIGYCATPTERLLVYPYMSNGSV-----ASRLREK--------- 278
RLKD N++RL+G C ++ YM NG + + L +K
Sbjct: 75 RLKD-------PNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVP 127
Query: 279 -----PALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGL 333
PA+ +++ +A+ A G+ YL +HRD+ N L+ + + DFG+
Sbjct: 128 PAHCLPAISYSSLLHVALQIASGMKYLSSL---NFVHRDLATRNCLVGENLTIKIADFGM 184
Query: 334 AKLLDHSDSHVTTAVRG----TVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALE 389
++ L D + ++G + +A E + G+ + +DV+ FG+ L E++ +
Sbjct: 185 SRNLYAGDYY---RIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQP 241
Query: 390 FGK 392
+G+
Sbjct: 242 YGE 244
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 1e-04
Identities = 30/104 (28%), Positives = 51/104 (49%), Gaps = 8/104 (7%)
Query: 295 RGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAK--LLDHSDSHVTTAVRGTV 352
R L Y+H + HRD+K N+L + C+ + DFGLA+ D + T T
Sbjct: 114 RALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATR 170
Query: 353 GHIAPEYLST--GQSSEKTDVFGFGILLLELITGMRALEFGKSI 394
+ APE + + + D++ G + E++TG + L GK++
Sbjct: 171 WYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTG-KPLFPGKNV 213
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 44.1 bits (104), Expect = 2e-04
Identities = 45/153 (29%), Positives = 65/153 (42%), Gaps = 21/153 (13%)
Query: 202 ENFSSKNILGAGGFGNVYKG-KLGDGTVLAVKRLK--DMI-------------SLAVHRN 245
E F + G FG VY G K + + AVK +K DMI +LA+ ++
Sbjct: 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKS 63
Query: 246 --LLRLIGYCATPTERLLVYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQ 303
++ L + LV Y+ G V S L D + A L YLH
Sbjct: 64 PFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRH 123
Query: 304 CDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKL 336
IIHRD+K N+L+ + + DFGL+K+
Sbjct: 124 ---GIIHRDLKPDNMLISNEGHIKLTDFGLSKV 153
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 2e-04
Identities = 26/96 (27%), Positives = 47/96 (48%), Gaps = 4/96 (4%)
Query: 289 IAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAV 348
+ + + L LH Q +IHRD+K+ ++LL + DFG + + V
Sbjct: 121 VCLAVLKALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLV 177
Query: 349 RGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITG 384
GT +APE +S + D++ GI+++E++ G
Sbjct: 178 -GTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 42.8 bits (101), Expect = 2e-04
Identities = 54/208 (25%), Positives = 81/208 (38%), Gaps = 47/208 (22%)
Query: 210 LGAGGFGNVYKGKL---GDGTV---------------------LAVKRLKDMISLAVHRN 245
LG G F N+YKG L D + LA ++S H++
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62
Query: 246 LLRLIGYCATPTERLLVYPYMSNGSVASRLREKPALDWNTRK-RIAIGAARGLLYLHEQC 304
L++L G C E ++V Y+ G + L + K +A A L YL ++
Sbjct: 63 LVKLYGVCVRD-ENIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDK- 120
Query: 305 DPKIIHRDVKAANVLL--DDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGH-------I 355
K++H +V N+L+ E V KL SD + V + I
Sbjct: 121 --KLVHGNVCGKNILVARYGLNEGYVPF---IKL---SDPGIPITV-LSREERVERIPWI 171
Query: 356 APEYLSTGQSS--EKTDVFGFGILLLEL 381
APE + GQ+S D + FG LLE+
Sbjct: 172 APECIRNGQASLTIAADKWSFGTTLLEI 199
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 42.8 bits (101), Expect = 3e-04
Identities = 34/114 (29%), Positives = 53/114 (46%), Gaps = 11/114 (9%)
Query: 296 GLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGHI 355
G+ +LH IIHRD+K +N+++ C + DFGLA+ S + T T +
Sbjct: 130 GIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMTPYVVTRYYR 184
Query: 356 APEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQ 409
APE + E D++ G ++ E+I G I+Q W K I+Q
Sbjct: 185 APEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQ------WNKIIEQ 232
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 4e-04
Identities = 44/216 (20%), Positives = 83/216 (38%), Gaps = 41/216 (18%)
Query: 202 ENFSSKNILGAGGFGNVYKGK-LGDGTVLAVKR-------------------LKDMISLA 241
+ + +G G +G VYK + G ++A+K+ L M+S +
Sbjct: 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSES 60
Query: 242 VHRNLLRLIGYCATPTER-------LLVYPYMSNG--SVASRLREKPA--LDWNTRKRIA 290
++ ++RL+ E LV+ Y+ + P L T K
Sbjct: 61 IY--IVRLL--DVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFM 116
Query: 291 IGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAI-VGDFGLAKLLDHSDSHVTTAVR 349
+G+ + H+ ++HRD+K N+L+D + + D GL + T +
Sbjct: 117 YQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIV 173
Query: 350 GTVGHIAPE-YLSTGQSSEKTDVFGFGILLLELITG 384
T+ + APE L + S D++ G + E+
Sbjct: 174 -TLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRK 208
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 4e-04
Identities = 50/196 (25%), Positives = 88/196 (44%), Gaps = 28/196 (14%)
Query: 210 LGAGGFGNVYKG--KLGDGTVLAVKRLK------DMISLAV----------HRNLLRLIG 251
+G G +G VYK ++ + T+ A+K+++ + S A+ H N++RL
Sbjct: 10 IGEGTYGVVYKARDRVTNETI-ALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQD 68
Query: 252 YCATPTERLLVYPYMSNGSVASRLREKPALDWNTR--KRIAIGAARGLLYLHEQCDPKII 309
+ LV+ Y+ + + + P N R K RG+ Y H +++
Sbjct: 69 VVHSEKRLYLVFEYL-DLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSH---RVL 124
Query: 310 HRDVKAANVLLDDFCEAI-VGDFGLAKLLDHSDSHVTTAVRGTVGHIAPE-YLSTGQSSE 367
HRD+K N+L+D A+ + DFGLA+ T V T+ + APE L + S
Sbjct: 125 HRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVV-TLWYRAPEILLGSRHYST 183
Query: 368 KTDVFGFGILLLELIT 383
D++ G + E++
Sbjct: 184 PVDIWSVGCIFAEMVN 199
|
Length = 294 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 42.0 bits (98), Expect = 6e-04
Identities = 36/121 (29%), Positives = 58/121 (47%), Gaps = 13/121 (10%)
Query: 296 GLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGHI 355
G+ +LH IIHRD+K +N+++ C + DFGLA+ S + T T +
Sbjct: 138 GIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTRYYR 192
Query: 356 APEYLSTGQSSEKTDVFGFGILLLELITGMRAL-------EFGKSINQKGA-MLEWVKKI 407
APE + E D++ G ++ E+I G ++ K I Q G E++KK+
Sbjct: 193 APEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKL 252
Query: 408 Q 408
Q
Sbjct: 253 Q 253
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 37.5 bits (88), Expect = 7e-04
Identities = 17/43 (39%), Positives = 24/43 (55%)
Query: 26 GSIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRL 68
G+ L NL+ + L NN++ P LP L++LDLS N L
Sbjct: 18 GAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 41.5 bits (98), Expect = 8e-04
Identities = 62/233 (26%), Positives = 91/233 (39%), Gaps = 57/233 (24%)
Query: 202 ENFSSKNILGAGGFGNVY--KGKLGDGTVLAVKRLK--DMI----SLAVH--RNLL---- 247
++F ++G G FG V+ + K G V A+K L+ DMI V R++L
Sbjct: 1 DDFEVIKVIGRGAFGEVWLVRDK-DTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADAD 59
Query: 248 -----RLIGYCA-TPTERL-LVYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYL 300
+L Y + E L LV YM G + + L K T + L +
Sbjct: 60 SPWIVKL--YYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSV 117
Query: 301 HEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAK-----------------------LL 337
H+ IHRD+K N+L+D + DFGL K +L
Sbjct: 118 HKL---GFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVL 174
Query: 338 DHSDSHVTTAVR-----GTVGHIAPEYLSTGQS-SEKTDVFGFGILLLELITG 384
H VR GT +IAPE L G + D + G++L E++ G
Sbjct: 175 VRRRDHKQRRVRANSTVGTPDYIAPEVL-RGTPYGLECDWWSLGVILYEMLYG 226
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 8e-04
Identities = 56/220 (25%), Positives = 94/220 (42%), Gaps = 42/220 (19%)
Query: 195 RELQQATENFSSKNILGAGGFGNV------YKGKLGDGTVLA----VKRL--------KD 236
R+L+ E++ ++G G FG V K+ +L+ +KR +D
Sbjct: 36 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERD 95
Query: 237 MISLAVHRNLLRLIGYCATPTERLL--VYPYMSNGSVASRLR-----EKPALDWNTRKRI 289
+++ A +++L + A +R L V YM G + + + EK A + +
Sbjct: 96 IMAFANSPWVVQL--FYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVL 153
Query: 290 AIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLA-KLLDHSDSHVTTAV 348
A+ A + + IHRDVK N+LLD + DFG K+ TAV
Sbjct: 154 ALDAIHSMGF---------IHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV 204
Query: 349 RGTVGHIAPEYLST----GQSSEKTDVFGFGILLLELITG 384
GT +I+PE L + G + D + G+ L E++ G
Sbjct: 205 -GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 0.001
Identities = 43/142 (30%), Positives = 64/142 (45%), Gaps = 29/142 (20%)
Query: 261 LVYPYMSNGSVASRLRE--KPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANV 318
++ P+M+ GS S L+ + I GA RGL YLH+ IHR++KA+++
Sbjct: 76 VISPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQN---GYIHRNIKASHI 132
Query: 319 LLDDFCEAIVGDFGLAKL--LDHSDSHVTTAVRGTVGHIAPEYLSTGQ---SSE------ 367
L I GD GL L L H S V + V + P++ ++ S E
Sbjct: 133 L-------ISGD-GLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDL 184
Query: 368 -----KTDVFGFGILLLELITG 384
K+D++ GI EL TG
Sbjct: 185 YGYNVKSDIYSVGITACELATG 206
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 41.3 bits (97), Expect = 0.001
Identities = 52/221 (23%), Positives = 82/221 (37%), Gaps = 49/221 (22%)
Query: 208 NILGAGGFGNVYKGK-LGDGTVLAVKRLKDMISLAVHRNLLR-LIGYCA---TPTERL-- 260
LG G +G V K G ++A+K++K +I ++ R L+G C T L
Sbjct: 15 AHLGEGTYGKVEKAYDTLTGKIVAIKKVK-IIEISNDVTKDRQLVGMCGIHFTTLRELKI 73
Query: 261 -----------------------LVYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGL 297
LV M+ + + K L + K I + GL
Sbjct: 74 MNEIKHENIMGLVDVYVEGDFINLVMDIMA-SDLKKVVDRKIRLTESQVKCILLQILNGL 132
Query: 298 LYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAK------LLDHSDSHVTTAVRG- 350
LH+ +HRD+ AN+ ++ + DFGLA+ D T R
Sbjct: 133 NVLHKW---YFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREE 189
Query: 351 ------TVGHIAPEYL-STGQSSEKTDVFGFGILLLELITG 384
T+ + APE L + D++ G + EL+TG
Sbjct: 190 MTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTG 230
|
Length = 335 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 0.001
Identities = 61/234 (26%), Positives = 94/234 (40%), Gaps = 48/234 (20%)
Query: 202 ENFSSKNILGAGGFGNVYKGKLGDG-TVLAVKRLK--DMISLAV------HRNLL----- 247
E+F ++G G FG V KL + V A+K L +M+ A R++L
Sbjct: 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDN 60
Query: 248 ---RLIGYCATPTERL-LVYPYMSNGSVAS-------RLREKPALDWNTRKRIAIGAARG 296
+ Y L LV Y G + + RL E A + IAI +
Sbjct: 61 QWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQ 120
Query: 297 LLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFG-LAKLLDHSDSHVTTAVRGTVGHI 355
L Y +HRD+K N+L+D + DFG KL++ + AV GT +I
Sbjct: 121 LHY---------VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAV-GTPDYI 170
Query: 356 APEYLST-----GQSSEKTDVFGFGILLLELITGMRAL-------EFGKSINQK 397
+PE L G+ + D + G+ + E++ G +GK +N K
Sbjct: 171 SPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHK 224
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 40.4 bits (95), Expect = 0.001
Identities = 56/221 (25%), Positives = 94/221 (42%), Gaps = 53/221 (23%)
Query: 210 LGAGGFGNVYKGK-LGDGTVLAVK--RLKDM-----------ISL---AVHRNLLRLIGY 252
+G G +G VYK + G ++A+K RL+ ISL H N++RL+
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDV 66
Query: 253 CATPTERLLVYPYMSNGSVASRLREKPALDWNTRKRIAIGAA----------RGLLYLHE 302
+ + LV+ ++ L K +D + + +G+ Y H
Sbjct: 67 VHSENKLYLVFEFLD-------LDLKKYMD--SSPLTGLDPPLIKSYLYQLLQGIAYCHS 117
Query: 303 QCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAK-----LLDHSDSHVTTAVRGTVGHIAP 357
+++HRD+K N+L+D + DFGLA+ + ++ VT R AP
Sbjct: 118 H---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVVTLWYR------AP 168
Query: 358 E-YLSTGQSSEKTDVFGFGILLLELITGMRALEFGKS-INQ 396
E L + Q S D++ G + E++ R L G S I+Q
Sbjct: 169 EILLGSRQYSTPVDIWSIGCIFAEMVNR-RPLFPGDSEIDQ 208
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.002
Identities = 29/97 (29%), Positives = 45/97 (46%), Gaps = 7/97 (7%)
Query: 294 ARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFG-LAKLLDHSDSHVTTAVRGTV 352
A +L +H +HRD+K NVLLD + DFG K+ + AV GT
Sbjct: 109 AEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAV-GTP 167
Query: 353 GHIAPEYLST-----GQSSEKTDVFGFGILLLELITG 384
+I+PE L G+ + D + G+ + E++ G
Sbjct: 168 DYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYG 204
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.003
Identities = 53/235 (22%), Positives = 92/235 (39%), Gaps = 55/235 (23%)
Query: 202 ENFSSKNILGAGGFGNVYKGKLGD-GTVLAVKRLK--DMIS------------LAVHRNL 246
E+F S ++G G FG V + D G V A+K L+ DM+ + V +
Sbjct: 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADS 60
Query: 247 LRLIGYCATPTERL---LVYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQ 303
L ++ + ++L L+ ++ G + + L +K L T + A +L +
Sbjct: 61 LWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTL---TEEETQFYIAETVLAIDSI 117
Query: 304 CDPKIIHRDVKAANVLLDDFCEAIVGDFGLA------------KLLDHS----------- 340
IHRD+K N+LLD + DFGL + L+HS
Sbjct: 118 HQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMN 177
Query: 341 -----------DSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITG 384
+ + GT +IAPE ++ D + G+++ E++ G
Sbjct: 178 SKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 39.7 bits (92), Expect = 0.003
Identities = 26/87 (29%), Positives = 44/87 (50%), Gaps = 5/87 (5%)
Query: 296 GLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGHI 355
G+ +LH IIHRD+K +N+++ C + DFGLA+ S + T T +
Sbjct: 131 GIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTRYYR 185
Query: 356 APEYLSTGQSSEKTDVFGFGILLLELI 382
APE + E D++ G ++ E++
Sbjct: 186 APEVILGMGYKENVDIWSVGCIMGEMV 212
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.004
Identities = 39/172 (22%), Positives = 64/172 (37%), Gaps = 19/172 (11%)
Query: 24 LSGSIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFLSIWLP 83
L I L+ L ++ L NN+I + L +L L L+LSNN+L + +
Sbjct: 201 LPPEIELLSALEELDLSNNSIIE-LLSSLSNLKNLSGLELSNNKLEDLP---ESIGNLSN 256
Query: 84 RKWDKRKCSGVDQGLLRLNNNSLSGAFPVFLAKISELAFLDLSYNNLSGPVPKFPARTFN 143
+ L L+NN +S L ++ L LDLS N+LS A
Sbjct: 257 LET------------LDLSNNQIS--SISSLGSLTNLRELDLSGNSLSNA-LPLIALLLL 301
Query: 144 VAGNPLICGSSSTNVCSGSANSVPLSFSLNSSPDKQEEGLISLGNLRNFTFR 195
+ L + + + + + L++ E L L +L N
Sbjct: 302 LLELLLNLLLTLKALELKLNSILLNNNILSNGETSSPEALSILESLNNLWTL 353
|
Length = 394 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 39.0 bits (91), Expect = 0.004
Identities = 27/82 (32%), Positives = 40/82 (48%), Gaps = 7/82 (8%)
Query: 309 IHRDVKAANVLLDDFCEAIVGDFG-LAKLLDHSDSHVTTAVRGTVGHIAPEYL-----ST 362
+HRD+K NVLLD + DFG +LL AV GT +I+PE L
Sbjct: 124 VHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAV-GTPDYISPEILQAMEDGK 182
Query: 363 GQSSEKTDVFGFGILLLELITG 384
G+ + D + G+ + E++ G
Sbjct: 183 GRYGPECDWWSLGVCMYEMLYG 204
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 534 | |||
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.97 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.97 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.97 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.97 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.97 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.97 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.97 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.97 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.96 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.96 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.96 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.96 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.95 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.95 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.95 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.95 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.95 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.95 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.94 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.94 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.93 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.89 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.88 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.88 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.87 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.87 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.86 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.84 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.84 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.83 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.83 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.81 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.8 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.8 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.8 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.79 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.78 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.75 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.74 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.73 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.71 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.7 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.69 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.68 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.67 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.65 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.62 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.58 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.57 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.56 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.56 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.51 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.51 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.47 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.47 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.45 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.4 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.32 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 99.31 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 99.28 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 99.27 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.26 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.19 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.18 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.17 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 99.17 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 99.13 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.12 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 99.1 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.1 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 99.07 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.06 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 99.03 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 98.99 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 98.98 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.97 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 98.96 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 98.89 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 98.88 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.87 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 98.83 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 98.81 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 98.78 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.78 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 98.75 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.75 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.75 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 98.72 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 98.7 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.63 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.61 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 98.58 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.54 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 98.53 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 98.53 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.51 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 98.48 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 98.48 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 98.48 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 98.46 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 98.46 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 98.43 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 98.42 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.42 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.41 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.4 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.36 | |
| PF12799 | 44 | LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_ | 98.35 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.21 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.21 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.08 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.01 | |
| PF12799 | 44 | LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_ | 97.98 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.92 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 97.84 | |
| KOG4658 | 889 | consensus Apoptotic ATPase [Signal transduction me | 97.8 |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-57 Score=526.79 Aligned_cols=426 Identities=29% Similarity=0.525 Sum_probs=330.7
Q ss_pred CcEEEEEecCCCceeecccccccCCCCCEEEccCCccCcCCCCCCCCCCCCCEEEcCCCcCccccCchhhhcccCccccc
Q 039819 8 NLVIGLGAPSQSLSGTLSGSIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFLSIWLPRKWD 87 (534)
Q Consensus 8 ~~l~~L~l~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~P~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~l~~~~~ 87 (534)
.+++.|+|++|++++.+|..|.++++|+.|+|++|++++.+|..|++|++|++|+|++|.|+|.+|..+..++
T Consensus 475 ~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~------- 547 (968)
T PLN00113 475 KRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMP------- 547 (968)
T ss_pred ccceEEECcCCccCCccChhhhhhhccCEEECcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHhCcc-------
Confidence 3577888888888888888888888888888888888888888888888888888888888888888887777
Q ss_pred ccccCCccccceeCCCCcCcccCChhhhcccccccccccCCCCCCCCCCCCC----ccccccCCcceecCCC---CCccc
Q 039819 88 KRKCSGVDQGLLRLNNNSLSGAFPVFLAKISELAFLDLSYNNLSGPVPKFPA----RTFNVAGNPLICGSSS---TNVCS 160 (534)
Q Consensus 88 ~~~~~~~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~----~~~~~~~N~~~cg~~~---~~~~~ 160 (534)
+|+.|+|++|+++|.+|..+..+.+|+.|++++|+++|.+|.... ....+.+||..|+... ...|.
T Consensus 548 -------~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~~~p~~~~~~~~~~~~~~~n~~lc~~~~~~~~~~c~ 620 (968)
T PLN00113 548 -------VLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTSGLPPCK 620 (968)
T ss_pred -------cCCEEECCCCcccccCChhHhcCcccCEEeccCCcceeeCCCcchhcccChhhhcCCccccCCccccCCCCCc
Confidence 888999999999999999999999999999999999999996422 3446789999998643 23443
Q ss_pred CCCCC----CCC--ccc-----------c--CCCCc-------ccccceecc-----CCccccCHHHHHHHHhCCCcCCe
Q 039819 161 GSANS----VPL--SFS-----------L--NSSPD-------KQEEGLISL-----GNLRNFTFRELQQATENFSSKNI 209 (534)
Q Consensus 161 ~~~~~----~~~--~~~-----------~--~~~~~-------~~~~~~~~~-----~~~~~~~~~~l~~~~~~~~~~~~ 209 (534)
..... ..+ ..+ . ...+. ......... .....++++++ ...|...+.
T Consensus 621 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~ 697 (968)
T PLN00113 621 RVRKTPSWWFYITCTLGAFLVLALVAFGFVFIRGRNNLELKRVENEDGTWELQFFDSKVSKSITINDI---LSSLKEENV 697 (968)
T ss_pred cccccceeeeehhHHHHHHHHHHHHHHHHHHHHhhhcccccccccccccccccccccccchhhhHHHH---HhhCCcccE
Confidence 22110 000 000 0 00000 000000000 01122344443 356778889
Q ss_pred eccCCcEEEEEEEE-CCCcEEEEEEehh----------hhhhcccCceeeEEEEEeCCCeeEEEeeccCCCChhhhcccC
Q 039819 210 LGAGGFGNVYKGKL-GDGTVLAVKRLKD----------MISLAVHRNLLRLIGYCATPTERLLVYPYMSNGSVASRLREK 278 (534)
Q Consensus 210 lG~G~~g~Vy~~~~-~~~~~vavK~~~~----------~l~~~~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~ 278 (534)
||+|+||.||+|+. .++..||||++.. .+++++|||||+++|+|.+.+..++|||||++|+|.++++.
T Consensus 698 ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~- 776 (968)
T PLN00113 698 ISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN- 776 (968)
T ss_pred EccCCCeeEEEEEECCCCcEEEEEEccCCccccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCcHHHHHhc-
Confidence 99999999999997 5789999998752 57788999999999999999999999999999999999963
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCCceeecccccccccccc
Q 039819 279 PALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGHIAPE 358 (534)
Q Consensus 279 ~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE 358 (534)
++|..+.+|+.|+|+||+|||+.+.++|+||||||+||+++.++.+++. ||.+...... ....||.+|+|||
T Consensus 777 --l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~-----~~~~~t~~y~aPE 848 (968)
T PLN00113 777 --LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD-----TKCFISSAYVAPE 848 (968)
T ss_pred --CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC-----CCccccccccCcc
Confidence 8999999999999999999997777799999999999999999998875 6665443221 2235789999999
Q ss_pred ccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceecccccCCC--CCHHHHHHHHHH
Q 039819 359 YLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELGSN--YDRIEVGEILQV 436 (534)
Q Consensus 359 ~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~--~~~~~~~~l~~l 436 (534)
++.+..++.++|||||||++|||+||+.||+.... ....+.+|++...........+|+.+... .+..+..++.++
T Consensus 849 ~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 926 (968)
T PLN00113 849 TRETKDITEKSDIYGFGLILIELLTGKSPADAEFG--VHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNL 926 (968)
T ss_pred cccCCCCCcccchhhHHHHHHHHHhCCCCCCcccC--CCCcHHHHHHHhcCccchhheeCccccCCCCccHHHHHHHHHH
Confidence 99999999999999999999999999999964322 23456778776655555556667766443 345566788999
Q ss_pred HHHhcccCCCCCCChHHHHHHhhcC
Q 039819 437 ALLCTQYLPVHRPKMSEVVRMLEGD 461 (534)
Q Consensus 437 ~~~Cl~~~P~~RPt~~ev~~~L~~~ 461 (534)
+.+||+.+|++||+|+||+++|+..
T Consensus 927 ~~~Cl~~~P~~RPt~~evl~~L~~~ 951 (968)
T PLN00113 927 ALHCTATDPTARPCANDVLKTLESA 951 (968)
T ss_pred HHhhCcCCchhCcCHHHHHHHHHHh
Confidence 9999999999999999999999863
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-57 Score=461.60 Aligned_cols=271 Identities=51% Similarity=0.865 Sum_probs=241.1
Q ss_pred CccccCHHHHHHHHhCCCcCCeeccCCcEEEEEEEECCCcEEEEEEehh--------------hhhhcccCceeeEEEEE
Q 039819 188 NLRNFTFRELQQATENFSSKNILGAGGFGNVYKGKLGDGTVLAVKRLKD--------------MISLAVHRNLLRLIGYC 253 (534)
Q Consensus 188 ~~~~~~~~~l~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~--------------~l~~~~h~niv~l~~~~ 253 (534)
..+.|+++||..||++|+..++||+|+||.||+|.+.+++.||||++.. ++++++|||+|+++|||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 5678999999999999999999999999999999999999999997642 67888999999999999
Q ss_pred eCCC-eeEEEeeccCCCChhhhcccCC--CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEe
Q 039819 254 ATPT-ERLLVYPYMSNGSVASRLREKP--ALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGD 330 (534)
Q Consensus 254 ~~~~-~~~lv~e~~~~gsL~~~l~~~~--~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~D 330 (534)
.+.+ +++||||||++|+|.++|+... .++|..|++||.++|+||+|||+.+.++||||||||+|||||+++++||+|
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsD 220 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSD 220 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccC
Confidence 9999 5999999999999999998654 899999999999999999999999999999999999999999999999999
Q ss_pred cccceecCC-CCCceeeccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhh
Q 039819 331 FGLAKLLDH-SDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQ 409 (534)
Q Consensus 331 FGla~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 409 (534)
||+|+.... ... ......||.+|+|||++..+..+.|+|||||||||+||+||+++.+..... ....+.+|+.....
T Consensus 221 FGLa~~~~~~~~~-~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~-~~~~l~~w~~~~~~ 298 (361)
T KOG1187|consen 221 FGLAKLGPEGDTS-VSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPR-GELSLVEWAKPLLE 298 (361)
T ss_pred ccCcccCCccccc-eeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCc-ccccHHHHHHHHHH
Confidence 999976654 222 111117999999999999999999999999999999999999998865422 23348899988888
Q ss_pred hcccceecccccC-CCCCH-HHHHHHHHHHHHhcccCCCCCCChHHHHHHhhc
Q 039819 410 EKKVEVLVDRELG-SNYDR-IEVGEILQVALLCTQYLPVHRPKMSEVVRMLEG 460 (534)
Q Consensus 410 ~~~~~~~~d~~l~-~~~~~-~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~ 460 (534)
...+.+++|+++. ..++. .+...+..++.+|++.+|.+||+|.||+++|+.
T Consensus 299 ~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~ 351 (361)
T KOG1187|consen 299 EGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEG 351 (361)
T ss_pred CcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHh
Confidence 8899999999987 56664 678889999999999999999999999999954
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-47 Score=387.70 Aligned_cols=233 Identities=36% Similarity=0.535 Sum_probs=196.7
Q ss_pred CeeccCCcEEEEEEEECCCcEEEEEEehh----------------hhhhcccCceeeEEEEEeCCC-eeEEEeeccCCCC
Q 039819 208 NILGAGGFGNVYKGKLGDGTVLAVKRLKD----------------MISLAVHRNLLRLIGYCATPT-ERLLVYPYMSNGS 270 (534)
Q Consensus 208 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~----------------~l~~~~h~niv~l~~~~~~~~-~~~lv~e~~~~gs 270 (534)
+.||+|+||+||+|.+.....||||++.. ++.+++|||||+++|+|.++. ..++|||||++|+
T Consensus 47 ~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~Gs 126 (362)
T KOG0192|consen 47 EVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPGGS 126 (362)
T ss_pred hhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCCCc
Confidence 45999999999999997666699998863 678899999999999999988 7899999999999
Q ss_pred hhhhccc--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCC-eEeccCCCCcEEeCCCC-cEEEEecccceecCCCCCceee
Q 039819 271 VASRLRE--KPALDWNTRKRIAIGAARGLLYLHEQCDPK-IIHRDVKAANVLLDDFC-EAIVGDFGLAKLLDHSDSHVTT 346 (534)
Q Consensus 271 L~~~l~~--~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~-ivH~Dlkp~NiLl~~~~-~~kl~DFGla~~~~~~~~~~~~ 346 (534)
|.++++. ...+++..+++|+.|||+||.|||++ + ||||||||+|||++.++ ++||+|||+++...... ...+
T Consensus 127 L~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~---~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~-~~~~ 202 (362)
T KOG0192|consen 127 LSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSE---GPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK-TSMT 202 (362)
T ss_pred HHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcC---CCeeecccChhhEEEcCCCCEEEECCCccceeecccc-cccc
Confidence 9999987 67899999999999999999999998 6 99999999999999998 99999999999775432 2334
Q ss_pred ccccccccccccccc--cCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceecccccCCC
Q 039819 347 AVRGTVGHIAPEYLS--TGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELGSN 424 (534)
Q Consensus 347 ~~~gt~~y~aPE~~~--~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 424 (534)
...||..|||||++. ...|+.|+|||||||++|||+||+.||..... .+.+..... ...+..
T Consensus 203 ~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~-------~~~~~~v~~---------~~~Rp~ 266 (362)
T KOG0192|consen 203 SVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP-------VQVASAVVV---------GGLRPP 266 (362)
T ss_pred CCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH-------HHHHHHHHh---------cCCCCC
Confidence 467999999999999 56899999999999999999999999975332 111111111 112222
Q ss_pred CCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhc
Q 039819 425 YDRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLEG 460 (534)
Q Consensus 425 ~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~ 460 (534)
.+..+...+..++.+||..+|..||++.+++..|+.
T Consensus 267 ~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~ 302 (362)
T KOG0192|consen 267 IPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLES 302 (362)
T ss_pred CCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHH
Confidence 333356789999999999999999999999999875
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-47 Score=368.69 Aligned_cols=241 Identities=27% Similarity=0.408 Sum_probs=202.5
Q ss_pred cCHHHHHHHHhCCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEeh---------------hhhhhcccCceeeEEEEEeC
Q 039819 192 FTFRELQQATENFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLK---------------DMISLAVHRNLLRLIGYCAT 255 (534)
Q Consensus 192 ~~~~~l~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~---------------~~l~~~~h~niv~l~~~~~~ 255 (534)
+++.||+. .+.||+|..|+||+++++ +++.+|+|.+. +++..+.||+||+++|.|..
T Consensus 76 i~~~dle~-------~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~ 148 (364)
T KOG0581|consen 76 ISLSDLER-------LGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYS 148 (364)
T ss_pred cCHHHhhh-------hhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEe
Confidence 45556554 467999999999999986 68999999983 26778889999999999999
Q ss_pred CC-eeEEEeeccCCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEeccCCCCcEEeCCCCcEEEEeccc
Q 039819 256 PT-ERLLVYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHE-QCDPKIIHRDVKAANVLLDDFCEAIVGDFGL 333 (534)
Q Consensus 256 ~~-~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~-~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGl 333 (534)
.. ...++||||++|+|.+.+...+.+++...-+|+.+|++||.|||+ . +||||||||+|||++..|++||||||.
T Consensus 149 ~~~~isI~mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~---~IIHRDIKPsNlLvNskGeVKicDFGV 225 (364)
T KOG0581|consen 149 NGEEISICMEYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEER---KIIHRDIKPSNLLVNSKGEVKICDFGV 225 (364)
T ss_pred CCceEEeehhhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcc---CeeeccCCHHHeeeccCCCEEeccccc
Confidence 88 599999999999999999988899999999999999999999996 5 999999999999999999999999999
Q ss_pred ceecCCCCCceeeccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhccc
Q 039819 334 AKLLDHSDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKV 413 (534)
Q Consensus 334 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 413 (534)
++.+..+ ...+++||..|||||.+.+..|+.++||||||++++|+++|+.|+.... .......+.+..+..+.
T Consensus 226 S~~lvnS---~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~--~~~~~~~~Ll~~Iv~~p-- 298 (364)
T KOG0581|consen 226 SGILVNS---IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPN--PPYLDIFELLCAIVDEP-- 298 (364)
T ss_pred cHHhhhh---hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcC--CCCCCHHHHHHHHhcCC--
Confidence 9988654 4566789999999999999999999999999999999999999997541 11222333333332221
Q ss_pred ceecccccCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 414 EVLVDRELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 414 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
-+++... ....++..++..|++.||.+||+++|+++
T Consensus 299 ----pP~lP~~---~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~ 334 (364)
T KOG0581|consen 299 ----PPRLPEG---EFSPEFRSFVSCCLRKDPSERPSAKQLLQ 334 (364)
T ss_pred ----CCCCCcc---cCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 1222222 35668999999999999999999999985
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-46 Score=380.83 Aligned_cols=233 Identities=26% Similarity=0.407 Sum_probs=202.6
Q ss_pred hCCCcCCeeccCCcEEEEEEEE-CCCcEEEEEEehh-----------------hhhhcccCceeeEEEEEeCCCeeEEEe
Q 039819 202 ENFSSKNILGAGGFGNVYKGKL-GDGTVLAVKRLKD-----------------MISLAVHRNLLRLIGYCATPTERLLVY 263 (534)
Q Consensus 202 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~-----------------~l~~~~h~niv~l~~~~~~~~~~~lv~ 263 (534)
..|...+.||+|||+.||+++. ..|..||+|++.+ +-+.+.|||||+++++|++.+..|||.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 4688899999999999999998 8899999998853 567888999999999999999999999
Q ss_pred eccCCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCCc
Q 039819 264 PYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSH 343 (534)
Q Consensus 264 e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~ 343 (534)
|+|++++|..+++...++++.+++.++.||+.||.|||+. +|||||||..|++|+++.++||+|||||..+.... .
T Consensus 98 ELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~---~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~-E 173 (592)
T KOG0575|consen 98 ELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSL---GIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDG-E 173 (592)
T ss_pred EecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhc---CceecccchhheeecCcCcEEecccceeeeecCcc-c
Confidence 9999999999999999999999999999999999999999 99999999999999999999999999999887543 3
Q ss_pred eeeccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceecccccCC
Q 039819 344 VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELGS 423 (534)
Q Consensus 344 ~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 423 (534)
...+.+||+.|+|||++.....+..+||||+|||+|-|++|++||+... +.+-...+.....
T Consensus 174 rk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~-------vkety~~Ik~~~Y----------- 235 (592)
T KOG0575|consen 174 RKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKT-------VKETYNKIKLNEY----------- 235 (592)
T ss_pred ccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccch-------HHHHHHHHHhcCc-----------
Confidence 4567899999999999998889999999999999999999999997432 2222222222111
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 424 NYDRIEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 424 ~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
..+.....+..+|+.++++.+|.+|||+.+|+.
T Consensus 236 ~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~ 268 (592)
T KOG0575|consen 236 SMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLD 268 (592)
T ss_pred ccccccCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 112233457889999999999999999999985
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-46 Score=361.54 Aligned_cols=186 Identities=28% Similarity=0.479 Sum_probs=170.8
Q ss_pred HhCCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEehh----------------hhhhcccCceeeEEEEEeCCCeeEEEe
Q 039819 201 TENFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLKD----------------MISLAVHRNLLRLIGYCATPTERLLVY 263 (534)
Q Consensus 201 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~----------------~l~~~~h~niv~l~~~~~~~~~~~lv~ 263 (534)
..+|...+.||+|+||+||+|+++ ++..||||.+.. +++.++|||||.+++++..++..||||
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM 88 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM 88 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence 467888888999999999999985 579999998752 788999999999999999999999999
Q ss_pred eccCCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCC------CcEEEEecccceec
Q 039819 264 PYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDF------CEAIVGDFGLAKLL 337 (534)
Q Consensus 264 e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~------~~~kl~DFGla~~~ 337 (534)
|||.+|+|.++++..+.+++.+.+.++.|+|.||++||++ +||||||||.||||+.. -.+||+|||+|+.+
T Consensus 89 EyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~---~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L 165 (429)
T KOG0595|consen 89 EYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHEN---NIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFL 165 (429)
T ss_pred EeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCcceEEeccCCCCCCCceEEecccchhhhC
Confidence 9999999999999999999999999999999999999999 99999999999999764 56899999999998
Q ss_pred CCCCCceeeccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCC
Q 039819 338 DHSDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFG 391 (534)
Q Consensus 338 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~ 391 (534)
... ....+.+|++-|||||+++..+|+.|+|+||.|+|||++++|+.||+..
T Consensus 166 ~~~--~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~ 217 (429)
T KOG0595|consen 166 QPG--SMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAE 217 (429)
T ss_pred Cch--hHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCcccc
Confidence 643 3355689999999999999999999999999999999999999999843
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-46 Score=362.15 Aligned_cols=238 Identities=24% Similarity=0.369 Sum_probs=197.4
Q ss_pred HhCCCcCCeeccCCcEEEEEEEE-CCCcEEEEEEehh---------------------hhhhcccCceeeEEEEEeCCCe
Q 039819 201 TENFSSKNILGAGGFGNVYKGKL-GDGTVLAVKRLKD---------------------MISLAVHRNLLRLIGYCATPTE 258 (534)
Q Consensus 201 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~---------------------~l~~~~h~niv~l~~~~~~~~~ 258 (534)
.+.|...+.||+|+||.|-+|.- .+|+.||||++.+ +|+++.|||||+++++|..++.
T Consensus 171 ~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds 250 (475)
T KOG0615|consen 171 NDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDS 250 (475)
T ss_pred cceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCc
Confidence 35677789999999999999976 5799999998862 7889999999999999999999
Q ss_pred eEEEeeccCCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCC---CcEEEEecccce
Q 039819 259 RLLVYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDF---CEAIVGDFGLAK 335 (534)
Q Consensus 259 ~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~---~~~kl~DFGla~ 335 (534)
.|||||||.||+|.+.+-.++.+.+...+.++.|++.|+.|||++ ||+||||||+|||+..+ ..+||+|||+|+
T Consensus 251 ~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~---GI~HRDiKPeNILl~~~~e~~llKItDFGlAK 327 (475)
T KOG0615|consen 251 SYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQ---GIIHRDIKPENILLSNDAEDCLLKITDFGLAK 327 (475)
T ss_pred eEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHc---CcccccCCcceEEeccCCcceEEEecccchhh
Confidence 999999999999999999999999999999999999999999999 99999999999999765 889999999999
Q ss_pred ecCCCCCceeeccccccccccccccccCCC---CcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcc
Q 039819 336 LLDHSDSHVTTAVRGTVGHIAPEYLSTGQS---SEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKK 412 (534)
Q Consensus 336 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 412 (534)
+.+. ...+.+.|||+.|.|||++.+..+ ..|+|+||+|||||-++||.+||....... ...+++.....
T Consensus 328 ~~g~--~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~------sl~eQI~~G~y 399 (475)
T KOG0615|consen 328 VSGE--GSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDP------SLKEQILKGRY 399 (475)
T ss_pred cccc--ceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCc------cHHHHHhcCcc
Confidence 8863 345678999999999999976543 348899999999999999999996432110 11122222111
Q ss_pred cceecccccCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 413 VEVLVDRELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 413 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
. + ....-....++..+++.+++..||++||++.|+++
T Consensus 400 ~---f----~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~ 436 (475)
T KOG0615|consen 400 A---F----GPLQWDRISEEALDLINWMLVVDPENRPSADEALN 436 (475)
T ss_pred c---c----cChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence 0 0 01112334668999999999999999999999885
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-46 Score=350.03 Aligned_cols=250 Identities=22% Similarity=0.293 Sum_probs=206.0
Q ss_pred hCCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEehh----------------hhhhcccCceeeEEEEEeCCCeeEEEee
Q 039819 202 ENFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLKD----------------MISLAVHRNLLRLIGYCATPTERLLVYP 264 (534)
Q Consensus 202 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~----------------~l~~~~h~niv~l~~~~~~~~~~~lv~e 264 (534)
+.|+....+|+|+||.||+++.+ .|+.||||++.+ ++++++|+|+|.++++|......+||+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 35677788999999999999986 589999999863 7899999999999999999999999999
Q ss_pred ccCCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCCce
Q 039819 265 YMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHV 344 (534)
Q Consensus 265 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~ 344 (534)
||+..-|.+.-+....++.+.+.+++.|++.|+.|+|++ ++|||||||+|||++.++.+||||||+|+.+.. ....
T Consensus 82 ~~dhTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~---n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~-pgd~ 157 (396)
T KOG0593|consen 82 YCDHTVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKN---NCIHRDIKPENILITQNGVVKLCDFGFARTLSA-PGDN 157 (396)
T ss_pred ecchHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhc---CeecccCChhheEEecCCcEEeccchhhHhhcC-Ccch
Confidence 999866666666667799999999999999999999999 999999999999999999999999999998864 3345
Q ss_pred eecccccccccccccccc-CCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhh--------cccce
Q 039819 345 TTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQE--------KKVEV 415 (534)
Q Consensus 345 ~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~ 415 (534)
.+.++.|.+|+|||.+.+ .+|+..+||||+||++.||+||.+.|++.++.++...+..-++.+... .....
T Consensus 158 YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~G 237 (396)
T KOG0593|consen 158 YTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHG 237 (396)
T ss_pred hhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceee
Confidence 677889999999999877 679999999999999999999999999988887766665444332221 11111
Q ss_pred ecccccC------CCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 416 LVDRELG------SNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 416 ~~d~~l~------~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
+.-|... ..++. ....+++++..|++.||.+|++.++++.
T Consensus 238 v~lP~~~~~epLe~k~p~-~s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 238 VRLPEPEHPEPLERKYPK-ISNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred eecCCCCCccchhhhccc-chHHHHHHHHHHhcCCccccccHHHHhc
Confidence 1111111 11111 2347889999999999999999999985
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-45 Score=368.39 Aligned_cols=244 Identities=30% Similarity=0.436 Sum_probs=206.0
Q ss_pred ccCHHHHHHHHhCCCcCCeeccCCcEEEEEEEECCCcEEEEEEehh-------------hhhhcccCceeeEEEEEeCCC
Q 039819 191 NFTFRELQQATENFSSKNILGAGGFGNVYKGKLGDGTVLAVKRLKD-------------MISLAVHRNLLRLIGYCATPT 257 (534)
Q Consensus 191 ~~~~~~l~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~-------------~l~~~~h~niv~l~~~~~~~~ 257 (534)
.+..+++... +.||+|.||+||.|.++....||||.++. +|++++|+|||+++|+|..++
T Consensus 202 ei~r~~l~l~-------~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~ 274 (468)
T KOG0197|consen 202 EIPREELKLI-------RELGSGQFGEVWLGKWNGSTKVAVKTIKEGSMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQE 274 (468)
T ss_pred eecHHHHHHH-------HHhcCCccceEEEEEEcCCCcccceEEeccccChhHHHHHHHHHHhCcccCeEEEEEEEecCC
Confidence 4455555443 56999999999999998888999998873 789999999999999999999
Q ss_pred eeEEEeeccCCCChhhhccc--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccce
Q 039819 258 ERLLVYPYMSNGSVASRLRE--KPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAK 335 (534)
Q Consensus 258 ~~~lv~e~~~~gsL~~~l~~--~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~ 335 (534)
..+||||||+.|+|.++|+. +..+...+.+.++.|||+|++||+++ ++|||||.++||||+++..+||+|||+|+
T Consensus 275 piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~---~~IHRDLAARNiLV~~~~~vKIsDFGLAr 351 (468)
T KOG0197|consen 275 PIYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESK---NYIHRDLAARNILVDEDLVVKISDFGLAR 351 (468)
T ss_pred ceEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhC---CccchhhhhhheeeccCceEEEccccccc
Confidence 99999999999999999986 56799999999999999999999999 99999999999999999999999999999
Q ss_pred ecCCCCCceeeccccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCcCCCccccccchHHHHHHHHhhhcccc
Q 039819 336 LLDHSDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GMRALEFGKSINQKGAMLEWVKKIQQEKKVE 414 (534)
Q Consensus 336 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 414 (534)
...++.........-...|.|||.+..+.++.|||||||||+||||+| |+.|++... ..+.+..+....+
T Consensus 352 ~~~d~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~ms-------n~ev~~~le~GyR-- 422 (468)
T KOG0197|consen 352 LIGDDEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMS-------NEEVLELLERGYR-- 422 (468)
T ss_pred ccCCCceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCC-------HHHHHHHHhccCc--
Confidence 655544433444444678999999999999999999999999999998 788876322 2344444444332
Q ss_pred eecccccCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhcC
Q 039819 415 VLVDRELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLEGD 461 (534)
Q Consensus 415 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~~ 461 (534)
-..+..++..+.+|+..||+.+|++|||++.+...|+..
T Consensus 423 --------lp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~ 461 (468)
T KOG0197|consen 423 --------LPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDF 461 (468)
T ss_pred --------CCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHh
Confidence 223455778999999999999999999999998888763
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-44 Score=346.36 Aligned_cols=229 Identities=27% Similarity=0.342 Sum_probs=196.2
Q ss_pred HhCCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEehh-----------------hhhhcccCceeeEEEEEeCCCeeEEE
Q 039819 201 TENFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLKD-----------------MISLAVHRNLLRLIGYCATPTERLLV 262 (534)
Q Consensus 201 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~-----------------~l~~~~h~niv~l~~~~~~~~~~~lv 262 (534)
.++|+..+.||+|+||.||.++.. .++.+|+|.+++ ++..++||.||+++-.|++.+..|||
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV 103 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV 103 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence 467889999999999999999865 689999998863 67889999999999999999999999
Q ss_pred eeccCCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCC
Q 039819 263 YPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDS 342 (534)
Q Consensus 263 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~ 342 (534)
+||+.||.|.-+|.+.+.+++..+.-++..|+.||.|||++ +||||||||+|||||.+|+++|+|||+++..-. ..
T Consensus 104 ld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~---gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~-~~ 179 (357)
T KOG0598|consen 104 LDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSK---GIIYRDLKPENILLDEQGHIKLTDFGLCKEDLK-DG 179 (357)
T ss_pred EeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHeeecCCCcEEEeccccchhccc-CC
Confidence 99999999999999999999999999999999999999999 999999999999999999999999999995432 22
Q ss_pred ceeeccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceecccccC
Q 039819 343 HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELG 422 (534)
Q Consensus 343 ~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 422 (534)
..+.+++||+.|||||++.+..|+..+|+||+||++|||++|.+||.... ...+...+.....
T Consensus 180 ~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~-------~~~~~~~I~~~k~---------- 242 (357)
T KOG0598|consen 180 DATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAED-------VKKMYDKILKGKL---------- 242 (357)
T ss_pred CccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCcc-------HHHHHHHHhcCcC----------
Confidence 34556899999999999999999999999999999999999999997433 2344444443320
Q ss_pred CCCCHHHHHHHHHHHHHhcccCCCCCCC
Q 039819 423 SNYDRIEVGEILQVALLCTQYLPVHRPK 450 (534)
Q Consensus 423 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPt 450 (534)
...+.-...+..+++.+.++.+|++|-.
T Consensus 243 ~~~p~~ls~~ardll~~LL~rdp~~RLg 270 (357)
T KOG0598|consen 243 PLPPGYLSEEARDLLKKLLKRDPRQRLG 270 (357)
T ss_pred CCCCccCCHHHHHHHHHHhccCHHHhcC
Confidence 0111112347889999999999999964
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-45 Score=339.79 Aligned_cols=239 Identities=23% Similarity=0.366 Sum_probs=196.0
Q ss_pred hCCCcCCeeccCCcEEEEEEEE-CCCcEEEEEEeh----------------hhhhhcccCceeeEEE-EEeCCCe-eEEE
Q 039819 202 ENFSSKNILGAGGFGNVYKGKL-GDGTVLAVKRLK----------------DMISLAVHRNLLRLIG-YCATPTE-RLLV 262 (534)
Q Consensus 202 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~----------------~~l~~~~h~niv~l~~-~~~~~~~-~~lv 262 (534)
.+|.+.+.||+|+||+||++.. .+|..||.|.+. .++++++|||||+.++ .+.+..+ .+||
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv 98 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV 98 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence 4566778899999999999975 689999999875 2789999999999998 4555555 7999
Q ss_pred eeccCCCChhhhcc----cCCCCCHHHHHHHHHHHHHHHHHHHhcCCC-CeEeccCCCCcEEeCCCCcEEEEecccceec
Q 039819 263 YPYMSNGSVASRLR----EKPALDWNTRKRIAIGAARGLLYLHEQCDP-KIIHRDVKAANVLLDDFCEAIVGDFGLAKLL 337 (534)
Q Consensus 263 ~e~~~~gsL~~~l~----~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~-~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~ 337 (534)
||||..|+|..+++ .++.+++..+++++.|+++||..+|.+... -|+||||||.||+++.+|.+|++|||+++++
T Consensus 99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l 178 (375)
T KOG0591|consen 99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFL 178 (375)
T ss_pred HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHh
Confidence 99999999999986 456799999999999999999999995322 3899999999999999999999999999998
Q ss_pred CCCCCceeeccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceec
Q 039819 338 DHSDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLV 417 (534)
Q Consensus 338 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 417 (534)
..... .....+||+.||+||.+...+|+.||||||+||++|||+.-++||.+. ...+..+.+...+.
T Consensus 179 ~s~~t-fA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~-------n~~~L~~KI~qgd~----- 245 (375)
T KOG0591|consen 179 SSKTT-FAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD-------NLLSLCKKIEQGDY----- 245 (375)
T ss_pred cchhH-HHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc-------cHHHHHHHHHcCCC-----
Confidence 75433 345678999999999999999999999999999999999999999754 23444444433211
Q ss_pred ccccCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 039819 418 DRELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRM 457 (534)
Q Consensus 418 d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~ 457 (534)
..-.+..-+..+.+|+..|+..||..||+...++..
T Consensus 246 ----~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~d 281 (375)
T KOG0591|consen 246 ----PPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQD 281 (375)
T ss_pred ----CCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHH
Confidence 111123456789999999999999999985444443
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-45 Score=358.53 Aligned_cols=251 Identities=21% Similarity=0.285 Sum_probs=208.0
Q ss_pred HHhCCCcCCeeccCCcEEEEEEEE-CCCcEEEEEEehh---------------hhhhcc-cCceeeEEEEEeCCC-eeEE
Q 039819 200 ATENFSSKNILGAGGFGNVYKGKL-GDGTVLAVKRLKD---------------MISLAV-HRNLLRLIGYCATPT-ERLL 261 (534)
Q Consensus 200 ~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~---------------~l~~~~-h~niv~l~~~~~~~~-~~~l 261 (534)
..++|...+.||.|.||.||+|+- ..+..||||++++ .+.++. |||||++.+++.+.+ ..|+
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~f 87 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYF 87 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEee
Confidence 346788889999999999999985 5788999999874 567777 999999999999988 8999
Q ss_pred EeeccCCCChhhhccc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCC
Q 039819 262 VYPYMSNGSVASRLRE-KPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHS 340 (534)
Q Consensus 262 v~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~ 340 (534)
|||||+. +|+++++. +..|++..++.|+.||++||+|+|.+ |+.|||+||+|||+.....+||+|||+|+.....
T Consensus 88 VfE~Md~-NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~---GfFHRDlKPENiLi~~~~~iKiaDFGLARev~Sk 163 (538)
T KOG0661|consen 88 VFEFMDC-NLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKH---GFFHRDLKPENILISGNDVIKIADFGLAREVRSK 163 (538)
T ss_pred eHHhhhh-hHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhc---CcccccCChhheEecccceeEecccccccccccC
Confidence 9999965 99999975 45799999999999999999999999 9999999999999999999999999999987654
Q ss_pred CCceeeccccccccccccccc-cCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccc-----
Q 039819 341 DSHVTTAVRGTVGHIAPEYLS-TGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVE----- 414 (534)
Q Consensus 341 ~~~~~~~~~gt~~y~aPE~~~-~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~----- 414 (534)
. ..+.++.|++|+|||++. .+.|+.+.||||+|||++|+.+-++.|++.++.++...+.+.++......+.+
T Consensus 164 p--PYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La 241 (538)
T KOG0661|consen 164 P--PYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLA 241 (538)
T ss_pred C--CcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHH
Confidence 3 367788999999999875 56789999999999999999999999999888887776666554443332211
Q ss_pred ---eecccccCC-----CCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 039819 415 ---VLVDRELGS-----NYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRM 457 (534)
Q Consensus 415 ---~~~d~~l~~-----~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~ 457 (534)
.+.-+...+ -.+. ...+..+++.+|+++||.+|||+.|++++
T Consensus 242 ~~mnf~~P~~~~~~l~~L~p~-~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 242 SAMNFRFPQVKPSPLKDLLPN-ASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred HHhccCCCcCCCCChHHhCcc-cCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 010111111 1112 45688999999999999999999999874
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-44 Score=358.26 Aligned_cols=246 Identities=26% Similarity=0.421 Sum_probs=208.8
Q ss_pred CccccCHHHHHHHHhCCCcCCeeccCCcEEEEEEEECCCcEEEEEEehh-------hhhhcccCceeeEEEEEeCCCeeE
Q 039819 188 NLRNFTFRELQQATENFSSKNILGAGGFGNVYKGKLGDGTVLAVKRLKD-------MISLAVHRNLLRLIGYCATPTERL 260 (534)
Q Consensus 188 ~~~~~~~~~l~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~-------~l~~~~h~niv~l~~~~~~~~~~~ 260 (534)
.+.++.++++.. .+-||+|+.|.||+|++. ++.||||++++ .+.+++|+||+.+.|+|.....++
T Consensus 117 e~WeiPFe~IsE-------LeWlGSGaQGAVF~Grl~-netVAVKKV~elkETdIKHLRkLkH~NII~FkGVCtqsPcyC 188 (904)
T KOG4721|consen 117 ELWEIPFEEISE-------LEWLGSGAQGAVFLGRLH-NETVAVKKVRELKETDIKHLRKLKHPNIITFKGVCTQSPCYC 188 (904)
T ss_pred hhccCCHHHhhh-------hhhhccCcccceeeeecc-CceehhHHHhhhhhhhHHHHHhccCcceeeEeeeecCCceeE
Confidence 455667777654 356999999999999995 56799998874 688999999999999999999999
Q ss_pred EEeeccCCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCC
Q 039819 261 LVYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHS 340 (534)
Q Consensus 261 lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~ 340 (534)
||||||+.|-|..+|+...+++......|..+||.|+.|||.+ .|||||||.-||||..+..+||+|||.++.....
T Consensus 189 IiMEfCa~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~h---KIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~ 265 (904)
T KOG4721|consen 189 IIMEFCAQGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLH---KIIHRDLKSPNILISYDDVVKISDFGTSKELSDK 265 (904)
T ss_pred EeeeccccccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHh---hHhhhccCCCceEeeccceEEeccccchHhhhhh
Confidence 9999999999999999999999999999999999999999999 9999999999999999999999999999977543
Q ss_pred CCceeeccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceecccc
Q 039819 341 DSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRE 420 (534)
Q Consensus 341 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 420 (534)
.....++||..|||||++.+.+.++|+||||||||||||+||.-||..-.... +-| -+-...
T Consensus 266 --STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssA-----IIw-----------GVGsNs 327 (904)
T KOG4721|consen 266 --STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSA-----IIW-----------GVGSNS 327 (904)
T ss_pred --hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhe-----eEE-----------eccCCc
Confidence 23456889999999999999999999999999999999999999986321100 001 011122
Q ss_pred cCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhcCC
Q 039819 421 LGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLEGDG 462 (534)
Q Consensus 421 l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~~~ 462 (534)
+.-..+..+++.+.-|+..||+..|..||++++++..|+...
T Consensus 328 L~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~ 369 (904)
T KOG4721|consen 328 LHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIAS 369 (904)
T ss_pred ccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhcC
Confidence 333456667889999999999999999999999999887643
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=348.24 Aligned_cols=233 Identities=21% Similarity=0.290 Sum_probs=197.3
Q ss_pred HHhCCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEehh-----------------hhhhcccCceeeEEEEEeCCCeeEE
Q 039819 200 ATENFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLKD-----------------MISLAVHRNLLRLIGYCATPTERLL 261 (534)
Q Consensus 200 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~-----------------~l~~~~h~niv~l~~~~~~~~~~~l 261 (534)
..++|..+..||+|+||.||+|+-+ .|..+|+|++++ +|....+|.||+++..|++.+..||
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL 218 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL 218 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence 4578999999999999999999865 699999999974 5666789999999999999999999
Q ss_pred EeeccCCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCC-
Q 039819 262 VYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHS- 340 (534)
Q Consensus 262 v~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~- 340 (534)
||||++||++..+|...+.|+++.+..++.+++-||.-+|+. |+|||||||+|+|||..|++||+||||++-+...
T Consensus 219 iMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~---gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~ 295 (550)
T KOG0605|consen 219 IMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQL---GYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKH 295 (550)
T ss_pred EEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHc---CcccccCChhheeecCCCCEeeccccccchhhhhh
Confidence 999999999999999999999999999999999999999999 9999999999999999999999999998633110
Q ss_pred ----------------------CCc----e-------------------eeccccccccccccccccCCCCcchhHHHHH
Q 039819 341 ----------------------DSH----V-------------------TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFG 375 (534)
Q Consensus 341 ----------------------~~~----~-------------------~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~G 375 (534)
... . ....+||+.|||||++.+..|+..+|+||+|
T Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG 375 (550)
T KOG0605|consen 296 RIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLG 375 (550)
T ss_pred hhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHHH
Confidence 000 0 1125699999999999999999999999999
Q ss_pred HHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceecccccCCCCCHHHHHHHHHHHHHhcccCCCCCCC
Q 039819 376 ILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELGSNYDRIEVGEILQVALLCTQYLPVHRPK 450 (534)
Q Consensus 376 vvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt 450 (534)
||+|||+.|.+||...........++.|...+..... .....+..+++.+|+. ||++|-.
T Consensus 376 ~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~--------------~~~s~eA~DLI~rll~-d~~~RLG 435 (550)
T KOG0605|consen 376 CIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEE--------------VDLSDEAKDLITRLLC-DPENRLG 435 (550)
T ss_pred HHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCc--------------CcccHHHHHHHHHHhc-CHHHhcC
Confidence 9999999999999876665555566677554432211 1112578899999998 9999986
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-43 Score=349.99 Aligned_cols=246 Identities=23% Similarity=0.359 Sum_probs=203.7
Q ss_pred HHHhCCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEehh-----------------hhhhc-ccCceeeEEEEEeCCCee
Q 039819 199 QATENFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLKD-----------------MISLA-VHRNLLRLIGYCATPTER 259 (534)
Q Consensus 199 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~-----------------~l~~~-~h~niv~l~~~~~~~~~~ 259 (534)
....+|..+++||+|+|++||+|+.. .++.+|||++.+ .|.++ .||.|++|+-.|++....
T Consensus 70 k~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sL 149 (604)
T KOG0592|consen 70 KTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESL 149 (604)
T ss_pred CChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccce
Confidence 34567889999999999999999864 689999998753 45555 899999999999999999
Q ss_pred EEEeeccCCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCC
Q 039819 260 LLVYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDH 339 (534)
Q Consensus 260 ~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~ 339 (534)
|+|+||+++|+|.+++++.+.|++...+.++.+|+.||+|||+. |||||||||+|||||++|++||+|||.|+.+..
T Consensus 150 YFvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~---GIIHRDlKPENILLd~dmhikITDFGsAK~l~~ 226 (604)
T KOG0592|consen 150 YFVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSN---GIIHRDLKPENILLDKDGHIKITDFGSAKILSP 226 (604)
T ss_pred EEEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeEcCCCcEEEeeccccccCCh
Confidence 99999999999999999999999999999999999999999999 999999999999999999999999999998854
Q ss_pred CCCc----------e--eeccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHH
Q 039819 340 SDSH----------V--TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKI 407 (534)
Q Consensus 340 ~~~~----------~--~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~ 407 (534)
.... . ...++||..|.+||++..+..+..+|+|+||||||.|+.|++||....+. .+. +.+
T Consensus 227 ~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ney----liF---qkI 299 (604)
T KOG0592|consen 227 SQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEY----LIF---QKI 299 (604)
T ss_pred hhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHH----HHH---HHH
Confidence 2211 1 14578999999999999999999999999999999999999999854421 111 111
Q ss_pred hhhcccceecccccCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHH--hhcCCchh
Q 039819 408 QQEKKVEVLVDRELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRM--LEGDGLAE 465 (534)
Q Consensus 408 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~--L~~~~~~~ 465 (534)
.. +|-. ++...++.+.+|+.+.+..||.+|+|.+++-+. +++.+...
T Consensus 300 ~~-------l~y~----fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~Vdw~n 348 (604)
T KOG0592|consen 300 QA-------LDYE----FPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEGVDWEN 348 (604)
T ss_pred HH-------hccc----CCCCCCHHHHHHHHHHHccCccccccHHHHhhCcccccCChhh
Confidence 11 1112 223334578899999999999999999988764 44444444
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-43 Score=346.59 Aligned_cols=252 Identities=23% Similarity=0.324 Sum_probs=205.2
Q ss_pred HhCCCcCCeeccCCcEEEEEEEE-CCCcEEEEEEeh----------------hhhhhcccCceeeEEEEEeCC--CeeEE
Q 039819 201 TENFSSKNILGAGGFGNVYKGKL-GDGTVLAVKRLK----------------DMISLAVHRNLLRLIGYCATP--TERLL 261 (534)
Q Consensus 201 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~----------------~~l~~~~h~niv~l~~~~~~~--~~~~l 261 (534)
.+.|+.++.||+|.||.||+|+. .+|+.||+|++. .++.++.||||+++.+...+. ...||
T Consensus 116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYl 195 (560)
T KOG0600|consen 116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYL 195 (560)
T ss_pred hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEE
Confidence 35566778899999999999986 579999999885 278999999999999998877 67899
Q ss_pred EeeccCCCChhhhccc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCC
Q 039819 262 VYPYMSNGSVASRLRE-KPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHS 340 (534)
Q Consensus 262 v~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~ 340 (534)
|+|||+. +|.-++.. .-.|+..+++-++.|++.||+|||++ +|+|||||.+|||||.+|.+||+|||||+++...
T Consensus 196 VFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~---gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~ 271 (560)
T KOG0600|consen 196 VFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSR---GVLHRDIKGSNILIDNNGVLKIADFGLARFYTPS 271 (560)
T ss_pred EEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhc---CeeeccccccceEEcCCCCEEeccccceeeccCC
Confidence 9999987 78777765 34699999999999999999999999 9999999999999999999999999999988766
Q ss_pred CCceeeccccccccccccccccC-CCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccc-eecc
Q 039819 341 DSHVTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVE-VLVD 418 (534)
Q Consensus 341 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~d 418 (534)
.....+..+-|.+|+|||.+.+. .|+.++|+||.||||.||++|++.|++..+.++...|....+....+.+.. .+-.
T Consensus 272 ~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP~ 351 (560)
T KOG0600|consen 272 GSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLPH 351 (560)
T ss_pred CCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCCc
Confidence 65556667789999999998774 599999999999999999999999998877777666666555444333220 0000
Q ss_pred cc-cC--CCCCH-------HHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 419 RE-LG--SNYDR-------IEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 419 ~~-l~--~~~~~-------~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
-. .. ..+.. ..+...++|+..+|..||.+|.|+.+++.
T Consensus 352 ~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~ 399 (560)
T KOG0600|consen 352 ATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ 399 (560)
T ss_pred ccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence 00 00 11111 12346788999999999999999999885
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=339.40 Aligned_cols=237 Identities=28% Similarity=0.424 Sum_probs=191.1
Q ss_pred hCCCcCCeeccCCcEEEEEEEECC-CcEEEEEEeh--------------hhhhhcccCceeeEEEEEeCCC--eeEEEee
Q 039819 202 ENFSSKNILGAGGFGNVYKGKLGD-GTVLAVKRLK--------------DMISLAVHRNLLRLIGYCATPT--ERLLVYP 264 (534)
Q Consensus 202 ~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~--------------~~l~~~~h~niv~l~~~~~~~~--~~~lv~e 264 (534)
.++...+.||+|+||.||++...+ |...|||... .++.+++|||||+.+|...... .++++||
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE 96 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME 96 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence 346667899999999999999864 8999999764 2678888999999999855554 5889999
Q ss_pred ccCCCChhhhcccCC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCC-CCcEEEEecccceecCC--C
Q 039819 265 YMSNGSVASRLREKP-ALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDD-FCEAIVGDFGLAKLLDH--S 340 (534)
Q Consensus 265 ~~~~gsL~~~l~~~~-~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~-~~~~kl~DFGla~~~~~--~ 340 (534)
|+++|+|.+++...+ .|++..++.++.||++||+|||++ +||||||||+|||++. ++.+||+|||+++.... .
T Consensus 97 y~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~---g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~ 173 (313)
T KOG0198|consen 97 YAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSK---GIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGT 173 (313)
T ss_pred ccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCcccceEEEeCCCCeEEeccCccccccccccc
Confidence 999999999998765 799999999999999999999999 9999999999999999 79999999999987653 2
Q ss_pred CCceeeccccccccccccccccCC-CCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceeccc
Q 039819 341 DSHVTTAVRGTVGHIAPEYLSTGQ-SSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDR 419 (534)
Q Consensus 341 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 419 (534)
.........||+.|||||++..+. ...++|||||||++.||+||++||..- ....+++-.+..... -|
T Consensus 174 ~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~------~~~~~~~~~ig~~~~-----~P 242 (313)
T KOG0198|consen 174 KSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF------FEEAEALLLIGREDS-----LP 242 (313)
T ss_pred cccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh------cchHHHHHHHhccCC-----CC
Confidence 222344578999999999998643 345999999999999999999999631 111222222221111 11
Q ss_pred ccCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 420 ELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 420 ~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
.++...+.+..+++.+|++.+|++|||+.++++
T Consensus 243 ----~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~ 275 (313)
T KOG0198|consen 243 ----EIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLE 275 (313)
T ss_pred ----CCCcccCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence 233334568899999999999999999999986
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-42 Score=315.70 Aligned_cols=250 Identities=24% Similarity=0.335 Sum_probs=202.9
Q ss_pred hCCCcCCeeccCCcEEEEEEEE-CCCcEEEEEEeh----------------hhhhhcccCceeeEEEEEeCCCeeEEEee
Q 039819 202 ENFSSKNILGAGGFGNVYKGKL-GDGTVLAVKRLK----------------DMISLAVHRNLLRLIGYCATPTERLLVYP 264 (534)
Q Consensus 202 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~----------------~~l~~~~h~niv~l~~~~~~~~~~~lv~e 264 (534)
.+|...+.||+|.||.||+|+. ..|+.||||+++ +.++.++|+||+.++++|...+...||+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 3577778999999999999986 479999999986 37888999999999999999999999999
Q ss_pred ccCCCChhhhcccC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCCc
Q 039819 265 YMSNGSVASRLREK-PALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSH 343 (534)
Q Consensus 265 ~~~~gsL~~~l~~~-~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~ 343 (534)
||+. +|...++.. ..++...+..++.++++||+|||++ .|+||||||.|+|++.+|.+||+|||+|+.+......
T Consensus 82 fm~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~---~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~ 157 (318)
T KOG0659|consen 82 FMPT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSK---WILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRI 157 (318)
T ss_pred eccc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhh---hhhcccCCccceEEcCCCcEEeecccchhccCCCCcc
Confidence 9976 899888754 5689999999999999999999999 8999999999999999999999999999988754432
Q ss_pred eeecccccccccccccccc-CCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccc--eeccc-
Q 039819 344 VTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVE--VLVDR- 419 (534)
Q Consensus 344 ~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~d~- 419 (534)
. +..+-|.+|+|||.+.+ ..|+..+||||.|||+.||+-|.+-|++.++.++...+..-++....+.+.+ .+-|-
T Consensus 158 ~-~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~ 236 (318)
T KOG0659|consen 158 Q-THQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYV 236 (318)
T ss_pred c-ccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHH
Confidence 2 22357999999998876 4589999999999999999999999998888777666655544433332211 11110
Q ss_pred -------ccCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 420 -------ELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 420 -------~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
......-........+++..++..||.+|+++.|+++
T Consensus 237 ~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~ 280 (318)
T KOG0659|consen 237 KIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALK 280 (318)
T ss_pred HHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhc
Confidence 0001111223456799999999999999999999886
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=340.12 Aligned_cols=235 Identities=25% Similarity=0.365 Sum_probs=196.9
Q ss_pred HHhCCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEehh-------------------hhhhcc-cCceeeEEEEEeCCCe
Q 039819 200 ATENFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLKD-------------------MISLAV-HRNLLRLIGYCATPTE 258 (534)
Q Consensus 200 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~-------------------~l~~~~-h~niv~l~~~~~~~~~ 258 (534)
..+.|...+.||+|+||.|+.|+.. ++..||||.+.+ ++..++ ||||+++++++.....
T Consensus 15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~ 94 (370)
T KOG0583|consen 15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK 94 (370)
T ss_pred ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence 4568889999999999999999764 679999996432 455666 9999999999999999
Q ss_pred eEEEeeccCCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCC-CcEEEEecccceec
Q 039819 259 RLLVYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDF-CEAIVGDFGLAKLL 337 (534)
Q Consensus 259 ~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~-~~~kl~DFGla~~~ 337 (534)
.++||||+.+|+|.+++.+.+++.+.+...++.|++.|++|||+. +|+||||||+|||++.+ +++||+|||++...
T Consensus 95 ~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~---gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~ 171 (370)
T KOG0583|consen 95 IYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSR---GIVHRDLKPENILLDGNEGNLKLSDFGLSAIS 171 (370)
T ss_pred EEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEecCCCCCEEEecccccccc
Confidence 999999999999999999988999999999999999999999999 99999999999999999 99999999999987
Q ss_pred CCCCCceeeccccccccccccccccCC-CC-cchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccce
Q 039819 338 DHSDSHVTTAVRGTVGHIAPEYLSTGQ-SS-EKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEV 415 (534)
Q Consensus 338 ~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 415 (534)
. .......+.+||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||+... .......+....
T Consensus 172 ~-~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~-------~~~l~~ki~~~~---- 239 (370)
T KOG0583|consen 172 P-GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSN-------VPNLYRKIRKGE---- 239 (370)
T ss_pred C-CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCcc-------HHHHHHHHhcCC----
Confidence 4 2233466788999999999998876 75 78999999999999999999998522 111112211110
Q ss_pred ecccccCCCCCHHH-HHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 416 LVDRELGSNYDRIE-VGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 416 ~~d~~l~~~~~~~~-~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
-.++... ..++..++.+|+..+|.+|+++.+++.
T Consensus 240 -------~~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~ 274 (370)
T KOG0583|consen 240 -------FKIPSYLLSPEARSLIEKMLVPDPSTRITLLEILE 274 (370)
T ss_pred -------ccCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhh
Confidence 0111112 558899999999999999999999983
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=345.10 Aligned_cols=241 Identities=27% Similarity=0.437 Sum_probs=189.4
Q ss_pred HhCCCcCCeeccCCcEEEEEEEE------CCCcEEEEEEehh---------------hhhhc-ccCceeeEEEEEeCCC-
Q 039819 201 TENFSSKNILGAGGFGNVYKGKL------GDGTVLAVKRLKD---------------MISLA-VHRNLLRLIGYCATPT- 257 (534)
Q Consensus 201 ~~~~~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~---------------~l~~~-~h~niv~l~~~~~~~~- 257 (534)
.++|...+.||+|+||.||+|.. .++..||||++.. ++..+ .||||++++++|....
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNG 85 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCC
Confidence 46788899999999999999974 2356899998752 34455 7999999999987654
Q ss_pred eeEEEeeccCCCChhhhcccC-----------------------------------------------------------
Q 039819 258 ERLLVYPYMSNGSVASRLREK----------------------------------------------------------- 278 (534)
Q Consensus 258 ~~~lv~e~~~~gsL~~~l~~~----------------------------------------------------------- 278 (534)
..++||||+++|+|.+++...
T Consensus 86 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (338)
T cd05102 86 PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDD 165 (338)
T ss_pred ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccc
Confidence 578999999999999888632
Q ss_pred ---CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCCc-eeecccccccc
Q 039819 279 ---PALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSH-VTTAVRGTVGH 354 (534)
Q Consensus 279 ---~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y 354 (534)
..+++..+..++.|+++||+|||+. +|+||||||+|||++.++.+||+|||+++........ ......++..|
T Consensus 166 ~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y 242 (338)
T cd05102 166 LWKSPLTMEDLICYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKW 242 (338)
T ss_pred cccCCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccc
Confidence 2478889999999999999999998 9999999999999999999999999999865432211 12233467889
Q ss_pred ccccccccCCCCcchhHHHHHHHHHHHHh-CCCCcCCCccccccchHHHHHHHHhhhcccceecccccCCCCCHHHHHHH
Q 039819 355 IAPEYLSTGQSSEKTDVFGFGILLLELIT-GMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELGSNYDRIEVGEI 433 (534)
Q Consensus 355 ~aPE~~~~~~~~~k~Dv~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l 433 (534)
+|||++.+..++.++|||||||++|||+| |+.||+..... ............ .. .+...+..+
T Consensus 243 ~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~------~~~~~~~~~~~~------~~----~~~~~~~~l 306 (338)
T cd05102 243 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIN------EEFCQRLKDGTR------MR----APENATPEI 306 (338)
T ss_pred cCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCcc------HHHHHHHhcCCC------CC----CCCCCCHHH
Confidence 99999988889999999999999999997 99999743211 011111111110 01 112234578
Q ss_pred HHHHHHhcccCCCCCCChHHHHHHhhc
Q 039819 434 LQVALLCTQYLPVHRPKMSEVVRMLEG 460 (534)
Q Consensus 434 ~~l~~~Cl~~~P~~RPt~~ev~~~L~~ 460 (534)
.+++.+|++.+|.+||++.|+++.|+.
T Consensus 307 ~~li~~cl~~dp~~RPs~~el~~~l~~ 333 (338)
T cd05102 307 YRIMLACWQGDPKERPTFSALVEILGD 333 (338)
T ss_pred HHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=328.00 Aligned_cols=272 Identities=22% Similarity=0.358 Sum_probs=214.1
Q ss_pred HhCCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEehh----------------hhhhcccCceeeEEEEEeC-----CCe
Q 039819 201 TENFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLKD----------------MISLAVHRNLLRLIGYCAT-----PTE 258 (534)
Q Consensus 201 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~----------------~l~~~~h~niv~l~~~~~~-----~~~ 258 (534)
...|...+.||+|+||.|..|... +|..||||++.+ ++..++|+||+.+.+.+.. -..
T Consensus 21 ~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~D 100 (359)
T KOG0660|consen 21 PRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFND 100 (359)
T ss_pred cceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccce
Confidence 345666788999999999999874 789999998862 6788899999999998865 246
Q ss_pred eEEEeeccCCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecC
Q 039819 259 RLLVYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLD 338 (534)
Q Consensus 259 ~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~ 338 (534)
.|+|+|+| ..+|...++.++.|+......+++|+++||.|+|+. +|+||||||+|+|++.++..||+|||+|+...
T Consensus 101 vYiV~elM-etDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSA---nViHRDLKPsNll~n~~c~lKI~DFGLAR~~~ 176 (359)
T KOG0660|consen 101 VYLVFELM-ETDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSA---NVIHRDLKPSNLLLNADCDLKICDFGLARYLD 176 (359)
T ss_pred eEEehhHH-hhHHHHHHHcCccccHHHHHHHHHHHHHhcchhhcc---cccccccchhheeeccCCCEEeccccceeecc
Confidence 79999999 559999999988899999999999999999999999 99999999999999999999999999999875
Q ss_pred CC-CCceeecccccccccccccccc-CCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhc-----
Q 039819 339 HS-DSHVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEK----- 411 (534)
Q Consensus 339 ~~-~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~----- 411 (534)
.. .....+.++.|.+|+|||++.. ..|+...||||.|||+.||++|++.|++.+..++...+.+.++....+.
T Consensus 177 ~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~ 256 (359)
T KOG0660|consen 177 KFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIR 256 (359)
T ss_pred ccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhc
Confidence 32 1223456778999999998754 6799999999999999999999999998887777666655443321110
Q ss_pred --ccceecc--ccc-CCCCCH---HHHHHHHHHHHHhcccCCCCCCChHHHHHHhhcCCchhhHHhhccCCCCCCCCccc
Q 039819 412 --KVEVLVD--REL-GSNYDR---IEVGEILQVALLCTQYLPVHRPKMSEVVRMLEGDGLAEKWAAAHNHTNPTMNNFHT 483 (534)
Q Consensus 412 --~~~~~~d--~~l-~~~~~~---~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~~~~~~~~~~~~~~~~p~~~~~~~ 483 (534)
.....+. +.. +..+.. ......+++..+++..||.+|+|++|+++ ||++..++.
T Consensus 257 s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~------------------hPYl~~~hd 318 (359)
T KOG0660|consen 257 SEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALA------------------HPYLAPYHD 318 (359)
T ss_pred cHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhc------------------ChhhhhhcC
Confidence 0000000 000 001111 12346788999999999999999998874 999999998
Q ss_pred CCCCCCCCCCC
Q 039819 484 NTKKSTSCPTS 494 (534)
Q Consensus 484 ~~~~~~~~~~~ 494 (534)
...++..++..
T Consensus 319 p~dEP~~~~~~ 329 (359)
T KOG0660|consen 319 PEDEPVCQPIF 329 (359)
T ss_pred CccCCCCCCCC
Confidence 87776666543
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-41 Score=315.62 Aligned_cols=222 Identities=26% Similarity=0.357 Sum_probs=191.4
Q ss_pred hCCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEehh-----------------hhhhcccCceeeEEEEEeCCCeeEEEe
Q 039819 202 ENFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLKD-----------------MISLAVHRNLLRLIGYCATPTERLLVY 263 (534)
Q Consensus 202 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~-----------------~l~~~~h~niv~l~~~~~~~~~~~lv~ 263 (534)
++|+..+.||.|+||.|.+++.+ +|..+|+|++.+ +++.+.||.++++++.|.+....||||
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm 123 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM 123 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence 56778899999999999999975 688999998863 788889999999999999999999999
Q ss_pred eccCCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCCc
Q 039819 264 PYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSH 343 (534)
Q Consensus 264 e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~ 343 (534)
||++||.|..++++.+++++..++-+|.+|+.||+|||+. .|++|||||+|||+|.+|.+||+|||+|+.....
T Consensus 124 eyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~---~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r--- 197 (355)
T KOG0616|consen 124 EYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSL---DIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR--- 197 (355)
T ss_pred eccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhc---CeeeccCChHHeeeccCCcEEEEeccceEEecCc---
Confidence 9999999999999999999999999999999999999999 9999999999999999999999999999987542
Q ss_pred eeeccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceecccccCC
Q 039819 344 VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELGS 423 (534)
Q Consensus 344 ~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 423 (534)
+.+.|||+.|+|||+++...++..+|.|||||++|||+.|.+||...... .....+...+ -
T Consensus 198 -T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~-------~iY~KI~~~~-----------v 258 (355)
T KOG0616|consen 198 -TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPI-------QIYEKILEGK-----------V 258 (355)
T ss_pred -EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChH-------HHHHHHHhCc-----------c
Confidence 66789999999999999999999999999999999999999999744321 1111111110 1
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCC
Q 039819 424 NYDRIEVGEILQVALLCTQYLPVHR 448 (534)
Q Consensus 424 ~~~~~~~~~l~~l~~~Cl~~~P~~R 448 (534)
.++.-....+.+|+...++.|-.+|
T Consensus 259 ~fP~~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 259 KFPSYFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred cCCcccCHHHHHHHHHHHhhhhHhh
Confidence 1333344577888888888888888
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-42 Score=363.28 Aligned_cols=238 Identities=28% Similarity=0.453 Sum_probs=196.3
Q ss_pred CCCcCCeeccCCcEEEEEEEE------CCCcEEEEEEehh---------------hhhhcccCceeeEEEEEeCCCeeEE
Q 039819 203 NFSSKNILGAGGFGNVYKGKL------GDGTVLAVKRLKD---------------MISLAVHRNLLRLIGYCATPTERLL 261 (534)
Q Consensus 203 ~~~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~---------------~l~~~~h~niv~l~~~~~~~~~~~l 261 (534)
+....+.||+|+||+||+|+. .+...||||.+++ ++..+.|||||+++|+|.+++..++
T Consensus 487 ~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~M 566 (774)
T KOG1026|consen 487 DIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLCM 566 (774)
T ss_pred heeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeEE
Confidence 344557799999999999985 3356799999873 7889999999999999999999999
Q ss_pred EeeccCCCChhhhccc--------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEE
Q 039819 262 VYPYMSNGSVASRLRE--------------KPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAI 327 (534)
Q Consensus 262 v~e~~~~gsL~~~l~~--------------~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~k 327 (534)
|+|||..|+|.++|+. ..+|+..+.+.||.|||.|+.||-++ .+|||||-.+|+||.++..||
T Consensus 567 vFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~---~FVHRDLATRNCLVge~l~VK 643 (774)
T KOG1026|consen 567 VFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH---HFVHRDLATRNCLVGENLVVK 643 (774)
T ss_pred EEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---cccccchhhhhceeccceEEE
Confidence 9999999999999962 12388999999999999999999999 999999999999999999999
Q ss_pred EEecccceecCCCCCceee-ccccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCcCCCccccccchHHHHHH
Q 039819 328 VGDFGLAKLLDHSDSHVTT-AVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GMRALEFGKSINQKGAMLEWVK 405 (534)
Q Consensus 328 l~DFGla~~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~ 405 (534)
|+|||+++.....+..... ...-...|||||.|..++||++||||||||||||++| |+.|+.+-... ..++.
T Consensus 644 IsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~----EVIe~-- 717 (774)
T KOG1026|consen 644 ISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQ----EVIEC-- 717 (774)
T ss_pred ecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchH----HHHHH--
Confidence 9999999976544432221 1122578999999999999999999999999999998 88898643321 11222
Q ss_pred HHhhhcccceecccccCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhc
Q 039819 406 KIQQEKKVEVLVDRELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLEG 460 (534)
Q Consensus 406 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~ 460 (534)
+. +..+ -..++.++.++..|+..||+.+|++||+++||-..|+.
T Consensus 718 -i~---------~g~l-L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~ 761 (774)
T KOG1026|consen 718 -IR---------AGQL-LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQA 761 (774)
T ss_pred -HH---------cCCc-ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHH
Confidence 11 1222 23456678899999999999999999999999998875
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=330.75 Aligned_cols=247 Identities=17% Similarity=0.261 Sum_probs=197.1
Q ss_pred CCccccCHHHHHHHHhCCCcCCeeccCCcEEEEEEEECCCcEEEEEEeh-----------------hhhhhcccCceeeE
Q 039819 187 GNLRNFTFRELQQATENFSSKNILGAGGFGNVYKGKLGDGTVLAVKRLK-----------------DMISLAVHRNLLRL 249 (534)
Q Consensus 187 ~~~~~~~~~~l~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~-----------------~~l~~~~h~niv~l 249 (534)
..+..++.+++ +......||+|++|.||+|.+ +|+.||||++. ..+.+++|||||++
T Consensus 10 ~~~~~i~~~~i-----~~~~~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~ 83 (283)
T PHA02988 10 NDIKCIESDDI-----DKYTSVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKI 83 (283)
T ss_pred CcceecCHHHc-----CCCCCeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEE
Confidence 34555566665 222336799999999999999 68899999875 26778899999999
Q ss_pred EEEEeC----CCeeEEEeeccCCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCc
Q 039819 250 IGYCAT----PTERLLVYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCE 325 (534)
Q Consensus 250 ~~~~~~----~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~ 325 (534)
+|++.+ ....++||||+++|+|.+++.....+++....+++.+++.||.|||+.. +++||||||+|||+++++.
T Consensus 84 ~g~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--~~~Hrdlkp~nill~~~~~ 161 (283)
T PHA02988 84 YGFIIDIVDDLPRLSLILEYCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYT--NKPYKNLTSVSFLVTENYK 161 (283)
T ss_pred eeeEEecccCCCceEEEEEeCCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcC--CCCCCcCChhhEEECCCCc
Confidence 999876 3467899999999999999998888999999999999999999999742 7889999999999999999
Q ss_pred EEEEecccceecCCCCCceeecccccccccccccccc--CCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHH
Q 039819 326 AIVGDFGLAKLLDHSDSHVTTAVRGTVGHIAPEYLST--GQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEW 403 (534)
Q Consensus 326 ~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~ 403 (534)
+||+|||+++.+.... ....|+..|+|||++.+ ..++.++|||||||++|||+||+.||..... .++
T Consensus 162 ~kl~dfg~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~-------~~~ 230 (283)
T PHA02988 162 LKIICHGLEKILSSPP----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTT-------KEI 230 (283)
T ss_pred EEEcccchHhhhcccc----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCH-------HHH
Confidence 9999999998654321 23457899999999976 6789999999999999999999999974321 122
Q ss_pred HHHHhhhcccceecccccCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhcC
Q 039819 404 VKKIQQEKKVEVLVDRELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLEGD 461 (534)
Q Consensus 404 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~~ 461 (534)
......... ....+...+..+.+++.+||+.+|++|||+.|+++.|+..
T Consensus 231 ~~~i~~~~~---------~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~ 279 (283)
T PHA02988 231 YDLIINKNN---------SLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLY 279 (283)
T ss_pred HHHHHhcCC---------CCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHH
Confidence 222111110 0111222355899999999999999999999999998753
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-40 Score=323.79 Aligned_cols=244 Identities=26% Similarity=0.379 Sum_probs=194.6
Q ss_pred hCCCcCCeeccCCcEEEEEEEE-CCCcEEEEEEeh---------------hhhhhcccCceeeEEEEEeCCCeeEEEeec
Q 039819 202 ENFSSKNILGAGGFGNVYKGKL-GDGTVLAVKRLK---------------DMISLAVHRNLLRLIGYCATPTERLLVYPY 265 (534)
Q Consensus 202 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~---------------~~l~~~~h~niv~l~~~~~~~~~~~lv~e~ 265 (534)
+.|.....||.|..+.||+|+. +.+..||||++. ..++.++||||++.+..|......|+||.|
T Consensus 26 ~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmpf 105 (516)
T KOG0582|consen 26 KDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMPF 105 (516)
T ss_pred cceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeehh
Confidence 5788889999999999999986 567999999985 267889999999999999999999999999
Q ss_pred cCCCChhhhccc--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCCc
Q 039819 266 MSNGSVASRLRE--KPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSH 343 (534)
Q Consensus 266 ~~~gsL~~~l~~--~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~ 343 (534)
|.+|++.+.++. ...+++..+..|..++++||.|||++ |.||||||+.||||+.+|.+||+|||.+..+......
T Consensus 106 Ma~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~---G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~R 182 (516)
T KOG0582|consen 106 MAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQN---GHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGDR 182 (516)
T ss_pred hcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhc---CceecccccccEEEcCCCcEEEcCceeeeeecccCce
Confidence 999999999974 34599999999999999999999999 9999999999999999999999999998876543321
Q ss_pred --ee-ecccccccccccccccc--CCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceecc
Q 039819 344 --VT-TAVRGTVGHIAPEYLST--GQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVD 418 (534)
Q Consensus 344 --~~-~~~~gt~~y~aPE~~~~--~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 418 (534)
.. ...+||+.|||||+++. ..|+.|+|||||||+..||++|..||..-.. +.-.+..+.. .......
T Consensus 183 ~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pP------mkvLl~tLqn--~pp~~~t 254 (516)
T KOG0582|consen 183 QVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPP------MKVLLLTLQN--DPPTLLT 254 (516)
T ss_pred eeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCCh------HHHHHHHhcC--CCCCccc
Confidence 11 45689999999999543 4589999999999999999999999962211 1111111111 1111111
Q ss_pred cccCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 419 RELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 419 ~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
..+..+..+.....+.+++..|++.||.+|||++++++
T Consensus 255 ~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk 292 (516)
T KOG0582|consen 255 SGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK 292 (516)
T ss_pred ccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 11111122233458889999999999999999999975
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-41 Score=338.49 Aligned_cols=235 Identities=22% Similarity=0.332 Sum_probs=198.0
Q ss_pred hCCCcCCeeccCCcEEEEEEEE-CCCcEEEEEEeh--------------hhhhhcccCceeeEEEEEeCCCeeEEEeecc
Q 039819 202 ENFSSKNILGAGGFGNVYKGKL-GDGTVLAVKRLK--------------DMISLAVHRNLLRLIGYCATPTERLLVYPYM 266 (534)
Q Consensus 202 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~--------------~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~ 266 (534)
..|..-..||+|+.|.||.|.. ..+..||||++. .+++..+|+|||++++.|...++.|+|||||
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym 352 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYM 352 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeec
Confidence 3567778899999999999975 578899999985 2678889999999999999999999999999
Q ss_pred CCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCCceee
Q 039819 267 SNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTT 346 (534)
Q Consensus 267 ~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~ 346 (534)
++|+|.+.+.... +++.++..|+.+++.||+|||.+ +|+|||||.+|||++.+|.+||+|||++..+..... ...
T Consensus 353 ~ggsLTDvVt~~~-~~E~qIA~Icre~l~aL~fLH~~---gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~-KR~ 427 (550)
T KOG0578|consen 353 EGGSLTDVVTKTR-MTEGQIAAICREILQGLKFLHAR---GIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS-KRS 427 (550)
T ss_pred CCCchhhhhhccc-ccHHHHHHHHHHHHHHHHHHHhc---ceeeeccccceeEeccCCcEEEeeeeeeeccccccC-ccc
Confidence 9999999887654 99999999999999999999999 999999999999999999999999999998765433 455
Q ss_pred ccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceecccccCCCCC
Q 039819 347 AVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELGSNYD 426 (534)
Q Consensus 347 ~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 426 (534)
+.+||+.|||||++....|++|+|||||||+++||+-|.+||-.... +.-+..+...+.. ++ ...
T Consensus 428 TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~P-------lrAlyLIa~ng~P------~l--k~~ 492 (550)
T KOG0578|consen 428 TMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENP-------LRALYLIATNGTP------KL--KNP 492 (550)
T ss_pred cccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCCh-------HHHHHHHhhcCCC------Cc--CCc
Confidence 67899999999999999999999999999999999999999964322 1112222222211 11 123
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 427 RIEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 427 ~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
......+.++..+|++.|+.+||++.|+++
T Consensus 493 ~klS~~~kdFL~~cL~~dv~~RasA~eLL~ 522 (550)
T KOG0578|consen 493 EKLSPELKDFLDRCLVVDVEQRASAKELLE 522 (550)
T ss_pred cccCHHHHHHHHHHhhcchhcCCCHHHHhc
Confidence 334568999999999999999999999986
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=338.15 Aligned_cols=239 Identities=21% Similarity=0.278 Sum_probs=194.7
Q ss_pred hCCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEehh-----------------hhhhcccCceeeEEEEEeCCCeeEEEe
Q 039819 202 ENFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLKD-----------------MISLAVHRNLLRLIGYCATPTERLLVY 263 (534)
Q Consensus 202 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~-----------------~l~~~~h~niv~l~~~~~~~~~~~lv~ 263 (534)
++|...+.||+|+||.||+|+.. +++.||||++.. ++..++||||+++++++...+..++||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 36888899999999999999986 588999998752 456778999999999999999999999
Q ss_pred eccCCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCCc
Q 039819 264 PYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSH 343 (534)
Q Consensus 264 e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~ 343 (534)
||+++|+|.+++.....+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 81 e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~---- 153 (333)
T cd05600 81 EYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHEL---GYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT---- 153 (333)
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEEEeCcCCccccc----
Confidence 9999999999998888899999999999999999999998 999999999999999999999999999986543
Q ss_pred eeeccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceecccccCC
Q 039819 344 VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELGS 423 (534)
Q Consensus 344 ~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 423 (534)
......||+.|+|||++.+..++.++|||||||++|||++|+.||...........+..|... +..+.. .
T Consensus 154 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~---------~~~~~~-~ 223 (333)
T cd05600 154 YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKET---------LQRPVY-D 223 (333)
T ss_pred ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhcccc---------ccCCCC-C
Confidence 233456899999999999889999999999999999999999999754321111111111100 000100 0
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 039819 424 NYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRM 457 (534)
Q Consensus 424 ~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~ 457 (534)
........++.+++.+|+..+|.+||++.++++.
T Consensus 224 ~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 224 DPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred ccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 0011234578899999999999999999999864
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-41 Score=316.80 Aligned_cols=251 Identities=23% Similarity=0.291 Sum_probs=202.3
Q ss_pred HhCCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEeh----------------hhhhhcccCceeeEEEEEeC--CCeeEE
Q 039819 201 TENFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLK----------------DMISLAVHRNLLRLIGYCAT--PTERLL 261 (534)
Q Consensus 201 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~----------------~~l~~~~h~niv~l~~~~~~--~~~~~l 261 (534)
.++|+..+.|++|.||.||+|+.. +++.||+|+++ .++.+++|||||.+..+... -+..|+
T Consensus 75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~ 154 (419)
T KOG0663|consen 75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYI 154 (419)
T ss_pred HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeee
Confidence 456777889999999999999975 68999999986 27888999999999988754 467899
Q ss_pred EeeccCCCChhhhcccC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCC
Q 039819 262 VYPYMSNGSVASRLREK-PALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHS 340 (534)
Q Consensus 262 v~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~ 340 (534)
|||||+. +|...+..- +++...+++-++.|+++|++|||.. -|+|||||++|+|++..|.+||+|||+|+.++..
T Consensus 155 VMe~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~---wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp 230 (419)
T KOG0663|consen 155 VMEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDN---WILHRDLKTSNLLLSHKGILKIADFGLAREYGSP 230 (419)
T ss_pred eHHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhc---eeEecccchhheeeccCCcEEecccchhhhhcCC
Confidence 9999976 888888753 4799999999999999999999999 8999999999999999999999999999988754
Q ss_pred CCceeeccccccccccccccccC-CCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhccccee---
Q 039819 341 DSHVTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVL--- 416 (534)
Q Consensus 341 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--- 416 (534)
. ...+..+-|.+|+|||.+.+. .|++.+|+||+|||+.||+++++.|++....++...+...++......+....
T Consensus 231 ~-k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp 309 (419)
T KOG0663|consen 231 L-KPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELP 309 (419)
T ss_pred c-ccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccc
Confidence 2 234556679999999998775 58999999999999999999999999888888777776665544333221100
Q ss_pred -cc---------cccCCCCCHH-HHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 417 -VD---------RELGSNYDRI-EVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 417 -~d---------~~l~~~~~~~-~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
+. ..+...+... ..+.-+++....+..||.+|-|+.|.++
T Consensus 310 ~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~ 360 (419)
T KOG0663|consen 310 AVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLK 360 (419)
T ss_pred hhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhc
Confidence 00 0111112111 2356788999999999999999999875
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=338.71 Aligned_cols=232 Identities=25% Similarity=0.313 Sum_probs=199.7
Q ss_pred hCCCcCCeeccCCcEEEEEEEE-CCCcEEEEEEehh-----------------hhhhcccCceeeEEEEEeCCCeeEEEe
Q 039819 202 ENFSSKNILGAGGFGNVYKGKL-GDGTVLAVKRLKD-----------------MISLAVHRNLLRLIGYCATPTERLLVY 263 (534)
Q Consensus 202 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~-----------------~l~~~~h~niv~l~~~~~~~~~~~lv~ 263 (534)
+-|...+.||.|+.|.|-.|+. .+|+.+|||++.+ +|+.+.|||++++++++++..++|+|.
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl 91 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL 91 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence 4566778899999999999987 4799999998863 788999999999999999999999999
Q ss_pred eccCCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCCc
Q 039819 264 PYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSH 343 (534)
Q Consensus 264 e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~ 343 (534)
||+++|.|++++..++++++.+..+++.||+.|+.|+|.. +|+||||||+|+|||..+++||+|||+|..-..+ .
T Consensus 92 Eyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~---~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~g--k 166 (786)
T KOG0588|consen 92 EYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAF---NICHRDLKPENLLLDVKNNIKIADFGMASLEVPG--K 166 (786)
T ss_pred EecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhh---cceeccCCchhhhhhcccCEeeeccceeecccCC--c
Confidence 9999999999999999999999999999999999999999 9999999999999999999999999999865433 3
Q ss_pred eeeccccccccccccccccCCC-CcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceecccccC
Q 039819 344 VTTAVRGTVGHIAPEYLSTGQS-SEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELG 422 (534)
Q Consensus 344 ~~~~~~gt~~y~aPE~~~~~~~-~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 422 (534)
...+.||++.|.|||++++.+| +.++||||.|||||-|+||+.||+.+ .+...+..+.....
T Consensus 167 lLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDd-------Nir~LLlKV~~G~f---------- 229 (786)
T KOG0588|consen 167 LLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDD-------NIRVLLLKVQRGVF---------- 229 (786)
T ss_pred cccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCc-------cHHHHHHHHHcCcc----------
Confidence 4556789999999999999998 57899999999999999999999832 23333333322211
Q ss_pred CCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 423 SNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 423 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
+.+...+.+..+|+.+|+..||++|.|++||++
T Consensus 230 -~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~k 262 (786)
T KOG0588|consen 230 -EMPSNISSEAQDLLRRMLDVDPSTRITTEEILK 262 (786)
T ss_pred -cCCCcCCHHHHHHHHHHhccCccccccHHHHhh
Confidence 112233458899999999999999999999986
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-40 Score=325.44 Aligned_cols=235 Identities=25% Similarity=0.374 Sum_probs=189.0
Q ss_pred CCCcCCeeccCCcEEEEEEEE-CCCcEEEEEEeh-----------------hhhhhcccCceeeEEEEEeCCCeeEEEee
Q 039819 203 NFSSKNILGAGGFGNVYKGKL-GDGTVLAVKRLK-----------------DMISLAVHRNLLRLIGYCATPTERLLVYP 264 (534)
Q Consensus 203 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~-----------------~~l~~~~h~niv~l~~~~~~~~~~~lv~e 264 (534)
.|+..+.||+|+||.||+|.. .+++.||||.+. +++..+.|+||+++.+++.+.+..++|||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 366778999999999999987 478999999764 15667789999999999999999999999
Q ss_pred ccCCCChhhhccc--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCC
Q 039819 265 YMSNGSVASRLRE--KPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDS 342 (534)
Q Consensus 265 ~~~~gsL~~~l~~--~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~ 342 (534)
|+++|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||++.......
T Consensus 81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~- 156 (285)
T cd05631 81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE- 156 (285)
T ss_pred ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC-
Confidence 9999999888753 34689999999999999999999998 99999999999999999999999999998764322
Q ss_pred ceeeccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceecccccC
Q 039819 343 HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELG 422 (534)
Q Consensus 343 ~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 422 (534)
......||..|+|||++.+..++.++|||||||++|||++|+.||......... ....... ... .
T Consensus 157 -~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~---~~~~~~~-~~~----------~ 221 (285)
T cd05631 157 -TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKR---EEVDRRV-KED----------Q 221 (285)
T ss_pred -eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhH---HHHHHHh-hcc----------c
Confidence 223456899999999999999999999999999999999999999754321110 0111111 000 0
Q ss_pred CCCCHHHHHHHHHHHHHhcccCCCCCCC-----hHHHHH
Q 039819 423 SNYDRIEVGEILQVALLCTQYLPVHRPK-----MSEVVR 456 (534)
Q Consensus 423 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPt-----~~ev~~ 456 (534)
..++......+.+++.+|++.+|.+||+ ++++++
T Consensus 222 ~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 260 (285)
T cd05631 222 EEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ 260 (285)
T ss_pred ccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence 1112223457889999999999999997 666664
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=329.33 Aligned_cols=252 Identities=20% Similarity=0.261 Sum_probs=193.9
Q ss_pred hCCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEehh----------------hhhhcccCceeeEEEEEeCCCeeEEEee
Q 039819 202 ENFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLKD----------------MISLAVHRNLLRLIGYCATPTERLLVYP 264 (534)
Q Consensus 202 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~----------------~l~~~~h~niv~l~~~~~~~~~~~lv~e 264 (534)
++|...+.||+|+||.||+|+.. ++..||||++.. ++..++||||+++++++...+..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 36888899999999999999986 578899998752 5678889999999999999999999999
Q ss_pred ccCCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCCce
Q 039819 265 YMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHV 344 (534)
Q Consensus 265 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~ 344 (534)
|++++.+..+......+++..++.++.|++.||.|||+. +|+||||||+||+++.++.+||+|||+++.........
T Consensus 81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 157 (287)
T cd07848 81 YVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNAN 157 (287)
T ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccCccccccccccc
Confidence 999987776655556799999999999999999999998 99999999999999999999999999998765433222
Q ss_pred eeccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHH--------HHHHhhhccccee
Q 039819 345 TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEW--------VKKIQQEKKVEVL 416 (534)
Q Consensus 345 ~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~ 416 (534)
.....||..|+|||++.+..++.++|||||||++|||++|+.||......+....+... .............
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (287)
T cd07848 158 YTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGL 237 (287)
T ss_pred ccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhccc
Confidence 33456899999999998888999999999999999999999999754322211111110 1100000000000
Q ss_pred cccccCC------CCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 417 VDRELGS------NYDRIEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 417 ~d~~l~~------~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
..+.... ......+..+.+++.+|++.+|++|||++|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 238 RFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred ccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 0000000 011113457899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-41 Score=330.21 Aligned_cols=234 Identities=27% Similarity=0.381 Sum_probs=201.1
Q ss_pred hCCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEeh---------------hhhhhcccCceeeEEEEEeCCCeeEEEeec
Q 039819 202 ENFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLK---------------DMISLAVHRNLLRLIGYCATPTERLLVYPY 265 (534)
Q Consensus 202 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~---------------~~l~~~~h~niv~l~~~~~~~~~~~lv~e~ 265 (534)
..|...+.||+|+||.||+|... .++.||+|++. .++..++++||.+.+|.+..+...+++|||
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey 92 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY 92 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence 35666789999999999999975 68899999885 268889999999999999999999999999
Q ss_pred cCCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCCcee
Q 039819 266 MSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVT 345 (534)
Q Consensus 266 ~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~ 345 (534)
|.+|++.+.++....+++....-|+.++..|+.|||.+ +.+|||||+.|||+..+|.+|++|||++..+...... .
T Consensus 93 ~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~---~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~r-r 168 (467)
T KOG0201|consen 93 CGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSE---KKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKR-R 168 (467)
T ss_pred hcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhc---ceecccccccceeEeccCcEEEEecceeeeeechhhc-c
Confidence 99999999999888888888999999999999999999 9999999999999999999999999999988765433 3
Q ss_pred eccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceecccccCCCC
Q 039819 346 TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELGSNY 425 (534)
Q Consensus 346 ~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 425 (534)
.+++||+.|||||++....|+.|+||||+||+.+||++|.+|+..-.. -++..++-+.-....
T Consensus 169 ~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hP-----------------mrvlflIpk~~PP~L 231 (467)
T KOG0201|consen 169 KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHP-----------------MRVLFLIPKSAPPRL 231 (467)
T ss_pred ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCc-----------------ceEEEeccCCCCCcc
Confidence 678899999999999988999999999999999999999999863221 112223333333333
Q ss_pred CHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 426 DRIEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 426 ~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
.......+.+++..|+..+|+.||++.++++
T Consensus 232 ~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLK 262 (467)
T KOG0201|consen 232 DGDFSPPFKEFVEACLDKNPEFRPSAKELLK 262 (467)
T ss_pred ccccCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence 3344567999999999999999999999986
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-40 Score=327.19 Aligned_cols=230 Identities=23% Similarity=0.272 Sum_probs=191.4
Q ss_pred hCCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEeh-----------------hhhhhcccCceeeEEEEEeCCCeeEEEe
Q 039819 202 ENFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLK-----------------DMISLAVHRNLLRLIGYCATPTERLLVY 263 (534)
Q Consensus 202 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~-----------------~~l~~~~h~niv~l~~~~~~~~~~~lv~ 263 (534)
++|+..+.||+|+||.||+|... +++.||+|++. +++..+.||||+++++++.+....++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 36888899999999999999975 68999999873 1567888999999999999999999999
Q ss_pred eccCCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCCc
Q 039819 264 PYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSH 343 (534)
Q Consensus 264 e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~ 343 (534)
||+++|+|.+++.....+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~--- 154 (291)
T cd05612 81 EYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR--- 154 (291)
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEEecCcchhccCC---
Confidence 9999999999998888899999999999999999999998 9999999999999999999999999999866432
Q ss_pred eeeccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceecccccCC
Q 039819 344 VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELGS 423 (534)
Q Consensus 344 ~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 423 (534)
.....||+.|+|||++.+..++.++|||||||++|||+||+.||..... .+....+.... .
T Consensus 155 -~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~-------~~~~~~i~~~~-------~---- 215 (291)
T cd05612 155 -TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNP-------FGIYEKILAGK-------L---- 215 (291)
T ss_pred -cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-------HHHHHHHHhCC-------c----
Confidence 2235689999999999888899999999999999999999999974321 11112111110 0
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCC-----hHHHHH
Q 039819 424 NYDRIEVGEILQVALLCTQYLPVHRPK-----MSEVVR 456 (534)
Q Consensus 424 ~~~~~~~~~l~~l~~~Cl~~~P~~RPt-----~~ev~~ 456 (534)
.++......+.+++.+|++.||.+||+ +.|+++
T Consensus 216 ~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 253 (291)
T cd05612 216 EFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKN 253 (291)
T ss_pred CCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhc
Confidence 111222447889999999999999995 666653
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=327.68 Aligned_cols=245 Identities=23% Similarity=0.349 Sum_probs=189.6
Q ss_pred hCCCcCCeeccCCcEEEEEEEECC-----------------CcEEEEEEehh---------------hhhhcccCceeeE
Q 039819 202 ENFSSKNILGAGGFGNVYKGKLGD-----------------GTVLAVKRLKD---------------MISLAVHRNLLRL 249 (534)
Q Consensus 202 ~~~~~~~~lG~G~~g~Vy~~~~~~-----------------~~~vavK~~~~---------------~l~~~~h~niv~l 249 (534)
++|...+.||+|+||.||+|.+.+ +..||+|.+.. ++..++||||+++
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 84 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL 84 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence 568888999999999999997632 34699998742 5677899999999
Q ss_pred EEEEeCCCeeEEEeeccCCCChhhhcccC-------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEe
Q 039819 250 IGYCATPTERLLVYPYMSNGSVASRLREK-------------------PALDWNTRKRIAIGAARGLLYLHEQCDPKIIH 310 (534)
Q Consensus 250 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~-------------------~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH 310 (534)
++++.+.+..++||||+++|+|.+++... ..++|..+.+++.|++.||.|||+. +|+|
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~ivH 161 (304)
T cd05096 85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL---NFVH 161 (304)
T ss_pred EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC---Cccc
Confidence 99999999999999999999999987532 2478899999999999999999998 9999
Q ss_pred ccCCCCcEEeCCCCcEEEEecccceecCCCCCc-eeeccccccccccccccccCCCCcchhHHHHHHHHHHHHhC--CCC
Q 039819 311 RDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITG--MRA 387 (534)
Q Consensus 311 ~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG--~~p 387 (534)
|||||+|||++.++.+||+|||+++.+...... ......++..|+|||++..+.++.++|||||||++|||+++ ..|
T Consensus 162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p 241 (304)
T cd05096 162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQP 241 (304)
T ss_pred cCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCC
Confidence 999999999999999999999999866433221 12233457899999999888899999999999999999974 455
Q ss_pred cCCCccccccchHHHHHHHHhhhcccceecccccCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhh
Q 039819 388 LEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLE 459 (534)
Q Consensus 388 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~ 459 (534)
|..... ......+........... ....+...+..+.+++.+||+.+|++||||.+|.+.|+
T Consensus 242 ~~~~~~----~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~ 303 (304)
T cd05096 242 YGELTD----EQVIENAGEFFRDQGRQV------YLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT 303 (304)
T ss_pred CCcCCH----HHHHHHHHHHhhhccccc------cccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence 543221 112222222111110000 00111223458899999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-40 Score=339.51 Aligned_cols=240 Identities=27% Similarity=0.411 Sum_probs=189.8
Q ss_pred hCCCcCCeeccCCcEEEEEEEE------CCCcEEEEEEehh---------------hhhhc-ccCceeeEEEEEeCCCee
Q 039819 202 ENFSSKNILGAGGFGNVYKGKL------GDGTVLAVKRLKD---------------MISLA-VHRNLLRLIGYCATPTER 259 (534)
Q Consensus 202 ~~~~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~---------------~l~~~-~h~niv~l~~~~~~~~~~ 259 (534)
++|+..+.||+|+||.||+|+. ..+..||||+++. ++..+ .||||++++++|......
T Consensus 35 ~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~~ 114 (375)
T cd05104 35 NRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGPT 114 (375)
T ss_pred HHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCcc
Confidence 4677889999999999999974 3456899998752 34455 799999999999999999
Q ss_pred EEEeeccCCCChhhhcccC-------------------------------------------------------------
Q 039819 260 LLVYPYMSNGSVASRLREK------------------------------------------------------------- 278 (534)
Q Consensus 260 ~lv~e~~~~gsL~~~l~~~------------------------------------------------------------- 278 (534)
++|||||++|+|.++++..
T Consensus 115 ~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (375)
T cd05104 115 LVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSY 194 (375)
T ss_pred eeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccccccee
Confidence 9999999999999888532
Q ss_pred --------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCCc-
Q 039819 279 --------------PALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSH- 343 (534)
Q Consensus 279 --------------~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~- 343 (534)
..++|..+.+++.||++||.|||+. +|+||||||+|||++.++.+||+|||+++........
T Consensus 195 ~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 271 (375)
T cd05104 195 IDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYV 271 (375)
T ss_pred cccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCchhhEEEECCCcEEEecCccceeccCccccc
Confidence 1478899999999999999999998 9999999999999999999999999999876433221
Q ss_pred eeeccccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCcCCCccccccchHHHHHHHHhhhcccceecccccC
Q 039819 344 VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELG 422 (534)
Q Consensus 344 ~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 422 (534)
......++..|+|||++.+..++.++|||||||++|||+| |..||...... .....++ .....
T Consensus 272 ~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~---~~~~~~~---~~~~~---------- 335 (375)
T cd05104 272 VKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVD---SKFYKMI---KEGYR---------- 335 (375)
T ss_pred ccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCch---HHHHHHH---HhCcc----------
Confidence 1122335678999999998899999999999999999998 88888642211 1111211 11100
Q ss_pred CCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhc
Q 039819 423 SNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLEG 460 (534)
Q Consensus 423 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~ 460 (534)
...+...+.++.+++.+|++.+|++||+|.||+++|+.
T Consensus 336 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~ 373 (375)
T cd05104 336 MLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQ 373 (375)
T ss_pred CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHh
Confidence 00111224578999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=326.16 Aligned_cols=228 Identities=23% Similarity=0.309 Sum_probs=186.5
Q ss_pred eccCCcEEEEEEEEC-CCcEEEEEEehh-----------------hhhhcccCceeeEEEEEeCCCeeEEEeeccCCCCh
Q 039819 210 LGAGGFGNVYKGKLG-DGTVLAVKRLKD-----------------MISLAVHRNLLRLIGYCATPTERLLVYPYMSNGSV 271 (534)
Q Consensus 210 lG~G~~g~Vy~~~~~-~~~~vavK~~~~-----------------~l~~~~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 271 (534)
||+|+||.||+|+.. +++.||+|.+.. ++..++||||+++++++...+..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 699999999999975 578999998742 56778899999999999999999999999999999
Q ss_pred hhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCCceeeccccc
Q 039819 272 ASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGT 351 (534)
Q Consensus 272 ~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt 351 (534)
.+++.....+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++...... .......||
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~gt 156 (312)
T cd05585 81 FHHLQREGRFDLSRARFYTAELLCALENLHKF---NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD-DKTNTFCGT 156 (312)
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHeEECCCCcEEEEECcccccCccCC-CccccccCC
Confidence 99998888899999999999999999999998 99999999999999999999999999998643222 223445799
Q ss_pred cccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceecccccCCCCCHHHHH
Q 039819 352 VGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELGSNYDRIEVG 431 (534)
Q Consensus 352 ~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~ 431 (534)
+.|+|||++.+..++.++|||||||++|||+||+.||.... ..+......... . .++.....
T Consensus 157 ~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~-------~~~~~~~~~~~~-------~----~~~~~~~~ 218 (312)
T cd05585 157 PEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDEN-------VNEMYRKILQEP-------L----RFPDGFDR 218 (312)
T ss_pred cccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCC-------HHHHHHHHHcCC-------C----CCCCcCCH
Confidence 99999999998889999999999999999999999996432 112222221110 0 11122345
Q ss_pred HHHHHHHHhcccCCCCCCChHHHHHHhh
Q 039819 432 EILQVALLCTQYLPVHRPKMSEVVRMLE 459 (534)
Q Consensus 432 ~l~~l~~~Cl~~~P~~RPt~~ev~~~L~ 459 (534)
.+.+++.+|++.+|.+||++.++.+.|.
T Consensus 219 ~~~~li~~~L~~dp~~R~~~~~~~e~l~ 246 (312)
T cd05585 219 DAKDLLIGLLSRDPTRRLGYNGAQEIKN 246 (312)
T ss_pred HHHHHHHHHcCCCHHHcCCCCCHHHHHc
Confidence 7889999999999999987655544443
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=336.98 Aligned_cols=237 Identities=20% Similarity=0.287 Sum_probs=186.5
Q ss_pred CCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEehh-----------------hhhhcccCceeeEEEEEeCCCeeEEEee
Q 039819 203 NFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLKD-----------------MISLAVHRNLLRLIGYCATPTERLLVYP 264 (534)
Q Consensus 203 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~-----------------~l~~~~h~niv~l~~~~~~~~~~~lv~e 264 (534)
.|...+.||+|+||.||+|+.. +++.||||++.. ++..++|+||+++++++.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 5778899999999999999874 678999998742 5677889999999999999999999999
Q ss_pred ccCCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCC--
Q 039819 265 YMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDS-- 342 (534)
Q Consensus 265 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~-- 342 (534)
|+++|+|.+++.....+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 82 ~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~---givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~ 158 (381)
T cd05626 82 YIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKM---GFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSK 158 (381)
T ss_pred cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCcHHHEEECCCCCEEEeeCcCCcccccccccc
Confidence 999999999998888899999999999999999999998 999999999999999999999999999764311000
Q ss_pred --------------------------------------------ceeeccccccccccccccccCCCCcchhHHHHHHHH
Q 039819 343 --------------------------------------------HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILL 378 (534)
Q Consensus 343 --------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl 378 (534)
.......||..|+|||++.+..++.++|||||||++
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~il 238 (381)
T cd05626 159 YYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVIL 238 (381)
T ss_pred cccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhHH
Confidence 001235699999999999888899999999999999
Q ss_pred HHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceecccccCCCCCHHHHHHHHHHHHH--hcccCCCCCCChHHHHH
Q 039819 379 LELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELGSNYDRIEVGEILQVALL--CTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 379 ~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~--Cl~~~P~~RPt~~ev~~ 456 (534)
|||+||+.||...........+..| .... .... ......++.+++.+ |+..+|..||++.|++.
T Consensus 239 ~elltG~~Pf~~~~~~~~~~~i~~~------~~~~------~~~~--~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~ 304 (381)
T cd05626 239 FEMLVGQPPFLAPTPTETQLKVINW------ENTL------HIPP--QVKLSPEAVDLITKLCCSAEERLGRNGADDIKA 304 (381)
T ss_pred HHHHhCCCCCcCCCHHHHHHHHHcc------cccc------CCCC--CCCCCHHHHHHHHHHccCcccccCCCCHHHHhc
Confidence 9999999999753321111011111 0000 0000 00123466677766 66677777999999986
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=321.62 Aligned_cols=239 Identities=25% Similarity=0.334 Sum_probs=191.6
Q ss_pred hCCCcCCeeccCCcEEEEEEEEC----CCcEEEEEEehh---------------hhhhcccCceeeEEEEEeCCCeeEEE
Q 039819 202 ENFSSKNILGAGGFGNVYKGKLG----DGTVLAVKRLKD---------------MISLAVHRNLLRLIGYCATPTERLLV 262 (534)
Q Consensus 202 ~~~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~---------------~l~~~~h~niv~l~~~~~~~~~~~lv 262 (534)
.+|+..+.||+|+||.||+|.+. .+..||+|.++. .+..++||||+++++++...+..++|
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 84 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIV 84 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEE
Confidence 46788899999999999999863 356899998652 56677899999999999999999999
Q ss_pred eeccCCCChhhhccc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCC
Q 039819 263 YPYMSNGSVASRLRE-KPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSD 341 (534)
Q Consensus 263 ~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~ 341 (534)
|||+++|+|.+++.. ...+++..++.++.|++.||+|||+. +++||||||+|||++.++.++++|||.+.......
T Consensus 85 ~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~~ 161 (266)
T cd05064 85 TEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEM---GYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEA 161 (266)
T ss_pred EEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeeccccHhhEEEcCCCcEEECCCcccccccccc
Confidence 999999999999875 35789999999999999999999998 99999999999999999999999999876543221
Q ss_pred CceeeccccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCcCCCccccccchHHHHHHHHhhhcccceecccc
Q 039819 342 SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRE 420 (534)
Q Consensus 342 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 420 (534)
........++..|+|||++.+..++.++|||||||++||+++ |+.||..... .+.+........
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~-------~~~~~~~~~~~~-------- 226 (266)
T cd05064 162 IYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSG-------QDVIKAVEDGFR-------- 226 (266)
T ss_pred hhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCH-------HHHHHHHHCCCC--------
Confidence 111122335678999999988999999999999999999775 9999964321 111222111100
Q ss_pred cCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhc
Q 039819 421 LGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLEG 460 (534)
Q Consensus 421 l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~ 460 (534)
...+...+..+.+++.+||+.+|.+||++.++.+.|..
T Consensus 227 --~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~ 264 (266)
T cd05064 227 --LPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSK 264 (266)
T ss_pred --CCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHh
Confidence 01122234578999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-40 Score=337.35 Aligned_cols=238 Identities=24% Similarity=0.308 Sum_probs=194.0
Q ss_pred hCCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEehh-----------------hhhhcccCceeeEEEEEeCCCeeEEEe
Q 039819 202 ENFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLKD-----------------MISLAVHRNLLRLIGYCATPTERLLVY 263 (534)
Q Consensus 202 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~-----------------~l~~~~h~niv~l~~~~~~~~~~~lv~ 263 (534)
++|...+.||+|+||.||+|+.. +++.||||++.. ++..+.|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 36888899999999999999986 689999998752 567788999999999999999999999
Q ss_pred eccCCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCC--
Q 039819 264 PYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSD-- 341 (534)
Q Consensus 264 e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~-- 341 (534)
||+++|+|.+++.....+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 81 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~---giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~ 157 (350)
T cd05573 81 EYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKL---GFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDR 157 (350)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEeecCCCCccCcccCcc
Confidence 9999999999998878899999999999999999999998 99999999999999999999999999998764332
Q ss_pred --------------------------CceeeccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCcccc
Q 039819 342 --------------------------SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSIN 395 (534)
Q Consensus 342 --------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~ 395 (534)
........||+.|+|||++.+..++.++|||||||++|||++|+.||.......
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~ 237 (350)
T cd05573 158 EYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQE 237 (350)
T ss_pred cccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHHH
Confidence 112234568999999999999899999999999999999999999997543211
Q ss_pred ccchHHHHHHHHhhhcccceecccccCCCCCHHHHHHHHHHHHHhcccCCCCCCC-hHHHHHH
Q 039819 396 QKGAMLEWVKKIQQEKKVEVLVDRELGSNYDRIEVGEILQVALLCTQYLPVHRPK-MSEVVRM 457 (534)
Q Consensus 396 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt-~~ev~~~ 457 (534)
....+... ...+ .+.. ....+..+.+++.+|+. +|.+||+ ++++++.
T Consensus 238 -------~~~~i~~~--~~~~---~~p~--~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 238 -------TYNKIINW--KESL---RFPP--DPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred -------HHHHHhcc--CCcc---cCCC--CCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 11111110 0000 0000 00134578899999997 9999999 9999863
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=328.53 Aligned_cols=230 Identities=24% Similarity=0.335 Sum_probs=191.3
Q ss_pred hCCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEehh-----------------hhhhcccCceeeEEEEEeCCCeeEEEe
Q 039819 202 ENFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLKD-----------------MISLAVHRNLLRLIGYCATPTERLLVY 263 (534)
Q Consensus 202 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~-----------------~l~~~~h~niv~l~~~~~~~~~~~lv~ 263 (534)
++|...+.||+|+||.||+|+.. +++.||||.+.. ++..++||||+++++++.+.+..++||
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 56888899999999999999985 688999998742 567788999999999999999999999
Q ss_pred eccCCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCCc
Q 039819 264 PYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSH 343 (534)
Q Consensus 264 e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~ 343 (534)
||+++|+|.+++.....+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 98 e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~--- 171 (329)
T PTZ00263 98 EFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR--- 171 (329)
T ss_pred cCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEECCCCCEEEeeccCceEcCCC---
Confidence 9999999999998888899999999999999999999998 9999999999999999999999999999876432
Q ss_pred eeeccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceecccccCC
Q 039819 344 VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELGS 423 (534)
Q Consensus 344 ~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 423 (534)
.....||+.|+|||++.+..++.++|||||||++|||+||+.||..... .+....+... .. .
T Consensus 172 -~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~-------~~~~~~i~~~-~~------~--- 233 (329)
T PTZ00263 172 -TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTP-------FRIYEKILAG-RL------K--- 233 (329)
T ss_pred -cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCH-------HHHHHHHhcC-Cc------C---
Confidence 2235699999999999988899999999999999999999999964321 1111111111 00 0
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCC-----hHHHHH
Q 039819 424 NYDRIEVGEILQVALLCTQYLPVHRPK-----MSEVVR 456 (534)
Q Consensus 424 ~~~~~~~~~l~~l~~~Cl~~~P~~RPt-----~~ev~~ 456 (534)
++......+.+++.+|++.||.+||+ +++++.
T Consensus 234 -~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 270 (329)
T PTZ00263 234 -FPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKN 270 (329)
T ss_pred -CCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 11112346889999999999999997 466554
|
|
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=335.26 Aligned_cols=251 Identities=19% Similarity=0.251 Sum_probs=193.0
Q ss_pred hCCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEeh--------hhhhhcccCceeeEEEEEeCCCeeEEEeeccCCCChh
Q 039819 202 ENFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLK--------DMISLAVHRNLLRLIGYCATPTERLLVYPYMSNGSVA 272 (534)
Q Consensus 202 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~--------~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~ 272 (534)
.+|...+.||+|+||.||+|... .++.||+|... ++++.++|||||++++++......++|+||+. ++|.
T Consensus 92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~-~~L~ 170 (391)
T PHA03212 92 AGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQRGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRYK-TDLY 170 (391)
T ss_pred CCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhhhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecCC-CCHH
Confidence 57999999999999999999874 68899999764 37889999999999999999999999999995 6898
Q ss_pred hhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCCceeecccccc
Q 039819 273 SRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTV 352 (534)
Q Consensus 273 ~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~ 352 (534)
+++.....+++..++.|+.|++.||.|||+. +||||||||+|||++.++.+||+|||+++..............||+
T Consensus 171 ~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~---~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~~~~~~~gt~ 247 (391)
T PHA03212 171 CYLAAKRNIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGWAGTI 247 (391)
T ss_pred HHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHhEEEcCCCCEEEEeCCcccccccccccccccccCcc
Confidence 8888777899999999999999999999998 9999999999999999999999999999764332222334467999
Q ss_pred ccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCcccccc----chHHHHHHHHhh---h------ccccee---
Q 039819 353 GHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQK----GAMLEWVKKIQQ---E------KKVEVL--- 416 (534)
Q Consensus 353 ~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~----~~~~~~~~~~~~---~------~~~~~~--- 416 (534)
.|+|||++.+..++.++|||||||++|||+||+.||......... ..+......... + ......
T Consensus 248 ~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~~~~~~~~~ 327 (391)
T PHA03212 248 ATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQANLDEIYIG 327 (391)
T ss_pred CCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchhHHHHHHHHH
Confidence 999999999889999999999999999999999887533211110 001000000000 0 000000
Q ss_pred ------cccccCCCC--CHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 417 ------VDRELGSNY--DRIEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 417 ------~d~~l~~~~--~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
..+...... ....+.++.+++.+|++.||.+|||++|+++
T Consensus 328 ~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~ 375 (391)
T PHA03212 328 LAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD 375 (391)
T ss_pred HHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence 000000000 0123457889999999999999999999985
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-40 Score=323.11 Aligned_cols=240 Identities=25% Similarity=0.346 Sum_probs=192.9
Q ss_pred HHHhCCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEehh----------------------------hhhhcccCceeeE
Q 039819 199 QATENFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLKD----------------------------MISLAVHRNLLRL 249 (534)
Q Consensus 199 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~----------------------------~l~~~~h~niv~l 249 (534)
...++|...+.||+|.||.|-+|... +++.||||++.+ +++++.|||||+|
T Consensus 94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~L 173 (576)
T KOG0585|consen 94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKL 173 (576)
T ss_pred eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEE
Confidence 44578999999999999999999874 789999998853 7899999999999
Q ss_pred EEEEeCC--CeeEEEeeccCCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEE
Q 039819 250 IGYCATP--TERLLVYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAI 327 (534)
Q Consensus 250 ~~~~~~~--~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~k 327 (534)
+++..++ +..|||+|||..|.+...-.....++..++++++.+++.||+|||.+ +||||||||+|+||+++|++|
T Consensus 174 iEvLDDP~s~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~Q---giiHRDIKPsNLLl~~~g~VK 250 (576)
T KOG0585|consen 174 IEVLDDPESDKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQ---GIIHRDIKPSNLLLSSDGTVK 250 (576)
T ss_pred EEeecCcccCceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEEcCCCcEE
Confidence 9999876 56899999999998765544555599999999999999999999999 999999999999999999999
Q ss_pred EEecccceecCCCCC----ceeeccccccccccccccccCC----CCcchhHHHHHHHHHHHHhCCCCcCCCccccccch
Q 039819 328 VGDFGLAKLLDHSDS----HVTTAVRGTVGHIAPEYLSTGQ----SSEKTDVFGFGILLLELITGMRALEFGKSINQKGA 399 (534)
Q Consensus 328 l~DFGla~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~----~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~ 399 (534)
|+|||.+.....+.. ......+||+.|+|||.+.++. .+.+.||||+||+||-|+.|+.||-...
T Consensus 251 IsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~------- 323 (576)
T KOG0585|consen 251 ISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDF------- 323 (576)
T ss_pred eeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccch-------
Confidence 999999987733211 1122357999999999987743 3568899999999999999999996322
Q ss_pred HHHHHHHHhhhcccceecccccCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 039819 400 MLEWVKKIQQEKKVEVLVDRELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRM 457 (534)
Q Consensus 400 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~ 457 (534)
+++....+.. ..+......+..+.+.+|+.++++.||++|.+..+|...
T Consensus 324 ~~~l~~KIvn---------~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~H 372 (576)
T KOG0585|consen 324 ELELFDKIVN---------DPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLH 372 (576)
T ss_pred HHHHHHHHhc---------CcccCCCcccccHHHHHHHHHHhhcChhheeehhhheec
Confidence 2233222221 112111122345688999999999999999999999764
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=321.07 Aligned_cols=248 Identities=23% Similarity=0.343 Sum_probs=197.5
Q ss_pred CCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEeh----------hhhhhcccCceeeEEEEEeCCC-----eeEEEeecc
Q 039819 203 NFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLK----------DMISLAVHRNLLRLIGYCATPT-----ERLLVYPYM 266 (534)
Q Consensus 203 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~----------~~l~~~~h~niv~l~~~~~~~~-----~~~lv~e~~ 266 (534)
.|...+++|+|+||.||+|.+. .+..||||+.. .+|..+.|||||+++-+|.... ...+|||||
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVleym 104 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVLEYM 104 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCcCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHHHhc
Confidence 4556789999999999999975 46899999874 3788999999999999886432 235999999
Q ss_pred CCCChhhhccc----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCC-CcEEEEecccceecCCCC
Q 039819 267 SNGSVASRLRE----KPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDF-CEAIVGDFGLAKLLDHSD 341 (534)
Q Consensus 267 ~~gsL~~~l~~----~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~-~~~kl~DFGla~~~~~~~ 341 (534)
|. +|.+.++. +..++.-.++-+..|+++||+|||+. +|+||||||.|+|+|.+ |.+||||||.|+.+..+.
T Consensus 105 P~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~---~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~e 180 (364)
T KOG0658|consen 105 PE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSH---GICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKGE 180 (364)
T ss_pred hH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhc---CcccCCCChheEEEcCCCCeEEeccCCcceeeccCC
Confidence 87 88888873 56788888999999999999999998 99999999999999976 999999999999987655
Q ss_pred CceeeccccccccccccccccC-CCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhc------ccc
Q 039819 342 SHVTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEK------KVE 414 (534)
Q Consensus 342 ~~~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~------~~~ 414 (534)
.. ..+..|+.|+|||.+.+. .|+.+.||||.|||+.||+-|++.|++.+..++...+...++....+. ...
T Consensus 181 pn--iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~~y~ 258 (364)
T KOG0658|consen 181 PN--ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNPNYT 258 (364)
T ss_pred Cc--eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCcccc
Confidence 43 334468999999998775 589999999999999999999999998777666555555544333221 111
Q ss_pred eecccccCCC-----CCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 415 VLVDRELGSN-----YDRIEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 415 ~~~d~~l~~~-----~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
+...+.+... +......+..+++.++++.+|.+|.++.|++.
T Consensus 259 ~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~ 305 (364)
T KOG0658|consen 259 EFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALA 305 (364)
T ss_pred cccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhc
Confidence 2222222211 22334568999999999999999999999985
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=331.20 Aligned_cols=232 Identities=24% Similarity=0.393 Sum_probs=202.6
Q ss_pred hCCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEehh----------------hhhhcccCceeeEEEEEeCCCeeEEEee
Q 039819 202 ENFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLKD----------------MISLAVHRNLLRLIGYCATPTERLLVYP 264 (534)
Q Consensus 202 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~----------------~l~~~~h~niv~l~~~~~~~~~~~lv~e 264 (534)
++|...+.||+|+||.||||+-+ +...||+|.+.+ ++..++|||||.++++|+...+.++|.|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 46777888999999999999865 678899997752 7888999999999999999999999999
Q ss_pred ccCCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCCce
Q 039819 265 YMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHV 344 (534)
Q Consensus 265 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~ 344 (534)
|+.+ +|+.++...+.++++.+..|+.+++.||.|||+. +|+|||+||.|||++..+.+|++|||+|+.+.. +...
T Consensus 82 ~a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~---rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~-~t~v 156 (808)
T KOG0597|consen 82 YAVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSN---RILHRDMKPQNILLEKGGTLKLCDFGLARAMST-NTSV 156 (808)
T ss_pred hhhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhc---CcccccCCcceeeecCCCceeechhhhhhhccc-Ccee
Confidence 9987 9999999999999999999999999999999999 999999999999999999999999999998875 3456
Q ss_pred eeccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceecccccCCC
Q 039819 345 TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELGSN 424 (534)
Q Consensus 345 ~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 424 (534)
.+.+.||+-|||||+..+.+|+..+|.||+|||+||+.+|++||.. ..+.+.++.+..+.. .
T Consensus 157 ltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a-------~si~~Lv~~I~~d~v-----------~ 218 (808)
T KOG0597|consen 157 LTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYA-------RSITQLVKSILKDPV-----------K 218 (808)
T ss_pred eeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchH-------HHHHHHHHHHhcCCC-----------C
Confidence 6778899999999999999999999999999999999999999962 234556655544321 1
Q ss_pred CCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 425 YDRIEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 425 ~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
++......+..++...+..||.+|.+-.+++.
T Consensus 219 ~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~ 250 (808)
T KOG0597|consen 219 PPSTASSSFVNFLQGLLIKDPAQRLTWTDLLG 250 (808)
T ss_pred CcccccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence 22234557889999999999999999988875
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-40 Score=337.94 Aligned_cols=240 Identities=29% Similarity=0.434 Sum_probs=189.1
Q ss_pred hCCCcCCeeccCCcEEEEEEEE------CCCcEEEEEEehh---------------hhhhc-ccCceeeEEEEEeCCCee
Q 039819 202 ENFSSKNILGAGGFGNVYKGKL------GDGTVLAVKRLKD---------------MISLA-VHRNLLRLIGYCATPTER 259 (534)
Q Consensus 202 ~~~~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~---------------~l~~~-~h~niv~l~~~~~~~~~~ 259 (534)
++|...+.||+|+||.||+|+. .++..||||++.. ++..+ +|+|||+++++|......
T Consensus 38 ~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~~ 117 (374)
T cd05106 38 DNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGPV 117 (374)
T ss_pred HHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCCe
Confidence 4688889999999999999874 2345799998752 44555 799999999999999999
Q ss_pred EEEeeccCCCChhhhcccC-------------------------------------------------------------
Q 039819 260 LLVYPYMSNGSVASRLREK------------------------------------------------------------- 278 (534)
Q Consensus 260 ~lv~e~~~~gsL~~~l~~~------------------------------------------------------------- 278 (534)
++||||+++|+|.+++...
T Consensus 118 ~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (374)
T cd05106 118 LVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDS 197 (374)
T ss_pred EEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccccc
Confidence 9999999999999887431
Q ss_pred ---------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCCc-eeecc
Q 039819 279 ---------PALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSH-VTTAV 348 (534)
Q Consensus 279 ---------~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~-~~~~~ 348 (534)
..+++.++++|+.|++.||.|||+. +|+||||||+|||+++++.+||+|||+++........ .....
T Consensus 198 ~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~ 274 (374)
T cd05106 198 KDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNA 274 (374)
T ss_pred cchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccCC
Confidence 2478899999999999999999998 9999999999999999999999999999865433221 11223
Q ss_pred ccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCcCCCccccccchHHHHHHHHhhhcccceecccccCCCCCH
Q 039819 349 RGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELGSNYDR 427 (534)
Q Consensus 349 ~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 427 (534)
.++..|+|||++.+..++.++|||||||++|||++ |+.||...... . .+........ ... .+.
T Consensus 275 ~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~---~---~~~~~~~~~~------~~~----~~~ 338 (374)
T cd05106 275 RLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVN---S---KFYKMVKRGY------QMS----RPD 338 (374)
T ss_pred CCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCcccccc---H---HHHHHHHccc------Ccc----CCC
Confidence 35678999999988899999999999999999997 99999742211 0 1111111100 000 111
Q ss_pred HHHHHHHHHHHHhcccCCCCCCChHHHHHHhhc
Q 039819 428 IEVGEILQVALLCTQYLPVHRPKMSEVVRMLEG 460 (534)
Q Consensus 428 ~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~ 460 (534)
..+.++.+++.+|++.+|.+||++.+|+++|+.
T Consensus 339 ~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~ 371 (374)
T cd05106 339 FAPPEIYSIMKMCWNLEPTERPTFSQISQLIQR 371 (374)
T ss_pred CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 123578999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=331.44 Aligned_cols=249 Identities=19% Similarity=0.352 Sum_probs=186.5
Q ss_pred CCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEehh----------------hhhhcccCceeeEEEEEeCCC-----eeE
Q 039819 203 NFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLKD----------------MISLAVHRNLLRLIGYCATPT-----ERL 260 (534)
Q Consensus 203 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~----------------~l~~~~h~niv~l~~~~~~~~-----~~~ 260 (534)
+|...+.||+|+||.||+|+.. ++..||||++.. ++..++||||+++++++.... ..+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 4777889999999999999975 689999998752 567788999999999886432 479
Q ss_pred EEeeccCCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCC
Q 039819 261 LVYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHS 340 (534)
Q Consensus 261 lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~ 340 (534)
+|||||. ++|.+++.....+++..+..++.|+++||.|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 81 lv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~ 156 (338)
T cd07859 81 VVFELME-SDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLARVAFND 156 (338)
T ss_pred EEEecCC-CCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEccCccccccccc
Confidence 9999995 68999998877899999999999999999999999 9999999999999999999999999999865322
Q ss_pred CC--ceeecccccccccccccccc--CCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHH--------HHHHh
Q 039819 341 DS--HVTTAVRGTVGHIAPEYLST--GQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEW--------VKKIQ 408 (534)
Q Consensus 341 ~~--~~~~~~~gt~~y~aPE~~~~--~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~--------~~~~~ 408 (534)
.. .......||..|+|||++.+ ..++.++|||||||++|||+||+.||...........+... .....
T Consensus 157 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 236 (338)
T cd07859 157 TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVR 236 (338)
T ss_pred cCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhh
Confidence 11 12234568999999999865 67899999999999999999999999754321111101000 00000
Q ss_pred hhc---ccceecccccCCCCCH---HHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 409 QEK---KVEVLVDRELGSNYDR---IEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 409 ~~~---~~~~~~d~~l~~~~~~---~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
... ....+ .+........ .....+.+++.+|++.+|++||+++|+++
T Consensus 237 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~ 289 (338)
T cd07859 237 NEKARRYLSSM-RKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALA 289 (338)
T ss_pred hhhHHHHHHhh-cccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 000 00000 0000000000 12346789999999999999999999985
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-39 Score=315.14 Aligned_cols=237 Identities=25% Similarity=0.424 Sum_probs=193.3
Q ss_pred hCCCcCCeeccCCcEEEEEEEECCCcEEEEEEeh-------------hhhhhcccCceeeEEEEEeCCCeeEEEeeccCC
Q 039819 202 ENFSSKNILGAGGFGNVYKGKLGDGTVLAVKRLK-------------DMISLAVHRNLLRLIGYCATPTERLLVYPYMSN 268 (534)
Q Consensus 202 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~-------------~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~~~ 268 (534)
++|...+.||+|+||.||++.+.++..+|+|.+. +++..++||||+++++++......++||||+++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~ 83 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMEN 83 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCCccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCCC
Confidence 4577788999999999999999888899999764 267888999999999999999999999999999
Q ss_pred CChhhhccc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCCceeec
Q 039819 269 GSVASRLRE-KPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTA 347 (534)
Q Consensus 269 gsL~~~l~~-~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~ 347 (534)
|+|.++++. ...+++..++.++.+++.||.|||+. +|+||||||+||+++.++.+||+|||+++............
T Consensus 84 ~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~~~~ 160 (256)
T cd05114 84 GCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERN---SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSG 160 (256)
T ss_pred CcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcceEEEcCCCeEEECCCCCccccCCCceeccCC
Confidence 999999874 34689999999999999999999998 99999999999999999999999999998654332222223
Q ss_pred cccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCcCCCccccccchHHHHHHHHhhhcccceecccccCCCCC
Q 039819 348 VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELGSNYD 426 (534)
Q Consensus 348 ~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 426 (534)
..++..|+|||++.+..++.++||||||+++|||++ |+.||..... .+.+......... . .+
T Consensus 161 ~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~-------~~~~~~i~~~~~~---~-------~~ 223 (256)
T cd05114 161 AKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSN-------YEVVEMISRGFRL---Y-------RP 223 (256)
T ss_pred CCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCH-------HHHHHHHHCCCCC---C-------CC
Confidence 345678999999988889999999999999999999 8999864321 1122222211110 0 11
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCChHHHHHHh
Q 039819 427 RIEVGEILQVALLCTQYLPVHRPKMSEVVRML 458 (534)
Q Consensus 427 ~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L 458 (534)
...+..+.+++.+||+.+|.+||+|.++++.|
T Consensus 224 ~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 224 KLASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred CCCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 11234789999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-40 Score=357.34 Aligned_cols=237 Identities=30% Similarity=0.482 Sum_probs=193.5
Q ss_pred CCcCCeeccCCcEEEEEEEECC--Cc----EEEEEEehh---------------hhhhcccCceeeEEEEEeCCCeeEEE
Q 039819 204 FSSKNILGAGGFGNVYKGKLGD--GT----VLAVKRLKD---------------MISLAVHRNLLRLIGYCATPTERLLV 262 (534)
Q Consensus 204 ~~~~~~lG~G~~g~Vy~~~~~~--~~----~vavK~~~~---------------~l~~~~h~niv~l~~~~~~~~~~~lv 262 (534)
....+.||+|+||.||.|...+ +. .||||.+++ +|+...|||||+++|+|.+....+++
T Consensus 694 v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~i~ 773 (1025)
T KOG1095|consen 694 VTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPLIL 773 (1025)
T ss_pred eEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcEEE
Confidence 3456789999999999998743 33 489998864 68899999999999999999999999
Q ss_pred eeccCCCChhhhcccC-------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccce
Q 039819 263 YPYMSNGSVASRLREK-------PALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAK 335 (534)
Q Consensus 263 ~e~~~~gsL~~~l~~~-------~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~ 335 (534)
+|||++|+|..+|++. ..++....+.++.|||+|+.||+++ ++|||||..+|+||+....+||+|||+|+
T Consensus 774 leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~---~fvHRDLAaRNCLL~~~r~VKIaDFGlAr 850 (1025)
T KOG1095|consen 774 LEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESK---HFVHRDLAARNCLLDERRVVKIADFGLAR 850 (1025)
T ss_pred ehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhC---CCcCcchhhhheeecccCcEEEcccchhH
Confidence 9999999999999854 3588999999999999999999999 99999999999999999999999999999
Q ss_pred ecCCCCCceeecc-ccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCcCCCccccccchHHHHHHHHhhhccc
Q 039819 336 LLDHSDSHVTTAV-RGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GMRALEFGKSINQKGAMLEWVKKIQQEKKV 413 (534)
Q Consensus 336 ~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 413 (534)
.....+....... .-...|||||.+..+.++.|+|||||||++||++| |..||+..... .++. .....+
T Consensus 851 Diy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~----~v~~---~~~~gg-- 921 (1025)
T KOG1095|consen 851 DIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNF----EVLL---DVLEGG-- 921 (1025)
T ss_pred hhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchH----HHHH---HHHhCC--
Confidence 5543332222111 22468999999999999999999999999999998 88888643221 1111 111111
Q ss_pred ceecccccCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhc
Q 039819 414 EVLVDRELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLEG 460 (534)
Q Consensus 414 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~ 460 (534)
+-+.+..+++.+.+++..||+.+|++||++..+++.+..
T Consensus 922 --------RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~ 960 (1025)
T KOG1095|consen 922 --------RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPA 960 (1025)
T ss_pred --------ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhh
Confidence 123455677899999999999999999999999996654
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=328.47 Aligned_cols=227 Identities=23% Similarity=0.283 Sum_probs=187.3
Q ss_pred CeeccCCcEEEEEEEEC-CCcEEEEEEehh-----------------hhhhcccCceeeEEEEEeCCCeeEEEeeccCCC
Q 039819 208 NILGAGGFGNVYKGKLG-DGTVLAVKRLKD-----------------MISLAVHRNLLRLIGYCATPTERLLVYPYMSNG 269 (534)
Q Consensus 208 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~-----------------~l~~~~h~niv~l~~~~~~~~~~~lv~e~~~~g 269 (534)
+.||+|+||.||+++.. +++.||||++.. ++..++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999874 689999998752 567788999999999999999999999999999
Q ss_pred ChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCCceeeccc
Q 039819 270 SVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVR 349 (534)
Q Consensus 270 sL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 349 (534)
+|.+++.....+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++...... .......
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~-~~~~~~~ 156 (323)
T cd05571 81 ELFFHLSRERVFSEDRARFYGAEIVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG-ATMKTFC 156 (323)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCC-Cccccee
Confidence 9999998888899999999999999999999998 99999999999999999999999999997542221 1233456
Q ss_pred cccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceecccccCCCCCHHH
Q 039819 350 GTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELGSNYDRIE 429 (534)
Q Consensus 350 gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 429 (534)
||+.|+|||++.+..++.++|||||||++|||+||+.||..... .......... +.. ++...
T Consensus 157 gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~-------~~~~~~~~~~-------~~~----~p~~~ 218 (323)
T cd05571 157 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-------EKLFELILME-------EIR----FPRTL 218 (323)
T ss_pred cCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCH-------HHHHHHHHcC-------CCC----CCCCC
Confidence 99999999999988999999999999999999999999964321 1111111111 011 12223
Q ss_pred HHHHHHHHHHhcccCCCCCC-----ChHHHHH
Q 039819 430 VGEILQVALLCTQYLPVHRP-----KMSEVVR 456 (534)
Q Consensus 430 ~~~l~~l~~~Cl~~~P~~RP-----t~~ev~~ 456 (534)
...+.+++.+|++.||++|| ++.++++
T Consensus 219 ~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 250 (323)
T cd05571 219 SPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME 250 (323)
T ss_pred CHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence 45788999999999999999 7888765
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=322.40 Aligned_cols=250 Identities=21% Similarity=0.297 Sum_probs=189.1
Q ss_pred hCCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEeh---------------hhhhhcccCceeeEEEEEeCCCeeEEEeec
Q 039819 202 ENFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLK---------------DMISLAVHRNLLRLIGYCATPTERLLVYPY 265 (534)
Q Consensus 202 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~---------------~~l~~~~h~niv~l~~~~~~~~~~~lv~e~ 265 (534)
++|...+.||+|+||.||+|... ++..||+|.+. .++..++||||+++++++......++||||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 56888899999999999999875 68899999774 267788999999999999999999999999
Q ss_pred cCCCChhhhcccC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCCce
Q 039819 266 MSNGSVASRLREK-PALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHV 344 (534)
Q Consensus 266 ~~~gsL~~~l~~~-~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~ 344 (534)
+++ +|.+++... ..+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++....... .
T Consensus 85 ~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~-~ 159 (288)
T cd07871 85 LDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK-T 159 (288)
T ss_pred CCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEECcCcceeeccCCCc-c
Confidence 975 898888643 4589999999999999999999998 999999999999999999999999999986543221 1
Q ss_pred eecccccccccccccccc-CCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhc--------ccce
Q 039819 345 TTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEK--------KVEV 415 (534)
Q Consensus 345 ~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~--------~~~~ 415 (534)
.....|+..|+|||++.+ ..++.++||||+||++|||+||+.||...........+........... ....
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (288)
T cd07871 160 YSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRS 239 (288)
T ss_pred ccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhhc
Confidence 233457999999998865 5689999999999999999999999975432221111111110000000 0000
Q ss_pred ecccccCCCC----CHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 416 LVDRELGSNY----DRIEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 416 ~~d~~l~~~~----~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
...+...... ......++.+++.+|++.+|.+|||++|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 240 YLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred cccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 0011100000 0012346789999999999999999999974
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=332.60 Aligned_cols=187 Identities=24% Similarity=0.365 Sum_probs=165.7
Q ss_pred hCCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEehh-----------------hhhhcccCceeeEEEEEeCCCeeEEEe
Q 039819 202 ENFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLKD-----------------MISLAVHRNLLRLIGYCATPTERLLVY 263 (534)
Q Consensus 202 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~-----------------~l~~~~h~niv~l~~~~~~~~~~~lv~ 263 (534)
++|+..+.||+|+||.||+|+.. +++.||||++.+ ++..+.|+||+++++.+.+....++||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 46888999999999999999875 588999998742 466778999999999999999999999
Q ss_pred eccCCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCC-
Q 039819 264 PYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDS- 342 (534)
Q Consensus 264 e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~- 342 (534)
||+++|+|.+++.....+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.+.....
T Consensus 81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~---givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~ 157 (363)
T cd05628 81 EFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQL---GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRT 157 (363)
T ss_pred cCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCCEEEeeccCcccccccccc
Confidence 9999999999998888899999999999999999999998 999999999999999999999999999875432110
Q ss_pred ---------------------------------ceeeccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcC
Q 039819 343 ---------------------------------HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALE 389 (534)
Q Consensus 343 ---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~ 389 (534)
......+||+.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~ 237 (363)
T cd05628 158 EFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFC 237 (363)
T ss_pred cccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCC
Confidence 01123579999999999998899999999999999999999999997
Q ss_pred CC
Q 039819 390 FG 391 (534)
Q Consensus 390 ~~ 391 (534)
..
T Consensus 238 ~~ 239 (363)
T cd05628 238 SE 239 (363)
T ss_pred CC
Confidence 43
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=323.13 Aligned_cols=249 Identities=22% Similarity=0.360 Sum_probs=186.8
Q ss_pred hCCCcCCeeccCCcEEEEEEEEC--CCcEEEEEEehh----------------h---hhhcccCceeeEEEEEeC-----
Q 039819 202 ENFSSKNILGAGGFGNVYKGKLG--DGTVLAVKRLKD----------------M---ISLAVHRNLLRLIGYCAT----- 255 (534)
Q Consensus 202 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~~vavK~~~~----------------~---l~~~~h~niv~l~~~~~~----- 255 (534)
++|...+.||+|+||.||+|+.. +++.||||++.. . +..+.||||++++++|..
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 36888899999999999999873 468899998751 1 233469999999999852
Q ss_pred CCeeEEEeeccCCCChhhhccc--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEeccc
Q 039819 256 PTERLLVYPYMSNGSVASRLRE--KPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGL 333 (534)
Q Consensus 256 ~~~~~lv~e~~~~gsL~~~l~~--~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGl 333 (534)
....++||||++ ++|.+++.. ...+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~---~iiH~dlkp~Nil~~~~~~~kl~Dfg~ 156 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGL 156 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEcCCCCEEEccccc
Confidence 345799999996 589888864 34589999999999999999999998 999999999999999999999999999
Q ss_pred ceecCCCCCceeeccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhccc
Q 039819 334 AKLLDHSDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKV 413 (534)
Q Consensus 334 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 413 (534)
++..... .......||..|+|||++.+..++.++|||||||++|||++|++||......+....+.+...........
T Consensus 157 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~ 234 (290)
T cd07862 157 ARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP 234 (290)
T ss_pred eEeccCC--cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhch
Confidence 9876433 22334568999999999988889999999999999999999999998654332222222211100000000
Q ss_pred c------eecccccCCC---CCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 414 E------VLVDRELGSN---YDRIEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 414 ~------~~~d~~l~~~---~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
. ..+....... ........+.+++.+|++.+|++|||+.|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 235 RDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred hhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 0 0000000000 00112346789999999999999999999984
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=316.90 Aligned_cols=239 Identities=26% Similarity=0.408 Sum_probs=195.6
Q ss_pred hCCCcCCeeccCCcEEEEEEEECCCcEEEEEEeh-------------hhhhhcccCceeeEEEEEeCCCeeEEEeeccCC
Q 039819 202 ENFSSKNILGAGGFGNVYKGKLGDGTVLAVKRLK-------------DMISLAVHRNLLRLIGYCATPTERLLVYPYMSN 268 (534)
Q Consensus 202 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~-------------~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~~~ 268 (534)
++|+..+.||+|+||.||+|...++..||+|.+. .++..++|+||+++++++......++||||+++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 85 (261)
T cd05072 6 ESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMAK 85 (261)
T ss_pred HHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCchhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCCC
Confidence 5688889999999999999998888899999765 266788899999999999999999999999999
Q ss_pred CChhhhccc--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCCceee
Q 039819 269 GSVASRLRE--KPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTT 346 (534)
Q Consensus 269 gsL~~~l~~--~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~ 346 (534)
|+|.++++. ...+++..++.++.|++.||+|||+. +++||||||+||+++.++.++|+|||++............
T Consensus 86 ~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~ 162 (261)
T cd05072 86 GSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERK---NYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTARE 162 (261)
T ss_pred CcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEecCCCcEEECCCccceecCCCceeccC
Confidence 999999864 35689999999999999999999998 9999999999999999999999999999876543222222
Q ss_pred ccccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCcCCCccccccchHHHHHHHHhhhcccceecccccCCCC
Q 039819 347 AVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELGSNY 425 (534)
Q Consensus 347 ~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 425 (534)
...++..|+|||++....++.++|||||||++|||+| |+.||...... ....+ ...... ...
T Consensus 163 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~----~~~~~---~~~~~~------~~~---- 225 (261)
T cd05072 163 GAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNS----DVMSA---LQRGYR------MPR---- 225 (261)
T ss_pred CCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHH----HHHHH---HHcCCC------CCC----
Confidence 3345678999999988889999999999999999999 99998642211 11111 111100 001
Q ss_pred CHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhc
Q 039819 426 DRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLEG 460 (534)
Q Consensus 426 ~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~ 460 (534)
....+..+.+++.+|+..+|++||++.++.+.|+.
T Consensus 226 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 226 MENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred CCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 11123578899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=329.95 Aligned_cols=237 Identities=24% Similarity=0.338 Sum_probs=188.8
Q ss_pred CCCcCCeeccCCcEEEEEEEE----CCCcEEEEEEehh------------------hhhhc-ccCceeeEEEEEeCCCee
Q 039819 203 NFSSKNILGAGGFGNVYKGKL----GDGTVLAVKRLKD------------------MISLA-VHRNLLRLIGYCATPTER 259 (534)
Q Consensus 203 ~~~~~~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~------------------~l~~~-~h~niv~l~~~~~~~~~~ 259 (534)
+|+..+.||+|+||.||+++. .+++.||+|.+.+ ++..+ .|+||+++++++......
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 477889999999999999975 3578999998742 34455 499999999999999999
Q ss_pred EEEeeccCCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCC
Q 039819 260 LLVYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDH 339 (534)
Q Consensus 260 ~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~ 339 (534)
++||||+++|+|.+++.....+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 81 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~ 157 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKL---GIVYRDIKLENILLDSEGHVVLTDFGLSKEFLS 157 (332)
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHeEECCCCCEEEeeCcCCccccc
Confidence 99999999999999998888899999999999999999999998 999999999999999999999999999986543
Q ss_pred CCCceeeccccccccccccccccC-CCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceecc
Q 039819 340 SDSHVTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVD 418 (534)
Q Consensus 340 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 418 (534)
..........||..|+|||++.+. .++.++|||||||++|||+||+.||......... ......... .+
T Consensus 158 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~---~~~~~~~~~-------~~ 227 (332)
T cd05614 158 EEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQ---SEVSRRILK-------CD 227 (332)
T ss_pred cCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCH---HHHHHHHhc-------CC
Confidence 333233446799999999998765 4788999999999999999999999643221111 111111111 01
Q ss_pred cccCCCCCHHHHHHHHHHHHHhcccCCCCCC-----ChHHHHH
Q 039819 419 RELGSNYDRIEVGEILQVALLCTQYLPVHRP-----KMSEVVR 456 (534)
Q Consensus 419 ~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RP-----t~~ev~~ 456 (534)
+.+ +......+.+++.+|++.+|++|| +++++++
T Consensus 228 ~~~----~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 266 (332)
T cd05614 228 PPF----PSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE 266 (332)
T ss_pred CCC----CCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence 111 122344788999999999999999 5556654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-39 Score=328.30 Aligned_cols=231 Identities=23% Similarity=0.273 Sum_probs=190.8
Q ss_pred HhCCCcCCeeccCCcEEEEEEEECC--CcEEEEEEeh-----------------hhhhhcccCceeeEEEEEeCCCeeEE
Q 039819 201 TENFSSKNILGAGGFGNVYKGKLGD--GTVLAVKRLK-----------------DMISLAVHRNLLRLIGYCATPTERLL 261 (534)
Q Consensus 201 ~~~~~~~~~lG~G~~g~Vy~~~~~~--~~~vavK~~~-----------------~~l~~~~h~niv~l~~~~~~~~~~~l 261 (534)
.++|...+.||+|+||.||+|+... +..||+|++. .++..++||||+++++++.+....++
T Consensus 29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 108 (340)
T PTZ00426 29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL 108 (340)
T ss_pred hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence 3568888999999999999998643 3689999874 25677889999999999999999999
Q ss_pred EeeccCCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCC
Q 039819 262 VYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSD 341 (534)
Q Consensus 262 v~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~ 341 (534)
||||+++|+|.+++.....+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 109 v~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~- 184 (340)
T PTZ00426 109 VLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSL---NIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR- 184 (340)
T ss_pred EEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEecCCCCeecCCC-
Confidence 999999999999998888899999999999999999999999 9999999999999999999999999999876432
Q ss_pred CceeeccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceeccccc
Q 039819 342 SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDREL 421 (534)
Q Consensus 342 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 421 (534)
.....||+.|+|||++.+..++.++|||||||++|||+||+.||...... .....+... . ..
T Consensus 185 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~-------~~~~~i~~~-~------~~- 246 (340)
T PTZ00426 185 ---TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPL-------LIYQKILEG-I------IY- 246 (340)
T ss_pred ---cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHH-------HHHHHHhcC-C------CC-
Confidence 23456999999999998888999999999999999999999999743211 111111111 0 00
Q ss_pred CCCCCHHHHHHHHHHHHHhcccCCCCCC-----ChHHHHH
Q 039819 422 GSNYDRIEVGEILQVALLCTQYLPVHRP-----KMSEVVR 456 (534)
Q Consensus 422 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RP-----t~~ev~~ 456 (534)
++......+.+++.+|++.+|++|+ +++++++
T Consensus 247 ---~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~ 283 (340)
T PTZ00426 247 ---FPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKE 283 (340)
T ss_pred ---CCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHc
Confidence 1112234678999999999999995 7887765
|
|
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-39 Score=315.26 Aligned_cols=240 Identities=29% Similarity=0.387 Sum_probs=195.2
Q ss_pred HhCCCcCCeeccCCcEEEEEEEECCCcEEEEEEehh-------------hhhhcccCceeeEEEEEeCCCeeEEEeeccC
Q 039819 201 TENFSSKNILGAGGFGNVYKGKLGDGTVLAVKRLKD-------------MISLAVHRNLLRLIGYCATPTERLLVYPYMS 267 (534)
Q Consensus 201 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~-------------~l~~~~h~niv~l~~~~~~~~~~~lv~e~~~ 267 (534)
.++|+..+.||+|+||.||+|...+++.||+|.++. .+..++|+||+++++++...+..++||||++
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 84 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELMK 84 (261)
T ss_pred hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCcccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeeccc
Confidence 356888899999999999999988888899998752 5678889999999999999999999999999
Q ss_pred CCChhhhcccC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCCcee
Q 039819 268 NGSVASRLREK--PALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVT 345 (534)
Q Consensus 268 ~gsL~~~l~~~--~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~ 345 (534)
+++|.+++... ..+++..+..++.+++.||.|||+. +|+||||||+||+++.++.+||+|||+++..........
T Consensus 85 ~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~ 161 (261)
T cd05068 85 YGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQ---NYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAR 161 (261)
T ss_pred CCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCcceEEEcCCCCEEECCcceEEEccCCccccc
Confidence 99999999754 3689999999999999999999998 999999999999999999999999999987753322111
Q ss_pred eccccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCcCCCccccccchHHHHHHHHhhhcccceecccccCCC
Q 039819 346 TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELGSN 424 (534)
Q Consensus 346 ~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 424 (534)
.....+..|+|||++.+..++.++||||||+++|||+| |+.||..... .... ....... ...
T Consensus 162 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~----~~~~---~~~~~~~----------~~~ 224 (261)
T cd05068 162 EGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTN----AEVL---QQVDQGY----------RMP 224 (261)
T ss_pred CCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCH----HHHH---HHHHcCC----------CCC
Confidence 22223458999999988889999999999999999999 9999863221 0111 1111110 001
Q ss_pred CCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhc
Q 039819 425 YDRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLEG 460 (534)
Q Consensus 425 ~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~ 460 (534)
.+...+..+.+++.+|++.+|.+||++.++++.|+.
T Consensus 225 ~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 225 CPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred CCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 112234588999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=333.30 Aligned_cols=237 Identities=22% Similarity=0.306 Sum_probs=189.4
Q ss_pred hCCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEehh-----------------hhhhcccCceeeEEEEEeCCCeeEEEe
Q 039819 202 ENFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLKD-----------------MISLAVHRNLLRLIGYCATPTERLLVY 263 (534)
Q Consensus 202 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~-----------------~l~~~~h~niv~l~~~~~~~~~~~lv~ 263 (534)
++|+..+.||+|+||.||+|+.. +++.||||++.. ++..++||||+++++++.+....++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 36888999999999999999975 689999998852 566778999999999999999999999
Q ss_pred eccCCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCCc
Q 039819 264 PYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSH 343 (534)
Q Consensus 264 e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~ 343 (534)
||+++|+|.+++.....+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.+......
T Consensus 81 E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~ 157 (364)
T cd05599 81 EYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKL---GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRT 157 (364)
T ss_pred CCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEeecccceeccccccc
Confidence 9999999999998888899999999999999999999999 9999999999999999999999999999765321100
Q ss_pred -------------------------------------eeeccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCC
Q 039819 344 -------------------------------------VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMR 386 (534)
Q Consensus 344 -------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~ 386 (534)
.....+||+.|+|||++.+..++.++|||||||++|||++|+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~ 237 (364)
T cd05599 158 EFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYP 237 (364)
T ss_pred cccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCC
Confidence 0112469999999999988889999999999999999999999
Q ss_pred CcCCCccccccchHHHHHHHHhhhcccceecccccCCCCCHHHHHHHHHHHHHhcccCCCCCCC---hHHHHH
Q 039819 387 ALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELGSNYDRIEVGEILQVALLCTQYLPVHRPK---MSEVVR 456 (534)
Q Consensus 387 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt---~~ev~~ 456 (534)
||...... +.......... .+ .... .......+.+++.+|+. +|.+|++ +.|+++
T Consensus 238 Pf~~~~~~-------~~~~~i~~~~~--~~---~~~~--~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~ 295 (364)
T cd05599 238 PFCSDNPQ-------ETYRKIINWKE--TL---QFPD--EVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKS 295 (364)
T ss_pred CCCCCCHH-------HHHHHHHcCCC--cc---CCCC--CCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhc
Confidence 99743321 11111111000 00 0000 01123467788888986 8999998 777765
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=329.90 Aligned_cols=237 Identities=22% Similarity=0.278 Sum_probs=191.3
Q ss_pred hCCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEehh-----------------hhhhcccCceeeEEEEEeCCCeeEEEe
Q 039819 202 ENFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLKD-----------------MISLAVHRNLLRLIGYCATPTERLLVY 263 (534)
Q Consensus 202 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~-----------------~l~~~~h~niv~l~~~~~~~~~~~lv~ 263 (534)
++|...+.||+|+||.||+++.. +++.||||+++. ++....|+||+++++++.+....++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 36888899999999999999875 688999998752 456778999999999999999999999
Q ss_pred eccCCCChhhhcccC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCC
Q 039819 264 PYMSNGSVASRLREK-PALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDS 342 (534)
Q Consensus 264 e~~~~gsL~~~l~~~-~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~ 342 (534)
||+++|+|.+++... ..+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++........
T Consensus 81 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~ 157 (330)
T cd05601 81 EYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQM---GYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKM 157 (330)
T ss_pred CCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEcccCchHheEECCCCCEEeccCCCCeECCCCCc
Confidence 999999999999765 6799999999999999999999999 999999999999999999999999999987754433
Q ss_pred ceeeccccccccccccccc------cCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhccccee
Q 039819 343 HVTTAVRGTVGHIAPEYLS------TGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVL 416 (534)
Q Consensus 343 ~~~~~~~gt~~y~aPE~~~------~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 416 (534)
.......||+.|+|||++. ...++.++|||||||++|||++|+.||...... .....+........
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~-------~~~~~i~~~~~~~~- 229 (330)
T cd05601 158 VNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSA-------KTYNNIMNFQRFLK- 229 (330)
T ss_pred eeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHH-------HHHHHHHcCCCccC-
Confidence 3334456899999999986 456789999999999999999999999743321 11111111110000
Q ss_pred cccccCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 417 VDRELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 417 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
.. ........+.+++..|++ +|.+||++.+++.
T Consensus 230 ----~~--~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~ 262 (330)
T cd05601 230 ----FP--EDPKVSSDFLDLIQSLLC-GQKERLGYEGLCC 262 (330)
T ss_pred ----CC--CCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence 00 011123578889999998 9999999999874
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=335.19 Aligned_cols=230 Identities=27% Similarity=0.373 Sum_probs=191.5
Q ss_pred HHHhCCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEehh-----------------hhhhc-ccCceeeEEEEEeCCCee
Q 039819 199 QATENFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLKD-----------------MISLA-VHRNLLRLIGYCATPTER 259 (534)
Q Consensus 199 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~-----------------~l~~~-~h~niv~l~~~~~~~~~~ 259 (534)
...++|...++||+|.||+|+++..+ +++.+|||.+++ ++... +||.+++++..|+..++.
T Consensus 365 ~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l 444 (694)
T KOG0694|consen 365 LTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHL 444 (694)
T ss_pred ccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeE
Confidence 34578999999999999999999985 678999999874 22222 599999999999999999
Q ss_pred EEEeeccCCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCC
Q 039819 260 LLVYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDH 339 (534)
Q Consensus 260 ~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~ 339 (534)
|+||||+.||++. ++...+.+++..+.-++..|+.||.|||++ +|||||||.+|||||.+|++||+|||+++..-.
T Consensus 445 ~fvmey~~Ggdm~-~~~~~~~F~e~rarfyaAev~l~L~fLH~~---~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~ 520 (694)
T KOG0694|consen 445 FFVMEYVAGGDLM-HHIHTDVFSEPRARFYAAEVVLGLQFLHEN---GIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMG 520 (694)
T ss_pred EEEEEecCCCcEE-EEEecccccHHHHHHHHHHHHHHHHHHHhc---CceeeecchhheEEcccCcEEecccccccccCC
Confidence 9999999999943 333456799999999999999999999999 999999999999999999999999999996421
Q ss_pred CCCceeeccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceeccc
Q 039819 340 SDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDR 419 (534)
Q Consensus 340 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 419 (534)
....+.+++||+.|||||++.+..|+..+|.|||||+||||+.|..||++.++.+ ....+..+ |
T Consensus 521 -~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee-------~FdsI~~d-------~- 584 (694)
T KOG0694|consen 521 -QGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEE-------VFDSIVND-------E- 584 (694)
T ss_pred -CCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHH-------HHHHHhcC-------C-
Confidence 2235778999999999999999999999999999999999999999998654321 11111111 0
Q ss_pred ccCCCCCHHHHHHHHHHHHHhcccCCCCCCCh
Q 039819 420 ELGSNYDRIEVGEILQVALLCTQYLPVHRPKM 451 (534)
Q Consensus 420 ~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~ 451 (534)
..++.-.+.+...|+.+.+..+|++|-.+
T Consensus 585 ---~~yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 585 ---VRYPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred ---CCCCCcccHHHHHHHHHHhccCcccccCC
Confidence 12344456688999999999999999988
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-39 Score=325.60 Aligned_cols=247 Identities=22% Similarity=0.329 Sum_probs=193.9
Q ss_pred hCCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEeh---------------hhhhhcccCceeeEEEEEeCCCeeEEEeec
Q 039819 202 ENFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLK---------------DMISLAVHRNLLRLIGYCATPTERLLVYPY 265 (534)
Q Consensus 202 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~---------------~~l~~~~h~niv~l~~~~~~~~~~~lv~e~ 265 (534)
++|+..+.||+|+||.||+++.. ++..||+|.+. +++..++||||+++++++...+..++||||
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 84 (331)
T cd06649 5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH 84 (331)
T ss_pred ccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEeec
Confidence 67888999999999999999976 67889999764 257788999999999999999999999999
Q ss_pred cCCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCCcee
Q 039819 266 MSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVT 345 (534)
Q Consensus 266 ~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~ 345 (534)
+++|+|.+++.....+++..+..++.|++.||.|||+.. +|+||||||+|||++.++.+||+|||++...... ..
T Consensus 85 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~---~~ 159 (331)
T cd06649 85 MDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---MA 159 (331)
T ss_pred CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCccccccccc---cc
Confidence 999999999988778999999999999999999999852 6999999999999999999999999999865432 12
Q ss_pred eccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcc-------------
Q 039819 346 TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKK------------- 412 (534)
Q Consensus 346 ~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~------------- 412 (534)
....||..|+|||++.+..++.++|||||||++|||+||+.||....... +............
T Consensus 160 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (331)
T cd06649 160 NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKE----LEAIFGRPVVDGEEGEPHSISPRPRP 235 (331)
T ss_pred ccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHH----HHHHhcccccccccCCccccCccccc
Confidence 34568999999999998889999999999999999999999996432110 1111000000000
Q ss_pred ---------------------cceecccccCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 039819 413 ---------------------VEVLVDRELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRM 457 (534)
Q Consensus 413 ---------------------~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~ 457 (534)
...++..............++.+++.+||+.+|++|||+.|+++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h 301 (331)
T cd06649 236 PGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNH 301 (331)
T ss_pred ccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 000000000000011234578999999999999999999999863
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=334.75 Aligned_cols=186 Identities=23% Similarity=0.326 Sum_probs=163.1
Q ss_pred CCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEehh-----------------hhhhcccCceeeEEEEEeCCCeeEEEee
Q 039819 203 NFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLKD-----------------MISLAVHRNLLRLIGYCATPTERLLVYP 264 (534)
Q Consensus 203 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~-----------------~l~~~~h~niv~l~~~~~~~~~~~lv~e 264 (534)
.|...+.||+|+||.||+|+.. +++.||||.+.. ++..+.|+|||++++.+.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 5778899999999999999874 678999998742 5677889999999999999999999999
Q ss_pred ccCCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCC---
Q 039819 265 YMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSD--- 341 (534)
Q Consensus 265 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~--- 341 (534)
||++|+|.+++.....+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++.......
T Consensus 82 ~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~---~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~ 158 (382)
T cd05625 82 YIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSK 158 (382)
T ss_pred CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEeECCCCcccccccccc
Confidence 999999999998877899999999999999999999998 99999999999999999999999999975321000
Q ss_pred -------------------------------------------CceeeccccccccccccccccCCCCcchhHHHHHHHH
Q 039819 342 -------------------------------------------SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILL 378 (534)
Q Consensus 342 -------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl 378 (534)
.......+||+.|+|||++.+..++.++|||||||++
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvil 238 (382)
T cd05625 159 YYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVIL 238 (382)
T ss_pred ccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHHH
Confidence 0001234699999999999988999999999999999
Q ss_pred HHHHhCCCCcCCC
Q 039819 379 LELITGMRALEFG 391 (534)
Q Consensus 379 ~elltG~~p~~~~ 391 (534)
|||+||+.||...
T Consensus 239 ~elltG~~Pf~~~ 251 (382)
T cd05625 239 YEMLVGQPPFLAQ 251 (382)
T ss_pred HHHHhCCCCCCCC
Confidence 9999999999754
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-40 Score=297.41 Aligned_cols=232 Identities=26% Similarity=0.395 Sum_probs=197.0
Q ss_pred HhCCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEehh-----------------hhhhcccCceeeEEEEEeCCCeeEEE
Q 039819 201 TENFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLKD-----------------MISLAVHRNLLRLIGYCATPTERLLV 262 (534)
Q Consensus 201 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~-----------------~l~~~~h~niv~l~~~~~~~~~~~lv 262 (534)
.++|+..+.||+|.||.||.|+.+ ++-.||+|++.+ +-+.++||||++++++|.+....||+
T Consensus 21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi 100 (281)
T KOG0580|consen 21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI 100 (281)
T ss_pred hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence 467889999999999999999975 678899998863 56788899999999999999999999
Q ss_pred eeccCCCChhhhcc--cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCC
Q 039819 263 YPYMSNGSVASRLR--EKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHS 340 (534)
Q Consensus 263 ~e~~~~gsL~~~l~--~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~ 340 (534)
+||.++|+++..|+ ....+++.....++.|+|.|+.|+|.. +||||||||+|+|++..+..||+|||.+...+.
T Consensus 101 lEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k---~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p~- 176 (281)
T KOG0580|consen 101 LEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPS- 176 (281)
T ss_pred EEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccC---CcccCCCCHHHhccCCCCCeeccCCCceeecCC-
Confidence 99999999999998 456799999999999999999999998 999999999999999999999999999986542
Q ss_pred CCceeeccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceecccc
Q 039819 341 DSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRE 420 (534)
Q Consensus 341 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 420 (534)
....+.+||..|.+||+..+...+.++|+|++||+.||++.|.+||+..... +..+.+..- ++.
T Consensus 177 --~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~-------etYkrI~k~----~~~--- 240 (281)
T KOG0580|consen 177 --NKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHS-------ETYKRIRKV----DLK--- 240 (281)
T ss_pred --CCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhH-------HHHHHHHHc----ccc---
Confidence 2356688999999999999999999999999999999999999999743311 111111110 111
Q ss_pred cCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 421 LGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 421 l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
++........+++.+|+..+|.+|.+..||+.
T Consensus 241 ----~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~ 272 (281)
T KOG0580|consen 241 ----FPSTISGGAADLISRLLVKNPIERLALTEVMD 272 (281)
T ss_pred ----CCcccChhHHHHHHHHhccCccccccHHHHhh
Confidence 22233458889999999999999999999986
|
|
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=322.20 Aligned_cols=230 Identities=23% Similarity=0.314 Sum_probs=183.0
Q ss_pred CeeccCCcEEEEEEEEC-CCcEEEEEEehh-----------------hhh-hcccCceeeEEEEEeCCCeeEEEeeccCC
Q 039819 208 NILGAGGFGNVYKGKLG-DGTVLAVKRLKD-----------------MIS-LAVHRNLLRLIGYCATPTERLLVYPYMSN 268 (534)
Q Consensus 208 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~-----------------~l~-~~~h~niv~l~~~~~~~~~~~lv~e~~~~ 268 (534)
+.||+|+||.||+|+.. +++.||+|.+.. ++. ..+||||+++++++......++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 46999999999999975 578999998752 222 23799999999999999999999999999
Q ss_pred CChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCCceeecc
Q 039819 269 GSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAV 348 (534)
Q Consensus 269 gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~~ 348 (534)
|+|..++.....+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++...... ......
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~-~~~~~~ 156 (329)
T cd05618 81 GDLMFHMQRQRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG-DTTSTF 156 (329)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCCEEEeeCCccccccCCC-Cccccc
Confidence 99999988878899999999999999999999998 99999999999999999999999999997542221 123345
Q ss_pred ccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccc-cchHHHHHHHHhhhcccceecccccCCCCCH
Q 039819 349 RGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQ-KGAMLEWVKKIQQEKKVEVLVDRELGSNYDR 427 (534)
Q Consensus 349 ~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 427 (534)
.||..|+|||++.+..++.++|||||||++|||+||+.||........ ......++......... ..+.
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~----------~~p~ 226 (329)
T cd05618 157 CGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI----------RIPR 226 (329)
T ss_pred cCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCC----------CCCC
Confidence 699999999999998999999999999999999999999963221111 11112222221111111 1122
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCh
Q 039819 428 IEVGEILQVALLCTQYLPVHRPKM 451 (534)
Q Consensus 428 ~~~~~l~~l~~~Cl~~~P~~RPt~ 451 (534)
.....+.+++.+|++.+|++||++
T Consensus 227 ~~~~~~~~ll~~~L~~dP~~R~~~ 250 (329)
T cd05618 227 SLSVKAASVLKSFLNKDPKERLGC 250 (329)
T ss_pred CCCHHHHHHHHHHhcCCHHHcCCC
Confidence 234578899999999999999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-39 Score=330.91 Aligned_cols=242 Identities=22% Similarity=0.282 Sum_probs=190.2
Q ss_pred HHHHHhCCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEehh-----------------hhhhcccCceeeEEEEEeCCCe
Q 039819 197 LQQATENFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLKD-----------------MISLAVHRNLLRLIGYCATPTE 258 (534)
Q Consensus 197 l~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~-----------------~l~~~~h~niv~l~~~~~~~~~ 258 (534)
+....++|+..+.||+|+||.||+++.. +++.+|+|.+.+ ++..++||||+++++++.+...
T Consensus 38 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~ 117 (370)
T cd05621 38 LQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKY 117 (370)
T ss_pred cCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCE
Confidence 3344578999999999999999999985 578999998742 5667789999999999999999
Q ss_pred eEEEeeccCCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecC
Q 039819 259 RLLVYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLD 338 (534)
Q Consensus 259 ~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~ 338 (534)
.++||||+++|+|.+++... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 118 ~~lv~Ey~~gg~L~~~l~~~-~~~~~~~~~~~~qil~aL~~LH~~---~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~ 193 (370)
T cd05621 118 LYMVMEYMPGGDLVNLMSNY-DVPEKWAKFYTAEVVLALDAIHSM---GLIHRDVKPDNMLLDKHGHLKLADFGTCMKMD 193 (370)
T ss_pred EEEEEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEEecccceecc
Confidence 99999999999999998754 589999999999999999999998 99999999999999999999999999998765
Q ss_pred CCCCceeeccccccccccccccccC----CCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccc
Q 039819 339 HSDSHVTTAVRGTVGHIAPEYLSTG----QSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVE 414 (534)
Q Consensus 339 ~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 414 (534)
...........||+.|+|||++.+. .++.++|||||||++|||+||+.||..... ......+.....
T Consensus 194 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~-------~~~~~~i~~~~~-- 264 (370)
T cd05621 194 ETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSL-------VGTYSKIMDHKN-- 264 (370)
T ss_pred cCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCH-------HHHHHHHHhCCc--
Confidence 4333233456799999999998653 378899999999999999999999974321 111111111110
Q ss_pred eecccccCCCCCHHHHHHHHHHHHHhcccCCCC--CCChHHHHH
Q 039819 415 VLVDRELGSNYDRIEVGEILQVALLCTQYLPVH--RPKMSEVVR 456 (534)
Q Consensus 415 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~--RPt~~ev~~ 456 (534)
.+...........+.+++..|++.++.+ ||++.|+++
T Consensus 265 -----~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~ 303 (370)
T cd05621 265 -----SLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQ 303 (370)
T ss_pred -----ccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhc
Confidence 0000011112446778888899855543 889988876
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=320.83 Aligned_cols=226 Identities=26% Similarity=0.355 Sum_probs=183.9
Q ss_pred CeeccCCcEEEEEEEEC-CCcEEEEEEehh-----------------hh-hhcccCceeeEEEEEeCCCeeEEEeeccCC
Q 039819 208 NILGAGGFGNVYKGKLG-DGTVLAVKRLKD-----------------MI-SLAVHRNLLRLIGYCATPTERLLVYPYMSN 268 (534)
Q Consensus 208 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~-----------------~l-~~~~h~niv~l~~~~~~~~~~~lv~e~~~~ 268 (534)
+.||+|+||.||+|+.. +++.||||.++. .+ ....||||+++++++......++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999975 578899998752 12 234799999999999999999999999999
Q ss_pred CChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCCceeecc
Q 039819 269 GSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAV 348 (534)
Q Consensus 269 gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~~ 348 (534)
|+|.+++.....+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++...... ......
T Consensus 81 g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~-~~~~~~ 156 (316)
T cd05592 81 GDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE-GKASTF 156 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC-Cccccc
Confidence 99999998878899999999999999999999998 99999999999999999999999999998653322 223445
Q ss_pred ccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceecccccCCCCCHH
Q 039819 349 RGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELGSNYDRI 428 (534)
Q Consensus 349 ~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 428 (534)
.||..|+|||++.+..++.++|||||||++|||++|+.||..... .+....+... ...++..
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~-------~~~~~~i~~~-----------~~~~~~~ 218 (316)
T cd05592 157 CGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDE-------DELFDSILND-----------RPHFPRW 218 (316)
T ss_pred cCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCH-------HHHHHHHHcC-----------CCCCCCC
Confidence 699999999999988899999999999999999999999974321 1111111111 0111222
Q ss_pred HHHHHHHHHHHhcccCCCCCCChHHHH
Q 039819 429 EVGEILQVALLCTQYLPVHRPKMSEVV 455 (534)
Q Consensus 429 ~~~~l~~l~~~Cl~~~P~~RPt~~ev~ 455 (534)
....+.+++.+|++.+|.+||++.+.+
T Consensus 219 ~~~~~~~ll~~~l~~~P~~R~~~~~~l 245 (316)
T cd05592 219 ISKEAKDCLSKLFERDPTKRLGVDGDI 245 (316)
T ss_pred CCHHHHHHHHHHccCCHHHcCCChHHH
Confidence 345778999999999999999986433
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=331.14 Aligned_cols=242 Identities=28% Similarity=0.438 Sum_probs=191.4
Q ss_pred hCCCcCCeeccCCcEEEEEEEECCCcEEEEEEehh----------------hhhhcccCceeeEEEEEeCCCeeEEEeec
Q 039819 202 ENFSSKNILGAGGFGNVYKGKLGDGTVLAVKRLKD----------------MISLAVHRNLLRLIGYCATPTERLLVYPY 265 (534)
Q Consensus 202 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~----------------~l~~~~h~niv~l~~~~~~~~~~~lv~e~ 265 (534)
+.+.....||+|.||+||+|++.. .||||.++. .+++-+|.||+-+.|||..+.. .||..+
T Consensus 392 ~ev~l~~rIGsGsFGtV~Rg~whG--dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AIiTqw 468 (678)
T KOG0193|consen 392 EEVLLGERIGSGSFGTVYRGRWHG--DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AIITQW 468 (678)
T ss_pred HHhhccceeccccccceeeccccc--ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-eeeehh
Confidence 334456789999999999999964 389999862 6788999999999999998887 999999
Q ss_pred cCCCChhhhcccC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCC-CCCc
Q 039819 266 MSNGSVASRLREK-PALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDH-SDSH 343 (534)
Q Consensus 266 ~~~gsL~~~l~~~-~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~-~~~~ 343 (534)
|+|-+|+.+++.. ..|+..+.+.|+.|||+|+.|||.+ +|||||||..||++.+++.|||+|||++..... ....
T Consensus 469 CeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK---~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~g~~ 545 (678)
T KOG0193|consen 469 CEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAK---NIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWSGEQ 545 (678)
T ss_pred ccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhh---hhhhhhccccceEEccCCcEEEecccceeeeeeecccc
Confidence 9999999999853 5689999999999999999999999 999999999999999999999999999975432 1112
Q ss_pred eeecccccccccccccccc---CCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceecccc
Q 039819 344 VTTAVRGTVGHIAPEYLST---GQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRE 420 (534)
Q Consensus 344 ~~~~~~gt~~y~aPE~~~~---~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 420 (534)
......|...|||||+++. .+|+..+||||||||+|||+||..||.... .++ ++-.+. . + ....|.
T Consensus 546 q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~-~dq---IifmVG---r-G--~l~pd~- 614 (678)
T KOG0193|consen 546 QLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQN-RDQ---IIFMVG---R-G--YLMPDL- 614 (678)
T ss_pred ccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCC-hhh---eEEEec---c-c--ccCccc-
Confidence 2333457889999999964 468999999999999999999999997221 111 100000 0 0 000000
Q ss_pred cCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhcCC
Q 039819 421 LGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLEGDG 462 (534)
Q Consensus 421 l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~~~ 462 (534)
......++.++.+|+..||..++++||.+.+|+.+|+..-
T Consensus 615 --s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~ 654 (678)
T KOG0193|consen 615 --SKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELL 654 (678)
T ss_pred --hhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhh
Confidence 0112335668999999999999999999999999887644
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=320.79 Aligned_cols=227 Identities=23% Similarity=0.286 Sum_probs=186.4
Q ss_pred CeeccCCcEEEEEEEEC-CCcEEEEEEehh-----------------hhhhcccCceeeEEEEEeCCCeeEEEeeccCCC
Q 039819 208 NILGAGGFGNVYKGKLG-DGTVLAVKRLKD-----------------MISLAVHRNLLRLIGYCATPTERLLVYPYMSNG 269 (534)
Q Consensus 208 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~-----------------~l~~~~h~niv~l~~~~~~~~~~~lv~e~~~~g 269 (534)
+.||+|+||.||+++.. ++..||+|.+.. ++..++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 46999999999999874 689999998752 567778999999999999999999999999999
Q ss_pred ChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCCceeeccc
Q 039819 270 SVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVR 349 (534)
Q Consensus 270 sL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 349 (534)
+|..++.....+++..++.++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++...... .......
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~-~~~~~~~ 156 (323)
T cd05595 81 ELFFHLSRERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG-ATMKTFC 156 (323)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEEcCCCCEEecccHHhccccCCC-Ccccccc
Confidence 9999998888899999999999999999999998 99999999999999999999999999987542221 1223456
Q ss_pred cccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceecccccCCCCCHHH
Q 039819 350 GTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELGSNYDRIE 429 (534)
Q Consensus 350 gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 429 (534)
||+.|+|||++.+..++.++|||||||++|||++|+.||...... .......... .. ++...
T Consensus 157 gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~-------~~~~~~~~~~-------~~----~p~~~ 218 (323)
T cd05595 157 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-------RLFELILMEE-------IR----FPRTL 218 (323)
T ss_pred CCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHH-------HHHHHHhcCC-------CC----CCCCC
Confidence 999999999999889999999999999999999999999643211 1111111100 01 11223
Q ss_pred HHHHHHHHHHhcccCCCCCC-----ChHHHHH
Q 039819 430 VGEILQVALLCTQYLPVHRP-----KMSEVVR 456 (534)
Q Consensus 430 ~~~l~~l~~~Cl~~~P~~RP-----t~~ev~~ 456 (534)
...+.+++.+|++.+|.+|| ++.++++
T Consensus 219 ~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~ 250 (323)
T cd05595 219 SPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 250 (323)
T ss_pred CHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence 45788999999999999998 7777765
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=320.73 Aligned_cols=228 Identities=24% Similarity=0.297 Sum_probs=187.7
Q ss_pred CeeccCCcEEEEEEEEC-CCcEEEEEEehh-----------------hhhhcccCceeeEEEEEeCCCeeEEEeeccCCC
Q 039819 208 NILGAGGFGNVYKGKLG-DGTVLAVKRLKD-----------------MISLAVHRNLLRLIGYCATPTERLLVYPYMSNG 269 (534)
Q Consensus 208 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~-----------------~l~~~~h~niv~l~~~~~~~~~~~lv~e~~~~g 269 (534)
+.||+|+||.||+++.. +++.||||++.+ ++..+.||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999875 689999998752 567778999999999999999999999999999
Q ss_pred ChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCCceeeccc
Q 039819 270 SVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVR 349 (534)
Q Consensus 270 sL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 349 (534)
+|.+++.....+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++...... .......
T Consensus 81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~-~~~~~~~ 156 (328)
T cd05593 81 ELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA-ATMKTFC 156 (328)
T ss_pred CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeEECCCCcEEEecCcCCccCCCcc-ccccccc
Confidence 9999998878899999999999999999999998 99999999999999999999999999987543221 1233456
Q ss_pred cccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceecccccCCCCCHHH
Q 039819 350 GTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELGSNYDRIE 429 (534)
Q Consensus 350 gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 429 (534)
||+.|+|||++.+..++.++|||||||++|||+||+.||..... .+........ +.. ++...
T Consensus 157 gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~-------~~~~~~~~~~-------~~~----~p~~~ 218 (328)
T cd05593 157 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-------EKLFELILME-------DIK----FPRTL 218 (328)
T ss_pred CCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCH-------HHHHHHhccC-------Ccc----CCCCC
Confidence 99999999999888899999999999999999999999964321 1111111110 011 11223
Q ss_pred HHHHHHHHHHhcccCCCCCC-----ChHHHHHH
Q 039819 430 VGEILQVALLCTQYLPVHRP-----KMSEVVRM 457 (534)
Q Consensus 430 ~~~l~~l~~~Cl~~~P~~RP-----t~~ev~~~ 457 (534)
...+.+++.+|++.+|.+|| ++.++++.
T Consensus 219 ~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 219 SADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred CHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 45788999999999999997 78888754
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-40 Score=335.00 Aligned_cols=239 Identities=31% Similarity=0.419 Sum_probs=192.7
Q ss_pred CCCcCCeeccCCcEEEEEEEECC--C--cE-EEEEEeh-----------------hhhhhcccCceeeEEEEEeCCCeeE
Q 039819 203 NFSSKNILGAGGFGNVYKGKLGD--G--TV-LAVKRLK-----------------DMISLAVHRNLLRLIGYCATPTERL 260 (534)
Q Consensus 203 ~~~~~~~lG~G~~g~Vy~~~~~~--~--~~-vavK~~~-----------------~~l~~~~h~niv~l~~~~~~~~~~~ 260 (534)
+-...+.||+|+||.||+|++.. + .. ||||..+ +++..++|||||+++|++......+
T Consensus 158 ~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~ 237 (474)
T KOG0194|consen 158 DIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLM 237 (474)
T ss_pred CccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccE
Confidence 33445789999999999998743 2 23 8999876 2677899999999999999999999
Q ss_pred EEeeccCCCChhhhcccCC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCC
Q 039819 261 LVYPYMSNGSVASRLREKP-ALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDH 339 (534)
Q Consensus 261 lv~e~~~~gsL~~~l~~~~-~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~ 339 (534)
+|||+|+||+|.++|++.+ .++..++..++.+.|.||+|||++ ++|||||-.+|+|++.++.+||+|||+++....
T Consensus 238 ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k---~~IHRDIAARNcL~~~~~~vKISDFGLs~~~~~ 314 (474)
T KOG0194|consen 238 LVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSK---NCIHRDIAARNCLYSKKGVVKISDFGLSRAGSQ 314 (474)
T ss_pred EEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHC---CCcchhHhHHHheecCCCeEEeCccccccCCcc
Confidence 9999999999999999766 599999999999999999999999 999999999999999999999999999886531
Q ss_pred CCCceeeccccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCcCCCccccccchHHHHHHHHhhhcccceecc
Q 039819 340 SDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVD 418 (534)
Q Consensus 340 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 418 (534)
- ........-...|+|||.+..+.|+.++|||||||++||+++ |..||++.... .+..++ ...+
T Consensus 315 ~-~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~----~v~~kI---~~~~------- 379 (474)
T KOG0194|consen 315 Y-VMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNY----EVKAKI---VKNG------- 379 (474)
T ss_pred e-eeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHH----HHHHHH---HhcC-------
Confidence 1 101111124578999999999999999999999999999999 88898753321 111222 1111
Q ss_pred cccCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhcC
Q 039819 419 RELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLEGD 461 (534)
Q Consensus 419 ~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~~ 461 (534)
.+...+...+..+..++.+||..+|++||+|.++.+.|+..
T Consensus 380 --~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~ 420 (474)
T KOG0194|consen 380 --YRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEAL 420 (474)
T ss_pred --ccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHH
Confidence 11122334566888999999999999999999999998764
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-39 Score=317.41 Aligned_cols=239 Identities=26% Similarity=0.463 Sum_probs=193.0
Q ss_pred hCCCcCCeeccCCcEEEEEEEECC------CcEEEEEEehh---------------hhhhcccCceeeEEEEEeCCCeeE
Q 039819 202 ENFSSKNILGAGGFGNVYKGKLGD------GTVLAVKRLKD---------------MISLAVHRNLLRLIGYCATPTERL 260 (534)
Q Consensus 202 ~~~~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~---------------~l~~~~h~niv~l~~~~~~~~~~~ 260 (534)
++|+..+.||+|+||.||+|.... ...||+|.+.. .+..+.||||+++++++......+
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC 84 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence 467788899999999999998643 25799998752 567788999999999999999999
Q ss_pred EEeeccCCCChhhhcccC----------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCC
Q 039819 261 LVYPYMSNGSVASRLREK----------------PALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFC 324 (534)
Q Consensus 261 lv~e~~~~gsL~~~l~~~----------------~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~ 324 (534)
++|||+++|+|.+++... ..+++..++.++.|++.||.|||+. +++||||||+||++++++
T Consensus 85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCLVGEGL 161 (283)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccccceEEEcCCC
Confidence 999999999999998643 4588999999999999999999998 999999999999999999
Q ss_pred cEEEEecccceecCCCCC-ceeeccccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCcCCCccccccchHHH
Q 039819 325 EAIVGDFGLAKLLDHSDS-HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GMRALEFGKSINQKGAMLE 402 (534)
Q Consensus 325 ~~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~ 402 (534)
.+||+|||+++....... .......++..|+|||++.+..++.++|||||||++|||+| |+.||..... ..+..
T Consensus 162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~----~~~~~ 237 (283)
T cd05048 162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSN----QEVIE 237 (283)
T ss_pred cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCH----HHHHH
Confidence 999999999986543221 12233446788999999988899999999999999999998 9999864321 11111
Q ss_pred HHHHHhhhcccceecccccCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhc
Q 039819 403 WVKKIQQEKKVEVLVDRELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLEG 460 (534)
Q Consensus 403 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~ 460 (534)
. +... . ....+...+.++.+++.+||+.+|.+||++.||++.|+.
T Consensus 238 ~---i~~~-~---------~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 238 M---IRSR-Q---------LLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred H---HHcC-C---------cCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 1 1111 0 011122345689999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-38 Score=319.16 Aligned_cols=230 Identities=23% Similarity=0.301 Sum_probs=183.4
Q ss_pred CeeccCCcEEEEEEEEC-CCcEEEEEEehh-----------------hhhhc-ccCceeeEEEEEeCCCeeEEEeeccCC
Q 039819 208 NILGAGGFGNVYKGKLG-DGTVLAVKRLKD-----------------MISLA-VHRNLLRLIGYCATPTERLLVYPYMSN 268 (534)
Q Consensus 208 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~-----------------~l~~~-~h~niv~l~~~~~~~~~~~lv~e~~~~ 268 (534)
+.||+|+||.||+|+.. +++.||+|++.. ++..+ .||||+++++++......++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999975 578999998862 23333 699999999999999999999999999
Q ss_pred CChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCCceeecc
Q 039819 269 GSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAV 348 (534)
Q Consensus 269 gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~~ 348 (534)
|+|..++.....+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++...... ......
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~~~~ 156 (327)
T cd05617 81 GDLMFHMQRQRKLPEEHARFYAAEICIALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG-DTTSTF 156 (327)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEeCCCCEEEeccccceeccCCC-Cceecc
Confidence 99999988777899999999999999999999998 99999999999999999999999999997532221 123446
Q ss_pred ccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceecccccCCCCCHH
Q 039819 349 RGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELGSNYDRI 428 (534)
Q Consensus 349 ~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 428 (534)
.||+.|+|||++.+..++.++|||||||++|||+||+.||......... ...++.......... ..+..
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~-~~~~~~~~~~~~~~~----------~~p~~ 225 (327)
T cd05617 157 CGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDM-NTEDYLFQVILEKPI----------RIPRF 225 (327)
T ss_pred cCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCccc-ccHHHHHHHHHhCCC----------CCCCC
Confidence 7999999999999889999999999999999999999999643221111 111222221111110 11222
Q ss_pred HHHHHHHHHHHhcccCCCCCCChH
Q 039819 429 EVGEILQVALLCTQYLPVHRPKMS 452 (534)
Q Consensus 429 ~~~~l~~l~~~Cl~~~P~~RPt~~ 452 (534)
.+..+.+++.+|++.+|.+||++.
T Consensus 226 ~~~~~~~li~~~L~~dP~~R~~~~ 249 (327)
T cd05617 226 LSVKASHVLKGFLNKDPKERLGCQ 249 (327)
T ss_pred CCHHHHHHHHHHhccCHHHcCCCC
Confidence 234778999999999999999864
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=323.87 Aligned_cols=230 Identities=23% Similarity=0.299 Sum_probs=183.3
Q ss_pred CeeccCCcEEEEEEEEC-CCcEEEEEEehh-----------------hhhhc-ccCceeeEEEEEeCCCeeEEEeeccCC
Q 039819 208 NILGAGGFGNVYKGKLG-DGTVLAVKRLKD-----------------MISLA-VHRNLLRLIGYCATPTERLLVYPYMSN 268 (534)
Q Consensus 208 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~-----------------~l~~~-~h~niv~l~~~~~~~~~~~lv~e~~~~ 268 (534)
+.||+|+||.||+|+.. +++.||||.++. ++..+ +||||+++++++.+....++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 46999999999999875 688999998862 23334 699999999999999999999999999
Q ss_pred CChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCCceeecc
Q 039819 269 GSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAV 348 (534)
Q Consensus 269 gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~~ 348 (534)
|+|.+++.....+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++...... ......
T Consensus 81 g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~-~~~~~~ 156 (329)
T cd05588 81 GDLMFHMQRQRKLPEEHARFYSAEISLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG-DTTSTF 156 (329)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEECcCccccccccCC-Cccccc
Confidence 99999998778899999999999999999999998 99999999999999999999999999987532211 123346
Q ss_pred ccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccc-cchHHHHHHHHhhhcccceecccccCCCCCH
Q 039819 349 RGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQ-KGAMLEWVKKIQQEKKVEVLVDRELGSNYDR 427 (534)
Q Consensus 349 ~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 427 (534)
.||..|+|||++.+..++.++|||||||++|||+||+.||+....... .....++.......... . .+.
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~------~----~p~ 226 (329)
T cd05588 157 CGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQI------R----IPR 226 (329)
T ss_pred cCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCC------C----CCC
Confidence 799999999999988999999999999999999999999974321111 11112222222111111 1 111
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCh
Q 039819 428 IEVGEILQVALLCTQYLPVHRPKM 451 (534)
Q Consensus 428 ~~~~~l~~l~~~Cl~~~P~~RPt~ 451 (534)
.....+.+++.+|++.+|.+||++
T Consensus 227 ~~~~~~~~li~~~L~~dP~~R~~~ 250 (329)
T cd05588 227 SLSVKASSVLKGFLNKDPKERLGC 250 (329)
T ss_pred CCCHHHHHHHHHHhccCHHHcCCC
Confidence 224578899999999999999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-39 Score=333.07 Aligned_cols=237 Identities=20% Similarity=0.237 Sum_probs=186.3
Q ss_pred CCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEehh-----------------hhhhcccCceeeEEEEEeCCCeeEEEee
Q 039819 203 NFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLKD-----------------MISLAVHRNLLRLIGYCATPTERLLVYP 264 (534)
Q Consensus 203 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~-----------------~l~~~~h~niv~l~~~~~~~~~~~lv~e 264 (534)
+|...+.||+|+||.||+|+.. +++.||||.+.. ++..+.|+||+++++.+.+.+..++|||
T Consensus 2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E 81 (376)
T cd05598 2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (376)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEe
Confidence 6888999999999999999875 588999998742 5677889999999999999999999999
Q ss_pred ccCCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCC---
Q 039819 265 YMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSD--- 341 (534)
Q Consensus 265 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~--- 341 (534)
|+++|+|.+++...+.+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++..+....
T Consensus 82 ~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~ 158 (376)
T cd05598 82 YIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSK 158 (376)
T ss_pred CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHEEECCCCCEEEEeCCCCcccccccccc
Confidence 999999999998888899999999999999999999998 99999999999999999999999999975321000
Q ss_pred ---------------------------------------CceeeccccccccccccccccCCCCcchhHHHHHHHHHHHH
Q 039819 342 ---------------------------------------SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELI 382 (534)
Q Consensus 342 ---------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~ell 382 (534)
........||+.|+|||++.+..++.++|||||||++|||+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyell 238 (376)
T cd05598 159 YYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEML 238 (376)
T ss_pred ccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeehh
Confidence 00012346999999999999888999999999999999999
Q ss_pred hCCCCcCCCccccccchHHHHHHHHhhhcccceecccccCCCCCHHHHHHHHHHHHHhcccCCCCCC---ChHHHHHH
Q 039819 383 TGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELGSNYDRIEVGEILQVALLCTQYLPVHRP---KMSEVVRM 457 (534)
Q Consensus 383 tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RP---t~~ev~~~ 457 (534)
||+.||....... +........ . .............+.+++.+|+ .+|.+|+ ++.++++.
T Consensus 239 ~G~~Pf~~~~~~~-------~~~~i~~~~--~-----~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h 301 (376)
T cd05598 239 VGQPPFLADTPAE-------TQLKVINWE--T-----TLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAH 301 (376)
T ss_pred hCCCCCCCCCHHH-------HHHHHhccC--c-----cccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCC
Confidence 9999997543211 111111000 0 0000000112335666777765 4999999 78888753
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-39 Score=313.61 Aligned_cols=238 Identities=27% Similarity=0.419 Sum_probs=192.5
Q ss_pred hCCCcCCeeccCCcEEEEEEEECCCcEEEEEEehh-------------hhhhcccCceeeEEEEEeCCCeeEEEeeccCC
Q 039819 202 ENFSSKNILGAGGFGNVYKGKLGDGTVLAVKRLKD-------------MISLAVHRNLLRLIGYCATPTERLLVYPYMSN 268 (534)
Q Consensus 202 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~-------------~l~~~~h~niv~l~~~~~~~~~~~lv~e~~~~ 268 (534)
++|...+.||+|+||.||+|+..++..+|||.+.. ++..+.||||+++++++.+....++||||+++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSN 83 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCcccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCCC
Confidence 45677889999999999999988777899997752 57788899999999999999899999999999
Q ss_pred CChhhhccc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCCceeec
Q 039819 269 GSVASRLRE-KPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTA 347 (534)
Q Consensus 269 gsL~~~l~~-~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~ 347 (534)
|+|.+++.. ...+++..++.++.|++.||.|||+. +++|+||||+||+++.++.+||+|||.++............
T Consensus 84 ~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~~~~ 160 (256)
T cd05113 84 GCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVG 160 (256)
T ss_pred CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCCEEECCCccceecCCCceeecCC
Confidence 999999875 34689999999999999999999998 99999999999999999999999999998664332222222
Q ss_pred cccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCcCCCccccccchHHHHHHHHhhhcccceecccccCCCCC
Q 039819 348 VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELGSNYD 426 (534)
Q Consensus 348 ~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 426 (534)
..++..|+|||++.+..++.++|||||||++|||+| |+.||...... +........... ..+
T Consensus 161 ~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~-------~~~~~~~~~~~~----------~~~ 223 (256)
T cd05113 161 SKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNS-------ETVEKVSQGLRL----------YRP 223 (256)
T ss_pred CccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHH-------HHHHHHhcCCCC----------CCC
Confidence 335678999999988889999999999999999999 99998632211 111111111100 011
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCChHHHHHHhh
Q 039819 427 RIEVGEILQVALLCTQYLPVHRPKMSEVVRMLE 459 (534)
Q Consensus 427 ~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~ 459 (534)
......+.+++.+||+.+|.+||++.++++.|+
T Consensus 224 ~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 224 HLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred CCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 112458899999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-39 Score=315.41 Aligned_cols=232 Identities=30% Similarity=0.500 Sum_probs=182.2
Q ss_pred CCeeccCCcEEEEEEEEC-----CCcEEEEEEehh---------------hhhhcccCceeeEEEEEeCCCeeEEEeecc
Q 039819 207 KNILGAGGFGNVYKGKLG-----DGTVLAVKRLKD---------------MISLAVHRNLLRLIGYCATPTERLLVYPYM 266 (534)
Q Consensus 207 ~~~lG~G~~g~Vy~~~~~-----~~~~vavK~~~~---------------~l~~~~h~niv~l~~~~~~~~~~~lv~e~~ 266 (534)
.+.||.|.||.||+|.+. .+..|+||.++. .+..++||||++++|+|......++||||+
T Consensus 4 ~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~~ 83 (259)
T PF07714_consen 4 IKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEYC 83 (259)
T ss_dssp EEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE--
T ss_pred eeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccccccccc
Confidence 467999999999999986 357899999842 567789999999999999888899999999
Q ss_pred CCCChhhhcccC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCC-c
Q 039819 267 SNGSVASRLREK--PALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDS-H 343 (534)
Q Consensus 267 ~~gsL~~~l~~~--~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~-~ 343 (534)
++|+|.+++... ..+++..+..|+.|+++||.|||+. +++|+||+++||+++.++.+||+|||++........ .
T Consensus 84 ~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~---~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~~ 160 (259)
T PF07714_consen 84 PGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSN---NIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKYK 160 (259)
T ss_dssp TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSEE
T ss_pred ccccccccccccccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccccccc
Confidence 999999999865 7799999999999999999999998 999999999999999999999999999987733222 1
Q ss_pred eeeccccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCcCCCccccccchHHHHHHHHhhhcccceecccccC
Q 039819 344 VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELG 422 (534)
Q Consensus 344 ~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 422 (534)
......+...|+|||.+....++.++||||||+++|||+| |+.||.... ..++..........
T Consensus 161 ~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~-------~~~~~~~~~~~~~~--------- 224 (259)
T PF07714_consen 161 NDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYD-------NEEIIEKLKQGQRL--------- 224 (259)
T ss_dssp ESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSC-------HHHHHHHHHTTEET---------
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccc-------cccccccccccccc---------
Confidence 2223446789999999988889999999999999999999 678875321 12233333222111
Q ss_pred CCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHh
Q 039819 423 SNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRML 458 (534)
Q Consensus 423 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L 458 (534)
..+...+..+.+++..||+.+|++||+|.++++.|
T Consensus 225 -~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 225 -PIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp -TSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred -eeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 11122345789999999999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=315.32 Aligned_cols=233 Identities=19% Similarity=0.331 Sum_probs=201.5
Q ss_pred hCCCcCCeeccCCcEEEEEEEE-CCCcEEEEEEehh-----------------hhhhcccCceeeEEEEEeCCCeeEEEe
Q 039819 202 ENFSSKNILGAGGFGNVYKGKL-GDGTVLAVKRLKD-----------------MISLAVHRNLLRLIGYCATPTERLLVY 263 (534)
Q Consensus 202 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~-----------------~l~~~~h~niv~l~~~~~~~~~~~lv~ 263 (534)
.+|++.+.||+|.||.|-+|.. ..|+.||||.+++ +++.++||||+.++++|++.+...|||
T Consensus 53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivM 132 (668)
T KOG0611|consen 53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVM 132 (668)
T ss_pred hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEE
Confidence 4567778899999999999986 6799999998763 789999999999999999999999999
Q ss_pred eccCCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCCc
Q 039819 264 PYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSH 343 (534)
Q Consensus 264 e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~ 343 (534)
||..+|.|++++.+.+.|++.+...++.||+.|+.|+|.+ +++|||||.+|||+|.++++||+|||++..+... .
T Consensus 133 EYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHkn---rVvHRDLKLENILLD~N~NiKIADFGLSNly~~~--k 207 (668)
T KOG0611|consen 133 EYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKN---RVVHRDLKLENILLDQNNNIKIADFGLSNLYADK--K 207 (668)
T ss_pred EecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhc---cceecccchhheeecCCCCeeeeccchhhhhccc--c
Confidence 9999999999999999999999999999999999999999 9999999999999999999999999999877543 3
Q ss_pred eeeccccccccccccccccCCC-CcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceecccccC
Q 039819 344 VTTAVRGTVGHIAPEYLSTGQS-SEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELG 422 (534)
Q Consensus 344 ~~~~~~gt~~y~aPE~~~~~~~-~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 422 (534)
...+++|++-|.+||++.+.+| ++.+|.||+||+||.|+.|..||++-+ ....++++......
T Consensus 208 fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~D-------hk~lvrQIs~GaYr--------- 271 (668)
T KOG0611|consen 208 FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRD-------HKRLVRQISRGAYR--------- 271 (668)
T ss_pred HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCch-------HHHHHHHhhccccc---------
Confidence 4567899999999999999888 588999999999999999999998532 22344444432211
Q ss_pred CCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHh
Q 039819 423 SNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRML 458 (534)
Q Consensus 423 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L 458 (534)
....+....-|+++|+..+|++|.|+.+|....
T Consensus 272 ---EP~~PSdA~gLIRwmLmVNP~RRATieDiAsHW 304 (668)
T KOG0611|consen 272 ---EPETPSDASGLIRWMLMVNPERRATIEDIASHW 304 (668)
T ss_pred ---CCCCCchHHHHHHHHHhcCcccchhHHHHhhhh
Confidence 112234667899999999999999999998753
|
|
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=321.95 Aligned_cols=226 Identities=26% Similarity=0.306 Sum_probs=185.5
Q ss_pred CeeccCCcEEEEEEEEC-CCcEEEEEEehh------------------hhhhcccCceeeEEEEEeCCCeeEEEeeccCC
Q 039819 208 NILGAGGFGNVYKGKLG-DGTVLAVKRLKD------------------MISLAVHRNLLRLIGYCATPTERLLVYPYMSN 268 (534)
Q Consensus 208 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~------------------~l~~~~h~niv~l~~~~~~~~~~~lv~e~~~~ 268 (534)
+.||+|+||.||+|+.. +++.||||++.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 36999999999999985 689999998752 34568899999999999999999999999999
Q ss_pred CChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCCceeecc
Q 039819 269 GSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAV 348 (534)
Q Consensus 269 gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~~ 348 (534)
|+|.+++.....+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++...... ......
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~-~~~~~~ 156 (323)
T cd05575 81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS-KTTSTF 156 (323)
T ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeccCCCcccccCC-Cccccc
Confidence 99999998888899999999999999999999998 99999999999999999999999999987542221 223345
Q ss_pred ccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceecccccCCCCCHH
Q 039819 349 RGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELGSNYDRI 428 (534)
Q Consensus 349 ~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 428 (534)
.||+.|+|||++.+..++.++|||||||++|||++|+.||..... .+......... ..+...
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~-------~~~~~~i~~~~-------~~~~~~---- 218 (323)
T cd05575 157 CGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDT-------AEMYDNILNKP-------LRLKPN---- 218 (323)
T ss_pred cCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCH-------HHHHHHHHcCC-------CCCCCC----
Confidence 699999999999988899999999999999999999999964321 12222211110 011111
Q ss_pred HHHHHHHHHHHhcccCCCCCCChHHHH
Q 039819 429 EVGEILQVALLCTQYLPVHRPKMSEVV 455 (534)
Q Consensus 429 ~~~~l~~l~~~Cl~~~P~~RPt~~ev~ 455 (534)
....+.+++.+|++.+|.+||++.+.+
T Consensus 219 ~~~~~~~li~~~l~~~p~~R~~~~~~~ 245 (323)
T cd05575 219 ISVSARHLLEGLLQKDRTKRLGAKDDF 245 (323)
T ss_pred CCHHHHHHHHHHhhcCHHhCCCCCCCH
Confidence 245788999999999999999986433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=327.81 Aligned_cols=240 Identities=22% Similarity=0.256 Sum_probs=192.0
Q ss_pred HHhCCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEehh-----------------hhhhcccCceeeEEEEEeCCCeeEE
Q 039819 200 ATENFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLKD-----------------MISLAVHRNLLRLIGYCATPTERLL 261 (534)
Q Consensus 200 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~-----------------~l~~~~h~niv~l~~~~~~~~~~~l 261 (534)
..++|...+.||+|+||.||+++.. ++..||+|.+.. ++..++||||+++++++.+....++
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l 120 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM 120 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence 4568899999999999999999875 688999998742 5677889999999999999999999
Q ss_pred EeeccCCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCC
Q 039819 262 VYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSD 341 (534)
Q Consensus 262 v~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~ 341 (534)
||||+++|+|.+++... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++.......
T Consensus 121 v~Ey~~gg~L~~~l~~~-~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~ 196 (370)
T cd05596 121 VMEYMPGGDLVNLMSNY-DIPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANG 196 (370)
T ss_pred EEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEcCCCCEEEEeccceeeccCCC
Confidence 99999999999988654 588899999999999999999998 99999999999999999999999999998765432
Q ss_pred CceeeccccccccccccccccC----CCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceec
Q 039819 342 SHVTTAVRGTVGHIAPEYLSTG----QSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLV 417 (534)
Q Consensus 342 ~~~~~~~~gt~~y~aPE~~~~~----~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 417 (534)
........||+.|+|||++.+. .++.++|||||||++|||++|+.||...... .....+.....
T Consensus 197 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~-------~~~~~i~~~~~----- 264 (370)
T cd05596 197 MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV-------GTYSKIMDHKN----- 264 (370)
T ss_pred cccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHH-------HHHHHHHcCCC-----
Confidence 2223345799999999998643 4788999999999999999999999743321 11111111100
Q ss_pred ccccCCCCCHHHHHHHHHHHHHhcccCCCC--CCChHHHHHH
Q 039819 418 DRELGSNYDRIEVGEILQVALLCTQYLPVH--RPKMSEVVRM 457 (534)
Q Consensus 418 d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~--RPt~~ev~~~ 457 (534)
.+........+..+.+++.+|++.+|.+ ||++.|+++.
T Consensus 265 --~~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 265 --SLTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred --cCCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 0000001112457889999999999988 9999999763
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-39 Score=340.69 Aligned_cols=273 Identities=17% Similarity=0.251 Sum_probs=197.4
Q ss_pred HHHHHHHhCCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEehh-------------hhhhcc------cCceeeEEEEEe
Q 039819 195 RELQQATENFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLKD-------------MISLAV------HRNLLRLIGYCA 254 (534)
Q Consensus 195 ~~l~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~-------------~l~~~~------h~niv~l~~~~~ 254 (534)
+++...+++|...+.||+|+||.||+|... .+..||||+++. ++..++ |.+++++++++.
T Consensus 122 ~~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~ 201 (467)
T PTZ00284 122 EDIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQ 201 (467)
T ss_pred CccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEE
Confidence 444456788999999999999999999875 578899998842 233333 456899999987
Q ss_pred CC-CeeEEEeeccCCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCC---------
Q 039819 255 TP-TERLLVYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFC--------- 324 (534)
Q Consensus 255 ~~-~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~--------- 324 (534)
.. ...++|||++ +++|.+++.....+++..+..|+.||+.||.|||+++ +||||||||+|||++.++
T Consensus 202 ~~~~~~~iv~~~~-g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~--gIiHrDlKP~NILl~~~~~~~~~~~~~ 278 (467)
T PTZ00284 202 NETGHMCIVMPKY-GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTEL--HLMHTDLKPENILMETSDTVVDPVTNR 278 (467)
T ss_pred cCCceEEEEEecc-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcC--CeecCCCCHHHEEEecCCccccccccc
Confidence 65 4678999988 7789998887788999999999999999999999732 899999999999998765
Q ss_pred -------cEEEEecccceecCCCCCceeeccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCcccccc
Q 039819 325 -------EAIVGDFGLAKLLDHSDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQK 397 (534)
Q Consensus 325 -------~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~ 397 (534)
.+||+|||.+..... ......||..|+|||++.+..++.++|||||||++|||+||+.||+........
T Consensus 279 ~~~~~~~~vkl~DfG~~~~~~~----~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~ 354 (467)
T PTZ00284 279 ALPPDPCRVRICDLGGCCDERH----SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHL 354 (467)
T ss_pred ccCCCCceEEECCCCccccCcc----ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHH
Confidence 499999998864322 234567999999999999999999999999999999999999999754432211
Q ss_pred chHHH--------HHHHHhh---------hcccceeccccc-----C--CCCCHHHHHHHHHHHHHhcccCCCCCCChHH
Q 039819 398 GAMLE--------WVKKIQQ---------EKKVEVLVDREL-----G--SNYDRIEVGEILQVALLCTQYLPVHRPKMSE 453 (534)
Q Consensus 398 ~~~~~--------~~~~~~~---------~~~~~~~~d~~l-----~--~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~e 453 (534)
..+.. |...... ........++.. . ..........+.+++.+|++.||.+|||++|
T Consensus 355 ~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e 434 (467)
T PTZ00284 355 HLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQ 434 (467)
T ss_pred HHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHH
Confidence 11111 1110000 000000000000 0 0000112346789999999999999999999
Q ss_pred HHHHhhcCCchhhHHhhccCCCCCCCCcccCCCCCCCCC
Q 039819 454 VVRMLEGDGLAEKWAAAHNHTNPTMNNFHTNTKKSTSCP 492 (534)
Q Consensus 454 v~~~L~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~ 492 (534)
+++ |||+..+....+..+..+
T Consensus 435 ~L~------------------Hp~~~~~~~~~~~~~~~~ 455 (467)
T PTZ00284 435 MTT------------------HPYVLKYYPECRQHPNYP 455 (467)
T ss_pred Hhc------------------CccccccCCccccCCCCC
Confidence 985 788776554433333333
|
|
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=313.71 Aligned_cols=239 Identities=26% Similarity=0.421 Sum_probs=193.6
Q ss_pred hCCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEehh-------------hhhhcccCceeeEEEEEeCCCeeEEEeeccC
Q 039819 202 ENFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLKD-------------MISLAVHRNLLRLIGYCATPTERLLVYPYMS 267 (534)
Q Consensus 202 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~-------------~l~~~~h~niv~l~~~~~~~~~~~lv~e~~~ 267 (534)
.+|...+.||+|+||.||+|... .++.||+|.+.. .+..+.|+||+++++++......++||||++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 85 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMT 85 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCchHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeCC
Confidence 34677789999999999999875 588899998752 5677889999999999999999999999999
Q ss_pred CCChhhhccc--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCCcee
Q 039819 268 NGSVASRLRE--KPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVT 345 (534)
Q Consensus 268 ~gsL~~~l~~--~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~ 345 (534)
+++|.+++.. ...+++..++.++.|++.||+|||+. +++||||||+||++++++.+||+|||++...........
T Consensus 86 ~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~~~ 162 (263)
T cd05052 86 YGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAH 162 (263)
T ss_pred CCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCcEEeCCCccccccccceeecc
Confidence 9999999864 34689999999999999999999998 999999999999999999999999999987654322222
Q ss_pred eccccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCcCCCccccccchHHHHHHHHhhhcccceecccccCCC
Q 039819 346 TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELGSN 424 (534)
Q Consensus 346 ~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 424 (534)
....++..|+|||++.+..++.++|||||||++|||+| |..||+.... .++........ ...
T Consensus 163 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~-------~~~~~~~~~~~----------~~~ 225 (263)
T cd05052 163 AGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL-------SQVYELLEKGY----------RME 225 (263)
T ss_pred CCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH-------HHHHHHHHCCC----------CCC
Confidence 22234668999999988889999999999999999998 9999864321 11212211110 011
Q ss_pred CCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhc
Q 039819 425 YDRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLEG 460 (534)
Q Consensus 425 ~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~ 460 (534)
.+...+..+.+++.+|++.+|++||++.+++++|+.
T Consensus 226 ~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~ 261 (263)
T cd05052 226 RPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFET 261 (263)
T ss_pred CCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHh
Confidence 122234588999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=317.21 Aligned_cols=248 Identities=25% Similarity=0.356 Sum_probs=187.2
Q ss_pred HhCCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEeh---------------hhhhhcccCceeeEEEEEeCCCeeEEEee
Q 039819 201 TENFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLK---------------DMISLAVHRNLLRLIGYCATPTERLLVYP 264 (534)
Q Consensus 201 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~---------------~~l~~~~h~niv~l~~~~~~~~~~~lv~e 264 (534)
.++|...+.||+|+||.||+|+.. +++.||||.+. .+++.+.||||+++++++.+....++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 367889999999999999999986 68899999875 25678899999999999999999999999
Q ss_pred ccCCCChhhhccc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCCc
Q 039819 265 YMSNGSVASRLRE-KPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSH 343 (534)
Q Consensus 265 ~~~~gsL~~~l~~-~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~ 343 (534)
|++ ++|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++...... .
T Consensus 84 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~ 158 (303)
T cd07869 84 YVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQR---YILHRDLKPQNLLISDTGELKLADFGLARAKSVPS-H 158 (303)
T ss_pred CCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECCCCcceeccCCC-c
Confidence 996 577777654 45689999999999999999999998 99999999999999999999999999997653322 1
Q ss_pred eeecccccccccccccccc-CCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhc----cc--ce-
Q 039819 344 VTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEK----KV--EV- 415 (534)
Q Consensus 344 ~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~----~~--~~- 415 (534)
......||+.|+|||++.+ ..++.++|||||||++|||+||+.||........ ..+......... .. ..
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~ 235 (303)
T cd07869 159 TYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQD---QLERIFLVLGTPNEDTWPGVHSL 235 (303)
T ss_pred cCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHH---HHHHHHHHhCCCChhhccchhhc
Confidence 2233558999999998865 4578899999999999999999999975322111 111110000000 00 00
Q ss_pred -ecccc-cC--CCCC--H-----HHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 416 -LVDRE-LG--SNYD--R-----IEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 416 -~~d~~-l~--~~~~--~-----~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
..++. .. .... . .....+.+++.+|++.||++|||+.|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 236 PHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred cccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 00000 00 0000 0 01246789999999999999999999974
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-39 Score=311.04 Aligned_cols=250 Identities=22% Similarity=0.319 Sum_probs=195.2
Q ss_pred hCCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEeh----------------hhhhhcccCc-eeeEEEEEeCCC------
Q 039819 202 ENFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLK----------------DMISLAVHRN-LLRLIGYCATPT------ 257 (534)
Q Consensus 202 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~----------------~~l~~~~h~n-iv~l~~~~~~~~------ 257 (534)
..|...+.||+|+||+||+|+.. +|..||+|++. .+++.++|+| ||++.+++....
T Consensus 11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~ 90 (323)
T KOG0594|consen 11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG 90 (323)
T ss_pred HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence 34555677999999999999864 78999999875 2788999999 999999998877
Q ss_pred eeEEEeeccCCCChhhhcccCC----CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEeccc
Q 039819 258 ERLLVYPYMSNGSVASRLREKP----ALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGL 333 (534)
Q Consensus 258 ~~~lv~e~~~~gsL~~~l~~~~----~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGl 333 (534)
..++||||++. +|..++.... .++...++.++.|+++||+|||++ +|+||||||.|||+++.|.+||+|||+
T Consensus 91 ~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~---~IlHRDLKPQNlLi~~~G~lKlaDFGl 166 (323)
T KOG0594|consen 91 KLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSH---GILHRDLKPQNLLISSSGVLKLADFGL 166 (323)
T ss_pred eEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCcceEEECCCCcEeeeccch
Confidence 77899999965 8888887533 577789999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCCceeeccccccccccccccccC-CCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcc
Q 039819 334 AKLLDHSDSHVTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKK 412 (534)
Q Consensus 334 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 412 (534)
|+...-.. ...+..++|.+|+|||++.+. .|+...||||+|||+.||+++++.|++.++.++...+.+.++......+
T Consensus 167 Ara~~ip~-~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~W 245 (323)
T KOG0594|consen 167 ARAFSIPM-RTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDW 245 (323)
T ss_pred HHHhcCCc-ccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCC
Confidence 99665322 224556689999999999876 6899999999999999999999999988887776666666655544433
Q ss_pred cceecccccCCCCC---------HHHH---HHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 413 VEVLVDRELGSNYD---------RIEV---GEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 413 ~~~~~d~~l~~~~~---------~~~~---~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
.....-++....+. .... ....+++.+|++.+|.+|.+++.++.
T Consensus 246 p~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~ 301 (323)
T KOG0594|consen 246 PGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALT 301 (323)
T ss_pred CCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhc
Confidence 22221111111110 1111 25667777777777777777776664
|
|
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=312.20 Aligned_cols=236 Identities=26% Similarity=0.399 Sum_probs=191.2
Q ss_pred CCCcCCeeccCCcEEEEEEEECCCcEEEEEEehh-------------hhhhcccCceeeEEEEEeCCCeeEEEeeccCCC
Q 039819 203 NFSSKNILGAGGFGNVYKGKLGDGTVLAVKRLKD-------------MISLAVHRNLLRLIGYCATPTERLLVYPYMSNG 269 (534)
Q Consensus 203 ~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~-------------~l~~~~h~niv~l~~~~~~~~~~~lv~e~~~~g 269 (534)
+|+..+.||+|+||.||+|...++..+|+|.+.+ ++..+.|+||+++++++......++||||++++
T Consensus 5 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 84 (256)
T cd05059 5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANG 84 (256)
T ss_pred HcchhhhhccCCCceEEEeEecCCccEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCCC
Confidence 4677789999999999999988778899998752 567788999999999999999999999999999
Q ss_pred Chhhhccc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCCceeecc
Q 039819 270 SVASRLRE-KPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAV 348 (534)
Q Consensus 270 sL~~~l~~-~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~~ 348 (534)
+|.+++.. ...+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.............
T Consensus 85 ~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 161 (256)
T cd05059 85 CLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESN---GFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGT 161 (256)
T ss_pred CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHhhEEECCCCcEEECCcccceecccccccccCCC
Confidence 99999875 44689999999999999999999998 999999999999999999999999999986643222111222
Q ss_pred ccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCcCCCccccccchHHHHHHHHhhhcccceecccccCCCCCH
Q 039819 349 RGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELGSNYDR 427 (534)
Q Consensus 349 ~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 427 (534)
.++..|+|||++.+..++.++|||||||++|||+| |+.||...... +......... . ...+.
T Consensus 162 ~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~-------~~~~~~~~~~------~----~~~~~ 224 (256)
T cd05059 162 KFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNS-------EVVESVSAGY------R----LYRPK 224 (256)
T ss_pred CCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHH-------HHHHHHHcCC------c----CCCCC
Confidence 24467999999988889999999999999999999 89888643211 1111111110 0 01112
Q ss_pred HHHHHHHHHHHHhcccCCCCCCChHHHHHHh
Q 039819 428 IEVGEILQVALLCTQYLPVHRPKMSEVVRML 458 (534)
Q Consensus 428 ~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L 458 (534)
..+..+.+++.+|+..+|++||+|.|+++.|
T Consensus 225 ~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 225 LAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred CCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 2355899999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=326.81 Aligned_cols=250 Identities=22% Similarity=0.320 Sum_probs=190.4
Q ss_pred CCCcCCeeccCCcEEEEEEEE-CCCcEEEEEEehh----------------hhhhcccCceeeEEEEEeCCC-----eeE
Q 039819 203 NFSSKNILGAGGFGNVYKGKL-GDGTVLAVKRLKD----------------MISLAVHRNLLRLIGYCATPT-----ERL 260 (534)
Q Consensus 203 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~----------------~l~~~~h~niv~l~~~~~~~~-----~~~ 260 (534)
+|+..+.||+|+||.||++.. .+++.||||++.. ++..++|+||+++++++.... ..+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 477889999999999999997 4789999997742 567788999999999998776 789
Q ss_pred EEeeccCCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCC
Q 039819 261 LVYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHS 340 (534)
Q Consensus 261 lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~ 340 (534)
+||||+. ++|.+.+.....+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 81 lv~e~~~-~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~ 156 (372)
T cd07853 81 VVTELMQ-SDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARVEEPD 156 (372)
T ss_pred EEeeccc-cCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHHEEECCCCCEEeccccceeecccC
Confidence 9999997 57888887777899999999999999999999998 9999999999999999999999999999876443
Q ss_pred CCceeeccccccccccccccccC-CCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhh-------hcc
Q 039819 341 DSHVTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQ-------EKK 412 (534)
Q Consensus 341 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~-------~~~ 412 (534)
.........+|..|+|||++.+. .++.++|||||||++|||++|+.||...........+.+....... ...
T Consensus 157 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~ 236 (372)
T cd07853 157 ESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGA 236 (372)
T ss_pred ccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHH
Confidence 33233344678999999998764 4789999999999999999999999755432222111111000000 000
Q ss_pred cceecc-----cccC--CCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 413 VEVLVD-----RELG--SNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 413 ~~~~~d-----~~l~--~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
...+.. +... .........++.+++.+|++.||.+|||+.|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 287 (372)
T cd07853 237 RAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALA 287 (372)
T ss_pred HHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhc
Confidence 000000 0000 0011112457889999999999999999999986
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-39 Score=331.97 Aligned_cols=238 Identities=19% Similarity=0.268 Sum_probs=186.8
Q ss_pred hCCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEehh-----------------hhhhcccCceeeEEEEEeCCCeeEEEe
Q 039819 202 ENFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLKD-----------------MISLAVHRNLLRLIGYCATPTERLLVY 263 (534)
Q Consensus 202 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~-----------------~l~~~~h~niv~l~~~~~~~~~~~lv~ 263 (534)
++|...+.||+|+||.||+++.. +++.||||++.. ++..+.|||||++++++.+....|+||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 36888899999999999999874 788999998742 456778999999999999999999999
Q ss_pred eccCCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCC-
Q 039819 264 PYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDS- 342 (534)
Q Consensus 264 e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~- 342 (534)
||+++|+|.+++.....+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 81 E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~---givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~ 157 (377)
T cd05629 81 EFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKL---GFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDS 157 (377)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEEeeccccccccccccc
Confidence 9999999999998888899999999999999999999998 999999999999999999999999999963311000
Q ss_pred ---------------------------------------------ceeeccccccccccccccccCCCCcchhHHHHHHH
Q 039819 343 ---------------------------------------------HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGIL 377 (534)
Q Consensus 343 ---------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvv 377 (534)
.......||+.|+|||++.+..++.++|||||||+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvi 237 (377)
T cd05629 158 AYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAI 237 (377)
T ss_pred ccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecchh
Confidence 00012469999999999988889999999999999
Q ss_pred HHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceecccccCCCCCHHHHHHHHHHHHHhcccCCCCC---CChHHH
Q 039819 378 LLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELGSNYDRIEVGEILQVALLCTQYLPVHR---PKMSEV 454 (534)
Q Consensus 378 l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~R---Pt~~ev 454 (534)
+|||+||+.||...........+..|. .. + .+.. ......++.+++.+|+. +|.+| +++.|+
T Consensus 238 l~elltG~~Pf~~~~~~~~~~~i~~~~------~~---~---~~p~--~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~ 302 (377)
T cd05629 238 MFECLIGWPPFCSENSHETYRKIINWR------ET---L---YFPD--DIHLSVEAEDLIRRLIT-NAENRLGRGGAHEI 302 (377)
T ss_pred hhhhhcCCCCCCCCCHHHHHHHHHccC------Cc---c---CCCC--CCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHH
Confidence 999999999997433211111111110 00 0 0000 00123467889999997 66665 588888
Q ss_pred HHH
Q 039819 455 VRM 457 (534)
Q Consensus 455 ~~~ 457 (534)
+..
T Consensus 303 l~h 305 (377)
T cd05629 303 KSH 305 (377)
T ss_pred hcC
Confidence 763
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=320.54 Aligned_cols=223 Identities=24% Similarity=0.293 Sum_probs=182.9
Q ss_pred CeeccCCcEEEEEEEEC-CCcEEEEEEehh------------------hhhhcccCceeeEEEEEeCCCeeEEEeeccCC
Q 039819 208 NILGAGGFGNVYKGKLG-DGTVLAVKRLKD------------------MISLAVHRNLLRLIGYCATPTERLLVYPYMSN 268 (534)
Q Consensus 208 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~------------------~l~~~~h~niv~l~~~~~~~~~~~lv~e~~~~ 268 (534)
+.||+|+||.||+|+.. ++..||+|.+.. ++..++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999985 688999998742 35677899999999999999999999999999
Q ss_pred CChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCCceeecc
Q 039819 269 GSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAV 348 (534)
Q Consensus 269 gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~~ 348 (534)
|+|...+.....+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++...... ......
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~-~~~~~~ 156 (321)
T cd05603 81 GELFFHLQRERCFLEPRARFYAAEVASAIGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE-ETTSTF 156 (321)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEccCCCCccCCCCC-Cccccc
Confidence 99999988777899999999999999999999998 99999999999999999999999999987542221 123345
Q ss_pred ccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceecccccCCCCCHH
Q 039819 349 RGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELGSNYDRI 428 (534)
Q Consensus 349 ~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 428 (534)
.||+.|+|||++.+..++.++|||||||++|||++|+.||..... .+........ . ...+..
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-------~~~~~~i~~~-~----------~~~~~~ 218 (321)
T cd05603 157 CGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDV-------SQMYDNILHK-P----------LQLPGG 218 (321)
T ss_pred cCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCH-------HHHHHHHhcC-C----------CCCCCC
Confidence 689999999999888899999999999999999999999964321 1111111111 0 011112
Q ss_pred HHHHHHHHHHHhcccCCCCCCChH
Q 039819 429 EVGEILQVALLCTQYLPVHRPKMS 452 (534)
Q Consensus 429 ~~~~l~~l~~~Cl~~~P~~RPt~~ 452 (534)
....+.+++.+|++.+|.+||+..
T Consensus 219 ~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 219 KTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred CCHHHHHHHHHHccCCHhhcCCCC
Confidence 244788999999999999999864
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=321.61 Aligned_cols=228 Identities=23% Similarity=0.289 Sum_probs=186.5
Q ss_pred CeeccCCcEEEEEEEEC-CCcEEEEEEehh-----------------hhhhcccCceeeEEEEEeCCCeeEEEeeccCCC
Q 039819 208 NILGAGGFGNVYKGKLG-DGTVLAVKRLKD-----------------MISLAVHRNLLRLIGYCATPTERLLVYPYMSNG 269 (534)
Q Consensus 208 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~-----------------~l~~~~h~niv~l~~~~~~~~~~~lv~e~~~~g 269 (534)
+.||+|+||.||+++.. ++..||+|.+.. ++..++||||+++.+++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999864 689999998752 466778999999999999999999999999999
Q ss_pred ChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCCceeecc
Q 039819 270 SVASRLREKPALDWNTRKRIAIGAARGLLYLHE-QCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAV 348 (534)
Q Consensus 270 sL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~-~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~~ 348 (534)
+|..++.....+++..+..++.|++.||.|||+ . +|+||||||+|||++.++.+||+|||+++....... .....
T Consensus 81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~---~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~-~~~~~ 156 (325)
T cd05594 81 ELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA-TMKTF 156 (325)
T ss_pred cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcC---CEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc-ccccc
Confidence 999999887889999999999999999999997 6 899999999999999999999999999875432221 22345
Q ss_pred ccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceecccccCCCCCHH
Q 039819 349 RGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELGSNYDRI 428 (534)
Q Consensus 349 ~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 428 (534)
.||..|+|||++.+..++.++|||||||++|||+||+.||..... .......... . .. ++..
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~-------~~~~~~i~~~-~------~~----~p~~ 218 (325)
T cd05594 157 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-------EKLFELILME-E------IR----FPRT 218 (325)
T ss_pred cCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCH-------HHHHHHHhcC-C------CC----CCCC
Confidence 699999999999888999999999999999999999999964321 1111111110 0 01 1112
Q ss_pred HHHHHHHHHHHhcccCCCCCC-----ChHHHHHH
Q 039819 429 EVGEILQVALLCTQYLPVHRP-----KMSEVVRM 457 (534)
Q Consensus 429 ~~~~l~~l~~~Cl~~~P~~RP-----t~~ev~~~ 457 (534)
....+.+++.+|++.+|++|+ ++.++++.
T Consensus 219 ~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 219 LSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred CCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 244788999999999999997 88888753
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=322.67 Aligned_cols=227 Identities=27% Similarity=0.356 Sum_probs=186.4
Q ss_pred CeeccCCcEEEEEEEE----CCCcEEEEEEehh------------------hhhhcccCceeeEEEEEeCCCeeEEEeec
Q 039819 208 NILGAGGFGNVYKGKL----GDGTVLAVKRLKD------------------MISLAVHRNLLRLIGYCATPTERLLVYPY 265 (534)
Q Consensus 208 ~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~------------------~l~~~~h~niv~l~~~~~~~~~~~lv~e~ 265 (534)
+.||+|+||.||+++. ..++.||||.+.. ++..+.||||+++++++...+..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 5799999999999985 3578999998742 57788899999999999999999999999
Q ss_pred cCCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCCcee
Q 039819 266 MSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVT 345 (534)
Q Consensus 266 ~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~ 345 (534)
+++|+|.+++.....+.+..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++...... ...
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~ 157 (323)
T cd05584 82 LSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG-TVT 157 (323)
T ss_pred CCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEeeCcCCeecccCC-Ccc
Confidence 99999999998888899999999999999999999998 99999999999999999999999999987543222 123
Q ss_pred eccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceecccccCCCC
Q 039819 346 TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELGSNY 425 (534)
Q Consensus 346 ~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 425 (534)
....||+.|+|||++.+..++.++|||||||++|||++|+.||..... ........... .. .
T Consensus 158 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~-------~~~~~~~~~~~-------~~----~ 219 (323)
T cd05584 158 HTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENR-------KKTIDKILKGK-------LN----L 219 (323)
T ss_pred cccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCH-------HHHHHHHHcCC-------CC----C
Confidence 345699999999999888899999999999999999999999974321 11111111110 01 1
Q ss_pred CHHHHHHHHHHHHHhcccCCCCCC-----ChHHHHH
Q 039819 426 DRIEVGEILQVALLCTQYLPVHRP-----KMSEVVR 456 (534)
Q Consensus 426 ~~~~~~~l~~l~~~Cl~~~P~~RP-----t~~ev~~ 456 (534)
+......+.+++.+|++.+|++|| ++.++++
T Consensus 220 ~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~ 255 (323)
T cd05584 220 PPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS 255 (323)
T ss_pred CCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence 112234788999999999999999 6777665
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-38 Score=316.80 Aligned_cols=224 Identities=27% Similarity=0.390 Sum_probs=182.9
Q ss_pred CeeccCCcEEEEEEEEC-CCcEEEEEEehh-----------------hhhh-cccCceeeEEEEEeCCCeeEEEeeccCC
Q 039819 208 NILGAGGFGNVYKGKLG-DGTVLAVKRLKD-----------------MISL-AVHRNLLRLIGYCATPTERLLVYPYMSN 268 (534)
Q Consensus 208 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~-----------------~l~~-~~h~niv~l~~~~~~~~~~~lv~e~~~~ 268 (534)
+.||+|+||.||+|+.. +++.||||++.. .+.. ..||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999975 578999998752 2222 3699999999999999999999999999
Q ss_pred CChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCCceeecc
Q 039819 269 GSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAV 348 (534)
Q Consensus 269 gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~~ 348 (534)
|+|.+++.....+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++...... ......
T Consensus 81 g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~---~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~-~~~~~~ 156 (320)
T cd05590 81 GDLMFHIQKSRRFDEARARFYAAEITSALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG-KTTSTF 156 (320)
T ss_pred chHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC-Cccccc
Confidence 99999998888899999999999999999999998 99999999999999999999999999987643221 123345
Q ss_pred ccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceecccccCCCCCHH
Q 039819 349 RGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELGSNYDRI 428 (534)
Q Consensus 349 ~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 428 (534)
.||+.|+|||++.+..++.++|||||||++|||++|+.||..... .+....+.... . ..+..
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~-------~~~~~~i~~~~-~----------~~~~~ 218 (320)
T cd05590 157 CGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENE-------DDLFEAILNDE-V----------VYPTW 218 (320)
T ss_pred ccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH-------HHHHHHHhcCC-C----------CCCCC
Confidence 699999999999888899999999999999999999999974321 11122221110 0 01112
Q ss_pred HHHHHHHHHHHhcccCCCCCCChHH
Q 039819 429 EVGEILQVALLCTQYLPVHRPKMSE 453 (534)
Q Consensus 429 ~~~~l~~l~~~Cl~~~P~~RPt~~e 453 (534)
....+.+++.+|++.+|++||++.+
T Consensus 219 ~~~~~~~li~~~L~~dP~~R~~~~~ 243 (320)
T cd05590 219 LSQDAVDILKAFMTKNPTMRLGSLT 243 (320)
T ss_pred CCHHHHHHHHHHcccCHHHCCCCCC
Confidence 2447889999999999999999843
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-38 Score=320.13 Aligned_cols=186 Identities=26% Similarity=0.408 Sum_probs=165.1
Q ss_pred HhCCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEeh---------------hhhhhcccCceeeEEEEEeCCCeeEEEee
Q 039819 201 TENFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLK---------------DMISLAVHRNLLRLIGYCATPTERLLVYP 264 (534)
Q Consensus 201 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~---------------~~l~~~~h~niv~l~~~~~~~~~~~lv~e 264 (534)
.++|+..+.||+|+||.||++... ++..+|+|.+. +++..++|+||++++++|.+.+..++|||
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence 367889999999999999999986 67889999754 25678889999999999999999999999
Q ss_pred ccCCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCCce
Q 039819 265 YMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHV 344 (534)
Q Consensus 265 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~ 344 (534)
|+++|+|.+++.....+++..+..++.+++.||.|||+.. +|+||||||+|||++.++.+||+|||++...... .
T Consensus 84 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~---~ 158 (333)
T cd06650 84 HMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---M 158 (333)
T ss_pred cCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh---c
Confidence 9999999999988778999999999999999999999742 6999999999999999999999999999765332 1
Q ss_pred eeccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCC
Q 039819 345 TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFG 391 (534)
Q Consensus 345 ~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~ 391 (534)
.....||..|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~ 205 (333)
T cd06650 159 ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPP 205 (333)
T ss_pred cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence 23356899999999998888999999999999999999999999743
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-38 Score=323.74 Aligned_cols=247 Identities=22% Similarity=0.276 Sum_probs=193.1
Q ss_pred HHHHHHHHhCCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEehh-----------------hhhhcccCceeeEEEEEeC
Q 039819 194 FRELQQATENFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLKD-----------------MISLAVHRNLLRLIGYCAT 255 (534)
Q Consensus 194 ~~~l~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~-----------------~l~~~~h~niv~l~~~~~~ 255 (534)
..++....++|...+.||+|+||.||+++.. +++.+|+|.+.. ++..++||||+++++.+.+
T Consensus 35 ~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~ 114 (371)
T cd05622 35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 114 (371)
T ss_pred HhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence 3445556689999999999999999999986 578999998741 4667789999999999999
Q ss_pred CCeeEEEeeccCCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccce
Q 039819 256 PTERLLVYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAK 335 (534)
Q Consensus 256 ~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~ 335 (534)
....++||||+++|+|.+++... .++...+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus 115 ~~~~~lv~Ey~~gg~L~~~~~~~-~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NIll~~~~~ikL~DfG~a~ 190 (371)
T cd05622 115 DRYLYMVMEYMPGGDLVNLMSNY-DVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCM 190 (371)
T ss_pred CCEEEEEEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHEEECCCCCEEEEeCCcee
Confidence 99999999999999999988754 488999999999999999999999 99999999999999999999999999998
Q ss_pred ecCCCCCceeeccccccccccccccccC----CCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhc
Q 039819 336 LLDHSDSHVTTAVRGTVGHIAPEYLSTG----QSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEK 411 (534)
Q Consensus 336 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 411 (534)
..............||+.|+|||++... .++.++|||||||++|||++|+.||..... ......+....
T Consensus 191 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~-------~~~~~~i~~~~ 263 (371)
T cd05622 191 KMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL-------VGTYSKIMNHK 263 (371)
T ss_pred EcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCH-------HHHHHHHHcCC
Confidence 7654332233456799999999998653 378899999999999999999999974332 11111111111
Q ss_pred ccceecccccCCCCCHHHHHHHHHHHHHhcccCCCC--CCChHHHHHHh
Q 039819 412 KVEVLVDRELGSNYDRIEVGEILQVALLCTQYLPVH--RPKMSEVVRML 458 (534)
Q Consensus 412 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~--RPt~~ev~~~L 458 (534)
....+ . ........+.+++.+|+...+.+ ||+++|+++..
T Consensus 264 ~~~~~-----~--~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~ 305 (371)
T cd05622 264 NSLTF-----P--DDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL 305 (371)
T ss_pred CcccC-----C--CcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence 00000 0 01122447788999999844443 77888888754
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=336.44 Aligned_cols=250 Identities=21% Similarity=0.292 Sum_probs=185.4
Q ss_pred HhCCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEeh----------hhhhhcccCceeeEEEEEeCC--------CeeEE
Q 039819 201 TENFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLK----------DMISLAVHRNLLRLIGYCATP--------TERLL 261 (534)
Q Consensus 201 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~----------~~l~~~~h~niv~l~~~~~~~--------~~~~l 261 (534)
..+|...+.||+|+||.||+|... .++.||||++. .++..++|||||++++++... ...++
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l~l 144 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNV 144 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCcchHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceEEEE
Confidence 357889999999999999999874 68899999874 278889999999999887432 23579
Q ss_pred EeeccCCCChhhhcc----cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCC-cEEEEeccccee
Q 039819 262 VYPYMSNGSVASRLR----EKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFC-EAIVGDFGLAKL 336 (534)
Q Consensus 262 v~e~~~~gsL~~~l~----~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~-~~kl~DFGla~~ 336 (534)
||||+++ +|.+++. ....+++..++.++.|++.||.|||+. +|+||||||+|||++.++ .+||+|||+++.
T Consensus 145 vmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~---~IiHrDLKp~NILl~~~~~~vkL~DFGla~~ 220 (440)
T PTZ00036 145 VMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSK---FICHRDLKPQNLLIDPNTHTLKLCDFGSAKN 220 (440)
T ss_pred EEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCcCHHHEEEcCCCCceeeeccccchh
Confidence 9999985 6666553 456799999999999999999999999 999999999999999664 799999999987
Q ss_pred cCCCCCceeecccccccccccccccc-CCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhh-----
Q 039819 337 LDHSDSHVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQE----- 410 (534)
Q Consensus 337 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~----- 410 (534)
+.... ......||+.|+|||++.+ ..++.++|||||||++|||+||++||...........+.+.......+
T Consensus 221 ~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~ 298 (440)
T PTZ00036 221 LLAGQ--RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEM 298 (440)
T ss_pred ccCCC--CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHh
Confidence 64322 1234568999999998865 468999999999999999999999997544322211111111000000
Q ss_pred -ccccee-----cccccCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 411 -KKVEVL-----VDRELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 411 -~~~~~~-----~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
.....+ ....+...++...+.++.+++.+|++.+|.+|||+.|+++
T Consensus 299 ~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~ 350 (440)
T PTZ00036 299 NPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALA 350 (440)
T ss_pred chhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhC
Confidence 000000 0000111111223457899999999999999999999875
|
|
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=321.00 Aligned_cols=239 Identities=25% Similarity=0.421 Sum_probs=189.7
Q ss_pred hCCCcCCeeccCCcEEEEEEEEC-CCc----EEEEEEehh---------------hhhhcccCceeeEEEEEeCCCeeEE
Q 039819 202 ENFSSKNILGAGGFGNVYKGKLG-DGT----VLAVKRLKD---------------MISLAVHRNLLRLIGYCATPTERLL 261 (534)
Q Consensus 202 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~----~vavK~~~~---------------~l~~~~h~niv~l~~~~~~~~~~~l 261 (534)
.+|+..+.||+|+||.||+|++. ++. .||||.+.. ++..+.||||++++|+|... ..++
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~ 85 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 85 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence 46888999999999999999863 333 489998741 56788899999999999764 5789
Q ss_pred EeeccCCCChhhhcccC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCC
Q 039819 262 VYPYMSNGSVASRLREK-PALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHS 340 (534)
Q Consensus 262 v~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~ 340 (534)
|+||+++|+|.+++... ..+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 86 v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~ 162 (316)
T cd05108 86 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAD 162 (316)
T ss_pred eeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEecCCCcEEEccccccccccCC
Confidence 99999999999999764 4689999999999999999999998 9999999999999999999999999999876543
Q ss_pred CCce-eeccccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCcCCCccccccchHHHHHHHHhhhcccceecc
Q 039819 341 DSHV-TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVD 418 (534)
Q Consensus 341 ~~~~-~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 418 (534)
.... .....++..|+|||++.+..++.++|||||||++|||+| |+.||..... .++..........
T Consensus 163 ~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~-------~~~~~~~~~~~~~----- 230 (316)
T cd05108 163 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA-------SEISSILEKGERL----- 230 (316)
T ss_pred CcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH-------HHHHHHHhCCCCC-----
Confidence 2211 122234678999999998899999999999999999998 9999864221 1111111111100
Q ss_pred cccCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhcC
Q 039819 419 RELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLEGD 461 (534)
Q Consensus 419 ~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~~ 461 (534)
..+......+.+++.+||+.+|.+||++.+++..+...
T Consensus 231 -----~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~ 268 (316)
T cd05108 231 -----PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 268 (316)
T ss_pred -----CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 01112234788999999999999999999999987754
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=316.69 Aligned_cols=225 Identities=27% Similarity=0.357 Sum_probs=182.9
Q ss_pred CCcCCeeccCCcEEEEEEEEC-CCcEEEEEEehh--------------------hhhhcccCceeeEEEEEeCCCeeEEE
Q 039819 204 FSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLKD--------------------MISLAVHRNLLRLIGYCATPTERLLV 262 (534)
Q Consensus 204 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~--------------------~l~~~~h~niv~l~~~~~~~~~~~lv 262 (534)
|...+.||+|+||.||+|... +++.||||.++. .+..++||||+++++++......|+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 556789999999999999875 689999998852 12456799999999999999999999
Q ss_pred eeccCCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCC
Q 039819 263 YPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDS 342 (534)
Q Consensus 263 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~ 342 (534)
|||+++|+|...++. ..+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 81 ~E~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~- 155 (324)
T cd05589 81 MEYAAGGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFG- 155 (324)
T ss_pred EcCCCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCcEEeCcccCCccCCCCC-
Confidence 999999999888865 4699999999999999999999998 99999999999999999999999999987543221
Q ss_pred ceeeccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceecccccC
Q 039819 343 HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELG 422 (534)
Q Consensus 343 ~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 422 (534)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||..... .+......... ..
T Consensus 156 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~-------~~~~~~i~~~~-------~~-- 219 (324)
T cd05589 156 DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDE-------EEVFDSIVNDE-------VR-- 219 (324)
T ss_pred CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCH-------HHHHHHHHhCC-------CC--
Confidence 223346799999999999988899999999999999999999999974321 11111111110 01
Q ss_pred CCCCHHHHHHHHHHHHHhcccCCCCCCCh
Q 039819 423 SNYDRIEVGEILQVALLCTQYLPVHRPKM 451 (534)
Q Consensus 423 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~ 451 (534)
++...+..+.+++.+|++.+|.+||++
T Consensus 220 --~p~~~~~~~~~li~~~L~~dP~~R~~~ 246 (324)
T cd05589 220 --YPRFLSREAISIMRRLLRRNPERRLGS 246 (324)
T ss_pred --CCCCCCHHHHHHHHHHhhcCHhHcCCC
Confidence 111224578899999999999999954
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=328.77 Aligned_cols=241 Identities=25% Similarity=0.353 Sum_probs=189.9
Q ss_pred HhCCCcCCeeccCCcEEEEEEEEC------CCcEEEEEEehh---------------hhhhcc-cCceeeEEEEEeCCCe
Q 039819 201 TENFSSKNILGAGGFGNVYKGKLG------DGTVLAVKRLKD---------------MISLAV-HRNLLRLIGYCATPTE 258 (534)
Q Consensus 201 ~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~---------------~l~~~~-h~niv~l~~~~~~~~~ 258 (534)
.++|...+.||+|+||.||+|+.. .+..||||++.. ++..+. |||||+++++|.+...
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~ 115 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGP 115 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCc
Confidence 357788899999999999999852 234699998852 455664 9999999999999999
Q ss_pred eEEEeeccCCCChhhhcccC------------------------------------------------------------
Q 039819 259 RLLVYPYMSNGSVASRLREK------------------------------------------------------------ 278 (534)
Q Consensus 259 ~~lv~e~~~~gsL~~~l~~~------------------------------------------------------------ 278 (534)
.++|||||++|+|.+++...
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (400)
T cd05105 116 IYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIK 195 (400)
T ss_pred eEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhh
Confidence 99999999999999887531
Q ss_pred ------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCC
Q 039819 279 ------------------------------------PALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDD 322 (534)
Q Consensus 279 ------------------------------------~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~ 322 (534)
..+++..+..++.|+++||.|||+. +|+||||||+|||++.
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dikp~Nill~~ 272 (400)
T cd05105 196 EASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK---NCVHRDLAARNVLLAQ 272 (400)
T ss_pred hhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHhEEEeC
Confidence 2478888999999999999999998 9999999999999999
Q ss_pred CCcEEEEecccceecCCCCCc-eeeccccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCcCCCccccccchH
Q 039819 323 FCEAIVGDFGLAKLLDHSDSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GMRALEFGKSINQKGAM 400 (534)
Q Consensus 323 ~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~ 400 (534)
++.+||+|||+++........ ......++..|+|||++.+..++.++|||||||++|||++ |..||+..... ..+
T Consensus 273 ~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~---~~~ 349 (400)
T cd05105 273 GKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVD---STF 349 (400)
T ss_pred CCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchh---HHH
Confidence 999999999999865432221 1222346788999999988889999999999999999997 99998642210 011
Q ss_pred HHHHHHHhhhcccceecccccCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhc
Q 039819 401 LEWVKKIQQEKKVEVLVDRELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLEG 460 (534)
Q Consensus 401 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~ 460 (534)
. ....... ....+...+..+.+++.+||+.+|++||++.+|+++|+.
T Consensus 350 ~---~~~~~~~----------~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~ 396 (400)
T cd05105 350 Y---NKIKSGY----------RMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVES 396 (400)
T ss_pred H---HHHhcCC----------CCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHH
Confidence 1 1111110 001112234578999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=320.93 Aligned_cols=227 Identities=26% Similarity=0.341 Sum_probs=185.4
Q ss_pred CCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEehh-----------------hhhhc-ccCceeeEEEEEeCCCeeEEEe
Q 039819 203 NFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLKD-----------------MISLA-VHRNLLRLIGYCATPTERLLVY 263 (534)
Q Consensus 203 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~-----------------~l~~~-~h~niv~l~~~~~~~~~~~lv~ 263 (534)
+|...+.||+|+||.||+|+.. ++..||||.+.. ++... .|++|+++.+++...+..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 4778899999999999999875 578999998752 12222 5899999999999999999999
Q ss_pred eccCCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCCc
Q 039819 264 PYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSH 343 (534)
Q Consensus 264 e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~ 343 (534)
||+++|+|.+.+.....+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++...... .
T Consensus 81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~-~ 156 (323)
T cd05616 81 EYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG-V 156 (323)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CEEecCCCHHHeEECCCCcEEEccCCCceecCCCC-C
Confidence 9999999999998878899999999999999999999998 99999999999999999999999999998543222 1
Q ss_pred eeeccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceecccccCC
Q 039819 344 VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELGS 423 (534)
Q Consensus 344 ~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 423 (534)
......||+.|+|||++.+..++.++|||||||++|||+||+.||...... +....+.... .
T Consensus 157 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~-------~~~~~i~~~~-----------~ 218 (323)
T cd05616 157 TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED-------ELFQSIMEHN-----------V 218 (323)
T ss_pred ccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHH-------HHHHHHHhCC-----------C
Confidence 233456999999999999999999999999999999999999999743221 1111111110 0
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCCh
Q 039819 424 NYDRIEVGEILQVALLCTQYLPVHRPKM 451 (534)
Q Consensus 424 ~~~~~~~~~l~~l~~~Cl~~~P~~RPt~ 451 (534)
.++.....++.+++.+|++.+|.+|++.
T Consensus 219 ~~p~~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 219 AYPKSMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred CCCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence 1122234578899999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=322.43 Aligned_cols=230 Identities=24% Similarity=0.283 Sum_probs=187.0
Q ss_pred CeeccCCcEEEEEEEEC-CCcEEEEEEehh------------------hhhhcccCceeeEEEEEeCCCeeEEEeeccCC
Q 039819 208 NILGAGGFGNVYKGKLG-DGTVLAVKRLKD------------------MISLAVHRNLLRLIGYCATPTERLLVYPYMSN 268 (534)
Q Consensus 208 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~------------------~l~~~~h~niv~l~~~~~~~~~~~lv~e~~~~ 268 (534)
+.||+|+||.||+|+.. +++.||||++.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 36999999999999874 689999998742 35668899999999999999999999999999
Q ss_pred CChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCCceeecc
Q 039819 269 GSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAV 348 (534)
Q Consensus 269 gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~~ 348 (534)
|+|..++.....+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++...... ......
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~---givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~-~~~~~~ 156 (325)
T cd05604 81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSI---NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQS-DTTTTF 156 (325)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEeecCCcccCCCCC-CCcccc
Confidence 99999998888899999999999999999999998 99999999999999999999999999987542211 123345
Q ss_pred ccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceecccccCCCCCHH
Q 039819 349 RGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELGSNYDRI 428 (534)
Q Consensus 349 ~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 428 (534)
.||..|+|||++.+..++.++|||||||++|||++|+.||..... .+........ . ..+.. .
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~-------~~~~~~~~~~-~------~~~~~----~ 218 (325)
T cd05604 157 CGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDV-------AEMYDNILHK-P------LVLRP----G 218 (325)
T ss_pred cCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCH-------HHHHHHHHcC-C------ccCCC----C
Confidence 699999999999998999999999999999999999999974321 1111111111 0 01111 1
Q ss_pred HHHHHHHHHHHhcccCCCCCCChHHHHHHhh
Q 039819 429 EVGEILQVALLCTQYLPVHRPKMSEVVRMLE 459 (534)
Q Consensus 429 ~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~ 459 (534)
....+.+++.+|++.+|.+||++++.++.+.
T Consensus 219 ~~~~~~~ll~~ll~~~p~~R~~~~~~~~~i~ 249 (325)
T cd05604 219 ASLTAWSILEELLEKDRQRRLGAKEDFLEIQ 249 (325)
T ss_pred CCHHHHHHHHHHhccCHHhcCCCCCCHHHHh
Confidence 2346789999999999999999975554443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=312.19 Aligned_cols=240 Identities=29% Similarity=0.419 Sum_probs=197.6
Q ss_pred HHhCCCcCCeeccCCcEEEEEEEECCCcEEEEEEehh--------------hhhhcccCceeeEEEEEeCCCeeEEEeec
Q 039819 200 ATENFSSKNILGAGGFGNVYKGKLGDGTVLAVKRLKD--------------MISLAVHRNLLRLIGYCATPTERLLVYPY 265 (534)
Q Consensus 200 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~--------------~l~~~~h~niv~l~~~~~~~~~~~lv~e~ 265 (534)
...+|...+.||.|+||.||+|...++..+|+|.+.. .+..++|+||+++++++......++||||
T Consensus 4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 83 (261)
T cd05148 4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITEL 83 (261)
T ss_pred cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEee
Confidence 4567888899999999999999998899999998752 56788999999999999999999999999
Q ss_pred cCCCChhhhccc--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCCc
Q 039819 266 MSNGSVASRLRE--KPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSH 343 (534)
Q Consensus 266 ~~~gsL~~~l~~--~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~ 343 (534)
+++|+|.+++.. ...+++..+..++.+++.||.|||+. +|+||||||+||+++.++.+||+|||++........
T Consensus 84 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~- 159 (261)
T cd05148 84 MEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVY- 159 (261)
T ss_pred cccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccCcceEEEcCCceEEEccccchhhcCCccc-
Confidence 999999999975 34689999999999999999999998 999999999999999999999999999987643321
Q ss_pred eeeccccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCcCCCccccccchHHHHHHHHhhhcccceecccccC
Q 039819 344 VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELG 422 (534)
Q Consensus 344 ~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 422 (534)
......++..|+|||++....++.++||||||+++|||++ |+.||..... ...... ..... .
T Consensus 160 ~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~----~~~~~~---~~~~~----------~ 222 (261)
T cd05148 160 LSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNN----HEVYDQ---ITAGY----------R 222 (261)
T ss_pred cccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCH----HHHHHH---HHhCC----------c
Confidence 1223346778999999988889999999999999999998 8999864321 111111 11110 0
Q ss_pred CCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhc
Q 039819 423 SNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLEG 460 (534)
Q Consensus 423 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~ 460 (534)
...+...+..+.+++.+|++.+|++|||+.++++.|+.
T Consensus 223 ~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~ 260 (261)
T cd05148 223 MPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDN 260 (261)
T ss_pred CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence 11122334578999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=320.02 Aligned_cols=227 Identities=25% Similarity=0.343 Sum_probs=183.9
Q ss_pred CCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEehh-----------------hhhhccc-CceeeEEEEEeCCCeeEEEe
Q 039819 203 NFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLKD-----------------MISLAVH-RNLLRLIGYCATPTERLLVY 263 (534)
Q Consensus 203 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~-----------------~l~~~~h-~niv~l~~~~~~~~~~~lv~ 263 (534)
+|...+.||+|+||.||+|+.. +++.||||++.. ++..+.| ++|+++++++...+..|+||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 4778899999999999999875 578899998752 3344545 56888999999999999999
Q ss_pred eccCCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCCc
Q 039819 264 PYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSH 343 (534)
Q Consensus 264 e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~ 343 (534)
||+++|+|.+++.....+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++...... .
T Consensus 81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~-~ 156 (324)
T cd05587 81 EYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGG-K 156 (324)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEEcCCCCEEEeecCcceecCCCC-C
Confidence 9999999999998888899999999999999999999998 99999999999999999999999999987532221 1
Q ss_pred eeeccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceecccccCC
Q 039819 344 VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELGS 423 (534)
Q Consensus 344 ~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 423 (534)
......||..|+|||++.+..++.++|||||||++|||+||+.||...... +....+... . .
T Consensus 157 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~-------~~~~~i~~~-~------~---- 218 (324)
T cd05587 157 TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDED-------ELFQSIMEH-N------V---- 218 (324)
T ss_pred ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH-------HHHHHHHcC-C------C----
Confidence 233456999999999999888999999999999999999999999743211 111111110 0 0
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCCh
Q 039819 424 NYDRIEVGEILQVALLCTQYLPVHRPKM 451 (534)
Q Consensus 424 ~~~~~~~~~l~~l~~~Cl~~~P~~RPt~ 451 (534)
.++......+.+++.+|++.+|.+|++.
T Consensus 219 ~~~~~~~~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 219 SYPKSLSKEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred CCCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence 1112234578899999999999999987
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-38 Score=317.04 Aligned_cols=226 Identities=27% Similarity=0.369 Sum_probs=183.8
Q ss_pred CeeccCCcEEEEEEEEC-CCcEEEEEEehh-----------------hhh-hcccCceeeEEEEEeCCCeeEEEeeccCC
Q 039819 208 NILGAGGFGNVYKGKLG-DGTVLAVKRLKD-----------------MIS-LAVHRNLLRLIGYCATPTERLLVYPYMSN 268 (534)
Q Consensus 208 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~-----------------~l~-~~~h~niv~l~~~~~~~~~~~lv~e~~~~ 268 (534)
+.||+|+||.||+|+.. +++.||||.++. .+. ...||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 36999999999999975 578999998753 222 34799999999999999999999999999
Q ss_pred CChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCCceeecc
Q 039819 269 GSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAV 348 (534)
Q Consensus 269 gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~~ 348 (534)
|+|.+++.....+++.++..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++....... .....
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~ 156 (316)
T cd05619 81 GDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA-KTCTF 156 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCC-ceeee
Confidence 99999998877899999999999999999999998 999999999999999999999999999875422221 23345
Q ss_pred ccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceecccccCCCCCHH
Q 039819 349 RGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELGSNYDRI 428 (534)
Q Consensus 349 ~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 428 (534)
.||..|+|||++.+..++.++|||||||++|||++|+.||..... .+......... +. ++..
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~-------~~~~~~i~~~~-------~~----~~~~ 218 (316)
T cd05619 157 CGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDE-------EELFQSIRMDN-------PC----YPRW 218 (316)
T ss_pred cCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCH-------HHHHHHHHhCC-------CC----CCcc
Confidence 689999999999888899999999999999999999999974321 11111111110 11 1112
Q ss_pred HHHHHHHHHHHhcccCCCCCCChH-HHH
Q 039819 429 EVGEILQVALLCTQYLPVHRPKMS-EVV 455 (534)
Q Consensus 429 ~~~~l~~l~~~Cl~~~P~~RPt~~-ev~ 455 (534)
....+.+++.+|++.+|++||++. ++.
T Consensus 219 ~~~~~~~li~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05619 219 LTREAKDILVKLFVREPERRLGVKGDIR 246 (316)
T ss_pred CCHHHHHHHHHHhccCHhhcCCChHHHH
Confidence 234788999999999999999997 553
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-38 Score=309.57 Aligned_cols=239 Identities=27% Similarity=0.425 Sum_probs=193.0
Q ss_pred hCCCcCCeeccCCcEEEEEEEECC----CcEEEEEEehh---------------hhhhcccCceeeEEEEEeCCCeeEEE
Q 039819 202 ENFSSKNILGAGGFGNVYKGKLGD----GTVLAVKRLKD---------------MISLAVHRNLLRLIGYCATPTERLLV 262 (534)
Q Consensus 202 ~~~~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~---------------~l~~~~h~niv~l~~~~~~~~~~~lv 262 (534)
++|...+.||+|+||.||+|++.. ...||||.+.. .+..++||||+++++++...+..++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 83 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII 83 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence 568888999999999999998742 45799998752 56788899999999999999999999
Q ss_pred eeccCCCChhhhccc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCC
Q 039819 263 YPYMSNGSVASRLRE-KPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSD 341 (534)
Q Consensus 263 ~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~ 341 (534)
|||+++++|.+++.. ...+++..+..++.|++.||.|||+. +|+||||||+||+++.++.++|+|||+++......
T Consensus 84 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~ 160 (266)
T cd05033 84 TEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSE 160 (266)
T ss_pred EEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCCEEECccchhhcccccc
Confidence 999999999999875 34689999999999999999999998 99999999999999999999999999999775222
Q ss_pred C-ceeeccccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCcCCCccccccchHHHHHHHHhhhcccceeccc
Q 039819 342 S-HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDR 419 (534)
Q Consensus 342 ~-~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 419 (534)
. .......++..|+|||.+.+..++.++||||||+++|||++ |..||..... .+...........
T Consensus 161 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~-------~~~~~~~~~~~~~------ 227 (266)
T cd05033 161 ATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSN-------QDVIKAVEDGYRL------ 227 (266)
T ss_pred cceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCH-------HHHHHHHHcCCCC------
Confidence 2 11222335678999999988889999999999999999998 9999853211 1111111111000
Q ss_pred ccCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhc
Q 039819 420 ELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLEG 460 (534)
Q Consensus 420 ~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~ 460 (534)
..+...+..+.+++.+|++.+|++||++.+|++.|+.
T Consensus 228 ----~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~ 264 (266)
T cd05033 228 ----PPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDK 264 (266)
T ss_pred ----CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHh
Confidence 0111234578999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=313.15 Aligned_cols=240 Identities=24% Similarity=0.384 Sum_probs=190.6
Q ss_pred HHhCCCcCCeeccCCcEEEEEEEEC------CCcEEEEEEehh---------------hhhhcccCceeeEEEEEeCCCe
Q 039819 200 ATENFSSKNILGAGGFGNVYKGKLG------DGTVLAVKRLKD---------------MISLAVHRNLLRLIGYCATPTE 258 (534)
Q Consensus 200 ~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~---------------~l~~~~h~niv~l~~~~~~~~~ 258 (534)
.+++|+..+.||+|+||.||+|... .+..||||.+.. .+..++|+||+++++++.+...
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 83 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 83 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 4578999999999999999999753 346799998742 4567789999999999999999
Q ss_pred eEEEeeccCCCChhhhcccC----------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEE
Q 039819 259 RLLVYPYMSNGSVASRLREK----------PALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIV 328 (534)
Q Consensus 259 ~~lv~e~~~~gsL~~~l~~~----------~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl 328 (534)
.++||||+++|+|.+++... ..+++..+..++.|++.||.|||+. +++||||||+||++++++.++|
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCcchheEEEcCCCCEEE
Confidence 99999999999999988642 2367889999999999999999998 9999999999999999999999
Q ss_pred EecccceecCCCCCce-eeccccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCcCCCccccccchHHHHHHH
Q 039819 329 GDFGLAKLLDHSDSHV-TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GMRALEFGKSINQKGAMLEWVKK 406 (534)
Q Consensus 329 ~DFGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~ 406 (534)
+|||+++......... .....++..|+|||++.+..++.++|||||||++|||++ |..||..... .+....
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~-------~~~~~~ 233 (277)
T cd05062 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSN-------EQVLRF 233 (277)
T ss_pred CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH-------HHHHHH
Confidence 9999997654322111 112235778999999988889999999999999999999 7888864321 111111
Q ss_pred HhhhcccceecccccCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhh
Q 039819 407 IQQEKKVEVLVDRELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLE 459 (534)
Q Consensus 407 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~ 459 (534)
..... .. ..+...+..+.+++.+|++.+|++||++.|+++.|+
T Consensus 234 ~~~~~-~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 276 (277)
T cd05062 234 VMEGG-LL---------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276 (277)
T ss_pred HHcCC-cC---------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence 11111 00 111223457899999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=314.07 Aligned_cols=226 Identities=26% Similarity=0.350 Sum_probs=183.9
Q ss_pred CeeccCCcEEEEEEEEC-CCcEEEEEEehh-----------------hhh-hcccCceeeEEEEEeCCCeeEEEeeccCC
Q 039819 208 NILGAGGFGNVYKGKLG-DGTVLAVKRLKD-----------------MIS-LAVHRNLLRLIGYCATPTERLLVYPYMSN 268 (534)
Q Consensus 208 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~-----------------~l~-~~~h~niv~l~~~~~~~~~~~lv~e~~~~ 268 (534)
+.||+|+||.||+|+.. ++..||+|.++. .+. ...||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 46999999999999985 688999998752 122 34799999999999999999999999999
Q ss_pred CChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCCceeecc
Q 039819 269 GSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAV 348 (534)
Q Consensus 269 gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~~ 348 (534)
|+|.+++.....+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++...... ......
T Consensus 81 g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~ 156 (316)
T cd05620 81 GDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD-NRASTF 156 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEeCccCCCeecccCC-Cceecc
Confidence 99999998878899999999999999999999998 99999999999999999999999999987532222 223456
Q ss_pred ccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceecccccCCCCCHH
Q 039819 349 RGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELGSNYDRI 428 (534)
Q Consensus 349 ~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 428 (534)
.||..|+|||++.+..++.++|||||||++|||++|+.||..... .+........ .+.. +..
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~-------~~~~~~~~~~-------~~~~----~~~ 218 (316)
T cd05620 157 CGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDE-------DELFESIRVD-------TPHY----PRW 218 (316)
T ss_pred CCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH-------HHHHHHHHhC-------CCCC----CCC
Confidence 799999999999988999999999999999999999999974321 1111111111 0111 111
Q ss_pred HHHHHHHHHHHhcccCCCCCCChH-HHH
Q 039819 429 EVGEILQVALLCTQYLPVHRPKMS-EVV 455 (534)
Q Consensus 429 ~~~~l~~l~~~Cl~~~P~~RPt~~-ev~ 455 (534)
...++.+++.+|++.+|++||++. ++.
T Consensus 219 ~~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 219 ITKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred CCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 234788999999999999999985 444
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-38 Score=308.26 Aligned_cols=238 Identities=29% Similarity=0.421 Sum_probs=192.7
Q ss_pred hCCCcCCeeccCCcEEEEEEEECCCcEEEEEEeh-------------hhhhhcccCceeeEEEEEeCCCeeEEEeeccCC
Q 039819 202 ENFSSKNILGAGGFGNVYKGKLGDGTVLAVKRLK-------------DMISLAVHRNLLRLIGYCATPTERLLVYPYMSN 268 (534)
Q Consensus 202 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~-------------~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~~~ 268 (534)
++|+..+.||+|+||.||+|...++..+|+|.+. .++..++|+|++++++++. ....++||||+++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~~ 84 (260)
T cd05070 6 ESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYMSK 84 (260)
T ss_pred HHhhhhheeccccCceEEEEEecCCceeEEEEecCCCCCHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEecCC
Confidence 4678889999999999999998888889999875 2677889999999999885 4567999999999
Q ss_pred CChhhhccc--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCCceee
Q 039819 269 GSVASRLRE--KPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTT 346 (534)
Q Consensus 269 gsL~~~l~~--~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~ 346 (534)
++|.+++.. ...+++..+..++.+++.||.|||+. +|+||||||+||++++++.++|+|||++............
T Consensus 85 ~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~ 161 (260)
T cd05070 85 GSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERM---NYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQ 161 (260)
T ss_pred CcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEEeCCceEEeCCceeeeeccCccccccc
Confidence 999999875 34589999999999999999999998 9999999999999999999999999999876543222222
Q ss_pred ccccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCcCCCccccccchHHHHHHHHhhhcccceecccccCCCC
Q 039819 347 AVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELGSNY 425 (534)
Q Consensus 347 ~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 425 (534)
...++..|+|||++.+..++.++||||||+++|||++ |+.||..... .+......... ....
T Consensus 162 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~-------~~~~~~~~~~~----------~~~~ 224 (260)
T cd05070 162 GAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNN-------REVLEQVERGY----------RMPC 224 (260)
T ss_pred CCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCH-------HHHHHHHHcCC----------CCCC
Confidence 2335678999999988889999999999999999999 8888864221 11111111110 0111
Q ss_pred CHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhc
Q 039819 426 DRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLEG 460 (534)
Q Consensus 426 ~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~ 460 (534)
+...+..+.+++.+|++.+|++|||+.++.+.|+.
T Consensus 225 ~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 225 PQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred CCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 22234579999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=320.66 Aligned_cols=230 Identities=23% Similarity=0.287 Sum_probs=186.9
Q ss_pred CeeccCCcEEEEEEEEC-CCcEEEEEEehh------------------hhhhcccCceeeEEEEEeCCCeeEEEeeccCC
Q 039819 208 NILGAGGFGNVYKGKLG-DGTVLAVKRLKD------------------MISLAVHRNLLRLIGYCATPTERLLVYPYMSN 268 (534)
Q Consensus 208 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~------------------~l~~~~h~niv~l~~~~~~~~~~~lv~e~~~~ 268 (534)
+.||+|+||.||+|+.. +++.||+|++.. ++..+.|+||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 36999999999999975 578899998742 24567899999999999999999999999999
Q ss_pred CChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCCceeecc
Q 039819 269 GSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAV 348 (534)
Q Consensus 269 gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~~ 348 (534)
|+|.+++.....+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++...... ......
T Consensus 81 ~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~-~~~~~~ 156 (325)
T cd05602 81 GELFYHLQRERCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN-GTTSTF 156 (325)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEEccCCCCcccccCC-CCcccc
Confidence 99999998877899999999999999999999998 99999999999999999999999999997543221 123445
Q ss_pred ccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceecccccCCCCCHH
Q 039819 349 RGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELGSNYDRI 428 (534)
Q Consensus 349 ~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 428 (534)
.||+.|+|||++.+..++.++|||||||++|||++|+.||..... .+......... . .. ...
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-------~~~~~~i~~~~-~------~~----~~~ 218 (325)
T cd05602 157 CGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT-------AEMYDNILNKP-L------QL----KPN 218 (325)
T ss_pred cCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCH-------HHHHHHHHhCC-c------CC----CCC
Confidence 699999999999998999999999999999999999999964321 11111111110 0 01 111
Q ss_pred HHHHHHHHHHHhcccCCCCCCChHHHHHHhh
Q 039819 429 EVGEILQVALLCTQYLPVHRPKMSEVVRMLE 459 (534)
Q Consensus 429 ~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~ 459 (534)
....+.+++.+|++.+|.+||++.+.+..+.
T Consensus 219 ~~~~~~~li~~~l~~~p~~R~~~~~~~~~i~ 249 (325)
T cd05602 219 ITNSARHLLEGLLQKDRTKRLGAKDDFMEIK 249 (325)
T ss_pred CCHHHHHHHHHHcccCHHHCCCCCCCHHHHh
Confidence 2347889999999999999999886554443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=312.51 Aligned_cols=238 Identities=24% Similarity=0.421 Sum_probs=187.6
Q ss_pred hCCCcCCeeccCCcEEEEEEEEC-CCc----EEEEEEehh---------------hhhhcccCceeeEEEEEeCCCeeEE
Q 039819 202 ENFSSKNILGAGGFGNVYKGKLG-DGT----VLAVKRLKD---------------MISLAVHRNLLRLIGYCATPTERLL 261 (534)
Q Consensus 202 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~----~vavK~~~~---------------~l~~~~h~niv~l~~~~~~~~~~~l 261 (534)
++|...+.||+|+||.||+|.+. ++. .+++|.+.. .++.+.||||+++++++.. ...++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~ 85 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQL 85 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEE
Confidence 46777889999999999999874 343 477887641 3467789999999998864 45789
Q ss_pred EeeccCCCChhhhccc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCC
Q 039819 262 VYPYMSNGSVASRLRE-KPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHS 340 (534)
Q Consensus 262 v~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~ 340 (534)
|+||+++|+|.+++.. ...+++..+..|+.|++.||.|||+. +++||||||+|||++.++.+||+|||+++.....
T Consensus 86 i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~ 162 (279)
T cd05111 86 VTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEH---RMVHRNLAARNILLKSDSIVQIADFGVADLLYPD 162 (279)
T ss_pred EEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEEcCCccceeccCC
Confidence 9999999999999975 45799999999999999999999998 9999999999999999999999999999876432
Q ss_pred CC-ceeeccccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCcCCCccccccchHHHHHHHHhhhcccceecc
Q 039819 341 DS-HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVD 418 (534)
Q Consensus 341 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 418 (534)
.. .......++..|+|||++.++.++.++|||||||++|||+| |+.||..... ..+.+++ ..... ...
T Consensus 163 ~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~----~~~~~~~---~~~~~---~~~ 232 (279)
T cd05111 163 DKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRP----HEVPDLL---EKGER---LAQ 232 (279)
T ss_pred CcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCH----HHHHHHH---HCCCc---CCC
Confidence 21 12233457789999999988899999999999999999998 9999864321 1111111 11110 001
Q ss_pred cccCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhc
Q 039819 419 RELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLEG 460 (534)
Q Consensus 419 ~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~ 460 (534)
+......+.+++.+|+..+|++||++.|+++.|..
T Consensus 233 -------~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~ 267 (279)
T cd05111 233 -------PQICTIDVYMVMVKCWMIDENVRPTFKELANEFTR 267 (279)
T ss_pred -------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHH
Confidence 11123467889999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-38 Score=308.84 Aligned_cols=238 Identities=27% Similarity=0.386 Sum_probs=192.2
Q ss_pred hCCCcCCeeccCCcEEEEEEEECCCcEEEEEEehh-------------hhhhcccCceeeEEEEEeCCCeeEEEeeccCC
Q 039819 202 ENFSSKNILGAGGFGNVYKGKLGDGTVLAVKRLKD-------------MISLAVHRNLLRLIGYCATPTERLLVYPYMSN 268 (534)
Q Consensus 202 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~-------------~l~~~~h~niv~l~~~~~~~~~~~lv~e~~~~ 268 (534)
++|...+.||+|+||.||+|+..+...||+|.+.. ++..+.|+||+++++++. ....++||||+++
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~~ 84 (262)
T cd05071 6 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMSK 84 (262)
T ss_pred HHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCccCHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcCCC
Confidence 56888899999999999999987777899998762 567788999999999875 4567999999999
Q ss_pred CChhhhccc--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCCceee
Q 039819 269 GSVASRLRE--KPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTT 346 (534)
Q Consensus 269 gsL~~~l~~--~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~ 346 (534)
|+|.+++.. ...+++..+..++.|++.||+|||+. +++||||||+||++++++.++|+|||.++...........
T Consensus 85 ~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~~~~ 161 (262)
T cd05071 85 GSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQ 161 (262)
T ss_pred CcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcccEEEcCCCcEEeccCCceeecccccccccc
Confidence 999999975 34589999999999999999999998 9999999999999999999999999999876543322222
Q ss_pred ccccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCcCCCccccccchHHHHHHHHhhhcccceecccccCCCC
Q 039819 347 AVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELGSNY 425 (534)
Q Consensus 347 ~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 425 (534)
...++..|+|||+..+..++.++|||||||++|||+| |+.||+..... +......... ....
T Consensus 162 ~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~-------~~~~~~~~~~----------~~~~ 224 (262)
T cd05071 162 GAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR-------EVLDQVERGY----------RMPC 224 (262)
T ss_pred CCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChH-------HHHHHHhcCC----------CCCC
Confidence 3446778999999988889999999999999999999 88888643211 1111111100 0011
Q ss_pred CHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhc
Q 039819 426 DRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLEG 460 (534)
Q Consensus 426 ~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~ 460 (534)
....+..+.+++.+|++.+|++||++.++++.|+.
T Consensus 225 ~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~ 259 (262)
T cd05071 225 PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLED 259 (262)
T ss_pred ccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHH
Confidence 22335578999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-38 Score=307.81 Aligned_cols=232 Identities=28% Similarity=0.391 Sum_probs=186.9
Q ss_pred eeccCCcEEEEEEEE---CCCcEEEEEEeh----------------hhhhhcccCceeeEEEEEeCCCeeEEEeeccCCC
Q 039819 209 ILGAGGFGNVYKGKL---GDGTVLAVKRLK----------------DMISLAVHRNLLRLIGYCATPTERLLVYPYMSNG 269 (534)
Q Consensus 209 ~lG~G~~g~Vy~~~~---~~~~~vavK~~~----------------~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~~~g 269 (534)
.||+|+||.||+|.+ .++..+|+|+++ .++..+.|+||+++++++. .+..++||||+++|
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 589999999999975 357889999874 1567788999999999885 45678999999999
Q ss_pred ChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCCcee--ec
Q 039819 270 SVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVT--TA 347 (534)
Q Consensus 270 sL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~--~~ 347 (534)
+|.+++.....+++..+..++.|++.||.|||++ +|+||||||+||+++.++.+||+|||+++.......... ..
T Consensus 81 ~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 157 (257)
T cd05116 81 PLNKFLQKNKHVTEKNITELVHQVSMGMKYLEET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTH 157 (257)
T ss_pred cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecCC
Confidence 9999998777899999999999999999999998 999999999999999999999999999987654332211 12
Q ss_pred cccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCcCCCccccccchHHHHHHHHhhhcccceecccccCCCCC
Q 039819 348 VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELGSNYD 426 (534)
Q Consensus 348 ~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 426 (534)
..++..|+|||.+....++.++|||||||++|||+| |+.||..... .++......... ...+
T Consensus 158 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~-------~~~~~~i~~~~~----------~~~~ 220 (257)
T cd05116 158 GKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKG-------NEVTQMIESGER----------MECP 220 (257)
T ss_pred CCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH-------HHHHHHHHCCCC----------CCCC
Confidence 234578999999988888999999999999999998 9999964321 122222221111 1112
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhcC
Q 039819 427 RIEVGEILQVALLCTQYLPVHRPKMSEVVRMLEGD 461 (534)
Q Consensus 427 ~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~~ 461 (534)
...+.++.+++.+|++.+|++||++.+|++.|+..
T Consensus 221 ~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~ 255 (257)
T cd05116 221 QRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY 255 (257)
T ss_pred CCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence 22345789999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=314.17 Aligned_cols=227 Identities=29% Similarity=0.372 Sum_probs=185.5
Q ss_pred CeeccCCcEEEEEEEEC-CCcEEEEEEehh-----------------hhhhc-ccCceeeEEEEEeCCCeeEEEeeccCC
Q 039819 208 NILGAGGFGNVYKGKLG-DGTVLAVKRLKD-----------------MISLA-VHRNLLRLIGYCATPTERLLVYPYMSN 268 (534)
Q Consensus 208 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~-----------------~l~~~-~h~niv~l~~~~~~~~~~~lv~e~~~~ 268 (534)
+.||+|+||.||+|+.. ++..||||.+.+ ++..+ .||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999876 578999998762 23333 699999999999999999999999999
Q ss_pred CChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCCceeecc
Q 039819 269 GSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAV 348 (534)
Q Consensus 269 gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~~ 348 (534)
|+|..++.....+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++...... ......
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~~~~~~ 156 (318)
T cd05570 81 GDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG-VTTSTF 156 (318)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEccCCCHHHeEECCCCcEEecccCCCeecCcCC-Ccccce
Confidence 99999998887899999999999999999999998 99999999999999999999999999987532221 123345
Q ss_pred ccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceecccccCCCCCHH
Q 039819 349 RGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELGSNYDRI 428 (534)
Q Consensus 349 ~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 428 (534)
.||..|+|||++.+..++.++|||||||++|||+||+.||..... .+....+.... . .++..
T Consensus 157 ~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~-------~~~~~~i~~~~-------~----~~~~~ 218 (318)
T cd05570 157 CGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDE-------DELFQSILEDE-------V----RYPRW 218 (318)
T ss_pred ecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCH-------HHHHHHHHcCC-------C----CCCCc
Confidence 689999999999998999999999999999999999999974321 11111111110 0 11122
Q ss_pred HHHHHHHHHHHhcccCCCCCCCh-----HHHHH
Q 039819 429 EVGEILQVALLCTQYLPVHRPKM-----SEVVR 456 (534)
Q Consensus 429 ~~~~l~~l~~~Cl~~~P~~RPt~-----~ev~~ 456 (534)
.+..+.+++.+|++.+|.+||++ .++++
T Consensus 219 ~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~ 251 (318)
T cd05570 219 LSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG 251 (318)
T ss_pred CCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence 34578999999999999999999 77764
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=322.83 Aligned_cols=240 Identities=27% Similarity=0.430 Sum_probs=188.3
Q ss_pred hCCCcCCeeccCCcEEEEEEEEC------CCcEEEEEEehh---------------hhhhc-ccCceeeEEEEEeCC-Ce
Q 039819 202 ENFSSKNILGAGGFGNVYKGKLG------DGTVLAVKRLKD---------------MISLA-VHRNLLRLIGYCATP-TE 258 (534)
Q Consensus 202 ~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~---------------~l~~~-~h~niv~l~~~~~~~-~~ 258 (534)
++|+..+.||+|+||.||+|... .++.||+|++.. .+..+ .|+||++++++|... ..
T Consensus 7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~ 86 (337)
T cd05054 7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGP 86 (337)
T ss_pred HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCC
Confidence 46888899999999999999642 347899998641 44555 799999999988755 45
Q ss_pred eEEEeeccCCCChhhhcccC------------------------------------------------------------
Q 039819 259 RLLVYPYMSNGSVASRLREK------------------------------------------------------------ 278 (534)
Q Consensus 259 ~~lv~e~~~~gsL~~~l~~~------------------------------------------------------------ 278 (534)
.+++|||+++|+|.+++...
T Consensus 87 ~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (337)
T cd05054 87 LMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELY 166 (337)
T ss_pred EEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHh
Confidence 78999999999999887531
Q ss_pred -CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCCc-eeecccccccccc
Q 039819 279 -PALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSH-VTTAVRGTVGHIA 356 (534)
Q Consensus 279 -~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~a 356 (534)
..++|..+..++.|++.||+|||+. +|+||||||+|||++.++.++|+|||+++.+...... ......++..|+|
T Consensus 167 ~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~a 243 (337)
T cd05054 167 KEPLTLEDLISYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMA 243 (337)
T ss_pred hcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccC
Confidence 2589999999999999999999998 9999999999999999999999999999876432221 1223446778999
Q ss_pred ccccccCCCCcchhHHHHHHHHHHHHh-CCCCcCCCccccccchHHHHHHHHhhhcccceecccccCCCCCHHHHHHHHH
Q 039819 357 PEYLSTGQSSEKTDVFGFGILLLELIT-GMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELGSNYDRIEVGEILQ 435 (534)
Q Consensus 357 PE~~~~~~~~~k~Dv~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~ 435 (534)
||++.+..++.++|||||||++|||++ |+.||...... . .+...... .. ....+......+.+
T Consensus 244 PE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~---~---~~~~~~~~-~~---------~~~~~~~~~~~~~~ 307 (337)
T cd05054 244 PESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQID---E---EFCRRLKE-GT---------RMRAPEYATPEIYS 307 (337)
T ss_pred cHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCcc---H---HHHHHHhc-cC---------CCCCCccCCHHHHH
Confidence 999999999999999999999999998 99998642211 0 11111111 10 00111223457899
Q ss_pred HHHHhcccCCCCCCChHHHHHHhhc
Q 039819 436 VALLCTQYLPVHRPKMSEVVRMLEG 460 (534)
Q Consensus 436 l~~~Cl~~~P~~RPt~~ev~~~L~~ 460 (534)
++.+|++.+|++||++.|++++|+.
T Consensus 308 l~~~cl~~~p~~RPs~~ell~~l~~ 332 (337)
T cd05054 308 IMLDCWHNNPEDRPTFSELVEILGD 332 (337)
T ss_pred HHHHHccCChhhCcCHHHHHHHHHH
Confidence 9999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=309.35 Aligned_cols=232 Identities=26% Similarity=0.317 Sum_probs=185.4
Q ss_pred eccCCcEEEEEEEEC-CCcEEEEEEeh-----------------hhhhhcccCceeeEEEEEeCCCeeEEEeeccCCCCh
Q 039819 210 LGAGGFGNVYKGKLG-DGTVLAVKRLK-----------------DMISLAVHRNLLRLIGYCATPTERLLVYPYMSNGSV 271 (534)
Q Consensus 210 lG~G~~g~Vy~~~~~-~~~~vavK~~~-----------------~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 271 (534)
||+|+||.||+++.. +|+.||+|++. +++..++||||+++.+++......++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 699999999999875 68999999874 257778999999999999999999999999999999
Q ss_pred hhhcccC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCCceeeccc
Q 039819 272 ASRLREK--PALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVR 349 (534)
Q Consensus 272 ~~~l~~~--~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 349 (534)
.+++... ..+++..+..++.|++.||.|||+. +|+||||||+||+++.++.++|+|||++....... ......
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~--~~~~~~ 155 (277)
T cd05607 81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSM---DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK--TITQRA 155 (277)
T ss_pred HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHC---CEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc--eeeccC
Confidence 9888543 3589999999999999999999998 99999999999999999999999999998764332 223456
Q ss_pred cccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceecccccCCCCCHHH
Q 039819 350 GTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELGSNYDRIE 429 (534)
Q Consensus 350 gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 429 (534)
|+..|+|||++.+..++.++|||||||++|||++|+.||....... ...+....... . ..... ....
T Consensus 156 ~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~---~~~~~~~~~~~-~--------~~~~~-~~~~ 222 (277)
T cd05607 156 GTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKV---AKEELKRRTLE-D--------EVKFE-HQNF 222 (277)
T ss_pred CCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchh---hHHHHHHHhhc-c--------ccccc-cccC
Confidence 8999999999988889999999999999999999999996422110 11111111111 0 00000 0112
Q ss_pred HHHHHHHHHHhcccCCCCCCChHHHHHHhh
Q 039819 430 VGEILQVALLCTQYLPVHRPKMSEVVRMLE 459 (534)
Q Consensus 430 ~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~ 459 (534)
..++.+++.+|++.+|++||+++|+++.+.
T Consensus 223 ~~~~~~li~~~L~~~P~~R~~~~~~~~~~~ 252 (277)
T cd05607 223 TEESKDICRLFLAKKPEDRLGSREKNDDPR 252 (277)
T ss_pred CHHHHHHHHHHhccCHhhCCCCccchhhhh
Confidence 447899999999999999999988775444
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-38 Score=322.61 Aligned_cols=232 Identities=22% Similarity=0.363 Sum_probs=181.5
Q ss_pred CCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEeh---------------hhhhhcccCceeeEEEEEeCCCeeEEEeecc
Q 039819 203 NFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLK---------------DMISLAVHRNLLRLIGYCATPTERLLVYPYM 266 (534)
Q Consensus 203 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~---------------~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~ 266 (534)
+|...+.||+|+||.||+|+.. +++.||||.+. +++..++|+||+++++++......++||||+
T Consensus 75 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 154 (353)
T PLN00034 75 ELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFM 154 (353)
T ss_pred HHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecC
Confidence 3455678999999999999875 68999999874 2567888999999999999999999999999
Q ss_pred CCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCCceee
Q 039819 267 SNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTT 346 (534)
Q Consensus 267 ~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~ 346 (534)
++|+|.+.. ...+..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++....... ...
T Consensus 155 ~~~~L~~~~----~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~-~~~ 226 (353)
T PLN00034 155 DGGSLEGTH----IADEQFLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD-PCN 226 (353)
T ss_pred CCCcccccc----cCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEcccccceecccccc-ccc
Confidence 999986532 356778889999999999999998 999999999999999999999999999987643221 223
Q ss_pred cccccccccccccccc-----CCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceeccccc
Q 039819 347 AVRGTVGHIAPEYLST-----GQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDREL 421 (534)
Q Consensus 347 ~~~gt~~y~aPE~~~~-----~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 421 (534)
...||..|+|||++.. ...+.++|||||||++|||++|+.||...... +|......... ..
T Consensus 227 ~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~-------~~~~~~~~~~~-------~~ 292 (353)
T PLN00034 227 SSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQG-------DWASLMCAICM-------SQ 292 (353)
T ss_pred ccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCc-------cHHHHHHHHhc-------cC
Confidence 4568999999998743 23456899999999999999999999732211 12111110000 00
Q ss_pred CCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 422 GSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 422 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
..........++.+++.+||+.+|++||++.|+++
T Consensus 293 ~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~ 327 (353)
T PLN00034 293 PPEAPATASREFRHFISCCLQREPAKRWSAMQLLQ 327 (353)
T ss_pred CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00111223457899999999999999999999986
|
|
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=311.87 Aligned_cols=238 Identities=26% Similarity=0.443 Sum_probs=191.7
Q ss_pred hCCCcCCeeccCCcEEEEEEEECC------CcEEEEEEehh---------------hhhhcccCceeeEEEEEeCCCeeE
Q 039819 202 ENFSSKNILGAGGFGNVYKGKLGD------GTVLAVKRLKD---------------MISLAVHRNLLRLIGYCATPTERL 260 (534)
Q Consensus 202 ~~~~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~---------------~l~~~~h~niv~l~~~~~~~~~~~ 260 (534)
++|...+.||+|+||.||+|...+ +..||||.+.. ++..+.|+||+++++++......+
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 84 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI 84 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence 457778899999999999998643 47899998752 577888999999999999999999
Q ss_pred EEeeccCCCChhhhcccC--------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcE
Q 039819 261 LVYPYMSNGSVASRLREK--------------PALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEA 326 (534)
Q Consensus 261 lv~e~~~~gsL~~~l~~~--------------~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~ 326 (534)
+||||+++++|.+++... ..+++..+..++.|++.|+.|||+. +++||||||+||+++.++.+
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~ 161 (280)
T cd05049 85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ---HFVHRDLATRNCLVGYDLVV 161 (280)
T ss_pred EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeeccccccceEEEcCCCeE
Confidence 999999999999998643 3478999999999999999999998 99999999999999999999
Q ss_pred EEEecccceecCCCCC-ceeeccccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCcCCCccccccchHHHHH
Q 039819 327 IVGDFGLAKLLDHSDS-HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GMRALEFGKSINQKGAMLEWV 404 (534)
Q Consensus 327 kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~ 404 (534)
||+|||+++....... .......++..|+|||++.+..++.++|||||||++|||++ |+.||...... +..
T Consensus 162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~-------~~~ 234 (280)
T cd05049 162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNE-------EVI 234 (280)
T ss_pred EECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHH-------HHH
Confidence 9999999986533221 11223345788999999999999999999999999999999 99998643211 111
Q ss_pred HHHhhhcccceecccccCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhh
Q 039819 405 KKIQQEKKVEVLVDRELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLE 459 (534)
Q Consensus 405 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~ 459 (534)
..... ... ...+...+..+.+++.+||+.+|.+||++.||++.|+
T Consensus 235 ~~~~~-~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 235 ECITQ-GRL---------LQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred HHHHc-CCc---------CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 11111 110 0111223458899999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-38 Score=304.41 Aligned_cols=232 Identities=30% Similarity=0.469 Sum_probs=187.4
Q ss_pred CeeccCCcEEEEEEEECCCcEEEEEEeh---------------hhhhhcccCceeeEEEEEeCCCeeEEEeeccCCCChh
Q 039819 208 NILGAGGFGNVYKGKLGDGTVLAVKRLK---------------DMISLAVHRNLLRLIGYCATPTERLLVYPYMSNGSVA 272 (534)
Q Consensus 208 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~---------------~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~ 272 (534)
++||+|+||.||+|...++..+|+|.+. +.+..+.||||+++++++......++||||+++++|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 3689999999999998889999999864 2566778999999999999999999999999999999
Q ss_pred hhccc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCCceeeccccc
Q 039819 273 SRLRE-KPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGT 351 (534)
Q Consensus 273 ~~l~~-~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt 351 (534)
+++.. ...+++..+..++.+++.||.|+|+. +++||||||+||+++.++.+||+|||++...............++
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~ 157 (250)
T cd05085 81 SFLRKKKDELKTKQLVKFALDAAAGMAYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIP 157 (250)
T ss_pred HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccChheEEEcCCCeEEECCCccceeccccccccCCCCCCc
Confidence 98864 34689999999999999999999998 999999999999999999999999999976543222112222346
Q ss_pred cccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCcCCCccccccchHHHHHHHHhhhcccceecccccCCCCCHHHH
Q 039819 352 VGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELGSNYDRIEV 430 (534)
Q Consensus 352 ~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 430 (534)
..|+|||++.++.++.++||||||+++||+++ |+.||...... ........... ...+...+
T Consensus 158 ~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~-------~~~~~~~~~~~----------~~~~~~~~ 220 (250)
T cd05085 158 IKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQ-------QAREQVEKGYR----------MSCPQKCP 220 (250)
T ss_pred ccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHH-------HHHHHHHcCCC----------CCCCCCCC
Confidence 78999999988889999999999999999998 99998643211 11111111100 01111234
Q ss_pred HHHHHHHHHhcccCCCCCCChHHHHHHhh
Q 039819 431 GEILQVALLCTQYLPVHRPKMSEVVRMLE 459 (534)
Q Consensus 431 ~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~ 459 (534)
..+.+++.+|++.+|++||++.|+++.|.
T Consensus 221 ~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 221 DDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred HHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 58899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=310.64 Aligned_cols=235 Identities=26% Similarity=0.370 Sum_probs=188.8
Q ss_pred CCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEehh-----------------hhhhcccCceeeEEEEEeCCCeeEEEee
Q 039819 203 NFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLKD-----------------MISLAVHRNLLRLIGYCATPTERLLVYP 264 (534)
Q Consensus 203 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~-----------------~l~~~~h~niv~l~~~~~~~~~~~lv~e 264 (534)
+|+..+.||+|+||.||++... +++.||||.+.. ++..++|+||+++++.+..++..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 4677889999999999999975 689999998741 4567789999999999999999999999
Q ss_pred ccCCCChhhhccc--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCC
Q 039819 265 YMSNGSVASRLRE--KPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDS 342 (534)
Q Consensus 265 ~~~~gsL~~~l~~--~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~ 342 (534)
|+++|+|.+++.. ...+++..+..++.|++.||.|||+. +|+||||||+||++++++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~- 156 (285)
T cd05605 81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE- 156 (285)
T ss_pred ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHEEECCCCCEEEeeCCCceecCCCC-
Confidence 9999999988754 34689999999999999999999998 99999999999999999999999999998764322
Q ss_pred ceeeccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceecccccC
Q 039819 343 HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELG 422 (534)
Q Consensus 343 ~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 422 (534)
......|+..|+|||++.+..++.++|||||||++|||++|+.||........ ..++...... . .
T Consensus 157 -~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~---~~~~~~~~~~-~----------~ 221 (285)
T cd05605 157 -TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVK---REEVERRVKE-D----------Q 221 (285)
T ss_pred -ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhH---HHHHHHHhhh-c----------c
Confidence 12334689999999999888899999999999999999999999974322110 0111111110 0 0
Q ss_pred CCCCHHHHHHHHHHHHHhcccCCCCCC-----ChHHHHH
Q 039819 423 SNYDRIEVGEILQVALLCTQYLPVHRP-----KMSEVVR 456 (534)
Q Consensus 423 ~~~~~~~~~~l~~l~~~Cl~~~P~~RP-----t~~ev~~ 456 (534)
..++...+..+.+++.+|++.||.+|| +++++++
T Consensus 222 ~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05605 222 EEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKA 260 (285)
T ss_pred cccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhc
Confidence 112223345788999999999999999 6667654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=319.50 Aligned_cols=227 Identities=25% Similarity=0.347 Sum_probs=184.5
Q ss_pred CeeccCCcEEEEEEEEC-CCcEEEEEEehh-----------------hhh-hcccCceeeEEEEEeCCCeeEEEeeccCC
Q 039819 208 NILGAGGFGNVYKGKLG-DGTVLAVKRLKD-----------------MIS-LAVHRNLLRLIGYCATPTERLLVYPYMSN 268 (534)
Q Consensus 208 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~-----------------~l~-~~~h~niv~l~~~~~~~~~~~lv~e~~~~ 268 (534)
+.||+|+||.||+|+.. +++.||||++.. ++. ...||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 36999999999999875 578999998752 222 23799999999999999999999999999
Q ss_pred CChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCCceeecc
Q 039819 269 GSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAV 348 (534)
Q Consensus 269 gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~~ 348 (534)
|+|...+.....+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++...... ......
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~-~~~~~~ 156 (321)
T cd05591 81 GDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG-VTTTTF 156 (321)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeecccceecccCC-cccccc
Confidence 99999998888899999999999999999999998 99999999999999999999999999998643222 223345
Q ss_pred ccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceecccccCCCCCHH
Q 039819 349 RGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELGSNYDRI 428 (534)
Q Consensus 349 ~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 428 (534)
.||..|+|||++.+..++.++|||||||++|||+||+.||...... +....+..... . .+..
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~-------~~~~~i~~~~~-------~----~p~~ 218 (321)
T cd05591 157 CGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNED-------DLFESILHDDV-------L----YPVW 218 (321)
T ss_pred ccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHH-------HHHHHHHcCCC-------C----CCCC
Confidence 6899999999998888999999999999999999999999743321 11111111110 0 1111
Q ss_pred HHHHHHHHHHHhcccCCCCCC-------ChHHHHH
Q 039819 429 EVGEILQVALLCTQYLPVHRP-------KMSEVVR 456 (534)
Q Consensus 429 ~~~~l~~l~~~Cl~~~P~~RP-------t~~ev~~ 456 (534)
...++.+++.+|++.+|++|| ++.++++
T Consensus 219 ~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~ 253 (321)
T cd05591 219 LSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQ 253 (321)
T ss_pred CCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhc
Confidence 234788999999999999999 6666664
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=325.64 Aligned_cols=246 Identities=26% Similarity=0.410 Sum_probs=203.3
Q ss_pred HHHHHHhCCCcCCeeccCCcEEEEEEEECC-CcEEEEEEehh-------------hhhhcccCceeeEEEEEeCCCeeEE
Q 039819 196 ELQQATENFSSKNILGAGGFGNVYKGKLGD-GTVLAVKRLKD-------------MISLAVHRNLLRLIGYCATPTERLL 261 (534)
Q Consensus 196 ~l~~~~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~-------------~l~~~~h~niv~l~~~~~~~~~~~l 261 (534)
+.+....+....+.||-|.||.||.|.|+. ...||||.+++ +|+.++|||+|+++|+|......||
T Consensus 261 kWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYI 340 (1157)
T KOG4278|consen 261 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYI 340 (1157)
T ss_pred hhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcchhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEE
Confidence 333334455667899999999999999864 67799999874 7889999999999999999999999
Q ss_pred EeeccCCCChhhhcccC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCC
Q 039819 262 VYPYMSNGSVASRLREK--PALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDH 339 (534)
Q Consensus 262 v~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~ 339 (534)
|+|||.+|+|.++|++. ..++--..++++.||+.|++||..+ ++|||||...|+|+.++..+||+|||+++++..
T Consensus 341 iTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkk---nFIHRDLAARNCLVgEnhiVKvADFGLsRlMtg 417 (1157)
T KOG4278|consen 341 ITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHIVKVADFGLSRLMTG 417 (1157)
T ss_pred EEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhccccccceEEeeccchhhhhcC
Confidence 99999999999999854 4577778889999999999999998 999999999999999999999999999999976
Q ss_pred CCCceeeccccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCcCCCccccccchHHHHHHHHhhhcccceecc
Q 039819 340 SDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVD 418 (534)
Q Consensus 340 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 418 (534)
+.........-...|.|||-+....++.|+|||+|||+|||+.| |..||++-+ +.+... ++.
T Consensus 418 DTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGid-------lSqVY~----------LLE 480 (1157)
T KOG4278|consen 418 DTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGID-------LSQVYG----------LLE 480 (1157)
T ss_pred CceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCcc-------HHHHHH----------HHh
Confidence 54433333344678999999999999999999999999999998 888887432 111111 112
Q ss_pred cccCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhcC
Q 039819 419 RELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLEGD 461 (534)
Q Consensus 419 ~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~~ 461 (534)
...+-+.+..++..+.+|++.||+++|.+||+++|+-+.++..
T Consensus 481 kgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtm 523 (1157)
T KOG4278|consen 481 KGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETM 523 (1157)
T ss_pred ccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHH
Confidence 2223334566788999999999999999999999999887753
|
|
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=322.28 Aligned_cols=224 Identities=25% Similarity=0.330 Sum_probs=185.3
Q ss_pred CeeccCCcEEEEEEEE----CCCcEEEEEEehh----------------hhhhcccCceeeEEEEEeCCCeeEEEeeccC
Q 039819 208 NILGAGGFGNVYKGKL----GDGTVLAVKRLKD----------------MISLAVHRNLLRLIGYCATPTERLLVYPYMS 267 (534)
Q Consensus 208 ~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~----------------~l~~~~h~niv~l~~~~~~~~~~~lv~e~~~ 267 (534)
+.||+|+||.||+++. .+++.||+|++.. ++..++||||+++++++......|+||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 5799999999999975 3678999998752 5677889999999999999999999999999
Q ss_pred CCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCCceeec
Q 039819 268 NGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTA 347 (534)
Q Consensus 268 ~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~ 347 (534)
+|+|.+++.....+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++...... .....
T Consensus 82 ~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~-~~~~~ 157 (318)
T cd05582 82 GGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE-KKAYS 157 (318)
T ss_pred CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHeEECCCCcEEEeeccCCcccCCCC-Cceec
Confidence 999999998878899999999999999999999998 99999999999999999999999999998654332 22334
Q ss_pred cccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceecccccCCCCCH
Q 039819 348 VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELGSNYDR 427 (534)
Q Consensus 348 ~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 427 (534)
..||..|+|||++.+..++.++|||||||++|||+||+.||..... .+......... ...+.
T Consensus 158 ~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~-------~~~~~~i~~~~-----------~~~p~ 219 (318)
T cd05582 158 FCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDR-------KETMTMILKAK-----------LGMPQ 219 (318)
T ss_pred ccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCH-------HHHHHHHHcCC-----------CCCCC
Confidence 5799999999999888889999999999999999999999974321 11111111110 01112
Q ss_pred HHHHHHHHHHHHhcccCCCCCCChHH
Q 039819 428 IEVGEILQVALLCTQYLPVHRPKMSE 453 (534)
Q Consensus 428 ~~~~~l~~l~~~Cl~~~P~~RPt~~e 453 (534)
.....+.+++.+|++.+|++||++.+
T Consensus 220 ~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 220 FLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred CCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 23457889999999999999999766
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-38 Score=305.78 Aligned_cols=232 Identities=29% Similarity=0.440 Sum_probs=185.1
Q ss_pred CeeccCCcEEEEEEEEC-CCcEEEEEEeh---------------hhhhhcccCceeeEEEEEeCCCeeEEEeeccCCCCh
Q 039819 208 NILGAGGFGNVYKGKLG-DGTVLAVKRLK---------------DMISLAVHRNLLRLIGYCATPTERLLVYPYMSNGSV 271 (534)
Q Consensus 208 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~---------------~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 271 (534)
+.||+|+||.||+|+.. +++.||+|... +++..+.||||++++++|......++||||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 36899999999999875 78899999753 256788999999999999999999999999999999
Q ss_pred hhhccc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCCcee-eccc
Q 039819 272 ASRLRE-KPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVT-TAVR 349 (534)
Q Consensus 272 ~~~l~~-~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~-~~~~ 349 (534)
.+++.. ...+++..++.++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++........... ....
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 157 (252)
T cd05084 81 LTFLRTEGPRLKVKELIQMVENAAAGMEYLESK---HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQ 157 (252)
T ss_pred HHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEEcCCCcEEECccccCcccccccccccCCCCC
Confidence 999875 34689999999999999999999998 999999999999999999999999999876543211111 1112
Q ss_pred cccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCcCCCccccccchHHHHHHHHhhhcccceecccccCCCCCHH
Q 039819 350 GTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELGSNYDRI 428 (534)
Q Consensus 350 gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 428 (534)
++..|+|||++.++.++.++|||||||++|||++ |..||...... ........ ......+..
T Consensus 158 ~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~-------~~~~~~~~----------~~~~~~~~~ 220 (252)
T cd05084 158 IPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQ-------QTREAIEQ----------GVRLPCPEL 220 (252)
T ss_pred CceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHH-------HHHHHHHc----------CCCCCCccc
Confidence 3457999999988889999999999999999998 88888532211 01111111 011112223
Q ss_pred HHHHHHHHHHHhcccCCCCCCChHHHHHHhh
Q 039819 429 EVGEILQVALLCTQYLPVHRPKMSEVVRMLE 459 (534)
Q Consensus 429 ~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~ 459 (534)
.+..+.+++.+|++.+|++||++.+|.++|+
T Consensus 221 ~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 221 CPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 3458899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=319.80 Aligned_cols=183 Identities=25% Similarity=0.378 Sum_probs=159.6
Q ss_pred HHhCCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEeh--------hhhhhcccCceeeEEEEEeCCCeeEEEeeccCCCC
Q 039819 200 ATENFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLK--------DMISLAVHRNLLRLIGYCATPTERLLVYPYMSNGS 270 (534)
Q Consensus 200 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~--------~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~~~gs 270 (534)
...+|...+.||+|+||.||+|+.. .+..||+|... .++..++|+||+++++++......++||||+. ++
T Consensus 64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~ 142 (357)
T PHA03209 64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKGTTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYS-SD 142 (357)
T ss_pred hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCccccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEccC-Cc
Confidence 3457999999999999999999975 56789999754 37888999999999999999999999999995 58
Q ss_pred hhhhccc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCCceeeccc
Q 039819 271 VASRLRE-KPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVR 349 (534)
Q Consensus 271 L~~~l~~-~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 349 (534)
|.+++.. ...+++..++.|+.||+.||.|||+. +||||||||+|||++.++.+||+|||+++...... ......
T Consensus 143 l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~--~~~~~~ 217 (357)
T PHA03209 143 LYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAP--AFLGLA 217 (357)
T ss_pred HHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEecCccccccccCc--cccccc
Confidence 8888754 45799999999999999999999998 99999999999999999999999999997543221 123456
Q ss_pred cccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCc
Q 039819 350 GTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRAL 388 (534)
Q Consensus 350 gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~ 388 (534)
||..|+|||++.+..++.++|||||||++|||+++..++
T Consensus 218 gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 218 GTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred ccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 899999999999889999999999999999999966654
|
|
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-38 Score=312.81 Aligned_cols=240 Identities=27% Similarity=0.429 Sum_probs=191.4
Q ss_pred hCCCcCCeeccCCcEEEEEEEE------CCCcEEEEEEehh--------------hhhhcccCceeeEEEEEeCCCeeEE
Q 039819 202 ENFSSKNILGAGGFGNVYKGKL------GDGTVLAVKRLKD--------------MISLAVHRNLLRLIGYCATPTERLL 261 (534)
Q Consensus 202 ~~~~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~--------------~l~~~~h~niv~l~~~~~~~~~~~l 261 (534)
.+|...+.||+|+||.||++.. .++..+|+|.+.. ++..+.|+||+++++++......++
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 84 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 5677889999999999999985 2346689998752 5678889999999999999999999
Q ss_pred EeeccCCCChhhhcccCC-------------CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEE
Q 039819 262 VYPYMSNGSVASRLREKP-------------ALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIV 328 (534)
Q Consensus 262 v~e~~~~gsL~~~l~~~~-------------~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl 328 (534)
||||+++++|.+++.... .+++..++.++.|++.||+|||+. +++||||||+|||+++++.+||
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~---~i~H~dlkp~Nili~~~~~~kl 161 (288)
T cd05093 85 VFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVKI 161 (288)
T ss_pred EEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCcEEe
Confidence 999999999999986432 489999999999999999999998 9999999999999999999999
Q ss_pred EecccceecCCCCCc-eeeccccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCcCCCccccccchHHHHHHH
Q 039819 329 GDFGLAKLLDHSDSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GMRALEFGKSINQKGAMLEWVKK 406 (534)
Q Consensus 329 ~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~ 406 (534)
+|||+++........ ......++..|+|||++.+..++.++|||||||++|||+| |+.||...... +....
T Consensus 162 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~-------~~~~~ 234 (288)
T cd05093 162 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN-------EVIEC 234 (288)
T ss_pred ccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH-------HHHHH
Confidence 999999865432211 1122335778999999988889999999999999999999 89998633211 11111
Q ss_pred HhhhcccceecccccCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhcC
Q 039819 407 IQQEKKVEVLVDRELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLEGD 461 (534)
Q Consensus 407 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~~ 461 (534)
.... ... .. +...+..+.+++.+|++.+|.+||++.+|++.|+..
T Consensus 235 i~~~-~~~-----~~----~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~ 279 (288)
T cd05093 235 ITQG-RVL-----QR----PRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNL 279 (288)
T ss_pred HHcC-CcC-----CC----CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHH
Confidence 1111 100 01 112234789999999999999999999999988763
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=320.93 Aligned_cols=235 Identities=27% Similarity=0.409 Sum_probs=200.2
Q ss_pred hCCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEeh----------------hhhhhcccCceeeEEEEEeCCCe-eEEEe
Q 039819 202 ENFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLK----------------DMISLAVHRNLLRLIGYCATPTE-RLLVY 263 (534)
Q Consensus 202 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~----------------~~l~~~~h~niv~l~~~~~~~~~-~~lv~ 263 (534)
++|...+.+|+|+||.++..+.+ +++.+++|.+. .++++++|||||.+.+.|.+.+. .+|||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 57888899999999999999864 67889999875 27899999999999999999888 89999
Q ss_pred eccCCCChhhhcccC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCC
Q 039819 264 PYMSNGSVASRLREK--PALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSD 341 (534)
Q Consensus 264 e~~~~gsL~~~l~~~--~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~ 341 (534)
+||+||++.+.+.+. ..++++.+..|+.|++.|+.|||+. .|+|||||+.||+++.+..+||+|||+|+.+....
T Consensus 84 ~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~---~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~ 160 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHEN---RVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPED 160 (426)
T ss_pred eecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhh---hhhcccchhhhhhccccCceeecchhhhhhcCCch
Confidence 999999999999754 4588999999999999999999988 99999999999999999999999999999987654
Q ss_pred CceeeccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceeccccc
Q 039819 342 SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDREL 421 (534)
Q Consensus 342 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 421 (534)
. ...++.||+.||+||.+.+.+|+.|+||||+||++|||++-+++|...+ +...+..+....
T Consensus 161 ~-~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~-------m~~Li~ki~~~~---------- 222 (426)
T KOG0589|consen 161 S-LASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASN-------MSELILKINRGL---------- 222 (426)
T ss_pred h-hhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccc-------hHHHHHHHhhcc----------
Confidence 3 3445779999999999999999999999999999999999999997433 222222222211
Q ss_pred CCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 039819 422 GSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRM 457 (534)
Q Consensus 422 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~ 457 (534)
....+.....++..++..|++.+|..||++.+++.+
T Consensus 223 ~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 223 YSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred CCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 112333445689999999999999999999999976
|
|
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-38 Score=311.40 Aligned_cols=239 Identities=23% Similarity=0.413 Sum_probs=190.9
Q ss_pred hCCCcCCeeccCCcEEEEEEEE-----CCCcEEEEEEeh---------------hhhhhcccCceeeEEEEEeCCCeeEE
Q 039819 202 ENFSSKNILGAGGFGNVYKGKL-----GDGTVLAVKRLK---------------DMISLAVHRNLLRLIGYCATPTERLL 261 (534)
Q Consensus 202 ~~~~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~---------------~~l~~~~h~niv~l~~~~~~~~~~~l 261 (534)
.+|+..+.||+|+||.||+|.. ..+..||+|.+. .+++.++||||+++++++......++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 4577788999999999999985 356789999885 26778889999999999999999999
Q ss_pred EeeccCCCChhhhccc-----------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCC
Q 039819 262 VYPYMSNGSVASRLRE-----------------KPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFC 324 (534)
Q Consensus 262 v~e~~~~gsL~~~l~~-----------------~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~ 324 (534)
||||+++++|.+++.. ...+++.....++.|++.||.|||+. +|+||||||+|||++.++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~nili~~~~ 161 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH---FFVHKDLAARNILIGEQL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc---CeehhccccceEEEcCCC
Confidence 9999999999998842 12478999999999999999999998 999999999999999999
Q ss_pred cEEEEecccceecCCCC-CceeeccccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCcCCCccccccchHHH
Q 039819 325 EAIVGDFGLAKLLDHSD-SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GMRALEFGKSINQKGAMLE 402 (534)
Q Consensus 325 ~~kl~DFGla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~ 402 (534)
.+||+|||+++...... ........++..|+|||++.+..++.++|||||||++|||++ |..||..... ..
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~-------~~ 234 (283)
T cd05090 162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSN-------QE 234 (283)
T ss_pred cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH-------HH
Confidence 99999999998654322 112233345778999999988889999999999999999999 9888863221 11
Q ss_pred HHHHHhhhcccceecccccCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhc
Q 039819 403 WVKKIQQEKKVEVLVDRELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLEG 460 (534)
Q Consensus 403 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~ 460 (534)
........... ..+...+..+.+++.+|++.+|++||++.+|.+.|..
T Consensus 235 ~~~~~~~~~~~----------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 235 VIEMVRKRQLL----------PCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred HHHHHHcCCcC----------CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 11111111100 1111234578899999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-38 Score=306.55 Aligned_cols=238 Identities=28% Similarity=0.441 Sum_probs=193.4
Q ss_pred hCCCcCCeeccCCcEEEEEEEECCCcEEEEEEehh-------------hhhhcccCceeeEEEEEeCCCeeEEEeeccCC
Q 039819 202 ENFSSKNILGAGGFGNVYKGKLGDGTVLAVKRLKD-------------MISLAVHRNLLRLIGYCATPTERLLVYPYMSN 268 (534)
Q Consensus 202 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~-------------~l~~~~h~niv~l~~~~~~~~~~~lv~e~~~~ 268 (534)
++|+..+.||+|+||.||+|...+++.||+|.+.. ++..+.|+||+++++++. .+..++||||+++
T Consensus 6 ~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~ 84 (260)
T cd05067 6 ETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYMEN 84 (260)
T ss_pred HHceeeeeeccCccceEEeeecCCCceEEEEEecCCCCcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcCCC
Confidence 56888899999999999999998999999998762 677889999999999874 4568999999999
Q ss_pred CChhhhccc--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCCceee
Q 039819 269 GSVASRLRE--KPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTT 346 (534)
Q Consensus 269 gsL~~~l~~--~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~ 346 (534)
++|.+++.. ...+++.++..++.|++.||+|||+. +++||||||+||+++.++.++|+|||++............
T Consensus 85 ~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~ 161 (260)
T cd05067 85 GSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERK---NYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTARE 161 (260)
T ss_pred CCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHHhEEEcCCCCEEEccCcceeecCCCCccccc
Confidence 999998864 34689999999999999999999998 9999999999999999999999999999876533222222
Q ss_pred ccccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCcCCCccccccchHHHHHHHHhhhcccceecccccCCCC
Q 039819 347 AVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELGSNY 425 (534)
Q Consensus 347 ~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 425 (534)
...++..|+|||++....++.++|||||||++|||++ |+.||...... +.......... .. .
T Consensus 162 ~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~-------~~~~~~~~~~~------~~----~ 224 (260)
T cd05067 162 GAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNP-------EVIQNLERGYR------MP----R 224 (260)
T ss_pred CCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChH-------HHHHHHHcCCC------CC----C
Confidence 3346778999999988889999999999999999999 99999643211 11111111100 01 1
Q ss_pred CHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhc
Q 039819 426 DRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLEG 460 (534)
Q Consensus 426 ~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~ 460 (534)
+...+.++.+++.+|++.+|++||++++++..|+.
T Consensus 225 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 225 PDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 11234579999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-38 Score=312.72 Aligned_cols=240 Identities=27% Similarity=0.449 Sum_probs=192.6
Q ss_pred hCCCcCCeeccCCcEEEEEEEEC------CCcEEEEEEehh--------------hhhhcccCceeeEEEEEeCCCeeEE
Q 039819 202 ENFSSKNILGAGGFGNVYKGKLG------DGTVLAVKRLKD--------------MISLAVHRNLLRLIGYCATPTERLL 261 (534)
Q Consensus 202 ~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~--------------~l~~~~h~niv~l~~~~~~~~~~~l 261 (534)
.+|...+.||+|+||.||+|+.. ++..+++|.+.. .+..++|+||+++++++......++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM 84 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence 45777889999999999999752 356689998752 5678899999999999999999999
Q ss_pred EeeccCCCChhhhcccC----------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCc
Q 039819 262 VYPYMSNGSVASRLREK----------------PALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCE 325 (534)
Q Consensus 262 v~e~~~~gsL~~~l~~~----------------~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~ 325 (534)
||||+++++|.+++... ..+++..++.++.|++.||+|||+. +|+||||||+|||++.++.
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil~~~~~~ 161 (291)
T cd05094 85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLVGANLL 161 (291)
T ss_pred EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCc
Confidence 99999999999998642 3489999999999999999999998 9999999999999999999
Q ss_pred EEEEecccceecCCCCC-ceeeccccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCcCCCccccccchHHHH
Q 039819 326 AIVGDFGLAKLLDHSDS-HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GMRALEFGKSINQKGAMLEW 403 (534)
Q Consensus 326 ~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~ 403 (534)
++|+|||++........ .......++..|+|||++.+..++.++|||||||++|||+| |+.||...... +.
T Consensus 162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~-------~~ 234 (291)
T cd05094 162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNT-------EV 234 (291)
T ss_pred EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH-------HH
Confidence 99999999986543221 11223446788999999988889999999999999999999 99998643211 11
Q ss_pred HHHHhhhcccceecccccCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhcC
Q 039819 404 VKKIQQEKKVEVLVDRELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLEGD 461 (534)
Q Consensus 404 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~~ 461 (534)
...... .... ......+..+.+++.+|++.+|++||++.+|+++|+..
T Consensus 235 ~~~~~~-~~~~---------~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~ 282 (291)
T cd05094 235 IECITQ-GRVL---------ERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHAL 282 (291)
T ss_pred HHHHhC-CCCC---------CCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHH
Confidence 111111 1100 11122345789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=308.63 Aligned_cols=224 Identities=27% Similarity=0.336 Sum_probs=180.3
Q ss_pred eccCCcEEEEEEEEC-CCcEEEEEEehh-----------------hhhhcccCceeeEEEEEeCCCeeEEEeeccCCCCh
Q 039819 210 LGAGGFGNVYKGKLG-DGTVLAVKRLKD-----------------MISLAVHRNLLRLIGYCATPTERLLVYPYMSNGSV 271 (534)
Q Consensus 210 lG~G~~g~Vy~~~~~-~~~~vavK~~~~-----------------~l~~~~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 271 (534)
||+|+||+||++... +++.||||.+.. ++..++|+||+++.+++......++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 699999999999875 688999998741 56778899999999999999999999999999999
Q ss_pred hhhcc----cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCCceeec
Q 039819 272 ASRLR----EKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTA 347 (534)
Q Consensus 272 ~~~l~----~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~ 347 (534)
...+. ....+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++........ ....
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~-~~~~ 156 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS-KTKG 156 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCccceecCCCCc-cccc
Confidence 87764 345689999999999999999999998 999999999999999999999999999987654322 2334
Q ss_pred cccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceecccccCCCCCH
Q 039819 348 VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELGSNYDR 427 (534)
Q Consensus 348 ~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 427 (534)
..||+.|+|||++.+..++.++|||||||++|||++|+.||........ .......... .. ..++.
T Consensus 157 ~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~---~~~~~~~~~~---------~~--~~~~~ 222 (280)
T cd05608 157 YAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE---NKELKQRILN---------DS--VTYPD 222 (280)
T ss_pred cCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchh---HHHHHHhhcc---------cC--CCCcc
Confidence 5689999999999999999999999999999999999999974322111 0111111100 00 01122
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCh
Q 039819 428 IEVGEILQVALLCTQYLPVHRPKM 451 (534)
Q Consensus 428 ~~~~~l~~l~~~Cl~~~P~~RPt~ 451 (534)
..+..+.+++.+|++.+|++||++
T Consensus 223 ~~~~~~~~li~~~l~~~P~~R~~~ 246 (280)
T cd05608 223 KFSPASKSFCEALLAKDPEKRLGF 246 (280)
T ss_pred cCCHHHHHHHHHHhcCCHHHhcCC
Confidence 234578899999999999999944
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=305.13 Aligned_cols=238 Identities=28% Similarity=0.411 Sum_probs=191.5
Q ss_pred hCCCcCCeeccCCcEEEEEEEECCCcEEEEEEeh-------------hhhhhcccCceeeEEEEEeCCCeeEEEeeccCC
Q 039819 202 ENFSSKNILGAGGFGNVYKGKLGDGTVLAVKRLK-------------DMISLAVHRNLLRLIGYCATPTERLLVYPYMSN 268 (534)
Q Consensus 202 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~-------------~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~~~ 268 (534)
++|...+.||+|+||.||+|....+..+|+|.+. ++++.+.|+|++++++++. ....++||||+++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~ 84 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMGK 84 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCCC
Confidence 4577888999999999999998877789999764 2677888999999999875 4567999999999
Q ss_pred CChhhhcccC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCCceee
Q 039819 269 GSVASRLREK--PALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTT 346 (534)
Q Consensus 269 gsL~~~l~~~--~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~ 346 (534)
|+|.++++.. ..+++..+..++.+++.||.|||+. +++||||||+||++++++.++|+|||++............
T Consensus 85 ~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~~~~ 161 (260)
T cd05069 85 GSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERM---NYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQ 161 (260)
T ss_pred CCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCeEEECCCccceEccCCcccccC
Confidence 9999999743 3589999999999999999999998 9999999999999999999999999999876433222222
Q ss_pred ccccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCcCCCccccccchHHHHHHHHhhhcccceecccccCCCC
Q 039819 347 AVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELGSNY 425 (534)
Q Consensus 347 ~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 425 (534)
...++..|+|||+..+..++.++|||||||++|||+| |+.||...... ....+ ...... ...
T Consensus 162 ~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~----~~~~~---~~~~~~----------~~~ 224 (260)
T cd05069 162 GAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNR----EVLEQ---VERGYR----------MPC 224 (260)
T ss_pred CCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHH----HHHHH---HHcCCC----------CCC
Confidence 3346778999999988889999999999999999999 89998643211 11111 111100 011
Q ss_pred CHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhc
Q 039819 426 DRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLEG 460 (534)
Q Consensus 426 ~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~ 460 (534)
+...+..+.+++.+|++.+|++||++++|++.|+.
T Consensus 225 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 225 PQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred CcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 22234578999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-38 Score=333.73 Aligned_cols=233 Identities=21% Similarity=0.292 Sum_probs=189.7
Q ss_pred CCcCCeeccCCcEEEEEEEEC-C-CcEEEEEEeh--------------hhhhhcccCceeeEEEEEeCCCeeEEEeeccC
Q 039819 204 FSSKNILGAGGFGNVYKGKLG-D-GTVLAVKRLK--------------DMISLAVHRNLLRLIGYCATPTERLLVYPYMS 267 (534)
Q Consensus 204 ~~~~~~lG~G~~g~Vy~~~~~-~-~~~vavK~~~--------------~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~~ 267 (534)
|...+.||+|+||.||+|... + +..||+|.+. .+++.++|||||+++++|...+..++||||++
T Consensus 69 y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~~ 148 (478)
T PTZ00267 69 YVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGS 148 (478)
T ss_pred EEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECCC
Confidence 777889999999999999764 3 5778888653 26788899999999999999999999999999
Q ss_pred CCChhhhcc----cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCC-
Q 039819 268 NGSVASRLR----EKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDS- 342 (534)
Q Consensus 268 ~gsL~~~l~----~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~- 342 (534)
+|+|.+++. ....+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 149 gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~ 225 (478)
T PTZ00267 149 GGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSR---KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSL 225 (478)
T ss_pred CCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCcCHHhEEECCCCcEEEEeCcCceecCCcccc
Confidence 999998775 345689999999999999999999998 999999999999999999999999999987654321
Q ss_pred ceeeccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceecccccC
Q 039819 343 HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELG 422 (534)
Q Consensus 343 ~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 422 (534)
......+||++|+|||++.+..++.++|||||||++|||+||+.||..... .+......... . +
T Consensus 226 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~-------~~~~~~~~~~~-~----~---- 289 (478)
T PTZ00267 226 DVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQ-------REIMQQVLYGK-Y----D---- 289 (478)
T ss_pred ccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH-------HHHHHHHHhCC-C----C----
Confidence 123445699999999999988999999999999999999999999964321 11122111111 0 0
Q ss_pred CCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 423 SNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 423 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
..+......+.+++.+|++.+|++||++.+++.
T Consensus 290 -~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 290 -PFPCPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred -CCCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 011123357899999999999999999999875
|
|
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=310.17 Aligned_cols=250 Identities=27% Similarity=0.367 Sum_probs=189.1
Q ss_pred CcCCeeccCCcEEEEEEEE-----CCCcEEEEEEehh---------------hhhhcccCceeeEEEEEeCC--CeeEEE
Q 039819 205 SSKNILGAGGFGNVYKGKL-----GDGTVLAVKRLKD---------------MISLAVHRNLLRLIGYCATP--TERLLV 262 (534)
Q Consensus 205 ~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~---------------~l~~~~h~niv~l~~~~~~~--~~~~lv 262 (534)
...+.||+|+||.||++.. .++..||+|.+.. .+..++||||+++++++... ...++|
T Consensus 7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 86 (283)
T cd05080 7 KKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLI 86 (283)
T ss_pred eeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEE
Confidence 7788999999999988753 3578899998752 56788999999999998754 357899
Q ss_pred eeccCCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCC
Q 039819 263 YPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDS 342 (534)
Q Consensus 263 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~ 342 (534)
|||+++|+|.+++... .+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 87 ~e~~~~~~l~~~~~~~-~l~~~~~~~i~~~l~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~ 162 (283)
T cd05080 87 MEYVPLGSLRDYLPKH-KLNLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHE 162 (283)
T ss_pred ecCCCCCCHHHHHHHc-CCCHHHHHHHHHHHHHHHHHHHHC---CeeccccChheEEEcCCCcEEEeecccccccCCcch
Confidence 9999999999998764 499999999999999999999998 999999999999999999999999999987653221
Q ss_pred c--eeeccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceecccc
Q 039819 343 H--VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRE 420 (534)
Q Consensus 343 ~--~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 420 (534)
. ......++..|+|||++....++.++|||||||++|||+||+.|+....... .....+..............+..
T Consensus 163 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 240 (283)
T cd05080 163 YYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKF--EEMIGPKQGQMTVVRLIELLERG 240 (283)
T ss_pred hhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchh--hhhhcccccccchhhhhhhhhcC
Confidence 1 1122235667999999988889999999999999999999999986322110 00000000000000011111111
Q ss_pred cCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhc
Q 039819 421 LGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLEG 460 (534)
Q Consensus 421 l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~ 460 (534)
.....+...+..+.+++.+|++.+|++||++++|+++|+.
T Consensus 241 ~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~ 280 (283)
T cd05080 241 MRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKE 280 (283)
T ss_pred CCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHH
Confidence 1111222335689999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=304.83 Aligned_cols=237 Identities=27% Similarity=0.351 Sum_probs=193.2
Q ss_pred hCCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEeh-------------------hhhhhcccCceeeEEEEEeCCCeeEE
Q 039819 202 ENFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLK-------------------DMISLAVHRNLLRLIGYCATPTERLL 261 (534)
Q Consensus 202 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~-------------------~~l~~~~h~niv~l~~~~~~~~~~~l 261 (534)
++|...+.||+|++|.||+|... ++..||+|.+. +++..++||||+++++++.+.+..++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 46888999999999999999874 68999999763 15677889999999999999999999
Q ss_pred EeeccCCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCC
Q 039819 262 VYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSD 341 (534)
Q Consensus 262 v~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~ 341 (534)
||||+++++|.+.+.....+++..+..++.+++.||.|||+. +|+||||||+||+++.++.++|+|||+++......
T Consensus 82 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~ 158 (263)
T cd06625 82 FMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTIC 158 (263)
T ss_pred EEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceeccccc
Confidence 999999999999998877899999999999999999999998 99999999999999999999999999998654322
Q ss_pred Ccee--eccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceeccc
Q 039819 342 SHVT--TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDR 419 (534)
Q Consensus 342 ~~~~--~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 419 (534)
.... ....|+..|+|||++.+..++.++|||||||++|||++|+.||..... .... .......
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~------~~~~-~~~~~~~-------- 223 (263)
T cd06625 159 SSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEA------MAAI-FKIATQP-------- 223 (263)
T ss_pred cccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccch------HHHH-HHHhccC--------
Confidence 1111 234578899999999988899999999999999999999999863211 1111 1111100
Q ss_pred ccCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 039819 420 ELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRM 457 (534)
Q Consensus 420 ~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~ 457 (534)
.....+......+.+++.+|+..+|.+||++.++++.
T Consensus 224 -~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 224 -TNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred -CCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 0111222334578899999999999999999999863
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-38 Score=310.30 Aligned_cols=239 Identities=28% Similarity=0.408 Sum_probs=189.8
Q ss_pred HhCCCcCCeeccCCcEEEEEEEECC------CcEEEEEEehh---------------hhhhcccCceeeEEEEEeCCCee
Q 039819 201 TENFSSKNILGAGGFGNVYKGKLGD------GTVLAVKRLKD---------------MISLAVHRNLLRLIGYCATPTER 259 (534)
Q Consensus 201 ~~~~~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~---------------~l~~~~h~niv~l~~~~~~~~~~ 259 (534)
+++|...+.||+|+||.||+|.+.+ +..||+|.... ++..++|+||+++++++.+....
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPR 84 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCc
Confidence 4678889999999999999998753 56789997641 56788999999999999999999
Q ss_pred EEEeeccCCCChhhhcccCC-------CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCC---cEEEE
Q 039819 260 LLVYPYMSNGSVASRLREKP-------ALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFC---EAIVG 329 (534)
Q Consensus 260 ~lv~e~~~~gsL~~~l~~~~-------~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~---~~kl~ 329 (534)
++||||+++++|.+++.... .+++..++.++.||+.||+|||+. +++||||||+||+++.++ .+||+
T Consensus 85 ~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~nil~~~~~~~~~~kl~ 161 (277)
T cd05036 85 FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKIA 161 (277)
T ss_pred EEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchheEEEeccCCCcceEec
Confidence 99999999999999986432 589999999999999999999998 999999999999998654 69999
Q ss_pred ecccceecCCCCCce-eeccccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCcCCCccccccchHHHHHHHH
Q 039819 330 DFGLAKLLDHSDSHV-TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GMRALEFGKSINQKGAMLEWVKKI 407 (534)
Q Consensus 330 DFGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~ 407 (534)
|||+++......... ......+..|+|||++.+..++.++|||||||++|||++ |+.||+..... +.....
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~-------~~~~~~ 234 (277)
T cd05036 162 DFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQ-------EVMEFV 234 (277)
T ss_pred cCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH-------HHHHHH
Confidence 999998763322111 111223568999999988889999999999999999997 99998743211 111111
Q ss_pred hhhcccceecccccCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhh
Q 039819 408 QQEKKVEVLVDRELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLE 459 (534)
Q Consensus 408 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~ 459 (534)
..... ...+...+..+.+++.+|++.+|++||++.+|++.|.
T Consensus 235 ~~~~~----------~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 235 TGGGR----------LDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred HcCCc----------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 11111 1112223457899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=335.43 Aligned_cols=253 Identities=27% Similarity=0.430 Sum_probs=210.2
Q ss_pred cccCHHHHHHHHhCC---------CcCCeeccCCcEEEEEEEEC----CCcEEEEEEehh---------------hhhhc
Q 039819 190 RNFTFRELQQATENF---------SSKNILGAGGFGNVYKGKLG----DGTVLAVKRLKD---------------MISLA 241 (534)
Q Consensus 190 ~~~~~~~l~~~~~~~---------~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~---------------~l~~~ 241 (534)
..+||||--+|...| .+.++||.|.||+||+|+++ ....||||.++. +|.+.
T Consensus 608 DP~TYEDPnqAvreFakEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQF 687 (996)
T KOG0196|consen 608 DPHTYEDPNQAVREFAKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQF 687 (996)
T ss_pred CCccccCccHHHHHhhhhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccC
Confidence 457777766666554 34578999999999999974 246799999973 78999
Q ss_pred ccCceeeEEEEEeCCCeeEEEeeccCCCChhhhccc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEe
Q 039819 242 VHRNLLRLIGYCATPTERLLVYPYMSNGSVASRLRE-KPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLL 320 (534)
Q Consensus 242 ~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl 320 (534)
.||||++|.|+.......+||.|||+||+|..+|+. .+.|++.+..-++++||.|+.||-+. ++|||||.++|||+
T Consensus 688 dHPNIIrLEGVVTks~PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm---~YVHRDLAARNILV 764 (996)
T KOG0196|consen 688 DHPNIIRLEGVVTKSKPVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDM---NYVHRDLAARNILV 764 (996)
T ss_pred CCCcEEEEEEEEecCceeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhc---Cchhhhhhhhheee
Confidence 999999999999999999999999999999999985 45699999999999999999999999 99999999999999
Q ss_pred CCCCcEEEEecccceecCCCCCceeecccc--ccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCcCCCcccccc
Q 039819 321 DDFCEAIVGDFGLAKLLDHSDSHVTTAVRG--TVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GMRALEFGKSINQK 397 (534)
Q Consensus 321 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~ellt-G~~p~~~~~~~~~~ 397 (534)
+.+..+||+|||+++.+.++.....++.-| ...|.|||.+...+++.++||||||||+||+++ |.+||..-+.
T Consensus 765 NsnLvCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSN---- 840 (996)
T KOG0196|consen 765 NSNLVCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN---- 840 (996)
T ss_pred ccceEEEeccccceeecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccch----
Confidence 999999999999999887655333443333 368999999999999999999999999999876 8889753221
Q ss_pred chHHHHHHHHhhhcccceecccccCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhcCC
Q 039819 398 GAMLEWVKKIQQEKKVEVLVDRELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLEGDG 462 (534)
Q Consensus 398 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~~~ 462 (534)
.+.++.+. ...+-..+.+++..+.+|++.||+++-.+||++.+++..|....
T Consensus 841 ---QdVIkaIe----------~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklI 892 (996)
T KOG0196|consen 841 ---QDVIKAIE----------QGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLI 892 (996)
T ss_pred ---HHHHHHHH----------hccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHh
Confidence 11222222 22233456678889999999999999999999999999998753
|
|
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=313.00 Aligned_cols=240 Identities=21% Similarity=0.252 Sum_probs=185.5
Q ss_pred hCCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEehh-----------------hhhhcccCceeeEEEEEeCCCeeEEEe
Q 039819 202 ENFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLKD-----------------MISLAVHRNLLRLIGYCATPTERLLVY 263 (534)
Q Consensus 202 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~-----------------~l~~~~h~niv~l~~~~~~~~~~~lv~ 263 (534)
++|...+.||+|+||.||+++.. +++.||||.+.+ ++..++|+||+++++++.+....++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 46888899999999999999975 588999998742 455668999999999999999999999
Q ss_pred eccCCCChhhhccc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCC
Q 039819 264 PYMSNGSVASRLRE-KPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDS 342 (534)
Q Consensus 264 e~~~~gsL~~~l~~-~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~ 342 (534)
||+++|+|.+++.. ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++........
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 157 (331)
T cd05597 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQL---GYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGT 157 (331)
T ss_pred ecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEECCCCHHHEEECCCCCEEEEECCceeecCCCCC
Confidence 99999999999975 45799999999999999999999999 999999999999999999999999999987654333
Q ss_pred ceeecccccccccccccccc-----CCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceec
Q 039819 343 HVTTAVRGTVGHIAPEYLST-----GQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLV 417 (534)
Q Consensus 343 ~~~~~~~gt~~y~aPE~~~~-----~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 417 (534)
.......||+.|+|||++.. ..++.++|||||||++|||++|+.||..... .+....+........
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~-------~~~~~~i~~~~~~~~-- 228 (331)
T cd05597 158 VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESL-------VETYGKIMNHKEHFQ-- 228 (331)
T ss_pred ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCH-------HHHHHHHHcCCCccc--
Confidence 22333569999999999863 4578899999999999999999999964321 122122211111000
Q ss_pred ccccCCCCCHHHHHHHHHHHHHhccc--CCCCCCChHHHHHH
Q 039819 418 DRELGSNYDRIEVGEILQVALLCTQY--LPVHRPKMSEVVRM 457 (534)
Q Consensus 418 d~~l~~~~~~~~~~~l~~l~~~Cl~~--~P~~RPt~~ev~~~ 457 (534)
+... ....+..+.+++.+|+.. ++..||+++++++.
T Consensus 229 ---~~~~-~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 229 ---FPPD-VTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred ---CCCc-cCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 0000 011234667777776654 34447888888763
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=325.43 Aligned_cols=187 Identities=22% Similarity=0.366 Sum_probs=165.1
Q ss_pred hCCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEehh-----------------hhhhcccCceeeEEEEEeCCCeeEEEe
Q 039819 202 ENFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLKD-----------------MISLAVHRNLLRLIGYCATPTERLLVY 263 (534)
Q Consensus 202 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~-----------------~l~~~~h~niv~l~~~~~~~~~~~lv~ 263 (534)
++|+..+.||+|+||.||+++.. +++.||||.+.. ++..+.|+||+++++.+.+.+..++||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 36788899999999999999875 688999998742 466778999999999999999999999
Q ss_pred eccCCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCC-
Q 039819 264 PYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDS- 342 (534)
Q Consensus 264 e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~- 342 (534)
||+++|+|.+++.....+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~---givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~ 157 (360)
T cd05627 81 EFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQL---GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRT 157 (360)
T ss_pred eCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEeeccCCccccccccc
Confidence 9999999999998888899999999999999999999998 999999999999999999999999999875432100
Q ss_pred ---------------------------------ceeeccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcC
Q 039819 343 ---------------------------------HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALE 389 (534)
Q Consensus 343 ---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~ 389 (534)
......+||+.|+|||++.+..++.++|||||||++|||+||+.||.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~ 237 (360)
T cd05627 158 EFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFC 237 (360)
T ss_pred ccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCCC
Confidence 01123469999999999999899999999999999999999999997
Q ss_pred CC
Q 039819 390 FG 391 (534)
Q Consensus 390 ~~ 391 (534)
..
T Consensus 238 ~~ 239 (360)
T cd05627 238 SE 239 (360)
T ss_pred CC
Confidence 43
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=333.15 Aligned_cols=239 Identities=25% Similarity=0.328 Sum_probs=191.4
Q ss_pred HHHhCCCcCCeeccCCcEEEEEEEE-CCCcEEEEEEehh----------------hhhhcccCceeeEEEEEeCCC----
Q 039819 199 QATENFSSKNILGAGGFGNVYKGKL-GDGTVLAVKRLKD----------------MISLAVHRNLLRLIGYCATPT---- 257 (534)
Q Consensus 199 ~~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~----------------~l~~~~h~niv~l~~~~~~~~---- 257 (534)
...++|...+.||+|+||.||+|+. .+++.||||++.. .+..+.|+||+++.+.+...+
T Consensus 29 ~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~ 108 (496)
T PTZ00283 29 EQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNP 108 (496)
T ss_pred ccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCc
Confidence 3456899999999999999999986 4789999998741 456778999999988775432
Q ss_pred ----eeEEEeeccCCCChhhhccc----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEE
Q 039819 258 ----ERLLVYPYMSNGSVASRLRE----KPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVG 329 (534)
Q Consensus 258 ----~~~lv~e~~~~gsL~~~l~~----~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~ 329 (534)
..++||||+++|+|.++++. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+
T Consensus 109 ~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~---~IiHrDLKP~NILl~~~~~vkL~ 185 (496)
T PTZ00283 109 ENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSK---HMIHRDIKSANILLCSNGLVKLG 185 (496)
T ss_pred ccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEeCCCCEEEE
Confidence 35799999999999998863 34689999999999999999999998 99999999999999999999999
Q ss_pred ecccceecCCCC-CceeeccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHh
Q 039819 330 DFGLAKLLDHSD-SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQ 408 (534)
Q Consensus 330 DFGla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~ 408 (534)
|||+++...... ........||+.|+|||++.+..++.++|||||||++|||++|+.||.... ..+++....
T Consensus 186 DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~-------~~~~~~~~~ 258 (496)
T PTZ00283 186 DFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGEN-------MEEVMHKTL 258 (496)
T ss_pred ecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC-------HHHHHHHHh
Confidence 999998764321 122334679999999999999899999999999999999999999997432 122222221
Q ss_pred hhcccceecccccCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 039819 409 QEKKVEVLVDRELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRM 457 (534)
Q Consensus 409 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~ 457 (534)
... . + ..+...+..+.+++.+|++.+|.+||++.+++..
T Consensus 259 ~~~-~----~-----~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 259 AGR-Y----D-----PLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred cCC-C----C-----CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 111 0 0 0112234578999999999999999999999763
|
|
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=304.54 Aligned_cols=240 Identities=29% Similarity=0.447 Sum_probs=195.3
Q ss_pred HhCCCcCCeeccCCcEEEEEEEECCCcEEEEEEehh-------------hhhhcccCceeeEEEEEeCCCeeEEEeeccC
Q 039819 201 TENFSSKNILGAGGFGNVYKGKLGDGTVLAVKRLKD-------------MISLAVHRNLLRLIGYCATPTERLLVYPYMS 267 (534)
Q Consensus 201 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~-------------~l~~~~h~niv~l~~~~~~~~~~~lv~e~~~ 267 (534)
.++|...+.||+|+||.||+|...++..||||.+.. .+..+.|+||+++++++......++||||++
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~ 84 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMS 84 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCccCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEeccC
Confidence 467888899999999999999988888999998862 5778899999999999999899999999999
Q ss_pred CCChhhhcccC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCCcee
Q 039819 268 NGSVASRLREK--PALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVT 345 (534)
Q Consensus 268 ~gsL~~~l~~~--~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~ 345 (534)
+++|.+++... ..+++..+..++.+++.||.|||+. +++|+||||+||+++.++.+||+|||+++..........
T Consensus 85 ~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~ 161 (261)
T cd05034 85 KGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESR---NYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAR 161 (261)
T ss_pred CCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcchheEEEcCCCCEEECccccceeccchhhhhh
Confidence 99999999754 4689999999999999999999998 999999999999999999999999999987653221111
Q ss_pred eccccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCcCCCccccccchHHHHHHHHhhhcccceecccccCCC
Q 039819 346 TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELGSN 424 (534)
Q Consensus 346 ~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 424 (534)
....++..|+|||.+.+..++.++|||||||++|||+| |+.||..... ....+ ....... ..
T Consensus 162 ~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~----~~~~~---~~~~~~~----------~~ 224 (261)
T cd05034 162 EGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTN----REVLE---QVERGYR----------MP 224 (261)
T ss_pred hccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH----HHHHH---HHHcCCC----------CC
Confidence 22234578999999988889999999999999999999 9999863221 11111 1111100 00
Q ss_pred CCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhc
Q 039819 425 YDRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLEG 460 (534)
Q Consensus 425 ~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~ 460 (534)
.+...+..+.+++.+|++.+|++||+++++++.|+.
T Consensus 225 ~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 225 RPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 111124578999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=304.89 Aligned_cols=242 Identities=20% Similarity=0.335 Sum_probs=195.7
Q ss_pred hCCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEeh-----------------hhhhhcccCceeeEEEEEeCCCeeEEEe
Q 039819 202 ENFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLK-----------------DMISLAVHRNLLRLIGYCATPTERLLVY 263 (534)
Q Consensus 202 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~-----------------~~l~~~~h~niv~l~~~~~~~~~~~lv~ 263 (534)
++|...+.||+|+||.||+|+.. +++.||||.+. ++++.++||||+++++++...+..++||
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 47888899999999999999874 78999999653 1567788999999999999999999999
Q ss_pred eccCCCChhhhcc----cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCC
Q 039819 264 PYMSNGSVASRLR----EKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDH 339 (534)
Q Consensus 264 e~~~~gsL~~~l~----~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~ 339 (534)
||+++|+|.+++. ....+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 9999999998875 234589999999999999999999998 999999999999999999999999999987653
Q ss_pred CCCceeeccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceeccc
Q 039819 340 SDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDR 419 (534)
Q Consensus 340 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 419 (534)
... ......|+..|+|||++.+..++.++||||||+++|||+||+.||..... ....+........ .+
T Consensus 159 ~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~-----~~~~~~~~~~~~~------~~ 226 (267)
T cd08228 159 KTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM-----NLFSLCQKIEQCD------YP 226 (267)
T ss_pred hhH-HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccc-----cHHHHHHHHhcCC------CC
Confidence 221 12234588899999999888889999999999999999999999853221 1122222211111 01
Q ss_pred ccCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhcC
Q 039819 420 ELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLEGD 461 (534)
Q Consensus 420 ~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~~ 461 (534)
..........+.+++.+||+.+|++||++.+|++.++..
T Consensus 227 ---~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~ 265 (267)
T cd08228 227 ---PLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM 265 (267)
T ss_pred ---CCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence 111123345789999999999999999999999998864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=318.40 Aligned_cols=249 Identities=22% Similarity=0.309 Sum_probs=185.7
Q ss_pred HHhCCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEeh----------------hhhhhcccCceeeEEEEEeCCC-----
Q 039819 200 ATENFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLK----------------DMISLAVHRNLLRLIGYCATPT----- 257 (534)
Q Consensus 200 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~----------------~~l~~~~h~niv~l~~~~~~~~----- 257 (534)
..++|...+.||+|+||.||++... .+..||||++. .++..++||||+++++++....
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 3578999999999999999999874 68899999874 1567788999999999986543
Q ss_pred -eeEEEeeccCCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEeccccee
Q 039819 258 -ERLLVYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKL 336 (534)
Q Consensus 258 -~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~ 336 (534)
..++||||+++ +|.+.+.. .+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 99 ~~~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~qi~~~L~~LH~~---~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~ 172 (359)
T cd07876 99 QDVYLVMELMDA-NLCQVIHM--ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLART 172 (359)
T ss_pred ceeEEEEeCCCc-CHHHHHhc--cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEecCCCccc
Confidence 46999999975 56555542 488999999999999999999998 999999999999999999999999999976
Q ss_pred cCCCCCceeeccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHH--------HH-----
Q 039819 337 LDHSDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAML--------EW----- 403 (534)
Q Consensus 337 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~--------~~----- 403 (534)
.... .......||..|+|||++.+..++.++|||||||++|||+||+.||...........+. ++
T Consensus 173 ~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (359)
T cd07876 173 ACTN--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQ 250 (359)
T ss_pred cccC--ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHH
Confidence 4322 12334568999999999998899999999999999999999999997543211100000 00
Q ss_pred --HHHHhhhc-cc-----ceeccccc-C--CCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 404 --VKKIQQEK-KV-----EVLVDREL-G--SNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 404 --~~~~~~~~-~~-----~~~~d~~l-~--~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
+....... .. .+....-. . ..........+.+++.+|++.||++|||+.|+++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 314 (359)
T cd07876 251 PTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALR 314 (359)
T ss_pred HHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhc
Confidence 00000000 00 00000000 0 0011122457889999999999999999999985
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=310.14 Aligned_cols=238 Identities=30% Similarity=0.417 Sum_probs=188.8
Q ss_pred CCCcCCeeccCCcEEEEEEEEC------CCcEEEEEEeh---------------hhhhhcccCceeeEEEEEeCCCeeEE
Q 039819 203 NFSSKNILGAGGFGNVYKGKLG------DGTVLAVKRLK---------------DMISLAVHRNLLRLIGYCATPTERLL 261 (534)
Q Consensus 203 ~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~---------------~~l~~~~h~niv~l~~~~~~~~~~~l 261 (534)
+|+..+.||+|+||.||+|... ....+|+|.+. ..+..+.||||+++++.|...+..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 4677889999999999999853 23578888764 25677889999999999999999999
Q ss_pred EeeccCCCChhhhcccC------------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCc
Q 039819 262 VYPYMSNGSVASRLREK------------------------PALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAAN 317 (534)
Q Consensus 262 v~e~~~~gsL~~~l~~~------------------------~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~N 317 (534)
||||+.+|+|.+++... ..+++..++.++.|++.||.|||+. +|+||||||+|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~ivH~dikp~n 157 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM---KLVHRDLAARN 157 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC---Ceehhhhhhhe
Confidence 99999999999887531 3478999999999999999999998 99999999999
Q ss_pred EEeCCCCcEEEEecccceecCCCCCc-eeeccccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCcCCCcccc
Q 039819 318 VLLDDFCEAIVGDFGLAKLLDHSDSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GMRALEFGKSIN 395 (534)
Q Consensus 318 iLl~~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~ellt-G~~p~~~~~~~~ 395 (534)
||+++++.+||+|||+++........ ......++..|+|||++.+..++.++||||||+++|||+| |+.||.....
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~-- 235 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAP-- 235 (290)
T ss_pred EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCH--
Confidence 99999999999999999865332211 1222345678999999988889999999999999999999 9999864321
Q ss_pred ccchHHHHHHHHhhhcccceecccccCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhc
Q 039819 396 QKGAMLEWVKKIQQEKKVEVLVDRELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLEG 460 (534)
Q Consensus 396 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~ 460 (534)
..+.++.. .. .....+...+..+.+++.+|++.+|++||++.++++.|+.
T Consensus 236 --~~~~~~~~---~~----------~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~ 285 (290)
T cd05045 236 --ERLFNLLK---TG----------YRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEK 285 (290)
T ss_pred --HHHHHHHh---CC----------CCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHH
Confidence 11112111 10 0011112234578899999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=310.31 Aligned_cols=248 Identities=23% Similarity=0.315 Sum_probs=185.2
Q ss_pred CCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEehh----------------h---hhhcccCceeeEEEEEeCC-----C
Q 039819 203 NFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLKD----------------M---ISLAVHRNLLRLIGYCATP-----T 257 (534)
Q Consensus 203 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~----------------~---l~~~~h~niv~l~~~~~~~-----~ 257 (534)
+|...+.||+|+||.||+|+.. +++.||+|.+.. . +..+.||||+++++++... .
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 4778889999999999999875 688999997751 2 2334699999999988642 3
Q ss_pred eeEEEeeccCCCChhhhcccC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccce
Q 039819 258 ERLLVYPYMSNGSVASRLREK--PALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAK 335 (534)
Q Consensus 258 ~~~lv~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~ 335 (534)
..++||||+++ +|.+++... ..+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus 81 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~kl~dfg~~~ 156 (288)
T cd07863 81 KVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGQVKLADFGLAR 156 (288)
T ss_pred eEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccCccc
Confidence 57899999985 888887643 4589999999999999999999999 99999999999999999999999999998
Q ss_pred ecCCCCCceeeccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccc-
Q 039819 336 LLDHSDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVE- 414 (534)
Q Consensus 336 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~- 414 (534)
...... ......||..|+|||++.+..++.++|||||||++|||++|++||...........+..+...........
T Consensus 157 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (288)
T cd07863 157 IYSCQM--ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRD 234 (288)
T ss_pred cccCcc--cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCccc
Confidence 764322 22345689999999999888899999999999999999999999975433222212222111100000000
Q ss_pred -----eecccccCC---CCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 415 -----VLVDRELGS---NYDRIEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 415 -----~~~d~~l~~---~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
..+.+.... .........+.+++.+|++.||++|||+.|++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 235 VTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred ccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 000000000 001112356789999999999999999999884
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=319.57 Aligned_cols=249 Identities=21% Similarity=0.290 Sum_probs=186.4
Q ss_pred HHhCCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEehh----------------hhhhcccCceeeEEEEEeCC------
Q 039819 200 ATENFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLKD----------------MISLAVHRNLLRLIGYCATP------ 256 (534)
Q Consensus 200 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~----------------~l~~~~h~niv~l~~~~~~~------ 256 (534)
..++|...+.||+|+||.||++... .++.||||++.. +++.++||||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 3578999999999999999999875 578899998742 56778899999999987543
Q ss_pred CeeEEEeeccCCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEeccccee
Q 039819 257 TERLLVYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKL 336 (534)
Q Consensus 257 ~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~ 336 (534)
...++||||+++ +|.+.+.. .+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 102 ~~~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~ 175 (364)
T cd07875 102 QDVYIVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLART 175 (364)
T ss_pred CeEEEEEeCCCC-CHHHHHHh--cCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEECCCCcEEEEeCCCccc
Confidence 346999999975 66666643 488999999999999999999998 999999999999999999999999999986
Q ss_pred cCCCCCceeeccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHH--------HHHHH-
Q 039819 337 LDHSDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLE--------WVKKI- 407 (534)
Q Consensus 337 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~--------~~~~~- 407 (534)
..... ......||..|+|||++.+..++.++|||||||++|||++|+.||...........+.. +....
T Consensus 176 ~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (364)
T cd07875 176 AGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQ 253 (364)
T ss_pred cCCCC--cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhh
Confidence 54322 22345689999999999988999999999999999999999999975433221111110 00000
Q ss_pred ------hhh-cccc-----eeccccc---CCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 408 ------QQE-KKVE-----VLVDREL---GSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 408 ------~~~-~~~~-----~~~d~~l---~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
... .... ....... ...........+.+++.+|++.||.+|||+.|+++
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~ 317 (364)
T cd07875 254 PTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ 317 (364)
T ss_pred HHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 000 0000 0000000 00011112347889999999999999999999875
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=301.74 Aligned_cols=233 Identities=27% Similarity=0.409 Sum_probs=192.1
Q ss_pred CCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEeh----------------hhhhhcccCceeeEEEEEeCCCeeEEEeec
Q 039819 203 NFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLK----------------DMISLAVHRNLLRLIGYCATPTERLLVYPY 265 (534)
Q Consensus 203 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~----------------~~l~~~~h~niv~l~~~~~~~~~~~lv~e~ 265 (534)
+|...+.||+|++|.||+|... +++.|++|.+. ++++.++||||+++++++.+.+..++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 4677789999999999999875 68899999864 257788999999999999999999999999
Q ss_pred cCCCChhhhcccC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCCc
Q 039819 266 MSNGSVASRLREK--PALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSH 343 (534)
Q Consensus 266 ~~~gsL~~~l~~~--~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~ 343 (534)
+++++|.+++... ..+++..+..++.+++.||.|||+. +++||||||+||+++.++.++|+|||+++.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~---~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~- 156 (256)
T cd08529 81 AENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN- 156 (256)
T ss_pred CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEeCCCCEEEcccccceeccCccc-
Confidence 9999999998753 5789999999999999999999998 999999999999999999999999999987654322
Q ss_pred eeeccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceecccccCC
Q 039819 344 VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELGS 423 (534)
Q Consensus 344 ~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 423 (534)
......|+..|+|||+..+..++.++|||||||++|||+||+.||..... ... ...... .. ..
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----~~~---~~~~~~-~~---------~~ 219 (256)
T cd08529 157 FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQ----GAL---ILKIIR-GV---------FP 219 (256)
T ss_pred hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH----HHH---HHHHHc-CC---------CC
Confidence 22334688999999999988899999999999999999999999964331 111 111111 10 01
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 424 NYDRIEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 424 ~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
.........+.+++.+|++.+|++||++.++++
T Consensus 220 ~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 252 (256)
T cd08529 220 PVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLR 252 (256)
T ss_pred CCccccCHHHHHHHHHHccCCcccCcCHHHHhh
Confidence 112233457899999999999999999999986
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-38 Score=312.24 Aligned_cols=241 Identities=30% Similarity=0.438 Sum_probs=191.1
Q ss_pred HHhCCCcCCeeccCCcEEEEEEEEC------CCcEEEEEEehh---------------hhhhc-ccCceeeEEEEEeCCC
Q 039819 200 ATENFSSKNILGAGGFGNVYKGKLG------DGTVLAVKRLKD---------------MISLA-VHRNLLRLIGYCATPT 257 (534)
Q Consensus 200 ~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~---------------~l~~~-~h~niv~l~~~~~~~~ 257 (534)
..++|+..+.||+|+||.||++... ....+|+|.+.. ++..+ +|+||+++++++....
T Consensus 10 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 89 (293)
T cd05053 10 PRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEG 89 (293)
T ss_pred CHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCC
Confidence 3457888899999999999999863 236799997752 34455 7999999999999999
Q ss_pred eeEEEeeccCCCChhhhccc----------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeC
Q 039819 258 ERLLVYPYMSNGSVASRLRE----------------KPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLD 321 (534)
Q Consensus 258 ~~~lv~e~~~~gsL~~~l~~----------------~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~ 321 (534)
..++||||+++|+|.+++.. ...+++..+++++.|++.||.|||+. +|+||||||+||+++
T Consensus 90 ~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~Nil~~ 166 (293)
T cd05053 90 PLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK---KCIHRDLAARNVLVT 166 (293)
T ss_pred CeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CccccccceeeEEEc
Confidence 99999999999999998853 24689999999999999999999998 999999999999999
Q ss_pred CCCcEEEEecccceecCCCCCc-eeeccccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCcCCCccccccch
Q 039819 322 DFCEAIVGDFGLAKLLDHSDSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GMRALEFGKSINQKGA 399 (534)
Q Consensus 322 ~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~ellt-G~~p~~~~~~~~~~~~ 399 (534)
.++.+||+|||+++.+...... ......++..|+|||++.+..++.++|||||||++|||++ |..||.....
T Consensus 167 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~------ 240 (293)
T cd05053 167 EDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV------ 240 (293)
T ss_pred CCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCH------
Confidence 9999999999999876433211 1122235678999999988889999999999999999998 9988863221
Q ss_pred HHHHHHHHhhhcccceecccccCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhc
Q 039819 400 MLEWVKKIQQEKKVEVLVDRELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLEG 460 (534)
Q Consensus 400 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~ 460 (534)
.+......... ....+......+.+++.+|++.+|++|||+.|+++.|+.
T Consensus 241 -~~~~~~~~~~~----------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~ 290 (293)
T cd05053 241 -EELFKLLKEGY----------RMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDR 290 (293)
T ss_pred -HHHHHHHHcCC----------cCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHH
Confidence 11111111110 001122234578999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=303.65 Aligned_cols=240 Identities=22% Similarity=0.322 Sum_probs=190.9
Q ss_pred hCCCcCCeeccCCcEEEEEEEE-CCCcEEEEEEeh--------------hhhhhcccCceeeEEEEEeCCCeeEEEeecc
Q 039819 202 ENFSSKNILGAGGFGNVYKGKL-GDGTVLAVKRLK--------------DMISLAVHRNLLRLIGYCATPTERLLVYPYM 266 (534)
Q Consensus 202 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~--------------~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~ 266 (534)
++|...+.||+|+||.||+|+. .+++.||+|++. .++..++||||+++++++...+..++||||+
T Consensus 9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~ 88 (267)
T cd06646 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYC 88 (267)
T ss_pred hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCC
Confidence 5788899999999999999997 468899999874 2567788999999999999999999999999
Q ss_pred CCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCCceee
Q 039819 267 SNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTT 346 (534)
Q Consensus 267 ~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~ 346 (534)
++++|.++++....+++..+..++.|++.||.|||+. +|+||||||+||+++.++.++|+|||++........ ...
T Consensus 89 ~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~-~~~ 164 (267)
T cd06646 89 GGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSK---GKMHRDIKGANILLTDNGDVKLADFGVAAKITATIA-KRK 164 (267)
T ss_pred CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEECcCccceeeccccc-ccC
Confidence 9999999998777899999999999999999999998 999999999999999999999999999986643211 123
Q ss_pred ccccccccccccccc---cCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceecccccCC
Q 039819 347 AVRGTVGHIAPEYLS---TGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELGS 423 (534)
Q Consensus 347 ~~~gt~~y~aPE~~~---~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 423 (534)
...|+..|+|||.+. ...++.++|||||||++|||++|+.||........ ...+ .. .....+....
T Consensus 165 ~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~---~~~~----~~----~~~~~~~~~~ 233 (267)
T cd06646 165 SFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA---LFLM----SK----SNFQPPKLKD 233 (267)
T ss_pred ccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhh---heee----ec----CCCCCCCCcc
Confidence 345889999999874 34578899999999999999999999853221100 0000 00 0000011110
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHh
Q 039819 424 NYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRML 458 (534)
Q Consensus 424 ~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L 458 (534)
....+..+.+++.+|++.+|++||+++++++.|
T Consensus 234 --~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 234 --KTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred --ccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 111245788999999999999999999998643
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=314.77 Aligned_cols=228 Identities=24% Similarity=0.336 Sum_probs=184.3
Q ss_pred CCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEehh-----------------hhhhc-ccCceeeEEEEEeCCCeeEEEe
Q 039819 203 NFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLKD-----------------MISLA-VHRNLLRLIGYCATPTERLLVY 263 (534)
Q Consensus 203 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~-----------------~l~~~-~h~niv~l~~~~~~~~~~~lv~ 263 (534)
+|+..+.||+|+||.||+|+.. +++.||||.+.. ++... .|++|+++.+++...+..++||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 3667789999999999999875 688999998752 22233 4678888999999999999999
Q ss_pred eccCCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCCc
Q 039819 264 PYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSH 343 (534)
Q Consensus 264 e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~ 343 (534)
||+++|+|.+++.....+++.++..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++...... .
T Consensus 81 Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~-~ 156 (323)
T cd05615 81 EYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG-V 156 (323)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeccccccccCCCC-c
Confidence 9999999999998878899999999999999999999998 99999999999999999999999999987543221 1
Q ss_pred eeeccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceecccccCC
Q 039819 344 VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELGS 423 (534)
Q Consensus 344 ~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 423 (534)
......||..|+|||++.+..++.++|||||||++|||+||+.||...... .....+.... .
T Consensus 157 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~-------~~~~~i~~~~-------~---- 218 (323)
T cd05615 157 TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDED-------ELFQSIMEHN-------V---- 218 (323)
T ss_pred cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHH-------HHHHHHHhCC-------C----
Confidence 233456899999999998888999999999999999999999999743211 1111111110 0
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCChH
Q 039819 424 NYDRIEVGEILQVALLCTQYLPVHRPKMS 452 (534)
Q Consensus 424 ~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ 452 (534)
.++......+.+++.+|++.+|.+|++..
T Consensus 219 ~~p~~~~~~~~~li~~~l~~~p~~R~~~~ 247 (323)
T cd05615 219 SYPKSLSKEAVSICKGLMTKHPSKRLGCG 247 (323)
T ss_pred CCCccCCHHHHHHHHHHcccCHhhCCCCC
Confidence 11122234778999999999999999864
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-38 Score=310.32 Aligned_cols=238 Identities=23% Similarity=0.361 Sum_probs=189.4
Q ss_pred CCCcCCeeccCCcEEEEEEEEC------CCcEEEEEEehh---------------hhhhcccCceeeEEEEEeCCCeeEE
Q 039819 203 NFSSKNILGAGGFGNVYKGKLG------DGTVLAVKRLKD---------------MISLAVHRNLLRLIGYCATPTERLL 261 (534)
Q Consensus 203 ~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~---------------~l~~~~h~niv~l~~~~~~~~~~~l 261 (534)
+|...+.||+|+||.||+|... ++..||||++.. ++..++||||+++++++......++
T Consensus 6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~ 85 (283)
T cd05091 6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSM 85 (283)
T ss_pred HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEE
Confidence 3556678999999999999863 357899998852 4567889999999999999999999
Q ss_pred EeeccCCCChhhhccc----------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCc
Q 039819 262 VYPYMSNGSVASRLRE----------------KPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCE 325 (534)
Q Consensus 262 v~e~~~~gsL~~~l~~----------------~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~ 325 (534)
++||+++++|.+++.. ...+++..+..++.|++.||.|||+. +|+||||||+||++++++.
T Consensus 86 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~ 162 (283)
T cd05091 86 IFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKLN 162 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc---CccccccchhheEecCCCc
Confidence 9999999999988742 23588999999999999999999998 9999999999999999999
Q ss_pred EEEEecccceecCCCCC-ceeeccccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCcCCCccccccchHHHH
Q 039819 326 AIVGDFGLAKLLDHSDS-HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GMRALEFGKSINQKGAMLEW 403 (534)
Q Consensus 326 ~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~ 403 (534)
+||+|||+++....... .......+++.|+|||++.++.++.++|||||||++|||+| |..||..... .++
T Consensus 163 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~-------~~~ 235 (283)
T cd05091 163 VKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN-------QDV 235 (283)
T ss_pred eEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCH-------HHH
Confidence 99999999886543221 11223345779999999988889999999999999999998 8888763221 122
Q ss_pred HHHHhhhcccceecccccCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhc
Q 039819 404 VKKIQQEKKVEVLVDRELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLEG 460 (534)
Q Consensus 404 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~ 460 (534)
...+..... ...+...+..+.+++..|++.+|.+||++.+|+..|+.
T Consensus 236 ~~~i~~~~~----------~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 236 IEMIRNRQV----------LPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred HHHHHcCCc----------CCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 222222111 01122234578999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=304.19 Aligned_cols=237 Identities=27% Similarity=0.433 Sum_probs=187.0
Q ss_pred CCcCCeeccCCcEEEEEEEECC----CcEEEEEEehh----------------hhhhcccCceeeEEEEEeCCCe-----
Q 039819 204 FSSKNILGAGGFGNVYKGKLGD----GTVLAVKRLKD----------------MISLAVHRNLLRLIGYCATPTE----- 258 (534)
Q Consensus 204 ~~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~----------------~l~~~~h~niv~l~~~~~~~~~----- 258 (534)
|...+.||+|+||.||+|.... +..||||+++. .+..+.|+||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 4567889999999999998742 36799998751 4667889999999999876554
Q ss_pred -eEEEeeccCCCChhhhccc------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEec
Q 039819 259 -RLLVYPYMSNGSVASRLRE------KPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDF 331 (534)
Q Consensus 259 -~~lv~e~~~~gsL~~~l~~------~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DF 331 (534)
.++||||+++|+|..++.. ...+++..+..++.|++.||.|||+. +++||||||+||++++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchheEEECCCCeEEECCc
Confidence 6899999999999988842 23689999999999999999999998 9999999999999999999999999
Q ss_pred ccceecCCCCCce-eeccccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCcCCCccccccchHHHHHHHHhh
Q 039819 332 GLAKLLDHSDSHV-TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GMRALEFGKSINQKGAMLEWVKKIQQ 409 (534)
Q Consensus 332 Gla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~ 409 (534)
|+++......... .....++..|+|||++.+..++.++|||||||++|||++ |..||..... ..+.++. ..
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~----~~~~~~~---~~ 230 (273)
T cd05035 158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVEN----HEIYDYL---RH 230 (273)
T ss_pred cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCH----HHHHHHH---Hc
Confidence 9998764332211 112234678999999988889999999999999999999 8888864221 1111221 11
Q ss_pred hcccceecccccCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhc
Q 039819 410 EKKVEVLVDRELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLEG 460 (534)
Q Consensus 410 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~ 460 (534)
... . ..+...+..+.+++.+|++.+|.+||++.|+++.|+.
T Consensus 231 ~~~------~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~ 271 (273)
T cd05035 231 GNR------L----KQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLEN 271 (273)
T ss_pred CCC------C----CCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHh
Confidence 110 0 1122234588999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=310.15 Aligned_cols=245 Identities=22% Similarity=0.385 Sum_probs=188.3
Q ss_pred hCCCcCCeeccCCcEEEEEEEECC---------------CcEEEEEEeh---------------hhhhhcccCceeeEEE
Q 039819 202 ENFSSKNILGAGGFGNVYKGKLGD---------------GTVLAVKRLK---------------DMISLAVHRNLLRLIG 251 (534)
Q Consensus 202 ~~~~~~~~lG~G~~g~Vy~~~~~~---------------~~~vavK~~~---------------~~l~~~~h~niv~l~~ 251 (534)
++|+..+.||+|+||.||++...+ ...||+|.+. +.+..++|+|++++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~ 84 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG 84 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence 578888999999999999987632 2358999764 2567889999999999
Q ss_pred EEeCCCeeEEEeeccCCCChhhhcccC------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEE
Q 039819 252 YCATPTERLLVYPYMSNGSVASRLREK------------PALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVL 319 (534)
Q Consensus 252 ~~~~~~~~~lv~e~~~~gsL~~~l~~~------------~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiL 319 (534)
++......++||||+++++|.+++... ..+++..++.++.|++.||.|||+. +++||||||+||+
T Consensus 85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil 161 (295)
T cd05097 85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL---NFVHRDLATRNCL 161 (295)
T ss_pred EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc---CeeccccChhhEE
Confidence 999999999999999999999988532 2478999999999999999999998 9999999999999
Q ss_pred eCCCCcEEEEecccceecCCCCCc-eeeccccccccccccccccCCCCcchhHHHHHHHHHHHHh--CCCCcCCCccccc
Q 039819 320 LDDFCEAIVGDFGLAKLLDHSDSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT--GMRALEFGKSINQ 396 (534)
Q Consensus 320 l~~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~ellt--G~~p~~~~~~~~~ 396 (534)
++.++.+||+|||++......... ......++..|+|||++..+.++.++|||||||++|||++ |..||.....
T Consensus 162 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~--- 238 (295)
T cd05097 162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSD--- 238 (295)
T ss_pred EcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccCh---
Confidence 999999999999999865432211 1122345678999999988889999999999999999998 4556653211
Q ss_pred cchHHHHHHHHhhhcccceecccccCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhh
Q 039819 397 KGAMLEWVKKIQQEKKVEVLVDRELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLE 459 (534)
Q Consensus 397 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~ 459 (534)
..+............ .......+...+..+.+++.+|++.+|++||+|.+|++.|+
T Consensus 239 -~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 239 -EQVIENTGEFFRNQG------RQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred -HHHHHHHHHhhhhcc------ccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 111111111111100 00000111123458999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=303.82 Aligned_cols=238 Identities=28% Similarity=0.421 Sum_probs=191.3
Q ss_pred CCcCCeeccCCcEEEEEEEEC-CCcEEEEEEehh----------------hhhhcccCceeeEEEEEeCCCeeEEEeecc
Q 039819 204 FSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLKD----------------MISLAVHRNLLRLIGYCATPTERLLVYPYM 266 (534)
Q Consensus 204 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~----------------~l~~~~h~niv~l~~~~~~~~~~~lv~e~~ 266 (534)
|+..+.||+|+||.||+++.. ++..+|+|.+.. .+..++||||+++++++......++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 456788999999999999986 456899998852 567778999999999999999999999999
Q ss_pred CCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCCceee
Q 039819 267 SNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTT 346 (534)
Q Consensus 267 ~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~ 346 (534)
++++|.+++.....+++..+..++.|+++||.|||+. +|+|+||||+||+++.++.++|+|||.+..... ......
T Consensus 81 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~---~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~-~~~~~~ 156 (260)
T PF00069_consen 81 PGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSK---GIVHRDIKPENILLDENGEVKLIDFGSSVKLSE-NNENFN 156 (260)
T ss_dssp TTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHT---TEEESSBSGGGEEESTTSEEEESSGTTTEESTS-TTSEBS
T ss_pred ccccccccccccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccc-cccccc
Confidence 9999999998777899999999999999999999999 999999999999999999999999999986522 222344
Q ss_pred ccccccccccccccc-cCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceecccccCCCC
Q 039819 347 AVRGTVGHIAPEYLS-TGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELGSNY 425 (534)
Q Consensus 347 ~~~gt~~y~aPE~~~-~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 425 (534)
...++..|+|||++. +..++.++||||+|+++|+|++|+.||......+....+..-........ .. .
T Consensus 157 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~---------~~--~ 225 (260)
T PF00069_consen 157 PFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSS---------SQ--Q 225 (260)
T ss_dssp SSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHH---------TT--S
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhccccccccc---------cc--c
Confidence 566899999999998 78889999999999999999999999975411111111111110000000 00 0
Q ss_pred CHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 426 DRIEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 426 ~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
.......+.+++.+|++.+|++||++.++++
T Consensus 226 ~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 226 SREKSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp HTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred cchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0001268999999999999999999999985
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=310.81 Aligned_cols=238 Identities=27% Similarity=0.399 Sum_probs=186.7
Q ss_pred hCCCcCCeeccCCcEEEEEEEECC-C--cEEEEEEehh---------------hhhhc-ccCceeeEEEEEeCCCeeEEE
Q 039819 202 ENFSSKNILGAGGFGNVYKGKLGD-G--TVLAVKRLKD---------------MISLA-VHRNLLRLIGYCATPTERLLV 262 (534)
Q Consensus 202 ~~~~~~~~lG~G~~g~Vy~~~~~~-~--~~vavK~~~~---------------~l~~~-~h~niv~l~~~~~~~~~~~lv 262 (534)
++|+..+.||+|+||.||+|...+ + ..+++|.++. .+.++ .||||+++++++......++|
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 467888999999999999998753 3 3468887652 34455 699999999999999999999
Q ss_pred eeccCCCChhhhcccC----------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcE
Q 039819 263 YPYMSNGSVASRLREK----------------PALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEA 326 (534)
Q Consensus 263 ~e~~~~gsL~~~l~~~----------------~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~ 326 (534)
|||+++|+|.+++... ..+++..++.|+.|++.||+|||+. +|+||||||+|||++.++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK---QFIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCcCCcceEEECCCCeE
Confidence 9999999999998643 2488999999999999999999998 99999999999999999999
Q ss_pred EEEecccceecCCCCCceeeccccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCcCCCccccccchHHHHHH
Q 039819 327 IVGDFGLAKLLDHSDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GMRALEFGKSINQKGAMLEWVK 405 (534)
Q Consensus 327 kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~ 405 (534)
||+|||++....... .......+..|+|||++....++.++|||||||++|||+| |+.||..... .++..
T Consensus 159 kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~-------~~~~~ 229 (297)
T cd05089 159 KIADFGLSRGEEVYV--KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTC-------AELYE 229 (297)
T ss_pred EECCcCCCcccccee--ccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH-------HHHHH
Confidence 999999986432111 1111223567999999988889999999999999999998 9999964321 11111
Q ss_pred HHhhhcccceecccccCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhcC
Q 039819 406 KIQQEKKVEVLVDRELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLEGD 461 (534)
Q Consensus 406 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~~ 461 (534)
..... .....+...+..+.+++.+|++.+|.+||++.++++.|+..
T Consensus 230 ~~~~~----------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 275 (297)
T cd05089 230 KLPQG----------YRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRM 275 (297)
T ss_pred HHhcC----------CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 11111 00111122345788999999999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=322.34 Aligned_cols=241 Identities=25% Similarity=0.357 Sum_probs=189.7
Q ss_pred HhCCCcCCeeccCCcEEEEEEEEC------CCcEEEEEEehh---------------hhhhcc-cCceeeEEEEEeCCCe
Q 039819 201 TENFSSKNILGAGGFGNVYKGKLG------DGTVLAVKRLKD---------------MISLAV-HRNLLRLIGYCATPTE 258 (534)
Q Consensus 201 ~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~---------------~l~~~~-h~niv~l~~~~~~~~~ 258 (534)
.++|...+.||+|+||.||+|++. .+..||||+++. ++..+. |||||+++++|.....
T Consensus 36 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~ 115 (401)
T cd05107 36 RDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGP 115 (401)
T ss_pred HHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCC
Confidence 346777889999999999999863 346799998862 455665 9999999999999999
Q ss_pred eEEEeeccCCCChhhhcccC------------------------------------------------------------
Q 039819 259 RLLVYPYMSNGSVASRLREK------------------------------------------------------------ 278 (534)
Q Consensus 259 ~~lv~e~~~~gsL~~~l~~~------------------------------------------------------------ 278 (534)
.++||||+++|+|.++++..
T Consensus 116 ~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (401)
T cd05107 116 IYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDM 195 (401)
T ss_pred cEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcc
Confidence 99999999999999988532
Q ss_pred --------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEe
Q 039819 279 --------------------------------------PALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLL 320 (534)
Q Consensus 279 --------------------------------------~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl 320 (534)
..+++..+++|+.|++.||.|||+. +|+||||||+|||+
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrdlkp~NiLl 272 (401)
T cd05107 196 KGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK---NCVHRDLAARNVLI 272 (401)
T ss_pred hhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CcCcccCCcceEEE
Confidence 2367888899999999999999998 99999999999999
Q ss_pred CCCCcEEEEecccceecCCCCC-ceeeccccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCcCCCccccccc
Q 039819 321 DDFCEAIVGDFGLAKLLDHSDS-HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GMRALEFGKSINQKG 398 (534)
Q Consensus 321 ~~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~ellt-G~~p~~~~~~~~~~~ 398 (534)
++++.+||+|||+++....... .......++..|+|||++.+..++.++|||||||++|||++ |+.||.......
T Consensus 273 ~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~--- 349 (401)
T cd05107 273 CEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNE--- 349 (401)
T ss_pred eCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchH---
Confidence 9999999999999986532221 11222346788999999988889999999999999999998 888986432110
Q ss_pred hHHHHHHHHhhhcccceecccccCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhc
Q 039819 399 AMLEWVKKIQQEKKVEVLVDRELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLEG 460 (534)
Q Consensus 399 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~ 460 (534)
.......... ....+......+.+++.+||+.+|.+||+++||++.|+.
T Consensus 350 ---~~~~~~~~~~----------~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~ 398 (401)
T cd05107 350 ---QFYNAIKRGY----------RMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGD 398 (401)
T ss_pred ---HHHHHHHcCC----------CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 0111111110 001111234588999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=307.77 Aligned_cols=246 Identities=24% Similarity=0.363 Sum_probs=192.6
Q ss_pred HhCCCcCCeeccCCcEEEEEEEECC-----------------CcEEEEEEehh---------------hhhhcccCceee
Q 039819 201 TENFSSKNILGAGGFGNVYKGKLGD-----------------GTVLAVKRLKD---------------MISLAVHRNLLR 248 (534)
Q Consensus 201 ~~~~~~~~~lG~G~~g~Vy~~~~~~-----------------~~~vavK~~~~---------------~l~~~~h~niv~ 248 (534)
.++|...+.||+|+||.||+|...+ +..||+|.+.. ++..++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 3578889999999999999997642 24689998752 567889999999
Q ss_pred EEEEEeCCCeeEEEeeccCCCChhhhcccCC-----------CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCc
Q 039819 249 LIGYCATPTERLLVYPYMSNGSVASRLREKP-----------ALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAAN 317 (534)
Q Consensus 249 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~-----------~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~N 317 (534)
++++|...+..++||||+++++|.+++.... .+++..++.++.|++.||+|||+. +|+||||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~---~i~H~dlkp~N 160 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRDLATRN 160 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc---Cccccccchhc
Confidence 9999999999999999999999999987544 689999999999999999999998 99999999999
Q ss_pred EEeCCCCcEEEEecccceecCCCCC-ceeeccccccccccccccccCCCCcchhHHHHHHHHHHHHh--CCCCcCCCccc
Q 039819 318 VLLDDFCEAIVGDFGLAKLLDHSDS-HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT--GMRALEFGKSI 394 (534)
Q Consensus 318 iLl~~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~ellt--G~~p~~~~~~~ 394 (534)
|+++.++.++|+|||+++....... .......++..|+|||++.+..++.++|||||||++|||++ |..||.....
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~- 239 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTD- 239 (296)
T ss_pred eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcCh-
Confidence 9999999999999999986543321 12233446788999999988889999999999999999998 6666653221
Q ss_pred cccchHHHHHHHHhhhcccceecccccCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhh
Q 039819 395 NQKGAMLEWVKKIQQEKKVEVLVDRELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLE 459 (534)
Q Consensus 395 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~ 459 (534)
..+...+.......... .....+...+.++.+++.+|++.+|++||++.||++.|+
T Consensus 240 ---~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 240 ---QQVIENAGHFFRDDGRQ------IYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred ---HHHHHHHHhcccccccc------ccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 11222221111111100 001111223458999999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=310.67 Aligned_cols=240 Identities=27% Similarity=0.396 Sum_probs=190.9
Q ss_pred hCCCcCCeeccCCcEEEEEEEE------CCCcEEEEEEehh---------------hhhhc-ccCceeeEEEEEeCCCee
Q 039819 202 ENFSSKNILGAGGFGNVYKGKL------GDGTVLAVKRLKD---------------MISLA-VHRNLLRLIGYCATPTER 259 (534)
Q Consensus 202 ~~~~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~---------------~l~~~-~h~niv~l~~~~~~~~~~ 259 (534)
++|...+.||+|+||.||+|.. ..+..||||+++. ++.++ +|+||+++++++...+..
T Consensus 35 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~ 114 (302)
T cd05055 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPI 114 (302)
T ss_pred HHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCce
Confidence 5688889999999999999974 2345799997642 45666 799999999999999999
Q ss_pred EEEeeccCCCChhhhcccC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceec
Q 039819 260 LLVYPYMSNGSVASRLREK--PALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLL 337 (534)
Q Consensus 260 ~lv~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~ 337 (534)
++||||+++|+|.++++.. ..+++.++..++.+++.||.|||+. +|+|+||||+|||++.++.++++|||+++..
T Consensus 115 ~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~~ 191 (302)
T cd05055 115 LVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNVLLTHGKIVKICDFGLARDI 191 (302)
T ss_pred EEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeehhhhccceEEEcCCCeEEECCCcccccc
Confidence 9999999999999998753 2389999999999999999999998 9999999999999999999999999999865
Q ss_pred CCCCCc-eeeccccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCcCCCccccccchHHHHHHHHhhhcccce
Q 039819 338 DHSDSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GMRALEFGKSINQKGAMLEWVKKIQQEKKVEV 415 (534)
Q Consensus 338 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 415 (534)
...... ......++..|+|||++.+..++.++|||||||++|||+| |+.||...... ....... .. .
T Consensus 192 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~---~~~~~~~---~~-~---- 260 (302)
T cd05055 192 MNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVD---SKFYKLI---KE-G---- 260 (302)
T ss_pred cCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCch---HHHHHHH---Hc-C----
Confidence 433221 1222345778999999988889999999999999999998 99998643211 1111111 11 1
Q ss_pred ecccccCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhc
Q 039819 416 LVDRELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLEG 460 (534)
Q Consensus 416 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~ 460 (534)
.....+...+..+.+++.+|++.+|++||++.|+++.|+.
T Consensus 261 -----~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~ 300 (302)
T cd05055 261 -----YRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGK 300 (302)
T ss_pred -----CcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHh
Confidence 0000111223578999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=306.56 Aligned_cols=239 Identities=26% Similarity=0.431 Sum_probs=189.0
Q ss_pred hCCCcCCeeccCCcEEEEEEEEC-CCc----EEEEEEehh---------------hhhhcccCceeeEEEEEeCCCeeEE
Q 039819 202 ENFSSKNILGAGGFGNVYKGKLG-DGT----VLAVKRLKD---------------MISLAVHRNLLRLIGYCATPTERLL 261 (534)
Q Consensus 202 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~----~vavK~~~~---------------~l~~~~h~niv~l~~~~~~~~~~~l 261 (534)
++|...+.||+|+||.||+|++. ++. .||+|.+.. .+..+.|+||+++++++.. ...++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~l 85 (279)
T cd05109 7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQL 85 (279)
T ss_pred hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcEE
Confidence 56788899999999999999853 444 489998752 4567789999999999975 45789
Q ss_pred EeeccCCCChhhhccc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCC
Q 039819 262 VYPYMSNGSVASRLRE-KPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHS 340 (534)
Q Consensus 262 v~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~ 340 (534)
+|||+++|+|.++++. ...+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 86 ~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~~ 162 (279)
T cd05109 86 VTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEV---RLVHRDLAARNVLVKSPNHVKITDFGLARLLDID 162 (279)
T ss_pred EEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEcCCCcEEECCCCceeecccc
Confidence 9999999999999976 45699999999999999999999998 9999999999999999999999999999877533
Q ss_pred CCce-eeccccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCcCCCccccccchHHHHHHHHhhhcccceecc
Q 039819 341 DSHV-TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVD 418 (534)
Q Consensus 341 ~~~~-~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 418 (534)
.... .....++..|+|||.+.+..++.++|||||||++|||+| |..||..... ..+..++. .....
T Consensus 163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~----~~~~~~~~---~~~~~----- 230 (279)
T cd05109 163 ETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPA----REIPDLLE---KGERL----- 230 (279)
T ss_pred cceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH----HHHHHHHH---CCCcC-----
Confidence 2211 112234678999999988889999999999999999998 8999863221 11222221 11000
Q ss_pred cccCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhcC
Q 039819 419 RELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLEGD 461 (534)
Q Consensus 419 ~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~~ 461 (534)
..+...+..+.+++.+|++.+|++||++.++++.|+..
T Consensus 231 -----~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~ 268 (279)
T cd05109 231 -----PQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRM 268 (279)
T ss_pred -----CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHh
Confidence 01112345788999999999999999999999888653
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=307.09 Aligned_cols=239 Identities=27% Similarity=0.419 Sum_probs=191.7
Q ss_pred HhCCCcCCeeccCCcEEEEEEEEC------CCcEEEEEEeh---------------hhhhhcccCceeeEEEEEeCCCee
Q 039819 201 TENFSSKNILGAGGFGNVYKGKLG------DGTVLAVKRLK---------------DMISLAVHRNLLRLIGYCATPTER 259 (534)
Q Consensus 201 ~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~---------------~~l~~~~h~niv~l~~~~~~~~~~ 259 (534)
.++|...+.||+|+||.||+|... .+..||+|.+. .++..+.|+||+++++++......
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT 84 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence 357888899999999999999864 24689999865 256777899999999999999999
Q ss_pred EEEeeccCCCChhhhcccC----------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEE
Q 039819 260 LLVYPYMSNGSVASRLREK----------PALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVG 329 (534)
Q Consensus 260 ~lv~e~~~~gsL~~~l~~~----------~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~ 329 (534)
++||||+++|+|.+++... ..++|..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+
T Consensus 85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~di~p~nill~~~~~~kl~ 161 (277)
T cd05032 85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK---KFVHRDLAARNCMVAEDLTVKIG 161 (277)
T ss_pred EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccChheEEEcCCCCEEEC
Confidence 9999999999999998532 2478999999999999999999998 99999999999999999999999
Q ss_pred ecccceecCCCCC-ceeeccccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCcCCCccccccchHHHHHHHH
Q 039819 330 DFGLAKLLDHSDS-HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GMRALEFGKSINQKGAMLEWVKKI 407 (534)
Q Consensus 330 DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~ 407 (534)
|||+++....... .......++..|+|||.+.++.++.++|||||||++|||+| |+.||..... .....+.
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~----~~~~~~~--- 234 (277)
T cd05032 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSN----EEVLKFV--- 234 (277)
T ss_pred CcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCH----HHHHHHH---
Confidence 9999986543321 11223346789999999988889999999999999999998 9999863221 1111111
Q ss_pred hhhcccceecccccCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhh
Q 039819 408 QQEKKVEVLVDRELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLE 459 (534)
Q Consensus 408 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~ 459 (534)
.... . .. .+...+..+.+++.+|++.+|++|||+.++++.|+
T Consensus 235 ~~~~-~-----~~----~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 235 IDGG-H-----LD----LPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred hcCC-C-----CC----CCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 1111 0 01 11122568899999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=316.67 Aligned_cols=249 Identities=20% Similarity=0.281 Sum_probs=186.5
Q ss_pred HHhCCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEehh----------------hhhhcccCceeeEEEEEeCC------
Q 039819 200 ATENFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLKD----------------MISLAVHRNLLRLIGYCATP------ 256 (534)
Q Consensus 200 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~----------------~l~~~~h~niv~l~~~~~~~------ 256 (534)
..++|...+.||+|+||.||++... .++.||||++.. +++.++||||+++++++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 4578999999999999999999874 688999998752 56678899999999988643
Q ss_pred CeeEEEeeccCCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEeccccee
Q 039819 257 TERLLVYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKL 336 (534)
Q Consensus 257 ~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~ 336 (534)
...++||||+++ +|.+.+.. .+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 95 ~~~~lv~e~~~~-~l~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~---givHrDikp~Nill~~~~~~kl~Dfg~~~~ 168 (355)
T cd07874 95 QDVYLVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLART 168 (355)
T ss_pred ceeEEEhhhhcc-cHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEECCCCCEEEeeCccccc
Confidence 346999999975 56666543 488999999999999999999998 999999999999999999999999999986
Q ss_pred cCCCCCceeeccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHH--------HH----
Q 039819 337 LDHSDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLE--------WV---- 404 (534)
Q Consensus 337 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~--------~~---- 404 (534)
.... .......||..|+|||++.+..++.++|||||||++|||++|+.||.............+ +.
T Consensus 169 ~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (355)
T cd07874 169 AGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 246 (355)
T ss_pred CCCc--cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhc
Confidence 5432 123345689999999999888899999999999999999999999975432111110000 00
Q ss_pred ---HHHhh-hcccceecccc------cC--CCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 405 ---KKIQQ-EKKVEVLVDRE------LG--SNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 405 ---~~~~~-~~~~~~~~d~~------l~--~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
..... ......+..+. .. ..........+.+++.+|++.||++|||+.|+++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~ 310 (355)
T cd07874 247 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQ 310 (355)
T ss_pred HHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhc
Confidence 00000 00000000000 00 0011122457889999999999999999999985
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=303.63 Aligned_cols=240 Identities=27% Similarity=0.467 Sum_probs=192.2
Q ss_pred HhCCCcCCeeccCCcEEEEEEEEC-CC---cEEEEEEeh---------------hhhhhcccCceeeEEEEEeCCCeeEE
Q 039819 201 TENFSSKNILGAGGFGNVYKGKLG-DG---TVLAVKRLK---------------DMISLAVHRNLLRLIGYCATPTERLL 261 (534)
Q Consensus 201 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~---~~vavK~~~---------------~~l~~~~h~niv~l~~~~~~~~~~~l 261 (534)
.++|+..+.||+|+||.||+|+.. ++ ..+|+|.+. +.+..+.|+|++++.+++...+..++
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI 83 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence 356778899999999999999874 23 379999864 25677789999999999999999999
Q ss_pred EeeccCCCChhhhccc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCC
Q 039819 262 VYPYMSNGSVASRLRE-KPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHS 340 (534)
Q Consensus 262 v~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~ 340 (534)
||||+++++|.+++.. ...+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||++......
T Consensus 84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~ 160 (268)
T cd05063 84 ITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDM---NYVHRDLAARNILVNSNLECKVSDFGLSRVLEDD 160 (268)
T ss_pred EEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEEcCCCcEEECCCccceecccc
Confidence 9999999999999975 45789999999999999999999998 9999999999999999999999999999876433
Q ss_pred CCceee--ccccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCcCCCccccccchHHHHHHHHhhhcccceec
Q 039819 341 DSHVTT--AVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLV 417 (534)
Q Consensus 341 ~~~~~~--~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 417 (534)
...... ....+..|+|||++....++.++|||||||++|||+| |+.||..... .++...+......
T Consensus 161 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~-------~~~~~~i~~~~~~---- 229 (268)
T cd05063 161 PEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSN-------HEVMKAINDGFRL---- 229 (268)
T ss_pred cccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCH-------HHHHHHHhcCCCC----
Confidence 221111 1223457999999988889999999999999999998 9999864321 1222222211100
Q ss_pred ccccCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhc
Q 039819 418 DRELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLEG 460 (534)
Q Consensus 418 d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~ 460 (534)
......+..+.+++.+|++.+|++||+|.+|++.|++
T Consensus 230 ------~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~ 266 (268)
T cd05063 230 ------PAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDK 266 (268)
T ss_pred ------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHh
Confidence 0111234578999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=317.55 Aligned_cols=240 Identities=19% Similarity=0.252 Sum_probs=187.0
Q ss_pred hCCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEehh-----------------hhhhcccCceeeEEEEEeCCCeeEEEe
Q 039819 202 ENFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLKD-----------------MISLAVHRNLLRLIGYCATPTERLLVY 263 (534)
Q Consensus 202 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~-----------------~l~~~~h~niv~l~~~~~~~~~~~lv~ 263 (534)
++|...+.||+|+||.||+++.. +++.||+|.+.+ ++....|+||+++++++.+.+..|+||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 46888899999999999999975 678899998742 455668999999999999999999999
Q ss_pred eccCCCChhhhccc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCC
Q 039819 264 PYMSNGSVASRLRE-KPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDS 342 (534)
Q Consensus 264 e~~~~gsL~~~l~~-~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~ 342 (534)
||+++|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 81 Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~---~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 157 (331)
T cd05624 81 DYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQL---HYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGT 157 (331)
T ss_pred eCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCchHHEEEcCCCCEEEEeccceeeccCCCc
Confidence 99999999999976 46789999999999999999999998 999999999999999999999999999987654333
Q ss_pred ceeecccccccccccccccc-----CCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceec
Q 039819 343 HVTTAVRGTVGHIAPEYLST-----GQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLV 417 (534)
Q Consensus 343 ~~~~~~~gt~~y~aPE~~~~-----~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 417 (534)
.......||+.|+|||++.+ +.++.++|||||||++|||+||+.||..... .+....+...... +
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~-------~~~~~~i~~~~~~--~- 227 (331)
T cd05624 158 VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESL-------VETYGKIMNHEER--F- 227 (331)
T ss_pred eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCH-------HHHHHHHHcCCCc--c-
Confidence 23334569999999999865 4678899999999999999999999964321 1111111111100 0
Q ss_pred ccccCCCCCHHHHHHHHHHHHHhcccCCCC--CCChHHHHHH
Q 039819 418 DRELGSNYDRIEVGEILQVALLCTQYLPVH--RPKMSEVVRM 457 (534)
Q Consensus 418 d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~--RPt~~ev~~~ 457 (534)
.+.... ...+..+.+++.+|+...+.+ |++++++++.
T Consensus 228 --~~p~~~-~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 228 --QFPSHI-TDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred --cCCCcc-ccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 000000 112457888898888865544 4577777653
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=311.02 Aligned_cols=240 Identities=29% Similarity=0.458 Sum_probs=191.1
Q ss_pred HhCCCcCCeeccCCcEEEEEEEE--------CCCcEEEEEEehh---------------hhhhc-ccCceeeEEEEEeCC
Q 039819 201 TENFSSKNILGAGGFGNVYKGKL--------GDGTVLAVKRLKD---------------MISLA-VHRNLLRLIGYCATP 256 (534)
Q Consensus 201 ~~~~~~~~~lG~G~~g~Vy~~~~--------~~~~~vavK~~~~---------------~l~~~-~h~niv~l~~~~~~~ 256 (534)
.++|...+.||+|+||.||+|+. .++..||+|.+.. .+..+ .||||+++++++...
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 93 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 93 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecC
Confidence 46778889999999999999974 1345799998742 45556 799999999999999
Q ss_pred CeeEEEeeccCCCChhhhcccC----------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEe
Q 039819 257 TERLLVYPYMSNGSVASRLREK----------------PALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLL 320 (534)
Q Consensus 257 ~~~~lv~e~~~~gsL~~~l~~~----------------~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl 320 (534)
...++||||+++|+|.+++... ..+++.++..++.|++.||.|||+. +|+||||||+||++
T Consensus 94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Nili 170 (304)
T cd05101 94 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDLAARNVLV 170 (304)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC---CeeecccccceEEE
Confidence 9999999999999999998642 3478899999999999999999998 99999999999999
Q ss_pred CCCCcEEEEecccceecCCCCCce-eeccccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCcCCCccccccc
Q 039819 321 DDFCEAIVGDFGLAKLLDHSDSHV-TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GMRALEFGKSINQKG 398 (534)
Q Consensus 321 ~~~~~~kl~DFGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~ellt-G~~p~~~~~~~~~~~ 398 (534)
+.++.+||+|||+++......... .....++..|+|||++.+..++.++|||||||++|||+| |..||....
T Consensus 171 ~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~------ 244 (304)
T cd05101 171 TENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP------ 244 (304)
T ss_pred cCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCC------
Confidence 999999999999998765432211 222345678999999988889999999999999999998 788875322
Q ss_pred hHHHHHHHHhhhcccceecccccCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhc
Q 039819 399 AMLEWVKKIQQEKKVEVLVDRELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLEG 460 (534)
Q Consensus 399 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~ 460 (534)
..++.......... ..+...+..+.+++.+|++.+|.+||+|.||++.|+.
T Consensus 245 -~~~~~~~~~~~~~~----------~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~ 295 (304)
T cd05101 245 -VEELFKLLKEGHRM----------DKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDR 295 (304)
T ss_pred -HHHHHHHHHcCCcC----------CCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHH
Confidence 12222222211110 0112234578899999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=312.40 Aligned_cols=250 Identities=20% Similarity=0.317 Sum_probs=187.5
Q ss_pred hCCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEeh---------------hhhhhcccCceeeEEEEEeCCCeeEEEeec
Q 039819 202 ENFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLK---------------DMISLAVHRNLLRLIGYCATPTERLLVYPY 265 (534)
Q Consensus 202 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~---------------~~l~~~~h~niv~l~~~~~~~~~~~lv~e~ 265 (534)
++|...+.||+|+||.||+|+.. ++..||+|++. ..+..++||||+++++++...+..++||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 56888899999999999999875 67889999875 156778899999999999999999999999
Q ss_pred cCCCChhhhccc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCCce
Q 039819 266 MSNGSVASRLRE-KPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHV 344 (534)
Q Consensus 266 ~~~gsL~~~l~~-~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~ 344 (534)
+++ +|.+++.. ...+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++....... .
T Consensus 86 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~ 160 (309)
T cd07872 86 LDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSVPTK-T 160 (309)
T ss_pred CCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECccccceecCCCcc-c
Confidence 975 78777764 34589999999999999999999998 999999999999999999999999999986543221 1
Q ss_pred eecccccccccccccccc-CCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhc-----ccceecc
Q 039819 345 TTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEK-----KVEVLVD 418 (534)
Q Consensus 345 ~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~d 418 (534)
.....+|..|+|||++.+ ..++.++|||||||++|||+||+.||......+....+........... ......+
T Consensus 161 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (309)
T cd07872 161 YSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKN 240 (309)
T ss_pred cccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhhh
Confidence 223457899999998865 4578999999999999999999999975432211111111000000000 0000000
Q ss_pred cccCCC-------CCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 419 RELGSN-------YDRIEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 419 ~~l~~~-------~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
...... ........+.+++.+|++.+|.+|||+.|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 285 (309)
T cd07872 241 YNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK 285 (309)
T ss_pred hhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence 000000 00112346789999999999999999999985
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=307.94 Aligned_cols=241 Identities=25% Similarity=0.396 Sum_probs=190.9
Q ss_pred HHhCCCcCCeeccCCcEEEEEEEEC------CCcEEEEEEeh---------------hhhhhcccCceeeEEEEEeCCCe
Q 039819 200 ATENFSSKNILGAGGFGNVYKGKLG------DGTVLAVKRLK---------------DMISLAVHRNLLRLIGYCATPTE 258 (534)
Q Consensus 200 ~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~---------------~~l~~~~h~niv~l~~~~~~~~~ 258 (534)
..++|+..+.||+|+||.||+|... .+..||+|.+. ..+..+.|+||+++++++.+...
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP 83 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 3568889999999999999999753 24579999764 15677889999999999999999
Q ss_pred eEEEeeccCCCChhhhcccC----------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEE
Q 039819 259 RLLVYPYMSNGSVASRLREK----------PALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIV 328 (534)
Q Consensus 259 ~~lv~e~~~~gsL~~~l~~~----------~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl 328 (534)
.++||||+++|+|.+++... ..+++..+..++.|++.||.|||+. +|+||||||+|||++.++.++|
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dikp~nili~~~~~~~L 160 (288)
T cd05061 84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKI 160 (288)
T ss_pred cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCCChheEEEcCCCcEEE
Confidence 99999999999999999632 3457788899999999999999998 9999999999999999999999
Q ss_pred EecccceecCCCCCc-eeeccccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCcCCCccccccchHHHHHHH
Q 039819 329 GDFGLAKLLDHSDSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GMRALEFGKSINQKGAMLEWVKK 406 (534)
Q Consensus 329 ~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~ 406 (534)
+|||+++........ ......++..|+|||++.++.++.++|||||||++|||++ |..||..... .++...
T Consensus 161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~-------~~~~~~ 233 (288)
T cd05061 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSN-------EQVLKF 233 (288)
T ss_pred CcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCH-------HHHHHH
Confidence 999999865332211 1122235678999999988889999999999999999999 7888853221 111111
Q ss_pred HhhhcccceecccccCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhc
Q 039819 407 IQQEKKVEVLVDRELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLEG 460 (534)
Q Consensus 407 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~ 460 (534)
....... ..+...+..+.+++.+|++.+|++||++.++++.|+.
T Consensus 234 ~~~~~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~ 277 (288)
T cd05061 234 VMDGGYL----------DQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKD 277 (288)
T ss_pred HHcCCCC----------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHh
Confidence 1111100 0111224589999999999999999999999998876
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=301.67 Aligned_cols=237 Identities=25% Similarity=0.447 Sum_probs=192.4
Q ss_pred hCCCcCCeeccCCcEEEEEEEECCCcEEEEEEehh-------------hhhhcccCceeeEEEEEeCCCeeEEEeeccCC
Q 039819 202 ENFSSKNILGAGGFGNVYKGKLGDGTVLAVKRLKD-------------MISLAVHRNLLRLIGYCATPTERLLVYPYMSN 268 (534)
Q Consensus 202 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~-------------~l~~~~h~niv~l~~~~~~~~~~~lv~e~~~~ 268 (534)
.+|+..+.||+|+||.||+|.+.++..+|+|.+.. .+..+.|||++++++++......++||||+++
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~ 83 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEH 83 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCCCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCCC
Confidence 45677789999999999999987788999998752 57788999999999999999999999999999
Q ss_pred CChhhhcccC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCCceeec
Q 039819 269 GSVASRLREK-PALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTA 347 (534)
Q Consensus 269 gsL~~~l~~~-~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~ 347 (534)
++|.+++... ..++++.++.++.+++.||+|||+. +++||||||+||+++.++.+||+|||+++............
T Consensus 84 ~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~~ 160 (256)
T cd05112 84 GCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESS---NVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTG 160 (256)
T ss_pred CcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccccceEEEcCCCeEEECCCcceeecccCcccccCC
Confidence 9999998753 4689999999999999999999998 99999999999999999999999999998654332211222
Q ss_pred cccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCcCCCccccccchHHHHHHHHhhhcccceecccccCCCCC
Q 039819 348 VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELGSNYD 426 (534)
Q Consensus 348 ~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 426 (534)
..++.+|+|||++.++.++.++|||||||++|||++ |+.||..... ............ ...+
T Consensus 161 ~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~-------~~~~~~~~~~~~---~~~~------- 223 (256)
T cd05112 161 TKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSN-------SEVVETINAGFR---LYKP------- 223 (256)
T ss_pred CccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCH-------HHHHHHHhCCCC---CCCC-------
Confidence 335678999999988889999999999999999998 9999863221 122222211110 0111
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCChHHHHHHh
Q 039819 427 RIEVGEILQVALLCTQYLPVHRPKMSEVVRML 458 (534)
Q Consensus 427 ~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L 458 (534)
...+..+.+++.+|++.+|++||++.+|+++|
T Consensus 224 ~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 224 RLASQSVYELMQHCWKERPEDRPSFSLLLHQL 255 (256)
T ss_pred CCCCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence 11245799999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=305.30 Aligned_cols=248 Identities=26% Similarity=0.402 Sum_probs=188.8
Q ss_pred hCCCcCCeeccCCcEEEEEEEE-----CCCcEEEEEEeh--------------hhhhhcccCceeeEEEEEeCC--CeeE
Q 039819 202 ENFSSKNILGAGGFGNVYKGKL-----GDGTVLAVKRLK--------------DMISLAVHRNLLRLIGYCATP--TERL 260 (534)
Q Consensus 202 ~~~~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~--------------~~l~~~~h~niv~l~~~~~~~--~~~~ 260 (534)
.+|+..+.||+|+||.||++.. .++..||+|.+. +.+..++||||+++++++... ...+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 83 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR 83 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence 4677889999999999999975 357899999875 256788999999999987543 4678
Q ss_pred EEeeccCCCChhhhcccC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCC
Q 039819 261 LVYPYMSNGSVASRLREK-PALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDH 339 (534)
Q Consensus 261 lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~ 339 (534)
+||||+++|+|.+++... ..+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 84 lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~ 160 (284)
T cd05081 84 LVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSK---RYVHRDLATRNILVESENRVKIGDFGLTKVLPQ 160 (284)
T ss_pred EEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHhhEEECCCCeEEECCCcccccccC
Confidence 999999999999999753 4689999999999999999999998 999999999999999999999999999987654
Q ss_pred CCCcee--eccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcc-----
Q 039819 340 SDSHVT--TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKK----- 412 (534)
Q Consensus 340 ~~~~~~--~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~----- 412 (534)
...... ....++..|+|||++.+..++.++|||||||++|||++|..++..... .+.........
T Consensus 161 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~ 232 (284)
T cd05081 161 DKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPA--------EFMRMMGNDKQGQMIV 232 (284)
T ss_pred CCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcch--------hhhhhcccccccccch
Confidence 322111 112234569999999888899999999999999999999877542110 01110000000
Q ss_pred --cceecccccCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhc
Q 039819 413 --VEVLVDRELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLEG 460 (534)
Q Consensus 413 --~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~ 460 (534)
+...+............+..+.+++.+||+.+|++||||.||++.|+.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~ 282 (284)
T cd05081 233 YHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEA 282 (284)
T ss_pred HHHHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHh
Confidence 000000000111112234579999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=300.44 Aligned_cols=234 Identities=29% Similarity=0.424 Sum_probs=192.3
Q ss_pred hCCCcCCeeccCCcEEEEEEEECCCcEEEEEEehh-------------hhhhcccCceeeEEEEEeCCCeeEEEeeccCC
Q 039819 202 ENFSSKNILGAGGFGNVYKGKLGDGTVLAVKRLKD-------------MISLAVHRNLLRLIGYCATPTERLLVYPYMSN 268 (534)
Q Consensus 202 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~-------------~l~~~~h~niv~l~~~~~~~~~~~lv~e~~~~ 268 (534)
++|...+.||+|+||.||+|... ++.||||.+.. ++..+.|+||+++++++......++||||+++
T Consensus 6 ~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~ 84 (256)
T cd05039 6 KELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAK 84 (256)
T ss_pred hhccceeeeecCCCceEEEEEec-CcEEEEEEeccchhHHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecCC
Confidence 56788899999999999999875 78899998763 56778899999999999999999999999999
Q ss_pred CChhhhcccCC--CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCCceee
Q 039819 269 GSVASRLREKP--ALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTT 346 (534)
Q Consensus 269 gsL~~~l~~~~--~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~ 346 (534)
++|.+++.... .+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||.++.......
T Consensus 85 ~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~---- 157 (256)
T cd05039 85 GSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEK---NFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD---- 157 (256)
T ss_pred CcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccchhcccceEEEeCCCCEEEcccccccccccccc----
Confidence 99999997654 699999999999999999999998 999999999999999999999999999987633211
Q ss_pred ccccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCcCCCccccccchHHHHHHHHhhhcccceecccccCCCC
Q 039819 347 AVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELGSNY 425 (534)
Q Consensus 347 ~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 425 (534)
...++..|+|||++..+.++.++||||||+++|||++ |+.||..... ..+.. ...... ....
T Consensus 158 ~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~----~~~~~---~~~~~~----------~~~~ 220 (256)
T cd05039 158 SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL----KDVVP---HVEKGY----------RMEA 220 (256)
T ss_pred cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCH----HHHHH---HHhcCC----------CCCC
Confidence 2334678999999988889999999999999999997 9999863221 11111 111110 0011
Q ss_pred CHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhc
Q 039819 426 DRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLEG 460 (534)
Q Consensus 426 ~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~ 460 (534)
+...+..+.+++.+|+..+|++||++.|++++|+.
T Consensus 221 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 221 PEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred ccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence 12234688999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=306.84 Aligned_cols=240 Identities=28% Similarity=0.416 Sum_probs=193.0
Q ss_pred HhCCCcCCeeccCCcEEEEEEEECC-----CcEEEEEEehh---------------hhhhcccCceeeEEEEEeC-CCee
Q 039819 201 TENFSSKNILGAGGFGNVYKGKLGD-----GTVLAVKRLKD---------------MISLAVHRNLLRLIGYCAT-PTER 259 (534)
Q Consensus 201 ~~~~~~~~~lG~G~~g~Vy~~~~~~-----~~~vavK~~~~---------------~l~~~~h~niv~l~~~~~~-~~~~ 259 (534)
.++|...+.||+|+||.||+|...+ +..||+|++.. .+..+.|+||+++++++.. ....
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 84 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPP 84 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCC
Confidence 4678888999999999999999765 78899998752 4667799999999998876 4678
Q ss_pred EEEeeccCCCChhhhcccC--------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEec
Q 039819 260 LLVYPYMSNGSVASRLREK--------PALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDF 331 (534)
Q Consensus 260 ~lv~e~~~~gsL~~~l~~~--------~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DF 331 (534)
++++||+++|+|.+++... ..+++..+..++.+++.||+|||+. +++||||||+||++++++.+||+||
T Consensus 85 ~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kl~d~ 161 (280)
T cd05043 85 FVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKITDN 161 (280)
T ss_pred EEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCHhhEEEcCCCcEEECCC
Confidence 9999999999999998642 4589999999999999999999998 9999999999999999999999999
Q ss_pred ccceecCCCCCce-eeccccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCcCCCccccccchHHHHHHHHhh
Q 039819 332 GLAKLLDHSDSHV-TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GMRALEFGKSINQKGAMLEWVKKIQQ 409 (534)
Q Consensus 332 Gla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~ 409 (534)
|+++.+....... .....++..|+|||++.+..++.++|||||||++||+++ |+.||..... .++......
T Consensus 162 g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~-------~~~~~~~~~ 234 (280)
T cd05043 162 ALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDP-------FEMAAYLKD 234 (280)
T ss_pred CCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCH-------HHHHHHHHc
Confidence 9998664332211 122345778999999988889999999999999999999 9999864321 122222111
Q ss_pred hcccceecccccCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhc
Q 039819 410 EKKVEVLVDRELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLEG 460 (534)
Q Consensus 410 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~ 460 (534)
.... ......+..+.+++.+|++.+|++||++.+|++.|+.
T Consensus 235 ~~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~ 275 (280)
T cd05043 235 GYRL----------AQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTD 275 (280)
T ss_pred CCCC----------CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHH
Confidence 1110 0111224578999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=301.52 Aligned_cols=231 Identities=28% Similarity=0.389 Sum_probs=183.9
Q ss_pred eccCCcEEEEEEEEC---CCcEEEEEEehh---------------hhhhcccCceeeEEEEEeCCCeeEEEeeccCCCCh
Q 039819 210 LGAGGFGNVYKGKLG---DGTVLAVKRLKD---------------MISLAVHRNLLRLIGYCATPTERLLVYPYMSNGSV 271 (534)
Q Consensus 210 lG~G~~g~Vy~~~~~---~~~~vavK~~~~---------------~l~~~~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 271 (534)
||+|+||.||+|.+. .+..||+|.+.. ++..++|+||+++++++. .+..++||||+++|+|
T Consensus 3 ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~L 81 (257)
T cd05115 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGPL 81 (257)
T ss_pred cCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCCH
Confidence 899999999999764 355799997742 567789999999999885 4577999999999999
Q ss_pred hhhccc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCCcee--ecc
Q 039819 272 ASRLRE-KPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVT--TAV 348 (534)
Q Consensus 272 ~~~l~~-~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~--~~~ 348 (534)
.+++.. ...+++..+++++.|++.||.|||+. +++||||||+|||++.++.+||+|||+++.......... ...
T Consensus 82 ~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 158 (257)
T cd05115 82 NKFLSGKKDEITVSNVVELMHQVSMGMKYLEGK---NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAG 158 (257)
T ss_pred HHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhc---CeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCCC
Confidence 999874 45799999999999999999999998 999999999999999999999999999986543322211 112
Q ss_pred ccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCcCCCccccccchHHHHHHHHhhhcccceecccccCCCCCH
Q 039819 349 RGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELGSNYDR 427 (534)
Q Consensus 349 ~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 427 (534)
.++..|+|||++.+..++.++|||||||++||+++ |+.||..... .++......... ...+.
T Consensus 159 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~-------~~~~~~~~~~~~----------~~~~~ 221 (257)
T cd05115 159 KWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKG-------PEVMSFIEQGKR----------LDCPA 221 (257)
T ss_pred CCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCH-------HHHHHHHHCCCC----------CCCCC
Confidence 23578999999988889999999999999999996 9999864321 112111111110 11222
Q ss_pred HHHHHHHHHHHHhcccCCCCCCChHHHHHHhhcC
Q 039819 428 IEVGEILQVALLCTQYLPVHRPKMSEVVRMLEGD 461 (534)
Q Consensus 428 ~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~~ 461 (534)
..+.++.+++.+||..+|++||++.+|.+.|+..
T Consensus 222 ~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 222 ECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 3356888999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-37 Score=322.11 Aligned_cols=252 Identities=21% Similarity=0.265 Sum_probs=189.8
Q ss_pred HhCCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEe--------hhhhhhcccCceeeEEEEEeCCCeeEEEeeccCCCCh
Q 039819 201 TENFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRL--------KDMISLAVHRNLLRLIGYCATPTERLLVYPYMSNGSV 271 (534)
Q Consensus 201 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~--------~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 271 (534)
...|...+.||+|+||.||+|... .++.||||.. .+++.+++|+|||++++++......++||||+. ++|
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~~-~~L 246 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWYASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKYR-SDL 246 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEccC-CCH
Confidence 347888999999999999999986 4788999964 247889999999999999999999999999995 688
Q ss_pred hhhccc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCC-ceeeccc
Q 039819 272 ASRLRE-KPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDS-HVTTAVR 349 (534)
Q Consensus 272 ~~~l~~-~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~-~~~~~~~ 349 (534)
.+++.. ...++|..++.|+.|++.||.|||+. +||||||||+|||++.++.+||+|||+++....... .......
T Consensus 247 ~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~ 323 (461)
T PHA03211 247 YTYLGARLRPLGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIA 323 (461)
T ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECcCCHHHEEECCCCCEEEcccCCceecccccccccccccC
Confidence 888764 35699999999999999999999998 999999999999999999999999999987643221 1223456
Q ss_pred cccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccc----cchHHHHHHHHhhh-cccce---------
Q 039819 350 GTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQ----KGAMLEWVKKIQQE-KKVEV--------- 415 (534)
Q Consensus 350 gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~----~~~~~~~~~~~~~~-~~~~~--------- 415 (534)
||..|+|||++.+..++.++|||||||++|||++|..++........ ...+...+...... .....
T Consensus 324 GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~~~l~~~ 403 (461)
T PHA03211 324 GTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAGSRLVSQ 403 (461)
T ss_pred CCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcchHHHHH
Confidence 99999999999998999999999999999999998876532211100 01111111111100 00000
Q ss_pred ecc---cccCCC-----CCH--HHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 416 LVD---RELGSN-----YDR--IEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 416 ~~d---~~l~~~-----~~~--~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
... ...... ... .....+.+++.+|++.||.+|||+.|+++
T Consensus 404 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~ 454 (461)
T PHA03211 404 YRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLR 454 (461)
T ss_pred HHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhh
Confidence 000 000000 000 11236788999999999999999999986
|
|
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=303.66 Aligned_cols=236 Identities=27% Similarity=0.394 Sum_probs=183.6
Q ss_pred CcCCeeccCCcEEEEEEEECCC---cEEEEEEeh----------------hhhhhcccCceeeEEEEEeCC------Cee
Q 039819 205 SSKNILGAGGFGNVYKGKLGDG---TVLAVKRLK----------------DMISLAVHRNLLRLIGYCATP------TER 259 (534)
Q Consensus 205 ~~~~~lG~G~~g~Vy~~~~~~~---~~vavK~~~----------------~~l~~~~h~niv~l~~~~~~~------~~~ 259 (534)
...+.||+|+||.||+|++.+. ..+|+|.++ ..+..++|+||+++++++... ...
T Consensus 2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 81 (272)
T cd05075 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP 81 (272)
T ss_pred ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence 4567899999999999997543 258999763 156778999999999987532 246
Q ss_pred EEEeeccCCCChhhhcc------cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEeccc
Q 039819 260 LLVYPYMSNGSVASRLR------EKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGL 333 (534)
Q Consensus 260 ~lv~e~~~~gsL~~~l~------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGl 333 (534)
++||||+++|+|.+++. ....+++.....++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+
T Consensus 82 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~ 158 (272)
T cd05075 82 VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSK---SFIHRDLAARNCMLNENMNVCVADFGL 158 (272)
T ss_pred EEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhheEEcCCCCEEECCCCc
Confidence 89999999999988773 223589999999999999999999998 999999999999999999999999999
Q ss_pred ceecCCCCCce-eeccccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCcCCCccccccchHHHHHHHHhhhc
Q 039819 334 AKLLDHSDSHV-TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GMRALEFGKSINQKGAMLEWVKKIQQEK 411 (534)
Q Consensus 334 a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~ 411 (534)
++......... .....++..|+|||+..+..++.++|||||||++|||++ |+.||..... .+.........
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~-------~~~~~~~~~~~ 231 (272)
T cd05075 159 SKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVEN-------SEIYDYLRQGN 231 (272)
T ss_pred ccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCH-------HHHHHHHHcCC
Confidence 98764332111 122235678999999988889999999999999999999 8888864221 11112221111
Q ss_pred ccceecccccCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhc
Q 039819 412 KVEVLVDRELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLEG 460 (534)
Q Consensus 412 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~ 460 (534)
.. . .....+..+.+++.+|++.+|++||++.++++.|+.
T Consensus 232 ~~------~----~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~ 270 (272)
T cd05075 232 RL------K----QPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEK 270 (272)
T ss_pred CC------C----CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHh
Confidence 10 0 111234578999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=306.92 Aligned_cols=238 Identities=26% Similarity=0.424 Sum_probs=189.5
Q ss_pred hCCCcCCeeccCCcEEEEEEEEC------CCcEEEEEEehh--------------hhhhcccCceeeEEEEEeCCCeeEE
Q 039819 202 ENFSSKNILGAGGFGNVYKGKLG------DGTVLAVKRLKD--------------MISLAVHRNLLRLIGYCATPTERLL 261 (534)
Q Consensus 202 ~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~--------------~l~~~~h~niv~l~~~~~~~~~~~l 261 (534)
.+|...+.||+|+||.||++... ++..+|+|.+.. .+..+.|+||+++++++......++
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM 84 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence 45677889999999999999742 456889997752 5678899999999999999999999
Q ss_pred EeeccCCCChhhhcccC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcE
Q 039819 262 VYPYMSNGSVASRLREK---------------PALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEA 326 (534)
Q Consensus 262 v~e~~~~gsL~~~l~~~---------------~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~ 326 (534)
||||+++|+|.+++... ..+++..++.++.|++.||+|||+. +++||||||+|||+++++.+
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~nil~~~~~~~ 161 (280)
T cd05092 85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL---HFVHRDLATRNCLVGQGLVV 161 (280)
T ss_pred EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC---CeecccccHhhEEEcCCCCE
Confidence 99999999999998643 2489999999999999999999998 99999999999999999999
Q ss_pred EEEecccceecCCCCC-ceeeccccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCcCCCccccccchHHHHH
Q 039819 327 IVGDFGLAKLLDHSDS-HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GMRALEFGKSINQKGAMLEWV 404 (534)
Q Consensus 327 kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~ 404 (534)
||+|||++........ .......++..|+|||++.+..++.++|||||||++|||++ |+.||...... +..
T Consensus 162 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~-------~~~ 234 (280)
T cd05092 162 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNT-------EAI 234 (280)
T ss_pred EECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHH-------HHH
Confidence 9999999986543221 11122335678999999988889999999999999999998 89998532211 111
Q ss_pred HHHhhhcccceecccccCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhh
Q 039819 405 KKIQQEKKVEVLVDRELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLE 459 (534)
Q Consensus 405 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~ 459 (534)
........ . ..+...+..+.+++.+||+.+|.+||++.||++.|+
T Consensus 235 ~~~~~~~~------~----~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 235 ECITQGRE------L----ERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred HHHHcCcc------C----CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 11111100 0 011123457889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=329.76 Aligned_cols=237 Identities=24% Similarity=0.284 Sum_probs=189.0
Q ss_pred CCCcCCeeccCCcEEEEEEEECCC-cEEEEEEeh--------------hhhhhcc-cCceeeEEEEE-eC------CCee
Q 039819 203 NFSSKNILGAGGFGNVYKGKLGDG-TVLAVKRLK--------------DMISLAV-HRNLLRLIGYC-AT------PTER 259 (534)
Q Consensus 203 ~~~~~~~lG~G~~g~Vy~~~~~~~-~~vavK~~~--------------~~l~~~~-h~niv~l~~~~-~~------~~~~ 259 (534)
++.+.+.|.+|||+.||.|+...+ ..||+|++. ++++++. |+|||.+++.. .. .-+.
T Consensus 38 ~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~Ev 117 (738)
T KOG1989|consen 38 RVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWEV 117 (738)
T ss_pred EEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeEE
Confidence 345678999999999999998766 999999985 2677776 99999999932 21 1356
Q ss_pred EEEeeccCCCChhhhcc--cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceec
Q 039819 260 LLVYPYMSNGSVASRLR--EKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLL 337 (534)
Q Consensus 260 ~lv~e~~~~gsL~~~l~--~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~ 337 (534)
+|.||||.+|.|-+++. ....|++.++++|+.++++|+++||.. .++|||||||-+||||+.+++.||||||.|...
T Consensus 118 llLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDFGSatt~ 196 (738)
T KOG1989|consen 118 LLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDFGSATTK 196 (738)
T ss_pred EeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCcccccccc
Confidence 89999999999999997 345699999999999999999999986 778999999999999999999999999998743
Q ss_pred CCCC-C-ce------eecccccccccccccc---ccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHH
Q 039819 338 DHSD-S-HV------TTAVRGTVGHIAPEYL---STGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKK 406 (534)
Q Consensus 338 ~~~~-~-~~------~~~~~gt~~y~aPE~~---~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~ 406 (534)
-... . .. .....-|+.|+|||++ .+..+++|+||||+||+||-|+....||+....
T Consensus 197 ~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~------------- 263 (738)
T KOG1989|consen 197 ILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK------------- 263 (738)
T ss_pred cCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc-------------
Confidence 2211 0 00 0112358999999987 567799999999999999999999999984321
Q ss_pred HhhhcccceecccccCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhc
Q 039819 407 IQQEKKVEVLVDRELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLEG 460 (534)
Q Consensus 407 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~ 460 (534)
..+++....-.........+.+||..||+.+|.+||++-+|+..+..
T Consensus 264 -------laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~ 310 (738)
T KOG1989|consen 264 -------LAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFE 310 (738)
T ss_pred -------eeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHH
Confidence 11222222222223456799999999999999999999999987654
|
|
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=301.33 Aligned_cols=234 Identities=27% Similarity=0.402 Sum_probs=189.3
Q ss_pred hCCCcCCeeccCCcEEEEEEEECCCcEEEEEEehh------------hhhhcccCceeeEEEEEe-CCCeeEEEeeccCC
Q 039819 202 ENFSSKNILGAGGFGNVYKGKLGDGTVLAVKRLKD------------MISLAVHRNLLRLIGYCA-TPTERLLVYPYMSN 268 (534)
Q Consensus 202 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~------------~l~~~~h~niv~l~~~~~-~~~~~~lv~e~~~~ 268 (534)
.+|...+.||+|+||.||++... +..||+|.+.. .++.+.|+|++++++++. .....++||||+++
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~ 84 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAK 84 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCCchHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECCCC
Confidence 46788899999999999999875 67789998752 677889999999999764 45678999999999
Q ss_pred CChhhhcccCC--CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCCceee
Q 039819 269 GSVASRLREKP--ALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTT 346 (534)
Q Consensus 269 gsL~~~l~~~~--~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~ 346 (534)
++|.+++.... .+++..++.++.+++.||+|||++ +++||||||+||++++++.+||+|||+++...... .
T Consensus 85 ~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~----~ 157 (256)
T cd05082 85 GSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ----D 157 (256)
T ss_pred CcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccccchheEEEcCCCcEEecCCccceeccccC----C
Confidence 99999987533 489999999999999999999998 99999999999999999999999999988653321 2
Q ss_pred ccccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCcCCCccccccchHHHHHHHHhhhcccceecccccCCCC
Q 039819 347 AVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELGSNY 425 (534)
Q Consensus 347 ~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 425 (534)
...++..|+|||++.+..++.++|||||||++|||++ |+.||.... ..+.......... ...
T Consensus 158 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~-------~~~~~~~~~~~~~----------~~~ 220 (256)
T cd05082 158 TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP-------LKDVVPRVEKGYK----------MDA 220 (256)
T ss_pred CCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCC-------HHHHHHHHhcCCC----------CCC
Confidence 2335678999999988889999999999999999998 999986322 1122222211110 111
Q ss_pred CHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhc
Q 039819 426 DRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLEG 460 (534)
Q Consensus 426 ~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~ 460 (534)
....+..+.+++.+|++.+|++|||+.++++.|+.
T Consensus 221 ~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 255 (256)
T cd05082 221 PDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEH 255 (256)
T ss_pred CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence 12234588999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=311.20 Aligned_cols=239 Identities=30% Similarity=0.435 Sum_probs=189.2
Q ss_pred hCCCcCCeeccCCcEEEEEEEEC--------CCcEEEEEEehh---------------hhhhc-ccCceeeEEEEEeCCC
Q 039819 202 ENFSSKNILGAGGFGNVYKGKLG--------DGTVLAVKRLKD---------------MISLA-VHRNLLRLIGYCATPT 257 (534)
Q Consensus 202 ~~~~~~~~lG~G~~g~Vy~~~~~--------~~~~vavK~~~~---------------~l~~~-~h~niv~l~~~~~~~~ 257 (534)
++|...+.||+|+||.||+++.. +...+|+|.+.. ++..+ +|+||++++++|...+
T Consensus 18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 97 (307)
T cd05098 18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG 97 (307)
T ss_pred HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCC
Confidence 56888999999999999999752 235699998752 34445 7999999999999999
Q ss_pred eeEEEeeccCCCChhhhcccC----------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeC
Q 039819 258 ERLLVYPYMSNGSVASRLREK----------------PALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLD 321 (534)
Q Consensus 258 ~~~lv~e~~~~gsL~~~l~~~----------------~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~ 321 (534)
..++||||+++|+|.+++... ..+++.++++++.|++.||+|||+. +++||||||+||+++
T Consensus 98 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nill~ 174 (307)
T cd05098 98 PLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVT 174 (307)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHHheEEc
Confidence 999999999999999999643 2489999999999999999999998 999999999999999
Q ss_pred CCCcEEEEecccceecCCCCCce-eeccccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCcCCCccccccch
Q 039819 322 DFCEAIVGDFGLAKLLDHSDSHV-TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GMRALEFGKSINQKGA 399 (534)
Q Consensus 322 ~~~~~kl~DFGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~ellt-G~~p~~~~~~~~~~~~ 399 (534)
.++.+||+|||+++......... .....++..|+|||++.+..++.++|||||||++|||++ |+.||....
T Consensus 175 ~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~------- 247 (307)
T cd05098 175 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP------- 247 (307)
T ss_pred CCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCC-------
Confidence 99999999999997654321111 111224568999999988889999999999999999998 888886322
Q ss_pred HHHHHHHHhhhcccceecccccCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhc
Q 039819 400 MLEWVKKIQQEKKVEVLVDRELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLEG 460 (534)
Q Consensus 400 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~ 460 (534)
..+.......... ...+......+.+++.+|++.+|.+||+|.+|++.|+.
T Consensus 248 ~~~~~~~~~~~~~----------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~ 298 (307)
T cd05098 248 VEELFKLLKEGHR----------MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDR 298 (307)
T ss_pred HHHHHHHHHcCCC----------CCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHH
Confidence 1122222211110 01122234588899999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=287.60 Aligned_cols=243 Identities=26% Similarity=0.350 Sum_probs=192.8
Q ss_pred hCCCcCCeeccCCcEEEEEEE-ECCCcEEEEEEeh--------------hhhhhcccCceeeEEEEEeCC-----CeeEE
Q 039819 202 ENFSSKNILGAGGFGNVYKGK-LGDGTVLAVKRLK--------------DMISLAVHRNLLRLIGYCATP-----TERLL 261 (534)
Q Consensus 202 ~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~--------------~~l~~~~h~niv~l~~~~~~~-----~~~~l 261 (534)
++|.+.+.||+|||+-||.++ ..++..+|+|++. +.-++++|||++++++++... ...||
T Consensus 21 ~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~yl 100 (302)
T KOG2345|consen 21 KRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAYL 100 (302)
T ss_pred ceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEEE
Confidence 578889999999999999998 5678899999875 256778899999999887543 34899
Q ss_pred EeeccCCCChhhhcc----cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceec
Q 039819 262 VYPYMSNGSVASRLR----EKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLL 337 (534)
Q Consensus 262 v~e~~~~gsL~~~l~----~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~ 337 (534)
+++|...|+|.+.+. ++..+++.+.+.|+.+|++||++||+. .+++.||||||.|||+.+.+.++|.|||.+...
T Consensus 101 l~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~GS~~~a 179 (302)
T KOG2345|consen 101 LLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDLGSATQA 179 (302)
T ss_pred EeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEeccCcccc
Confidence 999999999999885 345799999999999999999999997 456999999999999999999999999998765
Q ss_pred CCCCC--------ceeeccccccccccccccc---cCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHH
Q 039819 338 DHSDS--------HVTTAVRGTVGHIAPEYLS---TGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKK 406 (534)
Q Consensus 338 ~~~~~--------~~~~~~~gt~~y~aPE~~~---~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~ 406 (534)
.-.-. +.......|..|+|||.+. +...++++|||||||+||+|+.|..||+....
T Consensus 180 ~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~------------- 246 (302)
T KOG2345|consen 180 PIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQ------------- 246 (302)
T ss_pred ceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhh-------------
Confidence 32110 0112234689999999884 45678999999999999999999999973221
Q ss_pred Hhhhcccc-eecccccCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhc
Q 039819 407 IQQEKKVE-VLVDRELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLEG 460 (534)
Q Consensus 407 ~~~~~~~~-~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~ 460 (534)
+.+.+. .+....+.-......++.+.+++.+|++.||.+||++.+++..++.
T Consensus 247 --~GgSlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~ 299 (302)
T KOG2345|consen 247 --QGGSLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDD 299 (302)
T ss_pred --cCCeEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHh
Confidence 122221 1222222222223356789999999999999999999999988764
|
|
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=303.04 Aligned_cols=241 Identities=23% Similarity=0.359 Sum_probs=194.6
Q ss_pred hCCCcCCeeccCCcEEEEEEEE-CCCcEEEEEEeh-----------------hhhhhcccCceeeEEEEEeCCCeeEEEe
Q 039819 202 ENFSSKNILGAGGFGNVYKGKL-GDGTVLAVKRLK-----------------DMISLAVHRNLLRLIGYCATPTERLLVY 263 (534)
Q Consensus 202 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~-----------------~~l~~~~h~niv~l~~~~~~~~~~~lv~ 263 (534)
++|+..+.||+|+||.||+|.. .++..+|||.+. .++..+.|+||+++++++...+..++||
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 4677788999999999999996 478999999653 1567788999999999999999999999
Q ss_pred eccCCCChhhhccc----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCC
Q 039819 264 PYMSNGSVASRLRE----KPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDH 339 (534)
Q Consensus 264 e~~~~gsL~~~l~~----~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~ 339 (534)
||+++++|.+++.. ...+++..++.++.+++.||.|||+. +++|+||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 99999999998862 45689999999999999999999998 999999999999999999999999999886643
Q ss_pred CCCceeeccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceeccc
Q 039819 340 SDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDR 419 (534)
Q Consensus 340 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 419 (534)
... ......|+..|+|||++.+..++.++||||||+++|||++|..||..... ...++...... ...+
T Consensus 159 ~~~-~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-----~~~~~~~~~~~------~~~~ 226 (267)
T cd08229 159 KTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM-----NLYSLCKKIEQ------CDYP 226 (267)
T ss_pred CCc-ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccc-----hHHHHhhhhhc------CCCC
Confidence 322 12234588999999999888899999999999999999999999863221 11122111111 0011
Q ss_pred ccCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhc
Q 039819 420 ELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLEG 460 (534)
Q Consensus 420 ~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~ 460 (534)
.. ........+.+++.+|++.+|++||||.+|++.++.
T Consensus 227 ~~---~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~ 264 (267)
T cd08229 227 PL---PSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKR 264 (267)
T ss_pred CC---CcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhh
Confidence 11 112234578999999999999999999999998865
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=316.09 Aligned_cols=223 Identities=24% Similarity=0.297 Sum_probs=178.3
Q ss_pred eccCCcEEEEEEEEC-CCcEEEEEEehh-----------------hhhhc---ccCceeeEEEEEeCCCeeEEEeeccCC
Q 039819 210 LGAGGFGNVYKGKLG-DGTVLAVKRLKD-----------------MISLA---VHRNLLRLIGYCATPTERLLVYPYMSN 268 (534)
Q Consensus 210 lG~G~~g~Vy~~~~~-~~~~vavK~~~~-----------------~l~~~---~h~niv~l~~~~~~~~~~~lv~e~~~~ 268 (534)
||+|+||.||+|+.. ++..||||++.. ++... .||||+++++++.+....++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 699999999999875 589999998742 12222 699999999999999999999999999
Q ss_pred CChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCCceeecc
Q 039819 269 GSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAV 348 (534)
Q Consensus 269 gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~~ 348 (534)
|+|.+++.....+++..+..++.||++||+|||+. +|+||||||+|||++.++.+||+|||+++...... ......
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~-~~~~~~ 156 (330)
T cd05586 81 GELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKANLTDN-KTTNTF 156 (330)
T ss_pred ChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC-CCccCc
Confidence 99999998888899999999999999999999998 99999999999999999999999999987543222 123346
Q ss_pred ccccccccccccccC-CCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceecccccCCCCCH
Q 039819 349 RGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELGSNYDR 427 (534)
Q Consensus 349 ~gt~~y~aPE~~~~~-~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 427 (534)
.||..|+|||++.+. .++.++|||||||++|||+||+.||..... .+....+.... ..+.. .
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~-------~~~~~~i~~~~-------~~~~~---~ 219 (330)
T cd05586 157 CGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDT-------QQMYRNIAFGK-------VRFPK---N 219 (330)
T ss_pred cCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCH-------HHHHHHHHcCC-------CCCCC---c
Confidence 799999999998654 478999999999999999999999964321 11112211110 01111 1
Q ss_pred HHHHHHHHHHHHhcccCCCCCCChHH
Q 039819 428 IEVGEILQVALLCTQYLPVHRPKMSE 453 (534)
Q Consensus 428 ~~~~~l~~l~~~Cl~~~P~~RPt~~e 453 (534)
.....+.+++.+|++.+|.+||++.+
T Consensus 220 ~~~~~~~~li~~~L~~~P~~R~~~~~ 245 (330)
T cd05586 220 VLSDEGRQFVKGLLNRNPQHRLGAHR 245 (330)
T ss_pred cCCHHHHHHHHHHcCCCHHHCCCCCC
Confidence 12347789999999999999996543
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=299.64 Aligned_cols=241 Identities=23% Similarity=0.356 Sum_probs=196.2
Q ss_pred hCCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEeh-----------------hhhhhcccCceeeEEEEEeCCCeeEEEe
Q 039819 202 ENFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLK-----------------DMISLAVHRNLLRLIGYCATPTERLLVY 263 (534)
Q Consensus 202 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~-----------------~~l~~~~h~niv~l~~~~~~~~~~~lv~ 263 (534)
++|...+.||+|+||.||+|... +++.||+|.++ +++..+.|+|++++++++...+..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 57888899999999999999986 78999999764 1567788999999999999999999999
Q ss_pred eccCCCChhhhccc----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCC
Q 039819 264 PYMSNGSVASRLRE----KPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDH 339 (534)
Q Consensus 264 e~~~~gsL~~~l~~----~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~ 339 (534)
||+++|+|.+++.. ...+++..++.++.+++.||.|||+. +|+||||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 99999999988853 34589999999999999999999998 999999999999999999999999999986643
Q ss_pred CCCceeeccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceeccc
Q 039819 340 SDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDR 419 (534)
Q Consensus 340 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 419 (534)
... ......++..|+|||++.+..++.++|||||||++|||++|+.||..... ...++........
T Consensus 159 ~~~-~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-----~~~~~~~~~~~~~-------- 224 (267)
T cd08224 159 KTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM-----NLYSLCKKIEKCD-------- 224 (267)
T ss_pred CCc-ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCc-----cHHHHHhhhhcCC--------
Confidence 322 12234588999999999888899999999999999999999999863321 1112222211110
Q ss_pred ccCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhc
Q 039819 420 ELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLEG 460 (534)
Q Consensus 420 ~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~ 460 (534)
............+.+++.+|+..+|++||++.+|+++|+.
T Consensus 225 -~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~ 264 (267)
T cd08224 225 -YPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKE 264 (267)
T ss_pred -CCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHH
Confidence 0011111334578899999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-37 Score=319.32 Aligned_cols=252 Identities=21% Similarity=0.269 Sum_probs=193.3
Q ss_pred HhCCCcCCeeccCCcEEEEEEEEC---CCcEEEEEEeh---------hhhhhcccCceeeEEEEEeCCCeeEEEeeccCC
Q 039819 201 TENFSSKNILGAGGFGNVYKGKLG---DGTVLAVKRLK---------DMISLAVHRNLLRLIGYCATPTERLLVYPYMSN 268 (534)
Q Consensus 201 ~~~~~~~~~lG~G~~g~Vy~~~~~---~~~~vavK~~~---------~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~~~ 268 (534)
..+|...+.||+|+||.||++... .+..||||.+. ++++.++|||||++++++......++||||+.
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~e~~~- 169 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGKTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMPKYK- 169 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEeccccccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEehhcC-
Confidence 357889999999999999999753 35789999875 37888999999999999999999999999996
Q ss_pred CChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCC-ceeec
Q 039819 269 GSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDS-HVTTA 347 (534)
Q Consensus 269 gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~-~~~~~ 347 (534)
++|.+++.....+++..++.|+.|++.||.|||+. +||||||||+|||++.++.++|+|||+++....... .....
T Consensus 170 ~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~---givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~~~~~~~ 246 (392)
T PHA03207 170 CDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYG 246 (392)
T ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEccCccccccCcccccccccc
Confidence 68888887777899999999999999999999998 999999999999999999999999999986643322 12234
Q ss_pred cccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhc----------------
Q 039819 348 VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEK---------------- 411 (534)
Q Consensus 348 ~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~---------------- 411 (534)
..||..|+|||++.+..++.++|||||||++|||++|+.||...........+....+......
T Consensus 247 ~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~ 326 (392)
T PHA03207 247 WSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTNLCKHFK 326 (392)
T ss_pred cccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccchhHHHHHH
Confidence 5799999999999988999999999999999999999999965432221111111111110000
Q ss_pred ccceecccccC--CCC-CHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 412 KVEVLVDRELG--SNY-DRIEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 412 ~~~~~~d~~l~--~~~-~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
.......+... ... .......+.+++.+|++.+|++||++.|++.
T Consensus 327 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~ 374 (392)
T PHA03207 327 QYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILS 374 (392)
T ss_pred hhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhh
Confidence 00000000000 000 0011346778999999999999999999986
|
|
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=315.31 Aligned_cols=240 Identities=20% Similarity=0.241 Sum_probs=186.7
Q ss_pred hCCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEehh-----------------hhhhcccCceeeEEEEEeCCCeeEEEe
Q 039819 202 ENFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLKD-----------------MISLAVHRNLLRLIGYCATPTERLLVY 263 (534)
Q Consensus 202 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~-----------------~l~~~~h~niv~l~~~~~~~~~~~lv~ 263 (534)
++|...+.||+|+||.||+++.. .++.+|+|.+.+ ++...+|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 36888899999999999999976 478899998742 455678999999999999999999999
Q ss_pred eccCCCChhhhccc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCC
Q 039819 264 PYMSNGSVASRLRE-KPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDS 342 (534)
Q Consensus 264 e~~~~gsL~~~l~~-~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~ 342 (534)
||+++|+|.+++.. ...+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 81 ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~---~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~ 157 (332)
T cd05623 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT 157 (332)
T ss_pred eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEeecchheecccCCc
Confidence 99999999999976 46789999999999999999999998 999999999999999999999999999976543333
Q ss_pred ceeeccccccccccccccc-----cCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceec
Q 039819 343 HVTTAVRGTVGHIAPEYLS-----TGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLV 417 (534)
Q Consensus 343 ~~~~~~~gt~~y~aPE~~~-----~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 417 (534)
.......||+.|+|||++. ...++.++|||||||++|||++|+.||..... .+....+...... .
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~-------~~~~~~i~~~~~~--~- 227 (332)
T cd05623 158 VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESL-------VETYGKIMNHKER--F- 227 (332)
T ss_pred ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCH-------HHHHHHHhCCCcc--c-
Confidence 2333456999999999985 34678999999999999999999999974321 1222222111100 0
Q ss_pred ccccCCCCCHHHHHHHHHHHHHhcccCCC--CCCChHHHHHH
Q 039819 418 DRELGSNYDRIEVGEILQVALLCTQYLPV--HRPKMSEVVRM 457 (534)
Q Consensus 418 d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~--~RPt~~ev~~~ 457 (534)
.... ........+.+++.+|+..++. .|+++.|+++.
T Consensus 228 --~~p~-~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 228 --QFPA-QVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred --cCCC-ccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 0000 0112244677888887755443 47888888753
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=318.14 Aligned_cols=246 Identities=23% Similarity=0.327 Sum_probs=195.6
Q ss_pred CCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEehh-------------hhhhcc------cCceeeEEEEEeCCCeeEEE
Q 039819 203 NFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLKD-------------MISLAV------HRNLLRLIGYCATPTERLLV 262 (534)
Q Consensus 203 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~-------------~l~~~~------h~niv~l~~~~~~~~~~~lv 262 (534)
+|.+.+.||+|.||.|.+|... +++.||||++++ +|..++ --|+|+++++|.-.++.|||
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~HlciV 266 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCIV 266 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceeee
Confidence 7888999999999999999875 699999999984 455555 34899999999999999999
Q ss_pred eeccCCCChhhhcccC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCC--CCcEEEEecccceecC
Q 039819 263 YPYMSNGSVASRLREK--PALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDD--FCEAIVGDFGLAKLLD 338 (534)
Q Consensus 263 ~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~--~~~~kl~DFGla~~~~ 338 (534)
+|.+.. +|+++++.+ ..++...++.|+.||+.||.+||+. +|||+||||+||||.+ ...+||+|||.|.+..
T Consensus 267 fELL~~-NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l---~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~~ 342 (586)
T KOG0667|consen 267 FELLST-NLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHEL---GIIHCDLKPENILLKDPKRSRIKVIDFGSSCFES 342 (586)
T ss_pred ehhhhh-hHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCChhheeeccCCcCceeEEecccccccC
Confidence 999954 999999854 4689999999999999999999998 9999999999999964 3579999999998765
Q ss_pred CCCCceeeccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhh-----hccc
Q 039819 339 HSDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQ-----EKKV 413 (534)
Q Consensus 339 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~-----~~~~ 413 (534)
.. .. .+.-++.|+|||++.+.+|+.+.||||||||+.||+||.+.|++.+..++...|++..+.... ..+.
T Consensus 343 q~---vy-tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~~~~ 418 (586)
T KOG0667|consen 343 QR---VY-TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTAKKA 418 (586)
T ss_pred Cc---ce-eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhcccc
Confidence 43 22 455688999999999999999999999999999999999999988877776666654432111 0000
Q ss_pred ceeccc---------------------------------ccC-C------CCCHHHHHHHHHHHHHhcccCCCCCCChHH
Q 039819 414 EVLVDR---------------------------------ELG-S------NYDRIEVGEILQVALLCTQYLPVHRPKMSE 453 (534)
Q Consensus 414 ~~~~d~---------------------------------~l~-~------~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~e 453 (534)
..+++. ... + .........+.+++.+|+++||.+|+|..+
T Consensus 419 ~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~tp~q 498 (586)
T KOG0667|consen 419 HKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERITPAQ 498 (586)
T ss_pred ceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCCHHH
Confidence 111111 001 0 001122346789999999999999999998
Q ss_pred HHH
Q 039819 454 VVR 456 (534)
Q Consensus 454 v~~ 456 (534)
+++
T Consensus 499 al~ 501 (586)
T KOG0667|consen 499 ALN 501 (586)
T ss_pred Hhc
Confidence 875
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-38 Score=288.64 Aligned_cols=240 Identities=25% Similarity=0.352 Sum_probs=195.3
Q ss_pred HHHHhCCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEehh----------------------hh-hhcccCceeeEEEEE
Q 039819 198 QQATENFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLKD----------------------MI-SLAVHRNLLRLIGYC 253 (534)
Q Consensus 198 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~----------------------~l-~~~~h~niv~l~~~~ 253 (534)
+..-..|...++||+|..+.|-++..+ .|...|+|++.. ++ ....||+|+++.++|
T Consensus 13 ~~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~y 92 (411)
T KOG0599|consen 13 KGFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVY 92 (411)
T ss_pred hhHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeec
Confidence 344567888899999999999998764 678899998751 23 334599999999999
Q ss_pred eCCCeeEEEeeccCCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEeccc
Q 039819 254 ATPTERLLVYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGL 333 (534)
Q Consensus 254 ~~~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGl 333 (534)
+.+...++|+|.|+.|.|+++|...-.+++....+|+.|+.+|+.|||.. +||||||||+|||+|++.++||+|||+
T Consensus 93 es~sF~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~---~IVHRDLKpENILlddn~~i~isDFGF 169 (411)
T KOG0599|consen 93 ESDAFVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHAR---NIVHRDLKPENILLDDNMNIKISDFGF 169 (411)
T ss_pred cCcchhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHh---hhhhcccChhheeeccccceEEeccce
Confidence 99999999999999999999999999999999999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCCceeecccccccccccccccc------CCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHH
Q 039819 334 AKLLDHSDSHVTTAVRGTVGHIAPEYLST------GQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKI 407 (534)
Q Consensus 334 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~ 407 (534)
|..+..+. .....+||++|+|||.+.. ..|+..+|+||.|||+|.|+.|.+||.... .++ .++.+
T Consensus 170 a~~l~~Ge--kLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRk------Qml-MLR~I 240 (411)
T KOG0599|consen 170 ACQLEPGE--KLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRK------QML-MLRMI 240 (411)
T ss_pred eeccCCch--hHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHH------HHH-HHHHH
Confidence 99886543 4567899999999998842 347889999999999999999999996321 111 11222
Q ss_pred hhhcccceecccccCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 408 QQEKKVEVLVDRELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 408 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
...+ . .+-.++. ........+++.+|++.||.+|.|++|+++
T Consensus 241 meGk-y-qF~speW-----adis~~~KdLIsrlLqVdp~~Ritake~La 282 (411)
T KOG0599|consen 241 MEGK-Y-QFRSPEW-----ADISATVKDLISRLLQVDPTKRITAKEALA 282 (411)
T ss_pred Hhcc-c-ccCCcch-----hhccccHHHHHHHHHeeCchhcccHHHHhc
Confidence 2211 1 1111111 112457889999999999999999999985
|
|
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-37 Score=300.17 Aligned_cols=233 Identities=29% Similarity=0.454 Sum_probs=186.1
Q ss_pred CeeccCCcEEEEEEEECC----CcEEEEEEeh---------------hhhhhcccCceeeEEEEEeCCCeeEEEeeccCC
Q 039819 208 NILGAGGFGNVYKGKLGD----GTVLAVKRLK---------------DMISLAVHRNLLRLIGYCATPTERLLVYPYMSN 268 (534)
Q Consensus 208 ~~lG~G~~g~Vy~~~~~~----~~~vavK~~~---------------~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~~~ 268 (534)
+.||+|+||.||+|++.. +..+|+|.+. ..++.+.|+||+++++++. .+..++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 369999999999997632 2689999865 2567788999999999876 4567999999999
Q ss_pred CChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCCceee--
Q 039819 269 GSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTT-- 346 (534)
Q Consensus 269 gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~-- 346 (534)
|+|.+++.....+++..+..++.|++.||.|||.. +++||||||+|||++.++.+||+|||+++...........
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~~ 156 (257)
T cd05060 80 GPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESK---HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATT 156 (257)
T ss_pred CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhc---CeeccCcccceEEEcCCCcEEeccccccceeecCCccccccc
Confidence 99999998777899999999999999999999998 9999999999999999999999999999876443322111
Q ss_pred ccccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCcCCCccccccchHHHHHHHHhhhcccceecccccCCCC
Q 039819 347 AVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELGSNY 425 (534)
Q Consensus 347 ~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 425 (534)
...++..|+|||.+.+..++.++|||||||++|||++ |+.||..... ..+..+. ...... ..
T Consensus 157 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~----~~~~~~~---~~~~~~----------~~ 219 (257)
T cd05060 157 AGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG----AEVIAML---ESGERL----------PR 219 (257)
T ss_pred CccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCH----HHHHHHH---HcCCcC----------CC
Confidence 1223567999999988889999999999999999998 9999864321 1122221 111110 11
Q ss_pred CHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhcC
Q 039819 426 DRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLEGD 461 (534)
Q Consensus 426 ~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~~ 461 (534)
+...+..+.+++.+|+..+|++||++.++++.|++.
T Consensus 220 ~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 255 (257)
T cd05060 220 PEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD 255 (257)
T ss_pred CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence 112345788999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=309.95 Aligned_cols=246 Identities=24% Similarity=0.335 Sum_probs=191.0
Q ss_pred hCCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEeh---------------hhhhhcccCceeeEEEEEeCCCeeEEEeec
Q 039819 202 ENFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLK---------------DMISLAVHRNLLRLIGYCATPTERLLVYPY 265 (534)
Q Consensus 202 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~---------------~~l~~~~h~niv~l~~~~~~~~~~~lv~e~ 265 (534)
++|+..+.||+|+||.||+++.. ++..+|+|.+. +++..++||||++++++|...+..++||||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 36888899999999999999875 57888998764 256778999999999999999999999999
Q ss_pred cCCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCCcee
Q 039819 266 MSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVT 345 (534)
Q Consensus 266 ~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~ 345 (534)
+++++|.+++.....+++..+..++.|+++||.|||+.+ +++||||||+|||++.++.+||+|||++...... ..
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~---~~ 155 (308)
T cd06615 81 MDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---MA 155 (308)
T ss_pred cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhC--CEEECCCChHHEEEecCCcEEEccCCCccccccc---cc
Confidence 999999999988788999999999999999999999732 8999999999999999999999999998765332 12
Q ss_pred eccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhccc------------
Q 039819 346 TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKV------------ 413 (534)
Q Consensus 346 ~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~------------ 413 (534)
....|+..|+|||++.+..++.++|||||||++|||+||+.||....... ...+..........
T Consensus 156 ~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (308)
T cd06615 156 NSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKE----LEAMFGRPVSEGEAKESHRPVSGHPP 231 (308)
T ss_pred ccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhh----HHHhhcCccccccccCCcccccCCCC
Confidence 34568899999999988889999999999999999999999986432111 11111000000000
Q ss_pred --------ceeccccc---CCCC-CHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 414 --------EVLVDREL---GSNY-DRIEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 414 --------~~~~d~~l---~~~~-~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
....+... .... .......+.+++.+|++.+|++||++.+|++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~ 286 (308)
T cd06615 232 DSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTK 286 (308)
T ss_pred CccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00000000 0000 0112446889999999999999999999986
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-37 Score=301.18 Aligned_cols=238 Identities=24% Similarity=0.411 Sum_probs=193.0
Q ss_pred hCCCcCCeeccCCcEEEEEEEECCCcEEEEEEeh-------------hhhhhcccCceeeEEEEEeCCCeeEEEeeccCC
Q 039819 202 ENFSSKNILGAGGFGNVYKGKLGDGTVLAVKRLK-------------DMISLAVHRNLLRLIGYCATPTERLLVYPYMSN 268 (534)
Q Consensus 202 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~-------------~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~~~ 268 (534)
++|...+.||+|+||.||++...++..+|+|.+. +++..+.|+||+++.+++.. ...++||||+++
T Consensus 6 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~~~ 84 (260)
T cd05073 6 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFMAK 84 (260)
T ss_pred cceeEEeEecCccceEEEEEEecCCccEEEEecCCChhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeCCC
Confidence 5678889999999999999998888889999774 26778889999999999887 778999999999
Q ss_pred CChhhhccc--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCCceee
Q 039819 269 GSVASRLRE--KPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTT 346 (534)
Q Consensus 269 gsL~~~l~~--~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~ 346 (534)
|+|.+++.. ...+++..++.++.+++.||.|||+. +++||||||+||+++.++.+||+|||.+............
T Consensus 85 ~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~ 161 (260)
T cd05073 85 GSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTARE 161 (260)
T ss_pred CcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCCcceeeccCCCccccc
Confidence 999999865 34588999999999999999999998 9999999999999999999999999999866433222222
Q ss_pred ccccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCcCCCccccccchHHHHHHHHhhhcccceecccccCCCC
Q 039819 347 AVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELGSNY 425 (534)
Q Consensus 347 ~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 425 (534)
...++..|+|||++....++.++|||||||++||++| |+.||..... ..+..+.. .... ...
T Consensus 162 ~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~----~~~~~~~~---~~~~----------~~~ 224 (260)
T cd05073 162 GAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN----PEVIRALE---RGYR----------MPR 224 (260)
T ss_pred CCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCH----HHHHHHHh---CCCC----------CCC
Confidence 3345678999999988889999999999999999999 8999864321 11111111 1100 011
Q ss_pred CHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhc
Q 039819 426 DRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLEG 460 (534)
Q Consensus 426 ~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~ 460 (534)
....+..+.+++.+|++.+|++||++.++.+.|+.
T Consensus 225 ~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 225 PENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred cccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 12234578899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-38 Score=314.55 Aligned_cols=246 Identities=22% Similarity=0.343 Sum_probs=197.6
Q ss_pred CCCcCCeeccCCcEEEEEEEECCCcEEEEEEeh---------------hhhhhcccCceeeEEEEEeCCCeeEEEeeccC
Q 039819 203 NFSSKNILGAGGFGNVYKGKLGDGTVLAVKRLK---------------DMISLAVHRNLLRLIGYCATPTERLLVYPYMS 267 (534)
Q Consensus 203 ~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~---------------~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~~ 267 (534)
.....+.||+|.||+|..+....+..||||.++ ++|.+++|||||+++|+|..++..++|+|||+
T Consensus 539 ~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYmE 618 (807)
T KOG1094|consen 539 RLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYME 618 (807)
T ss_pred heehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHHh
Confidence 445668899999999999999888999999987 37889999999999999999999999999999
Q ss_pred CCChhhhcccC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCCc-e
Q 039819 268 NGSVASRLREK--PALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSH-V 344 (534)
Q Consensus 268 ~gsL~~~l~~~--~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~-~ 344 (534)
+|+|.+++.++ +.+.-....+|+.|||.|++||.+. ++|||||.+.|+|+|.++++||+|||+++.+..++.. .
T Consensus 619 nGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~---nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy~v 695 (807)
T KOG1094|consen 619 NGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESL---NFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYYRV 695 (807)
T ss_pred cCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhh---chhhccccccceeecCcccEEecCcccccccccCCceee
Confidence 99999999765 3345566778999999999999998 9999999999999999999999999999976554432 3
Q ss_pred eeccccccccccccccccCCCCcchhHHHHHHHHHHHHh--CCCCcCCCccccccchHHHHHHHHhhhcccceecccccC
Q 039819 345 TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT--GMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELG 422 (534)
Q Consensus 345 ~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~ellt--G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 422 (534)
....+-...|||||.+..++++.++|||+||+++||+++ ...||..... ..+++-........... ..
T Consensus 696 qgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~----e~vven~~~~~~~~~~~------~~ 765 (807)
T KOG1094|consen 696 QGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTD----EQVVENAGEFFRDQGRQ------VV 765 (807)
T ss_pred ecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhH----HHHHHhhhhhcCCCCcc------ee
Confidence 334445789999999999999999999999999999875 5667642111 11111111111111111 11
Q ss_pred CCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhcC
Q 039819 423 SNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLEGD 461 (534)
Q Consensus 423 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~~ 461 (534)
...+..++..+.+++.+||..+-++||+++++...|...
T Consensus 766 l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 766 LSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred ccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 123455677999999999999999999999999988754
|
|
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=304.15 Aligned_cols=238 Identities=26% Similarity=0.363 Sum_probs=187.0
Q ss_pred HHHhCCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEehh-------------hhhhc-ccCceeeEEEEEeCC------C
Q 039819 199 QATENFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLKD-------------MISLA-VHRNLLRLIGYCATP------T 257 (534)
Q Consensus 199 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~-------------~l~~~-~h~niv~l~~~~~~~------~ 257 (534)
.+++.|+..+.||+|+||.||+|... +++.||+|++.. ++..+ .|+||+++++++... .
T Consensus 3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (272)
T cd06637 3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDD 82 (272)
T ss_pred ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCc
Confidence 35677888899999999999999875 678999998741 34555 699999999998753 4
Q ss_pred eeEEEeeccCCCChhhhccc--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccce
Q 039819 258 ERLLVYPYMSNGSVASRLRE--KPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAK 335 (534)
Q Consensus 258 ~~~lv~e~~~~gsL~~~l~~--~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~ 335 (534)
..++||||+++|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+||++++++.++|+|||++.
T Consensus 83 ~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivh~dl~~~nili~~~~~~~l~Dfg~~~ 159 (272)
T cd06637 83 QLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSA 159 (272)
T ss_pred EEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHEEECCCCCEEEccCCCce
Confidence 57899999999999999875 34689999999999999999999998 99999999999999999999999999998
Q ss_pred ecCCCCCceeeccccccccccccccc-----cCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhh
Q 039819 336 LLDHSDSHVTTAVRGTVGHIAPEYLS-----TGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQE 410 (534)
Q Consensus 336 ~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 410 (534)
....... ......|+..|+|||++. ...++.++|||||||++|||++|+.||..... ...+... ..
T Consensus 160 ~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~------~~~~~~~-~~- 230 (272)
T cd06637 160 QLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHP------MRALFLI-PR- 230 (272)
T ss_pred ecccccc-cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCH------HHHHHHH-hc-
Confidence 6543221 223456899999999985 34578899999999999999999999863221 1111110 00
Q ss_pred cccceecccccCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 411 KKVEVLVDRELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 411 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
.. .+.. .....+..+.+++.+|+..+|.+||++.++++
T Consensus 231 ~~-----~~~~---~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 231 NP-----APRL---KSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred CC-----CCCC---CCCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 00 0111 11122347889999999999999999999975
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-38 Score=319.55 Aligned_cols=229 Identities=28% Similarity=0.406 Sum_probs=188.1
Q ss_pred eeccCCcEEEEEEEEC-CCcEEEEEEehh--------------hhhhcccCceeeEEEEEeCCCeeEEEeeccCCCChhh
Q 039819 209 ILGAGGFGNVYKGKLG-DGTVLAVKRLKD--------------MISLAVHRNLLRLIGYCATPTERLLVYPYMSNGSVAS 273 (534)
Q Consensus 209 ~lG~G~~g~Vy~~~~~-~~~~vavK~~~~--------------~l~~~~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~ 273 (534)
+||+|.||+||.|++. +...+|||.+.+ +-+.++|.|||+.+|.|.+.+..-+.||-++||+|.+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs 661 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS 661 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence 6999999999999976 456799998753 5578899999999999999999999999999999999
Q ss_pred hcccC-CCC--CHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeC-CCCcEEEEecccceecCCCCCceeeccc
Q 039819 274 RLREK-PAL--DWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLD-DFCEAIVGDFGLAKLLDHSDSHVTTAVR 349 (534)
Q Consensus 274 ~l~~~-~~l--~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~-~~~~~kl~DFGla~~~~~~~~~~~~~~~ 349 (534)
.|+.. +++ .+.+.-.+..||++||.|||++ .|||||||-+|||++ -.|.+||+|||-++.+..- ...+.++.
T Consensus 662 LLrskWGPlKDNEstm~fYtkQILeGLkYLHen---~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgi-nP~TETFT 737 (1226)
T KOG4279|consen 662 LLRSKWGPLKDNESTMNFYTKQILEGLKYLHEN---KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGI-NPCTETFT 737 (1226)
T ss_pred HHHhccCCCccchhHHHHHHHHHHHHhhhhhhc---ceeeccccCCcEEEeeccceEEecccccchhhccC-Cccccccc
Confidence 99854 556 6778888999999999999999 999999999999996 5789999999999987532 23456678
Q ss_pred cccccccccccccCC--CCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceecccccCCCCCH
Q 039819 350 GTVGHIAPEYLSTGQ--SSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELGSNYDR 427 (534)
Q Consensus 350 gt~~y~aPE~~~~~~--~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 427 (534)
||..|||||++..++ |+.++|||||||++.||.||++||-.-.+. ...+. +-+. -......+.
T Consensus 738 GTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elgsp--qAAMF-------kVGm------yKvHP~iPe 802 (1226)
T KOG4279|consen 738 GTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSP--QAAMF-------KVGM------YKVHPPIPE 802 (1226)
T ss_pred cchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCCh--hHhhh-------hhcc------eecCCCCcH
Confidence 999999999997655 788999999999999999999999521111 00000 0000 012234566
Q ss_pred HHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 428 IEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 428 ~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
....+...++++|+.++|.+||++.+++.
T Consensus 803 elsaeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 803 ELSAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred HHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 67788999999999999999999999986
|
|
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=302.10 Aligned_cols=239 Identities=26% Similarity=0.411 Sum_probs=191.1
Q ss_pred hCCCcCCeeccCCcEEEEEEEEC----CCcEEEEEEeh---------------hhhhhcccCceeeEEEEEeCCCeeEEE
Q 039819 202 ENFSSKNILGAGGFGNVYKGKLG----DGTVLAVKRLK---------------DMISLAVHRNLLRLIGYCATPTERLLV 262 (534)
Q Consensus 202 ~~~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~---------------~~l~~~~h~niv~l~~~~~~~~~~~lv 262 (534)
.+|...+.||+|+||.||+|... .+..+|+|.++ ..+..++||||+++++++...+..++|
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 56788899999999999999863 23479999864 156778899999999999999999999
Q ss_pred eeccCCCChhhhcccC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCC
Q 039819 263 YPYMSNGSVASRLREK-PALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSD 341 (534)
Q Consensus 263 ~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~ 341 (534)
|||+++++|.+++... ..+++.++..++.|++.||.|||+. +++||||||+|||++.++.++|+|||+++......
T Consensus 84 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd05066 84 TEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP 160 (267)
T ss_pred EEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeehhhchhcEEECCCCeEEeCCCCccccccccc
Confidence 9999999999999754 4689999999999999999999998 99999999999999999999999999998765433
Q ss_pred Cceeec--cccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCcCCCccccccchHHHHHHHHhhhcccceecc
Q 039819 342 SHVTTA--VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVD 418 (534)
Q Consensus 342 ~~~~~~--~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 418 (534)
...... ..++..|+|||++.+..++.++|||||||++||+++ |+.||...... +..........
T Consensus 161 ~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~-------~~~~~~~~~~~------ 227 (267)
T cd05066 161 EAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQ-------DVIKAIEEGYR------ 227 (267)
T ss_pred ceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHH-------HHHHHHhCCCc------
Confidence 222221 123568999999988889999999999999999886 99998633211 11111111100
Q ss_pred cccCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhc
Q 039819 419 RELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLEG 460 (534)
Q Consensus 419 ~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~ 460 (534)
. ......+..+.+++.+|++.+|.+||+|.++++.|+.
T Consensus 228 ~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 265 (267)
T cd05066 228 L----PAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDK 265 (267)
T ss_pred C----CCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHh
Confidence 0 0111234578899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=310.35 Aligned_cols=236 Identities=22% Similarity=0.325 Sum_probs=196.5
Q ss_pred HhCCCcCCeeccCCcEEEEEEEECC-CcEEEEEEehh-----------------hhhhcc-cCceeeEEEEEeCCCeeEE
Q 039819 201 TENFSSKNILGAGGFGNVYKGKLGD-GTVLAVKRLKD-----------------MISLAV-HRNLLRLIGYCATPTERLL 261 (534)
Q Consensus 201 ~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~-----------------~l~~~~-h~niv~l~~~~~~~~~~~l 261 (534)
...|...+.||+|.||.||+++... |+.+|+|.+.+ ++..+. |||||.+.++|.+....++
T Consensus 34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~l 113 (382)
T KOG0032|consen 34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYL 113 (382)
T ss_pred cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEE
Confidence 3567778899999999999999865 99999998853 567777 9999999999999999999
Q ss_pred EeeccCCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCC----CCcEEEEecccceec
Q 039819 262 VYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDD----FCEAIVGDFGLAKLL 337 (534)
Q Consensus 262 v~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~----~~~~kl~DFGla~~~ 337 (534)
|||++.||.|.+.+... .+++..+..++.|++.++.|||+. +|+||||||+|+|+.. ++.+|++|||++...
T Consensus 114 vmEL~~GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH~~---gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~ 189 (382)
T KOG0032|consen 114 VMELCEGGELFDRIVKK-HYSERDAAGIIRQILEAVKYLHSL---GVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFI 189 (382)
T ss_pred EEEecCCchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHhC---CceeccCCHHHeeeccccCCCCcEEEeeCCCceEc
Confidence 99999999999999766 499999999999999999999998 9999999999999953 357999999999988
Q ss_pred CCCCCceeeccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceec
Q 039819 338 DHSDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLV 417 (534)
Q Consensus 338 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 417 (534)
.. .......+||+.|+|||++....|+..+||||+||++|.|++|.+||........ .. .+.... .
T Consensus 190 ~~--~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~------~~-~i~~~~-~---- 255 (382)
T KOG0032|consen 190 KP--GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEI------FL-AILRGD-F---- 255 (382)
T ss_pred cC--CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHH------HH-HHHcCC-C----
Confidence 76 3456678899999999999989999999999999999999999999985442211 11 111111 0
Q ss_pred ccccCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 418 DRELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 418 d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
......-......+.+++..|+..||.+|+|+.++++
T Consensus 256 --~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~ 292 (382)
T KOG0032|consen 256 --DFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQ 292 (382)
T ss_pred --CCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhc
Confidence 1111111222557889999999999999999999987
|
|
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=306.05 Aligned_cols=252 Identities=21% Similarity=0.308 Sum_probs=193.6
Q ss_pred hCCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEeh----------------hhhhhcccCceeeEEEEEeCCCeeEEEee
Q 039819 202 ENFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLK----------------DMISLAVHRNLLRLIGYCATPTERLLVYP 264 (534)
Q Consensus 202 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~----------------~~l~~~~h~niv~l~~~~~~~~~~~lv~e 264 (534)
++|+..+.||+|+||.||+|... ++..||||+++ ++++.+.|+||+++++++...+..++|||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 36788899999999999999986 57899999764 25667889999999999999999999999
Q ss_pred ccCCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCCce
Q 039819 265 YMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHV 344 (534)
Q Consensus 265 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~ 344 (534)
|++++.+..+......+++..+..++.+++.||.|||+. +++||||+|+||++++++.+||+|||++..........
T Consensus 81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~ 157 (288)
T cd07833 81 YVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARALRARPASP 157 (288)
T ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEEeeecccccCCCcccc
Confidence 999988877776667799999999999999999999998 99999999999999999999999999998765443323
Q ss_pred eeccccccccccccccccC-CCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhh--------hcccce
Q 039819 345 TTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQ--------EKKVEV 415 (534)
Q Consensus 345 ~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~ 415 (534)
.....++..|+|||++.+. .++.++||||||+++|||++|+.||......+....+......... ......
T Consensus 158 ~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (288)
T cd07833 158 LTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAG 237 (288)
T ss_pred ccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCccccc
Confidence 3445678999999999887 7899999999999999999999999744322111111110000000 000000
Q ss_pred --ecccc----cCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 416 --LVDRE----LGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 416 --~~d~~----l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
..+.. ....++...+.++.+++.+|+..+|++||+++++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 238 VAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred cccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 00000 000112223568999999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=310.00 Aligned_cols=238 Identities=26% Similarity=0.407 Sum_probs=186.8
Q ss_pred hCCCcCCeeccCCcEEEEEEEEC-CCc--EEEEEEehh---------------hhhhc-ccCceeeEEEEEeCCCeeEEE
Q 039819 202 ENFSSKNILGAGGFGNVYKGKLG-DGT--VLAVKRLKD---------------MISLA-VHRNLLRLIGYCATPTERLLV 262 (534)
Q Consensus 202 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~--~vavK~~~~---------------~l~~~-~h~niv~l~~~~~~~~~~~lv 262 (534)
++|+..+.||+|+||.||+|... ++. .+|+|++.. ++.++ .|+||+++++++...+..++|
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv 86 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 86 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence 56788899999999999999874 343 468876642 34566 799999999999999999999
Q ss_pred eeccCCCChhhhcccC----------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcE
Q 039819 263 YPYMSNGSVASRLREK----------------PALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEA 326 (534)
Q Consensus 263 ~e~~~~gsL~~~l~~~----------------~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~ 326 (534)
|||+++|+|.++++.. ..+++.+++.++.|++.||+|||+. +|+||||||+|||++.++.+
T Consensus 87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dlkp~Nili~~~~~~ 163 (303)
T cd05088 87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVA 163 (303)
T ss_pred EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEecCCCcE
Confidence 9999999999998643 2578999999999999999999998 99999999999999999999
Q ss_pred EEEecccceecCCCCCceeeccccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCcCCCccccccchHHHHHH
Q 039819 327 IVGDFGLAKLLDHSDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GMRALEFGKSINQKGAMLEWVK 405 (534)
Q Consensus 327 kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~ 405 (534)
||+|||++....... ......++..|+|||++.+..++.++|||||||++|||+| |..||..... .+...
T Consensus 164 kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~-------~~~~~ 234 (303)
T cd05088 164 KIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC-------AELYE 234 (303)
T ss_pred EeCccccCcccchhh--hcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCCh-------HHHHH
Confidence 999999986432111 1111224668999999988889999999999999999998 9999863221 11111
Q ss_pred HHhhhcccceecccccCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhcC
Q 039819 406 KIQQEKKVEVLVDRELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLEGD 461 (534)
Q Consensus 406 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~~ 461 (534)
...... ....+...+..+.+++.+|++.+|++||++.+++..|+..
T Consensus 235 ~~~~~~----------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~ 280 (303)
T cd05088 235 KLPQGY----------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 280 (303)
T ss_pred HHhcCC----------cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 111110 0001111234788999999999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-37 Score=302.16 Aligned_cols=231 Identities=27% Similarity=0.423 Sum_probs=181.0
Q ss_pred CeeccCCcEEEEEEEECC-Cc--EEEEEEehh---------------hhhhc-ccCceeeEEEEEeCCCeeEEEeeccCC
Q 039819 208 NILGAGGFGNVYKGKLGD-GT--VLAVKRLKD---------------MISLA-VHRNLLRLIGYCATPTERLLVYPYMSN 268 (534)
Q Consensus 208 ~~lG~G~~g~Vy~~~~~~-~~--~vavK~~~~---------------~l~~~-~h~niv~l~~~~~~~~~~~lv~e~~~~ 268 (534)
++||+|+||.||+|++.+ +. .+|+|.++. .+.++ .||||++++++|......++||||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 368999999999999754 33 468887652 34556 799999999999999999999999999
Q ss_pred CChhhhcccCC----------------CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecc
Q 039819 269 GSVASRLREKP----------------ALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFG 332 (534)
Q Consensus 269 gsL~~~l~~~~----------------~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFG 332 (534)
|+|.+++.... .+++..++.++.|++.||+|||+. +++||||||+||++++++.+||+|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccccceEEEcCCCeEEECCCC
Confidence 99999986432 478999999999999999999998 99999999999999999999999999
Q ss_pred cceecCCCCCceeeccccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCcCCCccccccchHHHHHHHHhhhc
Q 039819 333 LAKLLDHSDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GMRALEFGKSINQKGAMLEWVKKIQQEK 411 (534)
Q Consensus 333 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~ 411 (534)
++....... .......+..|+|||++....++.++|||||||++|||+| |+.||..... .+.........
T Consensus 158 l~~~~~~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~-------~~~~~~~~~~~ 228 (270)
T cd05047 158 LSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC-------AELYEKLPQGY 228 (270)
T ss_pred Cccccchhh--hccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCH-------HHHHHHHhCCC
Confidence 986322111 1111223567999999988889999999999999999997 9999864221 11111111111
Q ss_pred ccceecccccCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhc
Q 039819 412 KVEVLVDRELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLEG 460 (534)
Q Consensus 412 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~ 460 (534)
.. ..+......+.+++.+|++.+|.+||++.+++..|..
T Consensus 229 ~~----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~ 267 (270)
T cd05047 229 RL----------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNR 267 (270)
T ss_pred CC----------CCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHH
Confidence 00 1111233478899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=300.08 Aligned_cols=235 Identities=25% Similarity=0.340 Sum_probs=186.3
Q ss_pred CCCcCCeeccCCcEEEEEEEE-CCCcEEEEEEeh---------------hhhhhcccCceeeEEEEEeCCCeeEEEeecc
Q 039819 203 NFSSKNILGAGGFGNVYKGKL-GDGTVLAVKRLK---------------DMISLAVHRNLLRLIGYCATPTERLLVYPYM 266 (534)
Q Consensus 203 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~---------------~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~ 266 (534)
+|+..+.||+|+||.||+|.. .++..||+|.+. +++..+.||||+++++++...+..++||||+
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 81 (279)
T cd06619 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFM 81 (279)
T ss_pred cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecC
Confidence 577788999999999999986 468899999864 1466788999999999999999999999999
Q ss_pred CCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCCceee
Q 039819 267 SNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTT 346 (534)
Q Consensus 267 ~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~ 346 (534)
++++|..+ ..+++..+..++.|++.||.|||+. +|+|+||||+|||++.++.++|+|||++...... ...
T Consensus 82 ~~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~---~~~ 151 (279)
T cd06619 82 DGGSLDVY----RKIPEHVLGRIAVAVVKGLTYLWSL---KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS---IAK 151 (279)
T ss_pred CCCChHHh----hcCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCCHHHEEECCCCCEEEeeCCcceecccc---ccc
Confidence 99998654 3478889999999999999999998 9999999999999999999999999999865432 123
Q ss_pred ccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceecccccCCCCC
Q 039819 347 AVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELGSNYD 426 (534)
Q Consensus 347 ~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 426 (534)
...||..|+|||++.+..++.++|||||||++|||+||+.||..............+........ .+.+. .
T Consensus 152 ~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~------~~~~~---~ 222 (279)
T cd06619 152 TYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDED------PPVLP---V 222 (279)
T ss_pred CCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccC------CCCCC---C
Confidence 35689999999999888899999999999999999999999964221111111111111111110 11111 1
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 427 RIEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 427 ~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
.....++.+++.+|++.+|++||+++|+++
T Consensus 223 ~~~~~~~~~li~~~l~~~P~~Rp~~~eil~ 252 (279)
T cd06619 223 GQFSEKFVHFITQCMRKQPKERPAPENLMD 252 (279)
T ss_pred CcCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence 112347889999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=303.27 Aligned_cols=234 Identities=25% Similarity=0.358 Sum_probs=187.1
Q ss_pred CCcCCeeccCCcEEEEEEEEC-CCcEEEEEEeh-----------------hhhhhcccCceeeEEEEEeCCCeeEEEeec
Q 039819 204 FSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLK-----------------DMISLAVHRNLLRLIGYCATPTERLLVYPY 265 (534)
Q Consensus 204 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~-----------------~~l~~~~h~niv~l~~~~~~~~~~~lv~e~ 265 (534)
|+..+.||+|+||.||++... +++.||||.+. .++..++|++++++.+.+.+.+..++||||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence 667789999999999999875 68899999763 156778899999999999999999999999
Q ss_pred cCCCChhhhcccC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCCc
Q 039819 266 MSNGSVASRLREK--PALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSH 343 (534)
Q Consensus 266 ~~~gsL~~~l~~~--~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~ 343 (534)
+++++|.+++... ..+++..+..++.|++.||.|||+. +|+||||||+||+++.++.++|+|||++........
T Consensus 82 ~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~- 157 (285)
T cd05630 82 MNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT- 157 (285)
T ss_pred cCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeccceeecCCCcc-
Confidence 9999999988532 3589999999999999999999998 999999999999999999999999999976543221
Q ss_pred eeeccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceecccccCC
Q 039819 344 VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELGS 423 (534)
Q Consensus 344 ~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 423 (534)
.....|+..|+|||++.+..++.++|||||||++|||++|+.||................... ..
T Consensus 158 -~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~--------------~~ 222 (285)
T cd05630 158 -IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEV--------------QE 222 (285)
T ss_pred -ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhh--------------hh
Confidence 223468999999999998899999999999999999999999997432111000000000000 00
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCC-----hHHHHH
Q 039819 424 NYDRIEVGEILQVALLCTQYLPVHRPK-----MSEVVR 456 (534)
Q Consensus 424 ~~~~~~~~~l~~l~~~Cl~~~P~~RPt-----~~ev~~ 456 (534)
.+.......+.+++.+|++.+|++||+ +.|+++
T Consensus 223 ~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 223 EYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred hcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence 111122346889999999999999999 677764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=301.42 Aligned_cols=251 Identities=23% Similarity=0.297 Sum_probs=192.0
Q ss_pred hCCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEeh----------------hhhhhcccCceeeEEEEEeCCCeeEEEee
Q 039819 202 ENFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLK----------------DMISLAVHRNLLRLIGYCATPTERLLVYP 264 (534)
Q Consensus 202 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~----------------~~l~~~~h~niv~l~~~~~~~~~~~lv~e 264 (534)
++|+..+.||+|+||.||+|+.. +++.||+|++. +++..+.|+|++++++++......++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 36788899999999999999986 58899999763 25678889999999999999999999999
Q ss_pred ccCCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCCce
Q 039819 265 YMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHV 344 (534)
Q Consensus 265 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~ 344 (534)
|+++++|..+......+++..++.++.|++.||.|||+. +++||||||+||+++.++.++|+|||++........ .
T Consensus 81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~-~ 156 (286)
T cd07847 81 YCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKH---NCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD-D 156 (286)
T ss_pred ccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCChhhEEEcCCCcEEECccccceecCCCcc-c
Confidence 999999988887777799999999999999999999998 999999999999999999999999999987654321 2
Q ss_pred eecccccccccccccccc-CCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHH--------hhhcccce
Q 039819 345 TTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKI--------QQEKKVEV 415 (534)
Q Consensus 345 ~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~ 415 (534)
.....++..|+|||++.+ ..++.++|||||||++|||+||+.||......+....+....... ........
T Consensus 157 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (286)
T cd07847 157 YTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKG 236 (286)
T ss_pred ccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhccccccccc
Confidence 223457889999999865 457899999999999999999999997543321111111100000 00000000
Q ss_pred ecccccCCCCC-----HHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 416 LVDRELGSNYD-----RIEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 416 ~~d~~l~~~~~-----~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
...+......+ ......+.+++.+|++.+|++||++.|++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 237 LSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred ccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 00111000000 012457889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=304.82 Aligned_cols=245 Identities=22% Similarity=0.351 Sum_probs=188.0
Q ss_pred hCCCcCCeeccCCcEEEEEEEEC-----------------CCcEEEEEEehh---------------hhhhcccCceeeE
Q 039819 202 ENFSSKNILGAGGFGNVYKGKLG-----------------DGTVLAVKRLKD---------------MISLAVHRNLLRL 249 (534)
Q Consensus 202 ~~~~~~~~lG~G~~g~Vy~~~~~-----------------~~~~vavK~~~~---------------~l~~~~h~niv~l 249 (534)
++|+..+.||+|+||.||++... +...||+|.+.. .+..++|+||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~ 84 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL 84 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence 56888899999999999998542 234689998752 4667889999999
Q ss_pred EEEEeCCCeeEEEeeccCCCChhhhcccC-----------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcE
Q 039819 250 IGYCATPTERLLVYPYMSNGSVASRLREK-----------PALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANV 318 (534)
Q Consensus 250 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~-----------~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~Ni 318 (534)
++++...+..++||||+++|+|.+++... ..+++.++..++.|++.||+|||+. +++||||||+||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dlkp~Ni 161 (296)
T cd05095 85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRDLATRNC 161 (296)
T ss_pred EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CeecccCChheE
Confidence 99999999999999999999999988642 2477889999999999999999998 999999999999
Q ss_pred EeCCCCcEEEEecccceecCCCCCc-eeeccccccccccccccccCCCCcchhHHHHHHHHHHHHh--CCCCcCCCcccc
Q 039819 319 LLDDFCEAIVGDFGLAKLLDHSDSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT--GMRALEFGKSIN 395 (534)
Q Consensus 319 Ll~~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~ellt--G~~p~~~~~~~~ 395 (534)
|++.++.++|+|||+++.+...... ......++..|+|||....+.++.++|||||||++|||+| |..||......
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~- 240 (296)
T cd05095 162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDE- 240 (296)
T ss_pred EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChH-
Confidence 9999999999999999865432211 1122334678999999888889999999999999999998 66777532211
Q ss_pred ccchHHHHHHHHhhhcccceecccccCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhh
Q 039819 396 QKGAMLEWVKKIQQEKKVEVLVDRELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLE 459 (534)
Q Consensus 396 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~ 459 (534)
.+............... . ...+..++..+.+++.+|++.+|.+||+|.+|++.|+
T Consensus 241 ---~~~~~~~~~~~~~~~~~-~-----~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 295 (296)
T cd05095 241 ---QVIENTGEFFRDQGRQV-Y-----LPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL 295 (296)
T ss_pred ---HHHHHHHHHHhhccccc-c-----CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 11111111111100000 0 0011123468899999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=297.14 Aligned_cols=235 Identities=27% Similarity=0.386 Sum_probs=178.4
Q ss_pred eeccCCcEEEEEEEECC---CcEEEEEEehh---------------hhhhcccCceeeEEEEEeCCCeeEEEeeccCCCC
Q 039819 209 ILGAGGFGNVYKGKLGD---GTVLAVKRLKD---------------MISLAVHRNLLRLIGYCATPTERLLVYPYMSNGS 270 (534)
Q Consensus 209 ~lG~G~~g~Vy~~~~~~---~~~vavK~~~~---------------~l~~~~h~niv~l~~~~~~~~~~~lv~e~~~~gs 270 (534)
.||+|+||.||+|++.+ +..+|+|.+.. .+..++||||+++++++.+....++||||+++|+
T Consensus 2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05087 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGD 81 (269)
T ss_pred cccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCCc
Confidence 58999999999998643 35789997742 5677889999999999999999999999999999
Q ss_pred hhhhcccC-----CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCCce-
Q 039819 271 VASRLREK-----PALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHV- 344 (534)
Q Consensus 271 L~~~l~~~-----~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~- 344 (534)
|.+++... ...++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||+++.........
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~ 158 (269)
T cd05087 82 LKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVT 158 (269)
T ss_pred HHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEECCccccccccCcceeec
Confidence 99998632 2467788889999999999999998 99999999999999999999999999997543322111
Q ss_pred eeccccccccccccccccC-------CCCcchhHHHHHHHHHHHHh-CCCCcCCCccccccchHHHHHHHHhhhccccee
Q 039819 345 TTAVRGTVGHIAPEYLSTG-------QSSEKTDVFGFGILLLELIT-GMRALEFGKSINQKGAMLEWVKKIQQEKKVEVL 416 (534)
Q Consensus 345 ~~~~~gt~~y~aPE~~~~~-------~~~~k~Dv~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 416 (534)
.....++..|+|||++... .++.++|||||||++|||++ |+.||...... ..... .. .......
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~----~~~~~--~~--~~~~~~~ 230 (269)
T cd05087 159 PDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDE----QVLTY--TV--REQQLKL 230 (269)
T ss_pred CCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChH----HHHHH--Hh--hcccCCC
Confidence 1234467889999998532 35789999999999999996 99999643211 11111 00 0111111
Q ss_pred cccccCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhh
Q 039819 417 VDRELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLE 459 (534)
Q Consensus 417 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~ 459 (534)
.++.+.. .....+.+++.+|+ .+|++|||++||+..|+
T Consensus 231 ~~~~~~~----~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 231 PKPRLKL----PLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCCccCC----CCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 1222211 12346778999998 58999999999998874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-37 Score=297.69 Aligned_cols=240 Identities=22% Similarity=0.255 Sum_probs=191.6
Q ss_pred hCCCcCCeeccCCcEEEEEEEECC-CcEEEEEEehh-----------------hhhhcccCceeeEEEEEeCCCeeEEEe
Q 039819 202 ENFSSKNILGAGGFGNVYKGKLGD-GTVLAVKRLKD-----------------MISLAVHRNLLRLIGYCATPTERLLVY 263 (534)
Q Consensus 202 ~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~-----------------~l~~~~h~niv~l~~~~~~~~~~~lv~ 263 (534)
+.|+..+.||+|.-|+||++++.+ +..+|+|++.+ +++.+.||.++.|++.|+.....|+||
T Consensus 77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~m 156 (459)
T KOG0610|consen 77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVM 156 (459)
T ss_pred HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEE
Confidence 345556789999999999999875 58999998853 788899999999999999999999999
Q ss_pred eccCCCChhhhcccC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCC--
Q 039819 264 PYMSNGSVASRLREK--PALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDH-- 339 (534)
Q Consensus 264 e~~~~gsL~~~l~~~--~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~-- 339 (534)
|||+||+|...++++ ..+++..++-++..|+-||+|||.. |||+|||||+||||.++|++.|+||.|+.....
T Consensus 157 eyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHml---GivYRDLKPENILvredGHIMLsDFDLS~~~~~~P 233 (459)
T KOG0610|consen 157 EYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHML---GIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSP 233 (459)
T ss_pred ecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhh---ceeeccCCcceeEEecCCcEEeeeccccccCCCCC
Confidence 999999999998754 4699999999999999999999999 999999999999999999999999998754311
Q ss_pred -------------------------------CCC----------------------ceeeccccccccccccccccCCCC
Q 039819 340 -------------------------------SDS----------------------HVTTAVRGTVGHIAPEYLSTGQSS 366 (534)
Q Consensus 340 -------------------------------~~~----------------------~~~~~~~gt~~y~aPE~~~~~~~~ 366 (534)
... .....++||-.|+|||++.+...+
T Consensus 234 t~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHg 313 (459)
T KOG0610|consen 234 TLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHG 313 (459)
T ss_pred eeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCC
Confidence 000 011235699999999999999999
Q ss_pred cchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceecccccCCCCCHHHHHHHHHHHHHhcccCCC
Q 039819 367 EKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELGSNYDRIEVGEILQVALLCTQYLPV 446 (534)
Q Consensus 367 ~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~ 446 (534)
.++|+|+|||++|||+.|+.||.+...... +... +-..+.-......+..+.+|+.+.+..||+
T Consensus 314 sAVDWWtfGIflYEmLyG~TPFKG~~~~~T---l~NI-------------v~~~l~Fp~~~~vs~~akDLIr~LLvKdP~ 377 (459)
T KOG0610|consen 314 SAVDWWTFGIFLYEMLYGTTPFKGSNNKET---LRNI-------------VGQPLKFPEEPEVSSAAKDLIRKLLVKDPS 377 (459)
T ss_pred chhhHHHHHHHHHHHHhCCCCcCCCCchhh---HHHH-------------hcCCCcCCCCCcchhHHHHHHHHHhccChh
Confidence 999999999999999999999986543211 1111 111111111123456889999999999999
Q ss_pred CCCChHHHHHHhhc
Q 039819 447 HRPKMSEVVRMLEG 460 (534)
Q Consensus 447 ~RPt~~ev~~~L~~ 460 (534)
+|-...-=+..+++
T Consensus 378 kRlg~~rGA~eIK~ 391 (459)
T KOG0610|consen 378 KRLGSKRGAAEIKR 391 (459)
T ss_pred hhhccccchHHhhc
Confidence 99984433333333
|
|
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-37 Score=304.61 Aligned_cols=240 Identities=26% Similarity=0.441 Sum_probs=190.9
Q ss_pred HhCCCcCCeeccCCcEEEEEEEEC------CCcEEEEEEehh---------------hhhhcccCceeeEEEEEeCCCee
Q 039819 201 TENFSSKNILGAGGFGNVYKGKLG------DGTVLAVKRLKD---------------MISLAVHRNLLRLIGYCATPTER 259 (534)
Q Consensus 201 ~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~---------------~l~~~~h~niv~l~~~~~~~~~~ 259 (534)
.++|+..+.||+|+||.||+|+.. ++..||+|.+.. +++.+.||||+++++++......
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~ 83 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM 83 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence 467888899999999999999863 467899998742 56777899999999999999999
Q ss_pred EEEeeccCCCChhhhcccC----------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCc
Q 039819 260 LLVYPYMSNGSVASRLREK----------------------PALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAAN 317 (534)
Q Consensus 260 ~lv~e~~~~gsL~~~l~~~----------------------~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~N 317 (534)
++||||+++|+|.+++... ..+++..++.++.|++.||.|||+. +++||||||+|
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~---~i~H~dl~p~n 160 (288)
T cd05050 84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLATRN 160 (288)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CeecccccHhh
Confidence 9999999999999998632 2478889999999999999999998 99999999999
Q ss_pred EEeCCCCcEEEEecccceecCCCCC-ceeeccccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCcCCCcccc
Q 039819 318 VLLDDFCEAIVGDFGLAKLLDHSDS-HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GMRALEFGKSIN 395 (534)
Q Consensus 318 iLl~~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~ellt-G~~p~~~~~~~~ 395 (534)
|+++.++.++|+|||++........ ........+..|+|||++.+..++.++|||||||++|||++ |..||.....
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~-- 238 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAH-- 238 (288)
T ss_pred eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH--
Confidence 9999999999999999886533221 11122234667999999988889999999999999999998 8888853221
Q ss_pred ccchHHHHHHHHhhhcccceecccccCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhc
Q 039819 396 QKGAMLEWVKKIQQEKKVEVLVDRELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLEG 460 (534)
Q Consensus 396 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~ 460 (534)
.++........ .. ..+...+.++.+++.+|++.+|++||++.|+++.|+.
T Consensus 239 -----~~~~~~~~~~~-~~---------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 239 -----EEVIYYVRDGN-VL---------SCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred -----HHHHHHHhcCC-CC---------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 12222221111 00 0111234578999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=310.20 Aligned_cols=247 Identities=24% Similarity=0.315 Sum_probs=185.5
Q ss_pred HHHhCCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEeh----------------hhhhhcccCceeeEEEEEeCC-----
Q 039819 199 QATENFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLK----------------DMISLAVHRNLLRLIGYCATP----- 256 (534)
Q Consensus 199 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~----------------~~l~~~~h~niv~l~~~~~~~----- 256 (534)
...++|...+.||+|+||.||+|... ++..||||++. +++..++||||+++++++...
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07878 12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN 91 (343)
T ss_pred hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence 35678999999999999999999864 67899999874 257788899999999987543
Q ss_pred -CeeEEEeeccCCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccce
Q 039819 257 -TERLLVYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAK 335 (534)
Q Consensus 257 -~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~ 335 (534)
...++++|++ +++|.+++.. ..+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus 92 ~~~~~~~~~~~-~~~l~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~ 166 (343)
T cd07878 92 FNEVYLVTNLM-GADLNNIVKC-QKLSDEHVQFLIYQLLRGLKYIHSA---GIIHRDLKPSNVAVNEDCELRILDFGLAR 166 (343)
T ss_pred cCcEEEEeecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhhEEECCCCCEEEcCCccce
Confidence 3468999998 7788877754 4699999999999999999999999 99999999999999999999999999998
Q ss_pred ecCCCCCceeecccccccccccccccc-CCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHH--------H
Q 039819 336 LLDHSDSHVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVK--------K 406 (534)
Q Consensus 336 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~--------~ 406 (534)
..... .....||..|+|||++.+ ..++.++|||||||++|||++|+.||...........+..... .
T Consensus 167 ~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (343)
T cd07878 167 QADDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKK 242 (343)
T ss_pred ecCCC----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 76432 234568999999999876 5688999999999999999999999975432211111111100 0
Q ss_pred HhhhcccceecccccCCCCC-------HHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 407 IQQEKKVEVLVDRELGSNYD-------RIEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 407 ~~~~~~~~~~~d~~l~~~~~-------~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
..... ..... ..+..... ......+.+++.+|++.||.+|||+.|+++
T Consensus 243 ~~~~~-~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~ 297 (343)
T cd07878 243 ISSEH-ARKYI-QSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALA 297 (343)
T ss_pred cchhh-HHHHh-hccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 00000 00000 00000000 001235789999999999999999999985
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-37 Score=305.53 Aligned_cols=235 Identities=20% Similarity=0.317 Sum_probs=190.2
Q ss_pred hCCCcCCeeccCCcEEEEEEEE-CCCcEEEEEEeh--------------hhhhhcccCceeeEEEEEeCCCeeEEEeecc
Q 039819 202 ENFSSKNILGAGGFGNVYKGKL-GDGTVLAVKRLK--------------DMISLAVHRNLLRLIGYCATPTERLLVYPYM 266 (534)
Q Consensus 202 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~--------------~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~ 266 (534)
.+|...+.||+|+||.||+|.. .++..||+|.+. .++..+.|+|++++++.+......++||||+
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~ 99 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeeccc
Confidence 4677888999999999999986 468899999774 2567778999999999999999999999999
Q ss_pred CCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCCceee
Q 039819 267 SNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTT 346 (534)
Q Consensus 267 ~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~ 346 (534)
++++|.+++... .+++.++..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++........ ...
T Consensus 100 ~~~~L~~~~~~~-~~~~~~~~~i~~ql~~aL~~LH~~---gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~-~~~ 174 (296)
T cd06654 100 AGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-KRS 174 (296)
T ss_pred CCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEECccccchhcccccc-ccC
Confidence 999999988643 589999999999999999999998 999999999999999999999999999886543221 122
Q ss_pred ccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceecccccCCCCC
Q 039819 347 AVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELGSNYD 426 (534)
Q Consensus 347 ~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 426 (534)
...|+..|+|||++.+..++.++|||||||++|||++|+.||...... ..+... ..... +.+ ..+
T Consensus 175 ~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~------~~~~~~-~~~~~------~~~--~~~ 239 (296)
T cd06654 175 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL------RALYLI-ATNGT------PEL--QNP 239 (296)
T ss_pred cccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHH------HhHHHH-hcCCC------CCC--CCc
Confidence 345889999999998888899999999999999999999999643211 111111 11000 000 111
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 427 RIEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 427 ~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
......+.+++.+|+..+|++||++.++++
T Consensus 240 ~~~~~~l~~li~~~l~~~p~~Rpt~~eil~ 269 (296)
T cd06654 240 EKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (296)
T ss_pred cccCHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence 223457889999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-37 Score=313.37 Aligned_cols=240 Identities=27% Similarity=0.420 Sum_probs=185.9
Q ss_pred hCCCcCCeeccCCcEEEEEEEE------CCCcEEEEEEehh---------------hhhhc-ccCceeeEEEEEeCC-Ce
Q 039819 202 ENFSSKNILGAGGFGNVYKGKL------GDGTVLAVKRLKD---------------MISLA-VHRNLLRLIGYCATP-TE 258 (534)
Q Consensus 202 ~~~~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~---------------~l~~~-~h~niv~l~~~~~~~-~~ 258 (534)
++|...+.||+|+||.||+|.. .+++.||||+++. .+..+ +|+||++++++|... ..
T Consensus 7 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 86 (343)
T cd05103 7 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP 86 (343)
T ss_pred hHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCCc
Confidence 5788899999999999999973 3568899998752 34455 689999999988765 45
Q ss_pred eEEEeeccCCCChhhhcccC------------------------------------------------------------
Q 039819 259 RLLVYPYMSNGSVASRLREK------------------------------------------------------------ 278 (534)
Q Consensus 259 ~~lv~e~~~~gsL~~~l~~~------------------------------------------------------------ 278 (534)
.++||||+++|+|.++++..
T Consensus 87 ~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (343)
T cd05103 87 LMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEA 166 (343)
T ss_pred eEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhh
Confidence 78999999999999887532
Q ss_pred -------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCC-ceeecccc
Q 039819 279 -------PALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDS-HVTTAVRG 350 (534)
Q Consensus 279 -------~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~-~~~~~~~g 350 (534)
..+++..+..++.|+++||+|||+. +|+||||||+|||++.++.+||+|||++........ .......+
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 243 (343)
T cd05103 167 EQEDLYKKVLTLEDLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL 243 (343)
T ss_pred hhhhhhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCC
Confidence 2368888999999999999999998 999999999999999999999999999986533221 11122345
Q ss_pred ccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCcCCCccccccchHHHHHHHHhhhcccceecccccCCCCCHHH
Q 039819 351 TVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELGSNYDRIE 429 (534)
Q Consensus 351 t~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 429 (534)
+..|+|||++.+..++.++|||||||++|||++ |..||...... ............ ... +...
T Consensus 244 ~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~------~~~~~~~~~~~~------~~~----~~~~ 307 (343)
T cd05103 244 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID------EEFCRRLKEGTR------MRA----PDYT 307 (343)
T ss_pred CcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCcccc------HHHHHHHhccCC------CCC----CCCC
Confidence 678999999988889999999999999999997 99998643211 011111111110 001 1112
Q ss_pred HHHHHHHHHHhcccCCCCCCChHHHHHHhhc
Q 039819 430 VGEILQVALLCTQYLPVHRPKMSEVVRMLEG 460 (534)
Q Consensus 430 ~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~ 460 (534)
...+.+++..|++.+|++||++.||++.|+.
T Consensus 308 ~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~ 338 (343)
T cd05103 308 TPEMYQTMLDCWHGEPSQRPTFSELVEHLGN 338 (343)
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 3478899999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=299.32 Aligned_cols=237 Identities=24% Similarity=0.354 Sum_probs=190.0
Q ss_pred CCCcCCeeccCCcEEEEEEEECC--CcEEEEEEehh------------------------hh-hhcccCceeeEEEEEeC
Q 039819 203 NFSSKNILGAGGFGNVYKGKLGD--GTVLAVKRLKD------------------------MI-SLAVHRNLLRLIGYCAT 255 (534)
Q Consensus 203 ~~~~~~~lG~G~~g~Vy~~~~~~--~~~vavK~~~~------------------------~l-~~~~h~niv~l~~~~~~ 255 (534)
+|+..+.||+|+||.||+|.... +..+|+|.+.. ++ +.++|+||+++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 46777889999999999999865 68899997631 12 34789999999999999
Q ss_pred CCeeEEEeeccCCCChhhhcc----cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEec
Q 039819 256 PTERLLVYPYMSNGSVASRLR----EKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDF 331 (534)
Q Consensus 256 ~~~~~lv~e~~~~gsL~~~l~----~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DF 331 (534)
.+..++||||+++++|.+++. ....+++..++.++.|++.||.|||+.. +++|+||||+||+++.++.+||+||
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--~i~H~dl~~~nil~~~~~~~~l~df 158 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEK--RIVHRDLTPNNIMLGEDDKVTITDF 158 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCC--ceeecCCCHHHEEECCCCcEEEecc
Confidence 999999999999999998874 3456899999999999999999999631 7999999999999999999999999
Q ss_pred ccceecCCCCCceeeccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhc
Q 039819 332 GLAKLLDHSDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEK 411 (534)
Q Consensus 332 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 411 (534)
|++....... ......|+..|+|||++.+..++.++||||||+++|||++|+.||..... ...........
T Consensus 159 g~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~-------~~~~~~~~~~~ 229 (269)
T cd08528 159 GLAKQKQPES--KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNM-------LSLATKIVEAV 229 (269)
T ss_pred cceeeccccc--ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCH-------HHHHHHHhhcc
Confidence 9998765432 23445688999999999988899999999999999999999999863221 11111111110
Q ss_pred ccceecccccCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhh
Q 039819 412 KVEVLVDRELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLE 459 (534)
Q Consensus 412 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~ 459 (534)
. .+ .........+.+++.+|++.+|++||++.||.++++
T Consensus 230 -~----~~----~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 230 -Y----EP----LPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred -C----Cc----CCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 0 00 011122457889999999999999999999999876
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=298.06 Aligned_cols=236 Identities=23% Similarity=0.366 Sum_probs=191.4
Q ss_pred CCCcCCeeccCCcEEEEEEEECCCcEEEEEEeh--------------------hhhhhcccCceeeEEEEEeCCCeeEEE
Q 039819 203 NFSSKNILGAGGFGNVYKGKLGDGTVLAVKRLK--------------------DMISLAVHRNLLRLIGYCATPTERLLV 262 (534)
Q Consensus 203 ~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~--------------------~~l~~~~h~niv~l~~~~~~~~~~~lv 262 (534)
+|...+.||+|+||.||+|...++..+|||.+. +.++.++|+||++++++|.+....++|
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 467788999999999999998889999999763 156778899999999999999999999
Q ss_pred eeccCCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCC-
Q 039819 263 YPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSD- 341 (534)
Q Consensus 263 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~- 341 (534)
|||+++++|.+++.....+++..+..++.|++.||+|||+. +|+|+||||+||+++.++.++|+|||++.......
T Consensus 81 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 157 (265)
T cd06631 81 MEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNN---CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGL 157 (265)
T ss_pred EecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHhEEECCCCeEEeccchhhHhhhhccc
Confidence 99999999999998777899999999999999999999998 99999999999999999999999999987653211
Q ss_pred ----CceeeccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceec
Q 039819 342 ----SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLV 417 (534)
Q Consensus 342 ----~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 417 (534)
........|+..|+|||++.+..++.++|||||||++|||+||+.||...... ............
T Consensus 158 ~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~------~~~~~~~~~~~~----- 226 (265)
T cd06631 158 HGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRL------AAMFYIGAHRGL----- 226 (265)
T ss_pred cccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChH------HHHHHhhhccCC-----
Confidence 11122345889999999998888999999999999999999999999642211 011000000000
Q ss_pred ccccCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 418 DRELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 418 d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
.+.+. ......+.+++.+|++.+|.+||++.+++.
T Consensus 227 ~~~~~----~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 227 MPRLP----DSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred CCCCC----CCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 11111 123457899999999999999999999875
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=302.43 Aligned_cols=230 Identities=25% Similarity=0.362 Sum_probs=184.7
Q ss_pred CCcCCeeccCCcEEEEEEEEC-CCcEEEEEEeh-----------------hhhhhcccCceeeEEEEEeCCCeeEEEeec
Q 039819 204 FSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLK-----------------DMISLAVHRNLLRLIGYCATPTERLLVYPY 265 (534)
Q Consensus 204 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~-----------------~~l~~~~h~niv~l~~~~~~~~~~~lv~e~ 265 (534)
|+..+.||+|+||+||+|... +++.||+|.+. +++..++|+||+++.+++...+..++||||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 566788999999999999875 68899999863 256678899999999999999999999999
Q ss_pred cCCCChhhhccc--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCCc
Q 039819 266 MSNGSVASRLRE--KPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSH 343 (534)
Q Consensus 266 ~~~gsL~~~l~~--~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~ 343 (534)
+++++|.+++.. ...+++..+..++.|++.||.|||+. +|+||||||+||+++.++.++|+|||++.......
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~---~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~-- 156 (285)
T cd05632 82 MNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE-- 156 (285)
T ss_pred ccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEECCCCCEEEecCCcceecCCCC--
Confidence 999999988854 34699999999999999999999998 99999999999999999999999999997654322
Q ss_pred eeeccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceecccccCC
Q 039819 344 VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELGS 423 (534)
Q Consensus 344 ~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 423 (534)
......|+..|+|||++.+..++.++|||||||++|||+||+.||....... ....+........ .
T Consensus 157 ~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~---~~~~~~~~~~~~~-----------~ 222 (285)
T cd05632 157 SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKV---KREEVDRRVLETE-----------E 222 (285)
T ss_pred cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHhhhccc-----------c
Confidence 1233468999999999988889999999999999999999999997432211 0111111111100 0
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCChH
Q 039819 424 NYDRIEVGEILQVALLCTQYLPVHRPKMS 452 (534)
Q Consensus 424 ~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ 452 (534)
.+.......+.+++.+|++.+|++||++.
T Consensus 223 ~~~~~~~~~~~~li~~~l~~~P~~R~~~~ 251 (285)
T cd05632 223 VYSAKFSEEAKSICKMLLTKDPKQRLGCQ 251 (285)
T ss_pred ccCccCCHHHHHHHHHHccCCHhHcCCCc
Confidence 11122244778999999999999999954
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=307.87 Aligned_cols=239 Identities=28% Similarity=0.442 Sum_probs=188.1
Q ss_pred hCCCcCCeeccCCcEEEEEEEEC--------CCcEEEEEEehh---------------hhhhc-ccCceeeEEEEEeCCC
Q 039819 202 ENFSSKNILGAGGFGNVYKGKLG--------DGTVLAVKRLKD---------------MISLA-VHRNLLRLIGYCATPT 257 (534)
Q Consensus 202 ~~~~~~~~lG~G~~g~Vy~~~~~--------~~~~vavK~~~~---------------~l~~~-~h~niv~l~~~~~~~~ 257 (534)
++|...+.||+|+||.||+|+.. ....+|+|.+.. ++..+ .||||++++++|....
T Consensus 12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (314)
T cd05099 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEG 91 (314)
T ss_pred HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCC
Confidence 56778899999999999999742 345789997652 34445 5999999999999999
Q ss_pred eeEEEeeccCCCChhhhcccC----------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeC
Q 039819 258 ERLLVYPYMSNGSVASRLREK----------------PALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLD 321 (534)
Q Consensus 258 ~~~lv~e~~~~gsL~~~l~~~----------------~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~ 321 (534)
..++||||+++|+|.+++... ..+++.++.+++.|++.||.|||+. +++||||||+|||++
T Consensus 92 ~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nill~ 168 (314)
T cd05099 92 PLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR---RCIHRDLAARNVLVT 168 (314)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC---CeeeccccceeEEEc
Confidence 999999999999999998642 3489999999999999999999998 999999999999999
Q ss_pred CCCcEEEEecccceecCCCCCce-eeccccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCcCCCccccccch
Q 039819 322 DFCEAIVGDFGLAKLLDHSDSHV-TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GMRALEFGKSINQKGA 399 (534)
Q Consensus 322 ~~~~~kl~DFGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~ellt-G~~p~~~~~~~~~~~~ 399 (534)
.++.+||+|||+++......... .....++..|+|||++.+..++.++|||||||++|||++ |+.||.....
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~------ 242 (314)
T cd05099 169 EDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPV------ 242 (314)
T ss_pred CCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCH------
Confidence 99999999999998664322111 111224467999999988889999999999999999999 8888863221
Q ss_pred HHHHHHHHhhhcccceecccccCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhc
Q 039819 400 MLEWVKKIQQEKKVEVLVDRELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLEG 460 (534)
Q Consensus 400 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~ 460 (534)
.+........... ..+...+..+.+++.+|++.+|++||++.++++.|+.
T Consensus 243 -~~~~~~~~~~~~~----------~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~ 292 (314)
T cd05099 243 -EELFKLLREGHRM----------DKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDK 292 (314)
T ss_pred -HHHHHHHHcCCCC----------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHH
Confidence 1111111111100 1112234578899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=297.15 Aligned_cols=232 Identities=34% Similarity=0.510 Sum_probs=190.2
Q ss_pred CeeccCCcEEEEEEEECC----CcEEEEEEehh---------------hhhhcccCceeeEEEEEeCCCeeEEEeeccCC
Q 039819 208 NILGAGGFGNVYKGKLGD----GTVLAVKRLKD---------------MISLAVHRNLLRLIGYCATPTERLLVYPYMSN 268 (534)
Q Consensus 208 ~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~---------------~l~~~~h~niv~l~~~~~~~~~~~lv~e~~~~ 268 (534)
+.||+|+||.||+|.... +..||+|.+.. .+..+.|+||+++++++......++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 468999999999999864 78899998752 56677899999999999999999999999999
Q ss_pred CChhhhcccC---------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCC
Q 039819 269 GSVASRLREK---------PALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDH 339 (534)
Q Consensus 269 gsL~~~l~~~---------~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~ 339 (534)
++|.+++... ..+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||.+.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcC---CcccCccCcceEEECCCCcEEEccccccccccc
Confidence 9999999864 7799999999999999999999998 999999999999999999999999999987654
Q ss_pred CCC-ceeeccccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCcCCCccccccchHHHHHHHHhhhcccceec
Q 039819 340 SDS-HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLV 417 (534)
Q Consensus 340 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 417 (534)
... .......++..|+|||.+....++.++|||||||++|||++ |+.||..... .+..........
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~-------~~~~~~~~~~~~----- 225 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSN-------EEVLEYLRKGYR----- 225 (262)
T ss_pred ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCH-------HHHHHHHHcCCC-----
Confidence 321 12233457889999999988889999999999999999999 6999874321 111111111100
Q ss_pred ccccCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhh
Q 039819 418 DRELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLE 459 (534)
Q Consensus 418 d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~ 459 (534)
...+...+..+.+++.+|++.+|++||++.|+++.|+
T Consensus 226 -----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 226 -----LPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred -----CCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 0112222558899999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=335.27 Aligned_cols=241 Identities=21% Similarity=0.324 Sum_probs=188.7
Q ss_pred hCCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEehh-----------------hhhhcccCceeeEEEEEeCCCeeEEEe
Q 039819 202 ENFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLKD-----------------MISLAVHRNLLRLIGYCATPTERLLVY 263 (534)
Q Consensus 202 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~-----------------~l~~~~h~niv~l~~~~~~~~~~~lv~ 263 (534)
++|...+.||+|+||.||+|... .++.||||++.. +++.++||||+++++++.+.+..++||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 57888999999999999999975 589999998742 567788999999999999999999999
Q ss_pred eccCCCChhhhccc-----------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecc
Q 039819 264 PYMSNGSVASRLRE-----------KPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFG 332 (534)
Q Consensus 264 e~~~~gsL~~~l~~-----------~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFG 332 (534)
||+++|+|.+++.. ...+++..+++++.|+++||+|||+. +|+||||||+|||++.++.+||+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~---GIIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC---CccccCCchheEEEcCCCCEEEEecC
Confidence 99999999998852 12456778899999999999999998 99999999999999999999999999
Q ss_pred cceecCCCCC-----------------ceeeccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCcccc
Q 039819 333 LAKLLDHSDS-----------------HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSIN 395 (534)
Q Consensus 333 la~~~~~~~~-----------------~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~ 395 (534)
+++....... .......||+.|+|||++.+..++.++|||||||++|||+||+.||......
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~- 237 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGR- 237 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchh-
Confidence 9987621110 0112346999999999999999999999999999999999999999742211
Q ss_pred ccchHHHHHHHHhhhcccceecccccCCCCCHHHHHHHHHHHHHhcccCCCCCC-ChHHHHHHhhc
Q 039819 396 QKGAMLEWVKKIQQEKKVEVLVDRELGSNYDRIEVGEILQVALLCTQYLPVHRP-KMSEVVRMLEG 460 (534)
Q Consensus 396 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RP-t~~ev~~~L~~ 460 (534)
.+ .+... ..++.-.. .....+..+.+++.+|++.+|++|| +++++.+.|+.
T Consensus 238 ---ki-~~~~~---------i~~P~~~~-p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~ 289 (932)
T PRK13184 238 ---KI-SYRDV---------ILSPIEVA-PYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEP 289 (932)
T ss_pred ---hh-hhhhh---------ccChhhcc-ccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 00 00000 00000000 0112245788999999999999996 56666666654
|
|
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=299.19 Aligned_cols=241 Identities=23% Similarity=0.335 Sum_probs=189.6
Q ss_pred HHHHHhCCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEeh--------------hhhhhcccCceeeEEEEEeCCCeeEE
Q 039819 197 LQQATENFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLK--------------DMISLAVHRNLLRLIGYCATPTERLL 261 (534)
Q Consensus 197 l~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~--------------~~l~~~~h~niv~l~~~~~~~~~~~l 261 (534)
++.+++++.....||+|+||.||+|... ++..||+|.+. .++..++|+||+++++++...+..++
T Consensus 3 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 82 (268)
T cd06624 3 YEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKI 82 (268)
T ss_pred cccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEE
Confidence 3445667777789999999999999865 67889999764 26778899999999999999999999
Q ss_pred EeeccCCCChhhhcccC-CCC--CHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCC-CCcEEEEecccceec
Q 039819 262 VYPYMSNGSVASRLREK-PAL--DWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDD-FCEAIVGDFGLAKLL 337 (534)
Q Consensus 262 v~e~~~~gsL~~~l~~~-~~l--~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~-~~~~kl~DFGla~~~ 337 (534)
||||+++++|.+++... ..+ ++..+..++.|++.||+|||+. +|+||||||+||+++. ++.++|+|||++...
T Consensus 83 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~ 159 (268)
T cd06624 83 FMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRL 159 (268)
T ss_pred EEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCeEEEecchhheec
Confidence 99999999999999754 445 8888999999999999999998 9999999999999986 679999999999865
Q ss_pred CCCCCceeeccccccccccccccccCC--CCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccce
Q 039819 338 DHSDSHVTTAVRGTVGHIAPEYLSTGQ--SSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEV 415 (534)
Q Consensus 338 ~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 415 (534)
..... ......|+..|+|||++.+.. ++.++|||||||++|||++|+.||...... ....|......
T Consensus 160 ~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~----~~~~~~~~~~~------ 228 (268)
T cd06624 160 AGINP-CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEP----QAAMFKVGMFK------ 228 (268)
T ss_pred ccCCC-ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccCh----hhhHhhhhhhc------
Confidence 43222 122345889999999986543 788999999999999999999998632110 01111100000
Q ss_pred ecccccCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 416 LVDRELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 416 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
.....+.....++.+++.+|++.+|.+||++.|++.
T Consensus 229 -----~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 264 (268)
T cd06624 229 -----IHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQ 264 (268)
T ss_pred -----cCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence 011122233457889999999999999999999985
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=305.80 Aligned_cols=251 Identities=24% Similarity=0.351 Sum_probs=191.3
Q ss_pred hCCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEeh----------------hhhhhcccCceeeEEEEEeCCCeeEEEee
Q 039819 202 ENFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLK----------------DMISLAVHRNLLRLIGYCATPTERLLVYP 264 (534)
Q Consensus 202 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~----------------~~l~~~~h~niv~l~~~~~~~~~~~lv~e 264 (534)
++|+..+.||+|+||.||+|... +++.||+|++. +++..++||||+++++++......++|||
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 36788899999999999999986 58999999764 25667889999999999999999999999
Q ss_pred ccCCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCCce
Q 039819 265 YMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHV 344 (534)
Q Consensus 265 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~ 344 (534)
|+++++|..+......+++..++.++.|++.||+|||+. +++||||+|+||++++++.++|+|||++....... ..
T Consensus 81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~-~~ 156 (286)
T cd07846 81 FVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG-EV 156 (286)
T ss_pred cCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc-cc
Confidence 999999988877666799999999999999999999998 99999999999999999999999999998764432 22
Q ss_pred eecccccccccccccccc-CCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhh-------c-ccce
Q 039819 345 TTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQE-------K-KVEV 415 (534)
Q Consensus 345 ~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~-------~-~~~~ 415 (534)
.....++..|+|||++.+ ..++.++|||||||++|||++|++||...........+..+....... . ....
T Consensus 157 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (286)
T cd07846 157 YTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAG 236 (286)
T ss_pred cCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhc
Confidence 233457899999999865 447889999999999999999999987443221111111111100000 0 0000
Q ss_pred ecccccCCCC-----CHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 416 LVDRELGSNY-----DRIEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 416 ~~d~~l~~~~-----~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
...+...... ....+..+.+++.+|++.+|++||++.++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 237 MRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred cccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 0000000000 0112457899999999999999999999885
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=300.77 Aligned_cols=239 Identities=27% Similarity=0.384 Sum_probs=191.0
Q ss_pred hCCCcCCeeccCCcEEEEEEEEC------CCcEEEEEEeh---------------hhhhhcccCceeeEEEEEeCCCeeE
Q 039819 202 ENFSSKNILGAGGFGNVYKGKLG------DGTVLAVKRLK---------------DMISLAVHRNLLRLIGYCATPTERL 260 (534)
Q Consensus 202 ~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~---------------~~l~~~~h~niv~l~~~~~~~~~~~ 260 (534)
++|+..+.||+|+||.||+|+.. +...||+|.+. +++..+.|+||+++++++.+....+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 57888899999999999999863 34679999763 2577889999999999999999999
Q ss_pred EEeeccCCCChhhhcccCC---------CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEec
Q 039819 261 LVYPYMSNGSVASRLREKP---------ALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDF 331 (534)
Q Consensus 261 lv~e~~~~gsL~~~l~~~~---------~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DF 331 (534)
+||||+++|+|.+++.... .+++..+..++.|++.||.|||+. +|+||||||+||+++.++.++|+||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc---CcccCcCccceEEEeCCCcEEEccc
Confidence 9999999999999997544 689999999999999999999998 9999999999999999999999999
Q ss_pred ccceecCCCCCceeeccccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCcCCCccccccchHHHHHHHHhhh
Q 039819 332 GLAKLLDHSDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GMRALEFGKSINQKGAMLEWVKKIQQE 410 (534)
Q Consensus 332 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~ 410 (534)
|++...............++..|+|||.+.+..++.++|||||||++|||++ |..||..... ...+.....
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~-------~~~~~~~~~- 233 (275)
T cd05046 162 SLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSD-------EEVLNRLQA- 233 (275)
T ss_pred ccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccch-------HHHHHHHHc-
Confidence 9987553322222223346778999999988888999999999999999999 7888853211 111111111
Q ss_pred cccceecccccCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhh
Q 039819 411 KKVEVLVDRELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLE 459 (534)
Q Consensus 411 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~ 459 (534)
.... .......+..+.+++.+|++.+|++||++.|++..|.
T Consensus 234 ~~~~--------~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 234 GKLE--------LPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred CCcC--------CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 1100 0011123458899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=300.54 Aligned_cols=245 Identities=24% Similarity=0.405 Sum_probs=190.5
Q ss_pred CCCcCCeeccCCcEEEEEEEE-----CCCcEEEEEEeh---------------hhhhhcccCceeeEEEEEeCC--CeeE
Q 039819 203 NFSSKNILGAGGFGNVYKGKL-----GDGTVLAVKRLK---------------DMISLAVHRNLLRLIGYCATP--TERL 260 (534)
Q Consensus 203 ~~~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~---------------~~l~~~~h~niv~l~~~~~~~--~~~~ 260 (534)
.|...+.||+|+||.||.+++ .++..||+|.+. .+++.+.|||++++.+++... ...+
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIK 84 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceE
Confidence 467788999999999999985 357889999875 257888999999999999875 5678
Q ss_pred EEeeccCCCChhhhcccC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCC
Q 039819 261 LVYPYMSNGSVASRLREK-PALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDH 339 (534)
Q Consensus 261 lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~ 339 (534)
+||||+++++|.+++... ..+++..+..++.|++.||+|||+. +++||||||+||+++.++.++|+|||+++....
T Consensus 85 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~ 161 (284)
T cd05079 85 LIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIET 161 (284)
T ss_pred EEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccchheEEEcCCCCEEECCCcccccccc
Confidence 999999999999998654 4689999999999999999999998 999999999999999999999999999987643
Q ss_pred CCCc--eeeccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccc--------cccchHHHHHHHHhh
Q 039819 340 SDSH--VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSI--------NQKGAMLEWVKKIQQ 409 (534)
Q Consensus 340 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~--------~~~~~~~~~~~~~~~ 409 (534)
.... ......++..|+|||++.+..++.++|||||||++|||+|++.|....... ........++.....
T Consensus 162 ~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (284)
T cd05079 162 DKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEE 241 (284)
T ss_pred CccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHHHc
Confidence 3221 122345677899999998888999999999999999999988765321100 000011111111111
Q ss_pred hcccceecccccCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhc
Q 039819 410 EKKVEVLVDRELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLEG 460 (534)
Q Consensus 410 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~ 460 (534)
... .......+..+.+++.+|++.+|.+||++.++++.|+.
T Consensus 242 ~~~----------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~ 282 (284)
T cd05079 242 GKR----------LPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEA 282 (284)
T ss_pred Ccc----------CCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHh
Confidence 100 01111234589999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=304.85 Aligned_cols=181 Identities=24% Similarity=0.362 Sum_probs=149.9
Q ss_pred CCeeccCCcEEEEEEEEC---CCcEEEEEEeh------------hhhhhcccCceeeEEEEEeC--CCeeEEEeeccCCC
Q 039819 207 KNILGAGGFGNVYKGKLG---DGTVLAVKRLK------------DMISLAVHRNLLRLIGYCAT--PTERLLVYPYMSNG 269 (534)
Q Consensus 207 ~~~lG~G~~g~Vy~~~~~---~~~~vavK~~~------------~~l~~~~h~niv~l~~~~~~--~~~~~lv~e~~~~g 269 (534)
.+.||+|+||.||+|+.. +++.||+|.+. .+++.++||||+++++++.. ....++||||+.+
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~- 84 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEH- 84 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCCcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccCC-
Confidence 357999999999999864 46789999875 26788899999999998854 4567899999864
Q ss_pred Chhhhccc---------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEe----CCCCcEEEEeccccee
Q 039819 270 SVASRLRE---------KPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLL----DDFCEAIVGDFGLAKL 336 (534)
Q Consensus 270 sL~~~l~~---------~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl----~~~~~~kl~DFGla~~ 336 (534)
+|.+++.. ...+++..+..++.|++.||.|||++ +|+||||||+|||+ +..+.+||+|||+++.
T Consensus 85 ~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~ 161 (317)
T cd07868 85 DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARL 161 (317)
T ss_pred CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEecCCCCcCcEEEeecCceec
Confidence 77776642 22589999999999999999999999 99999999999999 4668999999999987
Q ss_pred cCCCCC--ceeecccccccccccccccc-CCCCcchhHHHHHHHHHHHHhCCCCcCCC
Q 039819 337 LDHSDS--HVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELITGMRALEFG 391 (534)
Q Consensus 337 ~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~S~Gvvl~elltG~~p~~~~ 391 (534)
...... .......||+.|+|||++.+ ..++.++||||+||++|||+||++||...
T Consensus 162 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~ 219 (317)
T cd07868 162 FNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred cCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence 643221 12234568999999999876 45889999999999999999999999643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=300.33 Aligned_cols=239 Identities=27% Similarity=0.428 Sum_probs=189.8
Q ss_pred hCCCcCCeeccCCcEEEEEEEECC-C---cEEEEEEehh---------------hhhhcccCceeeEEEEEeCCCeeEEE
Q 039819 202 ENFSSKNILGAGGFGNVYKGKLGD-G---TVLAVKRLKD---------------MISLAVHRNLLRLIGYCATPTERLLV 262 (534)
Q Consensus 202 ~~~~~~~~lG~G~~g~Vy~~~~~~-~---~~vavK~~~~---------------~l~~~~h~niv~l~~~~~~~~~~~lv 262 (534)
.+|+..+.||+|+||.||+|.... + ..||||.+.. .+..+.||||+++.+++.+....++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 83 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII 83 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence 356778899999999999998743 2 4699998752 46778899999999999999999999
Q ss_pred eeccCCCChhhhccc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCC
Q 039819 263 YPYMSNGSVASRLRE-KPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSD 341 (534)
Q Consensus 263 ~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~ 341 (534)
|||+++|+|.+++.. .+.+++..++.++.|++.||.|||+. +++||||||+||+++.++.+||+|||+++......
T Consensus 84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~---g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~ 160 (269)
T cd05065 84 TEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT 160 (269)
T ss_pred EecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccChheEEEcCCCcEEECCCccccccccCc
Confidence 999999999999875 45689999999999999999999998 99999999999999999999999999998664322
Q ss_pred Cce--eeccc--cccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCcCCCccccccchHHHHHHHHhhhccccee
Q 039819 342 SHV--TTAVR--GTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GMRALEFGKSINQKGAMLEWVKKIQQEKKVEVL 416 (534)
Q Consensus 342 ~~~--~~~~~--gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 416 (534)
... ..... .+..|+|||++.+..++.++|||||||++|||++ |+.||...... .+..++. ....
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~----~~~~~i~---~~~~---- 229 (269)
T cd05065 161 SDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ----DVINAIE---QDYR---- 229 (269)
T ss_pred cccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHH----HHHHHHH---cCCc----
Confidence 211 11111 2457999999988899999999999999999886 99998643211 1222221 1100
Q ss_pred cccccCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhc
Q 039819 417 VDRELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLEG 460 (534)
Q Consensus 417 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~ 460 (534)
. ..+...+..+.+++.+|++.+|.+||+|.+|+..|+.
T Consensus 230 ----~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 267 (269)
T cd05065 230 ----L--PPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDK 267 (269)
T ss_pred ----C--CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHh
Confidence 0 0112234578899999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=301.44 Aligned_cols=242 Identities=25% Similarity=0.364 Sum_probs=193.9
Q ss_pred hCCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEeh---------------hhhhhcccCceeeEEEEEeCCCeeEEEeec
Q 039819 202 ENFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLK---------------DMISLAVHRNLLRLIGYCATPTERLLVYPY 265 (534)
Q Consensus 202 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~---------------~~l~~~~h~niv~l~~~~~~~~~~~lv~e~ 265 (534)
++|+..+.||+|+||.||++... +++.||+|.+. +++..++||||+++++++......++||||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF 84 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence 45677788999999999999875 58889999653 156778899999999999999999999999
Q ss_pred cCCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCCcee
Q 039819 266 MSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVT 345 (534)
Q Consensus 266 ~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~ 345 (534)
+++++|.+++...+.+++..+..++.+++.||.|||+.. +++||||||+||+++.++.++|+|||++....... .
T Consensus 85 ~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~---~ 159 (284)
T cd06620 85 MDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVH--RIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI---A 159 (284)
T ss_pred CCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhc--CeeccCCCHHHEEECCCCcEEEccCCcccchhhhc---c
Confidence 999999999988778999999999999999999999732 79999999999999999999999999987543221 2
Q ss_pred eccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCcccc----ccchHHHHHHHHhhhcccceeccccc
Q 039819 346 TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSIN----QKGAMLEWVKKIQQEKKVEVLVDREL 421 (534)
Q Consensus 346 ~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~d~~l 421 (534)
....|+..|+|||++.+..++.++|||||||++|||+||+.||....... ....+.++......... +.+
T Consensus 160 ~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~ 233 (284)
T cd06620 160 DTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPP------PRL 233 (284)
T ss_pred CccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccC------CCC
Confidence 23468999999999988889999999999999999999999997433211 11112233322221110 111
Q ss_pred CCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 039819 422 GSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRM 457 (534)
Q Consensus 422 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~ 457 (534)
. ....+..+.+++.+|++.+|.+||++.||+++
T Consensus 234 ~---~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~ 266 (284)
T cd06620 234 P---SSDFPEDLRDFVDACLLKDPTERPTPQQLCAM 266 (284)
T ss_pred C---chhcCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 1 11234578899999999999999999999975
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=295.20 Aligned_cols=236 Identities=26% Similarity=0.368 Sum_probs=192.3
Q ss_pred hCCCcCCeeccCCcEEEEEEEECC-CcEEEEEEehh------------hhhhcccCceeeEEEEEeCCCeeEEEeeccCC
Q 039819 202 ENFSSKNILGAGGFGNVYKGKLGD-GTVLAVKRLKD------------MISLAVHRNLLRLIGYCATPTERLLVYPYMSN 268 (534)
Q Consensus 202 ~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~------------~l~~~~h~niv~l~~~~~~~~~~~lv~e~~~~ 268 (534)
++|+..+.||+|+||.||+|...+ +..+|+|.+.. .+..++|+||+++++++......++++||+++
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~ 82 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCGA 82 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecCCC
Confidence 568888999999999999999865 78999998752 56777999999999999999999999999999
Q ss_pred CChhhhccc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCCceeec
Q 039819 269 GSVASRLRE-KPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTA 347 (534)
Q Consensus 269 gsL~~~l~~-~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~ 347 (534)
++|.+++.. ...+++..+..++.|++.||.|||+. +++||||+|+||+++.++.++|+|||++........ ....
T Consensus 83 ~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~-~~~~ 158 (256)
T cd06612 83 GSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA-KRNT 158 (256)
T ss_pred CcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEECCCCcEEEcccccchhcccCcc-cccc
Confidence 999999874 55789999999999999999999998 999999999999999999999999999987654321 2233
Q ss_pred cccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceecccccCCCCCH
Q 039819 348 VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELGSNYDR 427 (534)
Q Consensus 348 ~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 427 (534)
..|+..|+|||++.+..++.++|||||||++|||+||+.||....... .. ..... .. .+.. ..+.
T Consensus 159 ~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~------~~-~~~~~-~~-----~~~~--~~~~ 223 (256)
T cd06612 159 VIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMR------AI-FMIPN-KP-----PPTL--SDPE 223 (256)
T ss_pred ccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhh------hh-hhhcc-CC-----CCCC--Cchh
Confidence 457889999999988889999999999999999999999997432111 00 00000 00 0000 1112
Q ss_pred HHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 428 IEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 428 ~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
.....+.+++.+|++.+|++||++.||++
T Consensus 224 ~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 224 KWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred hcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 23457899999999999999999999985
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=293.98 Aligned_cols=232 Identities=29% Similarity=0.451 Sum_probs=186.8
Q ss_pred CeeccCCcEEEEEEEECCCcEEEEEEehh---------------hhhhcccCceeeEEEEEeCCCeeEEEeeccCCCChh
Q 039819 208 NILGAGGFGNVYKGKLGDGTVLAVKRLKD---------------MISLAVHRNLLRLIGYCATPTERLLVYPYMSNGSVA 272 (534)
Q Consensus 208 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~---------------~l~~~~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~ 272 (534)
+.||+|+||.||++...+++.||+|.+.. +++.+.|+||+++++++......++||||+++++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 36899999999999987799999997652 567788999999999999999999999999999999
Q ss_pred hhccc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCCcee-ecccc
Q 039819 273 SRLRE-KPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVT-TAVRG 350 (534)
Q Consensus 273 ~~l~~-~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~-~~~~g 350 (534)
+++.. ...+++..+..++.+++.||.|||++ +++||||||+||+++.++.+||+|||+++.......... ....+
T Consensus 81 ~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~ 157 (251)
T cd05041 81 TFLRKKKNRLTVKKLLQMSLDAAAGMEYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQI 157 (251)
T ss_pred HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCcc
Confidence 99864 45689999999999999999999998 999999999999999999999999999986542211111 11223
Q ss_pred ccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCcCCCccccccchHHHHHHHHhhhcccceecccccCCCCCHHH
Q 039819 351 TVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELGSNYDRIE 429 (534)
Q Consensus 351 t~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 429 (534)
+..|+|||++.++.++.++|||||||++|||+| |..||...... .......... ....+...
T Consensus 158 ~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~-------~~~~~~~~~~----------~~~~~~~~ 220 (251)
T cd05041 158 PIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQ-------QTRERIESGY----------RMPAPQLC 220 (251)
T ss_pred eeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHH-------HHHHHHhcCC----------CCCCCccC
Confidence 567999999988889999999999999999999 88888533211 1111111100 01112223
Q ss_pred HHHHHHHHHHhcccCCCCCCChHHHHHHhh
Q 039819 430 VGEILQVALLCTQYLPVHRPKMSEVVRMLE 459 (534)
Q Consensus 430 ~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~ 459 (534)
+..+.+++.+|++.+|.+||++.||++.|.
T Consensus 221 ~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 221 PEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred CHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 458999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=301.41 Aligned_cols=224 Identities=25% Similarity=0.370 Sum_probs=175.8
Q ss_pred eeccCCcEEEEEEEECC-------------------------CcEEEEEEehh--------------hhhhcccCceeeE
Q 039819 209 ILGAGGFGNVYKGKLGD-------------------------GTVLAVKRLKD--------------MISLAVHRNLLRL 249 (534)
Q Consensus 209 ~lG~G~~g~Vy~~~~~~-------------------------~~~vavK~~~~--------------~l~~~~h~niv~l 249 (534)
.||+|+||.||+|.+.. ...||+|.+.. +++.+.||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 58999999999997421 24588997742 5677889999999
Q ss_pred EEEEeCCCeeEEEeeccCCCChhhhccc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCC----
Q 039819 250 IGYCATPTERLLVYPYMSNGSVASRLRE-KPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFC---- 324 (534)
Q Consensus 250 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~---- 324 (534)
+++|.+....++||||+++|+|..++.. .+.+++..+..++.|+++||+|||++ +|+||||||+|||++..+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~Nill~~~~~~~~ 158 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDK---NLVHGNVCAKNILLARLGLAEG 158 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcC---CccCCCCCcccEEEeccCcccC
Confidence 9999999999999999999999999864 56789999999999999999999998 999999999999997644
Q ss_pred ---cEEEEecccceecCCCCCceeecccccccccccccccc-CCCCcchhHHHHHHHHHHH-HhCCCCcCCCccccccch
Q 039819 325 ---EAIVGDFGLAKLLDHSDSHVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLEL-ITGMRALEFGKSINQKGA 399 (534)
Q Consensus 325 ---~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~S~Gvvl~el-ltG~~p~~~~~~~~~~~~ 399 (534)
.+|++|||++...... ....++..|+|||++.+ ..++.++|||||||++||| ++|+.||...... .
T Consensus 159 ~~~~~kl~d~g~~~~~~~~-----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~----~ 229 (274)
T cd05076 159 TSPFIKLSDPGVSFTALSR-----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPS----E 229 (274)
T ss_pred ccceeeecCCccccccccc-----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChH----H
Confidence 3799999998654221 12346788999998865 5579999999999999999 4799998643211 1
Q ss_pred HHHHHHHHhhhcccceecccccCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhh
Q 039819 400 MLEWVKKIQQEKKVEVLVDRELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLE 459 (534)
Q Consensus 400 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~ 459 (534)
...+.. .. ...... ....+.+++.+||+.+|++||+|.+|++.|.
T Consensus 230 ~~~~~~---~~--------~~~~~~----~~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 230 KERFYE---KK--------HRLPEP----SCKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred HHHHHH---hc--------cCCCCC----CChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 111111 00 001111 1236889999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-39 Score=291.45 Aligned_cols=237 Identities=22% Similarity=0.289 Sum_probs=191.0
Q ss_pred HhCCCcCCeeccCCcEEEEEEEE-CCCcEEEEEEeh----------------hhhhhcccCceeeEEEEEeCCCeeEEEe
Q 039819 201 TENFSSKNILGAGGFGNVYKGKL-GDGTVLAVKRLK----------------DMISLAVHRNLLRLIGYCATPTERLLVY 263 (534)
Q Consensus 201 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~----------------~~l~~~~h~niv~l~~~~~~~~~~~lv~ 263 (534)
++.|+..+.||+|.|+.||++.. ..|+.+|+|.+. .+...++|||||++...+.+....|+|+
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF 89 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 89 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence 45677778899999999999875 467888877664 2567788999999999999999999999
Q ss_pred eccCCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeC---CCCcEEEEecccceecCCC
Q 039819 264 PYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLD---DFCEAIVGDFGLAKLLDHS 340 (534)
Q Consensus 264 e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~---~~~~~kl~DFGla~~~~~~ 340 (534)
|+|.|++|..-+-.+..+++..+-..+.||+++|.|+|.+ +|||||+||+|+|+- ...-+|++|||+|..++
T Consensus 90 e~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n---~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~-- 164 (355)
T KOG0033|consen 90 DLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSN---GIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN-- 164 (355)
T ss_pred ecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeeeeccCCCceeecccceEEEeC--
Confidence 9999999987776666678888889999999999999999 999999999999994 34568999999999887
Q ss_pred CCceeeccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceecccc
Q 039819 341 DSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRE 420 (534)
Q Consensus 341 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 420 (534)
+.......+||++|||||++...+|+..+|||+.|||||-|+.|+.||..... ..+ ..++.... .-+++.
T Consensus 165 ~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~----~rl---ye~I~~g~---yd~~~~ 234 (355)
T KOG0033|consen 165 DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ----HRL---YEQIKAGA---YDYPSP 234 (355)
T ss_pred CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccH----HHH---HHHHhccc---cCCCCc
Confidence 33455667899999999999999999999999999999999999999974321 112 22222211 111111
Q ss_pred cCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 421 LGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 421 l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
-.. ...++..+++.+|+..||.+|.|+.|.++
T Consensus 235 ~w~----~is~~Ak~LvrrML~~dP~kRIta~EAL~ 266 (355)
T KOG0033|consen 235 EWD----TVTPEAKSLIRRMLTVNPKKRITADEALK 266 (355)
T ss_pred ccC----cCCHHHHHHHHHHhccChhhhccHHHHhC
Confidence 111 12347789999999999999999999875
|
|
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=296.70 Aligned_cols=232 Identities=32% Similarity=0.463 Sum_probs=186.0
Q ss_pred CeeccCCcEEEEEEEECC--C--cEEEEEEehh---------------hhhhcccCceeeEEEEEeCCCeeEEEeeccCC
Q 039819 208 NILGAGGFGNVYKGKLGD--G--TVLAVKRLKD---------------MISLAVHRNLLRLIGYCATPTERLLVYPYMSN 268 (534)
Q Consensus 208 ~~lG~G~~g~Vy~~~~~~--~--~~vavK~~~~---------------~l~~~~h~niv~l~~~~~~~~~~~lv~e~~~~ 268 (534)
+.||+|++|.||+|.+.+ + ..||||.+.. .+++++|+||+++++++.. ...++||||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 368999999999998743 3 3689998652 5677889999999999988 888999999999
Q ss_pred CChhhhcccC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCCc--e
Q 039819 269 GSVASRLREK--PALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSH--V 344 (534)
Q Consensus 269 gsL~~~l~~~--~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~--~ 344 (534)
|+|.+++... ..+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||+++........ .
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 156 (257)
T cd05040 80 GSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVM 156 (257)
T ss_pred CcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhC---CccccccCcccEEEecCCEEEeccccccccccccccceec
Confidence 9999999754 3689999999999999999999998 9999999999999999999999999999876543221 1
Q ss_pred eeccccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCcCCCccccccchHHHHHHHHhhhcccceecccccCC
Q 039819 345 TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELGS 423 (534)
Q Consensus 345 ~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 423 (534)
.....++..|+|||++....++.++|||||||++|||+| |+.||..... .+.......... ..
T Consensus 157 ~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~-------~~~~~~~~~~~~-------~~-- 220 (257)
T cd05040 157 EEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSG-------SQILKKIDKEGE-------RL-- 220 (257)
T ss_pred ccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCH-------HHHHHHHHhcCC-------cC--
Confidence 123457789999999988889999999999999999999 9999863321 111111111110 00
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhh
Q 039819 424 NYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLE 459 (534)
Q Consensus 424 ~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~ 459 (534)
..+...+..+.+++.+|++.+|++||++.++++.|.
T Consensus 221 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 221 ERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred CCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 011223458899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=308.69 Aligned_cols=240 Identities=30% Similarity=0.428 Sum_probs=189.5
Q ss_pred hCCCcCCeeccCCcEEEEEEEEC--------CCcEEEEEEehh---------------hhhhc-ccCceeeEEEEEeCCC
Q 039819 202 ENFSSKNILGAGGFGNVYKGKLG--------DGTVLAVKRLKD---------------MISLA-VHRNLLRLIGYCATPT 257 (534)
Q Consensus 202 ~~~~~~~~lG~G~~g~Vy~~~~~--------~~~~vavK~~~~---------------~l~~~-~h~niv~l~~~~~~~~ 257 (534)
.+|...+.||+|+||.||+|+.. .+..||+|.+.. ++.++ .|+||++++++|....
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 91 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCC
Confidence 46788899999999999999742 124689997641 45556 7999999999999999
Q ss_pred eeEEEeeccCCCChhhhcccC----------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeC
Q 039819 258 ERLLVYPYMSNGSVASRLREK----------------PALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLD 321 (534)
Q Consensus 258 ~~~lv~e~~~~gsL~~~l~~~----------------~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~ 321 (534)
..++||||+++|+|.+++... ..+++.+++.++.|++.||.|||+. +|+||||||+|||++
T Consensus 92 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Nill~ 168 (334)
T cd05100 92 PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRDLAARNVLVT 168 (334)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEc
Confidence 999999999999999998642 2488999999999999999999998 999999999999999
Q ss_pred CCCcEEEEecccceecCCCCCc-eeeccccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCcCCCccccccch
Q 039819 322 DFCEAIVGDFGLAKLLDHSDSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GMRALEFGKSINQKGA 399 (534)
Q Consensus 322 ~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~ellt-G~~p~~~~~~~~~~~~ 399 (534)
.++.+||+|||+++........ ......++..|+|||++.+..++.++|||||||++|||++ |..||....
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~------- 241 (334)
T cd05100 169 EDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP------- 241 (334)
T ss_pred CCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCC-------
Confidence 9999999999999866432211 1122234567999999988889999999999999999998 888886432
Q ss_pred HHHHHHHHhhhcccceecccccCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhcC
Q 039819 400 MLEWVKKIQQEKKVEVLVDRELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLEGD 461 (534)
Q Consensus 400 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~~ 461 (534)
..++......... ...+...+..+.+++.+|++.+|.+||+|.|+++.|+..
T Consensus 242 ~~~~~~~~~~~~~----------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~ 293 (334)
T cd05100 242 VEELFKLLKEGHR----------MDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRV 293 (334)
T ss_pred HHHHHHHHHcCCC----------CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHH
Confidence 1122222211110 011112345788999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=304.20 Aligned_cols=250 Identities=20% Similarity=0.303 Sum_probs=187.5
Q ss_pred hCCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEeh---------------hhhhhcccCceeeEEEEEeCCCeeEEEeec
Q 039819 202 ENFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLK---------------DMISLAVHRNLLRLIGYCATPTERLLVYPY 265 (534)
Q Consensus 202 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~---------------~~l~~~~h~niv~l~~~~~~~~~~~lv~e~ 265 (534)
++|...+.||+|+||.||+|+.. ++..||+|.+. ..+..++|+||+++++++......++||||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 85 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 85 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence 56888899999999999999875 57899999875 256778899999999999999999999999
Q ss_pred cCCCChhhhccc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCCce
Q 039819 266 MSNGSVASRLRE-KPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHV 344 (534)
Q Consensus 266 ~~~gsL~~~l~~-~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~ 344 (534)
++ ++|.+++.. ...+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++........ .
T Consensus 86 ~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~-~ 160 (301)
T cd07873 86 LD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK-T 160 (301)
T ss_pred cc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC-c
Confidence 97 588888764 45689999999999999999999998 999999999999999999999999999976543221 1
Q ss_pred eeccccccccccccccccC-CCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhh--------hcccce
Q 039819 345 TTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQ--------EKKVEV 415 (534)
Q Consensus 345 ~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~ 415 (534)
.....++..|+|||++.+. .++.++|||||||++|||+||+.||...........+......... ......
T Consensus 161 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (301)
T cd07873 161 YSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKS 240 (301)
T ss_pred ccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccccccc
Confidence 2233568899999988653 4788999999999999999999999754321111111111000000 000000
Q ss_pred ecccccCCC----CCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 416 LVDRELGSN----YDRIEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 416 ~~d~~l~~~----~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
...+..... ........+.+++.+|++.+|.+|||+.|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~ 285 (301)
T cd07873 241 YNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK 285 (301)
T ss_pred cccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 000000000 00112346789999999999999999999985
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=297.33 Aligned_cols=223 Identities=22% Similarity=0.327 Sum_probs=175.9
Q ss_pred eeccCCcEEEEEEEECC-------------CcEEEEEEeh--------------hhhhhcccCceeeEEEEEeCCCeeEE
Q 039819 209 ILGAGGFGNVYKGKLGD-------------GTVLAVKRLK--------------DMISLAVHRNLLRLIGYCATPTERLL 261 (534)
Q Consensus 209 ~lG~G~~g~Vy~~~~~~-------------~~~vavK~~~--------------~~l~~~~h~niv~l~~~~~~~~~~~l 261 (534)
.||+|+||.||+|+... ...||+|.+. .++..++||||+++++++......++
T Consensus 2 ~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~l 81 (262)
T cd05077 2 HLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENIM 81 (262)
T ss_pred ccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCEE
Confidence 58999999999998532 2358888764 25677899999999999999999999
Q ss_pred EeeccCCCChhhhccc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCc-------EEEEeccc
Q 039819 262 VYPYMSNGSVASRLRE-KPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCE-------AIVGDFGL 333 (534)
Q Consensus 262 v~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~-------~kl~DFGl 333 (534)
||||+++|+|..++.. ...+++..+++++.|++.||+|||+. +|+||||||+|||++.++. ++++|||+
T Consensus 82 v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g~ 158 (262)
T cd05077 82 VEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIKLSDPGI 158 (262)
T ss_pred EEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhC---CeECCCCCcccEEEecCCccCCCCceeEeCCCCC
Confidence 9999999999988874 45699999999999999999999998 9999999999999987664 89999999
Q ss_pred ceecCCCCCceeeccccccccccccccc-cCCCCcchhHHHHHHHHHHHH-hCCCCcCCCccccccchHHHHHHHHhhhc
Q 039819 334 AKLLDHSDSHVTTAVRGTVGHIAPEYLS-TGQSSEKTDVFGFGILLLELI-TGMRALEFGKSINQKGAMLEWVKKIQQEK 411 (534)
Q Consensus 334 a~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~k~Dv~S~Gvvl~ell-tG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 411 (534)
+...... ....++..|+|||++. +..++.++|||||||++|||+ +|+.|+..... .+... ... .
T Consensus 159 ~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~-------~~~~~-~~~-~ 224 (262)
T cd05077 159 PITVLSR-----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTL-------AEKER-FYE-G 224 (262)
T ss_pred CccccCc-----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcch-------hHHHH-HHh-c
Confidence 8755322 2345788999999886 456899999999999999998 58887753211 11111 000 0
Q ss_pred ccceecccccCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHh
Q 039819 412 KVEVLVDRELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRML 458 (534)
Q Consensus 412 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L 458 (534)
.. .. .......+.+++.+||+.+|.+||++.++++.+
T Consensus 225 ~~------~~----~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 225 QC------ML----VTPSCKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred Cc------cC----CCCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 00 00 011234788999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=296.50 Aligned_cols=233 Identities=30% Similarity=0.455 Sum_probs=180.4
Q ss_pred CeeccCCcEEEEEEEEC----CCcEEEEEEehh---------------hhhhcccCceeeEEEEEeC-CCeeEEEeeccC
Q 039819 208 NILGAGGFGNVYKGKLG----DGTVLAVKRLKD---------------MISLAVHRNLLRLIGYCAT-PTERLLVYPYMS 267 (534)
Q Consensus 208 ~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~---------------~l~~~~h~niv~l~~~~~~-~~~~~lv~e~~~ 267 (534)
+.||+|+||.||+|.+. +...||+|++.. +++.++||||+++++++.. ....++||||++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 46899999999999863 245799998742 4567789999999998764 455789999999
Q ss_pred CCChhhhcccC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCC---c
Q 039819 268 NGSVASRLREK-PALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDS---H 343 (534)
Q Consensus 268 ~gsL~~~l~~~-~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~---~ 343 (534)
+|+|.+++... ..+++..+..++.|++.||.|||+. +++||||||+|||++.++.+||+|||+++....... .
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~ 157 (262)
T cd05058 81 HGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVH 157 (262)
T ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCccccccccCCcceeec
Confidence 99999998753 4578888899999999999999998 999999999999999999999999999976533211 1
Q ss_pred eeeccccccccccccccccCCCCcchhHHHHHHHHHHHHhC-CCCcCCCccccccchHHHHHHHHhhhcccceecccccC
Q 039819 344 VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITG-MRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELG 422 (534)
Q Consensus 344 ~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 422 (534)
......++..|+|||++.+..++.++|||||||++|||++| .+||.... ..+.......... .
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~-------~~~~~~~~~~~~~------~--- 221 (262)
T cd05058 158 NHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVD-------SFDITVYLLQGRR------L--- 221 (262)
T ss_pred ccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCC-------HHHHHHHHhcCCC------C---
Confidence 11223457789999999888899999999999999999995 55554221 1122222211110 0
Q ss_pred CCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhc
Q 039819 423 SNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLEG 460 (534)
Q Consensus 423 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~ 460 (534)
..+...+..+.+++.+|++.+|++||++.||++.|+.
T Consensus 222 -~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~ 258 (262)
T cd05058 222 -LQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQ 258 (262)
T ss_pred -CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHH
Confidence 0111224578899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=301.18 Aligned_cols=249 Identities=23% Similarity=0.306 Sum_probs=189.2
Q ss_pred CCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEehh-------------------hhhhcccCceeeEEEEEeCCCeeEEE
Q 039819 203 NFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLKD-------------------MISLAVHRNLLRLIGYCATPTERLLV 262 (534)
Q Consensus 203 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~-------------------~l~~~~h~niv~l~~~~~~~~~~~lv 262 (534)
+|...+.||+|+||.||+|... +++.||||++.. .+..++|+||+++++++.+....++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 4677789999999999999975 689999998741 46677899999999999999999999
Q ss_pred eeccCCCChhhhcccCC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCC
Q 039819 263 YPYMSNGSVASRLREKP-ALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSD 341 (534)
Q Consensus 263 ~e~~~~gsL~~~l~~~~-~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~ 341 (534)
|||+ +|+|.+++.... .+++..++.++.|+++||.|||+. +|+||||||+||+++.++.++|+|||+++......
T Consensus 81 ~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~ 156 (298)
T cd07841 81 FEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLARSFGSPN 156 (298)
T ss_pred Eccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCChhhEEEcCCCCEEEccceeeeeccCCC
Confidence 9999 999999998765 799999999999999999999998 99999999999999999999999999998765432
Q ss_pred Cceeecccccccccccccccc-CCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhh-----cccce
Q 039819 342 SHVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQE-----KKVEV 415 (534)
Q Consensus 342 ~~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~ 415 (534)
. ......++..|+|||++.+ ..++.++|||||||++|||++|.+||...........+.......... .....
T Consensus 157 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (298)
T cd07841 157 R-KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPD 235 (298)
T ss_pred c-cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcccccc
Confidence 2 1223346788999998854 457899999999999999999988876433221111111110000000 00000
Q ss_pred ecccccCCCC-----CHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 416 LVDRELGSNY-----DRIEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 416 ~~d~~l~~~~-----~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
.......... .......+.+++.+|++.+|++||++.||++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~ 281 (298)
T cd07841 236 YVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALE 281 (298)
T ss_pred cccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence 0000000011 1122457889999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=298.33 Aligned_cols=239 Identities=23% Similarity=0.390 Sum_probs=189.4
Q ss_pred hCCCcCCeeccCCcEEEEEEEECC----CcEEEEEEehh---------------hhhhcccCceeeEEEEEeCCCeeEEE
Q 039819 202 ENFSSKNILGAGGFGNVYKGKLGD----GTVLAVKRLKD---------------MISLAVHRNLLRLIGYCATPTERLLV 262 (534)
Q Consensus 202 ~~~~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~---------------~l~~~~h~niv~l~~~~~~~~~~~lv 262 (534)
++|...+.||+|+||.||+|...+ ...||||.... .+..+.||||+++++++.+ ...++|
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv 84 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIV 84 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEE
Confidence 457778899999999999998643 34689997641 5677889999999999875 457899
Q ss_pred eeccCCCChhhhcccC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCC
Q 039819 263 YPYMSNGSVASRLREK-PALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSD 341 (534)
Q Consensus 263 ~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~ 341 (534)
|||+++|+|.+++... ..+++..+..++.+++.||.|||+. +++||||||+||+++.++.+||+|||+++......
T Consensus 85 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~ 161 (270)
T cd05056 85 MELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESK---RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDES 161 (270)
T ss_pred EEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccChheEEEecCCCeEEccCceeeeccccc
Confidence 9999999999999753 4689999999999999999999998 99999999999999999999999999998765432
Q ss_pred CceeeccccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCcCCCccccccchHHHHHHHHhhhcccceecccc
Q 039819 342 SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRE 420 (534)
Q Consensus 342 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 420 (534)
........++..|+|||.+....++.++|||||||++|||++ |+.||...... ....+ ....... .
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~----~~~~~---~~~~~~~------~ 228 (270)
T cd05056 162 YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNN----DVIGR---IENGERL------P 228 (270)
T ss_pred ceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHH----HHHHH---HHcCCcC------C
Confidence 222222334568999999988889999999999999999996 99999643321 11111 1111110 0
Q ss_pred cCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhcC
Q 039819 421 LGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLEGD 461 (534)
Q Consensus 421 l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~~ 461 (534)
.+...+..+.+++.+|+..+|.+||++.++++.|+..
T Consensus 229 ----~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~ 265 (270)
T cd05056 229 ----MPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDI 265 (270)
T ss_pred ----CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 1122345789999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=293.54 Aligned_cols=233 Identities=24% Similarity=0.356 Sum_probs=188.9
Q ss_pred CCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEeh----------------hhhhhcccCceeeEEEEEeCC-CeeEEEee
Q 039819 203 NFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLK----------------DMISLAVHRNLLRLIGYCATP-TERLLVYP 264 (534)
Q Consensus 203 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~----------------~~l~~~~h~niv~l~~~~~~~-~~~~lv~e 264 (534)
+|+..+.||+|++|.||+++.. +++.||+|++. +.++.++|+|++++++.+... ...++|||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 4778899999999999999875 57889999874 256778899999999987654 45789999
Q ss_pred ccCCCChhhhccc--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCC
Q 039819 265 YMSNGSVASRLRE--KPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDS 342 (534)
Q Consensus 265 ~~~~gsL~~~l~~--~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~ 342 (534)
|+++++|.+++.. ...+++.++..++.+++.|++|||+. +++||||||+||+++.++.++|+|||++........
T Consensus 81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~---~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~ 157 (257)
T cd08223 81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCD 157 (257)
T ss_pred ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCchhEEEecCCcEEEecccceEEecccCC
Confidence 9999999999875 34689999999999999999999998 999999999999999999999999999987643222
Q ss_pred ceeeccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceecccccC
Q 039819 343 HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELG 422 (534)
Q Consensus 343 ~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 422 (534)
......|+..|+|||++.+..++.++|||||||+++||++|+.||+.... ..+...... ...
T Consensus 158 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~-------~~~~~~~~~-~~~--------- 219 (257)
T cd08223 158 -MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDM-------NSLVYRIIE-GKL--------- 219 (257)
T ss_pred -ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH-------HHHHHHHHh-cCC---------
Confidence 22345588999999999888899999999999999999999999864321 111111111 111
Q ss_pred CCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 423 SNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 423 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
...+......+.+++.+|++.+|++||++.++++
T Consensus 220 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 253 (257)
T cd08223 220 PPMPKDYSPELGELIATMLSKRPEKRPSVKSILR 253 (257)
T ss_pred CCCccccCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 0112233457899999999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=300.44 Aligned_cols=236 Identities=19% Similarity=0.308 Sum_probs=191.6
Q ss_pred HhCCCcCCeeccCCcEEEEEEEE-CCCcEEEEEEeh--------------hhhhhcccCceeeEEEEEeCCCeeEEEeec
Q 039819 201 TENFSSKNILGAGGFGNVYKGKL-GDGTVLAVKRLK--------------DMISLAVHRNLLRLIGYCATPTERLLVYPY 265 (534)
Q Consensus 201 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~--------------~~l~~~~h~niv~l~~~~~~~~~~~lv~e~ 265 (534)
..+|...+.||+|+||.||+|.. .++..||+|.+. .++..++|+||+++++++...+..++||||
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 97 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 97 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecc
Confidence 36788899999999999999996 478999999875 256778899999999999999999999999
Q ss_pred cCCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCCcee
Q 039819 266 MSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVT 345 (534)
Q Consensus 266 ~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~ 345 (534)
+++++|.+++.+ ..+++..+..++.+++.||.|||+. +++||||||+|||++.++.++|+|||++........ ..
T Consensus 98 ~~~~~L~~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~---~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~-~~ 172 (297)
T cd06656 98 LAGGSLTDVVTE-TCMDEGQIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-KR 172 (297)
T ss_pred cCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEECcCccceEccCCcc-Cc
Confidence 999999998865 3589999999999999999999998 999999999999999999999999999986643322 12
Q ss_pred eccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceecccccCCCC
Q 039819 346 TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELGSNY 425 (534)
Q Consensus 346 ~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 425 (534)
....++..|+|||++.+..++.++|||||||++|+|+||+.||......... . ..... .......
T Consensus 173 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~---~----~~~~~--------~~~~~~~ 237 (297)
T cd06656 173 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL---Y----LIATN--------GTPELQN 237 (297)
T ss_pred CcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchhe---e----eeccC--------CCCCCCC
Confidence 3345889999999998888999999999999999999999999643221100 0 00000 0000011
Q ss_pred CHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 426 DRIEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 426 ~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
+......+.+++.+|++.+|++||+++++++
T Consensus 238 ~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (297)
T cd06656 238 PERLSAVFRDFLNRCLEMDVDRRGSAKELLQ 268 (297)
T ss_pred ccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 2223456789999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=295.56 Aligned_cols=234 Identities=19% Similarity=0.302 Sum_probs=190.3
Q ss_pred CCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEeh---------------hhhhhcccCceeeEEEEEeCCCeeEEEeecc
Q 039819 203 NFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLK---------------DMISLAVHRNLLRLIGYCATPTERLLVYPYM 266 (534)
Q Consensus 203 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~---------------~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~ 266 (534)
+|+..+.||+|+||.||+++.. ++..+|+|.+. .++..+.|+||+++++++......++||||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 4677889999999999999875 68889999763 1567788999999999999999999999999
Q ss_pred CCCChhhhccc--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCCce
Q 039819 267 SNGSVASRLRE--KPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHV 344 (534)
Q Consensus 267 ~~gsL~~~l~~--~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~ 344 (534)
++|+|.+++.. ...+++..++.++.|++.||.|||+. +|+|+||||+||++++++.++++|||++........ .
T Consensus 81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~-~ 156 (255)
T cd08219 81 DGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA-Y 156 (255)
T ss_pred CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEECCCCcEEEcccCcceeeccccc-c
Confidence 99999998863 34589999999999999999999998 999999999999999999999999999987643322 2
Q ss_pred eeccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceecccccCCC
Q 039819 345 TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELGSN 424 (534)
Q Consensus 345 ~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 424 (534)
.....|+..|+|||++.+..++.++||||||+++|+|++|+.||..... .......... ... .
T Consensus 157 ~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~-------~~~~~~~~~~-~~~---------~ 219 (255)
T cd08219 157 ACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSW-------KNLILKVCQG-SYK---------P 219 (255)
T ss_pred cccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCH-------HHHHHHHhcC-CCC---------C
Confidence 2345688999999999888899999999999999999999999964321 1111111111 100 0
Q ss_pred CCHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 039819 425 YDRIEVGEILQVALLCTQYLPVHRPKMSEVVRM 457 (534)
Q Consensus 425 ~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~ 457 (534)
.+......+.+++.+||+.+|++||++.+++..
T Consensus 220 ~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 220 LPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred CCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 111223468899999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=298.03 Aligned_cols=232 Identities=30% Similarity=0.489 Sum_probs=183.8
Q ss_pred CeeccCCcEEEEEEEECC-------CcEEEEEEeh---------------hhhhhcccCceeeEEEEEeCCCeeEEEeec
Q 039819 208 NILGAGGFGNVYKGKLGD-------GTVLAVKRLK---------------DMISLAVHRNLLRLIGYCATPTERLLVYPY 265 (534)
Q Consensus 208 ~~lG~G~~g~Vy~~~~~~-------~~~vavK~~~---------------~~l~~~~h~niv~l~~~~~~~~~~~lv~e~ 265 (534)
+.||+|+||.||+|+..+ +..+|||.+. ..++.+.||||++++++|...+..++||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 368999999999998643 2578888664 256778899999999999999999999999
Q ss_pred cCCCChhhhccc-------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCC-----cEEEEeccc
Q 039819 266 MSNGSVASRLRE-------KPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFC-----EAIVGDFGL 333 (534)
Q Consensus 266 ~~~gsL~~~l~~-------~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~-----~~kl~DFGl 333 (534)
+++++|.+++.. ...+++..++.++.|++.||.|||+. +++|+||||+||+++.++ .++++|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhC---CcccCCCChheEEEecCCCCCCcceEECCccc
Confidence 999999999863 23478999999999999999999998 999999999999999877 899999999
Q ss_pred ceecCCCCCc-eeeccccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCcCCCccccccchHHHHHHHHhhhc
Q 039819 334 AKLLDHSDSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GMRALEFGKSINQKGAMLEWVKKIQQEK 411 (534)
Q Consensus 334 a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~ 411 (534)
++........ ......++..|+|||++.++.++.++|||||||++|||+| |+.||..... .+.........
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~-------~~~~~~~~~~~ 230 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNN-------QEVLQHVTAGG 230 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCH-------HHHHHHHhcCC
Confidence 9765432211 1122335678999999998899999999999999999998 9999864321 11111111111
Q ss_pred ccceecccccCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhh
Q 039819 412 KVEVLVDRELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLE 459 (534)
Q Consensus 412 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~ 459 (534)
. ...+...+..+.+++.+|++.+|.+||++.+|++.|+
T Consensus 231 ~----------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 268 (269)
T cd05044 231 R----------LQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ 268 (269)
T ss_pred c----------cCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 0 0112223567889999999999999999999999886
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=296.14 Aligned_cols=236 Identities=25% Similarity=0.310 Sum_probs=187.2
Q ss_pred hCCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEehh--------------hhhhcccCceeeEEEEEeCCCeeEEEeecc
Q 039819 202 ENFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLKD--------------MISLAVHRNLLRLIGYCATPTERLLVYPYM 266 (534)
Q Consensus 202 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~--------------~l~~~~h~niv~l~~~~~~~~~~~lv~e~~ 266 (534)
+.|+..+.||+|+||.||+|+.. ++..||+|.+.. .+..+.|+||+++++++......++||||+
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 91 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC 91 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence 56778889999999999999985 488999998751 567889999999999999999999999999
Q ss_pred CCCChhhhccc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCCcee
Q 039819 267 SNGSVASRLRE-KPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVT 345 (534)
Q Consensus 267 ~~gsL~~~l~~-~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~ 345 (534)
++++|..++.. ...+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||++....... ...
T Consensus 92 ~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~-~~~ 167 (292)
T cd06644 92 PGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSM---KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL-QRR 167 (292)
T ss_pred CCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcC---CeeecCCCcceEEEcCCCCEEEccCccceeccccc-ccc
Confidence 99999887754 45689999999999999999999998 99999999999999999999999999987543221 112
Q ss_pred eccccccccccccccc-----cCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceecccc
Q 039819 346 TAVRGTVGHIAPEYLS-----TGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRE 420 (534)
Q Consensus 346 ~~~~gt~~y~aPE~~~-----~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 420 (534)
....++..|+|||++. ...++.++|||||||++|||++|+.||..... .+.......... +.
T Consensus 168 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~-------~~~~~~~~~~~~------~~ 234 (292)
T cd06644 168 DSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP-------MRVLLKIAKSEP------PT 234 (292)
T ss_pred ceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccH-------HHHHHHHhcCCC------cc
Confidence 3345789999999984 34468899999999999999999999863221 111111111100 00
Q ss_pred cCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 421 LGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 421 l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
. ..+......+.+++.+|++.+|++||++.++++
T Consensus 235 ~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 268 (292)
T cd06644 235 L--SQPSKWSMEFRDFLKTALDKHPETRPSAAQLLE 268 (292)
T ss_pred C--CCCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 0 011122347889999999999999999999975
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=296.18 Aligned_cols=238 Identities=22% Similarity=0.334 Sum_probs=189.0
Q ss_pred hCCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEeh--------------hhhhhcccCceeeEEEEEeCCCeeEEEeecc
Q 039819 202 ENFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLK--------------DMISLAVHRNLLRLIGYCATPTERLLVYPYM 266 (534)
Q Consensus 202 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~--------------~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~ 266 (534)
++|...+.||+|+||.||+|+.. +++.||+|.++ .++..++||||+++++++...+..++||||+
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~ 88 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC 88 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence 46777788999999999999874 68899999864 2566778999999999999999999999999
Q ss_pred CCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCCceee
Q 039819 267 SNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTT 346 (534)
Q Consensus 267 ~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~ 346 (534)
++++|.+++...+.+++.+++.++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++........ ...
T Consensus 89 ~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~-~~~ 164 (267)
T cd06645 89 GGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSK---GKMHRDIKGANILLTDNGHVKLADFGVSAQITATIA-KRK 164 (267)
T ss_pred CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECcceeeeEccCccc-ccc
Confidence 9999999998888899999999999999999999999 999999999999999999999999999876643221 223
Q ss_pred ccccccccccccccc---cCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceecccccCC
Q 039819 347 AVRGTVGHIAPEYLS---TGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELGS 423 (534)
Q Consensus 347 ~~~gt~~y~aPE~~~---~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 423 (534)
...|+..|+|||++. ...++.++|||||||++|||++|+.||....... .. ....... ...+....
T Consensus 165 ~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~---~~----~~~~~~~----~~~~~~~~ 233 (267)
T cd06645 165 SFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMR---AL----FLMTKSN----FQPPKLKD 233 (267)
T ss_pred cccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchh---hH----HhhhccC----CCCCcccc
Confidence 446899999999874 4568899999999999999999999985322110 00 0000000 00011110
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 424 NYDRIEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 424 ~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
. ...+..+.+++.+|++.+|++||+++++++
T Consensus 234 ~--~~~~~~~~~li~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 234 K--MKWSNSFHHFVKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred c--CCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence 0 012346889999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=299.02 Aligned_cols=249 Identities=20% Similarity=0.302 Sum_probs=185.4
Q ss_pred CCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEeh----------------hhhhhcccCceeeEEEEEeCCCeeEEEeec
Q 039819 203 NFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLK----------------DMISLAVHRNLLRLIGYCATPTERLLVYPY 265 (534)
Q Consensus 203 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~----------------~~l~~~~h~niv~l~~~~~~~~~~~lv~e~ 265 (534)
+|+..+.||+|++|.||+|+.. ++..||||.+. .++..+.||||+++++++.++...++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 4777889999999999999975 68899999864 156677899999999999999999999999
Q ss_pred cCCCChhhhccc---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCC
Q 039819 266 MSNGSVASRLRE---KPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDS 342 (534)
Q Consensus 266 ~~~gsL~~~l~~---~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~ 342 (534)
++ ++|.+++.. ...+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++.......
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~- 155 (285)
T cd07861 81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV- 155 (285)
T ss_pred CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEEcCCCcEEECcccceeecCCCc-
Confidence 97 688887753 25689999999999999999999998 99999999999999999999999999998654322
Q ss_pred ceeeccccccccccccccccC-CCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhh--------ccc
Q 039819 343 HVTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQE--------KKV 413 (534)
Q Consensus 343 ~~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~--------~~~ 413 (534)
.......++..|+|||++.+. .++.++|||||||++|||+||+.||...................... ...
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (285)
T cd07861 156 RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDY 235 (285)
T ss_pred ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHH
Confidence 122233568899999988654 47889999999999999999999997543221111110000000000 000
Q ss_pred ceecccccCC---CCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 414 EVLVDRELGS---NYDRIEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 414 ~~~~d~~l~~---~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
...++..... ........++.+++.+|++.+|.+|||+.+|++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 236 KNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred HhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 0000000000 000112357789999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-36 Score=303.72 Aligned_cols=244 Identities=19% Similarity=0.261 Sum_probs=181.1
Q ss_pred CCeeccC--CcEEEEEEEEC-CCcEEEEEEehh----------------hhhhcccCceeeEEEEEeCCCeeEEEeeccC
Q 039819 207 KNILGAG--GFGNVYKGKLG-DGTVLAVKRLKD----------------MISLAVHRNLLRLIGYCATPTERLLVYPYMS 267 (534)
Q Consensus 207 ~~~lG~G--~~g~Vy~~~~~-~~~~vavK~~~~----------------~l~~~~h~niv~l~~~~~~~~~~~lv~e~~~ 267 (534)
.++||+| +|++||++... ++..||||++.. +++.++||||++++++|..++..++||||++
T Consensus 3 ~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~ 82 (327)
T cd08227 3 LTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMA 82 (327)
T ss_pred hhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEeccC
Confidence 4679999 78999999874 789999998852 4566789999999999999999999999999
Q ss_pred CCChhhhccc--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCCc--
Q 039819 268 NGSVASRLRE--KPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSH-- 343 (534)
Q Consensus 268 ~gsL~~~l~~--~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~-- 343 (534)
+|+|.+++.. ...+++..++.++.|++.||.|||+. +|+||||||+|||++.++.++++||+.+.........
T Consensus 83 ~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~ 159 (327)
T cd08227 83 YGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLR 159 (327)
T ss_pred CCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCChhhEEEecCCcEEEcccchhhcccccccccc
Confidence 9999999864 34589999999999999999999998 9999999999999999999999999865443211100
Q ss_pred ----eeecccccccccccccccc--CCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHH-Hh--------
Q 039819 344 ----VTTAVRGTVGHIAPEYLST--GQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKK-IQ-------- 408 (534)
Q Consensus 344 ----~~~~~~gt~~y~aPE~~~~--~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~-~~-------- 408 (534)
......++..|+|||++.+ ..++.++|||||||++|||++|+.||....... ........ ..
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~---~~~~~~~~~~~~~~~~~~~ 236 (327)
T cd08227 160 VVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQ---MLLEKLNGTVPCLLDTTTI 236 (327)
T ss_pred ccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhH---HHHHHhcCCccccccccch
Confidence 0112346778999999875 458899999999999999999999996422110 00000000 00
Q ss_pred -hhc----ccceeccccc-----------------CCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 409 -QEK----KVEVLVDREL-----------------GSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 409 -~~~----~~~~~~d~~l-----------------~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
.+. ......+... ...........+.+++.+|++.||++|||++|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~ 306 (327)
T cd08227 237 PAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLN 306 (327)
T ss_pred hhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhc
Confidence 000 0000000000 00111223457889999999999999999999985
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=297.24 Aligned_cols=233 Identities=27% Similarity=0.380 Sum_probs=191.0
Q ss_pred CCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEeh---------------hhhhhcccCceeeEEEEEeCCCeeEEEeecc
Q 039819 203 NFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLK---------------DMISLAVHRNLLRLIGYCATPTERLLVYPYM 266 (534)
Q Consensus 203 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~---------------~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~ 266 (534)
+|+..+.||.|+||.||+|+.. +++.||+|.+. ++++.+.|+||+++.+++.+....++|+||+
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (274)
T cd06609 2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYC 81 (274)
T ss_pred hhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEee
Confidence 5777889999999999999975 68899999764 2467778999999999999999999999999
Q ss_pred CCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCCceee
Q 039819 267 SNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTT 346 (534)
Q Consensus 267 ~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~ 346 (534)
++++|.+++... .+++..+..++.|++.||.|||+. +++||||+|+||++++++.++|+|||+++....... ...
T Consensus 82 ~~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~-~~~ 156 (274)
T cd06609 82 GGGSCLDLLKPG-KLDETYIAFILREVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMS-KRN 156 (274)
T ss_pred CCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEcccccceeeccccc-ccc
Confidence 999999999865 789999999999999999999998 999999999999999999999999999987754321 223
Q ss_pred ccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceecccccCCCCC
Q 039819 347 AVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELGSNYD 426 (534)
Q Consensus 347 ~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 426 (534)
...|+..|+|||++.+..++.++|||||||++|||+||+.||..... .......... . .+.+...
T Consensus 157 ~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~-------~~~~~~~~~~-~-----~~~~~~~-- 221 (274)
T cd06609 157 TFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHP-------MRVLFLIPKN-N-----PPSLEGN-- 221 (274)
T ss_pred cccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCch-------HHHHHHhhhc-C-----CCCCccc--
Confidence 34588899999999888899999999999999999999999964321 1111111111 0 1111111
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 427 RIEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 427 ~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
..+..+.+++.+|+..+|++||+++++++
T Consensus 222 -~~~~~~~~~l~~~l~~~p~~Rpt~~~il~ 250 (274)
T cd06609 222 -KFSKPFKDFVSLCLNKDPKERPSAKELLK 250 (274)
T ss_pred -ccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 03447889999999999999999999986
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=301.37 Aligned_cols=246 Identities=24% Similarity=0.325 Sum_probs=190.8
Q ss_pred CHHHHHHHHhCCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEehh-------------hhhhc-ccCceeeEEEEEe---
Q 039819 193 TFRELQQATENFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLKD-------------MISLA-VHRNLLRLIGYCA--- 254 (534)
Q Consensus 193 ~~~~l~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~-------------~l~~~-~h~niv~l~~~~~--- 254 (534)
.++.+..+.++|+..+.||+|+||.||++... +++.+|+|.+.. ++..+ .|+||+++++++.
T Consensus 9 ~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 88 (286)
T cd06638 9 IFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKD 88 (286)
T ss_pred EeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccchHHHHHHHHHHHHHHhcCCCeeeeeeeeeecc
Confidence 34556667889999999999999999999874 578999998642 35555 6999999999884
Q ss_pred --CCCeeEEEeeccCCCChhhhcc----cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEE
Q 039819 255 --TPTERLLVYPYMSNGSVASRLR----EKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIV 328 (534)
Q Consensus 255 --~~~~~~lv~e~~~~gsL~~~l~----~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl 328 (534)
.....++||||+++++|.+++. ....+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||
T Consensus 89 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~kl 165 (286)
T cd06638 89 VKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGGVKL 165 (286)
T ss_pred cCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhC---CccccCCCHHhEEECCCCCEEE
Confidence 3456899999999999998764 335689999999999999999999998 9999999999999999999999
Q ss_pred EecccceecCCCCCceeecccccccccccccccc-----CCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHH
Q 039819 329 GDFGLAKLLDHSDSHVTTAVRGTVGHIAPEYLST-----GQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEW 403 (534)
Q Consensus 329 ~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~ 403 (534)
+|||+++....... ......|+..|+|||++.. ..++.++|||||||++|||++|+.||....... .+
T Consensus 166 ~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~------~~ 238 (286)
T cd06638 166 VDFGVSAQLTSTRL-RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMR------AL 238 (286)
T ss_pred ccCCceeecccCCC-ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhH------HH
Confidence 99999987643221 2233468999999998753 447889999999999999999999986432110 11
Q ss_pred HHHHhhhcccceecccccCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 039819 404 VKKIQQEKKVEVLVDRELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRM 457 (534)
Q Consensus 404 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~ 457 (534)
.. ... .......+ +......+.+++.+|++.+|++||++.|+++.
T Consensus 239 ~~-~~~-~~~~~~~~-------~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 283 (286)
T cd06638 239 FK-IPR-NPPPTLHQ-------PELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH 283 (286)
T ss_pred hh-ccc-cCCCcccC-------CCCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence 00 000 00000001 11123478899999999999999999999874
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-36 Score=295.55 Aligned_cols=234 Identities=26% Similarity=0.363 Sum_probs=191.4
Q ss_pred hCCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEeh---------------hhhhhcccCceeeEEEEEeCCCeeEEEeec
Q 039819 202 ENFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLK---------------DMISLAVHRNLLRLIGYCATPTERLLVYPY 265 (534)
Q Consensus 202 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~---------------~~l~~~~h~niv~l~~~~~~~~~~~lv~e~ 265 (534)
..|+..+.||.|+||.||+|... ++..||||.+. .++..+.|+||+++++++.+....++||||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence 34667788999999999999975 58899999764 156677899999999999999999999999
Q ss_pred cCCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCCcee
Q 039819 266 MSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVT 345 (534)
Q Consensus 266 ~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~ 345 (534)
+++|+|.+++.. ..+++..+..++.+++.||.|||+. +++|+||+|+||+++.++.++|+|||++........ ..
T Consensus 84 ~~~~~L~~~i~~-~~l~~~~~~~~~~~l~~~l~~lh~~---~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~-~~ 158 (277)
T cd06640 84 LGGGSALDLLRA-GPFDEFQIATMLKEILKGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI-KR 158 (277)
T ss_pred CCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhC---CccCcCCChhhEEEcCCCCEEEcccccceeccCCcc-cc
Confidence 999999998875 4589999999999999999999998 999999999999999999999999999987643321 22
Q ss_pred eccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceecccccCCCC
Q 039819 346 TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELGSNY 425 (534)
Q Consensus 346 ~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 425 (534)
....++..|+|||++.+..++.++|||||||++|||+||+.||...... ....... .......
T Consensus 159 ~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~-------~~~~~~~----------~~~~~~~ 221 (277)
T cd06640 159 NTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPM-------RVLFLIP----------KNNPPTL 221 (277)
T ss_pred ccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChH-------hHhhhhh----------cCCCCCC
Confidence 3345788999999998888999999999999999999999998643211 1111110 0111123
Q ss_pred CHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 039819 426 DRIEVGEILQVALLCTQYLPVHRPKMSEVVRM 457 (534)
Q Consensus 426 ~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~ 457 (534)
....+..+.+++.+|++.+|++||++.+++..
T Consensus 222 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 222 TGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred chhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 33456688999999999999999999999763
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=295.03 Aligned_cols=234 Identities=26% Similarity=0.441 Sum_probs=190.4
Q ss_pred CCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEeh-----------------------hhhhhcccCceeeEEEEEeCCCe
Q 039819 203 NFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLK-----------------------DMISLAVHRNLLRLIGYCATPTE 258 (534)
Q Consensus 203 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~-----------------------~~l~~~~h~niv~l~~~~~~~~~ 258 (534)
+|.....||+|+||.||+|... +++.+|+|.+. .+++.+.||||+++++++.+...
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 3667789999999999999874 57889999663 25677899999999999999999
Q ss_pred eEEEeeccCCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecC
Q 039819 259 RLLVYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLD 338 (534)
Q Consensus 259 ~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~ 338 (534)
.++||||+++++|.+++.....+++..+..++.|++.||.|||+. +++||||||+||+++.++.++|+|||+++...
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~---~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~ 157 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNR---GIIHRDIKGANILVDNKGGIKISDFGISKKLE 157 (267)
T ss_pred cEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhc---CcccccCCHHHEEEcCCCCEEecccCCCcccc
Confidence 999999999999999998878899999999999999999999998 99999999999999999999999999998764
Q ss_pred CCCC-----ceeeccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhccc
Q 039819 339 HSDS-----HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKV 413 (534)
Q Consensus 339 ~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 413 (534)
.... .......|+..|+|||.+.+..++.++|||||||++|||+||+.||...... ..+ .....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---~~~----~~~~~---- 226 (267)
T cd06628 158 ANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQL---QAI----FKIGE---- 226 (267)
T ss_pred cccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHH---HHH----HHHhc----
Confidence 2111 0112345788999999998888999999999999999999999999743211 000 11000
Q ss_pred ceecccccCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 414 EVLVDRELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 414 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
...+. .+...+..+.+++.+|++.+|.+||++.++++
T Consensus 227 --~~~~~----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 227 --NASPE----IPSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred --cCCCc----CCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 01111 12223457889999999999999999999985
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=301.93 Aligned_cols=246 Identities=26% Similarity=0.337 Sum_probs=191.9
Q ss_pred cCHHHHHHHHhCCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEehh-------------hhhhc-ccCceeeEEEEEeCC
Q 039819 192 FTFRELQQATENFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLKD-------------MISLA-VHRNLLRLIGYCATP 256 (534)
Q Consensus 192 ~~~~~l~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~-------------~l~~~-~h~niv~l~~~~~~~ 256 (534)
++++++..++++|...+.||+|+||.||++... +++.+|+|.+.. .+..+ .|||++++++++...
T Consensus 12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~ 91 (291)
T cd06639 12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKA 91 (291)
T ss_pred hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEec
Confidence 455666677899999999999999999999874 688999998742 34444 799999999998754
Q ss_pred -----CeeEEEeeccCCCChhhhcc----cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEE
Q 039819 257 -----TERLLVYPYMSNGSVASRLR----EKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAI 327 (534)
Q Consensus 257 -----~~~~lv~e~~~~gsL~~~l~----~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~k 327 (534)
...++||||+++|+|.++++ ....+++..++.++.|++.||+|||+. +++||||||+||+++.++.+|
T Consensus 92 ~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~nili~~~~~~k 168 (291)
T cd06639 92 DKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVK 168 (291)
T ss_pred cccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEE
Confidence 35799999999999998875 345689999999999999999999998 999999999999999999999
Q ss_pred EEecccceecCCCCCceeeccccccccccccccccCC-----CCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHH
Q 039819 328 VGDFGLAKLLDHSDSHVTTAVRGTVGHIAPEYLSTGQ-----SSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLE 402 (534)
Q Consensus 328 l~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-----~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~ 402 (534)
|+|||++........ ......|+..|+|||++.... ++.++|||||||++|||++|+.||...... ..+..
T Consensus 169 l~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~---~~~~~ 244 (291)
T cd06639 169 LVDFGVSAQLTSTRL-RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPV---KTLFK 244 (291)
T ss_pred Eeecccchhcccccc-cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHH---HHHHH
Confidence 999999886543221 122345889999999875432 688999999999999999999998632211 11111
Q ss_pred HHHHHhhhcccceecccccCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 403 WVKKIQQEKKVEVLVDRELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 403 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
+ .. .....+. ........+.+++.+|++.+|++||++.|+++
T Consensus 245 ~----~~-~~~~~~~-------~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 286 (291)
T cd06639 245 I----PR-NPPPTLL-------HPEKWCRSFNHFISQCLIKDFEARPSVTHLLE 286 (291)
T ss_pred H----hc-CCCCCCC-------cccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 1 11 1000110 11122347899999999999999999999985
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=294.86 Aligned_cols=233 Identities=27% Similarity=0.413 Sum_probs=187.9
Q ss_pred hCCCcCCeeccCCcEEEEEEEECCCcEEEEEEeh------------hhhhhcccCceeeEEEEEeCCCeeEEEeeccCCC
Q 039819 202 ENFSSKNILGAGGFGNVYKGKLGDGTVLAVKRLK------------DMISLAVHRNLLRLIGYCATPTERLLVYPYMSNG 269 (534)
Q Consensus 202 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~------------~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~~~g 269 (534)
++|...+.||+|+||.||++.. .+..||+|.+. .++..++|||++++++++... ..++||||++++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~~~ 83 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDVTAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMSKG 83 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcchHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCCCC
Confidence 4578889999999999999985 67789999875 257788999999999998654 579999999999
Q ss_pred ChhhhcccC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCCceeec
Q 039819 270 SVASRLREK--PALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTA 347 (534)
Q Consensus 270 sL~~~l~~~--~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~ 347 (534)
+|.+++... ..+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||++....... ..
T Consensus 84 ~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~----~~ 156 (254)
T cd05083 84 NLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESK---KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV----DN 156 (254)
T ss_pred CHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCcEEECCCccceeccccC----CC
Confidence 999998743 3589999999999999999999998 99999999999999999999999999997643221 12
Q ss_pred cccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCcCCCccccccchHHHHHHHHhhhcccceecccccCCCCC
Q 039819 348 VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELGSNYD 426 (534)
Q Consensus 348 ~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 426 (534)
...+..|+|||++.++.++.++|||||||++|||++ |+.||..... .++........ .....
T Consensus 157 ~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~-------~~~~~~~~~~~----------~~~~~ 219 (254)
T cd05083 157 SKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSL-------KEVKECVEKGY----------RMEPP 219 (254)
T ss_pred CCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCH-------HHHHHHHhCCC----------CCCCC
Confidence 234568999999988889999999999999999998 9999864321 11222111110 01111
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhc
Q 039819 427 RIEVGEILQVALLCTQYLPVHRPKMSEVVRMLEG 460 (534)
Q Consensus 427 ~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~ 460 (534)
...+..+.+++.+|++.+|.+||+++++++.|+.
T Consensus 220 ~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 220 EGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred CcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 2234578899999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-36 Score=292.44 Aligned_cols=224 Identities=26% Similarity=0.420 Sum_probs=178.6
Q ss_pred CeeccCCcEEEEEEEECCCc-----------EEEEEEeh-------------hhhhhcccCceeeEEEEEeCCCeeEEEe
Q 039819 208 NILGAGGFGNVYKGKLGDGT-----------VLAVKRLK-------------DMISLAVHRNLLRLIGYCATPTERLLVY 263 (534)
Q Consensus 208 ~~lG~G~~g~Vy~~~~~~~~-----------~vavK~~~-------------~~l~~~~h~niv~l~~~~~~~~~~~lv~ 263 (534)
+.||+|+||.||+|...+.. .|++|.+. .+++.+.|+||+++++++.. ...++||
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~ 79 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMVE 79 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhhHHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEEE
Confidence 36899999999999985432 57788654 26778889999999999988 7789999
Q ss_pred eccCCCChhhhcccCC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCC-------cEEEEecccce
Q 039819 264 PYMSNGSVASRLREKP-ALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFC-------EAIVGDFGLAK 335 (534)
Q Consensus 264 e~~~~gsL~~~l~~~~-~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~-------~~kl~DFGla~ 335 (534)
||+++|+|.+++.... .+++..+..++.|++.||.|||++ +|+||||||+|||++.++ .+||+|||++.
T Consensus 80 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a~ 156 (259)
T cd05037 80 EYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPI 156 (259)
T ss_pred EcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhC---CeecccCccceEEEecCccccCCceeEEeCCCCccc
Confidence 9999999999998655 799999999999999999999998 999999999999999888 79999999998
Q ss_pred ecCCCCCceeeccccccccccccccccC--CCCcchhHHHHHHHHHHHHh-CCCCcCCCccccccchHHHHHHHHhhhcc
Q 039819 336 LLDHSDSHVTTAVRGTVGHIAPEYLSTG--QSSEKTDVFGFGILLLELIT-GMRALEFGKSINQKGAMLEWVKKIQQEKK 412 (534)
Q Consensus 336 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~k~Dv~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 412 (534)
.... .....++..|+|||++... .++.++|||||||++|||++ |..||..... .++........
T Consensus 157 ~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~-------~~~~~~~~~~~- 223 (259)
T cd05037 157 TVLS-----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSS-------SEKERFYQDQH- 223 (259)
T ss_pred cccc-----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCc-------hhHHHHHhcCC-
Confidence 6543 1223467789999998776 78999999999999999999 5666653221 11111111100
Q ss_pred cceecccccCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhh
Q 039819 413 VEVLVDRELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLE 459 (534)
Q Consensus 413 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~ 459 (534)
... ......+.+++.+|+..+|.+||++.+|++.|.
T Consensus 224 -------~~~----~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 224 -------RLP----MPDCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred -------CCC----CCCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 000 001158889999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-36 Score=293.97 Aligned_cols=234 Identities=26% Similarity=0.386 Sum_probs=184.7
Q ss_pred CCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEeh-------------------hhhhhcccCceeeEEEEEeCC--CeeE
Q 039819 203 NFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLK-------------------DMISLAVHRNLLRLIGYCATP--TERL 260 (534)
Q Consensus 203 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~-------------------~~l~~~~h~niv~l~~~~~~~--~~~~ 260 (534)
+|...+.||+|+||.||+|... .+..||+|++. .++..++||||+++++++... ...+
T Consensus 3 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 82 (266)
T cd06651 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLT 82 (266)
T ss_pred CccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEE
Confidence 6888899999999999999874 58899999763 167788999999999988753 5678
Q ss_pred EEeeccCCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCC
Q 039819 261 LVYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHS 340 (534)
Q Consensus 261 lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~ 340 (534)
++|||+++++|.+++.....+++..++.++.|++.||.|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 83 l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~---~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~ 159 (266)
T cd06651 83 IFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTI 159 (266)
T ss_pred EEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCCCccccccc
Confidence 9999999999999998777899999999999999999999998 9999999999999999999999999999865321
Q ss_pred C--CceeeccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceecc
Q 039819 341 D--SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVD 418 (534)
Q Consensus 341 ~--~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 418 (534)
. ........++..|+|||++.+..++.++|||||||++|||+||+.||..... ........... ..
T Consensus 160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~-------~~~~~~~~~~~-----~~ 227 (266)
T cd06651 160 CMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEA-------MAAIFKIATQP-----TN 227 (266)
T ss_pred cccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccch-------HHHHHHHhcCC-----CC
Confidence 1 1111234588999999999888899999999999999999999999963211 11111111100 01
Q ss_pred cccCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 419 RELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 419 ~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
+ ..+......+..++ +|+..+|++||+|+||++
T Consensus 228 ~----~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 228 P----QLPSHISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred C----CCchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 1 11222233555565 788899999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=292.59 Aligned_cols=235 Identities=26% Similarity=0.368 Sum_probs=175.8
Q ss_pred eeccCCcEEEEEEEECC---CcEEEEEEehh---------------hhhhcccCceeeEEEEEeCCCeeEEEeeccCCCC
Q 039819 209 ILGAGGFGNVYKGKLGD---GTVLAVKRLKD---------------MISLAVHRNLLRLIGYCATPTERLLVYPYMSNGS 270 (534)
Q Consensus 209 ~lG~G~~g~Vy~~~~~~---~~~vavK~~~~---------------~l~~~~h~niv~l~~~~~~~~~~~lv~e~~~~gs 270 (534)
.||+|+||.||+|...+ ...+|+|.+.. .++.++|+||++++++|......++||||+++|+
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD 81 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence 58999999999997643 35688887641 4566789999999999999999999999999999
Q ss_pred hhhhcccC-----CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCCc-e
Q 039819 271 VASRLREK-----PALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSH-V 344 (534)
Q Consensus 271 L~~~l~~~-----~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~-~ 344 (534)
|.+++... ...++.....++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++......... .
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~ 158 (269)
T cd05042 82 LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA---DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYIT 158 (269)
T ss_pred HHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhc---CEecccccHhheEecCCCcEEEeccccccccccchheec
Confidence 99998643 2356788899999999999999998 9999999999999999999999999998754322111 1
Q ss_pred eecccccccccccccccc-------CCCCcchhHHHHHHHHHHHHh-CCCCcCCCccccccchHHHHHHHHhhhccccee
Q 039819 345 TTAVRGTVGHIAPEYLST-------GQSSEKTDVFGFGILLLELIT-GMRALEFGKSINQKGAMLEWVKKIQQEKKVEVL 416 (534)
Q Consensus 345 ~~~~~gt~~y~aPE~~~~-------~~~~~k~Dv~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 416 (534)
.....++..|+|||++.. ..++.++|||||||++|||++ |..||...... +.......... ..+
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~-------~~~~~~~~~~~-~~~ 230 (269)
T cd05042 159 KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDE-------QVLKQVVREQD-IKL 230 (269)
T ss_pred cCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHH-------HHHHHHhhccC-ccC
Confidence 122345678999998742 356889999999999999999 77888633211 11111111111 111
Q ss_pred cccccCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhh
Q 039819 417 VDRELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLE 459 (534)
Q Consensus 417 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~ 459 (534)
.++.+ +......+.+++..|+ .+|++||++++|++.|.
T Consensus 231 ~~~~~----~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 231 PKPQL----DLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred CCCcc----cccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 11212 2223346777888898 59999999999998863
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=303.15 Aligned_cols=239 Identities=26% Similarity=0.455 Sum_probs=187.6
Q ss_pred hCCCcCCeeccCCcEEEEEEEEC-CCc----EEEEEEehh---------------hhhhcccCceeeEEEEEeCCCeeEE
Q 039819 202 ENFSSKNILGAGGFGNVYKGKLG-DGT----VLAVKRLKD---------------MISLAVHRNLLRLIGYCATPTERLL 261 (534)
Q Consensus 202 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~----~vavK~~~~---------------~l~~~~h~niv~l~~~~~~~~~~~l 261 (534)
++|+..+.||+|+||.||+|.+. ++. .||+|.+.. ++..+.||||++++++|... ..++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~ 85 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQL 85 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Ccee
Confidence 56778889999999999999863 343 578887652 56777899999999999764 4679
Q ss_pred EeeccCCCChhhhcccC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCC
Q 039819 262 VYPYMSNGSVASRLREK-PALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHS 340 (534)
Q Consensus 262 v~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~ 340 (534)
|+||+++|+|.+++... ..+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 86 v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~ 162 (303)
T cd05110 86 VTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGD 162 (303)
T ss_pred eehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhc---CeeccccccceeeecCCCceEEccccccccccCc
Confidence 99999999999998754 4689999999999999999999998 9999999999999999999999999999876432
Q ss_pred CCc-eeeccccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCcCCCccccccchHHHHHHHHhhhcccceecc
Q 039819 341 DSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVD 418 (534)
Q Consensus 341 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 418 (534)
... ......++..|+|||++.+..++.++|||||||++|||++ |+.||..... ....+++ .....
T Consensus 163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~----~~~~~~~---~~~~~------ 229 (303)
T cd05110 163 EKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPT----REIPDLL---EKGER------ 229 (303)
T ss_pred ccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCH----HHHHHHH---HCCCC------
Confidence 221 1122335678999999988889999999999999999998 8899863211 1111221 11110
Q ss_pred cccCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhcC
Q 039819 419 RELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLEGD 461 (534)
Q Consensus 419 ~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~~ 461 (534)
. .........+.+++..|+..+|++||+++++++.|...
T Consensus 230 --~--~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~ 268 (303)
T cd05110 230 --L--PQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRM 268 (303)
T ss_pred --C--CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 0 00111234788999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=298.87 Aligned_cols=241 Identities=21% Similarity=0.297 Sum_probs=192.1
Q ss_pred hCCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEehh-----------------hhhhcccCceeeEEEEEeCCCeeEEEe
Q 039819 202 ENFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLKD-----------------MISLAVHRNLLRLIGYCATPTERLLVY 263 (534)
Q Consensus 202 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~-----------------~l~~~~h~niv~l~~~~~~~~~~~lv~ 263 (534)
++|...+.||+|+||.||++... .++.||+|.+.. ++..++||||+++++.+...+..++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 36788899999999999999875 578899997742 467788999999999999999999999
Q ss_pred eccCCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCC--
Q 039819 264 PYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSD-- 341 (534)
Q Consensus 264 e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~-- 341 (534)
||+++++|.+++.....+++..+..++.+++.||.|||+. +++||||||+||+++.++.+||+|||+++......
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~ 157 (305)
T cd05609 81 EYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTT 157 (305)
T ss_pred ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHEEECCCCCEEEeeCCCccccCcCccc
Confidence 9999999999998877899999999999999999999998 99999999999999999999999999987421100
Q ss_pred ------------CceeeccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhh
Q 039819 342 ------------SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQ 409 (534)
Q Consensus 342 ------------~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 409 (534)
........|+..|+|||++....++.++|||||||++|||++|+.||..... .++......
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~-------~~~~~~~~~ 230 (305)
T cd05609 158 NLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTP-------EELFGQVIS 230 (305)
T ss_pred cccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-------HHHHHHHHh
Confidence 0011224578899999999888899999999999999999999999963221 122222111
Q ss_pred hcccceecccccCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhc
Q 039819 410 EKKVEVLVDRELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLEG 460 (534)
Q Consensus 410 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~ 460 (534)
.. ...+... ...+..+.+++.+|++.+|++||++.++.+.|+.
T Consensus 231 ~~----~~~~~~~----~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 231 DD----IEWPEGD----EALPADAQDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred cc----cCCCCcc----ccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence 11 0011110 1234578999999999999999998777776654
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=295.21 Aligned_cols=237 Identities=27% Similarity=0.384 Sum_probs=191.5
Q ss_pred CCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEehh---------------hhhhcccCceeeEEEEEeCCCeeEEEeecc
Q 039819 203 NFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLKD---------------MISLAVHRNLLRLIGYCATPTERLLVYPYM 266 (534)
Q Consensus 203 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~---------------~l~~~~h~niv~l~~~~~~~~~~~lv~e~~ 266 (534)
+|+..+.||+|+||.||++... +++.||+|++.. .++.+.||||+++++++......++|+||+
T Consensus 2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (265)
T cd06605 2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYM 81 (265)
T ss_pred cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEec
Confidence 5667788999999999999986 688999997642 466778999999999999999999999999
Q ss_pred CCCChhhhcccC-CCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCCce
Q 039819 267 SNGSVASRLREK-PALDWNTRKRIAIGAARGLLYLHE-QCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHV 344 (534)
Q Consensus 267 ~~gsL~~~l~~~-~~l~~~~~~~i~~~i~~~l~yLH~-~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~ 344 (534)
++++|.+++... ..+++..+..++.|++.||+|||+ . +++|+||||+||+++.++.++|+|||.+........
T Consensus 82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~-- 156 (265)
T cd06605 82 DGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKH---KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA-- 156 (265)
T ss_pred CCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCC---CeecCCCCHHHEEECCCCCEEEeecccchhhHHHHh--
Confidence 999999999765 779999999999999999999999 7 999999999999999999999999999876532211
Q ss_pred eeccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceecccccCCC
Q 039819 345 TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELGSN 424 (534)
Q Consensus 345 ~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 424 (534)
....++..|+|||++.+..++.++||||||+++|+|++|+.||...... .....+.+........ +.+.
T Consensus 157 -~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~------~~~~-- 225 (265)
T cd06605 157 -KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDP--PDGIFELLQYIVNEPP------PRLP-- 225 (265)
T ss_pred -hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccc--cccHHHHHHHHhcCCC------CCCC--
Confidence 1256889999999998888999999999999999999999999643211 1112222222211110 0111
Q ss_pred CCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 425 YDRIEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 425 ~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
.......+.+++.+|+..+|++||++.+++.
T Consensus 226 -~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 256 (265)
T cd06605 226 -SGKFSPDFQDFVNLCLIKDPRERPSYKELLE 256 (265)
T ss_pred -hhhcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence 1113457889999999999999999999985
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-36 Score=291.95 Aligned_cols=234 Identities=31% Similarity=0.489 Sum_probs=188.6
Q ss_pred CcCCeeccCCcEEEEEEEECC-----CcEEEEEEehh---------------hhhhcccCceeeEEEEEeCCCeeEEEee
Q 039819 205 SSKNILGAGGFGNVYKGKLGD-----GTVLAVKRLKD---------------MISLAVHRNLLRLIGYCATPTERLLVYP 264 (534)
Q Consensus 205 ~~~~~lG~G~~g~Vy~~~~~~-----~~~vavK~~~~---------------~l~~~~h~niv~l~~~~~~~~~~~lv~e 264 (534)
+..+.||+|+||.||+++..+ +..||+|.+.. .+..+.|+||+++++++.+....++|||
T Consensus 2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e 81 (258)
T smart00219 2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVME 81 (258)
T ss_pred cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEe
Confidence 456789999999999999754 48899998762 4567789999999999999999999999
Q ss_pred ccCCCChhhhcccCCC--CCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCC
Q 039819 265 YMSNGSVASRLREKPA--LDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDS 342 (534)
Q Consensus 265 ~~~~gsL~~~l~~~~~--l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~ 342 (534)
|+++++|.+++..... +++..+..++.|++.||+|||+. +++||||||+||+++.++.++|+|||+++.......
T Consensus 82 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~---~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~ 158 (258)
T smart00219 82 YMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDY 158 (258)
T ss_pred ccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcC---CeeecccccceEEEccCCeEEEcccCCceecccccc
Confidence 9999999999975443 99999999999999999999999 999999999999999999999999999987654322
Q ss_pred ceeeccccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCcCCCccccccchHHHHHHHHhhhcccceeccccc
Q 039819 343 HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDREL 421 (534)
Q Consensus 343 ~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 421 (534)
.......++..|+|||.+.+..++.++||||+|++++||++ |+.||..... ............
T Consensus 159 ~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~-------~~~~~~~~~~~~--------- 222 (258)
T smart00219 159 YKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSN-------EEVLEYLKKGYR--------- 222 (258)
T ss_pred cccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCH-------HHHHHHHhcCCC---------
Confidence 22212336789999999988889999999999999999998 7888763211 111111111111
Q ss_pred CCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHh
Q 039819 422 GSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRML 458 (534)
Q Consensus 422 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L 458 (534)
.......+..+.+++.+|+..+|++|||+.|+++.|
T Consensus 223 -~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 223 -LPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred -CCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 011112355789999999999999999999998764
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=299.58 Aligned_cols=180 Identities=24% Similarity=0.366 Sum_probs=148.7
Q ss_pred CeeccCCcEEEEEEEEC---CCcEEEEEEeh------------hhhhhcccCceeeEEEEEeC--CCeeEEEeeccCCCC
Q 039819 208 NILGAGGFGNVYKGKLG---DGTVLAVKRLK------------DMISLAVHRNLLRLIGYCAT--PTERLLVYPYMSNGS 270 (534)
Q Consensus 208 ~~lG~G~~g~Vy~~~~~---~~~~vavK~~~------------~~l~~~~h~niv~l~~~~~~--~~~~~lv~e~~~~gs 270 (534)
..||+|+||.||+|+.. ++..||+|.+. ++++.++||||+++++++.. ....++||||+.+ +
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~-~ 85 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH-D 85 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCCCcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCC-c
Confidence 57999999999999865 35789999875 26778899999999998854 4567899999875 6
Q ss_pred hhhhccc---------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEe----CCCCcEEEEecccceec
Q 039819 271 VASRLRE---------KPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLL----DDFCEAIVGDFGLAKLL 337 (534)
Q Consensus 271 L~~~l~~---------~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl----~~~~~~kl~DFGla~~~ 337 (534)
|.+++.. ...+++..+..++.|++.||.|||+. +|+||||||+|||+ +.++.+||+|||+++..
T Consensus 86 l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~~ 162 (317)
T cd07867 86 LWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLF 162 (317)
T ss_pred HHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEccCCCCCCcEEEeeccceecc
Confidence 7666531 23588999999999999999999998 99999999999999 56789999999999876
Q ss_pred CCCCC--ceeecccccccccccccccc-CCCCcchhHHHHHHHHHHHHhCCCCcCCC
Q 039819 338 DHSDS--HVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELITGMRALEFG 391 (534)
Q Consensus 338 ~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~S~Gvvl~elltG~~p~~~~ 391 (534)
..... .......||..|+|||++.+ ..++.++|||||||++|||+||+.||...
T Consensus 163 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~ 219 (317)
T cd07867 163 NSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred CCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence 43321 11233568999999999876 45789999999999999999999999643
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=292.73 Aligned_cols=235 Identities=23% Similarity=0.373 Sum_probs=175.8
Q ss_pred eeccCCcEEEEEEEECCC---cEEEEEEehh---------------hhhhcccCceeeEEEEEeCCCeeEEEeeccCCCC
Q 039819 209 ILGAGGFGNVYKGKLGDG---TVLAVKRLKD---------------MISLAVHRNLLRLIGYCATPTERLLVYPYMSNGS 270 (534)
Q Consensus 209 ~lG~G~~g~Vy~~~~~~~---~~vavK~~~~---------------~l~~~~h~niv~l~~~~~~~~~~~lv~e~~~~gs 270 (534)
.||+|+||.||+|+..++ ..+++|.+.. .+..++||||+++++.|......++||||+++|+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 81 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD 81 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence 589999999999976433 3456775441 3566789999999999999999999999999999
Q ss_pred hhhhcccC----CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCC-Ccee
Q 039819 271 VASRLREK----PALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSD-SHVT 345 (534)
Q Consensus 271 L~~~l~~~----~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~-~~~~ 345 (534)
|.+++... ..+++..+..++.|++.||.|||+. +++||||||+|||++.++.+||+|||++....... ....
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 158 (268)
T cd05086 82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE 158 (268)
T ss_pred HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CeeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence 99998743 3467778889999999999999998 99999999999999999999999999986432211 1112
Q ss_pred ecccccccccccccccc-------CCCCcchhHHHHHHHHHHHHh-CCCCcCCCccccccchHHHHHHHHhhhcccceec
Q 039819 346 TAVRGTVGHIAPEYLST-------GQSSEKTDVFGFGILLLELIT-GMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLV 417 (534)
Q Consensus 346 ~~~~gt~~y~aPE~~~~-------~~~~~k~Dv~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 417 (534)
....++..|+|||++.. ..++.++|||||||++|||++ |..||..... .+........ ....+.
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~-------~~~~~~~~~~-~~~~~~ 230 (268)
T cd05086 159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSD-------REVLNHVIKD-QQVKLF 230 (268)
T ss_pred cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCH-------HHHHHHHHhh-cccccC
Confidence 23457889999998743 235789999999999999997 4667753221 1111111111 112233
Q ss_pred ccccCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhh
Q 039819 418 DRELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLE 459 (534)
Q Consensus 418 d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~ 459 (534)
++.+...+ ...+.+++..|+ .+|.+||++++|++.|.
T Consensus 231 ~~~~~~~~----~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 231 KPQLELPY----SERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred CCccCCCC----cHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 33333322 346778889999 57999999999998763
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=294.91 Aligned_cols=234 Identities=24% Similarity=0.311 Sum_probs=185.2
Q ss_pred CCcCCeeccCCcEEEEEEEEC-CCcEEEEEEeh--------------hhhhhcccCceeeEEEEEeCCCeeEEEeeccCC
Q 039819 204 FSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLK--------------DMISLAVHRNLLRLIGYCATPTERLLVYPYMSN 268 (534)
Q Consensus 204 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~--------------~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~~~ 268 (534)
|+..+.||+|+||.||+|... ++..+|+|.+. +++..+.|+|++++++++......++||||+++
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~ 86 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 86 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence 456678999999999999986 47788998764 256778899999999999999999999999999
Q ss_pred CChhhhccc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCCceeec
Q 039819 269 GSVASRLRE-KPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTA 347 (534)
Q Consensus 269 gsL~~~l~~-~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~ 347 (534)
++|..++.. ...+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||++....... .....
T Consensus 87 ~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~-~~~~~ 162 (282)
T cd06643 87 GAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-QRRDS 162 (282)
T ss_pred CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEccCCCEEEccccccccccccc-ccccc
Confidence 999988764 45799999999999999999999998 99999999999999999999999999987653221 12233
Q ss_pred cccccccccccccc-----cCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceecccccC
Q 039819 348 VRGTVGHIAPEYLS-----TGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELG 422 (534)
Q Consensus 348 ~~gt~~y~aPE~~~-----~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 422 (534)
..++..|+|||++. +..++.++|||||||++|||++|+.||...... +.+........ +.+
T Consensus 163 ~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~-------~~~~~~~~~~~------~~~- 228 (282)
T cd06643 163 FIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPM-------RVLLKIAKSEP------PTL- 228 (282)
T ss_pred ccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHH-------HHHHHHhhcCC------CCC-
Confidence 46899999999974 345778999999999999999999998632211 11111111110 000
Q ss_pred CCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 423 SNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 423 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
..+...+..+.+++.+|++.+|.+||++.++++
T Consensus 229 -~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 261 (282)
T cd06643 229 -AQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQ 261 (282)
T ss_pred -CCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 011123457899999999999999999999875
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=299.08 Aligned_cols=232 Identities=26% Similarity=0.376 Sum_probs=187.8
Q ss_pred CCcCCeeccCCcEEEEEEEEC-CCcEEEEEEeh---------------hhhhhcccCceeeEEEEEeCCCeeEEEeeccC
Q 039819 204 FSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLK---------------DMISLAVHRNLLRLIGYCATPTERLLVYPYMS 267 (534)
Q Consensus 204 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~---------------~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~~ 267 (534)
|+..+.||+|+||.||+|... ++..||+|.+. +.++.++||||+++++++......++||||++
T Consensus 6 y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 85 (277)
T cd06642 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLG 85 (277)
T ss_pred HHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEccC
Confidence 445567999999999999875 57889999865 15677889999999999999999999999999
Q ss_pred CCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCCceeec
Q 039819 268 NGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTA 347 (534)
Q Consensus 268 ~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~ 347 (534)
+++|.+++.. ..+++..+..++.|++.|+.|||+. +++|+||+|+||++++++.++|+|||++........ ....
T Consensus 86 ~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~-~~~~ 160 (277)
T cd06642 86 GGSALDLLKP-GPLEETYIATILREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI-KRNT 160 (277)
T ss_pred CCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcC---CeeccCCChheEEEeCCCCEEEccccccccccCcch-hhhc
Confidence 9999998865 4689999999999999999999998 999999999999999999999999999986643221 1223
Q ss_pred cccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceecccccCCCCCH
Q 039819 348 VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELGSNYDR 427 (534)
Q Consensus 348 ~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 427 (534)
..|+..|+|||++.+..++.++|||||||++|||+||+.|+...... .+........ .+. ...
T Consensus 161 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~-------~~~~~~~~~~------~~~----~~~ 223 (277)
T cd06642 161 FVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPM-------RVLFLIPKNS------PPT----LEG 223 (277)
T ss_pred ccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchh-------hHHhhhhcCC------CCC----CCc
Confidence 45788999999998888999999999999999999999998632211 1111111100 111 122
Q ss_pred HHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 039819 428 IEVGEILQVALLCTQYLPVHRPKMSEVVRM 457 (534)
Q Consensus 428 ~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~ 457 (534)
..+..+.+++.+|++.+|.+||+|.++++.
T Consensus 224 ~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 224 QYSKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred ccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 234578899999999999999999999974
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=295.37 Aligned_cols=247 Identities=24% Similarity=0.363 Sum_probs=192.2
Q ss_pred hCCCcCCeeccCCcEEEEEEEEC-----CCcEEEEEEeh---------------hhhhhcccCceeeEEEEEeC--CCee
Q 039819 202 ENFSSKNILGAGGFGNVYKGKLG-----DGTVLAVKRLK---------------DMISLAVHRNLLRLIGYCAT--PTER 259 (534)
Q Consensus 202 ~~~~~~~~lG~G~~g~Vy~~~~~-----~~~~vavK~~~---------------~~l~~~~h~niv~l~~~~~~--~~~~ 259 (534)
..|...+.||+|+||.||+|++. .+..||||.+. +.++.+.|+||+++++++.. ....
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 35666789999999999999864 36889999875 25678889999999999987 5578
Q ss_pred EEEeeccCCCChhhhcccCC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecC
Q 039819 260 LLVYPYMSNGSVASRLREKP-ALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLD 338 (534)
Q Consensus 260 ~lv~e~~~~gsL~~~l~~~~-~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~ 338 (534)
++||||+++++|.+++.... .+++..+..++.|++.||+|||+. +++||||||+||+++.++.++|+|||++....
T Consensus 84 ~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 160 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQ---RYIHRDLAARNILVESEDLVKISDFGLAKVLP 160 (284)
T ss_pred EEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccccccccc
Confidence 99999999999999997544 699999999999999999999998 99999999999999999999999999998765
Q ss_pred CCCCc--eeeccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCcccccc--------chHHHHHHHHh
Q 039819 339 HSDSH--VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQK--------GAMLEWVKKIQ 408 (534)
Q Consensus 339 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~--------~~~~~~~~~~~ 408 (534)
..... ......++..|+|||.+.+..++.++||||||+++|||+||+.|+......... .....+.....
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (284)
T cd05038 161 EDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLK 240 (284)
T ss_pred cCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHHH
Confidence 32211 111233456799999998888999999999999999999999997542211100 00111111111
Q ss_pred hhcccceecccccCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhcC
Q 039819 409 QEKKVEVLVDRELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLEGD 461 (534)
Q Consensus 409 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~~ 461 (534)
.. .....+...+.++.+++.+|++.+|++||+|.||+++|+..
T Consensus 241 ~~----------~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 241 EG----------ERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred cC----------CcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 11 11111222346899999999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=298.74 Aligned_cols=225 Identities=24% Similarity=0.364 Sum_probs=176.3
Q ss_pred CeeccCCcEEEEEEEECC--------CcEEEEEEehh--------------hhhhcccCceeeEEEEEeCCCeeEEEeec
Q 039819 208 NILGAGGFGNVYKGKLGD--------GTVLAVKRLKD--------------MISLAVHRNLLRLIGYCATPTERLLVYPY 265 (534)
Q Consensus 208 ~~lG~G~~g~Vy~~~~~~--------~~~vavK~~~~--------------~l~~~~h~niv~l~~~~~~~~~~~lv~e~ 265 (534)
+.||+|+||.||+|.... ...||+|.+.. ++..+.|||++++++++..+...++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 358999999999998632 23478887641 56678899999999999999999999999
Q ss_pred cCCCChhhhcccC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCc--------EEEEeccccee
Q 039819 266 MSNGSVASRLREK-PALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCE--------AIVGDFGLAKL 336 (534)
Q Consensus 266 ~~~gsL~~~l~~~-~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~--------~kl~DFGla~~ 336 (534)
+++|+|.++++.. ..+++..++.++.|++.||+|||+. +|+||||||+||+++.++. ++++|||++..
T Consensus 81 ~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~ 157 (258)
T cd05078 81 VKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISIT 157 (258)
T ss_pred CCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEecccccccCCCceEEecccccccc
Confidence 9999999999754 4689999999999999999999998 9999999999999987765 58999998875
Q ss_pred cCCCCCceeeccccccccccccccccC-CCCcchhHHHHHHHHHHHHhCC-CCcCCCccccccchHHHHHHHHhhhcccc
Q 039819 337 LDHSDSHVTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELITGM-RALEFGKSINQKGAMLEWVKKIQQEKKVE 414 (534)
Q Consensus 337 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~S~Gvvl~elltG~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 414 (534)
... .....++..|+|||++.+. .++.++|||||||++|||++|. .|+..... ..........
T Consensus 158 ~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~-------~~~~~~~~~~---- 221 (258)
T cd05078 158 VLP-----KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDS-------QKKLQFYEDR---- 221 (258)
T ss_pred cCC-----chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccH-------HHHHHHHHcc----
Confidence 432 2234578899999999764 5789999999999999999995 45432111 0111110000
Q ss_pred eecccccCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhh
Q 039819 415 VLVDRELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLE 459 (534)
Q Consensus 415 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~ 459 (534)
.. .+.....++.+++.+|++.+|++|||++++++.|.
T Consensus 222 ----~~----~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 222 ----HQ----LPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred ----cc----CCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 01 11112347899999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-36 Score=292.23 Aligned_cols=233 Identities=26% Similarity=0.401 Sum_probs=190.6
Q ss_pred CCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEeh-------------------hhhhhcccCceeeEEEEEeCCCeeEEE
Q 039819 203 NFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLK-------------------DMISLAVHRNLLRLIGYCATPTERLLV 262 (534)
Q Consensus 203 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~-------------------~~l~~~~h~niv~l~~~~~~~~~~~lv 262 (534)
+|+..+.||+|+||.||+|... ++..|++|.+. .++..++|+||+++++++......++|
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 4667789999999999999986 78999999753 156778899999999999999999999
Q ss_pred eeccCCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCC
Q 039819 263 YPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDS 342 (534)
Q Consensus 263 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~ 342 (534)
|||+++++|.+++.....+++..+..++.|++.||+|||+. +|+|+||||+||+++.++.+||+|||++.......
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~- 156 (258)
T cd06632 81 LELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS- 156 (258)
T ss_pred EEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccceeccccc-
Confidence 99999999999998777799999999999999999999998 99999999999999999999999999998764332
Q ss_pred ceeeccccccccccccccccCC-CCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceeccccc
Q 039819 343 HVTTAVRGTVGHIAPEYLSTGQ-SSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDREL 421 (534)
Q Consensus 343 ~~~~~~~gt~~y~aPE~~~~~~-~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 421 (534)
......|+..|+|||.+.... ++.++|+|||||++|||++|+.||..... ..............
T Consensus 157 -~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~-------~~~~~~~~~~~~~~------- 221 (258)
T cd06632 157 -FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEG-------VAAVFKIGRSKELP------- 221 (258)
T ss_pred -cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcH-------HHHHHHHHhcccCC-------
Confidence 223455889999999987666 89999999999999999999999864321 11111111101110
Q ss_pred CCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 422 GSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 422 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
..+......+.+++.+|++.+|.+||++.+++.
T Consensus 222 --~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 222 --PIPDHLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred --CcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 111122457889999999999999999999985
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=300.58 Aligned_cols=239 Identities=23% Similarity=0.286 Sum_probs=189.0
Q ss_pred hCCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEeh-----------------hhhhhcccCceeeEEEEEeCCCeeEEEe
Q 039819 202 ENFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLK-----------------DMISLAVHRNLLRLIGYCATPTERLLVY 263 (534)
Q Consensus 202 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~-----------------~~l~~~~h~niv~l~~~~~~~~~~~lv~ 263 (534)
++|+..+.||+|+||.||+|... +++.||+|.+. +.+..+.|+||+++++++......++||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 36788899999999999999986 48999999774 2567778999999999999999999999
Q ss_pred eccCCCChhhhcccC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCC
Q 039819 264 PYMSNGSVASRLREK--PALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSD 341 (534)
Q Consensus 264 e~~~~gsL~~~l~~~--~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~ 341 (534)
||+.+++|.+++... ..+++..+..++.|++.||.|||+. +++||||||+||+++.++.++|+|||++.......
T Consensus 81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~ 157 (316)
T cd05574 81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLL---GIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEP 157 (316)
T ss_pred EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChHHeEEcCCCCEEEeecchhhcccccc
Confidence 999999999998743 5689999999999999999999998 99999999999999999999999999987653221
Q ss_pred Cc----------------------------eeeccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCcc
Q 039819 342 SH----------------------------VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKS 393 (534)
Q Consensus 342 ~~----------------------------~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~ 393 (534)
.. ......||..|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~ 237 (316)
T cd05574 158 PPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNR 237 (316)
T ss_pred cccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCch
Confidence 10 01124578899999999888899999999999999999999999964321
Q ss_pred ccccchHHHHHHHHhhhcccceecccccCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhh
Q 039819 394 INQKGAMLEWVKKIQQEKKVEVLVDRELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLE 459 (534)
Q Consensus 394 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~ 459 (534)
. ..+.... +...........+..+.+++.+|++.+|++||+++..++.+.
T Consensus 238 ~------~~~~~~~----------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll 287 (316)
T cd05574 238 D------ETFSNIL----------KKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIK 287 (316)
T ss_pred H------HHHHHHh----------cCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHH
Confidence 1 1111111 011100011113568999999999999999999444444433
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=297.23 Aligned_cols=235 Identities=20% Similarity=0.318 Sum_probs=190.6
Q ss_pred hCCCcCCeeccCCcEEEEEEEE-CCCcEEEEEEeh--------------hhhhhcccCceeeEEEEEeCCCeeEEEeecc
Q 039819 202 ENFSSKNILGAGGFGNVYKGKL-GDGTVLAVKRLK--------------DMISLAVHRNLLRLIGYCATPTERLLVYPYM 266 (534)
Q Consensus 202 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~--------------~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~ 266 (534)
.+|+..+.||.|+||.||+|.. .+++.||+|.+. ..+..++|+||+++++++...+..++||||+
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 98 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL 98 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence 3578888999999999999986 478899999774 2567788999999999999999999999999
Q ss_pred CCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCCceee
Q 039819 267 SNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTT 346 (534)
Q Consensus 267 ~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~ 346 (534)
++++|.+++... .+++.++..++.+++.||+|||+. +++||||||+||+++.++.+||+|||++........ ...
T Consensus 99 ~~~~L~~~~~~~-~l~~~~~~~i~~~l~~al~~LH~~---~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~-~~~ 173 (296)
T cd06655 99 AGGSLTDVVTET-CMDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS-KRS 173 (296)
T ss_pred CCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccchhcccccc-cCC
Confidence 999999988654 589999999999999999999999 999999999999999999999999999886543322 122
Q ss_pred ccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceecccccCCCCC
Q 039819 347 AVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELGSNYD 426 (534)
Q Consensus 347 ~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 426 (534)
...|+..|+|||.+.+..++.++|||||||++|||+||+.||....... ......... ... + ..+
T Consensus 174 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~-------~~~~~~~~~-~~~-----~--~~~ 238 (296)
T cd06655 174 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR-------ALYLIATNG-TPE-----L--QNP 238 (296)
T ss_pred CcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-------HHHHHHhcC-Ccc-----c--CCc
Confidence 3458899999999988889999999999999999999999997533211 111111100 000 0 011
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 427 RIEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 427 ~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
......+.+++.+|++.+|++||++.+++.
T Consensus 239 ~~~~~~~~~li~~~l~~dp~~Rpt~~~il~ 268 (296)
T cd06655 239 EKLSPIFRDFLNRCLEMDVEKRGSAKELLQ 268 (296)
T ss_pred ccCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 122347889999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=292.73 Aligned_cols=239 Identities=24% Similarity=0.386 Sum_probs=189.5
Q ss_pred CCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEeh------------------------hhhhhcccCceeeEEEEEeCCC
Q 039819 203 NFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLK------------------------DMISLAVHRNLLRLIGYCATPT 257 (534)
Q Consensus 203 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~------------------------~~l~~~~h~niv~l~~~~~~~~ 257 (534)
+|...+.||+|+||.||+|... +++.||+|.+. ..+..+.|+|++++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 3566789999999999999864 68899999753 1466778999999999999999
Q ss_pred eeEEEeeccCCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceec
Q 039819 258 ERLLVYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLL 337 (534)
Q Consensus 258 ~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~ 337 (534)
..++||||+++++|.+++.....+++..+..++.|++.||.|||+. +++||||||+||+++.++.++|+|||+++..
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~ 158 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSK---GILHRDLKADNLLVDADGICKISDFGISKKS 158 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhC---CeeecCCChhhEEEcCCCeEEEeeccccccc
Confidence 9999999999999999998878899999999999999999999998 9999999999999999999999999999865
Q ss_pred CCCCCc-eeeccccccccccccccccCC--CCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccc
Q 039819 338 DHSDSH-VTTAVRGTVGHIAPEYLSTGQ--SSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVE 414 (534)
Q Consensus 338 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~--~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 414 (534)
...... ......|+..|+|||++.... ++.++||||||+++||+++|+.||..... ...+...... . ..
T Consensus 159 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~------~~~~~~~~~~-~-~~ 230 (272)
T cd06629 159 DDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEA------IAAMFKLGNK-R-SA 230 (272)
T ss_pred cccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcch------HHHHHHhhcc-c-cC
Confidence 432111 123345889999999987654 78999999999999999999999853211 1111111100 0 00
Q ss_pred eecccccCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 415 VLVDRELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 415 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
..+... .....+..+.+++.+|++.+|.+||++.+|++
T Consensus 231 ~~~~~~----~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (272)
T cd06629 231 PPIPPD----VSMNLSPVALDFLNACFTINPDNRPTARELLQ 268 (272)
T ss_pred CcCCcc----ccccCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence 111111 11123458889999999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-36 Score=296.88 Aligned_cols=245 Identities=25% Similarity=0.387 Sum_probs=191.1
Q ss_pred cCHHHHHHHHhCCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEehh-------------hhhhc-ccCceeeEEEEEeC-
Q 039819 192 FTFRELQQATENFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLKD-------------MISLA-VHRNLLRLIGYCAT- 255 (534)
Q Consensus 192 ~~~~~l~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~-------------~l~~~-~h~niv~l~~~~~~- 255 (534)
.++.++....+.|+..+.||+|+||.||+|+.. +++.+|+|.+.. ++.++ .|+||+++++++..
T Consensus 6 ~~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 85 (282)
T cd06636 6 IDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFIKK 85 (282)
T ss_pred hhhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcc
Confidence 466677777889999999999999999999974 678999997641 34444 69999999999853
Q ss_pred -----CCeeEEEeeccCCCChhhhccc--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEE
Q 039819 256 -----PTERLLVYPYMSNGSVASRLRE--KPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIV 328 (534)
Q Consensus 256 -----~~~~~lv~e~~~~gsL~~~l~~--~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl 328 (534)
....++||||+++|+|.+++.. ...+++..+..++.|++.||.|||+. +|+||||||+||+++.++.++|
T Consensus 86 ~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dl~~~nili~~~~~~~l 162 (282)
T cd06636 86 SPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAH---KVIHRDIKGQNVLLTENAEVKL 162 (282)
T ss_pred cccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEE
Confidence 4567999999999999998864 34588999999999999999999998 9999999999999999999999
Q ss_pred EecccceecCCCCCceeeccccccccccccccc-----cCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHH
Q 039819 329 GDFGLAKLLDHSDSHVTTAVRGTVGHIAPEYLS-----TGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEW 403 (534)
Q Consensus 329 ~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~ 403 (534)
+|||++........ ......|+..|+|||++. ...++.++|||||||++|||+||+.||........ +.
T Consensus 163 ~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~---~~-- 236 (282)
T cd06636 163 VDFGVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRA---LF-- 236 (282)
T ss_pred eeCcchhhhhcccc-CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhh---hh--
Confidence 99999876532211 123356899999999875 34578899999999999999999999963221100 00
Q ss_pred HHHHhhhcccceecccccCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 404 VKKIQQEKKVEVLVDRELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 404 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
.... . ..+.. .....+..+.+++.+|++.+|.+||++.|+++
T Consensus 237 --~~~~-~-----~~~~~---~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 237 --LIPR-N-----PPPKL---KSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred --hHhh-C-----CCCCC---cccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 0000 0 00011 11123457899999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-36 Score=296.40 Aligned_cols=238 Identities=26% Similarity=0.435 Sum_probs=189.9
Q ss_pred hCCCcCCeeccCCcEEEEEEEECC-C----cEEEEEEehh---------------hhhhcccCceeeEEEEEeCCCeeEE
Q 039819 202 ENFSSKNILGAGGFGNVYKGKLGD-G----TVLAVKRLKD---------------MISLAVHRNLLRLIGYCATPTERLL 261 (534)
Q Consensus 202 ~~~~~~~~lG~G~~g~Vy~~~~~~-~----~~vavK~~~~---------------~l~~~~h~niv~l~~~~~~~~~~~l 261 (534)
.+|+..+.||+|+||.||+|.+.+ + ..+|+|.+.. .+..+.|+||++++++|.. ...++
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~ 85 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL 85 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence 467788999999999999998642 3 3589987642 5677889999999999987 78899
Q ss_pred EeeccCCCChhhhccc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCC
Q 039819 262 VYPYMSNGSVASRLRE-KPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHS 340 (534)
Q Consensus 262 v~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~ 340 (534)
||||+++|+|.+++.. ...+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||+++.....
T Consensus 86 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~ 162 (279)
T cd05057 86 ITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVD 162 (279)
T ss_pred EEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecccCcceEEEcCCCeEEECCCcccccccCc
Confidence 9999999999999975 34699999999999999999999998 9999999999999999999999999999876533
Q ss_pred CCcee-eccccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCcCCCccccccchHHHHHHHHhhhcccceecc
Q 039819 341 DSHVT-TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVD 418 (534)
Q Consensus 341 ~~~~~-~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 418 (534)
..... ....++..|+|||.+....++.++|||||||++||++| |+.||..... .++.........
T Consensus 163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~-------~~~~~~~~~~~~------ 229 (279)
T cd05057 163 EKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPA-------VEIPDLLEKGER------ 229 (279)
T ss_pred ccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCH-------HHHHHHHhCCCC------
Confidence 22111 11223568999999988889999999999999999999 9999974321 122222211110
Q ss_pred cccCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhc
Q 039819 419 RELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLEG 460 (534)
Q Consensus 419 ~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~ 460 (534)
...+......+.+++.+|+..+|.+||++.++++.|+.
T Consensus 230 ----~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~ 267 (279)
T cd05057 230 ----LPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSK 267 (279)
T ss_pred ----CCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHH
Confidence 01111233478899999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-36 Score=297.98 Aligned_cols=235 Identities=23% Similarity=0.379 Sum_probs=187.2
Q ss_pred CCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEeh---------------hhhhhcccCceeeEEEEEeCCCeeEEEeecc
Q 039819 203 NFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLK---------------DMISLAVHRNLLRLIGYCATPTERLLVYPYM 266 (534)
Q Consensus 203 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~---------------~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~ 266 (534)
+|+..+.||+|+||.||++... ++..||+|.+. +.+..++|+||+++++++......++||||+
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (286)
T cd06622 2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYM 81 (286)
T ss_pred hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeec
Confidence 5777889999999999999986 78999999764 2567788999999999999999999999999
Q ss_pred CCCChhhhcccC---CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCCc
Q 039819 267 SNGSVASRLREK---PALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSH 343 (534)
Q Consensus 267 ~~gsL~~~l~~~---~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~ 343 (534)
++++|..++... ..+++..+..++.+++.||.|||+.+ +|+||||||+||+++.++.+||+|||++.......
T Consensus 82 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~-- 157 (286)
T cd06622 82 DAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEH--NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL-- 157 (286)
T ss_pred CCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcC--CEeeCCCCHHHEEECCCCCEEEeecCCcccccCCc--
Confidence 999999888753 36899999999999999999999642 89999999999999999999999999997653321
Q ss_pred eeeccccccccccccccccCC------CCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceec
Q 039819 344 VTTAVRGTVGHIAPEYLSTGQ------SSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLV 417 (534)
Q Consensus 344 ~~~~~~gt~~y~aPE~~~~~~------~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 417 (534)
.....++..|+|||++.+.. ++.++|||||||++|||+||+.||...... ....-........
T Consensus 158 -~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~----~~~~~~~~~~~~~------ 226 (286)
T cd06622 158 -AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYA----NIFAQLSAIVDGD------ 226 (286)
T ss_pred -cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchh----hHHHHHHHHhhcC------
Confidence 22345788999999985433 478999999999999999999999643211 0111111111000
Q ss_pred ccccCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 418 DRELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 418 d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
....+......+.+++.+|++.+|++||++.+++.
T Consensus 227 ----~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 261 (286)
T cd06622 227 ----PPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLE 261 (286)
T ss_pred ----CCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence 01122224567889999999999999999999985
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-36 Score=291.22 Aligned_cols=234 Identities=24% Similarity=0.361 Sum_probs=192.3
Q ss_pred CCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEeh----------------hhhhhcccCceeeEEEEEeCCCeeEEEeec
Q 039819 203 NFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLK----------------DMISLAVHRNLLRLIGYCATPTERLLVYPY 265 (534)
Q Consensus 203 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~----------------~~l~~~~h~niv~l~~~~~~~~~~~lv~e~ 265 (534)
+|+..+.||.|+||.||.++.. ++..+++|.+. +++++++|+||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 4778899999999999999864 58889999754 267888999999999999999999999999
Q ss_pred cCCCChhhhcccC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCCc
Q 039819 266 MSNGSVASRLREK--PALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSH 343 (534)
Q Consensus 266 ~~~gsL~~~l~~~--~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~ 343 (534)
+++|+|.+++... ..+++..+..++.|++.||.|||+. +++||||||+||++++++.+||+|||++........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~- 156 (256)
T cd08221 81 ANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS- 156 (256)
T ss_pred cCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChHhEEEeCCCCEEECcCcceEEcccccc-
Confidence 9999999999754 5689999999999999999999998 999999999999999999999999999987654332
Q ss_pred eeeccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceecccccCC
Q 039819 344 VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELGS 423 (534)
Q Consensus 344 ~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 423 (534)
......|+..|+|||++.+..++.++||||||+++|||++|+.||+.... .+......... ..
T Consensus 157 ~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~-------~~~~~~~~~~~-~~--------- 219 (256)
T cd08221 157 MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNP-------LNLVVKIVQGN-YT--------- 219 (256)
T ss_pred cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCH-------HHHHHHHHcCC-CC---------
Confidence 22345689999999999888889999999999999999999999964321 12222221111 00
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 039819 424 NYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRM 457 (534)
Q Consensus 424 ~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~ 457 (534)
.........+.+++.+|++.+|.+||++.++++.
T Consensus 220 ~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~ 253 (256)
T cd08221 220 PVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQ 253 (256)
T ss_pred CCccccCHHHHHHHHHHcccCcccCCCHHHHhhC
Confidence 0112234578899999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=303.01 Aligned_cols=252 Identities=23% Similarity=0.342 Sum_probs=188.5
Q ss_pred HHhCCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEeh----------------hhhhhc-ccCceeeEEEEEeCC--Cee
Q 039819 200 ATENFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLK----------------DMISLA-VHRNLLRLIGYCATP--TER 259 (534)
Q Consensus 200 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~----------------~~l~~~-~h~niv~l~~~~~~~--~~~ 259 (534)
..++|...+.||+|+||.||+|... ++..+|||++. .++..+ .|+||++++++|... ...
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 3567888899999999999999975 57899999773 256677 999999999998654 357
Q ss_pred EEEeeccCCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCC
Q 039819 260 LLVYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDH 339 (534)
Q Consensus 260 ~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~ 339 (534)
++||||++ ++|.+++... .++|..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 85 ~lv~e~~~-~~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~---~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~ 159 (337)
T cd07852 85 YLVFEYME-TDLHAVIRAN-ILEDVHKRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARSLSE 159 (337)
T ss_pred EEEecccc-cCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccchhcccc
Confidence 99999997 5998888766 789999999999999999999998 999999999999999999999999999986643
Q ss_pred CCC----ceeecccccccccccccccc-CCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhh-----
Q 039819 340 SDS----HVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQ----- 409 (534)
Q Consensus 340 ~~~----~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~----- 409 (534)
... .......|+..|+|||++.+ ..++.++|||||||++|||+||+.||...........+..+......
T Consensus 160 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (337)
T cd07852 160 LEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIES 239 (337)
T ss_pred ccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHH
Confidence 221 12234568999999998754 45788999999999999999999999754432221111111100000
Q ss_pred --hcccceecc----cccC--CCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 410 --EKKVEVLVD----RELG--SNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 410 --~~~~~~~~d----~~l~--~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
......+++ .... .......+..+.+++.+|++.+|++||++.++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~ 294 (337)
T cd07852 240 IKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALE 294 (337)
T ss_pred HHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhh
Confidence 000000110 0000 0000113457899999999999999999999986
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=289.70 Aligned_cols=242 Identities=23% Similarity=0.299 Sum_probs=193.3
Q ss_pred CHHHHHHHHhCCCcCCee--ccCCcEEEEEEEEC-CCcEEEEEEehh---------hhh-hcccCceeeEEEEEeCCCee
Q 039819 193 TFRELQQATENFSSKNIL--GAGGFGNVYKGKLG-DGTVLAVKRLKD---------MIS-LAVHRNLLRLIGYCATPTER 259 (534)
Q Consensus 193 ~~~~l~~~~~~~~~~~~l--G~G~~g~Vy~~~~~-~~~~vavK~~~~---------~l~-~~~h~niv~l~~~~~~~~~~ 259 (534)
+..++....++|...+.+ |+|+||.||++... ++..+|+|.+.. ... ...|+||+++++++...+..
T Consensus 5 ~~~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~e~~~~~~~~~h~~iv~~~~~~~~~~~~ 84 (267)
T PHA03390 5 SLSELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAIEPMVHQLMKDNPNFIKLYYSVTTLKGH 84 (267)
T ss_pred HHHHHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchhhHHHHHHhhcCCCEEEEEEEEecCCee
Confidence 345556667788887776 99999999999874 678899998753 111 22699999999999999999
Q ss_pred EEEeeccCCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCC-cEEEEecccceecC
Q 039819 260 LLVYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFC-EAIVGDFGLAKLLD 338 (534)
Q Consensus 260 ~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~-~~kl~DFGla~~~~ 338 (534)
++||||+++|+|.+++.....+++..+..++.|+++||.|||+. +++||||||+||+++.++ .++|+|||+++...
T Consensus 85 ~iv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~ 161 (267)
T PHA03390 85 VLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIG 161 (267)
T ss_pred EEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEeCCCCeEEEecCccceecC
Confidence 99999999999999998777899999999999999999999998 999999999999999988 99999999998764
Q ss_pred CCCCceeeccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceecc
Q 039819 339 HSDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVD 418 (534)
Q Consensus 339 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 418 (534)
... ...|+..|+|||++.+..++.++|||||||++|||++|+.||...... .-....|......
T Consensus 162 ~~~-----~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~--~~~~~~~~~~~~~--------- 225 (267)
T PHA03390 162 TPS-----CYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDE--ELDLESLLKRQQK--------- 225 (267)
T ss_pred CCc-----cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcc--hhhHHHHHHhhcc---------
Confidence 322 235889999999998888999999999999999999999999733211 1011122221100
Q ss_pred cccCCCCCHHHHHHHHHHHHHhcccCCCCCCC-hHHHHH
Q 039819 419 RELGSNYDRIEVGEILQVALLCTQYLPVHRPK-MSEVVR 456 (534)
Q Consensus 419 ~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt-~~ev~~ 456 (534)
.. .........+.+++.+|++.+|.+||+ ++++++
T Consensus 226 -~~--~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 226 -KL--PFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred -cC--CcccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 00 111123457899999999999999996 688874
|
|
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=328.15 Aligned_cols=239 Identities=19% Similarity=0.325 Sum_probs=187.3
Q ss_pred HHHhCCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEeh----------------hhhhhcccCceeeEEEEEeC--CCee
Q 039819 199 QATENFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLK----------------DMISLAVHRNLLRLIGYCAT--PTER 259 (534)
Q Consensus 199 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~----------------~~l~~~~h~niv~l~~~~~~--~~~~ 259 (534)
...++|.+.+.||+|+||.||+|+.. .+..||+|.+. .++..+.|||||+++++|.. ....
T Consensus 10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~l 89 (1021)
T PTZ00266 10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKL 89 (1021)
T ss_pred cccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEE
Confidence 44578999999999999999999975 56788999764 26788899999999998854 3568
Q ss_pred EEEeeccCCCChhhhccc----CCCCCHHHHHHHHHHHHHHHHHHHhcCC----CCeEeccCCCCcEEeCC---------
Q 039819 260 LLVYPYMSNGSVASRLRE----KPALDWNTRKRIAIGAARGLLYLHEQCD----PKIIHRDVKAANVLLDD--------- 322 (534)
Q Consensus 260 ~lv~e~~~~gsL~~~l~~----~~~l~~~~~~~i~~~i~~~l~yLH~~~~----~~ivH~Dlkp~NiLl~~--------- 322 (534)
||||||+++|+|.+++.. ...+++..++.|+.||+.||.|||+... .+||||||||+||||+.
T Consensus 90 yIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~ 169 (1021)
T PTZ00266 90 YILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKIT 169 (1021)
T ss_pred EEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccccc
Confidence 999999999999998864 3569999999999999999999998521 25999999999999964
Q ss_pred --------CCcEEEEecccceecCCCCCceeecccccccccccccccc--CCCCcchhHHHHHHHHHHHHhCCCCcCCCc
Q 039819 323 --------FCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGHIAPEYLST--GQSSEKTDVFGFGILLLELITGMRALEFGK 392 (534)
Q Consensus 323 --------~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~ 392 (534)
.+.+||+|||++..+.... ......||+.|+|||++.+ ..++.++||||||||+|||+||+.||....
T Consensus 170 ~~~~n~ng~~iVKLsDFGlAr~l~~~s--~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~ 247 (1021)
T PTZ00266 170 AQANNLNGRPIAKIGDFGLSKNIGIES--MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKAN 247 (1021)
T ss_pred ccccccCCCCceEEccCCccccccccc--cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCC
Confidence 3458999999998764322 2234569999999999854 458899999999999999999999996432
Q ss_pred cccccchHHHHHHHHhhhcccceecccccCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 393 SINQKGAMLEWVKKIQQEKKVEVLVDRELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 393 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
. ...++..+.... .+.. ...+..+.+++..||+.+|.+||++.|++.
T Consensus 248 ~------~~qli~~lk~~p--------~lpi---~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 248 N------FSQLISELKRGP--------DLPI---KGKSKELNILIKNLLNLSAKERPSALQCLG 294 (1021)
T ss_pred c------HHHHHHHHhcCC--------CCCc---CCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence 2 112222211111 1100 112357889999999999999999999984
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=297.51 Aligned_cols=241 Identities=16% Similarity=0.209 Sum_probs=180.1
Q ss_pred hCCCcCCeeccCCcEEEEEEEECC----CcEEEEEEeh--------h-----------------hhhhcccCceeeEEEE
Q 039819 202 ENFSSKNILGAGGFGNVYKGKLGD----GTVLAVKRLK--------D-----------------MISLAVHRNLLRLIGY 252 (534)
Q Consensus 202 ~~~~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~--------~-----------------~l~~~~h~niv~l~~~ 252 (534)
++|...+.||+|+||.||+|+..+ +..+|+|... + .+..+.|+|++++++.
T Consensus 12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~ 91 (294)
T PHA02882 12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGC 91 (294)
T ss_pred CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEe
Confidence 578889999999999999999754 3456666432 0 1234579999999987
Q ss_pred EeCCC----eeEEEeeccCCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEE
Q 039819 253 CATPT----ERLLVYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIV 328 (534)
Q Consensus 253 ~~~~~----~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl 328 (534)
+.... ..++++|++.. ++.+.+......++..+..|+.|++.||.|||+. +|+||||||+|||++.++.++|
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiHrDiKp~Nill~~~~~~~l 167 (294)
T PHA02882 92 GSFKRCRMYYRFILLEKLVE-NTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEH---GISHGDIKPENIMVDGNNRGYI 167 (294)
T ss_pred eeEecCCceEEEEEEehhcc-CHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCcEEE
Confidence 65543 34678887743 5666665555578889999999999999999998 9999999999999999999999
Q ss_pred EecccceecCCCCC------ceeeccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccch--H
Q 039819 329 GDFGLAKLLDHSDS------HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGA--M 400 (534)
Q Consensus 329 ~DFGla~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~--~ 400 (534)
+|||+++....... .......||+.|+|||++.+..++.++|||||||++|||++|+.||........... .
T Consensus 168 ~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~~~ 247 (294)
T PHA02882 168 IDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAAK 247 (294)
T ss_pred EEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHHhH
Confidence 99999987642211 112234699999999999999999999999999999999999999975422111000 0
Q ss_pred HHHHHHHhhhcccceecccccCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHh
Q 039819 401 LEWVKKIQQEKKVEVLVDRELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRML 458 (534)
Q Consensus 401 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L 458 (534)
.++...+.... .. ....+..+.+++..|++.+|++||++.++++.+
T Consensus 248 ~~~~~~~~~~~---------~~---~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 248 CDFIKRLHEGK---------IK---IKNANKFIYDFIECVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred HHHHHHhhhhh---------hc---cCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence 12222221110 00 011245789999999999999999999999876
|
|
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-36 Score=296.93 Aligned_cols=235 Identities=25% Similarity=0.342 Sum_probs=183.5
Q ss_pred hCCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEehh----------------hhhhcccCceeeEEEEEeCCCeeEEEee
Q 039819 202 ENFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLKD----------------MISLAVHRNLLRLIGYCATPTERLLVYP 264 (534)
Q Consensus 202 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~----------------~l~~~~h~niv~l~~~~~~~~~~~lv~e 264 (534)
++|+..+.||+|+||.||+++.. +|+.||+|++.. .++...||||+++++++......++|||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 36788899999999999999975 689999998752 2455679999999999999999999999
Q ss_pred ccCCCChhhhcc----cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCC
Q 039819 265 YMSNGSVASRLR----EKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHS 340 (534)
Q Consensus 265 ~~~~gsL~~~l~----~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~ 340 (534)
|++ |+|.+++. ....+++..++.++.|++.||.|||+++ +++||||||+||+++.++.+||+|||++......
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 157 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS 157 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence 997 67776664 2356899999999999999999999853 7999999999999999999999999999865432
Q ss_pred CCceeecccccccccccccccc----CCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhccccee
Q 039819 341 DSHVTTAVRGTVGHIAPEYLST----GQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVL 416 (534)
Q Consensus 341 ~~~~~~~~~gt~~y~aPE~~~~----~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 416 (534)
. ......|+..|+|||++.+ ..++.++|||||||++|||++|+.||...... .+-........
T Consensus 158 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~------~~~~~~~~~~~----- 224 (283)
T cd06617 158 V--AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTP------FQQLKQVVEEP----- 224 (283)
T ss_pred c--ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccC------HHHHHHHHhcC-----
Confidence 1 1223458899999998854 44688999999999999999999998632110 11111111100
Q ss_pred cccccCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 417 VDRELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 417 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
.+.+. ....+..+.+++.+|+..+|.+||++.++++
T Consensus 225 -~~~~~---~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 225 -SPQLP---AEKFSPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred -CCCCC---ccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 01111 1112457899999999999999999999985
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-36 Score=296.79 Aligned_cols=250 Identities=23% Similarity=0.313 Sum_probs=189.3
Q ss_pred CCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEeh----------------hhhhhcccCceeeEEEEEeCCCeeEEEeec
Q 039819 203 NFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLK----------------DMISLAVHRNLLRLIGYCATPTERLLVYPY 265 (534)
Q Consensus 203 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~----------------~~l~~~~h~niv~l~~~~~~~~~~~lv~e~ 265 (534)
+|...+.||+|+||.||+|+.. +++.||||++. .+++.++|+||+++++++......++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 4777889999999999999975 68999999874 256777899999999999999999999999
Q ss_pred cCCCChhhhccc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCCce
Q 039819 266 MSNGSVASRLRE-KPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHV 344 (534)
Q Consensus 266 ~~~gsL~~~l~~-~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~ 344 (534)
+ +++|.+++.. ...+++..++.++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++..........
T Consensus 81 ~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~ 156 (286)
T cd07832 81 M-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHAN---GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRL 156 (286)
T ss_pred c-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCCc
Confidence 9 9999999864 45699999999999999999999998 99999999999999999999999999998765433222
Q ss_pred eeccccccccccccccccC-CCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhh--------cccce
Q 039819 345 TTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQE--------KKVEV 415 (534)
Q Consensus 345 ~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~ 415 (534)
.....|+..|+|||++.+. .++.++||||+||+++||+||++||...........+.......... .....
T Consensus 157 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (286)
T cd07832 157 YSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNK 236 (286)
T ss_pred cccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhhc
Confidence 3345689999999998654 46899999999999999999988876433211111111100000000 00000
Q ss_pred ecccccCC----CCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 416 LVDRELGS----NYDRIEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 416 ~~d~~l~~----~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
+..+.... .........+.+++.+|++.+|.+||++++++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~ 281 (286)
T cd07832 237 ITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALR 281 (286)
T ss_pred ccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 00000000 000112368899999999999999999999986
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=291.08 Aligned_cols=235 Identities=26% Similarity=0.364 Sum_probs=186.9
Q ss_pred hCCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEeh-------------------hhhhhcccCceeeEEEEEeCC--Cee
Q 039819 202 ENFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLK-------------------DMISLAVHRNLLRLIGYCATP--TER 259 (534)
Q Consensus 202 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~-------------------~~l~~~~h~niv~l~~~~~~~--~~~ 259 (534)
.+|...+.||+|+||.||+|... ++..||||.+. ..+..+.||||+++++++.+. ...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 46888899999999999999875 58999999763 257778899999999998764 457
Q ss_pred EEEeeccCCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCC
Q 039819 260 LLVYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDH 339 (534)
Q Consensus 260 ~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~ 339 (534)
++||||+++++|.+++.....+++....+++.|++.||.|||+. +++|+||||+||+++.++.++|+|||+++....
T Consensus 82 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~ 158 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASKRLQT 158 (265)
T ss_pred EEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEecCCCCEEECcCcccccccc
Confidence 89999999999999998777789999999999999999999998 999999999999999999999999999986532
Q ss_pred CC--CceeeccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceec
Q 039819 340 SD--SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLV 417 (534)
Q Consensus 340 ~~--~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 417 (534)
.. ........|+..|+|||++.+..++.++|||||||++|||++|+.||..... ..... ......
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~------~~~~~-~~~~~~------ 225 (265)
T cd06652 159 ICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEA------MAAIF-KIATQP------ 225 (265)
T ss_pred ccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccch------HHHHH-HHhcCC------
Confidence 11 1112234588999999999888899999999999999999999999863211 11111 110000
Q ss_pred ccccCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 418 DRELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 418 d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
.....+......+.+++.+|+. +|++||+++|+++
T Consensus 226 ---~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~ 260 (265)
T cd06652 226 ---TNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLR 260 (265)
T ss_pred ---CCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence 0111233344577888889985 8999999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=289.85 Aligned_cols=238 Identities=24% Similarity=0.352 Sum_probs=191.7
Q ss_pred hCCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEeh--------------hhhhhcccCceeeEEEEEeCCCeeEEEeecc
Q 039819 202 ENFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLK--------------DMISLAVHRNLLRLIGYCATPTERLLVYPYM 266 (534)
Q Consensus 202 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~--------------~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~ 266 (534)
++|...+.||+|+||.||+|... +++.+|+|.+. .+++.++||||+++++++......+++|||+
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~ 82 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYC 82 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCC
Confidence 56888899999999999999875 57889999764 2677889999999999999999999999999
Q ss_pred CCCChhhhcccC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCCcee
Q 039819 267 SNGSVASRLREK-PALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVT 345 (534)
Q Consensus 267 ~~gsL~~~l~~~-~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~ 345 (534)
++++|.+++... ..+++..+..++.|++.||.|||+. +++|+||||+||+++.++.+||+|||++....... ...
T Consensus 83 ~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~-~~~ 158 (262)
T cd06613 83 GGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHET---GKIHRDIKGANILLTEDGDVKLADFGVSAQLTATI-AKR 158 (262)
T ss_pred CCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhC---CceecCCChhhEEECCCCCEEECccccchhhhhhh-hcc
Confidence 999999998765 6799999999999999999999998 99999999999999999999999999988654322 122
Q ss_pred eccccccccccccccccC---CCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceecccccC
Q 039819 346 TAVRGTVGHIAPEYLSTG---QSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELG 422 (534)
Q Consensus 346 ~~~~gt~~y~aPE~~~~~---~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 422 (534)
....++..|+|||.+.+. .++.++|||||||++|||+||+.||....... ... ...... .....+
T Consensus 159 ~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~---~~~----~~~~~~----~~~~~~- 226 (262)
T cd06613 159 KSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMR---ALF----LISKSN----FPPPKL- 226 (262)
T ss_pred ccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHH---HHH----HHHhcc----CCCccc-
Confidence 335688899999998776 78999999999999999999999986422110 010 010100 000011
Q ss_pred CCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 423 SNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 423 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
......+..+.+++.+|++.+|.+||++.+|+.
T Consensus 227 -~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 227 -KDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred -cchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 112233567899999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-36 Score=296.39 Aligned_cols=227 Identities=25% Similarity=0.337 Sum_probs=181.3
Q ss_pred eeccCCcEEEEEEEEC-CCcEEEEEEehh--------------------hhhhcccCceeeEEEEEeCCCeeEEEeeccC
Q 039819 209 ILGAGGFGNVYKGKLG-DGTVLAVKRLKD--------------------MISLAVHRNLLRLIGYCATPTERLLVYPYMS 267 (534)
Q Consensus 209 ~lG~G~~g~Vy~~~~~-~~~~vavK~~~~--------------------~l~~~~h~niv~l~~~~~~~~~~~lv~e~~~ 267 (534)
+||+|+||.||++... +++.+|+|.+.+ ++....|+||+.+++++...+..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999975 588999997631 2223469999999999999999999999999
Q ss_pred CCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCCceeec
Q 039819 268 NGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTA 347 (534)
Q Consensus 268 ~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~ 347 (534)
+|+|.+++.....+++..+..++.|++.||.|||+. +|+||||||+|||++.++.++|+|||++....... ...
T Consensus 81 ~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~---~~~ 154 (279)
T cd05633 81 GGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---PHA 154 (279)
T ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcCCCCCCHHHEEECCCCCEEEccCCcceeccccC---ccC
Confidence 999999998878899999999999999999999998 99999999999999999999999999987654322 223
Q ss_pred ccccccccccccccc-CCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceecccccCCCCC
Q 039819 348 VRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELGSNYD 426 (534)
Q Consensus 348 ~~gt~~y~aPE~~~~-~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 426 (534)
..|+..|+|||.+.+ ..++.++|||||||++|||+||+.||........ ......... .... .+
T Consensus 155 ~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~-----~~~~~~~~~------~~~~----~~ 219 (279)
T cd05633 155 SVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK-----HEIDRMTLT------VNVE----LP 219 (279)
T ss_pred cCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCH-----HHHHHHhhc------CCcC----Cc
Confidence 468999999999864 4578999999999999999999999974322110 111111000 0111 12
Q ss_pred HHHHHHHHHHHHHhcccCCCCCC-----ChHHHHH
Q 039819 427 RIEVGEILQVALLCTQYLPVHRP-----KMSEVVR 456 (534)
Q Consensus 427 ~~~~~~l~~l~~~Cl~~~P~~RP-----t~~ev~~ 456 (534)
...+..+.+++.+|++.+|++|| +++++++
T Consensus 220 ~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~ 254 (279)
T cd05633 220 DSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKE 254 (279)
T ss_pred cccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHh
Confidence 22345788999999999999999 5888775
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=290.86 Aligned_cols=237 Identities=26% Similarity=0.424 Sum_probs=191.1
Q ss_pred CCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEeh----------------hhhhhcccCceeeEEEEEeCCCeeEEEeec
Q 039819 203 NFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLK----------------DMISLAVHRNLLRLIGYCATPTERLLVYPY 265 (534)
Q Consensus 203 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~----------------~~l~~~~h~niv~l~~~~~~~~~~~lv~e~ 265 (534)
+|...+.||+|+||.||+|... ++..||+|.+. ..+..++|+||+++++++...+..++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 4777889999999999999875 68899999875 267788999999999999999999999999
Q ss_pred cCCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCCcee
Q 039819 266 MSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVT 345 (534)
Q Consensus 266 ~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~ 345 (534)
+++++|.+++.....+++..+..|+.+++.||.|||+. +|+|+||||+||+++.++.+||+|||++...........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~ 157 (264)
T cd06626 81 CSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMG 157 (264)
T ss_pred CCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEcccccccccCCCCCccc
Confidence 99999999998877799999999999999999999998 999999999999999999999999999987654332211
Q ss_pred ---eccccccccccccccccCC---CCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceeccc
Q 039819 346 ---TAVRGTVGHIAPEYLSTGQ---SSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDR 419 (534)
Q Consensus 346 ---~~~~gt~~y~aPE~~~~~~---~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 419 (534)
....++..|+|||++.+.. ++.++||||||+++|||++|+.||...... ......... .. .+
T Consensus 158 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~------~~~~~~~~~-~~-----~~ 225 (264)
T cd06626 158 EEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNE------FQIMFHVGA-GH-----KP 225 (264)
T ss_pred ccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcch------HHHHHHHhc-CC-----CC
Confidence 1345788999999997766 789999999999999999999999643210 111111111 00 11
Q ss_pred ccCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 420 ELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 420 ~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
.+... ......+.+++.+|++.+|.+||++.|++.
T Consensus 226 ~~~~~--~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 226 PIPDS--LQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred CCCcc--cccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 11111 112457789999999999999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=291.58 Aligned_cols=238 Identities=28% Similarity=0.437 Sum_probs=191.5
Q ss_pred CCCcCCeeccCCcEEEEEEEE-CCCcEEEEEEeh--------------------hhhhhcccCceeeEEEEEeCCCeeEE
Q 039819 203 NFSSKNILGAGGFGNVYKGKL-GDGTVLAVKRLK--------------------DMISLAVHRNLLRLIGYCATPTERLL 261 (534)
Q Consensus 203 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~--------------------~~l~~~~h~niv~l~~~~~~~~~~~l 261 (534)
+|+..+.||+|+||.||+|.. .++..||+|.+. +.++.++|+||+++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 477788999999999999986 568899999774 15667789999999999999999999
Q ss_pred EeeccCCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCC-cEEEEecccceecCCC
Q 039819 262 VYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFC-EAIVGDFGLAKLLDHS 340 (534)
Q Consensus 262 v~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~-~~kl~DFGla~~~~~~ 340 (534)
||||+++++|.+++.....+++..+..++.|++.||.|||+. +++|+||||+||+++.++ .+||+|||.+......
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~---~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~ 157 (268)
T cd06630 81 FVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAK 157 (268)
T ss_pred EEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEcccccccccccc
Confidence 999999999999998877899999999999999999999998 999999999999998776 5999999999876432
Q ss_pred CC---ceeeccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceec
Q 039819 341 DS---HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLV 417 (534)
Q Consensus 341 ~~---~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 417 (534)
.. .......|+..|+|||++.+..++.++||||+|+++|||++|+.||........ ..........
T Consensus 158 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~----~~~~~~~~~~------- 226 (268)
T cd06630 158 GTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNH----LALIFKIASA------- 226 (268)
T ss_pred cccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcch----HHHHHHHhcc-------
Confidence 11 112234578999999999888889999999999999999999999864322111 1111111000
Q ss_pred ccccCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 418 DRELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 418 d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
......+......+.+++.+|++.+|.+||++.++++
T Consensus 227 --~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 227 --TTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred --CCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 0011223334568889999999999999999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-36 Score=291.24 Aligned_cols=233 Identities=21% Similarity=0.328 Sum_probs=190.9
Q ss_pred CCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEeh----------------hhhhhcccCceeeEEEEEeCCCeeEEEeec
Q 039819 203 NFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLK----------------DMISLAVHRNLLRLIGYCATPTERLLVYPY 265 (534)
Q Consensus 203 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~----------------~~l~~~~h~niv~l~~~~~~~~~~~lv~e~ 265 (534)
+|+..+.||+|+||.||+++.. +++.||+|++. ..++.+.|+||+++.+++.+.+..++||||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 4778899999999999999874 67899999764 267788899999999999999999999999
Q ss_pred cCCCChhhhcccC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCCc
Q 039819 266 MSNGSVASRLREK--PALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSH 343 (534)
Q Consensus 266 ~~~gsL~~~l~~~--~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~ 343 (534)
+++++|.+.+... ..+++..++.++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~- 156 (256)
T cd08218 81 CEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE- 156 (256)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEEeeccceeecCcchh-
Confidence 9999999988753 3589999999999999999999998 999999999999999999999999999986643221
Q ss_pred eeeccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceecccccCC
Q 039819 344 VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELGS 423 (534)
Q Consensus 344 ~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 423 (534)
......|+..|+|||+..+..++.++|||||||+++||+||+.||..... .+.+........ +
T Consensus 157 ~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~-------~~~~~~~~~~~~------~---- 219 (256)
T cd08218 157 LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNM-------KNLVLKIIRGSY------P---- 219 (256)
T ss_pred hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCH-------HHHHHHHhcCCC------C----
Confidence 12234578899999999888899999999999999999999999864321 122222111110 0
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 424 NYDRIEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 424 ~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
..+......+.+++.+|++.+|.+||+|.+|++
T Consensus 220 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~ 252 (256)
T cd08218 220 PVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILE 252 (256)
T ss_pred CCcccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 111223457899999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=288.73 Aligned_cols=230 Identities=22% Similarity=0.282 Sum_probs=184.8
Q ss_pred CeeccCCcEEEEEEEEC-CCcEEEEEEehh------------------hhhhcccCceeeEEEEEeCCCeeEEEeeccCC
Q 039819 208 NILGAGGFGNVYKGKLG-DGTVLAVKRLKD------------------MISLAVHRNLLRLIGYCATPTERLLVYPYMSN 268 (534)
Q Consensus 208 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~------------------~l~~~~h~niv~l~~~~~~~~~~~lv~e~~~~ 268 (534)
+.||+|+||.||+|... +++.||||.+.. +.....|+|++++++++...+..++||||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 46899999999999874 688999998742 22344799999999999999999999999999
Q ss_pred CChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCCceeecc
Q 039819 269 GSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAV 348 (534)
Q Consensus 269 gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~~ 348 (534)
++|.+++.....+++..+..++.|++.||.|||+. +++||||+|+||+++.++.++|+|||+++.... ....
T Consensus 82 ~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~-----~~~~ 153 (260)
T cd05611 82 GDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE-----NKKF 153 (260)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEeecccceeccc-----cccC
Confidence 99999998877899999999999999999999998 999999999999999999999999999886533 2234
Q ss_pred ccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceecccccCCCCCHH
Q 039819 349 RGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELGSNYDRI 428 (534)
Q Consensus 349 ~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 428 (534)
.|+..|+|||.+.+..++.++||||||+++|||+||..||..... ........... . .........
T Consensus 154 ~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-------~~~~~~~~~~~-~------~~~~~~~~~ 219 (260)
T cd05611 154 VGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETP-------DAVFDNILSRR-I------NWPEEVKEF 219 (260)
T ss_pred CCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCH-------HHHHHHHHhcc-c------CCCCccccc
Confidence 588899999999888889999999999999999999999964321 11111111100 0 000111112
Q ss_pred HHHHHHHHHHHhcccCCCCCCChHHHHHHhh
Q 039819 429 EVGEILQVALLCTQYLPVHRPKMSEVVRMLE 459 (534)
Q Consensus 429 ~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~ 459 (534)
.+..+.+++.+|++.+|++||++.++.+.|.
T Consensus 220 ~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~ 250 (260)
T cd05611 220 CSPEAVDLINRLLCMDPAKRLGANGYQEIKS 250 (260)
T ss_pred CCHHHHHHHHHHccCCHHHccCCCcHHHHHc
Confidence 3458899999999999999998876665543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=304.78 Aligned_cols=249 Identities=22% Similarity=0.327 Sum_probs=188.2
Q ss_pred HHhCCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEeh----------------hhhhhcccCceeeEEEEEeCC------
Q 039819 200 ATENFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLK----------------DMISLAVHRNLLRLIGYCATP------ 256 (534)
Q Consensus 200 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~----------------~~l~~~~h~niv~l~~~~~~~------ 256 (534)
..++|+..+.||+|+||.||+|... +++.||||.+. .++..+.|+||+++++++...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 3578999999999999999999875 78999999874 256778899999999988643
Q ss_pred CeeEEEeeccCCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEeccccee
Q 039819 257 TERLLVYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKL 336 (534)
Q Consensus 257 ~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~ 336 (534)
...++||||+. ++|.+.+... +++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.
T Consensus 94 ~~~~lv~e~~~-~~l~~~~~~~--l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~ 167 (353)
T cd07850 94 QDVYLVMELMD-ANLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLART 167 (353)
T ss_pred CcEEEEEeccC-CCHHHHHhhc--CCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCcccee
Confidence 34699999996 4888877644 89999999999999999999998 999999999999999999999999999987
Q ss_pred cCCCCCceeeccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHH--------HHHHHHh
Q 039819 337 LDHSDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAML--------EWVKKIQ 408 (534)
Q Consensus 337 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~--------~~~~~~~ 408 (534)
..... ......++..|+|||++.+..++.++|||||||++|+|++|+.||...........+. ++.....
T Consensus 168 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (353)
T cd07850 168 AGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQ 245 (353)
T ss_pred CCCCC--CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhh
Confidence 64322 1233457899999999998889999999999999999999999997543211111110 0100000
Q ss_pred -------h-hcc-----cceeccccc----CCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 409 -------Q-EKK-----VEVLVDREL----GSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 409 -------~-~~~-----~~~~~d~~l----~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
. ... ....+.... ...........+.+++.+|++.||++||++.|++.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~ 310 (353)
T cd07850 246 PTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQ 310 (353)
T ss_pred hhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 0 000 000000000 00011223557889999999999999999999985
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=290.66 Aligned_cols=236 Identities=25% Similarity=0.368 Sum_probs=189.0
Q ss_pred CCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEeh----------------hhhhhcccCceeeEEEEEeC--CCeeEEEe
Q 039819 203 NFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLK----------------DMISLAVHRNLLRLIGYCAT--PTERLLVY 263 (534)
Q Consensus 203 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~----------------~~l~~~~h~niv~l~~~~~~--~~~~~lv~ 263 (534)
+|+..+.||.|+||.||++... ++..+|+|++. +.++.++|+||+++++++.. ....+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 4777889999999999999864 67889999874 25677889999999998764 34578999
Q ss_pred eccCCCChhhhccc----CCCCCHHHHHHHHHHHHHHHHHHHhcC--CCCeEeccCCCCcEEeCCCCcEEEEecccceec
Q 039819 264 PYMSNGSVASRLRE----KPALDWNTRKRIAIGAARGLLYLHEQC--DPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLL 337 (534)
Q Consensus 264 e~~~~gsL~~~l~~----~~~l~~~~~~~i~~~i~~~l~yLH~~~--~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~ 337 (534)
||+++++|.+++.. ...+++..++.++.+++.||.|||..+ ..+++|+||||+||+++.++.+||+|||++...
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~ 160 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL 160 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence 99999999999864 467999999999999999999999322 229999999999999999999999999999877
Q ss_pred CCCCCceeeccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceec
Q 039819 338 DHSDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLV 417 (534)
Q Consensus 338 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 417 (534)
...... .....|+..|+|||++....++.++||||||+++|+|++|+.||..... . ++...... ..
T Consensus 161 ~~~~~~-~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~----~---~~~~~~~~-~~----- 226 (265)
T cd08217 161 GHDSSF-AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQ----L---QLASKIKE-GK----- 226 (265)
T ss_pred cCCccc-ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCH----H---HHHHHHhc-CC-----
Confidence 543321 2334689999999999888899999999999999999999999974321 1 11111111 10
Q ss_pred ccccCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 418 DRELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 418 d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
....+...+..+.+++.+|++.+|.+||++.+|++
T Consensus 227 ----~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~ 261 (265)
T cd08217 227 ----FRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQ 261 (265)
T ss_pred ----CCCCccccCHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 01122233458899999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-36 Score=296.15 Aligned_cols=246 Identities=20% Similarity=0.303 Sum_probs=184.9
Q ss_pred CCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEeh----------------hhhhhcccCceeeEEEEEeCCCeeEEEeec
Q 039819 203 NFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLK----------------DMISLAVHRNLLRLIGYCATPTERLLVYPY 265 (534)
Q Consensus 203 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~----------------~~l~~~~h~niv~l~~~~~~~~~~~lv~e~ 265 (534)
+|...+.||+|+||.||+|+.. +|..||+|++. ..+..++|+||+++++++.+....++|+||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 4677789999999999999975 68899999874 156778999999999999999999999999
Q ss_pred cCCCChhhhccc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCCce
Q 039819 266 MSNGSVASRLRE-KPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHV 344 (534)
Q Consensus 266 ~~~gsL~~~l~~-~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~ 344 (534)
++ ++|.+++.. ...+++..++.++.||++||.|||+. +|+||||||+||+++.++.+||+|||+++....... .
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~-~ 155 (284)
T cd07839 81 CD-QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR-C 155 (284)
T ss_pred CC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEcCCCcEEECccchhhccCCCCC-C
Confidence 97 477777753 56799999999999999999999998 999999999999999999999999999986543221 1
Q ss_pred eeccccccccccccccccCC-CCcchhHHHHHHHHHHHHhCCCCcCCCcccccc-chHH---------HHHHHHhhhccc
Q 039819 345 TTAVRGTVGHIAPEYLSTGQ-SSEKTDVFGFGILLLELITGMRALEFGKSINQK-GAML---------EWVKKIQQEKKV 413 (534)
Q Consensus 345 ~~~~~gt~~y~aPE~~~~~~-~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~-~~~~---------~~~~~~~~~~~~ 413 (534)
.....++..|+|||++.+.. ++.++|||||||++|||+||+.|+..+.+.... ..+. .|.... .....
T Consensus 156 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~ 234 (284)
T cd07839 156 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVS-KLPDY 234 (284)
T ss_pred cCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhh-hcccc
Confidence 22345788999999886644 689999999999999999999986533221110 0000 010000 00000
Q ss_pred ceecccccCCC-----CCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 414 EVLVDRELGSN-----YDRIEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 414 ~~~~d~~l~~~-----~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
... +..... ........+.+++.+|++.+|.+|||++++++
T Consensus 235 ~~~--~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 235 KPY--PMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred ccc--CCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 000 000000 01112457889999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=293.01 Aligned_cols=237 Identities=24% Similarity=0.321 Sum_probs=189.3
Q ss_pred HhCCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEeh--------------hhhhhcccCceeeEEEEEeCCCeeEEEeec
Q 039819 201 TENFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLK--------------DMISLAVHRNLLRLIGYCATPTERLLVYPY 265 (534)
Q Consensus 201 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~--------------~~l~~~~h~niv~l~~~~~~~~~~~lv~e~ 265 (534)
.++|...+.||.|+||.||++... ++..||+|.+. +++..++|+||+++++++......++||||
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF 83 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence 356788889999999999999975 68899999874 267788899999999999999999999999
Q ss_pred cCCCChhhhccc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCCce
Q 039819 266 MSNGSVASRLRE-KPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHV 344 (534)
Q Consensus 266 ~~~gsL~~~l~~-~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~ 344 (534)
+++++|.+++.. ...+++..+..++.|++.||.|||+. +|+|+||||+||+++.++.++|+|||++........ .
T Consensus 84 ~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~-~ 159 (280)
T cd06611 84 CDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ-K 159 (280)
T ss_pred cCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEECCCCCEEEccCccchhhccccc-c
Confidence 999999999875 35699999999999999999999999 999999999999999999999999999876543221 2
Q ss_pred eeccccccccccccccc-----cCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceeccc
Q 039819 345 TTAVRGTVGHIAPEYLS-----TGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDR 419 (534)
Q Consensus 345 ~~~~~gt~~y~aPE~~~-----~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 419 (534)
.....|+..|+|||++. ...++.++|||||||++|||++|+.||..... .+.......... +
T Consensus 160 ~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~-------~~~~~~~~~~~~------~ 226 (280)
T cd06611 160 RDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNP-------MRVLLKILKSEP------P 226 (280)
T ss_pred cceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCH-------HHHHHHHhcCCC------C
Confidence 23345899999999874 34467899999999999999999999863221 111111111100 0
Q ss_pred ccCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 420 ELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 420 ~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
.+ ..+......+.+++.+|++.+|.+||++.++++
T Consensus 227 ~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (280)
T cd06611 227 TL--DQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLK 261 (280)
T ss_pred Cc--CCcccCCHHHHHHHHHHhccChhhCcCHHHHhc
Confidence 00 011122347889999999999999999999975
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=296.71 Aligned_cols=250 Identities=20% Similarity=0.302 Sum_probs=188.9
Q ss_pred hCCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEeh----------------hhhhhcccCceeeEEEEEeCC--CeeEEE
Q 039819 202 ENFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLK----------------DMISLAVHRNLLRLIGYCATP--TERLLV 262 (534)
Q Consensus 202 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~----------------~~l~~~~h~niv~l~~~~~~~--~~~~lv 262 (534)
++|+..+.||+|+||.||+|... +++.+|+|.++ ..+..++||||+++++++... ...++|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 56888899999999999999986 58899999874 146678899999999999877 789999
Q ss_pred eeccCCCChhhhcccC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCC
Q 039819 263 YPYMSNGSVASRLREK-PALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSD 341 (534)
Q Consensus 263 ~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~ 341 (534)
|||+++ +|.+.+... ..+++..++.++.|++.||.|||+. +++||||||+||+++.++.+||+|||++.......
T Consensus 85 ~e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~ 160 (293)
T cd07843 85 MEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYGSPL 160 (293)
T ss_pred ehhcCc-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCcEEEeecCceeeccCCc
Confidence 999974 898888653 4599999999999999999999998 99999999999999999999999999998765432
Q ss_pred CceeeccccccccccccccccC-CCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHH---------H--Hhh
Q 039819 342 SHVTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVK---------K--IQQ 409 (534)
Q Consensus 342 ~~~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~---------~--~~~ 409 (534)
. ......++..|+|||++.+. .++.++|||||||++|||++|+.||...........+..... . ...
T Consensus 161 ~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (293)
T cd07843 161 K-PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPG 239 (293)
T ss_pred c-ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccch
Confidence 1 12234478899999988654 468999999999999999999999975432221111111110 0 000
Q ss_pred -h-cccceecccccCCCCCHH-HHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 410 -E-KKVEVLVDRELGSNYDRI-EVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 410 -~-~~~~~~~d~~l~~~~~~~-~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
. ..........+...++.. ....+.+++.+|++.+|++|||+.|++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 240 AKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred hcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 0 000000011111112222 3457889999999999999999999985
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-36 Score=297.29 Aligned_cols=248 Identities=20% Similarity=0.297 Sum_probs=186.4
Q ss_pred CCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEeh----------------hhhhhcccCceeeEEEEEeCCCeeEEEeec
Q 039819 203 NFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLK----------------DMISLAVHRNLLRLIGYCATPTERLLVYPY 265 (534)
Q Consensus 203 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~----------------~~l~~~~h~niv~l~~~~~~~~~~~lv~e~ 265 (534)
+|+..+.||.|++|.||+|+.. ++..||||++. +.++.++||||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 4778899999999999999875 68899999774 256788999999999999999999999999
Q ss_pred cCCCChhhhccc--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCCc
Q 039819 266 MSNGSVASRLRE--KPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSH 343 (534)
Q Consensus 266 ~~~gsL~~~l~~--~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~ 343 (534)
+. ++|.+++.. ...+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||+++.......
T Consensus 81 ~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~- 155 (284)
T cd07860 81 LH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR- 155 (284)
T ss_pred cc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEeeccchhhcccCcc-
Confidence 96 688888754 45689999999999999999999998 999999999999999999999999999886543221
Q ss_pred eeeccccccccccccccccCC-CCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhh------------h
Q 039819 344 VTTAVRGTVGHIAPEYLSTGQ-SSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQ------------E 410 (534)
Q Consensus 344 ~~~~~~gt~~y~aPE~~~~~~-~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~------------~ 410 (534)
......++..|+|||++.+.. ++.++|||||||++|||+||+.||......+....+.++...... .
T Consensus 156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T cd07860 156 TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYK 235 (284)
T ss_pred ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHH
Confidence 122334688999999886644 588999999999999999999999754322211111111100000 0
Q ss_pred cccceecccccCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 411 KKVEVLVDRELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 411 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
............ .........+.+++.+|++.+|.+||+++++++
T Consensus 236 ~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 280 (284)
T cd07860 236 PSFPKWARQDFS-KVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA 280 (284)
T ss_pred hhcccccccCHH-HHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence 000000000000 000112346789999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=298.01 Aligned_cols=231 Identities=21% Similarity=0.308 Sum_probs=195.3
Q ss_pred CCCcCCeeccCCcEEEEEEEE-CCCcEEEEEEehh----------------hhhhcccCceeeEEEEEeCCCeeEEEeec
Q 039819 203 NFSSKNILGAGGFGNVYKGKL-GDGTVLAVKRLKD----------------MISLAVHRNLLRLIGYCATPTERLLVYPY 265 (534)
Q Consensus 203 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~----------------~l~~~~h~niv~l~~~~~~~~~~~lv~e~ 265 (534)
-|...+.||+|.|+.|-+|+. -.|..||||++.+ .|+.+.|||||+++++...+...|||.|.
T Consensus 19 LYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLEL 98 (864)
T KOG4717|consen 19 LYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILEL 98 (864)
T ss_pred eehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEe
Confidence 355567899999999999985 4799999999863 68889999999999999999999999999
Q ss_pred cCCCChhhhcccC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEe-CCCCcEEEEecccceecCCCCCc
Q 039819 266 MSNGSVASRLREK-PALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLL-DDFCEAIVGDFGLAKLLDHSDSH 343 (534)
Q Consensus 266 ~~~gsL~~~l~~~-~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl-~~~~~~kl~DFGla~~~~~~~~~ 343 (534)
-++|+|++++.+. ..+.++...+++.||+.|+.|+|+. .+|||||||+||.+ .+-|.+|+.|||++..+..+ .
T Consensus 99 GD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqL---HVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG--~ 173 (864)
T KOG4717|consen 99 GDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQL---HVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPG--K 173 (864)
T ss_pred cCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhh---hhhcccCCcceeEEeeecCceEeeeccccccCCCc--c
Confidence 9999999999643 5699999999999999999999999 99999999999976 56799999999999876544 3
Q ss_pred eeeccccccccccccccccCCCC-cchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceecccccC
Q 039819 344 VTTAVRGTVGHIAPEYLSTGQSS-EKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELG 422 (534)
Q Consensus 344 ~~~~~~gt~~y~aPE~~~~~~~~-~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 422 (534)
..++.+|+..|-|||++.+..|+ +++||||+|||||-|++|+.||....+.+.... ++|- +
T Consensus 174 kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTm----------------ImDC--K 235 (864)
T KOG4717|consen 174 KLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTM----------------IMDC--K 235 (864)
T ss_pred hhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhh----------------hhcc--c
Confidence 45678899999999999998885 689999999999999999999985443222111 1121 1
Q ss_pred CCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 423 SNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 423 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
-..+.....++.+++..|+..+|++|.+.+|++.
T Consensus 236 YtvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s 269 (864)
T KOG4717|consen 236 YTVPSHVSKECRDLIQSMLVRDPKKRASLEEIVS 269 (864)
T ss_pred ccCchhhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence 2345556779999999999999999999999974
|
|
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=309.55 Aligned_cols=229 Identities=29% Similarity=0.406 Sum_probs=188.7
Q ss_pred CCCcCCeeccCCcEEEEEEEE-CCCcEEEEEEeh-----------------hhhhhcccCceeeEEEEEeCCCeeEEEee
Q 039819 203 NFSSKNILGAGGFGNVYKGKL-GDGTVLAVKRLK-----------------DMISLAVHRNLLRLIGYCATPTERLLVYP 264 (534)
Q Consensus 203 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~-----------------~~l~~~~h~niv~l~~~~~~~~~~~lv~e 264 (534)
-|+..+.||.|+||.||-|++ .+..+||||++. ..+..++|||+|.+.|+|-.....|||||
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME 106 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME 106 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence 355567899999999999987 477899999885 26788899999999999999999999999
Q ss_pred ccCCCChhhhcc-cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCCc
Q 039819 265 YMSNGSVASRLR-EKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSH 343 (534)
Q Consensus 265 ~~~~gsL~~~l~-~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~ 343 (534)
||- |+-.|++. .+.++-+.++..|..+.+.||+|||+. +.||||||..|||+++.|.||++|||.|..+...
T Consensus 107 YCl-GSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~---~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PA--- 179 (948)
T KOG0577|consen 107 YCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSH---NRIHRDIKAGNILLSEPGLVKLADFGSASIMAPA--- 179 (948)
T ss_pred HHh-ccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHh---hHHhhhccccceEecCCCeeeeccccchhhcCch---
Confidence 995 57777775 345688999999999999999999999 9999999999999999999999999999877543
Q ss_pred eeeccccccccccccccc---cCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceecccc
Q 039819 344 VTTAVRGTVGHIAPEYLS---TGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRE 420 (534)
Q Consensus 344 ~~~~~~gt~~y~aPE~~~---~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 420 (534)
..++||+.|||||++. .+.|+-|+||||+||+..||...++|+-... .+.-+..+..+.. |.
T Consensus 180 --nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMN-------AMSALYHIAQNes------Pt 244 (948)
T KOG0577|consen 180 --NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN-------AMSALYHIAQNES------PT 244 (948)
T ss_pred --hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCch-------HHHHHHHHHhcCC------CC
Confidence 3477999999999984 5789999999999999999999999975211 1222222333221 12
Q ss_pred cCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 421 LGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 421 l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
+. ...-...+..++..|++.-|.+|||.+++++
T Consensus 245 Lq---s~eWS~~F~~Fvd~CLqKipqeRptse~ll~ 277 (948)
T KOG0577|consen 245 LQ---SNEWSDYFRNFVDSCLQKIPQERPTSEELLK 277 (948)
T ss_pred CC---CchhHHHHHHHHHHHHhhCcccCCcHHHHhh
Confidence 21 2344668899999999999999999998865
|
|
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=294.53 Aligned_cols=230 Identities=25% Similarity=0.333 Sum_probs=190.0
Q ss_pred hCCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEeh-----------------hhhhhcccCceeeEEEEEeCCCeeEEEe
Q 039819 202 ENFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLK-----------------DMISLAVHRNLLRLIGYCATPTERLLVY 263 (534)
Q Consensus 202 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~-----------------~~l~~~~h~niv~l~~~~~~~~~~~lv~ 263 (534)
++|...+.||+|+||.||++... +++.||+|.+. ++++.+.||||+++++++.+....++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 36788899999999999999875 58999999874 2567788999999999999999999999
Q ss_pred eccCCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCCc
Q 039819 264 PYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSH 343 (534)
Q Consensus 264 e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~ 343 (534)
||+++++|.+++.....+++..+..++.|++.||.|||+. +|+||||+|+||+++.++.+||+|||+++.....
T Consensus 81 e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~--- 154 (290)
T cd05580 81 EYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR--- 154 (290)
T ss_pred ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEeeCCCccccCCC---
Confidence 9999999999998888899999999999999999999998 9999999999999999999999999999876543
Q ss_pred eeeccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceecccccCC
Q 039819 344 VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELGS 423 (534)
Q Consensus 344 ~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 423 (534)
.....|+..|+|||.+.+...+.++||||||+++|||++|+.||..... ......... .. ..
T Consensus 155 -~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-------~~~~~~~~~-~~------~~--- 216 (290)
T cd05580 155 -TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNP-------IQIYEKILE-GK------VR--- 216 (290)
T ss_pred -CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH-------HHHHHHHhc-CC------cc---
Confidence 2334688999999999888889999999999999999999999964321 011111111 10 11
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCC-----ChHHHHH
Q 039819 424 NYDRIEVGEILQVALLCTQYLPVHRP-----KMSEVVR 456 (534)
Q Consensus 424 ~~~~~~~~~l~~l~~~Cl~~~P~~RP-----t~~ev~~ 456 (534)
.+......+.+++.+|++.+|.+|| +++|+++
T Consensus 217 -~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~ 253 (290)
T cd05580 217 -FPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN 253 (290)
T ss_pred -CCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence 1112245788999999999999999 5556553
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=287.93 Aligned_cols=239 Identities=26% Similarity=0.397 Sum_probs=191.6
Q ss_pred hCCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEeh---------------hhhhhcccCceeeEEEEEeCCCeeEEEeec
Q 039819 202 ENFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLK---------------DMISLAVHRNLLRLIGYCATPTERLLVYPY 265 (534)
Q Consensus 202 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~---------------~~l~~~~h~niv~l~~~~~~~~~~~lv~e~ 265 (534)
++|+..+.||.|+||.||+|... ++..+|+|++. +.++.++|+|++++++.+...+..++||||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 46888899999999999999864 67889999874 146778999999999999999999999999
Q ss_pred cCCCChhhhcccC---CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCC
Q 039819 266 MSNGSVASRLREK---PALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDS 342 (534)
Q Consensus 266 ~~~gsL~~~l~~~---~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~ 342 (534)
+++++|.+++... ..+++..+..++.|++.||+|||+. +++||||||+||++++++.++|+|||++..+.....
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~---~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~ 157 (267)
T cd06610 81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSN---GQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD 157 (267)
T ss_pred cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence 9999999999753 4689999999999999999999998 999999999999999999999999999987654322
Q ss_pred c---eeeccccccccccccccccC-CCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceecc
Q 039819 343 H---VTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVD 418 (534)
Q Consensus 343 ~---~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 418 (534)
. ......|+..|+|||++... .++.++|||||||++|||++|+.||...... ....... .. . .
T Consensus 158 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~---~~~~~~~---~~-~------~ 224 (267)
T cd06610 158 RTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPM---KVLMLTL---QN-D------P 224 (267)
T ss_pred ccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChh---hhHHHHh---cC-C------C
Confidence 1 22334688999999998776 7899999999999999999999999643221 1111111 11 0 0
Q ss_pred cccCCCC-CHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 419 RELGSNY-DRIEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 419 ~~l~~~~-~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
+.+.... ....+..+.+++.+|++.+|++||++.++++
T Consensus 225 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 225 PSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred CCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 1111111 1123457889999999999999999999985
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=294.22 Aligned_cols=248 Identities=21% Similarity=0.310 Sum_probs=186.1
Q ss_pred CCcCCeeccCCcEEEEEEEEC-CCcEEEEEEeh----------------hhhhhcccCceeeEEEEEeCCCeeEEEeecc
Q 039819 204 FSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLK----------------DMISLAVHRNLLRLIGYCATPTERLLVYPYM 266 (534)
Q Consensus 204 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~----------------~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~ 266 (534)
|+..+.||.|++|.||+|... +|..||+|++. +.+..++|+|++++++++.+....++||||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 566788999999999999875 78999999764 2567788999999999999999999999999
Q ss_pred CCCChhhhcccCC--CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCCce
Q 039819 267 SNGSVASRLREKP--ALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHV 344 (534)
Q Consensus 267 ~~gsL~~~l~~~~--~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~ 344 (534)
+ ++|.+++.... .+++..+..++.|+++||.|||+. +++||||+|+||+++.++.++|+|||+++....... .
T Consensus 81 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~---~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~-~ 155 (283)
T cd07835 81 D-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR-T 155 (283)
T ss_pred C-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc-c
Confidence 5 68999887654 789999999999999999999998 999999999999999999999999999976543221 1
Q ss_pred eeccccccccccccccccC-CCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhc-----ccceecc
Q 039819 345 TTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEK-----KVEVLVD 418 (534)
Q Consensus 345 ~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~d 418 (534)
.....++..|+|||++.+. .++.++|||||||++|||+||+.||...........+.++........ .......
T Consensus 156 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (283)
T cd07835 156 YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKP 235 (283)
T ss_pred cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhh
Confidence 1223468899999987654 568899999999999999999999975433221111111110000000 0000000
Q ss_pred --cccC----CCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 419 --RELG----SNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 419 --~~l~----~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
+... ..........+.+++.+|++.+|.+||+++|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 279 (283)
T cd07835 236 TFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ 279 (283)
T ss_pred hcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 0000 0001112357889999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=290.45 Aligned_cols=233 Identities=25% Similarity=0.385 Sum_probs=186.8
Q ss_pred CCCcCCeeccCCcEEEEEEEE-CCCcEEEEEEehh---------------hhhhcc---cCceeeEEEEEeCCCeeEEEe
Q 039819 203 NFSSKNILGAGGFGNVYKGKL-GDGTVLAVKRLKD---------------MISLAV---HRNLLRLIGYCATPTERLLVY 263 (534)
Q Consensus 203 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~---------------~l~~~~---h~niv~l~~~~~~~~~~~lv~ 263 (534)
.|+..+.||+|+||.||+|.. .++..||+|.+.. +++.+. |||++++++++......++||
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 466778899999999999997 4789999997631 344554 999999999999999999999
Q ss_pred eccCCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCCc
Q 039819 264 PYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSH 343 (534)
Q Consensus 264 e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~ 343 (534)
||+++++|.+++... .+++..+..++.+++.||.|||+. +|+||||+|+||+++.++.++|+|||++........
T Consensus 82 e~~~~~~L~~~~~~~-~l~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~- 156 (277)
T cd06917 82 EYAEGGSVRTLMKAG-PIAEKYISVIIREVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSS- 156 (277)
T ss_pred ecCCCCcHHHHHHcc-CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHHEEEcCCCCEEEccCCceeecCCCcc-
Confidence 999999999988654 789999999999999999999998 999999999999999999999999999987754332
Q ss_pred eeeccccccccccccccccC-CCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceecccccC
Q 039819 344 VTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELG 422 (534)
Q Consensus 344 ~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 422 (534)
......|+..|+|||++.++ .++.++|||||||++|||++|+.||..... ..+....... ..+.+.
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~-------~~~~~~~~~~------~~~~~~ 223 (277)
T cd06917 157 KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDA-------FRAMMLIPKS------KPPRLE 223 (277)
T ss_pred ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCCh-------hhhhhccccC------CCCCCC
Confidence 22334689999999988654 468999999999999999999999964321 1111110000 011111
Q ss_pred CCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 423 SNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 423 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
.. ..+..+.+++.+|++.+|++||++.|++.
T Consensus 224 ~~---~~~~~~~~~i~~~l~~~p~~R~~~~~il~ 254 (277)
T cd06917 224 DN---GYSKLLREFVAACLDEEPKERLSAEELLK 254 (277)
T ss_pred cc---cCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence 11 13457889999999999999999999975
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=292.26 Aligned_cols=250 Identities=23% Similarity=0.371 Sum_probs=185.6
Q ss_pred hCCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEeh---------------hhhhhcccCceeeEEEEEeCCCeeEEEeec
Q 039819 202 ENFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLK---------------DMISLAVHRNLLRLIGYCATPTERLLVYPY 265 (534)
Q Consensus 202 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~---------------~~l~~~~h~niv~l~~~~~~~~~~~lv~e~ 265 (534)
++|+..+.||+|++|.||+|... +++.||||.+. ++++.++|+||+++++++.+.+..++||||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY 84 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence 57888899999999999999976 68899999864 257788999999999999999999999999
Q ss_pred cCCCChhhhccc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCCce
Q 039819 266 MSNGSVASRLRE-KPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHV 344 (534)
Q Consensus 266 ~~~gsL~~~l~~-~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~ 344 (534)
+++ +|.+++.. ...+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||+++....... .
T Consensus 85 ~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~-~ 159 (291)
T cd07844 85 LDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLARAKSVPSK-T 159 (291)
T ss_pred CCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCHHHEEEcCCCCEEECccccccccCCCCc-c
Confidence 985 89888864 34689999999999999999999998 999999999999999999999999999875432211 1
Q ss_pred eecccccccccccccccc-CCCCcchhHHHHHHHHHHHHhCCCCcCCCccccc-cchHHH---------HHHHHhhhccc
Q 039819 345 TTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELITGMRALEFGKSINQ-KGAMLE---------WVKKIQQEKKV 413 (534)
Q Consensus 345 ~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~-~~~~~~---------~~~~~~~~~~~ 413 (534)
.....++..|+|||++.+ ..++.++|||||||++|||++|+.||........ ...+.. |..........
T Consensus 160 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (291)
T cd07844 160 YSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFK 239 (291)
T ss_pred ccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhccccc
Confidence 122346889999998865 4578999999999999999999999964331100 000000 00000000000
Q ss_pred ce----ecccccCCCCCH-HHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 414 EV----LVDRELGSNYDR-IEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 414 ~~----~~d~~l~~~~~~-~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
.. .....+...... .....+.+++.+|++.+|++||++.|++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 240 PYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred cccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 00 000000000000 01146789999999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-35 Score=291.66 Aligned_cols=250 Identities=21% Similarity=0.278 Sum_probs=185.9
Q ss_pred HHhCCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEeh---------------hhhhhcccCceeeEEEEEeCCCeeEEEe
Q 039819 200 ATENFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLK---------------DMISLAVHRNLLRLIGYCATPTERLLVY 263 (534)
Q Consensus 200 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~---------------~~l~~~~h~niv~l~~~~~~~~~~~lv~ 263 (534)
++++|...+.||+|+||.||+|... ++..||+|++. ..+..++|+||+++.+++......++||
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 3578888999999999999999874 68899999864 1567788999999999999999999999
Q ss_pred eccCCCChhhhccc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCC
Q 039819 264 PYMSNGSVASRLRE-KPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDS 342 (534)
Q Consensus 264 e~~~~gsL~~~l~~-~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~ 342 (534)
||+. ++|.+++.. ...+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||+++.......
T Consensus 83 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 158 (291)
T cd07870 83 EYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQ 158 (291)
T ss_pred eccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEEcCCCcEEEeccccccccCCCCC
Confidence 9996 677666543 45688999999999999999999998 999999999999999999999999999976533221
Q ss_pred ceeeccccccccccccccccC-CCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHH-----------Hhhh
Q 039819 343 HVTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKK-----------IQQE 410 (534)
Q Consensus 343 ~~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~-----------~~~~ 410 (534)
......++..|+|||++.+. .++.++|||||||++|||+||+.||+...... ..+.+.... ....
T Consensus 159 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 235 (291)
T cd07870 159 -TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVF--EQLEKIWTVLGVPTEDTWPGVSKL 235 (291)
T ss_pred -CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHH--HHHHHHHHHcCCCChhhhhhhhhc
Confidence 12234478899999998654 47889999999999999999999997433210 011110000 0000
Q ss_pred -cccceecccccCCCCC-----HHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 411 -KKVEVLVDRELGSNYD-----RIEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 411 -~~~~~~~d~~l~~~~~-----~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
................ ......+.+++.+|++.+|.+|||+.|++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 236 PNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred ccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 0000000000000000 011347789999999999999999999874
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=288.87 Aligned_cols=222 Identities=25% Similarity=0.299 Sum_probs=182.7
Q ss_pred eccCCcEEEEEEEEC-CCcEEEEEEehh-----------------hhhhcccCceeeEEEEEeCCCeeEEEeeccCCCCh
Q 039819 210 LGAGGFGNVYKGKLG-DGTVLAVKRLKD-----------------MISLAVHRNLLRLIGYCATPTERLLVYPYMSNGSV 271 (534)
Q Consensus 210 lG~G~~g~Vy~~~~~-~~~~vavK~~~~-----------------~l~~~~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 271 (534)
||.|+||.||+|+.. ++..+|+|.+.. ++..+.||||+++++++.++...++||||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 699999999999986 488999998742 56778899999999999999999999999999999
Q ss_pred hhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCCceeeccccc
Q 039819 272 ASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGT 351 (534)
Q Consensus 272 ~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt 351 (534)
.+++.....+++..+..++.|++.||+|||+. +++|+||||+||+++.++.++|+|||+++...... ......|+
T Consensus 81 ~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~--~~~~~~~~ 155 (262)
T cd05572 81 WTILRDRGLFDEYTARFYIACVVLAFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ--KTWTFCGT 155 (262)
T ss_pred HHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc--ccccccCC
Confidence 99998877899999999999999999999998 99999999999999999999999999998765432 22334688
Q ss_pred cccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceecccccCCCCCHHHHH
Q 039819 352 VGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELGSNYDRIEVG 431 (534)
Q Consensus 352 ~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~ 431 (534)
..|+|||++....++.++|+||||+++|||++|+.||..... ...+........ .....++.....
T Consensus 156 ~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-----~~~~~~~~~~~~---------~~~~~~~~~~~~ 221 (262)
T cd05572 156 PEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDE-----DPMEIYNDILKG---------NGKLEFPNYIDK 221 (262)
T ss_pred cCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCC-----CHHHHHHHHhcc---------CCCCCCCcccCH
Confidence 999999999888899999999999999999999999974331 011222221110 001112222256
Q ss_pred HHHHHHHHhcccCCCCCCC
Q 039819 432 EILQVALLCTQYLPVHRPK 450 (534)
Q Consensus 432 ~l~~l~~~Cl~~~P~~RPt 450 (534)
.+.+++.+|++.+|.+||+
T Consensus 222 ~~~~~i~~~l~~~p~~R~~ 240 (262)
T cd05572 222 AAKDLIKQLLRRNPEERLG 240 (262)
T ss_pred HHHHHHHHHccCChhhCcC
Confidence 8999999999999999999
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=288.00 Aligned_cols=237 Identities=26% Similarity=0.381 Sum_probs=194.6
Q ss_pred hCCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEehh---------------hhhhcccCceeeEEEEEeCCCeeEEEeec
Q 039819 202 ENFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLKD---------------MISLAVHRNLLRLIGYCATPTERLLVYPY 265 (534)
Q Consensus 202 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~---------------~l~~~~h~niv~l~~~~~~~~~~~lv~e~ 265 (534)
++|+..+.||+|++|.||+|+.. ++..||||++.. .+..++|+|++++++++......++||||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 36788899999999999999986 489999998641 46677899999999999999999999999
Q ss_pred cCCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCCce
Q 039819 266 MSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHE-QCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHV 344 (534)
Q Consensus 266 ~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~-~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~ 344 (534)
+++++|.+++.....+++..+..++.|+++|+.|||+ . +++||||+|+||+++.++.++|+|||.+.........
T Consensus 81 ~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~---~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~- 156 (264)
T cd06623 81 MDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKR---HIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQ- 156 (264)
T ss_pred cCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccC---CCccCCCCHHHEEECCCCCEEEccCccceecccCCCc-
Confidence 9999999999877889999999999999999999999 8 9999999999999999999999999999876543322
Q ss_pred eeccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceecccccCCC
Q 039819 345 TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELGSN 424 (534)
Q Consensus 345 ~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 424 (534)
.....++..|+|||.+.+..++.++||||||+++|||+||+.||...... ...+......... .+ .
T Consensus 157 ~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~----~~~~~~~~~~~~~------~~----~ 222 (264)
T cd06623 157 CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQP----SFFELMQAICDGP------PP----S 222 (264)
T ss_pred ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccccc----CHHHHHHHHhcCC------CC----C
Confidence 22345789999999998888999999999999999999999999643210 1111111111110 01 1
Q ss_pred CCHH-HHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 425 YDRI-EVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 425 ~~~~-~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
.+.. .+..+.+++.+|++.+|++||++.++++
T Consensus 223 ~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~ 255 (264)
T cd06623 223 LPAEEFSPEFRDFISACLQKDPKKRPSAAELLQ 255 (264)
T ss_pred CCcccCCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence 1111 3458999999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-35 Score=289.66 Aligned_cols=242 Identities=24% Similarity=0.322 Sum_probs=188.6
Q ss_pred hCCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEeh---------------hhhhhcccCceeeEEEEEeCC--CeeEEEe
Q 039819 202 ENFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLK---------------DMISLAVHRNLLRLIGYCATP--TERLLVY 263 (534)
Q Consensus 202 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~---------------~~l~~~~h~niv~l~~~~~~~--~~~~lv~ 263 (534)
++|...+.||.|++|.||++... +++.+|+|.+. +.++.++||||++++++|.+. ...++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 35777889999999999999985 57889999775 267778999999999998654 4679999
Q ss_pred eccCCCChhhhcc----cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCC
Q 039819 264 PYMSNGSVASRLR----EKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDH 339 (534)
Q Consensus 264 e~~~~gsL~~~l~----~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~ 339 (534)
||+++++|.+++. ....+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 157 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVN 157 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence 9999999988764 245689999999999999999999998 999999999999999999999999999875533
Q ss_pred CCCceeeccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCcccc-ccchHHHHHHHHhhhcccceecc
Q 039819 340 SDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSIN-QKGAMLEWVKKIQQEKKVEVLVD 418 (534)
Q Consensus 340 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~d 418 (534)
.. .....++..|+|||.+.+..++.++|||||||++|||++|+.||+...... .......+.... . ...+ .
T Consensus 158 ~~---~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~---~-~~~~-~ 229 (287)
T cd06621 158 SL---AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNM---P-NPEL-K 229 (287)
T ss_pred cc---cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcC---C-chhh-c
Confidence 21 123457889999999988889999999999999999999999997543210 111122222111 0 0000 0
Q ss_pred cccCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 419 RELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 419 ~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
.... ........+.+++.+|++.+|.+|||+.|+++
T Consensus 230 ~~~~--~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~ 265 (287)
T cd06621 230 DEPG--NGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE 265 (287)
T ss_pred cCCC--CCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence 0000 01123457899999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-36 Score=297.68 Aligned_cols=230 Identities=20% Similarity=0.316 Sum_probs=184.7
Q ss_pred CCeeccCCcEEEEEEEEC-CCcEEEEEEeh--------------hhhhhcccCceeeEEEEEeCCCeeEEEeeccCCCCh
Q 039819 207 KNILGAGGFGNVYKGKLG-DGTVLAVKRLK--------------DMISLAVHRNLLRLIGYCATPTERLLVYPYMSNGSV 271 (534)
Q Consensus 207 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~--------------~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 271 (534)
...||+|+||.||++... ++..||||.+. ..+..+.|+||+++++.+...+..++||||+++++|
T Consensus 27 ~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L 106 (292)
T cd06658 27 FIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGAL 106 (292)
T ss_pred hhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCcH
Confidence 456999999999999874 68899999864 256677899999999999999999999999999999
Q ss_pred hhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCCceeeccccc
Q 039819 272 ASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGT 351 (534)
Q Consensus 272 ~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt 351 (534)
.+++... .+++.++..++.|++.||.|||+. +|+||||||+||+++.++.++|+|||++........ ......|+
T Consensus 107 ~~~~~~~-~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~-~~~~~~~~ 181 (292)
T cd06658 107 TDIVTHT-RMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP-KRKSLVGT 181 (292)
T ss_pred HHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEccCcchhhcccccc-cCceeecC
Confidence 9988543 589999999999999999999998 999999999999999999999999999876543221 12334588
Q ss_pred cccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceecccccCCCCCHHHHH
Q 039819 352 VGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELGSNYDRIEVG 431 (534)
Q Consensus 352 ~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~ 431 (534)
..|+|||++.+..++.++|||||||++|||++|+.||...... ..+..... .....+.. ......
T Consensus 182 ~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~-------~~~~~~~~------~~~~~~~~--~~~~~~ 246 (292)
T cd06658 182 PYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPL-------QAMRRIRD------NLPPRVKD--SHKVSS 246 (292)
T ss_pred ccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-------HHHHHHHh------cCCCcccc--ccccCH
Confidence 9999999998888999999999999999999999998643211 11111100 01111111 111234
Q ss_pred HHHHHHHHhcccCCCCCCChHHHHH
Q 039819 432 EILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 432 ~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
.+.+++.+|+..+|.+|||++++++
T Consensus 247 ~~~~li~~~l~~~P~~Rpt~~~il~ 271 (292)
T cd06658 247 VLRGFLDLMLVREPSQRATAQELLQ 271 (292)
T ss_pred HHHHHHHHHccCChhHCcCHHHHhh
Confidence 6888999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=286.94 Aligned_cols=232 Identities=25% Similarity=0.399 Sum_probs=188.3
Q ss_pred CCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEeh----------------hhhhhcccCceeeEEEEEeCCCeeEEEeec
Q 039819 203 NFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLK----------------DMISLAVHRNLLRLIGYCATPTERLLVYPY 265 (534)
Q Consensus 203 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~----------------~~l~~~~h~niv~l~~~~~~~~~~~lv~e~ 265 (534)
+|+..+.||+|+||.||++... ++..+|||.+. ++++.++|||++++++.+...+..++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 4778899999999999999874 67889999764 256778899999999999999999999999
Q ss_pred cCCCChhhhcccC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCC-CcEEEEecccceecCCCCC
Q 039819 266 MSNGSVASRLREK--PALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDF-CEAIVGDFGLAKLLDHSDS 342 (534)
Q Consensus 266 ~~~gsL~~~l~~~--~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~-~~~kl~DFGla~~~~~~~~ 342 (534)
+++++|.+++... ..+++..+.+++.+++.||.|||++ +++|+||||+||+++.+ +.+||+|||++........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~ 157 (256)
T cd08220 81 APGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTK---LILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSK 157 (256)
T ss_pred CCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCcc
Confidence 9999999999753 4589999999999999999999998 99999999999999854 5689999999987654321
Q ss_pred ceeeccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceecccccC
Q 039819 343 HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELG 422 (534)
Q Consensus 343 ~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 422 (534)
.....|+..|+|||.+.+..++.++||||||+++|+|++|+.||+.... ...+........
T Consensus 158 --~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~-------~~~~~~~~~~~~---------- 218 (256)
T cd08220 158 --AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANL-------PALVLKIMSGTF---------- 218 (256)
T ss_pred --ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCch-------HHHHHHHHhcCC----------
Confidence 2234588999999999888889999999999999999999999864321 111111111100
Q ss_pred CCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 423 SNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 423 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
...+......+.+++.+|++.+|.+|||+.|++.
T Consensus 219 ~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~ 252 (256)
T cd08220 219 APISDRYSPDLRQLILSMLNLDPSKRPQLSQIMA 252 (256)
T ss_pred CCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 0111123457889999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=303.44 Aligned_cols=236 Identities=25% Similarity=0.426 Sum_probs=194.0
Q ss_pred CcCCeeccCCcEEEEEEEECC---C--cEEEEEEehh---------------hhhhcccCceeeEEEEEeCCCeeEEEee
Q 039819 205 SSKNILGAGGFGNVYKGKLGD---G--TVLAVKRLKD---------------MISLAVHRNLLRLIGYCATPTERLLVYP 264 (534)
Q Consensus 205 ~~~~~lG~G~~g~Vy~~~~~~---~--~~vavK~~~~---------------~l~~~~h~niv~l~~~~~~~~~~~lv~e 264 (534)
...++||.|.||.||+|.+.+ | -.||||..+. ++..++|||||+++|+|.+. ..|+|||
T Consensus 392 tl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~-P~WivmE 470 (974)
T KOG4257|consen 392 TLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ-PMWIVME 470 (974)
T ss_pred cHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeecc-ceeEEEe
Confidence 445789999999999998633 2 4589998763 78899999999999999764 5799999
Q ss_pred ccCCCChhhhccc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCCc
Q 039819 265 YMSNGSVASRLRE-KPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSH 343 (534)
Q Consensus 265 ~~~~gsL~~~l~~-~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~ 343 (534)
.++-|.|..+|.. +..|+......++.||+.||+|||+. ++|||||..+|||+.....+|++|||+++.+......
T Consensus 471 L~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSk---rfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~yY 547 (974)
T KOG4257|consen 471 LAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESK---RFVHRDIAARNILVSSPQCVKLADFGLSRYLEDDAYY 547 (974)
T ss_pred cccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhh---chhhhhhhhhheeecCcceeeecccchhhhccccchh
Confidence 9999999999974 45799999999999999999999999 9999999999999999999999999999998766544
Q ss_pred eeeccccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCcCCCccccccchHHHHHHHHhhhcccceecccccC
Q 039819 344 VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELG 422 (534)
Q Consensus 344 ~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 422 (534)
......-...|||||.+.-.+++.++|||-|||.+||+++ |.+||.+-...+..+ .+...-+
T Consensus 548 kaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~-----------------~iEnGeR 610 (974)
T KOG4257|consen 548 KASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIG-----------------HIENGER 610 (974)
T ss_pred hccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEE-----------------EecCCCC
Confidence 3333344678999999999999999999999999999976 999997433221111 1111111
Q ss_pred CCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhcC
Q 039819 423 SNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLEGD 461 (534)
Q Consensus 423 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~~ 461 (534)
...+..++..+..++.+||..+|.+||.+.++...|...
T Consensus 611 lP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv 649 (974)
T KOG4257|consen 611 LPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDV 649 (974)
T ss_pred CCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHH
Confidence 233555677999999999999999999999998877653
|
|
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=303.06 Aligned_cols=249 Identities=20% Similarity=0.312 Sum_probs=187.4
Q ss_pred hCCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEehh----------------hhhhcccCceeeEEEEEeCC-----Cee
Q 039819 202 ENFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLKD----------------MISLAVHRNLLRLIGYCATP-----TER 259 (534)
Q Consensus 202 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~----------------~l~~~~h~niv~l~~~~~~~-----~~~ 259 (534)
.+|...+.||+|+||.||+|+.. +++.||||.+.. ++..+.|+||+++++++... ...
T Consensus 5 ~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~ 84 (337)
T cd07858 5 TKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDV 84 (337)
T ss_pred cceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcE
Confidence 56888899999999999999874 689999998642 56677899999999988654 247
Q ss_pred EEEeeccCCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCC
Q 039819 260 LLVYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDH 339 (534)
Q Consensus 260 ~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~ 339 (534)
++||||+. ++|.+++.....+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||+++....
T Consensus 85 ~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~ 160 (337)
T cd07858 85 YIVYELMD-TDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFGLARTTSE 160 (337)
T ss_pred EEEEeCCC-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcCccccccCC
Confidence 99999996 68999988778899999999999999999999998 999999999999999999999999999987643
Q ss_pred CCCceeecccccccccccccccc-CCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhc-------
Q 039819 340 SDSHVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEK------- 411 (534)
Q Consensus 340 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~------- 411 (534)
.. .......++..|+|||.+.. ..++.++|||||||++|||++|+.||...........+.+.........
T Consensus 161 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (337)
T cd07858 161 KG-DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNE 239 (337)
T ss_pred Cc-ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCch
Confidence 32 12233457889999998865 4688999999999999999999999975322111111111100000000
Q ss_pred cc-------ceecccccCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 412 KV-------EVLVDRELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 412 ~~-------~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
.. ....+..... ........+.+++.+|++.+|++||+++++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~ 290 (337)
T cd07858 240 KARRYIRSLPYTPRQSFAR-LFPHANPLAIDLLEKMLVFDPSKRITVEEALA 290 (337)
T ss_pred hhhHHHHhcCcccccCHHH-HcccCCHHHHHHHHHHhcCChhhccCHHHHHc
Confidence 00 0000000000 01123457889999999999999999999986
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=303.03 Aligned_cols=250 Identities=20% Similarity=0.348 Sum_probs=184.3
Q ss_pred HhCCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEeh---------------hhhhhcccCceeeEEEEEeCCC-----ee
Q 039819 201 TENFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLK---------------DMISLAVHRNLLRLIGYCATPT-----ER 259 (534)
Q Consensus 201 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~---------------~~l~~~~h~niv~l~~~~~~~~-----~~ 259 (534)
.++|...+.||+|+||.||+|... ++..||||.+. .++..++|+||+++++++.... ..
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 468999999999999999999864 68999999874 1567788999999999876543 57
Q ss_pred EEEeeccCCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCC
Q 039819 260 LLVYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDH 339 (534)
Q Consensus 260 ~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~ 339 (534)
++|+||+.+ +|.+.+.. ..+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++.....
T Consensus 84 ~lv~e~~~~-~l~~~~~~-~~l~~~~~~~i~~ql~~aL~~LH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~ 158 (336)
T cd07849 84 YIVQELMET-DLYKLIKT-QHLSNDHIQYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGLARIADP 158 (336)
T ss_pred EEEehhccc-CHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEECcccceeeccc
Confidence 999999975 78777754 4699999999999999999999998 999999999999999999999999999986543
Q ss_pred CCCc--eeecccccccccccccccc-CCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhccccee
Q 039819 340 SDSH--VTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVL 416 (534)
Q Consensus 340 ~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 416 (534)
.... ......||..|+|||++.+ ..++.++|||||||++|||++|+.||...........+...+..... .....+
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~-~~~~~~ 237 (336)
T cd07849 159 EHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQ-EDLNCI 237 (336)
T ss_pred cccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCH-HHHHHh
Confidence 2211 1223468899999998754 46889999999999999999999999643321110000000000000 000000
Q ss_pred cccc-------cC--CCCC-----HHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 417 VDRE-------LG--SNYD-----RIEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 417 ~d~~-------l~--~~~~-----~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
.+.. .. ...+ ......+.+++.+|++.+|++||++.|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~ 291 (336)
T cd07849 238 ISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALA 291 (336)
T ss_pred hchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 0000 00 0000 012357889999999999999999999985
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=291.30 Aligned_cols=245 Identities=23% Similarity=0.261 Sum_probs=182.8
Q ss_pred CCcCCeeccCCcEEEEEEEEC-CCcEEEEEEehh---------------hhhhc-ccCceeeEEEEEeCC--CeeEEEee
Q 039819 204 FSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLKD---------------MISLA-VHRNLLRLIGYCATP--TERLLVYP 264 (534)
Q Consensus 204 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~---------------~l~~~-~h~niv~l~~~~~~~--~~~~lv~e 264 (534)
|...+.||+|+||.||+|+.. ++..||+|+++. .+.++ .|+|++++++++.+. +..++|||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 456788999999999999875 688999998753 23444 499999999999987 88899999
Q ss_pred ccCCCChhhhccc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCCc
Q 039819 265 YMSNGSVASRLRE-KPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSH 343 (534)
Q Consensus 265 ~~~~gsL~~~l~~-~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~ 343 (534)
|++ |+|.+.+.. ...+++..+..++.|++.||+|||+. +++||||||+||+++. +.+||+|||+++.......
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~- 154 (282)
T cd07831 81 LMD-MNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRN---GIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPP- 154 (282)
T ss_pred cCC-ccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEcC-CCeEEEecccccccccCCC-
Confidence 997 578777765 45789999999999999999999998 9999999999999999 9999999999987643322
Q ss_pred eeecccccccccccccccc-CCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHH--------HHHHHHhhhcccc
Q 039819 344 VTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAML--------EWVKKIQQEKKVE 414 (534)
Q Consensus 344 ~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~--------~~~~~~~~~~~~~ 414 (534)
.....++..|+|||++.. ..++.++|||||||++|||++|+.||......+....+. .|........ ..
T Consensus 155 -~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~ 232 (282)
T cd07831 155 -YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSR-HM 232 (282)
T ss_pred -cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccc-cc
Confidence 223457899999997644 557889999999999999999999997543221111111 1110100000 00
Q ss_pred eecccccCC-C---CCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 415 VLVDRELGS-N---YDRIEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 415 ~~~d~~l~~-~---~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
....+.... . .....+..+.+++.+|++.+|++||++.++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 278 (282)
T cd07831 233 NYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR 278 (282)
T ss_pred cccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence 000000000 0 01123568999999999999999999999985
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-35 Score=293.79 Aligned_cols=230 Identities=29% Similarity=0.402 Sum_probs=184.6
Q ss_pred hCCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEeh-----------------hhhhhcccCceeeEEEEEeCCCeeEEEe
Q 039819 202 ENFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLK-----------------DMISLAVHRNLLRLIGYCATPTERLLVY 263 (534)
Q Consensus 202 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~-----------------~~l~~~~h~niv~l~~~~~~~~~~~lv~ 263 (534)
..|...+.||+|+||.||+|... ++..||+|.+. +.+..++||||+++.++|...+..++||
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 45788899999999999999875 68899999774 1467788999999999999999999999
Q ss_pred eccCCCChhhhcc-cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCC
Q 039819 264 PYMSNGSVASRLR-EKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDS 342 (534)
Q Consensus 264 e~~~~gsL~~~l~-~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~ 342 (534)
||++ |++.+.+. ....+++..+..++.|++.||.|||+. +|+||||+|+||+++.++.++|+|||++......
T Consensus 95 e~~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~---~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~-- 168 (307)
T cd06607 95 EYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSH---ERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA-- 168 (307)
T ss_pred HhhC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEECCCCCEEEeecCcceecCCC--
Confidence 9997 56666654 345699999999999999999999998 9999999999999999999999999999765432
Q ss_pred ceeeccccccccccccccc---cCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceeccc
Q 039819 343 HVTTAVRGTVGHIAPEYLS---TGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDR 419 (534)
Q Consensus 343 ~~~~~~~gt~~y~aPE~~~---~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 419 (534)
....++..|+|||++. ...++.++|||||||++|||+||+.||..... ............ +
T Consensus 169 ---~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~-------~~~~~~~~~~~~------~ 232 (307)
T cd06607 169 ---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-------MSALYHIAQNDS------P 232 (307)
T ss_pred ---CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccH-------HHHHHHHhcCCC------C
Confidence 2345788999999874 45688999999999999999999999863321 111111111100 0
Q ss_pred ccCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 420 ELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 420 ~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
.+ ........+.+++.+||+.+|++||+|.+++.
T Consensus 233 ~~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 266 (307)
T cd06607 233 TL---SSNDWSDYFRNFVDSCLQKIPQDRPSSEELLK 266 (307)
T ss_pred CC---CchhhCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 11 11223457899999999999999999999986
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=301.16 Aligned_cols=252 Identities=20% Similarity=0.301 Sum_probs=188.5
Q ss_pred HhCCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEehh----------------hhhhcccCceeeEEEEEeC----CCee
Q 039819 201 TENFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLKD----------------MISLAVHRNLLRLIGYCAT----PTER 259 (534)
Q Consensus 201 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~----------------~l~~~~h~niv~l~~~~~~----~~~~ 259 (534)
.++|+..+.||+|+||.||+|... ++..||+|++.. ++..+.||||+++++++.. ....
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 368888999999999999999875 689999998742 5677889999999998753 3467
Q ss_pred EEEeeccCCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCC
Q 039819 260 LLVYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDH 339 (534)
Q Consensus 260 ~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~ 339 (534)
++||||+. |+|.+++.....+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 84 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 159 (334)
T cd07855 84 YVVMDLME-SDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFGMARGLSS 159 (334)
T ss_pred EEEEehhh-hhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEecccccceeecc
Confidence 99999995 68999998777799999999999999999999998 999999999999999999999999999986543
Q ss_pred CCC---ceeecccccccccccccccc-CCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHh-------
Q 039819 340 SDS---HVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQ------- 408 (534)
Q Consensus 340 ~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~------- 408 (534)
... .......|+..|+|||++.. ..++.++|||||||++|||++|+.||...........+........
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~ 239 (334)
T cd07855 160 SPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRI 239 (334)
T ss_pred cCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhh
Confidence 221 11223468899999998765 4588999999999999999999999975432111100000000000
Q ss_pred hhcccceeccc-ccCCCC-----CHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 409 QEKKVEVLVDR-ELGSNY-----DRIEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 409 ~~~~~~~~~d~-~l~~~~-----~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
.........+. ...... ....+..+.+++.+|++.+|.+||++.+++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 293 (334)
T cd07855 240 GSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQ 293 (334)
T ss_pred chhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 00000000000 000000 0113467899999999999999999999886
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-35 Score=289.14 Aligned_cols=232 Identities=27% Similarity=0.391 Sum_probs=188.6
Q ss_pred CCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEeh---------------hhhhhcccCceeeEEEEEeCCCeeEEEeecc
Q 039819 203 NFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLK---------------DMISLAVHRNLLRLIGYCATPTERLLVYPYM 266 (534)
Q Consensus 203 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~---------------~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~ 266 (534)
-|+..+.||+|+||.||+|... ++..||||... +.+..++||||+++++++......++||||+
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL 84 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence 3667788999999999999874 68899999764 1566788999999999999999999999999
Q ss_pred CCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCCceee
Q 039819 267 SNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTT 346 (534)
Q Consensus 267 ~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~ 346 (534)
++++|.+++... .+++..+..++.+++.|+.|||+. +++|+||||+||+++.++.++|+|||++........ ...
T Consensus 85 ~~~~l~~~i~~~-~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~-~~~ 159 (277)
T cd06641 85 GGGSALDLLEPG-PLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI-KRN 159 (277)
T ss_pred CCCcHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHccC---CeecCCCCHHhEEECCCCCEEEeecccceecccchh-hhc
Confidence 999999988654 589999999999999999999998 999999999999999999999999999886643221 122
Q ss_pred ccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceecccccCCCCC
Q 039819 347 AVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELGSNYD 426 (534)
Q Consensus 347 ~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 426 (534)
...++..|+|||++.+..++.++|||||||++|||++|+.||..... ..+........ .+. ..
T Consensus 160 ~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~-------~~~~~~~~~~~------~~~----~~ 222 (277)
T cd06641 160 TFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHP-------MKVLFLIPKNN------PPT----LE 222 (277)
T ss_pred cccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccch-------HHHHHHHhcCC------CCC----CC
Confidence 34578899999999888889999999999999999999999863211 11111111110 011 12
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 427 RIEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 427 ~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
...+..+.+++.+|++.+|.+||++.++++
T Consensus 223 ~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 252 (277)
T cd06641 223 GNYSKPLKEFVEACLNKEPSFRPTAKELLK 252 (277)
T ss_pred cccCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 223457889999999999999999999987
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=290.49 Aligned_cols=227 Identities=26% Similarity=0.329 Sum_probs=182.0
Q ss_pred eeccCCcEEEEEEEEC-CCcEEEEEEehh--------------------hhhhcccCceeeEEEEEeCCCeeEEEeeccC
Q 039819 209 ILGAGGFGNVYKGKLG-DGTVLAVKRLKD--------------------MISLAVHRNLLRLIGYCATPTERLLVYPYMS 267 (534)
Q Consensus 209 ~lG~G~~g~Vy~~~~~-~~~~vavK~~~~--------------------~l~~~~h~niv~l~~~~~~~~~~~lv~e~~~ 267 (534)
+||+|+||.||+|... +++.||+|.+.. .+....||+|+++++++...+..++||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 4899999999999874 588999997641 2233469999999999999999999999999
Q ss_pred CCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCCceeec
Q 039819 268 NGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTA 347 (534)
Q Consensus 268 ~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~ 347 (534)
+|+|.+++.....+++..+..|+.|+++||.|||+. +|+||||||+||+++.++.++|+|||++....... ...
T Consensus 81 g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~---~~~ 154 (278)
T cd05606 81 GGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---PHA 154 (278)
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCCCCHHHEEECCCCCEEEccCcCccccCccC---CcC
Confidence 999999998777899999999999999999999998 99999999999999999999999999987654322 223
Q ss_pred cccccccccccccccC-CCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceecccccCCCCC
Q 039819 348 VRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELGSNYD 426 (534)
Q Consensus 348 ~~gt~~y~aPE~~~~~-~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 426 (534)
..|+..|+|||++.++ .++.++|||||||++|||++|+.||........ ....... . ..+..+ +
T Consensus 155 ~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~----~~~~~~~-~------~~~~~~----~ 219 (278)
T cd05606 155 SVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK----HEIDRMT-L------TMAVEL----P 219 (278)
T ss_pred cCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccch----HHHHHHh-h------ccCCCC----C
Confidence 4689999999998754 588999999999999999999999974322111 1110000 0 001111 1
Q ss_pred HHHHHHHHHHHHHhcccCCCCCC-----ChHHHHH
Q 039819 427 RIEVGEILQVALLCTQYLPVHRP-----KMSEVVR 456 (534)
Q Consensus 427 ~~~~~~l~~l~~~Cl~~~P~~RP-----t~~ev~~ 456 (534)
...+..+.+++.+|+..+|.+|| ++.++++
T Consensus 220 ~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 254 (278)
T cd05606 220 DSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 254 (278)
T ss_pred CcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence 12245889999999999999999 8888874
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=292.33 Aligned_cols=249 Identities=22% Similarity=0.326 Sum_probs=187.3
Q ss_pred CCcCCeeccCCcEEEEEEEEC-CCcEEEEEEehh----------------hhhhcccCceeeEEEEEeCC--CeeEEEee
Q 039819 204 FSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLKD----------------MISLAVHRNLLRLIGYCATP--TERLLVYP 264 (534)
Q Consensus 204 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~----------------~l~~~~h~niv~l~~~~~~~--~~~~lv~e 264 (534)
|...+.||+|+||.||+|+.. ++..+|+|++.. .+..+.|+|++++++++... ...++|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 556788999999999999976 588999998852 45677899999999999988 78999999
Q ss_pred ccCCCChhhhcccC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCCc
Q 039819 265 YMSNGSVASRLREK-PALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSH 343 (534)
Q Consensus 265 ~~~~gsL~~~l~~~-~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~ 343 (534)
|+++ +|.+++... ..+++..++.++.|++.||+|||+. +++|+||||+||++++++.+||+|||++.........
T Consensus 81 ~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~---~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~ 156 (287)
T cd07840 81 YMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSA 156 (287)
T ss_pred cccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEEcCCCCEEEccccceeeccCCCcc
Confidence 9975 888888654 5799999999999999999999998 9999999999999999999999999999877554322
Q ss_pred eeecccccccccccccccc-CCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcc--cce-----
Q 039819 344 VTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKK--VEV----- 415 (534)
Q Consensus 344 ~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~--~~~----- 415 (534)
......++..|+|||.+.+ ..++.++||||||+++|||+||+.||...........+............ ...
T Consensus 157 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (287)
T cd07840 157 DYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFE 236 (287)
T ss_pred cccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhhh
Confidence 2333456889999997754 45789999999999999999999999743322111111111100000000 000
Q ss_pred ------ecccccCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 416 ------LVDRELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 416 ------~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
.....+...+...++..+.+++.+|++.+|.+||+++++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 283 (287)
T cd07840 237 NLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ 283 (287)
T ss_pred hccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 00000000111112567899999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=293.32 Aligned_cols=231 Identities=19% Similarity=0.299 Sum_probs=185.3
Q ss_pred cCCeeccCCcEEEEEEEEC-CCcEEEEEEeh--------------hhhhhcccCceeeEEEEEeCCCeeEEEeeccCCCC
Q 039819 206 SKNILGAGGFGNVYKGKLG-DGTVLAVKRLK--------------DMISLAVHRNLLRLIGYCATPTERLLVYPYMSNGS 270 (534)
Q Consensus 206 ~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~--------------~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~~~gs 270 (534)
....||+|+||.||+|... ++..||+|.+. ..+..+.||||+++++++...+..++||||+++++
T Consensus 25 ~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~ 104 (297)
T cd06659 25 NYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGA 104 (297)
T ss_pred hhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCC
Confidence 3457999999999999875 68899999874 15667789999999999999999999999999999
Q ss_pred hhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCCceeecccc
Q 039819 271 VASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRG 350 (534)
Q Consensus 271 L~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~~~g 350 (534)
|.+++.. ..+++..++.++.|++.||.|||+. +++||||||+||+++.++.+||+|||++........ ......|
T Consensus 105 L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~-~~~~~~~ 179 (297)
T cd06659 105 LTDIVSQ-TRLNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP-KRKSLVG 179 (297)
T ss_pred HHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHeEEccCCcEEEeechhHhhcccccc-cccceec
Confidence 9987754 4589999999999999999999998 999999999999999999999999999875543221 2233568
Q ss_pred ccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceecccccCCCCCHHHH
Q 039819 351 TVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELGSNYDRIEV 430 (534)
Q Consensus 351 t~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 430 (534)
+..|+|||++.+..++.++|||||||++|||++|+.||...... +-+........ .... ......
T Consensus 180 ~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~-------~~~~~~~~~~~------~~~~--~~~~~~ 244 (297)
T cd06659 180 TPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPV-------QAMKRLRDSPP------PKLK--NAHKIS 244 (297)
T ss_pred CccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-------HHHHHHhccCC------CCcc--ccCCCC
Confidence 99999999998888999999999999999999999999643211 11111111100 0000 011123
Q ss_pred HHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 431 GEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 431 ~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
..+.+++.+|++.+|++||++.++++
T Consensus 245 ~~l~~~i~~~l~~~P~~Rps~~~ll~ 270 (297)
T cd06659 245 PVLRDFLERMLTREPQERATAQELLD 270 (297)
T ss_pred HHHHHHHHHHhcCCcccCcCHHHHhh
Confidence 46889999999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-36 Score=293.81 Aligned_cols=229 Identities=27% Similarity=0.357 Sum_probs=191.7
Q ss_pred hCCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEehh-----------------hhhhcccCceeeEEEEEeCCCeeEEEe
Q 039819 202 ENFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLKD-----------------MISLAVHRNLLRLIGYCATPTERLLVY 263 (534)
Q Consensus 202 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~-----------------~l~~~~h~niv~l~~~~~~~~~~~lv~ 263 (534)
+.|+.-++||+||||.||-++.+ +|+.+|.|.+.+ ++.++..+.||.+-..|++++..++|+
T Consensus 185 n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVL 264 (591)
T KOG0986|consen 185 NTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVL 264 (591)
T ss_pred cceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEE
Confidence 56788899999999999999875 688899887642 788889999999999999999999999
Q ss_pred eccCCCChhhhcccC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCC
Q 039819 264 PYMSNGSVASRLREK--PALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSD 341 (534)
Q Consensus 264 e~~~~gsL~~~l~~~--~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~ 341 (534)
..|.||+|.-++.+. +.+++..++-++.+|+-||++||.. .||+||+||+|||||+.|+++|+|.|+|..+....
T Consensus 265 tlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~---~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g~ 341 (591)
T KOG0986|consen 265 TLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRR---RIVYRDLKPENILLDDHGHVRISDLGLAVEIPEGK 341 (591)
T ss_pred EeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhc---ceeeccCChhheeeccCCCeEeeccceEEecCCCC
Confidence 999999999888654 4799999999999999999999999 99999999999999999999999999999886654
Q ss_pred CceeeccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceeccccc
Q 039819 342 SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDREL 421 (534)
Q Consensus 342 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 421 (534)
. ....+||.||||||++.++.|+...|.||+||++|||+.|+.||..-... +.| +-+|++.
T Consensus 342 ~--~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeK------vk~-----------eEvdrr~ 402 (591)
T KOG0986|consen 342 P--IRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEK------VKR-----------EEVDRRT 402 (591)
T ss_pred c--cccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhh------hhH-----------HHHHHHH
Confidence 3 33447999999999999999999999999999999999999999732211 111 0111111
Q ss_pred C---CCCCHHHHHHHHHHHHHhcccCCCCCCChH
Q 039819 422 G---SNYDRIEVGEILQVALLCTQYLPVHRPKMS 452 (534)
Q Consensus 422 ~---~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ 452 (534)
. ..++....++...+....++.||++|-..+
T Consensus 403 ~~~~~ey~~kFS~eakslc~~LL~Kdp~~RLGcr 436 (591)
T KOG0986|consen 403 LEDPEEYSDKFSEEAKSLCEGLLTKDPEKRLGCR 436 (591)
T ss_pred hcchhhcccccCHHHHHHHHHHHccCHHHhccCC
Confidence 1 224444566888899999999999998665
|
|
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=290.20 Aligned_cols=238 Identities=27% Similarity=0.374 Sum_probs=187.3
Q ss_pred HHhCCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEehh-------------hhhhc-ccCceeeEEEEEeCCC------e
Q 039819 200 ATENFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLKD-------------MISLA-VHRNLLRLIGYCATPT------E 258 (534)
Q Consensus 200 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~-------------~l~~~-~h~niv~l~~~~~~~~------~ 258 (534)
++++|+..+.||+|+||.||+|... ++..+++|.+.. ++..+ .|+||+++++++.... .
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~ 83 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQ 83 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCchhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceE
Confidence 5688999999999999999999985 578899998751 45555 6999999999997644 4
Q ss_pred eEEEeeccCCCChhhhccc----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccc
Q 039819 259 RLLVYPYMSNGSVASRLRE----KPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLA 334 (534)
Q Consensus 259 ~~lv~e~~~~gsL~~~l~~----~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla 334 (534)
.++||||+++++|.+++.. ...+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~~l~p~ni~~~~~~~~~l~d~~~~ 160 (275)
T cd06608 84 LWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVS 160 (275)
T ss_pred EEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEEccCCeEEECCCccc
Confidence 7999999999999998864 35799999999999999999999998 9999999999999999999999999999
Q ss_pred eecCCCCCceeecccccccccccccccc-----CCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhh
Q 039819 335 KLLDHSDSHVTTAVRGTVGHIAPEYLST-----GQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQ 409 (534)
Q Consensus 335 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 409 (534)
........ ......|+..|+|||++.. ..++.++|||||||++|||+||+.||...... ..+.. ...
T Consensus 161 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---~~~~~----~~~ 232 (275)
T cd06608 161 AQLDSTLG-RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPM---RALFK----IPR 232 (275)
T ss_pred eecccchh-hhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchH---HHHHH----hhc
Confidence 86543221 2233558899999998753 34678999999999999999999999632111 11111 111
Q ss_pred hcccceecccccCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 410 EKKVEVLVDRELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 410 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
. . .+.+. .+......+.+++.+|+..+|++|||+.++++
T Consensus 233 ~-~-----~~~~~--~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 233 N-P-----PPTLK--SPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred c-C-----CCCCC--chhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 0 0 00111 11123457889999999999999999999985
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-35 Score=291.11 Aligned_cols=235 Identities=20% Similarity=0.310 Sum_probs=190.4
Q ss_pred hCCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEehh--------------hhhhcccCceeeEEEEEeCCCeeEEEeecc
Q 039819 202 ENFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLKD--------------MISLAVHRNLLRLIGYCATPTERLLVYPYM 266 (534)
Q Consensus 202 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~--------------~l~~~~h~niv~l~~~~~~~~~~~lv~e~~ 266 (534)
++|...+.||+|+||.||++... ++..||+|.+.. ++..++|||+++++++|...+..++|+||+
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~ 98 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL 98 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence 67888899999999999999864 678899998741 567788999999999999999999999999
Q ss_pred CCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCCceee
Q 039819 267 SNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTT 346 (534)
Q Consensus 267 ~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~ 346 (534)
++++|.+++... .+++..+..++.+++.||.|||+. +++||||||+||+++.++.++|+|||++........ ...
T Consensus 99 ~~~~L~~~~~~~-~l~~~~~~~i~~~l~~al~~LH~~---gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~-~~~ 173 (293)
T cd06647 99 AGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-KRS 173 (293)
T ss_pred CCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhC---CEeeccCCHHHEEEcCCCCEEEccCcceeccccccc-ccc
Confidence 999999998754 488999999999999999999999 999999999999999999999999999876543322 223
Q ss_pred ccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceecccccCCCCC
Q 039819 347 AVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELGSNYD 426 (534)
Q Consensus 347 ~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 426 (534)
...|+..|+|||++....++.++|||||||++||+++|+.||......... ...... ........
T Consensus 174 ~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~-------~~~~~~--------~~~~~~~~ 238 (293)
T cd06647 174 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL-------YLIATN--------GTPELQNP 238 (293)
T ss_pred cccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhe-------eehhcC--------CCCCCCCc
Confidence 345888999999998888899999999999999999999999743221110 000000 00000111
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 427 RIEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 427 ~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
......+.+++.+|++.+|++||++.+++.
T Consensus 239 ~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 268 (293)
T cd06647 239 EKLSAIFRDFLNRCLEMDVEKRGSAKELLQ 268 (293)
T ss_pred cccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 223457889999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=287.64 Aligned_cols=234 Identities=19% Similarity=0.299 Sum_probs=188.9
Q ss_pred CCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEeh--------------hhhhhcccCceeeEEEEEeCCCeeEEEeeccC
Q 039819 203 NFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLK--------------DMISLAVHRNLLRLIGYCATPTERLLVYPYMS 267 (534)
Q Consensus 203 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~--------------~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~~ 267 (534)
.|...+.||+|++|.||++... ++..+|+|++. .++..+.|+|++++++++...+..++|+||++
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~ 99 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLE 99 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccC
Confidence 3445578999999999999864 68899999763 25667789999999999999999999999999
Q ss_pred CCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCCceeec
Q 039819 268 NGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTA 347 (534)
Q Consensus 268 ~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~ 347 (534)
+++|.+++.. ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++|+|||.+........ ....
T Consensus 100 ~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~-~~~~ 174 (285)
T cd06648 100 GGALTDIVTH-TRMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP-RRKS 174 (285)
T ss_pred CCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChhhEEEcCCCcEEEcccccchhhccCCc-cccc
Confidence 9999999877 5689999999999999999999998 999999999999999999999999998875543221 1233
Q ss_pred cccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceecccccCCCCCH
Q 039819 348 VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELGSNYDR 427 (534)
Q Consensus 348 ~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 427 (534)
..|+..|+|||.+.+..++.++|||||||++|||++|+.||..... ........... .+.... ..
T Consensus 175 ~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~-------~~~~~~~~~~~------~~~~~~--~~ 239 (285)
T cd06648 175 LVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPP-------LQAMKRIRDNL------PPKLKN--LH 239 (285)
T ss_pred ccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCH-------HHHHHHHHhcC------CCCCcc--cc
Confidence 4589999999999888899999999999999999999999864221 12222221111 011110 11
Q ss_pred HHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 428 IEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 428 ~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
.....+.+++.+|++.+|++||++.++++
T Consensus 240 ~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 240 KVSPRLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred cCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence 12357899999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-35 Score=292.70 Aligned_cols=253 Identities=23% Similarity=0.334 Sum_probs=188.3
Q ss_pred HHHhCCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEeh----------------hhhhhcccCceeeEEEEEeCCC----
Q 039819 199 QATENFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLK----------------DMISLAVHRNLLRLIGYCATPT---- 257 (534)
Q Consensus 199 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~----------------~~l~~~~h~niv~l~~~~~~~~---- 257 (534)
...++|+..+.||+|+||.||+|... +++.||||++. .++..++|||++++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 45678999999999999999999985 58899999884 1567788999999999987655
Q ss_pred ------eeEEEeeccCCCChhhhccc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEe
Q 039819 258 ------ERLLVYPYMSNGSVASRLRE-KPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGD 330 (534)
Q Consensus 258 ------~~~lv~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~D 330 (534)
..++|+||+++ ++...+.. ...+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~kl~d 159 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKK---NFLHRDIKCSNILLNNKGQIKLAD 159 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCcEEeCc
Confidence 78999999986 66666654 34699999999999999999999998 999999999999999999999999
Q ss_pred cccceecCCCCCceeecccccccccccccccc-CCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhh
Q 039819 331 FGLAKLLDHSDSHVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQ 409 (534)
Q Consensus 331 FGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 409 (534)
||++...............++..|+|||++.+ ..++.++|||||||++|||++|+.||...........+.+.......
T Consensus 160 fg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (302)
T cd07864 160 FGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCP 239 (302)
T ss_pred ccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCh
Confidence 99998765433222222346788999998754 45788999999999999999999999743322111111111100000
Q ss_pred hcc--ccee-----cc------cccCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 410 EKK--VEVL-----VD------RELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 410 ~~~--~~~~-----~d------~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
... +... .+ +....... ..+..+.+++.+|++.+|.+||++.+++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 298 (302)
T cd07864 240 AVWPDVIKLPYFNTMKPKKQYRRRLREEFS-FIPTPALDLLDHMLTLDPSKRCTAEEALN 298 (302)
T ss_pred hhcccccccccccccccccccccchhhhcC-CCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 000 0000 00 00000011 12457899999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=288.78 Aligned_cols=237 Identities=26% Similarity=0.399 Sum_probs=183.7
Q ss_pred CCcCCeeccCCcEEEEEEEEC----CCcEEEEEEeh----------------hhhhhcccCceeeEEEEEeCCC------
Q 039819 204 FSSKNILGAGGFGNVYKGKLG----DGTVLAVKRLK----------------DMISLAVHRNLLRLIGYCATPT------ 257 (534)
Q Consensus 204 ~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~----------------~~l~~~~h~niv~l~~~~~~~~------ 257 (534)
|...+.||+|+||.||+|.+. .+..||||++. +.++.+.||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 456678999999999999863 36789999764 2567788999999999886542
Q ss_pred eeEEEeeccCCCChhhhccc------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEec
Q 039819 258 ERLLVYPYMSNGSVASRLRE------KPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDF 331 (534)
Q Consensus 258 ~~~lv~e~~~~gsL~~~l~~------~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DF 331 (534)
..++++||+++|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccchhhEEEcCCCCEEECcc
Confidence 23789999999999887642 12578999999999999999999998 9999999999999999999999999
Q ss_pred ccceecCCCCCc-eeeccccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCcCCCccccccchHHHHHHHHhh
Q 039819 332 GLAKLLDHSDSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GMRALEFGKSINQKGAMLEWVKKIQQ 409 (534)
Q Consensus 332 Gla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~ 409 (534)
|+++........ ......++..|++||.+....++.++|||||||++|||++ |+.||..... ..+..+. ..
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~----~~~~~~~---~~ 230 (273)
T cd05074 158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVEN----SEIYNYL---IK 230 (273)
T ss_pred cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCH----HHHHHHH---Hc
Confidence 999866432211 1122335678999999988889999999999999999999 8888863221 1111111 11
Q ss_pred hcccceecccccCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhc
Q 039819 410 EKKVEVLVDRELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLEG 460 (534)
Q Consensus 410 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~ 460 (534)
.... . .+......+.+++.+|++.+|++||++.++++.|+.
T Consensus 231 ~~~~------~----~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~ 271 (273)
T cd05074 231 GNRL------K----QPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLEL 271 (273)
T ss_pred CCcC------C----CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHh
Confidence 1110 0 011224588999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=291.53 Aligned_cols=237 Identities=25% Similarity=0.354 Sum_probs=180.8
Q ss_pred CCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEehh---------------hhhhcc-cCceeeEEEEEeCCCeeEEEeec
Q 039819 203 NFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLKD---------------MISLAV-HRNLLRLIGYCATPTERLLVYPY 265 (534)
Q Consensus 203 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~---------------~l~~~~-h~niv~l~~~~~~~~~~~lv~e~ 265 (534)
+|...+.||+|+||.||++... +++.||+|.+.. .+.++. |+||+++++++..+...+++|||
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~ 84 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL 84 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence 3445578999999999999875 589999998741 345554 99999999999999999999999
Q ss_pred cCCCChhhh---cc--cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCC
Q 039819 266 MSNGSVASR---LR--EKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHS 340 (534)
Q Consensus 266 ~~~gsL~~~---l~--~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~ 340 (534)
+.. ++.++ +. ....+++..+..++.+++.||+|||+.. +++||||||+||+++.++.+||+|||+++.....
T Consensus 85 ~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 161 (288)
T cd06616 85 MDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDS 161 (288)
T ss_pred ccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcC--CeeccCCCHHHEEEccCCcEEEeecchhHHhccC
Confidence 864 44433 22 3457999999999999999999999742 8999999999999999999999999999765432
Q ss_pred CCceeeccccccccccccccccC---CCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceec
Q 039819 341 DSHVTTAVRGTVGHIAPEYLSTG---QSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLV 417 (534)
Q Consensus 341 ~~~~~~~~~gt~~y~aPE~~~~~---~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 417 (534)
. ......|+..|+|||++.+. .++.++|||||||++|||++|+.||.... ...+-+.......
T Consensus 162 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~------~~~~~~~~~~~~~------ 227 (288)
T cd06616 162 I--AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN------SVFDQLTQVVKGD------ 227 (288)
T ss_pred C--ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc------hHHHHHhhhcCCC------
Confidence 2 12233588999999998765 68899999999999999999999996322 1111111111100
Q ss_pred ccccCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 418 DRELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 418 d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
.+.+........+..+.+++.+|++.+|++||++.+|++
T Consensus 228 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~ 266 (288)
T cd06616 228 PPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLE 266 (288)
T ss_pred CCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 111211111223557899999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-35 Score=290.83 Aligned_cols=242 Identities=23% Similarity=0.326 Sum_probs=191.4
Q ss_pred CCCcCCeeccCCcEEEEEEEE----CCCcEEEEEEehh------------------hhhhc-ccCceeeEEEEEeCCCee
Q 039819 203 NFSSKNILGAGGFGNVYKGKL----GDGTVLAVKRLKD------------------MISLA-VHRNLLRLIGYCATPTER 259 (534)
Q Consensus 203 ~~~~~~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~------------------~l~~~-~h~niv~l~~~~~~~~~~ 259 (534)
+|...+.||+|+||.||+++. .+++.||||.+++ ++..+ .|+||+++++.+......
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 366778999999999999975 3578899998752 34455 599999999999999999
Q ss_pred EEEeeccCCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCC
Q 039819 260 LLVYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDH 339 (534)
Q Consensus 260 ~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~ 339 (534)
++||||+++|+|.+++.....+++..+..++.|+++||.|||+. +++||||||+||+++.++.++|+|||+++....
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~---~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 157 (288)
T cd05583 81 HLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQL---GIIYRDIKLENILLDSEGHVVLTDFGLSKEFLA 157 (288)
T ss_pred EEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEEECcccccccc
Confidence 99999999999999998777899999999999999999999998 999999999999999999999999999886543
Q ss_pred CCCceeeccccccccccccccccCC--CCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceec
Q 039819 340 SDSHVTTAVRGTVGHIAPEYLSTGQ--SSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLV 417 (534)
Q Consensus 340 ~~~~~~~~~~gt~~y~aPE~~~~~~--~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 417 (534)
..........|+..|+|||.+.+.. .+.++||||||+++|||+||+.||....... ...++.......
T Consensus 158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~---~~~~~~~~~~~~------- 227 (288)
T cd05583 158 EEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQN---SQSEISRRILKS------- 227 (288)
T ss_pred ccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccc---hHHHHHHHHHcc-------
Confidence 3322233356889999999987655 6889999999999999999999986322111 111111111110
Q ss_pred ccccCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhcC
Q 039819 418 DRELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLEGD 461 (534)
Q Consensus 418 d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~~ 461 (534)
.+. .+......+.+++.+|++.+|++|||+.+|.+.|...
T Consensus 228 ~~~----~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~ 267 (288)
T cd05583 228 KPP----FPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHP 267 (288)
T ss_pred CCC----CCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCc
Confidence 011 1122334788999999999999999999998877653
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=299.41 Aligned_cols=250 Identities=22% Similarity=0.335 Sum_probs=190.2
Q ss_pred CCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEehh----------------hhhhcccCceeeEEEEEeCCC-----eeE
Q 039819 203 NFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLKD----------------MISLAVHRNLLRLIGYCATPT-----ERL 260 (534)
Q Consensus 203 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~----------------~l~~~~h~niv~l~~~~~~~~-----~~~ 260 (534)
+|...+.||+|+||.||+|+.. .+..||||++.. .+..++|+||+++.+++.... ..+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 4778899999999999999975 488999997642 566778999999999998775 789
Q ss_pred EEeeccCCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCC
Q 039819 261 LVYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHS 340 (534)
Q Consensus 261 lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~ 340 (534)
+||||++ ++|.+++.....+++..+..++.+++.||+|||+. +|+||||||+|||++.++.++|+|||++......
T Consensus 81 lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~---gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~ 156 (330)
T cd07834 81 IVTELME-TDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARGVDPD 156 (330)
T ss_pred EEecchh-hhHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccCceEeeccc
Confidence 9999998 48999988777899999999999999999999998 9999999999999999999999999999976543
Q ss_pred CC--ceeeccccccccccccccccC-CCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhh-------
Q 039819 341 DS--HVTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQE------- 410 (534)
Q Consensus 341 ~~--~~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~------- 410 (534)
.. .......++..|+|||++.+. .++.++||||||+++|+|++|+.||...........+..+.......
T Consensus 157 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 236 (330)
T cd07834 157 EDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITS 236 (330)
T ss_pred ccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhccc
Confidence 21 112334578899999999877 78999999999999999999999997544221111111111000000
Q ss_pred cccceecc---cccC---CCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 411 KKVEVLVD---RELG---SNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 411 ~~~~~~~d---~~l~---~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
......+. .... ..........+.+++.+|++.+|.+||++++++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~ 288 (330)
T cd07834 237 EKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALA 288 (330)
T ss_pred cchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence 00000000 0000 0001112457889999999999999999999985
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-35 Score=289.82 Aligned_cols=236 Identities=24% Similarity=0.349 Sum_probs=186.0
Q ss_pred CCCcCCeeccCCcEEEEEEEE----CCCcEEEEEEehh------------------hhhhc-ccCceeeEEEEEeCCCee
Q 039819 203 NFSSKNILGAGGFGNVYKGKL----GDGTVLAVKRLKD------------------MISLA-VHRNLLRLIGYCATPTER 259 (534)
Q Consensus 203 ~~~~~~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~------------------~l~~~-~h~niv~l~~~~~~~~~~ 259 (534)
+|+..+.||+|+||.||+++. .+|..||+|++.. ++..+ .|+||+++++.+......
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 467788999999999999986 4688999998752 34555 589999999999998999
Q ss_pred EEEeeccCCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCC
Q 039819 260 LLVYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDH 339 (534)
Q Consensus 260 ~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~ 339 (534)
++||||+++++|.+++.....+++..+..++.|++.||.|||+. +++||||||+|||++.++.+||+|||++.....
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~ 157 (290)
T cd05613 81 HLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFHE 157 (290)
T ss_pred EEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEECCCCCEEEeeCccceeccc
Confidence 99999999999999998777899999999999999999999998 999999999999999999999999999987644
Q ss_pred CCCceeeccccccccccccccccC--CCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceec
Q 039819 340 SDSHVTTAVRGTVGHIAPEYLSTG--QSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLV 417 (534)
Q Consensus 340 ~~~~~~~~~~gt~~y~aPE~~~~~--~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 417 (534)
..........|+..|+|||++... .++.++||||||+++|||+||+.||....... ...++........
T Consensus 158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~---~~~~~~~~~~~~~------ 228 (290)
T cd05613 158 DEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKN---SQAEISRRILKSE------ 228 (290)
T ss_pred ccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccc---cHHHHHHHhhccC------
Confidence 332223345688999999998653 46789999999999999999999986432211 1112222111110
Q ss_pred ccccCCCCCHHHHHHHHHHHHHhcccCCCCCC-----ChHHHH
Q 039819 418 DRELGSNYDRIEVGEILQVALLCTQYLPVHRP-----KMSEVV 455 (534)
Q Consensus 418 d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RP-----t~~ev~ 455 (534)
+ .++......+.+++.+|++.+|++|| ++.+++
T Consensus 229 -~----~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~ 266 (290)
T cd05613 229 -P----PYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIK 266 (290)
T ss_pred -C----CCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHH
Confidence 0 11222345788999999999999998 455554
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-35 Score=289.44 Aligned_cols=248 Identities=23% Similarity=0.334 Sum_probs=186.7
Q ss_pred CCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEeh---------------hhhhhcccCceeeEEEEEeCCCeeEEEeecc
Q 039819 203 NFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLK---------------DMISLAVHRNLLRLIGYCATPTERLLVYPYM 266 (534)
Q Consensus 203 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~---------------~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~ 266 (534)
+|+..+.||.|++|.||+|+.. ++..||||.+. ..+..++|+||+++++++...+..++||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 4778899999999999999985 68899999764 2567788999999999999999999999999
Q ss_pred CCCChhhhcccC---CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCCc
Q 039819 267 SNGSVASRLREK---PALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSH 343 (534)
Q Consensus 267 ~~gsL~~~l~~~---~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~ 343 (534)
++ +|.+++... ..+++..+..++.|++.||.|||+. +++||||||+||++++++.++|+|||++........
T Consensus 81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~- 155 (284)
T cd07836 81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN- 155 (284)
T ss_pred Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc-
Confidence 85 888877542 4689999999999999999999998 999999999999999999999999999976543211
Q ss_pred eeeccccccccccccccccC-CCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhh-----cccceec
Q 039819 344 VTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQE-----KKVEVLV 417 (534)
Q Consensus 344 ~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~ 417 (534)
......++..|+|||++.+. .++.++|||||||++|||++|+.||...........+.+........ ......
T Consensus 156 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 234 (284)
T cd07836 156 TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEY- 234 (284)
T ss_pred ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchh-
Confidence 12234578899999988654 46889999999999999999999997543221111111110000000 000000
Q ss_pred ccccC-------CCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 418 DRELG-------SNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 418 d~~l~-------~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
..... ..........+.+++.+|++.+|.+||++.++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 235 KPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred cccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 00000 0001122457889999999999999999999985
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-35 Score=288.42 Aligned_cols=225 Identities=27% Similarity=0.332 Sum_probs=180.2
Q ss_pred eccCCcEEEEEEEEC-CCcEEEEEEeh-----------------hhhhhcccCceeeEEEEEeCCCeeEEEeeccCCCCh
Q 039819 210 LGAGGFGNVYKGKLG-DGTVLAVKRLK-----------------DMISLAVHRNLLRLIGYCATPTERLLVYPYMSNGSV 271 (534)
Q Consensus 210 lG~G~~g~Vy~~~~~-~~~~vavK~~~-----------------~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 271 (534)
||+|+||.||++... +++.||+|.+. +++..++||||+++++++...+..++||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 689999999999864 68899999763 257788899999999999999999999999999999
Q ss_pred hhhcccCC--CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCCceeeccc
Q 039819 272 ASRLREKP--ALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVR 349 (534)
Q Consensus 272 ~~~l~~~~--~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 349 (534)
.+++.... .+++..+..++.|++.||.|||+. +++||||||+||+++.++.++|+|||++....... ......
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~--~~~~~~ 155 (277)
T cd05577 81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK--KIKGRA 155 (277)
T ss_pred HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEccCcchhhhccCC--cccccc
Confidence 99987544 699999999999999999999998 99999999999999999999999999987654321 223345
Q ss_pred cccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceecccccCCCCCHHH
Q 039819 350 GTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELGSNYDRIE 429 (534)
Q Consensus 350 gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 429 (534)
++..|+|||++.+..++.++|||||||++|+|++|+.||.......... ....... . .....+...
T Consensus 156 ~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~---~~~~~~~-~----------~~~~~~~~~ 221 (277)
T cd05577 156 GTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKE---ELKRRTL-E----------MAVEYPDKF 221 (277)
T ss_pred CCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHH---HHHhccc-c----------ccccCCccC
Confidence 7889999999988889999999999999999999999996433211100 0000000 0 001112223
Q ss_pred HHHHHHHHHHhcccCCCCCCChHH
Q 039819 430 VGEILQVALLCTQYLPVHRPKMSE 453 (534)
Q Consensus 430 ~~~l~~l~~~Cl~~~P~~RPt~~e 453 (534)
...+.+++.+|++.+|.+||+.++
T Consensus 222 ~~~~~~li~~~l~~~p~~R~~~~~ 245 (277)
T cd05577 222 SPEAKDLCEALLQKDPEKRLGCRG 245 (277)
T ss_pred CHHHHHHHHHHccCChhHccCCCc
Confidence 457889999999999999995555
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=288.28 Aligned_cols=247 Identities=22% Similarity=0.330 Sum_probs=187.1
Q ss_pred CCcCCeeccCCcEEEEEEEEC-CCcEEEEEEehh---------------hhhhcc-cCceeeEEEEEeCCCeeEEEeecc
Q 039819 204 FSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLKD---------------MISLAV-HRNLLRLIGYCATPTERLLVYPYM 266 (534)
Q Consensus 204 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~---------------~l~~~~-h~niv~l~~~~~~~~~~~lv~e~~ 266 (534)
|...+.||+|+||.||+|+.. +++.||||++.. .+..++ |+|++++++++...+..++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 556788999999999999986 478899998753 345666 999999999999999999999999
Q ss_pred CCCChhhhcccCC--CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCCce
Q 039819 267 SNGSVASRLREKP--ALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHV 344 (534)
Q Consensus 267 ~~gsL~~~l~~~~--~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~ 344 (534)
+|+|.+.+.... .+++..+..++.|++.+|.|||+. +++|+||||+||+++.++.++|+|||+++.......
T Consensus 81 -~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~-- 154 (283)
T cd07830 81 -EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP-- 154 (283)
T ss_pred -CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCCEEEeecccceeccCCCC--
Confidence 889999887654 789999999999999999999998 999999999999999999999999999987643222
Q ss_pred eecccccccccccccccc-CCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHH---------HHHHHhhhcccc
Q 039819 345 TTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLE---------WVKKIQQEKKVE 414 (534)
Q Consensus 345 ~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~---------~~~~~~~~~~~~ 414 (534)
.....++..|+|||++.. ..++.++||||||++++||++|+.||......+....+.. |...........
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (283)
T cd07830 155 YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLG 234 (283)
T ss_pred cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcccc
Confidence 233457889999998754 4578999999999999999999999975432221111111 111111111111
Q ss_pred eecccccCC---CCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 415 VLVDRELGS---NYDRIEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 415 ~~~d~~l~~---~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
..+...... .........+.+++.+|++.+|++||+++|++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 279 (283)
T cd07830 235 FRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ 279 (283)
T ss_pred ccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence 000000000 000011357889999999999999999999975
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-35 Score=291.10 Aligned_cols=250 Identities=19% Similarity=0.254 Sum_probs=182.3
Q ss_pred hCCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEehh----------------hhhhc-ccCceeeEEEEEeCCCe-----
Q 039819 202 ENFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLKD----------------MISLA-VHRNLLRLIGYCATPTE----- 258 (534)
Q Consensus 202 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~----------------~l~~~-~h~niv~l~~~~~~~~~----- 258 (534)
++|+..+.||+|+||.||+|... +++.||||.+.. ++..+ .|+||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 36888899999999999999975 689999997641 34455 46999999999987665
Q ss_pred eEEEeeccCCCChhhhccc-----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCC-CCcEEEEecc
Q 039819 259 RLLVYPYMSNGSVASRLRE-----KPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDD-FCEAIVGDFG 332 (534)
Q Consensus 259 ~~lv~e~~~~gsL~~~l~~-----~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~-~~~~kl~DFG 332 (534)
.++||||+++ +|.+++.. ...+++..++.++.||+.||.|||+. +|+||||||+||+++. ++.+||+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEecCCCeEEEeecc
Confidence 7999999985 78887753 24589999999999999999999998 9999999999999998 8999999999
Q ss_pred cceecCCCCCceeecccccccccccccccc-CCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhc
Q 039819 333 LAKLLDHSDSHVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEK 411 (534)
Q Consensus 333 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 411 (534)
+++....... ......+++.|+|||++.+ ..++.++|||||||++|||++|+.||...........+...........
T Consensus 157 ~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (295)
T cd07837 157 LGRAFSIPVK-SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQV 235 (295)
T ss_pred cceecCCCcc-ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhh
Confidence 9986533211 1122346889999998865 4578999999999999999999999975432221111111110000000
Q ss_pred c--cceecc----cccCC----CCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 412 K--VEVLVD----RELGS----NYDRIEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 412 ~--~~~~~d----~~l~~----~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
. .....+ +.... ........++.+++.+|++.+|.+||++.|++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 236 WPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred CcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 0 000000 00000 000113457889999999999999999999985
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-36 Score=304.77 Aligned_cols=229 Identities=26% Similarity=0.436 Sum_probs=185.7
Q ss_pred CCeeccCCcEEEEEEEEC-CCcEEEEEEeh------------------hhhhhcccCceeeEEEEEeCCCe--eEEEeec
Q 039819 207 KNILGAGGFGNVYKGKLG-DGTVLAVKRLK------------------DMISLAVHRNLLRLIGYCATPTE--RLLVYPY 265 (534)
Q Consensus 207 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~------------------~~l~~~~h~niv~l~~~~~~~~~--~~lv~e~ 265 (534)
..+||+|+|-+||+|.+. +|..||=-.++ .+++.+.|+|||+++.++.+... ..+|+|.
T Consensus 45 ~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL 124 (632)
T KOG0584|consen 45 DEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITEL 124 (632)
T ss_pred hhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeec
Confidence 357999999999999875 46666521111 38899999999999999987765 6799999
Q ss_pred cCCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCC-CCcEEEEecccceecCCCCCce
Q 039819 266 MSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDD-FCEAIVGDFGLAKLLDHSDSHV 344 (534)
Q Consensus 266 ~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~-~~~~kl~DFGla~~~~~~~~~~ 344 (534)
|..|+|..++++.+.++....+.|+.||++||.|||++ .|+|||||||.+||+|+. .|.|||+|.|||+.+..+..
T Consensus 125 ~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~a-- 201 (632)
T KOG0584|consen 125 FTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSHA-- 201 (632)
T ss_pred ccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhhcccc--
Confidence 99999999999999999999999999999999999998 789999999999999985 58999999999998865432
Q ss_pred eeccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceecccccCCC
Q 039819 345 TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELGSN 424 (534)
Q Consensus 345 ~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 424 (534)
..+.||+.|||||+.- ..|++.+||||||+.++||+|+..||.-.. ...+..+.+....+...
T Consensus 202 -ksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~------n~AQIYKKV~SGiKP~s--------- 264 (632)
T KOG0584|consen 202 -KSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECT------NPAQIYKKVTSGIKPAA--------- 264 (632)
T ss_pred -ceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhC------CHHHHHHHHHcCCCHHH---------
Confidence 2367999999999884 789999999999999999999999986322 12233333333221111
Q ss_pred CCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 425 YDRIEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 425 ~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
+......++.+++.+|+.. .++||++.|++.
T Consensus 265 l~kV~dPevr~fIekCl~~-~~~R~sa~eLL~ 295 (632)
T KOG0584|consen 265 LSKVKDPEVREFIEKCLAT-KSERLSAKELLK 295 (632)
T ss_pred hhccCCHHHHHHHHHHhcC-chhccCHHHHhh
Confidence 1122234789999999999 999999999986
|
|
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=331.30 Aligned_cols=239 Identities=28% Similarity=0.360 Sum_probs=193.0
Q ss_pred HHhCCCcCCeeccCCcEEEEEEEE-CCCcEEEEEEeh----------------hhhhhcccCceeeEEEEEeCCCeeEEE
Q 039819 200 ATENFSSKNILGAGGFGNVYKGKL-GDGTVLAVKRLK----------------DMISLAVHRNLLRLIGYCATPTERLLV 262 (534)
Q Consensus 200 ~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~----------------~~l~~~~h~niv~l~~~~~~~~~~~lv 262 (534)
.+-++.....||.|.||.||-|.. ++|...|+|.++ +++..++|||+|+.+|+-...+..+|.
T Consensus 1233 V~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IF 1312 (1509)
T KOG4645|consen 1233 VTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIF 1312 (1509)
T ss_pred ceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHH
Confidence 344677788999999999999985 568888888664 378899999999999999999999999
Q ss_pred eeccCCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCC
Q 039819 263 YPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDS 342 (534)
Q Consensus 263 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~ 342 (534)
||||++|+|.+.+...+..++.....+..|++.|++|||+. +||||||||+||+|+.+|.+|++|||.|........
T Consensus 1313 MEyC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~---gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~ 1389 (1509)
T KOG4645|consen 1313 MEYCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEH---GIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQ 1389 (1509)
T ss_pred HHHhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhc---CceecCCCccceeeecCCcEEeecccceeEecCchh
Confidence 99999999999999888888888888999999999999999 999999999999999999999999999987754321
Q ss_pred ---ceeeccccccccccccccccCC---CCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhccccee
Q 039819 343 ---HVTTAVRGTVGHIAPEYLSTGQ---SSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVL 416 (534)
Q Consensus 343 ---~~~~~~~gt~~y~aPE~~~~~~---~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 416 (534)
.......||+.|||||++.+.. ...+.||||+|||++||+||++||..-+ -+|.-.....-
T Consensus 1390 ~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~d--------ne~aIMy~V~~----- 1456 (1509)
T KOG4645|consen 1390 TMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELD--------NEWAIMYHVAA----- 1456 (1509)
T ss_pred cCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhcc--------chhHHHhHHhc-----
Confidence 1223467999999999997644 3567899999999999999999996211 13322211110
Q ss_pred cccccCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 039819 417 VDRELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRM 457 (534)
Q Consensus 417 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~ 457 (534)
.-...++.....+-.+++.+|++.||+.|+++.|+++.
T Consensus 1457 ---gh~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1457 ---GHKPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred ---cCCCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence 00122344455677899999999999999888877753
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-36 Score=321.27 Aligned_cols=245 Identities=22% Similarity=0.275 Sum_probs=196.4
Q ss_pred HHHHHHHHhCCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEehh-----------------hhhhcccCceeeEEEEEeC
Q 039819 194 FRELQQATENFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLKD-----------------MISLAVHRNLLRLIGYCAT 255 (534)
Q Consensus 194 ~~~l~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~-----------------~l~~~~h~niv~l~~~~~~ 255 (534)
..++....++|.+.++||+|+||.|..++.. .++++|.|++.+ ++.....+-|+++.-.|.+
T Consensus 67 v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD 146 (1317)
T KOG0612|consen 67 VKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQD 146 (1317)
T ss_pred HHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcC
Confidence 3556666789999999999999999999985 688999998874 4555567789999999999
Q ss_pred CCeeEEEeeccCCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccce
Q 039819 256 PTERLLVYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAK 335 (534)
Q Consensus 256 ~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~ 335 (534)
..+.|+|||||+||+|..++.+...+++..++-++..|+-||.-+|+. |+|||||||+|||||..|++||+|||.+-
T Consensus 147 ~~~LYlVMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~m---gyVHRDiKPDNvLld~~GHikLADFGsCl 223 (1317)
T KOG0612|consen 147 ERYLYLVMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSM---GYVHRDIKPDNVLLDKSGHIKLADFGSCL 223 (1317)
T ss_pred ccceEEEEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhc---cceeccCCcceeEecccCcEeeccchhHH
Confidence 999999999999999999998877899999999999999999999999 99999999999999999999999999998
Q ss_pred ecCCCCCceeeccccccccccccccc----c-CCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhh
Q 039819 336 LLDHSDSHVTTAVRGTVGHIAPEYLS----T-GQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQE 410 (534)
Q Consensus 336 ~~~~~~~~~~~~~~gt~~y~aPE~~~----~-~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 410 (534)
.+.....-.....+|||.|++||++. + +.|+..+|.||+||++|||+.|..||...+ +++-...+...
T Consensus 224 km~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYads-------lveTY~KIm~h 296 (1317)
T KOG0612|consen 224 KMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADS-------LVETYGKIMNH 296 (1317)
T ss_pred hcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHH-------HHHHHHHHhch
Confidence 88766655666778999999999984 2 678999999999999999999999997433 22222222222
Q ss_pred cccceecccccCCCCCHHHHHHHHHHHHHhcccCCCCCCC---hHHHHH
Q 039819 411 KKVEVLVDRELGSNYDRIEVGEILQVALLCTQYLPVHRPK---MSEVVR 456 (534)
Q Consensus 411 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt---~~ev~~ 456 (534)
+..-.+ .-....+.+..+|+.+.+. +|+.|-. ++++-.
T Consensus 297 k~~l~F-------P~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~ 337 (1317)
T KOG0612|consen 297 KESLSF-------PDETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKN 337 (1317)
T ss_pred hhhcCC-------CcccccCHHHHHHHHHHhc-ChhhhcccccHHHHHh
Confidence 111111 0012245567777776554 4666665 776654
|
|
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=301.80 Aligned_cols=234 Identities=21% Similarity=0.307 Sum_probs=200.2
Q ss_pred HHHhCCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEehh----------------hhhhcccCceeeEEEEEeCCCeeEE
Q 039819 199 QATENFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLKD----------------MISLAVHRNLLRLIGYCATPTERLL 261 (534)
Q Consensus 199 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~----------------~l~~~~h~niv~l~~~~~~~~~~~l 261 (534)
..+..|.+...||+|.|+.|..|+.. .+..||||.+.+ +++.+.|||||+++.+...+...|+
T Consensus 53 ~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lyl 132 (596)
T KOG0586|consen 53 NSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYL 132 (596)
T ss_pred ccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEE
Confidence 34567888999999999999999875 689999998863 6888999999999999999999999
Q ss_pred EeeccCCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCC
Q 039819 262 VYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSD 341 (534)
Q Consensus 262 v~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~ 341 (534)
||||+.+|.+++++.+.+.+.+.....++.|+.+|++|||++ .|||||||++||||+.+.++||+|||++.++..
T Consensus 133 V~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k---~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~-- 207 (596)
T KOG0586|consen 133 VMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSK---NIVHRDLKAENILLDENMNIKIADFGFSTFFDY-- 207 (596)
T ss_pred EEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhc---ceeccccchhhcccccccceeeeccccceeecc--
Confidence 999999999999999988888899999999999999999999 999999999999999999999999999998863
Q ss_pred CceeeccccccccccccccccCCC-CcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceecccc
Q 039819 342 SHVTTAVRGTVGHIAPEYLSTGQS-SEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRE 420 (534)
Q Consensus 342 ~~~~~~~~gt~~y~aPE~~~~~~~-~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 420 (534)
.....+.+|++.|.|||++.+..| ++++|+||+|+|+|-|+.|..||++..-. .+-++.
T Consensus 208 ~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk--------------------~Lr~rv 267 (596)
T KOG0586|consen 208 GLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLK--------------------ELRPRV 267 (596)
T ss_pred cccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccc--------------------cccchh
Confidence 334667899999999999988776 68999999999999999999999854321 111122
Q ss_pred cCCC--CCHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 039819 421 LGSN--YDRIEVGEILQVALLCTQYLPVHRPKMSEVVRM 457 (534)
Q Consensus 421 l~~~--~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~ 457 (534)
+.+. .+.-...++.+++++.+..+|.+|+++.++.+.
T Consensus 268 l~gk~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~ 306 (596)
T KOG0586|consen 268 LRGKYRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKD 306 (596)
T ss_pred eeeeecccceeechhHHHHHHhhccCccccCCHHHhhhh
Confidence 2211 122223477889999999999999999999753
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=292.81 Aligned_cols=250 Identities=20% Similarity=0.273 Sum_probs=181.8
Q ss_pred CCCcCCeeccCCcEEEEEEEEC-C--CcEEEEEEehh----------------hhhhc-ccCceeeEEEEEeCC----Ce
Q 039819 203 NFSSKNILGAGGFGNVYKGKLG-D--GTVLAVKRLKD----------------MISLA-VHRNLLRLIGYCATP----TE 258 (534)
Q Consensus 203 ~~~~~~~lG~G~~g~Vy~~~~~-~--~~~vavK~~~~----------------~l~~~-~h~niv~l~~~~~~~----~~ 258 (534)
+|...+.||+|+||.||+++.. . +..||||++.. ++..+ .||||+++++++... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 4677789999999999999975 3 77899998652 34445 599999999875432 45
Q ss_pred eEEEeeccCCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecC
Q 039819 259 RLLVYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLD 338 (534)
Q Consensus 259 ~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~ 338 (534)
.++++||+. ++|.+++.....+++..++.++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 81 ~~~~~e~~~-~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~ 156 (332)
T cd07857 81 LYLYEELME-ADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDFGLARGFS 156 (332)
T ss_pred EEEEEeccc-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHeEEcCCCCEEeCcCCCceecc
Confidence 688899986 68999998778899999999999999999999998 99999999999999999999999999998654
Q ss_pred CCCC---ceeecccccccccccccccc-CCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHH--------HHH
Q 039819 339 HSDS---HVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEW--------VKK 406 (534)
Q Consensus 339 ~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~--------~~~ 406 (534)
.... .......||..|+|||++.+ ..++.++|||||||++|+|++|+.||...........+... ...
T Consensus 157 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (332)
T cd07857 157 ENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSR 236 (332)
T ss_pred cccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 3221 11223468999999998765 46889999999999999999999999754321111111111 000
Q ss_pred Hhhhcccc--eecccccCCCC---CHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 407 IQQEKKVE--VLVDRELGSNY---DRIEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 407 ~~~~~~~~--~~~d~~l~~~~---~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
........ ......-...+ .......+.+++.+|++.+|++|||+.+++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~ 291 (332)
T cd07857 237 IGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALE 291 (332)
T ss_pred hhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 00000000 00000000000 0012357889999999999999999999873
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-34 Score=277.66 Aligned_cols=234 Identities=28% Similarity=0.413 Sum_probs=191.1
Q ss_pred CCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEeh--------------hhhhhcccCceeeEEEEEeCCCeeEEEeeccC
Q 039819 203 NFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLK--------------DMISLAVHRNLLRLIGYCATPTERLLVYPYMS 267 (534)
Q Consensus 203 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~--------------~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~~ 267 (534)
+|...+.||+|++|.||++... ++..+++|++. +.+..+.|+|++++++++......++++||++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 3667789999999999999986 68899999874 25677789999999999999999999999999
Q ss_pred CCChhhhcccC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCCceee
Q 039819 268 NGSVASRLREK-PALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTT 346 (534)
Q Consensus 268 ~gsL~~~l~~~-~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~ 346 (534)
+++|.+++... ..+++..+..++.+++.||.|||.. +++||||+|+||++++++.++|+|||.+........ ..
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--~~ 155 (253)
T cd05122 81 GGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA--RN 155 (253)
T ss_pred CCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcC---CEecCCCCHHHEEEccCCeEEEeecccccccccccc--cc
Confidence 99999998765 6799999999999999999999998 999999999999999999999999999987654332 23
Q ss_pred ccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceecccccCCCCC
Q 039819 347 AVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELGSNYD 426 (534)
Q Consensus 347 ~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 426 (534)
...++..|+|||++....++.++||||||+++|+|++|+.||..... .+....... ..... +.. .
T Consensus 156 ~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-------~~~~~~~~~-~~~~~-----~~~--~ 220 (253)
T cd05122 156 TMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPP-------MKALFKIAT-NGPPG-----LRN--P 220 (253)
T ss_pred ceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCch-------HHHHHHHHh-cCCCC-----cCc--c
Confidence 45688999999999888899999999999999999999999864321 111111111 10000 000 1
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 427 RIEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 427 ~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
......+.+++.+|++.+|++|||+.|+++
T Consensus 221 ~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~ 250 (253)
T cd05122 221 EKWSDEFKDFLKKCLQKNPEKRPTAEQLLK 250 (253)
T ss_pred cccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 111457899999999999999999999985
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=288.63 Aligned_cols=239 Identities=24% Similarity=0.362 Sum_probs=193.9
Q ss_pred HHHhCCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEeh-------------hhhhhcccCceeeEEEEEeCCCeeEEEee
Q 039819 199 QATENFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLK-------------DMISLAVHRNLLRLIGYCATPTERLLVYP 264 (534)
Q Consensus 199 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~-------------~~l~~~~h~niv~l~~~~~~~~~~~lv~e 264 (534)
..++.|...+.||+|+||.||+|... ++..||+|.+. +.+..++|+|++++++++......++|+|
T Consensus 16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 95 (286)
T cd06614 16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVME 95 (286)
T ss_pred CccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCchhHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEe
Confidence 34567888889999999999999986 68889999875 25677889999999999999999999999
Q ss_pred ccCCCChhhhcccCC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCCc
Q 039819 265 YMSNGSVASRLREKP-ALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSH 343 (534)
Q Consensus 265 ~~~~gsL~~~l~~~~-~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~ 343 (534)
|+++++|.+++.... .+++..+..++.+++.||.|||+. +++|+||||+||+++.++.++|+|||++........
T Consensus 96 ~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~---gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~- 171 (286)
T cd06614 96 YMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS- 171 (286)
T ss_pred ccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCChhhEEEcCCCCEEECccchhhhhccchh-
Confidence 999999999998765 899999999999999999999998 999999999999999999999999999876543221
Q ss_pred eeeccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceecccccCC
Q 039819 344 VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELGS 423 (534)
Q Consensus 344 ~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 423 (534)
......++..|+|||++.+..++.++|||||||++|||++|+.||...... ......... .....
T Consensus 172 ~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~-------~~~~~~~~~-~~~~~------- 236 (286)
T cd06614 172 KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPL-------RALFLITTK-GIPPL------- 236 (286)
T ss_pred hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHH-------HHHHHHHhc-CCCCC-------
Confidence 122344788999999998888999999999999999999999998632211 111111111 00000
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 424 NYDRIEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 424 ~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
......+..+.+++.+|++.+|.+||++.++++
T Consensus 237 ~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 269 (286)
T cd06614 237 KNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQ 269 (286)
T ss_pred cchhhCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 011113457889999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=287.47 Aligned_cols=233 Identities=23% Similarity=0.292 Sum_probs=191.4
Q ss_pred CCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEehh-----------------hhhhcccCceeeEEEEEeCCCeeEEEee
Q 039819 203 NFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLKD-----------------MISLAVHRNLLRLIGYCATPTERLLVYP 264 (534)
Q Consensus 203 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~-----------------~l~~~~h~niv~l~~~~~~~~~~~lv~e 264 (534)
+|+..+.||.|+||.||+|... ++..||+|.+.+ .++.++||||+++++++.+....++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 4778889999999999999986 588999997742 5678889999999999999999999999
Q ss_pred ccCCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCCce
Q 039819 265 YMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHV 344 (534)
Q Consensus 265 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~ 344 (534)
|+.+++|.+++.....+++..+..|+.|+++||.|||+. +++|+||||+||++++++.++|+|||++....... .
T Consensus 81 ~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~--~ 155 (258)
T cd05578 81 LLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT--L 155 (258)
T ss_pred CCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEEcCCCCEEEeecccccccCCCc--c
Confidence 999999999998777899999999999999999999998 99999999999999999999999999988664332 2
Q ss_pred eeccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceecccccCCC
Q 039819 345 TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELGSN 424 (534)
Q Consensus 345 ~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 424 (534)
.....|+..|+|||++.+..++.++||||||+++|+|++|+.||...... ...+....... ....
T Consensus 156 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-----~~~~~~~~~~~----------~~~~ 220 (258)
T cd05578 156 TTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRT-----IRDQIRAKQET----------ADVL 220 (258)
T ss_pred ccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCcc-----HHHHHHHHhcc----------cccc
Confidence 23455888999999998888999999999999999999999999754321 11111111110 0011
Q ss_pred CCHHHHHHHHHHHHHhcccCCCCCCCh--HHHH
Q 039819 425 YDRIEVGEILQVALLCTQYLPVHRPKM--SEVV 455 (534)
Q Consensus 425 ~~~~~~~~l~~l~~~Cl~~~P~~RPt~--~ev~ 455 (534)
.+...+..+.+++.+|++.+|.+||++ +|++
T Consensus 221 ~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 221 YPATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred CcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 122234688899999999999999999 6554
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=287.38 Aligned_cols=232 Identities=24% Similarity=0.347 Sum_probs=193.4
Q ss_pred CCcCCeeccCCcEEEEEEEEC-CCcEEEEEEeh------------hhhhhcccCceeeEEEEEeCCCeeEEEeeccCCCC
Q 039819 204 FSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLK------------DMISLAVHRNLLRLIGYCATPTERLLVYPYMSNGS 270 (534)
Q Consensus 204 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~------------~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~~~gs 270 (534)
|.+...||+|+||.||+|..+ .|.++|||... .++.++..|++|+++|.|......|+|||||..|+
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGAGS 114 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGAGS 114 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCCCc
Confidence 444567999999999999875 69999999764 26788899999999999999999999999999999
Q ss_pred hhhhcc-cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCCceeeccc
Q 039819 271 VASRLR-EKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVR 349 (534)
Q Consensus 271 L~~~l~-~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 349 (534)
..+.++ ++.+|++.++..++...++||+|||.. .-||||||..|||++-+|.+|++|||.|..+.+.- ....++.
T Consensus 115 iSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~---~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTM-AKRNTVI 190 (502)
T KOG0574|consen 115 ISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDL---KKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTM-AKRNTVI 190 (502)
T ss_pred HHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHH---HHHHhhcccccEEEcccchhhhhhccccchhhhhH-HhhCccc
Confidence 999997 456899999999999999999999998 78999999999999999999999999998765422 2234577
Q ss_pred cccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceeccc-ccCCC--CC
Q 039819 350 GTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDR-ELGSN--YD 426 (534)
Q Consensus 350 gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~-~l~~~--~~ 426 (534)
||+.|||||++..-.|..++||||+|++..||..|++||..-.+.. ..++-+ .-... -+
T Consensus 191 GTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMR------------------AIFMIPT~PPPTF~KP 252 (502)
T KOG0574|consen 191 GTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMR------------------AIFMIPTKPPPTFKKP 252 (502)
T ss_pred cCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccc------------------eeEeccCCCCCCCCCh
Confidence 9999999999999899999999999999999999999986221110 001111 11112 23
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 039819 427 RIEVGEILQVALLCTQYLPVHRPKMSEVVRM 457 (534)
Q Consensus 427 ~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~ 457 (534)
..-..++.+++..|+-..|++|-|+.++++.
T Consensus 253 E~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 253 EEWSSEFNDFIRSCLIKKPEERKTALRLCEH 283 (502)
T ss_pred HhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence 4456789999999999999999999998763
|
|
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=279.65 Aligned_cols=236 Identities=27% Similarity=0.381 Sum_probs=193.5
Q ss_pred CCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEehh----------------hhhhcccCceeeEEEEEeCC--CeeEEEe
Q 039819 203 NFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLKD----------------MISLAVHRNLLRLIGYCATP--TERLLVY 263 (534)
Q Consensus 203 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~----------------~l~~~~h~niv~l~~~~~~~--~~~~lv~ 263 (534)
+|...+.||+|++|.||+|... +++.|++|.+.. .++++.|+||+++++.+... ...++|+
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 4667789999999999999986 688999997642 56778899999999999988 8899999
Q ss_pred eccCCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCCc
Q 039819 264 PYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSH 343 (534)
Q Consensus 264 e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~ 343 (534)
||+++++|.+++.....+++..+..++.+++.||+|||+. +++|+||+|+||+++.++.++|+|||.+.........
T Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 157 (260)
T cd06606 81 EYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETG 157 (260)
T ss_pred EecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEcccccEEeccccccc
Confidence 9999999999998777899999999999999999999998 9999999999999999999999999999877543321
Q ss_pred -eeeccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceecccccC
Q 039819 344 -VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELG 422 (534)
Q Consensus 344 -~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 422 (534)
......++..|+|||.+.+...+.++||||||+++++|++|+.||..... .......... ....
T Consensus 158 ~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~------~~~~~~~~~~---------~~~~ 222 (260)
T cd06606 158 EGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGN------PMAALYKIGS---------SGEP 222 (260)
T ss_pred ccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc------hHHHHHhccc---------cCCC
Confidence 12335588999999999888899999999999999999999999974331 1111111110 0111
Q ss_pred CCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 423 SNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 423 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
...+......+.+++.+|++.+|.+||++.+++.
T Consensus 223 ~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 223 PEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred cCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence 1122233568999999999999999999999985
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=286.26 Aligned_cols=244 Identities=23% Similarity=0.330 Sum_probs=184.8
Q ss_pred CCcCCeeccCCcEEEEEEEEC-CCcEEEEEEehh----------------h---hhhcccCceeeEEEEEeCCCe-----
Q 039819 204 FSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLKD----------------M---ISLAVHRNLLRLIGYCATPTE----- 258 (534)
Q Consensus 204 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~----------------~---l~~~~h~niv~l~~~~~~~~~----- 258 (534)
|+..+.||+|+||.||+|+.. ++..||+|++.. + +..+.|+|++++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 556788999999999999986 489999998851 2 233469999999999988776
Q ss_pred eEEEeeccCCCChhhhcccC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEeccccee
Q 039819 259 RLLVYPYMSNGSVASRLREK--PALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKL 336 (534)
Q Consensus 259 ~~lv~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~ 336 (534)
.+++|||+++ +|.+++... ..+++..++.++.|++.||.|||+. +++|+||||+||+++.++.+||+|||++..
T Consensus 81 ~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~---~i~h~~l~~~nili~~~~~~~l~dfg~~~~ 156 (287)
T cd07838 81 LTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLARI 156 (287)
T ss_pred eEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhEEEccCCCEEEeccCccee
Confidence 8999999974 788888653 3589999999999999999999998 999999999999999999999999999987
Q ss_pred cCCCCCceeeccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhc---cc
Q 039819 337 LDHSDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEK---KV 413 (534)
Q Consensus 337 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~ 413 (534)
...... .....++..|+|||++.+..++.++|||||||++|||+||+.||........ +..+........ ..
T Consensus 157 ~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~ 231 (287)
T cd07838 157 YSFEMA--LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQ---LDKIFDVIGLPSEEEWP 231 (287)
T ss_pred ccCCcc--cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHH---HHHHHHHcCCCChHhcC
Confidence 643321 2233478899999999888899999999999999999999999874332211 111111110000 00
Q ss_pred c------eecccccCCCC---CHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 414 E------VLVDRELGSNY---DRIEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 414 ~------~~~d~~l~~~~---~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
. ........... .......+.+++.+|++.+|.+||++.+++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 232 RNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred CCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 0 00000000000 1122457789999999999999999999984
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=282.60 Aligned_cols=233 Identities=23% Similarity=0.363 Sum_probs=188.7
Q ss_pred CCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEeh----------------hhhhhcccCceeeEEEEEeCCCeeEEEeec
Q 039819 203 NFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLK----------------DMISLAVHRNLLRLIGYCATPTERLLVYPY 265 (534)
Q Consensus 203 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~----------------~~l~~~~h~niv~l~~~~~~~~~~~lv~e~ 265 (534)
+|...+.||+|+||.||++... ++..+|+|.+. .+++.++|+||+++++.+......++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 4677889999999999999985 57889999873 146778899999999999999999999999
Q ss_pred cCCCChhhhcccC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCC-cEEEEecccceecCCCCC
Q 039819 266 MSNGSVASRLREK--PALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFC-EAIVGDFGLAKLLDHSDS 342 (534)
Q Consensus 266 ~~~gsL~~~l~~~--~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~-~~kl~DFGla~~~~~~~~ 342 (534)
+++++|.+++... ..+++..+..++.|++.||.|||+. +++|+||||+||++++++ .+||+|||.+........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~ 157 (257)
T cd08225 81 CDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME 157 (257)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEcCCCCeEEecccccchhccCCcc
Confidence 9999999998653 3589999999999999999999998 999999999999999875 569999999987654322
Q ss_pred ceeeccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceecccccC
Q 039819 343 HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELG 422 (534)
Q Consensus 343 ~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 422 (534)
......|+..|+|||+..+..++.++|||||||++|||++|+.||.... ..+++....... . .
T Consensus 158 -~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-------~~~~~~~~~~~~-~----~---- 220 (257)
T cd08225 158 -LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNN-------LHQLVLKICQGY-F----A---- 220 (257)
T ss_pred -cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCcc-------HHHHHHHHhccc-C----C----
Confidence 2233458899999999988889999999999999999999999986322 122222221111 0 0
Q ss_pred CCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 423 SNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 423 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
.........+.+++.+|++.+|++||++.|+++
T Consensus 221 -~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 253 (257)
T cd08225 221 -PISPNFSRDLRSLISQLFKVSPRDRPSITSILK 253 (257)
T ss_pred -CCCCCCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 011122347889999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=313.48 Aligned_cols=254 Identities=20% Similarity=0.252 Sum_probs=179.0
Q ss_pred HHHhCCCcCCeeccCCcEEEEEEEECC--CcEEE------------------EEEe-------------hhhhhhcccCc
Q 039819 199 QATENFSSKNILGAGGFGNVYKGKLGD--GTVLA------------------VKRL-------------KDMISLAVHRN 245 (534)
Q Consensus 199 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~--~~~va------------------vK~~-------------~~~l~~~~h~n 245 (534)
...++|...+.||+|+||.||++.++. +..++ .|.+ ..++..++|+|
T Consensus 145 ~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~Hpn 224 (501)
T PHA03210 145 EFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHEN 224 (501)
T ss_pred hhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCC
Confidence 345789999999999999999987532 11111 1111 12577889999
Q ss_pred eeeEEEEEeCCCeeEEEeeccCCCChhhhcccC-----CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEe
Q 039819 246 LLRLIGYCATPTERLLVYPYMSNGSVASRLREK-----PALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLL 320 (534)
Q Consensus 246 iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~-----~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl 320 (534)
||++++++...+..|+|+|++. ++|.+++... ..........|+.|++.||.|||+. +||||||||+|||+
T Consensus 225 Iv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~---gIiHrDLKP~NILl 300 (501)
T PHA03210 225 ILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKLENIFL 300 (501)
T ss_pred cCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEE
Confidence 9999999999999999999985 4676666422 2234566778999999999999998 99999999999999
Q ss_pred CCCCcEEEEecccceecCCCCCceeeccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchH
Q 039819 321 DDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAM 400 (534)
Q Consensus 321 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~ 400 (534)
+.++.+||+|||+++.+............||..|+|||++.+..++.++|||||||++|||++|..++...........+
T Consensus 301 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~ 380 (501)
T PHA03210 301 NCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQL 380 (501)
T ss_pred CCCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHH
Confidence 99999999999999877544333334467999999999999889999999999999999999987644322211111111
Q ss_pred HHHHHHHhh--hc------ccceeccc-ccC---CCCCH-----HHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 401 LEWVKKIQQ--EK------KVEVLVDR-ELG---SNYDR-----IEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 401 ~~~~~~~~~--~~------~~~~~~d~-~l~---~~~~~-----~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
.+....... .. .....++. .+. ..... .....+.+++.+|++.||.+|||+.|++.
T Consensus 381 ~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~ 453 (501)
T PHA03210 381 LKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLA 453 (501)
T ss_pred HHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhh
Confidence 111111100 00 00000000 000 00000 01235677899999999999999999986
|
|
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=290.85 Aligned_cols=230 Identities=28% Similarity=0.396 Sum_probs=183.1
Q ss_pred CCcCCeeccCCcEEEEEEEEC-CCcEEEEEEeh-----------------hhhhhcccCceeeEEEEEeCCCeeEEEeec
Q 039819 204 FSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLK-----------------DMISLAVHRNLLRLIGYCATPTERLLVYPY 265 (534)
Q Consensus 204 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~-----------------~~l~~~~h~niv~l~~~~~~~~~~~lv~e~ 265 (534)
|...+.||+|+||.||+|+.. ++..||+|.+. +.++.++|+|++++++++.+....++||||
T Consensus 27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 106 (317)
T cd06635 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY 106 (317)
T ss_pred hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeC
Confidence 566788999999999999974 68899999874 145677899999999999999999999999
Q ss_pred cCCCChhhhcc-cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCCce
Q 039819 266 MSNGSVASRLR-EKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHV 344 (534)
Q Consensus 266 ~~~gsL~~~l~-~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~ 344 (534)
+++ +|.+.+. ....+++..+..++.+++.||.|||+. +|+||||+|+||+++.++.++|+|||++......
T Consensus 107 ~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~---~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~---- 178 (317)
T cd06635 107 CLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASIASPA---- 178 (317)
T ss_pred CCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcccEEECCCCCEEEecCCCccccCCc----
Confidence 974 7777764 355699999999999999999999998 9999999999999999999999999998755332
Q ss_pred eeccccccccccccccc---cCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceeccccc
Q 039819 345 TTAVRGTVGHIAPEYLS---TGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDREL 421 (534)
Q Consensus 345 ~~~~~gt~~y~aPE~~~---~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 421 (534)
....|+..|+|||++. .+.++.++|||||||++|||++|+.||..... ............
T Consensus 179 -~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~-------~~~~~~~~~~~~--------- 241 (317)
T cd06635 179 -NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-------MSALYHIAQNES--------- 241 (317)
T ss_pred -ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccH-------HHHHHHHHhccC---------
Confidence 2345888999999973 45688999999999999999999999853211 111111111110
Q ss_pred CCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHh
Q 039819 422 GSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRML 458 (534)
Q Consensus 422 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L 458 (534)
...........+.+++.+|++.+|.+||++.++++.+
T Consensus 242 ~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~ 278 (317)
T cd06635 242 PTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHM 278 (317)
T ss_pred CCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhCh
Confidence 0001112345788999999999999999999999743
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=289.20 Aligned_cols=250 Identities=20% Similarity=0.296 Sum_probs=183.8
Q ss_pred hCCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEeh----------------hhhhhcccCceeeEEEEEeCCCeeEEEee
Q 039819 202 ENFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLK----------------DMISLAVHRNLLRLIGYCATPTERLLVYP 264 (534)
Q Consensus 202 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~----------------~~l~~~~h~niv~l~~~~~~~~~~~lv~e 264 (534)
++|+..+.||+|++|.||+|+.. +++.||+|.+. +.++.++|+||+++++++......++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 46888899999999999999975 68899999764 25677889999999999999999999999
Q ss_pred ccCCCChhhhcccCC--CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCC-CCcEEEEecccceecCCCC
Q 039819 265 YMSNGSVASRLREKP--ALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDD-FCEAIVGDFGLAKLLDHSD 341 (534)
Q Consensus 265 ~~~~gsL~~~l~~~~--~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~-~~~~kl~DFGla~~~~~~~ 341 (534)
|++ ++|.+.+.... .+++..+..++.|++.||+|||+. +++||||||+||+++. ++.+||+|||++.......
T Consensus 82 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~ 157 (294)
T PLN00009 82 YLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV 157 (294)
T ss_pred ccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCcceEEEECCCCEEEEcccccccccCCCc
Confidence 996 57877775433 357888889999999999999998 9999999999999985 5679999999997654321
Q ss_pred Cceeecccccccccccccccc-CCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcc--cceecc
Q 039819 342 SHVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKK--VEVLVD 418 (534)
Q Consensus 342 ~~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~d 418 (534)
. ......++..|+|||++.+ ..++.++|||||||++|||+||+.||......+....+..+......... ...+.+
T Consensus 158 ~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (294)
T PLN00009 158 R-TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPD 236 (294)
T ss_pred c-ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchh
Confidence 1 1223457889999998865 45789999999999999999999999754322111111111000000000 000000
Q ss_pred -----cccCCC----CCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 419 -----RELGSN----YDRIEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 419 -----~~l~~~----~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
+..... ........+.+++.+|++.+|++||++.++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~ 283 (294)
T PLN00009 237 YKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE 283 (294)
T ss_pred hhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence 000000 00112346889999999999999999999986
|
|
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=291.29 Aligned_cols=250 Identities=21% Similarity=0.321 Sum_probs=184.3
Q ss_pred CCCcCCeeccCCcEEEEEEEEC---CCcEEEEEEehh-----------------hhhhcccCceeeEEEEEeCC--CeeE
Q 039819 203 NFSSKNILGAGGFGNVYKGKLG---DGTVLAVKRLKD-----------------MISLAVHRNLLRLIGYCATP--TERL 260 (534)
Q Consensus 203 ~~~~~~~lG~G~~g~Vy~~~~~---~~~~vavK~~~~-----------------~l~~~~h~niv~l~~~~~~~--~~~~ 260 (534)
.|...+.||+|+||.||+|... ++..||+|.+.. ++..++||||+++++++.+. ...+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 3677788999999999999975 478999998753 56778899999999999988 7899
Q ss_pred EEeeccCCCChhhhccc-----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCC----CCcEEEEec
Q 039819 261 LVYPYMSNGSVASRLRE-----KPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDD----FCEAIVGDF 331 (534)
Q Consensus 261 lv~e~~~~gsL~~~l~~-----~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~----~~~~kl~DF 331 (534)
+||||+++ +|.+.+.. ...+++..++.++.|++.||.|||+. +|+||||||+||+++. ++.+||+||
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 99999975 66665531 23689999999999999999999998 9999999999999999 999999999
Q ss_pred ccceecCCCCC--ceeeccccccccccccccccC-CCCcchhHHHHHHHHHHHHhCCCCcCCCccccc------cchHHH
Q 039819 332 GLAKLLDHSDS--HVTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELITGMRALEFGKSINQ------KGAMLE 402 (534)
Q Consensus 332 Gla~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~------~~~~~~ 402 (534)
|++........ .......++..|+|||++.+. .++.++|||||||+++||++|+.||........ ...+..
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (316)
T cd07842 157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER 236 (316)
T ss_pred ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence 99987643321 112234578899999987664 578999999999999999999999975432210 001111
Q ss_pred HHHHHhhh-----------cccceecccccCCCCC---------H--HHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 403 WVKKIQQE-----------KKVEVLVDRELGSNYD---------R--IEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 403 ~~~~~~~~-----------~~~~~~~d~~l~~~~~---------~--~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
++...... .......+......++ . .....+.+++.+|++.+|++|||+.|+++
T Consensus 237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~ 312 (316)
T cd07842 237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE 312 (316)
T ss_pred HHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 11111000 0000000000000011 0 12346889999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=292.94 Aligned_cols=253 Identities=22% Similarity=0.359 Sum_probs=184.9
Q ss_pred CHHHHHHHH----hCCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEeh----------------hhhhhcccCceeeEEE
Q 039819 193 TFRELQQAT----ENFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLK----------------DMISLAVHRNLLRLIG 251 (534)
Q Consensus 193 ~~~~l~~~~----~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~----------------~~l~~~~h~niv~l~~ 251 (534)
+.+|+..++ ++|...+.||+|+||.||+|+.. ++..||||++. .++..++|+||+++++
T Consensus 2 ~~~~~~~~~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~ 81 (342)
T cd07879 2 YREEVNKTVWELPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLD 81 (342)
T ss_pred chhhhhhhhhccccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhh
Confidence 334444443 78988999999999999999864 68999999874 1566788999999999
Q ss_pred EEeCCC------eeEEEeeccCCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCc
Q 039819 252 YCATPT------ERLLVYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCE 325 (534)
Q Consensus 252 ~~~~~~------~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~ 325 (534)
++.... ..++|+||+.. +|..... ..+++..+..++.|++.||.|||+. +|+||||||+||+++.++.
T Consensus 82 ~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dlkp~NIll~~~~~ 155 (342)
T cd07879 82 VFTSAVSGDEFQDFYLVMPYMQT-DLQKIMG--HPLSEDKVQYLVYQMLCGLKYIHSA---GIIHRDLKPGNLAVNEDCE 155 (342)
T ss_pred eecccccCCCCceEEEEeccccc-CHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCC
Confidence 987543 45899999964 6666542 3589999999999999999999998 9999999999999999999
Q ss_pred EEEEecccceecCCCCCceeecccccccccccccccc-CCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHH-
Q 039819 326 AIVGDFGLAKLLDHSDSHVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEW- 403 (534)
Q Consensus 326 ~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~- 403 (534)
+||+|||+++..... .....++..|+|||++.+ ..++.++|||||||++|||++|+.||...........+...
T Consensus 156 ~kL~dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~ 231 (342)
T cd07879 156 LKILDFGLARHADAE----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVT 231 (342)
T ss_pred EEEeeCCCCcCCCCC----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhc
Confidence 999999999765322 223457889999999866 46889999999999999999999999754321111000000
Q ss_pred -------HHHHhhhcccceecc--ccc-CCCCC---HHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 404 -------VKKIQQEKKVEVLVD--REL-GSNYD---RIEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 404 -------~~~~~~~~~~~~~~d--~~l-~~~~~---~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
...... ......++ +.. ..... ......+.+++.+|++.+|++||++.+++.
T Consensus 232 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~ 296 (342)
T cd07879 232 GVPGPEFVQKLED-KAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALE 296 (342)
T ss_pred CCCCHHHHHHhcc-cchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 000000 00000000 000 00000 012346889999999999999999999975
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=291.29 Aligned_cols=251 Identities=25% Similarity=0.334 Sum_probs=186.5
Q ss_pred HhCCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEeh----------------hhhhhcccCceeeEEEEEeCC--CeeEE
Q 039819 201 TENFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLK----------------DMISLAVHRNLLRLIGYCATP--TERLL 261 (534)
Q Consensus 201 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~----------------~~l~~~~h~niv~l~~~~~~~--~~~~l 261 (534)
.++|+..+.||+|+||.||+|... ++..||+|.+. .++..++|+||+++++++... +..++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 467888999999999999999975 68999999874 256778999999999998765 46799
Q ss_pred EeeccCCCChhhhccc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCC
Q 039819 262 VYPYMSNGSVASRLRE-KPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHS 340 (534)
Q Consensus 262 v~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~ 340 (534)
||||+.+ +|.+++.. ...+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||++......
T Consensus 86 v~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~ 161 (309)
T cd07845 86 VMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHEN---FIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLP 161 (309)
T ss_pred EEecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccceeeecCCc
Confidence 9999975 78777764 46699999999999999999999999 9999999999999999999999999999876543
Q ss_pred CCceeecccccccccccccccc-CCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhc--------
Q 039819 341 DSHVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEK-------- 411 (534)
Q Consensus 341 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~-------- 411 (534)
.. ......++..|+|||++.+ ..++.++|||||||++|||++|+.||...........+..+........
T Consensus 162 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (309)
T cd07845 162 AK-PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLP 240 (309)
T ss_pred cC-CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhccc
Confidence 21 1222345788999999865 4578999999999999999999999975433221111111110000000
Q ss_pred cccee-cccccCCCCC---HHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 412 KVEVL-VDRELGSNYD---RIEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 412 ~~~~~-~d~~l~~~~~---~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
..... .......... ......+.+++.+|++.||++|||+.|++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~ 289 (309)
T cd07845 241 LVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALE 289 (309)
T ss_pred ccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 00000 0000000000 012456789999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=295.02 Aligned_cols=233 Identities=24% Similarity=0.360 Sum_probs=185.7
Q ss_pred hCCCcCCeeccCCcEEEEEEEECCCcEEEEEEehh----------------hhhhc-ccCceeeEEEEEeCCCeeEEEee
Q 039819 202 ENFSSKNILGAGGFGNVYKGKLGDGTVLAVKRLKD----------------MISLA-VHRNLLRLIGYCATPTERLLVYP 264 (534)
Q Consensus 202 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~----------------~l~~~-~h~niv~l~~~~~~~~~~~lv~e 264 (534)
..|+..+.||+||.+.||++...+.+.+|+|++.. .|.++ .|.+||++++|-..++..|||||
T Consensus 361 ~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvmE 440 (677)
T KOG0596|consen 361 REYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVME 440 (677)
T ss_pred chhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEee
Confidence 35778889999999999999999999999998752 34444 48999999999999999999999
Q ss_pred ccCCCChhhhcccCCC-C-CHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCC-
Q 039819 265 YMSNGSVASRLREKPA-L-DWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSD- 341 (534)
Q Consensus 265 ~~~~gsL~~~l~~~~~-l-~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~- 341 (534)
|= ..+|..+|+.+.. + .| .++.+..|++.|+.++|.. +|||.||||.|+|+-+ |.+||+|||+|.......
T Consensus 441 ~G-d~DL~kiL~k~~~~~~~~-~lk~ywkqML~aV~~IH~~---gIVHSDLKPANFLlVk-G~LKLIDFGIA~aI~~DTT 514 (677)
T KOG0596|consen 441 CG-DIDLNKILKKKKSIDPDW-FLKFYWKQMLLAVKTIHQH---GIVHSDLKPANFLLVK-GRLKLIDFGIANAIQPDTT 514 (677)
T ss_pred cc-cccHHHHHHhccCCCchH-HHHHHHHHHHHHHHHHHHh---ceeecCCCcccEEEEe-eeEEeeeechhcccCcccc
Confidence 86 4589999986543 3 34 7788899999999999999 9999999999999977 899999999999876443
Q ss_pred CceeeccccccccccccccccC-----------CCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHH-HHHHHHhh
Q 039819 342 SHVTTAVRGTVGHIAPEYLSTG-----------QSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAML-EWVKKIQQ 409 (534)
Q Consensus 342 ~~~~~~~~gt~~y~aPE~~~~~-----------~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~-~~~~~~~~ 409 (534)
+......+||+.||+||.+... +++.++||||+|||||+|+.|+.||.. +. .|.
T Consensus 515 sI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~---------~~n~~a----- 580 (677)
T KOG0596|consen 515 SIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQ---------IINQIA----- 580 (677)
T ss_pred ceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHH---------HHHHHH-----
Confidence 2334556899999999988421 257899999999999999999999951 11 222
Q ss_pred hcccceecccccCCCCCHHH-HHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 410 EKKVEVLVDRELGSNYDRIE-VGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 410 ~~~~~~~~d~~l~~~~~~~~-~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
++..+.|+...-.++... ..++++++..|++.||.+||++.++++
T Consensus 581 --Kl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLq 626 (677)
T KOG0596|consen 581 --KLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQ 626 (677)
T ss_pred --HHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhc
Confidence 223344554333333222 234999999999999999999999986
|
|
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=271.83 Aligned_cols=231 Identities=26% Similarity=0.383 Sum_probs=182.1
Q ss_pred CCeeccCCcEEEEEEEEC-CCcEEEEEEehh----------------hhhhcccCceeeEEEEEeCCCeeEEEeeccCCC
Q 039819 207 KNILGAGGFGNVYKGKLG-DGTVLAVKRLKD----------------MISLAVHRNLLRLIGYCATPTERLLVYPYMSNG 269 (534)
Q Consensus 207 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~----------------~l~~~~h~niv~l~~~~~~~~~~~lv~e~~~~g 269 (534)
...||.|..|.|++++.. .|..+|||.+.+ ++..-..|.||+.+|||......++.||.|..
T Consensus 97 l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelMs~- 175 (391)
T KOG0983|consen 97 LGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELMST- 175 (391)
T ss_pred HHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHHHH-
Confidence 355999999999999986 589999999863 22333379999999999999999999999853
Q ss_pred Chhhhcc-cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCCceeecc
Q 039819 270 SVASRLR-EKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAV 348 (534)
Q Consensus 270 sL~~~l~-~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~~ 348 (534)
.+..+++ -++++++...-++...++.||.||-++. +|||||+||+|||+|+.|++|+||||++-++-++. ..+..
T Consensus 176 C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSk--Ahtrs 251 (391)
T KOG0983|consen 176 CAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSK--AHTRS 251 (391)
T ss_pred HHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeeccc--ccccc
Confidence 4444444 3456888888899999999999999875 89999999999999999999999999998886544 34455
Q ss_pred cccccccccccccc---CCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceecccccCCCC
Q 039819 349 RGTVGHIAPEYLST---GQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELGSNY 425 (534)
Q Consensus 349 ~gt~~y~aPE~~~~---~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 425 (534)
+|.+.|||||.+.. ..|+.++|||||||+|+||+||+.||...... .+.+..+..+. -+.+.+.
T Consensus 252 AGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~td------Fe~ltkvln~e------PP~L~~~- 318 (391)
T KOG0983|consen 252 AGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTD------FEVLTKVLNEE------PPLLPGH- 318 (391)
T ss_pred cCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCcc------HHHHHHHHhcC------CCCCCcc-
Confidence 79999999999853 46889999999999999999999999854321 12222222111 1222221
Q ss_pred CHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 426 DRIEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 426 ~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
......+.++...|++.|+.+||...++++
T Consensus 319 -~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~ 348 (391)
T KOG0983|consen 319 -MGFSPDFQSFVKDCLTKDHRKRPKYNKLLE 348 (391)
T ss_pred -cCcCHHHHHHHHHHhhcCcccCcchHHHhc
Confidence 114558899999999999999999999986
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=290.67 Aligned_cols=254 Identities=26% Similarity=0.371 Sum_probs=185.9
Q ss_pred cCCeeccCCcEEEEEEEECCCcEEEEEEehh-------------hhhhcccCceeeEEEEEeCCC----eeEEEeeccCC
Q 039819 206 SKNILGAGGFGNVYKGKLGDGTVLAVKRLKD-------------MISLAVHRNLLRLIGYCATPT----ERLLVYPYMSN 268 (534)
Q Consensus 206 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~-------------~l~~~~h~niv~l~~~~~~~~----~~~lv~e~~~~ 268 (534)
..++||+|.||.||||++.+ +.||||++.. -+-.++|+||++++++-.... +++||+||-++
T Consensus 214 l~eli~~Grfg~V~KaqL~~-~~VAVKifp~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~fh~k 292 (534)
T KOG3653|consen 214 LLELIGRGRFGCVWKAQLDN-RLVAVKIFPEQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTEFHPK 292 (534)
T ss_pred hHHHhhcCccceeehhhccC-ceeEEEecCHHHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEeeeccC
Confidence 34679999999999999955 8999999863 234678999999999876555 78999999999
Q ss_pred CChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcC------CCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCC
Q 039819 269 GSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQC------DPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDS 342 (534)
Q Consensus 269 gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~------~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~ 342 (534)
|+|.++|+.+ .++|....+|+.-+++||+|||+.. +|+|+|||||++||||..++++.|+|||+|..+.....
T Consensus 293 GsL~dyL~~n-tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~~~p~~~ 371 (534)
T KOG3653|consen 293 GSLCDYLKAN-TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALRLEPGKP 371 (534)
T ss_pred CcHHHHHHhc-cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeEEecCCCC
Confidence 9999999865 5899999999999999999999753 56899999999999999999999999999998764332
Q ss_pred c-eeeccccccccccccccccCC-C-----CcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccc-
Q 039819 343 H-VTTAVRGTVGHIAPEYLSTGQ-S-----SEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVE- 414 (534)
Q Consensus 343 ~-~~~~~~gt~~y~aPE~~~~~~-~-----~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~- 414 (534)
. .....+||..|||||++-+.. + -.+.||||+|.|||||++....++.+...+-.....+-++....-+.+.
T Consensus 372 ~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hPt~e~mq~ 451 (534)
T KOG3653|consen 372 QGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHPTLEEMQE 451 (534)
T ss_pred CcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCCCHHHHHH
Confidence 1 223367999999999985432 1 2368999999999999998766542211111000000111100000110
Q ss_pred eecccccCCCCC-----HHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhcC
Q 039819 415 VLVDRELGSNYD-----RIEVGEILQVALLCTQYLPVHRPKMSEVVRMLEGD 461 (534)
Q Consensus 415 ~~~d~~l~~~~~-----~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~~ 461 (534)
..+.++.+..++ ...+..+.+.+..||..||+.|-|+.=|.+.+...
T Consensus 452 ~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l 503 (534)
T KOG3653|consen 452 LVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAEL 503 (534)
T ss_pred HHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHH
Confidence 011111111111 13356788999999999999999999888776653
|
|
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=291.66 Aligned_cols=251 Identities=20% Similarity=0.313 Sum_probs=187.9
Q ss_pred HHHHHhCCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEeh----------------hhhhhcccCceeeEEEEEeC-CCe
Q 039819 197 LQQATENFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLK----------------DMISLAVHRNLLRLIGYCAT-PTE 258 (534)
Q Consensus 197 l~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~----------------~~l~~~~h~niv~l~~~~~~-~~~ 258 (534)
+...+++|+..+.||+|+||.||+|... ++..||||++. +++..++||||+++.++|.. ...
T Consensus 5 ~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 84 (328)
T cd07856 5 VFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLED 84 (328)
T ss_pred eeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCc
Confidence 3456788999999999999999999865 78999999763 25678889999999999876 457
Q ss_pred eEEEeeccCCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecC
Q 039819 259 RLLVYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLD 338 (534)
Q Consensus 259 ~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~ 338 (534)
.++||||+ +++|.++++.. .+++.....++.|+++||.|||+. +|+||||||+||+++.++.++|+|||++....
T Consensus 85 ~~lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~~ql~~aL~~LH~~---~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~ 159 (328)
T cd07856 85 IYFVTELL-GTDLHRLLTSR-PLEKQFIQYFLYQILRGLKYVHSA---GVVHRDLKPSNILINENCDLKICDFGLARIQD 159 (328)
T ss_pred EEEEeehh-ccCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEeECCCCCEEeCccccccccC
Confidence 89999998 56888877643 578899999999999999999998 99999999999999999999999999997553
Q ss_pred CCCCceeecccccccccccccccc-CCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHH--------HHHHhh
Q 039819 339 HSDSHVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEW--------VKKIQQ 409 (534)
Q Consensus 339 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~--------~~~~~~ 409 (534)
.. .....++..|+|||++.+ ..++.++|||||||++|||+||+.||...........+.++ ......
T Consensus 160 ~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (328)
T cd07856 160 PQ----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICS 235 (328)
T ss_pred CC----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccc
Confidence 22 123457889999998765 56899999999999999999999999754321111111111 111100
Q ss_pred hcccceecccccCCCCCH-----HHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 410 EKKVEVLVDRELGSNYDR-----IEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 410 ~~~~~~~~d~~l~~~~~~-----~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
......+.........+. .....+.+++.+|++.+|++||++.+++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~ 287 (328)
T cd07856 236 ENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALA 287 (328)
T ss_pred hhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 000000000000011111 12357889999999999999999999874
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=283.88 Aligned_cols=231 Identities=26% Similarity=0.343 Sum_probs=186.0
Q ss_pred eccCCcEEEEEEEEC-CCcEEEEEEeh-----------------hhhhhcccCceeeEEEEEeCCCeeEEEeeccCCCCh
Q 039819 210 LGAGGFGNVYKGKLG-DGTVLAVKRLK-----------------DMISLAVHRNLLRLIGYCATPTERLLVYPYMSNGSV 271 (534)
Q Consensus 210 lG~G~~g~Vy~~~~~-~~~~vavK~~~-----------------~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 271 (534)
||+|+||.||+++.. ++..+|+|.+. +.+..++|+||+++++.+......++||||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 689999999999987 48999999874 156677899999999999999999999999999999
Q ss_pred hhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCC-------ce
Q 039819 272 ASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDS-------HV 344 (534)
Q Consensus 272 ~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~-------~~ 344 (534)
.+++.....+++..+..++.|++.||.|||+. +++||||+|+||+++.++.++|+|||++........ ..
T Consensus 81 ~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~ 157 (265)
T cd05579 81 ASLLENVGSLDEDVARIYIAEIVLALEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKE 157 (265)
T ss_pred HHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHc---CeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccccccc
Confidence 99998777899999999999999999999998 999999999999999999999999999876433211 12
Q ss_pred eeccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceecccccCCC
Q 039819 345 TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELGSN 424 (534)
Q Consensus 345 ~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 424 (534)
.....++..|+|||+......+.++||||||+++|||+||+.||..... .+........ .. ....
T Consensus 158 ~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~-------~~~~~~~~~~-~~------~~~~- 222 (265)
T cd05579 158 DKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETP-------EEIFQNILNG-KI------EWPE- 222 (265)
T ss_pred ccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCH-------HHHHHHHhcC-Cc------CCCc-
Confidence 2334578899999999888889999999999999999999999964321 1111111110 00 0000
Q ss_pred CCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhh
Q 039819 425 YDRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLE 459 (534)
Q Consensus 425 ~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~ 459 (534)
....+..+.+++.+|++.+|.+|||+.++.+.|+
T Consensus 223 -~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~ 256 (265)
T cd05579 223 -DVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN 256 (265)
T ss_pred -cccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence 0002458899999999999999999966666554
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=281.13 Aligned_cols=231 Identities=27% Similarity=0.355 Sum_probs=190.5
Q ss_pred CCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEehh----------------hhhhcccCceeeEEEEEeCCCeeEEEeec
Q 039819 203 NFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLKD----------------MISLAVHRNLLRLIGYCATPTERLLVYPY 265 (534)
Q Consensus 203 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~----------------~l~~~~h~niv~l~~~~~~~~~~~lv~e~ 265 (534)
+|+..+.||+|+||.||+++.. ++..+|+|.+.. .++.++|+||+++.+++......++||||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 4777889999999999999864 678899998641 46777899999999999999999999999
Q ss_pred cCCCChhhhccc----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCC
Q 039819 266 MSNGSVASRLRE----KPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSD 341 (534)
Q Consensus 266 ~~~gsL~~~l~~----~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~ 341 (534)
+++++|.+++.. ...+++..+..++.+++.||.|||+. +++|+||+|+||+++.++.+||+|||++......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~---~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~- 156 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKKN- 156 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEEecCCcEEEeeccchhhhccC-
Confidence 999999998865 45689999999999999999999998 9999999999999999999999999999876543
Q ss_pred CceeeccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceeccccc
Q 039819 342 SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDREL 421 (534)
Q Consensus 342 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 421 (534)
......++..|+|||++.+..++.++|+||||+++|||++|+.||...... +....... . .
T Consensus 157 --~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~-------~~~~~~~~-~---------~ 217 (256)
T cd08530 157 --MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQ-------DLRYKVQR-G---------K 217 (256)
T ss_pred --CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-------HHHHHHhc-C---------C
Confidence 222345788999999998888999999999999999999999999643211 11111111 0 1
Q ss_pred CCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 422 GSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 422 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
....+......+.+++.+|++.+|.+||++.++++
T Consensus 218 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 252 (256)
T cd08530 218 YPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILA 252 (256)
T ss_pred CCCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 11122234567999999999999999999999985
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=286.13 Aligned_cols=247 Identities=20% Similarity=0.279 Sum_probs=188.4
Q ss_pred CCcCCeeccCCcEEEEEEEEC-CCcEEEEEEehh----------------hhhhcccCceeeEEEEEeCCCeeEEEeecc
Q 039819 204 FSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLKD----------------MISLAVHRNLLRLIGYCATPTERLLVYPYM 266 (534)
Q Consensus 204 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~----------------~l~~~~h~niv~l~~~~~~~~~~~lv~e~~ 266 (534)
|...+.||+|++|.||+|... +++.+|+|++.. .++.++|+||+++++++..+...++||||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 456678999999999999875 688999998642 567788999999999999999999999999
Q ss_pred CCCChhhhccc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCCcee
Q 039819 267 SNGSVASRLRE-KPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVT 345 (534)
Q Consensus 267 ~~gsL~~~l~~-~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~ 345 (534)
++ +|.+.+.. ...+++..+..++.+++.||.|||+. +|+|+||||+||+++.++.++|+|||.+....... ...
T Consensus 81 ~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~-~~~ 155 (283)
T cd05118 81 DT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSH---GILHRDLKPENLLINTEGVLKLADFGLARSFGSPV-RPY 155 (283)
T ss_pred CC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHC---CeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc-ccc
Confidence 75 88887765 45799999999999999999999998 99999999999999999999999999998775432 122
Q ss_pred eccccccccccccccccC-CCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceecc------
Q 039819 346 TAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVD------ 418 (534)
Q Consensus 346 ~~~~gt~~y~aPE~~~~~-~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d------ 418 (534)
....++..|+|||.+.+. .++.++||||||+++|+|+||+.||......+....+.+.+..... .....+.+
T Consensus 156 ~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 234 (283)
T cd05118 156 THYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDP-EVWPKFTSLARNYK 234 (283)
T ss_pred cCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCch-Hhcccchhhhhhhh
Confidence 234578899999998776 6899999999999999999999999754432211111111000000 00000000
Q ss_pred -----cccC--CCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 419 -----RELG--SNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 419 -----~~l~--~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
.... ..........+.+++.+|++.+|.+||++++++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 235 FSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred hhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 0000 0011223568899999999999999999999985
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=279.40 Aligned_cols=245 Identities=26% Similarity=0.345 Sum_probs=190.9
Q ss_pred CccccCHHHHHHHHhCCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEehh----------------hhhhcccCceeeEE
Q 039819 188 NLRNFTFRELQQATENFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLKD----------------MISLAVHRNLLRLI 250 (534)
Q Consensus 188 ~~~~~~~~~l~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~----------------~l~~~~h~niv~l~ 250 (534)
.+..|+.++|+.. ..||.|+||+|+|-..+ .|+.+|||++.. .++.-..||||+++
T Consensus 57 ~~~~F~~~~Lqdl-------g~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfy 129 (361)
T KOG1006|consen 57 HLHTFTSDNLQDL-------GEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFY 129 (361)
T ss_pred cccccccchHHHH-------HHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHh
Confidence 4567777777655 45999999999999875 689999999862 45556689999999
Q ss_pred EEEeCCCeeEEEeeccCCCChhhhcc-----cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCc
Q 039819 251 GYCATPTERLLVYPYMSNGSVASRLR-----EKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCE 325 (534)
Q Consensus 251 ~~~~~~~~~~lv~e~~~~gsL~~~l~-----~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~ 325 (534)
|.+..+...|+.||.|+- ||..+.+ .+..+++.-.-.|...++.||.||-... .|||||+||+|||++..|.
T Consensus 130 Ga~F~EGdcWiCMELMd~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~ 206 (361)
T KOG1006|consen 130 GALFSEGDCWICMELMDI-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGD 206 (361)
T ss_pred hhhhcCCceeeeHHHHhh-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCC
Confidence 999999999999999954 5544332 4557899999999999999999998764 8999999999999999999
Q ss_pred EEEEecccceecCCCCCceeecccccccccccccccc--CCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHH
Q 039819 326 AIVGDFGLAKLLDHSDSHVTTAVRGTVGHIAPEYLST--GQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEW 403 (534)
Q Consensus 326 ~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~ 403 (534)
+|+||||++-.+..+ ...+.-+|...|||||.+.. ..|+.+|||||+||+|||+.||+.|++.-.+ +.+-
T Consensus 207 vKLCDFGIcGqLv~S--iAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s------vfeq 278 (361)
T KOG1006|consen 207 VKLCDFGICGQLVDS--IAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS------VFEQ 278 (361)
T ss_pred EeeecccchHhHHHH--HHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH------HHHH
Confidence 999999999876543 34555679999999999853 3488999999999999999999999973221 2232
Q ss_pred HHHHhhhcccceecccccCCCCC-HHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 404 VKKIQQEKKVEVLVDRELGSNYD-RIEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 404 ~~~~~~~~~~~~~~d~~l~~~~~-~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
+.++...... .+..... ......+..++..|+..+..+||...++.+
T Consensus 279 l~~Vv~gdpp------~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~ 326 (361)
T KOG1006|consen 279 LCQVVIGDPP------ILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKK 326 (361)
T ss_pred HHHHHcCCCC------eecCcccccccCHHHHHHHHHHhhcccccCcchhhhhc
Confidence 3333322211 1111111 123457899999999999999999999875
|
|
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=292.00 Aligned_cols=252 Identities=25% Similarity=0.337 Sum_probs=184.6
Q ss_pred HhCCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEeh----------------hhhhhcccCceeeEEEEEeCCC------
Q 039819 201 TENFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLK----------------DMISLAVHRNLLRLIGYCATPT------ 257 (534)
Q Consensus 201 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~----------------~~l~~~~h~niv~l~~~~~~~~------ 257 (534)
.++|...+.||+|+||.||+|+.. +++.+|||++. +.+..++|+||+++++++.+..
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 468889999999999999999975 68899999763 2577889999999999875543
Q ss_pred --eeEEEeeccCCCChhhhccc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccc
Q 039819 258 --ERLLVYPYMSNGSVASRLRE-KPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLA 334 (534)
Q Consensus 258 --~~~lv~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla 334 (534)
..++||||+.+ +|...+.. ...+++..+..++.|+++||.|||+. +|+||||||+||++++++.++|+|||++
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~ 162 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFGLA 162 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECcCccc
Confidence 45999999975 56666653 45799999999999999999999999 9999999999999999999999999999
Q ss_pred eecCCCCC----------ceeeccccccccccccccccC-CCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHH
Q 039819 335 KLLDHSDS----------HVTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEW 403 (534)
Q Consensus 335 ~~~~~~~~----------~~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~ 403 (534)
+....... .......++..|+|||++.+. .++.++|||||||++|||++|++||...........+...
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~ 242 (311)
T cd07866 163 RPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKL 242 (311)
T ss_pred hhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence 86543211 111234578889999987654 5789999999999999999999999754432221111111
Q ss_pred HHHHhhh-----cccceec----ccccCCCCC---HHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 404 VKKIQQE-----KKVEVLV----DRELGSNYD---RIEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 404 ~~~~~~~-----~~~~~~~----d~~l~~~~~---~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
....... ....... ......... ......+.+++.+|++.+|++|||+.|++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 243 CGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred hCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 1100000 0000000 000000000 011246889999999999999999999875
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=288.04 Aligned_cols=252 Identities=24% Similarity=0.336 Sum_probs=183.7
Q ss_pred HhCCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEeh----------------hhhhhcccCceeeEEEEEeCCC------
Q 039819 201 TENFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLK----------------DMISLAVHRNLLRLIGYCATPT------ 257 (534)
Q Consensus 201 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~----------------~~l~~~~h~niv~l~~~~~~~~------ 257 (534)
.++|+..+.||+|+||.||+|+.. ++..||||.+. ++++.++||||++++++|....
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 90 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY 90 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence 457888999999999999999975 68899999763 2567888999999999987654
Q ss_pred --eeEEEeeccCCCChhhhcccC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccc
Q 039819 258 --ERLLVYPYMSNGSVASRLREK-PALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLA 334 (534)
Q Consensus 258 --~~~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla 334 (534)
..++||||+.+ +|.+.+... ..+++.+++.++.|++.||.|||+. +++|+||||+||+++.++.+||+|||++
T Consensus 91 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~ 166 (310)
T cd07865 91 KGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLADFGLA 166 (310)
T ss_pred CceEEEEEcCCCc-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEECCCCcEEECcCCCc
Confidence 34999999975 777777644 3689999999999999999999998 9999999999999999999999999999
Q ss_pred eecCCCCCc---eeeccccccccccccccccC-CCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhh
Q 039819 335 KLLDHSDSH---VTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQE 410 (534)
Q Consensus 335 ~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 410 (534)
......... ......++..|+|||++.+. .++.++||||||+++|||+||+.||...........+..........
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (310)
T cd07865 167 RAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPE 246 (310)
T ss_pred ccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChh
Confidence 866432211 11234578899999988654 36889999999999999999999987543211111111000000000
Q ss_pred ----cccceeccc-ccCCCC---------CHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 411 ----KKVEVLVDR-ELGSNY---------DRIEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 411 ----~~~~~~~d~-~l~~~~---------~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
.......+. ...... .......+.+++.+|+..+|.+||+++|+++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~ 306 (310)
T cd07865 247 VWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN 306 (310)
T ss_pred hcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence 000000000 000000 0012346779999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=299.85 Aligned_cols=230 Identities=28% Similarity=0.410 Sum_probs=188.3
Q ss_pred CCeeccCCcEEEEEEEEC--CC--cEEEEEEehh---------------hhhhcccCceeeEEEEEeCCCeeEEEeeccC
Q 039819 207 KNILGAGGFGNVYKGKLG--DG--TVLAVKRLKD---------------MISLAVHRNLLRLIGYCATPTERLLVYPYMS 267 (534)
Q Consensus 207 ~~~lG~G~~g~Vy~~~~~--~~--~~vavK~~~~---------------~l~~~~h~niv~l~~~~~~~~~~~lv~e~~~ 267 (534)
.++||+|.||.|++|.|. .| ..||||.++. .|.+++|+|+++|+|+..+ ....+|||.++
T Consensus 115 ~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ELap 193 (1039)
T KOG0199|consen 115 YELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFELAP 193 (1039)
T ss_pred HHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhhcc
Confidence 357999999999999885 34 4589998863 6778899999999999887 66789999999
Q ss_pred CCChhhhccc--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCCcee
Q 039819 268 NGSVASRLRE--KPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVT 345 (534)
Q Consensus 268 ~gsL~~~l~~--~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~ 345 (534)
.|+|.+.|++ +..|-....-.++.|||.|+.||.++ ++|||||...|+||-..-.+||+||||.+.++.......
T Consensus 194 lGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLesk---rlvHRDLAARNlllasprtVKI~DFGLmRaLg~ned~Yv 270 (1039)
T KOG0199|consen 194 LGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESK---RLVHRDLAARNLLLASPRTVKICDFGLMRALGENEDMYV 270 (1039)
T ss_pred cchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhh---hhhhhhhhhhhheecccceeeeecccceeccCCCCcceE
Confidence 9999999986 44577888889999999999999999 999999999999999999999999999998876543321
Q ss_pred -e-ccccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCcCCCccccccchHHHHHHHHhhhcccceecccccC
Q 039819 346 -T-AVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELG 422 (534)
Q Consensus 346 -~-~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 422 (534)
. ...-...|+|||.+...+++.++|||+|||++|||+| |..||.+.... +.++.+ |..-+
T Consensus 271 m~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~-------qIL~~i----------D~~er 333 (1039)
T KOG0199|consen 271 MAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGI-------QILKNI----------DAGER 333 (1039)
T ss_pred ecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHH-------HHHHhc----------ccccc
Confidence 1 1223578999999999999999999999999999998 67888643321 122221 21112
Q ss_pred CCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 039819 423 SNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRM 457 (534)
Q Consensus 423 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~ 457 (534)
-.-+..+++.+++++..||..+|++|||+..+.+.
T Consensus 334 LpRPk~csedIY~imk~cWah~paDRptFsair~~ 368 (1039)
T KOG0199|consen 334 LPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIRED 368 (1039)
T ss_pred CCCCCCChHHHHHHHHHhccCCccccccHHHHHHh
Confidence 22355678899999999999999999999999743
|
|
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=299.82 Aligned_cols=234 Identities=21% Similarity=0.295 Sum_probs=185.4
Q ss_pred CCcCCeeccCCcEEEEEEEECCCcE-EEEEEeh--------------hhhhhcccCceeeEEEEEeCCCeeEEEeeccCC
Q 039819 204 FSSKNILGAGGFGNVYKGKLGDGTV-LAVKRLK--------------DMISLAVHRNLLRLIGYCATPTERLLVYPYMSN 268 (534)
Q Consensus 204 ~~~~~~lG~G~~g~Vy~~~~~~~~~-vavK~~~--------------~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~~~ 268 (534)
|.++..||.|+||.||+|+.++... .|.|.+. +++..+.||+||++++.|+-.+..+++.|||.|
T Consensus 34 WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~G 113 (1187)
T KOG0579|consen 34 WEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCGG 113 (1187)
T ss_pred HHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecCC
Confidence 4456678999999999998765433 3445442 378999999999999999999999999999999
Q ss_pred CChhhhcc-cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCCceeec
Q 039819 269 GSVASRLR-EKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTA 347 (534)
Q Consensus 269 gsL~~~l~-~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~ 347 (534)
|-....+- -...|++.++..++++++.||.|||++ +|||||||..|||++-+|.++|+|||.+..... .......
T Consensus 114 GAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~---~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~-t~qkRDs 189 (1187)
T KOG0579|consen 114 GAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQ---NIIHRDLKAGNILLTLDGDIRLADFGVSAKNKS-TRQKRDS 189 (1187)
T ss_pred chHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhc---chhhhhccccceEEEecCcEeeecccccccchh-HHhhhcc
Confidence 99887765 356799999999999999999999999 999999999999999999999999999865432 1223455
Q ss_pred cccccccccccccc-----cCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceecccccC
Q 039819 348 VRGTVGHIAPEYLS-----TGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELG 422 (534)
Q Consensus 348 ~~gt~~y~aPE~~~-----~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 422 (534)
+.||++|||||+.. ..+|+.++|||||||+|.||..+.+|-..- ..+..+..+..... ..++
T Consensus 190 FIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhel-------npMRVllKiaKSeP-PTLl----- 256 (1187)
T KOG0579|consen 190 FIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHEL-------NPMRVLLKIAKSEP-PTLL----- 256 (1187)
T ss_pred ccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCcccc-------chHHHHHHHhhcCC-Cccc-----
Confidence 77999999999874 467999999999999999999999886411 12222222222211 1111
Q ss_pred CCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 423 SNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 423 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
.+..-...+.++..+|+..||..||++.++++
T Consensus 257 --qPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~ 288 (1187)
T KOG0579|consen 257 --QPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLK 288 (1187)
T ss_pred --CcchhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence 12233457889999999999999999999986
|
|
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=278.82 Aligned_cols=233 Identities=23% Similarity=0.375 Sum_probs=192.4
Q ss_pred CCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEeh----------------hhhhhcccCceeeEEEEEeCCCeeEEEeec
Q 039819 203 NFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLK----------------DMISLAVHRNLLRLIGYCATPTERLLVYPY 265 (534)
Q Consensus 203 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~----------------~~l~~~~h~niv~l~~~~~~~~~~~lv~e~ 265 (534)
+|...+.||+|+||.||++... ++..+|+|++. +.+..++|+|++++.+.+......++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 4777889999999999999985 58899999875 256777899999999999999999999999
Q ss_pred cCCCChhhhcccC----CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCC
Q 039819 266 MSNGSVASRLREK----PALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSD 341 (534)
Q Consensus 266 ~~~gsL~~~l~~~----~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~ 341 (534)
+++++|.+++... ..+++..+..++.+++.||.|||+. +++|+||+|+||+++.++.++|+|||.+.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV 157 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence 9999999998753 6799999999999999999999998 99999999999999999999999999998765433
Q ss_pred CceeeccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceeccccc
Q 039819 342 SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDREL 421 (534)
Q Consensus 342 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 421 (534)
.......|+..|+|||......++.++||||+|+++++|++|+.||..... .+.........
T Consensus 158 -~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~-------~~~~~~~~~~~---------- 219 (258)
T cd08215 158 -DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENL-------LELALKILKGQ---------- 219 (258)
T ss_pred -ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcH-------HHHHHHHhcCC----------
Confidence 223345688999999999888899999999999999999999999864321 11111111110
Q ss_pred CCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 422 GSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 422 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
....+......+.+++.+|+..+|++||++.++++
T Consensus 220 ~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 254 (258)
T cd08215 220 YPPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQ 254 (258)
T ss_pred CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 01112223457899999999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-34 Score=284.77 Aligned_cols=237 Identities=27% Similarity=0.414 Sum_probs=182.6
Q ss_pred hCCCcCCeeccCCcEEEEEEEECC-CcEEEEEEehh---------------hhhhc-ccCceeeEEEEEeCCCeeEEEee
Q 039819 202 ENFSSKNILGAGGFGNVYKGKLGD-GTVLAVKRLKD---------------MISLA-VHRNLLRLIGYCATPTERLLVYP 264 (534)
Q Consensus 202 ~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~---------------~l~~~-~h~niv~l~~~~~~~~~~~lv~e 264 (534)
++|...+.||+|+||.||+|...+ ++.||||.+.. .+... .|+||++++++|.+....++|||
T Consensus 15 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e 94 (296)
T cd06618 15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICME 94 (296)
T ss_pred chheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEee
Confidence 567788999999999999999875 89999998752 12233 49999999999999999999999
Q ss_pred ccCCCChhhhccc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCCc
Q 039819 265 YMSNGSVASRLRE-KPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSH 343 (534)
Q Consensus 265 ~~~~gsL~~~l~~-~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~ 343 (534)
|+.+ ++.+.... ...+++..+..++.+++.||+|||+.. +|+||||+|+||++++++.+||+|||++........
T Consensus 95 ~~~~-~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~--~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~~- 170 (296)
T cd06618 95 LMST-CLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKH--GVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKA- 170 (296)
T ss_pred ccCc-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhC--CEecCCCcHHHEEEcCCCCEEECccccchhccCCCc-
Confidence 9854 66666543 457999999999999999999999732 899999999999999999999999999876543221
Q ss_pred eeeccccccccccccccccCC----CCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceeccc
Q 039819 344 VTTAVRGTVGHIAPEYLSTGQ----SSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDR 419 (534)
Q Consensus 344 ~~~~~~gt~~y~aPE~~~~~~----~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 419 (534)
.....++..|+|||++.+.. ++.++||||||+++|||++|+.||..... ..+.......... +
T Consensus 171 -~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~------~~~~~~~~~~~~~------~ 237 (296)
T cd06618 171 -KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKT------EFEVLTKILQEEP------P 237 (296)
T ss_pred -ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchh------HHHHHHHHhcCCC------C
Confidence 22334788999999986543 78899999999999999999999963211 0111111111110 0
Q ss_pred ccCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 039819 420 ELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRM 457 (534)
Q Consensus 420 ~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~ 457 (534)
.... ......++.+++.+|++.+|.+||++.+++..
T Consensus 238 ~~~~--~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 238 SLPP--NEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred CCCC--CCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 0100 01124578999999999999999999999863
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-34 Score=279.92 Aligned_cols=235 Identities=26% Similarity=0.343 Sum_probs=187.2
Q ss_pred hCCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEeh-------------------hhhhhcccCceeeEEEEEeCC--Cee
Q 039819 202 ENFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLK-------------------DMISLAVHRNLLRLIGYCATP--TER 259 (534)
Q Consensus 202 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~-------------------~~l~~~~h~niv~l~~~~~~~--~~~ 259 (534)
.+|...+.||+|+||.||+|... ++..||+|.+. ++++.++|+||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 46888899999999999999874 68899999752 156778999999999998764 457
Q ss_pred EEEeeccCCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCC
Q 039819 260 LLVYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDH 339 (534)
Q Consensus 260 ~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~ 339 (534)
++|+||+++++|.+++.....+++.....++.|++.||.|||+. +++|+||||+||+++.++.++|+|||+++....
T Consensus 82 ~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 158 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRIQT 158 (264)
T ss_pred EEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcccccccccc
Confidence 89999999999999998777799999999999999999999998 999999999999999999999999999986532
Q ss_pred CC--CceeeccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceec
Q 039819 340 SD--SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLV 417 (534)
Q Consensus 340 ~~--~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 417 (534)
.. ........|+..|+|||++.+..++.++|||||||++|||++|+.||..... .... .......
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~~~-~~~~~~~------ 225 (264)
T cd06653 159 ICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEA------MAAI-FKIATQP------ 225 (264)
T ss_pred ccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCH------HHHH-HHHHcCC------
Confidence 11 1112234588999999999888889999999999999999999999963211 1111 1111000
Q ss_pred ccccCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 418 DRELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 418 d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
.....+......+.+++.+|++ +|..||+..+++.
T Consensus 226 ---~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 226 ---TKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred ---CCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence 1111233344578999999999 5799999998764
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=288.86 Aligned_cols=258 Identities=23% Similarity=0.305 Sum_probs=191.1
Q ss_pred cccCHHHHHHHHhCCCcCCeeccCCcEEEEEEEE-CCCcEEEEEEehh----------------hhhhcccCceeeEEEE
Q 039819 190 RNFTFRELQQATENFSSKNILGAGGFGNVYKGKL-GDGTVLAVKRLKD----------------MISLAVHRNLLRLIGY 252 (534)
Q Consensus 190 ~~~~~~~l~~~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~----------------~l~~~~h~niv~l~~~ 252 (534)
+..+.+++..++++|...+.||+|+||.||+|.. .++..||+|++.. .+..++|+||++++++
T Consensus 5 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~ 84 (345)
T cd07877 5 RQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 84 (345)
T ss_pred hhhHHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeee
Confidence 3445677788889999999999999999999986 4788999998741 5677889999999998
Q ss_pred EeCC------CeeEEEeeccCCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcE
Q 039819 253 CATP------TERLLVYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEA 326 (534)
Q Consensus 253 ~~~~------~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~ 326 (534)
+... ...+++++++ +++|.+++... .+++..+..++.|++.||.|||+. +|+||||||+||++++++.+
T Consensus 85 ~~~~~~~~~~~~~~lv~~~~-~~~L~~~~~~~-~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~ 159 (345)
T cd07877 85 FTPARSLEEFNDVYLVTHLM-GADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCEL 159 (345)
T ss_pred eeecccccccccEEEEehhc-ccCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEcCCCCE
Confidence 8643 3467888887 77998877644 589999999999999999999998 99999999999999999999
Q ss_pred EEEecccceecCCCCCceeecccccccccccccccc-CCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHH-
Q 039819 327 IVGDFGLAKLLDHSDSHVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWV- 404 (534)
Q Consensus 327 kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~- 404 (534)
||+|||+++..... .....++..|+|||++.+ ..++.++|||||||++|||++|+.||...........+....
T Consensus 160 kl~dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~ 235 (345)
T cd07877 160 KILDFGLARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVG 235 (345)
T ss_pred EEeccccccccccc----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence 99999998865322 233457899999998865 467889999999999999999999996433211111111100
Q ss_pred -------HHHhhhc--ccceecccccCCCCC---HHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 405 -------KKIQQEK--KVEVLVDRELGSNYD---RIEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 405 -------~~~~~~~--~~~~~~d~~l~~~~~---~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
....... ......+......+. ......+.+++.+|++.+|.+||++.+++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 299 (345)
T cd07877 236 TPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 299 (345)
T ss_pred CCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhc
Confidence 0000000 000000000000000 012346889999999999999999999885
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-34 Score=276.22 Aligned_cols=233 Identities=27% Similarity=0.424 Sum_probs=191.3
Q ss_pred CCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEehh----------------hhhhcccCceeeEEEEEeCCCeeEEEeec
Q 039819 203 NFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLKD----------------MISLAVHRNLLRLIGYCATPTERLLVYPY 265 (534)
Q Consensus 203 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~----------------~l~~~~h~niv~l~~~~~~~~~~~lv~e~ 265 (534)
+|+..+.||+|++|.||+++.. +++.||+|.+.. ++..++|+|++++++++.+....++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 4677889999999999999875 678899998742 46778899999999999999999999999
Q ss_pred cCCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCCcee
Q 039819 266 MSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVT 345 (534)
Q Consensus 266 ~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~ 345 (534)
+++++|.+++.....+++..+..++.|++.||.|||+. +|+||||||+||+++.++.++|+|||++......... .
T Consensus 81 ~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~-~ 156 (254)
T cd06627 81 AENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD-D 156 (254)
T ss_pred CCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEECCCCCEEEeccccceecCCCccc-c
Confidence 99999999998778899999999999999999999998 9999999999999999999999999999877543321 2
Q ss_pred eccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceecccccCCCC
Q 039819 346 TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELGSNY 425 (534)
Q Consensus 346 ~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 425 (534)
....++..|+|||...+..++.++||||+|+++|+|++|+.||..... ...... .... . .+ ..
T Consensus 157 ~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~------~~~~~~-~~~~-~-----~~----~~ 219 (254)
T cd06627 157 ASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNP------MAALFR-IVQD-D-----HP----PL 219 (254)
T ss_pred cccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccH------HHHHHH-Hhcc-C-----CC----CC
Confidence 334588999999998877789999999999999999999999863221 111111 1000 0 01 11
Q ss_pred CHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 426 DRIEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 426 ~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
+......+.+++.+|+..+|++||++.+++.
T Consensus 220 ~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 220 PEGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred CCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 1222457889999999999999999999984
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-34 Score=288.87 Aligned_cols=242 Identities=22% Similarity=0.307 Sum_probs=178.7
Q ss_pred eeccC--CcEEEEEEEEC-CCcEEEEEEehh----------------hhhhcccCceeeEEEEEeCCCeeEEEeeccCCC
Q 039819 209 ILGAG--GFGNVYKGKLG-DGTVLAVKRLKD----------------MISLAVHRNLLRLIGYCATPTERLLVYPYMSNG 269 (534)
Q Consensus 209 ~lG~G--~~g~Vy~~~~~-~~~~vavK~~~~----------------~l~~~~h~niv~l~~~~~~~~~~~lv~e~~~~g 269 (534)
.||+| +||.||+++.. +++.||||.+.. +++.++||||++++++|...+..++||||+.++
T Consensus 5 ~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~~ 84 (328)
T cd08226 5 EIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYG 84 (328)
T ss_pred HhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccCC
Confidence 46666 99999999974 789999998741 345578999999999999999999999999999
Q ss_pred ChhhhcccC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCCce---
Q 039819 270 SVASRLREK--PALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHV--- 344 (534)
Q Consensus 270 sL~~~l~~~--~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~--- 344 (534)
+|.+++... ..+++..+..++.|++.||.|||+. +|+||||||+|||++.++.++++||+.+..........
T Consensus 85 ~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (328)
T cd08226 85 SANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQN---GYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVV 161 (328)
T ss_pred CHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccccc
Confidence 999988753 3589999999999999999999998 99999999999999999999999998654332111100
Q ss_pred ---eeccccccccccccccccC--CCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHh-----------
Q 039819 345 ---TTAVRGTVGHIAPEYLSTG--QSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQ----------- 408 (534)
Q Consensus 345 ---~~~~~gt~~y~aPE~~~~~--~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~----------- 408 (534)
.....++..|+|||++.+. .++.++|||||||++|||++|+.||....... ..........
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~ 238 (328)
T cd08226 162 YDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQ---MLLQKLKGPPYSPLDITTFPC 238 (328)
T ss_pred ccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHH---HHHHHhcCCCCCCccccccch
Confidence 0112346679999998763 47899999999999999999999997432110 0100000000
Q ss_pred -------h----h----------cccceecccccCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 409 -------Q----E----------KKVEVLVDRELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 409 -------~----~----------~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
. . .......+..+...........+.+++.+|++.+|++|||+.|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~ 307 (328)
T cd08226 239 EESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLS 307 (328)
T ss_pred hhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 0 0 0000011111111222334568899999999999999999999986
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-34 Score=289.43 Aligned_cols=251 Identities=22% Similarity=0.280 Sum_probs=187.1
Q ss_pred hCCCc-CCeeccCCcEEEEEEEEC-CCcEEEEEEeh----------------------------hhhhhcccCceeeEEE
Q 039819 202 ENFSS-KNILGAGGFGNVYKGKLG-DGTVLAVKRLK----------------------------DMISLAVHRNLLRLIG 251 (534)
Q Consensus 202 ~~~~~-~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~----------------------------~~l~~~~h~niv~l~~ 251 (534)
++|.. .+.||+|+||.||+|... +++.||||.+. +++..++|+||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 45543 467999999999999975 68899999763 1456788999999999
Q ss_pred EEeCCCeeEEEeeccCCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEec
Q 039819 252 YCATPTERLLVYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDF 331 (534)
Q Consensus 252 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DF 331 (534)
++...+..++||||+. |+|.+++.....+++.....++.|++.||.|||+. +|+||||||+||+++.++.++|+||
T Consensus 88 ~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~---~i~H~dl~~~nill~~~~~~kl~df 163 (335)
T PTZ00024 88 VYVEGDFINLVMDIMA-SDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKW---YFMHRDLSPANIFINSKGICKIADF 163 (335)
T ss_pred EEecCCcEEEEEeccc-cCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHeEECCCCCEEECCc
Confidence 9999999999999997 68999998777899999999999999999999998 9999999999999999999999999
Q ss_pred ccceecCCCC-------------CceeeccccccccccccccccC-CCCcchhHHHHHHHHHHHHhCCCCcCCCcccccc
Q 039819 332 GLAKLLDHSD-------------SHVTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELITGMRALEFGKSINQK 397 (534)
Q Consensus 332 Gla~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~ 397 (534)
|++....... ........++..|+|||++.+. .++.++|||||||++|||+||+.||.........
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~ 243 (335)
T PTZ00024 164 GLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQL 243 (335)
T ss_pred cceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 9998664111 0111223467899999998764 4689999999999999999999999754432211
Q ss_pred chHHHHHHHHhhhccccee-------cccccCCC---CCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 398 GAMLEWVKKIQQEKKVEVL-------VDRELGSN---YDRIEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 398 ~~~~~~~~~~~~~~~~~~~-------~d~~l~~~---~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
..+................ ........ ........+.+++.+|++.+|++||+++|++.
T Consensus 244 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 312 (335)
T PTZ00024 244 GRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALK 312 (335)
T ss_pred HHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence 1111111111000000000 00000000 00112457889999999999999999999985
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-35 Score=275.49 Aligned_cols=228 Identities=25% Similarity=0.313 Sum_probs=191.3
Q ss_pred HhCCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEehh-----------------hhhhcccCceeeEEEEEeCCCeeEEE
Q 039819 201 TENFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLKD-----------------MISLAVHRNLLRLIGYCATPTERLLV 262 (534)
Q Consensus 201 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~-----------------~l~~~~h~niv~l~~~~~~~~~~~lv 262 (534)
.++|...++||+|.||.|.+++-+ .++.+|+|++++ .+...+||.+..+...|+..+..++|
T Consensus 167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFV 246 (516)
T KOG0690|consen 167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFV 246 (516)
T ss_pred cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEE
Confidence 356778899999999999999864 789999998874 67888999999999999999999999
Q ss_pred eeccCCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCC
Q 039819 263 YPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDS 342 (534)
Q Consensus 263 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~ 342 (534)
|||..||.|+-+|.....+++...+-+-..|+.||.|||++ +||.||||.+|.|+|++|++||+|||+++.-- ...
T Consensus 247 MeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~---~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I-~~g 322 (516)
T KOG0690|consen 247 MEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSR---NIVYRDLKLENLLLDKDGHIKITDFGLCKEEI-KYG 322 (516)
T ss_pred EEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhC---CeeeeechhhhheeccCCceEeeecccchhcc-ccc
Confidence 99999999999999888999999999999999999999999 99999999999999999999999999998532 223
Q ss_pred ceeeccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceecccccC
Q 039819 343 HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELG 422 (534)
Q Consensus 343 ~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 422 (534)
..+.+++||+.|+|||++....|+..+|.|.+|||+|||++|+.||.... ...+.+.+.. .++
T Consensus 323 ~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~d----h~kLFeLIl~-------ed~------ 385 (516)
T KOG0690|consen 323 DTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKD----HEKLFELILM-------EDL------ 385 (516)
T ss_pred ceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccc----hhHHHHHHHh-------hhc------
Confidence 45677899999999999999999999999999999999999999996332 1122222110 111
Q ss_pred CCCCHHHHHHHHHHHHHhcccCCCCCCC
Q 039819 423 SNYDRIEVGEILQVALLCTQYLPVHRPK 450 (534)
Q Consensus 423 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPt 450 (534)
.++.....+...+....+..||.+|-.
T Consensus 386 -kFPr~ls~eAktLLsGLL~kdP~kRLG 412 (516)
T KOG0690|consen 386 -KFPRTLSPEAKTLLSGLLKKDPKKRLG 412 (516)
T ss_pred -cCCccCCHHHHHHHHHHhhcChHhhcC
Confidence 123333446778888899999999963
|
|
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=283.49 Aligned_cols=234 Identities=24% Similarity=0.339 Sum_probs=191.2
Q ss_pred hCCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEehh-----------------hhhhcc-cCceeeEEEEEeCCCeeEEE
Q 039819 202 ENFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLKD-----------------MISLAV-HRNLLRLIGYCATPTERLLV 262 (534)
Q Consensus 202 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~-----------------~l~~~~-h~niv~l~~~~~~~~~~~lv 262 (534)
++|...+.||+|+||.||+|... ++..||+|.+.. ++..+. |+||+++++++...+..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 36788899999999999999975 689999998742 455667 99999999999999999999
Q ss_pred eeccCCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCC
Q 039819 263 YPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDS 342 (534)
Q Consensus 263 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~ 342 (534)
|||+++++|.+++.....+++..+..|+.|++.||.|||+. +++|+||||+||+++.++.++++|||++........
T Consensus 81 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~---~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~ 157 (280)
T cd05581 81 LEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSS 157 (280)
T ss_pred EcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEecCCccccccCCccc
Confidence 99999999999998888899999999999999999999998 999999999999999999999999999986643221
Q ss_pred -------------------ceeeccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHH
Q 039819 343 -------------------HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEW 403 (534)
Q Consensus 343 -------------------~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~ 403 (534)
.......++..|+|||+.....++.++||||||++++++++|+.||..... ...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~-------~~~ 230 (280)
T cd05581 158 PESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNE-------YLT 230 (280)
T ss_pred cccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccH-------HHH
Confidence 112234578899999999888899999999999999999999999974321 011
Q ss_pred HHHHhhhcccceecccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCh----HHHHH
Q 039819 404 VKKIQQEKKVEVLVDRELGSNYDRIEVGEILQVALLCTQYLPVHRPKM----SEVVR 456 (534)
Q Consensus 404 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~----~ev~~ 456 (534)
....... ....+...+..+.+++.+|++.+|.+||++ +++++
T Consensus 231 ~~~~~~~-----------~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 231 FQKILKL-----------EYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred HHHHHhc-----------CCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 1111100 011122224578999999999999999999 66653
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=282.11 Aligned_cols=229 Identities=19% Similarity=0.305 Sum_probs=184.1
Q ss_pred CeeccCCcEEEEEEEEC-CCcEEEEEEeh--------------hhhhhcccCceeeEEEEEeCCCeeEEEeeccCCCChh
Q 039819 208 NILGAGGFGNVYKGKLG-DGTVLAVKRLK--------------DMISLAVHRNLLRLIGYCATPTERLLVYPYMSNGSVA 272 (534)
Q Consensus 208 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~--------------~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~ 272 (534)
..||+|+||.||++... ++..||||.+. ..++.+.|+|++++++++...+..++||||+++++|.
T Consensus 26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 105 (292)
T cd06657 26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT 105 (292)
T ss_pred HHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHH
Confidence 46999999999999874 78999999864 1567788999999999999999999999999999999
Q ss_pred hhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCCceeecccccc
Q 039819 273 SRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTV 352 (534)
Q Consensus 273 ~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~ 352 (534)
+++.. ..+++.....++.|++.||+|||+. +++||||||+||+++.++.++|+|||++........ ......|+.
T Consensus 106 ~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~---givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~ 180 (292)
T cd06657 106 DIVTH-TRMNEEQIAAVCLAVLKALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-RRKSLVGTP 180 (292)
T ss_pred HHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEcccccceecccccc-cccccccCc
Confidence 88754 3589999999999999999999998 999999999999999999999999999876543221 223356889
Q ss_pred ccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceecccccCCCCCHHHHHH
Q 039819 353 GHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELGSNYDRIEVGE 432 (534)
Q Consensus 353 ~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~ 432 (534)
.|+|||++.+..++.++|||||||++|||++|+.||...... +.+....... .+.+.. .......
T Consensus 181 ~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~-------~~~~~~~~~~------~~~~~~--~~~~~~~ 245 (292)
T cd06657 181 YWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL-------KAMKMIRDNL------PPKLKN--LHKVSPS 245 (292)
T ss_pred cccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-------HHHHHHHhhC------CcccCC--cccCCHH
Confidence 999999998888899999999999999999999998643211 1111111100 011100 0112346
Q ss_pred HHHHHHHhcccCCCCCCChHHHHH
Q 039819 433 ILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 433 l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
+.+++.+|++.+|.+||++.++++
T Consensus 246 l~~li~~~l~~~P~~R~~~~~ll~ 269 (292)
T cd06657 246 LKGFLDRLLVRDPAQRATAAELLK 269 (292)
T ss_pred HHHHHHHHHhCCcccCcCHHHHhc
Confidence 788999999999999999999885
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=286.56 Aligned_cols=247 Identities=22% Similarity=0.344 Sum_probs=185.0
Q ss_pred HHhCCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEeh----------------hhhhhcccCceeeEEEEEeCCC-----
Q 039819 200 ATENFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLK----------------DMISLAVHRNLLRLIGYCATPT----- 257 (534)
Q Consensus 200 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~----------------~~l~~~~h~niv~l~~~~~~~~----- 257 (534)
..++|...+.||+|+||.||+|... ++..||||++. .+++.++|+||+++++++....
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07880 13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRF 92 (343)
T ss_pred cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccccc
Confidence 4568999999999999999999864 78999999873 1577889999999999987543
Q ss_pred -eeEEEeeccCCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEeccccee
Q 039819 258 -ERLLVYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKL 336 (534)
Q Consensus 258 -~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~ 336 (534)
..++||||+ +++|.+++.. ..+++..+..++.|+++||.|||+. +|+||||||+||+++.++.++|+|||++..
T Consensus 93 ~~~~lv~e~~-~~~l~~~~~~-~~l~~~~~~~i~~qi~~al~~LH~~---gi~H~dlkp~Nill~~~~~~kl~dfg~~~~ 167 (343)
T cd07880 93 HDFYLVMPFM-GTDLGKLMKH-EKLSEDRIQFLVYQMLKGLKYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQ 167 (343)
T ss_pred ceEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccccc
Confidence 358999999 6788887764 4689999999999999999999998 999999999999999999999999999986
Q ss_pred cCCCCCceeecccccccccccccccc-CCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHH--------HHHHHH
Q 039819 337 LDHSDSHVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAML--------EWVKKI 407 (534)
Q Consensus 337 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~--------~~~~~~ 407 (534)
.... .....++..|+|||++.+ ..++.++|||||||++|+|++|+.||...........+. .|....
T Consensus 168 ~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (343)
T cd07880 168 TDSE----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKL 243 (343)
T ss_pred cccC----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhh
Confidence 5432 223457889999998865 457899999999999999999999997433211100000 111111
Q ss_pred hhhcc------cceecccccCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 408 QQEKK------VEVLVDRELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 408 ~~~~~------~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
..... ........+. .........+.+++.+|++.+|++|||+.+++.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~ 297 (343)
T cd07880 244 QSEDAKNYVKKLPRFRKKDFR-SLLPNANPLAVNVLEKMLVLDAESRITAAEALA 297 (343)
T ss_pred cchhHHHHHHhccccCcchHH-HhccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 00000 0000000000 000112346889999999999999999999885
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=283.36 Aligned_cols=228 Identities=30% Similarity=0.414 Sum_probs=181.3
Q ss_pred CCcCCeeccCCcEEEEEEEEC-CCcEEEEEEeh-----------------hhhhhcccCceeeEEEEEeCCCeeEEEeec
Q 039819 204 FSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLK-----------------DMISLAVHRNLLRLIGYCATPTERLLVYPY 265 (534)
Q Consensus 204 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~-----------------~~l~~~~h~niv~l~~~~~~~~~~~lv~e~ 265 (534)
|...+.||+|+||.||+|+.. ++..||+|.+. +.+..++|+|++++++++.+....++||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 555678999999999999874 68899999874 156778899999999999999999999999
Q ss_pred cCCCChhhhccc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCCce
Q 039819 266 MSNGSVASRLRE-KPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHV 344 (534)
Q Consensus 266 ~~~gsL~~~l~~-~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~ 344 (534)
+. |++.+.+.. ...+++.++..++.|++.||.|||+. +++||||||+||+++.++.+||+|||++.....
T Consensus 103 ~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~----- 173 (313)
T cd06633 103 CL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASKSSP----- 173 (313)
T ss_pred CC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChhhEEECCCCCEEEeecCCCcccCC-----
Confidence 96 577777653 45699999999999999999999998 999999999999999999999999999864322
Q ss_pred eeccccccccccccccc---cCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceeccccc
Q 039819 345 TTAVRGTVGHIAPEYLS---TGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDREL 421 (534)
Q Consensus 345 ~~~~~gt~~y~aPE~~~---~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 421 (534)
.....|+..|+|||++. ...++.++|||||||++|||++|+.||..... ...+........ +..
T Consensus 174 ~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~-------~~~~~~~~~~~~------~~~ 240 (313)
T cd06633 174 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-------MSALYHIAQNDS------PTL 240 (313)
T ss_pred CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh-------HHHHHHHHhcCC------CCC
Confidence 22346889999999984 45688899999999999999999999864321 111111111110 000
Q ss_pred CCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 422 GSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 422 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
........+.+++.+|++.+|.+||++.+++.
T Consensus 241 ---~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~ 272 (313)
T cd06633 241 ---QSNEWTDSFRGFVDYCLQKIPQERPASAELLR 272 (313)
T ss_pred ---CccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 11112346889999999999999999999985
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-34 Score=281.87 Aligned_cols=247 Identities=26% Similarity=0.345 Sum_probs=187.2
Q ss_pred CCcCCeeccCCcEEEEEEEEC-CCcEEEEEEehh----------------hhhhcccCceeeEEEEEeCCCeeEEEeecc
Q 039819 204 FSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLKD----------------MISLAVHRNLLRLIGYCATPTERLLVYPYM 266 (534)
Q Consensus 204 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~----------------~l~~~~h~niv~l~~~~~~~~~~~lv~e~~ 266 (534)
|+..+.||+|+||.||+|+.. +++.+|+|.+.. .+..+.|+|++++++++.+.+..++||||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 455678999999999999986 489999997652 566778999999999999999999999999
Q ss_pred CCCChhhhcccC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCCcee
Q 039819 267 SNGSVASRLREK-PALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVT 345 (534)
Q Consensus 267 ~~gsL~~~l~~~-~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~ 345 (534)
+ ++|.+++... ..+++..+..++.+++.||.|||+. +|+||||+|+||++++++.++|+|||+++....... ..
T Consensus 81 ~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~-~~ 155 (282)
T cd07829 81 D-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR-TY 155 (282)
T ss_pred C-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChheEEEcCCCCEEEecCCcccccCCCcc-cc
Confidence 8 5899999765 5799999999999999999999998 999999999999999999999999999987644322 12
Q ss_pred eccccccccccccccccC-CCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhc--cccee--cccc
Q 039819 346 TAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEK--KVEVL--VDRE 420 (534)
Q Consensus 346 ~~~~gt~~y~aPE~~~~~-~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~--~d~~ 420 (534)
....++..|+|||++.+. .++.++|||||||++|||++|+.||...........+........... ....+ .+..
T Consensus 156 ~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (282)
T cd07829 156 THEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPT 235 (282)
T ss_pred CccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhccccccccc
Confidence 223457789999998766 789999999999999999999999865432111111111110000000 00000 0000
Q ss_pred cC--------CCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 421 LG--------SNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 421 l~--------~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
.. ...+ .....+.+++.+|++.+|++||++.+++.
T Consensus 236 ~~~~~~~~~~~~~~-~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 236 FPKFPPKDLEKVLP-RLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred ccccCccchHHhcc-cccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 00 0001 11457899999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=273.75 Aligned_cols=213 Identities=21% Similarity=0.178 Sum_probs=173.9
Q ss_pred CCcEEEEEEEEC-CCcEEEEEEehh---------hhhhcccCceeeEEEEEeCCCeeEEEeeccCCCChhhhcccCCCCC
Q 039819 213 GGFGNVYKGKLG-DGTVLAVKRLKD---------MISLAVHRNLLRLIGYCATPTERLLVYPYMSNGSVASRLREKPALD 282 (534)
Q Consensus 213 G~~g~Vy~~~~~-~~~~vavK~~~~---------~l~~~~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~l~ 282 (534)
|.||.||+++.. +++.+|+|++.. .+....||||+++++++.+.+..++||||+++|+|.+++.....++
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~ 83 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSSEYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIP 83 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchhhhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHHhcCCC
Confidence 899999999975 688999999863 2333469999999999999999999999999999999998777799
Q ss_pred HHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCCceeecccccccccccccccc
Q 039819 283 WNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGHIAPEYLST 362 (534)
Q Consensus 283 ~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 362 (534)
+..+..++.|+++||.|||+. +|+||||||+||+++.++.++++|||.+...... .....++..|+|||++..
T Consensus 84 ~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~----~~~~~~~~~y~aPE~~~~ 156 (237)
T cd05576 84 EECVKRWAAEMVVALDALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS----CDGEAVENMYCAPEVGGI 156 (237)
T ss_pred HHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEecccchhccccc----cccCCcCccccCCcccCC
Confidence 999999999999999999998 9999999999999999999999999988765432 122345778999999988
Q ss_pred CCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceecccccCCCCCHHHHHHHHHHHHHhcc
Q 039819 363 GQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELGSNYDRIEVGEILQVALLCTQ 442 (534)
Q Consensus 363 ~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~ 442 (534)
..++.++||||+||++|||++|+.|+....... ....... .+......+.+++.+|++
T Consensus 157 ~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~------------------~~~~~~~----~~~~~~~~~~~li~~~l~ 214 (237)
T cd05576 157 SEETEACDWWSLGAILFELLTGKTLVECHPSGI------------------NTHTTLN----IPEWVSEEARSLLQQLLQ 214 (237)
T ss_pred CCCCchhhHHHHHHHHHHHHHCcchhhcCchhc------------------ccccccC----CcccCCHHHHHHHHHHcc
Confidence 888999999999999999999998875321100 0000001 111223578899999999
Q ss_pred cCCCCCCChHHH
Q 039819 443 YLPVHRPKMSEV 454 (534)
Q Consensus 443 ~~P~~RPt~~ev 454 (534)
.||++||++.+.
T Consensus 215 ~dp~~R~~~~~~ 226 (237)
T cd05576 215 FNPTERLGAGVA 226 (237)
T ss_pred CCHHHhcCCCcc
Confidence 999999997433
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-34 Score=290.63 Aligned_cols=247 Identities=22% Similarity=0.337 Sum_probs=186.1
Q ss_pred HHhCCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEeh----------------hhhhhcccCceeeEEEEEeCCCe----
Q 039819 200 ATENFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLK----------------DMISLAVHRNLLRLIGYCATPTE---- 258 (534)
Q Consensus 200 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~----------------~~l~~~~h~niv~l~~~~~~~~~---- 258 (534)
..++|...+.||+|+||.||+|+.. ++..||||++. .++..+.|+|++++.+++...+.
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 4578889999999999999999985 57899999864 15667789999999998866554
Q ss_pred --eEEEeeccCCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEeccccee
Q 039819 259 --RLLVYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKL 336 (534)
Q Consensus 259 --~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~ 336 (534)
.++|+||+ +++|.+++.. ..+++..+..++.|++.||.|||+. +|+||||||+||+++.++.++|+|||++..
T Consensus 93 ~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nill~~~~~~kL~dfg~~~~ 167 (343)
T cd07851 93 QDVYLVTHLM-GADLNNIVKC-QKLSDDHIQFLVYQILRGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDFGLARH 167 (343)
T ss_pred ccEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEcccccccc
Confidence 89999999 5699888875 4699999999999999999999998 999999999999999999999999999986
Q ss_pred cCCCCCceeecccccccccccccccc-CCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHH--------HHHH
Q 039819 337 LDHSDSHVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEW--------VKKI 407 (534)
Q Consensus 337 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~--------~~~~ 407 (534)
.... .....++..|+|||.+.+ ..++.++|||||||++|||+||+.||...........+.+. ....
T Consensus 168 ~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 243 (343)
T cd07851 168 TDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKI 243 (343)
T ss_pred cccc----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhc
Confidence 5432 233457889999998865 36789999999999999999999999754322111111110 0000
Q ss_pred hhhcccceecc---cccCCCCC---HHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 408 QQEKKVEVLVD---RELGSNYD---RIEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 408 ~~~~~~~~~~d---~~l~~~~~---~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
.... ...++. ......+. ......+.+++.+|++.+|++|||+.+|++
T Consensus 244 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~ 297 (343)
T cd07851 244 SSES-ARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA 297 (343)
T ss_pred cchh-HHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence 0000 000000 00000000 012457899999999999999999999974
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=305.04 Aligned_cols=248 Identities=18% Similarity=0.245 Sum_probs=167.7
Q ss_pred HHhCCCcCCeeccCCcEEEEEEEEC-C----CcEEEEEEehh-------h---hhhcccCceeeEEEE------EeCCCe
Q 039819 200 ATENFSSKNILGAGGFGNVYKGKLG-D----GTVLAVKRLKD-------M---ISLAVHRNLLRLIGY------CATPTE 258 (534)
Q Consensus 200 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~----~~~vavK~~~~-------~---l~~~~h~niv~l~~~------~~~~~~ 258 (534)
..++|...+.||+|+||.||+|++. + +..||||++.. + +....+.+++.++.. +.....
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~e~~~~e~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 209 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAVEIWMNERVRRACPNSCADFVYGFLEPVSSKKEDE 209 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchhHHHHHHHHHhhchhhHHHHHHhhhcccccccCCc
Confidence 5678999999999999999999985 4 68999998753 1 111122222222211 245567
Q ss_pred eEEEeeccCCCChhhhcccCCC--------------------CCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcE
Q 039819 259 RLLVYPYMSNGSVASRLREKPA--------------------LDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANV 318 (534)
Q Consensus 259 ~~lv~e~~~~gsL~~~l~~~~~--------------------l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~Ni 318 (534)
.++||||+++++|.+++..... .....+..|+.|++.||.|||+. +|+||||||+||
T Consensus 210 ~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~---gIiHRDLKP~NI 286 (566)
T PLN03225 210 YWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST---GIVHRDVKPQNI 286 (566)
T ss_pred eEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC---CEEeCcCCHHHE
Confidence 8999999999999998864321 12334567999999999999998 999999999999
Q ss_pred EeCC-CCcEEEEecccceecCCCCCceeeccccccccccccccccC----------------------CCCcchhHHHHH
Q 039819 319 LLDD-FCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGHIAPEYLSTG----------------------QSSEKTDVFGFG 375 (534)
Q Consensus 319 Ll~~-~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~~~k~Dv~S~G 375 (534)
|++. ++.+||+|||+|+.+............+|+.|+|||.+... .++.++||||||
T Consensus 287 Ll~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSlG 366 (566)
T PLN03225 287 IFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAG 366 (566)
T ss_pred EEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHHH
Confidence 9985 68999999999987654443444556789999999965321 234567999999
Q ss_pred HHHHHHHhCCCCcCCCccc------cccchHHHHHHHHhhhcccceecccccCCCCC--HHHHHHHHHHHHHhcccCCCC
Q 039819 376 ILLLELITGMRALEFGKSI------NQKGAMLEWVKKIQQEKKVEVLVDRELGSNYD--RIEVGEILQVALLCTQYLPVH 447 (534)
Q Consensus 376 vvl~elltG~~p~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~--~~~~~~l~~l~~~Cl~~~P~~ 447 (534)
|++|||+++..+++..... ........|....... ..+.+...+. ........+++.+|++.||++
T Consensus 367 viL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~k 440 (566)
T PLN03225 367 LIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKLVEPR------ASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQ 440 (566)
T ss_pred HHHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHhhccc------cchhhhhhhhhccccchHHHHHHHHHccCCccc
Confidence 9999999977664311000 0000111222111110 0000000000 001224568999999999999
Q ss_pred CCChHHHHH
Q 039819 448 RPKMSEVVR 456 (534)
Q Consensus 448 RPt~~ev~~ 456 (534)
|||+.|+++
T Consensus 441 R~ta~e~L~ 449 (566)
T PLN03225 441 RISAKAALA 449 (566)
T ss_pred CCCHHHHhC
Confidence 999999985
|
|
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=283.17 Aligned_cols=230 Identities=29% Similarity=0.404 Sum_probs=182.4
Q ss_pred CCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEeh-----------------hhhhhcccCceeeEEEEEeCCCeeEEEee
Q 039819 203 NFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLK-----------------DMISLAVHRNLLRLIGYCATPTERLLVYP 264 (534)
Q Consensus 203 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~-----------------~~l~~~~h~niv~l~~~~~~~~~~~lv~e 264 (534)
.|...+.||+|+||.||+|+.. ++..+|+|.+. +++..+.|+|++++.+++......++|||
T Consensus 16 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 95 (308)
T cd06634 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (308)
T ss_pred HHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEE
Confidence 3566678999999999999975 67889999864 14677789999999999999999999999
Q ss_pred ccCCCChhhhcc-cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCCc
Q 039819 265 YMSNGSVASRLR-EKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSH 343 (534)
Q Consensus 265 ~~~~gsL~~~l~-~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~ 343 (534)
|+. |++.+.+. ....+++..+..++.+++.||.|||+. +++||||||+||+++.++.++|+|||++......
T Consensus 96 ~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~--- 168 (308)
T cd06634 96 YCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA--- 168 (308)
T ss_pred ccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHhEEECCCCcEEECCcccceeecCc---
Confidence 997 57777664 345689999999999999999999998 9999999999999999999999999998865432
Q ss_pred eeeccccccccccccccc---cCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceecccc
Q 039819 344 VTTAVRGTVGHIAPEYLS---TGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRE 420 (534)
Q Consensus 344 ~~~~~~gt~~y~aPE~~~---~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 420 (534)
....|+..|+|||++. ...++.++|||||||++|||++|+.||..... ............ +.
T Consensus 169 --~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-------~~~~~~~~~~~~------~~ 233 (308)
T cd06634 169 --NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-------MSALYHIAQNES------PA 233 (308)
T ss_pred --ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccH-------HHHHHHHhhcCC------CC
Confidence 2345788999999974 35678899999999999999999999853211 111111111100 00
Q ss_pred cCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 039819 421 LGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRM 457 (534)
Q Consensus 421 l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~ 457 (534)
. ........+.+++.+|++.+|++||++.++++.
T Consensus 234 ~---~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~ 267 (308)
T cd06634 234 L---QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 267 (308)
T ss_pred c---CcccccHHHHHHHHHHhhCCcccCCCHHHHhhC
Confidence 0 111234578899999999999999999999864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=287.22 Aligned_cols=247 Identities=21% Similarity=0.298 Sum_probs=180.4
Q ss_pred hCCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEeh--------------hhhhhcccCceeeEEEEEeCC----------
Q 039819 202 ENFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLK--------------DMISLAVHRNLLRLIGYCATP---------- 256 (534)
Q Consensus 202 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~--------------~~l~~~~h~niv~l~~~~~~~---------- 256 (534)
.+|...+.||.|+||.||+|... ++..||+|.+. +++..++||||+++++++...
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 84 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGS 84 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccc
Confidence 57888899999999999999875 68899999763 257788999999999876543
Q ss_pred ----CeeEEEeeccCCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeC-CCCcEEEEec
Q 039819 257 ----TERLLVYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLD-DFCEAIVGDF 331 (534)
Q Consensus 257 ----~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~-~~~~~kl~DF 331 (534)
...++||||++ ++|.+.+.. ..+++..++.++.|++.||.|||+. +|+||||||+||+++ .++.+||+||
T Consensus 85 ~~~~~~~~lv~e~~~-~~L~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~---givH~dikp~Nili~~~~~~~kl~df 159 (342)
T cd07854 85 LTELNSVYIVQEYME-TDLANVLEQ-GPLSEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANVFINTEDLVLKIGDF 159 (342)
T ss_pred ccccceEEEEeeccc-ccHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCceEEECCc
Confidence 35789999997 588887754 3589999999999999999999998 999999999999997 4567899999
Q ss_pred ccceecCCCCCc--eeecccccccccccccccc-CCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHh
Q 039819 332 GLAKLLDHSDSH--VTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQ 408 (534)
Q Consensus 332 Gla~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~ 408 (534)
|+++........ ......++..|+|||++.. ..++.++|||||||++|||++|+.||.......... .......
T Consensus 160 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~---~~~~~~~ 236 (342)
T cd07854 160 GLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQ---LILESVP 236 (342)
T ss_pred ccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH---HHHHhcC
Confidence 999866432111 1122357889999998654 457889999999999999999999997443211110 1100000
Q ss_pred h--h---c----cc-ceecccccCCCCC-----HHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 409 Q--E---K----KV-EVLVDRELGSNYD-----RIEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 409 ~--~---~----~~-~~~~d~~l~~~~~-----~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
. . . .. ............+ .....++.+++.+|++.+|.+||++.|++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~ 299 (342)
T cd07854 237 VVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM 299 (342)
T ss_pred CCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence 0 0 0 00 0000000000000 012347889999999999999999999985
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-33 Score=279.86 Aligned_cols=242 Identities=22% Similarity=0.258 Sum_probs=177.7
Q ss_pred CeeccCCcEEEEEEEECCCcEEEEEEeh----------------hhhhhcccCceeeEEEEEeCCCeeEEEeeccCCCCh
Q 039819 208 NILGAGGFGNVYKGKLGDGTVLAVKRLK----------------DMISLAVHRNLLRLIGYCATPTERLLVYPYMSNGSV 271 (534)
Q Consensus 208 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~----------------~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 271 (534)
+.+|.|+++.||+++. +++.||||++. +.++.++|+||+++++++...+..+++|||+++|+|
T Consensus 8 ~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l 86 (314)
T cd08216 8 KCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSC 86 (314)
T ss_pred HhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCH
Confidence 3345555555565555 68899999874 156778899999999999999999999999999999
Q ss_pred hhhccc--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCC------c
Q 039819 272 ASRLRE--KPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDS------H 343 (534)
Q Consensus 272 ~~~l~~--~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~------~ 343 (534)
.+++.. ...+++.....++.|++.||.|||+. +|+||||||+||+++.++.+||+|||.+........ .
T Consensus 87 ~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~---~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~ 163 (314)
T cd08216 87 EDLLKTHFPEGLPELAIAFILKDVLNALDYIHSK---GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHD 163 (314)
T ss_pred HHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCcceEEEecCCceEEecCccceeecccccccccccc
Confidence 999874 34588999999999999999999999 999999999999999999999999998875532111 1
Q ss_pred eeecccccccccccccccc--CCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHH-----------hhh
Q 039819 344 VTTAVRGTVGHIAPEYLST--GQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKI-----------QQE 410 (534)
Q Consensus 344 ~~~~~~gt~~y~aPE~~~~--~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~-----------~~~ 410 (534)
......++..|+|||++.. ..++.++|||||||++|||++|+.||....... ...+-.... ...
T Consensus 164 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~ 240 (314)
T cd08216 164 FPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQ---MLLEKVRGTVPCLLDKSTYPLYE 240 (314)
T ss_pred ccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHhccCccccccCchhhhc
Confidence 1223457789999999865 357889999999999999999999997432211 111100000 000
Q ss_pred cccce----ecccccC----CCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 411 KKVEV----LVDRELG----SNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 411 ~~~~~----~~d~~l~----~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
..... ..++... ..........+.+++.+||+.+|++|||++++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~ 294 (314)
T cd08216 241 DSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLN 294 (314)
T ss_pred CCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhc
Confidence 00000 0011100 1112233457889999999999999999999986
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-33 Score=306.28 Aligned_cols=131 Identities=31% Similarity=0.429 Sum_probs=121.5
Q ss_pred hCCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEehh-----------------hhhhcccCceeeEEEEEeCCCeeEEEe
Q 039819 202 ENFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLKD-----------------MISLAVHRNLLRLIGYCATPTERLLVY 263 (534)
Q Consensus 202 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~-----------------~l~~~~h~niv~l~~~~~~~~~~~lv~ 263 (534)
++|...+.||+|+||.||+|... +++.||||++.. .+..++|+||+++++++......|+||
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm 83 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM 83 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence 57888899999999999999986 688999998752 467778999999999999999999999
Q ss_pred eccCCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccce
Q 039819 264 PYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAK 335 (534)
Q Consensus 264 e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~ 335 (534)
||+.+++|.+++.....+++..++.|+.||+.||.|||.. +||||||||+|||++.++.+||+|||+++
T Consensus 84 Ey~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~---gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 84 EYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred eCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 9999999999998777899999999999999999999998 99999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=268.72 Aligned_cols=238 Identities=22% Similarity=0.271 Sum_probs=187.2
Q ss_pred HHhCCCc-CCeeccCCcEEEEEEEEC-CCcEEEEEEehh----------hhhhcccCceeeEEEEEeC----CCeeEEEe
Q 039819 200 ATENFSS-KNILGAGGFGNVYKGKLG-DGTVLAVKRLKD----------MISLAVHRNLLRLIGYCAT----PTERLLVY 263 (534)
Q Consensus 200 ~~~~~~~-~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~----------~l~~~~h~niv~l~~~~~~----~~~~~lv~ 263 (534)
.|++|++ .++||-|-.|.|-.+..+ .++.+|+|.+.+ ......|||||.++++|.+ .....+||
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiVm 138 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDSPKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIVM 138 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcCHHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEeee
Confidence 4567765 368999999999999875 688999998874 2233459999999999864 34568999
Q ss_pred eccCCCChhhhcccCC--CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeC---CCCcEEEEecccceecC
Q 039819 264 PYMSNGSVASRLREKP--ALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLD---DFCEAIVGDFGLAKLLD 338 (534)
Q Consensus 264 e~~~~gsL~~~l~~~~--~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~---~~~~~kl~DFGla~~~~ 338 (534)
|+|+||.|+..+..++ .+++.++..|+.||+.|+.|||+. +|.||||||+|+|.. .+..+||+|||+|+...
T Consensus 139 E~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~---nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~ 215 (400)
T KOG0604|consen 139 ECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSM---NIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQ 215 (400)
T ss_pred ecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhc---chhhccCChhheeeecCCCCcceEecccccccccC
Confidence 9999999999997654 599999999999999999999999 999999999999996 46778999999999765
Q ss_pred CCCCceeeccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceecc
Q 039819 339 HSDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVD 418 (534)
Q Consensus 339 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 418 (534)
.. ....+.+-|+.|.|||++...+|+..+|+||+||++|-|++|.+||....... +..-++.-...+.
T Consensus 216 ~~--~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~a----ispgMk~rI~~gq------ 283 (400)
T KOG0604|consen 216 EP--GDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA----ISPGMKRRIRTGQ------ 283 (400)
T ss_pred CC--ccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCcc----CChhHHhHhhccC------
Confidence 32 23455678999999999999999999999999999999999999997432211 1000010000000
Q ss_pred cccCCCCCH----HHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 419 RELGSNYDR----IEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 419 ~~l~~~~~~----~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
-.++. ..++...++++..+..+|.+|-|+.+++.
T Consensus 284 ----y~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~ 321 (400)
T KOG0604|consen 284 ----YEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMD 321 (400)
T ss_pred ----ccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhc
Confidence 01222 23567788999999999999999999974
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-34 Score=294.46 Aligned_cols=239 Identities=25% Similarity=0.333 Sum_probs=183.8
Q ss_pred CcCCeeccCCcEEEEEEEE-CCCcEEEEEEehh---------------hhhhcccCceeeEEEEEeCCC------eeEEE
Q 039819 205 SSKNILGAGGFGNVYKGKL-GDGTVLAVKRLKD---------------MISLAVHRNLLRLIGYCATPT------ERLLV 262 (534)
Q Consensus 205 ~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~---------------~l~~~~h~niv~l~~~~~~~~------~~~lv 262 (534)
...+.||+|+||.||+|+. ..|+.||||.+++ ++++++|+|||++++.-.+.. ...+|
T Consensus 16 ~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlv 95 (732)
T KOG4250|consen 16 EMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLV 95 (732)
T ss_pred eehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEE
Confidence 3456799999999999995 5799999998763 789999999999998765443 56899
Q ss_pred eeccCCCChhhhccc---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeC--CCC--cEEEEecccce
Q 039819 263 YPYMSNGSVASRLRE---KPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLD--DFC--EAIVGDFGLAK 335 (534)
Q Consensus 263 ~e~~~~gsL~~~l~~---~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~--~~~--~~kl~DFGla~ 335 (534)
||||.+|||+..+.. ...|++.+.+.+..+++.||.|||+. +||||||||.||++- .+| .-||+|||.|+
T Consensus 96 mEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn---~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Ar 172 (732)
T KOG4250|consen 96 MEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLREN---GIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAAR 172 (732)
T ss_pred EeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHc---CceeccCCCCcEEEeecCCCceEEeeecccccc
Confidence 999999999999974 35699999999999999999999988 999999999999983 333 46999999999
Q ss_pred ecCCCCCceeeccccccccccccccc-cCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccc
Q 039819 336 LLDHSDSHVTTAVRGTVGHIAPEYLS-TGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVE 414 (534)
Q Consensus 336 ~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 414 (534)
.+.+.. ....++||..|++||+.- .+.|+..+|.|||||++||.+||..||..-..... ..-+.|.........+.
T Consensus 173 el~d~s--~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~-~~~~~~~~~tkkp~~v~ 249 (732)
T KOG4250|consen 173 ELDDNS--LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKN-NKEIMWHIITKKPSGVA 249 (732)
T ss_pred cCCCCC--eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccc-cchhhhhhhccCCCcee
Confidence 886543 567788999999999997 48899999999999999999999999974221110 01123433333322222
Q ss_pred eecccccCCC------------CCHHHHHHHHHHHHHhcccCCCCCC
Q 039819 415 VLVDRELGSN------------YDRIEVGEILQVALLCTQYLPVHRP 449 (534)
Q Consensus 415 ~~~d~~l~~~------------~~~~~~~~l~~l~~~Cl~~~P~~RP 449 (534)
...+++..+. ........+......++..+|++|.
T Consensus 250 i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~ 296 (732)
T KOG4250|consen 250 IGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRG 296 (732)
T ss_pred EeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhC
Confidence 2233322211 1223345666777788888899988
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=303.92 Aligned_cols=240 Identities=32% Similarity=0.426 Sum_probs=191.1
Q ss_pred hCCCcCCeeccCCcEEEEEEEEC--------CCcEEEEEEehh----------------hhhhcccCceeeEEEEEeCCC
Q 039819 202 ENFSSKNILGAGGFGNVYKGKLG--------DGTVLAVKRLKD----------------MISLAVHRNLLRLIGYCATPT 257 (534)
Q Consensus 202 ~~~~~~~~lG~G~~g~Vy~~~~~--------~~~~vavK~~~~----------------~l~~~~h~niv~l~~~~~~~~ 257 (534)
++....+.||+|.||.|++|... ....||||.+++ +.....|+||+.++|+|....
T Consensus 296 ~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~ 375 (609)
T KOG0200|consen 296 ENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQDG 375 (609)
T ss_pred hhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccCC
Confidence 44445568999999999999742 146799999873 334456999999999999989
Q ss_pred eeEEEeeccCCCChhhhcccCC----------------CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeC
Q 039819 258 ERLLVYPYMSNGSVASRLREKP----------------ALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLD 321 (534)
Q Consensus 258 ~~~lv~e~~~~gsL~~~l~~~~----------------~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~ 321 (534)
..++|+||+..|+|.++++..+ .++....+.++.|||.|++||++. ++|||||-.+|||+.
T Consensus 376 ~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~---~~vHRDLAaRNVLi~ 452 (609)
T KOG0200|consen 376 PLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV---PCVHRDLAARNVLIT 452 (609)
T ss_pred ceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC---CccchhhhhhhEEec
Confidence 9999999999999999997554 488899999999999999999999 999999999999999
Q ss_pred CCCcEEEEecccceecCCCCCceeecccc--ccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCcCCCccccccc
Q 039819 322 DFCEAIVGDFGLAKLLDHSDSHVTTAVRG--TVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GMRALEFGKSINQKG 398 (534)
Q Consensus 322 ~~~~~kl~DFGla~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~ellt-G~~p~~~~~~~~~~~ 398 (534)
++..+||+|||+|+............-.| ...|||||.+....|+.|+|||||||+||||+| |..|++.-. ...
T Consensus 453 ~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~---~~~ 529 (609)
T KOG0200|consen 453 KNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIP---PTE 529 (609)
T ss_pred CCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCC---cHH
Confidence 99999999999999765544333222222 346999999999999999999999999999998 777876311 011
Q ss_pred hHHHHHHHHhhhcccceecccccCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhc
Q 039819 399 AMLEWVKKIQQEKKVEVLVDRELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLEG 460 (534)
Q Consensus 399 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~ 460 (534)
.+.++++ ...+ ...+..+..++.+++..||+.+|++||++.++++.++.
T Consensus 530 ~l~~~l~---~G~r----------~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~ 578 (609)
T KOG0200|consen 530 ELLEFLK---EGNR----------MEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEK 578 (609)
T ss_pred HHHHHHh---cCCC----------CCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHH
Confidence 1222221 1111 12233446689999999999999999999999999887
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=306.39 Aligned_cols=238 Identities=27% Similarity=0.409 Sum_probs=182.0
Q ss_pred HHHHhCCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEeh---------------hhhhhcccCceeeEEEEE--------
Q 039819 198 QQATENFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLK---------------DMISLAVHRNLLRLIGYC-------- 253 (534)
Q Consensus 198 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~---------------~~l~~~~h~niv~l~~~~-------- 253 (534)
.+...+|+...+||+||||.||+++.+ ||+.+|||++. +.++++.|||||+++..+
T Consensus 475 SRY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~ 554 (1351)
T KOG1035|consen 475 SRYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELT 554 (1351)
T ss_pred hhHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccc
Confidence 567788999999999999999999976 89999999875 378899999999876421
Q ss_pred ----------------------------------------------------e---------------------------
Q 039819 254 ----------------------------------------------------A--------------------------- 254 (534)
Q Consensus 254 ----------------------------------------------------~--------------------------- 254 (534)
.
T Consensus 555 ~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS 634 (1351)
T KOG1035|consen 555 VLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTS 634 (1351)
T ss_pred cccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccc
Confidence 0
Q ss_pred -------------------------CC-------CeeEEEeeccCCCChhhhcccCCCC-CHHHHHHHHHHHHHHHHHHH
Q 039819 255 -------------------------TP-------TERLLVYPYMSNGSVASRLREKPAL-DWNTRKRIAIGAARGLLYLH 301 (534)
Q Consensus 255 -------------------------~~-------~~~~lv~e~~~~gsL~~~l~~~~~l-~~~~~~~i~~~i~~~l~yLH 301 (534)
++ ...||-||||+.-.+.++++.+... .-...++++.+|++||.|+|
T Consensus 635 ~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH 714 (1351)
T KOG1035|consen 635 DSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIH 714 (1351)
T ss_pred ccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHH
Confidence 00 1247889999998888888765543 46778899999999999999
Q ss_pred hcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecC----C-------------CCCceeeccccccccccccccccC-
Q 039819 302 EQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLD----H-------------SDSHVTTAVRGTVGHIAPEYLSTG- 363 (534)
Q Consensus 302 ~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~----~-------------~~~~~~~~~~gt~~y~aPE~~~~~- 363 (534)
++ +||||||||.||+++++..+||+|||+|+... . ......+..+||.-|+|||++.+.
T Consensus 715 ~~---giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~ 791 (1351)
T KOG1035|consen 715 DQ---GIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTS 791 (1351)
T ss_pred hC---ceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccc
Confidence 99 99999999999999999999999999998721 0 011123456799999999999654
Q ss_pred --CCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceecccccCC--CCCHHHHHHHHHHHHH
Q 039819 364 --QSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELGS--NYDRIEVGEILQVALL 439 (534)
Q Consensus 364 --~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~--~~~~~~~~~l~~l~~~ 439 (534)
+|+.|+|+||+|||++||+. ||..+ ++-+..+.. +-+..+.. ++.......-..++.+
T Consensus 792 ~~~Yn~KiDmYSLGIVlFEM~y---PF~Ts---------MERa~iL~~------LR~g~iP~~~~f~~~~~~~e~slI~~ 853 (1351)
T KOG1035|consen 792 SNKYNSKIDMYSLGIVLFEMLY---PFGTS---------MERASILTN------LRKGSIPEPADFFDPEHPEEASLIRW 853 (1351)
T ss_pred cccccchhhhHHHHHHHHHHhc---cCCch---------HHHHHHHHh------cccCCCCCCcccccccchHHHHHHHH
Confidence 49999999999999999985 46532 122222111 11222222 1222334455789999
Q ss_pred hcccCCCCCCChHHHHH
Q 039819 440 CTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 440 Cl~~~P~~RPt~~ev~~ 456 (534)
+++.||.+|||+.|++.
T Consensus 854 Ll~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 854 LLSHDPSKRPTATELLN 870 (1351)
T ss_pred HhcCCCccCCCHHHHhh
Confidence 99999999999999985
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=290.61 Aligned_cols=230 Identities=25% Similarity=0.320 Sum_probs=190.6
Q ss_pred HHhCCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEehh-----------hhhhcccCceeeEEEEEeCCCeeEEEeeccC
Q 039819 200 ATENFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLKD-----------MISLAVHRNLLRLIGYCATPTERLLVYPYMS 267 (534)
Q Consensus 200 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~-----------~l~~~~h~niv~l~~~~~~~~~~~lv~e~~~ 267 (534)
.++.|.....+|.|+|+.|-.+... .++..+||++.+ .+....||||+++.+.+.+..+.|+|||++.
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~l~ 399 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRADDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMELLD 399 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheeccccccccccccchhhhhcCCCcceeecceecCCceeeeeehhcc
Confidence 3567777788999999999999864 677889998864 3444569999999999999999999999999
Q ss_pred CCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEe-CCCCcEEEEecccceecCCCCCceee
Q 039819 268 NGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLL-DDFCEAIVGDFGLAKLLDHSDSHVTT 346 (534)
Q Consensus 268 ~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl-~~~~~~kl~DFGla~~~~~~~~~~~~ 346 (534)
++-+.+.+...+.+. ..+..|+.+++.|+.|||.+ +||||||||+|||+ +..++++|+|||.++..... ..
T Consensus 400 g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~~---gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~----~~ 471 (612)
T KOG0603|consen 400 GGELLRRIRSKPEFC-SEASQWAAELVSAVDYLHEQ---GVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS----CD 471 (612)
T ss_pred ccHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHHhc---CeeecCCChhheeecCCCCcEEEEEechhhhCchh----hc
Confidence 999988887766555 77888999999999999998 99999999999999 68999999999999977654 33
Q ss_pred ccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceecccccCCCCC
Q 039819 347 AVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELGSNYD 426 (534)
Q Consensus 347 ~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 426 (534)
..+-|..|.|||+.....|++++|+||||++||+|++|+.||...... .+....+ ..+.+.
T Consensus 472 tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~------~ei~~~i-------------~~~~~s 532 (612)
T KOG0603|consen 472 TPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG------IEIHTRI-------------QMPKFS 532 (612)
T ss_pred ccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch------HHHHHhh-------------cCCccc
Confidence 345688999999999889999999999999999999999999754321 1111111 112223
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 427 RIEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 427 ~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
...+....+|+.+|++.+|.+||+|.++..
T Consensus 533 ~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~ 562 (612)
T KOG0603|consen 533 ECVSDEAKDLLQQLLQVDPALRLGADEIGA 562 (612)
T ss_pred cccCHHHHHHHHHhccCChhhCcChhhhcc
Confidence 444568899999999999999999999874
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=274.64 Aligned_cols=232 Identities=25% Similarity=0.352 Sum_probs=182.8
Q ss_pred CCCcCCeeccCCcEEEEEEEECC-CcEEEEEEeh-------------------hhhhhcccCceeeEEEEEeCCCeeEEE
Q 039819 203 NFSSKNILGAGGFGNVYKGKLGD-GTVLAVKRLK-------------------DMISLAVHRNLLRLIGYCATPTERLLV 262 (534)
Q Consensus 203 ~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~-------------------~~l~~~~h~niv~l~~~~~~~~~~~lv 262 (534)
+|...+.||+|+||.||+++... +..+++|.++ .++..++||||+++++++.+....++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 47778899999999999998753 3334444332 256777899999999999999999999
Q ss_pred eeccCCCChhhhccc----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecC
Q 039819 263 YPYMSNGSVASRLRE----KPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLD 338 (534)
Q Consensus 263 ~e~~~~gsL~~~l~~----~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~ 338 (534)
|||+++++|.+++.. ...+++..++.++.|++.||.|||+. +++|+||||+||+++. +.++|+|||+++...
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR---RILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHc---CccccCCChhheEeec-CCEeecccCceeecC
Confidence 999999999988753 45699999999999999999999998 9999999999999976 569999999998764
Q ss_pred CCCCceeeccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceecc
Q 039819 339 HSDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVD 418 (534)
Q Consensus 339 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 418 (534)
... .......|+..|+|||+..+..++.++||||||+++|+|++|+.||.... ............ .
T Consensus 157 ~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~-------~~~~~~~~~~~~------~ 222 (260)
T cd08222 157 GSC-DLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQN-------FLSVVLRIVEGP------T 222 (260)
T ss_pred CCc-ccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCcc-------HHHHHHHHHcCC------C
Confidence 322 12234557889999999988888999999999999999999999986322 111111111110 1
Q ss_pred cccCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 419 RELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 419 ~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
+ ..+......+.+++.+|++.+|++||++.|+++
T Consensus 223 ~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 223 P----SLPETYSRQLNSIMQSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred C----CCcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence 1 122334558889999999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-34 Score=275.35 Aligned_cols=228 Identities=25% Similarity=0.346 Sum_probs=189.3
Q ss_pred hCCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEehh-----------------hhhh-cccCceeeEEEEEeCCCeeEEE
Q 039819 202 ENFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLKD-----------------MISL-AVHRNLLRLIGYCATPTERLLV 262 (534)
Q Consensus 202 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~-----------------~l~~-~~h~niv~l~~~~~~~~~~~lv 262 (534)
.+|....+||+|+||.|.+|.-+ ....+|||++++ ++.. -+-|.++++...|+..+..|+|
T Consensus 349 tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFV 428 (683)
T KOG0696|consen 349 TDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFV 428 (683)
T ss_pred cccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeE
Confidence 46888899999999999999765 467799998874 2222 2367888899999999999999
Q ss_pred eeccCCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCC
Q 039819 263 YPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDS 342 (534)
Q Consensus 263 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~ 342 (534)
|||+.||+|--.++.-+.+.+..+.-+|..||-||-|||++ +||+||||.+|||+|.+|++||+|||+++.--- ..
T Consensus 429 MEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~k---gIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~-~~ 504 (683)
T KOG0696|consen 429 MEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIF-DG 504 (683)
T ss_pred EEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcC---CeeeeeccccceEeccCCceEeeeccccccccc-CC
Confidence 99999999999998888899999999999999999999999 999999999999999999999999999985322 23
Q ss_pred ceeeccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceecccccC
Q 039819 343 HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELG 422 (534)
Q Consensus 343 ~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 422 (534)
..+.+++||+.|+|||++...+|+..+|.|||||+||||+.|++||++.++. +....+....
T Consensus 505 ~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~-------elF~aI~ehn----------- 566 (683)
T KOG0696|consen 505 VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDED-------ELFQAIMEHN----------- 566 (683)
T ss_pred cceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHH-------HHHHHHHHcc-----------
Confidence 3466789999999999999999999999999999999999999999865431 2222222211
Q ss_pred CCCCHHHHHHHHHHHHHhcccCCCCCCCh
Q 039819 423 SNYDRIEVGEILQVALLCTQYLPVHRPKM 451 (534)
Q Consensus 423 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~ 451 (534)
-.++...+.+...+....+...|.+|-..
T Consensus 567 vsyPKslSkEAv~ickg~ltK~P~kRLGc 595 (683)
T KOG0696|consen 567 VSYPKSLSKEAVAICKGLLTKHPGKRLGC 595 (683)
T ss_pred CcCcccccHHHHHHHHHHhhcCCccccCC
Confidence 12455556688889999999999999643
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=297.52 Aligned_cols=235 Identities=27% Similarity=0.428 Sum_probs=190.9
Q ss_pred CcCCeeccCCcEEEEEEEE-CC----CcEEEEEEehh---------------hhhhcccCceeeEEEEEeCCCeeEEEee
Q 039819 205 SSKNILGAGGFGNVYKGKL-GD----GTVLAVKRLKD---------------MISLAVHRNLLRLIGYCATPTERLLVYP 264 (534)
Q Consensus 205 ~~~~~lG~G~~g~Vy~~~~-~~----~~~vavK~~~~---------------~l~~~~h~niv~l~~~~~~~~~~~lv~e 264 (534)
...++||+|+||+||+|.+ ++ ..+||||.+.+ .|..+.|||+++++|+|.... ..||++
T Consensus 699 kk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq 777 (1177)
T KOG1025|consen 699 KKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQ 777 (1177)
T ss_pred hhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHH
Confidence 3457899999999999986 33 35689998763 678899999999999998776 789999
Q ss_pred ccCCCChhhhccc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCCc
Q 039819 265 YMSNGSVASRLRE-KPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSH 343 (534)
Q Consensus 265 ~~~~gsL~~~l~~-~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~ 343 (534)
||+.|+|.++++. +..+-.+..+.|..|||+||.|||.+ .+|||||-.+|||+..-.++||.|||+++.+......
T Consensus 778 ~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~q---rlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~e 854 (1177)
T KOG1025|consen 778 LMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQ---RLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKE 854 (1177)
T ss_pred hcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhc---chhhhhhhhhheeecCCCeEEEEecchhhccCccccc
Confidence 9999999999984 45788899999999999999999999 9999999999999999999999999999988654432
Q ss_pred eee-ccccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCcCCCccccccchHHHHHHHHhhhcccceeccccc
Q 039819 344 VTT-AVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDREL 421 (534)
Q Consensus 344 ~~~-~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 421 (534)
... ...-.+.|||-|.+....|+.++|||||||++||++| |..|+++....+ +.+. +..-.
T Consensus 855 y~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~e----I~dl-------------le~ge 917 (1177)
T KOG1025|consen 855 YSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEE----IPDL-------------LEKGE 917 (1177)
T ss_pred ccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHH----hhHH-------------Hhccc
Confidence 222 2223568999999999999999999999999999998 889987433211 1111 11111
Q ss_pred CCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhc
Q 039819 422 GSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLEG 460 (534)
Q Consensus 422 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~ 460 (534)
+-..+..+.-.+..++.+||..|+..||+++++...+..
T Consensus 918 RLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~ 956 (1177)
T KOG1025|consen 918 RLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSR 956 (1177)
T ss_pred cCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHH
Confidence 122345566789999999999999999999999887654
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-33 Score=270.17 Aligned_cols=222 Identities=28% Similarity=0.333 Sum_probs=183.4
Q ss_pred eccCCcEEEEEEEEC-CCcEEEEEEeh-----------------hhhhhcccCceeeEEEEEeCCCeeEEEeeccCCCCh
Q 039819 210 LGAGGFGNVYKGKLG-DGTVLAVKRLK-----------------DMISLAVHRNLLRLIGYCATPTERLLVYPYMSNGSV 271 (534)
Q Consensus 210 lG~G~~g~Vy~~~~~-~~~~vavK~~~-----------------~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 271 (534)
||+|+||.||++... ++..+|+|.+. ++++.++|+||+++++.+......++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 699999999999975 58899999764 256788899999999999999999999999999999
Q ss_pred hhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCCceeeccccc
Q 039819 272 ASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGT 351 (534)
Q Consensus 272 ~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt 351 (534)
.+++.....+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++....... .......++
T Consensus 81 ~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~---~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~ 156 (250)
T cd05123 81 FSHLSKEGRFSEERARFYAAEIVLALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG-SRTNTFCGT 156 (250)
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcceEEEcCCCcEEEeecCcceecccCC-CcccCCcCC
Confidence 99998877899999999999999999999998 99999999999999999999999999998764432 123345688
Q ss_pred cccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceecccccCCCCCHHHHH
Q 039819 352 VGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELGSNYDRIEVG 431 (534)
Q Consensus 352 ~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~ 431 (534)
..|+|||...+...+.++|+||||+++|||++|+.||..... .+........ .. ..+...+.
T Consensus 157 ~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~-------~~~~~~~~~~-------~~----~~~~~~~~ 218 (250)
T cd05123 157 PEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR-------KEIYEKILKD-------PL----RFPEFLSP 218 (250)
T ss_pred ccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH-------HHHHHHHhcC-------CC----CCCCCCCH
Confidence 999999999888889999999999999999999999964321 1111111110 00 11222245
Q ss_pred HHHHHHHHhcccCCCCCCChHH
Q 039819 432 EILQVALLCTQYLPVHRPKMSE 453 (534)
Q Consensus 432 ~l~~l~~~Cl~~~P~~RPt~~e 453 (534)
.+.+++.+|+..+|++||++.+
T Consensus 219 ~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 219 EARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred HHHHHHHHHhcCCHhhCCCccc
Confidence 7889999999999999999954
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-33 Score=273.75 Aligned_cols=247 Identities=24% Similarity=0.338 Sum_probs=186.9
Q ss_pred hCCCcCCeeccCCcEEEEEEEECCCcEEEEEEehh-------------hhhhcccCceeeEEEEEeCCC----eeEEEee
Q 039819 202 ENFSSKNILGAGGFGNVYKGKLGDGTVLAVKRLKD-------------MISLAVHRNLLRLIGYCATPT----ERLLVYP 264 (534)
Q Consensus 202 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~-------------~l~~~~h~niv~l~~~~~~~~----~~~lv~e 264 (534)
.+....+.||+|.||+||+|.+ .|..||||++.. .-..++|+||+.+++.-.... +.+||.+
T Consensus 211 rqI~L~e~IGkGRyGEVwrG~w-rGe~VAVKiF~srdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwLvTd 289 (513)
T KOG2052|consen 211 RQIVLQEIIGKGRFGEVWRGRW-RGEDVAVKIFSSRDERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWLVTD 289 (513)
T ss_pred heeEEEEEecCccccceeeccc-cCCceEEEEecccchhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEEeee
Confidence 3455678999999999999999 567899999863 234678999999988754432 5799999
Q ss_pred ccCCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHh-----cCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCC
Q 039819 265 YMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHE-----QCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDH 339 (534)
Q Consensus 265 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~-----~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~ 339 (534)
|-+.|||+|+|.. ..++-+..++++.-+|.||++||. +..|.|.|||||+.|||+.+++...|+|+|||.....
T Consensus 290 YHe~GSL~DyL~r-~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv~h~~ 368 (513)
T KOG2052|consen 290 YHEHGSLYDYLNR-NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDS 368 (513)
T ss_pred cccCCcHHHHHhh-ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceeeEEecc
Confidence 9999999999987 569999999999999999999995 4578999999999999999999999999999987755
Q ss_pred CCCc---eeeccccccccccccccccCC----C--CcchhHHHHHHHHHHHHhC----------CCCcCCCccccccchH
Q 039819 340 SDSH---VTTAVRGTVGHIAPEYLSTGQ----S--SEKTDVFGFGILLLELITG----------MRALEFGKSINQKGAM 400 (534)
Q Consensus 340 ~~~~---~~~~~~gt~~y~aPE~~~~~~----~--~~k~Dv~S~Gvvl~elltG----------~~p~~~~~~~~~~~~~ 400 (534)
.... .....+||..|||||++...- + -..+||||||.|+||++.. +.||..--+.+. .
T Consensus 369 ~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~DP---s 445 (513)
T KOG2052|consen 369 DTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSDP---S 445 (513)
T ss_pred cCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCCC---C
Confidence 4222 234567999999999985321 2 2358999999999999853 334431110000 0
Q ss_pred HHHHHHHhhhcccceecccccCCC-----CCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhcC
Q 039819 401 LEWVKKIQQEKKVEVLVDRELGSN-----YDRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLEGD 461 (534)
Q Consensus 401 ~~~~~~~~~~~~~~~~~d~~l~~~-----~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~~ 461 (534)
. ++-.+.+-..+++.. .+......+.+++..||..+|..|-|+--+-+.|...
T Consensus 446 ~--------eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l 503 (513)
T KOG2052|consen 446 F--------EEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKL 503 (513)
T ss_pred H--------HHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHH
Confidence 0 000111112222222 2345677899999999999999999999888877654
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-34 Score=247.94 Aligned_cols=265 Identities=20% Similarity=0.303 Sum_probs=197.8
Q ss_pred CCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEeh----------------hhhhhcccCceeeEEEEEeCCCeeEEEeec
Q 039819 203 NFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLK----------------DMISLAVHRNLLRLIGYCATPTERLLVYPY 265 (534)
Q Consensus 203 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~----------------~~l~~~~h~niv~l~~~~~~~~~~~lv~e~ 265 (534)
+|...+.||+|.||+||+|+.. .++.||+|+.+ -+++.++|.|||+++++.......-+|+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 4555678999999999999865 57899999875 168899999999999999999999999999
Q ss_pred cCCCChhhhcc-cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCCce
Q 039819 266 MSNGSVASRLR-EKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHV 344 (534)
Q Consensus 266 ~~~gsL~~~l~-~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~ 344 (534)
|.. +|..+.. -++.++.+.+..++.|+++||.|+|++ ++.|||+||.|.|++.+|+.|++|||+++.++-.-. .
T Consensus 83 cdq-dlkkyfdslng~~d~~~~rsfmlqllrgl~fchsh---nvlhrdlkpqnllin~ngelkladfglarafgipvr-c 157 (292)
T KOG0662|consen 83 CDQ-DLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSH---NVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVR-C 157 (292)
T ss_pred hhH-HHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhh---hhhhccCCcceEEeccCCcEEecccchhhhcCCceE-e
Confidence 964 6766665 356799999999999999999999999 999999999999999999999999999998764322 2
Q ss_pred eeccccccccccccccccCC-CCcchhHHHHHHHHHHHHh-CCCCcCCCccccccchHHHHHHHHhhhcc--cceecccc
Q 039819 345 TTAVRGTVGHIAPEYLSTGQ-SSEKTDVFGFGILLLELIT-GMRALEFGKSINQKGAMLEWVKKIQQEKK--VEVLVDRE 420 (534)
Q Consensus 345 ~~~~~gt~~y~aPE~~~~~~-~~~k~Dv~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~d~~ 420 (534)
....+-|.+|++|.++.+.+ |+...|+||-||++.|+.. |++.|++.+-.++...+...++...++.+ +..+-|-.
T Consensus 158 ysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk 237 (292)
T KOG0662|consen 158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYK 237 (292)
T ss_pred eeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCc
Confidence 23344689999999987765 7899999999999999985 67667765544444444433333333322 12222222
Q ss_pred cCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhcCCchhhHHhhccCCCCCCCCc
Q 039819 421 LGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLEGDGLAEKWAAAHNHTNPTMNNF 481 (534)
Q Consensus 421 l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~~~~~~~~~~~~~~~~p~~~~~ 481 (534)
....++.. ..-.+.-|.---+-+++++.|....++.++.+..+..||++..+
T Consensus 238 ~yp~ypat---------tswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf~d~ 289 (292)
T KOG0662|consen 238 PYPIYPAT---------TSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSDF 289 (292)
T ss_pred ccCCcccc---------chHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCcccccc
Confidence 22222211 11122334555566777777777777777777778889987654
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=269.63 Aligned_cols=188 Identities=24% Similarity=0.364 Sum_probs=157.1
Q ss_pred HHhCCCcCCeeccCCcEEEEEEEEC---C--CcEEEEEEehh----------------hhhhcccCceeeEEEEEeC-CC
Q 039819 200 ATENFSSKNILGAGGFGNVYKGKLG---D--GTVLAVKRLKD----------------MISLAVHRNLLRLIGYCAT-PT 257 (534)
Q Consensus 200 ~~~~~~~~~~lG~G~~g~Vy~~~~~---~--~~~vavK~~~~----------------~l~~~~h~niv~l~~~~~~-~~ 257 (534)
....|+....||+|.||.||+|.-. + .+.+|||+++. ++..++|||++.+..++.+ ..
T Consensus 22 ~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~ 101 (438)
T KOG0666|consen 22 DLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDK 101 (438)
T ss_pred HHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCc
Confidence 3457888899999999999999542 2 34789998863 5778899999999999877 67
Q ss_pred eeEEEeeccCCCChhhhcc-----cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCC----CcEEE
Q 039819 258 ERLLVYPYMSNGSVASRLR-----EKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDF----CEAIV 328 (534)
Q Consensus 258 ~~~lv~e~~~~gsL~~~l~-----~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~----~~~kl 328 (534)
..++++||.+. +|...++ +...++-..++.|+.||+.|++|||+. =|+||||||.|||+..+ |.+||
T Consensus 102 ~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~N---WvlHRDLKPaNIlvmgdgperG~VKI 177 (438)
T KOG0666|consen 102 KVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSN---WVLHRDLKPANILVMGDGPERGRVKI 177 (438)
T ss_pred eEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhh---heeeccCCcceEEEeccCCccCeeEe
Confidence 78999999976 7888775 234688899999999999999999998 69999999999999877 99999
Q ss_pred EecccceecCCCCCc--eeeccccccccccccccccC-CCCcchhHHHHHHHHHHHHhCCCCcCCC
Q 039819 329 GDFGLAKLLDHSDSH--VTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELITGMRALEFG 391 (534)
Q Consensus 329 ~DFGla~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~S~Gvvl~elltG~~p~~~~ 391 (534)
+|||+++.+...-.. ....++-|.+|+|||.+.+. .|+.+.||||.|||+.||+|-++.|...
T Consensus 178 aDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~ 243 (438)
T KOG0666|consen 178 ADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGR 243 (438)
T ss_pred ecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccch
Confidence 999999987543211 22345679999999998775 4899999999999999999998888653
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=279.36 Aligned_cols=235 Identities=24% Similarity=0.318 Sum_probs=195.3
Q ss_pred hCCCcCCeeccCCcEEEEEEEECCCc-EEEEEEehh-----------------hhhhcccCceeeEEEEEeCCCeeEEEe
Q 039819 202 ENFSSKNILGAGGFGNVYKGKLGDGT-VLAVKRLKD-----------------MISLAVHRNLLRLIGYCATPTERLLVY 263 (534)
Q Consensus 202 ~~~~~~~~lG~G~~g~Vy~~~~~~~~-~vavK~~~~-----------------~l~~~~h~niv~l~~~~~~~~~~~lv~ 263 (534)
.++.....||-|+||.|-+.+..... .+|+|.+++ ++..++.|.||+++-.|.+....|+.|
T Consensus 420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLm 499 (732)
T KOG0614|consen 420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLM 499 (732)
T ss_pred hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhH
Confidence 34555667999999999999886544 478887763 677888999999999999999999999
Q ss_pred eccCCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCCc
Q 039819 264 PYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSH 343 (534)
Q Consensus 264 e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~ 343 (534)
|-|-||.|...+++++.++..+..-++..+++|++|||++ +||+|||||+|.|++.+|-+||.|||+|+....+ .
T Consensus 500 EaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k---~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g--~ 574 (732)
T KOG0614|consen 500 EACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRK---GIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSG--R 574 (732)
T ss_pred HhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhc---CceeccCChhheeeccCCceEEeehhhHHHhccC--C
Confidence 9999999999999999999999999999999999999999 9999999999999999999999999999988654 3
Q ss_pred eeeccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceecccccCC
Q 039819 344 VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELGS 423 (534)
Q Consensus 344 ~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 423 (534)
.+-+++||+.|.|||++.+...+..+|.||+||++|||+||++||...+.......++.-+..+
T Consensus 575 KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i---------------- 638 (732)
T KOG0614|consen 575 KTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKI---------------- 638 (732)
T ss_pred ceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhh----------------
Confidence 4667899999999999999999999999999999999999999998655433222222111111
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCC-----hHHHHHH
Q 039819 424 NYDRIEVGEILQVALLCTQYLPVHRPK-----MSEVVRM 457 (534)
Q Consensus 424 ~~~~~~~~~l~~l~~~Cl~~~P~~RPt-----~~ev~~~ 457 (534)
.++........+++++....+|.+|-. +.|+-+.
T Consensus 639 ~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH 677 (732)
T KOG0614|consen 639 EFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKH 677 (732)
T ss_pred hcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhh
Confidence 133334457778888888999999986 5555543
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=275.28 Aligned_cols=241 Identities=24% Similarity=0.367 Sum_probs=187.9
Q ss_pred CCCcCCeeccCCcEEEEEEEE-CCCcEEEEEEeh---------------------hhhhhcccCceeeEEEEEe-CCCee
Q 039819 203 NFSSKNILGAGGFGNVYKGKL-GDGTVLAVKRLK---------------------DMISLAVHRNLLRLIGYCA-TPTER 259 (534)
Q Consensus 203 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~---------------------~~l~~~~h~niv~l~~~~~-~~~~~ 259 (534)
+|-..++||+|||+.||+|.+ ...+.||||+-. ++-+.+.||.||++++||. +.+..
T Consensus 464 RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtdsF 543 (775)
T KOG1151|consen 464 RYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDSF 543 (775)
T ss_pred HHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccccc
Confidence 455678899999999999974 578899999642 2567788999999999996 55678
Q ss_pred EEEeeccCCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeC---CCCcEEEEeccccee
Q 039819 260 LLVYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLD---DFCEAIVGDFGLAKL 336 (534)
Q Consensus 260 ~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~---~~~~~kl~DFGla~~ 336 (534)
+-|.|||+|.+|.-+|+....+++.++..|+.||+.||.||.+. .++|||-||||.||||- .-|.+||.|||+++.
T Consensus 544 CTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKITDFGLSKI 622 (775)
T KOG1151|consen 544 CTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKITDFGLSKI 622 (775)
T ss_pred eeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEeeecchhhh
Confidence 89999999999999999999999999999999999999999986 67899999999999994 458899999999999
Q ss_pred cCCCCC------ceeecccccccccccccccc----CCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHH
Q 039819 337 LDHSDS------HVTTAVRGTVGHIAPEYLST----GQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKK 406 (534)
Q Consensus 337 ~~~~~~------~~~~~~~gt~~y~aPE~~~~----~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~ 406 (534)
+..... ..+...+||.+|++||.+.- .+++.|+||||.|||+|..+.|++||...-+ ...+++.
T Consensus 623 MdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqs---QQdILqe--- 696 (775)
T KOG1151|consen 623 MDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQS---QQDILQE--- 696 (775)
T ss_pred ccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchh---HHHHHhh---
Confidence 865432 23345679999999998743 3478899999999999999999999974322 1112211
Q ss_pred HhhhcccceecccccCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 407 IQQEKKVEVLVDRELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 407 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
..+ +--.++.-........+...++++|++..-++|....++..
T Consensus 697 ----NTI--lkAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~ 740 (775)
T KOG1151|consen 697 ----NTI--LKATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLAC 740 (775)
T ss_pred ----hch--hcceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHcc
Confidence 110 00011111112223457888999999999999988777653
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=259.08 Aligned_cols=193 Identities=23% Similarity=0.402 Sum_probs=161.2
Q ss_pred CHHHHHHHHhCCCcCCeeccCCcEEEEEEE-ECCCcEEEEEEehh--------------hhhhc-ccCceeeEEEEEeCC
Q 039819 193 TFRELQQATENFSSKNILGAGGFGNVYKGK-LGDGTVLAVKRLKD--------------MISLA-VHRNLLRLIGYCATP 256 (534)
Q Consensus 193 ~~~~l~~~~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~--------------~l~~~-~h~niv~l~~~~~~~ 256 (534)
+++|+.+.|+ ++||+|+|+.|--++ +.+|..+|||++.+ ++..+ .|+||+++++||++.
T Consensus 74 ~F~d~YkLt~-----e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd 148 (463)
T KOG0607|consen 74 KFEDMYKLTS-----ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDD 148 (463)
T ss_pred hHHHHHHhHH-----HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhccc
Confidence 4677777765 679999999999886 57899999998864 22222 399999999999999
Q ss_pred CeeEEEeeccCCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCC---CcEEEEeccc
Q 039819 257 TERLLVYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDF---CEAIVGDFGL 333 (534)
Q Consensus 257 ~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~---~~~kl~DFGl 333 (534)
...|||||-|.||.|..++.++..+++.++.++..+|+.||.|||.+ +|.||||||+|||.... .-+||+||.+
T Consensus 149 ~~FYLVfEKm~GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~k---gIAHRDlKPENiLC~~pn~vsPvKiCDfDL 225 (463)
T KOG0607|consen 149 TRFYLVFEKMRGGPLLSHIQKRKHFNEREASRVVKDIASALDFLHTK---GIAHRDLKPENILCESPNKVSPVKICDFDL 225 (463)
T ss_pred ceEEEEEecccCchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhc---CcccccCCccceeecCCCCcCceeeecccc
Confidence 99999999999999999999999999999999999999999999999 99999999999999654 4479999988
Q ss_pred ceecCCCC--C----ceeeccccccccccccccc-----cCCCCcchhHHHHHHHHHHHHhCCCCcCCCcc
Q 039819 334 AKLLDHSD--S----HVTTAVRGTVGHIAPEYLS-----TGQSSEKTDVFGFGILLLELITGMRALEFGKS 393 (534)
Q Consensus 334 a~~~~~~~--~----~~~~~~~gt~~y~aPE~~~-----~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~ 393 (534)
..-..... + ....+.+|+..|||||+.. ...|+.++|.||+|||||-|++|.+||-+...
T Consensus 226 gSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg 296 (463)
T KOG0607|consen 226 GSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCG 296 (463)
T ss_pred ccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccC
Confidence 75432111 1 1123467999999999862 23578899999999999999999999976443
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.8e-33 Score=267.11 Aligned_cols=248 Identities=19% Similarity=0.263 Sum_probs=188.9
Q ss_pred HhCCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEehh-------------hhhhccc--C----ceeeEEEEEeCCCeeE
Q 039819 201 TENFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLKD-------------MISLAVH--R----NLLRLIGYCATPTERL 260 (534)
Q Consensus 201 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~-------------~l~~~~h--~----niv~l~~~~~~~~~~~ 260 (534)
+.+|.+...+|+|.||.|-++.+. .+..||||+++. .+.++.+ | .+|.+.++|.-.++.+
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghiC 167 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHIC 167 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCceE
Confidence 678999999999999999999875 468999999874 3344422 1 3788889999999999
Q ss_pred EEeeccCCCChhhhcccC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeC-----------------
Q 039819 261 LVYPYMSNGSVASRLREK--PALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLD----------------- 321 (534)
Q Consensus 261 lv~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~----------------- 321 (534)
+|+|.| |-|++++++++ .+++...+..|+.|++++++|||+. +++|-||||+|||+.
T Consensus 168 ivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~---kl~HTDLKPENILfvss~~~~~~~~k~~~~~~ 243 (415)
T KOG0671|consen 168 IVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDL---KLTHTDLKPENILFVSSEYFKTYNPKKKVCFI 243 (415)
T ss_pred EEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhc---ceeecCCChheEEEeccceEEEeccCCcccee
Confidence 999998 56999999865 4688899999999999999999999 999999999999982
Q ss_pred ---CCCcEEEEecccceecCCCCCceeeccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccc
Q 039819 322 ---DFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKG 398 (534)
Q Consensus 322 ---~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~ 398 (534)
++..++|+|||.|++-... ...++.|..|+|||++.+-.++.++||||+||||.|+.||...|..-+..+...
T Consensus 244 r~~ks~~I~vIDFGsAtf~~e~----hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~EHLa 319 (415)
T KOG0671|consen 244 RPLKSTAIKVIDFGSATFDHEH----HSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLEHLA 319 (415)
T ss_pred ccCCCcceEEEecCCcceeccC----cceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHHHHH
Confidence 2456899999999875432 245678999999999999999999999999999999999999998655433322
Q ss_pred hHHHHHHHHhh-------------hccc-----------ceecccccC----CCCCHHHHHHHHHHHHHhcccCCCCCCC
Q 039819 399 AMLEWVKKIQQ-------------EKKV-----------EVLVDRELG----SNYDRIEVGEILQVALLCTQYLPVHRPK 450 (534)
Q Consensus 399 ~~~~~~~~~~~-------------~~~~-----------~~~~d~~l~----~~~~~~~~~~l~~l~~~Cl~~~P~~RPt 450 (534)
.+...++++.. .+.+ ....++-.. -.....+..++++|+.+++..||.+|+|
T Consensus 320 MMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~RiT 399 (415)
T KOG0671|consen 320 MMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARRIT 399 (415)
T ss_pred HHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCcccccc
Confidence 22222111100 0000 000000000 0112335568999999999999999999
Q ss_pred hHHHHH
Q 039819 451 MSEVVR 456 (534)
Q Consensus 451 ~~ev~~ 456 (534)
+.|++.
T Consensus 400 l~EAL~ 405 (415)
T KOG0671|consen 400 LREALS 405 (415)
T ss_pred HHHHhc
Confidence 999875
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6e-32 Score=256.51 Aligned_cols=236 Identities=22% Similarity=0.284 Sum_probs=192.3
Q ss_pred HhCCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEehh------------------hhhhcccCceeeEEEEEeCCCeeEE
Q 039819 201 TENFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLKD------------------MISLAVHRNLLRLIGYCATPTERLL 261 (534)
Q Consensus 201 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~------------------~l~~~~h~niv~l~~~~~~~~~~~l 261 (534)
.++|...++||+|+|+.|..+++. ..+.+|+|++++ .-...+||.+|-+..+|......++
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff 328 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF 328 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence 357888999999999999999975 578899998875 1234469999999999999999999
Q ss_pred EeeccCCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCC
Q 039819 262 VYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSD 341 (534)
Q Consensus 262 v~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~ 341 (534)
|.||+++|+|--++..+..++++.++-+...|+-||.|||++ +||+||||.+|||+|..|++|+.|+|+++.--. .
T Consensus 329 vieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~r---giiyrdlkldnvlldaeghikltdygmcke~l~-~ 404 (593)
T KOG0695|consen 329 VIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLG-P 404 (593)
T ss_pred EEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhc---CeeeeeccccceEEccCCceeecccchhhcCCC-C
Confidence 999999999998888889999999999999999999999999 999999999999999999999999999985322 2
Q ss_pred CceeeccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceeccccc
Q 039819 342 SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDREL 421 (534)
Q Consensus 342 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 421 (534)
...+.+++||+.|.|||++.+..|...+|.|++||+++||+.|+.||+.-...+......+++-++..+..+.
T Consensus 405 gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqir------- 477 (593)
T KOG0695|consen 405 GDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIR------- 477 (593)
T ss_pred CcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhccc-------
Confidence 3346678999999999999999999999999999999999999999985333222222333433333322211
Q ss_pred CCCCCHHHHHHHHHHHHHhcccCCCCCCC
Q 039819 422 GSNYDRIEVGEILQVALLCTQYLPVHRPK 450 (534)
Q Consensus 422 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt 450 (534)
.+...+.....+...-+..||.+|-.
T Consensus 478 ---iprslsvkas~vlkgflnkdp~erlg 503 (593)
T KOG0695|consen 478 ---IPRSLSVKASHVLKGFLNKDPKERLG 503 (593)
T ss_pred ---ccceeehhhHHHHHHhhcCCcHHhcC
Confidence 22222345567788889999999864
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-31 Score=280.51 Aligned_cols=243 Identities=21% Similarity=0.233 Sum_probs=169.9
Q ss_pred HhCCCcCCeeccCCcEEEEEEEE-----------------CCCcEEEEEEehh---------------------------
Q 039819 201 TENFSSKNILGAGGFGNVYKGKL-----------------GDGTVLAVKRLKD--------------------------- 236 (534)
Q Consensus 201 ~~~~~~~~~lG~G~~g~Vy~~~~-----------------~~~~~vavK~~~~--------------------------- 236 (534)
.++|...++||+|+||.||+|.+ ..++.||||++..
T Consensus 144 ~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~ 223 (507)
T PLN03224 144 SDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEA 223 (507)
T ss_pred ccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHH
Confidence 57899999999999999999964 2456799999741
Q ss_pred -hhhhcccCc-----eeeEEEEEeC--------CCeeEEEeeccCCCChhhhcccC------------------------
Q 039819 237 -MISLAVHRN-----LLRLIGYCAT--------PTERLLVYPYMSNGSVASRLREK------------------------ 278 (534)
Q Consensus 237 -~l~~~~h~n-----iv~l~~~~~~--------~~~~~lv~e~~~~gsL~~~l~~~------------------------ 278 (534)
++.+++|.+ +++++++|.. ....+|||||+++|+|.++++..
T Consensus 224 ~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~ 303 (507)
T PLN03224 224 YMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQ 303 (507)
T ss_pred HHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhccc
Confidence 223344444 4677787753 35679999999999999888531
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCCceeecccccccccccc
Q 039819 279 PALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGHIAPE 358 (534)
Q Consensus 279 ~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE 358 (534)
..++|..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++.+............+|+.|+|||
T Consensus 304 ~~~~~~~~~~i~~ql~~aL~~lH~~---~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE 380 (507)
T PLN03224 304 DKRDINVIKGVMRQVLTGLRKLHRI---GIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPE 380 (507)
T ss_pred ccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChh
Confidence 1346788899999999999999998 9999999999999999999999999999765433221112223478999999
Q ss_pred ccccCCC----------------------CcchhHHHHHHHHHHHHhCCC-CcCCCccccc-----cchHHHHHHHHhhh
Q 039819 359 YLSTGQS----------------------SEKTDVFGFGILLLELITGMR-ALEFGKSINQ-----KGAMLEWVKKIQQE 410 (534)
Q Consensus 359 ~~~~~~~----------------------~~k~Dv~S~Gvvl~elltG~~-p~~~~~~~~~-----~~~~~~~~~~~~~~ 410 (534)
.+..... ..+.||||+|||+|||++|.. |+......+. ...+..|.......
T Consensus 381 ~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~~ 460 (507)
T PLN03224 381 ELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQK 460 (507)
T ss_pred hhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcccC
Confidence 8753221 134799999999999999875 6542111110 11112232111110
Q ss_pred cccceecccccCCCCCHHHHHHHHHHHHHhcccCC---CCCCChHHHHH
Q 039819 411 KKVEVLVDRELGSNYDRIEVGEILQVALLCTQYLP---VHRPKMSEVVR 456 (534)
Q Consensus 411 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P---~~RPt~~ev~~ 456 (534)
.+-. ..........+++.+++..+| .+|+|++|+++
T Consensus 461 ------~~~~----~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~ 499 (507)
T PLN03224 461 ------YDFS----LLDRNKEAGWDLACKLITKRDQANRGRLSVGQALS 499 (507)
T ss_pred ------CCcc----cccccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence 0000 111123577889999998765 68999999885
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-32 Score=273.94 Aligned_cols=182 Identities=27% Similarity=0.434 Sum_probs=159.6
Q ss_pred CCeeccCCcEEEEEEEEC-CCcEEEEEEehh----------------hhhhcccCceeeEEEEEeCCCeeEEEeeccCCC
Q 039819 207 KNILGAGGFGNVYKGKLG-DGTVLAVKRLKD----------------MISLAVHRNLLRLIGYCATPTERLLVYPYMSNG 269 (534)
Q Consensus 207 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~----------------~l~~~~h~niv~l~~~~~~~~~~~lv~e~~~~g 269 (534)
.+.||+|.||+||-|+.+ +|+.||||.+.+ ++..+.||.||.+--.|+.++..++|||-+.|.
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GD 648 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGD 648 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcch
Confidence 478999999999999975 799999998863 788999999999999999999999999999654
Q ss_pred Chhhhcc-cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeC---CCCcEEEEecccceecCCCCCcee
Q 039819 270 SVASRLR-EKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLD---DFCEAIVGDFGLAKLLDHSDSHVT 345 (534)
Q Consensus 270 sL~~~l~-~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~---~~~~~kl~DFGla~~~~~~~~~~~ 345 (534)
-|.-.|. +.+.|++....-++.||+.||.|||.+ +|||+||||+|||+. ...++||||||+|++.+... ..
T Consensus 649 MLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~k---nIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEks--FR 723 (888)
T KOG4236|consen 649 MLEMILSSEKGRLPERITKFLVTQILVALRYLHFK---NIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKS--FR 723 (888)
T ss_pred HHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhc---ceeeccCCchheeeccCCCCCceeeccccceeecchhh--hh
Confidence 4444443 567899999899999999999999999 999999999999995 45689999999999987532 34
Q ss_pred eccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCcc
Q 039819 346 TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKS 393 (534)
Q Consensus 346 ~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~ 393 (534)
..++||+.|+|||++....|...-|+||.|||+|--++|-.||..+.+
T Consensus 724 rsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEd 771 (888)
T KOG4236|consen 724 RSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDED 771 (888)
T ss_pred hhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccc
Confidence 567899999999999999999999999999999999999999975443
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=272.57 Aligned_cols=200 Identities=23% Similarity=0.365 Sum_probs=169.2
Q ss_pred CCCcCCeeccCCcEEEEEEEE-CCCcEEEEEEeh-----------------hhhhhcccCceeeEEEEEeCCCeeEEEee
Q 039819 203 NFSSKNILGAGGFGNVYKGKL-GDGTVLAVKRLK-----------------DMISLAVHRNLLRLIGYCATPTERLLVYP 264 (534)
Q Consensus 203 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~-----------------~~l~~~~h~niv~l~~~~~~~~~~~lv~e 264 (534)
-|..++.||-|+||+|.+++- +....+|.|.+. ++|.....+-||+|+-.|.+.+.+|+|||
T Consensus 630 mFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMd 709 (1034)
T KOG0608|consen 630 MFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 709 (1034)
T ss_pred ceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEe
Confidence 356678899999999999864 345566766654 47888889999999999999999999999
Q ss_pred ccCCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceec-------
Q 039819 265 YMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLL------- 337 (534)
Q Consensus 265 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~------- 337 (534)
|++||++-.+|.+-+.|.++.++-++..+..|+++.|.. |+|||||||+|||||.+|++||.||||+.-+
T Consensus 710 YIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkm---GFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdsk 786 (1034)
T KOG0608|consen 710 YIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSK 786 (1034)
T ss_pred ccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhc---cceecccCccceEEccCCceeeeeccccccceeccccc
Confidence 999999999999989999999999999999999999999 9999999999999999999999999998632
Q ss_pred --CCCCCc--------------------------------eeeccccccccccccccccCCCCcchhHHHHHHHHHHHHh
Q 039819 338 --DHSDSH--------------------------------VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT 383 (534)
Q Consensus 338 --~~~~~~--------------------------------~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~ellt 383 (534)
..++.. .....+||+.|+|||++....++..+|.||.|||||||+.
T Consensus 787 YYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~~ 866 (1034)
T KOG0608|consen 787 YYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEMLV 866 (1034)
T ss_pred cccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHhh
Confidence 110000 0113569999999999999999999999999999999999
Q ss_pred CCCCcCCCccccccchHHHHHH
Q 039819 384 GMRALEFGKSINQKGAMLEWVK 405 (534)
Q Consensus 384 G~~p~~~~~~~~~~~~~~~~~~ 405 (534)
|+.||-.....+....+..|..
T Consensus 867 g~~pf~~~tp~~tq~kv~nw~~ 888 (1034)
T KOG0608|consen 867 GQPPFLADTPGETQYKVINWRN 888 (1034)
T ss_pred CCCCccCCCCCcceeeeeehhh
Confidence 9999976666555556667754
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=239.53 Aligned_cols=182 Identities=25% Similarity=0.351 Sum_probs=154.4
Q ss_pred CcCCeeccCCcEEEEEEEE-CCCcEEEEEEehh----------------hhhhcccCceeeEEEEEeCCCeeEEEeeccC
Q 039819 205 SSKNILGAGGFGNVYKGKL-GDGTVLAVKRLKD----------------MISLAVHRNLLRLIGYCATPTERLLVYPYMS 267 (534)
Q Consensus 205 ~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~----------------~l~~~~h~niv~l~~~~~~~~~~~lv~e~~~ 267 (534)
.....||+|++|.|-+-++ .+|+..|+|++.. .+.....|.+|.++|.+......++.||.|+
T Consensus 49 ~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M~ 128 (282)
T KOG0984|consen 49 VGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELMD 128 (282)
T ss_pred hhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHhh
Confidence 3445699999999999886 4799999999863 2334458999999999999999999999996
Q ss_pred CCChhhhc----ccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCCc
Q 039819 268 NGSVASRL----REKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSH 343 (534)
Q Consensus 268 ~gsL~~~l----~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~ 343 (534)
. ||..+- ..+..+++...-+|+.-++.||.|||++. .+||||+||+|||++.+|++||||||.+-.+.++ .
T Consensus 129 t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dS--i 203 (282)
T KOG0984|consen 129 T-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDFGISGYLVDS--I 203 (282)
T ss_pred h-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEcccccceeehhh--h
Confidence 4 665443 46778999999999999999999999985 8999999999999999999999999999887543 2
Q ss_pred eeecccccccccccccccc----CCCCcchhHHHHHHHHHHHHhCCCCcCCC
Q 039819 344 VTTAVRGTVGHIAPEYLST----GQSSEKTDVFGFGILLLELITGMRALEFG 391 (534)
Q Consensus 344 ~~~~~~gt~~y~aPE~~~~----~~~~~k~Dv~S~Gvvl~elltG~~p~~~~ 391 (534)
..+...|...|||||.+.. ..|+-|+||||+|+++.||.+++.||+..
T Consensus 204 Akt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w 255 (282)
T KOG0984|consen 204 AKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESW 255 (282)
T ss_pred HHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhcccccccc
Confidence 3444568899999998843 46899999999999999999999999843
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.2e-33 Score=254.20 Aligned_cols=251 Identities=24% Similarity=0.361 Sum_probs=187.5
Q ss_pred CCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEeh----------------hhhhhcccCceeeEEEEEeCC--------C
Q 039819 203 NFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLK----------------DMISLAVHRNLLRLIGYCATP--------T 257 (534)
Q Consensus 203 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~----------------~~l~~~~h~niv~l~~~~~~~--------~ 257 (534)
.|.....||+|.||+||+|+.+ .++.||+|+.. +++..++|+|++.+++.|... .
T Consensus 18 ~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~ 97 (376)
T KOG0669|consen 18 KYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRA 97 (376)
T ss_pred HHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccc
Confidence 3444567999999999999875 56778988542 378889999999999988532 3
Q ss_pred eeEEEeeccCCCChhhhcccC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEeccccee
Q 039819 258 ERLLVYPYMSNGSVASRLREK-PALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKL 336 (534)
Q Consensus 258 ~~~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~ 336 (534)
..|+||++|+. +|.-.|.+. ..++..++.+++.++..||.|+|.. .|+|||+|++|+|++.++.+||+|||+++.
T Consensus 98 t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~---kilHRDmKaaNvLIt~dgilklADFGlar~ 173 (376)
T KOG0669|consen 98 TFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRN---KILHRDMKAANVLITKDGILKLADFGLARA 173 (376)
T ss_pred eeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHh---hHHhhcccHhhEEEcCCceEEeeccccccc
Confidence 46999999976 788888754 6799999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCCc---eeecccccccccccccccc-CCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcc
Q 039819 337 LDHSDSH---VTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKK 412 (534)
Q Consensus 337 ~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 412 (534)
+..+... ..+..+-|.+|++||.+.+ ..|+++.|||.-|||+.||+||.+.+.+.....+...+....+.+..+-+
T Consensus 174 fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkevW 253 (376)
T KOG0669|consen 174 FSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEVW 253 (376)
T ss_pred eecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcccC
Confidence 6443321 2334456999999998876 45899999999999999999999888765544333333333333333221
Q ss_pred cce-------ec--ccccCCCCCH--------HHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 039819 413 VEV-------LV--DRELGSNYDR--------IEVGEILQVALLCTQYLPVHRPKMSEVVRM 457 (534)
Q Consensus 413 ~~~-------~~--d~~l~~~~~~--------~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~ 457 (534)
... -+ .|-..+.+.. .-..+..+++..++..||.+|+++.+++..
T Consensus 254 P~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh 315 (376)
T KOG0669|consen 254 PNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNH 315 (376)
T ss_pred CCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhch
Confidence 100 00 0000001100 001267789999999999999999999864
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-30 Score=248.02 Aligned_cols=224 Identities=27% Similarity=0.360 Sum_probs=182.0
Q ss_pred CcEEEEEEEEC-CCcEEEEEEehh---------------hhhhcccCceeeEEEEEeCCCeeEEEeeccCCCChhhhccc
Q 039819 214 GFGNVYKGKLG-DGTVLAVKRLKD---------------MISLAVHRNLLRLIGYCATPTERLLVYPYMSNGSVASRLRE 277 (534)
Q Consensus 214 ~~g~Vy~~~~~-~~~~vavK~~~~---------------~l~~~~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~ 277 (534)
+||.||+|... ++..+|+|++.. .+..+.|+|++++++++......+++|||+++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 58999999986 489999998741 45677899999999999999999999999999999999987
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCCceeeccccccccccc
Q 039819 278 KPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGHIAP 357 (534)
Q Consensus 278 ~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aP 357 (534)
...+++..+..++.+++.++.|||+. +++|+||+|+||+++.++.++|+|||.+....... ......++..|++|
T Consensus 81 ~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~~p 155 (244)
T smart00220 81 RGRLSEDEARFYARQILSALEYLHSN---GIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--LLTTFVGTPEYMAP 155 (244)
T ss_pred ccCCCHHHHHHHHHHHHHHHHHHHHc---CeecCCcCHHHeEECCCCcEEEccccceeeecccc--ccccccCCcCCCCH
Confidence 66689999999999999999999998 99999999999999999999999999998775432 23345578899999
Q ss_pred cccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceecccccCCCCCHHHHHHHHHHH
Q 039819 358 EYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELGSNYDRIEVGEILQVA 437 (534)
Q Consensus 358 E~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~ 437 (534)
|......++.++||||||+++++|++|+.||..... ...+.++.. ...... .......+..+.+++
T Consensus 156 E~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~---~~~~~~~~~---~~~~~~--------~~~~~~~~~~~~~~i 221 (244)
T smart00220 156 EVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQ---LLELFKKIG---KPKPPF--------PPPEWKISPEAKDLI 221 (244)
T ss_pred HHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc---HHHHHHHHh---ccCCCC--------ccccccCCHHHHHHH
Confidence 999888889999999999999999999999864211 111222211 110000 000000345889999
Q ss_pred HHhcccCCCCCCChHHHHH
Q 039819 438 LLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 438 ~~Cl~~~P~~RPt~~ev~~ 456 (534)
.+|+..+|++||++.++++
T Consensus 222 ~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 222 RKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HHHccCCchhccCHHHHhh
Confidence 9999999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-32 Score=254.20 Aligned_cols=253 Identities=23% Similarity=0.317 Sum_probs=194.6
Q ss_pred CCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEehh----------------hhhhcccCceeeEEEEEeCCC-----eeE
Q 039819 203 NFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLKD----------------MISLAVHRNLLRLIGYCATPT-----ERL 260 (534)
Q Consensus 203 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~----------------~l~~~~h~niv~l~~~~~~~~-----~~~ 260 (534)
+.+..+.||.|+||.||...+. +|+.||.|++.+ ++...+|.|++..++...-+. +.|
T Consensus 54 Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiY 133 (449)
T KOG0664|consen 54 DIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELY 133 (449)
T ss_pred cCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHH
Confidence 3456789999999999999874 799999998753 677889999999888775442 568
Q ss_pred EEeeccCCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCC
Q 039819 261 LVYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHS 340 (534)
Q Consensus 261 lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~ 340 (534)
+|+|.|.. +|...+-..+.++.+.++-+.+||++||+|||+. +|.||||||.|.|++.+...||+|||+++.....
T Consensus 134 V~TELmQS-DLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA---~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d 209 (449)
T KOG0664|consen 134 VLTELMQS-DLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTA---NILHRDIKPGNLLVNSNCILKICDFGLARTWDQR 209 (449)
T ss_pred HHHHHHHh-hhhheeccCCCCCcchhhhhHHHHHhhhHHHhhc---chhhccCCCccEEeccCceEEecccccccccchh
Confidence 89999954 8888888888999999999999999999999999 9999999999999999999999999999977655
Q ss_pred CCceeeccccccccccccccccC-CCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhh-------cc
Q 039819 341 DSHVTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQE-------KK 412 (534)
Q Consensus 341 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~-------~~ 412 (534)
.....+..+-|..|+|||++++. .|+..+||||.|||+.|++-.+-.|.......+...+.+.++....+ +.
T Consensus 210 ~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGA 289 (449)
T KOG0664|consen 210 DRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGA 289 (449)
T ss_pred hhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhh
Confidence 44444445568999999999875 58999999999999999999988888777666666565554332211 11
Q ss_pred cceecccccCC-CC--------CHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhh
Q 039819 413 VEVLVDRELGS-NY--------DRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLE 459 (534)
Q Consensus 413 ~~~~~d~~l~~-~~--------~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~ 459 (534)
...++....+. .. +.....+...+...++..+|.+|.+..+.+..+.
T Consensus 290 k~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~ 345 (449)
T KOG0664|consen 290 KNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRY 345 (449)
T ss_pred HHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccc
Confidence 11111111110 00 0011235667778889999999999888876543
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.2e-31 Score=276.24 Aligned_cols=239 Identities=24% Similarity=0.352 Sum_probs=191.4
Q ss_pred HHHhCCCcCCeeccCCcEEEEEEEE-CCCcEEEEEEeh-------------h-hhhhcccCceeeEEEEEe-----CCCe
Q 039819 199 QATENFSSKNILGAGGFGNVYKGKL-GDGTVLAVKRLK-------------D-MISLAVHRNLLRLIGYCA-----TPTE 258 (534)
Q Consensus 199 ~~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~-------------~-~l~~~~h~niv~l~~~~~-----~~~~ 258 (534)
.-++-|.+.+.||.|.+|.||+++. ++++.+|||++. + ......|||++.++|++. .+++
T Consensus 16 dp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~Dq 95 (953)
T KOG0587|consen 16 DPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQ 95 (953)
T ss_pred CCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCe
Confidence 3456778889999999999999985 578888898875 1 344556999999999986 3578
Q ss_pred eEEEeeccCCCChhhhccc--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEeccccee
Q 039819 259 RLLVYPYMSNGSVASRLRE--KPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKL 336 (534)
Q Consensus 259 ~~lv~e~~~~gsL~~~l~~--~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~ 336 (534)
.|||||||.+|+..|+++. ...+.|..+..|++.++.|+.+||.. .++|||||-.|||++.++.+|+.|||++..
T Consensus 96 LWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~n---kviHRDikG~NiLLT~e~~VKLvDFGvSaQ 172 (953)
T KOG0587|consen 96 LWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNN---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQ 172 (953)
T ss_pred EEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhc---ceeeecccCceEEEeccCcEEEeeeeeeee
Confidence 8999999999999999973 56799999999999999999999998 999999999999999999999999999988
Q ss_pred cCCCCCceeecccccccccccccccc-----CCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhc
Q 039819 337 LDHSDSHVTTAVRGTVGHIAPEYLST-----GQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEK 411 (534)
Q Consensus 337 ~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 411 (534)
+.... ....+..||+.|||||++.. ..|+.++|+||+||+..||.-|.+|+-.... +..+-.+..
T Consensus 173 ldsT~-grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHP-------mraLF~IpR-- 242 (953)
T KOG0587|consen 173 LDSTV-GRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHP-------MRALFLIPR-- 242 (953)
T ss_pred eeccc-ccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcch-------hhhhccCCC--
Confidence 76433 23455679999999999953 3467789999999999999999999852211 011000111
Q ss_pred ccceecccccCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 412 KVEVLVDRELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 412 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
.|.....-+..-..++.+++..|+..|-++||++.++++
T Consensus 243 ------NPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~ 281 (953)
T KOG0587|consen 243 ------NPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK 281 (953)
T ss_pred ------CCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence 111112223445678999999999999999999999986
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.6e-31 Score=275.24 Aligned_cols=231 Identities=26% Similarity=0.334 Sum_probs=174.9
Q ss_pred CCcCCeeccCCcE-EEEEEEECCCcEEEEEEehh------------hhhhcccCceeeEEEEEeCCCeeEEEeeccCCCC
Q 039819 204 FSSKNILGAGGFG-NVYKGKLGDGTVLAVKRLKD------------MISLAVHRNLLRLIGYCATPTERLLVYPYMSNGS 270 (534)
Q Consensus 204 ~~~~~~lG~G~~g-~Vy~~~~~~~~~vavK~~~~------------~l~~~~h~niv~l~~~~~~~~~~~lv~e~~~~gs 270 (534)
|...+++|.|+-| .||+|.+ +++.||||++.. +...-.|||||++++.-.++...|+..|.|. -+
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~-~s 588 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVY-EGREVAVKRLLEEFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCA-CS 588 (903)
T ss_pred eccHHHcccCCCCcEEEEEee-CCceehHHHHhhHhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhh-hh
Confidence 4445678999988 6899999 678999999863 3344469999999998888899999999995 49
Q ss_pred hhhhcccC-CCC---CHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCC-----CCcEEEEecccceecCCCC
Q 039819 271 VASRLREK-PAL---DWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDD-----FCEAIVGDFGLAKLLDHSD 341 (534)
Q Consensus 271 L~~~l~~~-~~l---~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~-----~~~~kl~DFGla~~~~~~~ 341 (534)
|.+++... ..+ .-...+.+..|+++||++||+. +||||||||.||||+. ...++|+|||+++.+..+.
T Consensus 589 L~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl---~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~ 665 (903)
T KOG1027|consen 589 LQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSL---KIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGK 665 (903)
T ss_pred HHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhc---ccccccCCCceEEEEccCCCcceeEEecccccccccCCCc
Confidence 99998753 111 1133467888999999999997 9999999999999975 3578999999999886544
Q ss_pred Cce--eeccccccccccccccccCCCCcchhHHHHHHHHHHHHhC-CCCcCCCccccccchHHHHHHHHhhhcccceecc
Q 039819 342 SHV--TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITG-MRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVD 418 (534)
Q Consensus 342 ~~~--~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 418 (534)
+.. .....||-||+|||++....-+..+||||+|||+|+.+|| ++||...... + +........+..+
T Consensus 666 sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R--~------~NIl~~~~~L~~L-- 735 (903)
T KOG1027|consen 666 SSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLER--Q------ANILTGNYTLVHL-- 735 (903)
T ss_pred chhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHh--h------hhhhcCccceeee--
Confidence 322 3456799999999999988888899999999999999997 9999632110 0 0011111111100
Q ss_pred cccCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 419 RELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 419 ~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
.. .. .+ +..+|+.+|+.++|..||++.+|+.
T Consensus 736 ---~~-~~-d~--eA~dLI~~ml~~dP~~RPsa~~VL~ 766 (903)
T KOG1027|consen 736 ---EP-LP-DC--EAKDLISRMLNPDPQLRPSATDVLN 766 (903)
T ss_pred ---cc-Cc-hH--HHHHHHHHhcCCCcccCCCHHHHhC
Confidence 00 01 11 7789999999999999999999975
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.6e-30 Score=247.79 Aligned_cols=247 Identities=26% Similarity=0.356 Sum_probs=193.2
Q ss_pred HHHHHHHHhCCCcCCeeccCCcEEEEEEEECC------CcEEEEEEehh---------------hhhhcccCceeeEEEE
Q 039819 194 FRELQQATENFSSKNILGAGGFGNVYKGKLGD------GTVLAVKRLKD---------------MISLAVHRNLLRLIGY 252 (534)
Q Consensus 194 ~~~l~~~~~~~~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~---------------~l~~~~h~niv~l~~~ 252 (534)
..||.....+++...++-+|.||.||+|.+.+ .+.|-||.+++ ++-.+.|||+..+.++
T Consensus 276 ~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V 355 (563)
T KOG1024|consen 276 LQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGV 355 (563)
T ss_pred HHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEE
Confidence 45666666778888899999999999996643 34456676653 3445569999999999
Q ss_pred EeCC-CeeEEEeeccCCCChhhhcc-----c---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCC
Q 039819 253 CATP-TERLLVYPYMSNGSVASRLR-----E---KPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDF 323 (534)
Q Consensus 253 ~~~~-~~~~lv~e~~~~gsL~~~l~-----~---~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~ 323 (534)
+.+. ...+.+|.++.-|+|..+|. + .+.++-.+...++.|++.|++|||.. +|||.||..+|+++|+.
T Consensus 356 ~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~---~ViHkDiAaRNCvIdd~ 432 (563)
T KOG1024|consen 356 SIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNH---GVIHKDIAARNCVIDDQ 432 (563)
T ss_pred EeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhc---Ccccchhhhhcceehhh
Confidence 8764 56789999999999999996 1 24577788899999999999999999 99999999999999999
Q ss_pred CcEEEEecccceecCCCCCceee-ccccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCcCCCccccccchHH
Q 039819 324 CEAIVGDFGLAKLLDHSDSHVTT-AVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GMRALEFGKSINQKGAML 401 (534)
Q Consensus 324 ~~~kl~DFGla~~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~ 401 (534)
.++||+|-.+++.+-..+.+... .......||+||.+....|+..+|||||||++|||+| |+.|+-.-++ .
T Consensus 433 LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDP-------f 505 (563)
T KOG1024|consen 433 LQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDP-------F 505 (563)
T ss_pred eeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCH-------H
Confidence 99999999999976554433222 1224568999999999999999999999999999998 8888752221 1
Q ss_pred HHHHHHhhhcccceecccccCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhc
Q 039819 402 EWVKKIQQEKKVEVLVDRELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLEG 460 (534)
Q Consensus 402 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~ 460 (534)
+....+.... ++ ..+..++++++.++.-||...|++||++++++.-|.+
T Consensus 506 Em~~ylkdGy--------Rl--aQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLse 554 (563)
T KOG1024|consen 506 EMEHYLKDGY--------RL--AQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSE 554 (563)
T ss_pred HHHHHHhccc--------ee--cCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHH
Confidence 1111111111 11 1233467899999999999999999999999988765
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.4e-30 Score=257.16 Aligned_cols=183 Identities=24% Similarity=0.335 Sum_probs=162.1
Q ss_pred HhCCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEehh----------------------hhhhcc---cCceeeEEEEEe
Q 039819 201 TENFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLKD----------------------MISLAV---HRNLLRLIGYCA 254 (534)
Q Consensus 201 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~----------------------~l~~~~---h~niv~l~~~~~ 254 (534)
..+|...+.+|+|+||.|+.|.++ +...|+||.+.+ +|..++ |+||++++++|+
T Consensus 560 ~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFE 639 (772)
T KOG1152|consen 560 FSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFE 639 (772)
T ss_pred cccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheee
Confidence 346888999999999999999986 467789998763 455555 999999999999
Q ss_pred CCCeeEEEeecc-CCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEeccc
Q 039819 255 TPTERLLVYPYM-SNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGL 333 (534)
Q Consensus 255 ~~~~~~lv~e~~-~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGl 333 (534)
+.+.+||+||-- ++-+|++++..++.+++.+...|+.||+.|+++||++ +|||||||-+||.++.+|-+||+|||.
T Consensus 640 ddd~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~---~ivhrdikdenvivd~~g~~klidfgs 716 (772)
T KOG1152|consen 640 DDDYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQ---GIVHRDIKDENVIVDSNGFVKLIDFGS 716 (772)
T ss_pred cCCeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhcccccccc---CceecccccccEEEecCCeEEEeeccc
Confidence 999999999975 5779999999999999999999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCCceeeccccccccccccccccCCC-CcchhHHHHHHHHHHHHhCCCCcC
Q 039819 334 AKLLDHSDSHVTTAVRGTVGHIAPEYLSTGQS-SEKTDVFGFGILLLELITGMRALE 389 (534)
Q Consensus 334 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~k~Dv~S~Gvvl~elltG~~p~~ 389 (534)
|.....+ ....++||.+|.|||++.+.+| +..-|||++||+||.++....||.
T Consensus 717 aa~~ksg---pfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 717 AAYTKSG---PFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred hhhhcCC---CcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 9765443 2456789999999999999887 566899999999999998887774
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-29 Score=240.17 Aligned_cols=246 Identities=23% Similarity=0.306 Sum_probs=183.3
Q ss_pred hCCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEeh----------------hhhhhcccCceeeEEEEEeCC------Ce
Q 039819 202 ENFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLK----------------DMISLAVHRNLLRLIGYCATP------TE 258 (534)
Q Consensus 202 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~----------------~~l~~~~h~niv~l~~~~~~~------~~ 258 (534)
.+|.....+|.|.- .|-.|.+. .++.||+|++. .++..+.|+||++++.+|.-. .+
T Consensus 17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e 95 (369)
T KOG0665|consen 17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE 95 (369)
T ss_pred eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence 45666778888888 55555432 57889998764 267888999999999998533 35
Q ss_pred eEEEeeccCCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecC
Q 039819 259 RLLVYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLD 338 (534)
Q Consensus 259 ~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~ 338 (534)
.|+|||||. ++|...+. -.++-.+..+|+.|++.|+.|||+. +|+||||||+||++..++.+||.|||+|+...
T Consensus 96 ~y~v~e~m~-~nl~~vi~--~elDH~tis~i~yq~~~~ik~lhs~---~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~ 169 (369)
T KOG0665|consen 96 VYLVMELMD-ANLCQVIL--MELDHETISYILYQMLCGIKHLHSA---GIIHRDLKPSNIVVNSDCTLKILDFGLARTED 169 (369)
T ss_pred HHHHHHhhh-hHHHHHHH--HhcchHHHHHHHHHHHHHHHHHHhc---ceeecccCcccceecchhheeeccchhhcccC
Confidence 699999995 48877776 3477788999999999999999999 99999999999999999999999999998654
Q ss_pred CCCCceeeccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHH--------HHHhhh
Q 039819 339 HSDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWV--------KKIQQE 410 (534)
Q Consensus 339 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~--------~~~~~~ 410 (534)
.. ...+.++.|..|.|||++.+..+.+.+||||.||++.||++|+-.|++....++-..+.+.. .++...
T Consensus 170 ~~--~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~ 247 (369)
T KOG0665|consen 170 TD--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPT 247 (369)
T ss_pred cc--cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHH
Confidence 33 45677889999999999988889999999999999999999999998655444333332221 111110
Q ss_pred cc-------------c-ceecccccCC--CCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 411 KK-------------V-EVLVDRELGS--NYDRIEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 411 ~~-------------~-~~~~d~~l~~--~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
.. . +.+-|..... +.+......+.+++.+|+..+|++|-+++++++
T Consensus 248 ~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~ 309 (369)
T KOG0665|consen 248 VRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALR 309 (369)
T ss_pred HHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhc
Confidence 00 0 0001111110 112223456778899999999999999998875
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.3e-28 Score=239.27 Aligned_cols=116 Identities=24% Similarity=0.397 Sum_probs=99.0
Q ss_pred hCCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEehh-------------hhhhcc--------cCceeeEEEEEe----C
Q 039819 202 ENFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLKD-------------MISLAV--------HRNLLRLIGYCA----T 255 (534)
Q Consensus 202 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~-------------~l~~~~--------h~niv~l~~~~~----~ 255 (534)
.+|...+.||-|.|++||+|.+. +.+.||+|+.+. +++.++ -..||+|+++|. .
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGpN 157 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGPN 157 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCCC
Confidence 67889999999999999999875 578899999873 344333 346999999996 4
Q ss_pred CCeeEEEeeccCCCChhhhcc--cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEe
Q 039819 256 PTERLLVYPYMSNGSVASRLR--EKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLL 320 (534)
Q Consensus 256 ~~~~~lv~e~~~~gsL~~~l~--~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl 320 (534)
+.+.+||+|++ |-+|..++. ..+.++...+++|+.||+.||.|||.+| +|||-||||+|||+
T Consensus 158 G~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl 221 (590)
T KOG1290|consen 158 GQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLL 221 (590)
T ss_pred CcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeee
Confidence 56789999999 568888886 3467999999999999999999999998 99999999999999
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.7e-27 Score=222.32 Aligned_cols=195 Identities=35% Similarity=0.549 Sum_probs=171.6
Q ss_pred eccCCcEEEEEEEECC-CcEEEEEEehh---------------hhhhcccCceeeEEEEEeCCCeeEEEeeccCCCChhh
Q 039819 210 LGAGGFGNVYKGKLGD-GTVLAVKRLKD---------------MISLAVHRNLLRLIGYCATPTERLLVYPYMSNGSVAS 273 (534)
Q Consensus 210 lG~G~~g~Vy~~~~~~-~~~vavK~~~~---------------~l~~~~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~ 273 (534)
||+|++|.||++...+ +..+++|.+.. .+..+.|++++++++++......+++|||+++++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 6899999999999864 88999997642 4567789999999999999999999999999999999
Q ss_pred hcccC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCC-CCcEEEEecccceecCCCCCceeeccccc
Q 039819 274 RLREK-PALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDD-FCEAIVGDFGLAKLLDHSDSHVTTAVRGT 351 (534)
Q Consensus 274 ~l~~~-~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~-~~~~kl~DFGla~~~~~~~~~~~~~~~gt 351 (534)
++... ..+++..+..++.++++++.|||+. +++|+||+|.||+++. ++.++|+|||.+........ ......+.
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~ 156 (215)
T cd00180 81 LLKENEGKLSEDEILRILLQILEGLEYLHSN---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-LLKTIVGT 156 (215)
T ss_pred HHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-hhhcccCC
Confidence 98765 5789999999999999999999999 9999999999999999 89999999999987654321 12234578
Q ss_pred cccccccccccC-CCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceecccccCCCCCHHHH
Q 039819 352 VGHIAPEYLSTG-QSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELGSNYDRIEV 430 (534)
Q Consensus 352 ~~y~aPE~~~~~-~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 430 (534)
..|++||..... ..+.+.|+|++|+++++|
T Consensus 157 ~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l------------------------------------------------- 187 (215)
T cd00180 157 PAYMAPEVLLGKGYYSEKSDIWSLGVILYEL------------------------------------------------- 187 (215)
T ss_pred CCccChhHhcccCCCCchhhhHHHHHHHHHH-------------------------------------------------
Confidence 899999998776 788999999999999999
Q ss_pred HHHHHHHHHhcccCCCCCCChHHHHHH
Q 039819 431 GEILQVALLCTQYLPVHRPKMSEVVRM 457 (534)
Q Consensus 431 ~~l~~l~~~Cl~~~P~~RPt~~ev~~~ 457 (534)
..+.+++..|++.+|.+||++.++++.
T Consensus 188 ~~~~~~l~~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 188 PELKDLIRKMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence 377899999999999999999999864
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.2e-28 Score=221.50 Aligned_cols=246 Identities=19% Similarity=0.298 Sum_probs=179.3
Q ss_pred HhCCCcCCeeccCCcEEEEEEEE-CCCcEEEEEEehh-----------hhhhcc-cCceeeEEEEEeCCC--eeEEEeec
Q 039819 201 TENFSSKNILGAGGFGNVYKGKL-GDGTVLAVKRLKD-----------MISLAV-HRNLLRLIGYCATPT--ERLLVYPY 265 (534)
Q Consensus 201 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~-----------~l~~~~-h~niv~l~~~~~~~~--~~~lv~e~ 265 (534)
.++|++.+.+|+|.|++||.|.. .++..++||.++. ++..++ ||||+++++...++. ...||+||
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiFE~ 116 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIFEY 116 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHhhh
Confidence 35778888999999999999974 5778889998862 455555 999999999998775 45799999
Q ss_pred cCCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCC-CCcEEEEecccceecCCCCCce
Q 039819 266 MSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDD-FCEAIVGDFGLAKLLDHSDSHV 344 (534)
Q Consensus 266 ~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~-~~~~kl~DFGla~~~~~~~~~~ 344 (534)
+.+.+..... +.++...+..++.+++.||.|+|++ ||+|||+||.|+++|. .-..+|+|+|+|-+......
T Consensus 117 v~n~Dfk~ly---~tl~d~dIryY~~elLkALdyCHS~---GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~e-- 188 (338)
T KOG0668|consen 117 VNNTDFKQLY---PTLTDYDIRYYIYELLKALDYCHSM---GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE-- 188 (338)
T ss_pred hccccHHHHh---hhhchhhHHHHHHHHHHHHhHHHhc---CcccccCCcceeeechhhceeeeeecchHhhcCCCce--
Confidence 9987765544 4577788899999999999999999 9999999999999995 45689999999998754432
Q ss_pred eecccccccccccccccc-CCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhh------cccceec
Q 039819 345 TTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQE------KKVEVLV 417 (534)
Q Consensus 345 ~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~ 417 (534)
....+.+..|.-||.+-. ..|+..-|+|||||++..|+..+.||-.+.+... .++..++.+... .+...-+
T Consensus 189 YnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~D--QLVkIakVLGt~el~~Yl~KY~i~L 266 (338)
T KOG0668|consen 189 YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYD--QLVKIAKVLGTDELYAYLNKYQIDL 266 (338)
T ss_pred eeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHH--HHHHHHHHhChHHHHHHHHHHccCC
Confidence 334456889999999865 4478889999999999999999999976654322 222222221111 0111112
Q ss_pred ccccCC---C-------------CCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 418 DRELGS---N-------------YDRIEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 418 d~~l~~---~-------------~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
|++... . .......+.++++.+.+..|-++|||++|.+.
T Consensus 267 dp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~ 321 (338)
T KOG0668|consen 267 DPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA 321 (338)
T ss_pred ChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence 222211 0 11112346777777777777788887777653
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1e-28 Score=253.22 Aligned_cols=238 Identities=23% Similarity=0.289 Sum_probs=190.4
Q ss_pred HhCCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEehh--------------hhhhcccCceeeEEEEEeCCCeeEEEeec
Q 039819 201 TENFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLKD--------------MISLAVHRNLLRLIGYCATPTERLLVYPY 265 (534)
Q Consensus 201 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~--------------~l~~~~h~niv~l~~~~~~~~~~~lv~e~ 265 (534)
.++|.....+|+|.||.||||+.. .++..|||.++- +++..+|||||.++|.+...+..++.|||
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEy 93 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEY 93 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEe
Confidence 467888899999999999999974 688889998761 67888999999999999999999999999
Q ss_pred cCCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCCcee
Q 039819 266 MSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVT 345 (534)
Q Consensus 266 ~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~ 345 (534)
|.+|+|.+.-+-.+++++.++....+...+|++|||++ +=+|||||-.|||+++.|.+|++|||.+......- ...
T Consensus 94 cgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~---gk~hRdiKGanilltd~gDvklaDfgvsaqitati-~Kr 169 (829)
T KOG0576|consen 94 CGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQ---GKIHRDIKGANILLTDEGDVKLADFGVSAQITATI-AKR 169 (829)
T ss_pred cCCCcccceeeecccchhHHHHHHHhhhhccchhhhcC---CcccccccccceeecccCceeecccCchhhhhhhh-hhh
Confidence 99999999999889999999999999999999999999 88999999999999999999999999987654321 123
Q ss_pred ecccccccccccccc---ccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceeccc-cc
Q 039819 346 TAVRGTVGHIAPEYL---STGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDR-EL 421 (534)
Q Consensus 346 ~~~~gt~~y~aPE~~---~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~-~l 421 (534)
..+.||+.|||||+. ..+.|..++|||+.|+...|+-.-++|...-.. ++-...... ..+++ .+
T Consensus 170 ksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhp-------mr~l~LmTk-----S~~qpp~l 237 (829)
T KOG0576|consen 170 KSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHP-------MRALFLMTK-----SGFQPPTL 237 (829)
T ss_pred hcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccch-------HHHHHHhhc-----cCCCCCcc
Confidence 456799999999987 456789999999999999999887777531111 111111111 11111 11
Q ss_pred CCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 422 GSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 422 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
.. ...-...+.++++.|+..+|++||+++.++.
T Consensus 238 kD--k~kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 238 KD--KTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred cC--CccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 11 1112347889999999999999999987764
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.4e-27 Score=223.35 Aligned_cols=184 Identities=31% Similarity=0.474 Sum_probs=160.7
Q ss_pred CCcCCeeccCCcEEEEEEEECC-CcEEEEEEehh---------------hhhhcccCceeeEEEEEeCCCeeEEEeeccC
Q 039819 204 FSSKNILGAGGFGNVYKGKLGD-GTVLAVKRLKD---------------MISLAVHRNLLRLIGYCATPTERLLVYPYMS 267 (534)
Q Consensus 204 ~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~---------------~l~~~~h~niv~l~~~~~~~~~~~lv~e~~~ 267 (534)
|...+.||+|++|.||++...+ +..+|+|.+.. .+..++|+|++++++++......++++||++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 4556789999999999999875 88999998752 4566789999999999999999999999999
Q ss_pred CCChhhhcccCCC-CCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCCceee
Q 039819 268 NGSVASRLREKPA-LDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTT 346 (534)
Q Consensus 268 ~gsL~~~l~~~~~-l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~ 346 (534)
+++|.+++..... +++..+..++.+++.++.|||+. +++|+||+|+||+++.++.++|+|||.+............
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~~ 157 (225)
T smart00221 81 GGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSL---GIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALLK 157 (225)
T ss_pred CCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeCceeeEecCccccccc
Confidence 9999999987666 89999999999999999999998 9999999999999999999999999999877543211223
Q ss_pred cccccccccccccc-ccCCCCcchhHHHHHHHHHHHHhCCCCcCC
Q 039819 347 AVRGTVGHIAPEYL-STGQSSEKTDVFGFGILLLELITGMRALEF 390 (534)
Q Consensus 347 ~~~gt~~y~aPE~~-~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~ 390 (534)
...++..|++||.. ....++.++|||+||++++||++|+.||+.
T Consensus 158 ~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 158 TVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred ceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 34578899999998 666778899999999999999999999963
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.9e-28 Score=223.37 Aligned_cols=253 Identities=18% Similarity=0.279 Sum_probs=186.2
Q ss_pred HHhCCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEehh--------------hhhhcccCceeeEEEE-EeCCCeeEEEe
Q 039819 200 ATENFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLKD--------------MISLAVHRNLLRLIGY-CATPTERLLVY 263 (534)
Q Consensus 200 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~--------------~l~~~~h~niv~l~~~-~~~~~~~~lv~ 263 (534)
..+.|.+.+.+|+|.||.+-+++.+ ..+.+++|-+.+ -+....|.||+.-+++ |+..+.+++++
T Consensus 22 l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~q 101 (378)
T KOG1345|consen 22 LEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQ 101 (378)
T ss_pred hhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEee
Confidence 3467888899999999999999986 567899997653 1223348999987764 56677888999
Q ss_pred eccCCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeC--CCCcEEEEecccceecCCCC
Q 039819 264 PYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLD--DFCEAIVGDFGLAKLLDHSD 341 (534)
Q Consensus 264 e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~--~~~~~kl~DFGla~~~~~~~ 341 (534)
||++.|+|.+.+...+ +-+....+++.|+++||.|+|++ ++||||||.+|||+- +...+|+||||+.+..+..
T Consensus 102 E~aP~gdL~snv~~~G-igE~~~K~v~~ql~SAi~fMHsk---nlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~t- 176 (378)
T KOG1345|consen 102 EFAPRGDLRSNVEAAG-IGEANTKKVFAQLLSAIEFMHSK---NLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTT- 176 (378)
T ss_pred ccCccchhhhhcCccc-ccHHHHHHHHHHHHHHHHHhhcc---chhhcccccceEEEecCCccEEEeeecccccccCce-
Confidence 9999999999887643 77888899999999999999999 999999999999993 4568999999999865432
Q ss_pred Cceeecccccccccccccccc---C--CCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhccccee
Q 039819 342 SHVTTAVRGTVGHIAPEYLST---G--QSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVL 416 (534)
Q Consensus 342 ~~~~~~~~gt~~y~aPE~~~~---~--~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 416 (534)
.....-+..|.|||.... + ...+.+|||.|||+++.++||+.||.-.... .....+|..-.....
T Consensus 177 ---V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~--d~~Y~~~~~w~~rk~----- 246 (378)
T KOG1345|consen 177 ---VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIM--DKPYWEWEQWLKRKN----- 246 (378)
T ss_pred ---ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhcc--CchHHHHHHHhcccC-----
Confidence 122234678999997642 2 2467899999999999999999999833222 122334433222111
Q ss_pred cccccCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhcCCchhhHHhh
Q 039819 417 VDRELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLEGDGLAEKWAAA 470 (534)
Q Consensus 417 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~~~~~~~~~~~ 470 (534)
+.+...+ ....+.+.++..+-+..+|++|-...++.++........++.+.
T Consensus 247 --~~~P~~F-~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~E~~i~t~ 297 (378)
T KOG1345|consen 247 --PALPKKF-NPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWKEKLIKTV 297 (378)
T ss_pred --ccCchhh-cccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHHHHhhhccc
Confidence 1111111 12345788889999999999998888888776655544444433
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=4e-28 Score=274.21 Aligned_cols=196 Identities=15% Similarity=0.141 Sum_probs=141.3
Q ss_pred hhhccc-CceeeEEEEE-------eCCCeeEEEeeccCCCChhhhccc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCe
Q 039819 238 ISLAVH-RNLLRLIGYC-------ATPTERLLVYPYMSNGSVASRLRE-KPALDWNTRKRIAIGAARGLLYLHEQCDPKI 308 (534)
Q Consensus 238 l~~~~h-~niv~l~~~~-------~~~~~~~lv~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~i 308 (534)
.+...| +||++++++| ...+..++++||+ +++|.+++.. ...+++.+++.|+.||++||.|||++ +|
T Consensus 26 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~---gI 101 (793)
T PLN00181 26 SKSLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQ---GI 101 (793)
T ss_pred cchhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhC---Ce
Confidence 445667 6899999988 2334567888987 5699999975 45699999999999999999999998 99
Q ss_pred EeccCCCCcEEeCC-------------------CCcEEEEecccceecCCCC---------------Cceeecccccccc
Q 039819 309 IHRDVKAANVLLDD-------------------FCEAIVGDFGLAKLLDHSD---------------SHVTTAVRGTVGH 354 (534)
Q Consensus 309 vH~Dlkp~NiLl~~-------------------~~~~kl~DFGla~~~~~~~---------------~~~~~~~~gt~~y 354 (534)
|||||||+||||+. ++.+||+|||+++...... ........||+.|
T Consensus 102 vHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y 181 (793)
T PLN00181 102 VVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWY 181 (793)
T ss_pred eeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcce
Confidence 99999999999954 4456666666665321100 0001124588999
Q ss_pred ccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceecccccCCCCCHHHHHHHH
Q 039819 355 IAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELGSNYDRIEVGEIL 434 (534)
Q Consensus 355 ~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~ 434 (534)
||||++.+..++.++|||||||+||||++|..|+.... ......... ...+.. ........
T Consensus 182 ~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~---------~~~~~~~~~-----~~~~~~-----~~~~~~~~ 242 (793)
T PLN00181 182 TSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS---------RTMSSLRHR-----VLPPQI-----LLNWPKEA 242 (793)
T ss_pred EChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH---------HHHHHHHHh-----hcChhh-----hhcCHHHH
Confidence 99999999999999999999999999999988864211 011111000 001110 01123456
Q ss_pred HHHHHhcccCCCCCCChHHHHH
Q 039819 435 QVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 435 ~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
.++.+|++.+|.+||+|.|+++
T Consensus 243 ~~~~~~L~~~P~~Rps~~eil~ 264 (793)
T PLN00181 243 SFCLWLLHPEPSCRPSMSELLQ 264 (793)
T ss_pred HHHHHhCCCChhhCcChHHHhh
Confidence 7888999999999999999975
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.7e-26 Score=212.94 Aligned_cols=165 Identities=18% Similarity=0.177 Sum_probs=125.6
Q ss_pred CChhhhccc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCCceeec
Q 039819 269 GSVASRLRE-KPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTA 347 (534)
Q Consensus 269 gsL~~~l~~-~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~ 347 (534)
|+|.+++.. ...++|.+++.|+.|++.||.|||++ + ||+|||++.++.+|+ ||+++......
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~---~------kp~Nil~~~~~~~~~--fG~~~~~~~~~------ 63 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQ---A------KSGNILLTWDGLLKL--DGSVAFKTPEQ------ 63 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhc---C------CcccEeEcCccceee--ccceEeecccc------
Confidence 689999976 45699999999999999999999998 4 999999999999999 99998765422
Q ss_pred cccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceecccccCCCCCH
Q 039819 348 VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELGSNYDR 427 (534)
Q Consensus 348 ~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 427 (534)
..||+.|||||++.+..++.++|||||||++|||+||+.||....... ..+..+....... ++... ....
T Consensus 64 ~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~--~~~~~~~~~~~~~-------~~~~~-~~~~ 133 (176)
T smart00750 64 SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELS--AILEILLNGMPAD-------DPRDR-SNLE 133 (176)
T ss_pred CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhc--HHHHHHHHHhccC-------Ccccc-ccHH
Confidence 258999999999999999999999999999999999999986432111 1111221111110 00000 0111
Q ss_pred HHHH--HHHHHHHHhcccCCCCCCChHHHHHHhhc
Q 039819 428 IEVG--EILQVALLCTQYLPVHRPKMSEVVRMLEG 460 (534)
Q Consensus 428 ~~~~--~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~ 460 (534)
.... .+.+++.+|++.+|.+||++.|+++.+..
T Consensus 134 ~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~ 168 (176)
T smart00750 134 SVSAARSFADFMRVCASRLPQRREAANHYLAHCRA 168 (176)
T ss_pred HHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHH
Confidence 2222 68999999999999999999999987654
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.2e-28 Score=239.99 Aligned_cols=185 Identities=21% Similarity=0.234 Sum_probs=156.5
Q ss_pred HhCCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEehh-------------hhhhcc------cCceeeEEEEEeCCCeeE
Q 039819 201 TENFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLKD-------------MISLAV------HRNLLRLIGYCATPTERL 260 (534)
Q Consensus 201 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~-------------~l~~~~------h~niv~l~~~~~~~~~~~ 260 (534)
-.+|......|+|-|++|.+|... .|..||||++.+ +|+++. --++++++-.|....++|
T Consensus 431 D~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknHLC 510 (752)
T KOG0670|consen 431 DSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNHLC 510 (752)
T ss_pred cceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcceeE
Confidence 357888888999999999999875 477999999973 455554 347888988899999999
Q ss_pred EEeeccCCCChhhhcccC---CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCC-CcEEEEeccccee
Q 039819 261 LVYPYMSNGSVASRLREK---PALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDF-CEAIVGDFGLAKL 336 (534)
Q Consensus 261 lv~e~~~~gsL~~~l~~~---~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~-~~~kl~DFGla~~ 336 (534)
||||-+. .+|.++|++. -.|....+..++.|+.-||..|-.. +|+|.||||+|||+++. ...||||||.|.+
T Consensus 511 lVFE~Ls-lNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c---~vlHaDIKPDNiLVNE~k~iLKLCDfGSA~~ 586 (752)
T KOG0670|consen 511 LVFEPLS-LNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKC---GVLHADIKPDNILVNESKNILKLCDFGSASF 586 (752)
T ss_pred EEehhhh-chHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhc---CeeecccCccceEeccCcceeeeccCccccc
Confidence 9999884 5899999753 3588889999999999999999986 99999999999999875 4679999999987
Q ss_pred cCCCCCceeeccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCc
Q 039819 337 LDHSDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGK 392 (534)
Q Consensus 337 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~ 392 (534)
..... .+.+.-+..|.|||++.+-+|+...|+||.||+||||.||+-.|++..
T Consensus 587 ~~ene---itPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~T 639 (752)
T KOG0670|consen 587 ASENE---ITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRT 639 (752)
T ss_pred ccccc---ccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCC
Confidence 75432 233445778999999999999999999999999999999999998654
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.2e-26 Score=224.04 Aligned_cols=188 Identities=25% Similarity=0.386 Sum_probs=153.4
Q ss_pred HHHHHhCCCcCCeeccCCcEEEEEEEEC----CCcEEEEEEehh------------hhh-hcccCceeeEEEEEeCCCee
Q 039819 197 LQQATENFSSKNILGAGGFGNVYKGKLG----DGTVLAVKRLKD------------MIS-LAVHRNLLRLIGYCATPTER 259 (534)
Q Consensus 197 l~~~~~~~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~------------~l~-~~~h~niv~l~~~~~~~~~~ 259 (534)
+....+.|...++||+|.|++||+|.+. ..+.||+|.+.. ++. ...+.||+++.+++...+..
T Consensus 31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v 110 (418)
T KOG1167|consen 31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQV 110 (418)
T ss_pred hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCchHHHHHHHHHHHhccchhhhcchhhhccCCee
Confidence 3345567888999999999999999863 467899998852 333 33489999999999999999
Q ss_pred EEEeeccCCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCC-CCcEEEEecccceecC
Q 039819 260 LLVYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDD-FCEAIVGDFGLAKLLD 338 (534)
Q Consensus 260 ~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~-~~~~kl~DFGla~~~~ 338 (534)
.+|+||++.-...++... ++...+..++..+..||.++|.+ +||||||||+|+|.+. .+.-.|.|||+|....
T Consensus 111 ~ivlp~~~H~~f~~l~~~---l~~~~i~~Yl~~ll~Al~~~h~~---GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d 184 (418)
T KOG1167|consen 111 AIVLPYFEHDRFRDLYRS---LSLAEIRWYLRNLLKALAHLHKN---GIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYD 184 (418)
T ss_pred EEEecccCccCHHHHHhc---CCHHHHHHHHHHHHHHhhhhhcc---CccccCCCccccccccccCCceEEechhHHHHH
Confidence 999999999888777754 56888999999999999999999 9999999999999985 4667899999997211
Q ss_pred CC------C-------------------------------------Cceeecccccccccccccccc-CCCCcchhHHHH
Q 039819 339 HS------D-------------------------------------SHVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGF 374 (534)
Q Consensus 339 ~~------~-------------------------------------~~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~S~ 374 (534)
.. . .......+||+||+|||++.. ...++++||||-
T Consensus 185 ~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~ 264 (418)
T KOG1167|consen 185 GYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSA 264 (418)
T ss_pred hhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeec
Confidence 00 0 000123469999999999865 446899999999
Q ss_pred HHHHHHHHhCCCCcCC
Q 039819 375 GILLLELITGMRALEF 390 (534)
Q Consensus 375 Gvvl~elltG~~p~~~ 390 (534)
|||++-+++++.||-.
T Consensus 265 GVI~Lslls~~~PFf~ 280 (418)
T KOG1167|consen 265 GVILLSLLSRRYPFFK 280 (418)
T ss_pred cceeehhhcccccccc
Confidence 9999999999999864
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.3e-22 Score=205.68 Aligned_cols=151 Identities=23% Similarity=0.214 Sum_probs=118.5
Q ss_pred HHhCCCcCCeeccCCcEEEEEEEEC--CCcEEEEEEeh-------------------hhhhhcccCceeeEEEEEeCCCe
Q 039819 200 ATENFSSKNILGAGGFGNVYKGKLG--DGTVLAVKRLK-------------------DMISLAVHRNLLRLIGYCATPTE 258 (534)
Q Consensus 200 ~~~~~~~~~~lG~G~~g~Vy~~~~~--~~~~vavK~~~-------------------~~l~~~~h~niv~l~~~~~~~~~ 258 (534)
..++|...+.||+|+||.||+|... +++.||||++. +++..+.|+|+++.+.. ...
T Consensus 16 ~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---~~~ 92 (365)
T PRK09188 16 LSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---TGK 92 (365)
T ss_pred ccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---cCC
Confidence 3467899999999999999999874 57788999742 16778889999853322 245
Q ss_pred eEEEeeccCCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccC-CCCcEEeCCCCcEEEEecccceec
Q 039819 259 RLLVYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDV-KAANVLLDDFCEAIVGDFGLAKLL 337 (534)
Q Consensus 259 ~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dl-kp~NiLl~~~~~~kl~DFGla~~~ 337 (534)
.++||||+++++|... .... ...++.++++||.|||+. +|+|||| ||+|||++.++.+||+|||+|+.+
T Consensus 93 ~~LVmE~~~G~~L~~~-~~~~------~~~~~~~i~~aL~~lH~~---gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~~ 162 (365)
T PRK09188 93 DGLVRGWTEGVPLHLA-RPHG------DPAWFRSAHRALRDLHRA---GITHNDLAKPQNWLMGPDGEAAVIDFQLASVF 162 (365)
T ss_pred cEEEEEccCCCCHHHh-Cccc------hHHHHHHHHHHHHHHHHC---CCeeCCCCCcceEEEcCCCCEEEEECccceec
Confidence 7999999999999732 1111 146788999999999998 9999999 999999999999999999999977
Q ss_pred CCCCCce-------eeccccccccccccccccC
Q 039819 338 DHSDSHV-------TTAVRGTVGHIAPEYLSTG 363 (534)
Q Consensus 338 ~~~~~~~-------~~~~~gt~~y~aPE~~~~~ 363 (534)
....... .....+++.|+|||++...
T Consensus 163 ~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 163 RRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred ccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence 5432111 1345688899999998643
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.1e-21 Score=198.75 Aligned_cols=241 Identities=21% Similarity=0.258 Sum_probs=179.8
Q ss_pred CCCcCCeeccCCcEEEEEEEECCC--cEEEEEEehh--------------hhhhcc----cCceeeEEEEE-eCCCeeEE
Q 039819 203 NFSSKNILGAGGFGNVYKGKLGDG--TVLAVKRLKD--------------MISLAV----HRNLLRLIGYC-ATPTERLL 261 (534)
Q Consensus 203 ~~~~~~~lG~G~~g~Vy~~~~~~~--~~vavK~~~~--------------~l~~~~----h~niv~l~~~~-~~~~~~~l 261 (534)
+|...+.||+|+||.||.+..... ..+|+|.... .+..+. -+++..+++.. ......++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 788999999999999999997653 5788887653 223332 25788888888 47778899
Q ss_pred EeeccCCCChhhhccc--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCC-----CcEEEEecccc
Q 039819 262 VYPYMSNGSVASRLRE--KPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDF-----CEAIVGDFGLA 334 (534)
Q Consensus 262 v~e~~~~gsL~~~l~~--~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~-----~~~kl~DFGla 334 (534)
||+.+ |.+|.++... .+.++..+..+|+.|++.+|.++|+. ++|||||||+|+++... ..+.|.|||++
T Consensus 99 VM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~---G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGla 174 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSK---GFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLA 174 (322)
T ss_pred EEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhc---CcccCCcCHHHeeecCCCCcccceEEEEecCCC
Confidence 99988 6799987753 35799999999999999999999999 99999999999999865 46899999999
Q ss_pred eecC--CCCCc------e-eeccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHH
Q 039819 335 KLLD--HSDSH------V-TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVK 405 (534)
Q Consensus 335 ~~~~--~~~~~------~-~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~ 405 (534)
+... ..... . ....+||..|.++....+...+.+.|+||++.++.|++.|..||.......... . +.
T Consensus 175 r~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~---~-~~ 250 (322)
T KOG1164|consen 175 RRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKS---K-FE 250 (322)
T ss_pred ccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHH---H-HH
Confidence 8322 11110 1 234569999999999999999999999999999999999999996433221111 1 11
Q ss_pred HHhhhcccceecccccCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhc
Q 039819 406 KIQQEKKVEVLVDRELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLEG 460 (534)
Q Consensus 406 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~ 460 (534)
........ .. .....+..+.++...+-..+..++|....+...++.
T Consensus 251 ~~~~~~~~----~~-----~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~ 296 (322)
T KOG1164|consen 251 KDPRKLLT----DR-----FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKD 296 (322)
T ss_pred HHhhhhcc----cc-----ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHH
Confidence 11111000 00 111223466777777777999999999999988654
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.88 E-value=3e-21 Score=193.18 Aligned_cols=244 Identities=27% Similarity=0.379 Sum_probs=184.8
Q ss_pred CCcCCeeccCCcEEEEEEEECCCcEEEEEEehh-----------------hhhhcccC-ceeeEEEEEeCCCeeEEEeec
Q 039819 204 FSSKNILGAGGFGNVYKGKLGDGTVLAVKRLKD-----------------MISLAVHR-NLLRLIGYCATPTERLLVYPY 265 (534)
Q Consensus 204 ~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~-----------------~l~~~~h~-niv~l~~~~~~~~~~~lv~e~ 265 (534)
|.....||.|+||.||++... ..+|+|.+.. .+..+.|+ +++++.+++......+++++|
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 556678999999999999987 7788887752 45667777 799999999777778999999
Q ss_pred cCCCChhhhcccCC---CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCC-cEEEEecccceecCCCC
Q 039819 266 MSNGSVASRLREKP---ALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFC-EAIVGDFGLAKLLDHSD 341 (534)
Q Consensus 266 ~~~gsL~~~l~~~~---~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~-~~kl~DFGla~~~~~~~ 341 (534)
+.++++.+.+.... .+.......++.+++.++.|+|+. +++|||+||+||+++... .++++|||.++......
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~---~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~ 156 (384)
T COG0515 80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG 156 (384)
T ss_pred CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence 99999997776654 789999999999999999999999 899999999999999988 79999999998665433
Q ss_pred Cc-----eeecccccccccccccccc---CCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhccc
Q 039819 342 SH-----VTTAVRGTVGHIAPEYLST---GQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKV 413 (534)
Q Consensus 342 ~~-----~~~~~~gt~~y~aPE~~~~---~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 413 (534)
.. ......||..|+|||.+.. ..++...|+||+|++++++++|..||...............+......
T Consensus 157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~--- 233 (384)
T COG0515 157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTP--- 233 (384)
T ss_pred ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCc---
Confidence 21 2356679999999999987 578899999999999999999999976433210001111111111100
Q ss_pred ceecccccCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 039819 414 EVLVDRELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRM 457 (534)
Q Consensus 414 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~ 457 (534)
.................+.+++..|+..+|..|.++.+....
T Consensus 234 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 234 --SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred --ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 000000000001223477889999999999999999887764
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.87 E-value=4e-23 Score=222.70 Aligned_cols=239 Identities=21% Similarity=0.236 Sum_probs=179.1
Q ss_pred CcCCeeccCCcEEEEEEEEC-CCcEEEEEEeh----h----------------hhhhcccCceeeEEEEEeCCCeeEEEe
Q 039819 205 SSKNILGAGGFGNVYKGKLG-DGTVLAVKRLK----D----------------MISLAVHRNLLRLIGYCATPTERLLVY 263 (534)
Q Consensus 205 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~----~----------------~l~~~~h~niv~l~~~~~~~~~~~lv~ 263 (534)
...+++|.|++|.|+..... .....+.|... . +-..+.|+|++..+..+.+....+-+|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 35678999999988777542 22222333211 1 234567999988887777777777779
Q ss_pred eccCCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCC-
Q 039819 264 PYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDS- 342 (534)
Q Consensus 264 e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~- 342 (534)
|||++ +|+..+.....+...++--++.|+..|+.|+|+. +|.|||+|++|+++..+|.+||+|||.+........
T Consensus 401 E~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~---GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~ 476 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSM---GLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEK 476 (601)
T ss_pred hcccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhc---CceeccCccccEEEecCCceEEeecCcceeeccCcch
Confidence 99999 9999998887899999999999999999999999 999999999999999999999999999986643322
Q ss_pred --ceeeccccccccccccccccCCCCcc-hhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceeccc
Q 039819 343 --HVTTAVRGTVGHIAPEYLSTGQSSEK-TDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDR 419 (534)
Q Consensus 343 --~~~~~~~gt~~y~aPE~~~~~~~~~k-~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 419 (534)
......+|+..|+|||.+.+..|.+. .||||.|||+..|++|+.||......+... . ...........
T Consensus 477 ~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~------~---~~~~~~~~~~~ 547 (601)
T KOG0590|consen 477 NIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSF------K---TNNYSDQRNIF 547 (601)
T ss_pred hhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccch------h---hhccccccccc
Confidence 45566789999999999999998764 799999999999999999997654332211 0 00000000000
Q ss_pred ccCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 420 ELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 420 ~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
.-........+.+...++.++++++|.+|-||++|++
T Consensus 548 ~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 548 EGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred cChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 0001112334567788999999999999999999986
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.1e-22 Score=188.95 Aligned_cols=230 Identities=23% Similarity=0.352 Sum_probs=172.4
Q ss_pred CeeccCCcEEEEEEEECCCcEEEEEEeh----------------hhhhhcccCceeeEEEEEeCCCeeEEEeeccCCCCh
Q 039819 208 NILGAGGFGNVYKGKLGDGTVLAVKRLK----------------DMISLAVHRNLLRLIGYCATPTERLLVYPYMSNGSV 271 (534)
Q Consensus 208 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~----------------~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 271 (534)
..|.+...|+.|+|++..+..| +|++. ..+....||||+.++|.|..+....+|..||+.|+|
T Consensus 196 tkl~e~hsgelwrgrwqgndiv-akil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gsl 274 (448)
T KOG0195|consen 196 TKLAESHSGELWRGRWQGNDIV-AKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGSL 274 (448)
T ss_pred hhhccCCCcccccccccCcchh-hhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchHH
Confidence 4588899999999999766544 35443 145667799999999999999999999999999999
Q ss_pred hhhcccCC--CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCCceeeccc
Q 039819 272 ASRLREKP--ALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVR 349 (534)
Q Consensus 272 ~~~l~~~~--~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 349 (534)
+..++++. ..+-.+..+++.++|+|++|||+. ++-|.---|.+..|++|++.+++|+ .+-+++.- ......
T Consensus 275 ynvlhe~t~vvvd~sqav~faldiargmaflhsl-ep~ipr~~lns~hvmidedltaris-mad~kfsf-----qe~gr~ 347 (448)
T KOG0195|consen 275 YNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSL-EPMIPRFYLNSKHVMIDEDLTARIS-MADTKFSF-----QEVGRA 347 (448)
T ss_pred HHHHhcCccEEEecchHHHHHHHHHhhHHHHhhc-chhhhhhhcccceEEecchhhhhee-cccceeee-----eccccc
Confidence 99999764 367788999999999999999997 4444455689999999999999874 22222211 111122
Q ss_pred cccccccccccccCCCC---cchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceecccccCCCCC
Q 039819 350 GTVGHIAPEYLSTGQSS---EKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELGSNYD 426 (534)
Q Consensus 350 gt~~y~aPE~~~~~~~~---~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 426 (534)
-.+.||+||.++..+.+ ..+|+|||.|++||+.|...||..-+..+.. ..+.. ..++-..+
T Consensus 348 y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecg-------mkial---------eglrv~ip 411 (448)
T KOG0195|consen 348 YSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECG-------MKIAL---------EGLRVHIP 411 (448)
T ss_pred cCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhh-------hhhhh---------ccccccCC
Confidence 36889999999876643 4689999999999999999999643321111 11111 11222334
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhcC
Q 039819 427 RIEVGEILQVALLCTQYLPVHRPKMSEVVRMLEGD 461 (534)
Q Consensus 427 ~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~~ 461 (534)
......+.+++.-|...||.+||.+..|+-.|+..
T Consensus 412 pgis~hm~klm~icmnedpgkrpkfdmivpilekm 446 (448)
T KOG0195|consen 412 PGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKM 446 (448)
T ss_pred CCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHh
Confidence 44456889999999999999999999999888753
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.1e-21 Score=179.53 Aligned_cols=244 Identities=19% Similarity=0.229 Sum_probs=178.8
Q ss_pred hCCCcCCeeccCCcEEEEEEE-ECCCcEEEEEEehh------------hhhhccc-CceeeEEEEEeCCCeeEEEeeccC
Q 039819 202 ENFSSKNILGAGGFGNVYKGK-LGDGTVLAVKRLKD------------MISLAVH-RNLLRLIGYCATPTERLLVYPYMS 267 (534)
Q Consensus 202 ~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~------------~l~~~~h-~niv~l~~~~~~~~~~~lv~e~~~ 267 (534)
+.|...+.||+|+||.+|.|. ..+|..||||.... +...+++ ..|..+.-|..+...-.+|||.+
T Consensus 15 gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMdLL- 93 (341)
T KOG1163|consen 15 GKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMDLL- 93 (341)
T ss_pred cceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCCcchhHHHHHHHHhccCCCCchhhhhccccccceeeeecc-
Confidence 578889999999999999997 47899999998863 2222222 34455666777888889999998
Q ss_pred CCChhhhcc-cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCC---CcEEEEecccceecCCCCCc
Q 039819 268 NGSVASRLR-EKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDF---CEAIVGDFGLAKLLDHSDSH 343 (534)
Q Consensus 268 ~gsL~~~l~-~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~---~~~kl~DFGla~~~~~~~~~ 343 (534)
|.+|.+... -...++..+++-++-|++.-++|+|.+ ++|||||||+|+|..-+ ..+.++|||+|+...+....
T Consensus 94 GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r---~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~t~ 170 (341)
T KOG1163|consen 94 GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLR---NFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIRTR 170 (341)
T ss_pred CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhh---ccccccCCccceeeccccccceEEEEeccchhhhcccccc
Confidence 779998886 345689999999999999999999999 89999999999999643 45789999999977543221
Q ss_pred ------eeeccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceec
Q 039819 344 ------VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLV 417 (534)
Q Consensus 344 ------~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 417 (534)
......||..|.+-....+...+.+.|+-|+|.||.+...|..||.+-....... . ...+.+ .++...+
T Consensus 171 ~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~Q---K-yEkI~E-kK~s~~i 245 (341)
T KOG1163|consen 171 QHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQ---K-YEKISE-KKMSTPI 245 (341)
T ss_pred ccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHH---H-HHHHHH-hhcCCCH
Confidence 2234679999999877777777889999999999999999999998533221110 0 111111 1111100
Q ss_pred ccccCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhh
Q 039819 418 DRELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLE 459 (534)
Q Consensus 418 d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~ 459 (534)
. . .-...+.++...+.-|-..--++-|...-+.+.+.
T Consensus 246 e-~----LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFr 282 (341)
T KOG1163|consen 246 E-V----LCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFR 282 (341)
T ss_pred H-H----HhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHH
Confidence 0 0 11112457888888999999999998766655443
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=5.2e-21 Score=197.47 Aligned_cols=213 Identities=24% Similarity=0.378 Sum_probs=162.4
Q ss_pred hhhcccCceeeEEEEEeCCCeeEEEeeccCCCChhhhccc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCe-EeccCCC
Q 039819 238 ISLAVHRNLLRLIGYCATPTERLLVYPYMSNGSVASRLRE-KPALDWNTRKRIAIGAARGLLYLHEQCDPKI-IHRDVKA 315 (534)
Q Consensus 238 l~~~~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~i-vH~Dlkp 315 (534)
++.+.|.|+.+++|.+.++...+.|.+||..|+|.+.+.. ...++|.....++.+++.||.|+|+. +| .|+.+++
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s---~i~~hg~l~s 77 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNS---PIGYHGALKS 77 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcC---cceeeeeecc
Confidence 3567899999999999999999999999999999999986 56799999999999999999999987 55 9999999
Q ss_pred CcEEeCCCCcEEEEecccceecCCC-CCceeeccccccccccccccccCC-------CCcchhHHHHHHHHHHHHhCCCC
Q 039819 316 ANVLLDDFCEAIVGDFGLAKLLDHS-DSHVTTAVRGTVGHIAPEYLSTGQ-------SSEKTDVFGFGILLLELITGMRA 387 (534)
Q Consensus 316 ~NiLl~~~~~~kl~DFGla~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~-------~~~k~Dv~S~Gvvl~elltG~~p 387 (534)
.|+++|..+.+||+|||+....... .........-..-|.|||.+.... .+.++||||||++++|+++.+.|
T Consensus 78 ~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~ 157 (484)
T KOG1023|consen 78 SNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGP 157 (484)
T ss_pred ccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCc
Confidence 9999999999999999999876431 111111122345799999986531 46779999999999999999999
Q ss_pred cCCCccccccchHHHHHHHHhhhcccceecccccCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhc
Q 039819 388 LEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLEG 460 (534)
Q Consensus 388 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~ 460 (534)
|+..........+...++. .....+.|.+.... +....+..++..||..+|.+||++++|-..++.
T Consensus 158 ~~~~~~~~~~~eii~~~~~-----~~~~~~rP~i~~~~--e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~ 223 (484)
T KOG1023|consen 158 FDLRNLVEDPDEIILRVKK-----GGSNPFRPSIELLN--ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLT 223 (484)
T ss_pred cccccccCChHHHHHHHHh-----cCCCCcCcchhhhh--hcchHHHHHHHHhcccChhhCccHHHHHhhhhh
Confidence 9864433222223333222 11111222222111 333478999999999999999999999877654
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.8e-20 Score=178.97 Aligned_cols=186 Identities=20% Similarity=0.265 Sum_probs=156.8
Q ss_pred CCCcCCeeccCCcEEEEEEE-ECCCcEEEEEEehh------------hhhhc-ccCceeeEEEEEeCCCeeEEEeeccCC
Q 039819 203 NFSSKNILGAGGFGNVYKGK-LGDGTVLAVKRLKD------------MISLA-VHRNLLRLIGYCATPTERLLVYPYMSN 268 (534)
Q Consensus 203 ~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~------------~l~~~-~h~niv~l~~~~~~~~~~~lv~e~~~~ 268 (534)
+|.+.+.||+|.||..+.|+ +-++..||||-... ..+.+ ..+.|..++-|-.++.+-.||+|.+ |
T Consensus 29 hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL-G 107 (449)
T KOG1165|consen 29 HYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL-G 107 (449)
T ss_pred cceeccccccCcceeeecccccccCceEEEEeccccCCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh-C
Confidence 57788999999999999998 45789999997642 22222 4688888888888888889999998 6
Q ss_pred CChhhhcc-cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCC-----CCcEEEEecccceecCCCCC
Q 039819 269 GSVASRLR-EKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDD-----FCEAIVGDFGLAKLLDHSDS 342 (534)
Q Consensus 269 gsL~~~l~-~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~-----~~~~kl~DFGla~~~~~~~~ 342 (534)
.+|.|+.. ....|+..++..||.|++.-++|+|++ .+|.|||||+|+||.. ...+.|+|||+|+...+...
T Consensus 108 PSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k---~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp~T 184 (449)
T KOG1165|consen 108 PSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEK---DLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDPKT 184 (449)
T ss_pred cCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhc---ceeecccCccceeecCCCCCCCceEEEEeccchhhhcCccc
Confidence 79988886 456799999999999999999999999 9999999999999964 34578999999998765432
Q ss_pred c------eeeccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCc
Q 039819 343 H------VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGK 392 (534)
Q Consensus 343 ~------~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~ 392 (534)
. ......||..||+--...+...+.+.|+-|+|-|+++.+.|..||.+-.
T Consensus 185 kqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLK 240 (449)
T KOG1165|consen 185 KQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLK 240 (449)
T ss_pred cccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCcccccc
Confidence 2 2345679999999998889999999999999999999999999998644
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.83 E-value=3.3e-20 Score=172.88 Aligned_cols=126 Identities=16% Similarity=0.191 Sum_probs=98.1
Q ss_pred CCeeccCCcEEEEEEEECCCcEEEEEEehh----------------------------------------hhhhcccCce
Q 039819 207 KNILGAGGFGNVYKGKLGDGTVLAVKRLKD----------------------------------------MISLAVHRNL 246 (534)
Q Consensus 207 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~----------------------------------------~l~~~~h~ni 246 (534)
...||+|+||.||+|...+|+.||||+++. .+..+.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 357999999999999988899999998742 1223334444
Q ss_pred eeEEEEEeCCCeeEEEeeccCCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHH-HhcCCCCeEeccCCCCcEEeCCCCc
Q 039819 247 LRLIGYCATPTERLLVYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYL-HEQCDPKIIHRDVKAANVLLDDFCE 325 (534)
Q Consensus 247 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yL-H~~~~~~ivH~Dlkp~NiLl~~~~~ 325 (534)
.....+. ....+|||||++++++.........+++.....++.|++.+|.|+ |+. +|+||||||+|||++ ++.
T Consensus 82 ~~p~~~~--~~~~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~---giiHrDlkP~NIli~-~~~ 155 (190)
T cd05147 82 PCPEPIL--LKSHVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDC---RLVHADLSEYNLLYH-DGK 155 (190)
T ss_pred CCCcEEE--ecCCEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEE-CCc
Confidence 2222221 123489999999987765544456789999999999999999999 677 999999999999998 478
Q ss_pred EEEEecccceecC
Q 039819 326 AIVGDFGLAKLLD 338 (534)
Q Consensus 326 ~kl~DFGla~~~~ 338 (534)
++|+|||+|....
T Consensus 156 v~LiDFG~a~~~~ 168 (190)
T cd05147 156 LYIIDVSQSVEHD 168 (190)
T ss_pred EEEEEccccccCC
Confidence 9999999997553
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.83 E-value=6.9e-20 Score=171.19 Aligned_cols=127 Identities=20% Similarity=0.240 Sum_probs=100.4
Q ss_pred CCeeccCCcEEEEEEEECCCcEEEEEEehh----------------------------------------hhhhcccCce
Q 039819 207 KNILGAGGFGNVYKGKLGDGTVLAVKRLKD----------------------------------------MISLAVHRNL 246 (534)
Q Consensus 207 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~----------------------------------------~l~~~~h~ni 246 (534)
...||+|+||.||+|...+|+.||||++.. .+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 467999999999999988899999998652 2333445655
Q ss_pred eeEEEEEeCCCeeEEEeeccCCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEeccCCCCcEEeCCCCc
Q 039819 247 LRLIGYCATPTERLLVYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHE-QCDPKIIHRDVKAANVLLDDFCE 325 (534)
Q Consensus 247 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~-~~~~~ivH~Dlkp~NiLl~~~~~ 325 (534)
.....+... ..+|||||++++++.........++......++.+++.++.++|+ . +|+||||||+|||++ ++.
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~---givHrDlkP~NIll~-~~~ 155 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEA---GLVHGDLSEYNILYH-DGK 155 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhC---CEecCCCChhhEEEE-CCC
Confidence 433333222 248999999988654443334567888999999999999999999 7 999999999999999 799
Q ss_pred EEEEecccceecCC
Q 039819 326 AIVGDFGLAKLLDH 339 (534)
Q Consensus 326 ~kl~DFGla~~~~~ 339 (534)
++|+|||+++....
T Consensus 156 ~~liDFG~a~~~~~ 169 (190)
T cd05145 156 PYIIDVSQAVELDH 169 (190)
T ss_pred EEEEEcccceecCC
Confidence 99999999987654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=2.5e-20 Score=192.34 Aligned_cols=218 Identities=25% Similarity=0.281 Sum_probs=173.1
Q ss_pred eccCCcEEEEEEE----ECCCcEEEEEEehh----------------hhhhcc-cCceeeEEEEEeCCCeeEEEeeccCC
Q 039819 210 LGAGGFGNVYKGK----LGDGTVLAVKRLKD----------------MISLAV-HRNLLRLIGYCATPTERLLVYPYMSN 268 (534)
Q Consensus 210 lG~G~~g~Vy~~~----~~~~~~vavK~~~~----------------~l~~~~-h~niv~l~~~~~~~~~~~lv~e~~~~ 268 (534)
+|+|+||.|+.++ .+.+..+|.|.+++ ++..++ ||.+|++...++.+...+++.+|.-+
T Consensus 2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~rg 81 (612)
T KOG0603|consen 2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLRG 81 (612)
T ss_pred CCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhccc
Confidence 6899999998764 23455566665542 555555 99999999999999999999999999
Q ss_pred CChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCCceeecc
Q 039819 269 GSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAV 348 (534)
Q Consensus 269 gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~~ 348 (534)
|.|...+.....+++.....+...++-+++++|+. +|+|||+|++||+++.+|++++.|||+++..-.... .
T Consensus 82 g~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l---~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~-----~ 153 (612)
T KOG0603|consen 82 GDLFTRLSKEVMFDELDVAFYLAELALALDHLHKL---GIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI-----A 153 (612)
T ss_pred chhhhccccCCchHHHHHHHHHHHHHHHHhhcchh---HHHHhcccccceeecccCccccCCchhhhHhHhhhh-----c
Confidence 99999999988899999899999999999999999 999999999999999999999999999987643221 1
Q ss_pred ccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceecccccCCCCCHH
Q 039819 349 RGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELGSNYDRI 428 (534)
Q Consensus 349 ~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 428 (534)
+||.-|||||++. .....+|.||||++.+||+||-.||.. +.+..+...+ ...+..
T Consensus 154 cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~-----------~~~~~Il~~~-----------~~~p~~ 209 (612)
T KOG0603|consen 154 CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG-----------DTMKRILKAE-----------LEMPRE 209 (612)
T ss_pred ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch-----------HHHHHHhhhc-----------cCCchh
Confidence 8999999999997 456789999999999999999999863 1122222111 123444
Q ss_pred HHHHHHHHHHHhcccCCCCCCChH-HHHHHhh
Q 039819 429 EVGEILQVALLCTQYLPVHRPKMS-EVVRMLE 459 (534)
Q Consensus 429 ~~~~l~~l~~~Cl~~~P~~RPt~~-ev~~~L~ 459 (534)
....+..+.......+|..|--.. +++..+.
T Consensus 210 l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik 241 (612)
T KOG0603|consen 210 LSAEARSLFRQLFKRNPENRLGAGPDGVDEIK 241 (612)
T ss_pred hhHHHHHHHHHHHhhCHHHHhccCcchhHHHh
Confidence 556777888888899999998763 4444333
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.80 E-value=3.5e-19 Score=196.06 Aligned_cols=185 Identities=22% Similarity=0.244 Sum_probs=155.7
Q ss_pred HHHhCCCcCCeeccCCcEEEEEEEECCCcEEEEEEeh-----------hhhhhcc---cCceeeEEEEEeCCCeeEEEee
Q 039819 199 QATENFSSKNILGAGGFGNVYKGKLGDGTVLAVKRLK-----------DMISLAV---HRNLLRLIGYCATPTERLLVYP 264 (534)
Q Consensus 199 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~-----------~~l~~~~---h~niv~l~~~~~~~~~~~lv~e 264 (534)
..-+.|.+.+.||+|+||.||+|...+|+.||+|..+ +++.+++ -+-|..+...+.-.+.-+||+|
T Consensus 695 ~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WEfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~lv~e 774 (974)
T KOG1166|consen 695 VGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWEFYICLQVMERLKPQMLPSIMHISSAHVFQNASVLVSE 774 (974)
T ss_pred ecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCceeeeehHHHHHhhchhhhcchHHHHHHHccCCcceeeee
Confidence 3445678888999999999999999899999999876 3566666 2234444444455677899999
Q ss_pred ccCCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeC-------CCCcEEEEecccceec
Q 039819 265 YMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLD-------DFCEAIVGDFGLAKLL 337 (534)
Q Consensus 265 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~-------~~~~~kl~DFGla~~~ 337 (534)
|.+.|+|.+++...+.++|..+..++.|+++.++.||.. +|||+||||+|+||. ....++|+|||.+..+
T Consensus 775 y~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~---~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~siDm 851 (974)
T KOG1166|consen 775 YSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAM---GIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSIDM 851 (974)
T ss_pred ccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhc---ceecccCCcceeEeecccCCCCcccceEEEecccceee
Confidence 999999999999888999999999999999999999999 999999999999994 3456899999999765
Q ss_pred CC-CCCceeeccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCC
Q 039819 338 DH-SDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMR 386 (534)
Q Consensus 338 ~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~ 386 (534)
.- .+.......++|-++-.+|+..+...+..+|-|.|+.+++-|+.|+.
T Consensus 852 ~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 852 KLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred eEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence 32 22234566778999999999999999999999999999999999963
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=2.1e-20 Score=201.84 Aligned_cols=241 Identities=22% Similarity=0.267 Sum_probs=178.7
Q ss_pred CCCcCCeeccCCcEEEEEEEECCCcEEEEEEehh-----------------hhhhcccCceeeEEEEEeCCCeeEEEeec
Q 039819 203 NFSSKNILGAGGFGNVYKGKLGDGTVLAVKRLKD-----------------MISLAVHRNLLRLIGYCATPTERLLVYPY 265 (534)
Q Consensus 203 ~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~-----------------~l~~~~h~niv~l~~~~~~~~~~~lv~e~ 265 (534)
+|...+.||++.|=+|.+|+.++|. |+||++.+ .....+|||.+++.-+-......|||-+|
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqy 102 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQY 102 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence 4555678999999999999999997 78888753 24566799999887776666777899999
Q ss_pred cCCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceec--CCCCCc
Q 039819 266 MSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLL--DHSDSH 343 (534)
Q Consensus 266 ~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~--~~~~~~ 343 (534)
..+ +|+|++..++-+..-+.+=|+.|++.||.-+|.. +|+|||||.+|||++.-.=+.|+||..-+.. ..++..
T Consensus 103 vkh-nLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~---gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNPa 178 (1431)
T KOG1240|consen 103 VKH-NLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKL---GVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNPA 178 (1431)
T ss_pred Hhh-hhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHc---CccccccccceEEEeeechhhhhcccccCCccCCCCCcc
Confidence 865 9999999998888888888999999999999999 9999999999999999888999999876643 222211
Q ss_pred e----eecccccccccccccccc----------CC-CCcchhHHHHHHHHHHHHh-CCCCcCCCccccccchHHHHHHHH
Q 039819 344 V----TTAVRGTVGHIAPEYLST----------GQ-SSEKTDVFGFGILLLELIT-GMRALEFGKSINQKGAMLEWVKKI 407 (534)
Q Consensus 344 ~----~~~~~gt~~y~aPE~~~~----------~~-~~~k~Dv~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~ 407 (534)
. ..+...-..|+|||.+.. .. .+++-||||.|||+.||++ |++||..+ .+..+..
T Consensus 179 df~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS-------QL~aYr~-- 249 (1431)
T KOG1240|consen 179 DFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS-------QLLAYRS-- 249 (1431)
T ss_pred cceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH-------HHHhHhc--
Confidence 1 112222347999998732 11 5678899999999999987 68888621 1111111
Q ss_pred hhhcccceecccccCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhcCCchh
Q 039819 408 QQEKKVEVLVDRELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLEGDGLAE 465 (534)
Q Consensus 408 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~~~~~~ 465 (534)
.+. .|++.. ....+...+.+++..|++.+|++|-++++.++.-.+..+.+
T Consensus 250 -~~~-----~~~e~~--Le~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG~~FP~ 299 (1431)
T KOG1240|consen 250 -GNA-----DDPEQL--LEKIEDVSLRNLILSMIQRDPSKRLSAEDYLQKYRGLVFPE 299 (1431)
T ss_pred -cCc-----cCHHHH--HHhCcCccHHHHHHHHHccCchhccCHHHHHHhhhccccHH
Confidence 000 000000 01111236789999999999999999999999877765544
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.80 E-value=7e-20 Score=173.13 Aligned_cols=158 Identities=10% Similarity=0.067 Sum_probs=123.7
Q ss_pred HHhCCCcCCeeccCCcEEEEEEEECCCcEEEEEEehh-----------------------hhhhcccCceeeEEEEEeCC
Q 039819 200 ATENFSSKNILGAGGFGNVYKGKLGDGTVLAVKRLKD-----------------------MISLAVHRNLLRLIGYCATP 256 (534)
Q Consensus 200 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~-----------------------~l~~~~h~niv~l~~~~~~~ 256 (534)
..++|...+++|.|+||.||.+.. ++..+|||.+.. .+.++.|++|..+..++...
T Consensus 29 l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~ 107 (232)
T PRK10359 29 LSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA 107 (232)
T ss_pred hhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence 357899999999999999999766 566899998851 36677899999998886543
Q ss_pred --------CeeEEEeeccCCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEE
Q 039819 257 --------TERLLVYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIV 328 (534)
Q Consensus 257 --------~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl 328 (534)
...++||||++|.+|.++.. ++. ....+++.+|..+|+. +++|||+||+||+++.++ ++|
T Consensus 108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~~----~~~----~~~~~i~~~l~~lH~~---gi~H~Dikp~Nili~~~g-i~l 175 (232)
T PRK10359 108 ERKTLRYAHTYIMLIEYIEGVELNDMPE----ISE----DVKAKIKASIESLHQH---GMVSGDPHKGNFIVSKNG-LRI 175 (232)
T ss_pred ccccccccCCeEEEEEEECCccHHHhhh----ccH----HHHHHHHHHHHHHHHc---CCccCCCChHHEEEeCCC-EEE
Confidence 35789999999999987732 222 3456899999999999 999999999999999988 999
Q ss_pred EecccceecCCCCCceeeccccccccccccccccCCCCcchhHHHHHHHHHHHHh
Q 039819 329 GDFGLAKLLDHSDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT 383 (534)
Q Consensus 329 ~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~ellt 383 (534)
+|||.......... . ..+.....+..++|+||||+++.-...
T Consensus 176 iDfg~~~~~~e~~a--~-----------d~~vler~y~~~~di~~lg~~~~~~~~ 217 (232)
T PRK10359 176 IDLSGKRCTAQRKA--K-----------DRIDLERHYGIKNEIKDLGYYLLIYKK 217 (232)
T ss_pred EECCCcccccchhh--H-----------HHHHHHhHhcccccccceeEeehHHHH
Confidence 99998875532211 0 113445556789999999999876653
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=2.6e-19 Score=174.63 Aligned_cols=196 Identities=22% Similarity=0.251 Sum_probs=135.3
Q ss_pred cccCceeeEEEEEeC---------------------------CCeeEEEeeccCCCChhhhcccCCCCCHHHHHHHHHHH
Q 039819 241 AVHRNLLRLIGYCAT---------------------------PTERLLVYPYMSNGSVASRLREKPALDWNTRKRIAIGA 293 (534)
Q Consensus 241 ~~h~niv~l~~~~~~---------------------------~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i 293 (534)
.+|||||++.++|.+ +...|+||.-.+. +|.+++..+. .+...+.-|+.|+
T Consensus 273 a~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~~-~s~r~~~~~laQl 350 (598)
T KOG4158|consen 273 AKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTRH-RSYRTGRVILAQL 350 (598)
T ss_pred CCCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcCC-CchHHHHHHHHHH
Confidence 569999999987632 2345888887654 8888887655 4556677788999
Q ss_pred HHHHHHHHhcCCCCeEeccCCCCcEEe--CCCC--cEEEEecccceecCCCC-----CceeeccccccccccccccccC-
Q 039819 294 ARGLLYLHEQCDPKIIHRDVKAANVLL--DDFC--EAIVGDFGLAKLLDHSD-----SHVTTAVRGTVGHIAPEYLSTG- 363 (534)
Q Consensus 294 ~~~l~yLH~~~~~~ivH~Dlkp~NiLl--~~~~--~~kl~DFGla~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~- 363 (534)
++|+.|||.+ +|.|||+|++|||+ |+++ ...|+|||.+-.-..-. ..-....-|...-||||+....
T Consensus 351 LEav~hL~~h---gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~P 427 (598)
T KOG4158|consen 351 LEAVTHLHKH---GVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVP 427 (598)
T ss_pred HHHHHHHHHc---cchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCC
Confidence 9999999999 99999999999998 3333 45789999875332110 0011223477889999988542
Q ss_pred -CC----CcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceecccccCCCCCHHHHHHHHHHHH
Q 039819 364 -QS----SEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELGSNYDRIEVGEILQVAL 438 (534)
Q Consensus 364 -~~----~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~ 438 (534)
+. -.|+|.|+.|.+.||+++...||..... ..++... .++.. + ...+..++..+.+++.
T Consensus 428 Gp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGe-----m~L~~r~--Yqe~q--------L-Palp~~vpp~~rqlV~ 491 (598)
T KOG4158|consen 428 GPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGE-----MLLDTRT--YQESQ--------L-PALPSRVPPVARQLVF 491 (598)
T ss_pred CCceeeccchhhhhhhhhhHHHHhccCCcccccch-----heechhh--hhhhh--------C-CCCcccCChHHHHHHH
Confidence 21 3589999999999999999999964111 0111100 01111 1 1123344557889999
Q ss_pred HhcccCCCCCCChHHHHHH
Q 039819 439 LCTQYLPVHRPKMSEVVRM 457 (534)
Q Consensus 439 ~Cl~~~P~~RPt~~ev~~~ 457 (534)
..++.+|++|++..-....
T Consensus 492 ~lL~r~pskRvsp~iAANv 510 (598)
T KOG4158|consen 492 DLLKRDPSKRVSPNIAANV 510 (598)
T ss_pred HHhcCCccccCCccHHHhH
Confidence 9999999999986544443
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.8e-18 Score=160.19 Aligned_cols=170 Identities=18% Similarity=0.107 Sum_probs=126.6
Q ss_pred cCCeeccCCcEEEEEEEECCCcEEEEEEeh------------------hhhhhcc-cCceeeEEEEEeCCCeeEEEeecc
Q 039819 206 SKNILGAGGFGNVYKGKLGDGTVLAVKRLK------------------DMISLAV-HRNLLRLIGYCATPTERLLVYPYM 266 (534)
Q Consensus 206 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~------------------~~l~~~~-h~niv~l~~~~~~~~~~~lv~e~~ 266 (534)
....|++|+||+||.+.- .+..++.+.+. +++.++. |+++++++++ ...+++|||+
T Consensus 6 ~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI 80 (218)
T PRK12274 6 VNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYL 80 (218)
T ss_pred cceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeee
Confidence 456899999999997766 55666644432 3667774 4788888886 4569999999
Q ss_pred CCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccC-CCCcEEeCCCCcEEEEecccceecCCCCCc--
Q 039819 267 SNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDV-KAANVLLDDFCEAIVGDFGLAKLLDHSDSH-- 343 (534)
Q Consensus 267 ~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dl-kp~NiLl~~~~~~kl~DFGla~~~~~~~~~-- 343 (534)
.|.+|.+..... ...++.+++++|.++|++ +|+|||| ||+|||++.++.++|+|||++.........
T Consensus 81 ~G~~L~~~~~~~-------~~~~~~qi~~~L~~lH~~---GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r 150 (218)
T PRK12274 81 AGAAMYQRPPRG-------DLAYFRAARRLLQQLHRC---GVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMR 150 (218)
T ss_pred cCccHHhhhhhh-------hHHHHHHHHHHHHHHHHC---cCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHHH
Confidence 999987554221 245788999999999999 9999999 799999999999999999999865432210
Q ss_pred --e--------eeccccccccccccccccC-CCC-cchhHHHHHHHHHHHHhCCCCcCC
Q 039819 344 --V--------TTAVRGTVGHIAPEYLSTG-QSS-EKTDVFGFGILLLELITGMRALEF 390 (534)
Q Consensus 344 --~--------~~~~~gt~~y~aPE~~~~~-~~~-~k~Dv~S~Gvvl~elltG~~p~~~ 390 (534)
. ......++.|++|+...-- ..+ ...+.++-|.-+|.++|++.+.-.
T Consensus 151 ~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~ 209 (218)
T PRK12274 151 LLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWE 209 (218)
T ss_pred HHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccc
Confidence 0 1112357788888754321 233 567899999999999999888653
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.75 E-value=5.7e-18 Score=164.92 Aligned_cols=213 Identities=23% Similarity=0.294 Sum_probs=135.8
Q ss_pred cCCeeccCCcEEEEEEEEC-CCcEEEEEEehh---------------h--hhhcc----------cCceeeEEEEEe---
Q 039819 206 SKNILGAGGFGNVYKGKLG-DGTVLAVKRLKD---------------M--ISLAV----------HRNLLRLIGYCA--- 254 (534)
Q Consensus 206 ~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~---------------~--l~~~~----------h~niv~l~~~~~--- 254 (534)
..+.||.|+++.||.+++. .++.+|||.+.- . +.... |-.++..++...
T Consensus 16 ~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~~ 95 (288)
T PF14531_consen 16 RGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIPG 95 (288)
T ss_dssp EEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEETT
T ss_pred EccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEcC
Confidence 4578999999999999986 589999998741 1 11100 212222222211
Q ss_pred ------CC---C-----eeEEEeeccCCCChhhhcc---c-CC---CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccC
Q 039819 255 ------TP---T-----ERLLVYPYMSNGSVASRLR---E-KP---ALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDV 313 (534)
Q Consensus 255 ------~~---~-----~~~lv~e~~~~gsL~~~l~---~-~~---~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dl 313 (534)
.. . ..+++|+-+ .++|.+.+. . .. .+....++.+..|+++.+++||+. ++||+||
T Consensus 96 ~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~---GlVHgdi 171 (288)
T PF14531_consen 96 KPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSY---GLVHGDI 171 (288)
T ss_dssp S-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEEEST-
T ss_pred CCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhc---ceEeccc
Confidence 11 1 225677776 458877754 1 11 244556778889999999999999 9999999
Q ss_pred CCCcEEeCCCCcEEEEecccceecCCCCCceeecccccccccccccccc--------CCCCcchhHHHHHHHHHHHHhCC
Q 039819 314 KAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGHIAPEYLST--------GQSSEKTDVFGFGILLLELITGM 385 (534)
Q Consensus 314 kp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~k~Dv~S~Gvvl~elltG~ 385 (534)
||+|++++.+|.++|+||+.....+.. ......+..|.+||.... -.++.+.|.|++|+++|.|++|+
T Consensus 172 ~~~nfll~~~G~v~Lg~F~~~~r~g~~----~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~ 247 (288)
T PF14531_consen 172 KPENFLLDQDGGVFLGDFSSLVRAGTR----YRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGR 247 (288)
T ss_dssp SGGGEEE-TTS-EEE--GGGEEETTEE----EEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS
T ss_pred ceeeEEEcCCCCEEEcChHHHeecCce----eeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHcc
Confidence 999999999999999999988765431 111335678999997743 24788999999999999999999
Q ss_pred CCcCCCccccccchHHHHHHHHhhhcccceecccccCCCCCHHHHHHHHHHHHHhcccCCCCC
Q 039819 386 RALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELGSNYDRIEVGEILQVALLCTQYLPVHR 448 (534)
Q Consensus 386 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~R 448 (534)
.||+......... | .. .... ..++.+..|+..+++.+|.+|
T Consensus 248 lPf~~~~~~~~~~----~----------------~f-~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 248 LPFGLSSPEADPE----W----------------DF-SRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp -STCCCGGGSTSG----G----------------GG-TTSS----HHHHHHHHHHT-SSGGGS
T ss_pred CCCCCCCcccccc----c----------------cc-hhcC-CcCHHHHHHHHHHccCCcccC
Confidence 9998543221110 0 11 1122 456789999999999999988
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.74 E-value=4.6e-18 Score=183.81 Aligned_cols=213 Identities=24% Similarity=0.317 Sum_probs=146.7
Q ss_pred hCCCcCCeeccCCcEEEEEEEECC-CcEEEEEEehhhhhhcccCceeeEEEEEeCCCeeEEEeeccCCCChhhhcccCCC
Q 039819 202 ENFSSKNILGAGGFGNVYKGKLGD-GTVLAVKRLKDMISLAVHRNLLRLIGYCATPTERLLVYPYMSNGSVASRLREKPA 280 (534)
Q Consensus 202 ~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~ 280 (534)
.+|..+++|-.|+||.||..+++. .+.+|+|+=++.+-. +||..+. + ..+.| |+-...++.-+.
T Consensus 83 ~df~~IklisngAygavylvrh~~trqrfa~kiNkq~lil---Rnilt~a----~--npfvv------gDc~tllk~~g~ 147 (1205)
T KOG0606|consen 83 SDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQNLIL---RNILTFA----G--NPFVV------GDCATLLKNIGP 147 (1205)
T ss_pred cccceeEeeccCCCCceeeeeccccccchhhcccccchhh---hcccccc----C--Cccee------chhhhhcccCCC
Confidence 578888999999999999998864 566777433321111 1222211 1 11222 555556665555
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCC--------------Cceee
Q 039819 281 LDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSD--------------SHVTT 346 (534)
Q Consensus 281 l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~--------------~~~~~ 346 (534)
++... +.+++|+|+. +|+|||+||+|.+++.-|++|+.|||+++...... .....
T Consensus 148 lPvdm--------vla~Eylh~y---givhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~eg~I~k~t~Ef~dK 216 (1205)
T KOG0606|consen 148 LPVDM--------VLAVEYLHSY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKEGHIEKDTHEFQDK 216 (1205)
T ss_pred Ccchh--------hHHhHhhccC---CeecCCCCCCcceeeecccccccchhhhhhhhhhccchhhhcchHHHHHHhhhc
Confidence 55443 7889999999 99999999999999999999999999988532110 11233
Q ss_pred ccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceecccccCCCCC
Q 039819 347 AVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELGSNYD 426 (534)
Q Consensus 347 ~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 426 (534)
.++||+.|+|||++....|+..+|+|++|+|+||.+-|+.||.+.... +.+.+....... . .+-+
T Consensus 217 qvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpe-------elfg~visd~i~-------w-pE~d 281 (1205)
T KOG0606|consen 217 QVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPE-------ELFGQVISDDIE-------W-PEED 281 (1205)
T ss_pred cccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHH-------HHHhhhhhhhcc-------c-cccC
Confidence 468999999999999999999999999999999999999999765332 222222221100 0 0011
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCChHHHH
Q 039819 427 RIEVGEILQVALLCTQYLPVHRPKMSEVV 455 (534)
Q Consensus 427 ~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~ 455 (534)
.....+..+++.+.++.+|..|---...+
T Consensus 282 ea~p~Ea~dli~~LL~qnp~~Rlgt~ga~ 310 (1205)
T KOG0606|consen 282 EALPPEAQDLIEQLLRQNPLCRLGTGGAL 310 (1205)
T ss_pred cCCCHHHHHHHHHHHHhChHhhcccchhh
Confidence 22234788899999999999997544433
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.73 E-value=1.2e-18 Score=176.83 Aligned_cols=168 Identities=24% Similarity=0.320 Sum_probs=129.7
Q ss_pred eeEEEeeccCCCChhhhcccC---CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccc
Q 039819 258 ERLLVYPYMSNGSVASRLREK---PALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLA 334 (534)
Q Consensus 258 ~~~lv~e~~~~gsL~~~l~~~---~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla 334 (534)
..|+.|++|...+|.+++... ...++...+.++.|++.|+.| + +.+|||+||.||+...+..+||.|||+.
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k---~~ihrdlkp~nif~~~d~q~kIgDFgl~ 403 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---K---GLIHRDLKPSNIFFSDDDQLKIGDFGLV 403 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---c---cchhhhccccccccccchhhhhhhhhhe
Confidence 468999999999999999643 347888999999999999999 5 8999999999999999999999999999
Q ss_pred eecCCCC-----CceeeccccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCcCCCccccccchHHHHHHHHh
Q 039819 335 KLLDHSD-----SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GMRALEFGKSINQKGAMLEWVKKIQ 408 (534)
Q Consensus 335 ~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~ 408 (534)
..+.... ....+...||..||+||.+.+..|+.|+||||+|++|+|+++ -..+++.
T Consensus 404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er------------------ 465 (516)
T KOG1033|consen 404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFER------------------ 465 (516)
T ss_pred eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHH------------------
Confidence 8775443 223455679999999999999999999999999999999997 2222210
Q ss_pred hhcccceeccccc----CCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHH
Q 039819 409 QEKKVEVLVDREL----GSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVV 455 (534)
Q Consensus 409 ~~~~~~~~~d~~l----~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~ 455 (534)
.....++-|..+ ..+++ .-..+..+++.+.|.+||++.++.
T Consensus 466 -~~t~~d~r~g~ip~~~~~d~p-----~e~~ll~~lls~~p~~RP~~~~~~ 510 (516)
T KOG1033|consen 466 -IATLTDIRDGIIPPEFLQDYP-----EEYTLLQQLLSPSPEERPSAIEVA 510 (516)
T ss_pred -HHhhhhhhcCCCChHHhhcCc-----HHHHHHHHhcCCCcccCchHHHHh
Confidence 011112222222 22222 335788899999999999555543
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.71 E-value=7.4e-17 Score=151.98 Aligned_cols=123 Identities=15% Similarity=0.155 Sum_probs=93.7
Q ss_pred CCcCCeeccCCcEEEEEEEECCCcEEEEEEeh--------------hhhhhc-----ccCceeeEEEEEeCCC---eeE-
Q 039819 204 FSSKNILGAGGFGNVYKGKLGDGTVLAVKRLK--------------DMISLA-----VHRNLLRLIGYCATPT---ERL- 260 (534)
Q Consensus 204 ~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~--------------~~l~~~-----~h~niv~l~~~~~~~~---~~~- 260 (534)
+...+.||+|+||.||. .-.++.. +||++. +.+..+ .||||++++|++.+.. ..+
T Consensus 4 L~~~~~LG~G~~~~Vy~-hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~ 81 (210)
T PRK10345 4 LSEQSPLGTGRHRKCYA-HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYD 81 (210)
T ss_pred cCCcceecCCCceEEEE-CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEE
Confidence 34567899999999996 2233433 688654 144555 5899999999998874 323
Q ss_pred EEeec--cCCCChhhhcccCCCCCHHHHHHHHHHHHHHH-HHHHhcCCCCeEeccCCCCcEEeCC----CCcEEEEeccc
Q 039819 261 LVYPY--MSNGSVASRLREKPALDWNTRKRIAIGAARGL-LYLHEQCDPKIIHRDVKAANVLLDD----FCEAIVGDFGL 333 (534)
Q Consensus 261 lv~e~--~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l-~yLH~~~~~~ivH~Dlkp~NiLl~~----~~~~kl~DFGl 333 (534)
+|+|| +++|+|.+++.+. .+++. ..++.+++.++ +|||++ +||||||||+|||++. ++.++|+||+.
T Consensus 82 ~I~e~~G~~~~tL~~~l~~~-~~~e~--~~~~~~~L~~l~~yLh~~---~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G 155 (210)
T PRK10345 82 VIADFDGKPSITLTEFAEQC-RYEED--VAQLRQLLKKLKRYLLDN---RIVTMELKPQNILCQRISESEVIPVVCDNIG 155 (210)
T ss_pred EEecCCCCcchhHHHHHHcc-cccHh--HHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEeccCCCCCcEEEEECCC
Confidence 78999 5689999999764 46655 35678888777 999999 9999999999999974 34899999543
Q ss_pred c
Q 039819 334 A 334 (534)
Q Consensus 334 a 334 (534)
+
T Consensus 156 ~ 156 (210)
T PRK10345 156 E 156 (210)
T ss_pred C
Confidence 3
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.70 E-value=8.5e-17 Score=155.11 Aligned_cols=129 Identities=16% Similarity=0.193 Sum_probs=100.2
Q ss_pred CCCcCCeeccCCcEEEEEEE--ECCCcEEEEEEehhh--------------------------------------hhhcc
Q 039819 203 NFSSKNILGAGGFGNVYKGK--LGDGTVLAVKRLKDM--------------------------------------ISLAV 242 (534)
Q Consensus 203 ~~~~~~~lG~G~~g~Vy~~~--~~~~~~vavK~~~~~--------------------------------------l~~~~ 242 (534)
-|...+.||+|+||.||+|. ..+|+.||||.+... +..+.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 36778899999999999998 568999999987521 11111
Q ss_pred c--CceeeEEEEEeCCCeeEEEeeccCCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC-eEeccCCCCcEE
Q 039819 243 H--RNLLRLIGYCATPTERLLVYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPK-IIHRDVKAANVL 319 (534)
Q Consensus 243 h--~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~-ivH~Dlkp~NiL 319 (534)
+ ..+.+++++ ...++||||+++++|.........+.......++.|++.++.+||+. + |+||||||+||+
T Consensus 109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---g~iiH~Dikp~NIl 181 (237)
T smart00090 109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKE---GELVHGDLSEYNIL 181 (237)
T ss_pred hcCCCCCeeeEe----cCceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhc---CCEEeCCCChhhEE
Confidence 2 112233332 23589999999988877654445566667789999999999999999 8 999999999999
Q ss_pred eCCCCcEEEEecccceecCC
Q 039819 320 LDDFCEAIVGDFGLAKLLDH 339 (534)
Q Consensus 320 l~~~~~~kl~DFGla~~~~~ 339 (534)
++ ++.++|+|||.+.....
T Consensus 182 i~-~~~i~LiDFg~a~~~~~ 200 (237)
T smart00090 182 VH-DGKVVIIDVSQSVELDH 200 (237)
T ss_pred EE-CCCEEEEEChhhhccCC
Confidence 99 88999999999876543
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.2e-16 Score=151.84 Aligned_cols=120 Identities=21% Similarity=0.308 Sum_probs=103.0
Q ss_pred CeeccCCcEEEEEEEECCCcEEEEEEeh----------------------hhhhhcccCceeeEEEEEeCCCeeEEEeec
Q 039819 208 NILGAGGFGNVYKGKLGDGTVLAVKRLK----------------------DMISLAVHRNLLRLIGYCATPTERLLVYPY 265 (534)
Q Consensus 208 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~----------------------~~l~~~~h~niv~l~~~~~~~~~~~lv~e~ 265 (534)
+.||+|++|.||+|.. ++..|+||... ..+..+.|+++.....++......++||||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 5799999999999988 66778888643 145566788888777777777888999999
Q ss_pred cCCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEeccccee
Q 039819 266 MSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKL 336 (534)
Q Consensus 266 ~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~ 336 (534)
+++++|.+.+.... + .+..++.+++.+|.++|+. +++|||++|.|||++ ++.++|+|||.+..
T Consensus 81 ~~G~~L~~~~~~~~---~-~~~~i~~~i~~~l~~lH~~---~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSNG---M-EELELSREIGRLVGKLHSA---GIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhcc---H-HHHHHHHHHHHHHHHHHhC---CcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 99999999886543 2 7889999999999999998 999999999999999 78999999999875
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.68 E-value=2e-16 Score=148.77 Aligned_cols=131 Identities=19% Similarity=0.162 Sum_probs=101.0
Q ss_pred HHHHHHhCCCcCCeeccCCcEEEEEEEECCCcEEEEEEehh------------------------------------hhh
Q 039819 196 ELQQATENFSSKNILGAGGFGNVYKGKLGDGTVLAVKRLKD------------------------------------MIS 239 (534)
Q Consensus 196 ~l~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~------------------------------------~l~ 239 (534)
++...-..|...+.||+|+||.||++...+|+.||||++.. .+.
T Consensus 9 ~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 88 (198)
T cd05144 9 TLVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALK 88 (198)
T ss_pred HHHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHH
Confidence 34444344777899999999999999998899999996421 233
Q ss_pred hcccCc--eeeEEEEEeCCCeeEEEeeccCCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCc
Q 039819 240 LAVHRN--LLRLIGYCATPTERLLVYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAAN 317 (534)
Q Consensus 240 ~~~h~n--iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~N 317 (534)
.+.|++ +...++ ....++||||+++++|...... .....++.+++.++.++|+. +|+||||||+|
T Consensus 89 ~l~~~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~------~~~~~~~~~i~~~l~~lh~~---gi~H~Dl~p~N 155 (198)
T cd05144 89 ALYEEGFPVPKPID----WNRHAVVMEYIDGVELYRVRVL------EDPEEVLDEILEEIVKAYKH---GIIHGDLSEFN 155 (198)
T ss_pred HHHHcCCCCCceee----cCCceEEEEEeCCcchhhcccc------ccHHHHHHHHHHHHHHHHHC---CCCcCCCCccc
Confidence 334543 333333 2345899999999998765431 34567889999999999998 99999999999
Q ss_pred EEeCCCCcEEEEecccceecCC
Q 039819 318 VLLDDFCEAIVGDFGLAKLLDH 339 (534)
Q Consensus 318 iLl~~~~~~kl~DFGla~~~~~ 339 (534)
|++++++.++|+|||.+.....
T Consensus 156 ill~~~~~~~liDfg~~~~~~~ 177 (198)
T cd05144 156 ILVDDDEKIYIIDWPQMVSTDH 177 (198)
T ss_pred EEEcCCCcEEEEECCccccCCC
Confidence 9999999999999999976543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.67 E-value=2e-16 Score=171.18 Aligned_cols=126 Identities=19% Similarity=0.296 Sum_probs=103.3
Q ss_pred HHhCCCcCCeeccCCcEEEEEEEECCCcEEEEEEeh---------------------hhhhhcccCceeeEEEEEeCCCe
Q 039819 200 ATENFSSKNILGAGGFGNVYKGKLGDGTVLAVKRLK---------------------DMISLAVHRNLLRLIGYCATPTE 258 (534)
Q Consensus 200 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~---------------------~~l~~~~h~niv~l~~~~~~~~~ 258 (534)
....|...+.||+|+||.||+|.+.+...++.++.. +++..++|++++....++.....
T Consensus 331 ~~~~~~~~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~ 410 (535)
T PRK09605 331 VKRRKIPDHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEE 410 (535)
T ss_pred cccccCccceeccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCC
Confidence 344556778999999999999988654433221111 14667789999988888888788
Q ss_pred eEEEeeccCCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceec
Q 039819 259 RLLVYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLL 337 (534)
Q Consensus 259 ~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~ 337 (534)
.++||||+++++|.+++. .+..++.+++++|.|||+. +++||||||+|||+ .++.++|+|||+++..
T Consensus 411 ~~lv~E~~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH~~---giiHrDlkp~NILl-~~~~~~liDFGla~~~ 477 (535)
T PRK09605 411 KTIVMEYIGGKDLKDVLE--------GNPELVRKVGEIVAKLHKA---GIVHGDLTTSNFIV-RDDRLYLIDFGLGKYS 477 (535)
T ss_pred CEEEEEecCCCcHHHHHH--------HHHHHHHHHHHHHHHHHhC---CCccCCCChHHEEE-ECCcEEEEeCcccccC
Confidence 899999999999998875 4578999999999999998 99999999999999 6789999999999754
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.65 E-value=4.6e-16 Score=146.37 Aligned_cols=117 Identities=21% Similarity=0.318 Sum_probs=95.9
Q ss_pred eeccCCcEEEEEEEECCCcEEEEEEeh----------------------hhhhhcccCceeeEEEEEeCCCeeEEEeecc
Q 039819 209 ILGAGGFGNVYKGKLGDGTVLAVKRLK----------------------DMISLAVHRNLLRLIGYCATPTERLLVYPYM 266 (534)
Q Consensus 209 ~lG~G~~g~Vy~~~~~~~~~vavK~~~----------------------~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~ 266 (534)
+||+|+||.||+|.+ ++..|++|... +.+..+.|+++.....++......++||||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 489999999999996 56788888742 1345566777655555566667789999999
Q ss_pred CCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceec
Q 039819 267 SNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLL 337 (534)
Q Consensus 267 ~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~ 337 (534)
++++|.+.+..... .++.+++.+|.++|+. +++|||++|.||+++ ++.++++|||++...
T Consensus 80 ~g~~l~~~~~~~~~-------~~~~~i~~~l~~lH~~---gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~~ 139 (199)
T TIGR03724 80 EGKPLKDVIEEGND-------ELLREIGRLVGKLHKA---GIVHGDLTTSNIIVR-DDKLYLIDFGLGKYS 139 (199)
T ss_pred CCccHHHHHhhcHH-------HHHHHHHHHHHHHHHC---CeecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence 99999988754321 7899999999999998 999999999999999 799999999998753
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.62 E-value=7.2e-16 Score=143.48 Aligned_cols=122 Identities=20% Similarity=0.233 Sum_probs=89.3
Q ss_pred CCeeccCCcEEEEEEEECCCcEEEEEEehhh---------------hhhcccCce-------------------------
Q 039819 207 KNILGAGGFGNVYKGKLGDGTVLAVKRLKDM---------------ISLAVHRNL------------------------- 246 (534)
Q Consensus 207 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~---------------l~~~~h~ni------------------------- 246 (534)
.+.||+|+||.||+|...+++.||||++... +....|.+.
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 4679999999999999888999999986520 111112222
Q ss_pred eeEEEEEeCCCeeEEEeeccCCCChhhh-cccCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEeccCCCCcEEeCCCC
Q 039819 247 LRLIGYCATPTERLLVYPYMSNGSVASR-LREKPALDWNTRKRIAIGAARGLLYLHE-QCDPKIIHRDVKAANVLLDDFC 324 (534)
Q Consensus 247 v~l~~~~~~~~~~~lv~e~~~~gsL~~~-l~~~~~l~~~~~~~i~~~i~~~l~yLH~-~~~~~ivH~Dlkp~NiLl~~~~ 324 (534)
.+.+++ ...++||||++++.+... +... ... .....++.+++.++.++|. . +|+||||||+||+++ ++
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~-~~~-~~~~~~~~~~~~~l~~lh~~~---~ivH~Dl~p~Nili~-~~ 151 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDV-RLL-EDPEELYDQILELMRKLYREA---GLVHGDLSEYNILVD-DG 151 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhh-hhc-ccHHHHHHHHHHHHHHHhhcc---CcCcCCCChhhEEEE-CC
Confidence 222221 245899999999654321 1111 111 5678899999999999998 7 999999999999999 89
Q ss_pred cEEEEecccceecC
Q 039819 325 EAIVGDFGLAKLLD 338 (534)
Q Consensus 325 ~~kl~DFGla~~~~ 338 (534)
.++|+|||.+....
T Consensus 152 ~~~liDfg~a~~~~ 165 (187)
T cd05119 152 KVYIIDVPQAVEID 165 (187)
T ss_pred cEEEEECccccccc
Confidence 99999999997554
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.58 E-value=2.4e-16 Score=170.39 Aligned_cols=238 Identities=22% Similarity=0.293 Sum_probs=177.6
Q ss_pred CCCcCCeeccCCcEEEEEEEECC--CcEEEEEEehh----------------hhhhcc-cCceeeEEEEEeCCCeeEEEe
Q 039819 203 NFSSKNILGAGGFGNVYKGKLGD--GTVLAVKRLKD----------------MISLAV-HRNLLRLIGYCATPTERLLVY 263 (534)
Q Consensus 203 ~~~~~~~lG~G~~g~Vy~~~~~~--~~~vavK~~~~----------------~l~~~~-h~niv~l~~~~~~~~~~~lv~ 263 (534)
.|...+.||+|+|+.|-...... ...+|+|.+.. +-.... |.|++.+++...+++..+++.
T Consensus 21 ~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~ 100 (601)
T KOG0590|consen 21 QYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSL 100 (601)
T ss_pred cccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccccc
Confidence 45556679999999998886532 34455554421 222333 999999999999999999999
Q ss_pred eccCCCChhhhc-ccCC-CCCHHHHHHHHHHHHHHHHHHH-hcCCCCeEeccCCCCcEEeCCCC-cEEEEecccceecCC
Q 039819 264 PYMSNGSVASRL-REKP-ALDWNTRKRIAIGAARGLLYLH-EQCDPKIIHRDVKAANVLLDDFC-EAIVGDFGLAKLLDH 339 (534)
Q Consensus 264 e~~~~gsL~~~l-~~~~-~l~~~~~~~i~~~i~~~l~yLH-~~~~~~ivH~Dlkp~NiLl~~~~-~~kl~DFGla~~~~~ 339 (534)
+|..++++.+.+ .... ..+......++.|+..++.|+| .. ++.|||+||+|.+++..+ ..+++|||+|.....
T Consensus 101 ~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~---~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~ 177 (601)
T KOG0590|consen 101 SYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPEN---GVTHRDIKPSNSLLDESGSALKIADFGLATAYRN 177 (601)
T ss_pred CcccccccccccccCCccCCCCcchhhhhhhhccCccccCccc---ccccCCCCCccchhccCCCcccCCCchhhccccc
Confidence 999999999988 5443 5677778889999999999999 66 999999999999999999 999999999997765
Q ss_pred --CCCceeecccc-ccccccccccccC-CCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccce
Q 039819 340 --SDSHVTTAVRG-TVGHIAPEYLSTG-QSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEV 415 (534)
Q Consensus 340 --~~~~~~~~~~g-t~~y~aPE~~~~~-~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 415 (534)
+........+| ++.|+|||...+. ...+..|+||.|+++.-+++|..|++....... ....|...- .
T Consensus 178 ~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~--~~~~~~~~~---~---- 248 (601)
T KOG0590|consen 178 KNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDG--RYSSWKSNK---G---- 248 (601)
T ss_pred cCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccc--cceeecccc---c----
Confidence 33334455678 9999999998774 456789999999999999999999986543321 112222110 0
Q ss_pred ecccccCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 416 LVDRELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 416 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
......-........++..+++..+|..|.+.+++..
T Consensus 249 ----~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~ 285 (601)
T KOG0590|consen 249 ----RFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKL 285 (601)
T ss_pred ----ccccCccccCChhhhhcccccccCCchhccccccccc
Confidence 0000001112236677888888899999999998764
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.57 E-value=4.8e-15 Score=162.31 Aligned_cols=126 Identities=37% Similarity=0.570 Sum_probs=103.7
Q ss_pred CceecC-C----CcEEEEEecCCCceeecccccccCCCCCEEEccCCccCcCCCCCCCCCCCCCEEEcCCCcCccccCch
Q 039819 1 MITCSP-E----NLVIGLGAPSQSLSGTLSGSIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPAL 75 (534)
Q Consensus 1 ~v~c~~-~----~~l~~L~l~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~P~~~~~l~~L~~L~Ls~N~l~g~~p~~ 75 (534)
||+|.. . ..|+.|+|++|+|+|.+|..|+.|++|+.|+|++|+|+|.+|..++.|++|+.|||++|+|+|.+|..
T Consensus 406 Gv~C~~~~~~~~~~v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~ 485 (623)
T PLN03150 406 GADCQFDSTKGKWFIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPES 485 (623)
T ss_pred cceeeccCCCCceEEEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchH
Confidence 788952 1 24899999999999999999999999999999999999999999999999999999999999999999
Q ss_pred hhhcccCcccccccccCCccccceeCCCCcCcccCChhhhcc-cccccccccCCCCCCCCCCCCCccccccCCcceecCC
Q 039819 76 LFLSIWLPRKWDKRKCSGVDQGLLRLNNNSLSGAFPVFLAKI-SELAFLDLSYNNLSGPVPKFPARTFNVAGNPLICGSS 154 (534)
Q Consensus 76 ~~~l~~l~~~~~~~~~~~~~L~~L~L~~N~l~g~~p~~~~~l-~~L~~L~ls~N~l~g~~p~~~~~~~~~~~N~~~cg~~ 154 (534)
+..+. +|+.|+|++|+|+|.+|..++.+ .++.. +.+.+|+..|+..
T Consensus 486 l~~L~--------------~L~~L~Ls~N~l~g~iP~~l~~~~~~~~~-------------------l~~~~N~~lc~~p 532 (623)
T PLN03150 486 LGQLT--------------SLRILNLNGNSLSGRVPAALGGRLLHRAS-------------------FNFTDNAGLCGIP 532 (623)
T ss_pred HhcCC--------------CCCEEECcCCcccccCChHHhhccccCce-------------------EEecCCccccCCC
Confidence 88888 88899999999999999887653 12233 3455666677654
Q ss_pred CCCcc
Q 039819 155 STNVC 159 (534)
Q Consensus 155 ~~~~~ 159 (534)
....|
T Consensus 533 ~l~~C 537 (623)
T PLN03150 533 GLRAC 537 (623)
T ss_pred CCCCC
Confidence 44455
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.56 E-value=1.9e-14 Score=127.97 Aligned_cols=123 Identities=18% Similarity=0.134 Sum_probs=103.2
Q ss_pred CCeeccCCcEEEEEEEECCCcEEEEEEehh------------hhhhccc--CceeeEEEEEeCCCeeEEEeeccCCCChh
Q 039819 207 KNILGAGGFGNVYKGKLGDGTVLAVKRLKD------------MISLAVH--RNLLRLIGYCATPTERLLVYPYMSNGSVA 272 (534)
Q Consensus 207 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~------------~l~~~~h--~niv~l~~~~~~~~~~~lv~e~~~~gsL~ 272 (534)
.+.||+|.++.||++...+ ..++||.... .+..+.| ..++++++++...+..+++|||++++.+.
T Consensus 3 ~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~~~ 81 (155)
T cd05120 3 IKLLKGGLTNRVYLLGTKD-EDYVLKINPSREKGADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGETLD 81 (155)
T ss_pred ceecccccccceEEEEecC-CeEEEEecCCCCchhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCeecc
Confidence 4679999999999999855 6789997743 3445555 58889998888888899999999988776
Q ss_pred hhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceec
Q 039819 273 SRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLL 337 (534)
Q Consensus 273 ~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~ 337 (534)
.. +......++.+++++++++|.....+++|+|++|+||++++.+.+++.|||.+...
T Consensus 82 ~~-------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~~ 139 (155)
T cd05120 82 EV-------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGYG 139 (155)
T ss_pred cC-------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccCC
Confidence 54 66777889999999999999864457999999999999999999999999998743
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.56 E-value=5.8e-15 Score=171.44 Aligned_cols=147 Identities=30% Similarity=0.400 Sum_probs=118.2
Q ss_pred CceecCCCcEEEEEecCCCceeecccccccCCCCCEEEccCCccCcCCCCCCC-CCCCCCEEEcCCCcCccccCchhhhc
Q 039819 1 MITCSPENLVIGLGAPSQSLSGTLSGSIGNLTNLRQVLLQNNNISGGIPPQLG-SLPKLQTLDLSNNRLSGVIPALLFLS 79 (534)
Q Consensus 1 ~v~c~~~~~l~~L~l~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~P~~~~-~l~~L~~L~Ls~N~l~g~~p~~~~~l 79 (534)
||+|+..++|+.|+|++|+++|.+|..|..+++|++|+|++|+|+|.+|..+. ++++|++|+|++|+++|.+|.. .+
T Consensus 62 gv~c~~~~~v~~L~L~~~~i~~~~~~~~~~l~~L~~L~Ls~n~~~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~~--~l 139 (968)
T PLN00113 62 GITCNNSSRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPRG--SI 139 (968)
T ss_pred ceecCCCCcEEEEEecCCCccccCChHHhCCCCCCEEECCCCccCCcCChHHhccCCCCCEEECcCCccccccCcc--cc
Confidence 78998668999999999999999999999999999999999999999998865 8999999999999999888852 23
Q ss_pred ccCcccccccc-c---------CCccccceeCCCCcCcccCChhhhcccccccccccCCCCCCCCCCCCC-----ccccc
Q 039819 80 IWLPRKWDKRK-C---------SGVDQGLLRLNNNSLSGAFPVFLAKISELAFLDLSYNNLSGPVPKFPA-----RTFNV 144 (534)
Q Consensus 80 ~~l~~~~~~~~-~---------~~~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~-----~~~~~ 144 (534)
+.|..+..+.+ . ...+|+.|+|++|.+.+.+|..|+++++|++|+|++|++++.+|..+. +.+.+
T Consensus 140 ~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L 219 (968)
T PLN00113 140 PNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYL 219 (968)
T ss_pred CCCCEEECcCCcccccCChHHhcCCCCCEEECccCcccccCChhhhhCcCCCeeeccCCCCcCcCChHHcCcCCccEEEC
Confidence 33333221111 1 113788899999998888899899999999999999999888886544 45566
Q ss_pred cCCcc
Q 039819 145 AGNPL 149 (534)
Q Consensus 145 ~~N~~ 149 (534)
.+|..
T Consensus 220 ~~n~l 224 (968)
T PLN00113 220 GYNNL 224 (968)
T ss_pred cCCcc
Confidence 67755
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.51 E-value=1.2e-15 Score=133.29 Aligned_cols=139 Identities=24% Similarity=0.378 Sum_probs=85.0
Q ss_pred CcEEEEEecCCCceeecccccccCCCCCEEEccCCccCcCCCCCCCCCCCCCEEEcCCCcCccccCchhhhcccCc----
Q 039819 8 NLVIGLGAPSQSLSGTLSGSIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFLSIWLP---- 83 (534)
Q Consensus 8 ~~l~~L~l~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~P~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~l~---- 83 (534)
..++.|.|++|.|+ .+|+.|..|.+|+.|+++||+|+ .+|.+++.|++|+.|+++-|+|. .+|..|+.++.+.
T Consensus 33 s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~levldl 109 (264)
T KOG0617|consen 33 SNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEVLDL 109 (264)
T ss_pred hhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhhhhhc
Confidence 35666777777776 56666777777777777777776 66666766666666666666666 6666555544332
Q ss_pred ---------------------ccc-cccccC--------CccccceeCCCCcCcccCChhhhcccccccccccCCCCCCC
Q 039819 84 ---------------------RKW-DKRKCS--------GVDQGLLRLNNNSLSGAFPVFLAKISELAFLDLSYNNLSGP 133 (534)
Q Consensus 84 ---------------------~~~-~~~~~~--------~~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~ 133 (534)
.++ +.+.+. ..+|+.|.|..|.|- .+|..++.+.+|+.|++.+|+|+-.
T Consensus 110 tynnl~e~~lpgnff~m~tlralyl~dndfe~lp~dvg~lt~lqil~lrdndll-~lpkeig~lt~lrelhiqgnrl~vl 188 (264)
T KOG0617|consen 110 TYNNLNENSLPGNFFYMTTLRALYLGDNDFEILPPDVGKLTNLQILSLRDNDLL-SLPKEIGDLTRLRELHIQGNRLTVL 188 (264)
T ss_pred cccccccccCCcchhHHHHHHHHHhcCCCcccCChhhhhhcceeEEeeccCchh-hCcHHHHHHHHHHHHhcccceeeec
Confidence 221 111111 125666677777766 6777777777777777777777744
Q ss_pred CCCCCC-------ccccccCCcce
Q 039819 134 VPKFPA-------RTFNVAGNPLI 150 (534)
Q Consensus 134 ~p~~~~-------~~~~~~~N~~~ 150 (534)
+|+... ....+..|||.
T Consensus 189 ppel~~l~l~~~k~v~r~E~NPwv 212 (264)
T KOG0617|consen 189 PPELANLDLVGNKQVMRMEENPWV 212 (264)
T ss_pred ChhhhhhhhhhhHHHHhhhhCCCC
Confidence 443211 23456677773
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.51 E-value=1.1e-13 Score=133.65 Aligned_cols=122 Identities=18% Similarity=0.226 Sum_probs=94.4
Q ss_pred CCeec-cCCcEEEEEEEECCCcEEEEEEehh---------------------------hhhhcccCce--eeEEEEEeCC
Q 039819 207 KNILG-AGGFGNVYKGKLGDGTVLAVKRLKD---------------------------MISLAVHRNL--LRLIGYCATP 256 (534)
Q Consensus 207 ~~~lG-~G~~g~Vy~~~~~~~~~vavK~~~~---------------------------~l~~~~h~ni--v~l~~~~~~~ 256 (534)
..+|| .|+.|+||.+... +..++||++.. ++..+.|+++ ++.+++....
T Consensus 36 ~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred CceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 35788 8999999999885 56788886631 4455667774 6677765433
Q ss_pred Ce----eEEEeeccCC-CChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEec
Q 039819 257 TE----RLLVYPYMSN-GSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDF 331 (534)
Q Consensus 257 ~~----~~lv~e~~~~-gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DF 331 (534)
.. .++||||+++ .+|.+++... .++.. .+.+++.+|.+||+. +|+||||||.|||++.++.++|+||
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~~-~l~~~----~~~~i~~~l~~lH~~---GI~HrDlkp~NILv~~~~~v~LIDf 186 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQEA-PLSEE----QWQAIGQLIARFHDA---GVYHADLNAHNILLDPDGKFWLIDF 186 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhcC-CCCHH----HHHHHHHHHHHHHHC---CCCCCCCCchhEEEcCCCCEEEEEC
Confidence 22 2599999997 6888887653 45543 356899999999999 9999999999999999899999999
Q ss_pred ccceec
Q 039819 332 GLAKLL 337 (534)
Q Consensus 332 Gla~~~ 337 (534)
|.+...
T Consensus 187 g~~~~~ 192 (239)
T PRK01723 187 DRGELR 192 (239)
T ss_pred CCcccC
Confidence 988753
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.47 E-value=1.7e-14 Score=138.23 Aligned_cols=200 Identities=22% Similarity=0.278 Sum_probs=137.9
Q ss_pred hhhhcccCceeeEEEEEeCC-----CeeEEEeeccCCCChhhhccc----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCC
Q 039819 237 MISLAVHRNLLRLIGYCATP-----TERLLVYPYMSNGSVASRLRE----KPALDWNTRKRIAIGAARGLLYLHEQCDPK 307 (534)
Q Consensus 237 ~l~~~~h~niv~l~~~~~~~-----~~~~lv~e~~~~gsL~~~l~~----~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ 307 (534)
-+-++.|.|||++..|+.+. .+..++.|||..|++..+|++ +..+......+|+.||..||.|||+ |.|+
T Consensus 120 nllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs-~~Pp 198 (458)
T KOG1266|consen 120 NLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHS-CDPP 198 (458)
T ss_pred HHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhc-cCCc
Confidence 45666799999999998654 356899999999999999973 4467778888999999999999998 5899
Q ss_pred eEeccCCCCcEEeCCCCcEEEEecccceecC---CCCCceeeccccccccccccccccCCCCcchhHHHHHHHHHHHHhC
Q 039819 308 IIHRDVKAANVLLDDFCEAIVGDFGLAKLLD---HSDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITG 384 (534)
Q Consensus 308 ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~---~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG 384 (534)
|+|+++..+-|++..++-+||+----..... ...........+-++|.|||+-.....+..+|||+||...+||..+
T Consensus 199 iihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemail 278 (458)
T KOG1266|consen 199 IIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAIL 278 (458)
T ss_pred cccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHh
Confidence 9999999999999999999984321111110 0011112223467899999988777778899999999999999877
Q ss_pred CCCcCCCccccccchHHHHHHHHhhhcccceecccccCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 039819 385 MRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRM 457 (534)
Q Consensus 385 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~ 457 (534)
.--...+.+. ...+- .+ ...+.+- +-..=...+.+|++..|..||+|++++..
T Consensus 279 Eiq~tnseS~----~~~ee--------~i----a~~i~~l----en~lqr~~i~kcl~~eP~~rp~ar~llfH 331 (458)
T KOG1266|consen 279 EIQSTNSESK----VEVEE--------NI----ANVIIGL----ENGLQRGSITKCLEGEPNGRPDARLLLFH 331 (458)
T ss_pred eeccCCCcce----eehhh--------hh----hhheeec----cCccccCcCcccccCCCCCCcchhhhhcC
Confidence 4321111110 00000 00 0000000 00011245678999999999999998754
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.47 E-value=4.5e-14 Score=154.65 Aligned_cols=93 Identities=33% Similarity=0.486 Sum_probs=88.7
Q ss_pred CCCEEEccCCccCcCCCCCCCCCCCCCEEEcCCCcCccccCchhhhcccCcccccccccCCccccceeCCCCcCcccCCh
Q 039819 33 NLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFLSIWLPRKWDKRKCSGVDQGLLRLNNNSLSGAFPV 112 (534)
Q Consensus 33 ~L~~L~L~~N~l~g~~P~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~l~~~~~~~~~~~~~L~~L~L~~N~l~g~~p~ 112 (534)
.++.|+|++|.|+|.+|.+|+.|++|+.|+|++|+|+|.+|..+..+. +|+.|+|++|+|+|.+|.
T Consensus 419 ~v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~--------------~L~~LdLs~N~lsg~iP~ 484 (623)
T PLN03150 419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSIT--------------SLEVLDLSYNSFNGSIPE 484 (623)
T ss_pred EEEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCC--------------CCCEEECCCCCCCCCCch
Confidence 478999999999999999999999999999999999999999999888 889999999999999999
Q ss_pred hhhcccccccccccCCCCCCCCCCCCC
Q 039819 113 FLAKISELAFLDLSYNNLSGPVPKFPA 139 (534)
Q Consensus 113 ~~~~l~~L~~L~ls~N~l~g~~p~~~~ 139 (534)
.++.+++|+.|+|++|+|+|.+|..+.
T Consensus 485 ~l~~L~~L~~L~Ls~N~l~g~iP~~l~ 511 (623)
T PLN03150 485 SLGQLTSLRILNLNGNSLSGRVPAALG 511 (623)
T ss_pred HHhcCCCCCEEECcCCcccccCChHHh
Confidence 999999999999999999999998654
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.45 E-value=6.6e-15 Score=128.70 Aligned_cols=108 Identities=27% Similarity=0.445 Sum_probs=95.1
Q ss_pred cccCCCCCEEEccCCccCcCCCCCCCCCCCCCEEEcCCCcCccccCchhhhcccCcccccccccCCccccceeCCCCcCc
Q 039819 28 IGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFLSIWLPRKWDKRKCSGVDQGLLRLNNNSLS 107 (534)
Q Consensus 28 ~~~l~~L~~L~L~~N~l~g~~P~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~l~~~~~~~~~~~~~L~~L~L~~N~l~ 107 (534)
+-++.+++.|.||+|+|+ .+|+.+..|.+|+.|++++|+++ .+|..++.++ +|+.|+++-|.|.
T Consensus 29 Lf~~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~--------------klr~lnvgmnrl~ 92 (264)
T KOG0617|consen 29 LFNMSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLP--------------KLRILNVGMNRLN 92 (264)
T ss_pred ccchhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhch--------------hhhheecchhhhh
Confidence 446788999999999999 89999999999999999999999 8999999888 8999999999999
Q ss_pred ccCChhhhcccccccccccCCCCCC-CCCCCCC-----ccccccCCcceec
Q 039819 108 GAFPVFLAKISELAFLDLSYNNLSG-PVPKFPA-----RTFNVAGNPLICG 152 (534)
Q Consensus 108 g~~p~~~~~l~~L~~L~ls~N~l~g-~~p~~~~-----~~~~~~~N~~~cg 152 (534)
.+|..|+.++.|+.|||++|+|.. .+|..++ +.+.+.+|-+.--
T Consensus 93 -~lprgfgs~p~levldltynnl~e~~lpgnff~m~tlralyl~dndfe~l 142 (264)
T KOG0617|consen 93 -ILPRGFGSFPALEVLDLTYNNLNENSLPGNFFYMTTLRALYLGDNDFEIL 142 (264)
T ss_pred -cCccccCCCchhhhhhccccccccccCCcchhHHHHHHHHHhcCCCcccC
Confidence 999999999999999999999984 4665443 5677888876543
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.40 E-value=1.5e-12 Score=136.57 Aligned_cols=127 Identities=22% Similarity=0.259 Sum_probs=92.6
Q ss_pred CCeeccCCcEEEEEEEECCCcEEEEEEehh-----------hh-------------------------------------
Q 039819 207 KNILGAGGFGNVYKGKLGDGTVLAVKRLKD-----------MI------------------------------------- 238 (534)
Q Consensus 207 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~-----------~l------------------------------------- 238 (534)
.+.||.|++|.||+|++.+|+.||||+.+. ++
T Consensus 122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 368999999999999999999999998741 00
Q ss_pred ----------hhcccCceeeEEEEEe-CCCeeEEEeeccCCCChhhhcccC-CCCCHHHHHHHHHHHHH-HHHHHHhcCC
Q 039819 239 ----------SLAVHRNLLRLIGYCA-TPTERLLVYPYMSNGSVASRLREK-PALDWNTRKRIAIGAAR-GLLYLHEQCD 305 (534)
Q Consensus 239 ----------~~~~h~niv~l~~~~~-~~~~~~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~~i~~-~l~yLH~~~~ 305 (534)
....|.+-+.+-.++. .....+|||||++|++|.+..... ... .+.+++..++. .+..+|..
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~---~~~~ia~~~~~~~l~ql~~~-- 276 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGL---DRKALAENLARSFLNQVLRD-- 276 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCC---CHHHHHHHHHHHHHHHHHhC--
Confidence 0111222223222332 234579999999999998876422 122 24456666666 46788887
Q ss_pred CCeEeccCCCCcEEeCCCCcEEEEecccceecCC
Q 039819 306 PKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDH 339 (534)
Q Consensus 306 ~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~ 339 (534)
+++|+|+||.||+++.++.++++|||++..+..
T Consensus 277 -g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 277 -GFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred -CceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 999999999999999999999999999987653
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.32 E-value=2.5e-12 Score=133.45 Aligned_cols=232 Identities=21% Similarity=0.222 Sum_probs=170.0
Q ss_pred CCCcCCeecc--CCcEEEEEEEE---CCCcEEEEEEehh-----------------hhhhcccCceeeEEEEEeCCCeeE
Q 039819 203 NFSSKNILGA--GGFGNVYKGKL---GDGTVLAVKRLKD-----------------MISLAVHRNLLRLIGYCATPTERL 260 (534)
Q Consensus 203 ~~~~~~~lG~--G~~g~Vy~~~~---~~~~~vavK~~~~-----------------~l~~~~h~niv~l~~~~~~~~~~~ 260 (534)
.|.....+|. |.+|.||.+.. .++..+|+|+-+. ....-.|+|.++....+...+..+
T Consensus 115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lf 194 (524)
T KOG0601|consen 115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILF 194 (524)
T ss_pred hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcce
Confidence 4556678999 99999999987 3678889987331 112223889999888888888999
Q ss_pred EEeeccCCCChhhhcccCCC-CCHHHHHHHHHHHHH----HHHHHHhcCCCCeEeccCCCCcEEeCCC-CcEEEEecccc
Q 039819 261 LVYPYMSNGSVASRLREKPA-LDWNTRKRIAIGAAR----GLLYLHEQCDPKIIHRDVKAANVLLDDF-CEAIVGDFGLA 334 (534)
Q Consensus 261 lv~e~~~~gsL~~~l~~~~~-l~~~~~~~i~~~i~~----~l~yLH~~~~~~ivH~Dlkp~NiLl~~~-~~~kl~DFGla 334 (534)
+-.|++. .+|.++.+.... ++....+.+..+..+ |+.++|+. +++|-|+||.||+...+ ...+++|||+.
T Consensus 195 iqtE~~~-~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~---~~~~~~~kp~~i~~~~~~~s~~~~df~~v 270 (524)
T KOG0601|consen 195 IQTELCG-ESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSN---NIVHDDLKPANIFTTSDWTSCKLTDFGLV 270 (524)
T ss_pred eeecccc-chhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCC---cccccccchhheecccccceeecCCccee
Confidence 9999986 677777765433 677777777777777 99999998 99999999999999999 88999999999
Q ss_pred eecCCCCC----ceeeccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhh
Q 039819 335 KLLDHSDS----HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQE 410 (534)
Q Consensus 335 ~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 410 (534)
..+....- .......|...|++||.. .+.++...|+||+|.|.+|..++..+.-.+... .|...
T Consensus 271 ~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~-~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~-------~W~~~---- 338 (524)
T KOG0601|consen 271 SKISDGNFSSVFKVSKRPEGDCIYAAKELL-NGLATFASDIFSLGEVILEAILGSHLPSVGKNS-------SWSQL---- 338 (524)
T ss_pred EEccCCccccceeeeecCCCCceEeChhhh-ccccchHhhhcchhhhhHhhHhhcccccCCCCC-------Ccccc----
Confidence 88765431 112223578899999987 557788999999999999999998876544211 12110
Q ss_pred cccceecccccCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 411 KKVEVLVDRELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 411 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
... .+..++.......+......+++.+|..|++.+.+..
T Consensus 339 r~~------~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 339 RQG------YIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred ccc------cCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 000 0111111111234455888999999999999988865
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.31 E-value=1.3e-13 Score=135.25 Aligned_cols=123 Identities=27% Similarity=0.374 Sum_probs=80.2
Q ss_pred EEEEEecCCCceeecccccccCCCCCEEEccCCccCcCCCCCCCCCCCCCEEEcCCCcCccccCchhh-hcccCcccccc
Q 039819 10 VIGLGAPSQSLSGTLSGSIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLF-LSIWLPRKWDK 88 (534)
Q Consensus 10 l~~L~l~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~P~~~~~l~~L~~L~Ls~N~l~g~~p~~~~-~l~~l~~~~~~ 88 (534)
+..||..+|-|. ++|+.++.|.+|+-|+|..|+|. .+| +|.++..|++|+++.|+|+ .+|.+.. .+.
T Consensus 185 L~~ld~~~N~L~-tlP~~lg~l~~L~~LyL~~Nki~-~lP-ef~gcs~L~Elh~g~N~i~-~lpae~~~~L~-------- 252 (565)
T KOG0472|consen 185 LKHLDCNSNLLE-TLPPELGGLESLELLYLRRNKIR-FLP-EFPGCSLLKELHVGENQIE-MLPAEHLKHLN-------- 252 (565)
T ss_pred HHhcccchhhhh-cCChhhcchhhhHHHHhhhcccc-cCC-CCCccHHHHHHHhcccHHH-hhHHHHhcccc--------
Confidence 344444444443 45555555555555555555554 444 4555555555555555555 4444433 333
Q ss_pred cccCCccccceeCCCCcCcccCChhhhcccccccccccCCCCCCCCCCCCC---ccccccCCccee
Q 039819 89 RKCSGVDQGLLRLNNNSLSGAFPVFLAKISELAFLDLSYNNLSGPVPKFPA---RTFNVAGNPLIC 151 (534)
Q Consensus 89 ~~~~~~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~---~~~~~~~N~~~c 151 (534)
++..|||.+|+++ +.|+.++-+.+|.+||+|+|.+++.++.... +.+.+.|||+..
T Consensus 253 ------~l~vLDLRdNklk-e~Pde~clLrsL~rLDlSNN~is~Lp~sLgnlhL~~L~leGNPlrT 311 (565)
T KOG0472|consen 253 ------SLLVLDLRDNKLK-EVPDEICLLRSLERLDLSNNDISSLPYSLGNLHLKFLALEGNPLRT 311 (565)
T ss_pred ------cceeeeccccccc-cCchHHHHhhhhhhhcccCCccccCCcccccceeeehhhcCCchHH
Confidence 7889999999999 9999999999999999999999965554322 567889999843
|
|
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.28 E-value=7.9e-13 Score=135.97 Aligned_cols=137 Identities=26% Similarity=0.249 Sum_probs=92.1
Q ss_pred cEEEEEecCCCceeecccccccCCCCCEEEccCCccCcCCCCC-CCCCCCCCEEEcCCCcCccccCchhhhcccCccccc
Q 039819 9 LVIGLGAPSQSLSGTLSGSIGNLTNLRQVLLQNNNISGGIPPQ-LGSLPKLQTLDLSNNRLSGVIPALLFLSIWLPRKWD 87 (534)
Q Consensus 9 ~l~~L~l~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~P~~-~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~l~~~~~ 87 (534)
.++.||||+|+|. ..|..+.+-+++-+|+||+|+|. .||.. |-+|..|-+||||+|+|. .+|..+..+..|..+..
T Consensus 104 dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~Ie-tIPn~lfinLtDLLfLDLS~NrLe-~LPPQ~RRL~~LqtL~L 180 (1255)
T KOG0444|consen 104 DLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIE-TIPNSLFINLTDLLFLDLSNNRLE-MLPPQIRRLSMLQTLKL 180 (1255)
T ss_pred cceeeecchhhhh-hcchhhhhhcCcEEEEcccCccc-cCCchHHHhhHhHhhhccccchhh-hcCHHHHHHhhhhhhhc
Confidence 4777777777777 67777777777777777777777 56655 567777777777777777 66666555544333221
Q ss_pred cccc-----------------------------------CCccccceeCCCCcCcccCChhhhcccccccccccCCCCCC
Q 039819 88 KRKC-----------------------------------SGVDQGLLRLNNNSLSGAFPVFLAKISELAFLDLSYNNLSG 132 (534)
Q Consensus 88 ~~~~-----------------------------------~~~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g 132 (534)
+++- ...+|..++||.|.|. .+|..+-.+++|+.|+||+|+++
T Consensus 181 s~NPL~hfQLrQLPsmtsL~vLhms~TqRTl~N~Ptsld~l~NL~dvDlS~N~Lp-~vPecly~l~~LrrLNLS~N~it- 258 (1255)
T KOG0444|consen 181 SNNPLNHFQLRQLPSMTSLSVLHMSNTQRTLDNIPTSLDDLHNLRDVDLSENNLP-IVPECLYKLRNLRRLNLSGNKIT- 258 (1255)
T ss_pred CCChhhHHHHhcCccchhhhhhhcccccchhhcCCCchhhhhhhhhccccccCCC-cchHHHhhhhhhheeccCcCcee-
Confidence 1110 0025677888888887 78888888888888888888877
Q ss_pred CCCCCC-----CccccccCCcce
Q 039819 133 PVPKFP-----ARTFNVAGNPLI 150 (534)
Q Consensus 133 ~~p~~~-----~~~~~~~~N~~~ 150 (534)
.+.... .++++++.|.+.
T Consensus 259 eL~~~~~~W~~lEtLNlSrNQLt 281 (1255)
T KOG0444|consen 259 ELNMTEGEWENLETLNLSRNQLT 281 (1255)
T ss_pred eeeccHHHHhhhhhhccccchhc
Confidence 332211 156788888764
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.27 E-value=6.7e-13 Score=135.75 Aligned_cols=143 Identities=24% Similarity=0.207 Sum_probs=108.7
Q ss_pred CcEEEEEecCCCceeecccccccCCCCCEEEccCCccCcCCCCCCCCCCCCCEEEcCCCcCccccCchhhhcccCccccc
Q 039819 8 NLVIGLGAPSQSLSGTLSGSIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFLSIWLPRKWD 87 (534)
Q Consensus 8 ~~l~~L~l~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~P~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~l~~~~~ 87 (534)
.++..|+|+.|+++..-.+.+-+|++|+.|+||+|.|+.+.++++..+++|++||||+|+|+...|..|..+..|..+-.
T Consensus 269 ~kme~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnL 348 (873)
T KOG4194|consen 269 EKMEHLNLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQLEELNL 348 (873)
T ss_pred cccceeecccchhhhhhcccccccchhhhhccchhhhheeecchhhhcccceeEeccccccccCChhHHHHHHHhhhhcc
Confidence 36889999999999766778999999999999999999999999999999999999999999666677776664444322
Q ss_pred cc-cc--------CC-ccccceeCCCCcCcccCC---hhhhcccccccccccCCCCCCCCCCC-CC-----ccccccCCc
Q 039819 88 KR-KC--------SG-VDQGLLRLNNNSLSGAFP---VFLAKISELAFLDLSYNNLSGPVPKF-PA-----RTFNVAGNP 148 (534)
Q Consensus 88 ~~-~~--------~~-~~L~~L~L~~N~l~g~~p---~~~~~l~~L~~L~ls~N~l~g~~p~~-~~-----~~~~~~~N~ 148 (534)
+. .. .+ .+|+.|||++|.|++.+- ..|.+|++|+.|+|.+|+|. .+|.- +. +.+++.+|+
T Consensus 349 s~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~LrkL~l~gNqlk-~I~krAfsgl~~LE~LdL~~Na 427 (873)
T KOG4194|consen 349 SHNSIDHLAEGAFVGLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLRKLRLTGNQLK-SIPKRAFSGLEALEHLDLGDNA 427 (873)
T ss_pred cccchHHHHhhHHHHhhhhhhhcCcCCeEEEEEecchhhhccchhhhheeecCceee-ecchhhhccCcccceecCCCCc
Confidence 11 11 11 267788888888877665 35677888888888888887 56632 21 567888887
Q ss_pred cee
Q 039819 149 LIC 151 (534)
Q Consensus 149 ~~c 151 (534)
...
T Consensus 428 iaS 430 (873)
T KOG4194|consen 428 IAS 430 (873)
T ss_pred cee
Confidence 643
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.26 E-value=2.2e-11 Score=129.41 Aligned_cols=128 Identities=19% Similarity=0.196 Sum_probs=86.8
Q ss_pred HhCCCcCCeeccCCcEEEEEEEECC-CcEEEEEEehhh-----------h------------------------------
Q 039819 201 TENFSSKNILGAGGFGNVYKGKLGD-GTVLAVKRLKDM-----------I------------------------------ 238 (534)
Q Consensus 201 ~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~-----------l------------------------------ 238 (534)
...|+. +.||+|++|.||+|++.+ |+.||||+++.- +
T Consensus 119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l 197 (537)
T PRK04750 119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL 197 (537)
T ss_pred HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence 455766 789999999999999987 999999987510 0
Q ss_pred -----------------hhcccCceeeEEEEEeC-CCeeEEEeeccCCCChhhhc--ccCC----CCCHHHHHHHHHHHH
Q 039819 239 -----------------SLAVHRNLLRLIGYCAT-PTERLLVYPYMSNGSVASRL--REKP----ALDWNTRKRIAIGAA 294 (534)
Q Consensus 239 -----------------~~~~h~niv~l~~~~~~-~~~~~lv~e~~~~gsL~~~l--~~~~----~l~~~~~~~i~~~i~ 294 (534)
....+.+.+.+-.++.+ ....+|||||++|+.+.+.. ...+ .+.......++.|+
T Consensus 198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi- 276 (537)
T PRK04750 198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV- 276 (537)
T ss_pred HHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH-
Confidence 00012222332233322 34567999999999997742 2222 12222233333333
Q ss_pred HHHHHHHhcCCCCeEeccCCCCcEEeCCCC----cEEEEecccceecCC
Q 039819 295 RGLLYLHEQCDPKIIHRDVKAANVLLDDFC----EAIVGDFGLAKLLDH 339 (534)
Q Consensus 295 ~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~----~~kl~DFGla~~~~~ 339 (534)
+.. +++|+|+||.||+++.++ .+++.|||++..+..
T Consensus 277 ------f~~---GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 277 ------FRD---GFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred ------HhC---CeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 334 999999999999999888 999999999987754
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.19 E-value=1.2e-11 Score=128.52 Aligned_cols=235 Identities=20% Similarity=0.210 Sum_probs=170.4
Q ss_pred HHHHHhCCCcCCeeccCCcEEEEEEEEC--CCcEEEEEEehh-----------------hhhhcccCceeeEEEEEeCCC
Q 039819 197 LQQATENFSSKNILGAGGFGNVYKGKLG--DGTVLAVKRLKD-----------------MISLAVHRNLLRLIGYCATPT 257 (534)
Q Consensus 197 l~~~~~~~~~~~~lG~G~~g~Vy~~~~~--~~~~vavK~~~~-----------------~l~~~~h~niv~l~~~~~~~~ 257 (534)
....+.+|.....||.|.|+.|++...+ ++..+++|...+ ......|.++++....+..-+
T Consensus 260 ~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r 339 (524)
T KOG0601|consen 260 TSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLR 339 (524)
T ss_pred ceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccc
Confidence 4455678888999999999999998753 678899997764 112334888888777777777
Q ss_pred eeEEEeeccCCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCC-CcEEEEeccccee
Q 039819 258 ERLLVYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDF-CEAIVGDFGLAKL 336 (534)
Q Consensus 258 ~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~-~~~kl~DFGla~~ 336 (534)
..|+--|||.++++.........++...++++..+++.++.++|+. .++|+|+||+||++..+ +.-+++|||.++.
T Consensus 340 ~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~---~~~~~d~~psni~i~~~~~~~~~~~~~~~t~ 416 (524)
T KOG0601|consen 340 QGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSK---LFVHLDVKPSNILISNDGFFSKLGDFGCWTR 416 (524)
T ss_pred cccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccch---hhhcccccccceeeccchhhhhccccccccc
Confidence 8889999999999887776566788889999999999999999998 99999999999999886 7889999999874
Q ss_pred cCCCCCceeeccccccccc--cccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccc
Q 039819 337 LDHSDSHVTTAVRGTVGHI--APEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVE 414 (534)
Q Consensus 337 ~~~~~~~~~~~~~gt~~y~--aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 414 (534)
+... ......+-++. +++......+..+.|+||||.-+.|.++|..--+... +|...
T Consensus 417 ~~~~----~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~---------~~~~i-------- 475 (524)
T KOG0601|consen 417 LAFS----SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGV---------QSLTI-------- 475 (524)
T ss_pred ccee----cccccccccccccchhhccccccccccccccccccccccccCcccCcccc---------cceee--------
Confidence 3221 11122233344 4555555667889999999999999999875433111 11110
Q ss_pred eecccccCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhh
Q 039819 415 VLVDRELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLE 459 (534)
Q Consensus 415 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~ 459 (534)
....+ ...+.. ...+..++..+...++..||.+.++..+.+
T Consensus 476 --~~~~~-p~~~~~-~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~ 516 (524)
T KOG0601|consen 476 --RSGDT-PNLPGL-KLQLQVLLKVMINPDRKRRPSAVELSLHSE 516 (524)
T ss_pred --ecccc-cCCCch-HHhhhhhhhhhcCCccccchhhhhhcccch
Confidence 00000 011111 246777888889999999999988776443
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.18 E-value=7.8e-11 Score=107.52 Aligned_cols=116 Identities=19% Similarity=0.169 Sum_probs=84.4
Q ss_pred CeeccCCcEEEEEEEECCCcEEEEEEehh-------------hhhhcccCcee-eEEEEEeCCCeeEEEeeccCCCChhh
Q 039819 208 NILGAGGFGNVYKGKLGDGTVLAVKRLKD-------------MISLAVHRNLL-RLIGYCATPTERLLVYPYMSNGSVAS 273 (534)
Q Consensus 208 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~-------------~l~~~~h~niv-~l~~~~~~~~~~~lv~e~~~~gsL~~ 273 (534)
+.|+.|.++.||+++.. +..+++|.... .+..+.+.+++ +++.+. ....++||||+++.++.+
T Consensus 4 ~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l~~ 80 (170)
T cd05151 4 SPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTELLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSELLT 80 (170)
T ss_pred eecCCcccCceEEEEEC-CeEEEEEeCCCCcccccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCcccc
Confidence 56889999999999975 66789997532 33344344443 444443 334689999999988764
Q ss_pred hcccCCCCCHHHHHHHHHHHHHHHHHHHhcC--CCCeEeccCCCCcEEeCCCCcEEEEecccce
Q 039819 274 RLREKPALDWNTRKRIAIGAARGLLYLHEQC--DPKIIHRDVKAANVLLDDFCEAIVGDFGLAK 335 (534)
Q Consensus 274 ~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~--~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~ 335 (534)
.. .....++.+++++|+.||... ...++|+|++|.||+++ ++.++++|||.+.
T Consensus 81 ~~--------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 81 ED--------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred cc--------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 30 112346778999999999872 12369999999999999 6789999999876
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.17 E-value=2.9e-10 Score=105.41 Aligned_cols=124 Identities=17% Similarity=0.167 Sum_probs=87.8
Q ss_pred CeeccCCcEEEEEEEECC-------CcEEEEEEehh----------------------------------------hhhh
Q 039819 208 NILGAGGFGNVYKGKLGD-------GTVLAVKRLKD----------------------------------------MISL 240 (534)
Q Consensus 208 ~~lG~G~~g~Vy~~~~~~-------~~~vavK~~~~----------------------------------------~l~~ 240 (534)
..||.|--+.||.|...+ +..+|||..+- .+.+
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 468999999999998653 47899997651 1111
Q ss_pred ccc--CceeeEEEEEeCCCeeEEEeeccCCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHH-HhcCCCCeEeccCCCCc
Q 039819 241 AVH--RNLLRLIGYCATPTERLLVYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYL-HEQCDPKIIHRDVKAAN 317 (534)
Q Consensus 241 ~~h--~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yL-H~~~~~~ivH~Dlkp~N 317 (534)
+.. -++.+++++ ...+|||||+.+..+....-....++......+..+++.+|..+ |.. ++||+||++.|
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~---glVHGDLs~~N 155 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKEC---NLVHADLSEYN 155 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHH
Confidence 111 123334432 45689999998754432221222355566678889999999999 676 99999999999
Q ss_pred EEeCCCCcEEEEecccceecCC
Q 039819 318 VLLDDFCEAIVGDFGLAKLLDH 339 (534)
Q Consensus 318 iLl~~~~~~kl~DFGla~~~~~ 339 (534)
||+++ +.+.|+|||.+....+
T Consensus 156 IL~~~-~~v~iIDF~qav~~~h 176 (197)
T cd05146 156 MLWHD-GKVWFIDVSQSVEPTH 176 (197)
T ss_pred EEEEC-CcEEEEECCCceeCCC
Confidence 99974 7899999999876644
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.17 E-value=2e-12 Score=126.97 Aligned_cols=117 Identities=28% Similarity=0.398 Sum_probs=75.2
Q ss_pred EEEEecCCCceeecccccccCCCCCEEEccCCccCcCCCCCCCCCCCCCEEEcCCCcCccccCchhhhcccCcccccccc
Q 039819 11 IGLGAPSQSLSGTLSGSIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFLSIWLPRKWDKRK 90 (534)
Q Consensus 11 ~~L~l~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~P~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~l~~~~~~~~ 90 (534)
+.|.+++|.++ -+|..++.+++|..|+|+||-|. .+|.+++.+..|++||||+|+|. .+|..+..+..+..+..+++
T Consensus 415 T~l~lsnn~is-fv~~~l~~l~kLt~L~L~NN~Ln-~LP~e~~~lv~Lq~LnlS~NrFr-~lP~~~y~lq~lEtllas~n 491 (565)
T KOG0472|consen 415 TDLVLSNNKIS-FVPLELSQLQKLTFLDLSNNLLN-DLPEEMGSLVRLQTLNLSFNRFR-MLPECLYELQTLETLLASNN 491 (565)
T ss_pred HHHHhhcCccc-cchHHHHhhhcceeeecccchhh-hcchhhhhhhhhheecccccccc-cchHHHhhHHHHHHHHhccc
Confidence 34445555554 66777888999999999999998 89999999999999999999999 88987776652222111100
Q ss_pred -cCC---------ccccceeCCCCcCcccCChhhhcccccccccccCCCCC
Q 039819 91 -CSG---------VDQGLLRLNNNSLSGAFPVFLAKISELAFLDLSYNNLS 131 (534)
Q Consensus 91 -~~~---------~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~ 131 (534)
... .+|..|||.+|.+. .+|+.+++|.+|++|+|++|.|.
T Consensus 492 qi~~vd~~~l~nm~nL~tLDL~nNdlq-~IPp~LgnmtnL~hLeL~gNpfr 541 (565)
T KOG0472|consen 492 QIGSVDPSGLKNMRNLTTLDLQNNDLQ-QIPPILGNMTNLRHLELDGNPFR 541 (565)
T ss_pred cccccChHHhhhhhhcceeccCCCchh-hCChhhccccceeEEEecCCccC
Confidence 000 13444555555554 44555555555555555555554
|
|
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.13 E-value=4.4e-12 Score=130.57 Aligned_cols=141 Identities=24% Similarity=0.352 Sum_probs=109.4
Q ss_pred CcEEEEEecCCCceeecccccccCCCCCEEEccCCccCcCCCCCCCCCCCCCEEEcCCCcCccccCchhhhcccCccccc
Q 039819 8 NLVIGLGAPSQSLSGTLSGSIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFLSIWLPRKWD 87 (534)
Q Consensus 8 ~~l~~L~l~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~P~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~l~~~~~ 87 (534)
.++..+|||.|+|. .+|..+-++++|+.|+||.|+|+ .+-...+...+|++|+||.|+|+ .+|+.+..++.|.+++.
T Consensus 222 ~NL~dvDlS~N~Lp-~vPecly~l~~LrrLNLS~N~it-eL~~~~~~W~~lEtLNlSrNQLt-~LP~avcKL~kL~kLy~ 298 (1255)
T KOG0444|consen 222 HNLRDVDLSENNLP-IVPECLYKLRNLRRLNLSGNKIT-ELNMTEGEWENLETLNLSRNQLT-VLPDAVCKLTKLTKLYA 298 (1255)
T ss_pred hhhhhccccccCCC-cchHHHhhhhhhheeccCcCcee-eeeccHHHHhhhhhhccccchhc-cchHHHhhhHHHHHHHh
Confidence 46778888888888 78888888888888888888888 67777777888888888888888 78888888877766654
Q ss_pred cccc-------CC----ccccceeCCCCcCcccCChhhhcccccccccccCCCCCCCCCCCCC-----ccccccCCccee
Q 039819 88 KRKC-------SG----VDQGLLRLNNNSLSGAFPVFLAKISELAFLDLSYNNLSGPVPKFPA-----RTFNVAGNPLIC 151 (534)
Q Consensus 88 ~~~~-------~~----~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~-----~~~~~~~N~~~c 151 (534)
+++- ++ .+|+.+..++|.|. .+|.++++|..|+.|.|+.|+|- ++|+.+. ..+.+..||-+-
T Consensus 299 n~NkL~FeGiPSGIGKL~~Levf~aanN~LE-lVPEglcRC~kL~kL~L~~NrLi-TLPeaIHlL~~l~vLDlreNpnLV 376 (1255)
T KOG0444|consen 299 NNNKLTFEGIPSGIGKLIQLEVFHAANNKLE-LVPEGLCRCVKLQKLKLDHNRLI-TLPEAIHLLPDLKVLDLRENPNLV 376 (1255)
T ss_pred ccCcccccCCccchhhhhhhHHHHhhccccc-cCchhhhhhHHHHHhccccccee-echhhhhhcCCcceeeccCCcCcc
Confidence 3321 11 26788888999998 89999999999999999999988 6776543 456677777655
Q ss_pred cC
Q 039819 152 GS 153 (534)
Q Consensus 152 g~ 153 (534)
-+
T Consensus 377 MP 378 (1255)
T KOG0444|consen 377 MP 378 (1255)
T ss_pred CC
Confidence 43
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.12 E-value=8.1e-11 Score=128.46 Aligned_cols=232 Identities=18% Similarity=0.220 Sum_probs=156.6
Q ss_pred hCCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEe-------hh----------hhhhcccCceeeEEEEEeCCCeeEEEe
Q 039819 202 ENFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRL-------KD----------MISLAVHRNLLRLIGYCATPTERLLVY 263 (534)
Q Consensus 202 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~-------~~----------~l~~~~h~niv~l~~~~~~~~~~~lv~ 263 (534)
+.|.+.+-+-+|+++.++.++-. .|...++|.. .. ..-..++|-++....-+......+||+
T Consensus 804 d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~~ 883 (1205)
T KOG0606|consen 804 DGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLVG 883 (1205)
T ss_pred ccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchhh
Confidence 44555666778888888877532 2222222211 11 111123444444433334456779999
Q ss_pred eccCCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCC---
Q 039819 264 PYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHS--- 340 (534)
Q Consensus 264 e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~--- 340 (534)
+|..+++|...++..+..+.+-....+..+..+++|||.. .++|||++|.|+|...+++.+++|||.....+..
T Consensus 884 ~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~---~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p~ 960 (1205)
T KOG0606|consen 884 HYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSS---LRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPPT 960 (1205)
T ss_pred HHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccc---hhhcccccccchhhcccCCcccCccccccccccccCc
Confidence 9999999999999888777777777888899999999997 7999999999999999999999999843321100
Q ss_pred ------------------C---------CceeeccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCcc
Q 039819 341 ------------------D---------SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKS 393 (534)
Q Consensus 341 ------------------~---------~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~ 393 (534)
. ........||+.|.|||...+......+|+|++|++++|.++|.+||.....
T Consensus 961 ~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na~tp 1040 (1205)
T KOG0606|consen 961 TDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNAETP 1040 (1205)
T ss_pred CCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCCcch
Confidence 0 0112345689999999999999999999999999999999999999974322
Q ss_pred ccccchHHHHHHHHhhhcccceecccccC-CCCCHHHHHHHHHHHHHhcccCCCCCCChH
Q 039819 394 INQKGAMLEWVKKIQQEKKVEVLVDRELG-SNYDRIEVGEILQVALLCTQYLPVHRPKMS 452 (534)
Q Consensus 394 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~-~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ 452 (534)
.. .. +.+....+. ...+.....+..+++...+..+|.+|-.|.
T Consensus 1041 q~-------~f---------~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1041 QQ-------IF---------ENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred hh-------hh---------hccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence 10 00 111111111 111222334666777777788888887765
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.10 E-value=1e-11 Score=127.26 Aligned_cols=117 Identities=25% Similarity=0.225 Sum_probs=81.7
Q ss_pred cEEEEEecCCCceeecccccccCCCCCEEEccCCccCcCCCCCCCCCCCCCEEEcCCCcCccccCch---hhhcccCccc
Q 039819 9 LVIGLGAPSQSLSGTLSGSIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPAL---LFLSIWLPRK 85 (534)
Q Consensus 9 ~l~~L~l~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~P~~~~~l~~L~~L~Ls~N~l~g~~p~~---~~~l~~l~~~ 85 (534)
++..|+|++|+|+..-+++|..|..|++|+|++|+|+-.--.+|..|++|+.|||++|.|++.|-+. |..++
T Consensus 318 kL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IEDaa~~f~gl~----- 392 (873)
T KOG4194|consen 318 KLKELDLSSNRITRLDEGSFRVLSQLEELNLSHNSIDHLAEGAFVGLSSLHKLDLRSNELSWCIEDAAVAFNGLP----- 392 (873)
T ss_pred cceeEeccccccccCChhHHHHHHHhhhhcccccchHHHHhhHHHHhhhhhhhcCcCCeEEEEEecchhhhccch-----
Confidence 5666666666666545556666666666666666666444445666666666666666666665542 22333
Q ss_pred ccccccCCccccceeCCCCcCcccCChhhhcccccccccccCCCCCCCCCCCCC
Q 039819 86 WDKRKCSGVDQGLLRLNNNSLSGAFPVFLAKISELAFLDLSYNNLSGPVPKFPA 139 (534)
Q Consensus 86 ~~~~~~~~~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~ 139 (534)
.|+.|+|.+|+|...--.+|.++.+|+.|||.+|.+...-|..+.
T Consensus 393 ---------~LrkL~l~gNqlk~I~krAfsgl~~LE~LdL~~NaiaSIq~nAFe 437 (873)
T KOG4194|consen 393 ---------SLRKLRLTGNQLKSIPKRAFSGLEALEHLDLGDNAIASIQPNAFE 437 (873)
T ss_pred ---------hhhheeecCceeeecchhhhccCcccceecCCCCcceeecccccc
Confidence 789999999999955557999999999999999999865555443
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.10 E-value=6.8e-10 Score=116.66 Aligned_cols=164 Identities=20% Similarity=0.256 Sum_probs=119.7
Q ss_pred eccCCcEEEEEEEECCCcEEE--EEEehhhhhhcccCceeeEEEEEeCCCeeEEEeeccCCCChhhhcccCCCCCHHHHH
Q 039819 210 LGAGGFGNVYKGKLGDGTVLA--VKRLKDMISLAVHRNLLRLIGYCATPTERLLVYPYMSNGSVASRLREKPALDWNTRK 287 (534)
Q Consensus 210 lG~G~~g~Vy~~~~~~~~~va--vK~~~~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~ 287 (534)
-..|++-.|+.....++ .++ +|+-.+.++.+|||||++++..+......|||+|-+. -|..++.+.. .....
T Consensus 34 k~~~~~vsVF~~~~~~~-~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l~---~~~v~ 107 (690)
T KOG1243|consen 34 KADGGPVSVFVYKRSNG-EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKELG---KEEVC 107 (690)
T ss_pred eccCCceEEEEEeCCCc-hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHhH---HHHHH
Confidence 34577777877777666 222 3444457888999999999999999999999999875 3444454332 44556
Q ss_pred HHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCCceeeccccccccccccccccCCCCc
Q 039819 288 RIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGHIAPEYLSTGQSSE 367 (534)
Q Consensus 288 ~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 367 (534)
..+.||+.||.|||+.| +++|++|.-+-|+++..|+.||++|-++........ ......--..|..|+.+.... -
T Consensus 108 ~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~-~~~~~~~~~s~~~P~~~~~s~--~ 182 (690)
T KOG1243|consen 108 LGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA-PAKSLYLIESFDDPEEIDPSE--W 182 (690)
T ss_pred HHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc-ccccchhhhcccChhhcCccc--c
Confidence 67889999999999876 999999999999999999999999988764432211 001111223566676553222 3
Q ss_pred chhHHHHHHHHHHHHhC
Q 039819 368 KTDVFGFGILLLELITG 384 (534)
Q Consensus 368 k~Dv~S~Gvvl~elltG 384 (534)
..|.|-|||+++|++.|
T Consensus 183 s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 183 SIDSWGLGCLIEELFNG 199 (690)
T ss_pred chhhhhHHHHHHHHhCc
Confidence 46999999999999999
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.07 E-value=8.3e-12 Score=134.13 Aligned_cols=123 Identities=29% Similarity=0.421 Sum_probs=106.4
Q ss_pred cEEEEEecCCCceeecccccccCCCCCEEEccCCccCcCCCCC-CCCCCCCCEEEcCCCcCccccCchhhhcccCccccc
Q 039819 9 LVIGLGAPSQSLSGTLSGSIGNLTNLRQVLLQNNNISGGIPPQ-LGSLPKLQTLDLSNNRLSGVIPALLFLSIWLPRKWD 87 (534)
Q Consensus 9 ~l~~L~l~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~P~~-~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~l~~~~~ 87 (534)
.|+.|+|.+|.|+...=+.|.++.+|+.|+|++|+|. .+|.+ +.+|+.|+.|+||+|+|+ .+|..+..+.
T Consensus 360 ~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~-~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~------- 430 (1081)
T KOG0618|consen 360 ALQELYLANNHLTDSCFPVLVNFKHLKVLHLSYNRLN-SFPASKLRKLEELEELNLSGNKLT-TLPDTVANLG------- 430 (1081)
T ss_pred HHHHHHHhcCcccccchhhhccccceeeeeecccccc-cCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhh-------
Confidence 5778999999999888788999999999999999998 78875 789999999999999999 8999988888
Q ss_pred ccccCCccccceeCCCCcCcccCChhhhcccccccccccCCCCCC-CCCCCC----CccccccCCcc
Q 039819 88 KRKCSGVDQGLLRLNNNSLSGAFPVFLAKISELAFLDLSYNNLSG-PVPKFP----ARTFNVAGNPL 149 (534)
Q Consensus 88 ~~~~~~~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g-~~p~~~----~~~~~~~~N~~ 149 (534)
.|++|...+|+|. .+| .+..++.|+.+|||.|+|+- .+|... .+.++++||+|
T Consensus 431 -------~L~tL~ahsN~l~-~fP-e~~~l~qL~~lDlS~N~L~~~~l~~~~p~p~LkyLdlSGN~~ 488 (1081)
T KOG0618|consen 431 -------RLHTLRAHSNQLL-SFP-ELAQLPQLKVLDLSCNNLSEVTLPEALPSPNLKYLDLSGNTR 488 (1081)
T ss_pred -------hhHHHhhcCCcee-ech-hhhhcCcceEEecccchhhhhhhhhhCCCcccceeeccCCcc
Confidence 8889999999998 888 88999999999999999983 334322 26788899987
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.06 E-value=1.9e-11 Score=120.06 Aligned_cols=131 Identities=24% Similarity=0.280 Sum_probs=110.6
Q ss_pred CcEEEEEecCCCceeecccccccCCCCCEEEccCCccCcCCCCCCCCCCCCCEEEcCC-CcCccccCchhhhcccCcccc
Q 039819 8 NLVIGLGAPSQSLSGTLSGSIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSN-NRLSGVIPALLFLSIWLPRKW 86 (534)
Q Consensus 8 ~~l~~L~l~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~P~~~~~l~~L~~L~Ls~-N~l~g~~p~~~~~l~~l~~~~ 86 (534)
...+.|+|..|+|+.+.|.+|+.+++|+.|+||+|+|+-+-|.+|.+|++|..|-|.+ |+|+......|..|.
T Consensus 67 ~~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~~l~k~~F~gL~------ 140 (498)
T KOG4237|consen 67 PETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKITDLPKGAFGGLS------ 140 (498)
T ss_pred CcceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchhhhhhhHhhhHH------
Confidence 4689999999999976678999999999999999999999999999999988775555 999955556788887
Q ss_pred cccccCCccccceeCCCCcCcccCChhhhcccccccccccCCCCCCCCCCC-C-----CccccccCCcceecC
Q 039819 87 DKRKCSGVDQGLLRLNNNSLSGAFPVFLAKISELAFLDLSYNNLSGPVPKF-P-----ARTFNVAGNPLICGS 153 (534)
Q Consensus 87 ~~~~~~~~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~-~-----~~~~~~~~N~~~cg~ 153 (534)
.|+.|.|.-|++.-.....|..+++|..|.+..|.+. .++.. + .+++-++.||+.|..
T Consensus 141 --------slqrLllNan~i~Cir~~al~dL~~l~lLslyDn~~q-~i~~~tf~~l~~i~tlhlA~np~icdC 204 (498)
T KOG4237|consen 141 --------SLQRLLLNANHINCIRQDALRDLPSLSLLSLYDNKIQ-SICKGTFQGLAAIKTLHLAQNPFICDC 204 (498)
T ss_pred --------HHHHHhcChhhhcchhHHHHHHhhhcchhcccchhhh-hhccccccchhccchHhhhcCcccccc
Confidence 7788999999999788899999999999999999998 55542 2 256778889987743
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=99.03 E-value=2e-10 Score=104.43 Aligned_cols=104 Identities=34% Similarity=0.390 Sum_probs=38.9
Q ss_pred cEEEEEecCCCceeecccccc-cCCCCCEEEccCCccCcCCCCCCCCCCCCCEEEcCCCcCccccCchh-hhcccCcccc
Q 039819 9 LVIGLGAPSQSLSGTLSGSIG-NLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALL-FLSIWLPRKW 86 (534)
Q Consensus 9 ~l~~L~l~~n~l~g~~p~~~~-~l~~L~~L~L~~N~l~g~~P~~~~~l~~L~~L~Ls~N~l~g~~p~~~-~~l~~l~~~~ 86 (534)
+++.|+|.+|+|+ .|. .++ .+.+|+.|+|++|+|+ .++ .+..|++|++|+|++|+|+ .++..+ ..++
T Consensus 20 ~~~~L~L~~n~I~-~Ie-~L~~~l~~L~~L~Ls~N~I~-~l~-~l~~L~~L~~L~L~~N~I~-~i~~~l~~~lp------ 88 (175)
T PF14580_consen 20 KLRELNLRGNQIS-TIE-NLGATLDKLEVLDLSNNQIT-KLE-GLPGLPRLKTLDLSNNRIS-SISEGLDKNLP------ 88 (175)
T ss_dssp ------------------S--TT-TT--EEE-TTS--S---T-T----TT--EEE--SS----S-CHHHHHH-T------
T ss_pred ccccccccccccc-ccc-chhhhhcCCCEEECCCCCCc-ccc-CccChhhhhhcccCCCCCC-ccccchHHhCC------
Confidence 5788999999998 454 466 5788999999999998 565 4778899999999999998 555444 3466
Q ss_pred cccccCCccccceeCCCCcCcccC-ChhhhcccccccccccCCCCC
Q 039819 87 DKRKCSGVDQGLLRLNNNSLSGAF-PVFLAKISELAFLDLSYNNLS 131 (534)
Q Consensus 87 ~~~~~~~~~L~~L~L~~N~l~g~~-p~~~~~l~~L~~L~ls~N~l~ 131 (534)
+|+.|+|++|+|...- =..+..+++|+.|+|.+|.++
T Consensus 89 --------~L~~L~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~ 126 (175)
T PF14580_consen 89 --------NLQELYLSNNKISDLNELEPLSSLPKLRVLSLEGNPVC 126 (175)
T ss_dssp --------T--EEE-TTS---SCCCCGGGGG-TT--EEE-TT-GGG
T ss_pred --------cCCEEECcCCcCCChHHhHHHHcCCCcceeeccCCccc
Confidence 7888999999886321 145677888888888888776
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=98.99 E-value=4.5e-09 Score=100.13 Aligned_cols=128 Identities=24% Similarity=0.337 Sum_probs=99.4
Q ss_pred CeeccCCcEEEEEEEECCCcEEEEEEehh---------------hhhhccc--CceeeEEEEEeCCC---eeEEEeeccC
Q 039819 208 NILGAGGFGNVYKGKLGDGTVLAVKRLKD---------------MISLAVH--RNLLRLIGYCATPT---ERLLVYPYMS 267 (534)
Q Consensus 208 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~---------------~l~~~~h--~niv~l~~~~~~~~---~~~lv~e~~~ 267 (534)
+.|+.|.++.||++...+|..+++|.... .+..+.+ .++.+++.+..... ..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 56899999999999987778899997542 2444444 34566777766543 5689999999
Q ss_pred CCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcC-------------------------------------------
Q 039819 268 NGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQC------------------------------------------- 304 (534)
Q Consensus 268 ~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~------------------------------------------- 304 (534)
+.++.+.+.. ..++...+..++.+++++|.+||+..
T Consensus 84 G~~l~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (223)
T cd05154 84 GRVLRDRLLR-PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERLLR 162 (223)
T ss_pred CEecCCCCCC-CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHHHH
Confidence 9988876643 45788888889999999999998531
Q ss_pred ----------CCCeEeccCCCCcEEeCC--CCcEEEEeccccee
Q 039819 305 ----------DPKIIHRDVKAANVLLDD--FCEAIVGDFGLAKL 336 (534)
Q Consensus 305 ----------~~~ivH~Dlkp~NiLl~~--~~~~kl~DFGla~~ 336 (534)
...++|+|+.|.||+++. ++.+.|+||+.+..
T Consensus 163 ~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 163 WLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 235799999999999998 66789999998764
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.98 E-value=3.9e-09 Score=94.85 Aligned_cols=117 Identities=22% Similarity=0.309 Sum_probs=89.4
Q ss_pred CeeccCCcEEEEEEEECCCcEEEEEEe-h---------------------hhhhhcccCceeeEEEEEeCCCeeEEEeec
Q 039819 208 NILGAGGFGNVYKGKLGDGTVLAVKRL-K---------------------DMISLAVHRNLLRLIGYCATPTERLLVYPY 265 (534)
Q Consensus 208 ~~lG~G~~g~Vy~~~~~~~~~vavK~~-~---------------------~~l~~~~h~niv~l~~~~~~~~~~~lv~e~ 265 (534)
..+++|+-+.+|.+.+-+ ..+.+|.- . .++..++-..|...+=+..+++...|+|||
T Consensus 2 ~~i~~GAEa~i~~~~~~g-~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDFLG-LPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeeccC-cceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 357899999999997744 33555532 1 134444444444444566788888999999
Q ss_pred cCCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEeccccee
Q 039819 266 MSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKL 336 (534)
Q Consensus 266 ~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~ 336 (534)
++|-.|.+.+... +..++..+-.-+.-||.. +|||+||.++||++.... +.++|||++.+
T Consensus 81 I~G~~lkd~l~~~-------~~~~~r~vG~~vg~lH~~---givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 81 IEGELLKDALEEA-------RPDLLREVGRLVGKLHKA---GIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred eCChhHHHHHHhc-------chHHHHHHHHHHHHHHhc---CeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 9999998888755 356777888888999998 999999999999998855 89999999974
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.97 E-value=5.5e-10 Score=83.57 Aligned_cols=60 Identities=37% Similarity=0.486 Sum_probs=48.5
Q ss_pred cEEEEEecCCCceeecccccccCCCCCEEEccCCccCcCCCCCCCCCCCCCEEEcCCCcC
Q 039819 9 LVIGLGAPSQSLSGTLSGSIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRL 68 (534)
Q Consensus 9 ~l~~L~l~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~P~~~~~l~~L~~L~Ls~N~l 68 (534)
+|+.|+|++|+|+...+..|.++++|++|+|++|+|+...|..|.+|++|++|+|++|+|
T Consensus 2 ~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 2 NLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred cCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 577888888888865556788888888888888888866667788888888888888875
|
... |
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.96 E-value=5.6e-11 Score=121.72 Aligned_cols=123 Identities=27% Similarity=0.388 Sum_probs=98.7
Q ss_pred CcEEEEEecCCCceeecccccccCCCCCEEEccCCccCcCCCCCCCCCCCCCEEEcCCCcCccccCchhhhcccCccccc
Q 039819 8 NLVIGLGAPSQSLSGTLSGSIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFLSIWLPRKWD 87 (534)
Q Consensus 8 ~~l~~L~l~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~P~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~l~~~~~ 87 (534)
..++.|+|+.|+|+ .+|..++.|+ |+.|.++||+|+ .+|..++.++.|..||.|.|++. .+|..++.+..+..+..
T Consensus 121 ~~lt~l~ls~NqlS-~lp~~lC~lp-Lkvli~sNNkl~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~v 196 (722)
T KOG0532|consen 121 EALTFLDLSSNQLS-HLPDGLCDLP-LKVLIVSNNKLT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNV 196 (722)
T ss_pred hHHHHhhhccchhh-cCChhhhcCc-ceeEEEecCccc-cCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHH
Confidence 46888999999998 7898888765 899999999999 89999999999999999999999 78888877765544321
Q ss_pred c-cc-------cCCccccceeCCCCcCcccCChhhhcccccccccccCCCCCCCCCC
Q 039819 88 K-RK-------CSGVDQGLLRLNNNSLSGAFPVFLAKISELAFLDLSYNNLSGPVPK 136 (534)
Q Consensus 88 ~-~~-------~~~~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~ 136 (534)
. +. ...+.|..||+|+|+++ .||..|..|..|++|-|.+|.|+ .+|.
T Consensus 197 rRn~l~~lp~El~~LpLi~lDfScNkis-~iPv~fr~m~~Lq~l~LenNPLq-SPPA 251 (722)
T KOG0532|consen 197 RRNHLEDLPEELCSLPLIRLDFSCNKIS-YLPVDFRKMRHLQVLQLENNPLQ-SPPA 251 (722)
T ss_pred hhhhhhhCCHHHhCCceeeeecccCcee-ecchhhhhhhhheeeeeccCCCC-CChH
Confidence 1 10 01346778888888888 88888888888888888888888 5554
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.89 E-value=2.5e-10 Score=108.46 Aligned_cols=119 Identities=29% Similarity=0.400 Sum_probs=92.9
Q ss_pred cEEEEEecCCCceeecccccccCCCCCEEEccCCccCcCCCCCCCCCCCCCEEEcCCCcCccccCchhhhcccCcccccc
Q 039819 9 LVIGLGAPSQSLSGTLSGSIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFLSIWLPRKWDK 88 (534)
Q Consensus 9 ~l~~L~l~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~P~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~l~~~~~~ 88 (534)
-++.|||++|.|+ .+..+..-+++++.|+||+|.|. .+-. +..|++|+.||||+|.|+ .+-+.-..+.
T Consensus 285 ~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~-~v~n-La~L~~L~~LDLS~N~Ls-~~~Gwh~KLG-------- 352 (490)
T KOG1259|consen 285 ELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIR-TVQN-LAELPQLQLLDLSGNLLA-ECVGWHLKLG-------- 352 (490)
T ss_pred hhhhccccccchh-hhhhhhhhccceeEEecccccee-eehh-hhhcccceEeecccchhH-hhhhhHhhhc--------
Confidence 4788999999999 78888888999999999999998 4544 888999999999999998 5554434444
Q ss_pred cccCCccccceeCCCCcCcccCChhhhcccccccccccCCCCCC--------CCCCCCCccccccCCcc
Q 039819 89 RKCSGVDQGLLRLNNNSLSGAFPVFLAKISELAFLDLSYNNLSG--------PVPKFPARTFNVAGNPL 149 (534)
Q Consensus 89 ~~~~~~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g--------~~p~~~~~~~~~~~N~~ 149 (534)
+.+.|.|+.|.+. .+ ..+..+-+|..||+++|++.. .+|- .+++.+.+||+
T Consensus 353 ------NIKtL~La~N~iE-~L-SGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPC--LE~l~L~~NPl 411 (490)
T KOG1259|consen 353 ------NIKTLKLAQNKIE-TL-SGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPC--LETLRLTGNPL 411 (490)
T ss_pred ------CEeeeehhhhhHh-hh-hhhHhhhhheeccccccchhhHHHhcccccccH--HHHHhhcCCCc
Confidence 6678999999886 23 346777888999999999872 2221 15667778887
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=98.88 E-value=1.9e-09 Score=118.83 Aligned_cols=107 Identities=27% Similarity=0.341 Sum_probs=53.4
Q ss_pred CCCCEEEccCCccCcCCCCCCCCCCCCCEEEcCCCcCccccCchhhhcccCccccccccc-----CCccccceeCCCCcC
Q 039819 32 TNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFLSIWLPRKWDKRKC-----SGVDQGLLRLNNNSL 106 (534)
Q Consensus 32 ~~L~~L~L~~N~l~g~~P~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~l~~~~~~~~~-----~~~~L~~L~L~~N~l 106 (534)
.+|++|+|++|+|+ .+|... .+|+.|++++|+|+ .+|.....+..|.- ..+.. ...+|+.|+|++|+|
T Consensus 342 ~~Lq~LdLS~N~Ls-~LP~lp---~~L~~L~Ls~N~L~-~LP~l~~~L~~LdL--s~N~Lt~LP~l~s~L~~LdLS~N~L 414 (788)
T PRK15387 342 SGLQELSVSDNQLA-SLPTLP---SELYKLWAYNNRLT-SLPALPSGLKELIV--SGNRLTSLPVLPSELKELMVSGNRL 414 (788)
T ss_pred cccceEecCCCccC-CCCCCC---cccceehhhccccc-cCcccccccceEEe--cCCcccCCCCcccCCCEEEccCCcC
Confidence 48888888888888 466433 23444455555554 23433322221100 00000 001456666666666
Q ss_pred cccCChhhhcccccccccccCCCCCCCCCCCCC-----ccccccCCcce
Q 039819 107 SGAFPVFLAKISELAFLDLSYNNLSGPVPKFPA-----RTFNVAGNPLI 150 (534)
Q Consensus 107 ~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~-----~~~~~~~N~~~ 150 (534)
+ .+|..+ .+|+.|+|++|+|+ .+|..+. ..+.+.+|++.
T Consensus 415 s-sIP~l~---~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs~N~Ls 458 (788)
T PRK15387 415 T-SLPMLP---SGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLS 458 (788)
T ss_pred C-CCCcch---hhhhhhhhccCccc-ccChHHhhccCCCeEECCCCCCC
Confidence 6 355432 34556666666666 4554332 34556666653
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.87 E-value=1.7e-09 Score=80.95 Aligned_cols=61 Identities=38% Similarity=0.513 Sum_probs=43.3
Q ss_pred CCCCEEEccCCccCcCCCCCCCCCCCCCEEEcCCCcCccccCchhhhcccCcccccccccCCccccceeCCCCcC
Q 039819 32 TNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFLSIWLPRKWDKRKCSGVDQGLLRLNNNSL 106 (534)
Q Consensus 32 ~~L~~L~L~~N~l~g~~P~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~l~~~~~~~~~~~~~L~~L~L~~N~l 106 (534)
++|++|+|++|+|+..-+..|.++++|++|+|++|+|+...|..|..++ +|+.|+|++|+|
T Consensus 1 p~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~--------------~L~~L~l~~N~l 61 (61)
T PF13855_consen 1 PNLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLP--------------NLRYLDLSNNNL 61 (61)
T ss_dssp TTESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTST--------------TESEEEETSSSB
T ss_pred CcCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCC--------------CCCEEeCcCCcC
Confidence 4677788888888744445677788888888888888766666666666 666677777664
|
... |
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=98.83 E-value=4.6e-09 Score=116.39 Aligned_cols=116 Identities=25% Similarity=0.328 Sum_probs=66.7
Q ss_pred eecCCCcEEEEEecCCCceeecccccccCCCCCEEEccCCccCcCCCCCCCCCCCCCEEEcCCCcCccccCchhhhcccC
Q 039819 3 TCSPENLVIGLGAPSQSLSGTLSGSIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFLSIWL 82 (534)
Q Consensus 3 ~c~~~~~l~~L~l~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~P~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~l 82 (534)
.|. ..+.+.|+|++++|+ .+|..+. ++|+.|+|++|+|+ .+|..+. .+|++|+|++|+|+ .+|..+.. .|
T Consensus 174 ~Cl-~~~~~~L~L~~~~Lt-sLP~~Ip--~~L~~L~Ls~N~Lt-sLP~~l~--~nL~~L~Ls~N~Lt-sLP~~l~~--~L 243 (754)
T PRK15370 174 DCL-KNNKTELRLKILGLT-TIPACIP--EQITTLILDNNELK-SLPENLQ--GNIKTLYANSNQLT-SIPATLPD--TI 243 (754)
T ss_pred hhc-ccCceEEEeCCCCcC-cCCcccc--cCCcEEEecCCCCC-cCChhhc--cCCCEEECCCCccc-cCChhhhc--cc
Confidence 455 456677888888887 5676553 47778888888887 5776654 47778888888777 45643321 11
Q ss_pred ccccccc-ccC------CccccceeCCCCcCcccCChhhhcccccccccccCCCCC
Q 039819 83 PRKWDKR-KCS------GVDQGLLRLNNNSLSGAFPVFLAKISELAFLDLSYNNLS 131 (534)
Q Consensus 83 ~~~~~~~-~~~------~~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~ 131 (534)
..+..++ ... ..+|+.|+|++|+|+ .+|..+. .+|+.|+|++|+|+
T Consensus 244 ~~L~Ls~N~L~~LP~~l~s~L~~L~Ls~N~L~-~LP~~l~--~sL~~L~Ls~N~Lt 296 (754)
T PRK15370 244 QEMELSINRITELPERLPSALQSLDLFHNKIS-CLPENLP--EELRYLSVYDNSIR 296 (754)
T ss_pred cEEECcCCccCcCChhHhCCCCEEECcCCccC-ccccccC--CCCcEEECCCCccc
Confidence 1110000 000 014556666666665 4555442 35666666666666
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=98.81 E-value=1.1e-08 Score=113.37 Aligned_cols=108 Identities=25% Similarity=0.291 Sum_probs=64.1
Q ss_pred CCCCEEEccCCccCcCCCCCCCCCCCCCEEEcCCCcCccccCchhhhcccCcccccccc-cC------CccccceeCCCC
Q 039819 32 TNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFLSIWLPRKWDKRK-CS------GVDQGLLRLNNN 104 (534)
Q Consensus 32 ~~L~~L~L~~N~l~g~~P~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~l~~~~~~~~-~~------~~~L~~L~L~~N 104 (534)
.+...|+|++++|+ .+|..+. +.|+.|+|++|+|+ .+|..+. .+|..+..+++ +. ..+|+.|+|++|
T Consensus 178 ~~~~~L~L~~~~Lt-sLP~~Ip--~~L~~L~Ls~N~Lt-sLP~~l~--~nL~~L~Ls~N~LtsLP~~l~~~L~~L~Ls~N 251 (754)
T PRK15370 178 NNKTELRLKILGLT-TIPACIP--EQITTLILDNNELK-SLPENLQ--GNIKTLYANSNQLTSIPATLPDTIQEMELSIN 251 (754)
T ss_pred cCceEEEeCCCCcC-cCCcccc--cCCcEEEecCCCCC-cCChhhc--cCCCEEECCCCccccCChhhhccccEEECcCC
Confidence 46789999999999 6898765 58999999999999 6676543 22222211110 00 014555666666
Q ss_pred cCcccCChhhhcccccccccccCCCCCCCCCCCCC---ccccccCCcc
Q 039819 105 SLSGAFPVFLAKISELAFLDLSYNNLSGPVPKFPA---RTFNVAGNPL 149 (534)
Q Consensus 105 ~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~---~~~~~~~N~~ 149 (534)
+++ .+|..+. .+|+.|+|++|+|+ .+|..+. +.+.+.+|.+
T Consensus 252 ~L~-~LP~~l~--s~L~~L~Ls~N~L~-~LP~~l~~sL~~L~Ls~N~L 295 (754)
T PRK15370 252 RIT-ELPERLP--SALQSLDLFHNKIS-CLPENLPEELRYLSVYDNSI 295 (754)
T ss_pred ccC-cCChhHh--CCCCEEECcCCccC-ccccccCCCCcEEECCCCcc
Confidence 665 5555443 35666666666666 3443222 3344445543
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=98.78 E-value=4.2e-09 Score=95.84 Aligned_cols=113 Identities=33% Similarity=0.467 Sum_probs=36.0
Q ss_pred ecCCCceeecccccccCCCCCEEEccCCccCcCCCCCCC-CCCCCCEEEcCCCcCccccCchhhhcccCcccccccccCC
Q 039819 15 APSQSLSGTLSGSIGNLTNLRQVLLQNNNISGGIPPQLG-SLPKLQTLDLSNNRLSGVIPALLFLSIWLPRKWDKRKCSG 93 (534)
Q Consensus 15 l~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~P~~~~-~l~~L~~L~Ls~N~l~g~~p~~~~~l~~l~~~~~~~~~~~ 93 (534)
|..+.|. .+| .+.+..++++|+|++|+|+ .|. .++ .|.+|+.||||+|.|+ .++. +..+.
T Consensus 4 lt~~~i~-~~~-~~~n~~~~~~L~L~~n~I~-~Ie-~L~~~l~~L~~L~Ls~N~I~-~l~~-l~~L~------------- 64 (175)
T PF14580_consen 4 LTANMIE-QIA-QYNNPVKLRELNLRGNQIS-TIE-NLGATLDKLEVLDLSNNQIT-KLEG-LPGLP------------- 64 (175)
T ss_dssp ------------------------------------S--TT-TT--EEE-TTS--S---TT-----T-------------
T ss_pred ccccccc-ccc-ccccccccccccccccccc-ccc-chhhhhcCCCEEECCCCCCc-cccC-ccChh-------------
Confidence 4445554 233 4566678999999999999 564 566 5899999999999999 5543 44444
Q ss_pred ccccceeCCCCcCcccCChhh-hcccccccccccCCCCCCCCCCC------C-CccccccCCcc
Q 039819 94 VDQGLLRLNNNSLSGAFPVFL-AKISELAFLDLSYNNLSGPVPKF------P-ARTFNVAGNPL 149 (534)
Q Consensus 94 ~~L~~L~L~~N~l~g~~p~~~-~~l~~L~~L~ls~N~l~g~~p~~------~-~~~~~~~~N~~ 149 (534)
+|+.|+|++|.|+ .++..+ ..+++|+.|+|++|++.. +-+. . -+.+.+.+||+
T Consensus 65 -~L~~L~L~~N~I~-~i~~~l~~~lp~L~~L~L~~N~I~~-l~~l~~L~~l~~L~~L~L~~NPv 125 (175)
T PF14580_consen 65 -RLKTLDLSNNRIS-SISEGLDKNLPNLQELYLSNNKISD-LNELEPLSSLPKLRVLSLEGNPV 125 (175)
T ss_dssp -T--EEE--SS----S-CHHHHHH-TT--EEE-TTS---S-CCCCGGGGG-TT--EEE-TT-GG
T ss_pred -hhhhcccCCCCCC-ccccchHHhCCcCCEEECcCCcCCC-hHHhHHHHcCCCcceeeccCCcc
Confidence 8899999999999 566555 469999999999999984 2221 1 15678889987
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.78 E-value=3.9e-08 Score=90.88 Aligned_cols=112 Identities=21% Similarity=0.291 Sum_probs=71.7
Q ss_pred EEEEEEECCCcEEEEEEehh----------------------------------------hhhhcccC--ceeeEEEEEe
Q 039819 217 NVYKGKLGDGTVLAVKRLKD----------------------------------------MISLAVHR--NLLRLIGYCA 254 (534)
Q Consensus 217 ~Vy~~~~~~~~~vavK~~~~----------------------------------------~l~~~~h~--niv~l~~~~~ 254 (534)
.||.|...+|..+|||..+. .|.++... ++.+++++
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~-- 78 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY-- 78 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE--
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE--
Confidence 49999999999999997641 23333333 34445443
Q ss_pred CCCeeEEEeeccC--CCChhhhcccCCCCCHHHHHHHHHHHHHHHHHH-HhcCCCCeEeccCCCCcEEeCCCCcEEEEec
Q 039819 255 TPTERLLVYPYMS--NGSVASRLREKPALDWNTRKRIAIGAARGLLYL-HEQCDPKIIHRDVKAANVLLDDFCEAIVGDF 331 (534)
Q Consensus 255 ~~~~~~lv~e~~~--~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yL-H~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DF 331 (534)
...+|||||++ +..+..+.... ++......++.+++..+..+ |.. +|||+||.+.|||++++ .+.|+||
T Consensus 79 --~~~~ivME~I~~~G~~~~~l~~~~--~~~~~~~~~~~~il~~~~~~~~~~---givHGDLs~~NIlv~~~-~~~iIDf 150 (188)
T PF01163_consen 79 --NRNVIVMEYIGEDGVPLPRLKDVD--LSPEEPKELLEEILEEIIKMLHKA---GIVHGDLSEYNILVDDG-KVYIIDF 150 (188)
T ss_dssp --ETTEEEEE--EETTEEGGCHHHCG--GGGSTHHHHHHHHHHHHHHHHHCT---TEEESS-STTSEEEETT-CEEE--G
T ss_pred --eCCEEEEEecCCCccchhhHHhcc--ccchhHHHHHHHHHHHHHHHHHhc---CceecCCChhhEEeecc-eEEEEec
Confidence 24589999998 54443332211 11344566777888866664 566 99999999999999987 9999999
Q ss_pred ccceecC
Q 039819 332 GLAKLLD 338 (534)
Q Consensus 332 Gla~~~~ 338 (534)
|.+....
T Consensus 151 ~qav~~~ 157 (188)
T PF01163_consen 151 GQAVDSS 157 (188)
T ss_dssp TTEEETT
T ss_pred CcceecC
Confidence 9987654
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.75 E-value=8.8e-10 Score=118.89 Aligned_cols=104 Identities=27% Similarity=0.363 Sum_probs=91.1
Q ss_pred CCcEEEEEecCCCceeeccc-ccccCCCCCEEEccCCccCcCCCCCCCCCCCCCEEEcCCCcCccccCchhhhcccCccc
Q 039819 7 ENLVIGLGAPSQSLSGTLSG-SIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFLSIWLPRK 85 (534)
Q Consensus 7 ~~~l~~L~l~~n~l~g~~p~-~~~~l~~L~~L~L~~N~l~g~~P~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~l~~~ 85 (534)
...|+.|+|++|+|. .+|+ .+.+|..|+.|+||+|+|+ .+|.++.+++.|++|...+|+|. .+| .+..++
T Consensus 382 ~~hLKVLhLsyNrL~-~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~-~fP-e~~~l~----- 452 (1081)
T KOG0618|consen 382 FKHLKVLHLSYNRLN-SFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLL-SFP-ELAQLP----- 452 (1081)
T ss_pred ccceeeeeecccccc-cCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhcCCcee-ech-hhhhcC-----
Confidence 457999999999998 5665 6899999999999999999 89999999999999999999999 888 778887
Q ss_pred ccccccCCccccceeCCCCcCcc-cCChhhhcccccccccccCCC
Q 039819 86 WDKRKCSGVDQGLLRLNNNSLSG-AFPVFLAKISELAFLDLSYNN 129 (534)
Q Consensus 86 ~~~~~~~~~~L~~L~L~~N~l~g-~~p~~~~~l~~L~~L~ls~N~ 129 (534)
.|+.+||+.|+|+. .+|...- -++|++|||++|.
T Consensus 453 ---------qL~~lDlS~N~L~~~~l~~~~p-~p~LkyLdlSGN~ 487 (1081)
T KOG0618|consen 453 ---------QLKVLDLSCNNLSEVTLPEALP-SPNLKYLDLSGNT 487 (1081)
T ss_pred ---------cceEEecccchhhhhhhhhhCC-CcccceeeccCCc
Confidence 89999999999963 4444433 2899999999997
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.75 E-value=8.5e-08 Score=85.96 Aligned_cols=127 Identities=17% Similarity=0.223 Sum_probs=89.6
Q ss_pred cCCeeccCCcEEEEEEEECCCcEEEEEEe-hh---------------------hhhhcccCceeeEEEEEeCCCeeEEEe
Q 039819 206 SKNILGAGGFGNVYKGKLGDGTVLAVKRL-KD---------------------MISLAVHRNLLRLIGYCATPTERLLVY 263 (534)
Q Consensus 206 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~-~~---------------------~l~~~~h~niv~l~~~~~~~~~~~lv~ 263 (534)
...+|-+|+-+.|+++.+ .|+...||.- .+ .+.+++--.|.-..-++.+.....|+|
T Consensus 11 ~l~likQGAEArv~~~~~-~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSF-SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeecc-CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 457889999999999998 4566566632 11 233333333333333566777778999
Q ss_pred eccCC-CChhhhcccC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCC---cEEEEeccccee
Q 039819 264 PYMSN-GSVASRLREK--PALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFC---EAIVGDFGLAKL 336 (534)
Q Consensus 264 e~~~~-gsL~~~l~~~--~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~---~~kl~DFGla~~ 336 (534)
||+++ -++.+++... ..........++..|-+.+.-||.. .|||+||..+||++..++ .+.++|||++..
T Consensus 90 E~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~n---diiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDN---DIIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhC---CeecccccccceEEecCCCcCceEEEeecchhc
Confidence 99977 4677777532 2222233367888999999999998 999999999999996544 357999999863
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.75 E-value=2.1e-07 Score=95.30 Aligned_cols=153 Identities=20% Similarity=0.254 Sum_probs=119.6
Q ss_pred CcEEEEEEEE-CCCcEEEEEEeh--------------hhhhhcccCceeeEEEEEeC----CCeeEEEeeccCC-CChhh
Q 039819 214 GFGNVYKGKL-GDGTVLAVKRLK--------------DMISLAVHRNLLRLIGYCAT----PTERLLVYPYMSN-GSVAS 273 (534)
Q Consensus 214 ~~g~Vy~~~~-~~~~~vavK~~~--------------~~l~~~~h~niv~l~~~~~~----~~~~~lv~e~~~~-gsL~~ 273 (534)
.-.+.|++.. .||..+++||+. ++.+++.|.|+|++.+++.. ....++||+|.++ ++|.+
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d 367 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYD 367 (655)
T ss_pred ccceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHH
Confidence 3457899875 489999999992 47889999999999998863 3457899999985 56666
Q ss_pred hcc---------------cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecC
Q 039819 274 RLR---------------EKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLD 338 (534)
Q Consensus 274 ~l~---------------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~ 338 (534)
.-- .+...++...+.++.|+..||.++|+. |+..+-|.+.+||++.+.+++|+..|....+.
T Consensus 368 ~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss---GLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~ 444 (655)
T KOG3741|consen 368 LYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS---GLACKTLDLKKILVTGKMRIRISGCGIMDVLQ 444 (655)
T ss_pred HHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc---CceeecccHhHeEeeCcceEEEecccceeeec
Confidence 542 223567889999999999999999999 99999999999999999999998888776554
Q ss_pred CCCCceeeccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCC
Q 039819 339 HSDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRA 387 (534)
Q Consensus 339 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p 387 (534)
.... |-+ .--.+-|.-.||.+++-|.||...
T Consensus 445 ~d~~---------------~~l---e~~Qq~D~~~lG~ll~aLAt~~~n 475 (655)
T KOG3741|consen 445 EDPT---------------EPL---ESQQQNDLRDLGLLLLALATGTEN 475 (655)
T ss_pred CCCC---------------cch---hHHhhhhHHHHHHHHHHHhhcccc
Confidence 3220 111 112457899999999999999644
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.72 E-value=1.6e-09 Score=111.27 Aligned_cols=101 Identities=28% Similarity=0.393 Sum_probs=62.6
Q ss_pred EEEEEecCCCceeecccccccCCCCCEEEccCCccCcCCCCCCCCCC----------------------CCCEEEcCCCc
Q 039819 10 VIGLGAPSQSLSGTLSGSIGNLTNLRQVLLQNNNISGGIPPQLGSLP----------------------KLQTLDLSNNR 67 (534)
Q Consensus 10 l~~L~l~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~P~~~~~l~----------------------~L~~L~Ls~N~ 67 (534)
|..|-+++|+|+ .+|..++.+..|..|+.+.|.|. .+|..++.|. .|..||+|.|+
T Consensus 145 Lkvli~sNNkl~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~~lp~El~~LpLi~lDfScNk 222 (722)
T KOG0532|consen 145 LKVLIVSNNKLT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLEDLPEELCSLPLIRLDFSCNK 222 (722)
T ss_pred ceeEEEecCccc-cCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhhhCCHHHhCCceeeeecccCc
Confidence 444555555554 45555555555555555555554 4444444444 45566666666
Q ss_pred CccccCchhhhcccCcccccccccCCccccceeCCCCcCcccCChhhhcccc---cccccccCC
Q 039819 68 LSGVIPALLFLSIWLPRKWDKRKCSGVDQGLLRLNNNSLSGAFPVFLAKISE---LAFLDLSYN 128 (534)
Q Consensus 68 l~g~~p~~~~~l~~l~~~~~~~~~~~~~L~~L~L~~N~l~g~~p~~~~~l~~---L~~L~ls~N 128 (534)
++ .||-.|..+. .|++|.|.+|.|. ..|..++..-. .++|+..-.
T Consensus 223 is-~iPv~fr~m~--------------~Lq~l~LenNPLq-SPPAqIC~kGkVHIFKyL~~qA~ 270 (722)
T KOG0532|consen 223 IS-YLPVDFRKMR--------------HLQVLQLENNPLQ-SPPAQICEKGKVHIFKYLSTQAC 270 (722)
T ss_pred ee-ecchhhhhhh--------------hheeeeeccCCCC-CChHHHHhccceeeeeeecchhc
Confidence 66 6666666666 7899999999999 88888765443 356666554
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=98.70 E-value=2.3e-08 Score=110.39 Aligned_cols=131 Identities=25% Similarity=0.368 Sum_probs=87.7
Q ss_pred eecCCCcEEEEEecCCCceeecccccccCCCCCEEEccCCccCcCCCCCCCCCCCCCEEEcCCCcCccccCchhhhcccC
Q 039819 3 TCSPENLVIGLGAPSQSLSGTLSGSIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFLSIWL 82 (534)
Q Consensus 3 ~c~~~~~l~~L~l~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~P~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~l 82 (534)
.|. ...-..|+|++|+|+ .+|+.|. ++|+.|+|++|+|+ .+|.. +++|++|+|++|+|+ .+|..+..+..|
T Consensus 197 ~Cl-~~~~~~LdLs~~~Lt-sLP~~l~--~~L~~L~L~~N~Lt-~LP~l---p~~Lk~LdLs~N~Lt-sLP~lp~sL~~L 267 (788)
T PRK15387 197 ACL-NNGNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPAL---PPELRTLEVSGNQLT-SLPVLPPGLLEL 267 (788)
T ss_pred HHh-cCCCcEEEcCCCCCC-cCCcchh--cCCCEEEccCCcCC-CCCCC---CCCCcEEEecCCccC-cccCccccccee
Confidence 354 344567899999999 7888876 48999999999999 68853 578999999999999 566543333221
Q ss_pred cccccccccCC-----ccccceeCCCCcCcccCChhhhcccccccccccCCCCCCCCCCCCC--ccccccCCcc
Q 039819 83 PRKWDKRKCSG-----VDQGLLRLNNNSLSGAFPVFLAKISELAFLDLSYNNLSGPVPKFPA--RTFNVAGNPL 149 (534)
Q Consensus 83 ~~~~~~~~~~~-----~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~--~~~~~~~N~~ 149 (534)
. +..+.... .+|+.|+|++|+|+ .+|.. +++|+.|+|++|+|++ +|..+. ..+.+.+|.+
T Consensus 268 ~--Ls~N~L~~Lp~lp~~L~~L~Ls~N~Lt-~LP~~---p~~L~~LdLS~N~L~~-Lp~lp~~L~~L~Ls~N~L 334 (788)
T PRK15387 268 S--IFSNPLTHLPALPSGLCKLWIFGNQLT-SLPVL---PPGLQELSVSDNQLAS-LPALPSELCKLWAYNNQL 334 (788)
T ss_pred e--ccCCchhhhhhchhhcCEEECcCCccc-ccccc---ccccceeECCCCcccc-CCCCcccccccccccCcc
Confidence 0 01111111 25777888888887 56653 4678888999998885 454332 3344555544
|
|
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.63 E-value=7.5e-10 Score=116.32 Aligned_cols=126 Identities=33% Similarity=0.466 Sum_probs=99.3
Q ss_pred CcEEEEEecCCCceeecccccccCCCCCEEEccCCccCcCCCCCCCCCCCCCEEEcCCCcCccccCchhhhcccCccccc
Q 039819 8 NLVIGLGAPSQSLSGTLSGSIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFLSIWLPRKWD 87 (534)
Q Consensus 8 ~~l~~L~l~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~P~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~l~~~~~ 87 (534)
..+...+.+.|.|. ....++.-++.|+.|+|++|+++. .. .+..|++|++|||++|+|+ .+|..---
T Consensus 164 n~L~~a~fsyN~L~-~mD~SLqll~ale~LnLshNk~~~-v~-~Lr~l~~LkhLDlsyN~L~-~vp~l~~~--------- 230 (1096)
T KOG1859|consen 164 NKLATASFSYNRLV-LMDESLQLLPALESLNLSHNKFTK-VD-NLRRLPKLKHLDLSYNCLR-HVPQLSMV--------- 230 (1096)
T ss_pred hhHhhhhcchhhHH-hHHHHHHHHHHhhhhccchhhhhh-hH-HHHhcccccccccccchhc-cccccchh---------
Confidence 35778889999998 788899999999999999999994 44 7889999999999999999 66642111
Q ss_pred ccccCCccccceeCCCCcCcccCChhhhcccccccccccCCCCCCCC---CCC-CC--ccccccCCcceecC
Q 039819 88 KRKCSGVDQGLLRLNNNSLSGAFPVFLAKISELAFLDLSYNNLSGPV---PKF-PA--RTFNVAGNPLICGS 153 (534)
Q Consensus 88 ~~~~~~~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~---p~~-~~--~~~~~~~N~~~cg~ 153 (534)
+-.|+.|.|+||.++ .+ ..+.+|.+|+.|||++|-|.+-- |-+ +. ..+.+.|||+-|.+
T Consensus 231 -----gc~L~~L~lrnN~l~-tL-~gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~c~p 295 (1096)
T KOG1859|consen 231 -----GCKLQLLNLRNNALT-TL-RGIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLCCAP 295 (1096)
T ss_pred -----hhhheeeeecccHHH-hh-hhHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccccCH
Confidence 116888999999998 33 25778999999999999988531 111 11 56789999997753
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.61 E-value=3.3e-07 Score=89.74 Aligned_cols=125 Identities=14% Similarity=0.092 Sum_probs=87.6
Q ss_pred CeeccCCcEEEEEEEECCCcEEEEEEehh-------------------------hhhhcccCc--eeeEEEEEeC-----
Q 039819 208 NILGAGGFGNVYKGKLGDGTVLAVKRLKD-------------------------MISLAVHRN--LLRLIGYCAT----- 255 (534)
Q Consensus 208 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~-------------------------~l~~~~h~n--iv~l~~~~~~----- 255 (534)
+.+-......|++..+ +|+.+.||+... .+..+...+ ...++++...
T Consensus 28 e~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~ 106 (268)
T PRK15123 28 EVFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA 106 (268)
T ss_pred cEEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence 3444444445667766 566788896531 111221122 2344555533
Q ss_pred CCeeEEEeeccCCC-Chhhhccc--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCC-------CCc
Q 039819 256 PTERLLVYPYMSNG-SVASRLRE--KPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDD-------FCE 325 (534)
Q Consensus 256 ~~~~~lv~e~~~~g-sL~~~l~~--~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~-------~~~ 325 (534)
....+||+|++++- +|.+++.. ....+...+..++.+++..+.-||.. +|+|+|++++|||++. ++.
T Consensus 107 ~~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~---Gi~HgDL~~~NiLl~~~~~~~~~~~~ 183 (268)
T PRK15123 107 TRTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAA---GINHRDCYICHFLLHLPFPGREEDLK 183 (268)
T ss_pred cceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHC---cCccCCCChhhEEEeccccCCCCCce
Confidence 23468999999986 78888753 33456677889999999999999999 9999999999999975 578
Q ss_pred EEEEeccccee
Q 039819 326 AIVGDFGLAKL 336 (534)
Q Consensus 326 ~kl~DFGla~~ 336 (534)
+.++||+.+..
T Consensus 184 ~~LIDl~r~~~ 194 (268)
T PRK15123 184 LSVIDLHRAQI 194 (268)
T ss_pred EEEEECCcccc
Confidence 89999998864
|
|
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.58 E-value=2.5e-09 Score=90.70 Aligned_cols=128 Identities=24% Similarity=0.275 Sum_probs=99.5
Q ss_pred ecCCCcEEEEEecCCCceeecccccccC---CCCCEEEccCCccCcCCCCCCCCC-CCCCEEEcCCCcCccccCchhhhc
Q 039819 4 CSPENLVIGLGAPSQSLSGTLSGSIGNL---TNLRQVLLQNNNISGGIPPQLGSL-PKLQTLDLSNNRLSGVIPALLFLS 79 (534)
Q Consensus 4 c~~~~~l~~L~l~~n~l~g~~p~~~~~l---~~L~~L~L~~N~l~g~~P~~~~~l-~~L~~L~Ls~N~l~g~~p~~~~~l 79 (534)
|++...+-.|+|++.+|. .+++....+ ..|+..+|++|.|. .+|+.|... +.++.|+|++|.|+ .+|.++..+
T Consensus 23 cedakE~h~ldLssc~lm-~i~davy~l~~~~el~~i~ls~N~fk-~fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam 99 (177)
T KOG4579|consen 23 CEDAKELHFLDLSSCQLM-YIADAVYMLSKGYELTKISLSDNGFK-KFPKKFTIKFPTATTLNLANNEIS-DVPEELAAM 99 (177)
T ss_pred hHHHHHhhhcccccchhh-HHHHHHHHHhCCceEEEEecccchhh-hCCHHHhhccchhhhhhcchhhhh-hchHHHhhh
Confidence 444445667889999986 677665444 55666799999999 788888765 48999999999999 889888888
Q ss_pred ccCcccccccccCCccccceeCCCCcCcccCChhhhcccccccccccCCCCCCCCCCCCC-----ccccccCCcce
Q 039819 80 IWLPRKWDKRKCSGVDQGLLRLNNNSLSGAFPVFLAKISELAFLDLSYNNLSGPVPKFPA-----RTFNVAGNPLI 150 (534)
Q Consensus 80 ~~l~~~~~~~~~~~~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~-----~~~~~~~N~~~ 150 (534)
+ .|+.|++++|.|. ..|..+..|.+|..|+..+|.+. .+|.... ....+.+|||.
T Consensus 100 ~--------------aLr~lNl~~N~l~-~~p~vi~~L~~l~~Lds~~na~~-eid~dl~~s~~~al~~lgnepl~ 159 (177)
T KOG4579|consen 100 P--------------ALRSLNLRFNPLN-AEPRVIAPLIKLDMLDSPENARA-EIDVDLFYSSLPALIKLGNEPLG 159 (177)
T ss_pred H--------------HhhhcccccCccc-cchHHHHHHHhHHHhcCCCCccc-cCcHHHhccccHHHHHhcCCccc
Confidence 8 7888999999998 88888888999999999988887 6663221 23456677774
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.54 E-value=2.2e-08 Score=105.86 Aligned_cols=153 Identities=15% Similarity=0.250 Sum_probs=104.1
Q ss_pred HHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCCce--------eeccccccccccccc
Q 039819 288 RIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHV--------TTAVRGTVGHIAPEY 359 (534)
Q Consensus 288 ~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~--------~~~~~gt~~y~aPE~ 359 (534)
.=+.+++.|+.|+|... ++||++|.|++|.+++.+..||+.|+.+.......... .....-...|.|||+
T Consensus 103 ~nl~~v~dgl~flh~sA--k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~ 180 (700)
T KOG2137|consen 103 ANLGNVADGLAFLHRSA--KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEY 180 (700)
T ss_pred hhhhcccchhhhhccCc--ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchh
Confidence 33456679999999764 99999999999999999999999999886543311110 111123467999999
Q ss_pred cccCCCCcchhHHHHHHHHHHHH-hCCCCcCCCccccccchHHHHHHHHhhhcccceecccccCCCCCHHHHHHHHHHHH
Q 039819 360 LSTGQSSEKTDVFGFGILLLELI-TGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELGSNYDRIEVGEILQVAL 438 (534)
Q Consensus 360 ~~~~~~~~k~Dv~S~Gvvl~ell-tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~ 438 (534)
+.....+.++|+||+||++|.+. .|+.-+....... ....... .+..-...+....+.++.+=+.
T Consensus 181 ~~~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~----~~~~~~~----------~~~~~~~~~s~~~p~el~~~l~ 246 (700)
T KOG2137|consen 181 LLGTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLL----SYSFSRN----------LLNAGAFGYSNNLPSELRESLK 246 (700)
T ss_pred hccccccccccceeeeeEEEEEecCCcchhhccCCcc----hhhhhhc----------ccccccccccccCcHHHHHHHH
Confidence 98888899999999999999999 5555554321110 0000000 0000011122334568888888
Q ss_pred HhcccCCCCCCChHHHHH
Q 039819 439 LCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 439 ~Cl~~~P~~RPt~~ev~~ 456 (534)
+.+..++..||++.++..
T Consensus 247 k~l~~~~~~rp~~~~l~~ 264 (700)
T KOG2137|consen 247 KLLNGDSAVRPTLDLLLS 264 (700)
T ss_pred HHhcCCcccCcchhhhhc
Confidence 999999999998877754
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.53 E-value=5.9e-08 Score=101.31 Aligned_cols=104 Identities=35% Similarity=0.483 Sum_probs=75.9
Q ss_pred cEEEEEecCCCceeecccccccCC-CCCEEEccCCccCcCCCCCCCCCCCCCEEEcCCCcCccccCchhhhcccCccccc
Q 039819 9 LVIGLGAPSQSLSGTLSGSIGNLT-NLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFLSIWLPRKWD 87 (534)
Q Consensus 9 ~l~~L~l~~n~l~g~~p~~~~~l~-~L~~L~L~~N~l~g~~P~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~l~~~~~ 87 (534)
.++.|++.+|+++ .+|+..+.+. +|+.|++++|++. .+|..++.+++|+.|++++|+++ .+|...+.++
T Consensus 117 ~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N~l~-~l~~~~~~~~------- 186 (394)
T COG4886 117 NLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLS------- 186 (394)
T ss_pred ceeEEecCCcccc-cCccccccchhhcccccccccchh-hhhhhhhccccccccccCCchhh-hhhhhhhhhh-------
Confidence 5777777788877 6777777664 7888888888887 67777777788888888888877 5665544444
Q ss_pred ccccCCccccceeCCCCcCcccCChhhhcccccccccccCCCC
Q 039819 88 KRKCSGVDQGLLRLNNNSLSGAFPVFLAKISELAFLDLSYNNL 130 (534)
Q Consensus 88 ~~~~~~~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l 130 (534)
.|+.|++++|+++ .+|..+..+..|+.|.+++|++
T Consensus 187 -------~L~~L~ls~N~i~-~l~~~~~~~~~L~~l~~~~N~~ 221 (394)
T COG4886 187 -------NLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSI 221 (394)
T ss_pred -------hhhheeccCCccc-cCchhhhhhhhhhhhhhcCCcc
Confidence 6667788888877 7777666666677777777753
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.53 E-value=2.3e-08 Score=95.36 Aligned_cols=107 Identities=20% Similarity=0.196 Sum_probs=88.0
Q ss_pred CcEEEEEecCCCceeecccccccCCCCCEEEccCCccCcCCCCCCCCCCCCCEEEcCCCcCccccCchhhhcccCccccc
Q 039819 8 NLVIGLGAPSQSLSGTLSGSIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFLSIWLPRKWD 87 (534)
Q Consensus 8 ~~l~~L~l~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~P~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~l~~~~~ 87 (534)
..+..|+|++|+|. .+.. +..|.+|+.||||+|.|+ .+-.+-..|.++++|.|+.|.|. .+.+ +..+-
T Consensus 307 Pkir~L~lS~N~i~-~v~n-La~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIKtL~La~N~iE-~LSG-L~KLY------- 374 (490)
T KOG1259|consen 307 PKLRRLILSQNRIR-TVQN-LAELPQLQLLDLSGNLLA-ECVGWHLKLGNIKTLKLAQNKIE-TLSG-LRKLY------- 374 (490)
T ss_pred cceeEEecccccee-eehh-hhhcccceEeecccchhH-hhhhhHhhhcCEeeeehhhhhHh-hhhh-hHhhh-------
Confidence 57999999999998 4544 899999999999999999 67777788999999999999998 3322 22222
Q ss_pred ccccCCccccceeCCCCcCcccC-ChhhhcccccccccccCCCCCCC
Q 039819 88 KRKCSGVDQGLLRLNNNSLSGAF-PVFLAKISELAFLDLSYNNLSGP 133 (534)
Q Consensus 88 ~~~~~~~~L~~L~L~~N~l~g~~-p~~~~~l~~L~~L~ls~N~l~g~ 133 (534)
+|..||+++|++...- -..+++++-|+.|.|.+|.|.+.
T Consensus 375 -------SLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~~ 414 (490)
T KOG1259|consen 375 -------SLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAGS 414 (490)
T ss_pred -------hheeccccccchhhHHHhcccccccHHHHHhhcCCCcccc
Confidence 6788999999997322 24689999999999999999954
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.51 E-value=1.6e-06 Score=86.83 Aligned_cols=194 Identities=18% Similarity=0.209 Sum_probs=125.4
Q ss_pred eEEEeeccCCCC-hhhhcc------cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEec
Q 039819 259 RLLVYPYMSNGS-VASRLR------EKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDF 331 (534)
Q Consensus 259 ~~lv~e~~~~gs-L~~~l~------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DF 331 (534)
.-+.|..+.+.. ...++. ..+...|+..++.+..+|.+.+-||.. +.+-+|+.++|+|+++++.+.+.|-
T Consensus 85 iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~---Gh~vGDVn~~~~lVsd~~~V~LVds 161 (637)
T COG4248 85 IGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEH---GHVVGDVNQNSFLVSDDSKVVLVDS 161 (637)
T ss_pred eEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhc---CCcccccCccceeeecCceEEEEcc
Confidence 456677665531 222221 234589999999999999999999998 9999999999999999999999885
Q ss_pred ccceecCCCCCceeeccccccccccccccc-----cCCCCcchhHHHHHHHHHHHHhC-CCCcCCCccccccchHHHHHH
Q 039819 332 GLAKLLDHSDSHVTTAVRGTVGHIAPEYLS-----TGQSSEKTDVFGFGILLLELITG-MRALEFGKSINQKGAMLEWVK 405 (534)
Q Consensus 332 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~k~Dv~S~Gvvl~elltG-~~p~~~~~~~~~~~~~~~~~~ 405 (534)
..-.... +.......+|...|.+||.-. +...+...|-|.+||++++++.| ++||.+-........-.+-
T Consensus 162 Dsfqi~~--ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~-- 237 (637)
T COG4248 162 DSFQINA--NGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLET-- 237 (637)
T ss_pred cceeecc--CCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchh--
Confidence 4433332 223344566889999999764 33456789999999999999887 9999642211111100000
Q ss_pred HHhhhcccceecccc--c---CCCCC-HHHHHHHHHHHHHhcccC--CCCCCChHHHHHHhhc
Q 039819 406 KIQQEKKVEVLVDRE--L---GSNYD-RIEVGEILQVALLCTQYL--PVHRPKMSEVVRMLEG 460 (534)
Q Consensus 406 ~~~~~~~~~~~~d~~--l---~~~~~-~~~~~~l~~l~~~Cl~~~--P~~RPt~~ev~~~L~~ 460 (534)
.+.. +...+.-|.. . ....+ ...+..+..+..+|+... +.-||+.+..+..|..
T Consensus 238 ~Ia~-g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~a 299 (637)
T COG4248 238 DIAH-GRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDA 299 (637)
T ss_pred hhhc-ceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHH
Confidence 0000 0000000100 0 01111 122346777888888764 6789999999887764
|
|
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=98.48 E-value=3.4e-07 Score=107.85 Aligned_cols=102 Identities=21% Similarity=0.233 Sum_probs=60.8
Q ss_pred cEEEEEecCCCceeecccccccCCCCCEEEccCCccCcCCCCCCCCCCCCCEEEcCCCcCccccCchhhhcccCcccccc
Q 039819 9 LVIGLGAPSQSLSGTLSGSIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFLSIWLPRKWDK 88 (534)
Q Consensus 9 ~l~~L~l~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~P~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~l~~~~~~ 88 (534)
+++.|++.+|.+. .+|..| .+.+|+.|+|++|+|. .+|..+..+++|+.|+|++|...+.+|. +..++
T Consensus 590 ~Lr~L~~~~~~l~-~lP~~f-~~~~L~~L~L~~s~l~-~L~~~~~~l~~Lk~L~Ls~~~~l~~ip~-ls~l~-------- 657 (1153)
T PLN03210 590 KLRLLRWDKYPLR-CMPSNF-RPENLVKLQMQGSKLE-KLWDGVHSLTGLRNIDLRGSKNLKEIPD-LSMAT-------- 657 (1153)
T ss_pred ccEEEEecCCCCC-CCCCcC-CccCCcEEECcCcccc-ccccccccCCCCCEEECCCCCCcCcCCc-cccCC--------
Confidence 4667777777665 566666 3567777777777776 5666666777777777766554445553 33344
Q ss_pred cccCCccccceeCCCCcCcccCChhhhcccccccccccCC
Q 039819 89 RKCSGVDQGLLRLNNNSLSGAFPVFLAKISELAFLDLSYN 128 (534)
Q Consensus 89 ~~~~~~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N 128 (534)
+|+.|+|++|.....+|..++.+++|+.|++++|
T Consensus 658 ------~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L~~c 691 (1153)
T PLN03210 658 ------NLETLKLSDCSSLVELPSSIQYLNKLEDLDMSRC 691 (1153)
T ss_pred ------cccEEEecCCCCccccchhhhccCCCCEEeCCCC
Confidence 4555555554433355555555555555555554
|
syringae 6; Provisional |
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.48 E-value=3.5e-08 Score=97.49 Aligned_cols=90 Identities=26% Similarity=0.262 Sum_probs=64.9
Q ss_pred ccccCCCCCEEEccCCccCcCCCCCCCCCCCCCEEEcCCCcCccccCchhhhcccCcccccccccCCccccceeCCCCcC
Q 039819 27 SIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFLSIWLPRKWDKRKCSGVDQGLLRLNNNSL 106 (534)
Q Consensus 27 ~~~~l~~L~~L~L~~N~l~g~~P~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~l~~~~~~~~~~~~~L~~L~L~~N~l 106 (534)
.|..|++|+.|+|++|+|+++-+.+|.++..|+.|+|..|+|.-.-...|.++. .|+.|+|++|+|
T Consensus 269 cf~~L~~L~~lnlsnN~i~~i~~~aFe~~a~l~eL~L~~N~l~~v~~~~f~~ls--------------~L~tL~L~~N~i 334 (498)
T KOG4237|consen 269 CFKKLPNLRKLNLSNNKITRIEDGAFEGAAELQELYLTRNKLEFVSSGMFQGLS--------------GLKTLSLYDNQI 334 (498)
T ss_pred HHhhcccceEeccCCCccchhhhhhhcchhhhhhhhcCcchHHHHHHHhhhccc--------------cceeeeecCCee
Confidence 577777888888888888777777777777788888888877754445555555 667777777777
Q ss_pred cccCChhhhcccccccccccCCCC
Q 039819 107 SGAFPVFLAKISELAFLDLSYNNL 130 (534)
Q Consensus 107 ~g~~p~~~~~l~~L~~L~ls~N~l 130 (534)
+-.-|.+|..+.+|.+|+|-.|.+
T Consensus 335 t~~~~~aF~~~~~l~~l~l~~Np~ 358 (498)
T KOG4237|consen 335 TTVAPGAFQTLFSLSTLNLLSNPF 358 (498)
T ss_pred EEEecccccccceeeeeehccCcc
Confidence 767777777777777766655544
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.48 E-value=7e-08 Score=100.75 Aligned_cols=119 Identities=30% Similarity=0.385 Sum_probs=90.5
Q ss_pred cEEEEEecCCCceeecccccccCCCCCEEEccCCccCcCCCCCCCCCCCCCEEEcCCCcCccccCchhhhcccCcccccc
Q 039819 9 LVIGLGAPSQSLSGTLSGSIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFLSIWLPRKWDK 88 (534)
Q Consensus 9 ~l~~L~l~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~P~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~l~~~~~~ 88 (534)
+++.|++++|++. .+|..++.+++|+.|++++|+++ .+|...+.+++|+.|++++|+++ .+|.....+..+..++.+
T Consensus 141 nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N~l~-~l~~~~~~~~~L~~L~ls~N~i~-~l~~~~~~~~~L~~l~~~ 217 (394)
T COG4886 141 NLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLS 217 (394)
T ss_pred hcccccccccchh-hhhhhhhccccccccccCCchhh-hhhhhhhhhhhhhheeccCCccc-cCchhhhhhhhhhhhhhc
Confidence 7999999999999 78888999999999999999999 89988889999999999999999 778765444434333322
Q ss_pred cc-c--------CCccccceeCCCCcCcccCChhhhcccccccccccCCCCC
Q 039819 89 RK-C--------SGVDQGLLRLNNNSLSGAFPVFLAKISELAFLDLSYNNLS 131 (534)
Q Consensus 89 ~~-~--------~~~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~ 131 (534)
++ . ...++..|.+.+|++. .+|..++.+++|+.|++++|.++
T Consensus 218 ~N~~~~~~~~~~~~~~l~~l~l~~n~~~-~~~~~~~~l~~l~~L~~s~n~i~ 268 (394)
T COG4886 218 NNSIIELLSSLSNLKNLSGLELSNNKLE-DLPESIGNLSNLETLDLSNNQIS 268 (394)
T ss_pred CCcceecchhhhhcccccccccCCceee-eccchhccccccceecccccccc
Confidence 22 1 0114555667777776 44666777777777777777777
|
|
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=98.46 E-value=4.7e-08 Score=98.70 Aligned_cols=110 Identities=25% Similarity=0.195 Sum_probs=68.5
Q ss_pred cEEEEEecCCCce------eecccccccCCCCCEEEccCCccCcCCCCCCCCCCC---CCEEEcCCCcCccc----cCch
Q 039819 9 LVIGLGAPSQSLS------GTLSGSIGNLTNLRQVLLQNNNISGGIPPQLGSLPK---LQTLDLSNNRLSGV----IPAL 75 (534)
Q Consensus 9 ~l~~L~l~~n~l~------g~~p~~~~~l~~L~~L~L~~N~l~g~~P~~~~~l~~---L~~L~Ls~N~l~g~----~p~~ 75 (534)
.++.|+++++.+. ..++..|..+++|+.|+|++|.+++..+..|..+.+ |+.|+|++|++++. +...
T Consensus 52 ~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~ 131 (319)
T cd00116 52 SLKELCLSLNETGRIPRGLQSLLQGLTKGCGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKG 131 (319)
T ss_pred CceEEeccccccCCcchHHHHHHHHHHhcCceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHHHHHH
Confidence 4777777777776 223456667778888888888777655555555555 88888888877631 1112
Q ss_pred hhhc-ccCcccccccccCCccccceeCCCCcCccc----CChhhhcccccccccccCCCCCC
Q 039819 76 LFLS-IWLPRKWDKRKCSGVDQGLLRLNNNSLSGA----FPVFLAKISELAFLDLSYNNLSG 132 (534)
Q Consensus 76 ~~~l-~~l~~~~~~~~~~~~~L~~L~L~~N~l~g~----~p~~~~~l~~L~~L~ls~N~l~g 132 (534)
+..+ + +|+.|+|++|.+++. ++..+..+..|+.|++++|++++
T Consensus 132 l~~~~~--------------~L~~L~L~~n~l~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~ 179 (319)
T cd00116 132 LKDLPP--------------ALEKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGD 179 (319)
T ss_pred HHhCCC--------------CceEEEcCCCcCCchHHHHHHHHHHhCCCcCEEECcCCCCch
Confidence 2222 2 566777777777632 33345555667777777777763
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=98.46 E-value=4.7e-08 Score=98.69 Aligned_cols=110 Identities=29% Similarity=0.334 Sum_probs=77.7
Q ss_pred CcEEEEEecCCCceeecccccccCCC---CCEEEccCCccCc----CCCCCCCCC-CCCCEEEcCCCcCccccCc----h
Q 039819 8 NLVIGLGAPSQSLSGTLSGSIGNLTN---LRQVLLQNNNISG----GIPPQLGSL-PKLQTLDLSNNRLSGVIPA----L 75 (534)
Q Consensus 8 ~~l~~L~l~~n~l~g~~p~~~~~l~~---L~~L~L~~N~l~g----~~P~~~~~l-~~L~~L~Ls~N~l~g~~p~----~ 75 (534)
.+++.|+|++|.+.+..+..|..+.+ |++|+|++|++++ .+...+..+ ++|+.|+|++|.|++..+. .
T Consensus 81 ~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~~~~ 160 (319)
T cd00116 81 CGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAKA 160 (319)
T ss_pred CceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHHHHHH
Confidence 47999999999998777777777766 9999999999983 344456667 8999999999999854332 2
Q ss_pred hhhcccCcccccccccCCccccceeCCCCcCcc----cCChhhhcccccccccccCCCCC
Q 039819 76 LFLSIWLPRKWDKRKCSGVDQGLLRLNNNSLSG----AFPVFLAKISELAFLDLSYNNLS 131 (534)
Q Consensus 76 ~~~l~~l~~~~~~~~~~~~~L~~L~L~~N~l~g----~~p~~~~~l~~L~~L~ls~N~l~ 131 (534)
+..+. +|+.|+|++|.+++ .++..+..+++|+.|+|++|.++
T Consensus 161 ~~~~~--------------~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~ 206 (319)
T cd00116 161 LRANR--------------DLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLT 206 (319)
T ss_pred HHhCC--------------CcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccC
Confidence 33333 56677777777763 23334445557777777777665
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=98.43 E-value=6.6e-07 Score=105.50 Aligned_cols=125 Identities=19% Similarity=0.213 Sum_probs=98.7
Q ss_pred CcEEEEEecCCCceeecccccccCCCCCEEEccCCccCcCCCCCCCCCCCCCEEEcCCCcCccccCchhhhcccCccccc
Q 039819 8 NLVIGLGAPSQSLSGTLSGSIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFLSIWLPRKWD 87 (534)
Q Consensus 8 ~~l~~L~l~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~P~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~l~~~~~ 87 (534)
.+++.|+|++|+|. .++..+..+++|++|+|++|..-+.+| .++.+++|+.|+|++|.....+|..+..+.
T Consensus 611 ~~L~~L~L~~s~l~-~L~~~~~~l~~Lk~L~Ls~~~~l~~ip-~ls~l~~Le~L~L~~c~~L~~lp~si~~L~------- 681 (1153)
T PLN03210 611 ENLVKLQMQGSKLE-KLWDGVHSLTGLRNIDLRGSKNLKEIP-DLSMATNLETLKLSDCSSLVELPSSIQYLN------- 681 (1153)
T ss_pred cCCcEEECcCcccc-ccccccccCCCCCEEECCCCCCcCcCC-ccccCCcccEEEecCCCCccccchhhhccC-------
Confidence 57899999999998 688888999999999999876544777 488899999999999876668898888877
Q ss_pred ccccCCccccceeCCCCcCcccCChhhhcccccccccccCCCCCCCCCCCCC--ccccccCCcc
Q 039819 88 KRKCSGVDQGLLRLNNNSLSGAFPVFLAKISELAFLDLSYNNLSGPVPKFPA--RTFNVAGNPL 149 (534)
Q Consensus 88 ~~~~~~~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~--~~~~~~~N~~ 149 (534)
+|+.|+|++|..-..+|..+ ++++|+.|+|++|...+.+|.... +.+.+.+|..
T Consensus 682 -------~L~~L~L~~c~~L~~Lp~~i-~l~sL~~L~Lsgc~~L~~~p~~~~nL~~L~L~~n~i 737 (1153)
T PLN03210 682 -------KLEDLDMSRCENLEILPTGI-NLKSLYRLNLSGCSRLKSFPDISTNISWLDLDETAI 737 (1153)
T ss_pred -------CCCEEeCCCCCCcCccCCcC-CCCCCCEEeCCCCCCccccccccCCcCeeecCCCcc
Confidence 88889999865444788766 788999999999876666765432 3455666653
|
syringae 6; Provisional |
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.42 E-value=5.2e-08 Score=82.82 Aligned_cols=111 Identities=21% Similarity=0.258 Sum_probs=90.9
Q ss_pred CCcEEEEEecCCCceeecccccccC-CCCCEEEccCCccCcCCCCCCCCCCCCCEEEcCCCcCccccCchhhhcccCccc
Q 039819 7 ENLVIGLGAPSQSLSGTLSGSIGNL-TNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFLSIWLPRK 85 (534)
Q Consensus 7 ~~~l~~L~l~~n~l~g~~p~~~~~l-~~L~~L~L~~N~l~g~~P~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~l~~~ 85 (534)
...++.++|++|.+. ..|..|... +.++.|+|++|.|+ .+|.++..++.|+.|++++|.|. ..|..+..+.
T Consensus 52 ~~el~~i~ls~N~fk-~fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~lNl~~N~l~-~~p~vi~~L~----- 123 (177)
T KOG4579|consen 52 GYELTKISLSDNGFK-KFPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRSLNLRFNPLN-AEPRVIAPLI----- 123 (177)
T ss_pred CceEEEEecccchhh-hCCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhhcccccCccc-cchHHHHHHH-----
Confidence 456899999999998 677777654 58999999999999 89999999999999999999999 7888888777
Q ss_pred ccccccCCccccceeCCCCcCcccCChhhhcccccccccccCCCCCCCCC
Q 039819 86 WDKRKCSGVDQGLLRLNNNSLSGAFPVFLAKISELAFLDLSYNNLSGPVP 135 (534)
Q Consensus 86 ~~~~~~~~~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p 135 (534)
+|-.|+..+|.+. .+|..+-.-......++.+|.+.+.-|
T Consensus 124 ---------~l~~Lds~~na~~-eid~dl~~s~~~al~~lgnepl~~~~~ 163 (177)
T KOG4579|consen 124 ---------KLDMLDSPENARA-EIDVDLFYSSLPALIKLGNEPLGDETK 163 (177)
T ss_pred ---------hHHHhcCCCCccc-cCcHHHhccccHHHHHhcCCcccccCc
Confidence 7788999999998 777664333334445667777776554
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.42 E-value=9.7e-07 Score=84.26 Aligned_cols=125 Identities=20% Similarity=0.189 Sum_probs=79.5
Q ss_pred CcCCeeccCCcEEEEEEEECCCcEEEEEEeh-------------hhhhhccc---------------CceeeEEEE-E--
Q 039819 205 SSKNILGAGGFGNVYKGKLGDGTVLAVKRLK-------------DMISLAVH---------------RNLLRLIGY-C-- 253 (534)
Q Consensus 205 ~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~-------------~~l~~~~h---------------~niv~l~~~-~-- 253 (534)
.....||-|--+.||.|..+.|.++|||-=+ +.++.-.| .-+.++... +
T Consensus 94 ~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~V 173 (304)
T COG0478 94 AIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVKV 173 (304)
T ss_pred hhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCCC
Confidence 3457899999999999999999999999321 01111111 111122221 1
Q ss_pred ---eCCCeeEEEeeccCCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEe
Q 039819 254 ---ATPTERLLVYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGD 330 (534)
Q Consensus 254 ---~~~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~D 330 (534)
.+.+...+||||+++-.|...-- +......++..|++-+.-+-.. +|||+|+++-||+++++|.+.++|
T Consensus 174 P~P~~~nRHaVvMe~ieG~eL~~~r~-----~~en~~~il~~il~~~~~~~~~---GiVHGDlSefNIlV~~dg~~~vID 245 (304)
T COG0478 174 PKPIAWNRHAVVMEYIEGVELYRLRL-----DVENPDEILDKILEEVRKAYRR---GIVHGDLSEFNILVTEDGDIVVID 245 (304)
T ss_pred CCccccccceeeeehcccceeecccC-----cccCHHHHHHHHHHHHHHHHHc---CccccCCchheEEEecCCCEEEEe
Confidence 12345689999999866654321 1222223333344433333344 899999999999999999999999
Q ss_pred cccceec
Q 039819 331 FGLAKLL 337 (534)
Q Consensus 331 FGla~~~ 337 (534)
|--+...
T Consensus 246 wPQ~v~~ 252 (304)
T COG0478 246 WPQAVPI 252 (304)
T ss_pred CcccccC
Confidence 9766543
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.41 E-value=3.3e-06 Score=79.88 Aligned_cols=147 Identities=23% Similarity=0.326 Sum_probs=95.8
Q ss_pred ccccCHHHHHHHHhCCCcCCeec---cCCcEEEEEEEECCCcEEEEEEehhh----------------hhhc--------
Q 039819 189 LRNFTFRELQQATENFSSKNILG---AGGFGNVYKGKLGDGTVLAVKRLKDM----------------ISLA-------- 241 (534)
Q Consensus 189 ~~~~~~~~l~~~~~~~~~~~~lG---~G~~g~Vy~~~~~~~~~vavK~~~~~----------------l~~~-------- 241 (534)
....|++.|.....+..+..+.| .|--+.||+|...++..+|||+.+.. ....
T Consensus 32 ~D~~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv 111 (268)
T COG1718 32 FDKRTLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLV 111 (268)
T ss_pred hhhHHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHH
Confidence 34567777777777777766655 45566899999989999999988620 0000
Q ss_pred ------ccCceeeEEEEE-eCC-----CeeEEEeeccCCC-ChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCe
Q 039819 242 ------VHRNLLRLIGYC-ATP-----TERLLVYPYMSNG-SVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKI 308 (534)
Q Consensus 242 ------~h~niv~l~~~~-~~~-----~~~~lv~e~~~~g-sL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~i 308 (534)
.-.|+-++++.- ..+ ....|||||+... .-.=.|+.- .+...+...+..++++.+.-|-..+ ++
T Consensus 112 ~~W~~kEf~NL~R~~eAGVrvP~Pi~~~~nVLvMEfIg~~g~pAP~LkDv-~~e~~e~~~~~~~~v~~~~~l~~~a--~L 188 (268)
T COG1718 112 FAWARKEFRNLKRAYEAGVRVPEPIAFRNNVLVMEFIGDDGLPAPRLKDV-PLELEEAEGLYEDVVEYMRRLYKEA--GL 188 (268)
T ss_pred HHHHHHHHHHHHHHHHcCCCCCCceeecCCeEEEEeccCCCCCCCCcccC-CcCchhHHHHHHHHHHHHHHHHHhc--Cc
Confidence 011222222221 111 2347999999653 211122222 2333356677778888888777633 99
Q ss_pred EeccCCCCcEEeCCCCcEEEEecccceecCC
Q 039819 309 IHRDVKAANVLLDDFCEAIVGDFGLAKLLDH 339 (534)
Q Consensus 309 vH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~ 339 (534)
||+||+.-|||+. ++.+.|+|||-|....+
T Consensus 189 VHgDLSEyNiL~~-~~~p~iID~~QaV~~~h 218 (268)
T COG1718 189 VHGDLSEYNILVH-DGEPYIIDVSQAVTIDH 218 (268)
T ss_pred ccccchhhheEEE-CCeEEEEECccccccCC
Confidence 9999999999999 79999999998876543
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.40 E-value=1.8e-06 Score=91.67 Aligned_cols=127 Identities=17% Similarity=0.190 Sum_probs=86.0
Q ss_pred CeeccCCcEEEEEEEECCCcEEEEEEehh---------------------------------------------------
Q 039819 208 NILGAGGFGNVYKGKLGDGTVLAVKRLKD--------------------------------------------------- 236 (534)
Q Consensus 208 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~--------------------------------------------------- 236 (534)
+.|+.++-|.||+|++.+|+.||||+.+-
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 68999999999999999999999998751
Q ss_pred -------hhhhcccCceeeEEEEEe-CCCeeEEEeeccCCCChhhhcc-cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC
Q 039819 237 -------MISLAVHRNLLRLIGYCA-TPTERLLVYPYMSNGSVASRLR-EKPALDWNTRKRIAIGAARGLLYLHEQCDPK 307 (534)
Q Consensus 237 -------~l~~~~h~niv~l~~~~~-~~~~~~lv~e~~~~gsL~~~l~-~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ 307 (534)
.-...+...-+++=.+|. -.....|+|||++|-.+.+... +...++.........++.--.-+- . +
T Consensus 211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~ia~~~~~~f~~q~~~--d---g 285 (517)
T COG0661 211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAGIDRKELAELLVRAFLRQLLR--D---G 285 (517)
T ss_pred HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcCCCHHHHHHHHHHHHHHHHHh--c---C
Confidence 001111222223333333 3466799999999988888742 224455333332222222112222 2 8
Q ss_pred eEeccCCCCcEEeCCCCcEEEEecccceecCC
Q 039819 308 IIHRDVKAANVLLDDFCEAIVGDFGLAKLLDH 339 (534)
Q Consensus 308 ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~ 339 (534)
+.|.|..|.||+++.++.+.+.|||+...+..
T Consensus 286 ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 286 FFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred ccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 99999999999999999999999999987654
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.36 E-value=1.3e-06 Score=82.56 Aligned_cols=89 Identities=19% Similarity=0.243 Sum_probs=73.0
Q ss_pred eeeEEEEEeCCC----eeEEEeeccCCC-ChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEe
Q 039819 246 LLRLIGYCATPT----ERLLVYPYMSNG-SVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLL 320 (534)
Q Consensus 246 iv~l~~~~~~~~----~~~lv~e~~~~g-sL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl 320 (534)
..+.+++..... ..++|+|++++. +|.+++.....++......++.++++.++-||.. +|+|+|+++.|||+
T Consensus 75 tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~lH~~---gi~H~Dl~~~NILv 151 (206)
T PF06293_consen 75 TPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAKLHDA---GIYHGDLNPSNILV 151 (206)
T ss_pred CCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHHHHHC---cCCCCCCCcccEEE
Confidence 345556655432 348999999874 7998887654477778889999999999999999 99999999999999
Q ss_pred CCCC---cEEEEecccceec
Q 039819 321 DDFC---EAIVGDFGLAKLL 337 (534)
Q Consensus 321 ~~~~---~~kl~DFGla~~~ 337 (534)
+.+. .+.++||+-++..
T Consensus 152 ~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 152 DPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred eCCCCceeEEEEcchhceeC
Confidence 9887 8899999988754
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PF12799 LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_A 1XEU_A 2OMX_A 2OMU_A 2UZY_A 2WQU_D 1D0B_A 2WQW_A 1OTO_A 2WQV_B | Back alignment and domain information |
|---|
Probab=98.35 E-value=2.5e-07 Score=63.80 Aligned_cols=37 Identities=51% Similarity=0.861 Sum_probs=29.1
Q ss_pred CCCCEEEccCCccCcCCCCCCCCCCCCCEEEcCCCcCc
Q 039819 32 TNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLS 69 (534)
Q Consensus 32 ~~L~~L~L~~N~l~g~~P~~~~~l~~L~~L~Ls~N~l~ 69 (534)
++|++|+|++|+|+ .+|+.|++|++|++|+|++|+|+
T Consensus 1 ~~L~~L~l~~N~i~-~l~~~l~~l~~L~~L~l~~N~i~ 37 (44)
T PF12799_consen 1 KNLEELDLSNNQIT-DLPPELSNLPNLETLNLSNNPIS 37 (44)
T ss_dssp TT-SEEEETSSS-S-SHGGHGTTCTTSSEEEETSSCCS
T ss_pred CcceEEEccCCCCc-ccCchHhCCCCCCEEEecCCCCC
Confidence 47888888888888 67777888888888888888887
|
... |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.21 E-value=1.6e-05 Score=74.21 Aligned_cols=122 Identities=15% Similarity=0.107 Sum_probs=88.4
Q ss_pred eccCCcEEEEEEEECCCcEEEEEEehh-hhhhcccCc---------------------eeeEEEEEeC---C--CeeEEE
Q 039819 210 LGAGGFGNVYKGKLGDGTVLAVKRLKD-MISLAVHRN---------------------LLRLIGYCAT---P--TERLLV 262 (534)
Q Consensus 210 lG~G~~g~Vy~~~~~~~~~vavK~~~~-~l~~~~h~n---------------------iv~l~~~~~~---~--~~~~lv 262 (534)
-|+||.+.|++-.+.+. .+-+|+-.+ +...++||+ +.++. ++.. + -.-+||
T Consensus 26 ~~rgG~SgV~r~~~~g~-~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV 103 (216)
T PRK09902 26 YRRNGMSGVQCVERNGK-KLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV 103 (216)
T ss_pred cCCCCcceEEEEEeCCc-EEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence 47899999999887544 688998763 222222222 33333 3321 1 134799
Q ss_pred eeccCC-CChhhhcccC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCc--EEEEeccccee
Q 039819 263 YPYMSN-GSVASRLREK--PALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCE--AIVGDFGLAKL 336 (534)
Q Consensus 263 ~e~~~~-gsL~~~l~~~--~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~--~kl~DFGla~~ 336 (534)
+|-+++ -+|.+++.+. ...+...+..+..+++..++-||+. ++.|+|+.+.||+++.++. ++++||--++.
T Consensus 104 Te~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~---Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 104 TEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSV---NRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 997764 4788887653 3457778889999999999999999 9999999999999986666 89999976653
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.21 E-value=6.1e-06 Score=87.37 Aligned_cols=127 Identities=17% Similarity=0.195 Sum_probs=85.5
Q ss_pred CeeccCCcEEEEEEEECCCcEEEEEEehh---------------------------------------------------
Q 039819 208 NILGAGGFGNVYKGKLGDGTVLAVKRLKD--------------------------------------------------- 236 (534)
Q Consensus 208 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~--------------------------------------------------- 236 (534)
+.||.-+.|.||+|++++|..||||+-+.
T Consensus 167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~ 246 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK 246 (538)
T ss_pred chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence 57999999999999999999999997641
Q ss_pred ----hhhhcccCc---eeeEEEEEeC-CCeeEEEeeccCCCChhhhcc-cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC
Q 039819 237 ----MISLAVHRN---LLRLIGYCAT-PTERLLVYPYMSNGSVASRLR-EKPALDWNTRKRIAIGAARGLLYLHEQCDPK 307 (534)
Q Consensus 237 ----~l~~~~h~n---iv~l~~~~~~-~~~~~lv~e~~~~gsL~~~l~-~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ 307 (534)
......|-+ -|.+=.++.+ ...+.|+||||+|..+.+.-. +...++...+..-+.++..-+-+. .|
T Consensus 247 Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i~~~gi~~~~i~~~l~~~~~~qIf~-----~G 321 (538)
T KOG1235|consen 247 NAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAIDKRGISPHDILNKLVEAYLEQIFK-----TG 321 (538)
T ss_pred hHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHHHHcCCCHHHHHHHHHHHHHHHHHh-----cC
Confidence 122333444 1222222322 356799999999988776542 223355554333333322222222 28
Q ss_pred eEeccCCCCcEEeCC----CCcEEEEecccceecCC
Q 039819 308 IIHRDVKAANVLLDD----FCEAIVGDFGLAKLLDH 339 (534)
Q Consensus 308 ivH~Dlkp~NiLl~~----~~~~kl~DFGla~~~~~ 339 (534)
++|+|=.|.||+++. ++.+.+-|||+......
T Consensus 322 ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 322 FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH 357 (538)
T ss_pred CccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence 999999999999983 67899999999886644
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.08 E-value=2.1e-07 Score=97.55 Aligned_cols=171 Identities=18% Similarity=0.164 Sum_probs=124.4
Q ss_pred CeeccCCcEEEEEEEECCCcEEEEEEe---------hhhhhhcccCc-eeeEEEEEeCCCeeEEEeeccCCC-Chhh-hc
Q 039819 208 NILGAGGFGNVYKGKLGDGTVLAVKRL---------KDMISLAVHRN-LLRLIGYCATPTERLLVYPYMSNG-SVAS-RL 275 (534)
Q Consensus 208 ~~lG~G~~g~Vy~~~~~~~~~vavK~~---------~~~l~~~~h~n-iv~l~~~~~~~~~~~lv~e~~~~g-sL~~-~l 275 (534)
+-+++|+++.+||.+-...+...++.+ .+++.+++||| .+..++-+..++..+++++|+.+| +-.. ..
T Consensus 248 h~fvK~altknpKkRptaeklL~h~fvs~~l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs~~~~~~ 327 (829)
T KOG0576|consen 248 HNFVKGALTKNPKKRPTAEKLLQHPFVSQTLSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGRSSALEMT 327 (829)
T ss_pred HHHHHHHhcCCCccCCChhhheeceeeccchhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCccccccCC
Confidence 347899999999997543333333332 35899999999 666666666777889999999887 2221 11
Q ss_pred ccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCCceeeccccccccc
Q 039819 276 REKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGHI 355 (534)
Q Consensus 276 ~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~ 355 (534)
...-.+..-+...+...-.++++|+|+. .=+||| ||+..+ +..+..||+....+.... ......+|+.++
T Consensus 328 ~se~~~~~~~~~~~~r~et~~l~~l~~~---~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~--~~~t~~~~~~~~ 397 (829)
T KOG0576|consen 328 VSEIALEQYQFAYPLRKETRPLAELHSS---YKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM--KPRTAIGTPEPL 397 (829)
T ss_pred hhhHhhhhhhhhhhhhhhcccccccccc---cccCcc----cccccc-cccccccccCCcccCccc--ccccCCCCCCCC
Confidence 1122233334445666778899999986 458998 777666 788999999988776543 344566899999
Q ss_pred cccccccCCCCcchhHHHHHHHHHHHHhCCCCc
Q 039819 356 APEYLSTGQSSEKTDVFGFGILLLELITGMRAL 388 (534)
Q Consensus 356 aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~ 388 (534)
|||+.....+..+.|+|+.|+--.+|.-|-+|-
T Consensus 398 ~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr 430 (829)
T KOG0576|consen 398 APEVIQENTIDGCPDSGSLAVSAIQMAPGLPPR 430 (829)
T ss_pred CchhhcccccccCCCccCCCcchhhcCCCCCCC
Confidence 999999999999999999998777887776664
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.01 E-value=4.4e-05 Score=71.58 Aligned_cols=123 Identities=13% Similarity=0.112 Sum_probs=80.7
Q ss_pred HhCCCcCCeeccCCcEEEEEEEECCCcEEEEEEehh-----------------------hhhhccc---CceeeEEEEEe
Q 039819 201 TENFSSKNILGAGGFGNVYKGKLGDGTVLAVKRLKD-----------------------MISLAVH---RNLLRLIGYCA 254 (534)
Q Consensus 201 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~-----------------------~l~~~~h---~niv~l~~~~~ 254 (534)
..+|...+++-......|.+-.. +|..+.+|..++ .+..++. .....++.+..
T Consensus 30 ~~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~e 108 (229)
T PF06176_consen 30 DNNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAE 108 (229)
T ss_pred hCCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeee
Confidence 35666667777766677777766 556778887652 0111111 11222222221
Q ss_pred -----CCCeeEEEeeccCCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEE
Q 039819 255 -----TPTERLLVYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVG 329 (534)
Q Consensus 255 -----~~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~ 329 (534)
-....++||||++|-.|.+... ++. .++..+++++.-+|.. |++|+|..|.|+++++++ +++.
T Consensus 109 kk~~~~~~~~~ll~EYIeG~~l~d~~~----i~e----~~~~ki~~~ikqlH~~---G~~HGD~hpgNFlv~~~~-i~iI 176 (229)
T PF06176_consen 109 KKIFRYTSSYVLLMEYIEGVELNDIED----IDE----DLAEKIVEAIKQLHKH---GFYHGDPHPGNFLVSNNG-IRII 176 (229)
T ss_pred eeeccceeEEEEEEEEecCeecccchh----cCH----HHHHHHHHHHHHHHHc---CCccCCCCcCcEEEECCc-EEEE
Confidence 2234569999999988766542 222 3456677889999999 999999999999999654 8899
Q ss_pred eccccee
Q 039819 330 DFGLAKL 336 (534)
Q Consensus 330 DFGla~~ 336 (534)
||+..+.
T Consensus 177 D~~~k~~ 183 (229)
T PF06176_consen 177 DTQGKRM 183 (229)
T ss_pred ECccccc
Confidence 9987653
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >PF12799 LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_A 1XEU_A 2OMX_A 2OMU_A 2UZY_A 2WQU_D 1D0B_A 2WQW_A 1OTO_A 2WQV_B | Back alignment and domain information |
|---|
Probab=97.98 E-value=3.9e-06 Score=57.87 Aligned_cols=39 Identities=31% Similarity=0.406 Sum_probs=33.5
Q ss_pred cEEEEEecCCCceeecccccccCCCCCEEEccCCccCcCCC
Q 039819 9 LVIGLGAPSQSLSGTLSGSIGNLTNLRQVLLQNNNISGGIP 49 (534)
Q Consensus 9 ~l~~L~l~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~P 49 (534)
+|+.|+|++|+|+ .+|+.|++|++|++|+|++|+|+ .+|
T Consensus 2 ~L~~L~l~~N~i~-~l~~~l~~l~~L~~L~l~~N~i~-~i~ 40 (44)
T PF12799_consen 2 NLEELDLSNNQIT-DLPPELSNLPNLETLNLSNNPIS-DIS 40 (44)
T ss_dssp T-SEEEETSSS-S-SHGGHGTTCTTSSEEEETSSCCS-BEG
T ss_pred cceEEEccCCCCc-ccCchHhCCCCCCEEEecCCCCC-CCc
Confidence 6889999999999 68888999999999999999999 444
|
... |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.92 E-value=4.6e-05 Score=70.72 Aligned_cols=96 Identities=22% Similarity=0.216 Sum_probs=76.6
Q ss_pred hhhccc-CceeeEEEEEeCCCeeEEEeeccCCCChhhh---cccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccC
Q 039819 238 ISLAVH-RNLLRLIGYCATPTERLLVYPYMSNGSVASR---LREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDV 313 (534)
Q Consensus 238 l~~~~h-~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~---l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dl 313 (534)
+..+.+ +++.+++|+| ..++|.||...+++... +..--..+|..|.+||.++++.+.++++.....+.-.|+
T Consensus 13 l~~l~~~~~~pk~lG~C----G~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~~~lcDv 88 (188)
T PF12260_consen 13 LQLLQGSEPFPKLLGSC----GRFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGFFYLCDV 88 (188)
T ss_pred HHHcCCCCCCCCeeeEC----CCEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCcEEEeec
Confidence 344444 4899999999 44789999988766432 222234689999999999999999999865546888999
Q ss_pred CCCcEEeCCCCcEEEEecccceec
Q 039819 314 KAANVLLDDFCEAIVGDFGLAKLL 337 (534)
Q Consensus 314 kp~NiLl~~~~~~kl~DFGla~~~ 337 (534)
+++|+-+++++.+|+.|...+...
T Consensus 89 ~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 89 SPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred chHHeEEeCCCcEEEEechhcchh
Confidence 999999999999999999876543
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=97.84 E-value=0.00017 Score=69.07 Aligned_cols=124 Identities=14% Similarity=0.133 Sum_probs=71.4
Q ss_pred CeeccCCcEEEEEEEECCCcEEEEEEehh------------hhhhcccCc--eeeEEEEEeCCCeeEEEeeccCCCC-hh
Q 039819 208 NILGAGGFGNVYKGKLGDGTVLAVKRLKD------------MISLAVHRN--LLRLIGYCATPTERLLVYPYMSNGS-VA 272 (534)
Q Consensus 208 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~------------~l~~~~h~n--iv~l~~~~~~~~~~~lv~e~~~~gs-L~ 272 (534)
..||+|..+.||+.. +..+++|.... .+..+..-. +.+.+++....+...+|||+++|.. +.
T Consensus 7 ~~i~~G~t~~~y~~~---~~~~VlR~~~~~~~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~~~ 83 (226)
T TIGR02172 7 TQTGEGGNGESYTHK---TGKWMLKLYNPGFDKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRSFS 83 (226)
T ss_pred eeecCCCCcceeEec---CCCEEEEeCCCCCCHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccchh
Confidence 578999999999842 33456776542 333333222 3566777777777889999999863 11
Q ss_pred hhc---------------------ccC--CCCCHHHHHH-HHH----------HHHH-HHHHHHhc-CCCCeEeccCCCC
Q 039819 273 SRL---------------------REK--PALDWNTRKR-IAI----------GAAR-GLLYLHEQ-CDPKIIHRDVKAA 316 (534)
Q Consensus 273 ~~l---------------------~~~--~~l~~~~~~~-i~~----------~i~~-~l~yLH~~-~~~~ivH~Dlkp~ 316 (534)
..+ +.- .......... +.. .+.+ ...+|... ..+.++|+|+.|.
T Consensus 84 ~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~~~~ 163 (226)
T TIGR02172 84 RIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDFQIG 163 (226)
T ss_pred hhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCCCCC
Confidence 111 110 1111111110 000 0111 12222211 1235789999999
Q ss_pred cEEeCCCCcEEEEecccce
Q 039819 317 NVLLDDFCEAIVGDFGLAK 335 (534)
Q Consensus 317 NiLl~~~~~~kl~DFGla~ 335 (534)
||++++++ +.|+||+.+.
T Consensus 164 Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 164 NLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred cEEEcCCC-cEEEechhcC
Confidence 99999888 9999998775
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.80 E-value=8.4e-06 Score=92.22 Aligned_cols=102 Identities=28% Similarity=0.430 Sum_probs=47.9
Q ss_pred EEEEEecCCCceeecccccccCCCCCEEEccCCc--cCcCCCCC-CCCCCCCCEEEcCCCcCccccCchhhhcccCcccc
Q 039819 10 VIGLGAPSQSLSGTLSGSIGNLTNLRQVLLQNNN--ISGGIPPQ-LGSLPKLQTLDLSNNRLSGVIPALLFLSIWLPRKW 86 (534)
Q Consensus 10 l~~L~l~~n~l~g~~p~~~~~l~~L~~L~L~~N~--l~g~~P~~-~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~l~~~~ 86 (534)
+....+-+|++. .++.+..+ ++|++|-+..|. +. .++.. |..++.|++||||+|.=-+.+|..++.+-
T Consensus 525 ~rr~s~~~~~~~-~~~~~~~~-~~L~tLll~~n~~~l~-~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li------ 595 (889)
T KOG4658|consen 525 VRRMSLMNNKIE-HIAGSSEN-PKLRTLLLQRNSDWLL-EISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELV------ 595 (889)
T ss_pred eeEEEEeccchh-hccCCCCC-CccceEEEeecchhhh-hcCHHHHhhCcceEEEECCCCCccCcCChHHhhhh------
Confidence 444444444444 33333322 245555555553 33 22222 44455555555554443344555555444
Q ss_pred cccccCCccccceeCCCCcCcccCChhhhcccccccccccCCC
Q 039819 87 DKRKCSGVDQGLLRLNNNSLSGAFPVFLAKISELAFLDLSYNN 129 (534)
Q Consensus 87 ~~~~~~~~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~ 129 (534)
+|++|+|++..++ .+|..|.+|..|.+||+..+.
T Consensus 596 --------~LryL~L~~t~I~-~LP~~l~~Lk~L~~Lnl~~~~ 629 (889)
T KOG4658|consen 596 --------HLRYLDLSDTGIS-HLPSGLGNLKKLIYLNLEVTG 629 (889)
T ss_pred --------hhhcccccCCCcc-ccchHHHHHHhhheecccccc
Confidence 4445555555555 555555555555555555444
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 534 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 1e-108 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 1e-106 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 2e-36 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 3e-36 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-34 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 5e-34 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 6e-34 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 2e-32 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 2e-19 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 2e-19 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 2e-19 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 2e-19 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 2e-19 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 2e-19 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 3e-19 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 3e-19 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 3e-19 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 3e-19 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 4e-19 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 4e-19 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 1e-18 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 2e-18 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 2e-18 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 7e-18 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 1e-16 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 1e-16 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 3e-16 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 3e-16 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 4e-16 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 4e-16 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 5e-16 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 5e-16 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 6e-16 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 6e-16 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 6e-16 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 6e-16 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 6e-16 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 6e-16 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 7e-16 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 8e-16 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 8e-16 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 8e-16 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 8e-16 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 8e-16 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 9e-16 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 1e-15 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-15 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 1e-15 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 1e-15 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 1e-15 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 1e-15 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-15 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-15 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 2e-15 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 2e-15 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 3e-15 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 3e-15 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 3e-15 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 4e-15 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 4e-15 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 4e-15 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 4e-15 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 4e-15 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 5e-15 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 5e-15 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 5e-15 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 5e-15 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 5e-15 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 6e-15 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 6e-15 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 6e-15 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 6e-15 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 6e-15 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 6e-15 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 7e-15 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 7e-15 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 9e-15 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 1e-14 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 2e-14 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 2e-14 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 2e-14 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 2e-14 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-14 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 3e-14 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 3e-14 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-14 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 3e-14 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 3e-14 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 3e-14 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 3e-14 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 3e-14 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 3e-14 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-14 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-14 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 3e-14 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 3e-14 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 3e-14 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 3e-14 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 3e-14 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 3e-14 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 3e-14 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 4e-14 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 4e-14 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 4e-14 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 4e-14 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 4e-14 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 4e-14 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 4e-14 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 4e-14 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 4e-14 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 4e-14 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 5e-14 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 5e-14 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 5e-14 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 5e-14 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 5e-14 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 5e-14 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 5e-14 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 5e-14 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 5e-14 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-14 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-14 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-14 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 6e-14 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 6e-14 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-14 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 6e-14 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-14 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 6e-14 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 6e-14 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 6e-14 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 6e-14 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 6e-14 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 6e-14 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 7e-14 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-14 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 7e-14 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 7e-14 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 7e-14 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 7e-14 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 8e-14 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 8e-14 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 8e-14 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 9e-14 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 9e-14 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 9e-14 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 1e-13 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 1e-13 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-13 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 1e-13 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 1e-13 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 1e-13 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-13 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 1e-13 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 1e-13 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 1e-13 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 1e-13 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 1e-13 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 1e-13 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 1e-13 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 1e-13 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 1e-13 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 1e-13 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 1e-13 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 1e-13 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 2e-13 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 2e-13 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-13 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 2e-13 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 2e-13 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-13 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 2e-13 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 2e-13 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 2e-13 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 2e-13 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 2e-13 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 3e-13 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-13 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 3e-13 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 3e-13 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 3e-13 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 3e-13 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 3e-13 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 4e-13 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-13 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 4e-13 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 4e-13 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 5e-13 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 5e-13 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 5e-13 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 6e-13 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 6e-13 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 6e-13 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 7e-13 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 7e-13 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 8e-13 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 8e-13 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 1e-12 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 1e-12 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 2e-12 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 2e-12 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 2e-12 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 2e-12 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 2e-12 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 2e-12 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 2e-12 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 3e-12 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-12 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 3e-12 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-12 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 3e-12 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 4e-12 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 4e-12 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 4e-12 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 4e-12 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 4e-12 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 4e-12 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 4e-12 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 5e-12 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 5e-12 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 5e-12 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 6e-12 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 6e-12 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 6e-12 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 7e-12 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 7e-12 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 7e-12 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 7e-12 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 7e-12 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 8e-12 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 8e-12 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 8e-12 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 8e-12 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 8e-12 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 9e-12 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 9e-12 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 9e-12 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 9e-12 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-11 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 1e-11 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 1e-11 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 1e-11 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 1e-11 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 1e-11 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-11 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 1e-11 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 1e-11 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 1e-11 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 1e-11 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 1e-11 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 1e-11 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 1e-11 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 1e-11 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 1e-11 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 1e-11 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 1e-11 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 1e-11 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 1e-11 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 1e-11 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 1e-11 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 1e-11 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-11 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 2e-11 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 2e-11 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 2e-11 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 2e-11 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-11 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 2e-11 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-11 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 2e-11 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-11 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-11 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 2e-11 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 2e-11 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 2e-11 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 2e-11 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-11 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 2e-11 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 2e-11 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 3e-11 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 3e-11 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 3e-11 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 3e-11 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-11 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 3e-11 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 3e-11 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 3e-11 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-11 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 3e-11 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-11 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-11 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 3e-11 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 3e-11 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 3e-11 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 3e-11 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 3e-11 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 3e-11 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 4e-11 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 4e-11 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 4e-11 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 4e-11 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 4e-11 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 4e-11 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 4e-11 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 4e-11 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 4e-11 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 4e-11 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 4e-11 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 4e-11 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 4e-11 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 4e-11 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 4e-11 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 5e-11 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 5e-11 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 6e-11 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 6e-11 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 6e-11 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 8e-11 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 9e-11 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 9e-11 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 1e-10 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-10 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 1e-10 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 1e-10 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 1e-10 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 1e-10 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 1e-10 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 1e-10 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 1e-10 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 1e-10 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 1e-10 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 1e-10 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-10 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-10 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 1e-10 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 1e-10 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 1e-10 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 1e-10 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-10 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-10 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-10 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 2e-10 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 2e-10 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 2e-10 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 2e-10 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 2e-10 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 2e-10 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 2e-10 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 2e-10 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 2e-10 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 2e-10 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 2e-10 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 2e-10 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 2e-10 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 2e-10 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 2e-10 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 2e-10 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 2e-10 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 2e-10 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 2e-10 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 2e-10 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 3e-10 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 3e-10 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 3e-10 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 3e-10 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 3e-10 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 3e-10 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 3e-10 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 3e-10 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-10 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 3e-10 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 3e-10 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 3e-10 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 3e-10 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 3e-10 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 3e-10 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 4e-10 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 4e-10 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 4e-10 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 4e-10 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 4e-10 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 4e-10 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 4e-10 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 5e-10 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 5e-10 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 5e-10 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 5e-10 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 5e-10 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 5e-10 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 5e-10 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 5e-10 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 6e-10 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 6e-10 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 6e-10 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 6e-10 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 7e-10 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 7e-10 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 7e-10 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 7e-10 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 7e-10 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 8e-10 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 8e-10 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 8e-10 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 9e-10 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 9e-10 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 9e-10 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 1e-09 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 1e-09 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 1e-09 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 1e-09 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 1e-09 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 1e-09 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 1e-09 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 1e-09 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 2e-09 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 2e-09 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 2e-09 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 2e-09 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 2e-09 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 2e-09 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 2e-09 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 2e-09 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 2e-09 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 2e-09 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 2e-09 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 2e-09 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 2e-09 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 2e-09 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-09 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 2e-09 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 2e-09 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 2e-09 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 2e-09 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 2e-09 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 3e-09 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 3e-09 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 3e-09 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-09 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 3e-09 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-09 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 3e-09 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-09 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 3e-09 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-09 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 3e-09 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-09 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 3e-09 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 3e-09 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 3e-09 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 3e-09 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 3e-09 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-09 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-09 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 3e-09 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 4e-09 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 4e-09 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 4e-09 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 4e-09 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-09 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 4e-09 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 4e-09 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-09 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 5e-09 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 5e-09 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 5e-09 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 5e-09 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 5e-09 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 5e-09 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-09 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 5e-09 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 5e-09 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 6e-09 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-09 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 6e-09 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 6e-09 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-09 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 6e-09 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 6e-09 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 6e-09 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-09 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 6e-09 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 6e-09 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 6e-09 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 6e-09 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-09 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 7e-09 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 7e-09 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 7e-09 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 7e-09 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 7e-09 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 8e-09 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 9e-09 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 1e-08 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 1e-08 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 1e-08 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-08 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 1e-08 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 1e-08 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 1e-08 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 1e-08 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 2e-08 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-08 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-08 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 2e-08 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 2e-08 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-08 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 2e-08 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-08 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 2e-08 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 2e-08 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 2e-08 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-08 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 2e-08 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-08 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 2e-08 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 2e-08 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-08 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 2e-08 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-08 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 2e-08 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-08 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 2e-08 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 2e-08 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-08 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 3e-08 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-08 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 3e-08 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 3e-08 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 3e-08 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 3e-08 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 3e-08 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 3e-08 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 3e-08 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 3e-08 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 3e-08 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-08 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-08 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 3e-08 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 3e-08 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 4e-08 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 4e-08 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 4e-08 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 4e-08 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 4e-08 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 4e-08 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 4e-08 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 4e-08 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 4e-08 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 5e-08 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 6e-08 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 6e-08 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 6e-08 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 6e-08 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 6e-08 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 6e-08 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 6e-08 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 6e-08 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 6e-08 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 6e-08 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 6e-08 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 6e-08 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 6e-08 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 6e-08 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 6e-08 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 6e-08 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 6e-08 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 6e-08 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 6e-08 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 6e-08 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 6e-08 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 6e-08 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 6e-08 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 6e-08 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 6e-08 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 6e-08 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 6e-08 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 6e-08 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 6e-08 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 6e-08 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 6e-08 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 6e-08 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 6e-08 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 6e-08 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 6e-08 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 7e-08 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 7e-08 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 7e-08 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 7e-08 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 8e-08 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 8e-08 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 8e-08 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 8e-08 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 9e-08 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 1e-07 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-07 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 2e-07 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 2e-07 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 2e-07 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 2e-07 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 2e-07 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 2e-07 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 2e-07 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 2e-07 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 2e-07 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 3e-07 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 3e-07 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 3e-07 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 3e-07 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 3e-07 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 3e-07 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 3e-07 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 3e-07 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 3e-07 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 3e-07 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 3e-07 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 4e-07 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 4e-07 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 4e-07 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 4e-07 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 4e-07 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 4e-07 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 5e-07 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 5e-07 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 5e-07 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 5e-07 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 5e-07 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 5e-07 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 5e-07 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 5e-07 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 5e-07 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 5e-07 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 5e-07 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 5e-07 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 6e-07 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 6e-07 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 6e-07 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 6e-07 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 6e-07 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 6e-07 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 6e-07 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 6e-07 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 6e-07 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 6e-07 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 6e-07 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 6e-07 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 6e-07 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 7e-07 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 7e-07 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 7e-07 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 7e-07 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 8e-07 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 8e-07 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 8e-07 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 8e-07 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 8e-07 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 9e-07 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 9e-07 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 9e-07 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 9e-07 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 1e-06 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 1e-06 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 1e-06 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 1e-06 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 1e-06 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 1e-06 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 1e-06 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 1e-06 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-06 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 1e-06 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 1e-06 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 1e-06 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-06 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 1e-06 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 1e-06 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 1e-06 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 1e-06 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-06 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-06 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 1e-06 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-06 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 1e-06 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 1e-06 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 1e-06 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 1e-06 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 1e-06 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-06 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 1e-06 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 1e-06 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-06 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 1e-06 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 2e-06 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 2e-06 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 2e-06 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 2e-06 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 2e-06 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 2e-06 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 2e-06 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 2e-06 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 2e-06 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 2e-06 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 2e-06 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 2e-06 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 2e-06 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 2e-06 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 2e-06 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 2e-06 | ||
| 3riz_A | 772 | Crystal Structure Of The Plant Steroid Receptor Bri | 2e-06 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-06 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 2e-06 | ||
| 3rgx_A | 768 | Structural Insight Into Brassinosteroid Perception | 2e-06 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 2e-06 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-06 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 2e-06 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 3e-06 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 3e-06 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 3e-06 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 3e-06 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 3e-06 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 4e-06 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 4e-06 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 4e-06 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 5e-06 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 5e-06 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 5e-06 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 5e-06 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 5e-06 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-06 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 7e-06 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 7e-06 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 7e-06 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 7e-06 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 7e-06 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 8e-06 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 8e-06 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 8e-06 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 8e-06 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 8e-06 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 8e-06 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 8e-06 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 8e-06 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 8e-06 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 8e-06 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 8e-06 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 8e-06 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 8e-06 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 8e-06 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 8e-06 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 8e-06 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 8e-06 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 9e-06 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 9e-06 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 9e-06 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 9e-06 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 9e-06 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 9e-06 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 9e-06 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 9e-06 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 9e-06 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 9e-06 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 9e-06 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 9e-06 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 1e-05 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 1e-05 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 1e-05 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 1e-05 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 1e-05 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-05 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 1e-05 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 1e-05 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 1e-05 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 1e-05 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-05 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 1e-05 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 1e-05 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 1e-05 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-05 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 1e-05 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-05 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 1e-05 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 1e-05 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 1e-05 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 1e-05 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 2e-05 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-05 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 2e-05 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-05 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 2e-05 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 2e-05 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 2e-05 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 2e-05 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 2e-05 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 2e-05 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 2e-05 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 2e-05 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-05 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-05 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 2e-05 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-05 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 3e-05 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 3e-05 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-05 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 3e-05 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 3e-05 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 3e-05 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 3e-05 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-05 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 3e-05 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 3e-05 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-05 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 3e-05 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 3e-05 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-05 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 3e-05 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 3e-05 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 3e-05 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 3e-05 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 3e-05 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 4e-05 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 4e-05 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 4e-05 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 4e-05 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-05 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 4e-05 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 4e-05 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 4e-05 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 4e-05 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 4e-05 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 4e-05 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 4e-05 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 4e-05 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 4e-05 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 4e-05 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 4e-05 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 4e-05 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 4e-05 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 4e-05 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 4e-05 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 4e-05 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 5e-05 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 5e-05 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 5e-05 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 5e-05 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 5e-05 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 6e-05 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 6e-05 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 6e-05 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 6e-05 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 7e-05 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 7e-05 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 7e-05 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 8e-05 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 8e-05 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 8e-05 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 8e-05 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 8e-05 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 8e-05 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 8e-05 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 8e-05 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 8e-05 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 8e-05 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 9e-05 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 9e-05 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 9e-05 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 9e-05 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 9e-05 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 9e-05 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 9e-05 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 1e-04 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 1e-04 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 1e-04 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 1e-04 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 1e-04 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 1e-04 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-04 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-04 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 1e-04 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 1e-04 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-04 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-04 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 1e-04 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 1e-04 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 1e-04 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 1e-04 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 1e-04 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 1e-04 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-04 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 1e-04 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 1e-04 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-04 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-04 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 1e-04 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-04 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 1e-04 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 1e-04 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-04 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-04 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 2e-04 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 2e-04 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 2e-04 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 2e-04 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 2e-04 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-04 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-04 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 2e-04 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 2e-04 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 2e-04 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 2e-04 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 2e-04 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 3e-04 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 3e-04 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 3e-04 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 3e-04 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 3e-04 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 3e-04 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 3e-04 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 3e-04 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 3e-04 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 3e-04 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 3e-04 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 3e-04 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 3e-04 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 4e-04 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 4e-04 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 4e-04 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 4e-04 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 4e-04 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 4e-04 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 4e-04 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 4e-04 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 4e-04 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 4e-04 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 5e-04 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 5e-04 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 5e-04 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 5e-04 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 5e-04 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 5e-04 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 6e-04 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 6e-04 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 6e-04 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 6e-04 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 6e-04 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 6e-04 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 7e-04 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 7e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 513 bits (1324), Expect = 0.0
Identities = 202/314 (64%), Positives = 245/314 (78%), Gaps = 20/314 (6%)
Query: 179 QEEGLISLGNLRNFTFRELQQATENFSSKNILGAGGFGNVYKGKLGDGTVLAVKRLKD-- 236
+E+ + LG L+ F+ RELQ A++NFS+KNILG GGFG VYKG+L DGT++AVKRLK+
Sbjct: 7 EEDPEVHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEER 66
Query: 237 -------------MISLAVHRNLLRLIGYCATPTERLLVYPYMSNGSVASRLRE----KP 279
MIS+AVHRNLLRL G+C TPTERLLVYPYM+NGSVAS LRE +P
Sbjct: 67 TQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQP 126
Query: 280 ALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDH 339
LDW R+RIA+G+ARGL YLH+ CDPKIIHRDVKAAN+LLD+ EA+VGDFGLAKL+D+
Sbjct: 127 PLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 186
Query: 340 SDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGA 399
D+HVTTAVRGT+GHIAPEYLSTG+SSEKTDVFG+G++LLELITG RA + + N
Sbjct: 187 KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDV 246
Query: 400 ML-EWVKKIQQEKKVEVLVDRELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRML 458
ML +WVK + +EKK+E LVD +L NY EV +++QVALLCTQ P+ RPKMSEVVRML
Sbjct: 247 MLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRML 306
Query: 459 EGDGLAEKWAAAHN 472
EGDGLAE+W
Sbjct: 307 EGDGLAERWEEWQK 320
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 392 bits (1009), Expect = e-134
Identities = 101/312 (32%), Positives = 169/312 (54%), Gaps = 38/312 (12%)
Query: 179 QEEGLISLGNLRNFTFRELQQATENFSSK------NILGAGGFGNVYKGKLGDGTVLAVK 232
+ +S +F+F EL+ T NF + N +G GGFG VYKG + + T +AVK
Sbjct: 2 NKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVK 60
Query: 233 RLK------------------DMISLAVHRNLLRLIGYCATPTERLLVYPYMSNGSVASR 274
+L +++ H NL+ L+G+ + + LVY YM NGS+ R
Sbjct: 61 KLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDR 120
Query: 275 L---REKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDF 331
L P L W+ R +IA GAA G+ +LHE IHRD+K+AN+LLD+ A + DF
Sbjct: 121 LSCLDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDF 177
Query: 332 GLAKLLDHSD-SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEF 390
GLA+ + + +T+ + GT ++APE L G+ + K+D++ FG++LLE+ITG+ A++
Sbjct: 178 GLARASEKFAQTVMTSRIVGTTAYMAPEAL-RGEITPKSDIYSFGVVLLEIITGLPAVDE 236
Query: 391 GKSINQKGAMLEWVKKIQQEKK-VEVLVDRELGSNYDRIEVGEILQVALLCTQYLPVHRP 449
+ + +L+ ++I+ E+K +E +D+++ + D V + VA C RP
Sbjct: 237 HR---EPQLLLDIKEEIEDEEKTIEDYIDKKMN-DADSTSVEAMYSVASQCLHEKKNKRP 292
Query: 450 KMSEVVRMLEGD 461
+ +V ++L+
Sbjct: 293 DIKKVQQLLQEM 304
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 368 bits (948), Expect = e-125
Identities = 101/312 (32%), Positives = 154/312 (49%), Gaps = 23/312 (7%)
Query: 169 SFSLNSSPDKQEEGLISLGNLRNFTFRELQQATENFSSKNILGAGGFGNVYKGKLGDGTV 228
S + NS D + +L++AT NF K ++G G FG VYKG L DG
Sbjct: 6 SKATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAK 65
Query: 229 LAVKRLK--------------DMISLAVHRNLLRLIGYCATPTERLLVYPYMSNGSVASR 274
+A+KR + +S H +L+ LIG+C E +L+Y YM NG++
Sbjct: 66 VALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRH 125
Query: 275 L----REKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGD 330
L ++ W R I IGAARGL YLH + IIHRDVK+ N+LLD+ + D
Sbjct: 126 LYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITD 182
Query: 331 FGLAKL-LDHSDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALE 389
FG++K + +H++T V+GT+G+I PEY G+ +EK+DV+ FG++L E++ A+
Sbjct: 183 FGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIV 242
Query: 390 FGKSINQKGAMLEWVKKIQQEKKVEVLVDRELGSNYDRIEVGEILQVALLCTQYLPVHRP 449
+ EW + ++E +VD L + + A+ C RP
Sbjct: 243 QSLPREMVN-LAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRP 301
Query: 450 KMSEVVRMLEGD 461
M +V+ LE
Sbjct: 302 SMGDVLWKLEYA 313
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 227 bits (580), Expect = 3e-70
Identities = 69/306 (22%), Positives = 113/306 (36%), Gaps = 39/306 (12%)
Query: 190 RNFTFRELQQATENFSSKNILGAGGFGNVYKGKLGDGTVLAVKRLKD------------- 236
+ L + + G FG V+K +L + V AVK
Sbjct: 12 VDLGTENLYFQSMPLQLLEVKARGRFGCVWKAQLLNEYV-AVKIFPIQDKQSWQNEYEVY 70
Query: 237 MISLAVHRNLLRLIGYCATP----TERLLVYPYMSNGSVASRLREKPALDWNTRKRIAIG 292
+ H N+L+ IG + L+ + GS++ L+ + WN IA
Sbjct: 71 SLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANV-VSWNELCHIAET 129
Query: 293 AARGLLYLHE-------QCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHV- 344
ARGL YLHE P I HRD+K+ NVLL + A + DFGLA + S
Sbjct: 130 MARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGD 189
Query: 345 TTAVRGTVGHIAPEYLSTG-----QSSEKTDVFGFGILLLELITGMRALEFGKSINQKGA 399
T GT ++APE L + + D++ G++L EL + A + G
Sbjct: 190 THGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAAD-GPVDEYMLP 248
Query: 400 MLEWVKKIQQEKKVEVLVDRE-----LGSNYDRIEV-GEILQVALLCTQYLPVHRPKMSE 453
E + + + ++ +V + L + + + + C + R
Sbjct: 249 FEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGC 308
Query: 454 VVRMLE 459
V +
Sbjct: 309 VGERIT 314
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 193 bits (491), Expect = 4e-57
Identities = 72/314 (22%), Positives = 116/314 (36%), Gaps = 48/314 (15%)
Query: 192 FTFRELQQATENFSSKNILGAGGFGNVYKGKLGDGTVLAVKRLKD-------------MI 238
E +N ++G G +G VYKG L + V AVK +
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSLDERPV-AVKVFSFANRQNFINEKNIYRV 61
Query: 239 SLAVHRNLLRLIGYC-----ATPTERLLVYPYMSNGSVASRLREKPALDWNTRKRIAIGA 293
L H N+ R I E LLV Y NGS+ L DW + R+A
Sbjct: 62 PLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLS-LHTSDWVSSCRLAHSV 120
Query: 294 ARGLLYLHE------QCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHS------- 340
RGL YLH P I HRD+ + NVL+ + ++ DFGL+ L +
Sbjct: 121 TRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGE 180
Query: 341 DSHVTTAVRGTVGHIAPEYL-------STGQSSEKTDVFGFGILLLELITGMRALEFGKS 393
+ + + GT+ ++APE L + ++ D++ G++ E+ L G+S
Sbjct: 181 EDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGES 240
Query: 394 INQ-KGAMLEWVKKIQQEKKVEVLVDRE-----LGSNYDRIEVG--EILQVALLCTQYLP 445
+ + + A V + ++VLV RE + + + + C
Sbjct: 241 VPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDA 300
Query: 446 VHRPKMSEVVRMLE 459
R +
Sbjct: 301 EARLTAQXAEERMA 314
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 171 bits (436), Expect = 2e-49
Identities = 67/282 (23%), Positives = 99/282 (35%), Gaps = 47/282 (16%)
Query: 207 KNILGAGGFGNVYKGKL-GDGTVLAVKRLKDMISLAV--------------HRNLLRLIG 251
+LG G FG K G V+ +K L H N+L+ IG
Sbjct: 15 GEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIG 74
Query: 252 YCATPTERLLVYPYMSNGSVASRLREK-PALDWNTRKRIAIGAARGLLYLHEQCDPKIIH 310
+ Y+ G++ ++ W+ R A A G+ YLH IIH
Sbjct: 75 VLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSM---NIIH 131
Query: 311 RDVKAANVLLDDFCEAIVGDFGLAKLLD-------------HSDSHVTTAVRGTVGHIAP 357
RD+ + N L+ + +V DFGLA+L+ D V G +AP
Sbjct: 132 RDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAP 191
Query: 358 EYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLV 417
E ++ EK DVF FGI+L E+I + A + V +
Sbjct: 192 EMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGL-----------NVRGFL 240
Query: 418 DRELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLE 459
DR N + + C P RP ++ LE
Sbjct: 241 DRYCPPNCPP----SFFPITVRCCDLDPEKRPSFVKLEHWLE 278
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 170 bits (432), Expect = 7e-49
Identities = 73/278 (26%), Positives = 124/278 (44%), Gaps = 50/278 (17%)
Query: 207 KNILGAGGFGNVYKGKLGDGTVLAVKRLKD----------------MISLAVHRNLLRLI 250
K +GAG FG V++ + G+ +AVK L + ++ H N++ +
Sbjct: 42 KEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFM 100
Query: 251 GYCATPTERLLVYPYMSNGSVASRLRE---KPALDWNTRKRIAIGAARGLLYLHEQCDPK 307
G P +V Y+S GS+ L + + LD R +A A+G+ YLH +P
Sbjct: 101 GAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH-NRNPP 159
Query: 308 IIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGHIAPEYLSTGQSSE 367
I+HR++K+ N+L+D V DFGL++L + + + GT +APE L S+E
Sbjct: 160 IVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLS-SKSAAGTPEWMAPEVLRDEPSNE 218
Query: 368 KTDVFGFGILLLELIT------GMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDREL 421
K+DV+ FG++L EL T + + ++ K L E+
Sbjct: 219 KSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRL------------------EI 260
Query: 422 GSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLE 459
N + +V I++ C P RP + ++ +L
Sbjct: 261 PRNLNP-QVAAIIE---GCWTNEPWKRPSFATIMDLLR 294
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 168 bits (428), Expect = 2e-48
Identities = 66/288 (22%), Positives = 124/288 (43%), Gaps = 61/288 (21%)
Query: 207 KNILGAGGFGNVYKGK-LGDGTVLAVKRLKD---------------------MISLAVHR 244
+ +G GGFG V+KG+ + D +V+A+K L ++S H
Sbjct: 24 EKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHP 83
Query: 245 NLLRLIGYCATP----TERLLVYPYMSNGSVASRLREKP-ALDWNTRKRIAIGAARGLLY 299
N+++L G P E ++ G + RL +K + W+ + R+ + A G+ Y
Sbjct: 84 NIVKLYGLMHNPPRMVME------FVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEY 137
Query: 300 LHEQCDPKIIHRDVKAANVLLDDFCEAI-----VGDFGLAKLLDHSDSHVTTAVRGTVGH 354
+ +P I+HRD+++ N+ L E V DFGL++ HS + + G
Sbjct: 138 MQ-NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHS----VSGLLGNFQW 192
Query: 355 IAPEYLSTGQS--SEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKK 412
+APE + + +EK D + F ++L ++TG + ++++ I++E
Sbjct: 193 MAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFD-----EYSYGKIKFINMIREEGL 247
Query: 413 VEVLVDR-ELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLE 459
R + + + +++ LC P RP S +V+ L
Sbjct: 248 ------RPTIPEDCPP-RLRNVIE---LCWSGDPKKRPHFSYIVKELS 285
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 167 bits (424), Expect = 4e-48
Identities = 65/285 (22%), Positives = 109/285 (38%), Gaps = 59/285 (20%)
Query: 207 KNILGAGGFGNVYKGKLGDGTVLAVKRLKD------------------MISLAVHRNLLR 248
+ I+G GGFG VY+ V AVK + + ++ H N++
Sbjct: 12 EEIIGIGGFGKVYRAFWIGDEV-AVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIA 70
Query: 249 LIGYCATPTERLLVYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKI 308
L G C LV + G + L K + + A+ ARG+ YLH++ I
Sbjct: 71 LRGVCLKEPNLCLVMEFARGGPLNRVLSGKR-IPPDILVNWAVQIARGMNYLHDEAIVPI 129
Query: 309 IHRDVKAANVLLDDFCEAI--------VGDFGLAKLLDHSDSHVTTAVRGTVGHIAPEYL 360
IHRD+K++N+L+ E + DFGLA+ + + G +APE +
Sbjct: 130 IHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTT---KMSAAGAYAWMAPEVI 186
Query: 361 STGQSSEKTDVFGFGILLLELITG------MRALEFGKSINQKGAMLEWVKKIQQEKKVE 414
S+ +DV+ +G+LL EL+TG + L + L
Sbjct: 187 RASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLAL------------- 233
Query: 415 VLVDRELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLE 459
+ S ++++ C P RP + ++ L
Sbjct: 234 -----PIPSTCPE-PFAKLME---DCWNPDPHSRPSFTNILDQLT 269
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 167 bits (424), Expect = 1e-47
Identities = 65/277 (23%), Positives = 108/277 (38%), Gaps = 54/277 (19%)
Query: 207 KNILGAGGFGNVYKGKLGDGTVLAVKRLKD------------MISLAVHRNLLRLIGYCA 254
+ ++G G FG V K K +A+K+++ +S H N+++L G C
Sbjct: 13 EEVVGRGAFGVVCKAKW-RAKDVAIKQIESESERKAFIVELRQLSRVNHPNIVKLYGACL 71
Query: 255 TP----TERLLVYPYMSNGSVASRLREK---PALDWNTRKRIAIGAARGLLYLHEQCDPK 307
P E Y GS+ + L P + ++G+ YLH
Sbjct: 72 NPVCLVME------YAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKA 125
Query: 308 IIHRDVKAANVLLDDFCEAI-VGDFGLAKLLDHSDSHVTTAVRGTVGHIAPEYLSTGQSS 366
+IHRD+K N+LL + + DFG A + T +G+ +APE S
Sbjct: 126 LIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH----MTNNKGSAAWMAPEVFEGSNYS 181
Query: 367 EKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDR----ELG 422
EK DVF +GI+L E+IT + + + ++ V L
Sbjct: 182 EKCDVFSWGIILWEVITRRKP---------------FDEIGGPAFRIMWAVHNGTRPPLI 226
Query: 423 SNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLE 459
N + + ++ C P RP M E+V+++
Sbjct: 227 KNLPK-PIESLMT---RCWSKDPSQRPSMEEIVKIMT 259
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 161 bits (409), Expect = 9e-46
Identities = 75/276 (27%), Positives = 118/276 (42%), Gaps = 49/276 (17%)
Query: 210 LGAGGFGNVYKGKLGDGTVLAVKRLKD----------------MISLAVHRNLLRLIGYC 253
+G+G FG VYKGK G V AVK L ++ H N+L +GY
Sbjct: 32 IGSGSFGTVYKGKW-HGDV-AVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 89
Query: 254 ATP-----TERLLVYPYMSNGSVASRLR-EKPALDWNTRKRIAIGAARGLLYLHEQCDPK 307
P T+ + S+ L + + IA ARG+ YLH +
Sbjct: 90 TAPQLAIVTQ------WCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAK---S 140
Query: 308 IIHRDVKAANVLLDDFCEAIVGDFGLAKLLDH-SDSHVTTAVRGTVGHIAPEYLSTGQS- 365
IIHRD+K+ N+ L + +GDFGLA S SH + G++ +APE + S
Sbjct: 141 IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSN 200
Query: 366 --SEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELGS 423
S ++DV+ FGI+L EL+TG +IN + ++E V + ++ S
Sbjct: 201 PYSFQSDVYAFGIVLYELMTGQLPYS---NINNRDQIIEMV-----GRGSLSPDLSKVRS 252
Query: 424 NYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLE 459
N + + ++ C + RP ++ +E
Sbjct: 253 NCPK-RMKRLMA---ECLKKKRDERPSFPRILAEIE 284
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 3e-45
Identities = 56/282 (19%), Positives = 103/282 (36%), Gaps = 59/282 (20%)
Query: 207 KNILGAGGFGNVYKGKLGDGTVLAVKRLKD----------------MISLAVHRNLLRLI 250
L G ++KG+ G + VK LK + + H N+L ++
Sbjct: 15 LTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVL 73
Query: 251 GYCATPTERLL--VYPYMSNGSVASRLREKP--ALDWNTRKRIAIGAARGLLYLHEQCDP 306
G C +P + +M GS+ + L E +D + + A+ ARG+ +LH +P
Sbjct: 74 GACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLH-TLEP 132
Query: 307 KIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGHIAPEYLSTGQS- 365
I + + +V++D+ A + + S + +APE L
Sbjct: 133 LIPRHALNSRSVMIDEDMTARISMADVKF------SFQSPGRMYAPAWVAPEALQKKPED 186
Query: 366 --SEKTDVFGFGILLLELIT------GMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLV 417
D++ F +LL EL+T + +E G + +G
Sbjct: 187 TNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRP---------------- 230
Query: 418 DRELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLE 459
+ V ++++ +C P RPK +V +LE
Sbjct: 231 --TIPPGISP-HVSKLMK---ICMNEDPAKRPKFDMIVPILE 266
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 159 bits (405), Expect = 5e-45
Identities = 61/290 (21%), Positives = 113/290 (38%), Gaps = 43/290 (14%)
Query: 208 NILGAGGFGNVYKGKLGDGTVLAVKRL-----------KDMISLAV--HRNLLRLIGYC- 253
+G G +G V++G V AVK ++ + + H N+L I
Sbjct: 14 ECVGKGRYGEVWRGSWQGENV-AVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDM 72
Query: 254 ---ATPTERLLVYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHE-----QCD 305
+ T+ L+ Y GS+ L+ LD + RI + A GL +LH Q
Sbjct: 73 TSRHSSTQLWLITHYHEMGSLYDYLQLTT-LDTVSCLRIVLSIASGLAHLHIEIFGTQGK 131
Query: 306 PKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHV---TTAVRGTVGHIAPE---- 358
P I HRD+K+ N+L+ + + D GLA + S + + GT ++APE
Sbjct: 132 PAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDE 191
Query: 359 --YLSTGQSSEKTDVFGFGILLLELITGMRALEFGKS-------INQKGAMLEWVKKIQQ 409
+ S ++ D++ FG++L E+ M + + + E ++K+
Sbjct: 192 TIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVC 251
Query: 410 EKKVEVLVDRELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLE 459
+ + S+ + ++++ C P R + + L
Sbjct: 252 VDQQRPNIPNRWFSDPTLTSLAKLMK---ECWYQNPSARLTALRIKKTLT 298
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 8e-45
Identities = 63/288 (21%), Positives = 103/288 (35%), Gaps = 39/288 (13%)
Query: 208 NILGAGGFGNVYKGKLGDGTVLAVKRLKD-------------MISLAVHRNLLRLIGYCA 254
+G G +G V+ GK V AVK L H N+L I
Sbjct: 43 KQIGKGRYGEVWMGKWRGEKV-AVKVFFTTEEASWFRETEIYQTVLMRHENILGFIAADI 101
Query: 255 TP----TERLLVYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHE-----QCD 305
T+ L+ Y NGS+ L+ LD + ++A + GL +LH Q
Sbjct: 102 KGTGSWTQLYLITDYHENGSLYDYLKSTT-LDAKSMLKLAYSSVSGLCHLHTEIFSTQGK 160
Query: 306 PKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHV---TTAVRGTVGHIAPE---- 358
P I HRD+K+ N+L+ + D GLA + V GT ++ PE
Sbjct: 161 PAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDE 220
Query: 359 --YLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVL 416
+ QS D++ FG++L E+ + + L ++ + V
Sbjct: 221 SLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVC 280
Query: 417 VDR---ELGSNYDRIEVGEILQVALL--CTQYLPVHRPKMSEVVRMLE 459
+ + + + E + L+ C + P R V + L
Sbjct: 281 IKKLRPSFPNRWSSDECLRQM-GKLMTECWAHNPASRLTALRVKKTLA 327
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 9e-45
Identities = 62/283 (21%), Positives = 107/283 (37%), Gaps = 52/283 (18%)
Query: 207 KNILGAGGFGNVYKGKLGDGTVLAVKRLKD----------------MISLAVHRNLLRLI 250
++G G FG VY G+ G V A++ + H N++ +
Sbjct: 38 GELIGKGRFGQVYHGRW-HGEV-AIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFM 95
Query: 251 GYCATPTERLLVYPYMSNGSVASRLR-EKPALDWNTRKRIAIGAARGLLYLHEQCDPKII 309
G C +P ++ ++ S +R K LD N ++IA +G+ YLH + I+
Sbjct: 96 GACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAK---GIL 152
Query: 310 HRDVKAANVLLDDFCEAIVGDFGLAKLLDH----SDSHVTTAVRGTVGHIAPEYLSTGQS 365
H+D+K+ NV D+ ++ DFGL + G + H+APE +
Sbjct: 153 HKDLKSKNVFYDNGK-VVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSP 211
Query: 366 ---------SEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVL 416
S+ +DVF G + EL + Q + W +
Sbjct: 212 DTEEDKLPFSKHSDVFALGTIWYELHAREWPFK-----TQPAEAIIWQ--------MGTG 258
Query: 417 VDRELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLE 459
+ L E+ +IL C + RP ++++ MLE
Sbjct: 259 MKPNLSQIGMGKEISDILL---FCWAFEQEERPTFTKLMDMLE 298
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 156 bits (395), Expect = 3e-43
Identities = 60/288 (20%), Positives = 104/288 (36%), Gaps = 39/288 (13%)
Query: 208 NILGAGGFGNVYKGKLGDGTVLAVKRLKD-------------MISLAVHRNLLRLIGYC- 253
+G G FG V++GK V AVK + H N+L I
Sbjct: 48 ESIGKGRFGEVWRGKWRGEEV-AVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADN 106
Query: 254 ---ATPTERLLVYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHE-----QCD 305
T T+ LV Y +GS+ L + + ++A+ A GL +LH Q
Sbjct: 107 KDNGTWTQLWLVSDYHEHGSLFDYLN-RYTVTVEGMIKLALSTASGLAHLHMEIVGTQGK 165
Query: 306 PKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVT---TAVRGTVGHIAPEYL-- 360
P I HRD+K+ N+L+ + D GLA D + + GT ++APE L
Sbjct: 166 PAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDD 225
Query: 361 ----STGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVL 416
+S ++ D++ G++ E+ + L +E + V
Sbjct: 226 SINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVC 285
Query: 417 VDR---ELGSNYDRIEVGEILQVALL--CTQYLPVHRPKMSEVVRMLE 459
+ + + + E ++ ++ C R + + L
Sbjct: 286 EQKLRPNIPNRWQSCEALRVM-AKIMRECWYANGAARLTALRIKKTLS 332
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 7e-37
Identities = 66/293 (22%), Positives = 110/293 (37%), Gaps = 71/293 (24%)
Query: 202 ENFSSKNILGAGGFGNVYKGKL-GDGTVLAVKRLKD----------------MISLAVHR 244
E+ +G G FG V+ G+L D T++AVK ++ + + H
Sbjct: 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYS-HP 172
Query: 245 NLLRLIGYCATPTERLLVYPYMSNGSVASRLR-EKPALDWNTRKRIAIGAARGLLYLHEQ 303
N++RLIG C +V + G + LR E L T ++ AA G+ YL +
Sbjct: 173 NIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESK 232
Query: 304 CDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTA-----VRGTVGHIAPE 358
IHRD+ A N L+ + + DFG+++ + V+ T APE
Sbjct: 233 ---CCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWT----APE 285
Query: 359 YLSTGQSSEKTDVFGFGILLLELIT-------GMRALEFGKSINQKGAMLEWVKKIQQEK 411
L+ G+ S ++DV+ FGILL E + + +
Sbjct: 286 ALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQ---------------------- 323
Query: 412 KVEVLVDRELGSNYDRIEV-----GEILQVALLCTQYLPVHRPKMSEVVRMLE 459
+ R+ + ++ C Y P RP S + + L+
Sbjct: 324 -----TREFVEKGG-RLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQ 370
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 2e-33
Identities = 64/298 (21%), Positives = 109/298 (36%), Gaps = 78/298 (26%)
Query: 202 ENFSSKNILGAGGFGNVYKGKLGDG-----TVLAVKRLKD----------------MISL 240
F +LG+G FG VYKG +A+K L++ M S+
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 241 AVHRNLLRLIGYCATPTERLLVYPYMSNGSVASRLRE-KPALDWNTRKRIAIGAARGLLY 299
+ ++ RL+G C + L+ M G + +RE K + + A+G+ Y
Sbjct: 75 D-NPHVCRLLGIC-LTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNY 132
Query: 300 LHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTA-----VRGTVGH 354
L ++ +++HRD+ A NVL+ + DFGLAKLL + ++
Sbjct: 133 LEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM--- 186
Query: 355 IAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKS--INQKGAMLEWVKKIQQEKK 412
A E + + ++DV+ +G+ + EL+T FG +
Sbjct: 187 -ALESILHRIYTHQSDVWSYGVTVWELMT------FGSKPYDGIPAS------------- 226
Query: 413 VEVLVDRELGSNYDRIEVGEIL-----------QVALLCTQYLPVHRPKMSEVVRMLE 459
E+ +E GE L + C RPK E++
Sbjct: 227 -EIS---------SILEKGERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFS 274
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 4e-33
Identities = 63/291 (21%), Positives = 115/291 (39%), Gaps = 56/291 (19%)
Query: 207 KNILGAGGFGNVYKGKL-----GDGTVLAVKRLKD----------------MISLAVHRN 245
LG G FG V + G +AVK LK + +L H N
Sbjct: 26 IRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLY-HEN 84
Query: 246 LLRLIGYCATPTER--LLVYPYMSNGSVASRLRE-KPALDWNTRKRIAIGAARGLLYLHE 302
+++ G C L+ ++ +GS+ L + K ++ + + A+ +G+ YL
Sbjct: 85 IVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGS 144
Query: 303 QCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGHI---APEY 359
+ + +HRD+ A NVL++ + +GDFGL K + +D T + APE
Sbjct: 145 R---QYVHRDLAARNVLVESEHQVKIGDFGLTKAI-ETDKEYYTVKDDRDSPVFWYAPEC 200
Query: 360 LSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDR 419
L + +DV+ FG+ L EL+T + S + A+ + + +
Sbjct: 201 LMQSKFYIASDVWSFGVTLHELLT------YCDSDSSPMALFLKMIGPTHGQ----MTVT 250
Query: 420 ELGSNYDRIEVGEIL-----------QVALLCTQYLPVHRPKMSEVVRMLE 459
L + ++ G+ L Q+ C ++ P +R ++ E
Sbjct: 251 RL---VNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFE 298
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 7e-33
Identities = 78/324 (24%), Positives = 118/324 (36%), Gaps = 86/324 (26%)
Query: 184 ISLGNLRNFTFRELQQATENFSSKNI-----LGAGGFGNVYKGKL----GDGTVLAVKRL 234
I L L + +Q SS + +G G FG VY G L G AVK L
Sbjct: 2 IDLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL 61
Query: 235 KDMISLAV---------------HRNLLRLIGYCATPTE--RLLVYPYMSNGSVASRLR- 276
+ + H N+L L+G C +E L+V PYM +G + + +R
Sbjct: 62 NRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGIC-LRSEGSPLVVLPYMKHGDLRNFIRN 120
Query: 277 EKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKL 336
E + A+G+ YL + K +HRD+ A N +LD+ V DFGLA+
Sbjct: 121 ETHNPTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARD 177
Query: 337 LDHSDSHVTTAVRGTVGHI-----APEYLSTGQSSEKTDVFGFGILLLELITGMRALEFG 391
+ + + + T + A E L T + + K+DV+ FG+LL EL+T G
Sbjct: 178 MYDKEYY--SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT------RG 229
Query: 392 KS-----INQKGAMLEWVKKIQQEKKVEVLVDRELGSNYDRIEVGEIL-----------Q 435
++ + G L +
Sbjct: 230 APPYPDVNTF-----------------DIT---------VYLLQGRRLLQPEYCPDPLYE 263
Query: 436 VALLCTQYLPVHRPKMSEVVRMLE 459
V L C RP SE+V +
Sbjct: 264 VMLKCWHPKAEMRPSFSELVSRIS 287
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 8e-33
Identities = 67/319 (21%), Positives = 116/319 (36%), Gaps = 65/319 (20%)
Query: 207 KNILGAGGFGNVYKGKL-----GDGTVLAVKRLKD---------------MISLAVHRNL 246
+ LG G FG+V + G ++AVK+L+ + +L +
Sbjct: 28 ISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALH-SDFI 86
Query: 247 LRLIGYCATPTER--LLVYPYMSNGSVASRLRE-KPALDWNTRKRIAIGAARGLLYLHEQ 303
++ G P + LV Y+ +G + L+ + LD + + +G+ YL +
Sbjct: 87 VKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSR 146
Query: 304 CDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRG------TVGHIAP 357
+ +HRD+ A N+L++ + DFGLAKLL + G AP
Sbjct: 147 ---RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWY----AP 199
Query: 358 EYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKS--INQKGAMLEWVKKIQQEKKVEV 415
E LS S ++DV+ FG++L EL T + + + +
Sbjct: 200 ESLSDNIFSRQSDVWSFGVVLYELFT------YCDKSCSPSAEFLRMMGCERDVPALSRL 253
Query: 416 LVDRELGSNYDRIEVGEIL-----------QVALLCTQYLPVHRPKMSEVVRMLEGDGLA 464
L + +E G+ L ++ LC P RP S + L+
Sbjct: 254 L---------ELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSG 304
Query: 465 EKWAAAHNHTNPTMNNFHT 483
+ H T H+
Sbjct: 305 SRGCETHAFTAHPEGKHHS 323
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 1e-32
Identities = 62/296 (20%), Positives = 109/296 (36%), Gaps = 66/296 (22%)
Query: 207 KNILGAGGFGNVYKGKL-----GDGTVLAVKRLKD---------------MISLAVHRNL 246
LG G FG+V + G V+AVK+L+ + SL H N+
Sbjct: 15 LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQ-HDNI 73
Query: 247 LRLIGYCATPTER--LLVYPYMSNGSVASRLRE-KPALDWNTRKRIAIGAARGLLYLHEQ 303
++ G C + R L+ Y+ GS+ L++ K +D + +G+ YL +
Sbjct: 74 VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTK 133
Query: 304 CDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRG------TVGHIAP 357
+ IHRD+ N+L+++ +GDFGL K+L G AP
Sbjct: 134 ---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWY----AP 186
Query: 358 EYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQ---QEKKVE 414
E L+ + S +DV+ FG++L EL T + + A + Q
Sbjct: 187 ESLTESKFSVASDVWSFGVVLYELFT------YIEKSKSPPAEFMRMIGNDKQGQMIVFH 240
Query: 415 VLVDRELGSNYDRIEVGEIL-----------QVALLCTQYLPVHRPKMSEVVRMLE 459
++ + ++ L + C RP ++ ++
Sbjct: 241 LI---------ELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVD 287
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 2e-32
Identities = 63/289 (21%), Positives = 114/289 (39%), Gaps = 52/289 (17%)
Query: 207 KNILGAGGFGNVYKGKL-----GDGTVLAVKRLKD---------------MISLAVHRNL 246
LG G FG+V + G V+AVK+L+ + SL H N+
Sbjct: 46 LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQ-HDNI 104
Query: 247 LRLIGYCATPTER--LLVYPYMSNGSVASRLRE-KPALDWNTRKRIAIGAARGLLYLHEQ 303
++ G C + R L+ Y+ GS+ L++ K +D + +G+ YL +
Sbjct: 105 VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTK 164
Query: 304 CDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGT--VGHIAPEYLS 361
+ IHRD+ N+L+++ +GDFGL K+L + G + APE L+
Sbjct: 165 ---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLT 221
Query: 362 TGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDREL 421
+ S +DV+ FG++L EL T + + A + ++ ++ V L
Sbjct: 222 ESKFSVASDVWSFGVVLYELFT------YIEKSKSPPAEFMRMIGNDKQGQMIV---FHL 272
Query: 422 GSNYDRIEVGEIL-----------QVALLCTQYLPVHRPKMSEVVRMLE 459
+ ++ L + C RP ++ ++
Sbjct: 273 ---IELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVD 318
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 7e-32
Identities = 65/280 (23%), Positives = 121/280 (43%), Gaps = 47/280 (16%)
Query: 202 ENFSSKNILGAGGFGNVYKGKL-GDGTVLAVKRLKD--------------MISLAVHRNL 246
+ + K+ LG G +G VY+G +AVK LK+ M + H NL
Sbjct: 220 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIK-HPNL 278
Query: 247 LRLIGYCATPTERLLVYPYMSNGSVASRLR--EKPALDWNTRKRIAIGAARGLLYLHEQC 304
++L+G C ++ +M+ G++ LR + + +A + + YL ++
Sbjct: 279 VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK- 337
Query: 305 DPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGHIAPEYLSTGQ 364
IHR++ A N L+ + V DFGL++L+ + + APE L+ +
Sbjct: 338 --NFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNK 395
Query: 365 SSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELGSN 424
S K+DV+ FG+LL E+ T +G S + + + +++ +
Sbjct: 396 FSIKSDVWAFGVLLWEIAT------YGMSPYPGIDLSQVYELLEK--------------D 435
Query: 425 YDRIEV-----GEILQVALLCTQYLPVHRPKMSEVVRMLE 459
Y R+E ++ ++ C Q+ P RP +E+ + E
Sbjct: 436 Y-RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFE 474
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 8e-32
Identities = 50/198 (25%), Positives = 83/198 (41%), Gaps = 27/198 (13%)
Query: 209 ILGAGGFGNVYKGK-LGDGTVLAVK-------------RLKDMISL---AVHRNLLRLIG 251
+G G F VYKG +A R K+ + H N++R
Sbjct: 33 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92
Query: 252 YCATPTE---RLLVYP-YMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPK 307
+ + +++ M++G++ + L+ + + +GL +LH P
Sbjct: 93 SWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHT-RTPP 151
Query: 308 IIHRDVKAANVLLDDFCEAI-VGDFGLAKLLDHSDSHVTTAVRGTVGHIAPEYLSTGQSS 366
IIHRD+K N+ + ++ +GD GLA L S + AV GT +APE
Sbjct: 152 IIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAK---AVIGTPEFMAPEMYEEK-YD 207
Query: 367 EKTDVFGFGILLLELITG 384
E DV+ FG+ +LE+ T
Sbjct: 208 ESVDVYAFGMCMLEMATS 225
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 8e-32
Identities = 70/279 (25%), Positives = 112/279 (40%), Gaps = 47/279 (16%)
Query: 202 ENFSSKNILGAGGFGNVYKGKLGDGTVLAVKRLKD--------------MISLAVHRNLL 247
E+ + LG G FG V+ G T +A+K LK M L H L+
Sbjct: 184 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLR-HEKLV 242
Query: 248 RLIGYCATPTERLLVYPYMSNGSVASRLREK--PALDWNTRKRIAIGAARGLLYLHEQCD 305
+L + +V YMS GS+ L+ + L +A A G+ Y+
Sbjct: 243 QLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM-- 299
Query: 306 PKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGHIAPEYLSTGQS 365
+HRD++AAN+L+ + V DFGLA+L++ ++ + + APE G+
Sbjct: 300 -NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRF 358
Query: 366 SEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELGSNY 425
+ K+DV+ FGILL EL T KG + ++ V ++ Y
Sbjct: 359 TIKSDVWSFGILLTELTT-------------KGRVPYPGMVNRE-------VLDQVERGY 398
Query: 426 DRIEV-----GEILQVALLCTQYLPVHRPKMSEVVRMLE 459
R+ + + C + P RP + LE
Sbjct: 399 -RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLE 436
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 9e-32
Identities = 70/295 (23%), Positives = 105/295 (35%), Gaps = 66/295 (22%)
Query: 207 KNILGAGGFGNVYKGKL-----GDGTVLAVKRLKD----------------MISLAVHRN 245
LG G FG V G G ++AVK LK + +L H +
Sbjct: 36 IRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTL-YHEH 94
Query: 246 LLRLIGYCATPTER--LLVYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQ 303
+++ G C LV Y+ GS+ L + ++ A G+ YLH Q
Sbjct: 95 IIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLP-RHSIGLAQLLLFAQQICEGMAYLHAQ 153
Query: 304 CDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRG------TVGHIAP 357
IHRD+ A NVLLD+ +GDFGLAK + + G AP
Sbjct: 154 ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWY----AP 206
Query: 358 EYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKI--QQEKKVEV 415
E L + +DV+ FG+ L EL+T S + I Q + +
Sbjct: 207 ECLKEYKFYYASDVWSFGVTLYELLT------HCDSSQSPPTKFLELIGIAQGQMTVLRL 260
Query: 416 LVDRELGSNYDRIEVGEIL-----------QVALLCTQYLPVHRPKMSEVVRMLE 459
+ +E GE L + C + RP ++ +L+
Sbjct: 261 T---------ELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILK 306
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 1e-31
Identities = 80/346 (23%), Positives = 121/346 (34%), Gaps = 86/346 (24%)
Query: 162 SANSVPLSFSLNSSPDKQEEGLISLGNLRNFTFRELQQATENFSSKNI-----LGAGGFG 216
S + + S N I L L + +Q SS + +G G FG
Sbjct: 44 STSLYKKAGSENLYFQGANTVHIDLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFG 103
Query: 217 NVYKGKL----GDGTVLAVKRLKDMISLAV---------------HRNLLRLIGYCATPT 257
VY G L G AVK L + + H N+L L+G C +
Sbjct: 104 CVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGIC-LRS 162
Query: 258 E--RLLVYPYMSNGSVASRLR-EKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVK 314
E L+V PYM +G + + +R E + A+G+ +L + K +HRD+
Sbjct: 163 EGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLA 219
Query: 315 AANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGHI-----APEYLSTGQSSEKT 369
A N +LD+ V DFGLA+ + + T + A E L T + + K+
Sbjct: 220 ARNCMLDEKFTVKVADFGLARDMYDKEFDSVHN--KTGAKLPVKWMALESLQTQKFTTKS 277
Query: 370 DVFGFGILLLELITGMRALEFGKS-----INQKGAMLEWVKKIQQEKKVEVLVDRELGSN 424
DV+ FG+LL EL+T G ++
Sbjct: 278 DVWSFGVLLWELMT------RGAPPYPDVNTF-----------------DIT-------- 306
Query: 425 YDRIEVGEIL-----------QVALLCTQYLPVHRPKMSEVVRMLE 459
+ G L +V L C RP SE+V +
Sbjct: 307 -VYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRIS 351
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 1e-31
Identities = 60/215 (27%), Positives = 92/215 (42%), Gaps = 33/215 (15%)
Query: 196 ELQQATENFSSKNILGAGGFGNVYKGKLGDG----TVLAVKRLKDMISLAV--------- 242
+ S ++G G FG VY G+ D A+K L + +
Sbjct: 15 LIPHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGL 74
Query: 243 ------HRNLLRLIGYCATPTE--RLLVYPYMSNGSVASRLR-EKPALDWNTRKRIAIGA 293
H N+L LIG P E ++ PYM +G + +R + +
Sbjct: 75 LMRGLNHPNVLALIGIM-LPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQV 133
Query: 294 ARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVG 353
ARG+ YL EQ K +HRD+ A N +LD+ V DFGLA+ + + + +
Sbjct: 134 ARGMEYLAEQ---KFVHRDLAARNCMLDESFTVKVADFGLARDILDRE--YYSVQQHRHA 188
Query: 354 HI-----APEYLSTGQSSEKTDVFGFGILLLELIT 383
+ A E L T + + K+DV+ FG+LL EL+T
Sbjct: 189 RLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLT 223
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 4e-31
Identities = 59/198 (29%), Positives = 87/198 (43%), Gaps = 25/198 (12%)
Query: 202 ENFSSKNILGAGGFGNVYKGKLGDGTVLAVKRLKD-------------MISLAVHRNLLR 248
+ +G G FG+V G V AVK +K+ M L H NL++
Sbjct: 193 KELKLLQTIGKGEFGDVMLGDYRGNKV-AVKCIKNDATAQAFLAEASVMTQLR-HSNLVQ 250
Query: 249 LIGYCATPTERL-LVYPYMSNGSVAS--RLREKPALDWNTRKRIAIGAARGLLYLHEQCD 305
L+G L +V YM+ GS+ R R + L + + ++ + YL
Sbjct: 251 LLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN-- 308
Query: 306 PKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGHIAPEYLSTGQS 365
+HRD+ A NVL+ + A V DFGL K + V+ T APE L +
Sbjct: 309 -NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT----APEALREKKF 363
Query: 366 SEKTDVFGFGILLLELIT 383
S K+DV+ FGILL E+ +
Sbjct: 364 STKSDVWSFGILLWEIYS 381
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 4e-31
Identities = 56/224 (25%), Positives = 101/224 (45%), Gaps = 39/224 (17%)
Query: 187 GNLRNFTFRELQQATENFSSKNILGAGGFGNVYKGKL-----GDGTVLAVKRLKD----- 236
G ++ R ++ +LG+G FG V+KG + +K ++D
Sbjct: 1 GAMKVLA-RIFKE--TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQ 57
Query: 237 -----------MISLAVHRNLLRLIGYCATPTERLLVYPYMSNGSVASRLRE-KPALDWN 284
+ SL H +++RL+G C + LV Y+ GS+ +R+ + AL
Sbjct: 58 SFQAVTDHMLAIGSLD-HAHIVRLLGLC-PGSSLQLVTQYLPLGSLLDHVRQHRGALGPQ 115
Query: 285 TRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHV 344
+ A+G+ YL E ++HR++ A NVLL + V DFG+A LL D +
Sbjct: 116 LLLNWGVQIAKGMYYLEEH---GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQL 172
Query: 345 TTA-----VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT 383
+ ++ A E + G+ + ++DV+ +G+ + EL+T
Sbjct: 173 LYSEAKTPIKWM----ALESIHFGKYTHQSDVWSYGVTVWELMT 212
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 4e-31
Identities = 70/351 (19%), Positives = 119/351 (33%), Gaps = 90/351 (25%)
Query: 202 ENFSSKNILGAGGFGNVYKGKLGDG-----TVLAVKRLKD----------------MISL 240
F +LG+G FG VYKG +A+K L++ M S+
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 241 AVHRNLLRLIGYCATPTERLLVYPYMSNGSVASRLRE-KPALDWNTRKRIAIGAARGLLY 299
+ ++ RL+G C + L+ M G + +RE K + + A+G+ Y
Sbjct: 75 D-NPHVCRLLGIC-LTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNY 132
Query: 300 LHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTA-----VRGTVGH 354
L ++ +++HRD+ A NVL+ + DFGLAKLL + ++
Sbjct: 133 LEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM--- 186
Query: 355 IAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKS-----INQKGAMLEWVKKIQQ 409
A E + + ++DV+ +G+ + EL+T FG
Sbjct: 187 -ALESILHRIYTHQSDVWSYGVTVWELMT------FGSKPYDGIPAS------------- 226
Query: 410 EKKVEVLVDRELGSNYDRIEVGEIL-----------QVALLCTQYLPVHRPKMSEVVRML 458
E+ +E GE L + + C RPK E++
Sbjct: 227 ----EIS---------SILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEF 273
Query: 459 EGDGLAEKWAAAHNHTNPTMNNFHTNTKKSTSCPTSAPKHDHEEKNDQSSM 509
K A + + T D E+ +D
Sbjct: 274 ------SKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDA 318
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 5e-31
Identities = 70/281 (24%), Positives = 113/281 (40%), Gaps = 51/281 (18%)
Query: 202 ENFSSKNILGAGGFGNVYKGKLGDGTVLAVKRLKD--------------MISLAVHRNLL 247
E+ + LG G FG V+ G T +A+K LK M L H L+
Sbjct: 267 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLR-HEKLV 325
Query: 248 RLIGYCATPTER--LLVYPYMSNGSVASRLREKPALDWNTRK--RIAIGAARGLLYLHEQ 303
+L +E +V YMS GS+ L+ + + +A A G+ Y+
Sbjct: 326 QLYAVV---SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM 382
Query: 304 CDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGHIAPEYLSTG 363
+HRD++AAN+L+ + V DFGLA+L++ ++ + + APE G
Sbjct: 383 ---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYG 439
Query: 364 QSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELGS 423
+ + K+DV+ FGILL EL T KG + ++ V ++
Sbjct: 440 RFTIKSDVWSFGILLTELTT-------------KGRVPYPGMVNRE-------VLDQVER 479
Query: 424 NYDRIEV-----GEILQVALLCTQYLPVHRPKMSEVVRMLE 459
Y R+ + + C + P RP + LE
Sbjct: 480 GY-RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLE 519
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 5e-31
Identities = 67/289 (23%), Positives = 105/289 (36%), Gaps = 75/289 (25%)
Query: 209 ILGAGGFGNVYKGKL---GDGTVLAVKRLKD-----------------MISLAVHRNLLR 248
LG+G FG V KG +AVK LK+ M L + ++R
Sbjct: 24 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQL-DNPYIVR 82
Query: 249 LIGYCATPTERLLVYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKI 308
+IG C + +LV G + L++ + + + G+ YL E
Sbjct: 83 MIGICEAES-WMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEES---NF 138
Query: 309 IHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRG------TVGHIAPEYLST 362
+HRD+ A NVLL A + DFGL+K L +++ G APE ++
Sbjct: 139 VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWY----APECINY 194
Query: 363 GQSSEKTDVFGFGILLLELIT-GMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDREL 421
+ S K+DV+ FG+L+ E + G + + EV
Sbjct: 195 YKFSSKSDVWSFGVLMWEAFSYGQKP--YRGMKGS-----------------EVT----- 230
Query: 422 GSNYDRIEVGEIL-----------QVALLCTQYLPVHRPKMSEVVRMLE 459
+E GE + + LC Y +RP + V L
Sbjct: 231 ----AMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLR 275
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 9e-31
Identities = 65/291 (22%), Positives = 106/291 (36%), Gaps = 75/291 (25%)
Query: 207 KNILGAGGFGNVYKGKL--GDGTVL-AVKRLKD----------------MISLAVHRNLL 247
LG G FG+V +G + A+K LK M L + ++
Sbjct: 15 DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQL-DNPYIV 73
Query: 248 RLIGYCATPTERLLVYPYMSNGSVASRLRE-KPALDWNTRKRIAIGAARGLLYLHEQCDP 306
RLIG C +LV G + L + + + + + G+ YL E+
Sbjct: 74 RLIGVCQAEA-LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEK--- 129
Query: 307 KIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRG------TVGHIAPEYL 360
+HRD+ A NVLL + A + DFGL+K L DS+ T G APE +
Sbjct: 130 NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWY----APECI 185
Query: 361 STGQSSEKTDVFGFGILLLELIT-GMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDR 419
+ + S ++DV+ +G+ + E ++ G + + K EV+
Sbjct: 186 NFRKFSSRSDVWSYGVTMWEALSYGQKP--YKKMKGP-----------------EVM--- 223
Query: 420 ELGSNYDRIEVGEIL-----------QVALLCTQYLPVHRPKMSEVVRMLE 459
IE G+ + + C Y RP V + +
Sbjct: 224 ------AFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMR 268
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 9e-31
Identities = 64/204 (31%), Positives = 97/204 (47%), Gaps = 33/204 (16%)
Query: 202 ENFSSKNILGAGGFGNVYKGKLGDGTVLAVKRLKD--------------MISLAVHRNLL 247
E LGAG FG V+ G T +AVK LK M L H+ L+
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQ-HQRLV 71
Query: 248 RLIGYCATPTER--LLVYPYMSNGSVASRLR--EKPALDWNTRKRIAIGAARGLLYLHEQ 303
RL T+ ++ YM NGS+ L+ L N +A A G+ ++ E+
Sbjct: 72 RLYAVV---TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER 128
Query: 304 CDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTA----VRGTVGHIAPEY 359
IHRD++AAN+L+ D + DFGLA+L++ ++ ++ T APE
Sbjct: 129 ---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWT----APEA 181
Query: 360 LSTGQSSEKTDVFGFGILLLELIT 383
++ G + K+DV+ FGILL E++T
Sbjct: 182 INYGTFTIKSDVWSFGILLTEIVT 205
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 1e-30
Identities = 66/294 (22%), Positives = 113/294 (38%), Gaps = 77/294 (26%)
Query: 202 ENFSSKNILGAGGFGNVYKGKLGDGTVLAVKRLKD--------------MISLAVHRNLL 247
+ +G+G FG V+ G + +A+K +++ M+ L+ H L+
Sbjct: 8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLS-HPKLV 66
Query: 248 RLIGYCATPTERLLVYPYMSNGSVASRLRE-KPALDWNTRKRIAIGAARGLLYLHEQCDP 306
+L G C LV +M +G ++ LR + T + + G+ YL E
Sbjct: 67 QLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA--- 123
Query: 307 KIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTA-----VRGTVGHIAPEYLS 361
+IHRD+ A N L+ + V DFG+ + + D + ++ V+ +PE S
Sbjct: 124 CVIHRDLAARNCLVGENQVIKVSDFGMTRFV-LDDQYTSSTGTKFPVKWA----SPEVFS 178
Query: 362 TGQSSEKTDVFGFGILLLELITGMRALEFGKS-----INQKGAMLEWVKKIQQEKKVEVL 416
+ S K+DV+ FG+L+ E+ + GK N EV+
Sbjct: 179 FSRYSSKSDVWSFGVLMWEVFS------EGKIPYENRSNS-----------------EVV 215
Query: 417 VDRELGSNYDRIEVGEIL-----------QVALLCTQYLPVHRPKMSEVVRMLE 459
+ I G L Q+ C + P RP S ++R L
Sbjct: 216 ---------EDISTGFRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLA 260
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 1e-30
Identities = 68/293 (23%), Positives = 110/293 (37%), Gaps = 75/293 (25%)
Query: 202 ENFSSKNILGAGGFGNVYKGKLGDGTVLAVKRLKD--------------MISLAVHRNLL 247
E + LG+G FG V GK +AVK +K+ M+ L+ H L+
Sbjct: 8 EEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLS-HPKLV 66
Query: 248 RLIGYCATPTERLLVYPYMSNGSVASRLR-EKPALDWNTRKRIAIGAARGLLYLHEQCDP 306
+ G C+ +V Y+SNG + + LR L+ + + G+ +L
Sbjct: 67 KFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESH--- 123
Query: 307 KIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTA----VRGTVGHIAPEYLST 362
+ IHRD+ A N L+D V DFG+ + + + V+ + APE
Sbjct: 124 QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWS----APEVFHY 179
Query: 363 GQSSEKTDVFGFGILLLELITGMRALEFGKS-----INQKGAMLEWVKKIQQEKKVEVLV 417
+ S K+DV+ FGIL+ E+ + GK N EV+
Sbjct: 180 FKYSSKSDVWAFGILMWEVFS------LGKMPYDLYTNS-----------------EVV- 215
Query: 418 DRELGSNYDRIEVGEIL-----------QVALLCTQYLPVHRPKMSEVVRMLE 459
++ G L Q+ C LP RP +++ +E
Sbjct: 216 --------LKVSQGHRLYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIE 260
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 1e-30
Identities = 69/233 (29%), Positives = 97/233 (41%), Gaps = 45/233 (19%)
Query: 202 ENFSSKNILGAGGFGNVYKGKL----GDGTVLAVKRLKD------------------MIS 239
++ LG G FG V +G+ G +AVK LK M S
Sbjct: 18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 77
Query: 240 LAVHRNLLRLIGYCATPTERLLVYPYMSNGSVASRLRE-KPALDWNTRKRIAIGAARGLL 298
L HRNL+RL G TP +V GS+ RLR+ + T R A+ A G+
Sbjct: 78 LD-HRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMG 135
Query: 299 YLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRG------TV 352
YL + + IHRD+ A N+LL +GDFGL + L +D H
Sbjct: 136 YLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC- 191
Query: 353 GHIAPEYLSTGQSSEKTDVFGFGILLLELIT-------GMRALEFGKSINQKG 398
APE L T S +D + FG+ L E+ T G+ + I+++G
Sbjct: 192 ---APESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEG 241
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 2e-30
Identities = 64/301 (21%), Positives = 114/301 (37%), Gaps = 86/301 (28%)
Query: 202 ENFSSKNILGAGGFGNVYKGKL----GDGTVLAVKRLKD----------------MISLA 241
E+ ILG G FG VY+G G+ +AVK K M +L
Sbjct: 12 EDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLD 71
Query: 242 VHRNLLRLIGYC-ATPTERLLVYPYMSNGSVASRLRE-KPALDWNTRKRIAIGAARGLLY 299
H ++++LIG PT ++ G + L K +L T ++ + + Y
Sbjct: 72 -HPHIVKLIGIIEEEPT--WIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAY 128
Query: 300 LHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGHI---- 355
L +HRD+ N+L+ +GDFGL++ ++ D + +V +
Sbjct: 129 LESI---NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDED-----YYKASVTRLPIKW 180
Query: 356 -APEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKS-----INQKGAMLEWVKKIQQ 409
+PE ++ + + +DV+ F + + E+++ FGK N+
Sbjct: 181 MSPESINFRRFTTASDVWMFAVCMWEILS------FGKQPFFWLENK------------- 221
Query: 410 EKKVEVLVDRELGSNYDRIEVGEIL-----------QVALLCTQYLPVHRPKMSEVVRML 458
+V+ +E G+ L + C Y P RP+ +E+V L
Sbjct: 222 ----DVI---------GVLEKGDRLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSL 268
Query: 459 E 459
Sbjct: 269 S 269
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 3e-30
Identities = 61/292 (20%), Positives = 107/292 (36%), Gaps = 73/292 (25%)
Query: 202 ENFSSKNILGAGGFGNVYKGKLGDGTVLAVKRLKD--------------MISLAVHRNLL 247
++ + LG G FG V GK +A+K +K+ M++L+ H L+
Sbjct: 24 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLS-HEKLV 82
Query: 248 RLIGYCATPTERLLVYPYMSNGSVASRLRE-KPALDWNTRKRIAIGAARGLLYLHEQCDP 306
+L G C ++ YM+NG + + LRE + + + YL +
Sbjct: 83 QLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESK--- 139
Query: 307 KIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGHI---APEYLSTG 363
+ +HRD+ A N L++D V DFGL++ + + T+ G+ + PE L
Sbjct: 140 QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE---YTSSVGSKFPVRWSPPEVLMYS 196
Query: 364 QSSEKTDVFGFGILLLELITGMRALEFGKS-----INQKGAMLEWVKKIQQEKKVEVLVD 418
+ S K+D++ FG+L+ E+ + GK N E
Sbjct: 197 KFSSKSDIWAFGVLMWEIYS------LGKMPYERFTNS-----------------ETA-- 231
Query: 419 RELGSNYDRIEVGEIL-----------QVALLCTQYLPVHRPKMSEVVRMLE 459
+ I G L + C RP ++ +
Sbjct: 232 -------EHIAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNIL 276
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 123 bits (309), Expect = 6e-30
Identities = 63/299 (21%), Positives = 113/299 (37%), Gaps = 82/299 (27%)
Query: 202 ENFSSKNILGAGGFGNVYKGKL----GDGTVLAVKRLK---------DMISLAV------ 242
E +G G FG+V++G +A+K K + A+
Sbjct: 390 ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFD 449
Query: 243 HRNLLRLIGYC-ATPTERLLVYPYMSNGSVASRLRE-KPALDWNTRKRIAIGAARGLLYL 300
H ++++LIG P ++ + G + S L+ K +LD + A + L YL
Sbjct: 450 HPHIVKLIGVITENPV--WIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYL 507
Query: 301 HEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTA----VRGTVGHIA 356
+ + +HRD+ A NVL+ +GDFGL++ ++ S + + ++ A
Sbjct: 508 ESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWM----A 560
Query: 357 PEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKS-----INQKGAMLEWVKKIQQEK 411
PE ++ + + +DV+ FG+ + E++ G N
Sbjct: 561 PESINFRRFTSASDVWMFGVCMWEILM------HGVKPFQGVKNN--------------- 599
Query: 412 KVEVLVDRELGSNYDRIEVGEIL-----------QVALLCTQYLPVHRPKMSEVVRMLE 459
+V+ RIE GE L + C Y P RP+ +E+ L
Sbjct: 600 --DVI---------GRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLS 647
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 7e-30
Identities = 64/287 (22%), Positives = 107/287 (37%), Gaps = 67/287 (23%)
Query: 207 KNILGAGGFGNVYKGKL--GDGTVL-AVKRLKD----------------MISLAVHRNLL 247
LG G FG+V +G + A+K LK M L + ++
Sbjct: 341 DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQL-DNPYIV 399
Query: 248 RLIGYCATPTERLLVYPYMSNGSVASRLRE-KPALDWNTRKRIAIGAARGLLYLHEQCDP 306
RLIG C +LV G + L + + + + + G+ YL E+
Sbjct: 400 RLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEK--- 455
Query: 307 KIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGT--VGHIAPEYLSTGQ 364
+HR++ A NVLL + A + DFGL+K L DS+ T G + APE ++ +
Sbjct: 456 NFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRK 515
Query: 365 SSEKTDVFGFGILLLELIT-GMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELGS 423
S ++DV+ +G+ + E ++ G + + K EV+
Sbjct: 516 FSSRSDVWSYGVTMWEALSYGQKP--YKKMKGP-----------------EVM------- 549
Query: 424 NYDRIEVGEIL-----------QVALLCTQYLPVHRPKMSEVVRMLE 459
IE G+ + + C Y RP V + +
Sbjct: 550 --AFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMR 594
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 8e-30
Identities = 59/198 (29%), Positives = 87/198 (43%), Gaps = 25/198 (12%)
Query: 202 ENFSSKNILGAGGFGNVYKGKLGDGTVLAVKRLKD-------------MISLAVHRNLLR 248
+ +G G FG+V G V AVK +K+ M L H NL++
Sbjct: 21 KELKLLQTIGKGEFGDVMLGDYRGNKV-AVKCIKNDATAQAFLAEASVMTQLR-HSNLVQ 78
Query: 249 LIGYCATPTERL-LVYPYMSNGSVAS--RLREKPALDWNTRKRIAIGAARGLLYLHEQCD 305
L+G L +V YM+ GS+ R R + L + + ++ + YL
Sbjct: 79 LLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN-- 136
Query: 306 PKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGHIAPEYLSTGQS 365
+HRD+ A NVL+ + A V DFGL K + V+ T APE L +
Sbjct: 137 -NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT----APEALREKKF 191
Query: 366 SEKTDVFGFGILLLELIT 383
S K+DV+ FGILL E+ +
Sbjct: 192 STKSDVWSFGILLWEIYS 209
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 1e-29
Identities = 57/201 (28%), Positives = 96/201 (47%), Gaps = 27/201 (13%)
Query: 202 ENFSSKNILGAGGFGNVYKGKLGDGTVLAVKRLKD--------------MISLAVHRNLL 247
E+ + LGAG FG V+ T +AVK +K M +L H L+
Sbjct: 188 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQ-HDKLV 246
Query: 248 RLIGYCATPTERLLVYPYMSNGSVASRLR--EKPALDWNTRKRIAIGAARGLLYLHEQCD 305
+L T ++ +M+ GS+ L+ E + A G+ ++ ++
Sbjct: 247 KLHAVV-TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR-- 303
Query: 306 PKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGHI---APEYLST 362
IHRD++AAN+L+ + DFGLA++++ ++ TA G I APE ++
Sbjct: 304 -NYIHRDLRAANILVSASLVCKIADFGLARVIEDNE---YTAREGAKFPIKWTAPEAINF 359
Query: 363 GQSSEKTDVFGFGILLLELIT 383
G + K+DV+ FGILL+E++T
Sbjct: 360 GSFTIKSDVWSFGILLMEIVT 380
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 116 bits (294), Expect = 1e-29
Identities = 64/300 (21%), Positives = 112/300 (37%), Gaps = 84/300 (28%)
Query: 202 ENFSSKNILGAGGFGNVYKGKL----GDGTVLAVKRLKD----------------MISLA 241
E +G G FG+V++G +A+K K+ M
Sbjct: 15 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 74
Query: 242 VHRNLLRLIGYCATPTERLLVYPYMSNGSVASRLRE-KPALDWNTRKRIAIGAARGLLYL 300
H ++++LIG T ++ + G + S L+ K +LD + A + L YL
Sbjct: 75 -HPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYL 132
Query: 301 HEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGHI----- 355
+ + +HRD+ A NVL+ +GDFGL++ ++ S + + G +
Sbjct: 133 ESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST-----YYKASKGKLPIKWM 184
Query: 356 APEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKS-----INQKGAMLEWVKKIQQE 410
APE ++ + + +DV+ FG+ + E++ G N
Sbjct: 185 APESINFRRFTSASDVWMFGVCMWEILM------HGVKPFQGVKNN-------------- 224
Query: 411 KKVEVLVDRELGSNYDRIEVGEIL-----------QVALLCTQYLPVHRPKMSEVVRMLE 459
+V+ RIE GE L + C Y P RP+ +E+ L
Sbjct: 225 ---DVI---------GRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLS 272
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 2e-29
Identities = 37/141 (26%), Positives = 55/141 (39%), Gaps = 24/141 (17%)
Query: 19 SLSGTLSGSIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFL 78
L+G + + NL NL V L N + G GS Q + L+ N L+ + +
Sbjct: 185 RLTGKIPPTFANL-NLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLS 243
Query: 79 SIWLPRKWDKRKCSGVDQGL--LRLNNNSLSGAFPVFLAKISELAFLDLSYNNLSGPVPK 136
L L L NN + G P L ++ L L++S+NNL G +P+
Sbjct: 244 K-----------------NLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ 286
Query: 137 FP----ARTFNVAGNPLICGS 153
A N +CGS
Sbjct: 287 GGNLQRFDVSAYANNKCLCGS 307
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 1e-27
Identities = 33/117 (28%), Positives = 52/117 (44%), Gaps = 14/117 (11%)
Query: 19 SLSGTLSGSIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFL 78
++SG + + + L + N +SG +PP + SLP L + NR+SG IP
Sbjct: 112 NVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYG- 170
Query: 79 SIWLPRKWDKRKCSGVDQGLLRLNNNSLSGAFPVFLAKISELAFLDLSYNNLSGPVP 135
S + + ++ N L+G P A ++ LAF+DLS N L G
Sbjct: 171 -----------SFSKLFT-SMTISRNRLTGKIPPTFANLN-LAFVDLSRNMLEGDAS 214
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 2e-26
Identities = 35/141 (24%), Positives = 59/141 (41%), Gaps = 20/141 (14%)
Query: 2 ITCSPENL---VIGLGAPSQSLSGT--LSGSIGNLTNLRQVLLQN-NNISGGIPPQLGSL 55
+ C + V L +L + S+ NL L + + NN+ G IPP + L
Sbjct: 41 VLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKL 100
Query: 56 PKLQTLDLSNNRLSGVIPALLFLSIWLPRKWDKRKCSGVDQGLLRLNNNSLSGAFPVFLA 115
+L L +++ +SG IP FLS + + L + N+LSG P ++
Sbjct: 101 TQLHYLYITHTNVSGAIPD--FLS----------QIKTLVT--LDFSYNALSGTLPPSIS 146
Query: 116 KISELAFLDLSYNNLSGPVPK 136
+ L + N +SG +P
Sbjct: 147 SLPNLVGITFDGNRISGAIPD 167
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 2e-26
Identities = 34/118 (28%), Positives = 53/118 (44%), Gaps = 15/118 (12%)
Query: 19 SLSGTLSGSIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFL 78
+L G + +I LT L + + + N+SG IP L + L TLD S N LSG +P +
Sbjct: 88 NLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSIS- 146
Query: 79 SIWLPRKWDKRKCSGVDQGLLRLNNNSLSGAFPVFLAKISELA-FLDLSYNNLSGPVP 135
+ + + N +SGA P S+L + +S N L+G +P
Sbjct: 147 -----------SLPNLVG--ITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIP 191
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 94.5 bits (236), Expect = 1e-21
Identities = 35/120 (29%), Positives = 52/120 (43%), Gaps = 17/120 (14%)
Query: 19 SLSGTLSGSIGNLTNLRQVLLQNNNISG--GIPPQLGSLPKLQTLDLSN-NRLSGVIPAL 75
+ G L + + + L N+ IP L +LP L L + N L G IP
Sbjct: 37 TWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPA 96
Query: 76 LFLSIWLPRKWDKRKCSGVDQGLLRLNNNSLSGAFPVFLAKISELAFLDLSYNNLSGPVP 135
+ K + + L + + ++SGA P FL++I L LD SYN LSG +P
Sbjct: 97 IA------------KLTQL--HYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLP 142
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 2e-29
Identities = 57/256 (22%), Positives = 100/256 (39%), Gaps = 25/256 (9%)
Query: 152 GSSSTNVCSGSANSVPLSFSLNSSPDKQ------EEGLISLGNLRNFTFRELQQATENFS 205
GS S+ A+ S ++ + EG++ L+ + E ++ +
Sbjct: 3 GSVSSGQAHSLASLAKTWSSGSAKLQRLGPETEDNEGVLLTEKLKPVDY-EYREEVHWMT 61
Query: 206 SKNILGAGGFGNVYKGK-LGDGTVLAVKRLK---------DMISLAVHRNLLRLIGYCAT 255
+ +G G FG V++ K G AVK+++ + ++ L G
Sbjct: 62 HQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVEELVACAGLSSPRIVPLYGAVRE 121
Query: 256 PTERLLVYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKA 315
+ + GS+ +++ L + A GL YLH + +I+H DVKA
Sbjct: 122 GPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTR---RILHGDVKA 178
Query: 316 ANVLLD-DFCEAIVGDFGLAKLLDHSDSHVTTA----VRGTVGHIAPEYLSTGQSSEKTD 370
NVLL D A + DFG A L + + GT H+APE + K D
Sbjct: 179 DNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVD 238
Query: 371 VFGFGILLLELITGMR 386
++ ++L ++ G
Sbjct: 239 IWSSCCMMLHMLNGCH 254
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 3e-29
Identities = 57/204 (27%), Positives = 97/204 (47%), Gaps = 31/204 (15%)
Query: 202 ENFSSKNILGAGGFGNVYKGKL-GDGTVLAVKRLKD--------------MISLAVHRNL 246
+ + K+ LG G +G VY+G +AVK LK+ M + H NL
Sbjct: 13 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIK-HPNL 71
Query: 247 LRLIGYCATPTERLLVYPYMSNGSVASRLR--EKPALDWNTRKRIAIGAARGLLYLHEQC 304
++L+G C ++ +M+ G++ LR + + +A + + YL ++
Sbjct: 72 VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK- 130
Query: 305 DPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTA-----VRGTVGHIAPEY 359
IHRD+ A N L+ + V DFGL++L+ D++ A ++ T APE
Sbjct: 131 --NFIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWT----APES 183
Query: 360 LSTGQSSEKTDVFGFGILLLELIT 383
L+ + S K+DV+ FG+LL E+ T
Sbjct: 184 LAYNKFSIKSDVWAFGVLLWEIAT 207
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 3e-29
Identities = 75/292 (25%), Positives = 117/292 (40%), Gaps = 75/292 (25%)
Query: 207 KNILGAGGFGNVYKGKL---GDGTVL-AVKRLKD----------------MISLAVHRNL 246
+ I+G+G G V G+L G V A+K LK M H N+
Sbjct: 54 EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQF-DHPNI 112
Query: 247 LRLIGYCATPTERLLVYPYMSNGSVASRLRE-KPALDWNTRKRIAIGAARGLLYLHEQCD 305
+RL G ++V YM NGS+ + LR + G G+ YL +
Sbjct: 113 IRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDL-- 170
Query: 306 PKIIHRDVKAANVLLDDFCEAIVGDFGLAKLL-DHSDSHVTTA-----VRGTVGHIAPEY 359
+HRD+ A NVL+D V DFGL+++L D D+ TT +R T APE
Sbjct: 171 -GYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWT----APEA 225
Query: 360 LSTGQSSEKTDVFGFGILLLELIT-GMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVD 418
++ S +DV+ FG+++ E++ G R + N+ +V+
Sbjct: 226 IAFRTFSSASDVWSFGVVMWEVLAYGERP--YWNMTNR-----------------DVI-- 264
Query: 419 RELGSNYDRIEVGEIL-----------QVALLCTQYLPVHRPKMSEVVRMLE 459
+E G L Q+ L C RP+ S++V +L+
Sbjct: 265 -------SSVEEGYRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLD 309
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 5e-29
Identities = 69/312 (22%), Positives = 114/312 (36%), Gaps = 86/312 (27%)
Query: 202 ENFSSKNILGAGGFGNVYKGKL--------GDGTVLAVKRLKD----------------M 237
+ + LG G FG V + + +AVK LKD M
Sbjct: 81 DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 140
Query: 238 ISLAVHRNLLRLIGYCATPTERLLVYPYMSNGSVASRLR----------------EKPAL 281
+ H+N++ L+G C ++ Y S G++ LR + +
Sbjct: 141 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 200
Query: 282 DWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSD 341
+ ARG+ YL Q K IHRD+ A NVL+ + + DFGLA+ +++ D
Sbjct: 201 TFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNID 257
Query: 342 SHVTTA-----VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-------GMRALE 389
+ T V+ APE L + ++DV+ FG+L+ E+ T G+ E
Sbjct: 258 YYKKTTNGRLPVKWM----APEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE 313
Query: 390 FGKSINQKGAMLEWVKKIQQEKKVEVLVDRELGSNYDRIEV--GEILQVALLCTQYLPVH 447
K + + M D+ E+ + C +P
Sbjct: 314 LFKLLKEGHRM-------------------------DKPANCTNELYMMMRDCWHAVPSQ 348
Query: 448 RPKMSEVVRMLE 459
RP ++V L+
Sbjct: 349 RPTFKQLVEDLD 360
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 7e-29
Identities = 70/310 (22%), Positives = 113/310 (36%), Gaps = 85/310 (27%)
Query: 202 ENFSSKNILGAGGFGNVYKGKL------GDGTVLAVKRLKD----------------MIS 239
N LGAG FG V + +AVK LK M
Sbjct: 46 NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 105
Query: 240 LAVHRNLLRLIGYCATPTERLLVYPYMSNGSVASRLREK-PALDWNTRK----------- 287
L H N++ L+G C L++ Y G + + LR K L+ +
Sbjct: 106 LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRD 165
Query: 288 --RIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVT 345
+ A+G+ +L + IHRDV A NVLL + A +GDFGLA+ + + +++
Sbjct: 166 LLHFSSQVAQGMAFLASK---NCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIV 222
Query: 346 TA-----VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAM 400
V+ APE + + ++DV+ +GILL E+ + G + G +
Sbjct: 223 KGNARLPVKWM----APESIFDCVYTVQSDVWSYGILLWEIFS------LGLNPYP-GIL 271
Query: 401 LEWVKKIQQEKKVEVLVDRELGSNYDRIEVG-----------EILQVALLCTQYLPVHRP 449
V+ + Y ++ G I + C P HRP
Sbjct: 272 ----------------VNSKF---YKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRP 312
Query: 450 KMSEVVRMLE 459
++ L+
Sbjct: 313 TFQQICSFLQ 322
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 7e-29
Identities = 64/305 (20%), Positives = 111/305 (36%), Gaps = 80/305 (26%)
Query: 202 ENFSSKNILGAGGFGNVYKGKL----GDGTVLAVKRLKDMISLAV--------------- 242
+ F+ +LG G FG+V + +L G +AVK LK I +
Sbjct: 23 QQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEF 82
Query: 243 -HRNLLRLIGYC------ATPTERLLVYPYMSNGSVASRLR------EKPALDWNTRKRI 289
H ++ +L+G +++ P+M +G + + L L T R
Sbjct: 83 DHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRF 142
Query: 290 AIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTA-- 347
+ A G+ YL + IHRD+ A N +L + V DFGL++ + D +
Sbjct: 143 MVDIACGMEYLSSR---NFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCAS 199
Query: 348 ---VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKS-----INQKGA 399
V+ A E L+ + +DV+ FG+ + E++T G++ N
Sbjct: 200 KLPVKWL----ALESLADNLYTVHSDVWAFGVTMWEIMT------RGQTPYAGIENA--- 246
Query: 400 MLEWVKKIQQEKKVEVLVDRELGSNYDRIEV-----GEILQVALLCTQYLPVHRPKMSEV 454
E+ L R++ E+ + C P RP + +
Sbjct: 247 --------------EIY--NYLIGGN-RLKQPPECMEEVYDLMYQCWSADPKQRPSFTCL 289
Query: 455 VRMLE 459
LE
Sbjct: 290 RMELE 294
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 8e-29
Identities = 68/305 (22%), Positives = 110/305 (36%), Gaps = 91/305 (29%)
Query: 207 KNILGAGGFGNVYKGKL----GDGTVLAVKRLK----------------DMISLAVHRNL 246
ILG G FG+V +G L G +AVK +K + H N+
Sbjct: 39 GKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNV 98
Query: 247 LRLIGYC-----ATPTERLLVYPYMSNGSVASRLR------EKPALDWNTRKRIAIGAAR 295
+RL+G C + +++ P+M G + + L + T + + A
Sbjct: 99 IRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIAL 158
Query: 296 GLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTA-----VRG 350
G+ YL + +HRD+ A N +L D V DFGL+K + D + V+
Sbjct: 159 GMEYLSNR---NFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKW 215
Query: 351 TVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKS-----INQKGAMLEWVK 405
A E L+ + K+DV+ FG+ + E+ T G + N
Sbjct: 216 I----AIESLADRVYTSKSDVWAFGVTMWEIAT------RGMTPYPGVQNH--------- 256
Query: 406 KIQQEKKVEVLVDRELGSNYDRIEVGEIL-----------QVALLCTQYLPVHRPKMSEV 454
E+ YD + G L ++ C + P+ RP S +
Sbjct: 257 --------EM---------YDYLLHGHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVL 299
Query: 455 VRMLE 459
LE
Sbjct: 300 RLQLE 304
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 1e-28
Identities = 57/227 (25%), Positives = 92/227 (40%), Gaps = 52/227 (22%)
Query: 202 ENFSSKNILGAGGFGNVYKGKL--------GDGTVLAVKRLKD----------------M 237
+ + LG G FG V + + +AVK LKD M
Sbjct: 35 DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 238 ISLAVHRNLLRLIGYCATPTERLLVYPYMSNGSVASRLR----------------EKPAL 281
+ H+N++ L+G C ++ Y S G++ LR + +
Sbjct: 95 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 282 DWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSD 341
+ ARG+ YL Q K IHRD+ A NVL+ + + DFGLA+ +++ D
Sbjct: 155 TFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNID 211
Query: 342 SHVTTA-----VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT 383
+ T V+ APE L + ++DV+ FG+L+ E+ T
Sbjct: 212 YYKKTTNGRLPVKWM----APEALFDRVYTHQSDVWSFGVLMWEIFT 254
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 4e-28
Identities = 75/297 (25%), Positives = 123/297 (41%), Gaps = 75/297 (25%)
Query: 202 ENFSSKNILGAGGFGNVYKGKL----GDGTVLAVKRLKD----------------MISLA 241
N S ++GAG FG V G+L +A+K LK M
Sbjct: 45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQF- 103
Query: 242 VHRNLLRLIGYCATPTERLLVYPYMSNGSVASRLRE-KPALDWNTRKRIAIGAARGLLYL 300
H N++RL G ++V YM NGS+ S LR+ + G A G+ YL
Sbjct: 104 DHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYL 163
Query: 301 HEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLL-DHSDSHVTTA-----VRGTVGH 354
+ +HRD+ A N+L++ V DFGL ++L D ++ TT +R T
Sbjct: 164 SDM---GYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWT--- 217
Query: 355 IAPEYLSTGQSSEKTDVFGFGILLLELIT-GMRALEFGKSINQKGAMLEWVKKIQQEKKV 413
+PE ++ + + +DV+ +GI+L E+++ G R + + NQ
Sbjct: 218 -SPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP--YWEMSNQ----------------- 257
Query: 414 EVLVDRELGSNYDRIEVGEIL-----------QVALLCTQYLPVHRPKMSEVVRMLE 459
+V+ ++ G L Q+ L C Q +RPK ++V +L+
Sbjct: 258 DVI---------KAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILD 305
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 4e-28
Identities = 53/217 (24%), Positives = 96/217 (44%), Gaps = 50/217 (23%)
Query: 207 KNILGAGGFGNVYKGKL---GDGTVLAVKRLKD----------------MISLAVHRNLL 247
++++G G FG V K ++ G A+KR+K+ + L H N++
Sbjct: 30 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 89
Query: 248 RLIGYCATPTERLLVYPYMSNGSVASRLREKPALDWNTRK----------------RIAI 291
L+G C L Y +G++ LR+ L+ + A
Sbjct: 90 NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 149
Query: 292 GAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGT 351
ARG+ YL ++ + IHRD+ A N+L+ + A + DFGL++ + V+ T
Sbjct: 150 DVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQE-------VYVKKT 199
Query: 352 VGHI-----APEYLSTGQSSEKTDVFGFGILLLELIT 383
+G + A E L+ + +DV+ +G+LL E+++
Sbjct: 200 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 236
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 4e-28
Identities = 68/309 (22%), Positives = 112/309 (36%), Gaps = 90/309 (29%)
Query: 207 KNILGAGGFGNVYKGKL------GDGTVLAVKRLKD----------------MISLAVHR 244
LG G FG V + +AVK LK+ +I + H
Sbjct: 32 GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 91
Query: 245 NLLRLIGYCATPTE-RLLVYPYMSNGSVASRLRE----------------KPALDWNTRK 287
N++ L+G C P +++ + G++++ LR K L
Sbjct: 92 NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLI 151
Query: 288 RIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTA 347
+ A+G+ +L + K IHRD+ A N+LL + + DFGLA+ + +V
Sbjct: 152 CYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKG 208
Query: 348 -----VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-------GMRALEFGKSIN 395
++ APE + + ++DV+ FG+LL E+ + G+ I+
Sbjct: 209 DARLPLKWM----APETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV-------KID 257
Query: 396 QKGAMLEWVKKIQQEKKVEVLVDRELGSNYDRIEV-----GEILQVALLCTQYLPVHRPK 450
+ E R L R+ E+ Q L C P RP
Sbjct: 258 E-----------------EFC--RRLKEGT-RMRAPDYTTPEMYQTMLDCWHGEPSQRPT 297
Query: 451 MSEVVRMLE 459
SE+V L
Sbjct: 298 FSELVEHLG 306
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 4e-28
Identities = 75/302 (24%), Positives = 123/302 (40%), Gaps = 84/302 (27%)
Query: 202 ENFSSKNILGAGGFGNVYKGKLGDGTVL-----AVKRLKD----------------MISL 240
+ + ++GAG FG VYKG L + A+K LK M
Sbjct: 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 103
Query: 241 AVHRNLLRLIGYCATPTERLLVYPYMSNGSVASRLRE-KPALDWNTRKRIAIGAARGLLY 299
+ H N++RL G + +++ YM NG++ LRE + G A G+ Y
Sbjct: 104 S-HHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKY 162
Query: 300 LHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLL-DHSDSHVTTA-----VRGTVG 353
L +HRD+ A N+L++ V DFGL+++L D ++ TT+ +R T
Sbjct: 163 LANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWT-- 217
Query: 354 HIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKS-----INQKGAMLEWVKKIQ 408
APE +S + + +DV+ FGI++ E++T +G+ N
Sbjct: 218 --APEAISYRKFTSASDVWSFGIVMWEVMT------YGERPYWELSNH------------ 257
Query: 409 QEKKVEVLVDRELGSNYDRIEVGEIL-----------QVALLCTQYLPVHRPKMSEVVRM 457
EV+ I G L Q+ + C Q RPK +++V +
Sbjct: 258 -----EVM---------KAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSI 303
Query: 458 LE 459
L+
Sbjct: 304 LD 305
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 5e-28
Identities = 58/222 (26%), Positives = 87/222 (39%), Gaps = 52/222 (23%)
Query: 207 KNILGAGGFGNVYKGKL--------GDGTVLAVKRLKD----------------MISLAV 242
LG G FG V + T +AVK LK M +
Sbjct: 74 GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 133
Query: 243 HRNLLRLIGYCATPTERLLVYPYMSNGSVASRLREKPALDWNTRK--------------- 287
H+N++ L+G C ++ Y S G++ L+ +
Sbjct: 134 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 193
Query: 288 -RIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTT 346
A ARG+ YL + K IHRD+ A NVL+ + + DFGLA+ + H D + T
Sbjct: 194 VSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 250
Query: 347 A-----VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT 383
V+ APE L + ++DV+ FG+LL E+ T
Sbjct: 251 TNGRLPVKWM----APEALFDRIYTHQSDVWSFGVLLWEIFT 288
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 6e-28
Identities = 70/303 (23%), Positives = 111/303 (36%), Gaps = 77/303 (25%)
Query: 202 ENFSSKNILGAGGFGNVYKGKL------GDGTVLAVKRLKD---------------MISL 240
+N + LG G FG VY+G++ +AVK L + +IS
Sbjct: 30 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 89
Query: 241 AVHRNLLRLIGYCATPTERLLVYPYMSNGSVASRLR-------EKPALDWNTRKRIAIGA 293
H+N++R IG R ++ M+ G + S LR + +L +A
Sbjct: 90 FNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 149
Query: 294 ARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIV---GDFGLAKLLDHSDSHVTTAVRG 350
A G YL E IHRD+ A N LL V GDFG+A+ + + +G
Sbjct: 150 ACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAS----YYRKG 202
Query: 351 TVGHI-----APEYLSTGQSSEKTDVFGFGILLLELIT-------GMRALEFGKSINQKG 398
+ PE G + KTD + FG+LL E+ + E + + G
Sbjct: 203 GCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGG 262
Query: 399 AMLEWVKKIQQEKKVEVLVDRELGSNYDRIEV--GEILQVALLCTQYLPVHRPKMSEVVR 456
M D + G + ++ C Q+ P RP + ++
Sbjct: 263 RM-------------------------DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILE 297
Query: 457 MLE 459
+E
Sbjct: 298 RIE 300
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 9e-28
Identities = 58/301 (19%), Positives = 102/301 (33%), Gaps = 80/301 (26%)
Query: 202 ENFSSKNILGAGGFGNVYKGKL--------GDGTVLAVKRLKD---------------MI 238
E+ LG G F ++KG T + +K L M
Sbjct: 8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMS 67
Query: 239 SLAVHRNLLRLIGYCATPTERLLVYPYMSNGSVASRLRE-KPALDWNTRKRIAIGAARGL 297
L+ H++L+ G C E +LV ++ GS+ + L++ K ++ + +A A +
Sbjct: 68 KLS-HKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAM 126
Query: 298 LYLHEQCDPKIIHRDVKAANVLLDDFCEAI--------VGDFGLAKLLDHSDSHVTTAVR 349
+L E +IH +V A N+LL + + D G++ + + +
Sbjct: 127 HFLEEN---TLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITV-LPKDILQERIP 182
Query: 350 GTVGHIAPEYLSTGQS-SEKTDVFGFGILLLELIT-GMRALEFGKSINQKGAMLEWVKKI 407
PE + ++ + TD + FG L E+ + G + L +Q
Sbjct: 183 WV----PPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLS-ALD-SQ----------- 225
Query: 408 QQEKKVEVLVDRELGSNYDRIEVGEIL---------QVALLCTQYLPVHRPKMSEVVRML 458
L E L + C Y P HRP ++R L
Sbjct: 226 ------RKL---------QFYEDRHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDL 270
Query: 459 E 459
Sbjct: 271 N 271
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 2e-27
Identities = 62/308 (20%), Positives = 111/308 (36%), Gaps = 77/308 (25%)
Query: 202 ENFSSKNILGAGGFGNVYKGKL------GDGTVLAVKRLKD----------------MIS 239
S LGAG FG V + +AVK LK +
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 240 LAVHRNLLRLIGYCATPTERLLVYPYMSNGSVASRLREKPALDWNTRK------------ 287
L H N++ L+G C L++ Y G + + LR K ++
Sbjct: 83 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 288 ------RIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSD 341
+ A+G+ +L + IHRD+ A N+LL + DFGLA+ + +
Sbjct: 143 DLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 199
Query: 342 SHVTTA-----VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQ 396
++V V+ APE + + ++DV+ +GI L EL + + G ++
Sbjct: 200 NYVVKGNARLPVKWM----APESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS 255
Query: 397 KGAMLEWVKKIQQEKKVEVLVDRELGSNYDRIEV-----GEILQVALLCTQYLPVHRPKM 451
+ + + + R+ E+ + C P+ RP
Sbjct: 256 -----------------KFY--KMIKEGF-RMLSPEHAPAEMYDIMKTCWDADPLKRPTF 295
Query: 452 SEVVRMLE 459
++V+++E
Sbjct: 296 KQIVQLIE 303
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 3e-27
Identities = 41/131 (31%), Positives = 63/131 (48%), Gaps = 18/131 (13%)
Query: 19 SLSGTLSGSIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPA---- 74
+G + ++ N + L + L N +SG IP LGSL KL+ L L N L G IP
Sbjct: 405 GFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMY 464
Query: 75 ---LLFLSIW-------LPRKWDKRKCSGVDQGLLRLNNNSLSGAFPVFLAKISELAFLD 124
L L + +P C+ ++ + L+NN L+G P ++ ++ LA L
Sbjct: 465 VKTLETLILDFNDLTGEIPSGL--SNCTNLN--WISLSNNRLTGEIPKWIGRLENLAILK 520
Query: 125 LSYNNLSGPVP 135
LS N+ SG +P
Sbjct: 521 LSNNSFSGNIP 531
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 2e-24
Identities = 40/120 (33%), Positives = 55/120 (45%), Gaps = 14/120 (11%)
Query: 19 SLSGTL-SGSIGNLTNLRQVLLQNNNISGGIPPQLGSL-PKLQTLDLSNNRLSGVIPALL 76
+ SG L ++ + L+ + L N SG +P L +L L TLDLS+N SG I L
Sbjct: 329 NFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNL 388
Query: 77 FLSIWLPRKWDKRKCSGVDQGLLRLNNNSLSGAFPVFLAKISELAFLDLSYNNLSGPVPK 136
+ + L L NN +G P L+ SEL L LS+N LSG +P
Sbjct: 389 CQNPKNTLQE------------LYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPS 436
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 5e-24
Identities = 38/120 (31%), Positives = 56/120 (46%), Gaps = 16/120 (13%)
Query: 19 SLSGTLSGSIGN--LTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALL 76
+ SG + ++ L+++ LQNN +G IPP L + +L +L LS N LSG IP+ L
Sbjct: 379 NFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSL 438
Query: 77 FLSIWLPRKWDKRKCSGVDQGLLRLNNNSLSGAFPVFLAKISELAFLDLSYNNLSGPVPK 136
L L+L N L G P L + L L L +N+L+G +P
Sbjct: 439 GSLSKL--------------RDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPS 484
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 5e-24
Identities = 40/118 (33%), Positives = 52/118 (44%), Gaps = 15/118 (12%)
Query: 19 SLSGTLSGSIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFL 78
LSG S +I T L+ + + +N G IPP L LQ L L+ N+ +G IP L
Sbjct: 234 KLSGDFSRAISTCTELKLLNISSNQFVGPIPP--LPLKSLQYLSLAENKFTGEIPDFLSG 291
Query: 79 SIWLPRKWDKRKCSGVDQGLLRLNNNSLSGAFPVFLAKISELAFLDLSYNNLSGPVPK 136
+ C + L L+ N GA P F S L L LS NN SG +P
Sbjct: 292 A-----------CDTLTG--LDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPM 336
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 8e-24
Identities = 38/119 (31%), Positives = 52/119 (43%), Gaps = 15/119 (12%)
Query: 19 SLSGTLSGSI-GNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLF 77
+G + + G L + L N+ G +PP GS L++L LS+N SG +P
Sbjct: 280 KFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTL 339
Query: 78 LSIWLPRKWDKRKCSGVDQGLLRLNNNSLSGAFPVFLAKIS-ELAFLDLSYNNLSGPVP 135
K G+ L L+ N SG P L +S L LDLS NN SGP+
Sbjct: 340 -----------LKMRGLKV--LDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPIL 385
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 1e-23
Identities = 31/119 (26%), Positives = 52/119 (43%), Gaps = 18/119 (15%)
Query: 19 SLSGTLSGSIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFL 78
+ S + +G+ + L+ + + N +SG + + +L+ L++S+N+ G IP L
Sbjct: 211 NFSTGIP-FLGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPLPLK 269
Query: 79 SIWLPRKWDKRKCSGVDQGLLRLNNNSLSGAFPVFLA-KISELAFLDLSYNNLSGPVPK 136
S+ L L N +G P FL+ L LDLS N+ G VP
Sbjct: 270 SLQ----------------YLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPP 312
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 5e-23
Identities = 37/177 (20%), Positives = 56/177 (31%), Gaps = 46/177 (25%)
Query: 19 SLSGTLSGSIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFL 78
G S + L+ + + G P + + LD+S N LSG IP +
Sbjct: 595 EFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIG- 653
Query: 79 SIWLPRKWDKRKCSGVDQGLLRLN--NNSLSGAFPVFLAKISELAFLDLSYNNLSGPVPK 136
L LN +N +SG+ P + + L LDLS N L G +P+
Sbjct: 654 -----------SM----PYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQ 698
Query: 137 FPA-------------------------RTFNV---AGNPLICGSSSTNVCSGSANS 165
+ TF NP +CG +A+
Sbjct: 699 AMSALTMLTEIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGLCGYPLPRCDPSNADG 755
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 98.4 bits (246), Expect = 8e-22
Identities = 36/139 (25%), Positives = 56/139 (40%), Gaps = 27/139 (19%)
Query: 19 SLSGTLSGSI---GNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPAL 75
S+SG L+ + + N ISG + + L+ LD+S+N S IP L
Sbjct: 162 SISGANVVGWVLSDGCGELKHLAISGNKISGDVD--VSRCVNLEFLDVSSNNFSTGIPFL 219
Query: 76 LFLSIWLPRKWDKRKCSGVDQGL--LRLNNNSLSGAFPVFLAKISELAFLDLSYNNLSGP 133
S L L ++ N LSG F ++ +EL L++S N GP
Sbjct: 220 GDCS-----------------ALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGP 262
Query: 134 VPKFPA---RTFNVAGNPL 149
+P P + ++A N
Sbjct: 263 IPPLPLKSLQYLSLAENKF 281
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 2e-21
Identities = 35/123 (28%), Positives = 51/123 (41%), Gaps = 18/123 (14%)
Query: 19 SLSGTLSGSIGNLTNLRQVLLQNNNISGGIPPQ-LGSLPKLQTLDLSNNRLSGVIPALLF 77
G + G+ + L + L +NN SG +P L + L+ LDLS N SG +P L
Sbjct: 305 HFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLT 364
Query: 78 -LSIWLPRKWDKRKCSGVDQGLLRLNNNSLSGAFPVFLAKI--SELAFLDLSYNNLSGPV 134
LS L L L++N+ SG L + + L L L N +G +
Sbjct: 365 NLSASL--------------LTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKI 410
Query: 135 PKF 137
P
Sbjct: 411 PPT 413
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 95.7 bits (239), Expect = 6e-21
Identities = 41/138 (29%), Positives = 65/138 (47%), Gaps = 18/138 (13%)
Query: 2 ITCSPENLVIGLGAPSQSLS---GTLSGSIGNLTNLRQVLLQNNNISGGIPPQLGSLPKL 58
+TC + V + S+ L+ +S S+ +LT L + L N++I+G + L
Sbjct: 45 VTCRDDK-VTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVSG-FKCSASL 102
Query: 59 QTLDLSNNRLSGVIPALLFLSIWLPRKWDKRKCSGVDQGLLRLNNNSLSGAFPV-FLAKI 117
+LDLS N LSG + L L CSG+ L +++N+L V K+
Sbjct: 103 TSLDLSRNSLSGPVTTLTSLG----------SCSGLK--FLNVSSNTLDFPGKVSGGLKL 150
Query: 118 SELAFLDLSYNNLSGPVP 135
+ L LDLS N++SG
Sbjct: 151 NSLEVLDLSANSISGANV 168
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 95.7 bits (239), Expect = 6e-21
Identities = 41/157 (26%), Positives = 59/157 (37%), Gaps = 30/157 (19%)
Query: 19 SLSGTLSGSIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFL 78
L+G + + N TNL + L NN ++G IP +G L L L LSNN SG IPA L
Sbjct: 477 DLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELG- 535
Query: 79 SIWLPRKWDKRKCSGVDQGLLRLNNNSLSGAFPVFLAKISELAFLDLSYNNLSGPVPKFP 138
C + L LN N +G P + K S ++ N ++G +
Sbjct: 536 -----------DCRSL--IWLDLNTNLFNGTIPAAMFKQS----GKIAANFIAGKRYVY- 577
Query: 139 ARTFNVAGNPLICGSSSTNVCSGSANSVPLSFSLNSS 175
I C G+ N + +
Sbjct: 578 -----------IKNDGMKKECHGAGNLLEFQGIRSEQ 603
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 3e-19
Identities = 32/124 (25%), Positives = 49/124 (39%), Gaps = 25/124 (20%)
Query: 19 SLSGTLSGSIG-NLTNLRQVLLQNNNISGGIPPQL---GSLPKLQTLDLSNNRLSGVIPA 74
+L S G L +L + L N+ISG +L+ L +S N++SG +
Sbjct: 137 TLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGELKHLAISGNKISGDVDV 196
Query: 75 --LLFLSIWLPRKWDKRKCSGVDQGLLRLNNNSLSGAFPVFLAKISELAFLDLSYNNLSG 132
+ L L +++N+ S P FL S L LD+S N LSG
Sbjct: 197 SRCVNLEF------------------LDVSSNNFSTGIP-FLGDCSALQHLDISGNKLSG 237
Query: 133 PVPK 136
+
Sbjct: 238 DFSR 241
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 4e-27
Identities = 70/303 (23%), Positives = 111/303 (36%), Gaps = 77/303 (25%)
Query: 202 ENFSSKNILGAGGFGNVYKGKL------GDGTVLAVKRLKD---------------MISL 240
+N + LG G FG VY+G++ +AVK L + +IS
Sbjct: 71 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 130
Query: 241 AVHRNLLRLIGYCATPTERLLVYPYMSNGSVASRLR-------EKPALDWNTRKRIAIGA 293
H+N++R IG R ++ M+ G + S LR + +L +A
Sbjct: 131 FNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 190
Query: 294 ARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIV---GDFGLAKLLDHSDSHVTTAVRG 350
A G YL E IHRD+ A N LL V GDFG+A+ + + +G
Sbjct: 191 ACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAG----YYRKG 243
Query: 351 TVGHI-----APEYLSTGQSSEKTDVFGFGILLLELIT-------GMRALEFGKSINQKG 398
+ PE G + KTD + FG+LL E+ + E + + G
Sbjct: 244 GCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGG 303
Query: 399 AMLEWVKKIQQEKKVEVLVDRELGSNYDRIEV--GEILQVALLCTQYLPVHRPKMSEVVR 456
M D + G + ++ C Q+ P RP + ++
Sbjct: 304 RM-------------------------DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILE 338
Query: 457 MLE 459
+E
Sbjct: 339 RIE 341
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 6e-27
Identities = 63/315 (20%), Positives = 106/315 (33%), Gaps = 96/315 (30%)
Query: 207 KNILGAGGFGNVYKGKL------GDGTVLAVKRLKD----------------MISLAVHR 244
+LG+G FG V G +AVK LK+ M L H
Sbjct: 50 GKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHE 109
Query: 245 NLLRLIGYCATPTERLLVYPYMSNGSVASRLREKPALDWNTRK----------------- 287
N++ L+G C L++ Y G + + LR K
Sbjct: 110 NIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVL 169
Query: 288 ------RIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSD 341
A A+G+ +L + +HRD+ A NVL+ + DFGLA+ +
Sbjct: 170 TFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDS 226
Query: 342 SHVTTA-----VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-------GMRALE 389
++V V+ APE L G + K+DV+ +GILL E+ + G+
Sbjct: 227 NYVVRGNARLPVKWM----APESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGI---- 278
Query: 390 FGKSINQKGAMLEWVKKIQQEKKVEVLVDRELGSNYDRIEV-----GEILQVALLCTQYL 444
++ + + + + +++ EI + C +
Sbjct: 279 ---PVDA-----------------NFY--KLIQNGF-KMDQPFYATEEIYIIMQSCWAFD 315
Query: 445 PVHRPKMSEVVRMLE 459
RP + L
Sbjct: 316 SRKRPSFPNLTSFLG 330
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 7e-27
Identities = 63/303 (20%), Positives = 119/303 (39%), Gaps = 77/303 (25%)
Query: 202 ENFSSKNILGAGGFGNVYKGKL------GDGTVLAVKRLKDMISLAV------------- 242
E + LG G FG VY+G T +A+K + + S+
Sbjct: 25 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 84
Query: 243 --HRNLLRLIGYCATPTERLLVYPYMSNGSVASRLR-------EKPALDWNTRKR---IA 290
+++RL+G + L++ M+ G + S LR P L + + +A
Sbjct: 85 FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 144
Query: 291 IGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRG 350
A G+ YL+ K +HRD+ A N ++ + +GDFG+ + + +D +G
Sbjct: 145 GEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETD----YYRKG 197
Query: 351 TVGHI-----APEYLSTGQSSEKTDVFGFGILLLELIT-------GMRALEFGKSINQKG 398
G + +PE L G + +DV+ FG++L E+ T G+ + + + + G
Sbjct: 198 GKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGG 257
Query: 399 AMLEWVKKIQQEKKVEVLVDRELGSNYDRIEV--GEILQVALLCTQYLPVHRPKMSEVVR 456
+ D+ + + ++ +C QY P RP E++
Sbjct: 258 LL-------------------------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIIS 292
Query: 457 MLE 459
++
Sbjct: 293 SIK 295
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 2e-26
Identities = 51/216 (23%), Positives = 75/216 (34%), Gaps = 30/216 (13%)
Query: 202 ENFSSKNILGAGGFGNVYKG-KLGDGTVLAVKRLK-----------------DMISLAVH 243
++F + LG G +G V+K DG + AVKR + H
Sbjct: 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQH 116
Query: 244 RNLLRLIGYCATPTERLLVYPYM--SNGSVASRL-REKPALDWNTRKRIAIGAARGLLYL 300
+RL +Y S+ +L L +L
Sbjct: 117 PCCVRLEQAWEEGGI---LYLQTELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHL 173
Query: 301 HEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGHIAPEYL 360
H Q ++H DVK AN+ L +GDFGL L + + G ++APE L
Sbjct: 174 HSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGA--GEVQEGDPRYMAPELL 228
Query: 361 STGQSSEKTDVFGFGILLLELITGMRALEFGKSINQ 396
G DVF G+ +LE+ M G+ Q
Sbjct: 229 Q-GSYGTAADVFSLGLTILEVACNMELPHGGEGWQQ 263
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 2e-26
Identities = 50/339 (14%), Positives = 105/339 (30%), Gaps = 48/339 (14%)
Query: 135 PKFPARTFNVAGNPLICGSSSTNVCSGSANSVPLSFSLNSSPDKQEEGLISLGNLRNFTF 194
P+ + A N ++ + + LS ++S P+ E L ++ T
Sbjct: 3 PQMSSLGTVDAPNFIVGNPWDDKLIFKLLSG--LSKPVSSYPNTFEW-QCKLPAIKPKT- 58
Query: 195 RELQQATENFSSKNILGAGGFGNVYKGKLGD------GTVLAVK--------------RL 234
E Q ++ ++LG G F VY+ GD +K +L
Sbjct: 59 -EFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQL 117
Query: 235 KDMISLAVHRNLLRLIGYCATPTERLLVYPYMSNGSVASRLREKPALDW-----NTRKRI 289
+ + ++ ++ +LV S G++ + +
Sbjct: 118 MERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISF 177
Query: 290 AIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVG-----------DFGLAKLLD 338
A+ + +H+ +IIH D+K N +L + D G + +
Sbjct: 178 AMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMK 234
Query: 339 -HSDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQK 397
+ TA T G E LS + + D FG + ++ G ++ +
Sbjct: 235 LFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFG-TYMKVKNE-GGE 292
Query: 398 GAMLEWVKKIQQEKKVEVLVDRELGSN-YDRIEVGEILQ 435
+++ L + ++L+
Sbjct: 293 CKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLR 331
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 7e-26
Identities = 61/216 (28%), Positives = 89/216 (41%), Gaps = 36/216 (16%)
Query: 201 TENFSSKNILGAGGFGNVYKGK-LGDGTVLAVKRLK---------------DMISLAVHR 244
E F+ +G G FG V+KG V+A+K + ++S
Sbjct: 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 80
Query: 245 NLLRLIGYCATPTERLLVYPYMSNGSVASRLREKPALDWNTRKRIAI---GAARGLLYLH 301
+ + G T+ ++ Y+ GS L P +IA +GL YLH
Sbjct: 81 YVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPL----DETQIATILREILKGLDYLH 136
Query: 302 EQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGHIAPEYLS 361
+ K IHRD+KAANVLL + E + DFG+A L + T V GT +APE +
Sbjct: 137 SE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIK 192
Query: 362 TGQSSEKTDVFGFGILLLELITG---------MRAL 388
K D++ GI +EL G M+ L
Sbjct: 193 QSAYDSKADIWSLGITAIELARGEPPHSELHPMKVL 228
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 1e-25
Identities = 56/238 (23%), Positives = 90/238 (37%), Gaps = 42/238 (17%)
Query: 171 SLNSSPDKQEEGLISLGNLRNFTFRELQQATENFSSKNILGAGGFGNVYKGKLGDGTVLA 230
SL +E ++ +G + F K++LG G G + + D +A
Sbjct: 6 SLEQDDGDEETSVVIVGKIS-------------FCPKDVLGHGAEGTIVYRGMFDNRDVA 52
Query: 231 VKR-LKDMISLA-----------VHRNLLRLIGYCATPTERLLVYPYMSNGSVASRLREK 278
VKR L + S A H N++R + + + ++ + +K
Sbjct: 53 VKRILPECFSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA-ATLQEYVEQK 111
Query: 279 PALDWNTR-KRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCE-----AIVGDFG 332
+ GL +LH I+HRD+K N+L+ A++ DFG
Sbjct: 112 DFAHLGLEPITLLQQTTSGLAHLHSL---NIVHRDLKPHNILISMPNAHGKIKAMISDFG 168
Query: 333 LAKLLD---HSDSHVTTAVRGTVGHIAPEYLSTGQS---SEKTDVFGFGILLLELITG 384
L K L HS S + GT G IAPE LS + D+F G + +I+
Sbjct: 169 LCKKLAVGRHSFSRRSGVP-GTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISE 225
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 1e-25
Identities = 66/304 (21%), Positives = 114/304 (37%), Gaps = 84/304 (27%)
Query: 207 KNILGAGGFGNVYKGKL------GDGTVLAVKRLKD--------------MISLAVHRNL 246
K LG G FG V+ + D ++AVK LKD +++ H ++
Sbjct: 20 KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHI 79
Query: 247 LRLIGYCATPTERLLVYPYMSNGSVASRLREK-PALDWNTRKR---------------IA 290
++ G C ++V+ YM +G + LR P + IA
Sbjct: 80 VKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIA 139
Query: 291 IGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTA--- 347
A G++YL Q +HRD+ N L+ +GDFG+++ + +D +
Sbjct: 140 SQIASGMVYLASQ---HFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTM 196
Query: 348 --VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKS-----INQKGAM 400
+R PE + + + ++DV+ FG++L E+ T +GK N
Sbjct: 197 LPIRWM----PPESIMYRKFTTESDVWSFGVILWEIFT------YGKQPWFQLSNT---- 242
Query: 401 LEWVKKIQQEKKVEVLVDRELGSNYDRIEV-----GEILQVALLCTQYLPVHRPKMSEVV 455
EV+ + +E E+ V L C Q P R + E+
Sbjct: 243 -------------EVI--ECITQGR-VLERPRVCPKEVYDVMLGCWQREPQQRLNIKEIY 286
Query: 456 RMLE 459
++L
Sbjct: 287 KILH 290
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 2e-25
Identities = 60/311 (19%), Positives = 106/311 (34%), Gaps = 97/311 (31%)
Query: 207 KNILGAGGFGNVYKGKL------GDGTVLAVKRLKDMISLAV---------------HRN 245
LG FG VYKG L +A+K LKD + H N
Sbjct: 14 MEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPN 73
Query: 246 LLRLIGYCATPTERLLVYPYMSNGSVASRLRE----------------KPALDWNTRKRI 289
++ L+G +++ Y S+G + L K AL+ +
Sbjct: 74 VVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHL 133
Query: 290 AIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTA-- 347
A G+ YL ++H+D+ NVL+ D + D GL + + +D +
Sbjct: 134 VAQIAAGMEYLSSH---HVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNS 190
Query: 348 ---VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKS-----INQKGA 399
+R APE + G+ S +D++ +G++L E+ + +G NQ
Sbjct: 191 LLPIRWM----APEAIMYGKFSIDSDIWSYGVVLWEVFS------YGLQPYCGYSNQ--- 237
Query: 400 MLEWVKKIQQEKKVEVLVDRELGSNYDRIEVGEIL-----------QVALLCTQYLPVHR 448
+V+ + I ++L + + C P R
Sbjct: 238 --------------DVV---------EMIRNRQVLPCPDDCPAWVYALMIECWNEFPSRR 274
Query: 449 PKMSEVVRMLE 459
P+ ++ L
Sbjct: 275 PRFKDIHSRLR 285
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 104 bits (263), Expect = 2e-25
Identities = 47/193 (24%), Positives = 78/193 (40%), Gaps = 22/193 (11%)
Query: 210 LGAGGFGNVYKGK-LGDGTVLAVKRL-KDMI----------------SLAVHRNLLRLIG 251
LG GGF ++ V A K + K ++ H++++ G
Sbjct: 23 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82
Query: 252 YCATPTERLLVYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHR 311
+ +V S+ + + AL + G YLH ++IHR
Sbjct: 83 FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRN---RVIHR 139
Query: 312 DVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDV 371
D+K N+ L++ E +GDFGLA +++ GT +IAPE LS S + DV
Sbjct: 140 DLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC-GTPNYIAPEVLSKKGHSFEVDV 198
Query: 372 FGFGILLLELITG 384
+ G ++ L+ G
Sbjct: 199 WSIGCIMYTLLVG 211
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 3e-25
Identities = 48/225 (21%), Positives = 97/225 (43%), Gaps = 34/225 (15%)
Query: 202 ENFSSKNILGAGGFGNVYKGK-LGDGTVLAVKRLK----------DMISLAVHRNLLRLI 250
+F ++G+GGFG V+K K DG +KR+K ++ H N++
Sbjct: 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYN 70
Query: 251 GY-------------CATPTERLLVYPYM---SNGSVASRLREKPA--LDWNTRKRIAIG 292
G ++ ++ ++ M G++ + ++ LD +
Sbjct: 71 GCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQ 130
Query: 293 AARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTV 352
+G+ Y+H + K+I+RD+K +N+ L D + +GDFGL L + + GT+
Sbjct: 131 ITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSK--GTL 185
Query: 353 GHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQK 397
+++PE +S+ ++ D++ G++L EL+
Sbjct: 186 RYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTD 230
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 3e-25
Identities = 58/291 (19%), Positives = 106/291 (36%), Gaps = 53/291 (18%)
Query: 202 ENFSSKNILGAGGFGNVYKGK-LGDGTVLAVKR-------------LKDMISLAV--HRN 245
+F LG GGFG V++ K D A+KR ++++ +LA H
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64
Query: 246 LLRLIGYCATPTERLLVYP------------YMSNGSVASRLREKPAL---DWNTRKRIA 290
++R + P ++ + + + + + I
Sbjct: 65 IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIF 124
Query: 291 IGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVR- 349
+ A + +LH + ++HRD+K +N+ VGDFGL +D + T
Sbjct: 125 LQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPM 181
Query: 350 ----------GTVGHIAPEYLSTGQSSEKTDVFGFGILLLELI----TGMRALEFGKSIN 395
GT +++PE + S K D+F G++L EL+ T M + +
Sbjct: 182 PAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYPFSTQMERVRTLTDVR 241
Query: 396 QKGAMLEWVKKIQQEKKVEVLVDRELGSN-YDRIEVGEILQVALLCTQYLP 445
+ +K E +V L + +R E I++ A+ P
Sbjct: 242 NLKFPPLFTQKYPCEYV---MVQDMLSPSPMERPEAINIIENAVFEDLDFP 289
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 4e-25
Identities = 56/249 (22%), Positives = 94/249 (37%), Gaps = 46/249 (18%)
Query: 188 NLRNFTFRELQQATENFSSKNILGAGGFGNVYKGK-LGDGTVLAVK--RLKDM------- 237
N F+ + E + +G G FG K DG +K + M
Sbjct: 14 GTENLYFQSM----EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREE 69
Query: 238 -------ISLAVHRNLLRLIGYCATPTERLLVYPYMSNGSVASRLR--------EKPALD 282
++ H N+++ +V Y G + R+ E LD
Sbjct: 70 SRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILD 129
Query: 283 WNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDS 342
W + L ++H++ KI+HRD+K+ N+ L +GDFG+A++L+ +
Sbjct: 130 W------FVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVE 180
Query: 343 HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLE 402
+ GT +++PE + K+D++ G +L EL T A E S M
Sbjct: 181 LARACI-GTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFE-AGS------MKN 232
Query: 403 WVKKIQQEK 411
V KI
Sbjct: 233 LVLKIISGS 241
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 4e-25
Identities = 49/199 (24%), Positives = 91/199 (45%), Gaps = 25/199 (12%)
Query: 209 ILGAGGFGNVYKGK-LGDGTVLAVKRLK--------------DMISLAVHRNLLRLIGYC 253
+LG G +G VY G+ L + +A+K + + H+N+++ +G
Sbjct: 29 VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSF 88
Query: 254 ATPTERLLVYPYMSNGSVASRLREKPALDWNTRKRIAIGAA---RGLLYLHEQCDPKIIH 310
+ + + GS+++ LR K + + I GL YLH+ +I+H
Sbjct: 89 SENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN---QIVH 145
Query: 311 RDVKAANVLLDDFCEAI-VGDFGLAKLLDHSDSHVTTAVRGTVGHIAPEYLSTGQS--SE 367
RD+K NVL++ + + + DFG +K L + T GT+ ++APE + G +
Sbjct: 146 RDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET-FTGTLQYMAPEIIDKGPRGYGK 204
Query: 368 KTDVFGFGILLLELITGMR 386
D++ G ++E+ TG
Sbjct: 205 AADIWSLGCTIIEMATGKP 223
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 4e-25
Identities = 54/217 (24%), Positives = 84/217 (38%), Gaps = 37/217 (17%)
Query: 202 ENFSSKNILGAGGFGNVYKGK-LGDGTVLAVKRLK--------------DMISLAVHRNL 246
+++ LG GGF V + L DG A+KR+ DM L H N+
Sbjct: 29 KHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNI 88
Query: 247 LRLIGYCATPTER----LLVYPYMSNGSVA----SRLREKPALDWNTRKRIAIGAARGLL 298
LRL+ YC L+ P+ G++ + L + + +G RGL
Sbjct: 89 LRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLE 148
Query: 299 YLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVR--------G 350
+H HRD+K N+LL D + ++ D G A+
Sbjct: 149 AIH---AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRC 205
Query: 351 TVGHIAPEYLST---GQSSEKTDVFGFGILLLELITG 384
T+ + APE S E+TDV+ G +L ++ G
Sbjct: 206 TISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFG 242
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 4e-25
Identities = 62/303 (20%), Positives = 110/303 (36%), Gaps = 83/303 (27%)
Query: 207 KNILGAGGFGNVYKGKL------GDGTVLAVKRLKD--------------MISLAVHRNL 246
K LG G FG V+ + D ++AVK LK+ ++++ H+++
Sbjct: 46 KWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHI 105
Query: 247 LRLIGYCATPTERLLVYPYMSNGSVASRLRE-KPALDWNTRKR--------------IAI 291
+R G C L+V+ YM +G + LR P +A
Sbjct: 106 VRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVAS 165
Query: 292 GAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGT 351
A G++YL +HRD+ N L+ +GDFG+++ + +D G
Sbjct: 166 QVAAGMVYLAGL---HFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTD----YYRVGG 218
Query: 352 VGHI-----APEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKS-----INQKGAML 401
+ PE + + + ++DV+ FG++L E+ T +GK N
Sbjct: 219 RTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFT------YGKQPWYQLSNT----- 267
Query: 402 EWVKKIQQEKKVEVLVDRELGSNYDRIEV-----GEILQVALLCTQYLPVHRPKMSEVVR 456
E + + +E E+ + C Q P R + +V
Sbjct: 268 ------------EAI--DCITQGR-ELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHA 312
Query: 457 MLE 459
L+
Sbjct: 313 RLQ 315
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 4e-25
Identities = 57/225 (25%), Positives = 87/225 (38%), Gaps = 41/225 (18%)
Query: 202 ENFSSKNILGAGGFGNVYKGK-LGDGTVLAVKRLK---------------DMISLAVHRN 245
+++ + ++G+G V +A+KR+ +S H N
Sbjct: 15 DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74
Query: 246 LLRLIGYCATPTERLLVYPYMSNGSVASRLREKPALDWNTRKR-----IAI---GAARGL 297
++ E LV +S GSV ++ A + IA GL
Sbjct: 75 IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 134
Query: 298 LYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGT-VGH-- 354
YLH+ IHRDVKA N+LL + + DFG++ L VR T VG
Sbjct: 135 EYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPC 191
Query: 355 -IAPEYLSTGQS-SEKTDVFGFGILLLELITG---------MRAL 388
+APE + + K D++ FGI +EL TG M+ L
Sbjct: 192 WMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVL 236
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 5e-25
Identities = 47/193 (24%), Positives = 78/193 (40%), Gaps = 22/193 (11%)
Query: 210 LGAGGFGNVYKGK-LGDGTVLAVKRL-KDMI----------------SLAVHRNLLRLIG 251
LG GGF ++ V A K + K ++ H++++ G
Sbjct: 49 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108
Query: 252 YCATPTERLLVYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHR 311
+ +V S+ + + AL + G YLH ++IHR
Sbjct: 109 FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRN---RVIHR 165
Query: 312 DVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDV 371
D+K N+ L++ E +GDFGLA +++ GT +IAPE LS S + DV
Sbjct: 166 DLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC-GTPNYIAPEVLSKKGHSFEVDV 224
Query: 372 FGFGILLLELITG 384
+ G ++ L+ G
Sbjct: 225 WSIGCIMYTLLVG 237
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 8e-25
Identities = 52/225 (23%), Positives = 91/225 (40%), Gaps = 35/225 (15%)
Query: 190 RNFTFRELQQATENFSSKNILGAGGFGNVYKGKLGDGTVLAVKRL-------KDMISL-- 240
N F+ + +S +G+GG V++ + A+K + + + S
Sbjct: 16 ENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRN 75
Query: 241 --AVHRNL-------LRLIGYCATPTERLLVYPYMSNGSVASRLREKPALDWNTRKRIAI 291
A L +RL Y T +V N + S L++K ++D RK
Sbjct: 76 EIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWK 134
Query: 292 GAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLL-DHSDSHVTTAVRG 350
+ +H+ I+H D+K AN L+ D ++ DFG+A + + S V + G
Sbjct: 135 NMLEAVHTIHQH---GIVHSDLKPANFLIVDGMLKLI-DFGIANQMQPDTTSVVKDSQVG 190
Query: 351 TVGHIAPEYL-----------STGQSSEKTDVFGFGILLLELITG 384
TV ++ PE + S + S K+DV+ G +L + G
Sbjct: 191 TVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYG 235
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 2e-24
Identities = 58/201 (28%), Positives = 83/201 (41%), Gaps = 24/201 (11%)
Query: 202 ENFSSKNILGAGGFGNVYKGK-LGDGTVLAVKRL-KDMI----------------SLAVH 243
E+F LG G FGNVY + +LA+K L K + S H
Sbjct: 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 68
Query: 244 RNLLRLIGYCATPTERLLVYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQ 303
N+LRL GY T L+ Y G+V L++ D A L Y H +
Sbjct: 69 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK 128
Query: 304 CDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGHIAPEYLSTG 363
++IHRD+K N+LL E + DFG + S GT+ ++ PE +
Sbjct: 129 ---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP-SSRRTDLC--GTLDYLPPEMIEGR 182
Query: 364 QSSEKTDVFGFGILLLELITG 384
EK D++ G+L E + G
Sbjct: 183 MHDEKVDLWSLGVLCYEFLVG 203
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 2e-24
Identities = 57/233 (24%), Positives = 94/233 (40%), Gaps = 59/233 (25%)
Query: 202 ENFSSKNILGAGGFGNVYKGKL------GDGTVLAVKRLKD----------------MIS 239
+N LG G FG V K T +AVK LK+ +
Sbjct: 23 KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQ 82
Query: 240 LAVHRNLLRLIGYCATPTERLLVYPYMSNGSVASRLREKPALDWNTRK------------ 287
+ H ++++L G C+ LL+ Y GS+ LRE +
Sbjct: 83 VN-HPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDH 141
Query: 288 ------------RIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAK 335
A ++G+ YL E K++HRD+ A N+L+ + + + DFGL++
Sbjct: 142 PDERALTMGDLISFAWQISQGMQYLAEM---KLVHRDLAARNILVAEGRKMKISDFGLSR 198
Query: 336 LLDHSDSHVTTA-----VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT 383
+ DS+V + V+ A E L + ++DV+ FG+LL E++T
Sbjct: 199 DVYEEDSYVKRSQGRIPVKWM----AIESLFDHIYTTQSDVWSFGVLLWEIVT 247
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 2e-24
Identities = 70/287 (24%), Positives = 110/287 (38%), Gaps = 55/287 (19%)
Query: 202 ENFSSKNILGAGGFGNVYKGK-LGDGTVLAVKRLK----------------DMISLAVHR 244
E++ +G G +G K + DG +L K L +++ H
Sbjct: 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65
Query: 245 NLLRLIGYCATPTERLL--VYPYMSNGSVASRLR----------EKPALDWNTRKRIAIG 292
N++R T L V Y G +AS + E+ L
Sbjct: 66 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRV------MTQ 119
Query: 293 AARGLLYLHEQCDP--KIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRG 350
L H + D ++HRD+K ANV LD +GDFGLA++L+H S T V G
Sbjct: 120 LTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFV-G 178
Query: 351 TVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQE 410
T +++PE ++ +EK+D++ G LL EL M S E KI++
Sbjct: 179 TPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFT-AFS------QKELAGKIREG 231
Query: 411 KKVEVLVDRELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRM 457
K R + Y E+ ++ HRP + E++
Sbjct: 232 KF------RRIPYRYSD----ELNEIITRMLNLKDYHRPSVEEILEN 268
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 4e-24
Identities = 59/282 (20%), Positives = 111/282 (39%), Gaps = 48/282 (17%)
Query: 202 ENFSSKNILGAGGFGNVYKGK-LGDGTVLAVK--RLKDMIS-------------LAV--H 243
NF + +G G F VY+ L DG +A+K ++ D++ L H
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91
Query: 244 RNLLRLIGYCATPTERLLVYPYMSNGSVASRLRE----KPALDWNTRKRIAIGAARGLLY 299
N+++ E +V G ++ ++ K + T + + L +
Sbjct: 92 PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEH 151
Query: 300 LHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGHIAPEY 359
+H + +++HRD+K ANV + +GD GL + + + V GT +++PE
Sbjct: 152 MHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPER 207
Query: 360 LSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDR 419
+ + K+D++ G LL E+ G +N + KKI+Q
Sbjct: 208 IHENGYNFKSDIWSLGCLLYEMAALQSPFY-GDKMN----LYSLCKKIEQ---------- 252
Query: 420 ELGSNYDRIEVG----EILQVALLCTQYLPVHRPKMSEVVRM 457
+Y + E+ Q+ +C P RP ++ V +
Sbjct: 253 ---CDYPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDV 291
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 5e-24
Identities = 48/227 (21%), Positives = 82/227 (36%), Gaps = 50/227 (22%)
Query: 201 TENFSSKNILGAGGFGNVYKG-KLGDGTVLAVKR--------------LKDMISLAV--- 242
T F +G+G FG+V+K K DG + A+KR L+++ + AV
Sbjct: 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69
Query: 243 HRNLLRLIGYCATPTERLLVYPYMSNGSVASRLRE----KPALDWNTRKRIAIGAARGLL 298
H +++R A L+ Y + GS+A + E K + + RGL
Sbjct: 70 HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLR 129
Query: 299 YLHEQCDPKIIHRDVKAANVLLD---------------DFCEAIV----GDFGLAKLLDH 339
Y+H ++H D+K +N+ + D+ V GD G +
Sbjct: 130 YIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISS 186
Query: 340 SDSHVTTAVRGTVGHIAPEYLSTGQS-SEKTDVFGFGILLLELITGM 385
G +A E L + K D+F + ++
Sbjct: 187 PQVEE-----GDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAE 228
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 6e-24
Identities = 51/215 (23%), Positives = 88/215 (40%), Gaps = 39/215 (18%)
Query: 202 ENFSSKNILGAGGFGNVYKGKLGDGTVLAVKRL-------KDMISL----AVHRNL---- 246
+S +G+GG V++ + A+K + + + S A L
Sbjct: 9 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 68
Query: 247 ---LRLIGYCATPTERLLVYPYM--SNGSVASRLREKPALDWNTRKRIAIGAARGLLYLH 301
+RL Y T +Y M N + S L++K ++D RK + +H
Sbjct: 69 DKIIRLYDYEITDQY---IYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIH 125
Query: 302 EQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLL-DHSDSHVTTAVRGTVGHIAPEYL 360
+ I+H D+K AN L+ D ++ DFG+A + + S V + GTV ++ PE +
Sbjct: 126 QH---GIVHSDLKPANFLIVDGMLKLI-DFGIANQMQPDTTSVVKDSQVGTVNYMPPEAI 181
Query: 361 -----------STGQSSEKTDVFGFGILLLELITG 384
S + S K+DV+ G +L + G
Sbjct: 182 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYG 216
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 6e-24
Identities = 51/201 (25%), Positives = 78/201 (38%), Gaps = 37/201 (18%)
Query: 210 LGAGGFGNVYKGK-LGDGTVLAVKRL-KDMI----------------SLAVHRNLLRLIG 251
LG G F VY+ + + G +A+K + K + H ++L L
Sbjct: 19 LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYN 78
Query: 252 YCATPTERLLVYPYMSNGSVASRLREKPALDWNTRKRIAIGAAR--------GLLYLHEQ 303
Y LV NG + L+ + K + AR G+LYLH
Sbjct: 79 YFEDSNYVYLVLEMCHNGEMNRYLKNR-------VKPFSENEARHFMHQIITGMLYLHSH 131
Query: 304 CDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGHIAPEYLSTG 363
I+HRD+ +N+LL + DFGLA L T GT +I+PE +
Sbjct: 132 ---GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLC-GTPNYISPEIATRS 187
Query: 364 QSSEKTDVFGFGILLLELITG 384
++DV+ G + L+ G
Sbjct: 188 AHGLESDVWSLGCMFYTLLIG 208
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 1e-23
Identities = 53/262 (20%), Positives = 96/262 (36%), Gaps = 42/262 (16%)
Query: 160 SGSANSVPLSFSLNSSPDKQEEGLISLGNLRNFTFRELQQATENFSSKN-------ILGA 212
S ++ + + + S + + A E S K +G+
Sbjct: 7 SSGLVPRGSGMKETAAAKFERQHMDSPDLGTDDDDKASSSANECISVKGRIYSILKQIGS 66
Query: 213 GGFGNVYKGKLGDGTVLAVKRL-------KDMISL----AVHRNL-------LRLIGYCA 254
GG V++ + A+K + + + S A L +RL Y
Sbjct: 67 GGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEI 126
Query: 255 TPTERLLVYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVK 314
T +V N + S L++K ++D RK + +H+ I+H D+K
Sbjct: 127 TDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLK 182
Query: 315 AANVLLDDFCEAIVGDFGLAKLL-DHSDSHVTTAVRGTVGHIAPEYLS-----------T 362
AN L+ D ++ DFG+A + + S V + G V ++ PE +
Sbjct: 183 PANFLIVDGMLKLI-DFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSK 241
Query: 363 GQSSEKTDVFGFGILLLELITG 384
+ S K+DV+ G +L + G
Sbjct: 242 SKISPKSDVWSLGCILYYMTYG 263
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 2e-23
Identities = 53/228 (23%), Positives = 92/228 (40%), Gaps = 47/228 (20%)
Query: 201 TENFSSKNILGAGGFGNVYKGK-LGDGTVLAVKRLK-------------DMISLAVHRNL 246
+F +LG G FG V K + D A+K+++ +++ H+ +
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYV 64
Query: 247 LRLIG-YCATPTERLLVYP------------YMSNGSVASRLREKPA-LDWNTRKRIAIG 292
+R + + Y NG++ + + + R+
Sbjct: 65 VRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQ 124
Query: 293 AARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHS------------ 340
L Y+H Q IIHRD+K N+ +D+ +GDFGLAK + S
Sbjct: 125 ILEALSYIHSQ---GIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLP 181
Query: 341 --DSHVTTAVRGTVGHIAPEYLS-TGQSSEKTDVFGFGILLLELITGM 385
++T+A+ GT ++A E L TG +EK D++ GI+ E+I
Sbjct: 182 GSSDNLTSAI-GTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPF 228
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 99.5 bits (248), Expect = 5e-23
Identities = 56/199 (28%), Positives = 97/199 (48%), Gaps = 21/199 (10%)
Query: 202 ENFSSKNILGAGGFGNVYKGKL-GDGTVLAVKRLKDMISLAVHRNLLRLIGY---CATP- 256
++F + LGAG G V+K G V+A K + I A+ ++R + C +P
Sbjct: 33 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 92
Query: 257 -----------TERLLVYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCD 305
E + +M GS+ L++ + +++I +GL YL E+
Sbjct: 93 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKH- 151
Query: 306 PKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGHIAPEYLSTGQS 365
KI+HRDVK +N+L++ E + DFG++ L DS + V GT +++PE L
Sbjct: 152 -KIMHRDVKPSNILVNSRGEIKLCDFGVSGQL--IDSMANSFV-GTRSYMSPERLQGTHY 207
Query: 366 SEKTDVFGFGILLLELITG 384
S ++D++ G+ L+E+ G
Sbjct: 208 SVQSDIWSMGLSLVEMAVG 226
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 6e-23
Identities = 57/213 (26%), Positives = 93/213 (43%), Gaps = 31/213 (14%)
Query: 201 TENFSSKNILGAGGFGNVYKGK-LGDGTVLAVKRLK------------DMISLAVHRNLL 247
E F LG G +G+VYK G ++A+K++ ++ +++
Sbjct: 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIKEISIMQQCDSPHVV 87
Query: 248 RLIGYCATPTERLLVYPYMSNGSVASRLREKPALDWNTRKRIAI---GAARGLLYLHEQC 304
+ G T+ +V Y GSV+ +R + T IA +GL YLH
Sbjct: 88 KYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKT--LTEDEIATILQSTLKGLEYLHFM- 144
Query: 305 DPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGHIAPEYLSTGQ 364
+ IHRD+KA N+LL+ A + DFG+A L + + T + GT +APE +
Sbjct: 145 --RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVI-GTPFWMAPEVIQEIG 201
Query: 365 SSEKTDVFGFGILLLELITG---------MRAL 388
+ D++ GI +E+ G MRA+
Sbjct: 202 YNCVADIWSLGITAIEMAEGKPPYADIHPMRAI 234
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 1e-22
Identities = 63/324 (19%), Positives = 114/324 (35%), Gaps = 105/324 (32%)
Query: 202 ENFSSKNILGAGGFGNVYKGKL------GDGTVLAVKRLKD---------------MISL 240
N +G G FG V++ + T++AVK LK+ +++
Sbjct: 47 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 106
Query: 241 AVHRNLLRLIGYCATPTERLLVYPYMSNGSVASRLRE-KPALDWNTRK------------ 287
+ N+++L+G CA L++ YM+ G + LR P +
Sbjct: 107 FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 166
Query: 288 -----------RIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKL 336
IA A G+ YL E+ K +HRD+ N L+ + + DFGL++
Sbjct: 167 GPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRN 223
Query: 337 LDHSDSHVTTAVRGTVGHI-----APEYLSTGQSSEKTDVFGFGILLLELITGMRALEFG 391
+ +D I PE + + + ++DV+ +G++L E+ + +G
Sbjct: 224 IYSAD----YYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS------YG 273
Query: 392 KS-----INQKGAMLEWVKKIQQEKKVEVLVDRELGSNYDRIEVG-----------EILQ 435
++ EV + G E+
Sbjct: 274 LQPYYGMAHE-----------------EV---------IYYVRDGNILACPENCPLELYN 307
Query: 436 VALLCTQYLPVHRPKMSEVVRMLE 459
+ LC LP RP + R+L+
Sbjct: 308 LMRLCWSKLPADRPSFCSIHRILQ 331
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 1e-22
Identities = 62/245 (25%), Positives = 103/245 (42%), Gaps = 49/245 (20%)
Query: 185 SLGNLRNFTFRELQQATENFSSKNILGAGGFGNVYKGK-LGDGTVLAVKRL-------KD 236
+L L+ F ++G G +G VYKG+ + G + A+K + ++
Sbjct: 7 PARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEE 66
Query: 237 MI-------SLAVHRNLLRLIG-----YCATPTERL-LVYPYMSNGSVA---SRLREKPA 280
+ + HRN+ G ++L LV + GSV +
Sbjct: 67 IKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTL 126
Query: 281 LDWNTRKRIAI---GAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLL 337
+ IA RGL +LH+ K+IHRD+K NVLL + E + DFG++ L
Sbjct: 127 ----KEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQL 179
Query: 338 DHSDSHVTTAVRGTVGHIAPEYLSTGQSSE-----KTDVFGFGILLLELITG-------- 384
D + T + GT +APE ++ ++ + K+D++ GI +E+ G
Sbjct: 180 DRTVGRRNTFI-GTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMH 238
Query: 385 -MRAL 388
MRAL
Sbjct: 239 PMRAL 243
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 99.1 bits (247), Expect = 2e-22
Identities = 58/241 (24%), Positives = 88/241 (36%), Gaps = 50/241 (20%)
Query: 186 LGNLRNFTFRELQQATENFSSKNILGAGGFGNVYKGKLGDGTVLAVKR-LKDMISLAV-- 242
+ N+ NF Q S+ ILG G G V G +AVKR L D +A+
Sbjct: 3 IANIPNFE----QSLKNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIALME 58
Query: 243 ---------HRNLLRLIGYCATPTERLLVYPYMSNGSVASRLREKPALDWNTRKRIAIGA 293
H N++R T + N ++ + K D N + +
Sbjct: 59 IKLLTESDDHPNVIRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNP 117
Query: 294 AR-------GLLYLHEQCDPKIIHRDVKAANVLLD-------------DFCEAIVGDFGL 333
G+ +LH KIIHRD+K N+L+ + ++ DFGL
Sbjct: 118 ISLLRQIASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGL 174
Query: 334 AKLLDHSDSHVTTAVR---GTVGHIAPEYLSTGQS-------SEKTDVFGFGILLLELIT 383
K LD S T + GT G APE L + + D+F G + +++
Sbjct: 175 CKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILS 234
Query: 384 G 384
Sbjct: 235 K 235
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 2e-22
Identities = 48/215 (22%), Positives = 89/215 (41%), Gaps = 35/215 (16%)
Query: 201 TENFSSKNILGAGGFGNVYKGK-LGDGTVLAVKRLK--------------DMISLAVHRN 245
+ ++ +G G G VY + G +A++++ ++ + N
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78
Query: 246 LLRLIGYCATPTERLLVYPYMSNGSVASRLREKPALDWNTRKRIAI---GAARGLLYLHE 302
++ + E +V Y++ GS+ + E +IA + L +LH
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCM----DEGQIAAVCRECLQALEFLHS 134
Query: 303 QCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGHIAPEYLST 362
++IHRD+K+ N+LL + DFG + S +T V GT +APE ++
Sbjct: 135 N---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTR 190
Query: 363 GQSSEKTDVFGFGILLLELITG---------MRAL 388
K D++ GI+ +E+I G +RAL
Sbjct: 191 KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRAL 225
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 97.9 bits (244), Expect = 2e-22
Identities = 45/216 (20%), Positives = 75/216 (34%), Gaps = 47/216 (21%)
Query: 210 LGAGGFGNVYKGKLGDGTVLAVKRLK-------------------------------DMI 238
L G F + + D A+K+ + +I
Sbjct: 39 LNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQII 97
Query: 239 SLAVHRNLLRLIGYCATPTERLLVYPYMSNGSVASRLREKPALDWNTRKRIAIGAAR--- 295
+ + L G E ++Y YM N S+ LD N I I +
Sbjct: 98 TDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCII 157
Query: 296 -----GLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRG 350
Y+H + + I HRDVK +N+L+D + DFG ++ + D + + G
Sbjct: 158 KSVLNSFSYIHNEKN--ICHRDVKPSNILMDKNGRVKLSDFGESEYMV--DKKIKGSR-G 212
Query: 351 TVGHIAPEYLST--GQSSEKTDVFGFGILLLELITG 384
T + PE+ S + K D++ GI L +
Sbjct: 213 TYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYN 248
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 96.1 bits (240), Expect = 2e-22
Identities = 52/193 (26%), Positives = 82/193 (42%), Gaps = 24/193 (12%)
Query: 210 LGAGGFGNVYKGK-LGDGTVLAVKRL-KDMI----------------SLAVHRNLLRLIG 251
LG G FGNVY + + ++A+K L K + S H N+LR+
Sbjct: 22 LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYN 81
Query: 252 YCATPTERLLVYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHR 311
Y L+ + G + L++ D A L Y HE+ K+IHR
Sbjct: 82 YFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHER---KVIHR 138
Query: 312 DVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDV 371
D+K N+L+ E + DFG + H+ S + GT+ ++ PE + EK D+
Sbjct: 139 DIKPENLLMGYKGELKIADFGWSV---HAPSLRRRTMCGTLDYLPPEMIEGKTHDEKVDL 195
Query: 372 FGFGILLLELITG 384
+ G+L E + G
Sbjct: 196 WCAGVLCYEFLVG 208
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 97.3 bits (242), Expect = 5e-22
Identities = 37/215 (17%), Positives = 64/215 (29%), Gaps = 41/215 (19%)
Query: 211 GAGGFGNVYKGK-LGDGTVLAVKRLK----------------DMISLAVHRNLLRLIGYC 253
G V + G + V+R+ + L H N++
Sbjct: 36 GFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATF 95
Query: 254 ATPTERLLVYPYMSNGSVASRLREKPALDWNTRKRIAI---GAARGLLYLHEQCDPKIIH 310
E +V +M+ GS + D IA G + L Y+H +H
Sbjct: 96 IADNELWVVTSFMAYGSAKDLICTHFM-DGMNELAIAYILQGVLKALDYIHHM---GYVH 151
Query: 311 RDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGHI------APEYLSTGQ 364
R VKA+++L+ + + + + +PE L
Sbjct: 152 RSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNL 211
Query: 365 S--SEKTDVFGFGILLLELITG---------MRAL 388
K+D++ GI EL G + L
Sbjct: 212 QGYDAKSDIYSVGITACELANGHVPFKDMPATQML 246
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 5e-22
Identities = 52/221 (23%), Positives = 92/221 (41%), Gaps = 40/221 (18%)
Query: 201 TENFSSKNILGAGGFGNVYKGK-LGDGTVLAVKRLK--------------DMISLAVHRN 245
E + LG G FG VYK K G + A K ++ ++++ H
Sbjct: 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPY 77
Query: 246 LLRLIGYCATPTERLLVYPYMSNGSVASRLREKP-ALDWNTRKRIAI---GAARGLLYLH 301
+++L+G + ++ + G+V + + E L T +I + L +LH
Sbjct: 78 IVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGL---TEPQIQVVCRQMLEALNFLH 134
Query: 302 EQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGHIAPEYLS 361
+ +IIHRD+KA NVL+ + + DFG++ + + + GT +APE +
Sbjct: 135 SK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFI-GTPYWMAPEVVM 190
Query: 362 TGQSSE-----KTDVFGFGILLLELITG---------MRAL 388
+ K D++ GI L+E+ MR L
Sbjct: 191 CETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVL 231
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 8e-22
Identities = 43/215 (20%), Positives = 85/215 (39%), Gaps = 35/215 (16%)
Query: 201 TENFSSKNILGAGGFGNVYKGK-LGDGTVLAVKRLK--------------DMISLAVHRN 245
S +G G G V + G +AVK + ++ H N
Sbjct: 44 RLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFN 103
Query: 246 LLRLIGYCATPTERLLVYPYMSNGSVASRLREKPALDWNTRKRIAI---GAARGLLYLHE 302
++ + E ++ ++ G++ + + ++IA + L YLH
Sbjct: 104 VVEMYKSYLVGEELWVLMEFLQGGALTDIVSQVRL----NEEQIATVCEAVLQALAYLHA 159
Query: 303 QCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGHIAPEYLST 362
Q +IHRD+K+ ++LL + DFG + + V GT +APE +S
Sbjct: 160 Q---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV-GTPYWMAPEVISR 215
Query: 363 GQSSEKTDVFGFGILLLELITG---------MRAL 388
+ + D++ GI+++E++ G ++A+
Sbjct: 216 SLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAM 250
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 95.6 bits (238), Expect = 8e-22
Identities = 50/215 (23%), Positives = 83/215 (38%), Gaps = 41/215 (19%)
Query: 210 LGAGGFGNVYKGK-LGDGTVLAVKRL---------------KDMISLAVHRNLLRLIGYC 253
L GGF VY+ + +G G A+KRL M L+ H N+++
Sbjct: 36 LAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAA 95
Query: 254 ATPTER-------LLVYPYMSNGSVAS---RLREKPALDWNTRKRIAIGAARGLLYLHEQ 303
+ E L+ + G + ++ + L +T +I R + ++H Q
Sbjct: 96 SIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQ 155
Query: 304 CDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTA-----------VRGTV 352
P IIHRD+K N+LL + + DFG A + H + +A T
Sbjct: 156 -KPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTP 214
Query: 353 GHIAPEYLSTGQS---SEKTDVFGFGILLLELITG 384
+ PE + + EK D++ G +L L
Sbjct: 215 MYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFR 249
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 94.2 bits (235), Expect = 1e-21
Identities = 49/195 (25%), Positives = 83/195 (42%), Gaps = 25/195 (12%)
Query: 210 LGAGGFGNVYKGKLGD---GTVLAVKRLK-----DMISLA------------VHRNLLRL 249
LG GG VY + D +A+K + +L H+N++ +
Sbjct: 19 LGGGGMSTVYLAE--DTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSM 76
Query: 250 IGYCATPTERLLVYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKII 309
I LV Y+ +++ + L +T G+ + H+ +I+
Sbjct: 77 IDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDM---RIV 133
Query: 310 HRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGHIAPEYLSTGQSSEKT 369
HRD+K N+L+D + DFG+AK L + T V GTV + +PE + E T
Sbjct: 134 HRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEATDECT 193
Query: 370 DVFGFGILLLELITG 384
D++ GI+L E++ G
Sbjct: 194 DIYSIGIVLYEMLVG 208
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 95.5 bits (237), Expect = 1e-21
Identities = 29/258 (11%), Positives = 64/258 (24%), Gaps = 71/258 (27%)
Query: 190 RNFTFR-ELQQATENFSSKNILGAGGFGNVYKGK-LGDGTVLAVKRLK------------ 235
+ F EL + +LG + G V
Sbjct: 60 QPFRVESELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQ 119
Query: 236 ------------------------------DMISLAVHRNLLRLIGYCATPT--ERLLVY 263
D++ + ++R+ R +Y
Sbjct: 120 MKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLY 179
Query: 264 PYMSN------GSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAAN 317
P M + + S +L + R ++ + R L LH ++H ++ +
Sbjct: 180 PRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVD 236
Query: 318 VLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGHIAPEYLSTGQS-----------S 366
++LD + F + G PE + + +
Sbjct: 237 IVLDQRGGVFLTGFEHLVRDGA-----RVVSSVSRGFEPPELEARRATISYHRDRRTLMT 291
Query: 367 EKTDVFGFGILLLELITG 384
D + G+++ +
Sbjct: 292 FSFDAWALGLVIYWIWCA 309
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 2e-21
Identities = 52/232 (22%), Positives = 95/232 (40%), Gaps = 36/232 (15%)
Query: 179 QEEGLISLGNLRNFTFRELQQATENFSSKNILGAGGFGNVYKGK-LGDGTVLAVKRL--- 234
+ G + + +++ F E+ +G G +G+V K G ++AVKR+
Sbjct: 4 ESSGKLKISPEQHWDFT-----AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRST 58
Query: 235 ------KDMI-------SLAVHRNLLRLIGYCATPTERLLVYPYMSNGSVASRLREKPAL 281
K ++ + +++ G + + M + S + ++
Sbjct: 59 VDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELM-STSFDKFYKYVYSV 117
Query: 282 DWNTRK-----RIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKL 336
+ +I + + L +L E KIIHRD+K +N+LLD + DFG++
Sbjct: 118 LDDVIPEEILGKITLATVKALNHLKENL--KIIHRDIKPSNILLDRSGNIKLCDFGISGQ 175
Query: 337 LDHSDSHVTTAVRGTVGHIAPEYLSTGQS----SEKTDVFGFGILLLELITG 384
L S + A G ++APE + S ++DV+ GI L EL TG
Sbjct: 176 LVDSIAKTRDA--GCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATG 225
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 94.0 bits (234), Expect = 2e-21
Identities = 48/212 (22%), Positives = 94/212 (44%), Gaps = 26/212 (12%)
Query: 195 RELQQATENFSSKNILGAGGFGNVYKGK-LGDGTVLAVKRLKDMISLAVHRNLLR----L 249
+ Q + + +G+G G V+K + G V+AVK+++ + ++ +L +
Sbjct: 18 QRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVV 77
Query: 250 IGYCATP------------TERLLVYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGL 297
+ P T+ + M + + R + + ++ + + L
Sbjct: 78 LKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKAL 137
Query: 298 LYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGHIAP 357
YL E+ +IHRDVK +N+LLD+ + + DFG++ L + +A G ++AP
Sbjct: 138 YYLKEK--HGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRSA--GCAAYMAP 193
Query: 358 EYLSTGQSSE-----KTDVFGFGILLLELITG 384
E + ++ + DV+ GI L+EL TG
Sbjct: 194 ERIDPPDPTKPDYDIRADVWSLGISLVELATG 225
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 95.1 bits (236), Expect = 3e-21
Identities = 26/232 (11%), Positives = 55/232 (23%), Gaps = 59/232 (25%)
Query: 209 ILGAGGFGNVYKGK-LGDGTVLAVKRLK-------------------------------- 235
+LG + G V
Sbjct: 85 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 144
Query: 236 ----------DMISLAVHRNLLRLIGYCATP--TERLLVYPYMSN------GSVASRLRE 277
D++ + ++R+ R +YP M + + S
Sbjct: 145 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 204
Query: 278 KPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLL 337
+L + R ++ + R L LH ++H ++ +++LD + F
Sbjct: 205 HKSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRD 261
Query: 338 DHSDSHVTTAVRGTVGHIAPEYLS-----TGQSSEKTDVFGFGILLLELITG 384
S A L + D + G+ + +
Sbjct: 262 GASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCA 313
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 3e-21
Identities = 51/202 (25%), Positives = 84/202 (41%), Gaps = 33/202 (16%)
Query: 210 LGAGGFGNVYKGKLGDGTVL----AVKRLK-----DMISLA------------VHRNLLR 248
LG GG V+ + D AVK L+ D H ++
Sbjct: 20 LGFGGMSEVHLAR--D-LRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVA 76
Query: 249 L--IGYCATPTERL--LVYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQC 304
+ G TP L +V Y+ ++ + + + + A + L + H+
Sbjct: 77 VYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQN- 135
Query: 305 DPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTT--AVRGTVGHIAPEYLST 362
IIHRDVK AN+++ V DFG+A+ + S + VT AV GT +++PE
Sbjct: 136 --GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARG 193
Query: 363 GQSSEKTDVFGFGILLLELITG 384
++DV+ G +L E++TG
Sbjct: 194 DSVDARSDVYSLGCVLYEVLTG 215
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 94.4 bits (234), Expect = 2e-20
Identities = 66/294 (22%), Positives = 106/294 (36%), Gaps = 45/294 (15%)
Query: 198 QQATENFSSKNILGAGGFGNVYKGK-LGDGTVLAVK--------RLKDMISLAV------ 242
Q + K LG GGFG V + G +A+K + ++ L +
Sbjct: 10 TQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKL 69
Query: 243 -HRNLLRLI------GYCATPTERLLVYPYMSNGSVASRLREK---PALDWNTRKRIAIG 292
H N++ A LL Y G + L + L + +
Sbjct: 70 NHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSD 129
Query: 293 AARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAI---VGDFGLAKLLDHSDSHVTTAVR 349
+ L YLHE +IIHRD+K N++L + + + D G AK LD T V
Sbjct: 130 ISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELD-QGELCTEFV- 184
Query: 350 GTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITG-------MRALEFGKSINQKGAM-- 400
GT+ ++APE L + + D + FG L E ITG + +++ + +K
Sbjct: 185 GTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHI 244
Query: 401 LEWVKKIQQEKKVEVLVDRELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEV 454
+ + K VL S ++ LQ L + R +
Sbjct: 245 VVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCML---MWHQRQRGTDPQN 295
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 2e-20
Identities = 24/140 (17%), Positives = 43/140 (30%), Gaps = 21/140 (15%)
Query: 19 SLSGTLSGSIGNLTNLRQVLLQNNNISGGIPPQ-LGSLPKLQTLDLSNNRLSGVIPALLF 77
+G L++L + + N+ P L L LDLS +L + P
Sbjct: 432 HTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAF- 490
Query: 78 LSIWLPRKWDKRKCSGVDQGLLRLNNNSLSGAFPVFLAKISELAFLDLSYNNLSGPVPKF 137
S + L +++N+ ++ L LD S N++ +
Sbjct: 491 -----------NSLSSLQV--LNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQE 537
Query: 138 PA------RTFNVAGNPLIC 151
N+ N C
Sbjct: 538 LQHFPSSLAFLNLTQNDFAC 557
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 5e-17
Identities = 30/187 (16%), Positives = 61/187 (32%), Gaps = 28/187 (14%)
Query: 19 SLSGTLSGSIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFL 78
L S S + L+ + L I SL L TL L+ N + +
Sbjct: 39 PLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAF-- 96
Query: 79 SIWLPRKWDKRKCSGVDQGLLRLNNNSLSGAFPVFLAKISELAFLDLSYNNL-SGPVPKF 137
S + + L +L+ + + L L++++N + S +P++
Sbjct: 97 ----------SGLSSLQK--LVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEY 144
Query: 138 PA-----RTFNVAGNPL--ICGSSSTNVCSGSANSVPLSFSLNSSPDKQEEGLISLGNLR 190
+ +++ N + I + + ++ L SLN I G +
Sbjct: 145 FSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNF------IQPGAFK 198
Query: 191 NFTFREL 197
+L
Sbjct: 199 EIRLHKL 205
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 7e-17
Identities = 24/119 (20%), Positives = 44/119 (36%), Gaps = 18/119 (15%)
Query: 19 SLSGTLSGSIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFL 78
S G S S T+L+ + L N + + L +L+ LD ++ L + +FL
Sbjct: 360 SFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFL 418
Query: 79 SIWLPRKWDKRKCSGVDQGL--LRLNNNSLSGAFPVFLAKISELAFLDLSYNNLSGPVP 135
S+ + L L +++ AF +S L L ++ N+
Sbjct: 419 SL---------------RNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFL 462
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 4e-13
Identities = 24/122 (19%), Positives = 40/122 (32%), Gaps = 22/122 (18%)
Query: 19 SLSGTLSGSIGNLTNLRQVLLQNNNIS--GGIPPQLGSLPKLQTLDLSNNRLSGVIPALL 76
S G + S +L +L + L N +S G L+ LDLS N + + L
Sbjct: 334 SNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSNFL 393
Query: 77 FLSIWLPRKWDKRKCSGVDQGL--LRLNNNSLSGAFPV-FLAKISELAFLDLSYNNLSGP 133
L L L +++L + L +LD+S+ +
Sbjct: 394 GLE-----------------QLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVA 436
Query: 134 VP 135
Sbjct: 437 FN 438
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 6e-13
Identities = 20/109 (18%), Positives = 31/109 (28%), Gaps = 24/109 (22%)
Query: 32 TNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFLSIWLPRKWDKRKC 91
+ + + L N + S P+LQ LDLS + +
Sbjct: 28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAY--------------- 72
Query: 92 SGVDQGL-----LRLNNNSLSGAFPVFLAKISELAFLDLSYNNLSGPVP 135
Q L L L N + + +S L L NL+
Sbjct: 73 ----QSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLEN 117
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 1e-11
Identities = 22/119 (18%), Positives = 35/119 (29%), Gaps = 15/119 (12%)
Query: 19 SLSGTLSGSIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFL 78
L + +L++L+ + + +NN L LQ LD S N + L
Sbjct: 481 QLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQH 540
Query: 79 SIWLPRKWDKRKCSGVDQGLLRLNNNSLSGAFPV--FLAKISELAFLDLSYNNLSGPVP 135
P L L N + FL I + L + + P
Sbjct: 541 ---FPSS----------LAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVERMECATP 586
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 5e-10
Identities = 17/141 (12%), Positives = 34/141 (24%), Gaps = 25/141 (17%)
Query: 19 SLSGTLSGSIGNLTNLRQVL----LQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPA 74
+ + L + + L N ++ I P +L L L NN S +
Sbjct: 160 KIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNF-IQPGAFKEIRLHKLTLRNNFDSLNVMK 218
Query: 75 LLF--------LSIWLPRKWDKRKCSGVDQGLL-----------RLNNNSLS-GAFPVFL 114
+ L ++ D+ L RL
Sbjct: 219 TCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLF 278
Query: 115 AKISELAFLDLSYNNLSGPVP 135
++ ++ L +
Sbjct: 279 NCLTNVSSFSLVSVTIERVKD 299
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 9e-09
Identities = 29/119 (24%), Positives = 38/119 (31%), Gaps = 17/119 (14%)
Query: 19 SLSGTLSGSIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLS--GVIPALL 76
L G L L + GG LP L+ LDLS N LS G
Sbjct: 310 ELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSD 369
Query: 77 FLSIWLPRKWDKRKCSGVDQGLLRLNNNSLSGAFPVFLAKISELAFLDLSYNNLSGPVP 135
F + L L L+ N + FL + +L LD ++NL
Sbjct: 370 FGTTSL--------------KYLDLSFNGVITMSSNFL-GLEQLEHLDFQHSNLKQMSE 413
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 1e-07
Identities = 26/131 (19%), Positives = 42/131 (32%), Gaps = 8/131 (6%)
Query: 8 NLVIGLGAPSQSLSGTLSGSIGNLTNLRQVLLQ---NNNISGGIPPQLGSLPKLQTLDLS 64
LV+G +L ++ L NL + + I L + + L
Sbjct: 231 RLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLV 290
Query: 65 NNRLSGVIPALLFLSIW----LPRKWDKRKCSGVDQGLLRLNNNSLSGAFPVFLAKISEL 120
+ + + + W L + + + L RL S G + L
Sbjct: 291 SVTIER-VKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSL 349
Query: 121 AFLDLSYNNLS 131
FLDLS N LS
Sbjct: 350 EFLDLSRNGLS 360
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 5e-20
Identities = 44/200 (22%), Positives = 80/200 (40%), Gaps = 35/200 (17%)
Query: 210 LGAGGFGNVYKGKLGDGTVL----AVKRLKDMISLA-------------------VHRNL 246
+G GG G+VY+ + D TV A+K + + +L+ ++
Sbjct: 42 VGRGGMGDVYEAE--D-TVRERIVALKLMSE--TLSSDPVFRTRMQREARTAGRLQEPHV 96
Query: 247 LRLIGYCATPTERLLVYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDP 306
+ + + + + ++ +A+ LR + L I L H
Sbjct: 97 VPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAA--- 153
Query: 307 KIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTT--AVRGTVGHIAPEYLSTGQ 364
HRDVK N+L+ A + DFG+A D +T GT+ ++APE S
Sbjct: 154 GATHRDVKPENILVSADDFAYLVDFGIASATT--DEKLTQLGNTVGTLYYMAPERFSESH 211
Query: 365 SSEKTDVFGFGILLLELITG 384
++ + D++ +L E +TG
Sbjct: 212 ATYRADIYALTCVLYECLTG 231
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 90.2 bits (224), Expect = 6e-20
Identities = 65/262 (24%), Positives = 106/262 (40%), Gaps = 50/262 (19%)
Query: 162 SANSVPLSFSLNSSPDKQEEGLISLGNLRNFTFRELQQATENFSSKNILGAGGFGNVYKG 221
+ ++ +++ P G + ++ F++ + FS +G G FG VY
Sbjct: 16 TTENLYFQGAMDPMPAGGRAGSLKDPDVAELFFKD--DPEKLFSDLREIGHGSFGAVYFA 73
Query: 222 K-LGDGTVLAVKRL-------KDMISLAV----------HRNLLRLIGYCATPTERLLVY 263
+ + + V+A+K++ + + H N ++ G LV
Sbjct: 74 RDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133
Query: 264 PYMSNGSVAS--RLREKPALDWNTRKRIAI---GAARGLLYLHEQCDPKIIHRDVKAANV 318
Y GS + + +KP IA GA +GL YLH +IHRDVKA N+
Sbjct: 134 EYCL-GSASDLLEVHKKPL----QEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNI 185
Query: 319 LLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGHIAPEYLSTGQSSE---KTDVFGFG 375
LL + +GDFG A ++ ++S V GT +APE + + K DV+ G
Sbjct: 186 LLSEPGLVKLGDFGSASIMAPANSFV-----GTPYWMAPEVILAMDEGQYDGKVDVWSLG 240
Query: 376 ILLLELITG---------MRAL 388
I +EL M AL
Sbjct: 241 ITCIELAERKPPLFNMNAMSAL 262
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 92.2 bits (229), Expect = 7e-20
Identities = 34/202 (16%), Positives = 67/202 (33%), Gaps = 40/202 (19%)
Query: 210 LGAGGFGNVYKGK---LGDGTVLAVKRLKD----------------MISLAVHRNLLRLI 250
+ GG G +Y + V +K L + + H +++++
Sbjct: 88 IAHGGLGWIYLALDRNVNGRPV-VLKGLVHSGDAEAQAMAMAERQFLAEVV-HPSIVQIF 145
Query: 251 GYCATPTERLLVYPYM-----SNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCD 305
+ Y+ S+ +K L + L YLH
Sbjct: 146 NFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK--LPVAEAIAYLLEILPALSYLHSI-- 201
Query: 306 PKIIHRDVKAANVLLDDFCEAI-VGDFGLAKLLDHSDSHVTTAVRGTVGHIAPEYLSTGQ 364
+++ D+K N++L + E + + D G ++ + GT G APE +
Sbjct: 202 -GLVYNDLKPENIMLTE--EQLKLIDLGAVSRINS-----FGYLYGTPGFQAPE-IVRTG 252
Query: 365 SSEKTDVFGFGILLLELITGMR 386
+ TD++ G L L +
Sbjct: 253 PTVATDIYTVGRTLAALTLDLP 274
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 89.7 bits (222), Expect = 1e-19
Identities = 24/241 (9%), Positives = 51/241 (21%), Gaps = 59/241 (24%)
Query: 196 ELQQATENFSSKNILGAGGFGNVYKGK-LGDGTVLAVK-----------------RLKDM 237
L Q L G V+ + + A+K
Sbjct: 56 LLSQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFA 115
Query: 238 ISLAVHRNLLRLIGYC--------------------------ATPTERLLVYPYMS---- 267
+ + + LL+ P S
Sbjct: 116 AARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLE 175
Query: 268 --NGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCE 325
++ + + R L + ++H N+ +
Sbjct: 176 LLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSK---GLVHGHFTPDNLFIMPDGR 232
Query: 326 AIVGDFGLAKLLDHSDSHVTTAVRGTVGHIAPEYL--STGQSSEKTDVFGFGILLLELIT 383
++GD A V + E+L ST + + + G+ + +
Sbjct: 233 LMLGDVSAL----WKVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWC 288
Query: 384 G 384
Sbjct: 289 L 289
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 2e-19
Identities = 45/217 (20%), Positives = 85/217 (39%), Gaps = 48/217 (22%)
Query: 202 ENFSSKNILGAGGFGNVYKGK-LGDGTVLAVKRLKDMISLAVHRNLLRLIG--------- 251
++ LG G +G V K + + G ++AVKR++ ++ + LL +
Sbjct: 7 DDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCP 66
Query: 252 --------------------YCATPTERLLVYPYMSNGSVASRLREKPALDWNTRKRIAI 291
T ++ + E +IA+
Sbjct: 67 FTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQ----TIPEDIL------GKIAV 116
Query: 292 GAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGT 351
+ L +LH + +IHRDVK +NVL++ + + DFG++ L + A G
Sbjct: 117 SIVKALEHLHSKL--SVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDA--GC 172
Query: 352 VGHIAPEYLSTGQS----SEKTDVFGFGILLLELITG 384
++APE ++ + S K+D++ GI ++EL
Sbjct: 173 KPYMAPERINPELNQKGYSVKSDIWSLGITMIELAIL 209
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 2e-19
Identities = 26/122 (21%), Positives = 47/122 (38%), Gaps = 11/122 (9%)
Query: 19 SLSGTLSGSIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFL 78
T NL +L V + N +P L +LP++Q ++++ NR
Sbjct: 236 QQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDW 295
Query: 79 SIWLPRKWDKRKCSGVDQGL--LRLNNNSL-SGAFPVFLAKISELAFLDLSYNNLSGPVP 135
+ V + + + + N+L + L K+ +L L+ YN L G +P
Sbjct: 296 QALAD--------APVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLP 347
Query: 136 KF 137
F
Sbjct: 348 AF 349
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 2e-16
Identities = 20/158 (12%), Positives = 42/158 (26%), Gaps = 25/158 (15%)
Query: 17 SQSLSGTLSGSIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALL 76
S ++ S Q+ +NNI+ + + L KL+ + N+
Sbjct: 168 SDPQQKSIKKSSRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEA 226
Query: 77 FLSIWLPRKWDKRKCSGVDQGLLRLNNNSLSGAFPVFLAKISELAFLDLSYNNLSGPVPK 136
+ + + +L +++ +P
Sbjct: 227 WE-------------------NENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPT 267
Query: 137 FPA-----RTFNVAGNPLICGSSSTNVCSGSANSVPLS 169
F + NVA N I G + A++
Sbjct: 268 FLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGE 305
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 7e-16
Identities = 19/123 (15%), Positives = 36/123 (29%), Gaps = 20/123 (16%)
Query: 13 LGAPSQSLSGTLSGSIGNLTNLRQVLLQNNNISGG-IPPQLGSLPKLQTLDLSNNRLSGV 71
+ ++ + + NN+ + L + KL L+ N+L G
Sbjct: 286 ISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGK 345
Query: 72 IPALLFLSIWLPRKWDKRKCSGVDQGL--LRLNNNSLSGAFPVFLAKISELAFLDLSYNN 129
+PA L L L N ++ F ++ L ++N
Sbjct: 346 LPAFGSEI-----------------KLASLNLAYNQITEIPANFCGFTEQVENLSFAHNK 388
Query: 130 LSG 132
L
Sbjct: 389 LKY 391
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 7e-16
Identities = 29/170 (17%), Positives = 52/170 (30%), Gaps = 26/170 (15%)
Query: 17 SQSLSGTLSGSIGNLTNLRQVLLQNNNISGGIPP--QLGSLPKLQTLDLSNNRLSGVIPA 74
++ + + N L + L+ N ++ + + +LP L +DLS N S P
Sbjct: 473 PKNSLKDENENFKNTYLLTSIDLRFNKLTK-LSDDFRATTLPYLVGIDLSYNSFSK-FPT 530
Query: 75 LLFLSIWLPRKWDKRKCSGVDQGL-----LRLNNNSLSGAFPVFLAKISELAFLDLSYNN 129
S L +G N +P + L L + N+
Sbjct: 531 QPLNSSTL-------------KGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSND 577
Query: 130 LSGPVPKFPA--RTFNVAGNPLICGSSSTNVCSGSANSVPLSFSLNSSPD 177
+ K ++ NP I S VC + + + D
Sbjct: 578 IRKVNEKITPNISVLDIKDNPNISIDLS-YVCPYIEAGM-YMLFYDKTQD 625
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 6e-15
Identities = 25/202 (12%), Positives = 53/202 (26%), Gaps = 38/202 (18%)
Query: 2 ITCSPENLVIGLGAPSQSLSGTLSGSIGNLTNLRQVLLQNNNISGG----IPPQLGSLPK 57
++ + V GL SG + +IG LT L + L ++ P + +
Sbjct: 75 VSLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMS 134
Query: 58 LQTLDLSNNRLSGVIPALLFLSIWLPRKWDKRKCSGVDQGLLRLNNNSLSGAFPVFLAKI 117
+ + D +N++ +
Sbjct: 135 DEQKQKMRMHYQKTFVDYDPREDFS------------DLIKDCINSDPQQKSIKKSSRIT 182
Query: 118 SELAFLDLSYNNLSGPVPKFPA--------RTFNVAGNPLICGSSSTNVCSGSANSVPLS 169
+ + NN++ R F + +P + N+C N
Sbjct: 183 LKDTQIGQLSNNITF----VSKAVMRLTKLRQFYMGNSPF----VAENICEAWENENSEY 234
Query: 170 FSLNSSPDKQEEGLISLGNLRN 191
+ D + NL++
Sbjct: 235 AQQYKTED------LKWDNLKD 250
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 1e-14
Identities = 22/125 (17%), Positives = 44/125 (35%), Gaps = 23/125 (18%)
Query: 19 SLSGTLSGSIGNLTNLRQVLLQNNNISGGIPPQL-GSLPKLQTLDLSNNRLSGVIPALLF 77
L G L + G+ L + L N I+ IP G +++ L ++N+L IP +
Sbjct: 341 QLEGKLP-AFGSEIKLASLNLAYNQITE-IPANFCGFTEQVENLSFAHNKLKY-IPNIFD 397
Query: 78 LSIWLPRKWDKRKCSGVDQGLLRLNNNSLSGAFPVFLAKISE-------LAFLDLSYNNL 130
+ S + + + N + + ++ ++LS N +
Sbjct: 398 A----------KSVSVM--SAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQI 445
Query: 131 SGPVP 135
S
Sbjct: 446 SKFPK 450
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 4e-14
Identities = 24/121 (19%), Positives = 42/121 (34%), Gaps = 8/121 (6%)
Query: 13 LGAPSQSLSGTLSGSIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVI 72
+G+ L + N+ + L NN IS + L +++L N L+ I
Sbjct: 414 IGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTE-I 472
Query: 73 PALLFLSIWLPRKWDKRKCSGVDQGLLRLNNNSLSGAFP-VFLAKISELAFLDLSYNNLS 131
P + + + + L N L+ + L +DLSYN+ S
Sbjct: 473 PKNSLKDENE----NFKNTYLLTS--IDLRFNKLTKLSDDFRATTLPYLVGIDLSYNSFS 526
Query: 132 G 132
Sbjct: 527 K 527
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 88.8 bits (220), Expect = 9e-19
Identities = 57/205 (27%), Positives = 89/205 (43%), Gaps = 28/205 (13%)
Query: 202 ENFSSKNILGAGGFGNVYKG-KLGDGTVLAVKRL-KDMI-------SLAVHRNLLRLIGY 252
+FS I+G GGFG VY K G + A+K L K I R +L L+
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 248
Query: 253 CATP-----------TERL-LVYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYL 300
P ++L + M+ G + L + + A GL ++
Sbjct: 249 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHM 308
Query: 301 HEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGHIAPEYL 360
H + +++RD+K AN+LLD+ + D GLA H +V GT G++APE L
Sbjct: 309 HNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH--ASV-GTHGYMAPEVL 362
Query: 361 STGQSSEKT-DVFGFGILLLELITG 384
G + + + D F G +L +L+ G
Sbjct: 363 QKGVAYDSSADWFSLGCMLFKLLRG 387
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 86.0 bits (213), Expect = 1e-18
Identities = 42/220 (19%), Positives = 81/220 (36%), Gaps = 38/220 (17%)
Query: 198 QQATENFSSKNILGAGGFGNVYKGK-LGDGTVLAVK-----RLKDMISLAV--------- 242
+ + +ILG G NV++G+ G + A+K + + +
Sbjct: 5 STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKL 64
Query: 243 -HRNLLRLIGYCATPTERL--LVYPYMSNGSVASRLREK---PALDWNTRKRIAIGAARG 296
H+N+++L T R L+ + GS+ + L E L + + G
Sbjct: 65 NHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGG 124
Query: 297 LLYLHEQCDPKIIHRDVKAANVLLDDFCEAI----VGDFGLAKLLDHSDSHVTTAVRGTV 352
+ +L E I+HR++K N++ + + DFG A+ L+ D + GT
Sbjct: 125 MNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE-DDEQFVSLY-GTE 179
Query: 353 GHIAPEYLSTGQS--------SEKTDVFGFGILLLELITG 384
++ P+ D++ G+ TG
Sbjct: 180 EYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATG 219
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 85.7 bits (212), Expect = 3e-18
Identities = 42/220 (19%), Positives = 81/220 (36%), Gaps = 38/220 (17%)
Query: 198 QQATENFSSKNILGAGGFGNVYKGK-LGDGTVLAVK-----RLKDMISLAV--------- 242
+ + +ILG G NV++G+ G + A+K + + +
Sbjct: 5 STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKL 64
Query: 243 -HRNLLRLIGYCATPTERL--LVYPYMSNGSVASRLREK---PALDWNTRKRIAIGAARG 296
H+N+++L T R L+ + GS+ + L E L + + G
Sbjct: 65 NHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGG 124
Query: 297 LLYLHEQCDPKIIHRDVKAANVLLDDFCEAI----VGDFGLAKLLDHSDSHVTTAVRGTV 352
+ +L E I+HR++K N++ + + DFG A+ L+ D + GT
Sbjct: 125 MNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE-DDEQFVSLY-GTE 179
Query: 353 GHIAPEYLSTGQS--------SEKTDVFGFGILLLELITG 384
++ P+ D++ G+ TG
Sbjct: 180 EYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATG 219
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 85.6 bits (212), Expect = 9e-18
Identities = 61/237 (25%), Positives = 93/237 (39%), Gaps = 30/237 (12%)
Query: 171 SLNSSPDKQEEGLISLGNLRNFTFRELQQAT-ENFSSKNILGAGGFGNVYKGKL-GDGTV 228
L+ +P I + + E Q T F +LG GGFG V ++ G +
Sbjct: 152 YLSVAPFADYLDSIYFNRFLQWKWLERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKM 211
Query: 229 LAVKRL-KDMI-------SLAVHRNLLRLIG--------YCATPTERL-LVYPYMSNGSV 271
A K+L K I + +L + Y + L LV M+ G +
Sbjct: 212 YACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDL 271
Query: 272 ASRLREKPALDWNTRKRIAIGAAR---GLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIV 328
+ + R AA GL LH + +I++RD+K N+LLDD +
Sbjct: 272 KFHIYHMGQAGF-PEARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRI 327
Query: 329 GDFGLAKLLDHSDSHVTTAVRGTVGHIAPEYLSTGQSSEKT-DVFGFGILLLELITG 384
D GLA + GTVG++APE + + + D + G LL E+I G
Sbjct: 328 SDLGLAV--HVPEGQTIKGRVGTVGYMAPEVV-KNERYTFSPDWWALGCLLYEMIAG 381
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 83.4 bits (206), Expect = 1e-17
Identities = 27/103 (26%), Positives = 45/103 (43%), Gaps = 14/103 (13%)
Query: 296 GLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVR------ 349
+ +LH + ++HRD+K +N+ VGDFGL +D + T
Sbjct: 176 AVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYAT 232
Query: 350 -----GTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRA 387
GT +++PE + S K D+F G++L EL+
Sbjct: 233 HTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFST 275
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 84.4 bits (209), Expect = 2e-17
Identities = 60/217 (27%), Positives = 92/217 (42%), Gaps = 29/217 (13%)
Query: 192 FTFRELQQAT-ENFSSKNILGAGGFGNVYKGKL-GDGTVLAVKRL-KDMI-------SLA 241
+ + E Q + F +LG GGFG V+ ++ G + A K+L K +
Sbjct: 174 WKWLEAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAM 233
Query: 242 VHRNLLRLIG--------YC-ATPTERLLVYPYMSNGSVASRLREKPALDWN-TRKRIAI 291
V + +L + Y T T+ LV M+ G + + + R
Sbjct: 234 VEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIF 293
Query: 292 GAAR---GLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAV 348
A+ GL +LH++ II+RD+K NVLLDD + D GLA L +
Sbjct: 294 YTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYA 350
Query: 349 RGTVGHIAPEYLSTGQSSEKT-DVFGFGILLLELITG 384
GT G +APE L G+ + + D F G+ L E+I
Sbjct: 351 -GTPGFMAPELL-LGEEYDFSVDYFALGVTLYEMIAA 385
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 83.4 bits (206), Expect = 6e-17
Identities = 26/118 (22%), Positives = 41/118 (34%), Gaps = 10/118 (8%)
Query: 19 SLSGTLSGSIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFL 78
S NL +L V L N +P L LP+LQ+L+++ NR
Sbjct: 478 KQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADW 537
Query: 79 SIWLPRKWDKRKCSGVDQGL--LRLNNNSLSG-AFPVFLAKISELAFLDLSYNNLSGP 133
+ L D + + N+L L K+ +L LD +N +
Sbjct: 538 TR-LADDEDTGPK------IQIFYMGYNNLEEFPASASLQKMVKLGLLDCVHNKVRHL 588
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 78.4 bits (193), Expect = 2e-15
Identities = 28/162 (17%), Positives = 52/162 (32%), Gaps = 14/162 (8%)
Query: 17 SQSLSGTLSGSIGNLTNLRQVLLQNNNISGGIPPQL--GSLPKLQTLDLSNNRLSGVIPA 74
++ G+ N L + L+ N ++ + +LP L +D+S N S P
Sbjct: 713 PENSLKPKDGNYKNTYLLTTIDLRFNKLTS-LSDDFRATTLPYLSNMDVSYNCFSS-FPT 770
Query: 75 LLFLSIWLPRKWDKRKCSGVDQGLLRLNNNSLSGAFPVFLAKISELAFLDLSYNNLSG-P 133
S L + + R N + +P + L L + N++
Sbjct: 771 QPLNSSQL-KAFGIR-------HQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDIRKVD 822
Query: 134 VPKFPA-RTFNVAGNPLICGSSSTNVCSGSANSVPLSFSLNS 174
P ++A NP I ++ A L +
Sbjct: 823 EKLTPQLYILDIADNPNISIDVTSVCPYIEAGMYVLLYDKTQ 864
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 71.8 bits (176), Expect = 3e-13
Identities = 20/126 (15%), Positives = 38/126 (30%), Gaps = 11/126 (8%)
Query: 27 SIGNLTNLRQVLLQNNNISG------GIPPQLGSLPKLQTLDLSNNRLSGVIPALLFLSI 80
+ + ++ L++ I I + L KLQ + +N+ + A+ +
Sbjct: 413 EMKPIKKDSRISLKDTQIGNLTNRITFISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDA 472
Query: 81 WLPRKWDKRKCSGVDQGL-----LRLNNNSLSGAFPVFLAKISELAFLDLSYNNLSGPVP 135
L + L N P FL + EL L+++ N
Sbjct: 473 NSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQ 532
Query: 136 KFPART 141
T
Sbjct: 533 LKADWT 538
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 67.6 bits (165), Expect = 5e-12
Identities = 13/106 (12%), Positives = 28/106 (26%), Gaps = 13/106 (12%)
Query: 27 SIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFLSIWLPRKW 86
+ N + + L G +P +G L +L+ L + + +
Sbjct: 318 DLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTP---- 373
Query: 87 DKRKCSGVDQGLLRLNNNSLSGAFPVFLAKISELAFLDLSYNNLSG 132
+ +FL L DL + ++
Sbjct: 374 ---------DMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINR 410
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 66.8 bits (163), Expect = 8e-12
Identities = 23/143 (16%), Positives = 45/143 (31%), Gaps = 27/143 (18%)
Query: 16 PSQSLSGTLSGSIGNLTNLRQVLLQNNNISG-GIPPQLGSLPKLQTLDLSNNRLSGVIPA 74
++ L+ ++ + NN+ L + KL LD +N++ + A
Sbjct: 532 QLKADWTRLADDEDTGPKIQIFYMGYNNLEEFPASASLQKMVKLGLLDCVHNKVR-HLEA 590
Query: 75 LLFLSIWLPRKWDKRKCSGVDQGL--LRLNNNSLSGAFPVFLAKISELAFLDLSYNNLSG 132
L L+L+ N + F A ++ L S+N L
Sbjct: 591 FGTNV-----------------KLTDLKLDYNQIEEIPEDFCAFTDQVEGLGFSHNKLKY 633
Query: 133 PVPKFPA------RTFNVAGNPL 149
F A + + + N +
Sbjct: 634 IPNIFNAKSVYVMGSVDFSYNKI 656
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 63.7 bits (155), Expect = 9e-11
Identities = 16/120 (13%), Positives = 30/120 (25%), Gaps = 26/120 (21%)
Query: 25 SGSIGNLTNLRQVLLQNNNISG-----GIPPQLGSLPKLQTLDLSNNRLSGVIPALLFLS 79
+ ++ + V N I T+ LS N + L
Sbjct: 637 IFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATG 696
Query: 80 IWLPRKWDKRKCSGVDQGLLRLNNNSLS-------GAFPVFLAKISELAFLDLSYNNLSG 132
+ + L+NN ++ L +DL +N L+
Sbjct: 697 SPI--------------STIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKLTS 742
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 62.2 bits (151), Expect = 2e-10
Identities = 22/112 (19%), Positives = 35/112 (31%), Gaps = 14/112 (12%)
Query: 25 SGSIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFLSIWLPR 84
S N V L N I + + T+ LSNN ++ + L +
Sbjct: 666 SMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYK 725
Query: 85 KWDKRKCSGVDQGL--LRLNNNSLSGAFP--VFLAKISELAFLDLSYNNLSG 132
L + L N L+ + L+ +D+SYN S
Sbjct: 726 NT---------YLLTTIDLRFNKLTS-LSDDFRATTLPYLSNMDVSYNCFSS 767
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 61.8 bits (150), Expect = 3e-10
Identities = 20/148 (13%), Positives = 33/148 (22%), Gaps = 54/148 (36%)
Query: 23 TLSGSIGNLTNLR------QVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALL 76
+ N + L+ Q + N I P + + P L L + +N + V L
Sbjct: 767 SFPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDIRKVDEKLT 826
Query: 77 FLSIWLPRKWDKRKCSGVDQGLLRLNNNSLSGAFPVFLAKISELAFLDLSYNNL-SGPVP 135
+L LD++ N S V
Sbjct: 827 -----------------------------------------PQLYILDIADNPNISIDVT 845
Query: 136 KFP------ARTFNVAGNPLICGSSSTN 157
I G +
Sbjct: 846 SVCPYIEAGMYVLLYDKTQDIRGCDALG 873
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 56.8 bits (137), Expect = 1e-08
Identities = 17/165 (10%), Positives = 44/165 (26%), Gaps = 17/165 (10%)
Query: 2 ITCSPENLVIGLGAPSQSLSGTLSGSIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTL 61
+ V GL G + +IG LT L+ + ++ +
Sbjct: 317 VDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMS 376
Query: 62 DLSNNRLSGVIPALLF--------------LSIWLPRKWDKRKCSGVDQGLLRLNN--NS 105
+ +R+ + P +K S + ++ N N
Sbjct: 377 EERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNR 436
Query: 106 LSGAFPVFLAKISELAFLDLSYNNLSGPVPKFPARTFNVAGNPLI 150
++ + ++++L + + + + N
Sbjct: 437 ITF-ISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQY 480
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 81.3 bits (201), Expect = 1e-16
Identities = 57/213 (26%), Positives = 86/213 (40%), Gaps = 31/213 (14%)
Query: 197 LQQATENFSSK----NILGAGGFGNVYKGK-LGDGTVLAVKRL-KDMISLAV-------- 242
+Q +T FS + +LG G FG V K G AVK + K +
Sbjct: 17 VQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLRE 76
Query: 243 --------HRNLLRLIGYCATPTERLLVYPYMSNGSVASRLREKPALDWNTRKRIAIGAA 294
H N+++L + LV + G + + + RI
Sbjct: 77 VQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVL 136
Query: 295 RGLLYLHEQCDPKIIHRDVKAANVLL---DDFCEAIVGDFGLAKLLDHSDSHVTTAVRGT 351
G+ Y+H+ KI+HRD+K N+LL + DFGL+ + S GT
Sbjct: 137 SGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKI--GT 191
Query: 352 VGHIAPEYLSTGQSSEKTDVFGFGILLLELITG 384
+IAPE L G EK DV+ G++L L++G
Sbjct: 192 AYYIAPEVLH-GTYDEKCDVWSTGVILYILLSG 223
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 2e-16
Identities = 25/118 (21%), Positives = 42/118 (35%), Gaps = 12/118 (10%)
Query: 19 SLSGTLSGSIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFL 78
S+ + NL + L +N +S L LQ L LSNN++ + L +
Sbjct: 108 SIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDI 167
Query: 79 SIWLPRKWDKRKCSGVDQGLLRLNNNSLSGAFPVFLAKISELAFLDLSYNNLSGPVPK 136
S + + L L++N + P I L L L+ L + +
Sbjct: 168 F----------ANSSLKK--LELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTE 213
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 2e-15
Identities = 26/147 (17%), Positives = 46/147 (31%), Gaps = 28/147 (19%)
Query: 19 SLSGTLSGSIGNLTNLRQVLLQNNNIS--------GGIPPQLGSLPKLQTLDLSNNRLSG 70
+++ + L L + LQ+NN++ GG L L L L+L +N
Sbjct: 491 NIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDE 550
Query: 71 VIPALLFLSIWLPRKWDKRKCSGVDQGLLRLNNNSLSGAFPVFLAKISELAFLDLSYNNL 130
+ + L + L N+L+ L L+L N +
Sbjct: 551 IPVEVFKDLFELKI--------------IDLGLNNLNTLPASVFNNQVSLKSLNLQKNLI 596
Query: 131 SGPVPKFPA------RTFNVAGNPLIC 151
+ K ++ NP C
Sbjct: 597 TSVEKKVFGPAFRNLTELDMRFNPFDC 623
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 2e-15
Identities = 28/117 (23%), Positives = 43/117 (36%), Gaps = 14/117 (11%)
Query: 19 SLSGTLSGSIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFL 78
L + + + L + + N IS P LP L+ L+L +N LS +
Sbjct: 36 QLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTF-- 93
Query: 79 SIWLPRKWDKRKCSGVDQGLLRLNNNSLSGAFPVFLAKISELAFLDLSYNNLSGPVP 135
C+ + + L L +NS+ K L LDLS+N LS
Sbjct: 94 ----------AFCTNLTE--LHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKL 138
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 2e-14
Identities = 26/124 (20%), Positives = 41/124 (33%), Gaps = 12/124 (9%)
Query: 13 LGAPSQSLSGTLSGSIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGV- 71
SL S L L + +++N+I G L L+ L LSN+ S
Sbjct: 310 QSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRT 369
Query: 72 IPALLFLSIWLPRKWDKRKCSGVDQGLLRLNNNSLSGAFPVFLAKISELAFLDLSYNNLS 131
+ F+S+ L L N +S + + L LDL N +
Sbjct: 370 LTNETFVSLAHSPLHI-----------LNLTKNKISKIESDAFSWLGHLEVLDLGLNEIG 418
Query: 132 GPVP 135
+
Sbjct: 419 QELT 422
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 2e-14
Identities = 23/132 (17%), Positives = 38/132 (28%), Gaps = 31/132 (23%)
Query: 19 SLSGTLSGSIGNLTNLRQVLLQNNNISGGIPPQ-LGSLPKLQTLDLSNNRLSGVIPALLF 77
+S S + L +L + L N I + Q L + + LS N+ +
Sbjct: 392 KISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSF- 450
Query: 78 LSIWLPRKWDKRKCSGVDQGL-----LRLNNNSLSG--AFPVFLAKISELAFLDLSYNNL 130
+ L L +L + P + L LDLS NN+
Sbjct: 451 ------------------ALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNI 492
Query: 131 SGPVPKFPARTF 142
+
Sbjct: 493 AN----INDDML 500
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 1e-13
Identities = 30/121 (24%), Positives = 43/121 (35%), Gaps = 16/121 (13%)
Query: 22 GTLSGSIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFLSIW 81
+ L NL + L NNNI+ L L KL+ LDL +N L+
Sbjct: 470 DSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLA-----------R 518
Query: 82 LPRKWDKRKCSGVDQGL-----LRLNNNSLSGAFPVFLAKISELAFLDLSYNNLSGPVPK 136
L + + +GL L L +N + EL +DL NNL+
Sbjct: 519 LWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPAS 578
Query: 137 F 137
Sbjct: 579 V 579
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 1e-13
Identities = 27/119 (22%), Positives = 42/119 (35%), Gaps = 23/119 (19%)
Query: 19 SLSGTLSGS-IGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLF 77
+ L+G L N+ ++ L N +P LQ L L L V +
Sbjct: 416 EIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSP 475
Query: 78 LSIWLPRKWDKRKCSGVDQGL-----LRLNNNSLSGAFPVFLAKISELAFLDLSYNNLS 131
Q L L L+NN+++ L + +L LDL +NNL+
Sbjct: 476 F-----------------QPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLA 517
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 5e-13
Identities = 21/118 (17%), Positives = 40/118 (33%), Gaps = 15/118 (12%)
Query: 16 PSQSLSGTLSGSIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPAL 75
+ G + L++L + L++N L +L+ +DL N L+ + ++
Sbjct: 520 WKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASV 579
Query: 76 LFLSIWLPRKWDKRKCSGVDQGLLRLNNNSLSGAFP-VFLAKISELAFLDLSYNNLSG 132
+ L L L N ++ VF L LD+ +N
Sbjct: 580 FNNQVSLKS--------------LNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDC 623
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 2e-12
Identities = 25/135 (18%), Positives = 43/135 (31%), Gaps = 21/135 (15%)
Query: 19 SLSGTLSGSIGNL--TNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPA-- 74
LS T + + L TNL + L NN++ LP+L+ L N + +
Sbjct: 233 QLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSL 292
Query: 75 --------LLFLSIWLPRKWDKRKCSGVDQGL---------LRLNNNSLSGAFPVFLAKI 117
L + + +D L + +N + G +
Sbjct: 293 HGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGL 352
Query: 118 SELAFLDLSYNNLSG 132
L +L LS + S
Sbjct: 353 INLKYLSLSNSFTSL 367
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 3e-12
Identities = 19/105 (18%), Positives = 29/105 (27%), Gaps = 17/105 (16%)
Query: 30 NLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFLSIWLPRKWDKR 89
+ L + L N IS L L+ LDL N + + + L
Sbjct: 379 AHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRG--LEN----- 431
Query: 90 KCSGVDQGL--LRLNNNSLSGAFPVFLAKISELAFLDLSYNNLSG 132
+ + L+ N A + L L L L
Sbjct: 432 --------IFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKN 468
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 2e-11
Identities = 23/110 (20%), Positives = 36/110 (32%), Gaps = 24/110 (21%)
Query: 31 LTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFLSIWLPRKWDKRK 90
TN+ + L +N + +L +LD+ N +S + P L
Sbjct: 24 PTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELC-------------- 69
Query: 91 CSGVDQGL-----LRLNNNSLSGAFPVFLAKISELAFLDLSYNNLSGPVP 135
Q L L L +N LS A + L L L N++
Sbjct: 70 -----QKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKN 114
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 4e-08
Identities = 13/65 (20%), Positives = 26/65 (40%), Gaps = 1/65 (1%)
Query: 19 SLSGTLSGSIGNLTNLRQVLLQNNNISGGIPPQLG-SLPKLQTLDLSNNRLSGVIPALLF 77
+L+ + N +L+ + LQ N I+ G + L LD+ N ++ +
Sbjct: 571 NLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCESIAW 630
Query: 78 LSIWL 82
W+
Sbjct: 631 FVNWI 635
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 51.5 bits (124), Expect = 4e-07
Identities = 19/104 (18%), Positives = 38/104 (36%), Gaps = 17/104 (16%)
Query: 32 TNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFLSIWLPRKWDKRKC 91
+ + ++ +P L + L+L++N+L + A +
Sbjct: 4 VSHEVADCSHLKLTQ-VPDDL--PTNITVLNLTHNQLRRLPAANF------------TRY 48
Query: 92 SGVDQGLLRLNNNSLSGAFPVFLAKISELAFLDLSYNNLSGPVP 135
S + L + N++S P K+ L L+L +N LS
Sbjct: 49 SQLTS--LDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSD 90
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 80.5 bits (199), Expect = 3e-16
Identities = 50/238 (21%), Positives = 88/238 (36%), Gaps = 29/238 (12%)
Query: 167 PLSFSLNSSPDKQEEGLISLGNLRNFTFRELQQATENFSSKNILGAGGFGNVYKGK-LGD 225
S + Q + + G F + +E + LG+G +G V +
Sbjct: 5 HHHSSGRENLYFQGDLQATPGM---FITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVT 61
Query: 226 GTVLAVK-----RLKDMISLAV-----------HRNLLRLIGYCATPTERLLVYPYMSNG 269
A+K + + + H N+++L + LV G
Sbjct: 62 HVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGG 121
Query: 270 SVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLL---DDFCEA 326
+ + + + I G+ YLH+ I+HRD+K N+LL +
Sbjct: 122 ELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALI 178
Query: 327 IVGDFGLAKLLDHSDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITG 384
+ DFGL+ + ++ GT +IAPE L + EK DV+ G++L L+ G
Sbjct: 179 KIVDFGLSAVFENQKKMKERL--GTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAG 233
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 5e-16
Identities = 24/139 (17%), Positives = 45/139 (32%), Gaps = 20/139 (14%)
Query: 19 SLSGTLSGSIGNLTNLRQVLLQNNNISGGIPPQ-LGSLPKLQTLDLSNNRLSGVIPALLF 77
+ G LT+L + + N+ + L LDLS +L + +
Sbjct: 435 NTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFD 494
Query: 78 LSIWLPRKWDKRKCSGVDQGLLRLNNNSLSGAFPVFLAKISELAFLDLSYNNLSGPVPKF 137
L + L +++N+L ++ L+ LD S+N +
Sbjct: 495 TLHRL--QL------------LNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGIL 540
Query: 138 PA-----RTFNVAGNPLIC 151
FN+ N + C
Sbjct: 541 QHFPKSLAFFNLTNNSVAC 559
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 8e-14
Identities = 27/169 (15%), Positives = 52/169 (30%), Gaps = 32/169 (18%)
Query: 19 SLSGTLSGSIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFL 78
L S S N + L+ + L I L L L L+ N + P
Sbjct: 43 PLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSF-- 100
Query: 79 SIWLPRKWDKRKCSGVDQGL-----LRLNNNSLSGAFPVFLAKISELAFLDLSYNNLSG- 132
GL L L+ + ++ L L++++N +
Sbjct: 101 -----------------SGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSC 143
Query: 133 PVPKFPA-----RTFNVAGNPL--ICGSSSTNVCSGSANSVPLSFSLNS 174
+P + + +++ N + I + + ++ L SLN
Sbjct: 144 KLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNP 192
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 2e-11
Identities = 25/128 (19%), Positives = 38/128 (29%), Gaps = 30/128 (23%)
Query: 23 TLSGSIGNLTNLRQVLLQNNNISGGIPPQ-LGSLPKLQTLDLSNNRLSGVIPALLFLSIW 81
+S + L L+ + Q++ + SL KL LD+S +
Sbjct: 390 IMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIF----- 444
Query: 82 LPRKWDKRKCSGVDQGL-----LRLNNNSLSGAFPV-FLAKISELAFLDLSYNNLSGPVP 135
GL L++ NS A + L FLDLS L
Sbjct: 445 --------------LGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQ--- 487
Query: 136 KFPARTFN 143
F+
Sbjct: 488 -ISWGVFD 494
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 2e-11
Identities = 31/188 (16%), Positives = 53/188 (28%), Gaps = 27/188 (14%)
Query: 19 SLSGTLSGSIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLF- 77
+ GS LT+L ++ ++ +G L L+ L++++N + F
Sbjct: 91 PIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFS 150
Query: 78 ---------LS---IWLPRKWDKRKCSGVDQGLLRLN--NNSLSGAFPVFLAKISELAFL 123
LS I D + Q L L+ N + I L L
Sbjct: 151 NLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPIDFIQDQAFQGIK-LHEL 209
Query: 124 DLSYNNLSGPVPKFPARTFNVAGNPLICGSSSTNVCSGSANSVPLSFSLNSSPDKQEEGL 183
L N S + K + + +V +L EGL
Sbjct: 210 TLRGNFNSSNIMK-----------TCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGL 258
Query: 184 ISLGNLRN 191
+
Sbjct: 259 CDVTIDEF 266
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 2e-11
Identities = 22/113 (19%), Positives = 38/113 (33%), Gaps = 18/113 (15%)
Query: 25 SGSIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFLSIWLPR 84
S S +LR + L N + L +LQ LD ++ L V FLS+
Sbjct: 369 SYSDLGTNSLRHLDLSFNGAII-MSANFMGLEELQHLDFQHSTLKRVTEFSAFLSL---- 423
Query: 85 KWDKRKCSGVDQGL--LRLNNNSLSGAFPVFLAKISELAFLDLSYNNLSGPVP 135
+ L L ++ + F ++ L L ++ N+
Sbjct: 424 -----------EKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTL 465
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 2e-09
Identities = 17/106 (16%), Positives = 31/106 (29%), Gaps = 24/106 (22%)
Query: 32 TNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFLSIWLPRKWDKRKC 91
++ + + L N + + +LQ LDLS + +
Sbjct: 32 SSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAW--------------- 76
Query: 92 SGVDQGL-----LRLNNNSLSGAFPVFLAKISELAFLDLSYNNLSG 132
GL L L N + P + ++ L L L+
Sbjct: 77 ----HGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLAS 118
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 5e-09
Identities = 25/108 (23%), Positives = 36/108 (33%), Gaps = 19/108 (17%)
Query: 27 SIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFLSIWLPRKW 86
+L L+ + L N S I + +LP L LDLS N LS + +
Sbjct: 323 PTLDLPFLKSLTLTMNKGS--ISFKKVALPSLSYLDLSRNALSF-SGCCSYSDLGTNS-- 377
Query: 87 DKRKCSGVDQGL--LRLNNNSLSGAFPVFLAKISELAFLDLSYNNLSG 132
L L L+ N + EL LD ++ L
Sbjct: 378 -----------LRHLDLSFNGAII-MSANFMGLEELQHLDFQHSTLKR 413
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 6e-09
Identities = 21/140 (15%), Positives = 37/140 (26%), Gaps = 24/140 (17%)
Query: 19 SLSGTLSGSIGNLTNLRQVL----LQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPA 74
+ + L QV + N I I Q KL L L N S I
Sbjct: 164 YIQTITVNDLQFLRENPQVNLSLDMSLNPIDF-IQDQAFQGIKLHELTLRGNFNSSNIMK 222
Query: 75 LLF--------LSIWLPRKWDKRKCSGVDQGL-----------LRLNNNSLSGAFPVFLA 115
+ L D+R + + RL + V
Sbjct: 223 TCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFH 282
Query: 116 KISELAFLDLSYNNLSGPVP 135
++ ++ + L+ ++
Sbjct: 283 CLANVSAMSLAGVSIKYLED 302
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 2e-08
Identities = 24/117 (20%), Positives = 39/117 (33%), Gaps = 22/117 (18%)
Query: 21 SGTLSGSIGNLTNLRQVLLQNNNIS--GGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFL 78
G++S L +L + L N +S G L+ LDLS N + + L
Sbjct: 339 KGSISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAIIMSANFMGL 398
Query: 79 SIWLPRKWDKRKCSGVDQGL--LRLNNNSLSGAFPV-FLAKISELAFLDLSYNNLSG 132
L L +++L + +L +LD+SY N
Sbjct: 399 E-----------------ELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKI 438
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 7e-07
Identities = 24/115 (20%), Positives = 36/115 (31%), Gaps = 23/115 (20%)
Query: 19 SLSGTLSGSIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPA-LLF 77
+ L N+ + L +I + K Q+L + +L L F
Sbjct: 272 NDFSDDIVKFHCLANVSAMSLAGVSIKY--LEDVPKHFKWQSLSIIRCQLKQFPTLDLPF 329
Query: 78 LSIWLPRKWDKRKCSGVDQGLLRLNNNSLSGAFPVFLAKISELAFLDLSYNNLSG 132
L L L N S +F + L++LDLS N LS
Sbjct: 330 LKS------------------LTLTMNKGSISFK--KVALPSLSYLDLSRNALSF 364
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 5e-16
Identities = 42/205 (20%), Positives = 76/205 (37%), Gaps = 24/205 (11%)
Query: 194 FRELQQATENFSS----KNILGAGGFGNVYKG-KLGDGTVLAVKRLKD-----------M 237
++L + + F+ K +G G + + AVK + +
Sbjct: 10 VQQLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEEIEIL 69
Query: 238 ISLAVHRNLLRLIGYCATPTERLLVYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGL 297
+ H N++ L +V M G + ++ + + + +
Sbjct: 70 LRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTV 129
Query: 298 LYLHEQCDPKIIHRDVKAANVLL---DDFCEAI-VGDFGLAKLLDHSDSHVTTAVRGTVG 353
YLH Q ++HRD+K +N+L E+I + DFG AK L + + T T
Sbjct: 130 EYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPC-YTAN 185
Query: 354 HIAPEYLSTGQSSEKTDVFGFGILL 378
+APE L D++ G+LL
Sbjct: 186 FVAPEVLERQGYDAACDIWSLGVLL 210
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 8e-16
Identities = 50/209 (23%), Positives = 80/209 (38%), Gaps = 46/209 (22%)
Query: 210 LGAGGFGNVYKGK-LGDGTVLAVKR------------------------LKDMISLAVHR 244
LG GGFG V+ G L D +A+K L + + H
Sbjct: 39 LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98
Query: 245 NLLRLIGYCATPTERLLVYPYMSNG-------SVASRLREKPALDWNTRKRIAIGAARGL 297
++RL+ + T +LV + L E P+ + +
Sbjct: 99 GVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPS------RCFFGQVVAAI 152
Query: 298 LYLHEQCDPKIIHRDVKAANVLLD-DFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGHIA 356
+ H + ++HRD+K N+L+D A + DFG LL D T GT +
Sbjct: 153 QHCHSR---GVVHRDIKDENILIDLRRGCAKLIDFGSGALL--HDEPYTDFD-GTRVYSP 206
Query: 357 PEYLSTGQ-SSEKTDVFGFGILLLELITG 384
PE++S Q + V+ GILL +++ G
Sbjct: 207 PEWISRHQYHALPATVWSLGILLYDMVCG 235
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 75.9 bits (187), Expect = 6e-15
Identities = 49/221 (22%), Positives = 84/221 (38%), Gaps = 41/221 (18%)
Query: 195 RELQQATENFSSKNILGAGGFGNVYKGKL-GDGTVLAVKRLK--DMISLA--VH----RN 245
++++ E+F ++G G FG V KL V A+K L +M+ A R+
Sbjct: 67 KQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERD 126
Query: 246 LLRLIG--------YCATPTERL-LVYPYMSNGSVASRLREKPALDWNTRKRIAIGAAR- 295
+L Y L LV Y G + + L R+ AR
Sbjct: 127 VLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLS-------KFEDRLPEEMARF 179
Query: 296 -------GLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAV 348
+ +H+ +HRD+K N+L+D + DFG L + ++
Sbjct: 180 YLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVA 236
Query: 349 RGTVGHIAPEYLSTGQSSEKT-----DVFGFGILLLELITG 384
GT +I+PE L + + D + G+ + E++ G
Sbjct: 237 VGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYG 277
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 75.5 bits (186), Expect = 7e-15
Identities = 51/238 (21%), Positives = 87/238 (36%), Gaps = 35/238 (14%)
Query: 173 NSSPDKQEEGLISLGNLRNFTFRELQQATENFSSK----NILGAGGFGNVYKGK-LGDGT 227
P + + + + ++ + LG+G FG V++ G
Sbjct: 18 YDGPKINDYDKFYEDIWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCVEKATGR 77
Query: 228 VLAVK-----RLKD----------MISLAVHRNLLRLIGYCATPTERLLVYPYMSNGSVA 272
V K D M L H L+ L E +L+ ++S G +
Sbjct: 78 VFVAKFINTPYPLDKYTVKNEISIMNQLH-HPKLINLHDAFEDKYEMVLILEFLSGGELF 136
Query: 273 SRLREKPALDWNTRKRIAIGAAR----GLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIV 328
R+ + D+ + I R GL ++HE I+H D+K N++ + + V
Sbjct: 137 DRIAAE---DYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSV 190
Query: 329 --GDFGLAKLLDHSDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITG 384
DFGLA L+ + V T APE + TD++ G+L L++G
Sbjct: 191 KIIDFGLATKLNPDEI-VKVTT-ATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSG 246
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 7e-15
Identities = 41/190 (21%), Positives = 72/190 (37%), Gaps = 20/190 (10%)
Query: 205 SSKNILGAGGFGNVYKG-KLGDGTVLAVK-----RLKD-------MISLAVHRNLLRLIG 251
LG G F K AVK + + H N+++L
Sbjct: 14 LKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKEITALKLCEGHPNIVKLHE 73
Query: 252 YCATPTERLLVYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHR 311
LV ++ G + R+++K I + ++H+ ++HR
Sbjct: 74 VFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDV---GVVHR 130
Query: 312 DVKAANVLL---DDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGHIAPEYLSTGQSSEK 368
D+K N+L +D E + DFG A+L + + T T+ + APE L+ E
Sbjct: 131 DLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPC-FTLHYAAPELLNQNGYDES 189
Query: 369 TDVFGFGILL 378
D++ G++L
Sbjct: 190 CDLWSLGVIL 199
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 9e-15
Identities = 49/210 (23%), Positives = 82/210 (39%), Gaps = 38/210 (18%)
Query: 202 ENFSSKNILGAGGFGNVYKGKL-GDGTVLAVKRL-----------------KDMISLAVH 243
E+F ILG G F V + A+K L +D++S H
Sbjct: 30 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 244 RNLLRLIGYCATPTERLLVYPYMSNGSVASRLREKPALDWNTRKRIAIGAAR-------- 295
++L + Y NG + +R+ R
Sbjct: 90 PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI--------GSFDETCTRFYTAEIVS 141
Query: 296 GLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLL-DHSDSHVTTAVRGTVGH 354
L YLH + IIHRD+K N+LL++ + DFG AK+L S + GT +
Sbjct: 142 ALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQY 198
Query: 355 IAPEYLSTGQSSEKTDVFGFGILLLELITG 384
++PE L+ + + +D++ G ++ +L+ G
Sbjct: 199 VSPELLTEKSACKSSDLWALGCIIYQLVAG 228
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 1e-14
Identities = 46/217 (21%), Positives = 83/217 (38%), Gaps = 41/217 (18%)
Query: 192 FTFRELQQATENFS-----SKNILGAGGFGNVYKG-KLGDGTVLAVKRLKD--------- 236
F+ + + SK +LG G G V + G A+K L D
Sbjct: 14 VLFQGPEPKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQEVD 73
Query: 237 -MISLAVHRNLLRLIGYCATPTER----LLVYPYMSNGSVASRLREKPALDWNTRKRIAI 291
+ +++ ++ L++ M G + SR++E+ + R+
Sbjct: 74 HHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTERE---- 129
Query: 292 GAAR-------GLLYLHEQCDPKIIHRDVKAANVLLDDFCE-AIV--GDFGLAKLLDHSD 341
AA + +LH I HRDVK N+L + A++ DFG AK +
Sbjct: 130 -AAEIMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA 185
Query: 342 SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILL 378
+ T T ++APE L + + D++ G+++
Sbjct: 186 --LQTPC-YTPYYVAPEVLGPEKYDKSCDMWSLGVIM 219
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 75.5 bits (186), Expect = 1e-14
Identities = 47/223 (21%), Positives = 79/223 (35%), Gaps = 41/223 (18%)
Query: 197 LQQATENFSSK----NILGAGGFGNVYKGK-LGDGTVLAVKRL-KDMISLAV-------- 242
+++ LG+G +G V K + A+K + K
Sbjct: 27 VRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNI 86
Query: 243 ------------------HRNLLRLIGYCATPTERLLVYPYMSNGSVASRLREKPALDWN 284
H N+++L LV + G + ++ + D
Sbjct: 87 EKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDEC 146
Query: 285 TRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLL---DDFCEAIVGDFGLAKLLDHSD 341
I G+ YLH+ I+HRD+K N+LL + + DFGL+
Sbjct: 147 DAANIMKQILSGICYLHKH---NIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDY 203
Query: 342 SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITG 384
GT +IAPE L + +EK DV+ G+++ L+ G
Sbjct: 204 KLRDRL--GTAYYIAPEVL-KKKYNEKCDVWSCGVIMYILLCG 243
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 73.4 bits (181), Expect = 1e-14
Identities = 46/201 (22%), Positives = 73/201 (36%), Gaps = 34/201 (16%)
Query: 198 QQATENFSSK----NILGAGGFGNVYKGK-LGDGTVLAVK-------------RLKD--- 236
+T F ILG G V + AVK +++
Sbjct: 9 SHSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELRE 68
Query: 237 --------MISLAVHRNLLRLIGYCATPTERLLVYPYMSNGSVASRLREKPALDWNTRKR 288
+ ++ H N+++L T T LV+ M G + L EK L ++
Sbjct: 69 ATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRK 128
Query: 289 IAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAV 348
I + LH+ I+HRD+K N+LLDD + DFG + LD +
Sbjct: 129 IMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLD-PGEKLREVC 184
Query: 349 RGTVGHIAPEYLSTGQSSEKT 369
GT ++APE + +
Sbjct: 185 -GTPSYLAPEIIECSMNDNHP 204
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 1e-14
Identities = 52/239 (21%), Positives = 87/239 (36%), Gaps = 46/239 (19%)
Query: 202 ENFSSKNILGAGGFGNVYKG-KLGDGTVLAVKRL-KDMI--SLAVH-----RNLLRLIG- 251
++F +G G FG V K + A+K + K V +++ +
Sbjct: 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEH 74
Query: 252 -------YCATPTERL-LVYPYMSNGSVASRLREKPALDWNTRKRIAIGAAR-------- 295
Y E + +V + G + L++ +
Sbjct: 75 PFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQN--------VHFKEETVKLFICELVM 126
Query: 296 GLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGHI 355
L YL Q +IIHRD+K N+LLD+ + DF +A +L T A GT ++
Sbjct: 127 ALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTMA--GTKPYM 181
Query: 356 APEYLSTGQSSEKT---DVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEK 411
APE S+ + + + D + G+ EL+ G R S + K E V +
Sbjct: 182 APEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSK----EIVHTFETTV 236
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 74.0 bits (182), Expect = 2e-14
Identities = 54/221 (24%), Positives = 93/221 (42%), Gaps = 37/221 (16%)
Query: 192 FTFRELQQATENFSS------KNILGAGGFGNVYKGK-LGDGTVLAVK-----RLKD--- 236
F R + +S ILG G FG V+K + G LA K +KD
Sbjct: 73 FDHRIVTAKQGAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEE 132
Query: 237 -------MISLAVHRNLLRLIGYCATPTERLLVYPYMSNGSVASRLREKPALDWNTRKRI 289
M L H NL++L + + +LV Y+ G + R+ ++ +N +
Sbjct: 133 VKNEISVMNQLD-HANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDE---SYNLTELD 188
Query: 290 AIGAAR----GLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIV--GDFGLAKLLDHSDSH 343
I + G+ ++H+ I+H D+K N+L + + DFGLA+ +
Sbjct: 189 TILFMKQICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK- 244
Query: 344 VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITG 384
+ GT +APE ++ S TD++ G++ L++G
Sbjct: 245 LKVNF-GTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSG 284
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 74.9 bits (184), Expect = 2e-14
Identities = 49/238 (20%), Positives = 82/238 (34%), Gaps = 35/238 (14%)
Query: 173 NSSPDKQEEGLISLGNLRNFTFRELQQATENFSSK----NILGAGGFGNVYKGK-LGDGT 227
+ + + ++ ++ LG G FG V++ G
Sbjct: 124 GKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGN 183
Query: 228 VLAVK-----RLKD----------MISLAVHRNLLRLIGYCATPTERLLVYPYMSNGSVA 272
A K D M L H L+ L E +++Y +MS G +
Sbjct: 184 NFAAKFVMTPHESDKETVRKEIQTMSVLR-HPTLVNLHDAFEDDNEMVMIYEFMSGGELF 242
Query: 273 SRLREKPALDWNTRKRIAIGAAR----GLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIV 328
++ ++ + A+ R GL ++HE +H D+K N++ +
Sbjct: 243 EKVADE---HNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNEL 296
Query: 329 --GDFGLAKLLDHSDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITG 384
DFGL LD S V GT APE TD++ G+L L++G
Sbjct: 297 KLIDFGLTAHLDPKQS-VKVTT-GTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSG 352
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 2e-14
Identities = 49/241 (20%), Positives = 91/241 (37%), Gaps = 46/241 (19%)
Query: 184 ISLGNLRNFTFR-------ELQQATENFSSK----NILGAGGFGNVYKGK-LGDGTVLAV 231
I+L RN F + + + LG+G G V +A+
Sbjct: 106 IALSLSRNKVFVFFDLTVDDQSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAI 165
Query: 232 KRL-KDMISLAV---------------------HRNLLRLIGYCATPTERLLVYPYMSNG 269
+ + K ++ H ++++ + + +V M G
Sbjct: 166 RIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE-DYYIVLELMEGG 224
Query: 270 SVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLL---DDFCEA 326
+ ++ L T K + YLHE IIHRD+K NVLL ++ C
Sbjct: 225 ELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLI 281
Query: 327 IVGDFGLAKLLDHSDSHVTTAVRGTVGHIAPEYLSTGQS---SEKTDVFGFGILLLELIT 383
+ DFG +K+L ++ + + GT ++APE L + + + D + G++L ++
Sbjct: 282 KITDFGHSKILG--ETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLS 339
Query: 384 G 384
G
Sbjct: 340 G 340
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 74.4 bits (183), Expect = 2e-14
Identities = 51/253 (20%), Positives = 86/253 (33%), Gaps = 46/253 (18%)
Query: 168 LSFSLNSSPDKQEEGLISLGNLRNFTFRELQQAT---ENFSSKNILGAGGFGNVYKGKL- 223
+ L +S Q++ + L++ ++F ++G G F V K+
Sbjct: 24 VHQELGASELAQDKYVADFLQWAEPIVVRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMK 83
Query: 224 GDGTVLAVKRLK--DMISLA------VHRNLLRLIG-------YCA--TPTERLLVYPYM 266
G V A+K + DM+ R++L + A LV Y
Sbjct: 84 QTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVMEYY 143
Query: 267 SNGSVASRLREKPALDWNTRKRIAIGAAR--------GLLYLHEQCDPKIIHRDVKAANV 318
G + + L +RI AR + +H +HRD+K N+
Sbjct: 144 VGGDLLTLLS-------KFGERIPAEMARFYLAEIVMAIDSVHRL---GYVHRDIKPDNI 193
Query: 319 LLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFG----- 373
LLD + DFG L + + GT +++PE L T +G
Sbjct: 194 LLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDW 253
Query: 374 --FGILLLELITG 384
G+ E+ G
Sbjct: 254 WALGVFAYEMFYG 266
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 2e-14
Identities = 22/113 (19%), Positives = 33/113 (29%), Gaps = 14/113 (12%)
Query: 20 LSGTLSGSIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFLS 79
L + + L NL + L I S +L TL L+ N L + L
Sbjct: 45 LPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETAL--- 101
Query: 80 IWLPRKWDKRKCSGVDQGLLRLNNNSLSGAFPVFLAKISELAFLDLSYNNLSG 132
+ L +S + L L L L N++S
Sbjct: 102 ---------SGPKALKH--LFFIQTGISSIDFIPLHNQKTLESLYLGSNHISS 143
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 6e-14
Identities = 22/120 (18%), Positives = 42/120 (35%), Gaps = 13/120 (10%)
Query: 19 SLSGTLSGSIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFL 78
S + + NL++L+ + L N P+L+ LDL+ RL F
Sbjct: 363 ETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQ 422
Query: 79 SIWLPRKWDKRKCSGVDQGLLRLNNNSLSGAFPVFLAKISELAFLDLSYNNLSGPVPKFP 138
++ L + L L+++ L + + L L+L N+ +
Sbjct: 423 NLHLLKV-------------LNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKT 469
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 1e-13
Identities = 31/141 (21%), Positives = 55/141 (39%), Gaps = 23/141 (16%)
Query: 19 SLSGTLSGSIGNLTNLRQVLLQNNNISGGI---PPQLGSLPKLQTLDLSNNRLSGVIPAL 75
L + L L+ + LQ N+ G L +L +L+ L LS LS +
Sbjct: 436 LLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHA 495
Query: 76 LFLSIWLPRKWDKRKCSGVDQGLLRLNNNSLSGAFPVFLAKISELAFLDLSYNNLSGPVP 135
+ + L++N L+ + L+ + + +L+L+ N++S +P
Sbjct: 496 FTSLKMM--------------NHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHISIILP 540
Query: 136 KFPA-----RTFNVAGNPLIC 151
RT N+ NPL C
Sbjct: 541 SLLPILSQQRTINLRQNPLDC 561
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 1e-12
Identities = 22/117 (18%), Positives = 40/117 (34%), Gaps = 20/117 (17%)
Query: 19 SLSGTLSGSIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFL 78
S + + L+++ L ++S +P L L L+ L LS N+ +
Sbjct: 265 YFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISAS- 322
Query: 79 SIWLPRKWDKRKCSGVDQGL--LRLNNNSLSGA-FPVFLAKISELAFLDLSYNNLSG 132
P L L + N+ L + L LDLS++++
Sbjct: 323 --NFPS-------------LTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIET 364
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 2e-12
Identities = 25/115 (21%), Positives = 43/115 (37%), Gaps = 15/115 (13%)
Query: 18 QSLSGTLSGSIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLF 77
+ + S+ L L ++L ++S SL + +DLS+NRL+ L
Sbjct: 462 PKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEAL- 520
Query: 78 LSIWLPRKWDKRKCSGVDQGLLRLNNNSLSGAFPVFLAKISELAFLDLSYNNLSG 132
S + L L +N +S P L +S+ ++L N L
Sbjct: 521 --------------SHLKGIYLNLASNHISIILPSLLPILSQQRTINLRQNPLDC 561
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 1e-11
Identities = 29/194 (14%), Positives = 58/194 (29%), Gaps = 36/194 (18%)
Query: 19 SLSGTLSGSIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFL 78
+ + + L ++L N + L L+ L +S + L
Sbjct: 68 QIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLH- 126
Query: 79 SIWLPRKWDKRKCSGVDQGL--LRLNNNSLSGAFPVFLAKISELAFLDLSYNNLS----- 131
L L L +N +S +L LD N +
Sbjct: 127 --NQKT-------------LESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKE 171
Query: 132 --GPVPKFPARTFNVAGNPLICGSSSTNVCSGSANSVP---LSFSLNSSPDKQEEGLI-- 184
+ + + N+ GN + + G+ +S L+F + +GL
Sbjct: 172 DMSSLQQATNLSLNLNGNDI------AGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNS 225
Query: 185 SLGNLRNFTFRELQ 198
++ +L TF ++
Sbjct: 226 TIQSLWLGTFEDMD 239
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 1e-10
Identities = 24/173 (13%), Positives = 41/173 (23%), Gaps = 31/173 (17%)
Query: 31 LTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFLSIWLPRKWDKRK 90
+ + N + L L LDL+ ++ +
Sbjct: 32 PNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTF-------------- 77
Query: 91 CSGVDQGL-----LRLNNNSLSGAFPVFLAKISELAFLDLSYNNLSGPVPK-FPA----R 140
Q L L N L L+ L L +S
Sbjct: 78 -----QSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLE 132
Query: 141 TFNVAGNPLICGSSSTNVCSGSANSVPLSFSLNSSPDKQEEGLISLGNLRNFT 193
+ + N + S + L F N+ +E + SL N +
Sbjct: 133 SLYLGSNHI--SSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLS 183
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 7e-10
Identities = 20/125 (16%), Positives = 37/125 (29%), Gaps = 17/125 (13%)
Query: 23 TLSGSIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFLSIWL 82
L + L+ L++++L N + P L L + N + + L
Sbjct: 292 ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLEN--L 349
Query: 83 P----------RKWDKRKCSGVDQGL-----LRLNNNSLSGAFPVFLAKISELAFLDLSY 127
C+ + L L L+ N + +L LDL++
Sbjct: 350 ENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAF 409
Query: 128 NNLSG 132
L
Sbjct: 410 TRLKV 414
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 8e-10
Identities = 18/105 (17%), Positives = 30/105 (28%), Gaps = 15/105 (14%)
Query: 31 LTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFLSIWLPRKWDKRK 90
++ + LQ + LQ LDL+ LS + L+ LS
Sbjct: 253 EMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLSELPSGLVGLSTLK-------- 304
Query: 91 CSGVDQGLLRLNNNSLSGAFPVFLAKISELAFLDLSYNNLSGPVP 135
L L+ N + + L L + N +
Sbjct: 305 -------KLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELG 342
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 3e-08
Identities = 19/134 (14%), Positives = 33/134 (24%), Gaps = 15/134 (11%)
Query: 19 SLSGTLSGSIGNLTNLRQVLLQ-NNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPA--- 74
++ + +L + L N N GI P Q+L+ + VI
Sbjct: 164 AIHYLSKEDMSSLQQATNLSLNLNGNDIAGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLK 223
Query: 75 -----------LLFLSIWLPRKWDKRKCSGVDQGLLRLNNNSLSGAFPVFLAKISELAFL 123
+ + + L + S L L
Sbjct: 224 NSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQEL 283
Query: 124 DLSYNNLSGPVPKF 137
DL+ +LS
Sbjct: 284 DLTATHLSELPSGL 297
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 4e-05
Identities = 21/113 (18%), Positives = 40/113 (35%), Gaps = 19/113 (16%)
Query: 19 SLSGTLSGSIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFL 78
L+ + ++ +L + + L +N+IS +P L L + +T++L N L + ++
Sbjct: 511 RLTSSSIEALSHLKGI-YLNLASNHISIILPSLLPILSQQRTINLRQNPLDC-TCSNIYF 568
Query: 79 SIWLPRKWDKRKCSGVDQGLLRLNNNSLSGAFPVFLAKISELAFLDLSYNNLS 131
W + N L L + LS LS
Sbjct: 569 LEW-----------------YKENMQKLEDTEDTLCENPPLLRGVRLSDVTLS 604
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 3e-14
Identities = 48/201 (23%), Positives = 82/201 (40%), Gaps = 32/201 (15%)
Query: 210 LGAGGFGNVYKGK-LGDGTVLAVK-----RLKDMISLA-----------------VHRNL 246
LG+GGFG+VY G + D +A+K R+ D L +
Sbjct: 51 LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 110
Query: 247 LRLIGYCATPTERLLVYPYMSN-GSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCD 305
+RL+ + P +L+ + + E+ AL + + + H
Sbjct: 111 IRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNC-- 168
Query: 306 PKIIHRDVKAANVLLD-DFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGHIAPEYLSTGQ 364
++HRD+K N+L+D + E + DFG LL D+ T GT + PE++ +
Sbjct: 169 -GVLHRDIKDENILIDLNRGELKLIDFGSGALLK--DTVYTDFD-GTRVYSPPEWIRYHR 224
Query: 365 -SSEKTDVFGFGILLLELITG 384
V+ GILL +++ G
Sbjct: 225 YHGRSAAVWSLGILLYDMVCG 245
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 73.6 bits (181), Expect = 4e-14
Identities = 52/204 (25%), Positives = 86/204 (42%), Gaps = 26/204 (12%)
Query: 201 TENFSSKNILGAGGFGNVYKGK-LGDGTVLAVK-----RLKDMISLAV-----------H 243
E ++ +LG G FG V K K AVK K+ + + H
Sbjct: 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80
Query: 244 RNLLRLIGYCATPTERLLVYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQ 303
N+++L + +V + G + + ++ + RI G+ Y+H+
Sbjct: 81 PNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKH 140
Query: 304 CDPKIIHRDVKAANVLL---DDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGHIAPEYL 360
I+HRD+K N+LL + C+ + DFGL+ + GT +IAPE L
Sbjct: 141 ---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRI--GTAYYIAPEVL 195
Query: 361 STGQSSEKTDVFGFGILLLELITG 384
G EK DV+ G++L L++G
Sbjct: 196 R-GTYDEKCDVWSAGVILYILLSG 218
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 4e-14
Identities = 45/205 (21%), Positives = 79/205 (38%), Gaps = 31/205 (15%)
Query: 201 TENFSSKNILGAGGFGNVYKGK-LGDGTVLAVK-----RLKDMISLAV------------ 242
+ + ++G G F V + G AVK + L+
Sbjct: 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHM 82
Query: 243 --HRNLLRLIGYCATPTERLLVYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLL-- 298
H +++ L+ ++ +V+ +M + + ++ + + +A R +L
Sbjct: 83 LKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEA 142
Query: 299 --YLHEQCDPKIIHRDVKAANVLLDDFCEAI---VGDFGLAKLLDHSDSHVTTAVRGTVG 353
Y H+ IIHRDVK VLL + +G FG+A L S V GT
Sbjct: 143 LRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRV-GTPH 198
Query: 354 HIAPEYLSTGQSSEKTDVFGFGILL 378
+APE + + DV+G G++L
Sbjct: 199 FMAPEVVKREPYGKPVDVWGCGVIL 223
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 72.1 bits (177), Expect = 7e-14
Identities = 53/270 (19%), Positives = 89/270 (32%), Gaps = 47/270 (17%)
Query: 133 PVPKFPARTFNVAGNPLICGSSSTNVCSGSANSVPLSFSLNSSPDKQEEGLISLGNLRN- 191
+ P + S SAN + + LN + K E L
Sbjct: 25 EIRHLPNLNREQRRAFIRSLRDDP---SQSANLLAEAKKLNDAQPKGTENLYFQSMGPED 81
Query: 192 --FTFRELQQATENFSSKNILGAGGFGNVYKGK-LGDGTVLAVK-----RLKD------- 236
+ ++ + + K+++G G V + G AVK +
Sbjct: 82 ELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEE 141
Query: 237 -----------MISLAVHRNLLRLIGYCATPTERLLVYPYMSNGS-----VAS-RLREKP 279
+ +A H +++ LI + + LV+ M G L EK
Sbjct: 142 VREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKE 201
Query: 280 ALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDH 339
+ I + +LH I+HRD+K N+LLDD + + DFG + L+
Sbjct: 202 T------RSIMRSLLEAVSFLHAN---NIVHRDLKPENILLDDNMQIRLSDFGFSCHLEP 252
Query: 340 SDSHVTTAVRGTVGHIAPEYLSTGQSSEKT 369
+ GT G++APE L
Sbjct: 253 -GEKLRELC-GTPGYLAPEILKCSMDETHP 280
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 7e-14
Identities = 48/220 (21%), Positives = 84/220 (38%), Gaps = 41/220 (18%)
Query: 197 LQQATENFSSK-----NILGAGGFGNVYKGK-LGDGTVLAVK-----RLKD--------- 236
Q+ ENF++ LG G F V + G A K R
Sbjct: 19 YFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHE 78
Query: 237 ---MISLAVHRNLLRLIGYCATPTERLLVYPYMSNGSVASRLREKPALDWNTRKRIAIGA 293
+ ++ L +E +L+ Y + G + S + A + I
Sbjct: 79 IAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSEND--VIRL 136
Query: 294 AR----GLLYLHEQCDPKIIHRDVKAANVLLDDFCE-----AIVGDFGLAKLLDHSDSHV 344
+ G+ YLH+ I+H D+K N+LL + DFG+++ + H+ +
Sbjct: 137 IKQILEGVYYLHQN---NIVHLDLKPQNILLSSIYPLGDIKIV--DFGMSRKIGHACE-L 190
Query: 345 TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITG 384
+ GT ++APE L+ + TD++ GI+ L+T
Sbjct: 191 REIM-GTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTH 229
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 7e-14
Identities = 50/250 (20%), Positives = 89/250 (35%), Gaps = 45/250 (18%)
Query: 168 LSFSLNSSPDKQEEGLISLGNLRNFTFRELQQAT---ENFSSKNILGAGGFGNVYKGKL- 223
L + L+ ++ + + + + T +++ E++ ++G G FG V +
Sbjct: 32 LVYDLDFPALRKNKNIDNFLSRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHK 91
Query: 224 GDGTVLAVKRLK--DMISLA--VH----RNLLRLIG--------YCATPTERL-LVYPYM 266
V A+K L +MI + R+++ Y L +V YM
Sbjct: 92 STRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYM 151
Query: 267 SNGSVASRLREKPALDWNTRKRIAIGAAR--------GLLYLHEQCDPKIIHRDVKAANV 318
G + + + + AR L +H IHRDVK N+
Sbjct: 152 PGGDLVNLMS---------NYDVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNM 199
Query: 319 LLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGHIAPEYLSTGQSSEK----TDVFGF 374
LLD + DFG ++ GT +I+PE L + D +
Sbjct: 200 LLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSV 259
Query: 375 GILLLELITG 384
G+ L E++ G
Sbjct: 260 GVFLYEMLVG 269
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 71.9 bits (176), Expect = 7e-14
Identities = 31/108 (28%), Positives = 53/108 (49%), Gaps = 4/108 (3%)
Query: 277 EKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKL 336
K L + A+G+ +L + K IHRD+ A N+LL + + DFGLA+
Sbjct: 186 YKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARD 242
Query: 337 LDHSDSHV-TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT 383
+ +V R + +APE + + ++DV+ FG+LL E+ +
Sbjct: 243 IYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 290
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 58.4 bits (141), Expect = 2e-09
Identities = 32/165 (19%), Positives = 54/165 (32%), Gaps = 30/165 (18%)
Query: 202 ENFSSKNILGAGGFGNVYKGKL------GDGTVLAVKRLKD----------------MIS 239
+ LG G FG V + +AVK LK+ +I
Sbjct: 22 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 81
Query: 240 LAVHRNLLRLIGYCATPTERLLV-YPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLL 298
+ H N++ L+G C P L+V + G++++ LR K R +G
Sbjct: 82 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSK-------RNEFVPYKTKGAR 134
Query: 299 YLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSH 343
+ + I D+K + + F K L +
Sbjct: 135 FRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEE 179
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 8e-14
Identities = 49/201 (24%), Positives = 77/201 (38%), Gaps = 25/201 (12%)
Query: 202 ENFSSKNILGAGGFGNVYKGKL-GDGTVLAVKRL-----------------KDMISLAVH 243
+ F LG G FG V K G A+K L K ++
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 244 RNLLRLIGYCATPTERLLVYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQ 303
L++L + +V Y++ G + S LR + A YLH
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL 160
Query: 304 CDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGHIAPEYLSTG 363
+I+RD+K N+L+D V DFG AK + T + GT +APE + +
Sbjct: 161 ---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK----GRTWTLCGTPEALAPEIILSK 213
Query: 364 QSSEKTDVFGFGILLLELITG 384
++ D + G+L+ E+ G
Sbjct: 214 GYNKAVDWWALGVLIYEMAAG 234
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 71.1 bits (175), Expect = 9e-14
Identities = 45/214 (21%), Positives = 82/214 (38%), Gaps = 40/214 (18%)
Query: 201 TENFSSKNILGAGGFGNVYKGK-LGDGTVLAVK-----RLKD----------------MI 238
+ + LG+G F V K + G A K + + +
Sbjct: 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILR 70
Query: 239 SLAVHRNLLRLIGYCATPTERLLVYPYMSNGSVASRLREKPALDWNTRKRIAIGAAR--- 295
+ H N++ L T+ +L+ +S G + L +K +L + A +
Sbjct: 71 QVL-HHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESL----SEEEATSFIKQIL 125
Query: 296 -GLLYLHEQCDPKIIHRDVKAANVLL----DDFCEAIVGDFGLAKLLDHSDSHVTTAVRG 350
G+ YLH + KI H D+K N++L + DFGLA ++ G
Sbjct: 126 DGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE-FKNIF-G 180
Query: 351 TVGHIAPEYLSTGQSSEKTDVFGFGILLLELITG 384
T +APE ++ + D++ G++ L++G
Sbjct: 181 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 70.7 bits (174), Expect = 1e-13
Identities = 51/209 (24%), Positives = 84/209 (40%), Gaps = 33/209 (15%)
Query: 201 TENFSSKNILGAGGFGNVYKGK-LGDGTVLAVKRL-KDMISLAV--------------HR 244
+ F K LG+G FG+V+ + G +K + KD + + H
Sbjct: 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHP 80
Query: 245 NLLRLIGYCATPTERLLVYPYMSNGSVASRLREKPALDWNTRKRIAIGAAR----GLLYL 300
N++++ +V G + R+ A + + L Y
Sbjct: 81 NIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYF 140
Query: 301 HEQCDPKIIHRDVKAANVLLDDFCE-----AIVGDFGLAKLLDHSDSHVTTAVRGTVGHI 355
H Q ++H+D+K N+L D I DFGLA+L SD H T A GT ++
Sbjct: 141 HSQ---HVVHKDLKPENILFQDTSPHSPIKII--DFGLAELFK-SDEHSTNAA-GTALYM 193
Query: 356 APEYLSTGQSSEKTDVFGFGILLLELITG 384
APE + K D++ G+++ L+TG
Sbjct: 194 APEVFK-RDVTFKCDIWSAGVVMYFLLTG 221
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 70.3 bits (173), Expect = 1e-13
Identities = 50/202 (24%), Positives = 80/202 (39%), Gaps = 39/202 (19%)
Query: 210 LGAGGFGNVYKGK-LGDGTVLAVK-----RLKDMIS----------LAVHRNLLRLIGYC 253
LG G +G V +AVK R D + H N+++ G+
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 254 ATPTERLLVYPYMSNGSVASRLREKPALDWNTRKRIAIGAAR--------GLLYLHEQCD 305
+ L Y S G + R+ + A+ G++YLH
Sbjct: 75 REGNIQYLFLEYCSGGELFDRIEPD--------IGMPEPDAQRFFHQLMAGVVYLHGI-- 124
Query: 306 PKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDH--SDSHVTTAVRGTVGHIAPEYLS-T 362
I HRD+K N+LLD+ + DFGLA + + + + GT+ ++APE L
Sbjct: 125 -GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYVAPELLKRR 182
Query: 363 GQSSEKTDVFGFGILLLELITG 384
+E DV+ GI+L ++ G
Sbjct: 183 EFHAEPVDVWSCGIVLTAMLAG 204
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 1e-13
Identities = 46/155 (29%), Positives = 75/155 (48%), Gaps = 26/155 (16%)
Query: 243 HRNLLRLIGYCATPTERLL--VYPYMSNGSVASRLREKPALDWNTRKRIAIGAAR----- 295
H N+++L+ P E L V+ ++ G V ++ T K ++ AR
Sbjct: 95 HPNVVKLVEVLDDPNEDHLYMVFELVNQGPV---------MEVPTLKPLSEDQARFYFQD 145
Query: 296 ---GLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTV 352
G+ YLH Q KIIHRD+K +N+L+ + + DFG++ SD+ ++ V GT
Sbjct: 146 LIKGIEYLHYQ---KIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALLSNTV-GTP 201
Query: 353 GHIAPEYLSTGQ---SSEKTDVFGFGILLLELITG 384
+APE LS + S + DV+ G+ L + G
Sbjct: 202 AFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFG 236
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 72.1 bits (177), Expect = 1e-13
Identities = 58/276 (21%), Positives = 95/276 (34%), Gaps = 37/276 (13%)
Query: 135 PKFPARTFNV-------AGNPLICGSSSTNVCSGSANSVPLSFSLNSSPDKQEEGLISLG 187
RTF+V I + +A S S + + +E +
Sbjct: 81 TTVIERTFHVETPEEREEWTTAIQTVADGLKKQAAAEMDFRSGSPSDNSGAEEMEVSLAK 140
Query: 188 NLRNFTFRELQQATENFSSKNILGAGGFGNVYKGKL-GDGTVLAVKRLK--------DMI 238
T F +LG G FG V K G A+K LK ++
Sbjct: 141 PKHRVTM-------NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVA 193
Query: 239 SLAVHRNLLRLIG--------YCATPTERL-LVYPYMSNGSVASRLREKPALDWNTRKRI 289
+L+ Y +RL V Y + G + L + + +
Sbjct: 194 HTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFY 253
Query: 290 AIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVR 349
L YLH + + +++RD+K N++LD + DFGL K D
Sbjct: 254 GAEIVSALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCK-EGIKDGATMKTFC 310
Query: 350 GTVGHIAPEYLSTGQSSEKT-DVFGFGILLLELITG 384
GT ++APE L + D +G G+++ E++ G
Sbjct: 311 GTPEYLAPEVL-EDNDYGRAVDWWGLGVVMYEMMCG 345
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 70.3 bits (173), Expect = 2e-13
Identities = 41/204 (20%), Positives = 78/204 (38%), Gaps = 28/204 (13%)
Query: 201 TENFSSKNILGAGGFGNVYKGK-LGDGTVLAVKRLK-------------DMISLAVHRNL 246
E + LG G FG V++ K +K ++++A HRN+
Sbjct: 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNI 63
Query: 247 LRLIGYCATPTERLLVYPYMSNGSVASRLREKPALDWNTRKRIAIGAAR----GLLYLHE 302
L L + E ++++ ++S + R+ + +R + L +LH
Sbjct: 64 LHLHESFESMEELVMIFEFISGLDIFERINTS---AFELNEREIVSYVHQVCEALQFLHS 120
Query: 303 QCDPKIIHRDVKAANVLLDDFCEAIV--GDFGLAKLLDHSDSHVTTAVRGTVGHIAPEYL 360
I H D++ N++ + + +FG A+ L D+ + APE
Sbjct: 121 H---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN-FRLLF-TAPEYYAPEVH 175
Query: 361 STGQSSEKTDVFGFGILLLELITG 384
S TD++ G L+ L++G
Sbjct: 176 QHDVVSTATDMWSLGTLVYVLLSG 199
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 69.5 bits (171), Expect = 3e-13
Identities = 47/205 (22%), Positives = 72/205 (35%), Gaps = 34/205 (16%)
Query: 201 TENFSSK----NILGAGGFGNVYKGK-LGDGTVLAVK-----RLKD----------MISL 240
+ + N +G G +G V G A K ++D M SL
Sbjct: 4 KGDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSL 63
Query: 241 AVHRNLLRLIGYCATPTERLLVYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYL 300
H N++RL T+ LV + G + R+ K + RI + Y
Sbjct: 64 D-HPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYC 122
Query: 301 HEQCDPKIIHRDVKAANVLL---DDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGHIAP 357
H+ + HRD+K N L + DFGLA T GT +++P
Sbjct: 123 HKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKV--GTPYYVSP 177
Query: 358 EYLSTGQSSEKTDVFGFG----ILL 378
+ L G + D + G +LL
Sbjct: 178 QVLE-GLYGPECDEWSAGVMMYVLL 201
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 3e-13
Identities = 51/202 (25%), Positives = 83/202 (41%), Gaps = 30/202 (14%)
Query: 201 TENFSSKNILGAGGFGNVYKGK-LGDGTVLAVKRL--KDMISLAV--------------H 243
E ++ +LG G FG V K K AVK + + H
Sbjct: 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80
Query: 244 RNLLRLIGYCATPTERLLVYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQ 303
N+++L + +V + G + + ++ + RI G+ Y+H+
Sbjct: 81 PNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKH 140
Query: 304 CDPKIIHRDVKAANVLL---DDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGHIAPEYL 360
I+HRD+K N+LL + C+ + DFGL+ ++ + + GT +IAPE L
Sbjct: 141 ---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ-QNTKMKDRI-GTAYYIAPEVL 195
Query: 361 STGQSSEKTDVFGFG----ILL 378
G EK DV+ G ILL
Sbjct: 196 R-GTYDEKCDVWSAGVILYILL 216
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 3e-13
Identities = 51/208 (24%), Positives = 81/208 (38%), Gaps = 44/208 (21%)
Query: 210 LGAGGFGNVYKGK-LGDGTVLAVK--------RLKDM-------IS---LAVHRNLLRL- 249
LG G +G V + AVK R+ + I H+N+++L
Sbjct: 13 LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLV 72
Query: 250 -IGYCATPTERLLVYPYMSNGSVASRLREKPALDWNTRKRIAIGAAR--------GLLYL 300
+ Y + +V Y G ++E LD KR + A GL YL
Sbjct: 73 DVLYNEEKQKMYMVMEYCVCG-----MQE--MLDSVPEKRFPVCQAHGYFCQLIDGLEYL 125
Query: 301 HEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDH--SDSHVTTAVRGTVGHIAPE 358
H Q I+H+D+K N+LL + G+A+ L +D T+ +G+ PE
Sbjct: 126 HSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTS-QGSPAFQPPE 181
Query: 359 YLSTGQ--SSEKTDVFGFGILLLELITG 384
+ S K D++ G+ L + TG
Sbjct: 182 IANGLDTFSGFKVDIWSAGVTLYNITTG 209
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 5e-13
Identities = 45/214 (21%), Positives = 82/214 (38%), Gaps = 40/214 (18%)
Query: 201 TENFSSKNILGAGGFGNVYKGK-LGDGTVLAVK-----RLKD----------------MI 238
+ + LG+G F V K + G A K + + +
Sbjct: 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILR 70
Query: 239 SLAVHRNLLRLIGYCATPTERLLVYPYMSNGSVASRLREKPALDWNTRKRIAIGAAR--- 295
+ H N++ L T+ +L+ +S G + L +K +L + A +
Sbjct: 71 QVL-HPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESL----SEEEATSFIKQIL 125
Query: 296 -GLLYLHEQCDPKIIHRDVKAANVLL----DDFCEAIVGDFGLAKLLDHSDSHVTTAVRG 350
G+ YLH + KI H D+K N++L + DFGLA ++ G
Sbjct: 126 DGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE-FKNIF-G 180
Query: 351 TVGHIAPEYLSTGQSSEKTDVFGFGILLLELITG 384
T +APE ++ + D++ G++ L++G
Sbjct: 181 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 69.5 bits (170), Expect = 5e-13
Identities = 52/261 (19%), Positives = 79/261 (30%), Gaps = 72/261 (27%)
Query: 192 FTFRELQQATENFSSKNILGAGGFGNVYKGK-LGDGTVLAVK-----RLKDMISLAV--- 242
F L + + + K +G G +G V + A+K +++ + V
Sbjct: 16 FQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERI 75
Query: 243 -----------HRNLLRLIGYCATPTERLLVYPYMSNGSVASRLREKPALDWNTRKRIAI 291
H N+ RL LV G + +L +
Sbjct: 76 KTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVV 135
Query: 292 G---------------------------------AAR-------GLLYLHEQCDPKIIHR 311
+ L YLH Q I HR
Sbjct: 136 KTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQ---GICHR 192
Query: 312 DVKAANVLLDDFCEAIV--GDFGLAKLLDHSDSH----VTTAVRGTVGHIAPEYLSTGQS 365
D+K N L + DFGL+K ++ +TT GT +APE L+T
Sbjct: 193 DIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKA-GTPYFVAPEVLNTTNE 251
Query: 366 S--EKTDVFGFGILLLELITG 384
S K D + G+LL L+ G
Sbjct: 252 SYGPKCDAWSAGVLLHLLLMG 272
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 8e-13
Identities = 39/189 (20%), Positives = 65/189 (34%), Gaps = 30/189 (15%)
Query: 206 SKNILGAGGFGNVYKGK-LGDGTVLAVK-----RLKD----------MISLAVHRNLLRL 249
+++LG G V L AVK + HRN+L L
Sbjct: 17 QEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLEL 76
Query: 250 IGYCATPTERLLVYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKII 309
I + LV+ M GS+ S + ++ + + A L +LH + I
Sbjct: 77 IEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNK---GIA 133
Query: 310 HRDVKAANVLLDDFCEAI---VGDFGLAKLLDHSDSHV-------TTAVRGTVGHIAPEY 359
HRD+K N+L + + + DF L + + T G+ ++APE
Sbjct: 134 HRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPC-GSAEYMAPEV 192
Query: 360 LSTGQSSEK 368
+
Sbjct: 193 VEAFSEEAS 201
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 8e-13
Identities = 43/194 (22%), Positives = 75/194 (38%), Gaps = 25/194 (12%)
Query: 210 LGAGGFGNVY-----------------KGKLGDGTVLAVKRLKDMISLAVHRNLLRLIGY 252
+G G F V K +L ++ + R ++ + H N+++L
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82
Query: 253 CATPTERLLVYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRD 312
T L+ Y S G V L + + + Y H++ I+HRD
Sbjct: 83 IETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKR---IVHRD 139
Query: 313 VKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGHIAPEYLSTGQSSE--KTD 370
+KA N+LLD + DFG + + G + APE G+ + + D
Sbjct: 140 LKAENLLLDADMNIKIADFGFSNEFTV-GGKLDAFC-GAPPYAAPELFQ-GKKYDGPEVD 196
Query: 371 VFGFGILLLELITG 384
V+ G++L L++G
Sbjct: 197 VWSLGVILYTLVSG 210
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 9e-13
Identities = 50/202 (24%), Positives = 80/202 (39%), Gaps = 39/202 (19%)
Query: 210 LGAGGFGNVYKGK-LGDGTVLAVK-----RLKDMIS----------LAVHRNLLRLIGYC 253
LG G +G V +AVK R D + H N+++ G+
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 254 ATPTERLLVYPYMSNGSVASRLREKPALDWNTRKRIAIGAAR--------GLLYLHEQCD 305
+ L Y S G + R+ + A+ G++YLH
Sbjct: 75 REGNIQYLFLEYCSGGELFDRIEPD--------IGMPEPDAQRFFHQLMAGVVYLHGI-- 124
Query: 306 PKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDH--SDSHVTTAVRGTVGHIAPEYLS-T 362
I HRD+K N+LLD+ + DFGLA + + + + GT+ ++APE L
Sbjct: 125 -GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYVAPELLKRR 182
Query: 363 GQSSEKTDVFGFGILLLELITG 384
+E DV+ GI+L ++ G
Sbjct: 183 EFHAEPVDVWSCGIVLTAMLAG 204
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 1e-12
Identities = 52/230 (22%), Positives = 90/230 (39%), Gaps = 39/230 (16%)
Query: 198 QQATENFSSKNILGAGGFGNVYKGKLGD-GTVLAVKRLKD-------------MISLAVH 243
++ + F + + G G FG V GK G +A+K++ +++ H
Sbjct: 19 RKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLHH 78
Query: 244 RNLLRLIGYCATPTER-------LLVYPYMS---NGSVASRLREKPALDWNTRKRIAIGA 293
N+++L Y T ER +V Y+ + + R + A K
Sbjct: 79 PNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQL 138
Query: 294 ARGLLYLHEQCDPKIIHRDVKAANVLLDDF-CEAIVGDFGLAKLLDHSDSHVTTAV---- 348
R + LH + HRD+K NVL+++ + DFG AK L S+ +V
Sbjct: 139 IRSIGCLHLPS-VNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYICSRYY 197
Query: 349 RGTVGHIAPEYLSTGQS-SEKTDVFGFGILLLELITGMRALEFGKS-INQ 396
R APE + Q + D++ G + E++ G + G + Q
Sbjct: 198 R------APELIFGNQHYTTAVDIWSVGCIFAEMMLG-EPIFRGDNSAGQ 240
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 68.6 bits (168), Expect = 1e-12
Identities = 43/197 (21%), Positives = 77/197 (39%), Gaps = 35/197 (17%)
Query: 207 KNILGAGGFGNVYKG-KLGDGTVLAVKRLKD----------MISLAVHRNLLRLIGYCAT 255
+LG G G V + A+K L+D + +++R++
Sbjct: 67 SQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYEN 126
Query: 256 PTER----LLVYPYMSNGSVASRLREKPALDWNTRKRIAIGAAR-------GLLYLHEQC 304
L+V + G + SR++++ + R+ A+ + YLH
Sbjct: 127 LYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTERE-----ASEIMKSIGEAIQYLHSI- 180
Query: 305 DPKIIHRDVKAANVLLDDFCEAI---VGDFGLAKLLDHSDSHVTTAVRGTVGHIAPEYLS 361
I HRDVK N+L + DFG AK S + +TT T ++APE L
Sbjct: 181 --NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT-SHNSLTTPC-YTPYYVAPEVLG 236
Query: 362 TGQSSEKTDVFGFGILL 378
+ + D++ G+++
Sbjct: 237 PEKYDKSCDMWSLGVIM 253
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 69.3 bits (169), Expect = 1e-12
Identities = 59/203 (29%), Positives = 89/203 (43%), Gaps = 25/203 (12%)
Query: 202 ENFSSKNILGAGGFGNVYKGKL-GDGTVLAVKRLK--------DMISLAVHRNLLRLIG- 251
+F+ +LG G FG V + G + AVK LK D+ V + +L L G
Sbjct: 341 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGK 400
Query: 252 --------YCATPTERL-LVYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHE 302
C +RL V Y++ G + +++ A A GL +L
Sbjct: 401 PPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQS 460
Query: 303 QCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGHIAPEYLST 362
+ II+RD+K NV+LD + DFG+ K + D T GT +IAPE +
Sbjct: 461 K---GIIYRDLKLDNVMLDSEGHIKIADFGMCK-ENIWDGVTTKTFCGTPDYIAPEII-A 515
Query: 363 GQSSEKT-DVFGFGILLLELITG 384
Q K+ D + FG+LL E++ G
Sbjct: 516 YQPYGKSVDWWAFGVLLYEMLAG 538
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 67.2 bits (165), Expect = 2e-12
Identities = 49/214 (22%), Positives = 87/214 (40%), Gaps = 40/214 (18%)
Query: 201 TENFSSKNILGAGGFGNVYKGK-LGDGTVLAVK-----RLKD----------------MI 238
+++ LG+G F V K + G G A K RL +
Sbjct: 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILR 63
Query: 239 SLAVHRNLLRLIGYCATPTERLLVYPYMSNGSVASRLREKPALDWNTRKRIAIGAAR--- 295
+ H N++ L T+ +L+ +S G + L EK +L + A +
Sbjct: 64 EIR-HPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLT----EDEATQFLKQIL 118
Query: 296 -GLLYLHEQCDPKIIHRDVKAANVLLDDFCE---AI-VGDFGLAKLLDHSDSHVTTAVRG 350
G+ YLH + +I H D+K N++L D I + DFG+A ++ + G
Sbjct: 119 DGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNE-FKNIF-G 173
Query: 351 TVGHIAPEYLSTGQSSEKTDVFGFGILLLELITG 384
T +APE ++ + D++ G++ L++G
Sbjct: 174 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 207
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 2e-12
Identities = 42/206 (20%), Positives = 78/206 (37%), Gaps = 36/206 (17%)
Query: 201 TENFSSKNILGAGGFGNVYKGK-LGDGTVLAVK-----RLKDMISLAV-----------H 243
TE + LG G F V + + G A +L + H
Sbjct: 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKH 69
Query: 244 RNLLRLIGYCATPTERLLVYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLL----Y 299
N++RL + L++ ++ G + + + + A + +L +
Sbjct: 70 PNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYS----EADASHCIQQILEAVLH 125
Query: 300 LHEQCDPKIIHRDVKAANVLLDDFCE--AI-VGDFGLAKLLDHSDSHVTTAVRGTVGHIA 356
H+ ++HR++K N+LL + A+ + DFGLA ++ GT G+++
Sbjct: 126 CHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFA-GTPGYLS 181
Query: 357 PEYLSTGQSSEKTDVFGFG----ILL 378
PE L + D++ G ILL
Sbjct: 182 PEVLRKDPYGKPVDLWACGVILYILL 207
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 66.8 bits (164), Expect = 2e-12
Identities = 48/207 (23%), Positives = 76/207 (36%), Gaps = 35/207 (16%)
Query: 201 TENFSSK----NILGAGGFGNVYKG-KLGDGTVLAVK-----RLKD------------MI 238
+ FS LG G F V + G A K +L
Sbjct: 1 STKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICR 60
Query: 239 SLAVHRNLLRLIGYCATPTERLLVYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLL 298
L H N++RL + LV+ ++ G + + + +
Sbjct: 61 KLQ-HPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIA 119
Query: 299 YLHEQCDPKIIHRDVKAANVLLDDFCE--AI-VGDFGLAKLLDHSDSHVTTAVRGTVGHI 355
Y H I+HR++K N+LL + A+ + DFGLA ++ DS GT G++
Sbjct: 120 YCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN--DSEAWHGFAGTPGYL 174
Query: 356 APEYLSTGQSSEKTDVFGFG----ILL 378
+PE L S+ D++ G ILL
Sbjct: 175 SPEVLKKDPYSKPVDIWACGVILYILL 201
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 2e-12
Identities = 50/223 (22%), Positives = 84/223 (37%), Gaps = 39/223 (17%)
Query: 185 SLGNLRNFTFRELQQATENFSSKNILGAGGFGNVYKG-KLGDGTVLAVK----------- 232
+G F + ++N+ K LG G F V + G A K
Sbjct: 12 QMGRGSEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARD 71
Query: 233 --RLKD----MISLAVHRNLLRLIGYCATPTERLLVYPYMSNGSVASRLREKPALDWNTR 286
+L+ L H N++RL + LV+ ++ G + + +
Sbjct: 72 FQKLEREARICRKLQ-HPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYS---- 126
Query: 287 KRIAIGAAR----GLLYLHEQCDPKIIHRDVKAANVLLDDFCEAI---VGDFGLAKLLDH 339
+ A + + Y H I+HR++K N+LL + + DFGLA ++
Sbjct: 127 EADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN- 182
Query: 340 SDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFG----ILL 378
DS GT G+++PE L S+ D++ G ILL
Sbjct: 183 -DSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILL 224
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 66.4 bits (163), Expect = 3e-12
Identities = 55/206 (26%), Positives = 88/206 (42%), Gaps = 40/206 (19%)
Query: 201 TENFSSKNILGAGGFGNVYKGK-LGDGTVLAVKRLK-------DMIS--LAV-----HRN 245
+ F +LG+G F V+ K G + A+K +K + +AV H N
Sbjct: 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHEN 67
Query: 246 LLRLIGYCATPTERLLVYPYMSNG------SVASRLREKPALDWNTRKRIAIGAARGLLY 299
++ L + T LV +S G EK A + + Y
Sbjct: 68 IVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDA------SLVIQQVLSAVKY 121
Query: 300 LHEQCDPKIIHRDVKAANVLL---DDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGHIA 356
LHE I+HRD+K N+L ++ + ++ DFGL+K+ + ++TA GT G++A
Sbjct: 122 LHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ--NGIMSTAC-GTPGYVA 175
Query: 357 PEYLSTGQSSEKTDVFGFG----ILL 378
PE L+ S+ D + G ILL
Sbjct: 176 PEVLAQKPYSKAVDCWSIGVITYILL 201
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 3e-12
Identities = 50/205 (24%), Positives = 81/205 (39%), Gaps = 30/205 (14%)
Query: 202 ENFSSKNILGAGGFGNVYKGKL-GDGTVLAVKRLK--------DMISLAVHRNLLRLIG- 251
+F +LG G FG V + G A+K L+ ++ +L+
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 252 -------YCATPTERL-LVYPYMSNGSVASRLREKPALDWNTRKRIAIGAAR---GLLYL 300
Y +RL V Y + G + L + T +R A L YL
Sbjct: 65 PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVF---TEERARFYGAEIVSALEYL 121
Query: 301 HEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGHIAPEYL 360
H + +++RD+K N++LD + DFGL K SD GT ++APE L
Sbjct: 122 HSR---DVVYRDIKLENLMLDKDGHIKITDFGLCK-EGISDGATMKTFCGTPEYLAPEVL 177
Query: 361 STGQSSEKT-DVFGFGILLLELITG 384
+ D +G G+++ E++ G
Sbjct: 178 -EDNDYGRAVDWWGLGVVMYEMMCG 201
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 4e-12
Identities = 56/203 (27%), Positives = 85/203 (41%), Gaps = 25/203 (12%)
Query: 202 ENFSSKNILGAGGFGNVYKGKL-GDGTVLAVKRLK--------DMISLAVHRNLLRLIG- 251
E+F +LG G FG V+ + A+K LK D+ V + +L L
Sbjct: 17 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 76
Query: 252 --------YCATPTERL-LVYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHE 302
E L V Y++ G + ++ D + A GL +LH
Sbjct: 77 HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHS 136
Query: 303 QCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGHIAPEYLST 362
+ I++RD+K N+LLD + DFG+ K + T GT +IAPE L
Sbjct: 137 K---GIVYRDLKLDNILLDKDGHIKIADFGMCK-ENMLGDAKTNTFCGTPDYIAPEIL-L 191
Query: 363 GQSSEKT-DVFGFGILLLELITG 384
GQ + D + FG+LL E++ G
Sbjct: 192 GQKYNHSVDWWSFGVLLYEMLIG 214
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 4e-12
Identities = 58/263 (22%), Positives = 109/263 (41%), Gaps = 40/263 (15%)
Query: 161 GSANSVPLSFS-LNSSPDKQEEGLISLGNLRNFTFRELQQATENFSSKNILGAGGFGNVY 219
GS + + +P +I + + +Q +++ ++G G FG V+
Sbjct: 1 GSFTMSNAPLNGVKLNPLDDPNKVIKV---LASDGKTGEQREIAYTNCKVIGNGSFGVVF 57
Query: 220 KGKLGDGTVLAVKR-LKDM------ISL---AVHRNLLRLIGYCATPTERL------LVY 263
+ KL + +A+K+ L+D + + H N++ L + + ++ LV
Sbjct: 58 QAKLVESDEVAIKKVLQDKRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVL 117
Query: 264 PYMS---NGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLL 320
Y+ + + K + K R L Y+H I HRD+K N+LL
Sbjct: 118 EYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSI---GICHRDIKPQNLLL 174
Query: 321 DDFCEAI-VGDFGLAKLLDHSDSHVTTAV----RGTVGHIAPEYLSTGQS-SEKTDVFGF 374
D + + DFG AK+L + +V+ R APE + + + D++
Sbjct: 175 DPPSGVLKLIDFGSAKILIAGEPNVSYICSRYYR------APELIFGATNYTTNIDIWST 228
Query: 375 GILLLELITGMRALEFGKS-INQ 396
G ++ EL+ G + L G+S I+Q
Sbjct: 229 GCVMAELMQG-QPLFPGESGIDQ 250
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 4e-12
Identities = 58/202 (28%), Positives = 89/202 (44%), Gaps = 33/202 (16%)
Query: 201 TENFSSKNILGAGGFGNVYKGK-LGDGTVLAVKRLK-----DMISLAV-------HRNLL 247
++ F ++ LG G VY+ K G A+K LK ++ + H N++
Sbjct: 52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRTEIGVLLRLSHPNII 111
Query: 248 RLIGYCATPTERLLVYPYMSNGSVASRLREKPALDWNTRKRIAIGAAR----GLLYLHEQ 303
+L TPTE LV ++ G + R+ EK +R A A + + YLHE
Sbjct: 112 KLKEIFETPTEISLVLELVTGGELFDRIVEKGYYS----ERDAADAVKQILEAVAYLHEN 167
Query: 304 CDPKIIHRDVKAANVLLDDFCEAI---VGDFGLAKLLDHSDSHVTTAVRGTVGHIAPEYL 360
I+HRD+K N+L + DFGL+K+++H T GT G+ APE L
Sbjct: 168 ---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVC--GTPGYCAPEIL 222
Query: 361 STGQSSEKTDVFGFG----ILL 378
+ D++ G ILL
Sbjct: 223 RGCAYGPEVDMWSVGIITYILL 244
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 5e-12
Identities = 55/234 (23%), Positives = 90/234 (38%), Gaps = 52/234 (22%)
Query: 202 ENFSSKNILGAGGFGNVYKGK-LGDGTVLAVKRLK-DM------------ISL---AVHR 244
+ +G G FG V+K + G +A+K++ + I + H
Sbjct: 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 76
Query: 245 NLLRLIGYCATPTERL--------LVYPYMSN--GSVASRLREKPALDWNTRKRIAIGAA 294
N++ LI C T LV+ + + + S + K + KR+
Sbjct: 77 NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK--FTLSEIKRVMQMLL 134
Query: 295 RGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHV----TTAV-- 348
GL Y+H KI+HRD+KAANVL+ + DFGLA+ + + T V
Sbjct: 135 NGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVT 191
Query: 349 ---RGTVGHIAPEYL--STGQSSEKTDVFGFGILLLELITGMRALEFGKS-INQ 396
R PE L D++G G ++ E+ T + G + +Q
Sbjct: 192 LWYR------PPELLLGERDYGPP-IDLWGAGCIMAEMWTR-SPIMQGNTEQHQ 237
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 66.1 bits (162), Expect = 5e-12
Identities = 47/214 (21%), Positives = 83/214 (38%), Gaps = 40/214 (18%)
Query: 201 TENFSSKNILGAGGFGNVYKGK-LGDGTVLAVK-----RLKD----------------MI 238
+ + + LG+G F V K + G A K R K +
Sbjct: 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69
Query: 239 SLAVHRNLLRLIGYCATPTERLLVYPYMSNGSVASRLREKPALDWNTRKRIAIGAAR--- 295
+ H N++ L T+ +L+ ++ G + L EK +L + A +
Sbjct: 70 EIQ-HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLT----EEEATEFLKQIL 124
Query: 296 -GLLYLHEQCDPKIIHRDVKAANVLL----DDFCEAIVGDFGLAKLLDHSDSHVTTAVRG 350
G+ YLH +I H D+K N++L + DFGLA +D + G
Sbjct: 125 NGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE-FKNIF-G 179
Query: 351 TVGHIAPEYLSTGQSSEKTDVFGFGILLLELITG 384
T +APE ++ + D++ G++ L++G
Sbjct: 180 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 5e-12
Identities = 57/206 (27%), Positives = 87/206 (42%), Gaps = 31/206 (15%)
Query: 202 ENFSSKNILGAGGFGNVYKGKL-GDGTVLAVKRL-KDMI-------SLAVHRNLLRLIG- 251
+NF +LG G FG V ++ G + AVK L KD+I + +L L
Sbjct: 23 DNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARN 82
Query: 252 --------YCATPTERL-LVYPYMSNGSVASRLREKPALDWNTRKRIAIGAAR---GLLY 299
C +RL V +++ G + +++ R AA L++
Sbjct: 83 HPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRF---DEARARFYAAEIISALMF 139
Query: 300 LHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGHIAPEY 359
LH++ II+RD+K NVLLD + DFG+ K + T GT +IAPE
Sbjct: 140 LHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCK-EGICNGVTTATFCGTPDYIAPEI 195
Query: 360 LSTGQSSEKT-DVFGFGILLLELITG 384
L D + G+LL E++ G
Sbjct: 196 L-QEMLYGPAVDWWAMGVLLYEMLCG 220
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 66.1 bits (162), Expect = 5e-12
Identities = 50/225 (22%), Positives = 85/225 (37%), Gaps = 42/225 (18%)
Query: 202 ENFSSKNILGAGGFGNVYKGK-LGDGTVLAVKRLK-DM------------ISL---AVHR 244
+ + LG G +G VYK +A+KR++ + +SL HR
Sbjct: 34 DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHR 93
Query: 245 NLLRLIGYCATPTERLLVYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQC 304
N++ L L++ Y N + + + P + K G+ + H +
Sbjct: 94 NIIELKSVIHHNHRLHLIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSR- 151
Query: 305 DPKIIHRDVKAANVLLDDFCEAIVG-----DFGLAKLL---DHSDSH--VTTAVRGTVGH 354
+ +HRD+K N+LL + DFGLA+ +H +T R
Sbjct: 152 --RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLWYR----- 204
Query: 355 IAPEYL--STGQSSEKTDVFGFGILLLELITGMRALEFGKS-INQ 396
PE L S S+ D++ + E++ L G S I+Q
Sbjct: 205 -PPEILLGSRHYSTS-VDIWSIACIWAEMLMK-TPLFPGDSEIDQ 246
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 6e-12
Identities = 59/259 (22%), Positives = 102/259 (39%), Gaps = 47/259 (18%)
Query: 161 GSANSVPLSFSLNSSPDKQEEGLISLGNLRNFTFRELQQAT-ENFSSKNILGAGGFGNVY 219
G ++ S + ++ + ++ ENF +LG G +G V+
Sbjct: 12 GGSSGGAAGTSADGGDGGEQLLTVKHELRTANLTGHAEKVGIENFELLKVLGTGAYGKVF 71
Query: 220 ----KGKLGDGTVLAVKRL-KDMI----SLAVH----RNLLRLIG--------YCA--TP 256
G + A+K L K I H R +L I + A T
Sbjct: 72 LVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTE 131
Query: 257 TERL-LVYPYMSNGSVASRLREKPALDWNTRKRIAIGAAR--------GLLYLHEQCDPK 307
+L L+ Y++ G + + L + R+R + L +LH+
Sbjct: 132 -TKLHLILDYINGGELFTHLSQ--------RERFTEHEVQIYVGEIVLALEHLHKL---G 179
Query: 308 IIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGHIAPEYLSTGQSSE 367
II+RD+K N+LLD ++ DFGL+K ++ GT+ ++AP+ + G S
Sbjct: 180 IIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGH 239
Query: 368 KTDV--FGFGILLLELITG 384
V + G+L+ EL+TG
Sbjct: 240 DKAVDWWSLGVLMYELLTG 258
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 66.0 bits (162), Expect = 6e-12
Identities = 51/213 (23%), Positives = 88/213 (41%), Gaps = 44/213 (20%)
Query: 202 ENFSSKNILGAGGFGNVY----KGKLGDGTVLAVKRL-KDMISL--AVH----RNLLRLI 250
F +LG G FG V+ + A+K L K + + V R++L +
Sbjct: 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEV 83
Query: 251 G-------YCA--TPTERL-LVYPYMSNGSVASRLREKPALDWNTRKRIAIGAAR----- 295
+ A T +L L+ ++ G + +RL + +
Sbjct: 84 NHPFIVKLHYAFQTE-GKLYLILDFLRGGDLFTRLSK--------EVMFTEEDVKFYLAE 134
Query: 296 ---GLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTV 352
L +LH II+RD+K N+LLD+ + DFGL+K + GTV
Sbjct: 135 LALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSK-ESIDHEKKAYSFCGTV 190
Query: 353 GHIAPEYLSTGQSSEKT-DVFGFGILLLELITG 384
++APE + + ++ D + FG+L+ E++TG
Sbjct: 191 EYMAPEVV-NRRGHTQSADWWSFGVLMFEMLTG 222
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 8e-12
Identities = 45/207 (21%), Positives = 73/207 (35%), Gaps = 44/207 (21%)
Query: 210 LGAGGFGNVYKGK-LGDGTVLAVKRL-KDMI---------------------SLAVHRNL 246
LG+G FG V+ + VK + K+ + S H N+
Sbjct: 32 LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91
Query: 247 LRLIGYCATPTERLLVYPYMSNG-------SVASRLREKPALDWNTRKRIAIGAARGLLY 299
++++ LV +G RL E A I + Y
Sbjct: 92 IKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLA------SYIFRQLVSAVGY 145
Query: 300 LHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGHIAPEY 359
L + IIHRD+K N+++ + + DFG A L T GT+ + APE
Sbjct: 146 LRLK---DIIHRDIKDENIVIAEDFTIKLIDFGSAAYL-ERGKLFYTFC-GTIEYCAPEV 200
Query: 360 LSTGQSSE--KTDVFGFGILLLELITG 384
L G + +++ G+ L L+
Sbjct: 201 LM-GNPYRGPELEMWSLGVTLYTLVFE 226
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 65.2 bits (160), Expect = 8e-12
Identities = 59/209 (28%), Positives = 93/209 (44%), Gaps = 41/209 (19%)
Query: 202 ENFSSKNILGAGGFGNVYKGKL-GDGTVLAVKRLK-----------------DMISLAVH 243
++F LG G FG V+ + +G A+K LK M+S+ H
Sbjct: 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 65
Query: 244 RNLLRLIGYCATPTERLLVYPYMSNGSVASRLREKPALDWNTRKRIAIGAAR-------- 295
++R+ G + ++ Y+ G + S LR+ +R A+
Sbjct: 66 PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRK--------SQRFPNPVAKFYAAEVCL 117
Query: 296 GLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGHI 355
L YLH + II+RD+K N+LLD + DFG AK + VT + GT +I
Sbjct: 118 ALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVP----DVTYTLCGTPDYI 170
Query: 356 APEYLSTGQSSEKTDVFGFGILLLELITG 384
APE +ST ++ D + FGIL+ E++ G
Sbjct: 171 APEVVSTKPYNKSIDWWSFGILIYEMLAG 199
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 64.8 bits (159), Expect = 8e-12
Identities = 48/221 (21%), Positives = 86/221 (38%), Gaps = 37/221 (16%)
Query: 202 ENFSSKNILGAGGFGNVYKGK-LGDGTVLAVKRLK-DM------------ISL---AVHR 244
+ + +G G +G V+K K ++A+KR++ D I L H+
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 245 NLLRLIGYCATPTERLLVYPYMSNGSVASRLREKPA-LDWNTRKRIAIGAARGLLYLHEQ 303
N++RL + + LV+ + + LD K +GL + H +
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSR 120
Query: 304 CDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAV-----RGTVGHIAPE 358
++HRD+K N+L++ E + +FGLA+ + V R P+
Sbjct: 121 ---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYR------PPD 171
Query: 359 YL--STGQSSEKTDVFGFGILLLELITGMRALEFGKS-INQ 396
L + S+ D++ G + EL R L G +Q
Sbjct: 172 VLFGAKLYSTS-IDMWSAGCIFAELANAGRPLFPGNDVDDQ 211
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 65.3 bits (160), Expect = 9e-12
Identities = 60/224 (26%), Positives = 95/224 (42%), Gaps = 37/224 (16%)
Query: 198 QQATENFSSKNILGAGGFGNVYKGKLGDGTVLAVKRLK-DM------------ISL---A 241
Q E + +G G +G VYK K G ++A+KR++ D ISL
Sbjct: 17 QGLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKEL 76
Query: 242 VHRNLLRLIGYCATPTERLLVYPYMSNGSVASRLREKPA-LDWNTRKRIAIGAARGLLYL 300
H N++ LI + LV+ +M + L E L + K RG+ +
Sbjct: 77 HHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHC 135
Query: 301 HEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAV-----RGTVGHI 355
H+ +I+HRD+K N+L++ + DFGLA+ T V R
Sbjct: 136 HQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYR------ 186
Query: 356 APEYL--STGQSSEKTDVFGFGILLLELITGMRALEFGKS-INQ 396
AP+ L S S+ D++ G + E+ITG + L G + +Q
Sbjct: 187 APDVLMGSKKYSTS-VDIWSIGCIFAEMITG-KPLFPGVTDDDQ 228
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 65.3 bits (160), Expect = 1e-11
Identities = 49/211 (23%), Positives = 87/211 (41%), Gaps = 41/211 (19%)
Query: 202 ENFSSKNILGAGGFGNVYKGKL-GDGTVLAVKRLK--------DMISLAVHRNLLRLIG- 251
++F ++G G + V +L + A+K +K D+ + +++
Sbjct: 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASN 68
Query: 252 --------YCATPTERL-LVYPYMSNGSVASRLREKPALDWNTRKRIAIGAAR------- 295
C RL V Y++ G + ++ + +++ AR
Sbjct: 69 HPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQ--------RKLPEEHARFYSAEIS 120
Query: 296 -GLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGH 354
L YLHE+ II+RD+K NVLLD + D+G+ K T+ GT +
Sbjct: 121 LALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCK-EGLRPGDTTSTFCGTPNY 176
Query: 355 IAPEYLSTGQSSEKT-DVFGFGILLLELITG 384
IAPE L G+ + D + G+L+ E++ G
Sbjct: 177 IAPEIL-RGEDYGFSVDWWALGVLMFEMMAG 206
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 64.9 bits (159), Expect = 1e-11
Identities = 59/203 (29%), Positives = 90/203 (44%), Gaps = 25/203 (12%)
Query: 202 ENFSSKNILGAGGFGNVYKGKL-GDGTVLAVKRL-KDMI-------SLAVHRNLLRLIG- 251
+F+ +LG G FG V + G + AVK L KD++ V + +L L G
Sbjct: 20 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGK 79
Query: 252 --------YCATPTERL-LVYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHE 302
C +RL V Y++ G + +++ A A GL +L
Sbjct: 80 PPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQS 139
Query: 303 QCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGHIAPEYLST 362
+ II+RD+K NV+LD + DFG+ K + D T GT +IAPE +
Sbjct: 140 K---GIIYRDLKLDNVMLDSEGHIKIADFGMCK-ENIWDGVTTKTFCGTPDYIAPEII-A 194
Query: 363 GQSSEKT-DVFGFGILLLELITG 384
Q K+ D + FG+LL E++ G
Sbjct: 195 YQPYGKSVDWWAFGVLLYEMLAG 217
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 65.9 bits (161), Expect = 1e-11
Identities = 23/136 (16%), Positives = 39/136 (28%), Gaps = 28/136 (20%)
Query: 26 GSIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFLSIWLPRK 85
+L NL + + + + L L+ L ++ N +F
Sbjct: 415 SVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIF-------- 466
Query: 86 WDKRKCSGVDQGL-----LRLNNNSLSGAFPVFLAKISELAFLDLSYNNLSG-PVPKFPA 139
L L L+ L P +S L L+++ N L P F
Sbjct: 467 ----------TELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDR 516
Query: 140 ----RTFNVAGNPLIC 151
+ + NP C
Sbjct: 517 LTSLQKIWLHTNPWDC 532
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 3e-11
Identities = 24/119 (20%), Positives = 44/119 (36%), Gaps = 18/119 (15%)
Query: 19 SLSGTLSGSIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFL 78
S G S S T+L+ + L N + + L +L+ LD ++ L + +FL
Sbjct: 360 SFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFL 418
Query: 79 SIWLPRKWDKRKCSGVDQGL--LRLNNNSLSGAFPVFLAKISELAFLDLSYNNLSGPVP 135
S+ + L L +++ AF +S L L ++ N+
Sbjct: 419 SL---------------RNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFL 462
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 3e-11
Identities = 31/187 (16%), Positives = 60/187 (32%), Gaps = 40/187 (21%)
Query: 25 SGSIGNLTNLRQVLLQNNNISGGIPPQ-LGSLPKLQTLDLSNNRLSGVIPALLFLSIWLP 83
S S + L+ + L I I SL L TL L+ N + +
Sbjct: 45 SYSFFSFPELQVLDLSRCEIQT-IEDGAYQSLSHLSTLILTGNPIQSLALGAF------- 96
Query: 84 RKWDKRKCSGVDQGL-----LRLNNNSLSGAFPVFLAKISELAFLDLSYNNL-SGPVPKF 137
GL L +L+ + + L L++++N + S +P++
Sbjct: 97 ------------SGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEY 144
Query: 138 PA-----RTFNVAGNPL--ICGSSSTNVCSGSANSVPLSFSLNSSPDKQEEGLISLGNLR 190
+ +++ N + I + + ++ L SLN I G +
Sbjct: 145 FSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNF------IQPGAFK 198
Query: 191 NFTFREL 197
+L
Sbjct: 199 EIRLHKL 205
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 60.9 bits (148), Expect = 5e-10
Identities = 30/119 (25%), Positives = 52/119 (43%), Gaps = 12/119 (10%)
Query: 19 SLSGTLSGSIGNLTNLRQVLLQNNNI-SGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLF 77
+L+ + IG+L L+++ + +N I S +P +L L+ LDLS+N++ + L
Sbjct: 111 NLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLR 170
Query: 78 LSIWLPRKWDKRKCSGVDQGLLRLNNNSLSGAFPVFLAKISELAFLDLSYNNLSGPVPK 136
+ +P L L+ N ++ P +I L L L N S V K
Sbjct: 171 VLHQMPLLNLS----------LDLSLNPMNFIQPGAFKEIR-LHKLTLRNNFDSLNVMK 218
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 1e-08
Identities = 22/115 (19%), Positives = 36/115 (31%), Gaps = 19/115 (16%)
Query: 20 LSGTLSGSIGNLTNLRQVLLQNNNISGGIPPQ-LGSLPKLQTLDLSNNRLSGVIPALLFL 78
+G L++L + + N+ P L L LDLS +L + F
Sbjct: 433 TRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQ-LSPTAFN 491
Query: 79 SIWLPRKWDKRKCSGVDQGL--LRLNNNSLSGAFPVFLAKISELAFLDLSYNNLS 131
S L L L + +N L +++ L + L N
Sbjct: 492 S--LSS-------------LQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWD 531
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 2e-07
Identities = 17/72 (23%), Positives = 30/72 (41%), Gaps = 4/72 (5%)
Query: 26 GSIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFLSIWLPRK 85
+ +L++L+ + + +N + L LQ + L N P + +LS WL +
Sbjct: 488 TAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRIDYLSRWLNKN 547
Query: 86 ----WDKRKCSG 93
KCSG
Sbjct: 548 SQKEQGSAKCSG 559
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 1e-06
Identities = 35/181 (19%), Positives = 60/181 (33%), Gaps = 23/181 (12%)
Query: 21 SGTLSGSIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQ----TLDLSNNRLSGVIPALL 76
S L NLTNL + L +N I L L ++ +LDLS N ++ I
Sbjct: 138 SFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNF-IQPGA 196
Query: 77 FLSIWLPRKWDKRKCSGVDQGLLRLNNNSLSGA-FPVFLAKISELAFLDLSYNNL--SGP 133
F I L + L L NN S + ++ L L G
Sbjct: 197 FKEIRLHK--------------LTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGN 242
Query: 134 VPKFPARTFNVAGNPLICGSSSTNVCSGSANSVPLSFSLNSSPDKQEEGLISLGNLRNFT 193
+ KF N L + + F+ ++ +++ +++F+
Sbjct: 243 LEKFDKSALEGLCN-LTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFS 301
Query: 194 F 194
+
Sbjct: 302 Y 302
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 42.8 bits (101), Expect = 2e-04
Identities = 25/133 (18%), Positives = 42/133 (31%), Gaps = 12/133 (9%)
Query: 8 NLVIGLGAPSQSLSGTLSGSIGNLTNLRQVLL---QNNNISGGIPPQLGSLPKLQTLDLS 64
LV+G +L ++ L NL + I L + + L
Sbjct: 231 RLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLV 290
Query: 65 NNRLSGVIPALLFL----SIWLPRKWDKRKCSGVDQGL--LRLNNNSLSGAFPVFLAKIS 118
+ + + + + L + + + L L +N AF +
Sbjct: 291 SVTIER-VKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFS--EVDLP 347
Query: 119 ELAFLDLSYNNLS 131
L FLDLS N LS
Sbjct: 348 SLEFLDLSRNGLS 360
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 2e-11
Identities = 61/227 (26%), Positives = 96/227 (42%), Gaps = 39/227 (17%)
Query: 198 QQATENFSSKNILGAGGFGNVYKGKLGD-GTVLAVKR-----------LKDMISLAVHRN 245
+ +++ ++G G FG VY+ KL D G ++A+K+ L+ M L H N
Sbjct: 50 RPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLD-HCN 108
Query: 246 LLRLIGYCATPTERL------LVYPYMS---NGSVASRLREKPALDWNTRKRIAIGAARG 296
++RL + + E+ LV Y+ R K L K R
Sbjct: 109 IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 168
Query: 297 LLYLHEQCDPKIIHRDVKAANVLLDDFCEAI-VGDFGLAKLLDHSDSHVTTAV----RGT 351
L Y+H I HRD+K N+LLD + + DFG AK L + +V+ R
Sbjct: 169 LAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYR-- 223
Query: 352 VGHIAPEYLSTGQS-SEKTDVFGFGILLLELITGMRALEFGKS-INQ 396
APE + + DV+ G +L EL+ G + + G S ++Q
Sbjct: 224 ----APELIFGATDYTSSIDVWSAGCVLAELLLG-QPIFPGDSGVDQ 265
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 2e-11
Identities = 51/243 (20%), Positives = 91/243 (37%), Gaps = 31/243 (12%)
Query: 165 SVPLSFSLNSSPDKQEEGLISLGNLRNFTFRELQQATENFSSKNILGAGGFGNVYKGKL- 223
+ + E N R ++F ++G G + V +L
Sbjct: 15 PTTENLYFQGAMGSGIEEEKEAMNTRESGKASSSLGLQDFDLLRVIGRGSYAKVLLVRLK 74
Query: 224 GDGTVLAVKRLK--------DMISLAVHRNLLRLIG---------YCATPTERL-LVYPY 265
+ A++ +K D+ + +++ C RL V Y
Sbjct: 75 KTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEY 134
Query: 266 MSNGSVASRLREKPALDWNTRKRIAIGAAR---GLLYLHEQCDPKIIHRDVKAANVLLDD 322
++ G + ++ + L + +A L YLHE+ II+RD+K NVLLD
Sbjct: 135 VNGGDLMFHMQRQRKL---PEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDS 188
Query: 323 FCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGHIAPEYLSTGQSSEKT-DVFGFGILLLEL 381
+ D+G+ K T+ GT +IAPE L G+ + D + G+L+ E+
Sbjct: 189 EGHIKLTDYGMCK-EGLRPGDTTSTFCGTPNYIAPEIL-RGEDYGFSVDWWALGVLMFEM 246
Query: 382 ITG 384
+ G
Sbjct: 247 MAG 249
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 2e-11
Identities = 54/220 (24%), Positives = 89/220 (40%), Gaps = 36/220 (16%)
Query: 202 ENFSSKNILGAGGFGNVYKGK-LGDGTVLAVKRLKDM-------------ISL---AVHR 244
E + + ++G G +G V K + G ++A+K+ + I L H
Sbjct: 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHE 84
Query: 245 NLLRLIGYCATPTERLLVYPYMSNGSVASRLREKP-ALDWNTRKRIAIGAARGLLYLHEQ 303
NL+ L+ C LV+ ++ + ++ L P LD+ ++ G+ + H
Sbjct: 85 NLVNLLEVCKKKKRWYLVFEFVDH-TILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSH 143
Query: 304 CDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLL---DHSDSH--VTTAVRGTVGHIAPE 358
IIHRD+K N+L+ + DFG A+ L T R APE
Sbjct: 144 ---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYR------APE 194
Query: 359 YL-STGQSSEKTDVFGFGILLLELITGMRALEFGKS-INQ 396
L + + DV+ G L+ E+ G L G S I+Q
Sbjct: 195 LLVGDVKYGKAVDVWAIGCLVTEMFMG-EPLFPGDSDIDQ 233
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 63.4 bits (155), Expect = 3e-11
Identities = 56/233 (24%), Positives = 92/233 (39%), Gaps = 46/233 (19%)
Query: 199 QATENFSSKNILGAGGFGNVYKGK-LGDGTVLAVKRLK-DM---------------ISL- 240
AT + +G G +G VYK + G +A+K ++ ++L
Sbjct: 6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALL 65
Query: 241 -----AVHRNLLRLIGYCATPTERL-----LVYPYMSN--GSVASRLREKPALDWNTRKR 288
H N++RL+ CAT LV+ ++ + + P L T K
Sbjct: 66 RRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPP-PGLPAETIKD 124
Query: 289 IAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSD--SH--V 344
+ RGL +LH I+HRD+K N+L+ + DFGLA++ + + V
Sbjct: 125 LMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPVVV 181
Query: 345 TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKS-INQ 396
T R APE L + D++ G + E+ + L G S +Q
Sbjct: 182 TLWYR------APEVLLQSTYATPVDMWSVGCIFAEMFRR-KPLFCGNSEADQ 227
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 63.8 bits (156), Expect = 3e-11
Identities = 51/231 (22%), Positives = 95/231 (41%), Gaps = 44/231 (19%)
Query: 199 QATENFSSKNILGAGGFGNVYKGK--LGDGTVLAVKRLK-DM------------ISL--- 240
+A + + +G G +G V+K + G +A+KR++ +++
Sbjct: 8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRH 67
Query: 241 ---AVHRNLLRLIGYCATPTERL-----LVYPYMSN--GSVASRLREKPALDWNTRKRIA 290
H N++RL C LV+ ++ + ++ E P + T K +
Sbjct: 68 LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPE-PGVPTETIKDMM 126
Query: 291 IGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSD--SH--VTT 346
RGL +LH +++HRD+K N+L+ + + DFGLA++ + VT
Sbjct: 127 FQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTL 183
Query: 347 AVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKS-INQ 396
R APE L + D++ G + E+ + L G S ++Q
Sbjct: 184 WYR------APEVLLQSSYATPVDLWSVGCIFAEMFRR-KPLFRGSSDVDQ 227
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 63.8 bits (156), Expect = 3e-11
Identities = 60/246 (24%), Positives = 97/246 (39%), Gaps = 46/246 (18%)
Query: 167 PLSFSLNSSPDKQEEGLISLGNLRNFTFRELQQATENFSSKNILGAGGFGNVYKGKL-GD 225
P + N +P I+LG N + +F ++G G FG V + +
Sbjct: 8 PELMNANPAPPPAPSQQINLGPSSNPHAK-----PSDFHFLKVIGKGSFGKVLLARHKAE 62
Query: 226 GTVLAVKRL-KDMI-------SLAVHRNLLRLIG---------YCATPTERL-LVYPYMS 267
AVK L K I + RN+L + ++L V Y++
Sbjct: 63 EVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYIN 122
Query: 268 NGSVASRLREKPALDWNTRKRIAIGAAR--------GLLYLHEQCDPKIIHRDVKAANVL 319
G + L+ + + AR L YLH I++RD+K N+L
Sbjct: 123 GGELFYHLQRE--------RCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENIL 171
Query: 320 LDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGHIAPEYLSTGQSSEKT-DVFGFGILL 378
LD ++ DFGL K + + T+ GT ++APE L Q ++T D + G +L
Sbjct: 172 LDSQGHIVLTDFGLCK-ENIEHNSTTSTFCGTPEYLAPEVL-HKQPYDRTVDWWCLGAVL 229
Query: 379 LELITG 384
E++ G
Sbjct: 230 YEMLYG 235
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 63.4 bits (155), Expect = 4e-11
Identities = 53/221 (23%), Positives = 87/221 (39%), Gaps = 38/221 (17%)
Query: 202 ENFSSKNILGAGGFGNVYKGK-LGDGTVLAVKRLKDM-------------ISL---AVHR 244
E + +G G +G V+K + G ++A+K+ + I + H
Sbjct: 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHP 62
Query: 245 NLLRLIGYCATPTERLLVYPYMSNGSVASRLREKP-ALDWNTRKRIAIGAARGLLYLHEQ 303
NL+ L+ LV+ Y + +V L + + K I + + + H+
Sbjct: 63 NLVNLLEVFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKH 121
Query: 304 CDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAV-----RGTVGHIAPE 358
IHRDVK N+L+ + DFG A+LL + V R +PE
Sbjct: 122 ---NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYR------SPE 172
Query: 359 YL--STGQSSEKTDVFGFGILLLELITGMRALEFGKS-INQ 396
L T DV+ G + EL++G L GKS ++Q
Sbjct: 173 LLVGDTQYGPP-VDVWAIGCVFAELLSG-VPLWPGKSDVDQ 211
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 63.4 bits (155), Expect = 4e-11
Identities = 59/221 (26%), Positives = 97/221 (43%), Gaps = 39/221 (17%)
Query: 202 ENFSSKNILGAGGFGNVYKGKLGD-GTVLAVKRLKDM-------------ISL---AVHR 244
E + + LG G + VYKGK ++A+K ++ + +SL H
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIR-LEHEEGAPCTAIREVSLLKDLKHA 60
Query: 245 NLLRLIGYCATPTERLLVYPYMSNGSVASRLREKPA-LDWNTRKRIAIGAARGLLYLHEQ 303
N++ L T LV+ Y+ + L + ++ + K RGL Y H Q
Sbjct: 61 NIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQ 119
Query: 304 CDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLL---DHSDSH--VTTAVRGTVGHIAPE 358
K++HRD+K N+L+++ E + DFGLA+ + + VT R P+
Sbjct: 120 ---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVVTLWYR------PPD 170
Query: 359 YL--STGQSSEKTDVFGFGILLLELITGMRALEFGKS-INQ 396
L ST S++ D++G G + E+ TG R L G + Q
Sbjct: 171 ILLGSTDYSTQ-IDMWGVGCIFYEMATG-RPLFPGSTVEEQ 209
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 63.4 bits (155), Expect = 4e-11
Identities = 63/229 (27%), Positives = 98/229 (42%), Gaps = 44/229 (19%)
Query: 199 QATENFSSKNILGAGGFGNVYKGK-LGDGTVLAVKRLKDM-------------ISL---A 241
++ F LG G + VYKG G +A+K +K + ISL
Sbjct: 2 SSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVK-LDSEEGTPSTAIREISLMKEL 60
Query: 242 VHRNLLRLIGYCATPTERLLVYPYMSN------GSVASRLREKPALDWNTRKRIAIGAAR 295
H N++RL T + LV+ +M N S + L+ N K +
Sbjct: 61 KHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRG-LELNLVKYFQWQLLQ 119
Query: 296 GLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAV-----RG 350
GL + HE KI+HRD+K N+L++ + +GDFGLA+ + ++ V R
Sbjct: 120 GLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVVTLWYR- 175
Query: 351 TVGHIAPEYL--STGQSSEKTDVFGFGILLLELITGMRALEFGKS-INQ 396
AP+ L S S+ D++ G +L E+ITG + L G + Q
Sbjct: 176 -----APDVLMGSRTYSTS-IDIWSCGCILAEMITG-KPLFPGTNDEEQ 217
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 62.9 bits (154), Expect = 4e-11
Identities = 52/220 (23%), Positives = 93/220 (42%), Gaps = 37/220 (16%)
Query: 202 ENFSSKNILGAGGFGNVYKGKLGDGTVLAVKRLK-DM------------ISL---AVHRN 245
E + +G G +G VYK + G A+K+++ + IS+ H N
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 246 LLRLIGYCATPTERLLVYPYMSNGSVASRLREKPA-LDWNTRKRIAIGAARGLLYLHEQC 304
+++L T +LV+ ++ + L L+ T K + G+ Y H++
Sbjct: 62 IVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDR- 119
Query: 305 DPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAV-----RGTVGHIAPEY 359
+++HRD+K N+L++ E + DFGLA+ T + R AP+
Sbjct: 120 --RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYR------APDV 171
Query: 360 L--STGQSSEKTDVFGFGILLLELITGMRALEFGKS-INQ 396
L S S+ D++ G + E++ G L G S +Q
Sbjct: 172 LMGSKKYSTT-IDIWSVGCIFAEMVNG-TPLFPGVSEADQ 209
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 62.6 bits (153), Expect = 5e-11
Identities = 53/202 (26%), Positives = 88/202 (43%), Gaps = 40/202 (19%)
Query: 210 LGAGGFGNVYKGK-LGDGTVLAVKRL-KDMIS----------------LAVHRNLLRLIG 251
LG G FG V G+ G +AVK L + I L H ++++L
Sbjct: 19 LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78
Query: 252 YCATPTERLLVYPYMSNGSVASRLREKPALDWNTRKRIAIGAAR--------GLLYLHEQ 303
+TPT+ +V Y+S G + + + R+ AR + Y H
Sbjct: 79 VISTPTDFFMVMEYVSGGELFDYICKH--------GRVEEMEARRLFQQILSAVDYCHRH 130
Query: 304 CDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGHIAPEYLS-T 362
++HRD+K NVLLD A + DFGL+ ++ + T+ G+ + APE +S
Sbjct: 131 ---MVVHRDLKPENVLLDAHMNAKIADFGLSNMM-SDGEFLRTSC-GSPNYAAPEVISGR 185
Query: 363 GQSSEKTDVFGFGILLLELITG 384
+ + D++ G++L L+ G
Sbjct: 186 LYAGPEVDIWSCGVILYALLCG 207
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 5e-11
Identities = 26/139 (18%), Positives = 45/139 (32%), Gaps = 31/139 (22%)
Query: 25 SGSIGNLTNLRQVLLQNNNISGGIPPQ-LGSLPKLQTLDLSNNRLSGVIPALLFLSIWLP 83
+G L++L + + N+ P L L LDLS +L + F
Sbjct: 143 NGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE-QLSPTAF------ 195
Query: 84 RKWDKRKCSGVDQGL-----LRLNNNSLSGAFPVFLAKISELAFLDLSYNNLS----GPV 134
L L +++N+ ++ L LD S N++ +
Sbjct: 196 ------------NSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQEL 243
Query: 135 PKFPA--RTFNVAGNPLIC 151
FP+ N+ N C
Sbjct: 244 QHFPSSLAFLNLTQNDFAC 262
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 9e-10
Identities = 28/129 (21%), Positives = 42/129 (32%), Gaps = 32/129 (24%)
Query: 23 TLSGSIGNLTNLRQVLLQNNNISGGIPPQ--LGSLPKLQTLDLSNNRLSGVIPALLFLSI 80
T+S + L L + Q++N+ + SL L LD+S+ V +F
Sbjct: 92 TMSSNFLGLEQLEHLDFQHSNLK-QMSEFSVFLSLRNLIYLDISHTHTR-VAFNGIF--- 146
Query: 81 WLPRKWDKRKCSGVDQGLLRL------NNNSLSGAFPVFLAKISELAFLDLSYNNLSGPV 134
GL L N+ P ++ L FLDLS L
Sbjct: 147 ---------------NGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE--- 188
Query: 135 PKFPARTFN 143
+ FN
Sbjct: 189 -QLSPTAFN 196
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 56.9 bits (138), Expect = 4e-09
Identities = 23/108 (21%), Positives = 41/108 (37%), Gaps = 18/108 (16%)
Query: 25 SGSIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFLSIWLPR 84
S S T+L+ + L N + + L +L+ LD ++ L + +FLS L
Sbjct: 71 SQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLS--LRN 127
Query: 85 KWDKRKCSGVDQGL--LRLNNNSLSGAFPVFLAKISELAFLDLSYNNL 130
L L +++ AF +S L L ++ N+
Sbjct: 128 -------------LIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSF 162
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 2e-07
Identities = 25/116 (21%), Positives = 40/116 (34%), Gaps = 30/116 (25%)
Query: 25 SGSIGNLTNLRQVLLQNNNIS-GGIPPQ-LGSLPKLQTLDLSNNRLSGVIPALLFLSIWL 82
G LT L ++ L +N +S G Q L+ LDLS N + + L L
Sbjct: 45 HGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSNFLGLE--- 101
Query: 83 PRKWDKRKCSGVDQGL--LRLNNNSLS-----GAFPVFLAKISELAFLDLSYNNLS 131
L L +++L F + L +LD+S+ +
Sbjct: 102 --------------QLEHLDFQHSNLKQMSEFSVF----LSLRNLIYLDISHTHTR 139
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 3e-07
Identities = 25/108 (23%), Positives = 41/108 (37%), Gaps = 29/108 (26%)
Query: 32 TNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFLSIWLPRKWDKRKC 91
++ ++ L++N + L +L L LS+N LS F C
Sbjct: 28 SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLS-------FKGC----------C 70
Query: 92 SGVDQGL-----LRLNNN---SLSGAFPVFLAKISELAFLDLSYNNLS 131
S D G L L+ N ++S F + +L LD ++NL
Sbjct: 71 SQSDFGTTSLKYLDLSFNGVITMSSNF----LGLEQLEHLDFQHSNLK 114
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 8e-07
Identities = 23/122 (18%), Positives = 38/122 (31%), Gaps = 29/122 (23%)
Query: 18 QSLSGTLSGSIGNLTNLRQVLLQNNNISGGIPPQ-LGSLPKLQTLDLSNNRLSGVIPALL 76
L L NL + L + + P SL LQ L++S+N +
Sbjct: 161 SFQENFLPDIFTELRNLTFLDLSQCQLE-QLSPTAFNSLSSLQVLNMSHNNFF-SLDTFP 218
Query: 77 FLSIWLPRKWDKRKCSGVDQGL-----LRLNNNSLSGAFP--VFLAKISELAFLDLSYNN 129
+ + L L + N + S LAFL+L+ N+
Sbjct: 219 Y------------------KCLNSLQVLDYSLNHIM-TSKKQELQHFPSSLAFLNLTQND 259
Query: 130 LS 131
+
Sbjct: 260 FA 261
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 6e-11
Identities = 45/213 (21%), Positives = 80/213 (37%), Gaps = 47/213 (22%)
Query: 201 TENFSSKNILGAGGFGNVYKGK-LGDGTVLAVKRL-KDMISLAV---------------- 242
+ + LG+G G V +A+K + K ++
Sbjct: 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEI 68
Query: 243 -----HRNLLRLIGYCATPTERLLVYPYMSNG------SVASRLREKPALDWNTRKRIAI 291
H ++++ + + +V M G RL+E K
Sbjct: 69 LKKLNHPCIIKIKNFFDAE-DYYIVLELMEGGELFDKVVGNKRLKEATC------KLYFY 121
Query: 292 GAARGLLYLHEQCDPKIIHRDVKAANVLL---DDFCEAIVGDFGLAKLLDHSDSHVTTAV 348
+ YLHE IIHRD+K NVLL ++ C + DFG +K+L ++ + +
Sbjct: 122 QMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG--ETSLMRTL 176
Query: 349 RGTVGHIAPEYLSTGQS---SEKTDVFGFGILL 378
GT ++APE L + + + D + G++L
Sbjct: 177 CGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 209
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 6e-11
Identities = 28/186 (15%), Positives = 57/186 (30%), Gaps = 36/186 (19%)
Query: 25 SGSIGNLTNLRQVLLQNNNISGGIPPQL-GSLPKLQTLDLSNNRLSGVIPALLFLSIWLP 83
G + ++ + L+ N I +L S L+ L+L N + + +
Sbjct: 137 DLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQVVF----- 190
Query: 84 RKWDKRKCSGVDQGL--LRLNNNSLSGAFPVFLAKISELAFLDLSYNNLSGPVPKFPA-- 139
L L L++N L+ + + ++ L N L
Sbjct: 191 ------------AKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV----LIEKAL 233
Query: 140 ------RTFNVAGNPLICGSSSTNVCSGSANSVPLSFSLNSSPDKQEE--GLISLGNLRN 191
F++ GN CG+ ++ + EE + +LG+
Sbjct: 234 RFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYGA 293
Query: 192 FTFREL 197
+ +L
Sbjct: 294 YCCEDL 299
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 8e-10
Identities = 22/113 (19%), Positives = 38/113 (33%), Gaps = 26/113 (23%)
Query: 24 LSGSIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFLSIWLP 83
+ N + + ++++ + S ++ LDLS N LS + A L
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADL------- 54
Query: 84 RKWDKRKCSGVDQGL-----LRLNNNSLSGAFPVFLAKISELAFLDLSYNNLS 131
L L++N L L +S L LDL+ N +
Sbjct: 55 ------------APFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQ 93
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 1e-09
Identities = 29/127 (22%), Positives = 44/127 (34%), Gaps = 29/127 (22%)
Query: 19 SLSGTLSGSIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFL 78
SL L+ + N++++ L N +S L KL+ L+LS+N L L L
Sbjct: 21 SLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYE-TLDLESL 79
Query: 79 SIWLPRKWDKRKCSGVDQGL--LRLNNNSLSGAFPVFLAKISELAFLDLSYNNLSGPVPK 136
S L L LNNN + L + L + NN+S +
Sbjct: 80 S-----------------TLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS----R 113
Query: 137 FPARTFN 143
Sbjct: 114 VSCSRGQ 120
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 3e-09
Identities = 26/111 (23%), Positives = 39/111 (35%), Gaps = 22/111 (19%)
Query: 23 TLSGSIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFLSIWL 82
+ + L + LQ N I + Q+ KL+TLDLS+N+L+ + P +
Sbjct: 160 NFAELAASSDTLEHLNLQYNFIY-DVKGQV-VFAKLKTLDLSSNKLAFMGPEFQSAA--- 214
Query: 83 PRKWDKRKCSGVDQGL--LRLNNNSLSGAFPVFLAKISELAFLDLSYNNLS 131
G+ + L NN L L L DL N
Sbjct: 215 --------------GVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFH 250
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 2e-08
Identities = 20/106 (18%), Positives = 35/106 (33%), Gaps = 18/106 (16%)
Query: 27 SIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFLSIWLPRKW 86
+ ++ + NNNIS + + + L+NN+++ + L R
Sbjct: 94 ELLVGPSIETLHAANNNIS-RVSC--SRGQGKKNIYLANNKITM-LRDLDEGC--RSRV- 146
Query: 87 DKRKCSGVDQGLLRLNNNSLSG-AFPVFLAKISELAFLDLSYNNLS 131
L L N + F A L L+L YN +
Sbjct: 147 ----------QYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY 182
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 51.5 bits (124), Expect = 2e-07
Identities = 21/130 (16%), Positives = 37/130 (28%), Gaps = 18/130 (13%)
Query: 30 NLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFLSIWLPRKWDKR 89
L+ + L +N ++ + P+ S + + L NN+L +I L S L
Sbjct: 189 VFAKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEH----- 241
Query: 90 KCSGVDQGLLRLNNNSLS-GAFPVFLAKISELAFLDLSYN-NLSGPVPKFPARTFNVAGN 147
L N G F +K + + L+G +
Sbjct: 242 ---------FDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYG 292
Query: 148 PLICGSSSTN 157
C
Sbjct: 293 AYCCEDLPAP 302
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 40.7 bits (96), Expect = 7e-04
Identities = 17/90 (18%), Positives = 30/90 (33%), Gaps = 24/90 (26%)
Query: 47 GIPPQLGSLPKLQTLDLSNNRLSGVIPALLFLSIWLPRKWDKRKCSGVDQGL-----LRL 101
I + + + ++++ L + +L Q L L
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLR-------------------QSAWNVKELDL 41
Query: 102 NNNSLSGAFPVFLAKISELAFLDLSYNNLS 131
+ N LS LA ++L L+LS N L
Sbjct: 42 SGNPLSQISAADLAPFTKLELLNLSSNVLY 71
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 8e-11
Identities = 32/103 (31%), Positives = 50/103 (48%), Gaps = 7/103 (6%)
Query: 295 RGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGH 354
G+ +LH IIHRD+K +N+++ C + DFGLA+ S + T T +
Sbjct: 138 CGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG--TSFMMTPYVVTRYY 192
Query: 355 IAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKS-INQ 396
APE + E D++ G ++ E+I G L G I+Q
Sbjct: 193 RAPEVILGMGYKENVDIWSVGCIMGEMIKG-GVLFPGTDHIDQ 234
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 62.2 bits (151), Expect = 8e-11
Identities = 27/110 (24%), Positives = 38/110 (34%), Gaps = 17/110 (15%)
Query: 31 LTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFLSIWLPRKWDKRK 90
L+ + + + Q+ P L TLDLS+N G + L
Sbjct: 148 KPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISAL------------ 195
Query: 91 CSGVDQGL--LRLNNN---SLSGAFPVFLAKISELAFLDLSYNNLSGPVP 135
C L L L N + SG A +L LDLS+N+L
Sbjct: 196 CPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAG 245
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 61.5 bits (149), Expect = 1e-10
Identities = 33/131 (25%), Positives = 44/131 (33%), Gaps = 28/131 (21%)
Query: 29 GNLTNLRQVLLQNNN---ISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFLSIWLPRK 85
L+ + L+N SG + +LQ LDLS+N L A W +
Sbjct: 198 LKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCD--WPSQ- 254
Query: 86 WDKRKCSGVDQGLLRLN--NNSLSGAFPVFLAKISELAFLDLSYNNLSGPVPKFPA---- 139
L LN L AK L+ LDLSYN L P
Sbjct: 255 ------------LNSLNLSFTGLKQVPKGLPAK---LSVLDLSYNRLDR-NPSPDELPQV 298
Query: 140 RTFNVAGNPLI 150
++ GNP +
Sbjct: 299 GNLSLKGNPFL 309
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 57.2 bits (138), Expect = 4e-09
Identities = 23/119 (19%), Positives = 38/119 (31%), Gaps = 24/119 (20%)
Query: 18 QSLSGTLSGSIGNLTNLRQVLLQNNNISGGIPPQLGSLP-KLQTLDLSNNRLSGVIPALL 76
++ SG S L+ + L +N++ P +L +L+LS L V L
Sbjct: 214 ETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLKQVPKGLP 273
Query: 77 FLSIWLPRKWDKRKCSGVDQGL--LRLNNNSLSGAFPVFLAKISELAFLDLSYNNLSGP 133
L L L+ N L P ++ ++ L L N
Sbjct: 274 -------------------AKLSVLDLSYNRLDR-NP-SPDELPQVGNLSLKGNPFLDS 311
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 55.7 bits (134), Expect = 1e-08
Identities = 30/126 (23%), Positives = 45/126 (35%), Gaps = 14/126 (11%)
Query: 16 PSQSLSGTLSGSIGNLTNLRQVLLQNNNISGGIPPQLGSL--PKLQTLDLSNNRLSGVIP 73
PS+ L G L + ++ L+++ L+N ++G PP L P L L+L N +
Sbjct: 81 PSRILFGALR--VLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDA 138
Query: 74 ALLFLSIWLPRKWDKRKCSGVDQGLLRLNNNSLSGAFPVFLAKISELAFLDLSYNNLSGP 133
L L WL L + + L+ LDLS N G
Sbjct: 139 WLAELQQWLKPGLKV----------LSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGE 188
Query: 134 VPKFPA 139
A
Sbjct: 189 RGLISA 194
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 62.2 bits (152), Expect = 9e-11
Identities = 55/214 (25%), Positives = 85/214 (39%), Gaps = 44/214 (20%)
Query: 202 ENFSSKNILGAGGFGNVY----KGKLGDGTVLAVKRL-KDMI--------SLAVHRNLLR 248
E F +LG GG+G V+ G + A+K L K MI RN+L
Sbjct: 17 ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILE 76
Query: 249 LIG--------YCATPTERL-LVYPYMSNGSVASRLREKPALDWNTRKRIAIGAAR---- 295
+ Y +L L+ Y+S G + +L A
Sbjct: 77 EVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLER--------EGIFMEDTACFYLA 128
Query: 296 ----GLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGT 351
L +LH++ II+RD+K N++L+ + DFGL K D VT GT
Sbjct: 129 EISMALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCK-ESIHDGTVTHTFCGT 184
Query: 352 VGHIAPEYLSTGQSSEKT-DVFGFGILLLELITG 384
+ ++APE L + D + G L+ +++TG
Sbjct: 185 IEYMAPEIL-MRSGHNRAVDWWSLGALMYDMLTG 217
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 62.2 bits (152), Expect = 1e-10
Identities = 30/128 (23%), Positives = 51/128 (39%), Gaps = 25/128 (19%)
Query: 27 SIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFLSIWLPRKW 86
+ NL+ L + + N IS + L KL+ L++ +N++S I L LS
Sbjct: 238 PLANLSQLTWLEIGTNQISD--INAVKDLTKLKMLNVGSNQISD-ISVLNNLS------- 287
Query: 87 DKRKCSGVDQGL--LRLNNNSLSGAFPVFLAKISELAFLDLSYNNLSG--PVPKFPA-RT 141
L L LNNN L + ++ L L LS N+++ P+ +
Sbjct: 288 ----------QLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRPLASLSKMDS 337
Query: 142 FNVAGNPL 149
+ A +
Sbjct: 338 ADFANQVI 345
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 58.3 bits (142), Expect = 2e-09
Identities = 22/105 (20%), Positives = 46/105 (43%), Gaps = 18/105 (17%)
Query: 27 SIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFLSIWLPRKW 86
++ +LT L+ + + +N IS L +L +L +L L+NN+L ++
Sbjct: 260 AVKDLTKLKMLNVGSNQISD--ISVLNNLSQLNSLFLNNNQLGNEDMEVI---------- 307
Query: 87 DKRKCSGVDQGLLRLNNNSLSGAFPVFLAKISELAFLDLSYNNLS 131
+ + L L+ N ++ P LA +S++ D + +
Sbjct: 308 --GGLTNLTT--LFLSQNHITDIRP--LASLSKMDSADFANQVIK 346
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 56.0 bits (136), Expect = 9e-09
Identities = 20/107 (18%), Positives = 39/107 (36%), Gaps = 23/107 (21%)
Query: 28 IGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFLSIWLPRKWD 87
+ NL L + + N I+ L +L L+ L L+ + +S I L L+
Sbjct: 84 LSNLVKLTNLYIGTNKIT--DISALQNLTNLRELYLNEDNISD-ISPLANLT-------- 132
Query: 88 KRKCSGVDQGL--LRLNNNSLSGAFPVFLAKISELAFLDLSYNNLSG 132
+ L L N L+ ++ L +L ++ + +
Sbjct: 133 ---------KMYSLNLGANHNLS-DLSPLSNMTGLNYLTVTESKVKD 169
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 56.0 bits (136), Expect = 1e-08
Identities = 31/113 (27%), Positives = 49/113 (43%), Gaps = 24/113 (21%)
Query: 27 SIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFLSIWLPRKW 86
I LTNL + L N I+ I P L +L KL L + N+++ I AL L+
Sbjct: 61 GIEYLTNLEYLNLNGNQITD-ISP-LSNLVKLTNLYIGTNKITD-ISALQNLT------- 110
Query: 87 DKRKCSGVDQGL--LRLNNNSLSGAFPVFLAKISELAFLDLSYNNLSGPVPKF 137
L L LN +++S P LA ++++ L+L N+ +
Sbjct: 111 ----------NLRELYLNEDNISDISP--LANLTKMYSLNLGANHNLSDLSPL 151
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 56.0 bits (136), Expect = 1e-08
Identities = 22/111 (19%), Positives = 45/111 (40%), Gaps = 24/111 (21%)
Query: 27 SIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFLSIWLPRKW 86
+ +LT+L N I+ I P + ++ +L +L + NN+++ + L LS
Sbjct: 194 PLASLTSLHYFTAYVNQITD-ITP-VANMTRLNSLKIGNNKITD-LSPLANLS------- 243
Query: 87 DKRKCSGVDQGL--LRLNNNSLSGAFPVFLAKISELAFLDLSYNNLSGPVP 135
L L + N +S + +++L L++ N +S
Sbjct: 244 ----------QLTWLEIGTNQISDINA--VKDLTKLKMLNVGSNQISDISV 282
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 54.9 bits (133), Expect = 3e-08
Identities = 16/106 (15%), Positives = 43/106 (40%), Gaps = 20/106 (18%)
Query: 27 SIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFLSIWLPRKW 86
+ L ++ ++++ ++ I + L L+ L+L+ N+++ + P + +
Sbjct: 39 TQEELESITKLVVAGEKVAS-IQG-IEYLTNLEYLNLNGNQITDISPLSNLVKLT----- 91
Query: 87 DKRKCSGVDQGLLRLNNNSLSGAFPVFLAKISELAFLDLSYNNLSG 132
L + N ++ L ++ L L L+ +N+S
Sbjct: 92 -----------NLYIGTNKITD--ISALQNLTNLRELYLNEDNISD 124
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 54.5 bits (132), Expect = 3e-08
Identities = 22/108 (20%), Positives = 40/108 (37%), Gaps = 23/108 (21%)
Query: 27 SIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIP--ALLFLSIWLPR 84
+ NLT + + L N+ + P L ++ L L ++ +++ V P L L
Sbjct: 127 PLANLTKMYSLNLGANHNLSDLSP-LSNMTGLNYLTVTESKVKDVTPIANLTDLYS---- 181
Query: 85 KWDKRKCSGVDQGLLRLNNNSLSGAFPVFLAKISELAFLDLSYNNLSG 132
L LN N + P LA ++ L + N ++
Sbjct: 182 --------------LSLNYNQIEDISP--LASLTSLHYFTAYVNQITD 213
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 52.2 bits (126), Expect = 2e-07
Identities = 17/111 (15%), Positives = 41/111 (36%), Gaps = 24/111 (21%)
Query: 27 SIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFLSIWLPRKW 86
+L + +LQ +++ + L + L ++ +++ I + +L+
Sbjct: 17 PDADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKVAS-IQGIEYLT------- 66
Query: 87 DKRKCSGVDQGL--LRLNNNSLSGAFPVFLAKISELAFLDLSYNNLSGPVP 135
L L LN N ++ P L+ + +L L + N ++
Sbjct: 67 ----------NLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKITDISA 105
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 49.1 bits (118), Expect = 2e-06
Identities = 18/50 (36%), Positives = 25/50 (50%), Gaps = 2/50 (4%)
Query: 20 LSGTLSGSIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLS 69
L IG LTNL + L N+I+ I P L SL K+ + D +N +
Sbjct: 299 LGNEDMEVIGGLTNLTTLFLSQNHIT-DIRP-LASLSKMDSADFANQVIK 346
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 63.3 bits (154), Expect = 1e-10
Identities = 24/110 (21%), Positives = 42/110 (38%), Gaps = 17/110 (15%)
Query: 25 SGSIGNLTNLRQVLLQNNNISGGIPPQ-LGSLPKLQTLDLSNNRLSGVIPALLFLSIWLP 83
+ S L L+ + L + I + +LP L+ LDL ++++ + F ++
Sbjct: 41 ASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIY-FLHPDAFQGLFHL 99
Query: 84 RKWDKRKCSGVDQGLLRLNNNSLSGAF--PVFLAKISELAFLDLSYNNLS 131
+ LRL LS A + + L LDLS N +
Sbjct: 100 FE-------------LRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIR 136
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 59.0 bits (143), Expect = 2e-09
Identities = 32/135 (23%), Positives = 49/135 (36%), Gaps = 25/135 (18%)
Query: 25 SGSIGNLTNLRQVLLQNNNISGGIPPQL-----GSLPKLQTLDLSNNRLSGVIPALLFLS 79
+ +L Q+ L N + +L L LQ L L++N L+ +P +F
Sbjct: 444 DQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLN-SLPPGVFSH 502
Query: 80 IWLPR-KWDKRKCSGVDQGLLRLNNNSLSGAFPVFLAKISELAFLDLSYNNLSGPVPKFP 138
L + L LN+N L+ L + L LD+S N L P P
Sbjct: 503 --LTALRG------------LSLNSNRLTVLSHNDLP--ANLEILDISRNQLLAPNPDVF 546
Query: 139 A--RTFNVAGNPLIC 151
++ N IC
Sbjct: 547 VSLSVLDITHNKFIC 561
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 56.7 bits (137), Expect = 1e-08
Identities = 25/109 (22%), Positives = 40/109 (36%), Gaps = 18/109 (16%)
Query: 25 SGSIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFLSIWLPR 84
S L +L+ + L N I+ L LQ L+LS N L + + F LP+
Sbjct: 283 SRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLG-ELYSSNF--YGLPK 339
Query: 85 KWDKRKCSGVDQGL--LRLNNNSLSGAFPVFLAKISELAFLDLSYNNLS 131
+ + L N ++ + +L LDL N L+
Sbjct: 340 -------------VAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALT 375
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 56.0 bits (135), Expect = 2e-08
Identities = 30/183 (16%), Positives = 57/183 (31%), Gaps = 28/183 (15%)
Query: 30 NLTNLRQVLLQNNNISGGIPPQ--LGSLPKLQTLDLSNNRLSGVIPALLFLSIWLPRKWD 87
L +L ++ L +S + +L L LDLS N++ + F L
Sbjct: 95 GLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGK--LNSLK- 151
Query: 88 KRKCSGVDQGLLRLNNNSLS----GAFPVFLAKISELAFLDLSYNNLSGPVPKFPARTFN 143
+ ++N + + L+F L+ N+L + +
Sbjct: 152 ----------SIDFSSNQIFLVCEHELEPL--QGKTLSFFSLAANSLY----SRVSVDWG 195
Query: 144 VAGNPLICGSSSTNVCSGSANS-VPLSFSLNSSPDKQEEGLISLGNLR--NFTFRELQQA 200
NP SG+ + N+ Q LI ++ F F ++
Sbjct: 196 KCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDP 255
Query: 201 TEN 203
+N
Sbjct: 256 DQN 258
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 53.7 bits (129), Expect = 1e-07
Identities = 23/104 (22%), Positives = 34/104 (32%), Gaps = 17/104 (16%)
Query: 30 NLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFLSIWLPRKWDKR 89
L ++LL N I L +LQ L+L + I F + LP
Sbjct: 22 VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRN--LPN----- 74
Query: 90 KCSGVDQGL--LRLNNNSLSGAFPVFLAKISELAFLDLSYNNLS 131
L L L ++ + P + L L L + LS
Sbjct: 75 --------LRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLS 110
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 53.3 bits (128), Expect = 2e-07
Identities = 24/111 (21%), Positives = 37/111 (33%), Gaps = 19/111 (17%)
Query: 25 SGSIGNLTNLRQVLLQNNNISGGIPPQ-LGSLPKLQTLDLSNNRLSGVIPALLFLSIWLP 83
+ NL NLR + L ++ I + P L L L L LS + + L
Sbjct: 66 KEAFRNLPNLRILDLGSSKIYF-LHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFR-NLK 123
Query: 84 RKWDKRKCSGVDQGL--LRLNNNSLSG-AFPVFLAKISELAFLDLSYNNLS 131
L L L+ N + K++ L +D S N +
Sbjct: 124 A-------------LTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIF 161
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 51.3 bits (123), Expect = 6e-07
Identities = 25/136 (18%), Positives = 48/136 (35%), Gaps = 19/136 (13%)
Query: 25 SGSIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFLSIWLPR 84
L++L+ + L +N ++ P L L+ L L++NRL+ + L ++
Sbjct: 473 WDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDLPANL---- 528
Query: 85 KWDKRKCSGVDQGLLRLNNNSLSGAFPVFLAKISELAFLDLSYNNLSGPVPKFPARTFNV 144
+L ++ N L P +S LD+++N +
Sbjct: 529 ------------EILDISRNQLLAPNPDVFVSLSV---LDITHNKFICECELSTFINWLN 573
Query: 145 AGNPLICGSSSTNVCS 160
N I G + C
Sbjct: 574 HTNVTIAGPPADIYCV 589
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 49.4 bits (118), Expect = 2e-06
Identities = 37/157 (23%), Positives = 56/157 (35%), Gaps = 25/157 (15%)
Query: 16 PSQSLSGTLSGSIGNLT-NLRQVLLQNNNISG-GIPPQLGSLPKLQTLDLSNNRLSGVIP 73
P LSG ++ + + L N + I L +P LQ L L+ NR S
Sbjct: 384 PDIFLSGNKLVTLPKINLTANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSG 443
Query: 74 ALLFLSIWLP-------------RKWDKRKCSGVDQGL-----LRLNNNSLSGAFPVFLA 115
P W+ C V +GL L LN+N L+ P +
Sbjct: 444 DQTP--SENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFS 501
Query: 116 KISELAFLDLSYNNLSG-PVPKFPA--RTFNVAGNPL 149
++ L L L+ N L+ PA +++ N L
Sbjct: 502 HLTALRGLSLNSNRLTVLSHNDLPANLEILDISRNQL 538
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 49.0 bits (117), Expect = 3e-06
Identities = 17/106 (16%), Positives = 41/106 (38%), Gaps = 24/106 (22%)
Query: 31 LTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFLSIWLPRKWDKRK 90
+++R + L + + +L L+ L+L+ N+++ +
Sbjct: 265 RSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIAD----------------- 307
Query: 91 CSGVDQGL-----LRLNNNSLSGAFPVFLAKISELAFLDLSYNNLS 131
GL L L+ N L + + ++A++DL N+++
Sbjct: 308 --EAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIA 351
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 48.3 bits (115), Expect = 5e-06
Identities = 19/114 (16%), Positives = 37/114 (32%), Gaps = 6/114 (5%)
Query: 24 LSGSIGNLTNLRQVLLQNNNISGGIPPQLGSL--PKLQTLDLSNNRLSGVIPALLFLSIW 81
L S G L +L+ + +N I +L L L L+ N L + +
Sbjct: 140 LHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMN 199
Query: 82 LPRKWDKRKC----SGVDQGLLRLNNNSLSGAFPVFLAKISELAFLDLSYNNLS 131
R +G + +N++S + L + ++N+
Sbjct: 200 PFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIK 253
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 46.7 bits (111), Expect = 2e-05
Identities = 27/137 (19%), Positives = 48/137 (35%), Gaps = 30/137 (21%)
Query: 19 SLSGTLSGSIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFL 78
++ + L NL+ + L N + LPK+ +DL N ++ +I F
Sbjct: 301 KINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIA-IIQDQTF- 358
Query: 79 SIWLPRKWDKRKCSGVDQGL-----LRLNNNSLSGAFPVFLAKISELAFLDLSYNNLSG- 132
+ L L L +N+L+ + I + + LS N L
Sbjct: 359 -----------------KFLEKLQTLDLRDNALT-----TIHFIPSIPDIFLSGNKLVTL 396
Query: 133 PVPKFPARTFNVAGNPL 149
P A +++ N L
Sbjct: 397 PKINLTANLIHLSENRL 413
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 41.3 bits (97), Expect = 7e-04
Identities = 18/127 (14%), Positives = 33/127 (25%), Gaps = 18/127 (14%)
Query: 29 GNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFLSIWLPR---- 84
GN + +N IS L + + + F +
Sbjct: 213 GNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIK-DPDQNTFAGLARSSVRHL 271
Query: 85 KWDKRKCSGVDQGL---------LRLNNNSLSGAFPVFLAKISELAFLDLSYNNLSGPVP 135
++ + L L N ++ + L L+LSYN L
Sbjct: 272 DLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLG---- 327
Query: 136 KFPARTF 142
+ + F
Sbjct: 328 ELYSSNF 334
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 2e-10
Identities = 25/151 (16%), Positives = 51/151 (33%), Gaps = 43/151 (28%)
Query: 25 SGSIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFLSIWLPR 84
+ L NL + + N +P K++ L+LS+ + V+ + ++
Sbjct: 380 GEILLTLKNLTSLDISRNTFHP-MPDSCQWPEKMRFLNLSSTGIR-VVKTCIPQTL---- 433
Query: 85 KWDKRKCSGVDQGLLRLNNNSLSGAFPVFLAKISEL-------------AF------LDL 125
+L ++NN+L +F +FL ++ EL + + +
Sbjct: 434 ------------EVLDVSNNNLD-SFSLFLPRLQELYISRNKLKTLPDASLFPVLLVMKI 480
Query: 126 SYNNLSGPVPKFPA-----RTFNVAGNPLIC 151
S N L + + NP C
Sbjct: 481 SRNQLKSVPDGIFDRLTSLQKIWLHTNPWDC 511
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 55.9 bits (135), Expect = 2e-08
Identities = 29/190 (15%), Positives = 56/190 (29%), Gaps = 26/190 (13%)
Query: 25 SGSIGNLTNLRQVLLQNNNISGGIPPQ-LGSLPKLQTLDLSNNRLSGVIPALLFLSIWLP 83
+ +L +L + L +N++S + G L L+ L+L N + LF + L
Sbjct: 67 GDAFYSLGSLEHLDLSDNHLSS-LSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPN--LT 123
Query: 84 RKWDKRKCSGVDQGLLRL---NNNSLSGAFPVFLAKISELAFLDLSYNNLSGPVPKFPA- 139
L L N + S + A ++ L L++ +L +
Sbjct: 124 N-------------LQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKS 170
Query: 140 ----RTFNVAGNPLICGSSSTNVCSGSANSVPLSF-SLNSSPDKQEEGLISLGNLRNFTF 194
+ + S + L +L ++ F
Sbjct: 171 IRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAF 230
Query: 195 RELQQATENF 204
R E+F
Sbjct: 231 RGSVLTDESF 240
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 6e-08
Identities = 21/128 (16%), Positives = 40/128 (31%), Gaps = 16/128 (12%)
Query: 19 SLSGTLSGSIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFL 78
L LS L ++++ ++N+ + L L+ LDLS N +
Sbjct: 297 YLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSAC 356
Query: 79 SIWLP----------RKWDKRKCSGVDQGL-----LRLNNNSLSGAFPVFLAKISELAFL 123
P +K + L L ++ N+ ++ FL
Sbjct: 357 KGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFHPMPDSC-QWPEKMRFL 415
Query: 124 DLSYNNLS 131
+LS +
Sbjct: 416 NLSSTGIR 423
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 53.2 bits (128), Expect = 1e-07
Identities = 33/182 (18%), Positives = 59/182 (32%), Gaps = 33/182 (18%)
Query: 29 GNLTNLRQVLLQNNNISGGIPPQ-LGSLPKLQTLDLSNNRLSGVIPALLFLSIWLPRKWD 87
G ++ + L N I+ I L + LQ L L ++R++ I F
Sbjct: 23 GLTAAMKSLDLSFNKITY-IGHGDLRACANLQVLILKSSRIN-TIEGDAF---------- 70
Query: 88 KRKCSGVDQGL-----LRLNNNSLSGAFPVFLAKISELAFLDLSYNNLSG-PVPKFPA-- 139
L L L++N LS + +S L +L+L N V
Sbjct: 71 --------YSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNL 122
Query: 140 ---RTFNVAGNPLICGSSSTNVCSGSANSVPLSFSLNSSPDKQEEGLISLGNLRNFTFRE 196
+T + +G + L S + Q + L S+ ++ + T
Sbjct: 123 TNLQTLRIGNVETFS-EIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHL 181
Query: 197 LQ 198
+
Sbjct: 182 SE 183
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 49.0 bits (117), Expect = 3e-06
Identities = 17/72 (23%), Positives = 25/72 (34%), Gaps = 6/72 (8%)
Query: 27 SIGNLTNLRQVLLQNNNISGGIPPQ-LGSLPKLQTLDLSNNRLSGVIPALLFLSIWLPRK 85
L + + N + +P L LQ + L N P + +LS WL +
Sbjct: 468 DASLFPVLLVMKISRNQLKS-VPDGIFDRLTSLQKIWLHTNPWDCSCPRIDYLSRWLNKN 526
Query: 86 ----WDKRKCSG 93
KCSG
Sbjct: 527 SQKEQGSAKCSG 538
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 47.8 bits (114), Expect = 7e-06
Identities = 16/110 (14%), Positives = 35/110 (31%), Gaps = 27/110 (24%)
Query: 30 NLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFLSIWLPRKWDKR 89
+R++ + + + L K++ + + N+++ ++P
Sbjct: 284 ETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVF-LVPCSFS------------ 330
Query: 90 KCSGVDQGL-----LRLNNNSLSGAF---PVFLAKISELAFLDLSYNNLS 131
Q L L L+ N + + L L LS N+L
Sbjct: 331 ------QHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLR 374
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 4e-05
Identities = 24/181 (13%), Positives = 52/181 (28%), Gaps = 22/181 (12%)
Query: 18 QSLSGTLSGSIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLF 77
++ S LT+L ++ ++ ++ L S+ + L L + + + +
Sbjct: 134 ETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESA-FLLEIFA 192
Query: 78 LSIWLPRKWDKRKCSGVDQGLLRLNNNSLSGAFPVFLAKISELAFLDLSYNNLSGPVPKF 137
L L L + +L+ L + + S
Sbjct: 193 D--ILSSVR-----------YLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGS----VL 235
Query: 138 PARTFNVAGNPLICGSSSTNVCSGSANSVPLSFSLNSSPDKQEEGLISLGNLRNFTFREL 197
+FN L + + L+ L + + + LG + T R L
Sbjct: 236 TDESFN---ELLKLLRYILELSEVEFDDCTLN-GLGDFNPSESDVVSELGKVETVTIRRL 291
Query: 198 Q 198
Sbjct: 292 H 292
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 61.8 bits (150), Expect = 2e-10
Identities = 36/153 (23%), Positives = 57/153 (37%), Gaps = 42/153 (27%)
Query: 30 NLTNLRQVLLQNNNISGGIPPQ-LGSLPKLQTLDLSNNRLSGVIPALLFLSIW------- 81
LTNL +LL +N+++ I + +P L+ LDLS+N L + LF +
Sbjct: 62 RLTNLHSLLLSHNHLNF-ISSEAFVPVPNLRYLDLSSNHLH-TLDEFLFSDLQALEVLLL 119
Query: 82 -------LPRKWDKRKCSGVDQGL-----LRLNNNSLS----GAFPVFLAKISELAFLDL 125
+ R + + L L+ N +S K+ +L LDL
Sbjct: 120 YNNHIVVVDR--------NAFEDMAQLQKLYLSQNQISRFPVELI-KDGNKLPKLMLLDL 170
Query: 126 SYNNLS-------GPVPKFPARTFNVAGNPLIC 151
S N L +P + + NPL C
Sbjct: 171 SSNKLKKLPLTDLQKLPAWVKNGLYLHNNPLEC 203
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 61.8 bits (150), Expect = 2e-10
Identities = 48/221 (21%), Positives = 87/221 (39%), Gaps = 35/221 (15%)
Query: 201 TENFSSKNILGAGGFGNVYKGK-LGDGTVLAVKRLKDMISLAV----------------H 243
+ + + +G+G G V +A+K+L H
Sbjct: 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 120
Query: 244 RNLLRLIGYCATPTERL-------LVYPYMSNGSVASRLREKPALDWNTRKRIAIGAARG 296
+N++ L+ TP + L LV M + ++ + LD + G
Sbjct: 121 KNIISLL-NVFTPQKTLEEFQDVYLVMELM--DANLCQVIQME-LDHERMSYLLYQMLCG 176
Query: 297 LLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGHIA 356
+ +LH IIHRD+K +N+++ C + DFGLA+ S + T T + A
Sbjct: 177 IKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG--TSFMMTPYVVTRYYRA 231
Query: 357 PEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKS-INQ 396
PE + E D++ G ++ E++ + L G+ I+Q
Sbjct: 232 PEVILGMGYKENVDIWSVGCIMGEMVRH-KILFPGRDYIDQ 271
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 2e-10
Identities = 50/200 (25%), Positives = 76/200 (38%), Gaps = 38/200 (19%)
Query: 210 LGAGGFGNVYKGK-LGDGTVLAVKRL-KDMIS------------LAVHRNLLRLIGYCAT 255
+G+G FG + ++AVK + + H N++R T
Sbjct: 28 IGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRFKEVILT 87
Query: 256 PTERLLVYPYMSNGSVASRLREKPALDWNTRKRIAIGAAR--------GLLYLHEQCDPK 307
PT ++ Y S G + R+ R + AR G+ Y H +
Sbjct: 88 PTHLAIIMEYASGGELYERICNA--------GRFSEDEARFFFQQLLSGVSYCHSM---Q 136
Query: 308 IIHRDVKAANVLLDDFCEAI--VGDFGLAKLLDHSDSHVTTAVRGTVGHIAPEYLS-TGQ 364
I HRD+K N LLD + DFG +K S + V GT +IAPE L
Sbjct: 137 ICHRDLKLENTLLDGSPAPRLKICDFGYSKSS-VLHSQPKSTV-GTPAYIAPEVLLRQEY 194
Query: 365 SSEKTDVFGFGILLLELITG 384
+ DV+ G+ L ++ G
Sbjct: 195 DGKIADVWSCGVTLYVMLVG 214
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 61.4 bits (149), Expect = 3e-10
Identities = 46/223 (20%), Positives = 82/223 (36%), Gaps = 50/223 (22%)
Query: 210 LGAGGFGNVYKGK---LGDGTVLAVKRLKDM---------ISL---AVHRNLLRLIGYCA 254
+G G +G+VYK K D A+K+++ I+L H N++ L
Sbjct: 29 VGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFL 88
Query: 255 TPTERL--LVYPYMS--------NGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQC 304
+ +R L++ Y + ++ L K + G+ YLH
Sbjct: 89 SHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN- 147
Query: 305 DPKIIHRDVKAANVLLDDFCEAI----VGDFGLAKLL---DHSDSHVTTAV-----RGTV 352
++HRD+K AN+L+ + D G A+L + + V R
Sbjct: 148 --WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYR--- 202
Query: 353 GHIAPEYL--STGQSSEKTDVFGFGILLLELITGMRALEFGKS 393
APE L + + D++ G + EL+T + +
Sbjct: 203 ---APELLLGARHYTKA-IDIWAIGCIFAELLTS-EPIFHCRQ 240
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 3e-10
Identities = 34/142 (23%), Positives = 50/142 (35%), Gaps = 39/142 (27%)
Query: 25 SGSIGNLTNLRQVLLQNNNISGGIPPQ-LGSLPKLQTLDLSNNRLSGVIPALLFLSIWLP 83
G L L+ + LQ+N + +P L L L L NR+S +P F
Sbjct: 122 PGLFRGLAALQYLYLQDNALQA-LPDDTFRDLGNLTHLFLHGNRIS-SVPERAF------ 173
Query: 84 RKWDKRKCSGVDQGL-----LRLNNNSLS----GAFPVFLAKISELAFLDLSYNNLS--- 131
+GL L L+ N ++ AF + L L L NNLS
Sbjct: 174 ------------RGLHSLDRLLLHQNRVAHVHPHAF----RDLGRLMTLYLFANNLSALP 217
Query: 132 -GPVPKFPA-RTFNVAGNPLIC 151
+ A + + NP +C
Sbjct: 218 TEALAPLRALQYLRLNDNPWVC 239
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 1e-08
Identities = 29/129 (22%), Positives = 41/129 (31%), Gaps = 37/129 (28%)
Query: 25 SGSIGNLTNLRQVLLQNNNISGGIPPQ-LGSLPKLQTLDLSNNRLSGVIPALLFLSIWLP 83
+ S NL + L +N ++ I L L+ LDLS+N + F
Sbjct: 49 AASFRACRNLTILWLHSNVLA-RIDAAAFTGLALLEQLDLSDNAQLRSVDPATF------ 101
Query: 84 RKWDKRKCSGVDQGL-----LRLNNNSLS----GAFPVFLAKISELAFLDLSYNNLSGPV 134
GL L L+ L G F ++ L +L L N L
Sbjct: 102 ------------HGLGRLHTLHLDRCGLQELGPGLF----RGLAALQYLYLQDNALQ--- 142
Query: 135 PKFPARTFN 143
P TF
Sbjct: 143 -ALPDDTFR 150
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 49.2 bits (118), Expect = 1e-06
Identities = 23/121 (19%), Positives = 34/121 (28%), Gaps = 37/121 (30%)
Query: 32 TNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFLSIWLPRKWDKRKC 91
+++ L N IS + L L L +N L+ I A F
Sbjct: 32 AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLA-RIDAAAF-------------- 76
Query: 92 SGVDQGL-----LRLNNNSL-----SGAFPVFLAKISELAFLDLSYNNLSGPVPKFPART 141
GL L L++N+ F + L L L L +
Sbjct: 77 ----TGLALLEQLDLSDNAQLRSVDPATF----HGLGRLHTLHLDRCGLQ----ELGPGL 124
Query: 142 F 142
F
Sbjct: 125 F 125
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 61.4 bits (149), Expect = 3e-10
Identities = 25/179 (13%), Positives = 53/179 (29%), Gaps = 26/179 (14%)
Query: 20 LSGTLSGSIGNLTNLRQVLLQNNNISGGIPPQL-GSLPKLQTLDLSNNRLSGVIPALLFL 78
++ G + ++ + L+ N I +L S L+ L+L N + + +
Sbjct: 132 ITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQVVF 190
Query: 79 SIWLPRKWDKRKCSGVDQGL--LRLNNNSLSGAFPVFLAKISELAFLDLSYNNLS---GP 133
+ L L L++N L+ + + ++ L N L
Sbjct: 191 A-----------------KLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLVLIEKA 232
Query: 134 VPKFPA-RTFNVAGNPLICGSSSTNVCSGSANSVPLSFSLNSSPDKQEEGLISLGNLRN 191
+ F++ GN CG+ ++ + EE
Sbjct: 233 LRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHY 291
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 60.2 bits (146), Expect = 6e-10
Identities = 22/109 (20%), Positives = 37/109 (33%), Gaps = 26/109 (23%)
Query: 28 IGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFLSIWLPRKWD 87
N + + ++++ + S ++ LDLS N LS + A L
Sbjct: 6 KQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADL----------- 54
Query: 88 KRKCSGVDQGL-----LRLNNNSLSGAFPVFLAKISELAFLDLSYNNLS 131
L L++N L L +S L LDL+ N +
Sbjct: 55 --------APFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQ 93
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 60.2 bits (146), Expect = 7e-10
Identities = 29/127 (22%), Positives = 44/127 (34%), Gaps = 29/127 (22%)
Query: 19 SLSGTLSGSIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFL 78
SL L+ + N++++ L N +S L KL+ L+LS+N L L L
Sbjct: 21 SLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYE-TLDLESL 79
Query: 79 SIWLPRKWDKRKCSGVDQGL--LRLNNNSLSGAFPVFLAKISELAFLDLSYNNLSGPVPK 136
S L L LNNN + L + L + NN+S +
Sbjct: 80 S-----------------TLRTLDLNNNYVQE-----LLVGPSIETLHAANNNIS----R 113
Query: 137 FPARTFN 143
Sbjct: 114 VSCSRGQ 120
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 57.5 bits (139), Expect = 5e-09
Identities = 27/211 (12%), Positives = 52/211 (24%), Gaps = 26/211 (12%)
Query: 23 TLSGSIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFLSIWL 82
+ + + + L+NN + I L L+ DL N F
Sbjct: 205 FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQR 263
Query: 83 PRKWDKRKCSGVDQG---------LLRLNNNSLSGAFPVFLAKISELAFLDLSYNNLSG- 132
+ K+ + L F ++ L + + + G
Sbjct: 264 VQTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGS 323
Query: 133 PVPKFPARTF--------NVAGNPLICGSSSTNVCSGSANSVPLSFSLNSSPDKQEEGLI 184
+ + + V + L + ++ G
Sbjct: 324 ETERLECERENQARQREIDALKEQY--RTVIDQVTLRKQAKITLEQKKKALDEQVSNGRR 381
Query: 185 SLGNLRNFTFR-----ELQQATENFSSKNIL 210
+ L + ELQ ATE S +L
Sbjct: 382 AHAELDGTLQQAVGQIELQHATEEQSPLQLL 412
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 54.9 bits (132), Expect = 4e-08
Identities = 20/108 (18%), Positives = 36/108 (33%), Gaps = 22/108 (20%)
Query: 27 SIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFLSIWLPRKW 86
+ ++ + NNNIS + + + L+NN+++ + L R
Sbjct: 94 ELLVGPSIETLHAANNNIS-RVSC--SRGQGKKNIYLANNKITM-LRDLDEGC--RSR-- 145
Query: 87 DKRKCSGVDQGL--LRLNNNSLSG-AFPVFLAKISELAFLDLSYNNLS 131
+ L L N + F A L L+L YN +
Sbjct: 146 -----------VQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY 182
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 53.3 bits (128), Expect = 1e-07
Identities = 26/107 (24%), Positives = 36/107 (33%), Gaps = 19/107 (17%)
Query: 27 SIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFLSIWLPRKW 86
S + + L NN I+ G ++Q LDL N + V A L S
Sbjct: 115 SCSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASS------ 168
Query: 87 DKRKCSGVDQGL--LRLNNNSLSGAFPVFLAKISELAFLDLSYNNLS 131
L L L N + ++L LDLS N L+
Sbjct: 169 ---------DTLEHLNLQYNFIY-DVKG-QVVFAKLKTLDLSSNKLA 204
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 51.4 bits (123), Expect = 4e-07
Identities = 15/110 (13%), Positives = 34/110 (30%), Gaps = 9/110 (8%)
Query: 30 NLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFLS----IWLPR- 84
L+ + L +N ++ + P+ S + + L NN+L + AL F L
Sbjct: 189 VFAKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNKLVLIEKALRFSQNLEHFDLRGN 247
Query: 85 KWD---KRKCSGVDQGLLRLNNNSLSGAFPVFLAKISELAFLDLSYNNLS 131
+ R +Q + + ++ + +
Sbjct: 248 GFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCE 297
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 41.8 bits (98), Expect = 5e-04
Identities = 17/91 (18%), Positives = 30/91 (32%), Gaps = 24/91 (26%)
Query: 47 GIPPQLGSLPKLQTLDLSNNRLSGVIPALLFLSIWLPRKWDKRKCSGVDQGL-----LRL 101
I + + + ++++ L + +L Q L L
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLR-------------------QSAWNVKELDL 41
Query: 102 NNNSLSGAFPVFLAKISELAFLDLSYNNLSG 132
+ N LS LA ++L L+LS N L
Sbjct: 42 SGNPLSQISAADLAPFTKLELLNLSSNVLYE 72
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 61.4 bits (148), Expect = 5e-10
Identities = 52/351 (14%), Positives = 95/351 (27%), Gaps = 83/351 (23%)
Query: 230 AVKRLKDMISLAVH---------------RNLLRL-----------IGYCATPTERL--- 260
A+ L+ ++ + + + C +P L
Sbjct: 143 ALLELRPAKNVLIDGVLGSGKTWVALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEML 202
Query: 261 --LVYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANV 318
L+Y N + S L ++ + R LL + ++ +V+ A
Sbjct: 203 QKLLYQIDPNWTSRSDHSSNIKLRIHSIQA----ELRRLLKSKPYENCLLVLLNVQNAKA 258
Query: 319 LLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRG-TVGHIAPEYLSTGQSSEKTDVFGFGIL 377
+ F + LL VT + T HI+ ++ S + ++
Sbjct: 259 -WNAF------NLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKS------ 305
Query: 378 LLELITGMRALE---------------FGKSINQKGAMLEWVKKIQQEKK-------VEV 415
LL R + +SI A + K + +K + V
Sbjct: 306 LLLKYLDCRPQDLPREVLTTNPRRLSIIAESIRDGLATWDNWKHVNCDKLTTIIESSLNV 365
Query: 416 LVDRELGSNYDRIEV---GEILQVALLCTQYLPVHRPKMSEVVRMLEGDGLAEKWAAAHN 472
L E +DR+ V + LL + V + + VV L L EK
Sbjct: 366 LEPAEYRKMFDRLSVFPPSAHIPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKEST 425
Query: 473 HTNPTMNNFHTNTKKSTSCPTSAPKH----DHEEKNDQSSMFGTAVDEDDD 519
++ + + K H DH D
Sbjct: 426 I---SIPSIYLELKV--KLENEYALHRSIVDHYNIPKTFDSDDLIPPYLDQ 471
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 59.9 bits (144), Expect = 1e-09
Identities = 77/481 (16%), Positives = 149/481 (30%), Gaps = 129/481 (26%)
Query: 27 SIGNLTNLRQVLLQNNNISGGIPPQLGSLPKL-----QTLDLSNNRLSGVIP------AL 75
++ N + VL + I P S + L ++ L
Sbjct: 188 NLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCL 247
Query: 76 LFLS-IWLPRKWDK--RKCSGVDQGLL----RLNNNSLSGA--FPVFLAKISELAF---- 122
L L + + W+ C + LL + + LS A + L S
Sbjct: 248 LVLLNVQNAKAWNAFNLSC----KILLTTRFKQVTDFLSAATTTHISLDHHSM-TLTPDE 302
Query: 123 -LDLSYNNLSGPVPKFPARTFNVAGNPLICGSSSTNVCSGSANSVPLSFSLNSSPDKQEE 181
L L P V + + P S+ + +
Sbjct: 303 VKSLLLKYLDCRPQDLPRE-----------------VLTTN----PRRLSI--IAESIRD 339
Query: 182 GLISLGNLRNFTFRELQQATENFSSKNILGAGGFGNVYKGKLGDGTVLAVKRLKDMISLA 241
GL + N ++ +L E SS N+L + ++ L+V
Sbjct: 340 GLATWDNWKHVNCDKLTTIIE--SSLNVLEPAEYRKMFDR-------LSVFP-PS----- 384
Query: 242 VHRNLLRLIGYCATPTERLLVY----PYMSNGSVASRLREKPALD-WNTRKRIAIGAARG 296
H I PT L + V ++L + ++ I+I +
Sbjct: 385 AH------I-----PTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTISIPS--- 430
Query: 297 LLYLHEQC---DPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVG 353
+YL + + +HR + + F D + + D + +
Sbjct: 431 -IYLELKVKLENEYALHRSIVDHYNIPKTFDS---DDL----IPPYLDQYFYS------- 475
Query: 354 HIAPEY-LSTGQSSEKTDVFGFGILLLELITGMRALE-----FGKSINQKGAMLEWVKKI 407
HI + L + E+ + F ++ L+ R LE + N G++L ++++
Sbjct: 476 HIG--HHLKNIEHPERMTL--FRMVFLDF----RFLEQKIRHDSTAWNASGSILNTLQQL 527
Query: 408 QQEKKVEVLVDRELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVR---MLEGDGLA 464
+ K + D + Y+R+ V IL + L K ++++R M E + +
Sbjct: 528 KFYKP--YICDND--PKYERL-VNAILDFLPKIEENL--ICSKYTDLLRIALMAEDEAIF 580
Query: 465 E 465
E
Sbjct: 581 E 581
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 43.3 bits (101), Expect = 2e-04
Identities = 32/218 (14%), Positives = 62/218 (28%), Gaps = 74/218 (33%)
Query: 301 HEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGHIAPEYL 360
H D + + + +L F +A V +F + D S ++ + HI +
Sbjct: 4 HHHMDFETGEHQYQYKD-ILSVFEDAFVDNFDCKDVQDMPKSILSKEE---IDHI----I 55
Query: 361 STGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRE 420
+ + T F LL +QE+ V+ V+
Sbjct: 56 MSKDAVSGTLRL-FWTLLS----------------------------KQEEMVQKFVEEV 86
Query: 421 LGSNYD----RIEVGEILQVALLCTQY----------------LPVHRPKMSEVVR---- 456
L NY I+ E Q +++ Y V R + +R
Sbjct: 87 LRINYKFLMSPIKT-EQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQALL 145
Query: 457 --------MLEGDGLAEKW----AAAHNHTNPTMNNFH 482
+++G + K ++ +F
Sbjct: 146 ELRPAKNVLIDGVLGSGKTWVALDVCLSYKVQCKMDFK 183
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 59.9 bits (146), Expect = 6e-10
Identities = 40/162 (24%), Positives = 72/162 (44%), Gaps = 27/162 (16%)
Query: 196 ELQQATENFSSKNILGAGGFGNVYKGK-LGDGTVLAVKRLKDM----------------- 237
+++ + + + LG G F VYK + ++A+K++K +
Sbjct: 4 DVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIK-LGHRSEAKDGINRTALRE 62
Query: 238 ISL---AVHRNLLRLIGYCATPTERLLVYPYMSNGSVASRLREKP-ALDWNTRKRIAIGA 293
I L H N++ L+ + LV+ +M + +++ L + K +
Sbjct: 63 IKLLQELSHPNIIGLLDAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMT 121
Query: 294 ARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAK 335
+GL YLH+ I+HRD+K N+LLD+ + DFGLAK
Sbjct: 122 LQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAK 160
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 60.2 bits (146), Expect = 7e-10
Identities = 53/202 (26%), Positives = 89/202 (44%), Gaps = 40/202 (19%)
Query: 210 LGAGGFGNVYKGK-LGDGTVLAVKRL-KDMIS----------------LAVHRNLLRLIG 251
LG G FG V GK G +AVK L + I L H ++++L
Sbjct: 24 LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQ 83
Query: 252 YCATPTERLLVYPYMSNGSVASRLREKPALDWNTRKRIAIGAAR--------GLLYLHEQ 303
+TP++ +V Y+S G + + + R+ +R G+ Y H
Sbjct: 84 VISTPSDIFMVMEYVSGGELFDYICKN--------GRLDEKESRRLFQQILSGVDYCHRH 135
Query: 304 CDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGHIAPEYLS-T 362
++HRD+K NVLLD A + DFGL+ ++ + T+ G+ + APE +S
Sbjct: 136 ---MVVHRDLKPENVLLDAHMNAKIADFGLSNMM-SDGEFLRTSC-GSPNYAAPEVISGR 190
Query: 363 GQSSEKTDVFGFGILLLELITG 384
+ + D++ G++L L+ G
Sbjct: 191 LYAGPEVDIWSSGVILYALLCG 212
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 8e-10
Identities = 33/141 (23%), Positives = 49/141 (34%), Gaps = 39/141 (27%)
Query: 25 SGSIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFLSIWLPR 84
G+ L NL+ + L NI P L L L+ L++S N I F
Sbjct: 189 EGAFEGLFNLKYLNLGMCNIKD--MPNLTPLVGLEELEMSGNHFP-EIRPGSF------- 238
Query: 85 KWDKRKCSGVDQGL-----LRLNNNSLS----GAFPVFLAKISELAFLDLSYNNLS---- 131
GL L + N+ +S AF ++ L L+L++NNLS
Sbjct: 239 -----------HGLSSLKKLWVMNSQVSLIERNAF----DGLASLVELNLAHNNLSSLPH 283
Query: 132 GPVPKFPA-RTFNVAGNPLIC 151
++ NP C
Sbjct: 284 DLFTPLRYLVELHLHHNPWNC 304
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 54.8 bits (132), Expect = 4e-08
Identities = 28/115 (24%), Positives = 42/115 (36%), Gaps = 34/115 (29%)
Query: 25 SGSIGNLTNLRQVLLQNNNISGGIPPQ-LGSLPKLQTLDLSNNRLSGVIPALLFLSIWLP 83
+ + +L +L + L N+I I L L TL+L +N L+ VIP+ F
Sbjct: 92 ADTFRHLHHLEVLQLGRNSIR-QIEVGAFNGLASLNTLELFDNWLT-VIPSGAF------ 143
Query: 84 RKWDKRKCSGVDQGL-----LRLNNNSLS----GAFPVFLAKISELAFLDLSYNN 129
+ L L L NN + AF ++ L LDL
Sbjct: 144 ------------EYLSKLRELWLRNNPIESIPSYAF----NRVPSLMRLDLGELK 182
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 51.7 bits (124), Expect = 3e-07
Identities = 30/121 (24%), Positives = 40/121 (33%), Gaps = 36/121 (29%)
Query: 32 TNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFLSIWLPRKWDKRKC 91
+N R + L NNI L L+ L L N + I F
Sbjct: 75 SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIR-QIEVGAF-------------- 119
Query: 92 SGVDQGL-----LRLNNNSLS----GAFPVFLAKISELAFLDLSYNNLSGPVPKFPARTF 142
GL L L +N L+ GAF +S+L L L N + P+ F
Sbjct: 120 ----NGLASLNTLELFDNWLTVIPSGAF----EYLSKLRELWLRNNPIE----SIPSYAF 167
Query: 143 N 143
N
Sbjct: 168 N 168
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 8e-10
Identities = 38/104 (36%), Positives = 59/104 (56%), Gaps = 10/104 (9%)
Query: 295 RGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGH 354
RGL Y+H IIHRD+K +N+ +++ CE + DFGLA+ H+ +T V T +
Sbjct: 143 RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTADEMTGYV-ATRWY 195
Query: 355 IAPE-YLSTGQSSEKTDVFGFGILLLELITGMRALEFGKS-INQ 396
APE L+ ++ D++ G ++ EL+TG R L G I+Q
Sbjct: 196 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTG-RTLFPGTDHIDQ 238
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 9e-10
Identities = 29/108 (26%), Positives = 45/108 (41%), Gaps = 24/108 (22%)
Query: 27 SIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIP--ALLFLSIWLPR 84
+ NLT L ++ + +N +S L L L++L +NN++S + P L L
Sbjct: 172 PLANLTTLERLDISSNKVSD--ISVLAKLTNLESLIATNNQISDITPLGILTNLDE---- 225
Query: 85 KWDKRKCSGVDQGLLRLNNNSLSGAFPVFLAKISELAFLDLSYNNLSG 132
L LN N L LA ++ L LDL+ N +S
Sbjct: 226 --------------LSLNGNQLKD--IGTLASLTNLTDLDLANNQISN 257
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 2e-09
Identities = 29/111 (26%), Positives = 48/111 (43%), Gaps = 24/111 (21%)
Query: 27 SIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIP--ALLFLSIWLPR 84
+ L NL Q+ NN ++ I P L +L KL + ++NN+++ + P L L+
Sbjct: 63 GVEYLNNLTQINFSNNQLTD-ITP-LKNLTKLVDILMNNNQIADITPLANLTNLTG---- 116
Query: 85 KWDKRKCSGVDQGLLRLNNNSLSGAFPVFLAKISELAFLDLSYNNLSGPVP 135
L L NN ++ P L ++ L L+LS N +S
Sbjct: 117 --------------LTLFNNQITDIDP--LKNLTNLNRLELSSNTISDISA 151
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 58.8 bits (143), Expect = 2e-09
Identities = 26/128 (20%), Positives = 43/128 (33%), Gaps = 27/128 (21%)
Query: 27 SIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIP--ALLFLSIWLPR 84
+ LT L + L N + I P + +L L L L N +S + P +L L
Sbjct: 282 PLAGLTALTNLELNENQLED-ISP-ISNLKNLTYLTLYFNNISDISPVSSLTKLQR---- 335
Query: 85 KWDKRKCSGVDQGLLRLNNNSLSGAFPVFLAKISELAFLDLSYNNLSG--PVPKFPA-RT 141
L NN +S LA ++ + +L +N +S P+
Sbjct: 336 --------------LFFYNNKVSD--VSSLANLTNINWLSAGHNQISDLTPLANLTRITQ 379
Query: 142 FNVAGNPL 149
+
Sbjct: 380 LGLNDQAW 387
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 4e-09
Identities = 36/112 (32%), Positives = 50/112 (44%), Gaps = 24/112 (21%)
Query: 26 GSIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFLSIWLPRK 85
G++ +LTNL + L NN IS + P L L KL L L N++S I L L+
Sbjct: 237 GTLASLTNLTDLDLANNQIS-NLAP-LSGLTKLTELKLGANQISN-ISPLAGLT------ 287
Query: 86 WDKRKCSGVDQGL--LRLNNNSLSGAFPVFLAKISELAFLDLSYNNLSGPVP 135
L L LN N L P ++ + L +L L +NN+S P
Sbjct: 288 -----------ALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP 326
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 4e-08
Identities = 23/111 (20%), Positives = 40/111 (36%), Gaps = 24/111 (21%)
Query: 27 SIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIP--ALLFLSIWLPR 84
S +L + + I + L L ++ SNN+L+ + P L L
Sbjct: 41 SQTDLDQVTTLQADRLGIK--SIDGVEYLNNLTQINFSNNQLTDITPLKNLTKLVD---- 94
Query: 85 KWDKRKCSGVDQGLLRLNNNSLSGAFPVFLAKISELAFLDLSYNNLSGPVP 135
+ +NNN ++ P LA ++ L L L N ++ P
Sbjct: 95 --------------ILMNNNQIADITP--LANLTNLTGLTLFNNQITDIDP 129
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 53.0 bits (128), Expect = 1e-07
Identities = 17/111 (15%), Positives = 40/111 (36%), Gaps = 24/111 (21%)
Query: 27 SIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFLSIWLPRKW 86
+ L + +L N++ + L ++ TL + I + +L+
Sbjct: 19 TDTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKS-IDGVEYLN------- 68
Query: 87 DKRKCSGVDQGL--LRLNNNSLSGAFPVFLAKISELAFLDLSYNNLSGPVP 135
L + +NN L+ P L +++L + ++ N ++ P
Sbjct: 69 ----------NLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP 107
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 2e-07
Identities = 21/109 (19%), Positives = 41/109 (37%), Gaps = 22/109 (20%)
Query: 27 SIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIP--ALLFLSIWLPR 84
+ +LT L+++ NN +S L +L + L +N++S + P L ++
Sbjct: 326 PVSSLTKLQRLFFYNNKVSD--VSSLANLTNINWLSAGHNQISDLTPLANLTRITQ---- 379
Query: 85 KWDKRKCSGVDQGLLRLNNNSLSGAFPVFLAKISELAFLDLSYNNLSGP 133
L LN+ + + A + A +S + L P
Sbjct: 380 --------------LGLNDQAWTNAPVNYKANVSIPNTVKNVTGALIAP 414
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 3e-07
Identities = 28/108 (25%), Positives = 43/108 (39%), Gaps = 25/108 (23%)
Query: 27 SIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIP--ALLFLSIWLPR 84
+ NLTNL ++ L +N IS L L LQ L N ++ + P L L
Sbjct: 129 PLKNLTNLNRLELSSNTISD--ISALSGLTSLQQLSFGNQ-VTDLKPLANLTTLER---- 181
Query: 85 KWDKRKCSGVDQGLLRLNNNSLSGAFPVFLAKISELAFLDLSYNNLSG 132
L +++N +S LAK++ L L + N +S
Sbjct: 182 --------------LDISSNKVSD--ISVLAKLTNLESLIATNNQISD 213
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 1e-09
Identities = 35/109 (32%), Positives = 60/109 (55%), Gaps = 20/109 (18%)
Query: 295 RGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAV-----R 349
+GL Y+H ++HRD+K N+ +++ CE + DFGLA+ H+D+ +T V R
Sbjct: 137 KGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLAR---HADAEMTGYVVTRWYR 190
Query: 350 GTVGHIAPE-YLSTGQSSEKTDVFGFGILLLELITGMRALEFGKS-INQ 396
APE LS ++ D++ G ++ E++TG + L GK ++Q
Sbjct: 191 ------APEVILSWMHYNQTVDIWSVGCIMAEMLTG-KTLFKGKDYLDQ 232
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 1e-09
Identities = 36/109 (33%), Positives = 59/109 (54%), Gaps = 20/109 (18%)
Query: 295 RGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAV-----R 349
+GL Y+H IIHRD+K N+ +++ CE + DFGLA+ +DS +T V R
Sbjct: 139 KGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLAR---QADSEMTGYVVTRWYR 192
Query: 350 GTVGHIAPEY-LSTGQSSEKTDVFGFGILLLELITGMRALEFGKS-INQ 396
APE L+ + ++ D++ G ++ E+ITG + L G ++Q
Sbjct: 193 ------APEVILNWMRYTQTVDIWSVGCIMAEMITG-KTLFKGSDHLDQ 234
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 1e-09
Identities = 29/124 (23%), Positives = 47/124 (37%), Gaps = 29/124 (23%)
Query: 25 SGSIGNLTNLRQVLLQNNNISGGIPPQ-LGSLPKLQTLDLSNNRLSGVIPALLFLSIWLP 83
G NL NL ++L NN IS I P L KL+ L LS N+L +P + ++
Sbjct: 69 DGDFKNLKNLHTLILINNKIS-KISPGAFAPLVKLERLYLSKNQLK-ELPEKMPKTL--- 123
Query: 84 RKWDKRKCSGVDQGLLRLNNNSLS----GAFPVFLAKISELAFLDLSYNNLSGPVPKFPA 139
LR++ N ++ F ++++ ++L N L
Sbjct: 124 -------------QELRVHENEITKVRKSVF----NGLNQMIVVELGTNPLK--SSGIEN 164
Query: 140 RTFN 143
F
Sbjct: 165 GAFQ 168
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 2e-08
Identities = 24/120 (20%), Positives = 43/120 (35%), Gaps = 23/120 (19%)
Query: 25 SGSIGNLTNLRQVLLQNNNI-SGGIPPQ-LGSLPKLQTLDLSNNRLSGVIPALLFLSIWL 82
L + V L N + S GI + KL + +++ ++ IP L S+
Sbjct: 138 KSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGLPPSL-- 194
Query: 83 PRKWDKRKCSGVDQGLLRLNNNSLSGAFPVFLAKISELAFLDLSYNNLSGPVPKFPARTF 142
L L+ N ++ L ++ LA L LS+N++S +
Sbjct: 195 --------------TELHLDGNKITKVDAASLKGLNNLAKLGLSFNSIS----AVDNGSL 236
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 2e-08
Identities = 27/114 (23%), Positives = 49/114 (42%), Gaps = 23/114 (20%)
Query: 25 SGSIGNLTNLRQVLLQNNNISGGIPPQ-LGSLPKLQTLDLSNNRLSGVIPALLFLSIWLP 83
+ S+ L NL ++ L N+IS + L + P L+ L L+NN+L +P L ++
Sbjct: 209 AASLKGLNNLAKLGLSFNSISA-VDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQ 266
Query: 84 RKWDKRKCSGVDQGLLRLNNNSLS----GAF--PVFLAKISELAFLDLSYNNLS 131
+ L+NN++S F P + K + + + L N +
Sbjct: 267 V--------------VYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQ 306
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 54.2 bits (131), Expect = 3e-08
Identities = 28/115 (24%), Positives = 41/115 (35%), Gaps = 21/115 (18%)
Query: 29 GNLTNLRQVLLQNNNISGGIPPQ-LGSLPKLQTLDLSNNRLSGVIPALLFLSIWLPRKWD 87
G +L ++ L N I+ + L L L L LS N +S + + R+
Sbjct: 189 GLPPSLTELHLDGNKITK-VDAASLKGLNNLAKLGLSFNSISA-VDNGSLANTPHLRE-- 244
Query: 88 KRKCSGVDQGLLRLNNNSLSGAFPVFLAKISELAFLDLSYNNLSGPVPKFPARTF 142
L LNNN L P LA + + L NN+S + F
Sbjct: 245 -----------LHLNNNKLV-KVPGGLADHKYIQVVYLHNNNIS----AIGSNDF 283
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 8e-08
Identities = 23/109 (21%), Positives = 38/109 (34%), Gaps = 19/109 (17%)
Query: 26 GSIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFLSIWLPRK 85
GS+ N +LR++ L NN + +P L +Q + L NN +S I + F K
Sbjct: 234 GSLANTPHLRELHLNNNKLVK-VPGGLADHKYIQVVYLHNNNIS-AIGSNDFCPPGYNTK 291
Query: 86 WDKRKCSGVDQGLLRLNNNSL------SGAFPVFLAKISELAFLDLSYN 128
+ L +N + F + A + L
Sbjct: 292 KASYS-------GVSLFSNPVQYWEIQPSTF----RCVYVRAAVQLGNY 329
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 4e-06
Identities = 27/122 (22%), Positives = 37/122 (30%), Gaps = 41/122 (33%)
Query: 32 TNLRQVLLQNNNISGGIPP-QLGSLPKLQTLDLSNNRLSGVIPALLFLSIWLPRKWDKRK 90
+ + LQNN I+ I +L L TL L NN++S I F
Sbjct: 52 PDTALLDLQNNKITE-IKDGDFKNLKNLHTLILINNKIS-KISPGAF------------- 96
Query: 91 CSGVDQGL-----LRLNNNSLS----GAFPVFLAKISELAFLDLSYNNLSGPVPKFPART 141
L L L+ N L L L + N ++ K
Sbjct: 97 -----APLVKLERLYLSKNQLKELPEKMPK-------TLQELRVHENEIT----KVRKSV 140
Query: 142 FN 143
FN
Sbjct: 141 FN 142
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 2e-09
Identities = 28/148 (18%), Positives = 51/148 (34%), Gaps = 47/148 (31%)
Query: 23 TLSGSIGNLTNLRQVLLQNNNISGGIPPQ-LGSLPKLQTLDLSNNRLSGVIPALLFLSIW 81
T++ + NL + + + N++ +P + L L+ L+LS N +S I +
Sbjct: 215 TMTPNCLYGLNLTSLSITHCNLT-AVPYLAVRHLVYLRFLNLSYNPIS-TIEGSML---- 268
Query: 82 LPRKWDKRKCSGVDQGL-----LRLNNNSLS----GAFPVFLAKISELAFLDLSYNNLSG 132
L ++L L+ AF ++ L L++S N L+
Sbjct: 269 --------------HELLRLQEIQLVGGQLAVVEPYAF----RGLNYLRVLNVSGNQLT- 309
Query: 133 PVPKFPARTF---------NVAGNPLIC 151
F + NPL C
Sbjct: 310 ---TLEESVFHSVGNLETLILDSNPLAC 334
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 59.0 bits (143), Expect = 2e-09
Identities = 26/125 (20%), Positives = 45/125 (36%), Gaps = 30/125 (24%)
Query: 25 SGSIGNLTNLRQVLLQNNNISGGIPPQ-LGSLPKLQTLDLSNNRLSGVIPALLFLSIWLP 83
+ +L ++ L N +S + P +L L+TL L +NRL +IP +F
Sbjct: 49 QDEFASFPHLEELELNENIVSA-VEPGAFNNLFNLRTLGLRSNRLK-LIPLGVF------ 100
Query: 84 RKWDKRKCSGVDQGL-----LRLNNNSLSGAFPVFLAKISELAFLDLSYNNLSGPVPKFP 138
GL L ++ N + + L L++ N+L
Sbjct: 101 ------------TGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLV----YIS 144
Query: 139 ARTFN 143
R F+
Sbjct: 145 HRAFS 149
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 5e-09
Identities = 26/123 (21%), Positives = 43/123 (34%), Gaps = 26/123 (21%)
Query: 25 SGSIGNLTNLRQVLLQNNNISGGIPPQ-LGSLPKLQTLDLSNNRLSGVIPALLFLSIWLP 83
+ L +L Q+ L+ N++ IP + L L L L L + ++ I F L
Sbjct: 145 HRAFSGLNSLEQLTLEKCNLT-SIPTEALSHLHGLIVLRLRHLNIN-AIRDYSFK--RLY 200
Query: 84 RKWDKRKCSGVDQGLLRL---NNNSLSGAFPVFLAKISELAFLDLSYNNLSGPVPKFPAR 140
R L L + L P L ++ L L +++ NL+ P
Sbjct: 201 R-------------LKVLEISHWPYLDTMTPNCLYGLN-LTSLSITHCNLT----AVPYL 242
Query: 141 TFN 143
Sbjct: 243 AVR 245
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 2e-08
Identities = 21/119 (17%), Positives = 45/119 (37%), Gaps = 20/119 (16%)
Query: 25 SGSIGNLTNLRQVLLQNNNISGGIPPQ-LGSLPKLQTLDLSNNRLSGVIPALLFLSIWLP 83
+ ++ +L L + L++ NI+ I L +L+ L++S+ + + L
Sbjct: 169 TEALSHLHGLIVLRLRHLNINA-IRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLT 227
Query: 84 RKWDKRKCSGVDQGLLRLNNNSLSGAFPVFLAKISELAFLDLSYNNLSGPVPKFPARTF 142
L + + +L+ + + + L FL+LSYN +S
Sbjct: 228 S--------------LSITHCNLTAVPYLAVRHLVYLRFLNLSYNPIS----TIEGSML 268
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 5e-08
Identities = 19/107 (17%), Positives = 38/107 (35%), Gaps = 26/107 (24%)
Query: 30 NLTNLRQVLLQNNNISGGIPPQ-LGSLPKLQTLDLSNNRLSGVIPALLFLSIWLPRKWDK 88
+L NL+ + + +N++ I + L L+ L L L+ IP
Sbjct: 126 DLYNLKSLEVGDNDLVY-ISHRAFSGLNSLEQLTLEKCNLT-SIPTEAL----------- 172
Query: 89 RKCSGVDQGL-----LRLNNNSLSGAFPVFLAKISELAFLDLSYNNL 130
L LRL + +++ ++ L L++S+
Sbjct: 173 -------SHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPY 212
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 53.6 bits (129), Expect = 9e-08
Identities = 25/117 (21%), Positives = 36/117 (30%), Gaps = 28/117 (23%)
Query: 32 TNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFLSIWLPRKWDKRKC 91
T R + L N I + S P L+ L+L+ N +S + F
Sbjct: 32 TETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVS-AVEPGAF-------------- 76
Query: 92 SGVDQGL-----LRLNNNSLSGAFPVFLAKISELAFLDLSYNNLSGPVPKFPARTFN 143
L L L +N L +S L LD+S N + F
Sbjct: 77 ----NNLFNLRTLGLRSNRLKLIPLGVFTGLSNLTKLDISENKIV----ILLDYMFQ 125
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 2e-09
Identities = 31/109 (28%), Positives = 51/109 (46%), Gaps = 18/109 (16%)
Query: 295 RGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAV-----R 349
GL LHE ++HRD+ N+LL D + + DF LA+ +D++ T V R
Sbjct: 145 LGLHVLHEA---GVVHRDLHPGNILLADNNDITICDFNLAREDT-ADANKTHYVTHRWYR 200
Query: 350 GTVGHIAPEY-LSTGQSSEKTDVFGFGILLLELITGMRALEFGKS-INQ 396
APE + ++ D++ G ++ E+ +AL G + NQ
Sbjct: 201 ------APELVMQFKGFTKLVDMWSAGCVMAEMFNR-KALFRGSTFYNQ 242
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 2e-09
Identities = 27/120 (22%), Positives = 44/120 (36%), Gaps = 21/120 (17%)
Query: 25 SGSIGNLTNLRQVLLQNNNISGGIPPQ-LGSLPKLQTLDLSNNRLSGVIPALLFLSIWLP 83
L +L ++L NN IS I + L KLQ L +S N L IP L S+
Sbjct: 71 KDDFKGLQHLYALVLVNNKIS-KIHEKAFSPLRKLQKLYISKNHLV-EIPPNLPSSL--- 125
Query: 84 RKWDKRKCSGVDQGLLRLNNNSLSGAFPVFLAKISELAFLDLSYNNLSGPVPKFPARTFN 143
LR+++N + + + + +++ N L F F+
Sbjct: 126 -------------VELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLE--NSGFEPGAFD 170
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 5e-08
Identities = 27/120 (22%), Positives = 40/120 (33%), Gaps = 31/120 (25%)
Query: 29 GNLTNLRQVLLQNNNISGGIPPQ-LGSLPKLQTLDLSNNRLSGVIPALLFLSIWLPRKWD 87
L ++ L +N I I + L KL L L +N++ +I
Sbjct: 190 DLPETLNELHLDHNKIQA-IELEDLLRYSKLYRLGLGHNQIR-MIENGSL---------- 237
Query: 88 KRKCSGVDQGL-----LRLNNNSLSGAFPVFLAKISELAFLDLSYNNLSGPVPKFPARTF 142
L L L+NN LS P L + L + L NN++ K F
Sbjct: 238 --------SFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNIT----KVGVNDF 284
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 8e-08
Identities = 22/110 (20%), Positives = 39/110 (35%), Gaps = 19/110 (17%)
Query: 25 SGSIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFLSIWLPR 84
+GS+ L LR++ L NN +S +P L L LQ + L N ++ + F +
Sbjct: 234 NGSLSFLPTLRELHLDNNKLSR-VPAGLPDLKLLQVVYLHTNNIT-KVGVNDFCPVGFGV 291
Query: 85 KWDKRKCSGVDQGLLRLNNNSLS------GAFPVFLAKISELAFLDLSYN 128
K + L NN + F +++ +
Sbjct: 292 KRAYYN-------GISLFNNPVPYWEVQPATF----RCVTDRLAIQFGNY 330
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 2e-07
Identities = 24/108 (22%), Positives = 41/108 (37%), Gaps = 18/108 (16%)
Query: 25 SGSIGNLTNLRQVLLQNNNI-SGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFLSIWLP 83
G L N+ + + N + + G P KL L +S +L+G IP L ++
Sbjct: 140 KGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLTG-IPKDLPETLN-- 196
Query: 84 RKWDKRKCSGVDQGLLRLNNNSLSGAFPVFLAKISELAFLDLSYNNLS 131
L L++N + L + S+L L L +N +
Sbjct: 197 --------------ELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIR 230
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 58.6 bits (142), Expect = 2e-09
Identities = 37/145 (25%), Positives = 52/145 (35%), Gaps = 47/145 (32%)
Query: 25 SGSIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFLSIWLPR 84
G+ L+NLR + L N+ P L L KL LDLS N LS I F
Sbjct: 178 EGAFEGLSNLRYLNLAMCNLRE--IPNLTPLIKLDELDLSGNHLS-AIRPGSF------- 227
Query: 85 KWDKRKCSGVDQGL-----LRLNNNSLS----GAFPVFLAKISELAFLDLSYNNLSGPVP 135
QGL L + + + AF + L ++L++NNL+
Sbjct: 228 -----------QGLMHLQKLWMIQSQIQVIERNAF----DNLQSLVEINLAHNNLT---- 268
Query: 136 KFPARTF---------NVAGNPLIC 151
P F ++ NP C
Sbjct: 269 LLPHDLFTPLHHLERIHLHHNPWNC 293
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 54.0 bits (130), Expect = 6e-08
Identities = 30/115 (26%), Positives = 39/115 (33%), Gaps = 34/115 (29%)
Query: 25 SGSIGNLTNLRQVLLQNNNISGGIPPQ-LGSLPKLQTLDLSNNRLSGVIPALLFLSIWLP 83
S +L +L + L N+I I L L TL+L +NRL+ IP F
Sbjct: 81 VNSFKHLRHLEILQLSRNHIR-TIEIGAFNGLANLNTLELFDNRLT-TIPNGAF------ 132
Query: 84 RKWDKRKCSGVDQGL-----LRLNNNSLS----GAFPVFLAKISELAFLDLSYNN 129
L L L NN + AF +I L LDL
Sbjct: 133 ------------VYLSKLKELWLRNNPIESIPSYAF----NRIPSLRRLDLGELK 171
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 53.2 bits (128), Expect = 1e-07
Identities = 33/114 (28%), Positives = 47/114 (41%), Gaps = 29/114 (25%)
Query: 25 SGSIGNLTNLRQVLLQNNNISGGIPPQL-GSLPKLQTLDLS-NNRLSGVIPALLFLSIWL 82
+G+ L+ L+++ L+NN I IP +P L+ LDL RLS I F
Sbjct: 129 NGAFVYLSKLKELWLRNNPIES-IPSYAFNRIPSLRRLDLGELKRLS-YISEGAF----- 181
Query: 83 PRKWDKRKCSGVDQGL-----LRLNNNSLSGAFPVFLAKISELAFLDLSYNNLS 131
+GL L L +L P + +L LDLS N+LS
Sbjct: 182 -------------EGLSNLRYLNLAMCNLR-EIPNL-TPLIKLDELDLSGNHLS 220
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 51.7 bits (124), Expect = 4e-07
Identities = 31/121 (25%), Positives = 40/121 (33%), Gaps = 36/121 (29%)
Query: 32 TNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFLSIWLPRKWDKRKC 91
TN R + L N I L L+ L LS N + I F
Sbjct: 64 TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIR-TIEIGAF-------------- 108
Query: 92 SGVDQGL-----LRLNNNSLS----GAFPVFLAKISELAFLDLSYNNLSGPVPKFPARTF 142
GL L L +N L+ GAF +S+L L L N + P+ F
Sbjct: 109 ----NGLANLNTLELFDNRLTTIPNGAF----VYLSKLKELWLRNNPIE----SIPSYAF 156
Query: 143 N 143
N
Sbjct: 157 N 157
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 58.6 bits (141), Expect = 3e-09
Identities = 26/108 (24%), Positives = 40/108 (37%), Gaps = 22/108 (20%)
Query: 27 SIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGV--IPALLFLSIWLPR 84
+ L + + L +N + +PP L +L L+ L S+N L V + L L
Sbjct: 458 HLEQLLLVTHLDLSHNRLRA-LPPALAALRCLEVLQASDNALENVDGVANLPRLQE---- 512
Query: 85 KWDKRKCSGVDQGLLRLNNNSLSGAFPV-FLAKISELAFLDLSYNNLS 131
L L NN L + + L L L+L N+L
Sbjct: 513 --------------LLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLC 546
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 50.1 bits (119), Expect = 1e-06
Identities = 31/132 (23%), Positives = 51/132 (38%), Gaps = 31/132 (23%)
Query: 27 SIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFLSIWLPRKW 86
++R + L + +++ + L L + LDLS+NRL + PAL L L
Sbjct: 436 LKMEYADVRVLHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPPALAALR-CLEV-- 490
Query: 87 DKRKCSGVDQGLLRLNNN---SLSGAFPVFLAKISELAFLDLSYNNLS-----GPVPKFP 138
L+ ++N ++ G +A + L L L N L P+ P
Sbjct: 491 ------------LQASDNALENVDG-----VANLPRLQELLLCNNRLQQSAAIQPLVSCP 533
Query: 139 A-RTFNVAGNPL 149
N+ GN L
Sbjct: 534 RLVLLNLQGNSL 545
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 48.2 bits (114), Expect = 4e-06
Identities = 19/62 (30%), Positives = 28/62 (45%), Gaps = 2/62 (3%)
Query: 23 TLSGSIGNLTNLRQVLLQNNNISG-GIPPQLGSLPKLQTLDLSNNRLSGVIPALLFLSIW 81
+ G + NL L+++LL NN + L S P+L L+L N L L+
Sbjct: 500 NVDG-VANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEM 558
Query: 82 LP 83
LP
Sbjct: 559 LP 560
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 47.4 bits (112), Expect = 8e-06
Identities = 16/57 (28%), Positives = 26/57 (45%), Gaps = 3/57 (5%)
Query: 23 TLSGSIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFLS 79
L ++ L L + +N + + + +LP+LQ L L NNRL A+ L
Sbjct: 477 ALPPALAALRCLEVLQASDNALE-NVDG-VANLPRLQELLLCNNRLQQ-SAAIQPLV 530
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 4e-09
Identities = 34/113 (30%), Positives = 55/113 (48%), Gaps = 21/113 (18%)
Query: 295 RGLLYLHEQCDPKIIHRDVKAANVLLDDF-CEAIVGDFGLAKLLDHSDSH--------VT 345
RGL Y+H ++HRD+K AN+ ++ +GDFGLA+++D SH VT
Sbjct: 131 RGLKYIHSA---NVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVT 187
Query: 346 TAVRGTVGHIAPE-YLSTGQSSEKTDVFGFGILLLELITGMRALEFGKS-INQ 396
R +P LS ++ D++ G + E++TG + L G + Q
Sbjct: 188 KWYR------SPRLLLSPNNYTKAIDMWAAGCIFAEMLTG-KTLFAGAHELEQ 233
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 4e-09
Identities = 31/128 (24%), Positives = 48/128 (37%), Gaps = 22/128 (17%)
Query: 23 TLSGSIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPA-------L 75
L++L+ + + + +P + L+TL L+ N L +PA L
Sbjct: 95 QFPDQAFRLSHLQHMTIDAAGLME-LPDTMQQFAGLETLTLARNPLR-ALPASIASLNRL 152
Query: 76 LFLSIW-------LPRKWDKRKCSGVDQGL-----LRLNNNSLSGAFPVFLAKISELAFL 123
LSI LP SG QGL LRL + + P +A + L L
Sbjct: 153 RELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSL 211
Query: 124 DLSYNNLS 131
+ + LS
Sbjct: 212 KIRNSPLS 219
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 50.3 bits (121), Expect = 6e-07
Identities = 18/110 (16%), Positives = 39/110 (35%), Gaps = 16/110 (14%)
Query: 23 TLSGSIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSN-NRLSGVIPALLFLSIW 81
L +I +L L ++ L+ PP G L+ L L + + L +P I
Sbjct: 220 ALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLL-TLPL----DIH 274
Query: 82 LPRKWDKRKCSGVDQGLLRLNNNSLSGAFPVFLAKISELAFLDLSYNNLS 131
+ + +++ L L P +A++ + + + +
Sbjct: 275 --------RLTQLEK--LDLRGCVNLSRLPSLIAQLPANCIILVPPHLQA 314
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 1e-06
Identities = 29/114 (25%), Positives = 48/114 (42%), Gaps = 15/114 (13%)
Query: 23 TLSGSIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFLSIWL 82
+L SI NL NL+ + ++N+ +S + P + LPKL+ LDL P + L
Sbjct: 197 SLPASIANLQNLKSLKIRNSPLSA-LGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPL 255
Query: 83 PRKWDKRKCSGVDQGLLRLNNNSLSGAFPVFLAKISELAFLDLSYNNLSGPVPK 136
R L L + S P+ + ++++L LDL +P
Sbjct: 256 KR--------------LILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPS 295
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 49.2 bits (118), Expect = 2e-06
Identities = 10/55 (18%), Positives = 20/55 (36%)
Query: 23 TLSGSIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLF 77
TL I LT L ++ L+ +P + LP + + + + +
Sbjct: 268 TLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQAQLDQHRPV 322
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 48.0 bits (115), Expect = 4e-06
Identities = 25/111 (22%), Positives = 41/111 (36%), Gaps = 20/111 (18%)
Query: 21 SGTLSGSIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFLSI 80
S SG L NL+ + L+ I +P + +L L++L + N+ LS + PA+ L
Sbjct: 172 STDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSALGPAIHHLP- 229
Query: 81 WLPRKWDKRKCSGVDQGL--LRLNNNSLSGAFPVFLAKISELAFLDLSYNN 129
L L L + +P + L L L +
Sbjct: 230 ----------------KLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCS 264
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 45.7 bits (109), Expect = 2e-05
Identities = 20/118 (16%), Positives = 37/118 (31%), Gaps = 23/118 (19%)
Query: 23 TLSGSIGNLT--NLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFLSI 80
+ + + T + L++ + P Q L LQ + + L + +
Sbjct: 70 ATADLLEDATQPGRVALELRSVPLPQ-FPDQAFRLSHLQHMTIDAAGLMELPDTMQQF-- 126
Query: 81 WLPRKWDKRKCSGVDQGL--LRLNNNSLSGAFPVFLAKISELAFLDLSYNNLSGPVPK 136
GL L L N L A P +A ++ L L + +P+
Sbjct: 127 ---------------AGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPE 168
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 6e-09
Identities = 19/110 (17%), Positives = 41/110 (37%), Gaps = 27/110 (24%)
Query: 28 IGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFLSIWLPRKWD 87
I L+NL ++ + +++ P L L L LD+S++ I +
Sbjct: 84 ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKI----------- 132
Query: 88 KRKCSGVDQGLLRL------NNNSLSGAFPVFLAKISELAFLDLSYNNLS 131
L ++ N +++ P L + EL L++ ++ +
Sbjct: 133 --------NTLPKVNSIDLSYNGAITDIMP--LKTLPELKSLNIQFDGVH 172
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 3e-08
Identities = 16/108 (14%), Positives = 38/108 (35%), Gaps = 26/108 (24%)
Query: 28 IGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFLSIWLPRKWD 87
I N++ + + N + + P + L L+ L + ++ L
Sbjct: 62 IEYAHNIKDLTINNIHAT-NYNP-ISGLSNLERLRIMGKDVTSDKIPNL----------- 108
Query: 88 KRKCSGVDQGL-----LRLNNNSLSGAFPVFLAKISELAFLDLSYNNL 130
GL L +++++ + + + ++ +DLSYN
Sbjct: 109 --------SGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGA 148
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 51.5 bits (124), Expect = 1e-07
Identities = 19/108 (17%), Positives = 38/108 (35%), Gaps = 21/108 (19%)
Query: 27 SIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFLSIWLPRKW 86
++ LT+L + + ++ I ++ +LPK+ ++DLS N I L L
Sbjct: 107 NLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIMPLKTLP------- 159
Query: 87 DKRKCSGVDQGL--LRLNNNSLSGAFPVFLAKISELAFLDLSYNNLSG 132
L L + + + + +L L + G
Sbjct: 160 ----------ELKSLNIQFDGVHDYRG--IEDFPKLNQLYAFSQTIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 46.5 bits (111), Expect = 5e-06
Identities = 16/112 (14%), Positives = 39/112 (34%), Gaps = 22/112 (19%)
Query: 27 SIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIP--ALLFLSIWLPR 84
+ + +L + L N N++ + + ++ L ++N + P L L
Sbjct: 39 TEAQMNSLTYITLANINVT-DLTG-IEYAHNIKDLTINNIHATNYNPISGLSNLER---- 92
Query: 85 KWDKRKCSGVDQGLLRLNNNSLSGAFPVFLAKISELAFLDLSYNNLSGPVPK 136
LR+ ++ L+ ++ L LD+S++ +
Sbjct: 93 --------------LRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILT 130
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 2e-04
Identities = 8/45 (17%), Positives = 17/45 (37%), Gaps = 2/45 (4%)
Query: 27 SIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGV 71
+ L L+ + +Q + + + PKL L + + G
Sbjct: 154 PLKTLPELKSLNIQFDGVHD-YRG-IEDFPKLNQLYAFSQTIGGK 196
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 56.9 bits (138), Expect = 6e-09
Identities = 34/112 (30%), Positives = 58/112 (51%), Gaps = 20/112 (17%)
Query: 295 RGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSH--------VTT 346
RGL Y+H ++HRD+K +N+LL+ C+ + DFGLA++ D H T
Sbjct: 139 RGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATR 195
Query: 347 AVRGTVGHIAPEY-LSTGQSSEKTDVFGFGILLLELITGMRALEFGKS-INQ 396
R APE L++ ++ D++ G +L E+++ R + GK ++Q
Sbjct: 196 WYR------APEIMLNSKGYTKSIDIWSVGCILAEMLSN-RPIFPGKHYLDQ 240
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 56.1 bits (136), Expect = 7e-09
Identities = 33/151 (21%), Positives = 57/151 (37%), Gaps = 27/151 (17%)
Query: 207 KNILGAGGFGNVYKGK-LGDGTVLAVKRLKD----------MISLAVHRNLLRLIGYCAT 255
+LG G G V + A+K L+D + +++R++
Sbjct: 23 SQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYEN 82
Query: 256 PTER----LLVYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLL----YLHEQCDPK 307
L+V + G + SR++++ + R+ A + + YLH
Sbjct: 83 LYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTERE--ASEIMKSIGEAIQYLHSI---N 137
Query: 308 IIHRDVKAANVLLDDFCE--AI-VGDFGLAK 335
I HRDVK N+L + + DFG AK
Sbjct: 138 IAHRDVKPENLLYTSKRPNAILKLTDFGFAK 168
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 56.5 bits (137), Expect = 7e-09
Identities = 33/114 (28%), Positives = 55/114 (48%), Gaps = 17/114 (14%)
Query: 295 RGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGH 354
R + LH +IHRD+K +N+L++ C+ V DFGLA+++D + + G
Sbjct: 123 RAVKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIID-ESAADNSEPTGQQSG 178
Query: 355 I----------APEY-LSTGQSSEKTDVFGFGILLLELITGMRALEFGKS-INQ 396
+ APE L++ + S DV+ G +L EL R + G+ +Q
Sbjct: 179 MVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLR-RPIFPGRDYRHQ 231
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 56.7 bits (137), Expect = 7e-09
Identities = 52/260 (20%), Positives = 90/260 (34%), Gaps = 71/260 (27%)
Query: 197 LQQATENFSSKNILGAGGFGNVYKGKLGD-GTVLAVKR-----------LKDMISLAVHR 244
L+ +++ +S LG G FG V + + G A+K+ L M L H
Sbjct: 2 LETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRELDIMKVLD-HV 60
Query: 245 NLLRLIGYCATPTERLLVYPYMSNGSVASRLREKPALDWNTRKRIAIGA----------- 293
N+++L+ Y T + P + + + + +
Sbjct: 61 NIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYV 120
Query: 294 ------------------------------ARGLLYLHEQCDPKIIHRDVKAANVLLDDF 323
R + ++H I HRD+K N+L++
Sbjct: 121 PDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSL---GICHRDIKPQNLLVNSK 177
Query: 324 CEAI-VGDFGLAKLLDHSDSHVTTAV----RGTVGHIAPE-YLSTGQSSEKTDVFGFGIL 377
+ + DFG AK L S+ V R APE L + + D++ G +
Sbjct: 178 DNTLKLCDFGSAKKLIPSEPSVAYICSRFYR------APELMLGATEYTPSIDLWSIGCV 231
Query: 378 LLELITGMRALEFGKS-INQ 396
ELI G + L G++ I+Q
Sbjct: 232 FGELILG-KPLFSGETSIDQ 250
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 7e-09
Identities = 28/108 (25%), Positives = 41/108 (37%), Gaps = 27/108 (25%)
Query: 29 GNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFLSIWLPRKWDK 88
L + LQ+NN++ L + P L +DLS N L I F
Sbjct: 223 PVNVELTILKLQHNNLTD--TAWLLNYPGLVEVDLSYNELE-KIMYHPF----------- 268
Query: 89 RKCSGVDQGL-----LRLNNNSLSGAFPVFLAKISELAFLDLSYNNLS 131
+ L ++NN L A ++ I L LDLS+N+L
Sbjct: 269 -------VKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL 308
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 1e-08
Identities = 24/132 (18%), Positives = 43/132 (32%), Gaps = 26/132 (19%)
Query: 26 GSIGNLTNLRQVLLQNNNISGGIPPQ-LGSLPKLQTLDLSNNRLS---GVIPALLFLSIW 81
+ N L +V L N + I + +L+ L +SNNRL + L +
Sbjct: 242 AWLLNYPGLVEVDLSYNELE-KIMYHPFVKMQRLERLYISNNRLVALNLYGQPIPTLKV- 299
Query: 82 LPRKWDKRKCSGVDQGLLRLNNNSLSGAFPVFLAKISELAFLDLSYNNLSG-PVPKFPA- 139
L L++N L + L L L +N++ +
Sbjct: 300 -----------------LDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTLKLSTHHTL 341
Query: 140 RTFNVAGNPLIC 151
+ ++ N C
Sbjct: 342 KNLTLSHNDWDC 353
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 3e-08
Identities = 24/134 (17%), Positives = 40/134 (29%), Gaps = 30/134 (22%)
Query: 25 SGSIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFLSIWLPR 84
+ L ++ + NN + + +P L+ LDLS+N L + L
Sbjct: 265 YHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLEN 322
Query: 85 KWDKRKCSGVDQGLLRLNNNSLS----GAFPVFLAKISELAFLDLSYNNLSGPVPKFPAR 140
L L++NS+ L L LS+N+ + R
Sbjct: 323 --------------LYLDHNSIVTLKLSTHH-------TLKNLTLSHNDWDCNSLRALFR 361
Query: 141 TFN---VAGNPLIC 151
V C
Sbjct: 362 NVARPAVDDADQHC 375
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 1e-07
Identities = 30/113 (26%), Positives = 47/113 (41%), Gaps = 29/113 (25%)
Query: 25 SGSIGNLTNLRQVLLQNNNISGGIPPQL-GSLPKLQTLDLSNNRLSGVIPALLFLSIWLP 83
N+ L ++L+ N++S +P + + PKL TL +SNN L I F
Sbjct: 110 PHVFQNVPLLTVLVLERNDLSS-LPRGIFHNTPKLTTLSMSNNNLE-RIEDDTF------ 161
Query: 84 RKWDKRKCSGVDQGL-----LRLNNNSLSGAFPVFLAKISELAFLDLSYNNLS 131
Q L+L++N L+ L+ I L ++SYN LS
Sbjct: 162 ------------QATTSLQNLQLSSNRLT-HVD--LSLIPSLFHANVSYNLLS 199
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 1e-07
Identities = 22/117 (18%), Positives = 42/117 (35%), Gaps = 28/117 (23%)
Query: 27 SIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFLSIWLPRKW 86
+ + +L + N +S L ++ LD S+N ++ V+ + + +
Sbjct: 181 DLSLIPSLFHANVSYNLLS-----TLAIPIAVEELDASHNSIN-VVRGPVNVELT----- 229
Query: 87 DKRKCSGVDQGLLRLNNNSLSGAFPVFLAKISELAFLDLSYNNLSGPVPKFPARTFN 143
+L+L +N+L+ L +DLSYN L K F
Sbjct: 230 -----------ILKLQHNNLT-DTAWL-LNYPGLVEVDLSYNELE----KIMYHPFV 269
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 2e-06
Identities = 8/58 (13%), Positives = 23/58 (39%), Gaps = 2/58 (3%)
Query: 23 TLSGSIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFLSI 80
L+ + L+ + L +N++ + +L+ L L +N + + ++
Sbjct: 286 ALNLYGQPIPTLKVLDLSHNHLLH-VERNQPQFDRLENLYLDHNSIV-TLKLSTHHTL 341
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 5e-05
Identities = 16/132 (12%), Positives = 33/132 (25%), Gaps = 28/132 (21%)
Query: 16 PSQSLSGTLSGSIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPAL 75
P Q + ++ V + + +L + + N+ + +PA
Sbjct: 5 PRQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAA 63
Query: 76 LFLSIWLPRKWDKRKCSGVDQGL-----LRLNNNSLSGAFPVFLAKISELAFLDLSYNNL 130
L L LN+ + A + L + +N +
Sbjct: 64 LL------------------DSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAI 105
Query: 131 SGPVPKFPARTF 142
P F
Sbjct: 106 R----YLPPHVF 113
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 56.1 bits (136), Expect = 9e-09
Identities = 28/105 (26%), Positives = 43/105 (40%), Gaps = 8/105 (7%)
Query: 295 RGLLYLHEQCDPKIIHRDVKAANVLLD-DFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVG 353
+ L Y H I+HRDVK NV++D + + + D+GLA+ H V +
Sbjct: 141 KALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY-HPGQEYNVRV-ASRY 195
Query: 354 HIAPEYLSTGQS-SEKTDVFGFGILLLELITGMRALEFGKS-INQ 396
PE L Q D++ G +L +I G +Q
Sbjct: 196 FKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQ 240
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 56.1 bits (135), Expect = 2e-08
Identities = 28/108 (25%), Positives = 41/108 (37%), Gaps = 27/108 (25%)
Query: 29 GNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFLSIWLPRKWDK 88
L + LQ+NN++ L + P L +DLS N L I F
Sbjct: 229 PVNVELTILKLQHNNLTD--TAWLLNYPGLVEVDLSYNELE-KIMYHPF----------- 274
Query: 89 RKCSGVDQGL-----LRLNNNSLSGAFPVFLAKISELAFLDLSYNNLS 131
+ L ++NN L A ++ I L LDLS+N+L
Sbjct: 275 -------VKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL 314
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 54.9 bits (132), Expect = 4e-08
Identities = 22/113 (19%), Positives = 36/113 (31%), Gaps = 31/113 (27%)
Query: 25 SGSIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFLSIWLPR 84
+ L ++ + NN + + +P L+ LDLS+N L V
Sbjct: 271 YHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLLHVERNQPQFD----- 324
Query: 85 KWDKRKCSGVDQGL--LRLNNNSLS----GAFPVFLAKISELAFLDLSYNNLS 131
L L L++NS+ L L LS+N+
Sbjct: 325 ------------RLENLYLDHNSIVTLKLSTHH-------TLKNLTLSHNDWD 358
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 53.4 bits (128), Expect = 1e-07
Identities = 30/113 (26%), Positives = 47/113 (41%), Gaps = 29/113 (25%)
Query: 25 SGSIGNLTNLRQVLLQNNNISGGIPPQL-GSLPKLQTLDLSNNRLSGVIPALLFLSIWLP 83
N+ L ++L+ N++S +P + + PKL TL +SNN L I F
Sbjct: 116 PHVFQNVPLLTVLVLERNDLSS-LPRGIFHNTPKLTTLSMSNNNLE-RIEDDTF------ 167
Query: 84 RKWDKRKCSGVDQGL-----LRLNNNSLSGAFPVFLAKISELAFLDLSYNNLS 131
Q L+L++N L+ L+ I L ++SYN LS
Sbjct: 168 ------------QATTSLQNLQLSSNRLT-HVD--LSLIPSLFHANVSYNLLS 205
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 52.2 bits (125), Expect = 3e-07
Identities = 22/117 (18%), Positives = 42/117 (35%), Gaps = 28/117 (23%)
Query: 27 SIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFLSIWLPRKW 86
+ + +L + N +S L ++ LD S+N ++ V+ + + +
Sbjct: 187 DLSLIPSLFHANVSYNLLS-----TLAIPIAVEELDASHNSIN-VVRGPVNVELT----- 235
Query: 87 DKRKCSGVDQGLLRLNNNSLSGAFPVFLAKISELAFLDLSYNNLSGPVPKFPARTFN 143
+L+L +N+L+ L +DLSYN L K F
Sbjct: 236 -----------ILKLQHNNLT-DTAWL-LNYPGLVEVDLSYNELE----KIMYHPFV 275
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 49.5 bits (118), Expect = 2e-06
Identities = 14/107 (13%), Positives = 34/107 (31%), Gaps = 19/107 (17%)
Query: 23 TLSGSIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFLSIWL 82
L+ + L+ + L +N++ + +L+ L L +N + + + L
Sbjct: 292 ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLKLSTHHT--L 347
Query: 83 PRKWDKRKCSGVDQGLLRLNNNSLSG-AFPVFLAKISELAFLDLSYN 128
L L++N + ++ A D +
Sbjct: 348 KN--------------LTLSHNDWDCNSLRALFRNVARPAVDDADQH 380
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 42.6 bits (100), Expect = 3e-04
Identities = 16/132 (12%), Positives = 33/132 (25%), Gaps = 28/132 (21%)
Query: 16 PSQSLSGTLSGSIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPAL 75
P Q + ++ V + + +L + + N+ + +PA
Sbjct: 11 PRQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAA 69
Query: 76 LFLSIWLPRKWDKRKCSGVDQGL-----LRLNNNSLSGAFPVFLAKISELAFLDLSYNNL 130
L L LN+ + A + L + +N +
Sbjct: 70 LL------------------DSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAI 111
Query: 131 SGPVPKFPARTF 142
P F
Sbjct: 112 R----YLPPHVF 119
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 2e-08
Identities = 26/156 (16%), Positives = 47/156 (30%), Gaps = 36/156 (23%)
Query: 25 SGSIGNLTNLRQVLLQNNNISGGIPPQ-LGSLPKLQTLDLSNNRLSGVIPALLFL----- 78
LT L ++ + +++ P+ L S+ + L L + ++ +
Sbjct: 167 RKDFAGLTFLEELEIDASDLQS-YEPKSLKSIQNVSHLILHMKQHI-LLLEIFVDVTSSV 224
Query: 79 ------SIWLPRKWDKRKCSGVDQGL--------LRLNNNSLSGAFPVFLAKISELAFLD 124
L +G L +++ + SL L +IS L L+
Sbjct: 225 ECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLF-QVMKLLNQISGLLELE 283
Query: 125 LSYNNLSGPVPKFPARTF---------NVAGNPLIC 151
S N L P F + NP C
Sbjct: 284 FSRNQLKS----VPDGIFDRLTSLQKIWLHTNPWDC 315
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 53.6 bits (129), Expect = 6e-08
Identities = 22/127 (17%), Positives = 37/127 (29%), Gaps = 18/127 (14%)
Query: 30 NLTNLRQVLLQNNNISGGIPPQL-GSLPKLQTLDLSNNRLSGVIPALLF------LSIWL 82
+L +L + L N +S + L L L+L N + LF + +
Sbjct: 98 SLGSLEHLDLSYNYLSN-LSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRV 156
Query: 83 PRKWDKRK-CSGVDQGL-----LRLNNNSLSGAFPVFLAKISELAFLDLSYNNLSGPVPK 136
K GL L ++ + L P L I ++ L L
Sbjct: 157 GNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHI----L 212
Query: 137 FPARTFN 143
+
Sbjct: 213 LLEIFVD 219
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 1e-06
Identities = 26/110 (23%), Positives = 37/110 (33%), Gaps = 34/110 (30%)
Query: 32 TNLRQVLLQNNNISGGIPP-QLGSLPKLQTLDLSNNRLSGVIPALLFLSIWLPRKWDKRK 90
++ + L NN I+ I L LQ L L++N ++ I F
Sbjct: 52 EAVKSLDLSNNRITY-ISNSDLQRCVNLQALVLTSNGIN-TIEEDSF------------- 96
Query: 91 CSGVDQGL-----LRLNNNSLS----GAFPVFLAKISELAFLDLSYNNLS 131
L L L+ N LS F +S L FL+L N
Sbjct: 97 -----SSLGSLEHLDLSYNYLSNLSSSWF----KPLSSLTFLNLLGNPYK 137
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 47.8 bits (114), Expect = 5e-06
Identities = 25/116 (21%), Positives = 47/116 (40%), Gaps = 16/116 (13%)
Query: 30 NLTNLRQVLLQNNNISGGIPPQL-GSLPKLQTLDLSNNRLSGVIPALLFL------SIWL 82
NL+ ++L +N I+ I SL L+ LDLS N LS + + F + L
Sbjct: 74 RCVNLQALVLTSNGIN-TIEEDSFSSLGSLEHLDLSYNYLS-NLSSSWFKPLSSLTFLNL 131
Query: 83 PR-KWDKRKCSGVDQGLLRL------NNNSLSGAFPVFLAKISELAFLDLSYNNLS 131
+ + + L +L N ++ + A ++ L L++ ++L
Sbjct: 132 LGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQ 187
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 7e-05
Identities = 18/76 (23%), Positives = 30/76 (39%), Gaps = 6/76 (7%)
Query: 23 TLSGSIGNLTNLRQVLLQNNNISGGIPPQ-LGSLPKLQTLDLSNNRLSGVIPALLFLSIW 81
+ + ++ L ++ N + +P L LQ + L N P + +LS W
Sbjct: 268 QVMKLLNQISGLLELEFSRNQLK-SVPDGIFDRLTSLQKIWLHTNPWDCSCPRIDYLSRW 326
Query: 82 LPRKWDKR----KCSG 93
L + K KCSG
Sbjct: 327 LNKNSQKEQGSAKCSG 342
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 2e-08
Identities = 24/145 (16%), Positives = 38/145 (26%), Gaps = 41/145 (28%)
Query: 25 SGSIGNLTNLRQVLLQNNNISGGIPPQL-GSLPKLQTLDLSNNRLSGVIPALLFLSIWLP 83
S L +L+ + ++ I L L L L N+ + F
Sbjct: 47 ETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFL-QLETGAF------ 99
Query: 84 RKWDKRKCSGVDQGL-----LRLNNNSLS------GAFPVFLAKISELAFLDLSYNNLS- 131
GL L L +L F ++ L L L NN+
Sbjct: 100 ------------NGLANLEVLTLTQCNLDGAVLSGNFFK----PLTSLEMLVLRDNNIKK 143
Query: 132 -GPVPKFPA----RTFNVAGNPLIC 151
P F ++ N +
Sbjct: 144 IQPASFFLNMRRFHVLDLTFNKVKS 168
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 51.3 bits (123), Expect = 4e-07
Identities = 28/131 (21%), Positives = 43/131 (32%), Gaps = 25/131 (19%)
Query: 25 SGSIGNLTNLRQVLLQNNNI-SGGIPPQL-GSLPKLQTLDLSNNRLSGVIPALLFLS--- 79
+G+ L NL + L N+ + L L+ L L +N + + PA FL+
Sbjct: 96 TGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRR 155
Query: 80 ---IWLPR-KWDKRKCSGVDQGL-------LRLNNNSLSGAFPVFLAKISELAF------ 122
+ L K C LRL++ +L +L
Sbjct: 156 FHVLDLTFNKVK-SICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSI 214
Query: 123 --LDLSYNNLS 131
LDLS N
Sbjct: 215 TTLDLSGNGFK 225
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 48.6 bits (116), Expect = 4e-06
Identities = 26/113 (23%), Positives = 38/113 (33%), Gaps = 33/113 (29%)
Query: 32 TNLRQVLLQNNNISGGIPPQ-LGSLPKLQTLDLSNNRLSGVIPALLFLSIWLPRKWDKRK 90
++ V L N+I+ + L LQ L + VI F
Sbjct: 30 AHVNYVDLSLNSIAE-LNETSFSRLQDLQFLKVEQQTPGLVIRNNTF------------- 75
Query: 91 CSGVDQGL-----LRLNNNSLS----GAFPVFLAKISELAFLDLSYNNLSGPV 134
+GL L+L+ N GAF ++ L L L+ NL G V
Sbjct: 76 -----RGLSSLIILKLDYNQFLQLETGAF----NGLANLEVLTLTQCNLDGAV 119
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 5e-05
Identities = 22/116 (18%), Positives = 42/116 (36%), Gaps = 28/116 (24%)
Query: 32 TNLRQVLLQNNNISGGIPPQL-GSLPKLQTLDLSNNRLSGVIPALLFLSIWLPRKWDKRK 90
+ ++ L + I + + L+ L L+ N ++ I F
Sbjct: 275 SGVKTCDLSKSKIFA-LLKSVFSHFTDLEQLTLAQNEIN-KIDDNAF-----------WG 321
Query: 91 CSGVDQGLLRLNNNSL----SGAFPVFLAKISELAFLDLSYNNLSGPVPKFPARTF 142
+ + + L L+ N L S F + +L LDLSYN++ ++F
Sbjct: 322 LTHLLK--LNLSQNFLGSIDSRMF----ENLDKLEVLDLSYNHIRA----LGDQSF 367
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 42.8 bits (101), Expect = 2e-04
Identities = 26/116 (22%), Positives = 42/116 (36%), Gaps = 34/116 (29%)
Query: 25 SGSIGNLTNLRQVLLQNNNISGGIPPQL-GSLPKLQTLDLSNNRLSGVIPALLFLSIWLP 83
+ LT+L ++ L N + I ++ +L KL+ LDLS N + + F
Sbjct: 316 DNAFWGLTHLLKLNLSQNFLGS-IDSRMFENLDKLEVLDLSYNHIR-ALGDQSF------ 367
Query: 84 RKWDKRKCSGVDQGL-----LRLNNNSLS----GAFPVFLAKISELAFLDLSYNNL 130
GL L L+ N L G F +++ L + L N
Sbjct: 368 ------------LGLPNLKELALDTNQLKSVPDGIF----DRLTSLQKIWLHTNPW 407
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 2e-08
Identities = 51/203 (25%), Positives = 89/203 (43%), Gaps = 43/203 (21%)
Query: 210 LGAGGFGNVYKGK-LGDGTVLAVKRL-KDMIS----------------LAVHRNLLRLIG 251
LG G FG V +A+K + + ++ L H ++++L
Sbjct: 17 LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYD 76
Query: 252 YCATPTERLLVYPYMSNGSVASRLREKPALDWNTRKRIAIGAAR--------GLLYLHEQ 303
TPT+ ++V Y + G + + EK KR+ R + Y H
Sbjct: 77 VITTPTDIVMVIEY-AGGELFDYIVEK--------KRMTEDEGRRFFQQIICAIEYCHRH 127
Query: 304 CDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGHIAPEYLSTG 363
KI+HRD+K N+LLDD + DFGL+ ++ + + T+ G+ + APE ++ G
Sbjct: 128 ---KIVHRDLKPENLLLDDNLNVKIADFGLSNIM-TDGNFLKTSC-GSPNYAAPEVIN-G 181
Query: 364 QSSE--KTDVFGFGILLLELITG 384
+ + DV+ GI+L ++ G
Sbjct: 182 KLYAGPEVDVWSCGIVLYVMLVG 204
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 54.7 bits (131), Expect = 3e-08
Identities = 24/126 (19%), Positives = 41/126 (32%), Gaps = 35/126 (27%)
Query: 27 SIGNLTNLRQVLLQNNNISGGIPPQ-LGSLPKLQTLDLSNNRLSGVIPALLFLSIWLPRK 85
+ NL ++ ++N + + L L +L+ L + + L + F PR
Sbjct: 26 HLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVAPDAFHF--TPRL 82
Query: 86 WDKRKCSGVDQGLLRLNNNSLSGAFPVFLAKISELAFLDLSYNNLSGPVPKFPARTFNVA 145
L L+ N+L +S LS L ++
Sbjct: 83 -----------SRLNLSFNALE--------SLSWKTVQGLSLQEL------------VLS 111
Query: 146 GNPLIC 151
GNPL C
Sbjct: 112 GNPLHC 117
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 47.4 bits (112), Expect = 6e-06
Identities = 11/56 (19%), Positives = 20/56 (35%), Gaps = 3/56 (5%)
Query: 25 SGSIGNLTNLRQVLLQNNNISGGIPPQ-LGSLPKLQTLDLSNNRLSGVIPALLFLS 79
+ L LR + + + + + P P+L L+LS N L +
Sbjct: 49 LRDLRGLGELRNLTIVKSGLR-FVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQG 102
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 54.5 bits (131), Expect = 5e-08
Identities = 28/144 (19%), Positives = 54/144 (37%), Gaps = 32/144 (22%)
Query: 18 QSLSGTLSGSIGNLTNLRQVLLQNNNISGGIPPQL-GSLPKLQTLDLSNNRLSGVIPALL 76
+ LS ++ + +L+Q+ + N++S L +L++S+N L+ I L
Sbjct: 361 KELS-KIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCL 419
Query: 77 FLSIWLPRKWDKRKCSGVDQGLLRLNNNSLSGAFPVFLAKISELAFLDLSYNNLSGPVPK 136
I +L L++N + + P + K+ L L+++ N L
Sbjct: 420 PPRI----------------KVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLK----S 458
Query: 137 FPARTF---------NVAGNPLIC 151
P F + NP C
Sbjct: 459 VPDGIFDRLTSLQKIWLHTNPWDC 482
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 54.1 bits (130), Expect = 6e-08
Identities = 26/129 (20%), Positives = 44/129 (34%), Gaps = 25/129 (19%)
Query: 19 SLSGTLSGSIGNLTNLRQVLLQNNNISGGIPPQLG---SLPKLQTLDLSNNRLSGVIPAL 75
L+ T+ + G+LT L ++LQ N + + + LQ LD+S N +S
Sbjct: 335 LLTDTVFENCGHLTELETLILQMNQLKE-LSKIAEMTTQMKSLQQLDISQNSVSYDEKKG 393
Query: 76 LFLSIWLPRKWDKRKCSGVDQGLLRLNNNSL-SGAFPVFLAKISELAFLDLSYNNLSGPV 134
W L +++N L F + + LDL N +
Sbjct: 394 DC--SWTKSL-----------LSLNMSSNILTDTIFRCLPPR---IKVLDLHSNKIK--- 434
Query: 135 PKFPARTFN 143
P +
Sbjct: 435 -SIPKQVVK 442
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 46.4 bits (110), Expect = 2e-05
Identities = 24/109 (22%), Positives = 45/109 (41%), Gaps = 20/109 (18%)
Query: 25 SGSIGNLTNLRQVLLQNNNISGGIPPQ-LGSLPKLQTLDLSNNRLSGVIPALLFLSIWLP 83
+ I +L+ LR +++ +N I + +L+ LDLS+N+L I +++
Sbjct: 38 TSDILSLSKLRILIISHNRIQ-YLDISVFKFNQELEYLDLSHNKLVK-ISCHPTVNLK-- 93
Query: 84 RKWDKRKCSGVDQGLLRLNNNSL-SGAFPVFLAKISELAFLDLSYNNLS 131
L L+ N+ + +S+L FL LS +L
Sbjct: 94 --------------HLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLE 128
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 45.2 bits (107), Expect = 4e-05
Identities = 22/100 (22%), Positives = 35/100 (35%), Gaps = 17/100 (17%)
Query: 32 TNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFLSIWLPRKWDKRKC 91
+ + N IS + SL KL+ L +S+NR+ + +F
Sbjct: 21 QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQY-LDISVFKFNQELEY------ 73
Query: 92 SGVDQGLLRLNNNSLSGAFPVFLAKISELAFLDLSYNNLS 131
L L++N L + L LDLS+N
Sbjct: 74 -------LDLSHNKLVK---ISCHPTVNLKHLDLSFNAFD 103
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 44.9 bits (106), Expect = 5e-05
Identities = 18/76 (23%), Positives = 32/76 (42%), Gaps = 6/76 (7%)
Query: 23 TLSGSIGNLTNLRQVLLQNNNISGGIPPQ-LGSLPKLQTLDLSNNRLSGVIPALLFLSIW 81
++ + L L+++ + +N + +P L LQ + L N P + +LS W
Sbjct: 435 SIPKQVVKLEALQELNVASNQLKS-VPDGIFDRLTSLQKIWLHTNPWDCSCPRIDYLSRW 493
Query: 82 LPRK----WDKRKCSG 93
L + KCSG
Sbjct: 494 LNKNSQKEQGSAKCSG 509
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 43.3 bits (102), Expect = 1e-04
Identities = 20/115 (17%), Positives = 38/115 (33%), Gaps = 9/115 (7%)
Query: 27 SIGNLTNLRQVLLQNNNI-SGGIPPQLGSLPKLQTLDLSNNRLS----GVIPALLFLSIW 81
S NL+ + L N + I + G++ +L+ L LS L I L +
Sbjct: 85 SCHPTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLNISKVL 144
Query: 82 LPRKWDKRKCSGVDQ----GLLRLNNNSLSGAFPVFLAKISELAFLDLSYNNLSG 132
L + + L+ + F+ +S +L +N+
Sbjct: 145 LVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKC 199
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 5e-08
Identities = 29/124 (23%), Positives = 51/124 (41%), Gaps = 26/124 (20%)
Query: 295 RGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGH 354
+ + YLH ++HRD+K +N+LL+ C V DFGL++ + +
Sbjct: 120 KVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINEN 176
Query: 355 I--------------------APEYLSTGQS-SEKTDVFGFGILLLELITGMRALEFGKS 393
APE L ++ D++ G +L E++ G + + G S
Sbjct: 177 TENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCG-KPIFPGSS 235
Query: 394 -INQ 396
+NQ
Sbjct: 236 TMNQ 239
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 7e-08
Identities = 25/117 (21%), Positives = 40/117 (34%), Gaps = 20/117 (17%)
Query: 30 NLTNLRQVLLQNNNISGGIPPQ-LGSLPKLQTLDLSNNRLSGVIPALLFLSIWLPRKWDK 88
NL+ + + ++N I P L LP L+ L + N L + P L +
Sbjct: 78 NLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLK-MFPDLTKVY--------- 127
Query: 89 RKCSGVDQGLLRLNNNSLSGAFP--VFLAKISELAFLDLSYNNLSGPVPKFPARTFN 143
S +L + +N + P F +E L L N + FN
Sbjct: 128 ---STDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT----SVQGYAFN 177
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 4e-06
Identities = 20/116 (17%), Positives = 38/116 (32%), Gaps = 21/116 (18%)
Query: 25 SGSIGNLTNLRQVLLQNNNISGGIPPQL-GSLPKLQTLDLSNNRLSGVIPALLFLSIWLP 83
S + NL N+ ++ + + + +L K+ +++ N R I LP
Sbjct: 48 SHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKE--LP 105
Query: 84 RKWDKRKCSGVDQGL--LRLNNNSLSGAFP--VFLAKISELAFLDLSYNNLSGPVP 135
L L + N L FP + L+++ N +P
Sbjct: 106 L-------------LKFLGIFNTGLK-MFPDLTKVYSTDIFFILEITDNPYMTSIP 147
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 1e-05
Identities = 24/134 (17%), Positives = 44/134 (32%), Gaps = 40/134 (29%)
Query: 25 SGSIGNLTNLRQVLLQNNNISGGIPPQ--LGSLPKLQTLDLSNNRLSGVIPALLFLSIWL 82
++ L L+ + + N + P + S L++++N IP F L
Sbjct: 98 PDALKELPLLKFLGIFNTGLK-MFPDLTKVYSTDIFFILEITDNPYMTSIPVNAFQG--L 154
Query: 83 PRKWDKRKCSGVDQGLLRLNNNSLS----GAFP------------VFLAKISELAF---- 122
+ L+L NN + AF +L I + AF
Sbjct: 155 CN----------ETLTLKLYNNGFTSVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVY 204
Query: 123 -----LDLSYNNLS 131
LD+S +++
Sbjct: 205 SGPSLLDVSQTSVT 218
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 2e-05
Identities = 18/123 (14%), Positives = 37/123 (30%), Gaps = 38/123 (30%)
Query: 31 LTNLRQVLLQNNNISGGIPPQ-LGSLPKLQTLDLSNNRLSGVIPALLFLSIWLPRKWDKR 89
+ + + L ++ IP +LP + + +S + + + F
Sbjct: 30 PPSTQTLKLIETHLRT-IPSHAFSNLPNISRIYVSIDVTLQQLESHSF------------ 76
Query: 90 KCSGVDQGLLRL------NNNSLS----GAFPVFLAKISELAFLDLSYNNLSGPVPKFPA 139
L ++ N +L+ A ++ L FL + L FP
Sbjct: 77 ------YNLSKVTHIEIRNTRNLTYIDPDAL----KELPLLKFLGIFNTGLK----MFPD 122
Query: 140 RTF 142
T
Sbjct: 123 LTK 125
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 9e-08
Identities = 26/104 (25%), Positives = 41/104 (39%), Gaps = 21/104 (20%)
Query: 28 IGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFLSIWLPRKWD 87
+ TNL+++ L +N IS + P L L KL+ L ++ NRL + + +
Sbjct: 59 MQFFTNLKELHLSHNQISD-LSP-LKDLTKLEELSVNRNRLK-NLNGIPSACLS------ 109
Query: 88 KRKCSGVDQGLLRLNNNSLSGAFPVFLAKISELAFLDLSYNNLS 131
L L+NN L L + L L + N L
Sbjct: 110 ----------RLFLDNNELRDTDS--LIHLKNLEILSIRNNKLK 141
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 2e-04
Identities = 23/104 (22%), Positives = 39/104 (37%), Gaps = 24/104 (23%)
Query: 30 NLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFLSIWLPRKWDKR 89
L ++ L NN + L L L+ L + NN+L I L FLS
Sbjct: 104 PSACLSRLFLDNNELRD-TDS-LIHLKNLEILSIRNNKLK-SIVMLGFLS---------- 150
Query: 90 KCSGVDQGL--LRLNNNSLSGAFPVFLAKISELAFLDLSYNNLS 131
L L L+ N ++ L ++ ++ ++DL+
Sbjct: 151 -------KLEVLDLHGNEITNTGG--LTRLKKVNWIDLTGQKCV 185
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 2e-04
Identities = 16/43 (37%), Positives = 25/43 (58%), Gaps = 2/43 (4%)
Query: 27 SIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLS 69
S+ +L NL + ++NN + I LG L KL+ LDL N ++
Sbjct: 123 SLIHLKNLEILSIRNNKLK-SIVM-LGFLSKLEVLDLHGNEIT 163
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 40.4 bits (95), Expect = 7e-04
Identities = 18/106 (16%), Positives = 38/106 (35%), Gaps = 24/106 (22%)
Query: 28 IGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFLSIWLPRKWD 87
L N + L +++ + L +Q + N+ + + + F +
Sbjct: 15 DPGLANAVKQNLGKQSVTD-LVS-QKELSGVQNFNGDNSNIQ-SLAGMQFFT-------- 63
Query: 88 KRKCSGVDQGL--LRLNNNSLSGAFPVFLAKISELAFLDLSYNNLS 131
L L L++N +S P L +++L L ++ N L
Sbjct: 64 ---------NLKELHLSHNQISDLSP--LKDLTKLEELSVNRNRLK 98
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 53.4 bits (128), Expect = 1e-07
Identities = 29/135 (21%), Positives = 49/135 (36%), Gaps = 24/135 (17%)
Query: 23 TLSGSIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFLSIW- 81
+L L L + N ++ +P L +L L + L L I+
Sbjct: 75 SLPALPPELRTLE---VSGNQLTS-LPVLPPGLLELSIFSNPLTHLPALPSGLCKLWIFG 130
Query: 82 -----LPRKWDKRKCSGVDQGLLRLNNNSLSGAFPVFLAKISELAFLDLSYNNLSGPVPK 136
LP + L +++N L+ + P A SEL L N L+ +P
Sbjct: 131 NQLTSLPVLPPGLQE-------LSVSDNQLA-SLP---ALPSELCKLWAYNNQLTS-LPM 178
Query: 137 FPA--RTFNVAGNPL 149
P+ + +V+ N L
Sbjct: 179 LPSGLQELSVSDNQL 193
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 51.8 bits (124), Expect = 3e-07
Identities = 34/192 (17%), Positives = 58/192 (30%), Gaps = 35/192 (18%)
Query: 23 TLSGSIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFLSIWL 82
+L L L + N ++ +P L + L +S NRL+ +P L
Sbjct: 215 SLPALPSGLKELI---VSGNRLTS-LPVLPSEL---KELMVSGNRLTS-LPMLP------ 260
Query: 83 PRKWDKRKCSGVDQGL--LRLNNNSLSGAFPVFLAKISELAFLDLSYNNLSGPVPKFPAR 140
GL L + N L+ P L +S ++L N LS +
Sbjct: 261 -------------SGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQALRE 306
Query: 141 --TFNVAGNPLICGSSSTNVCSGSANSVPLSFSLNSSPDKQEEGLISLGNLRNFTFRELQ 198
+ P+I S + L + EG + + + F +
Sbjct: 307 ITSAPGYSGPII--RFDMAGASAPRETRALHLAAADWLVPAREGEPAPADRWH-MFGQED 363
Query: 199 QATENFSSKNIL 210
A + L
Sbjct: 364 NADAFSLFLDRL 375
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 47.6 bits (113), Expect = 8e-06
Identities = 33/129 (25%), Positives = 51/129 (39%), Gaps = 32/129 (24%)
Query: 23 TLSGSIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFLSIWL 82
+L L L NN ++ +P L Q L +S+N+L+ +P L L
Sbjct: 155 SLPALPSELCKLW---AYNNQLTS-LPMLPSGL---QELSVSDNQLA-SLPTLPSE---L 203
Query: 83 PRKWDKRKCSGVDQGLLRLNNNSLSGAFPVFLAKISELAFLDLSYNNLSGPVPKFPA--R 140
+ L NN L+ + P A S L L +S N L+ +P P+ +
Sbjct: 204 YK--------------LWAYNNRLT-SLP---ALPSGLKELIVSGNRLTS-LPVLPSELK 244
Query: 141 TFNVAGNPL 149
V+GN L
Sbjct: 245 ELMVSGNRL 253
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 44.1 bits (104), Expect = 9e-05
Identities = 20/121 (16%), Positives = 41/121 (33%), Gaps = 28/121 (23%)
Query: 31 LTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFLSIWLPRKWDKRK 90
+ + + ++ +P L + + TL + +N L+ + L
Sbjct: 39 NNGNAVLNVGESGLTT-LPDCLPA--HITTLVIPDNNLTSLPALPPELRT---------- 85
Query: 91 CSGVDQGLLRLNNNSLSGAFPVFLAKISELAFLDLSYNNLSGPVPKFPA--RTFNVAGNP 148
L ++ N L+ + PV + EL+ +L P P+ + GN
Sbjct: 86 --------LEVSGNQLT-SLPVLPPGLLELSIFSNPLTHL----PALPSGLCKLWIFGNQ 132
Query: 149 L 149
L
Sbjct: 133 L 133
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 52.9 bits (127), Expect = 1e-07
Identities = 20/74 (27%), Positives = 33/74 (44%), Gaps = 3/74 (4%)
Query: 295 RGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGH 354
G+ Y+H I+HRD+K AN L++ C V DFGLA+ +D+ ++ +
Sbjct: 167 VGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPRED 223
Query: 355 IAPEYLSTGQSSEK 368
+ K
Sbjct: 224 DMNLVTFPHTKNLK 237
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 2e-07
Identities = 27/115 (23%), Positives = 46/115 (40%), Gaps = 25/115 (21%)
Query: 295 RGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGH 354
G ++HE IIHRD+K AN LL+ C V DFGLA+ ++
Sbjct: 140 LGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEE 196
Query: 355 I---------------------APEYLSTGQS-SEKTDVFGFGILLLELITGMRA 387
APE + ++ ++ D++ G + EL+ +++
Sbjct: 197 PGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQS 251
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 2e-07
Identities = 33/124 (26%), Positives = 46/124 (37%), Gaps = 37/124 (29%)
Query: 29 GNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFLSIWLPRKWDK 88
G L L + L +N + +P +LP L LD+S NRL+ +P
Sbjct: 74 GTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLT-SLPL-------------- 117
Query: 89 RKCSGVDQGL-----LRLNNNSLS----GAFPVFLAKISELAFLDLSYNNLSGPVPKFPA 139
G +GL L L N L G +L L L+ NNL+ + PA
Sbjct: 118 ----GALRGLGELQELYLKGNELKTLPPGLL----TPTPKLEKLSLANNNLT----ELPA 165
Query: 140 RTFN 143
N
Sbjct: 166 GLLN 169
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 48.6 bits (116), Expect = 2e-06
Identities = 21/112 (18%), Positives = 36/112 (32%), Gaps = 21/112 (18%)
Query: 32 TNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFLSIWLPRKWDKRKC 91
+ + L N + L +L L+L L+ + L
Sbjct: 31 KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQVDGTL------------- 76
Query: 92 SGVDQGLLRLNNNSLSGAFPVFLAKISELAFLDLSYNNLSGPVPKFPARTFN 143
G L L++N L + P+ + L LD+S+N L+ P
Sbjct: 77 --PVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLT----SLPLGALR 121
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 48.6 bits (116), Expect = 2e-06
Identities = 26/115 (22%), Positives = 40/115 (34%), Gaps = 26/115 (22%)
Query: 23 TLSGSIGNLTNLRQVLLQNNNISGGIPPQL-GSLPKLQTLDLSNNRLSGVIPALLFLSIW 81
+L L L + + N ++ +P L +LQ L L N L +P L
Sbjct: 91 SLPLLGQTLPALTVLDVSFNRLTS-LPLGALRGLGELQELYLKGNELK-TLPPGLLTP-- 146
Query: 82 LPR-KWDKRKCSGVDQGLLRLNNNSLS----GAFPVFLAKISELAFLDLSYNNLS 131
P+ + L L NN+L+ G + L L L N+L
Sbjct: 147 TPKLEK------------LSLANNNLTELPAGLL----NGLENLDTLLLQENSLY 185
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 51.7 bits (124), Expect = 2e-07
Identities = 23/200 (11%), Positives = 46/200 (23%), Gaps = 65/200 (32%)
Query: 210 LGAGGFGNVYKGKLGDGTVL----AVKRLKDMISLA-----------------VHRNLLR 248
G ++ D T L A+ + L + R
Sbjct: 39 HGGVPPLQFWQAL--D-TALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVAR 95
Query: 249 LIGYCATPTERLLVYPYMSNGSVASRLREKP----ALDWNTRKRIAIGAARGLLYLHEQC 304
++ T L+V ++ GS+ P A+ R A H
Sbjct: 96 VLDVVHTRAGGLVVAEWIRGGSLQEVADTSPSPVGAI------RAMQSLAAAADAAHRA- 148
Query: 305 DPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGHIAPEYLSTGQ 364
+ + V + + ++
Sbjct: 149 --GVALSIDHPSRVRVSIDGDVVLAYPATM----------------------------PD 178
Query: 365 SSEKTDVFGFGILLLELITG 384
++ + D+ G G L L+
Sbjct: 179 ANPQDDIRGIGASLYALLVN 198
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 3e-07
Identities = 38/160 (23%), Positives = 64/160 (40%), Gaps = 33/160 (20%)
Query: 27 SIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIP--ALLFLSIWLPR 84
+ LTNL+ + + N +S + P L +L KL TL +N++S + P +L L
Sbjct: 146 PLAGLTNLQYLSIGNAQVS-DLTP-LANLSKLTTLKADDNKISDISPLASLPNLIE---- 199
Query: 85 KWDKRKCSGVDQGLLRLNNNSLSGAFPVFLAKISELAFLDLSYNNLSGPVP------KFP 138
+ L NN +S P LA S L + L+ ++ P
Sbjct: 200 --------------VHLKNNQISDVSP--LANTSNLFIVTLTNQTITNQPVFYNNNLVVP 243
Query: 139 ARTFNVAGNPLICGSSSTNVCSGSANSVPLSFSLNSSPDK 178
+G P+ + S N G+ S L+++L S +
Sbjct: 244 NVVKGPSGAPIAPATISDN---GTYASPNLTWNLTSFINN 280
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 1e-06
Identities = 28/106 (26%), Positives = 45/106 (42%), Gaps = 24/106 (22%)
Query: 28 IGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIP--ALLFLSIWLPRK 85
+ L+NL+ + L N I+ I P L L LQ L + N ++S + P L L+
Sbjct: 125 LAGLSNLQVLYLDLNQITN-ISP-LAGLTNLQYLSIGNAQVSDLTPLANLSKLTT----- 177
Query: 86 WDKRKCSGVDQGLLRLNNNSLSGAFPVFLAKISELAFLDLSYNNLS 131
L+ ++N +S P LA + L + L N +S
Sbjct: 178 -------------LKADDNKISDISP--LASLPNLIEVHLKNNQIS 208
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 2e-06
Identities = 23/106 (21%), Positives = 46/106 (43%), Gaps = 24/106 (22%)
Query: 28 IGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIP--ALLFLSIWLPRK 85
+ NLT + ++ L N + + + L ++TLDL++ +++ V P L L +
Sbjct: 81 LKNLTKITELELSGNPLKN-VSA-IAGLQSIKTLDLTSTQITDVTPLAGLSNLQV----- 133
Query: 86 WDKRKCSGVDQGLLRLNNNSLSGAFPVFLAKISELAFLDLSYNNLS 131
L L+ N ++ P LA ++ L +L + +S
Sbjct: 134 -------------LYLDLNQITNISP--LAGLTNLQYLSIGNAQVS 164
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 3e-06
Identities = 28/106 (26%), Positives = 46/106 (43%), Gaps = 24/106 (22%)
Query: 28 IGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFLSIWLPRKWD 87
+ L NL + L++N I+ + P L +L K+ L+LS N L + A+ L
Sbjct: 59 VQYLNNLIGLELKDNQITD-LAP-LKNLTKITELELSGNPLK-NVSAIAGL--------- 106
Query: 88 KRKCSGVDQGL--LRLNNNSLSGAFPVFLAKISELAFLDLSYNNLS 131
Q + L L + ++ P LA +S L L L N ++
Sbjct: 107 --------QSIKTLDLTSTQITDVTP--LAGLSNLQVLYLDLNQIT 142
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 47.8 bits (114), Expect = 5e-06
Identities = 27/107 (25%), Positives = 44/107 (41%), Gaps = 24/107 (22%)
Query: 27 SIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFLSIWLPRKW 86
+I L +++ + L + I+ + P L L LQ L L N+++ I L L+
Sbjct: 102 AIAGLQSIKTLDLTSTQIT-DVTP-LAGLSNLQVLYLDLNQIT-NISPLAGLT------- 151
Query: 87 DKRKCSGVDQGL--LRLNNNSLSGAFPVFLAKISELAFLDLSYNNLS 131
L L + N +S P LA +S+L L N +S
Sbjct: 152 ----------NLQYLSIGNAQVSDLTP--LANLSKLTTLKADDNKIS 186
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 1e-04
Identities = 17/107 (15%), Positives = 39/107 (36%), Gaps = 24/107 (22%)
Query: 27 SIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIP--ALLFLSIWLPR 84
+ +L + + ++ I + L L L+L +N+++ + P L ++
Sbjct: 36 TQADLDGITTLSAFGTGVT-TIEG-VQYLNNLIGLELKDNQITDLAPLKNLTKITE---- 89
Query: 85 KWDKRKCSGVDQGLLRLNNNSLSGAFPVFLAKISELAFLDLSYNNLS 131
L L+ N L +A + + LDL+ ++
Sbjct: 90 --------------LELSGNPLKNVSA--IAGLQSIKTLDLTSTQIT 120
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 42.8 bits (101), Expect = 1e-04
Identities = 19/104 (18%), Positives = 39/104 (37%), Gaps = 24/104 (23%)
Query: 30 NLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFLSIWLPRKWDKR 89
L N ++ +N++ + L + TL ++ I + +L+
Sbjct: 17 ALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVTT-IEGVQYLN---------- 63
Query: 90 KCSGVDQGL--LRLNNNSLSGAFPVFLAKISELAFLDLSYNNLS 131
L L L +N ++ P L ++++ L+LS N L
Sbjct: 64 -------NLIGLELKDNQITDLAP--LKNLTKITELELSGNPLK 98
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 3e-07
Identities = 27/129 (20%), Positives = 38/129 (29%), Gaps = 28/129 (21%)
Query: 23 TLSGSIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFLSIWL 82
L +L + NN + P+L +LP L + NN L + L L
Sbjct: 167 KLPDLPPSLEFIA---AGNNQLE--ELPELQNLPFLTAIYADNNSLKKLPDLPLSLES-- 219
Query: 83 PRKWDKRKCSGVDQGLLRLNNNSLSGAFPVFLAKISELAFLDLSYNNLSGPVPKFPA--R 140
+ NN L L + L + N L +P P
Sbjct: 220 ----------------IVAGNNILE--ELPELQNLPFLTTIYADNNLLKT-LPDLPPSLE 260
Query: 141 TFNVAGNPL 149
NV N L
Sbjct: 261 ALNVRDNYL 269
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 6e-07
Identities = 24/144 (16%), Positives = 39/144 (27%), Gaps = 38/144 (26%)
Query: 23 TLSGSIGNLTNLRQVLLQNNNISGGIP---------------PQLGSLPKLQTLDLSNNR 67
L +L +L +S P P+L + L+ +D+ NN
Sbjct: 105 ELPELPQSLKSLLVDNNNLKALSDLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNS 164
Query: 68 LSGVIPALLFLSIWLPRKWDKRKCSGVDQGLLRLNNNSLSGAFPVFLAKISELAFLDLSY 127
L + L + NN L P + L +
Sbjct: 165 LKKLPDLPPSLEF------------------IAAGNNQLE-ELPEL-QNLPFLTAIYADN 204
Query: 128 NNLSGPVPKFPA--RTFNVAGNPL 149
N+L +P P + N L
Sbjct: 205 NSLKK-LPDLPLSLESIVAGNNIL 227
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 8e-07
Identities = 20/124 (16%), Positives = 34/124 (27%), Gaps = 34/124 (27%)
Query: 23 TLSGSIGNLTNLRQVLLQNNNISGGIPPQLGSL-------------PKLQTLDLSNNRLS 69
+ N+ + + + PP G + L+L+N LS
Sbjct: 25 EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLS 84
Query: 70 GVIPALLF-LSIWLPRKWDKRKCSGVDQGLLRLNNNSLSGAFPVFLAKISELAFLDLSYN 128
+P L L L + NSL+ P + L + +
Sbjct: 85 -SLPELPPHLES------------------LVASCNSLT-ELPELPQSLKSLLVDNNNLK 124
Query: 129 NLSG 132
LS
Sbjct: 125 ALSD 128
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 4e-06
Identities = 33/135 (24%), Positives = 54/135 (40%), Gaps = 24/135 (17%)
Query: 23 TLSGSIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFLSI-- 80
TL +L L +++N ++ +P SL L + + LS + P L +L+
Sbjct: 251 TLPDLPPSLEALN---VRDNYLTD-LPELPQSLTFLDVSENIFSGLSELPPNLYYLNASS 306
Query: 81 ----WLPRKWDKRKCSGVDQGLLRLNNNSLSGAFPVFLAKISELAFLDLSYNNLSGPVPK 136
L + L ++NN L P A L L S+N+L+ VP+
Sbjct: 307 NEIRSLCDLPPSLEE-------LNVSNNKLI-ELP---ALPPRLERLIASFNHLAE-VPE 354
Query: 137 FPA--RTFNVAGNPL 149
P + +V NPL
Sbjct: 355 LPQNLKQLHVEYNPL 369
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 3e-05
Identities = 17/109 (15%), Positives = 29/109 (26%), Gaps = 30/109 (27%)
Query: 23 TLSGSIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFLSIWL 82
L L L N+++ +P +L + L + N L P +
Sbjct: 331 ELPALPPRLERLI---ASFNHLAE-VPELPQNL---KQLHVEYNPLR-EFPDIPE----- 377
Query: 83 PRKWDKRKCSGVDQGLLRLNNNSLSGAFPVFLAKISELAFLDLSYNNLS 131
LR+N++ L L + N L
Sbjct: 378 ------------SVEDLRMNSHLAE-----VPELPQNLKQLHVETNPLR 409
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 41.1 bits (97), Expect = 7e-04
Identities = 13/111 (11%), Positives = 31/111 (27%), Gaps = 30/111 (27%)
Query: 23 TLSGSIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFLSIWL 82
++ +LR N+ +P L+ L + N L P +
Sbjct: 371 EFPDIPESVEDLRM-----NSHLAEVPE---LPQNLKQLHVETNPLR-EFPDIP------ 415
Query: 83 PRKWDKRKCSGVDQGL--LRLNNNSLSGAFPVFLAKISELAFLDLSYNNLS 131
+ + LR+N+ + + +L +++
Sbjct: 416 -------------ESVEDLRMNSERVVDPYEFAHETTDKLEDDVFEHHHHH 453
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 51.3 bits (122), Expect = 6e-07
Identities = 29/106 (27%), Positives = 45/106 (42%), Gaps = 24/106 (22%)
Query: 28 IGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFLSIWLPRKWD 87
+ NL NL + L N I + L L KL++L L +N +S I L+ L
Sbjct: 83 LTNLKNLGWLFLDENKIKD-LSS-LKDLKKLKSLSLEHNGIS-DINGLVHLP-------- 131
Query: 88 KRKCSGVDQGL--LRLNNNSLSGAFPVFLAKISELAFLDLSYNNLS 131
L L L NN ++ L+++++L L L N +S
Sbjct: 132 ---------QLESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQIS 166
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 48.2 bits (114), Expect = 5e-06
Identities = 29/104 (27%), Positives = 41/104 (39%), Gaps = 20/104 (19%)
Query: 28 IGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFLSIWLPRKWD 87
+ +L L + L NN I+ I L L KL TL L +N++S I L L+ L
Sbjct: 127 LVHLPQLESLYLGNNKITD-ITV-LSRLTKLDTLSLEDNQISD-IVPLAGLT-KLQN--- 179
Query: 88 KRKCSGVDQGLLRLNNNSLSGAFPVFLAKISELAFLDLSYNNLS 131
L L+ N +S LA + L L+L
Sbjct: 180 -----------LYLSKNHISDLRA--LAGLKNLDVLELFSQECL 210
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 44.7 bits (105), Expect = 6e-05
Identities = 19/43 (44%), Positives = 24/43 (55%), Gaps = 2/43 (4%)
Query: 27 SIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLS 69
+ LT L + L++N IS I P L L KLQ L LS N +S
Sbjct: 148 VLSRLTKLDTLSLEDNQIS-DIVP-LAGLTKLQNLYLSKNHIS 188
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 44.7 bits (105), Expect = 6e-05
Identities = 23/107 (21%), Positives = 42/107 (39%), Gaps = 24/107 (22%)
Query: 27 SIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFLSIWLPRKW 86
+ L ++ Q++ N++I + + LP + L L+ N+L+ I L L
Sbjct: 38 TQNELNSIDQIIANNSDIKS-VQG-IQYLPNVTKLFLNGNKLT-DIKPLTNLK------- 87
Query: 87 DKRKCSGVDQGL--LRLNNNSLSGAFPVFLAKISELAFLDLSYNNLS 131
L L L+ N + L + +L L L +N +S
Sbjct: 88 ----------NLGWLFLDENKIKDLSS--LKDLKKLKSLSLEHNGIS 122
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 43.2 bits (101), Expect = 2e-04
Identities = 17/104 (16%), Positives = 34/104 (32%), Gaps = 24/104 (23%)
Query: 30 NLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGV--IPALLFLSIWLPRKWD 87
+ L+ +++ + L + + +N+ + V I L ++
Sbjct: 19 AFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSVQGIQYLPNVTK------- 69
Query: 88 KRKCSGVDQGLLRLNNNSLSGAFPVFLAKISELAFLDLSYNNLS 131
L LN N L+ P L + L +L L N +
Sbjct: 70 -----------LFLNGNKLTDIKP--LTNLKNLGWLFLDENKIK 100
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 51.1 bits (122), Expect = 6e-07
Identities = 22/109 (20%), Positives = 38/109 (34%), Gaps = 19/109 (17%)
Query: 23 TLSGSIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFLSIWL 82
L +L L ++NN ++ +P SL + LD+S N L +PA+ +
Sbjct: 154 MLPELPTSLEVLS---VRNNQLTF-LPELPESL---EALDVSTNLLES-LPAVPVRNHHS 205
Query: 83 PRKWDKRKCSGVDQGLLRLNNNSLSGAFPVFLAKISELAFLDLSYNNLS 131
R N ++ P + + + L N LS
Sbjct: 206 EETE----------IFFRCRENRIT-HIPENILSLDPTCTIILEDNPLS 243
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 48.8 bits (116), Expect = 3e-06
Identities = 29/131 (22%), Positives = 50/131 (38%), Gaps = 36/131 (27%)
Query: 23 TLSGSIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFLSIWL 82
+L +L L +N +S +P SL + LD+ NN+L+ ++P L
Sbjct: 94 SLPELPASLEYLD---ACDNRLST-LPELPASL---KHLDVDNNQLT-MLPELP------ 139
Query: 83 PRKWDKRKCSGVDQGL--LRLNNNSLSGAFPVFLAKISELAFLDLSYNNLSGPVPKFPA- 139
L + +NN L+ P + L L + N L+ +P+ P
Sbjct: 140 -------------ALLEYINADNNQLT-MLP---ELPTSLEVLSVRNNQLTF-LPELPES 181
Query: 140 -RTFNVAGNPL 149
+V+ N L
Sbjct: 182 LEALDVSTNLL 192
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 48.8 bits (116), Expect = 3e-06
Identities = 15/65 (23%), Positives = 23/65 (35%), Gaps = 5/65 (7%)
Query: 23 TLSGSIGNLTNLRQVL----LQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFL 78
+L + + + N I+ IP + SL T+ L +N LS I L
Sbjct: 194 SLPAVPVRNHHSEETEIFFRCRENRITH-IPENILSLDPTCTIILEDNPLSSRIRESLSQ 252
Query: 79 SIWLP 83
P
Sbjct: 253 QTAQP 257
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 46.1 bits (109), Expect = 2e-05
Identities = 29/146 (19%), Positives = 52/146 (35%), Gaps = 25/146 (17%)
Query: 7 ENLVIGLGAPSQSLSGTLSGSIGNLTNLRQVLLQNNNISGGIP-PQLGSLPKLQTLDLSN 65
N + + ++SGT + + L N + + + + + L L+
Sbjct: 9 NNFSLSQNSFYNTISGTYADYFSAWDKWEKQALPGENRNEAVSLLKECLINQFSELQLNR 68
Query: 66 NRLSGVIPALLFLSIWLPRKWDKRKCSGVDQGLLRLNNNSLSGAFPVFLAKISELAFLDL 125
LS +P L I +L + N+L + P + L +LD
Sbjct: 69 LNLS-SLPDNLPPQIT----------------VLEITQNALI-SLP---ELPASLEYLDA 107
Query: 126 SYNNLSGPVPKFPA--RTFNVAGNPL 149
N LS +P+ PA + +V N L
Sbjct: 108 CDNRLST-LPELPASLKHLDVDNNQL 132
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 8e-07
Identities = 29/138 (21%), Positives = 48/138 (34%), Gaps = 37/138 (26%)
Query: 24 LSGSIGNLTNLRQVLLQNNNIS---GGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFLSI 80
+ ++ L + + L NNI L + L+ L L N + I L ++
Sbjct: 40 MDATLSTLKACKHLALSTNNIEKISS-----LSGMENLRILSLGRNLIK-KIENLDAVAD 93
Query: 81 WLPRKWDKRKCSGVDQGLLRLNNN---SLSGAFPVFLAKISELAFLDLSYNNLS-----G 132
L L ++ N SLSG + K+ L L +S N ++
Sbjct: 94 TLEE--------------LWISYNQIASLSG-----IEKLVNLRVLYMSNNKITNWGEID 134
Query: 133 PVPKFPA-RTFNVAGNPL 149
+ +AGNPL
Sbjct: 135 KLAALDKLEDLLLAGNPL 152
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 1e-06
Identities = 26/141 (18%), Positives = 47/141 (33%), Gaps = 37/141 (26%)
Query: 25 SGSIGNLTNLRQVLLQNNNISGGIPPQ-LGSLPKLQTLDLSNNRLSGVIPALLFLSIWLP 83
+G L LR++ NN I+ I + + L++NRL + +F
Sbjct: 50 TGIFKKLPQLRKINFSNNKITD-IEEGAFEGASGVNEILLTSNRLEN-VQHKMF------ 101
Query: 84 RKWDKRKCSGVDQGLLRLNNNSLS----GAFPVFLAKISELAFLDLSYNNLSGPVPKFPA 139
+ + L L +N ++ +F +S + L L N ++
Sbjct: 102 -----KGLESLKT--LMLRSNRITCVGNDSF----IGLSSVRLLSLYDNQIT----TVAP 146
Query: 140 RTF---------NVAGNPLIC 151
F N+ NP C
Sbjct: 147 GAFDTLHSLSTLNLLANPFNC 167
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 49.4 bits (118), Expect = 1e-06
Identities = 18/118 (15%), Positives = 33/118 (27%), Gaps = 30/118 (25%)
Query: 32 TNLRQVLLQNNNISGGIPPQ-LGSLPKLQTLDLSNNRLSGVIPALLFLSIWLPRKWDKRK 90
N ++ + I L+ +++S N + VI A +F
Sbjct: 30 RNAIELRFVLTKLRV-IQKGAFSGFGDLEKIEISQNDVLEVIEADVF------------- 75
Query: 91 CSGVDQGLLRL------NNNSLSGAFPVFLAKISELAFLDLSYNNLSGPVPKFPARTF 142
L +L N+L P + L +L +S + P
Sbjct: 76 -----SNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIK----HLPDVHK 124
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 47.9 bits (114), Expect = 4e-06
Identities = 20/109 (18%), Positives = 38/109 (34%), Gaps = 20/109 (18%)
Query: 25 SGSIGNLTNLRQVLLQNNNISGGIPPQ-LGSLPKLQTLDLSN-NRLSGVIPALLFLSIWL 82
G+ +L ++ + N++ I +LPKL + + N L I F + L
Sbjct: 47 KGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLL-YINPEAFQN--L 103
Query: 83 PR-KWDKRKCSGVDQGLLRLNNNSLSGAFPVFL-AKISELAFLDLSYNN 129
P ++ L ++N + P + LD+ N
Sbjct: 104 PNLQY------------LLISNTGIK-HLPDVHKIHSLQKVLLDIQDNI 139
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 46.4 bits (110), Expect = 1e-05
Identities = 27/135 (20%), Positives = 44/135 (32%), Gaps = 27/135 (20%)
Query: 2 ITCSPENLVIGLGAPSQSLS------GTLSGSIGNLTNLRQV-LLQNNNISGGIPPQ-LG 53
I N +GL S L + S N T L ++ L NNN+ +P
Sbjct: 141 IHTIERNSFVGLSFESVILWLNKNGIQEIHNSAFNGTQLDELNLSDNNNLEE-LPNDVFH 199
Query: 54 SLPKLQTLDLSNNRLSGVIPALLFLSIWLPRKWDKRKCSGVDQGLLRLNNNSLSGAFPVF 113
LD+S R+ +P+ ++ + L + +L P
Sbjct: 200 GASGPVILDISRTRIH-SLPSYGLENL---------------KKLRARSTYNLK-KLPTL 242
Query: 114 LAKISELAFLDLSYN 128
K+ L L+Y
Sbjct: 243 -EKLVALMEASLTYP 256
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 43.7 bits (103), Expect = 9e-05
Identities = 24/133 (18%), Positives = 40/133 (30%), Gaps = 30/133 (22%)
Query: 30 NLTNLRQVLLQNNNISGGIPPQL-GSLPKLQTLDLSNNRLSGVIPALLFLSIWLPRKWDK 88
NL NL+ +L+ N I +P + LD+ +N I F+ L +
Sbjct: 102 NLPNLQYLLISNTGIKH-LPDVHKIHSLQKVLLDIQDNINIHTIERNSFVG--LSFESVI 158
Query: 89 RKCSG-----VDQG---------LLRLNNNSLS----GAFPVFLAKISELAFLDLSYNNL 130
+ + L +NN+L F S LD+S +
Sbjct: 159 LWLNKNGIQEIHNSAFNGTQLDELNLSDNNNLEELPNDVF----HGASGPVILDISRTRI 214
Query: 131 SGPVPKFPARTFN 143
P+
Sbjct: 215 H----SLPSYGLE 223
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 42.9 bits (101), Expect = 2e-04
Identities = 19/140 (13%), Positives = 33/140 (23%), Gaps = 14/140 (10%)
Query: 25 SGSIGNLTNLRQVLLQNNNISGGIPPQL--GSLPKLQTLDLSNNRLSGVIPALLFLSIWL 82
+ + +Q+N I G + L L+ N + I F L
Sbjct: 121 DVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ-EIHNSAFNGTQL 179
Query: 83 PRKWDKRK------CSGVDQGL-----LRLNNNSLSGAFPVFLAKISELAFLDLSYNNLS 131
+ V G L ++ + L + +L
Sbjct: 180 DELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLKKL 239
Query: 132 GPVPKFPARTFNVAGNPLIC 151
+ K A P C
Sbjct: 240 PTLEKLVALMEASLTYPSHC 259
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 48.0 bits (115), Expect = 3e-06
Identities = 24/124 (19%), Positives = 39/124 (31%), Gaps = 23/124 (18%)
Query: 25 SGSIGNLTNLRQVLLQNNNISGGIPPQL-GSLPKLQTLDLSNNRLSGVIPALLFL----- 78
S S + L+ + L I I SL L TL L+ N + + F
Sbjct: 45 SYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGNPIQ-SLALGAFSGLSSL 102
Query: 79 -SIWLPRKWDKRKCSGVDQGL-----LRLNNNSLS-----GAFPVFLAKISELAFLDLSY 127
+ + L L + +N + F + ++ L LDLS
Sbjct: 103 QKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYF----SNLTNLEHLDLSS 158
Query: 128 NNLS 131
N +
Sbjct: 159 NKIQ 162
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 6e-06
Identities = 25/110 (22%), Positives = 36/110 (32%), Gaps = 34/110 (30%)
Query: 32 TNLRQVLLQNNNISGGIPP-QLGSLPKLQTLDLSNNRLSGVIPALLFLSIWLPRKWDKRK 90
+ + + L N + + S P+LQ LDLS + I
Sbjct: 28 FSTKNLDLSFNPLRH-LGSYSFFSFPELQVLDLSRCEIQ-TIED---------------- 69
Query: 91 CSGVDQGL-----LRLNNNSLS----GAFPVFLAKISELAFLDLSYNNLS 131
G Q L L L N + GAF + +S L L NL+
Sbjct: 70 --GAYQSLSHLSTLILTGNPIQSLALGAF----SGLSSLQKLVAVETNLA 113
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 7e-06
Identities = 27/133 (20%), Positives = 52/133 (39%), Gaps = 32/133 (24%)
Query: 18 QSLSGTLSGSIGNLTNLRQVLLQNNNISGGIPPQL-GSLPKLQTLDLSNNRLSGVIPALL 76
QSL+ G+ L++L++++ N++ + G L L+ L++++N +
Sbjct: 89 QSLA---LGAFSGLSSLQKLVAVETNLAS-LENFPIGHLKTLKELNVAHNLIQSFKLPEY 144
Query: 77 FLSIWLPRKWDKRKCSGVDQGL--LRLNNNSLS----GAFPVFLAKISELAF-LDLSYNN 129
F + L L L L++N + V L ++ L LDLS N
Sbjct: 145 FSN--LTN-------------LEHLDLSSNKIQSIYCTDLRV-LHQMPLLNLSLDLSLNP 188
Query: 130 LSGPVPKFPARTF 142
++ F
Sbjct: 189 MN----FIQPGAF 197
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 4e-06
Identities = 29/112 (25%), Positives = 45/112 (40%), Gaps = 34/112 (30%)
Query: 30 NLTNLRQVLLQNNNISGGIPPQL-GSLPKLQTLDLSNNRLSGVIPALLFLSIWLPRKWDK 88
LT LR + L +N + +P + L L+TL +++N+L +P
Sbjct: 59 RLTKLRLLYLNDNKLQT-LPAGIFKELKNLETLWVTDNKLQ-ALPI-------------- 102
Query: 89 RKCSGVDQGL-----LRLNNNSLS----GAFPVFLAKISELAFLDLSYNNLS 131
GV L LRL+ N L F +++L +L L YN L
Sbjct: 103 ----GVFDQLVNLAELRLDRNQLKSLPPRVF----DSLTKLTYLSLGYNELQ 146
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 43.4 bits (103), Expect = 7e-05
Identities = 35/117 (29%), Positives = 45/117 (38%), Gaps = 34/117 (29%)
Query: 25 SGSIGNLTNLRQVLLQNNNISGGIPPQL-GSLPKLQTLDLSNNRLSGVIPALLFLSIWLP 83
G L NL ++ L N + +PP++ SL KL L L N L +P +F
Sbjct: 102 IGVFDQLVNLAELRLDRNQLK-SLPPRVFDSLTKLTYLSLGYNELQ-SLPKGVF------ 153
Query: 84 RKWDKRKCSGVDQGL-----LRLNNNSLS----GAFPVFLAKISELAFLDLSYNNLS 131
L LRL NN L GAF K++EL L L N L
Sbjct: 154 ------------DKLTSLKELRLYNNQLKRVPEGAF----DKLTELKTLKLDNNQLK 194
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 48.0 bits (113), Expect = 4e-06
Identities = 31/218 (14%), Positives = 49/218 (22%), Gaps = 64/218 (29%)
Query: 192 FTFRELQQATENFSSKNILGAGGFGNVYKGKLGDGTVLAVK------------------- 232
F TE +G G FG V++ V A+K
Sbjct: 11 VPFSHCL-PTEKLQRCEKIGEGVFGEVFQTIADHTPV-AIKIIAIEGPDLVNGSHQKTFE 68
Query: 233 -------RLKDMISLAV-----HRNLLRLIGYC----ATPTERLLVYPYM--SNGSVASR 274
K++ L+ + L + P L + + + GS R
Sbjct: 69 EILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDR 128
Query: 275 LREKPA-----------------------LDWNTRKRIAIGAARGLLYLHEQCDPKIIHR 311
T K I L + HR
Sbjct: 129 PDFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASL--RFEHR 186
Query: 312 DVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVR 349
D+ NVLL + K + ++
Sbjct: 187 DLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSII 224
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 5e-06
Identities = 25/125 (20%), Positives = 49/125 (39%), Gaps = 24/125 (19%)
Query: 27 SIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFLSIWLPRKW 86
+ + T L ++ N + +L TLD S N+++ +
Sbjct: 143 DVSHNTQLTELDCHLNKKIT--KLDVTPQTQLTTLDCSFNKITEL--------------- 185
Query: 87 DKRKCSGVDQGLLRLNNNSLSGAFPVFLAKISELAFLDLSYNNLSG-PVPKFPA-RTFNV 144
D + +++ L + N+++ + L + +L FLD S N L+ V F+
Sbjct: 186 DVSQNKLLNR--LNCDTNNITK---LDLNQNIQLTFLDCSSNKLTEIDVTPLTQLTYFDC 240
Query: 145 AGNPL 149
+ NPL
Sbjct: 241 SVNPL 245
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 9e-06
Identities = 24/134 (17%), Positives = 51/134 (38%), Gaps = 26/134 (19%)
Query: 19 SLSGTLSGSIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGV-IPALLF 77
+ T + S L L + N++I+ + + L L L ++N ++ + +
Sbjct: 29 EMQATDTISEEQLATLTSLDCHNSSIT-DMTG-IEKLTGLTKLICTSNNITTLDLSQNTN 86
Query: 78 LSIWLPRKWDKRKCSGVDQGLLRLNNNSLSGAFPVFLAKISELAFLDLSYNNLSG-PVPK 136
L+ L ++N L+ + + +++L +L+ N L+ V +
Sbjct: 87 LTY------------------LACDSNKLTN---LDVTPLTKLTYLNCDTNKLTKLDVSQ 125
Query: 137 FPA-RTFNVAGNPL 149
P N A N L
Sbjct: 126 NPLLTYLNCARNTL 139
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 1e-05
Identities = 21/105 (20%), Positives = 43/105 (40%), Gaps = 25/105 (23%)
Query: 28 IGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGV-IPALLFLSIWLPRKW 86
I LT L +++ +NNI+ + L L L +N+L+ + + L L+
Sbjct: 60 IEKLTGLTKLICTSNNIT-TLD--LSQNTNLTYLACDSNKLTNLDVTPLTKLTY------ 110
Query: 87 DKRKCSGVDQGLLRLNNNSLSGAFPVFLAKISELAFLDLSYNNLS 131
L + N L+ + +++ L +L+ + N L+
Sbjct: 111 ------------LNCDTNKLT---KLDVSQNPLLTYLNCARNTLT 140
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 1e-05
Identities = 24/162 (14%), Positives = 52/162 (32%), Gaps = 33/162 (20%)
Query: 23 TLSGSIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGV-IPALLFLSIW 81
+ T L + N I+ + + L L+ N ++ + + + L+
Sbjct: 161 ITKLDVTPQTQLTTLDCSFNKIT-ELD--VSQNKLLNRLNCDTNNITKLDLNQNIQLTF- 216
Query: 82 LPRKWDKRKCSGVDQGLLRLNNNSLSGAFPVFLAKISELAFLDLSYNNLSG-PVPKFPA- 139
L ++N L+ + + +++L + D S N L+ V
Sbjct: 217 -----------------LDCSSNKLTE---IDVTPLTQLTYFDCSVNPLTELDVSTLSKL 256
Query: 140 RTFNVAGNPL--ICGSSSTNV----CSGSANSVPLSFSLNSS 175
T + L I + +T + G L + N+
Sbjct: 257 TTLHCIQTDLLEIDLTHNTQLIYFQAEGCRKIKELDVTHNTQ 298
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 1e-05
Identities = 24/131 (18%), Positives = 50/131 (38%), Gaps = 15/131 (11%)
Query: 27 SIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGV----IPALLFLSIWL 82
+ TNL + +N ++ + + L KL L+ N+L+ + P L +L+
Sbjct: 80 DLSQNTNLTYLACDSNKLTN-LD--VTPLTKLTYLNCDTNKLTKLDVSQNPLLTYLNCAR 136
Query: 83 PR--KWDKRKCSGVDQGLLRLNNNSLSGAFPVFLAKISELAFLDLSYNNLSG-PVPKFPA 139
+ D + + + L + N + ++L LD S+N ++ V +
Sbjct: 137 NTLTEIDVSHNTQLTE--LDCHLNKKITKLD--VTPQTQLTTLDCSFNKITELDVSQNKL 192
Query: 140 -RTFNVAGNPL 149
N N +
Sbjct: 193 LNRLNCDTNNI 203
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 2e-05
Identities = 18/131 (13%), Positives = 39/131 (29%), Gaps = 15/131 (11%)
Query: 27 SIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLS----GVIPALLFLSIWL 82
+ L + +N ++ I + L +L D S N L+ + L L
Sbjct: 207 DLNQNIQLTFLDCSSNKLTE-ID--VTPLTQLTYFDCSVNPLTELDVSTLSKLTTLHCIQ 263
Query: 83 PR--KWDKRKCSGVDQGLLRLNNNSLSGAFPVFLAKISELAFLDLSYNNLSG-PVPKFPA 139
+ D + L+ + + ++L LD ++ + + P
Sbjct: 264 TDLLEIDLTHNT----QLIYFQAEGCRKIKELDVTHNTQLYLLDCQAAGITELDLSQNPK 319
Query: 140 -RTFNVAGNPL 149
+ L
Sbjct: 320 LVYLYLNNTEL 330
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 2e-05
Identities = 25/164 (15%), Positives = 46/164 (28%), Gaps = 33/164 (20%)
Query: 25 SGSIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFLSIWLPR 84
+ + T L + Q I+ + L PKL L L+N L+ + +
Sbjct: 290 ELDVTHNTQLYLLDCQAAGITE-LD--LSQNPKLVYLYLNNTELT-ELDVSHNTKLK--- 342
Query: 85 KWDKRKCSGVDQGLLRLNNNSLSGAFPVFLAKISELAFLDLSYNNLSG-PVPKFPART-- 141
L N + F + KI L + P +
Sbjct: 343 -------------SLSCVNAHIQ-DFSS-VGKIPALNNNFEAEGQTITMPKETLTNNSLT 387
Query: 142 -------FNVAGNPLICGSSSTNVCSGSANSVPLSFSLNSSPDK 178
+ GNP+ V + N++ +L++
Sbjct: 388 IAVSPDLLDQFGNPMNIEPGDGGVYDQATNTITWE-NLSTDNPA 430
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 1e-04
Identities = 20/121 (16%), Positives = 38/121 (31%), Gaps = 25/121 (20%)
Query: 33 NLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGV--IPALLFLSIWLPRKWDKRK 90
N + + L L +LD N+ ++ + I L L+
Sbjct: 19 NFASEVAAAFEMQATDTISEEQLATLTSLDCHNSSITDMTGIEKLTGLTK---------- 68
Query: 91 CSGVDQGLLRLNNNSLSGAFPVFLAKISELAFLDLSYNNLSG-PVPKFPA-RTFNVAGNP 148
L +N+++ + L++ + L +L N L+ V N N
Sbjct: 69 --------LICTSNNITT---LDLSQNTNLTYLACDSNKLTNLDVTPLTKLTYLNCDTNK 117
Query: 149 L 149
L
Sbjct: 118 L 118
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 47.9 bits (114), Expect = 6e-06
Identities = 19/114 (16%), Positives = 45/114 (39%), Gaps = 19/114 (16%)
Query: 18 QSLSGTLSGSIGNLTNLRQVLLQNNNISGGIPPQLGSLP-KLQTLDLSNNRLSGVIPALL 76
++ + N+++L + + N+++ + + + L+LS+N L +
Sbjct: 390 KNFFKV-ALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNML----TGSV 444
Query: 77 FLSIWLPRKWDKRKCSGVDQGLLRLNNNSLSGAFPVFLAKISELAFLDLSYNNL 130
F + K L L+NN + + P + + L L+++ N L
Sbjct: 445 FRCLPPKVKV------------LDLHNNRIM-SIPKDVTHLQALQELNVASNQL 485
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 43.3 bits (102), Expect = 1e-04
Identities = 25/119 (21%), Positives = 38/119 (31%), Gaps = 13/119 (10%)
Query: 25 SGSIGNLTNLRQVLLQNNNISGGIPPQL-GSLPKLQTLDLSNNRLSGVIPALLFLS---I 80
I L+ LR + L +N I + + L+ LD+S+NRL I S +
Sbjct: 69 MPDISFLSELRVLRLSHNRIRS-LDFHVFLFNQDLEYLDVSHNRLQN-ISCCPMASLRHL 126
Query: 81 WLPR-KWDKRKCSGVDQGL-----LRLNNNSL-SGAFPVFLAKISELAFLDLSYNNLSG 132
L +D L L L+ LDL ++ G
Sbjct: 127 DLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQLDLLPVAHLHLSCILLDLVSYHIKG 185
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 41.8 bits (98), Expect = 5e-04
Identities = 22/115 (19%), Positives = 39/115 (33%), Gaps = 19/115 (16%)
Query: 24 LSGSIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFLSIWLP 83
+ ++ + N + + +L +LQTL L N L + ++ +
Sbjct: 345 HMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLK-NFFKVALMTKNMS 403
Query: 84 RKWDKRKCSGVDQGLLRLNNNSL----SGAFPVFLAKISELAFLDLSYNNLSGPV 134
L + SL S A+ A + L+LS N L+G V
Sbjct: 404 S--------------LETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSV 444
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 8e-06
Identities = 32/109 (29%), Positives = 46/109 (42%), Gaps = 22/109 (20%)
Query: 287 KRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAI------VGDFGLAKLLDHS 340
K+I+ GL Y+H +C IIH D+K NVL++ + D G A D
Sbjct: 134 KQISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDE- 190
Query: 341 DSHVTTAV-----RGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITG 384
H T ++ R +PE L D++ L+ ELITG
Sbjct: 191 --HYTNSIQTREYR------SPEVLLGAPWGCGADIWSTACLIFELITG 231
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 8e-06
Identities = 13/42 (30%), Positives = 23/42 (54%)
Query: 28 IGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLS 69
+ L L+++ L +N +SGG+ P L L+LS N++
Sbjct: 60 LPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIK 101
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 2e-05
Identities = 29/115 (25%), Positives = 43/115 (37%), Gaps = 21/115 (18%)
Query: 17 SQSLSGTLSGSIGNLTNLRQVLLQNNNIS--GGIPPQLGSLPKLQTLDLSNNRLSGVIPA 74
S+S G L G L + N ++ +P L KL+ L+LS+NR+SG +
Sbjct: 27 SRSNEGKLEGLTDEFEELEFLSTINVGLTSIANLP----KLNKLKKLELSDNRVSGGLEV 82
Query: 75 LLFLSIWLPRKWDKRKCSGVDQGLLRLNNNSLSG-AFPVFLAKISELAFLDLSYN 128
L L L L+ N + + L K+ L LDL
Sbjct: 83 LAEKCPNLTH--------------LNLSGNKIKDLSTIEPLKKLENLKSLDLFNC 123
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 3e-05
Identities = 22/105 (20%), Positives = 42/105 (40%), Gaps = 21/105 (20%)
Query: 30 NLTNLRQVLLQNNNIS-GGIPPQLGSLPKLQTLDLSNNRLSGV--IPALLFLSIWLPRKW 86
+++++++L N+ + G + +L+ L N L+ + +P L L
Sbjct: 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSIANLPKLNKLKK------ 68
Query: 87 DKRKCSGVDQGLLRLNNNSLSGAFPVFLAKISELAFLDLSYNNLS 131
L L++N +SG V K L L+LS N +
Sbjct: 69 ------------LELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIK 101
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 8e-06
Identities = 28/106 (26%), Positives = 41/106 (38%), Gaps = 24/106 (22%)
Query: 28 IGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIP--ALLFLSIWLPRK 85
+ +L L + L NN I+ I L L KL TL L +N++S ++P L L
Sbjct: 130 LVHLPQLESLYLGNNKITD-ITV-LSRLTKLDTLSLEDNQISDIVPLAGLTKLQN----- 182
Query: 86 WDKRKCSGVDQGLLRLNNNSLSGAFPVFLAKISELAFLDLSYNNLS 131
L L+ N +S LA + L L+L
Sbjct: 183 -------------LYLSKNHISDLRA--LAGLKNLDVLELFSQECL 213
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 1e-05
Identities = 28/106 (26%), Positives = 45/106 (42%), Gaps = 24/106 (22%)
Query: 28 IGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFLSIWLPRKWD 87
+ NL NL + L N + + L L KL++L L +N +S I L+ L
Sbjct: 86 LANLKNLGWLFLDENKVKD-LSS-LKDLKKLKSLSLEHNGIS-DINGLVHLP-------- 134
Query: 88 KRKCSGVDQGL--LRLNNNSLSGAFPVFLAKISELAFLDLSYNNLS 131
L L L NN ++ L+++++L L L N +S
Sbjct: 135 ---------QLESLYLGNNKITDITV--LSRLTKLDTLSLEDNQIS 169
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 2e-04
Identities = 19/43 (44%), Positives = 24/43 (55%), Gaps = 2/43 (4%)
Query: 27 SIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLS 69
+ LT L + L++N IS I P L L KLQ L LS N +S
Sbjct: 151 VLSRLTKLDTLSLEDNQIS-DIVP-LAGLTKLQNLYLSKNHIS 191
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 41.6 bits (98), Expect = 4e-04
Identities = 21/107 (19%), Positives = 42/107 (39%), Gaps = 24/107 (22%)
Query: 27 SIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGV--IPALLFLSIWLPR 84
+ L ++ Q++ N++I + + LP + L L+ N+L+ + + L L
Sbjct: 41 TQNELNSIDQIIANNSDIKS-VQG-IQYLPNVTKLFLNGNKLTDIKPLANLKNLGW---- 94
Query: 85 KWDKRKCSGVDQGLLRLNNNSLSGAFPVFLAKISELAFLDLSYNNLS 131
L L+ N + L + +L L L +N +S
Sbjct: 95 --------------LFLDENKVKDLSS--LKDLKKLKSLSLEHNGIS 125
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 9e-06
Identities = 21/104 (20%), Positives = 36/104 (34%), Gaps = 21/104 (20%)
Query: 30 NLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGV--IPALLFLSIWLPRKWD 87
N R++ L+ I I +L + +D S+N + + P L L
Sbjct: 17 NAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKLDGFPLLRRLKT------- 68
Query: 88 KRKCSGVDQGLLRLNNNSLSGAFPVFLAKISELAFLDLSYNNLS 131
L +NNN + + +L L L+ N+L
Sbjct: 69 -----------LLVNNNRICRIGEGLDQALPDLTELILTNNSLV 101
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 1e-05
Identities = 15/54 (27%), Positives = 21/54 (38%), Gaps = 3/54 (5%)
Query: 19 SLSGTLSGSIGN---LTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLS 69
S + L L+ +L+ NN I +LP L L L+NN L
Sbjct: 48 DFSDNEIRKLDGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLV 101
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 1e-04
Identities = 29/117 (24%), Positives = 41/117 (35%), Gaps = 25/117 (21%)
Query: 19 SLSGTLSGSIGNL----TNLRQVLLQNNNIS--GGIPPQLGSLPKLQTLDLSNNRLSGVI 72
L G I NL + +N I G P L +L+TL ++NNR+ +
Sbjct: 25 DLRGYKIPVIENLGATLDQFDAIDFSDNEIRKLDGFP----LLRRLKTLLVNNNRICRIG 80
Query: 73 PALLFLSIWLPRKWDKRKCSGVDQGLLRLNNNSLSGAFPV-FLAKISELAFLDLSYN 128
L L L L NNSL + LA + L +L + N
Sbjct: 81 EGLDQALPDL--------------TELILTNNSLVELGDLDPLASLKSLTYLCILRN 123
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 46.9 bits (110), Expect = 1e-05
Identities = 25/134 (18%), Positives = 44/134 (32%), Gaps = 25/134 (18%)
Query: 10 VIGLGAPSQSLSGTLSGSIGNLTNLRQVLLQNNNISGGIPPQL------GSLPKLQTLDL 63
+I G P + L + NL L + + G P L+ L +
Sbjct: 200 IISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGI 259
Query: 64 SNNRLSGVIPALLFLSIWLPRKWDKRKCSGVDQGL--LRLNNNSLSG----AFPVFLAKI 117
+ V+ + S LP+ L + ++ L+ + KI
Sbjct: 260 VDAEEQNVVVEMFLESDILPQ-------------LETMDISAGVLTDEGARLLLDHVDKI 306
Query: 118 SELAFLDLSYNNLS 131
L F+++ YN LS
Sbjct: 307 KHLKFINMKYNYLS 320
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 1e-05
Identities = 15/42 (35%), Positives = 22/42 (52%)
Query: 28 IGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLS 69
+ L L+++ L N I GG+ LP L L+LS N+L
Sbjct: 67 LPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLK 108
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 8e-05
Identities = 25/105 (23%), Positives = 35/105 (33%), Gaps = 21/105 (20%)
Query: 30 NLTNLRQ-VLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGV--IPALLFLSIWLPRKW 86
+R+ VL + G I L+ L L N L V +P L L
Sbjct: 22 TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISVSNLPKLPKLKK------ 75
Query: 87 DKRKCSGVDQGLLRLNNNSLSGAFPVFLAKISELAFLDLSYNNLS 131
L L+ N + G + K+ L L+LS N L
Sbjct: 76 ------------LELSENRIFGGLDMLAEKLPNLTHLNLSGNKLK 108
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 41.3 bits (97), Expect = 2e-04
Identities = 30/115 (26%), Positives = 42/115 (36%), Gaps = 21/115 (18%)
Query: 17 SQSLSGTLSGSIGNLTNLRQVLLQNNNIS--GGIPPQLGSLPKLQTLDLSNNRLSGVIPA 74
+S G + G NL + L N + +P LPKL+ L+LS NR+ G +
Sbjct: 34 CKSNDGKIEGLTAEFVNLEFLSLINVGLISVSNLP----KLPKLKKLELSENRIFGGLDM 89
Query: 75 LLFLSIWLPRKWDKRKCSGVDQGLLRLNNNSLSGAFPV-FLAKISELAFLDLSYN 128
L L L L+ N L + L K+ L LDL
Sbjct: 90 LAEKLPNL--------------THLNLSGNKLKDISTLEPLKKLECLKSLDLFNC 130
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 4e-05
Identities = 38/153 (24%), Positives = 56/153 (36%), Gaps = 51/153 (33%)
Query: 32 TNLRQVLLQNNNISGGIPPQ-LGSLPKLQTLDLSNNRLSGVIPA--------LLFLSIW- 81
+ ++ L+ N I IPP KL+ +DLSNN++S + L L ++
Sbjct: 32 ETITEIRLEQNTIKV-IPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYG 89
Query: 82 -----LPRKWDKRKCSGVDQGL-----LRLNNNSLS----GAFPVFLAKISELAFLDLSY 127
LP + +GL L LN N ++ AF + L L L
Sbjct: 90 NKITELP--------KSLFEGLFSLQLLLLNANKINCLRVDAF----QDLHNLNLLSLYD 137
Query: 128 NNLSGPVPKFPARTFN---------VAGNPLIC 151
N L TF+ +A NP IC
Sbjct: 138 NKLQ----TIAKGTFSPLRAIQTMHLAQNPFIC 166
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 43.2 bits (102), Expect = 1e-04
Identities = 37/173 (21%), Positives = 57/173 (32%), Gaps = 45/173 (26%)
Query: 210 LGAGGFGNVYKGK-LGDGTVLAVKRLK----------------------DMISLAVHRNL 246
+G+GGFG +Y A +K D I + R
Sbjct: 45 IGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQ 104
Query: 247 LRLIG-----YCATPTERLLVYPYMSNGSVASRL--------REKPALDWNTRKRIAIGA 293
L +G + Y +M V RL + +T ++ I
Sbjct: 105 LDYLGIPLFYGSGLTEFKGRSYRFM----VMERLGIDLQKISGQNGTFKKSTVLQLGIRM 160
Query: 294 ARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIV--GDFGLAKLLDHSDSHV 344
L Y+HE +H D+KAAN+LL V D+GL+ + +H
Sbjct: 161 LDVLEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHK 210
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 41.7 bits (98), Expect = 4e-04
Identities = 31/178 (17%), Positives = 56/178 (31%), Gaps = 52/178 (29%)
Query: 210 LGAGGFGNVYKGKLGDGTVLAVKRL-------------------------KDMISLAVHR 244
+G GGFG +Y + + + I +
Sbjct: 43 IGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRT 102
Query: 245 NLLRLIG-----YCATPTERLLVYPYMSNGSVASRLREKPAL----DWNTRK-------R 288
L+ +G + Y +M + R L + N ++ +
Sbjct: 103 RKLKYLGVPKYWGSGLHDKNGKSYRFM----IMDRF--GSDLQKIYEANAKRFSRKTVLQ 156
Query: 289 IAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIV--GDFGLAKLLDHSDSHV 344
+++ L Y+HE +H D+KA+N+LL+ V D+GLA H
Sbjct: 157 LSLRILDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHK 211
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 40.8 bits (96), Expect = 5e-04
Identities = 39/131 (29%), Positives = 54/131 (41%), Gaps = 29/131 (22%)
Query: 31 LTNLRQVLLQNNNISGGIPPQL-GSLPKLQTLDLSNNRLSGVIPALLFLSIWLPRKWDKR 89
LT L + L NN ++ +P + L +L L L N+L +P+ +F D+
Sbjct: 82 LTELGTLGLANNQLA-SLPLGVFDHLTQLDKLYLGGNQLKS-LPSGVF---------DRL 130
Query: 90 KCSGVDQGLLRLNNNSLS----GAFPVFLAKISELAFLDLSYNNL-SGPVPKFPA----R 140
LRLN N L GAF K++ L L LS N L S P F +
Sbjct: 131 ----TKLKELRLNTNQLQSIPAGAF----DKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQ 182
Query: 141 TFNVAGNPLIC 151
T + GN C
Sbjct: 183 TITLFGNQFDC 193
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 41.4 bits (97), Expect = 6e-04
Identities = 28/149 (18%), Positives = 45/149 (30%), Gaps = 59/149 (39%)
Query: 287 KRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLL-------------------------- 320
K+I +GL YLH +C +IIH D+K N+LL
Sbjct: 149 KKIIQQVLQGLDYLHTKC--RIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPS 206
Query: 321 -----------------------DDFCEAIVGDFGLAKLLD--HSDSHVTTAVRGTVGHI 355
+ + + D G A + ++ T R
Sbjct: 207 GSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQYR------ 260
Query: 356 APEYLSTGQSSEKTDVFGFGILLLELITG 384
+ E L + D++ + EL TG
Sbjct: 261 SLEVLIGSGYNTPADIWSTACMAFELATG 289
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 534 | |||
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.95 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.93 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.87 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.79 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.77 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.76 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 99.76 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 99.76 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.74 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 99.74 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.73 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.72 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.7 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 99.7 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.7 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.69 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.69 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.69 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 99.68 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.67 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.67 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.66 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 99.66 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.65 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.65 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.65 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 99.64 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.64 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.64 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 99.64 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.63 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.63 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.62 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.62 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 99.61 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.6 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.6 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.6 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 99.59 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.59 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.59 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.58 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.58 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.58 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.57 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.57 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.57 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.57 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.57 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.57 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.56 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.56 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.55 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 99.55 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 99.55 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 99.54 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 99.53 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.53 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 99.53 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 99.52 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.52 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 99.52 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 99.51 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.5 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 99.5 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.5 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.49 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.49 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.49 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 99.49 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.48 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.48 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.48 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.48 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 99.48 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.47 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 99.47 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 99.47 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.47 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.46 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 99.46 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 99.46 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.46 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 99.46 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.45 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.45 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.45 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 99.45 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.44 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 99.44 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 99.44 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.44 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.44 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.42 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 99.42 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.42 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 99.42 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.42 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.41 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 99.4 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.4 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 99.4 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 99.4 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 99.39 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.39 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.37 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.35 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.35 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 99.33 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.33 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.32 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.32 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.31 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.3 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.3 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.3 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.29 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.29 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 99.29 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.27 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.23 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 99.23 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.22 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 99.2 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 99.2 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 99.2 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 99.18 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 99.17 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.16 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 99.15 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.14 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.14 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.1 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.1 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.08 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.05 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.05 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.05 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.04 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.03 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.02 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.85 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 98.83 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 98.83 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.74 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.73 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 98.71 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 98.58 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 98.52 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 98.44 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.42 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.42 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.37 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 98.34 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 98.27 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.06 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 98.04 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 97.98 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 97.96 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 97.94 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 97.94 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 97.87 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 97.83 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 97.79 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 97.77 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 97.59 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.54 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.48 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 97.43 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.33 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 97.29 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.26 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 97.03 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 96.98 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 96.89 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 96.83 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 96.74 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 96.6 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 96.59 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 96.46 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 96.46 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 96.28 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 96.25 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 96.17 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 96.03 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 95.97 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 95.93 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 95.86 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 95.8 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 95.73 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 95.72 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 95.33 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 95.26 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 94.88 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 89.43 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 87.1 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 81.01 |
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-54 Score=432.61 Aligned_cols=259 Identities=23% Similarity=0.245 Sum_probs=209.9
Q ss_pred hCCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEehh---------hhhhcccCceeeEEEEEeCCCeeEEEeeccCCCCh
Q 039819 202 ENFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLKD---------MISLAVHRNLLRLIGYCATPTERLLVYPYMSNGSV 271 (534)
Q Consensus 202 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~---------~l~~~~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 271 (534)
+.|...+.||+|+||.||+|+.. +|+.||||+++. +++.++|||||++++++.+.+..|||||||++|+|
T Consensus 58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~L 137 (336)
T 4g3f_A 58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSL 137 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCCTTCBH
T ss_pred hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHhHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCCCcH
Confidence 45777788999999999999975 689999999862 67889999999999999999999999999999999
Q ss_pred hhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCC-cEEEEecccceecCCCCCc----eee
Q 039819 272 ASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFC-EAIVGDFGLAKLLDHSDSH----VTT 346 (534)
Q Consensus 272 ~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~-~~kl~DFGla~~~~~~~~~----~~~ 346 (534)
.++++..+.+++..+..|+.||+.||+|||++ +||||||||+||||+.++ ++||+|||+|+.+...... ...
T Consensus 138 ~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~~~~~~~ 214 (336)
T 4g3f_A 138 GQLIKQMGCLPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGD 214 (336)
T ss_dssp HHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCCGGGEEECTTSCCEEECCCTTCEEC------------C
T ss_pred HHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcccceecCC
Confidence 99999888899999999999999999999999 999999999999999987 6999999999987543211 123
Q ss_pred ccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceecccccCCCCC
Q 039819 347 AVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELGSNYD 426 (534)
Q Consensus 347 ~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 426 (534)
..+||+.|||||++.+..|+.++|||||||++|||+||+.||....... +.. .+...... -..+ +
T Consensus 215 ~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~----~~~---~i~~~~~~----~~~~----~ 279 (336)
T 4g3f_A 215 YIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGP----LCL---KIASEPPP----IREI----P 279 (336)
T ss_dssp CCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSC----CHH---HHHHSCCG----GGGS----C
T ss_pred ccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHH----HHH---HHHcCCCC----chhc----C
Confidence 4679999999999999999999999999999999999999997543221 111 11111100 0111 2
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhcCCchhhHHhhccCCCCCCCCccc
Q 039819 427 RIEVGEILQVALLCTQYLPVHRPKMSEVVRMLEGDGLAEKWAAAHNHTNPTMNNFHT 483 (534)
Q Consensus 427 ~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~~~~~~~~~~~~~~~~p~~~~~~~ 483 (534)
...+..+.+++.+||+.||.+|||+.|+++.|.. ......+..|||+..+..
T Consensus 280 ~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~-----~l~~~~~l~hPw~~~~~~ 331 (336)
T 4g3f_A 280 PSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGK-----ALQEVGGLKSPWKGEYKE 331 (336)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH-----HHHHTTSSCSCSSSSCCC
T ss_pred ccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHH-----HHhhhhhccCCCcCCCCC
Confidence 2234578899999999999999999999998753 334456788999876553
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-54 Score=432.38 Aligned_cols=239 Identities=23% Similarity=0.361 Sum_probs=198.0
Q ss_pred CCCcCCeeccCCcEEEEEEEEC------CCcEEEEEEehh---------------hhhhcccCceeeEEEEEeCCCeeEE
Q 039819 203 NFSSKNILGAGGFGNVYKGKLG------DGTVLAVKRLKD---------------MISLAVHRNLLRLIGYCATPTERLL 261 (534)
Q Consensus 203 ~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~---------------~l~~~~h~niv~l~~~~~~~~~~~l 261 (534)
+++..+.||+|+||+||+|++. +++.||||+++. ++++++|||||+++|+|.+.+..+|
T Consensus 27 ~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~l 106 (308)
T 4gt4_A 27 AVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSM 106 (308)
T ss_dssp GEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred HCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEE
Confidence 3455678999999999999873 467899999852 6788999999999999999999999
Q ss_pred EeeccCCCChhhhcccC----------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCc
Q 039819 262 VYPYMSNGSVASRLREK----------------PALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCE 325 (534)
Q Consensus 262 v~e~~~~gsL~~~l~~~----------------~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~ 325 (534)
|||||++|+|.++|... ..++|..+++|+.|||+||+|||++ +||||||||+||||++++.
T Consensus 107 V~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLK~~NILl~~~~~ 183 (308)
T 4gt4_A 107 IFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVLVYDKLN 183 (308)
T ss_dssp EEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGC
T ss_pred EEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCccccceEECCCCC
Confidence 99999999999999532 3599999999999999999999999 9999999999999999999
Q ss_pred EEEEecccceecCCCC-CceeeccccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCcCCCccccccchHHHH
Q 039819 326 AIVGDFGLAKLLDHSD-SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GMRALEFGKSINQKGAMLEW 403 (534)
Q Consensus 326 ~kl~DFGla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~ 403 (534)
+||+|||+|+...... ........||+.|||||++.++.|+.++|||||||++|||+| |+.||..... .+.
T Consensus 184 ~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~-------~~~ 256 (308)
T 4gt4_A 184 VKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN-------QDV 256 (308)
T ss_dssp EEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCH-------HHH
T ss_pred EEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCH-------HHH
Confidence 9999999998764332 223345679999999999999999999999999999999999 8999974321 122
Q ss_pred HHHHhhhcccceecccccCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhcC
Q 039819 404 VKKIQQEKKVEVLVDRELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLEGD 461 (534)
Q Consensus 404 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~~ 461 (534)
+..+..... ...+..++..+.+++.+||+.+|++||||.||++.|+..
T Consensus 257 ~~~i~~~~~----------~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~ 304 (308)
T 4gt4_A 257 VEMIRNRQV----------LPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW 304 (308)
T ss_dssp HHHHHTTCC----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred HHHHHcCCC----------CCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 222222111 112233456899999999999999999999999999853
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-54 Score=431.24 Aligned_cols=239 Identities=26% Similarity=0.425 Sum_probs=197.5
Q ss_pred hCCCcCCeeccCCcEEEEEEEEC------CCcEEEEEEehh--------------hhhhcccCceeeEEEEEeCCCeeEE
Q 039819 202 ENFSSKNILGAGGFGNVYKGKLG------DGTVLAVKRLKD--------------MISLAVHRNLLRLIGYCATPTERLL 261 (534)
Q Consensus 202 ~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~--------------~l~~~~h~niv~l~~~~~~~~~~~l 261 (534)
++|...+.||+|+||.||+|++. ++..||||+++. ++++++|||||+++|+|.+++..+|
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 92 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 92 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence 46777889999999999999874 478899999862 6888999999999999999999999
Q ss_pred EeeccCCCChhhhcccC-------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEE
Q 039819 262 VYPYMSNGSVASRLREK-------------PALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIV 328 (534)
Q Consensus 262 v~e~~~~gsL~~~l~~~-------------~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl 328 (534)
|||||++|+|.++++.. ..++|.+++.|+.|||+||.|||++ +||||||||+|||+++++.+||
T Consensus 93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDlKp~NILl~~~~~~Ki 169 (299)
T 4asz_A 93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVKI 169 (299)
T ss_dssp EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccCHhhEEECCCCcEEE
Confidence 99999999999999643 3699999999999999999999998 9999999999999999999999
Q ss_pred EecccceecCCCCCc-eeeccccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCcCCCccccccchHHHHHHH
Q 039819 329 GDFGLAKLLDHSDSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GMRALEFGKSINQKGAMLEWVKK 406 (534)
Q Consensus 329 ~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~ 406 (534)
+|||+|+........ ......||+.|||||++.+..|+.++|||||||++|||+| |+.||..... .+.+..
T Consensus 170 ~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~-------~~~~~~ 242 (299)
T 4asz_A 170 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN-------NEVIEC 242 (299)
T ss_dssp CCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH-------HHHHHH
T ss_pred CCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH-------HHHHHH
Confidence 999999876543322 2233568999999999999999999999999999999999 8999974321 122222
Q ss_pred HhhhcccceecccccCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhc
Q 039819 407 IQQEKKVEVLVDRELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLEG 460 (534)
Q Consensus 407 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~ 460 (534)
+..... ...+..++.++.+++.+||+.+|++||||+||++.|+.
T Consensus 243 i~~~~~----------~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~ 286 (299)
T 4asz_A 243 ITQGRV----------LQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQN 286 (299)
T ss_dssp HHHTCC----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHcCCC----------CCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 222111 01222345688999999999999999999999999875
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-54 Score=431.86 Aligned_cols=239 Identities=26% Similarity=0.427 Sum_probs=191.5
Q ss_pred hCCCcCCeeccCCcEEEEEEEEC------CCcEEEEEEehh--------------hhhhcccCceeeEEEEEeCCCeeEE
Q 039819 202 ENFSSKNILGAGGFGNVYKGKLG------DGTVLAVKRLKD--------------MISLAVHRNLLRLIGYCATPTERLL 261 (534)
Q Consensus 202 ~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~--------------~l~~~~h~niv~l~~~~~~~~~~~l 261 (534)
++|...+.||+|+||.||+|++. +++.||||+++. ++++++|||||+++|+|.+.+..+|
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 120 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM 120 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 45666788999999999999874 478899999862 6888999999999999999999999
Q ss_pred EeeccCCCChhhhcccC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcE
Q 039819 262 VYPYMSNGSVASRLREK---------------PALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEA 326 (534)
Q Consensus 262 v~e~~~~gsL~~~l~~~---------------~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~ 326 (534)
|||||++|+|.++++.. .+++|.+++.|+.|||+||+|||++ +||||||||+||||++++.+
T Consensus 121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLKp~NILl~~~~~~ 197 (329)
T 4aoj_A 121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL---HFVHRDLATRNCLVGQGLVV 197 (329)
T ss_dssp EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHhhEEECCCCcE
Confidence 99999999999998642 3599999999999999999999998 99999999999999999999
Q ss_pred EEEecccceecCCCCC-ceeeccccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCcCCCccccccchHHHHH
Q 039819 327 IVGDFGLAKLLDHSDS-HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GMRALEFGKSINQKGAMLEWV 404 (534)
Q Consensus 327 kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~ 404 (534)
||+|||+|+....... .......||+.|||||++.+..++.++|||||||++|||+| |+.||..... .+.+
T Consensus 198 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~-------~~~~ 270 (329)
T 4aoj_A 198 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSN-------TEAI 270 (329)
T ss_dssp EECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCH-------HHHH
T ss_pred EEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCH-------HHHH
Confidence 9999999997654332 23345679999999999999999999999999999999999 8999974321 1222
Q ss_pred HHHhhhcccceecccccCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhc
Q 039819 405 KKIQQEKKVEVLVDRELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLEG 460 (534)
Q Consensus 405 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~ 460 (534)
..+..... . ..+..++.++.+|+.+||+.||++||||.||+++|+.
T Consensus 271 ~~i~~g~~------~----~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~ 316 (329)
T 4aoj_A 271 DCITQGRE------L----ERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQA 316 (329)
T ss_dssp HHHHHTCC------C----CCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHH
T ss_pred HHHHcCCC------C----CCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHH
Confidence 22222211 1 1222345688999999999999999999999999875
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-53 Score=421.80 Aligned_cols=241 Identities=27% Similarity=0.403 Sum_probs=189.6
Q ss_pred hCCCcCCeeccCCcEEEEEEEECCCcEEEEEEeh----------------hhhhhcccCceeeEEEEEeCCCeeEEEeec
Q 039819 202 ENFSSKNILGAGGFGNVYKGKLGDGTVLAVKRLK----------------DMISLAVHRNLLRLIGYCATPTERLLVYPY 265 (534)
Q Consensus 202 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~----------------~~l~~~~h~niv~l~~~~~~~~~~~lv~e~ 265 (534)
+++...+.||+|+||+||+|++.+ .||||+++ +++++++|||||+++|+|.+ +..+|||||
T Consensus 36 ~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmEy 112 (307)
T 3omv_A 36 SEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQW 112 (307)
T ss_dssp TSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred HHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEEc
Confidence 456677899999999999999754 58999875 26889999999999999865 568999999
Q ss_pred cCCCChhhhccc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCC-Cc
Q 039819 266 MSNGSVASRLRE-KPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSD-SH 343 (534)
Q Consensus 266 ~~~gsL~~~l~~-~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~-~~ 343 (534)
|++|+|.++++. ...++|.+++.|+.|||.||+|||++ +||||||||+||||++++.+||+|||+|+...... ..
T Consensus 113 ~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~---~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~ 189 (307)
T 3omv_A 113 CEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAK---NIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQ 189 (307)
T ss_dssp CSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCSSSEEEETTEEEEECCCSSCBC--------
T ss_pred CCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCccCHHHEEECCCCcEEEeeccCceecccCCcce
Confidence 999999999975 45799999999999999999999998 99999999999999999999999999998765322 22
Q ss_pred eeecccccccccccccccc---CCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceecccc
Q 039819 344 VTTAVRGTVGHIAPEYLST---GQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRE 420 (534)
Q Consensus 344 ~~~~~~gt~~y~aPE~~~~---~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 420 (534)
.....+||+.|||||++.+ ++|+.++|||||||++|||+||+.||...... ..+........ ..+.
T Consensus 190 ~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~-------~~~~~~~~~~~----~~p~ 258 (307)
T 3omv_A 190 QVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNR-------DQIIFMVGRGY----ASPD 258 (307)
T ss_dssp ----CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCH-------HHHHHHHHTTC----CCCC
T ss_pred eecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChH-------HHHHHHHhcCC----CCCC
Confidence 3455689999999999853 46899999999999999999999999743221 11111111111 1111
Q ss_pred cCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhc
Q 039819 421 LGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLEG 460 (534)
Q Consensus 421 l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~ 460 (534)
+. ..+..++..+.+++.+||+.+|++||||.||++.|+.
T Consensus 259 ~~-~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~ 297 (307)
T 3omv_A 259 LS-KLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIEL 297 (307)
T ss_dssp ST-TSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHH
T ss_pred cc-cccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 11 1222345688999999999999999999999998864
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-52 Score=414.84 Aligned_cols=233 Identities=22% Similarity=0.314 Sum_probs=199.3
Q ss_pred hCCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEehh-----------------hhhhcccCceeeEEEEEeCCCeeEEEe
Q 039819 202 ENFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLKD-----------------MISLAVHRNLLRLIGYCATPTERLLVY 263 (534)
Q Consensus 202 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~-----------------~l~~~~h~niv~l~~~~~~~~~~~lv~ 263 (534)
++|+..+.||+|+||+||+|+.. +++.||||++.+ +++.++|||||++++++.+.+..||||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 57999999999999999999975 689999998852 678889999999999999999999999
Q ss_pred eccCCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCC-C
Q 039819 264 PYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSD-S 342 (534)
Q Consensus 264 e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~-~ 342 (534)
|||++|+|.+++.+.+.+++..+..|+.||+.||+|||++ +||||||||+|||++.++.+||+|||+|+.+.... .
T Consensus 112 Ey~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~~ 188 (311)
T 4aw0_A 112 SYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ 188 (311)
T ss_dssp CCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTTC
T ss_pred ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCCc
Confidence 9999999999999888899999999999999999999999 99999999999999999999999999999875432 2
Q ss_pred ceeeccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceecccccC
Q 039819 343 HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELG 422 (534)
Q Consensus 343 ~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 422 (534)
......+||+.|||||++.+..|+.++||||+||++|||+||+.||..... .+....+.... ..+.
T Consensus 189 ~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~-------~~~~~~i~~~~-------~~~p 254 (311)
T 4aw0_A 189 ARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE-------GLIFAKIIKLE-------YDFP 254 (311)
T ss_dssp CCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHHHHHTC-------CCCC
T ss_pred ccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH-------HHHHHHHHcCC-------CCCC
Confidence 334567899999999999999999999999999999999999999975332 12222222211 1111
Q ss_pred CCCCHHHHHHHHHHHHHhcccCCCCCCChHHHH
Q 039819 423 SNYDRIEVGEILQVALLCTQYLPVHRPKMSEVV 455 (534)
Q Consensus 423 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~ 455 (534)
. ..+.++.+++.+|++.||++|||++|+.
T Consensus 255 ~----~~s~~~~dli~~lL~~dp~~R~t~~e~~ 283 (311)
T 4aw0_A 255 E----KFFPKARDLVEKLLVLDATKRLGCEEME 283 (311)
T ss_dssp T----TCCHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred c----ccCHHHHHHHHHHccCCHhHCcChHHHc
Confidence 1 2234788999999999999999999874
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-52 Score=418.53 Aligned_cols=235 Identities=19% Similarity=0.291 Sum_probs=197.2
Q ss_pred hCCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEeh--------------hhhhhcccCceeeEEEEEeCCCeeEEEeecc
Q 039819 202 ENFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLK--------------DMISLAVHRNLLRLIGYCATPTERLLVYPYM 266 (534)
Q Consensus 202 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~--------------~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~ 266 (534)
+.|+..+.||+|+||.||+|+.. +|+.||||++. ++++.++|||||+++++|.+.+..|||||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 153 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 153 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence 46888899999999999999985 68999999884 2788899999999999999999999999999
Q ss_pred CCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCCceee
Q 039819 267 SNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTT 346 (534)
Q Consensus 267 ~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~ 346 (534)
++|+|.+++... .+++..+..|+.||+.||+|||++ +||||||||+||||+.++.+||+|||+|+.+..... ...
T Consensus 154 ~gg~L~~~l~~~-~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~-~~~ 228 (346)
T 4fih_A 154 EGGALTDIVTHT-RMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-RRK 228 (346)
T ss_dssp TTEEHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC-CBC
T ss_pred CCCcHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEECCCCCEEEecCcCceecCCCCC-ccc
Confidence 999999998764 599999999999999999999999 999999999999999999999999999998754322 345
Q ss_pred ccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceecccccCCCCC
Q 039819 347 AVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELGSNYD 426 (534)
Q Consensus 347 ~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 426 (534)
..+||+.|||||++.+..|+.++|||||||++|||+||+.||..... .+....+.... .+.+. ..
T Consensus 229 ~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~-------~~~~~~i~~~~------~~~~~--~~ 293 (346)
T 4fih_A 229 SLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP-------LKAMKMIRDNL------PPRLK--NL 293 (346)
T ss_dssp CCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH-------HHHHHHHHHSS------CCCCS--CG
T ss_pred ccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH-------HHHHHHHHcCC------CCCCC--cc
Confidence 67899999999999999999999999999999999999999974322 11122221111 01111 11
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 427 RIEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 427 ~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
...+.++.+++.+||+.||++|||+.|+++
T Consensus 294 ~~~s~~~~dli~~~L~~dP~~R~ta~e~l~ 323 (346)
T 4fih_A 294 HKVSPSLKGFLDRLLVRDPAQRATAAELLK 323 (346)
T ss_dssp GGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 123457899999999999999999999874
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-52 Score=419.48 Aligned_cols=251 Identities=22% Similarity=0.326 Sum_probs=193.6
Q ss_pred CCCcCCeeccCCcEEEEEEEECCCcEEEEEEehh-------------hhhhcccCceeeEEEEEeCCC----eeEEEeec
Q 039819 203 NFSSKNILGAGGFGNVYKGKLGDGTVLAVKRLKD-------------MISLAVHRNLLRLIGYCATPT----ERLLVYPY 265 (534)
Q Consensus 203 ~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~-------------~l~~~~h~niv~l~~~~~~~~----~~~lv~e~ 265 (534)
+|...+.||+|+||+||+|++ +|+.||||++.. .+..++|||||+++|+|.+.+ ..+|||||
T Consensus 4 ~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~Ey 82 (303)
T 3hmm_A 4 TIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDY 82 (303)
T ss_dssp GEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEEC
T ss_pred EEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEecC
Confidence 466678999999999999998 588999999852 345678999999999998654 57999999
Q ss_pred cCCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcC-----CCCeEeccCCCCcEEeCCCCcEEEEecccceecCCC
Q 039819 266 MSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQC-----DPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHS 340 (534)
Q Consensus 266 ~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~-----~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~ 340 (534)
|++|+|.++++.. .++|+.+.+|+.|+++||+|||+++ .++||||||||+||||+.++++||+|||+|+.....
T Consensus 83 ~~~gsL~~~l~~~-~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~ 161 (303)
T 3hmm_A 83 HEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSA 161 (303)
T ss_dssp CTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEEETT
T ss_pred CCCCcHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCccccCC
Confidence 9999999999765 5999999999999999999999763 458999999999999999999999999999987544
Q ss_pred CCc---eeeccccccccccccccccC------CCCcchhHHHHHHHHHHHHhCCCCcCCCccccc--------cchHHHH
Q 039819 341 DSH---VTTAVRGTVGHIAPEYLSTG------QSSEKTDVFGFGILLLELITGMRALEFGKSINQ--------KGAMLEW 403 (534)
Q Consensus 341 ~~~---~~~~~~gt~~y~aPE~~~~~------~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~--------~~~~~~~ 403 (534)
... .....+||+.|||||++.+. .++.++||||||||+|||+||++|+........ .....++
T Consensus 162 ~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~ 241 (303)
T 3hmm_A 162 TDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEM 241 (303)
T ss_dssp TTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHH
T ss_pred CCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccchHHHH
Confidence 322 22345799999999998654 467899999999999999999988753322110 0011112
Q ss_pred HHHHhhhcccceecccccCCCC-CHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhc
Q 039819 404 VKKIQQEKKVEVLVDRELGSNY-DRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLEG 460 (534)
Q Consensus 404 ~~~~~~~~~~~~~~d~~l~~~~-~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~ 460 (534)
...... ...++.+.... +...+..+.+++.+||+.||++||||.||++.|+.
T Consensus 242 ~~~~~~-----~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~ 294 (303)
T 3hmm_A 242 RKVVCE-----QKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ 294 (303)
T ss_dssp HHHHTT-----SCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHH
T ss_pred HHHHhc-----ccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHH
Confidence 111111 11223332221 23456688999999999999999999999999875
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-52 Score=411.83 Aligned_cols=232 Identities=25% Similarity=0.396 Sum_probs=187.3
Q ss_pred CcCCeeccCCcEEEEEEEEC-CCcEEEEEEehh----------------hhhhcccCceeeEEEEEeC----CCeeEEEe
Q 039819 205 SSKNILGAGGFGNVYKGKLG-DGTVLAVKRLKD----------------MISLAVHRNLLRLIGYCAT----PTERLLVY 263 (534)
Q Consensus 205 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~----------------~l~~~~h~niv~l~~~~~~----~~~~~lv~ 263 (534)
...+.||+|+||.||+|... ++..||||++.. +++.++|||||+++++|.+ ....||||
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm 108 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence 34567999999999999975 688999998842 6788999999999999865 34579999
Q ss_pred eccCCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeC-CCCcEEEEecccceecCCCCC
Q 039819 264 PYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLD-DFCEAIVGDFGLAKLLDHSDS 342 (534)
Q Consensus 264 e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~-~~~~~kl~DFGla~~~~~~~~ 342 (534)
|||++|+|.+++.+...+++..+..|+.||+.||+|||++ .++||||||||+|||++ .++.+||+|||+|+.....
T Consensus 109 Ey~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~-~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~~-- 185 (290)
T 3fpq_A 109 ELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS-- 185 (290)
T ss_dssp ECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCTT--
T ss_pred eCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC-CCCEEecccChhheeEECCCCCEEEEeCcCCEeCCCC--
Confidence 9999999999999888899999999999999999999998 12399999999999998 4899999999999865432
Q ss_pred ceeeccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceecccccC
Q 039819 343 HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELG 422 (534)
Q Consensus 343 ~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 422 (534)
.....+||+.|||||++. ++|+.++|||||||++|||+||+.||..... .......+...... ..
T Consensus 186 -~~~~~~GTp~YmAPE~~~-~~y~~~~DiwSlGvilyelltg~~Pf~~~~~------~~~~~~~i~~~~~~-----~~-- 250 (290)
T 3fpq_A 186 -FAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQN------AAQIYRRVTSGVKP-----AS-- 250 (290)
T ss_dssp -SBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSS------HHHHHHHHTTTCCC-----GG--
T ss_pred -ccCCcccCccccCHHHcC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCc------HHHHHHHHHcCCCC-----CC--
Confidence 344578999999999886 4699999999999999999999999964322 11222222221110 01
Q ss_pred CCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 423 SNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 423 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
.+...+.++.+++.+||+.||++|||++|+++
T Consensus 251 --~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~ 282 (290)
T 3fpq_A 251 --FDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp --GGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred --CCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 11112347889999999999999999999974
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-52 Score=419.23 Aligned_cols=234 Identities=22% Similarity=0.335 Sum_probs=191.2
Q ss_pred hCCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEeh----------------hhhhhcccCceeeEEEEEeCCCeeEEEee
Q 039819 202 ENFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLK----------------DMISLAVHRNLLRLIGYCATPTERLLVYP 264 (534)
Q Consensus 202 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~----------------~~l~~~~h~niv~l~~~~~~~~~~~lv~e 264 (534)
++|...+.||+|+||.||+|+.. +|+.||||++. ++++.++|||||++++++.+.+..|||||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE 103 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD 103 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence 57889999999999999999975 68999999885 26788999999999999999999999999
Q ss_pred ccCCCChhhhcccC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCC
Q 039819 265 YMSNGSVASRLREK--PALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDS 342 (534)
Q Consensus 265 ~~~~gsL~~~l~~~--~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~ 342 (534)
||++|+|.+++... ..+++.+++.|+.||+.||.|||++ +||||||||+||||+.++.+||+|||+|+.+....
T Consensus 104 y~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~- 179 (350)
T 4b9d_A 104 YCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV- 179 (350)
T ss_dssp CCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCEETTCCGGGEEECTTCCEEECSTTEESCCCHHH-
T ss_pred CCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCCEEEcccccceeecCCc-
Confidence 99999999999643 4579999999999999999999999 99999999999999999999999999998764321
Q ss_pred ceeeccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceecccccC
Q 039819 343 HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELG 422 (534)
Q Consensus 343 ~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 422 (534)
......+||+.|||||++.+..|+.++|||||||++|||+||+.||..... .+.+..+..... +.+.
T Consensus 180 ~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~-------~~~~~~i~~~~~------~~~~ 246 (350)
T 4b9d_A 180 ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSM-------KNLVLKIISGSF------PPVS 246 (350)
T ss_dssp HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH-------HHHHHHHHHTCC------CCCC
T ss_pred ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH-------HHHHHHHHcCCC------CCCC
Confidence 223456799999999999999999999999999999999999999975432 222222222211 1111
Q ss_pred CCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 423 SNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 423 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
. ..+.++.+++.+||+.||++|||++|+++
T Consensus 247 ~----~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 276 (350)
T 4b9d_A 247 L----HYSYDLRSLVSQLFKRNPRDRPSVNSILE 276 (350)
T ss_dssp T----TSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred c----cCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1 22457899999999999999999999986
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-51 Score=410.22 Aligned_cols=228 Identities=25% Similarity=0.315 Sum_probs=191.4
Q ss_pred hCCCcCCeeccCCcEEEEEEEEC----CCcEEEEEEehh----------------hhhhcccCceeeEEEEEeCCCeeEE
Q 039819 202 ENFSSKNILGAGGFGNVYKGKLG----DGTVLAVKRLKD----------------MISLAVHRNLLRLIGYCATPTERLL 261 (534)
Q Consensus 202 ~~~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~----------------~l~~~~h~niv~l~~~~~~~~~~~l 261 (534)
++|+..+.||+|+||+||+|+.. .++.||||++.+ +++.++|||||++++++.+++..|+
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 57899999999999999999862 468999998752 6788899999999999999999999
Q ss_pred EeeccCCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCC
Q 039819 262 VYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSD 341 (534)
Q Consensus 262 v~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~ 341 (534)
|||||++|+|.+++.+.+.+++.++..|+.||+.||+|||++ +||||||||+|||++.++.+||+|||+|+......
T Consensus 104 vmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~ 180 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE 180 (304)
T ss_dssp EECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTSCEEEESSEEEEC-----
T ss_pred EEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHeEEcCCCCEEecccccceeccCCC
Confidence 999999999999999888899999999999999999999999 99999999999999999999999999998754332
Q ss_pred CceeeccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceeccccc
Q 039819 342 SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDREL 421 (534)
Q Consensus 342 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 421 (534)
......+||+.|||||++.+..|+.++|||||||++|||+||+.||..... .+....+.... ..
T Consensus 181 -~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~-------~~~~~~i~~~~-------~~- 244 (304)
T 3ubd_A 181 -KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDR-------KETMTMILKAK-------LG- 244 (304)
T ss_dssp -CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHHHHHCC-------CC-
T ss_pred -ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCH-------HHHHHHHHcCC-------CC-
Confidence 233457899999999999999999999999999999999999999975332 12222222111 01
Q ss_pred CCCCCHHHHHHHHHHHHHhcccCCCCCCCh
Q 039819 422 GSNYDRIEVGEILQVALLCTQYLPVHRPKM 451 (534)
Q Consensus 422 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~ 451 (534)
++...+.++.+++.+||+.||++|||+
T Consensus 245 ---~p~~~s~~~~~li~~~L~~dP~~R~ta 271 (304)
T 3ubd_A 245 ---MPQFLSPEAQSLLRMLFKRNPANRLGA 271 (304)
T ss_dssp ---CCTTSCHHHHHHHHHHTCSSGGGSTTC
T ss_pred ---CCCcCCHHHHHHHHHHcccCHHHCCCC
Confidence 122234578999999999999999995
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-50 Score=419.37 Aligned_cols=235 Identities=19% Similarity=0.291 Sum_probs=197.2
Q ss_pred hCCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEeh--------------hhhhhcccCceeeEEEEEeCCCeeEEEeecc
Q 039819 202 ENFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLK--------------DMISLAVHRNLLRLIGYCATPTERLLVYPYM 266 (534)
Q Consensus 202 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~--------------~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~ 266 (534)
+.|+..+.||+|+||.||+|+.. +|+.||||++. .+++.++|||||+++++|.+.+..|||||||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~ 230 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 230 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCC
Confidence 46888999999999999999985 68999999884 2788899999999999999999999999999
Q ss_pred CCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCCceee
Q 039819 267 SNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTT 346 (534)
Q Consensus 267 ~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~ 346 (534)
++|+|.+++... .+++..+..|+.||+.||+|||++ +||||||||+||||+.++.+||+|||+|+.+..... ...
T Consensus 231 ~gG~L~~~i~~~-~l~e~~~~~~~~qil~aL~ylH~~---~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~-~~~ 305 (423)
T 4fie_A 231 EGGALTDIVTHT-RMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-RRK 305 (423)
T ss_dssp TTEEHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCC-CBC
T ss_pred CCCcHHHHHhcc-CCCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEecCccceECCCCCc-ccc
Confidence 999999998754 599999999999999999999999 999999999999999999999999999998754332 345
Q ss_pred ccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceecccccCCCCC
Q 039819 347 AVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELGSNYD 426 (534)
Q Consensus 347 ~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 426 (534)
..+||+.|||||++.+..|+.++|||||||++|||++|+.||..... .+.+..+.... .+.+. ..
T Consensus 306 ~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~-------~~~~~~i~~~~------~~~~~--~~ 370 (423)
T 4fie_A 306 SLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP-------LKAMKMIRDNL------PPRLK--NL 370 (423)
T ss_dssp CCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH-------HHHHHHHHHSC------CCCCS--CT
T ss_pred ccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH-------HHHHHHHHcCC------CCCCc--cc
Confidence 67899999999999999999999999999999999999999974322 11222222111 01111 11
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 427 RIEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 427 ~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
...+.++.+++.+||+.||++|||+.|+++
T Consensus 371 ~~~s~~~~dli~~~L~~dP~~R~ta~ell~ 400 (423)
T 4fie_A 371 HKVSPSLKGFLDRLLVRDPAQRATAAELLK 400 (423)
T ss_dssp TSSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 112357889999999999999999999864
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-52 Score=420.70 Aligned_cols=242 Identities=26% Similarity=0.406 Sum_probs=197.0
Q ss_pred HHhCCCcCCeeccCCcEEEEEEEECC------CcEEEEEEehh---------------hhhhccc-CceeeEEEEEeCC-
Q 039819 200 ATENFSSKNILGAGGFGNVYKGKLGD------GTVLAVKRLKD---------------MISLAVH-RNLLRLIGYCATP- 256 (534)
Q Consensus 200 ~~~~~~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~---------------~l~~~~h-~niv~l~~~~~~~- 256 (534)
..++|...+.||+|+||.||+|++.. ++.||||++.. ++..+.| ||||+++|+|.+.
T Consensus 62 ~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~ 141 (353)
T 4ase_A 62 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG 141 (353)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTT
T ss_pred cHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecC
Confidence 34678889999999999999998632 36899999852 4566655 8999999999765
Q ss_pred CeeEEEeeccCCCChhhhccc----------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEe
Q 039819 257 TERLLVYPYMSNGSVASRLRE----------------KPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLL 320 (534)
Q Consensus 257 ~~~~lv~e~~~~gsL~~~l~~----------------~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl 320 (534)
...++|||||++|+|.++|+. ...++|..++.|+.|||+||+|||++ +||||||||+|||+
T Consensus 142 ~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~---~iiHRDLK~~NILl 218 (353)
T 4ase_A 142 GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILL 218 (353)
T ss_dssp SCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEE
T ss_pred CEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhC---CeecCccCccceee
Confidence 568999999999999999964 23589999999999999999999999 99999999999999
Q ss_pred CCCCcEEEEecccceecCCCCC-ceeeccccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCcCCCccccccc
Q 039819 321 DDFCEAIVGDFGLAKLLDHSDS-HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GMRALEFGKSINQKG 398 (534)
Q Consensus 321 ~~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~ellt-G~~p~~~~~~~~~~~ 398 (534)
++++.+||+|||+|+.+..... ......+||+.|||||++.+..|+.++|||||||++|||+| |+.||...... .
T Consensus 219 ~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~---~ 295 (353)
T 4ase_A 219 SEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID---E 295 (353)
T ss_dssp CGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS---H
T ss_pred CCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHH---H
Confidence 9999999999999997754433 23445679999999999999999999999999999999998 99999743221 1
Q ss_pred hHHHHHHHHhhhcccceecccccCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhc
Q 039819 399 AMLEWVKKIQQEKKVEVLVDRELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLEG 460 (534)
Q Consensus 399 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~ 460 (534)
.....+..... . ..+...+.++.+++.+||+.||++||||.||++.|+.
T Consensus 296 ---~~~~~i~~g~~------~----~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~ 344 (353)
T 4ase_A 296 ---EFCRRLKEGTR------M----RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGN 344 (353)
T ss_dssp ---HHHHHHHHTCC------C----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ---HHHHHHHcCCC------C----CCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHH
Confidence 11222222111 1 1122234588999999999999999999999999865
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-51 Score=399.25 Aligned_cols=231 Identities=21% Similarity=0.345 Sum_probs=183.6
Q ss_pred hCCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEeh-----------------hhhhhcccCceeeEEEEEeCCCeeEEEe
Q 039819 202 ENFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLK-----------------DMISLAVHRNLLRLIGYCATPTERLLVY 263 (534)
Q Consensus 202 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~-----------------~~l~~~~h~niv~l~~~~~~~~~~~lv~ 263 (534)
++|+..+.||+|+||.||+|+.. +++.||||++. ++++.++|||||++++++.+.+..|+||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 68999999999999999999974 68999999874 2678889999999999999999999999
Q ss_pred eccCCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCCc
Q 039819 264 PYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSH 343 (534)
Q Consensus 264 e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~ 343 (534)
||+ +|+|.+++...+.+++..+..++.||+.||+|||++ +||||||||+|||++.++.+||+|||+|+......
T Consensus 93 Ey~-~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~-- 166 (275)
T 3hyh_A 93 EYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN-- 166 (275)
T ss_dssp ECC-CEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTCCEEECCSSCC---------
T ss_pred eCC-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCChHHeEECCCCCEEEeecCCCeecCCCC--
Confidence 999 689999999888999999999999999999999999 99999999999999999999999999998765432
Q ss_pred eeeccccccccccccccccCCC-CcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceecccccC
Q 039819 344 VTTAVRGTVGHIAPEYLSTGQS-SEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELG 422 (534)
Q Consensus 344 ~~~~~~gt~~y~aPE~~~~~~~-~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 422 (534)
.....+||+.|||||++.+..+ +.++||||+||++|||+||+.||.... ..+....+.... ..+
T Consensus 167 ~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~-------~~~~~~~i~~~~-------~~~- 231 (275)
T 3hyh_A 167 FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDES-------IPVLFKNISNGV-------YTL- 231 (275)
T ss_dssp --------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS-------HHHHHHHHHHTC-------CCC-
T ss_pred ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCC-------HHHHHHHHHcCC-------CCC-
Confidence 2345689999999999988776 589999999999999999999997432 122222222211 111
Q ss_pred CCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 423 SNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 423 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
+...+.++.+++.+|++.||++|||++|+++
T Consensus 232 ---p~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 262 (275)
T 3hyh_A 232 ---PKFLSPGAAGLIKRMLIVNPLNRISIHEIMQ 262 (275)
T ss_dssp ---CTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred ---CCCCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 1122457889999999999999999999986
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-49 Score=396.29 Aligned_cols=286 Identities=70% Similarity=1.154 Sum_probs=247.9
Q ss_pred eccCCccccCHHHHHHHHhCCCcCCeeccCCcEEEEEEEECCCcEEEEEEeh---------------hhhhhcccCceee
Q 039819 184 ISLGNLRNFTFRELQQATENFSSKNILGAGGFGNVYKGKLGDGTVLAVKRLK---------------DMISLAVHRNLLR 248 (534)
Q Consensus 184 ~~~~~~~~~~~~~l~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~---------------~~l~~~~h~niv~ 248 (534)
...+....|+++++....++|...+.||+|+||.||+|+..+++.||||++. +++..++||||++
T Consensus 12 ~~~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~ 91 (326)
T 3uim_A 12 VHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLR 91 (326)
T ss_dssp ---CCCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCC
T ss_pred cccCccceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccc
Confidence 3456678899999999999999999999999999999998889999999875 2677888999999
Q ss_pred EEEEEeCCCeeEEEeeccCCCChhhhcccC----CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCC
Q 039819 249 LIGYCATPTERLLVYPYMSNGSVASRLREK----PALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFC 324 (534)
Q Consensus 249 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~----~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~ 324 (534)
++++|......++||||+++|+|.+++... ..+++..+..|+.|++.||.|||+.+.++|+||||||+|||++.++
T Consensus 92 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~ 171 (326)
T 3uim_A 92 LRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEF 171 (326)
T ss_dssp CCEEECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTC
T ss_pred eEEEEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCC
Confidence 999999999999999999999999999753 3499999999999999999999998777899999999999999999
Q ss_pred cEEEEecccceecCCCCCceeeccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccc-cccchHHHH
Q 039819 325 EAIVGDFGLAKLLDHSDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSI-NQKGAMLEW 403 (534)
Q Consensus 325 ~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~-~~~~~~~~~ 403 (534)
.+||+|||+++..............||+.|+|||++.+..++.++|||||||++|||+||+.||+..... .......+|
T Consensus 172 ~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~ 251 (326)
T 3uim_A 172 EAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDW 251 (326)
T ss_dssp CEEECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHH
T ss_pred CEEeccCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHH
Confidence 9999999999987655555556667999999999998888999999999999999999999999632211 122345577
Q ss_pred HHHHhhhcccceecccccCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhcCCchhhHHh
Q 039819 404 VKKIQQEKKVEVLVDRELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLEGDGLAEKWAA 469 (534)
Q Consensus 404 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~~~~~~~~~~ 469 (534)
+...........+.+..+........+..+.+++.+|++.+|.+|||+.||+++|++.+..++|..
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~~~~~~~ 317 (326)
T 3uim_A 252 VKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGLAERWEE 317 (326)
T ss_dssp HTTTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSSCSSSCC-
T ss_pred HHHHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcchhhhhhh
Confidence 776666667777788888888888889999999999999999999999999999999877766544
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-48 Score=386.12 Aligned_cols=231 Identities=20% Similarity=0.341 Sum_probs=176.8
Q ss_pred HhCCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEeh---------------hhhhhcccCceeeEEEEEeCCC-------
Q 039819 201 TENFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLK---------------DMISLAVHRNLLRLIGYCATPT------- 257 (534)
Q Consensus 201 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~---------------~~l~~~~h~niv~l~~~~~~~~------- 257 (534)
.++|+..+.||+|+||.||+|+.. +++.||||++. ++++.++|||||+++++|.+.+
T Consensus 4 l~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~ 83 (299)
T 4g31_A 4 LTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQP 83 (299)
T ss_dssp HHHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-------
T ss_pred chhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccc
Confidence 456889999999999999999975 68999999874 2678899999999999987544
Q ss_pred -----eeEEEeeccCCCChhhhcccCCC---CCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEE
Q 039819 258 -----ERLLVYPYMSNGSVASRLREKPA---LDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVG 329 (534)
Q Consensus 258 -----~~~lv~e~~~~gsL~~~l~~~~~---l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~ 329 (534)
..|+|||||++|+|.+++..... .++..++.|+.||+.||+|||++ +||||||||+|||++.++.+||+
T Consensus 84 ~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~---~IiHRDlKp~NILl~~~~~vKl~ 160 (299)
T 4g31_A 84 SSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVG 160 (299)
T ss_dssp ---CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEEC
T ss_pred cCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHC---cCccccCcHHHeEECCCCcEEEc
Confidence 36899999999999999986543 56677899999999999999999 99999999999999999999999
Q ss_pred ecccceecCCCCCc-----------eeeccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccc
Q 039819 330 DFGLAKLLDHSDSH-----------VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKG 398 (534)
Q Consensus 330 DFGla~~~~~~~~~-----------~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~ 398 (534)
|||+|+.+...... ..+..+||+.|||||++.+..|+.++|||||||++|||++ ||....
T Consensus 161 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~------ 231 (299)
T 4g31_A 161 DFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQM------ 231 (299)
T ss_dssp CCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHH------
T ss_pred cCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCcc------
Confidence 99999977543211 1234579999999999999999999999999999999996 664211
Q ss_pred hHHHHHHHHhhhcccceecccccCCCCCH---HHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 399 AMLEWVKKIQQEKKVEVLVDRELGSNYDR---IEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 399 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~---~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
.....+..... ..++. .....+.+++.+||+.||++|||+.|+++
T Consensus 232 ~~~~~~~~~~~-------------~~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 279 (299)
T 4g31_A 232 ERVRTLTDVRN-------------LKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIE 279 (299)
T ss_dssp HHHHHHHHHHT-------------TCCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHHHHHHhc-------------CCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 01111111111 01111 12245678999999999999999999975
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-48 Score=401.40 Aligned_cols=250 Identities=19% Similarity=0.299 Sum_probs=192.8
Q ss_pred hCCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEehh----------------hhhhcccCceeeEEEEEeCC------Ce
Q 039819 202 ENFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLKD----------------MISLAVHRNLLRLIGYCATP------TE 258 (534)
Q Consensus 202 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~----------------~l~~~~h~niv~l~~~~~~~------~~ 258 (534)
++|...+.||+|+||.||+|+.. +|+.||||++.. +++.++|||||++++++... ..
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~ 133 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS 133 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence 57889999999999999999975 799999999852 67888999999999997643 56
Q ss_pred eEEEeeccCCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecC
Q 039819 259 RLLVYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLD 338 (534)
Q Consensus 259 ~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~ 338 (534)
.|||||||+ |+|.+++...+.+++..+..|+.||+.||.|||++ +||||||||+|||++.++.+||+|||+|+.+.
T Consensus 134 ~~ivmE~~~-g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~ 209 (398)
T 4b99_A 134 VYVVLDLME-SDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSA---QVIHRDLKPSNLLVNENCELKIGDFGMARGLC 209 (398)
T ss_dssp EEEEEECCS-EEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTCBCC-
T ss_pred EEEEEeCCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---cCcCCCcCccccccCCCCCEEEeecceeeecc
Confidence 799999996 68999999888999999999999999999999999 99999999999999999999999999998764
Q ss_pred CCC---CceeeccccccccccccccccC-CCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccc
Q 039819 339 HSD---SHVTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVE 414 (534)
Q Consensus 339 ~~~---~~~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 414 (534)
... .......+||+.|||||++.+. .++.++||||+|||+|||+||+.||......+....+........... ..
T Consensus 210 ~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~-~~ 288 (398)
T 4b99_A 210 TSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAV-IQ 288 (398)
T ss_dssp ------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGG-TC
T ss_pred cCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHH-hh
Confidence 321 2234567899999999998765 569999999999999999999999986544332222222111100000 00
Q ss_pred eec-------ccccCC--CCCH-----HHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 415 VLV-------DRELGS--NYDR-----IEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 415 ~~~-------d~~l~~--~~~~-----~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
... ...+.. ..+. ....++.+++.+||+.||.+|||+.|+++
T Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 344 (398)
T 4b99_A 289 AVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALR 344 (398)
T ss_dssp -----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred hhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 000 000000 0000 11347889999999999999999999864
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-47 Score=390.89 Aligned_cols=188 Identities=23% Similarity=0.377 Sum_probs=161.1
Q ss_pred HHHhCCCcCCeeccCCcEEEEEEEEC----CCcEEEEEEehh------------hhhhc-ccCceeeEEEEEeCCCeeEE
Q 039819 199 QATENFSSKNILGAGGFGNVYKGKLG----DGTVLAVKRLKD------------MISLA-VHRNLLRLIGYCATPTERLL 261 (534)
Q Consensus 199 ~~~~~~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~------------~l~~~-~h~niv~l~~~~~~~~~~~l 261 (534)
...+.|+..+.||+|+||.||+|+.+ .++.||||++.. ++..+ .|||||++++++.+.+..|+
T Consensus 18 ~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~l 97 (361)
T 4f9c_A 18 QLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSHPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVI 97 (361)
T ss_dssp GGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSCHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEE
T ss_pred CccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccCHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEE
Confidence 34578999999999999999999753 467899998752 45555 69999999999999999999
Q ss_pred EeeccCCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCC-CcEEEEecccceecCCC
Q 039819 262 VYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDF-CEAIVGDFGLAKLLDHS 340 (534)
Q Consensus 262 v~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~-~~~kl~DFGla~~~~~~ 340 (534)
|||||++|+|.++++ .+++.++..++.|++.||+|||++ +||||||||+|||++.+ +.+||+|||+|+.....
T Consensus 98 vmE~~~g~~L~~~~~---~l~~~~~~~~~~qll~al~ylH~~---gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~ 171 (361)
T 4f9c_A 98 AMPYLEHESFLDILN---SLSFQEVREYMLNLFKALKRIHQF---GIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDT 171 (361)
T ss_dssp EEECCCCCCHHHHHT---TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCEECTTC
T ss_pred EEeCCCcccHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCc
Confidence 999999999999984 489999999999999999999999 99999999999999876 79999999999865432
Q ss_pred CC---------------------------ceeeccccccccccccccccC-CCCcchhHHHHHHHHHHHHhCCCCcCCCc
Q 039819 341 DS---------------------------HVTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELITGMRALEFGK 392 (534)
Q Consensus 341 ~~---------------------------~~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~S~Gvvl~elltG~~p~~~~~ 392 (534)
.. ......+||+.|||||++.+. .++.++||||+|||+|||+||+.||..+.
T Consensus 172 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~~ 251 (361)
T 4f9c_A 172 KIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKAS 251 (361)
T ss_dssp SCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCCS
T ss_pred cccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCCC
Confidence 11 112345799999999999775 48999999999999999999999996543
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=406.49 Aligned_cols=230 Identities=24% Similarity=0.305 Sum_probs=191.8
Q ss_pred HhCCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEehh--------------------hhhhcccCceeeEEEEEeCCCee
Q 039819 201 TENFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLKD--------------------MISLAVHRNLLRLIGYCATPTER 259 (534)
Q Consensus 201 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~--------------------~l~~~~h~niv~l~~~~~~~~~~ 259 (534)
.++|...+.||+|+||.||+|+.. +|+.||||++.+ ++..++|||||+++++|.+.+..
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l 267 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 267 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence 367999999999999999999975 689999999852 34456899999999999999999
Q ss_pred EEEeeccCCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCC
Q 039819 260 LLVYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDH 339 (534)
Q Consensus 260 ~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~ 339 (534)
|||||||+||+|.+++...+.+++..+..|+.||+.||+|||++ +||||||||+||||+.+|++||+|||+|+.+..
T Consensus 268 ylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~---gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~~ 344 (689)
T 3v5w_A 268 SFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSK 344 (689)
T ss_dssp EEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred EEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHeEEeCCCCEEecccceeeecCC
Confidence 99999999999999999888899999999999999999999999 999999999999999999999999999998754
Q ss_pred CCCceeecccccccccccccccc-CCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceecc
Q 039819 340 SDSHVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVD 418 (534)
Q Consensus 340 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 418 (534)
.. ....+||+.|||||++.. ..|+.++||||+||++|||+||+.||......+ ..+........ .
T Consensus 345 ~~---~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~----~~~i~~~i~~~-~------ 410 (689)
T 3v5w_A 345 KK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD----KHEIDRMTLTM-A------ 410 (689)
T ss_dssp CC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCC----HHHHHHHHHHC-C------
T ss_pred CC---CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH----HHHHHHhhcCC-C------
Confidence 32 345689999999999965 579999999999999999999999997433211 11111111111 0
Q ss_pred cccCCCCCHHHHHHHHHHHHHhcccCCCCCCCh
Q 039819 419 RELGSNYDRIEVGEILQVALLCTQYLPVHRPKM 451 (534)
Q Consensus 419 ~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~ 451 (534)
.. ++...+.++.+++.+|++.||.+|++.
T Consensus 411 ~~----~p~~~S~~a~dLI~~lL~~dP~~Rl~~ 439 (689)
T 3v5w_A 411 VE----LPDSFSPELRSLLEGLLQRDVNRRLGC 439 (689)
T ss_dssp CC----CCTTSCHHHHHHHHHHTCSCGGGCTTC
T ss_pred CC----CCccCCHHHHHHHHHHccCCHhHCCCC
Confidence 11 122234578999999999999999983
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=372.98 Aligned_cols=266 Identities=37% Similarity=0.653 Sum_probs=226.8
Q ss_pred ccCHHHHHHHHhCCCcCCeeccCCcEEEEEEEECCCcEEEEEEeh--------------hhhhhcccCceeeEEEEEeCC
Q 039819 191 NFTFRELQQATENFSSKNILGAGGFGNVYKGKLGDGTVLAVKRLK--------------DMISLAVHRNLLRLIGYCATP 256 (534)
Q Consensus 191 ~~~~~~l~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~--------------~~l~~~~h~niv~l~~~~~~~ 256 (534)
.+++.++..++++|...+.||+|+||.||+|+..++..||||++. ..+..++||||+++++++.+.
T Consensus 28 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 107 (321)
T 2qkw_B 28 RVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDER 107 (321)
T ss_dssp --CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCT
T ss_pred eecHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCC
Confidence 344555566788999999999999999999999889999999864 267788999999999999999
Q ss_pred CeeEEEeeccCCCChhhhcccCC----CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecc
Q 039819 257 TERLLVYPYMSNGSVASRLREKP----ALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFG 332 (534)
Q Consensus 257 ~~~~lv~e~~~~gsL~~~l~~~~----~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFG 332 (534)
+..++||||+++|+|.+++.... .++|..++.++.|++.||.|||+. +|+||||||+|||++.++.+||+|||
T Consensus 108 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg 184 (321)
T 2qkw_B 108 NEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDFG 184 (321)
T ss_dssp TCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCSTTEEECTTCCEEECCCT
T ss_pred CeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCC---CeecCCCCHHHEEECCCCCEEEeecc
Confidence 99999999999999999997542 599999999999999999999998 99999999999999999999999999
Q ss_pred cceecCCCC-CceeeccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhc
Q 039819 333 LAKLLDHSD-SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEK 411 (534)
Q Consensus 333 la~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 411 (534)
+++...... ........||+.|+|||++.+..++.++|||||||++|||+||+.||....... ......|........
T Consensus 185 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~-~~~~~~~~~~~~~~~ 263 (321)
T 2qkw_B 185 ISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPRE-MVNLAEWAVESHNNG 263 (321)
T ss_dssp TCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSS-CCCHHHHTHHHHTTT
T ss_pred cccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHH-HHHHHHHhhhccccc
Confidence 998754322 222344568999999999988899999999999999999999999997544322 234556665555556
Q ss_pred ccceecccccCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhc
Q 039819 412 KVEVLVDRELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLEG 460 (534)
Q Consensus 412 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~ 460 (534)
.....+++.+........+..+.+++.+|++.+|++|||+.||++.|+.
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~ 312 (321)
T 2qkw_B 264 QLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEY 312 (321)
T ss_dssp CCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred cHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHH
Confidence 6667777777777788888999999999999999999999999999875
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=399.64 Aligned_cols=237 Identities=21% Similarity=0.285 Sum_probs=197.4
Q ss_pred HhCCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEeh--------------hhhhhcccCceeeEEEEEeCCCeeEEEeec
Q 039819 201 TENFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLK--------------DMISLAVHRNLLRLIGYCATPTERLLVYPY 265 (534)
Q Consensus 201 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~--------------~~l~~~~h~niv~l~~~~~~~~~~~lv~e~ 265 (534)
.++|...+.||+|+||.||+|+.. +|+.||||.+. ++++.++|||||+++++|.+....||||||
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~ 235 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 235 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence 368999999999999999999975 68999999875 267889999999999999999999999999
Q ss_pred cCCCChhhhccc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCC--CcEEEEecccceecCCCCC
Q 039819 266 MSNGSVASRLRE-KPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDF--CEAIVGDFGLAKLLDHSDS 342 (534)
Q Consensus 266 ~~~gsL~~~l~~-~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~--~~~kl~DFGla~~~~~~~~ 342 (534)
|++|+|.+++.. ...+++.++..|+.||+.||.|||++ +|+||||||+|||++.+ +.+||+|||+|+.+....
T Consensus 236 ~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~- 311 (573)
T 3uto_A 236 MSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ- 311 (573)
T ss_dssp CCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTS-
T ss_pred cCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhccccCCCCCCEEEeeccceeEccCCC-
Confidence 999999999864 46799999999999999999999999 99999999999999854 899999999999875432
Q ss_pred ceeeccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceecccccC
Q 039819 343 HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELG 422 (534)
Q Consensus 343 ~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 422 (534)
.....+||+.|||||++.+..|+.++||||+||++|||++|+.||...... +....+..... -+.....
T Consensus 312 -~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~-------~~~~~i~~~~~---~~~~~~~ 380 (573)
T 3uto_A 312 -SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDD-------ETLRNVKSCDW---NMDDSAF 380 (573)
T ss_dssp -EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH-------HHHHHHHTTCC---CCCSGGG
T ss_pred -ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH-------HHHHHHHhCCC---CCCcccc
Confidence 345568999999999999999999999999999999999999999754321 12222221110 0111111
Q ss_pred CCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 423 SNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 423 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
.. .+..+.+++.+||+.||.+|||+.|+++
T Consensus 381 ~~----~s~~~~dli~~~L~~dp~~R~t~~e~l~ 410 (573)
T 3uto_A 381 SG----ISEDGKDFIRKLLLADPNTRMTIHQALE 410 (573)
T ss_dssp TT----SCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred cC----CCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 11 2347889999999999999999999986
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-43 Score=356.27 Aligned_cols=233 Identities=21% Similarity=0.327 Sum_probs=196.4
Q ss_pred HhCCCcCCeeccCCcEEEEEEEE-CCCcEEEEEEehh----------------hhhhcccCceeeEEEEEeCCCeeEEEe
Q 039819 201 TENFSSKNILGAGGFGNVYKGKL-GDGTVLAVKRLKD----------------MISLAVHRNLLRLIGYCATPTERLLVY 263 (534)
Q Consensus 201 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~----------------~l~~~~h~niv~l~~~~~~~~~~~lv~ 263 (534)
.++|...+.||+|+||.||+|+. .+|+.||||++.. +++.++||||+++++++......++||
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 93 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM 93 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence 45788899999999999999998 5789999998742 567889999999999999999999999
Q ss_pred eccCCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCCc
Q 039819 264 PYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSH 343 (534)
Q Consensus 264 e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~ 343 (534)
||+++|+|.+++...+.+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 94 e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~-- 168 (328)
T 3fe3_A 94 EYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG-- 168 (328)
T ss_dssp CCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSC--
T ss_pred ECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCCHHHEEEcCCCCEEEeeccCceecCCCC--
Confidence 9999999999998888899999999999999999999999 99999999999999999999999999998765432
Q ss_pred eeeccccccccccccccccCCCC-cchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceecccccC
Q 039819 344 VTTAVRGTVGHIAPEYLSTGQSS-EKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELG 422 (534)
Q Consensus 344 ~~~~~~gt~~y~aPE~~~~~~~~-~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 422 (534)
.....+||+.|+|||++.+..+. .++|||||||++|||+||+.||+.... .+......... . .
T Consensus 169 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-------~~~~~~i~~~~-~------~-- 232 (328)
T 3fe3_A 169 KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNL-------KELRERVLRGK-Y------R-- 232 (328)
T ss_dssp GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHHHHHCC-C------C--
T ss_pred ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCH-------HHHHHHHHhCC-C------C--
Confidence 23456799999999999887764 799999999999999999999975331 12222221111 0 1
Q ss_pred CCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 423 SNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 423 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
.+...+..+.+++.+|++.||.+|||++|+++
T Consensus 233 --~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 264 (328)
T 3fe3_A 233 --IPFYMSTDCENLLKRFLVLNPIKRGTLEQIMK 264 (328)
T ss_dssp --CCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTT
T ss_pred --CCCCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 11122457889999999999999999999874
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=347.37 Aligned_cols=264 Identities=38% Similarity=0.677 Sum_probs=217.2
Q ss_pred CccccCHHHHHHHHhCCCcC------CeeccCCcEEEEEEEECCCcEEEEEEeh------------------hhhhhccc
Q 039819 188 NLRNFTFRELQQATENFSSK------NILGAGGFGNVYKGKLGDGTVLAVKRLK------------------DMISLAVH 243 (534)
Q Consensus 188 ~~~~~~~~~l~~~~~~~~~~------~~lG~G~~g~Vy~~~~~~~~~vavK~~~------------------~~l~~~~h 243 (534)
....|++.++..++++|... +.||+|+||.||+|.. +++.||||++. .++..++|
T Consensus 11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h 89 (307)
T 2nru_A 11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQH 89 (307)
T ss_dssp CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCC
T ss_pred CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCC
Confidence 35689999999999999887 8999999999999997 67899999874 15678899
Q ss_pred CceeeEEEEEeCCCeeEEEeeccCCCChhhhccc---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEe
Q 039819 244 RNLLRLIGYCATPTERLLVYPYMSNGSVASRLRE---KPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLL 320 (534)
Q Consensus 244 ~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~---~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl 320 (534)
|||+++++++.+....++||||+++|+|.+++.. ...+++..++.++.|++.||.|||+. +|+||||||+||++
T Consensus 90 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nili 166 (307)
T 2nru_A 90 ENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILL 166 (307)
T ss_dssp TTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEE
T ss_pred CCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEEE
Confidence 9999999999999999999999999999999863 45699999999999999999999999 99999999999999
Q ss_pred CCCCcEEEEecccceecCCCCCc-eeeccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccch
Q 039819 321 DDFCEAIVGDFGLAKLLDHSDSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGA 399 (534)
Q Consensus 321 ~~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~ 399 (534)
+.++.+||+|||+++........ ......||+.|+|||.+.+ .++.++|||||||++|||+||+.||........
T Consensus 167 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~--- 242 (307)
T 2nru_A 167 DEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQL--- 242 (307)
T ss_dssp CTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSB---
T ss_pred cCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHH---
Confidence 99999999999999876543222 2334569999999998854 588999999999999999999999975443221
Q ss_pred HHHHHHHHhh-hcccceecccccCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhc
Q 039819 400 MLEWVKKIQQ-EKKVEVLVDRELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLEG 460 (534)
Q Consensus 400 ~~~~~~~~~~-~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~ 460 (534)
+..+...... ...+...+++.+ .......+..+.+++.+|++.+|.+||++.+|++.|+.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~ 303 (307)
T 2nru_A 243 LLDIKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQE 303 (307)
T ss_dssp TTHHHHHHHTTSCCHHHHSCSSC-SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred HHHHHHHhhhhhhhhhhhccccc-cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHH
Confidence 2233222222 122233334433 23456677889999999999999999999999999976
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-43 Score=370.00 Aligned_cols=248 Identities=18% Similarity=0.246 Sum_probs=201.6
Q ss_pred CHHHHHHHHhCCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEehh-----------------hhhhcccCceeeEEEEEe
Q 039819 193 TFRELQQATENFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLKD-----------------MISLAVHRNLLRLIGYCA 254 (534)
Q Consensus 193 ~~~~l~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~-----------------~l~~~~h~niv~l~~~~~ 254 (534)
.+.++...+++|...+.||+|+||.||+|+.. +++.||||++.+ ++..++||||++++++|.
T Consensus 65 ~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~ 144 (437)
T 4aw2_A 65 KVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQ 144 (437)
T ss_dssp HHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred hhhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe
Confidence 34455556789999999999999999999986 478999998852 567788999999999999
Q ss_pred CCCeeEEEeeccCCCChhhhccc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEeccc
Q 039819 255 TPTERLLVYPYMSNGSVASRLRE-KPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGL 333 (534)
Q Consensus 255 ~~~~~~lv~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGl 333 (534)
+....++|||||++|+|.+++.. ...+++..++.++.|++.||.|||+. +||||||||+|||++.++.+||+|||+
T Consensus 145 ~~~~~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILl~~~g~vkL~DFGl 221 (437)
T 4aw2_A 145 DDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGS 221 (437)
T ss_dssp CSSEEEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred eCCEEEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeeEcCCCCEEEcchhh
Confidence 99999999999999999999986 56799999999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCCceeeccccccccccccccc-----cCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHh
Q 039819 334 AKLLDHSDSHVTTAVRGTVGHIAPEYLS-----TGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQ 408 (534)
Q Consensus 334 a~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~ 408 (534)
++.............+||+.|+|||++. ...++.++|||||||++|||+||+.||...........+..+..
T Consensus 222 a~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~--- 298 (437)
T 4aw2_A 222 CLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKE--- 298 (437)
T ss_dssp CEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHH---
T ss_pred hhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccc---
Confidence 9877654444445578999999999986 56789999999999999999999999975432211111111110
Q ss_pred hhcccceecccccCCCCCHHHHHHHHHHHHHhcccCCCC--CCChHHHHH
Q 039819 409 QEKKVEVLVDRELGSNYDRIEVGEILQVALLCTQYLPVH--RPKMSEVVR 456 (534)
Q Consensus 409 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~--RPt~~ev~~ 456 (534)
.. .-+..... ....+.+++.+|+..+|++ ||+++|+++
T Consensus 299 ---~~---~~p~~~~~----~s~~~~dLi~~lL~~~~~r~~r~~~~eil~ 338 (437)
T 4aw2_A 299 ---RF---QFPTQVTD----VSENAKDLIRRLICSREHRLGQNGIEDFKK 338 (437)
T ss_dssp ---HC---CCCSSCCC----SCHHHHHHHHTTSSCGGGCTTTTTTHHHHT
T ss_pred ---cc---cCCccccc----CCHHHHHHHHHHhcccccccCCCCHHHHhC
Confidence 00 00111111 2347889999999888888 999999986
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=354.80 Aligned_cols=240 Identities=26% Similarity=0.418 Sum_probs=197.0
Q ss_pred hCCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEeh--------------hhhhhcccCceeeEEEEEeCCCeeEEEeecc
Q 039819 202 ENFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLK--------------DMISLAVHRNLLRLIGYCATPTERLLVYPYM 266 (534)
Q Consensus 202 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~--------------~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~ 266 (534)
++|...+.||+|+||.||+|+.. ++..||+|++. +++..++||||+++++++.+....++||||+
T Consensus 10 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 89 (310)
T 3s95_A 10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYI 89 (310)
T ss_dssp GGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred hHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEec
Confidence 56788899999999999999985 68999999874 2677889999999999999999999999999
Q ss_pred CCCChhhhccc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCCce-
Q 039819 267 SNGSVASRLRE-KPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHV- 344 (534)
Q Consensus 267 ~~gsL~~~l~~-~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~- 344 (534)
++|+|.+++.. ...+++.++..|+.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.........
T Consensus 90 ~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 166 (310)
T 3s95_A 90 KGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSM---NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPE 166 (310)
T ss_dssp TTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEECTTSCEEECCCTTCEECC-------
T ss_pred CCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCcCeEEECCCCCEEEeecccceeccccccccc
Confidence 99999999986 56799999999999999999999999 99999999999999999999999999998764332211
Q ss_pred ------------eeccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCcccccc--chHHHHHHHHhhh
Q 039819 345 ------------TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQK--GAMLEWVKKIQQE 410 (534)
Q Consensus 345 ------------~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~--~~~~~~~~~~~~~ 410 (534)
.....||+.|+|||++.+..++.++|||||||++|||++|..|+......... ........
T Consensus 167 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~----- 241 (310)
T 3s95_A 167 GLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLD----- 241 (310)
T ss_dssp -------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHH-----
T ss_pred ccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhcccc-----
Confidence 11457999999999999999999999999999999999999998743221111 01111111
Q ss_pred cccceecccccCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhcC
Q 039819 411 KKVEVLVDRELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLEGD 461 (534)
Q Consensus 411 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~~ 461 (534)
... +...+..+.+++.+|++.+|++|||+.++++.|+..
T Consensus 242 --------~~~----~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l 280 (310)
T 3s95_A 242 --------RYC----PPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETL 280 (310)
T ss_dssp --------HTC----CTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --------ccC----CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 011 111234788999999999999999999999998763
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=358.83 Aligned_cols=252 Identities=26% Similarity=0.331 Sum_probs=196.5
Q ss_pred hCCCcCCeeccCCcEEEEEEEECCCcEEEEEEehh-------------hhhhcccCceeeEEEEEeCCC----eeEEEee
Q 039819 202 ENFSSKNILGAGGFGNVYKGKLGDGTVLAVKRLKD-------------MISLAVHRNLLRLIGYCATPT----ERLLVYP 264 (534)
Q Consensus 202 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~-------------~l~~~~h~niv~l~~~~~~~~----~~~lv~e 264 (534)
++|+..+.||+|+||.||+|+.. ++.||||++.. .+..++|||||++++++.... ..++|||
T Consensus 24 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~e 102 (322)
T 3soc_A 24 MPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITA 102 (322)
T ss_dssp EEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEE
T ss_pred hhchhhheecccCceEEEEEEEC-CCEEEEEEeecCchHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEEEe
Confidence 57888899999999999999985 78999999852 467789999999999998754 3699999
Q ss_pred ccCCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcC-------CCCeEeccCCCCcEEeCCCCcEEEEecccceec
Q 039819 265 YMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQC-------DPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLL 337 (534)
Q Consensus 265 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~-------~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~ 337 (534)
|+++|+|.+++... .+++..++.|+.|++.||.|||+.+ .++|+||||||+|||++.++.+||+|||+++..
T Consensus 103 ~~~~g~L~~~l~~~-~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg~a~~~ 181 (322)
T 3soc_A 103 FHEKGSLSDFLKAN-VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKF 181 (322)
T ss_dssp CCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCTTCEEE
T ss_pred cCCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccCCccccc
Confidence 99999999999765 4999999999999999999999752 237999999999999999999999999999876
Q ss_pred CCCCCc-eeecccccccccccccccc-----CCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccc---------hHHH
Q 039819 338 DHSDSH-VTTAVRGTVGHIAPEYLST-----GQSSEKTDVFGFGILLLELITGMRALEFGKSINQKG---------AMLE 402 (534)
Q Consensus 338 ~~~~~~-~~~~~~gt~~y~aPE~~~~-----~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~---------~~~~ 402 (534)
...... ......||+.|+|||++.+ ..++.++|||||||++|||+||+.||.......... ....
T Consensus 182 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 261 (322)
T 3soc_A 182 EAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLED 261 (322)
T ss_dssp CTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSCCHHH
T ss_pred ccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccCCchhh
Confidence 543321 2334579999999999876 346678999999999999999999997543221111 1111
Q ss_pred HHHHHhhhcccceecccccCCC-CCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhc
Q 039819 403 WVKKIQQEKKVEVLVDRELGSN-YDRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLEG 460 (534)
Q Consensus 403 ~~~~~~~~~~~~~~~d~~l~~~-~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~ 460 (534)
+........ ..+.+... .....+..+.+++.+||+.||++|||+.||++.|+.
T Consensus 262 ~~~~~~~~~-----~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~ 315 (322)
T 3soc_A 262 MQEVVVHKK-----KRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQ 315 (322)
T ss_dssp HHHHHTTSC-----CCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred hhhhhhccc-----CCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 111111111 11111111 122345679999999999999999999999999876
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-43 Score=362.97 Aligned_cols=245 Identities=22% Similarity=0.278 Sum_probs=199.2
Q ss_pred HHHHHHHhCCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEehh-----------------hhhhcccCceeeEEEEEeCC
Q 039819 195 RELQQATENFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLKD-----------------MISLAVHRNLLRLIGYCATP 256 (534)
Q Consensus 195 ~~l~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~-----------------~l~~~~h~niv~l~~~~~~~ 256 (534)
+++....++|...+.||+|+||.||+|+.. +++.||+|++.+ ++..++|||||+++++|.+.
T Consensus 62 ~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~ 141 (410)
T 3v8s_A 62 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD 141 (410)
T ss_dssp HHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred HhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEEC
Confidence 344455678999999999999999999986 588999998752 56778999999999999999
Q ss_pred CeeEEEeeccCCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEeccccee
Q 039819 257 TERLLVYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKL 336 (534)
Q Consensus 257 ~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~ 336 (534)
...|+|||||++|+|.+++... .+++..+..++.||+.||.|||+. +||||||||+|||++.++.+||+|||+++.
T Consensus 142 ~~~~lV~E~~~gg~L~~~l~~~-~~~e~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFG~a~~ 217 (410)
T 3v8s_A 142 RYLYMVMEYMPGGDLVNLMSNY-DVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMK 217 (410)
T ss_dssp SEEEEEECCCTTEEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred CEEEEEEeCCCCCcHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeeECCCCCEEEeccceeEe
Confidence 9999999999999999998754 589999999999999999999999 999999999999999999999999999988
Q ss_pred cCCCCCceeeccccccccccccccccCC----CCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcc
Q 039819 337 LDHSDSHVTTAVRGTVGHIAPEYLSTGQ----SSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKK 412 (534)
Q Consensus 337 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 412 (534)
............+||+.|+|||++.+.. ++.++|||||||++|||+||+.||...... +....+.....
T Consensus 218 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~-------~~~~~i~~~~~ 290 (410)
T 3v8s_A 218 MNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV-------GTYSKIMNHKN 290 (410)
T ss_dssp CCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHH-------HHHHHHHTHHH
T ss_pred eccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChh-------hHHHHHHhccc
Confidence 7654433344678999999999997654 789999999999999999999999754321 11111111100
Q ss_pred cceecccccCCCCCHHHHHHHHHHHHHhcccCCCC--CCChHHHHHH
Q 039819 413 VEVLVDRELGSNYDRIEVGEILQVALLCTQYLPVH--RPKMSEVVRM 457 (534)
Q Consensus 413 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~--RPt~~ev~~~ 457 (534)
.. .... ....+..+.+++.+|++.+|.+ ||+++||++.
T Consensus 291 ~~-----~~p~--~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~H 330 (410)
T 3v8s_A 291 SL-----TFPD--DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 330 (410)
T ss_dssp HC-----CCCT--TCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred cc-----cCCC--cccccHHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence 00 0000 0012347889999999999988 9999999863
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-42 Score=344.93 Aligned_cols=236 Identities=20% Similarity=0.316 Sum_probs=196.1
Q ss_pred HhCCCcCCeeccCCcEEEEEEEE-CCCcEEEEEEeh--------------hhhhhcccCceeeEEEEEeCCCeeEEEeec
Q 039819 201 TENFSSKNILGAGGFGNVYKGKL-GDGTVLAVKRLK--------------DMISLAVHRNLLRLIGYCATPTERLLVYPY 265 (534)
Q Consensus 201 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~--------------~~l~~~~h~niv~l~~~~~~~~~~~lv~e~ 265 (534)
.++|...+.||+|+||.||+|.. .+++.||||++. .++..++||||+++++++...+..++||||
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 98 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence 36799999999999999999996 578999999874 257788999999999999999999999999
Q ss_pred cCCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCCcee
Q 039819 266 MSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVT 345 (534)
Q Consensus 266 ~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~ 345 (534)
+++|+|.+++... .+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++........ ..
T Consensus 99 ~~~~~L~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~ 173 (297)
T 3fxz_A 99 LAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-KR 173 (297)
T ss_dssp CTTCBHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC-CB
T ss_pred CCCCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEECCCCCEEEeeCCCceecCCccc-cc
Confidence 9999999999765 589999999999999999999999 999999999999999999999999999987654332 23
Q ss_pred eccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceecccccCCCC
Q 039819 346 TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELGSNY 425 (534)
Q Consensus 346 ~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 425 (534)
....||+.|+|||++.+..++.++|||||||++|||+||+.||...... ............. ...
T Consensus 174 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-------~~~~~~~~~~~~~--------~~~ 238 (297)
T 3fxz_A 174 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL-------RALYLIATNGTPE--------LQN 238 (297)
T ss_dssp CCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH-------HHHHHHHHHCSCC--------CSC
T ss_pred CCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-------HHHHHHHhCCCCC--------CCC
Confidence 4567999999999999999999999999999999999999999743221 1111111111100 011
Q ss_pred CHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 426 DRIEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 426 ~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
+...+..+.+++.+|++.||++|||+.|+++
T Consensus 239 ~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 269 (297)
T 3fxz_A 239 PEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ 269 (297)
T ss_dssp GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ccccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 1223457889999999999999999999985
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-43 Score=352.82 Aligned_cols=239 Identities=29% Similarity=0.433 Sum_probs=189.1
Q ss_pred HhCCCcCCeeccCCcEEEEEEEECCCcEEEEEEeh----------------hhhhhcccCceeeEEEEEeCCCeeEEEee
Q 039819 201 TENFSSKNILGAGGFGNVYKGKLGDGTVLAVKRLK----------------DMISLAVHRNLLRLIGYCATPTERLLVYP 264 (534)
Q Consensus 201 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~----------------~~l~~~~h~niv~l~~~~~~~~~~~lv~e 264 (534)
.++|+..+.||+|+||.||+|+. .+..||||++. +++..++||||+++++++.+....++|||
T Consensus 36 ~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 114 (309)
T 3p86_A 36 WCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTE 114 (309)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEEE
T ss_pred hhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEEe
Confidence 45788889999999999999988 67889999874 25788899999999999999999999999
Q ss_pred ccCCCChhhhcccCCC---CCHHHHHHHHHHHHHHHHHHHhcCCCC--eEeccCCCCcEEeCCCCcEEEEecccceecCC
Q 039819 265 YMSNGSVASRLREKPA---LDWNTRKRIAIGAARGLLYLHEQCDPK--IIHRDVKAANVLLDDFCEAIVGDFGLAKLLDH 339 (534)
Q Consensus 265 ~~~~gsL~~~l~~~~~---l~~~~~~~i~~~i~~~l~yLH~~~~~~--ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~ 339 (534)
|+++|+|.+++..... +++..++.++.|++.||+|||+. + |+||||||+|||++.++.+||+|||+++....
T Consensus 115 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~ 191 (309)
T 3p86_A 115 YLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR---NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKAS 191 (309)
T ss_dssp CCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTS---SSCCCCTTCCGGGEEECTTCCEEECCCC-------
T ss_pred cCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcC---CCCEECCCCChhhEEEeCCCcEEECCCCCCccccc
Confidence 9999999999986553 99999999999999999999998 7 99999999999999999999999999986543
Q ss_pred CCCceeeccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceeccc
Q 039819 340 SDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDR 419 (534)
Q Consensus 340 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 419 (534)
.. .......||+.|+|||++.+..++.++|||||||++|||+||+.||...... +.......... ..
T Consensus 192 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~-------~~~~~~~~~~~-----~~ 258 (309)
T 3p86_A 192 TF-LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPA-------QVVAAVGFKCK-----RL 258 (309)
T ss_dssp -----------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHH-------HHHHHHHHSCC-----CC
T ss_pred cc-cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-------HHHHHHHhcCC-----CC
Confidence 22 2233456999999999999989999999999999999999999999743221 11111111110 01
Q ss_pred ccCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhc
Q 039819 420 ELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLEG 460 (534)
Q Consensus 420 ~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~ 460 (534)
..+...+..+.+++.+||+.+|.+|||+.++++.|+.
T Consensus 259 ----~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~ 295 (309)
T 3p86_A 259 ----EIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRP 295 (309)
T ss_dssp ----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ----CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 1122234578999999999999999999999999875
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-43 Score=361.08 Aligned_cols=240 Identities=28% Similarity=0.437 Sum_probs=196.2
Q ss_pred HhCCCcCCeeccCCcEEEEEEEE--------CCCcEEEEEEehh---------------hhhhc-ccCceeeEEEEEeCC
Q 039819 201 TENFSSKNILGAGGFGNVYKGKL--------GDGTVLAVKRLKD---------------MISLA-VHRNLLRLIGYCATP 256 (534)
Q Consensus 201 ~~~~~~~~~lG~G~~g~Vy~~~~--------~~~~~vavK~~~~---------------~l~~~-~h~niv~l~~~~~~~ 256 (534)
.++|...+.||+|+||.||+|+. .++..||||+++. ++..+ +||||++++++|.+.
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 159 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 159 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence 36788889999999999999986 2456799998852 56666 899999999999999
Q ss_pred CeeEEEeeccCCCChhhhcccC----------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEe
Q 039819 257 TERLLVYPYMSNGSVASRLREK----------------PALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLL 320 (534)
Q Consensus 257 ~~~~lv~e~~~~gsL~~~l~~~----------------~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl 320 (534)
+..++||||+++|+|.+++... ..+++..++.++.||+.||.|||++ +|+||||||+|||+
T Consensus 160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll 236 (370)
T 2psq_A 160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLV 236 (370)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEE
T ss_pred CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchhhEEE
Confidence 9999999999999999999753 2489999999999999999999999 99999999999999
Q ss_pred CCCCcEEEEecccceecCCCCCc-eeeccccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCcCCCccccccc
Q 039819 321 DDFCEAIVGDFGLAKLLDHSDSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GMRALEFGKSINQKG 398 (534)
Q Consensus 321 ~~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~ellt-G~~p~~~~~~~~~~~ 398 (534)
+.++.+||+|||+++........ ......+|+.|+|||++.+..++.++|||||||++|||+| |+.||......
T Consensus 237 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~---- 312 (370)
T 2psq_A 237 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE---- 312 (370)
T ss_dssp CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG----
T ss_pred CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHH----
Confidence 99999999999999976543221 2233457889999999999899999999999999999999 99999743211
Q ss_pred hHHHHHHHHhhhcccceecccccCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhc
Q 039819 399 AMLEWVKKIQQEKKVEVLVDRELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLEG 460 (534)
Q Consensus 399 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~ 460 (534)
.+.. ...... ....+...+..+.+++.+||+.+|.+||++.|+++.|+.
T Consensus 313 ~~~~---~~~~~~----------~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~ 361 (370)
T 2psq_A 313 ELFK---LLKEGH----------RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDR 361 (370)
T ss_dssp GHHH---HHHTTC----------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHH---HHhcCC----------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 1111 111111 011122234578999999999999999999999999875
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-43 Score=344.21 Aligned_cols=242 Identities=27% Similarity=0.415 Sum_probs=201.7
Q ss_pred HhCCCcCCeeccCCcEEEEEEEECCCcEEEEEEehh-------------hhhhcccCceeeEEEEEeCCCeeEEEeeccC
Q 039819 201 TENFSSKNILGAGGFGNVYKGKLGDGTVLAVKRLKD-------------MISLAVHRNLLRLIGYCATPTERLLVYPYMS 267 (534)
Q Consensus 201 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~-------------~l~~~~h~niv~l~~~~~~~~~~~lv~e~~~ 267 (534)
.++|...+.||+|+||.||+|+..++..||||.+.. .+..++||||+++++++.+....++||||++
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 86 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYIS 86 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTBCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCT
T ss_pred hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCCcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEccC
Confidence 367888899999999999999999888999998852 6778899999999999999999999999999
Q ss_pred CCChhhhcccC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCCceee
Q 039819 268 NGSVASRLREK-PALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTT 346 (534)
Q Consensus 268 ~gsL~~~l~~~-~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~ 346 (534)
+++|.+++... ..+++..++.++.|++.||.|||+. +|+||||||+||+++.++.+||+|||+++...........
T Consensus 87 ~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 163 (268)
T 3sxs_A 87 NGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESH---QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSV 163 (268)
T ss_dssp TCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEEECC
T ss_pred CCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCcceEEECCCCCEEEccCccceecchhhhhccc
Confidence 99999999754 4599999999999999999999999 9999999999999999999999999999977654433334
Q ss_pred ccccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCcCCCccccccchHHHHHHHHhhhcccceecccccCCCC
Q 039819 347 AVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELGSNY 425 (534)
Q Consensus 347 ~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 425 (534)
...+|..|+|||.+.+..++.++||||||+++|||+| |+.||...... +.......... . ..
T Consensus 164 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~-------~~~~~~~~~~~---~-------~~ 226 (268)
T 3sxs_A 164 GTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNS-------EVVLKVSQGHR---L-------YR 226 (268)
T ss_dssp SCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHH-------HHHHHHHTTCC---C-------CC
T ss_pred CCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChH-------HHHHHHHcCCC---C-------CC
Confidence 4556788999999988889999999999999999999 99999743321 11111111110 0 01
Q ss_pred CHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhcCC
Q 039819 426 DRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLEGDG 462 (534)
Q Consensus 426 ~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~~~ 462 (534)
+...+..+.+++.+|++.+|.+|||+.|+++.|+...
T Consensus 227 ~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~ 263 (268)
T 3sxs_A 227 PHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLR 263 (268)
T ss_dssp CTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGC
T ss_pred CCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 1112347899999999999999999999999998754
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-42 Score=346.69 Aligned_cols=247 Identities=19% Similarity=0.280 Sum_probs=202.9
Q ss_pred cccCHHHHHHHHhC----------CCcCCeeccCCcEEEEEEEEC-CCcEEEEEEeh--------------hhhhhcccC
Q 039819 190 RNFTFRELQQATEN----------FSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLK--------------DMISLAVHR 244 (534)
Q Consensus 190 ~~~~~~~l~~~~~~----------~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~--------------~~l~~~~h~ 244 (534)
..|+++++..+++. |...+.||+|+||.||+|+.. +|+.||||++. ..+..++||
T Consensus 23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ 102 (321)
T 2c30_A 23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHF 102 (321)
T ss_dssp --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCT
T ss_pred CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCC
Confidence 45788999988875 566678999999999999986 79999999875 267788999
Q ss_pred ceeeEEEEEeCCCeeEEEeeccCCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCC
Q 039819 245 NLLRLIGYCATPTERLLVYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFC 324 (534)
Q Consensus 245 niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~ 324 (534)
||+++++++...+..++||||+++|+|.+++.. ..+++..+..++.|++.||.|||+. +|+||||||+|||++.++
T Consensus 103 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~ 178 (321)
T 2c30_A 103 NVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ-VRLNEEQIATVCEAVLQALAYLHAQ---GVIHRDIKSDSILLTLDG 178 (321)
T ss_dssp TBCCEEEEEEETTEEEEEECCCCSCBHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTC
T ss_pred CcceEEEEEEECCEEEEEEecCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCC
Confidence 999999999999999999999999999998875 4599999999999999999999998 999999999999999999
Q ss_pred cEEEEecccceecCCCCCceeeccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHH
Q 039819 325 EAIVGDFGLAKLLDHSDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWV 404 (534)
Q Consensus 325 ~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~ 404 (534)
.+||+|||+++....... ......||+.|+|||++.+..++.++|||||||++|||+||+.||..... .+..
T Consensus 179 ~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~-------~~~~ 250 (321)
T 2c30_A 179 RVKLSDFGFCAQISKDVP-KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSP-------VQAM 250 (321)
T ss_dssp CEEECCCTTCEECCSSSC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH-------HHHH
T ss_pred cEEEeeeeeeeecccCcc-ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-------HHHH
Confidence 999999999987654322 23446799999999999998999999999999999999999999974322 1111
Q ss_pred HHHhhhcccceecccccCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 405 KKIQQEKKVEVLVDRELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 405 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
....... .+.+. .....+..+.+++.+|++.+|++|||+.|+++
T Consensus 251 ~~~~~~~------~~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 294 (321)
T 2c30_A 251 KRLRDSP------PPKLK--NSHKVSPVLRDFLERMLVRDPQERATAQELLD 294 (321)
T ss_dssp HHHHHSS------CCCCT--TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHHhcCC------CCCcC--ccccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1111111 01111 11122347889999999999999999999986
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-42 Score=356.72 Aligned_cols=237 Identities=23% Similarity=0.314 Sum_probs=191.3
Q ss_pred HhCCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEehh-----------------hhhhc-ccCceeeEEEEEeCCCeeEE
Q 039819 201 TENFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLKD-----------------MISLA-VHRNLLRLIGYCATPTERLL 261 (534)
Q Consensus 201 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~-----------------~l~~~-~h~niv~l~~~~~~~~~~~l 261 (534)
.++|...+.||+|+||.||+|+.. +++.||||++++ ++..+ +|||||++++++.+....++
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 130 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 130 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence 357888999999999999999986 578999998863 23333 79999999999999999999
Q ss_pred EeeccCCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCC
Q 039819 262 VYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSD 341 (534)
Q Consensus 262 v~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~ 341 (534)
||||+++|+|..++.....+++..++.++.||+.||.|||++ +||||||||+|||++.++.+||+|||+++.....
T Consensus 131 V~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFGla~~~~~~- 206 (396)
T 4dc2_A 131 VIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP- 206 (396)
T ss_dssp EEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT-
T ss_pred EEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEECCCCCEEEeecceeeecccC-
Confidence 999999999999998888899999999999999999999999 9999999999999999999999999999863322
Q ss_pred CceeeccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCcccccc-chHHHHHHHHhhhcccceecccc
Q 039819 342 SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQK-GAMLEWVKKIQQEKKVEVLVDRE 420 (534)
Q Consensus 342 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~d~~ 420 (534)
.......+||+.|+|||++.+..++.++|||||||++|||++|+.||......... ....+++......... .
T Consensus 207 ~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~------~ 280 (396)
T 4dc2_A 207 GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI------R 280 (396)
T ss_dssp TCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCC------C
T ss_pred CCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhcccc------C
Confidence 22345578999999999999999999999999999999999999999743221110 1111111111111111 1
Q ss_pred cCCCCCHHHHHHHHHHHHHhcccCCCCCCCh
Q 039819 421 LGSNYDRIEVGEILQVALLCTQYLPVHRPKM 451 (534)
Q Consensus 421 l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~ 451 (534)
++......+.+++.+|++.||.+||++
T Consensus 281 ----~p~~~s~~~~~li~~lL~~dP~~R~~~ 307 (396)
T 4dc2_A 281 ----IPRSLSVKAASVLKSFLNKDPKERLGC 307 (396)
T ss_dssp ----CCTTSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred ----CCCcCCHHHHHHHHHHhcCCHhHcCCC
Confidence 122234578899999999999999996
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=351.24 Aligned_cols=238 Identities=23% Similarity=0.336 Sum_probs=195.5
Q ss_pred HhCCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEeh---------------hhhhhcccCceeeEEEEEeCCCeeEEEee
Q 039819 201 TENFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLK---------------DMISLAVHRNLLRLIGYCATPTERLLVYP 264 (534)
Q Consensus 201 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~---------------~~l~~~~h~niv~l~~~~~~~~~~~lv~e 264 (534)
.++|...+.||+|+||.||+|+.. +++.||||++. .++..++||||+++++++.+....++|||
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 85 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence 367888999999999999999986 78999999873 26778899999999999999999999999
Q ss_pred ccCCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCC-Cc
Q 039819 265 YMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSD-SH 343 (534)
Q Consensus 265 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~-~~ 343 (534)
|+++|+|.+++.....+++..++.++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++...... ..
T Consensus 86 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 162 (323)
T 3tki_A 86 YCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER 162 (323)
T ss_dssp CCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEEC
T ss_pred cCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccccchHHEEEeCCCCEEEEEeeccceeccCCccc
Confidence 999999999999888899999999999999999999998 99999999999999999999999999998764322 12
Q ss_pred eeeccccccccccccccccCCC-CcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceecccccC
Q 039819 344 VTTAVRGTVGHIAPEYLSTGQS-SEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELG 422 (534)
Q Consensus 344 ~~~~~~gt~~y~aPE~~~~~~~-~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 422 (534)
......||+.|+|||++.+..+ +.++|||||||++|||+||+.||....... .....|.. ....
T Consensus 163 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~--~~~~~~~~---~~~~---------- 227 (323)
T 3tki_A 163 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC--QEYSDWKE---KKTY---------- 227 (323)
T ss_dssp CBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTS--HHHHHHHT---TCTT----------
T ss_pred ccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHH--HHHHHHhc---cccc----------
Confidence 2335679999999999987765 789999999999999999999997543211 11111111 0000
Q ss_pred CCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 423 SNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 423 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
..........+.+++.+|++.+|.+|||+.|+++
T Consensus 228 ~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~ 261 (323)
T 3tki_A 228 LNPWKKIDSAPLALLHKILVENPSARITIPDIKK 261 (323)
T ss_dssp STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CCccccCCHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 0001122357889999999999999999999874
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=346.80 Aligned_cols=248 Identities=23% Similarity=0.355 Sum_probs=193.5
Q ss_pred HhCCCcCCeeccCCcEEEEEEEECCCcEEEEEEehh-----------hhhh--cccCceeeEEEEEeC----CCeeEEEe
Q 039819 201 TENFSSKNILGAGGFGNVYKGKLGDGTVLAVKRLKD-----------MISL--AVHRNLLRLIGYCAT----PTERLLVY 263 (534)
Q Consensus 201 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~-----------~l~~--~~h~niv~l~~~~~~----~~~~~lv~ 263 (534)
.++|...+.||+|+||.||+|+. +++.||||++.. ++.. ++||||+++++++.. ....++||
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~lv~ 85 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLIT 85 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGGGHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccccchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEEeh
Confidence 46788999999999999999998 688999999852 2333 789999999998754 34578999
Q ss_pred eccCCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHH--------hcCCCCeEeccCCCCcEEeCCCCcEEEEecccce
Q 039819 264 PYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLH--------EQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAK 335 (534)
Q Consensus 264 e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH--------~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~ 335 (534)
||+++|+|.++++. ..+++..++.|+.|++.||.||| +. +|+||||||+|||++.++.+||+|||+++
T Consensus 86 e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~ 161 (301)
T 3q4u_A 86 HYHEMGSLYDYLQL-TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP---AIAHRDLKSKNILVKKNGQCCIADLGLAV 161 (301)
T ss_dssp CCCTTCBHHHHHTT-CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBC---EEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred hhccCCCHHHHHhh-cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCC---CeecCCCChHhEEEcCCCCEEEeeCCCee
Confidence 99999999999964 46999999999999999999999 66 99999999999999999999999999998
Q ss_pred ecCCCCCce---eeccccccccccccccccC------CCCcchhHHHHHHHHHHHHhC----------CCCcCCCccccc
Q 039819 336 LLDHSDSHV---TTAVRGTVGHIAPEYLSTG------QSSEKTDVFGFGILLLELITG----------MRALEFGKSINQ 396 (534)
Q Consensus 336 ~~~~~~~~~---~~~~~gt~~y~aPE~~~~~------~~~~k~Dv~S~Gvvl~elltG----------~~p~~~~~~~~~ 396 (534)
......... .....||+.|+|||++.+. .++.++|||||||++|||+|| +.||........
T Consensus 162 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~~~ 241 (301)
T 3q4u_A 162 MHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDP 241 (301)
T ss_dssp EEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred ecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCCCCc
Confidence 765443322 2234799999999999776 456799999999999999999 777754322111
Q ss_pred cchHHHHHHHHhhhcccceecccccCC-CCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhc
Q 039819 397 KGAMLEWVKKIQQEKKVEVLVDRELGS-NYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLEG 460 (534)
Q Consensus 397 ~~~~~~~~~~~~~~~~~~~~~d~~l~~-~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~ 460 (534)
. ............. .+.+.. ......+..+.+++.+||+.+|++|||+.||++.|+.
T Consensus 242 ~--~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~ 299 (301)
T 3q4u_A 242 S--FEDMRKVVCVDQQ-----RPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTK 299 (301)
T ss_dssp C--HHHHHHHHTTSCC-----CCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHH
T ss_pred c--hhhhhHHHhccCC-----CCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhc
Confidence 1 1111111111111 111111 1223456789999999999999999999999999875
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-42 Score=343.45 Aligned_cols=244 Identities=24% Similarity=0.318 Sum_probs=194.3
Q ss_pred hCCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEeh-----------------hhhhhcccCceeeEEEEEeCCCeeEEEe
Q 039819 202 ENFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLK-----------------DMISLAVHRNLLRLIGYCATPTERLLVY 263 (534)
Q Consensus 202 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~-----------------~~l~~~~h~niv~l~~~~~~~~~~~lv~ 263 (534)
++|...+.||+|+||.||+|+.. ++..||||.+. ..+..++||||+++++++.+.+..++||
T Consensus 11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 90 (294)
T 4eqm_A 11 ERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVM 90 (294)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEEE
T ss_pred ccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEEE
Confidence 57888899999999999999975 68999999873 1567788999999999999999999999
Q ss_pred eccCCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCCc
Q 039819 264 PYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSH 343 (534)
Q Consensus 264 e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~ 343 (534)
||+++|+|.+++.....+++..++.++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++........
T Consensus 91 e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 167 (294)
T 4eqm_A 91 EYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLT 167 (294)
T ss_dssp ECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCSSSTTC------
T ss_pred eCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEEeCCCcccccccccc
Confidence 9999999999998888899999999999999999999999 9999999999999999999999999999876544333
Q ss_pred eeeccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceecccccCC
Q 039819 344 VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELGS 423 (534)
Q Consensus 344 ~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 423 (534)
......||+.|+|||++.+..++.++|||||||++|||+||+.||...... .......... ... .......
T Consensus 168 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~-------~~~~~~~~~~-~~~-~~~~~~~ 238 (294)
T 4eqm_A 168 QTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAV-------SIAIKHIQDS-VPN-VTTDVRK 238 (294)
T ss_dssp -------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHH-------HHHHHHHSSC-CCC-HHHHSCT
T ss_pred ccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH-------HHHHHHhhcc-CCC-cchhccc
Confidence 344567999999999999989999999999999999999999999753321 1111111110 000 0011111
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCC-ChHHHHHHhhcC
Q 039819 424 NYDRIEVGEILQVALLCTQYLPVHRP-KMSEVVRMLEGD 461 (534)
Q Consensus 424 ~~~~~~~~~l~~l~~~Cl~~~P~~RP-t~~ev~~~L~~~ 461 (534)
..+..+.+++.+|++.+|.+|| +++++.+.|+..
T Consensus 239 ----~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~ 273 (294)
T 4eqm_A 239 ----DIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSV 273 (294)
T ss_dssp ----TSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTS
T ss_pred ----CCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHH
Confidence 2245789999999999999999 899999888753
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-43 Score=362.99 Aligned_cols=247 Identities=20% Similarity=0.240 Sum_probs=198.7
Q ss_pred CHHHHHHHHhCCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEehh-----------------hhhhcccCceeeEEEEEe
Q 039819 193 TFRELQQATENFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLKD-----------------MISLAVHRNLLRLIGYCA 254 (534)
Q Consensus 193 ~~~~l~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~-----------------~l~~~~h~niv~l~~~~~ 254 (534)
.+++.....++|...+.||+|+||.||+|+.. +++.||||++.+ ++..++||||+++++++.
T Consensus 52 ~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~ 131 (412)
T 2vd5_A 52 RLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQ 131 (412)
T ss_dssp HHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred hhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEe
Confidence 44555556789999999999999999999985 689999998852 466778999999999999
Q ss_pred CCCeeEEEeeccCCCChhhhcccC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEeccc
Q 039819 255 TPTERLLVYPYMSNGSVASRLREK-PALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGL 333 (534)
Q Consensus 255 ~~~~~~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGl 333 (534)
+....|+||||+++|+|.+++... ..+++..++.++.||+.||.|||+. +||||||||+|||++.++++||+|||+
T Consensus 132 ~~~~~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILld~~g~vkL~DFGl 208 (412)
T 2vd5_A 132 DENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRL---GYVHRDIKPDNILLDRCGHIRLADFGS 208 (412)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred eCCEEEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccCHHHeeecCCCCEEEeechh
Confidence 999999999999999999999764 4799999999999999999999998 999999999999999999999999999
Q ss_pred ceecCCCCCceeeccccccccccccccc-------cCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHH
Q 039819 334 AKLLDHSDSHVTTAVRGTVGHIAPEYLS-------TGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKK 406 (534)
Q Consensus 334 a~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~ 406 (534)
++.............+||+.|+|||++. ...++.++|||||||++|||+||+.||....... ....
T Consensus 209 a~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~-------~~~~ 281 (412)
T 2vd5_A 209 CLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAE-------TYGK 281 (412)
T ss_dssp CEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHH-------HHHH
T ss_pred heeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHH-------HHHH
Confidence 9987654433344568999999999986 3568999999999999999999999997543211 1111
Q ss_pred HhhhcccceecccccCCCCCHHHHHHHHHHHHHhcccCCCCC---CChHHHHH
Q 039819 407 IQQEKKVEVLVDRELGSNYDRIEVGEILQVALLCTQYLPVHR---PKMSEVVR 456 (534)
Q Consensus 407 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~R---Pt~~ev~~ 456 (534)
+...... ..-+.. ....+.++.+++.+|+. +|.+| |+++|+++
T Consensus 282 i~~~~~~--~~~p~~----~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~ 327 (412)
T 2vd5_A 282 IVHYKEH--LSLPLV----DEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRT 327 (412)
T ss_dssp HHTHHHH--CCCC--------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHT
T ss_pred HHhcccC--cCCCcc----ccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhc
Confidence 1110000 000111 11224578999999999 99998 58888864
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=349.85 Aligned_cols=251 Identities=22% Similarity=0.291 Sum_probs=192.8
Q ss_pred HhCCCcCCeeccCCcEEEEEEEECCCcEEEEEEeh----------------hhhhhcccCceeeEEEEEeCCCeeEEEee
Q 039819 201 TENFSSKNILGAGGFGNVYKGKLGDGTVLAVKRLK----------------DMISLAVHRNLLRLIGYCATPTERLLVYP 264 (534)
Q Consensus 201 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~----------------~~l~~~~h~niv~l~~~~~~~~~~~lv~e 264 (534)
.++|...+.||+|+||.||+|+..+++.||||++. +++..++||||+++++++.+....++|||
T Consensus 20 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 99 (311)
T 3niz_A 20 MEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFE 99 (311)
T ss_dssp SCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEE
T ss_pred HhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEc
Confidence 36788899999999999999999889999999875 26778899999999999999999999999
Q ss_pred ccCCCChhhhccc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCCc
Q 039819 265 YMSNGSVASRLRE-KPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSH 343 (534)
Q Consensus 265 ~~~~gsL~~~l~~-~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~ 343 (534)
|+++ +|.+.+.. ...+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 100 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~- 174 (311)
T 3niz_A 100 FMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVR- 174 (311)
T ss_dssp CCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEETTSCCC-
T ss_pred CCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCchHhEEECCCCCEEEccCcCceecCCCcc-
Confidence 9985 77777764 45699999999999999999999999 999999999999999999999999999997753322
Q ss_pred eeecccccccccccccccc-CCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcc-----cceec
Q 039819 344 VTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKK-----VEVLV 417 (534)
Q Consensus 344 ~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~ 417 (534)
......||+.|+|||++.+ ..++.++|||||||++|||+||+.||...........+............ .....
T Consensus 175 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 254 (311)
T 3niz_A 175 SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWK 254 (311)
T ss_dssp ---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHHHH
T ss_pred cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccchhh
Confidence 2334568999999999876 56899999999999999999999999754433222111111110000000 00000
Q ss_pred cccc--CCCCC-----HHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 418 DREL--GSNYD-----RIEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 418 d~~l--~~~~~-----~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
+... ..... .....++.+++.+|++.||++|||++|+++
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 300 (311)
T 3niz_A 255 QRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN 300 (311)
T ss_dssp SCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred hcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 0000 00000 112347889999999999999999999985
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=346.37 Aligned_cols=234 Identities=23% Similarity=0.285 Sum_probs=196.4
Q ss_pred hCCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEehh-----------------hhhhcccCceeeEEEEEeCCCeeEEEe
Q 039819 202 ENFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLKD-----------------MISLAVHRNLLRLIGYCATPTERLLVY 263 (534)
Q Consensus 202 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~-----------------~l~~~~h~niv~l~~~~~~~~~~~lv~ 263 (534)
++|...+.||+|+||.||+|+.. +++.||||++.+ ++..++||||+++++++.+.+..++||
T Consensus 5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~ 84 (337)
T 1o6l_A 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEE
Confidence 57888999999999999999985 689999998852 567788999999999999999999999
Q ss_pred eccCCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCCc
Q 039819 264 PYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSH 343 (534)
Q Consensus 264 e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~ 343 (534)
||+++|+|.+++.....+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++...... .
T Consensus 85 E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~-~ 160 (337)
T 1o6l_A 85 EYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG-A 160 (337)
T ss_dssp ECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT-C
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCCHHHEEECCCCCEEEeeccchhhcccCC-C
Confidence 9999999999998888899999999999999999999999 99999999999999999999999999998643222 2
Q ss_pred eeeccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceecccccCC
Q 039819 344 VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELGS 423 (534)
Q Consensus 344 ~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 423 (534)
.....+||+.|+|||++.+..++.++|||||||++|||++|+.||..... .+....+.... ..
T Consensus 161 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~-------~~~~~~i~~~~-------~~--- 223 (337)
T 1o6l_A 161 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-------ERLFELILMEE-------IR--- 223 (337)
T ss_dssp CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHHHHHCC-------CC---
T ss_pred cccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCH-------HHHHHHHHcCC-------CC---
Confidence 34456799999999999998999999999999999999999999974321 11112211111 01
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCC-----ChHHHHHH
Q 039819 424 NYDRIEVGEILQVALLCTQYLPVHRP-----KMSEVVRM 457 (534)
Q Consensus 424 ~~~~~~~~~l~~l~~~Cl~~~P~~RP-----t~~ev~~~ 457 (534)
++...+..+.+++.+|++.+|.+|| +++|+++.
T Consensus 224 -~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h 261 (337)
T 1o6l_A 224 -FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp -CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred -CCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence 1122345789999999999999999 88888763
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=343.33 Aligned_cols=254 Identities=17% Similarity=0.252 Sum_probs=201.3
Q ss_pred hCCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEehh---------------hhhhcccCceeeEEEEEeCCC--eeEEEe
Q 039819 202 ENFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLKD---------------MISLAVHRNLLRLIGYCATPT--ERLLVY 263 (534)
Q Consensus 202 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~---------------~l~~~~h~niv~l~~~~~~~~--~~~lv~ 263 (534)
++|...+.||+|+||.||+|+.. +++.||||++.. ++..++||||+++++++.... ..++||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 88 (319)
T 4euu_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM 88 (319)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred CCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEE
Confidence 56888899999999999999986 489999998752 677889999999999998765 679999
Q ss_pred eccCCCChhhhcccCC---CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEe----CCCCcEEEEeccccee
Q 039819 264 PYMSNGSVASRLREKP---ALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLL----DDFCEAIVGDFGLAKL 336 (534)
Q Consensus 264 e~~~~gsL~~~l~~~~---~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl----~~~~~~kl~DFGla~~ 336 (534)
||+++|+|.+++.... .+++..++.|+.|++.||.|||+. +|+||||||+|||+ +.++.+||+|||+++.
T Consensus 89 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~ 165 (319)
T 4euu_A 89 EFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE 165 (319)
T ss_dssp ECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEECTTSCEEEEECCCTTCEE
T ss_pred eCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEeccCCCCceEEEccCCCcee
Confidence 9999999999997543 399999999999999999999999 99999999999999 8888999999999998
Q ss_pred cCCCCCceeeccccccccccccccc--------cCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHH-HHHHHH
Q 039819 337 LDHSDSHVTTAVRGTVGHIAPEYLS--------TGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAML-EWVKKI 407 (534)
Q Consensus 337 ~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~-~~~~~~ 407 (534)
...... .....||..|+|||++. +..++.++|||||||++|||+||+.||...........+. ......
T Consensus 166 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 243 (319)
T 4euu_A 166 LEDDEQ--FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGK 243 (319)
T ss_dssp CCTTCC--BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHHC
T ss_pred cCCCCc--eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcCC
Confidence 754332 33456999999999985 5678999999999999999999999997433222222121 211111
Q ss_pred hhhccccee---------cccc--cCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhcC
Q 039819 408 QQEKKVEVL---------VDRE--LGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLEGD 461 (534)
Q Consensus 408 ~~~~~~~~~---------~d~~--l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~~ 461 (534)
.......+ .... ............+.+++.+|++.||++|||++|+++...+.
T Consensus 244 -p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~ 307 (319)
T 4euu_A 244 -PSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI 307 (319)
T ss_dssp -CTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred -CcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHH
Confidence 11111100 1111 12244567778899999999999999999999999987653
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-43 Score=343.98 Aligned_cols=239 Identities=26% Similarity=0.423 Sum_probs=198.9
Q ss_pred hCCCcCCeeccCCcEEEEEEEECCCcEEEEEEehh-------------hhhhcccCceeeEEEEEeCCCeeEEEeeccCC
Q 039819 202 ENFSSKNILGAGGFGNVYKGKLGDGTVLAVKRLKD-------------MISLAVHRNLLRLIGYCATPTERLLVYPYMSN 268 (534)
Q Consensus 202 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~-------------~l~~~~h~niv~l~~~~~~~~~~~lv~e~~~~ 268 (534)
++|...+.||+|+||.||+|+..++..||||++.. ++..++||||+++++++.+....++||||+++
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 89 (269)
T 4hcu_A 10 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEH 89 (269)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTT
T ss_pred hhceeeheecCCCccEEEEEEecCCCeEEEEEecccccCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCCC
Confidence 56788899999999999999998899999998752 67888999999999999999999999999999
Q ss_pred CChhhhccc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCCceeec
Q 039819 269 GSVASRLRE-KPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTA 347 (534)
Q Consensus 269 gsL~~~l~~-~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~ 347 (534)
|+|.+++.. ...+++..++.++.|++.||.|||+. +|+||||||+||+++.++.+||+|||+++............
T Consensus 90 ~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 166 (269)
T 4hcu_A 90 GCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTG 166 (269)
T ss_dssp CBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHHSTTS
T ss_pred CcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhC---CeecCCcchheEEEcCCCCEEeccccccccccccccccccC
Confidence 999999964 45699999999999999999999999 99999999999999999999999999998764432222334
Q ss_pred cccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCcCCCccccccchHHHHHHHHhhhcccceecccccCCCCC
Q 039819 348 VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELGSNYD 426 (534)
Q Consensus 348 ~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 426 (534)
..+|..|+|||++.+..++.++||||||+++|||+| |+.||..... .+.......... ...+
T Consensus 167 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~-------~~~~~~~~~~~~----------~~~~ 229 (269)
T 4hcu_A 167 TKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN-------SEVVEDISTGFR----------LYKP 229 (269)
T ss_dssp TTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH-------HHHHHHHHTTCC----------CCCC
T ss_pred cccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCH-------HHHHHHHhcCcc----------CCCC
Confidence 457788999999988899999999999999999999 9999974321 112222211110 1111
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhc
Q 039819 427 RIEVGEILQVALLCTQYLPVHRPKMSEVVRMLEG 460 (534)
Q Consensus 427 ~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~ 460 (534)
...+..+.+++.+|++.+|++||++.++++.|+.
T Consensus 230 ~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~ 263 (269)
T 4hcu_A 230 RLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAE 263 (269)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHH
Confidence 2224578999999999999999999999999875
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-43 Score=352.21 Aligned_cols=239 Identities=26% Similarity=0.404 Sum_probs=194.6
Q ss_pred hCCCcCCeeccCCcEEEEEEEEC----CCcEEEEEEehh---------------hhhhcccCceeeEEEEEeCCCeeEEE
Q 039819 202 ENFSSKNILGAGGFGNVYKGKLG----DGTVLAVKRLKD---------------MISLAVHRNLLRLIGYCATPTERLLV 262 (534)
Q Consensus 202 ~~~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~---------------~l~~~~h~niv~l~~~~~~~~~~~lv 262 (534)
++|...+.||+|+||.||+|++. .+..||||++.. ++..++||||+++++++.+....++|
T Consensus 49 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 128 (325)
T 3kul_A 49 SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIV 128 (325)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEEE
T ss_pred hHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEEE
Confidence 56778899999999999999984 455799998852 57788999999999999999999999
Q ss_pred eeccCCCChhhhcccC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCC
Q 039819 263 YPYMSNGSVASRLREK-PALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSD 341 (534)
Q Consensus 263 ~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~ 341 (534)
|||+++|+|.+++... ..+++..++.|+.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 129 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 205 (325)
T 3kul_A 129 TEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDL---GYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDP 205 (325)
T ss_dssp EECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCSSCEECC---
T ss_pred eeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEECCCCCEEECCCCcccccccCc
Confidence 9999999999999654 5799999999999999999999999 99999999999999999999999999999875432
Q ss_pred Cc--eeeccccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCcCCCccccccchHHHHHHHHhhhcccceecc
Q 039819 342 SH--VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVD 418 (534)
Q Consensus 342 ~~--~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 418 (534)
.. ......+|..|+|||++.+..++.++|||||||++|||++ |+.||..... .+..........
T Consensus 206 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~-------~~~~~~~~~~~~------ 272 (325)
T 3kul_A 206 DAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTN-------RDVISSVEEGYR------ 272 (325)
T ss_dssp -CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCH-------HHHHHHHHTTCC------
T ss_pred cceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCH-------HHHHHHHHcCCC------
Confidence 21 2223346778999999988899999999999999999999 9999964321 111121111111
Q ss_pred cccCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhc
Q 039819 419 RELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLEG 460 (534)
Q Consensus 419 ~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~ 460 (534)
...+...+..+.+++.+||+.+|.+||++.+|++.|+.
T Consensus 273 ----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~ 310 (325)
T 3kul_A 273 ----LPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDA 310 (325)
T ss_dssp ----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ----CCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 11122234588999999999999999999999999986
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-42 Score=350.43 Aligned_cols=237 Identities=23% Similarity=0.275 Sum_probs=196.4
Q ss_pred HhCCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEehh--------------------hhhhcccCceeeEEEEEeCCCee
Q 039819 201 TENFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLKD--------------------MISLAVHRNLLRLIGYCATPTER 259 (534)
Q Consensus 201 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~--------------------~l~~~~h~niv~l~~~~~~~~~~ 259 (534)
.+.|...+.||+|+||.||+|+.. +|..||||.+.. ++..+.||||+++++++.+....
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 90 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV 90 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence 467888999999999999999985 689999998742 56778899999999999999999
Q ss_pred EEEeeccCCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCC----cEEEEecccce
Q 039819 260 LLVYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFC----EAIVGDFGLAK 335 (534)
Q Consensus 260 ~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~----~~kl~DFGla~ 335 (534)
++||||+++|+|.+++.....+++..+..++.||+.||.|||+. +|+||||||+|||++.++ .+||+|||+++
T Consensus 91 ~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~ 167 (361)
T 2yab_A 91 VLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH 167 (361)
T ss_dssp EEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCCSSCE
T ss_pred EEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeCCCCCccCEEEEecCCce
Confidence 99999999999999998888899999999999999999999999 999999999999998877 79999999999
Q ss_pred ecCCCCCceeeccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccce
Q 039819 336 LLDHSDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEV 415 (534)
Q Consensus 336 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 415 (534)
...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||..... .+....+.....
T Consensus 168 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~-------~~~~~~i~~~~~--- 235 (361)
T 2yab_A 168 EIEDGV--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK-------QETLANITAVSY--- 235 (361)
T ss_dssp ECCTTC--CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH-------HHHHHHHHTTCC---
T ss_pred EcCCCC--ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH-------HHHHHHHHhcCC---
Confidence 775432 23456799999999999988999999999999999999999999974321 111222211100
Q ss_pred ecccccCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 416 LVDRELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 416 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
-+++..... .+..+.+++.+|++.||.+|||+.|+++
T Consensus 236 ~~~~~~~~~----~s~~~~~li~~~L~~dP~~R~t~~e~l~ 272 (361)
T 2yab_A 236 DFDEEFFSQ----TSELAKDFIRKLLVKETRKRLTIQEALR 272 (361)
T ss_dssp CCCHHHHTT----SCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CCCchhccC----CCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 001111111 2347889999999999999999999986
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-43 Score=361.41 Aligned_cols=241 Identities=27% Similarity=0.417 Sum_probs=196.7
Q ss_pred HhCCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEehh---------------hhhhcccCceeeEEEEEeCCCeeEEEee
Q 039819 201 TENFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLKD---------------MISLAVHRNLLRLIGYCATPTERLLVYP 264 (534)
Q Consensus 201 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~---------------~l~~~~h~niv~l~~~~~~~~~~~lv~e 264 (534)
.++|...+.||+|+||.||+|++. +++.||||.++. ++..++||||++++++|......++|||
T Consensus 113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 192 (377)
T 3cbl_A 113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVME 192 (377)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEE
Confidence 356778899999999999999986 789999998752 5778899999999999999999999999
Q ss_pred ccCCCChhhhcccC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCCc
Q 039819 265 YMSNGSVASRLREK-PALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSH 343 (534)
Q Consensus 265 ~~~~gsL~~~l~~~-~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~ 343 (534)
|+++|+|.++++.. ..+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++........
T Consensus 193 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~ 269 (377)
T 3cbl_A 193 LVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESK---CCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYA 269 (377)
T ss_dssp CCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEEE
T ss_pred cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcCCcccCHHHEEEcCCCcEEECcCCCceecCCCcee
Confidence 99999999999754 4699999999999999999999999 9999999999999999999999999999865432111
Q ss_pred ee-eccccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCcCCCccccccchHHHHHHHHhhhcccceeccccc
Q 039819 344 VT-TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDREL 421 (534)
Q Consensus 344 ~~-~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 421 (534)
.. ....++..|+|||.+..+.++.++|||||||++|||+| |+.||...... +..........
T Consensus 270 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~-------~~~~~~~~~~~--------- 333 (377)
T 3cbl_A 270 ASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQ-------QTREFVEKGGR--------- 333 (377)
T ss_dssp CCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHH-------HHHHHHHTTCC---------
T ss_pred ecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH-------HHHHHHHcCCC---------
Confidence 11 11235778999999988899999999999999999999 99999743211 11111111111
Q ss_pred CCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhcC
Q 039819 422 GSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLEGD 461 (534)
Q Consensus 422 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~~ 461 (534)
...+...+..+.+++.+||+.+|++|||+.++++.|+..
T Consensus 334 -~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 372 (377)
T 3cbl_A 334 -LPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSI 372 (377)
T ss_dssp -CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHH
Confidence 111222345889999999999999999999999998753
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-42 Score=352.41 Aligned_cols=234 Identities=27% Similarity=0.379 Sum_probs=190.3
Q ss_pred HhCCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEehh-----------------hhhhc-ccCceeeEEEEEeCCCeeEE
Q 039819 201 TENFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLKD-----------------MISLA-VHRNLLRLIGYCATPTERLL 261 (534)
Q Consensus 201 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~-----------------~l~~~-~h~niv~l~~~~~~~~~~~l 261 (534)
.++|...+.||+|+||.||+|+.. +++.||||++.+ ++..+ .||||+++++++.+....|+
T Consensus 22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 101 (353)
T 3txo_A 22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFF 101 (353)
T ss_dssp -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEE
Confidence 468889999999999999999975 589999998852 34444 69999999999999999999
Q ss_pred EeeccCCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCC
Q 039819 262 VYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSD 341 (534)
Q Consensus 262 v~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~ 341 (534)
||||+++|+|.+++.....+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 102 v~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~- 177 (353)
T 3txo_A 102 VMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICN- 177 (353)
T ss_dssp EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC--
T ss_pred EEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCCHHHEEECCCCCEEEccccceeecccC-
Confidence 999999999999998888899999999999999999999999 9999999999999999999999999999864322
Q ss_pred CceeeccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceeccccc
Q 039819 342 SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDREL 421 (534)
Q Consensus 342 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 421 (534)
.......+||+.|+|||++.+..++.++|||||||++|||+||+.||...... +....+.... .
T Consensus 178 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~-------~~~~~i~~~~-------~-- 241 (353)
T 3txo_A 178 GVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENED-------DLFEAILNDE-------V-- 241 (353)
T ss_dssp --------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHHHHHHCC-------C--
T ss_pred CccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHH-------HHHHHHHcCC-------C--
Confidence 22344567999999999998888999999999999999999999999754321 1122221111 0
Q ss_pred CCCCCHHHHHHHHHHHHHhcccCCCCCCCh------HHHHH
Q 039819 422 GSNYDRIEVGEILQVALLCTQYLPVHRPKM------SEVVR 456 (534)
Q Consensus 422 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~------~ev~~ 456 (534)
.++......+.+++.+|++.+|.+||++ +|+++
T Consensus 242 --~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~ 280 (353)
T 3txo_A 242 --VYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR 280 (353)
T ss_dssp --CCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred --CCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence 1112234578899999999999999998 66654
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=350.09 Aligned_cols=239 Identities=22% Similarity=0.276 Sum_probs=172.9
Q ss_pred CCeeccCCcEEEEEEEEC-CCcEEEEEEehh-----------hhhhcc-cCceeeEEEEEeCCCeeEEEeeccCCCChhh
Q 039819 207 KNILGAGGFGNVYKGKLG-DGTVLAVKRLKD-----------MISLAV-HRNLLRLIGYCATPTERLLVYPYMSNGSVAS 273 (534)
Q Consensus 207 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~-----------~l~~~~-h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~ 273 (534)
.+.||+|+||.||+|+.. +++.||||++.. .+..+. ||||+++++++.+....++||||+++|+|.+
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~ 95 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFE 95 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEGGGHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBHHH
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEEChhhhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCcHHH
Confidence 378999999999999985 689999999863 455565 9999999999999999999999999999999
Q ss_pred hcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCC---cEEEEecccceecCCCCCceeecccc
Q 039819 274 RLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFC---EAIVGDFGLAKLLDHSDSHVTTAVRG 350 (534)
Q Consensus 274 ~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~---~~kl~DFGla~~~~~~~~~~~~~~~g 350 (534)
++.....+++..+..|+.|++.||.|||++ +|+||||||+|||++.++ .+||+|||+++...... .......|
T Consensus 96 ~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~~~ 171 (325)
T 3kn6_A 96 RIKKKKHFSETEASYIMRKLVSAVSHMHDV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDN-QPLKTPCF 171 (325)
T ss_dssp HHHHCSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEC----CEEEECCCTTCEECCC-----------
T ss_pred HHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CCeecCCCHHHEEEecCCCcccEEEeccccceecCCCC-CcccccCC
Confidence 999888899999999999999999999999 999999999999997665 89999999998765432 22344568
Q ss_pred ccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceecccccCCCCCHHHH
Q 039819 351 TVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELGSNYDRIEV 430 (534)
Q Consensus 351 t~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 430 (534)
|+.|+|||++.+..++.++|||||||++|||++|+.||.............+....+..... ..........+
T Consensus 172 t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~-------~~~~~~~~~~s 244 (325)
T 3kn6_A 172 TLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDF-------SFEGEAWKNVS 244 (325)
T ss_dssp ------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCC-------CCCSHHHHTSC
T ss_pred CcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCC-------CCCcccccCCC
Confidence 99999999999889999999999999999999999999754332211222233332222110 00000001124
Q ss_pred HHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 431 GEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 431 ~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
..+.+++.+|++.||.+|||+.|+++
T Consensus 245 ~~~~~li~~~L~~dP~~Rpt~~ell~ 270 (325)
T 3kn6_A 245 QEAKDLIQGLLTVDPNKRLKMSGLRY 270 (325)
T ss_dssp HHHHHHHHHHHCCCTTTCCCTTTSTT
T ss_pred HHHHHHHHHHCCCChhHCCCHHHHhc
Confidence 57899999999999999999998863
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-43 Score=344.57 Aligned_cols=240 Identities=23% Similarity=0.373 Sum_probs=196.5
Q ss_pred HhCCCcCCeeccCCcEEEEEEEECCCcEEEEEEehh-------------hhhhcccCceeeEEEEEeCCCeeEEEeeccC
Q 039819 201 TENFSSKNILGAGGFGNVYKGKLGDGTVLAVKRLKD-------------MISLAVHRNLLRLIGYCATPTERLLVYPYMS 267 (534)
Q Consensus 201 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~-------------~l~~~~h~niv~l~~~~~~~~~~~lv~e~~~ 267 (534)
.++|...+.||+|+||.||+|+..++..||||++.. ++..+.||||+++++++.+....++||||++
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 102 (283)
T 3gen_A 23 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA 102 (283)
T ss_dssp GGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCCT
T ss_pred HHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCCCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEeccC
Confidence 357888899999999999999999888999998862 6778889999999999999999999999999
Q ss_pred CCChhhhccc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCCceee
Q 039819 268 NGSVASRLRE-KPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTT 346 (534)
Q Consensus 268 ~gsL~~~l~~-~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~ 346 (534)
+|+|.+++.. ...+++..++.++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++...........
T Consensus 103 ~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~ 179 (283)
T 3gen_A 103 NGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSV 179 (283)
T ss_dssp TCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHHHSTT
T ss_pred CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCccceEEEcCCCCEEEcccccccccccccccccc
Confidence 9999999976 56799999999999999999999999 9999999999999999999999999999876443222223
Q ss_pred ccccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCcCCCccccccchHHHHHHHHhhhcccceecccccCCCC
Q 039819 347 AVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELGSNY 425 (534)
Q Consensus 347 ~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 425 (534)
...+|..|+|||++.+..++.++||||||+++|||+| |+.||...... +......... ....
T Consensus 180 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~-------~~~~~~~~~~----------~~~~ 242 (283)
T 3gen_A 180 GSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS-------ETAEHIAQGL----------RLYR 242 (283)
T ss_dssp STTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHH-------HHHHHHHTTC----------CCCC
T ss_pred CCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChh-------HHHHHHhccc----------CCCC
Confidence 3456788999999998899999999999999999999 99999743221 1111111111 0111
Q ss_pred CHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhc
Q 039819 426 DRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLEG 460 (534)
Q Consensus 426 ~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~ 460 (534)
+...+..+.+++.+|++.+|.+|||+.++++.|+.
T Consensus 243 ~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~ 277 (283)
T 3gen_A 243 PHLASEKVYTIMYSCWHEKADERPTFKILLSNILD 277 (283)
T ss_dssp CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred CCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHH
Confidence 11223578999999999999999999999999875
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-41 Score=340.27 Aligned_cols=230 Identities=27% Similarity=0.386 Sum_probs=195.1
Q ss_pred hCCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEehh-----------------hhhhcccCceeeEEEEEeCCCeeEEEe
Q 039819 202 ENFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLKD-----------------MISLAVHRNLLRLIGYCATPTERLLVY 263 (534)
Q Consensus 202 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~-----------------~l~~~~h~niv~l~~~~~~~~~~~lv~ 263 (534)
++|...+.||+|+||.||+|+.. +++.||+|++.+ ++..+.||||+++++++.+....++||
T Consensus 6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~ 85 (318)
T 1fot_A 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 85 (318)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEE
Confidence 57888999999999999999985 689999998752 566788999999999999999999999
Q ss_pred eccCCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCCc
Q 039819 264 PYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSH 343 (534)
Q Consensus 264 e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~ 343 (534)
||+++|+|.+++.....+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 86 e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~--- 159 (318)
T 1fot_A 86 DYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV--- 159 (318)
T ss_dssp CCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSSC---
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChheEEEcCCCCEEEeecCcceecCCc---
Confidence 9999999999999888899999999999999999999998 9999999999999999999999999999876432
Q ss_pred eeeccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceecccccCC
Q 039819 344 VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELGS 423 (534)
Q Consensus 344 ~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 423 (534)
....+||+.|+|||++.+..++.++|||||||++|||++|+.||..... .+....+.... ..
T Consensus 160 -~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-------~~~~~~i~~~~-------~~--- 221 (318)
T 1fot_A 160 -TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT-------MKTYEKILNAE-------LR--- 221 (318)
T ss_dssp -BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH-------HHHHHHHHHCC-------CC---
T ss_pred -cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH-------HHHHHHHHhCC-------CC---
Confidence 3346799999999999998999999999999999999999999974321 11112211111 01
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCC-----ChHHHHH
Q 039819 424 NYDRIEVGEILQVALLCTQYLPVHRP-----KMSEVVR 456 (534)
Q Consensus 424 ~~~~~~~~~l~~l~~~Cl~~~P~~RP-----t~~ev~~ 456 (534)
++......+.+++.+|++.+|++|| +++|+++
T Consensus 222 -~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~ 258 (318)
T 1fot_A 222 -FPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 258 (318)
T ss_dssp -CCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred -CCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence 1112235789999999999999999 7888875
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-42 Score=347.18 Aligned_cols=251 Identities=24% Similarity=0.334 Sum_probs=178.9
Q ss_pred HhCCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEeh---------------hhhhhcccCceeeEEEEEeCCCeeEEEee
Q 039819 201 TENFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLK---------------DMISLAVHRNLLRLIGYCATPTERLLVYP 264 (534)
Q Consensus 201 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~---------------~~l~~~~h~niv~l~~~~~~~~~~~lv~e 264 (534)
.++|...+.||+|+||.||+|... +++.||||++. +++..++||||+++++++...+..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 467889999999999999999875 68999999874 26778899999999999999999999999
Q ss_pred ccCCCChhhhcccC------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecC
Q 039819 265 YMSNGSVASRLREK------PALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLD 338 (534)
Q Consensus 265 ~~~~gsL~~~l~~~------~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~ 338 (534)
|++ |+|.+++... ..+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 159 (317)
T 2pmi_A 84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFG 159 (317)
T ss_dssp CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence 998 5999888632 4589999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCceeecccccccccccccccc-CCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcc--cce
Q 039819 339 HSDSHVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKK--VEV 415 (534)
Q Consensus 339 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~--~~~ 415 (534)
.... ......||+.|+|||++.+ ..++.++|||||||++|||+||+.||...........+............ ...
T Consensus 160 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 238 (317)
T 2pmi_A 160 IPVN-TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTK 238 (317)
T ss_dssp SCCC-CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGG
T ss_pred CCcc-cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhh
Confidence 3322 2234568999999999876 46899999999999999999999999754432211111111100000000 000
Q ss_pred --ecccccCC------------CCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 416 --LVDRELGS------------NYDRIEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 416 --~~d~~l~~------------~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
...+.+.. .........+.+++.+|++.||++|||+.|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~ 293 (317)
T 2pmi_A 239 LPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH 293 (317)
T ss_dssp CTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence 00000000 000112347899999999999999999999874
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-43 Score=368.42 Aligned_cols=240 Identities=24% Similarity=0.407 Sum_probs=197.8
Q ss_pred HhCCCcCCeeccCCcEEEEEEEECCCcEEEEEEehh-------------hhhhcccCceeeEEEEEeCCCeeEEEeeccC
Q 039819 201 TENFSSKNILGAGGFGNVYKGKLGDGTVLAVKRLKD-------------MISLAVHRNLLRLIGYCATPTERLLVYPYMS 267 (534)
Q Consensus 201 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~-------------~l~~~~h~niv~l~~~~~~~~~~~lv~e~~~ 267 (534)
.++|...+.||+|+||.||+|.+.++..||||+++. +++.++|||||++++++. .+..++|||||+
T Consensus 187 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~~~ 265 (454)
T 1qcf_A 187 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEFMA 265 (454)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECCCT
T ss_pred hHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCCccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEeecC
Confidence 467788899999999999999998899999998862 678889999999999986 567899999999
Q ss_pred CCChhhhcccC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCCcee
Q 039819 268 NGSVASRLREK--PALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVT 345 (534)
Q Consensus 268 ~gsL~~~l~~~--~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~ 345 (534)
+|+|.++++.. ..+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++..........
T Consensus 266 ~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~ 342 (454)
T 1qcf_A 266 KGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAR 342 (454)
T ss_dssp TCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHHHTT
T ss_pred CCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCceecc
Confidence 99999999753 3689999999999999999999999 999999999999999999999999999987643221122
Q ss_pred eccccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCcCCCccccccchHHHHHHHHhhhcccceecccccCCC
Q 039819 346 TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELGSN 424 (534)
Q Consensus 346 ~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 424 (534)
....+|..|+|||++....++.++|||||||++|||+| |+.||..... .+....+..... ..
T Consensus 343 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~-------~~~~~~i~~~~~----------~~ 405 (454)
T 1qcf_A 343 EGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN-------PEVIRALERGYR----------MP 405 (454)
T ss_dssp CSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH-------HHHHHHHHHTCC----------CC
T ss_pred CCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCH-------HHHHHHHHcCCC----------CC
Confidence 23446789999999998899999999999999999999 9999974321 111222211111 01
Q ss_pred CCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhcC
Q 039819 425 YDRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLEGD 461 (534)
Q Consensus 425 ~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~~ 461 (534)
.+...+..+.+++.+||+.+|++|||+.+|++.|+..
T Consensus 406 ~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~ 442 (454)
T 1qcf_A 406 RPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDF 442 (454)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred CCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence 1222345889999999999999999999999999864
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=357.91 Aligned_cols=240 Identities=28% Similarity=0.428 Sum_probs=185.7
Q ss_pred hCCCcCCeeccCCcEEEEEEEEC----CCcEEEEEEeh---------------hhhhhcccCceeeEEEEEeCCCeeEEE
Q 039819 202 ENFSSKNILGAGGFGNVYKGKLG----DGTVLAVKRLK---------------DMISLAVHRNLLRLIGYCATPTERLLV 262 (534)
Q Consensus 202 ~~~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~---------------~~l~~~~h~niv~l~~~~~~~~~~~lv 262 (534)
++|...+.||+|+||.||+|+.. ++..||||+++ .++..++||||+++++++.+....++|
T Consensus 45 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 124 (373)
T 2qol_A 45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIV 124 (373)
T ss_dssp GGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEE
Confidence 57888999999999999999874 57789999875 257788999999999999999999999
Q ss_pred eeccCCCChhhhcccC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCC
Q 039819 263 YPYMSNGSVASRLREK-PALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSD 341 (534)
Q Consensus 263 ~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~ 341 (534)
|||+++|+|.+++... ..+++..++.|+.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 125 ~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 201 (373)
T 2qol_A 125 TEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDP 201 (373)
T ss_dssp EECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred EeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEEcCCCCEEECcCccccccccCC
Confidence 9999999999999764 4699999999999999999999999 99999999999999999999999999998765432
Q ss_pred Cce--eeccccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCcCCCccccccchHHHHHHHHhhhcccceecc
Q 039819 342 SHV--TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVD 418 (534)
Q Consensus 342 ~~~--~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 418 (534)
... .....+|..|+|||++.+..++.++|||||||++|||++ |+.||..... .+..........
T Consensus 202 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~-------~~~~~~i~~~~~------ 268 (373)
T 2qol_A 202 EAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN-------QDVIKAVDEGYR------ 268 (373)
T ss_dssp ------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCH-------HHHHHHHHTTEE------
T ss_pred ccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCH-------HHHHHHHHcCCC------
Confidence 211 122235778999999998999999999999999999998 9999964321 111222111110
Q ss_pred cccCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhcC
Q 039819 419 RELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLEGD 461 (534)
Q Consensus 419 ~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~~ 461 (534)
...+...+..+.+++.+|++.+|.+||++.+|+++|+..
T Consensus 269 ----~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~ 307 (373)
T 2qol_A 269 ----LPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL 307 (373)
T ss_dssp ----CCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ----CCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHH
Confidence 111222345889999999999999999999999998764
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-43 Score=358.18 Aligned_cols=249 Identities=25% Similarity=0.393 Sum_probs=198.4
Q ss_pred CHHHHHHHHhCCCcCCeeccCCcEEEEEEEE------CCCcEEEEEEehh---------------hhhhc-ccCceeeEE
Q 039819 193 TFRELQQATENFSSKNILGAGGFGNVYKGKL------GDGTVLAVKRLKD---------------MISLA-VHRNLLRLI 250 (534)
Q Consensus 193 ~~~~l~~~~~~~~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~---------------~l~~~-~h~niv~l~ 250 (534)
...+.....++|...+.||+|+||.||+|++ .+++.||||++.. ++..+ .|||||+++
T Consensus 13 ~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~ 92 (359)
T 3vhe_A 13 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL 92 (359)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred CcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeee
Confidence 3344445568899999999999999999974 3468899999852 45555 799999999
Q ss_pred EEEeCCCe-eEEEeeccCCCChhhhcccCCC-------------------------------------------------
Q 039819 251 GYCATPTE-RLLVYPYMSNGSVASRLREKPA------------------------------------------------- 280 (534)
Q Consensus 251 ~~~~~~~~-~~lv~e~~~~gsL~~~l~~~~~------------------------------------------------- 280 (534)
++|.+.+. .++||||+++|+|.+++.....
T Consensus 93 ~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (359)
T 3vhe_A 93 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKS 172 (359)
T ss_dssp EEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-------------------------------------------
T ss_pred eeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccc
Confidence 99988655 8999999999999999975432
Q ss_pred -----------------CCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCC-C
Q 039819 281 -----------------LDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSD-S 342 (534)
Q Consensus 281 -----------------l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~-~ 342 (534)
+++..++.|+.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++...... .
T Consensus 173 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 249 (359)
T 3vhe_A 173 LSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY 249 (359)
T ss_dssp -----------CTTTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTC
T ss_pred cchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCcEEEEeccceeeecccccc
Confidence 89999999999999999999999 99999999999999999999999999998764332 2
Q ss_pred ceeeccccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCcCCCccccccchHHHHHHHHhhhcccceeccccc
Q 039819 343 HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDREL 421 (534)
Q Consensus 343 ~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 421 (534)
.......||..|+|||++.+..++.++|||||||++|||+| |+.||....... .+ ......... .
T Consensus 250 ~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~---~~---~~~~~~~~~------~-- 315 (359)
T 3vhe_A 250 VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE---EF---CRRLKEGTR------M-- 315 (359)
T ss_dssp EEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH---HH---HHHHHHTCC------C--
T ss_pred hhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhH---HH---HHHHHcCCC------C--
Confidence 23345568999999999999999999999999999999999 999997533211 11 111111110 0
Q ss_pred CCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhc
Q 039819 422 GSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLEG 460 (534)
Q Consensus 422 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~ 460 (534)
..+......+.+++.+|++.+|.+|||+.||++.|+.
T Consensus 316 --~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~ 352 (359)
T 3vhe_A 316 --RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGN 352 (359)
T ss_dssp --CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred --CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHH
Confidence 1111234578999999999999999999999999975
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=351.71 Aligned_cols=235 Identities=24% Similarity=0.331 Sum_probs=194.7
Q ss_pred hCCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEehh-----------------hhhhcccCceeeEEEEEeCCCeeEEEe
Q 039819 202 ENFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLKD-----------------MISLAVHRNLLRLIGYCATPTERLLVY 263 (534)
Q Consensus 202 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~-----------------~l~~~~h~niv~l~~~~~~~~~~~lv~ 263 (534)
++|...+.||+|+||.||+|+.. +++.||||.+.. ++..++|||||+++++|.+....++||
T Consensus 15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~ 94 (384)
T 4fr4_A 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVV 94 (384)
T ss_dssp GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence 57888999999999999999975 588999998742 577889999999999999999999999
Q ss_pred eccCCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCCc
Q 039819 264 PYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSH 343 (534)
Q Consensus 264 e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~ 343 (534)
||+++|+|.+++.....+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 95 e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~-- 169 (384)
T 4fr4_A 95 DLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRET-- 169 (384)
T ss_dssp CCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCTTC--
T ss_pred ecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEECCCCCEEEeccceeeeccCCC--
Confidence 9999999999999888899999999999999999999999 99999999999999999999999999999775432
Q ss_pred eeecccccccccccccccc---CCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceecccc
Q 039819 344 VTTAVRGTVGHIAPEYLST---GQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRE 420 (534)
Q Consensus 344 ~~~~~~gt~~y~aPE~~~~---~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 420 (534)
.....+||+.|+|||++.. ..++.++|||||||++|||+||+.||....... ..+.........
T Consensus 170 ~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~----~~~~~~~~~~~~--------- 236 (384)
T 4fr4_A 170 QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTS----SKEIVHTFETTV--------- 236 (384)
T ss_dssp CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSC----HHHHHHHHHHCC---------
T ss_pred ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCcc----HHHHHHHHhhcc---------
Confidence 3445679999999999864 458999999999999999999999997433221 111111111110
Q ss_pred cCCCCCHHHHHHHHHHHHHhcccCCCCCCC-hHHHHH
Q 039819 421 LGSNYDRIEVGEILQVALLCTQYLPVHRPK-MSEVVR 456 (534)
Q Consensus 421 l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt-~~ev~~ 456 (534)
..++...+..+.+++.+|++.+|.+||+ ++++.+
T Consensus 237 --~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 237 --VTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp --CCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred --cCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 0112223458899999999999999999 666654
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=342.20 Aligned_cols=237 Identities=22% Similarity=0.282 Sum_probs=195.8
Q ss_pred HhCCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEeh--------------------hhhhhcccCceeeEEEEEeCCCee
Q 039819 201 TENFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLK--------------------DMISLAVHRNLLRLIGYCATPTER 259 (534)
Q Consensus 201 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~--------------------~~l~~~~h~niv~l~~~~~~~~~~ 259 (534)
.++|...+.||+|+||.||+|+.. ++..||||.+. .++..++||||+++++++.+....
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 89 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 89 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 456888999999999999999985 68999999874 156788899999999999999999
Q ss_pred EEEeeccCCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCC----cEEEEecccce
Q 039819 260 LLVYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFC----EAIVGDFGLAK 335 (534)
Q Consensus 260 ~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~----~~kl~DFGla~ 335 (534)
++||||+++|+|.+++.....+++..+..++.|++.||.|||+. +|+||||||+|||++.++ .+||+|||+++
T Consensus 90 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~ 166 (326)
T 2y0a_A 90 ILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 166 (326)
T ss_dssp EEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred EEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHC---CeEcCCCCHHHEEEecCCCCCCCEEEEECCCCe
Confidence 99999999999999998888899999999999999999999999 999999999999999887 89999999998
Q ss_pred ecCCCCCceeeccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccce
Q 039819 336 LLDHSDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEV 415 (534)
Q Consensus 336 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 415 (534)
...... ......||+.|+|||++.+..++.++|||||||++|||+||+.||...... +.......... .
T Consensus 167 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-------~~~~~~~~~~~--~ 235 (326)
T 2y0a_A 167 KIDFGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ-------ETLANVSAVNY--E 235 (326)
T ss_dssp ECCTTS--CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH-------HHHHHHHHTCC--C
T ss_pred ECCCCC--ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHH-------HHHHHHHhcCC--C
Confidence 775432 233456999999999998889999999999999999999999999743211 11111111100 0
Q ss_pred ecccccCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 416 LVDRELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 416 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
....... ..+..+.+++.+|++.+|.+|||+.|+++
T Consensus 236 -~~~~~~~----~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 271 (326)
T 2y0a_A 236 -FEDEYFS----NTSALAKDFIRRLLVKDPKKRMTIQDSLQ 271 (326)
T ss_dssp -CCHHHHT----TSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred -cCccccc----cCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 0000001 12347889999999999999999999987
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-42 Score=340.78 Aligned_cols=249 Identities=21% Similarity=0.269 Sum_probs=190.2
Q ss_pred hCCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEeh----------------hhhhhcccCceeeEEEEEeCCCeeEEEee
Q 039819 202 ENFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLK----------------DMISLAVHRNLLRLIGYCATPTERLLVYP 264 (534)
Q Consensus 202 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~----------------~~l~~~~h~niv~l~~~~~~~~~~~lv~e 264 (534)
++|+..+.||+|+||.||+|+.. +++.||||++. .++..++||||+++++++.+....++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 46888899999999999999985 68999999885 25778899999999999999999999999
Q ss_pred ccCCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCCce
Q 039819 265 YMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHV 344 (534)
Q Consensus 265 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~ 344 (534)
|++++.+..+......+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++....... .
T Consensus 82 ~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~---~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~ 157 (292)
T 3o0g_A 82 FCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR-C 157 (292)
T ss_dssp CCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCS-C
T ss_pred cCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceecCCccc-c
Confidence 998644444444567899999999999999999999999 999999999999999999999999999987653322 2
Q ss_pred eeccccccccccccccccCC-CCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhh---hcc--cceecc
Q 039819 345 TTAVRGTVGHIAPEYLSTGQ-SSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQ---EKK--VEVLVD 418 (534)
Q Consensus 345 ~~~~~gt~~y~aPE~~~~~~-~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~---~~~--~~~~~d 418 (534)
.....||..|+|||++.+.. ++.++|||||||++|||+||+.||....... ..+......... ... .....+
T Consensus 158 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~--~~~~~i~~~~~~~~~~~~~~~~~~~~ 235 (292)
T 3o0g_A 158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD--DQLKRIFRLLGTPTEEQWPSMTKLPD 235 (292)
T ss_dssp CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHH--HHHHHHHHHHCCCCTTTCTTGGGSTT
T ss_pred ccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHH--HHHHHHHHHhCCCChhhhhhhccccc
Confidence 34456899999999987765 7999999999999999999988864332211 111111111110 000 000000
Q ss_pred ---------cccCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 419 ---------RELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 419 ---------~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
..............+.+++.+|++.||++|||++|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 282 (292)
T 3o0g_A 236 YKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp CCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence 00000111123457889999999999999999999985
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-42 Score=358.06 Aligned_cols=263 Identities=24% Similarity=0.372 Sum_probs=189.2
Q ss_pred HHHhCCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEehh----------------hhhhcc-cCceeeEEEEEeCCC--e
Q 039819 199 QATENFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLKD----------------MISLAV-HRNLLRLIGYCATPT--E 258 (534)
Q Consensus 199 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~----------------~l~~~~-h~niv~l~~~~~~~~--~ 258 (534)
...++|...+.||+|+||.||+|... +++.||||++.. ++..+. ||||+++++++...+ .
T Consensus 6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 85 (388)
T 3oz6_A 6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRD 85 (388)
T ss_dssp HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSC
T ss_pred cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCE
Confidence 34678999999999999999999874 689999998741 455665 999999999997654 6
Q ss_pred eEEEeeccCCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecC
Q 039819 259 RLLVYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLD 338 (534)
Q Consensus 259 ~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~ 338 (534)
.|+|||||+ |+|.+++.. ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 86 ~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 160 (388)
T 3oz6_A 86 VYLVFDYME-TDLHAVIRA-NILEPVHKQYVVYQLIKVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLSRSFV 160 (388)
T ss_dssp EEEEEECCS-EEHHHHHHH-TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEESS
T ss_pred EEEEecccC-cCHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHeEEcCCCCEEecCCccccccc
Confidence 799999998 589888876 4699999999999999999999999 99999999999999999999999999998753
Q ss_pred CC--------------------CCceeecccccccccccccccc-CCCCcchhHHHHHHHHHHHHhCCCCcCCCcccccc
Q 039819 339 HS--------------------DSHVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELITGMRALEFGKSINQK 397 (534)
Q Consensus 339 ~~--------------------~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~ 397 (534)
.. ........+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.........
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~ 240 (388)
T 3oz6_A 161 NIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQL 240 (388)
T ss_dssp SCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred ccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 21 1112344679999999999876 67899999999999999999999999865433322
Q ss_pred chHHHHHHHHhhhcccce------------------ecccccCCCCC------------HHHHHHHHHHHHHhcccCCCC
Q 039819 398 GAMLEWVKKIQQEKKVEV------------------LVDRELGSNYD------------RIEVGEILQVALLCTQYLPVH 447 (534)
Q Consensus 398 ~~~~~~~~~~~~~~~~~~------------------~~d~~l~~~~~------------~~~~~~l~~l~~~Cl~~~P~~ 447 (534)
..+.......... .+.. .........++ ......+.+++.+|++.||.+
T Consensus 241 ~~i~~~~~~p~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~ 319 (388)
T 3oz6_A 241 ERIIGVIDFPSNE-DVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNK 319 (388)
T ss_dssp HHHHHHHCCCCHH-HHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGG
T ss_pred HHHHHhcCCCCHH-HHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCccc
Confidence 2221111000000 0000 00000000000 012347889999999999999
Q ss_pred CCChHHHHHHhhcCCchhhHHhhccCCCCCCCCcccCC
Q 039819 448 RPKMSEVVRMLEGDGLAEKWAAAHNHTNPTMNNFHTNT 485 (534)
Q Consensus 448 RPt~~ev~~~L~~~~~~~~~~~~~~~~~p~~~~~~~~~ 485 (534)
|||++|+++ |||+..++...
T Consensus 320 R~t~~e~l~------------------Hp~~~~~~~~~ 339 (388)
T 3oz6_A 320 RISANDALK------------------HPFVSIFHNPN 339 (388)
T ss_dssp SCCHHHHTT------------------STTTTTTCCGG
T ss_pred CCCHHHHhC------------------CHHHHHhcCCc
Confidence 999999874 78877766443
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-42 Score=353.96 Aligned_cols=237 Identities=23% Similarity=0.290 Sum_probs=196.2
Q ss_pred hCCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEehh------------------hhhhcccCceeeEEEEEeCCCeeEEE
Q 039819 202 ENFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLKD------------------MISLAVHRNLLRLIGYCATPTERLLV 262 (534)
Q Consensus 202 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~------------------~l~~~~h~niv~l~~~~~~~~~~~lv 262 (534)
++|...+.||+|+||.||+|+.. +++.||||++.+ +++.++||||+++++++.+.+..|+|
T Consensus 38 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv 117 (373)
T 2r5t_A 38 SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFV 117 (373)
T ss_dssp GGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEE
Confidence 57888999999999999999986 578999998752 24667899999999999999999999
Q ss_pred eeccCCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCC
Q 039819 263 YPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDS 342 (534)
Q Consensus 263 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~ 342 (534)
|||+++|+|.+++.....+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++......
T Consensus 118 ~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~~- 193 (373)
T 2r5t_A 118 LDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN- 193 (373)
T ss_dssp EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCCC-
T ss_pred EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEeeCccccccccCC-
Confidence 99999999999998878899999999999999999999999 99999999999999999999999999998643222
Q ss_pred ceeeccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceecccccC
Q 039819 343 HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELG 422 (534)
Q Consensus 343 ~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 422 (534)
......+||+.|+|||++.+..++.++|||||||++|||++|+.||..... .+....+.... ..+.
T Consensus 194 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~-------~~~~~~i~~~~-------~~~~ 259 (373)
T 2r5t_A 194 STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT-------AEMYDNILNKP-------LQLK 259 (373)
T ss_dssp CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBH-------HHHHHHHHHSC-------CCCC
T ss_pred CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH-------HHHHHHHHhcc-------cCCC
Confidence 234456799999999999998999999999999999999999999974322 11112221110 0111
Q ss_pred CCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhc
Q 039819 423 SNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLEG 460 (534)
Q Consensus 423 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~ 460 (534)
.. ....+.+++.+|++.+|.+||++.+.++.+..
T Consensus 260 ~~----~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~ 293 (373)
T 2r5t_A 260 PN----ITNSARHLLEGLLQKDRTKRLGAKDDFMEIKS 293 (373)
T ss_dssp SS----SCHHHHHHHHHHTCSSGGGSTTTTTTHHHHHT
T ss_pred CC----CCHHHHHHHHHHcccCHHhCCCCCCCHHHHhC
Confidence 11 23478899999999999999999765555544
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-41 Score=343.40 Aligned_cols=230 Identities=23% Similarity=0.301 Sum_probs=195.3
Q ss_pred hCCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEehh-----------------hhhhcccCceeeEEEEEeCCCeeEEEe
Q 039819 202 ENFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLKD-----------------MISLAVHRNLLRLIGYCATPTERLLVY 263 (534)
Q Consensus 202 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~-----------------~l~~~~h~niv~l~~~~~~~~~~~lv~ 263 (534)
++|...+.||+|+||.||+|+.. +++.||||++.. ++..+.||||+++++++.+....++||
T Consensus 41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 120 (350)
T 1rdq_E 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence 57888999999999999999985 689999998742 567789999999999999999999999
Q ss_pred eccCCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCCc
Q 039819 264 PYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSH 343 (534)
Q Consensus 264 e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~ 343 (534)
||+++|+|.+++.....+++..++.++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 121 e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~--- 194 (350)
T 1rdq_E 121 EYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR--- 194 (350)
T ss_dssp ECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSSC---
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCccceEEECCCCCEEEcccccceeccCC---
Confidence 9999999999998877899999999999999999999999 9999999999999999999999999999976532
Q ss_pred eeeccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceecccccCC
Q 039819 344 VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELGS 423 (534)
Q Consensus 344 ~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 423 (534)
....+||+.|+|||++.+..++.++|||||||++|||++|+.||..... .+....+.... ..
T Consensus 195 -~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~-------~~~~~~i~~~~-------~~--- 256 (350)
T 1rdq_E 195 -TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP-------IQIYEKIVSGK-------VR--- 256 (350)
T ss_dssp -BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHHHHHCC-------CC---
T ss_pred -cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCH-------HHHHHHHHcCC-------CC---
Confidence 2345799999999999988999999999999999999999999974321 12222222111 01
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCC-----hHHHHH
Q 039819 424 NYDRIEVGEILQVALLCTQYLPVHRPK-----MSEVVR 456 (534)
Q Consensus 424 ~~~~~~~~~l~~l~~~Cl~~~P~~RPt-----~~ev~~ 456 (534)
++...+..+.+++.+|++.+|.+||+ ++|+++
T Consensus 257 -~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~ 293 (350)
T 1rdq_E 257 -FPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp -CCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred -CCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence 11123457899999999999999998 777765
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-42 Score=346.54 Aligned_cols=230 Identities=24% Similarity=0.306 Sum_probs=185.1
Q ss_pred HhCCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEehh-----------------hhhhcccCceeeEEEEEeCCCeeEEE
Q 039819 201 TENFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLKD-----------------MISLAVHRNLLRLIGYCATPTERLLV 262 (534)
Q Consensus 201 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~-----------------~l~~~~h~niv~l~~~~~~~~~~~lv 262 (534)
.++|+..+.||+|+||+||+|+.. +++.||||++.. +.....||||++++++|.+....++|
T Consensus 56 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv 135 (311)
T 3p1a_A 56 QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQ 135 (311)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEE
Confidence 367899999999999999999986 789999998742 22334899999999999999999999
Q ss_pred eeccCCCChhhhccc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCC
Q 039819 263 YPYMSNGSVASRLRE-KPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSD 341 (534)
Q Consensus 263 ~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~ 341 (534)
|||+ +++|.+++.. ...++|..++.|+.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 136 ~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~ 211 (311)
T 3p1a_A 136 TELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAG 211 (311)
T ss_dssp EECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECGGGCEEECCCTTCEECC---
T ss_pred Eecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEccceeeeecccCC
Confidence 9999 6788888764 45699999999999999999999999 99999999999999999999999999998765432
Q ss_pred CceeeccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceeccccc
Q 039819 342 SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDREL 421 (534)
Q Consensus 342 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 421 (534)
......||++|+|||++.+ .++.++|||||||++|||++|..|+.... .|. ..... . ..+..
T Consensus 212 --~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~---------~~~-~~~~~-~----~~~~~ 273 (311)
T 3p1a_A 212 --AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGE---------GWQ-QLRQG-Y----LPPEF 273 (311)
T ss_dssp -----CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHH---------HHH-HHTTT-C----CCHHH
T ss_pred --CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCcc---------HHH-HHhcc-C----CCccc
Confidence 2344569999999998865 78999999999999999999987765321 111 11110 0 00111
Q ss_pred CCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 422 GSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 422 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
.. ..+..+.+++.+|++.+|++|||+.|+++
T Consensus 274 ~~----~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 304 (311)
T 3p1a_A 274 TA----GLSSELRSVLVMMLEPDPKLRATAEALLA 304 (311)
T ss_dssp HT----TSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred cc----CCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 11 12357899999999999999999999985
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-42 Score=348.19 Aligned_cols=231 Identities=23% Similarity=0.326 Sum_probs=193.1
Q ss_pred hCCCcCCeeccCCcEEEEEEEE-CCCcEEEEEEehh-----------------hhhhcccCceeeEEEEEeCCCeeEEEe
Q 039819 202 ENFSSKNILGAGGFGNVYKGKL-GDGTVLAVKRLKD-----------------MISLAVHRNLLRLIGYCATPTERLLVY 263 (534)
Q Consensus 202 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~-----------------~l~~~~h~niv~l~~~~~~~~~~~lv~ 263 (534)
++|...+.||+|+||.||+|+. .+++.||||++.. ++..++||||+++++++......++||
T Consensus 9 ~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 88 (336)
T 3h4j_B 9 GPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVI 88 (336)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 5788899999999999999997 5789999998742 567788999999999999999999999
Q ss_pred eccCCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCCc
Q 039819 264 PYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSH 343 (534)
Q Consensus 264 e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~ 343 (534)
||+ +|+|.+++.....+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++.......
T Consensus 89 E~~-~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~-- 162 (336)
T 3h4j_B 89 EYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN-- 162 (336)
T ss_dssp CCC-CEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHH---TCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSB--
T ss_pred ECC-CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCchhhEEEcCCCCEEEEEeccceeccCCc--
Confidence 999 789999998878899999999999999999999999 99999999999999999999999999998765432
Q ss_pred eeeccccccccccccccccCCC-CcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceecccccC
Q 039819 344 VTTAVRGTVGHIAPEYLSTGQS-SEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELG 422 (534)
Q Consensus 344 ~~~~~~gt~~y~aPE~~~~~~~-~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 422 (534)
.....+||+.|+|||++.+..+ +.++|||||||++|||++|+.||+........ ..+.. ..
T Consensus 163 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~----------------~~i~~--~~ 224 (336)
T 3h4j_B 163 FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLF----------------KKVNS--CV 224 (336)
T ss_dssp TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCB----------------CCCCS--SC
T ss_pred ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHH----------------HHHHc--CC
Confidence 2344579999999999987776 78999999999999999999999743221110 00000 00
Q ss_pred CCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 423 SNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 423 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
...+...+..+.+++.+|++.||.+|||++|+++
T Consensus 225 ~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 258 (336)
T 3h4j_B 225 YVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRR 258 (336)
T ss_dssp CCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTT
T ss_pred CCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 1112223457889999999999999999999975
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-42 Score=353.19 Aligned_cols=249 Identities=17% Similarity=0.204 Sum_probs=194.5
Q ss_pred HhCCCcCCeeccCCcEEEEEEEECC------CcEEEEEEehh-------------------------hhhhcccCceeeE
Q 039819 201 TENFSSKNILGAGGFGNVYKGKLGD------GTVLAVKRLKD-------------------------MISLAVHRNLLRL 249 (534)
Q Consensus 201 ~~~~~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~-------------------------~l~~~~h~niv~l 249 (534)
.++|...+.||+|+||.||+|.+.. ++.||||++.. .+..+.||||+++
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~ 113 (364)
T 3op5_A 34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKY 113 (364)
T ss_dssp CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCE
T ss_pred CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeE
Confidence 3578888999999999999998864 47899998642 2355679999999
Q ss_pred EEEEeCC----CeeEEEeeccCCCChhhhcccC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeC--C
Q 039819 250 IGYCATP----TERLLVYPYMSNGSVASRLREK-PALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLD--D 322 (534)
Q Consensus 250 ~~~~~~~----~~~~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~--~ 322 (534)
++++... ...++||||+ +++|.+++... ..+++..++.|+.|++.||.|||+. +|+||||||+|||++ .
T Consensus 114 ~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~---~iiHrDlkp~Nill~~~~ 189 (364)
T 3op5_A 114 WGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEH---EYVHGDIKASNLLLNYKN 189 (364)
T ss_dssp EEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEESSC
T ss_pred EeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeEEecCCHHHEEEecCC
Confidence 9998764 4579999999 99999999765 6799999999999999999999999 999999999999999 8
Q ss_pred CCcEEEEecccceecCCCCCc------eeeccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccc
Q 039819 323 FCEAIVGDFGLAKLLDHSDSH------VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQ 396 (534)
Q Consensus 323 ~~~~kl~DFGla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~ 396 (534)
++.+||+|||+++.+...... ......||+.|+|||++.+..++.++|||||||++|||+||+.||......
T Consensus 190 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~-- 267 (364)
T 3op5_A 190 PDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKD-- 267 (364)
T ss_dssp TTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTC--
T ss_pred CCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccC--
Confidence 899999999999876432211 113345999999999999988999999999999999999999999742211
Q ss_pred cchHHHHHHHHhhhcccceecccccCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhc
Q 039819 397 KGAMLEWVKKIQQEKKVEVLVDRELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLEG 460 (534)
Q Consensus 397 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~ 460 (534)
.....+..... ...+..++++.+.. ...+.++.+++..|++.+|.+||++.++++.|+.
T Consensus 268 -~~~~~~~~~~~-~~~~~~~~~~~~~~---~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~ 326 (364)
T 3op5_A 268 -PKYVRDSKIRY-RENIASLMDKCFPA---ANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQ 326 (364)
T ss_dssp -HHHHHHHHHHH-HHCHHHHHHHHSCT---TCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHH
T ss_pred -HHHHHHHHHHh-hhhHHHHHHHhccc---ccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHH
Confidence 11111111111 11222233322211 1123578999999999999999999999998875
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=370.07 Aligned_cols=241 Identities=26% Similarity=0.430 Sum_probs=200.4
Q ss_pred HhCCCcCCeeccCCcEEEEEEEECC-CcEEEEEEehh-------------hhhhcccCceeeEEEEEeCCCeeEEEeecc
Q 039819 201 TENFSSKNILGAGGFGNVYKGKLGD-GTVLAVKRLKD-------------MISLAVHRNLLRLIGYCATPTERLLVYPYM 266 (534)
Q Consensus 201 ~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~-------------~l~~~~h~niv~l~~~~~~~~~~~lv~e~~ 266 (534)
.++|...+.||+|+||.||+|++.. +..||||.++. ++..++|||||+++++|......++|||||
T Consensus 219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~~ 298 (495)
T 1opk_A 219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 298 (495)
T ss_dssp GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEcc
Confidence 4567888999999999999999864 88999998862 678889999999999999999999999999
Q ss_pred CCCChhhhccc--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCCce
Q 039819 267 SNGSVASRLRE--KPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHV 344 (534)
Q Consensus 267 ~~gsL~~~l~~--~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~ 344 (534)
++|+|.+++.. ...+++..++.|+.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.........
T Consensus 299 ~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~ 375 (495)
T 1opk_A 299 TYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTA 375 (495)
T ss_dssp TTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEECCTTCEECCTTCCEEC
T ss_pred CCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChhhEEECCCCcEEEeecccceeccCCceee
Confidence 99999999975 34699999999999999999999999 99999999999999999999999999999775433222
Q ss_pred eeccccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCcCCCccccccchHHHHHHHHhhhcccceecccccCC
Q 039819 345 TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELGS 423 (534)
Q Consensus 345 ~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 423 (534)
.....++..|+|||++....++.++|||||||++|||+| |+.||...... .+.+.+ ... ...
T Consensus 376 ~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~----~~~~~~---~~~----------~~~ 438 (495)
T 1opk_A 376 HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS----QVYELL---EKD----------YRM 438 (495)
T ss_dssp CTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGG----GHHHHH---HTT----------CCC
T ss_pred cCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHH----HHHHHH---HcC----------CCC
Confidence 333456789999999988899999999999999999999 99999753321 122211 111 111
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhcC
Q 039819 424 NYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLEGD 461 (534)
Q Consensus 424 ~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~~ 461 (534)
..+...+..+.+++.+||+.+|.+|||+.+|++.|+..
T Consensus 439 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~ 476 (495)
T 1opk_A 439 ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 476 (495)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred CCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHH
Confidence 12223345889999999999999999999999999875
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-42 Score=340.70 Aligned_cols=247 Identities=20% Similarity=0.315 Sum_probs=189.6
Q ss_pred hCCCcCCeeccCCcEEEEEEEECCCcEEEEEEeh----------------hhhhhcccCceeeEEEEEeCCCeeEEEeec
Q 039819 202 ENFSSKNILGAGGFGNVYKGKLGDGTVLAVKRLK----------------DMISLAVHRNLLRLIGYCATPTERLLVYPY 265 (534)
Q Consensus 202 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~----------------~~l~~~~h~niv~l~~~~~~~~~~~lv~e~ 265 (534)
++|...+.||+|+||.||+|+..+++.||||++. +++..++||||+++++++...+..++||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 4688889999999999999999889999999874 267788999999999999999999999999
Q ss_pred cCCCChhhhccc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCCce
Q 039819 266 MSNGSVASRLRE-KPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHV 344 (534)
Q Consensus 266 ~~~gsL~~~l~~-~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~ 344 (534)
+++ +|.+++.. ...+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++....... .
T Consensus 82 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~ 156 (288)
T 1ob3_A 82 LDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR-K 156 (288)
T ss_dssp CSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----
T ss_pred cCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEeECccccccCcccc-c
Confidence 986 88888875 46799999999999999999999999 999999999999999999999999999987643221 2
Q ss_pred eecccccccccccccccc-CCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhh---cc--cc--ee
Q 039819 345 TTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQE---KK--VE--VL 416 (534)
Q Consensus 345 ~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~---~~--~~--~~ 416 (534)
.....||+.|+|||++.+ ..++.++|||||||++|||+||+.||........ +.......... .. .. ..
T Consensus 157 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~ 233 (288)
T 1ob3_A 157 YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQ---LMRIFRILGTPNSKNWPNVTELPK 233 (288)
T ss_dssp -----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHHHHCCCCTTTSTTGGGSTT
T ss_pred cccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHHCCCChhhchhhhcccc
Confidence 234568999999999865 4589999999999999999999999975432211 11111111000 00 00 00
Q ss_pred cccccC-------CCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 417 VDRELG-------SNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 417 ~d~~l~-------~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
.++... ..........+.+++.+|++.||++|||++|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 280 (288)
T 1ob3_A 234 YDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (288)
T ss_dssp CCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 011110 0011122457889999999999999999999985
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=342.80 Aligned_cols=244 Identities=18% Similarity=0.201 Sum_probs=196.6
Q ss_pred hCCCcCCeeccCCcEEEEEEEE-CCCcEEEEEEeh------------hhhhhc-ccCceeeEEEEEeCCCeeEEEeeccC
Q 039819 202 ENFSSKNILGAGGFGNVYKGKL-GDGTVLAVKRLK------------DMISLA-VHRNLLRLIGYCATPTERLLVYPYMS 267 (534)
Q Consensus 202 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~------------~~l~~~-~h~niv~l~~~~~~~~~~~lv~e~~~ 267 (534)
++|...+.||+|+||.||+|+. .+++.||||.+. +++..+ .||||+++++++......++||||+
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~- 87 (330)
T 2izr_A 9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLELL- 87 (330)
T ss_dssp TTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEECC-
T ss_pred CCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEeC-
Confidence 5788889999999999999997 578999999875 256777 8999999999999999999999999
Q ss_pred CCChhhhccc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCc-----EEEEecccceecCCCC
Q 039819 268 NGSVASRLRE-KPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCE-----AIVGDFGLAKLLDHSD 341 (534)
Q Consensus 268 ~gsL~~~l~~-~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~-----~kl~DFGla~~~~~~~ 341 (534)
+++|.+++.. ...+++..++.|+.|++.||+|||+. +|+||||||+|||++.++. +||+|||+++......
T Consensus 88 ~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~~~ 164 (330)
T 2izr_A 88 GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSK---NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPE 164 (330)
T ss_dssp CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBCTT
T ss_pred CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeeccCCCCCCceEEEEEcccceeeecCC
Confidence 9999999975 46799999999999999999999999 9999999999999998887 9999999999765432
Q ss_pred Cc------eeeccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccce
Q 039819 342 SH------VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEV 415 (534)
Q Consensus 342 ~~------~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 415 (534)
.. ......||+.|+|||++.+..++.++|||||||++|||+||+.||....... ..+....+........
T Consensus 165 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~----~~~~~~~i~~~~~~~~ 240 (330)
T 2izr_A 165 TKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADT----LKERYQKIGDTKRATP 240 (330)
T ss_dssp TCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSS----HHHHHHHHHHHHHHSC
T ss_pred CCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCcccccccc----HHHHHHHHHhhhccCC
Confidence 21 1245679999999999999999999999999999999999999997543211 1111111111100000
Q ss_pred ecccccCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhc
Q 039819 416 LVDRELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLEG 460 (534)
Q Consensus 416 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~ 460 (534)
...+.. ..+ ++.+++..|++.+|.+||++.+|++.|+.
T Consensus 241 --~~~~~~----~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~ 278 (330)
T 2izr_A 241 --IEVLCE----NFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTD 278 (330)
T ss_dssp --HHHHTT----TCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHH
T ss_pred --HHHHhc----cCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHH
Confidence 000000 113 88999999999999999999999998874
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-42 Score=347.60 Aligned_cols=240 Identities=25% Similarity=0.430 Sum_probs=190.9
Q ss_pred hCCCcCCeeccCCcEEEEEEEEC-CCc----EEEEEEehh---------------hhhhcccCceeeEEEEEeCCCeeEE
Q 039819 202 ENFSSKNILGAGGFGNVYKGKLG-DGT----VLAVKRLKD---------------MISLAVHRNLLRLIGYCATPTERLL 261 (534)
Q Consensus 202 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~----~vavK~~~~---------------~l~~~~h~niv~l~~~~~~~~~~~l 261 (534)
++|...+.||+|+||.||+|+.. ++. .||+|.+.. .+..++||||++++++|. ....++
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~ 91 (325)
T 3kex_A 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQL 91 (325)
T ss_dssp TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEE
T ss_pred hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEE
Confidence 46788899999999999999974 343 378887641 567789999999999986 456899
Q ss_pred EeeccCCCChhhhcccC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCC
Q 039819 262 VYPYMSNGSVASRLREK-PALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHS 340 (534)
Q Consensus 262 v~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~ 340 (534)
||||+++|+|.+++... ..+++..++.|+.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 92 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~ 168 (325)
T 3kex_A 92 VTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEH---GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPD 168 (325)
T ss_dssp EEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHT---TCCCSCCSSTTEEESSSSCEEECSCSGGGGSCCC
T ss_pred EEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhC---CCCCCccchheEEECCCCeEEECCCCcccccCcc
Confidence 99999999999999764 5799999999999999999999999 9999999999999999999999999999977543
Q ss_pred CC-ceeeccccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCcCCCccccccchHHHHHHHHhhhcccceecc
Q 039819 341 DS-HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVD 418 (534)
Q Consensus 341 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 418 (534)
.. .......||..|+|||++.+..++.++|||||||++|||+| |+.||...... .+... .......
T Consensus 169 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~----~~~~~---~~~~~~~----- 236 (325)
T 3kex_A 169 DKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLA----EVPDL---LEKGERL----- 236 (325)
T ss_dssp TTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTT----HHHHH---HHTTCBC-----
T ss_pred cccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHH----HHHHH---HHcCCCC-----
Confidence 32 22344567889999999998999999999999999999999 99999753321 11111 1111110
Q ss_pred cccCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhcCC
Q 039819 419 RELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLEGDG 462 (534)
Q Consensus 419 ~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~~~ 462 (534)
..+...+..+.+++.+||+.+|.+||++.++++.|+...
T Consensus 237 -----~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~ 275 (325)
T 3kex_A 237 -----AQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMA 275 (325)
T ss_dssp -----CCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHT
T ss_pred -----CCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 011112336788999999999999999999999998653
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-42 Score=354.83 Aligned_cols=240 Identities=30% Similarity=0.428 Sum_probs=196.5
Q ss_pred hCCCcCCeeccCCcEEEEEEEE--------CCCcEEEEEEehh---------------hhhhc-ccCceeeEEEEEeCCC
Q 039819 202 ENFSSKNILGAGGFGNVYKGKL--------GDGTVLAVKRLKD---------------MISLA-VHRNLLRLIGYCATPT 257 (534)
Q Consensus 202 ~~~~~~~~lG~G~~g~Vy~~~~--------~~~~~vavK~~~~---------------~l~~~-~h~niv~l~~~~~~~~ 257 (534)
++|...+.||+|+||.||+|+. ..+..||||++.. ++..+ +|||||+++++|....
T Consensus 69 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~ 148 (382)
T 3tt0_A 69 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG 148 (382)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred hheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccCC
Confidence 5778889999999999999986 2346799998852 45666 8999999999999999
Q ss_pred eeEEEeeccCCCChhhhcccC----------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeC
Q 039819 258 ERLLVYPYMSNGSVASRLREK----------------PALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLD 321 (534)
Q Consensus 258 ~~~lv~e~~~~gsL~~~l~~~----------------~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~ 321 (534)
..++||||+++|+|.+++... ..+++..++.|+.|++.||.|||+. +|+||||||+|||++
T Consensus 149 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~ 225 (382)
T 3tt0_A 149 PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVT 225 (382)
T ss_dssp SCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEC
T ss_pred ceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCcceEEEc
Confidence 999999999999999999753 3599999999999999999999999 999999999999999
Q ss_pred CCCcEEEEecccceecCCCCC-ceeeccccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCcCCCccccccch
Q 039819 322 DFCEAIVGDFGLAKLLDHSDS-HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GMRALEFGKSINQKGA 399 (534)
Q Consensus 322 ~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~ellt-G~~p~~~~~~~~~~~~ 399 (534)
.++.+||+|||+++....... .......+|..|+|||++.+..++.++|||||||++|||+| |+.||.....
T Consensus 226 ~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~------ 299 (382)
T 3tt0_A 226 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV------ 299 (382)
T ss_dssp TTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH------
T ss_pred CCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH------
Confidence 999999999999987654322 22334457889999999999999999999999999999999 9999974321
Q ss_pred HHHHHHHHhhhcccceecccccCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhcC
Q 039819 400 MLEWVKKIQQEKKVEVLVDRELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLEGD 461 (534)
Q Consensus 400 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~~ 461 (534)
.+........... ..+...+..+.+++.+||+.+|++||++.||++.|+..
T Consensus 300 -~~~~~~~~~~~~~----------~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~ 350 (382)
T 3tt0_A 300 -EELFKLLKEGHRM----------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 350 (382)
T ss_dssp -HHHHHHHHTTCCC----------CCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -HHHHHHHHcCCCC----------CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 1222222221110 11112345789999999999999999999999998763
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-41 Score=344.75 Aligned_cols=238 Identities=24% Similarity=0.303 Sum_probs=187.4
Q ss_pred HhCCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEeh------------hhhhhcccCceeeEEEEEeCCCeeEEEeeccC
Q 039819 201 TENFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLK------------DMISLAVHRNLLRLIGYCATPTERLLVYPYMS 267 (534)
Q Consensus 201 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~------------~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~~ 267 (534)
.++|...+.||+|+||.||+|+.. +++.||||++. +++..++||||++++++|.+....++||||++
T Consensus 52 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 131 (349)
T 2w4o_A 52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVT 131 (349)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC----------CHHHHHCCCTTBCCEEEEEECSSEEEEEECCCC
T ss_pred cCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccchhHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEeCC
Confidence 467888999999999999999986 57899999875 26788899999999999999999999999999
Q ss_pred CCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCC---CCcEEEEecccceecCCCCCce
Q 039819 268 NGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDD---FCEAIVGDFGLAKLLDHSDSHV 344 (534)
Q Consensus 268 ~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~---~~~~kl~DFGla~~~~~~~~~~ 344 (534)
+|+|.+++.....+++..++.++.|++.||.|||+. +|+||||||+|||++. ++.+||+|||+++...... .
T Consensus 132 ~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~--~ 206 (349)
T 2w4o_A 132 GGELFDRIVEKGYYSERDAADAVKQILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQV--L 206 (349)
T ss_dssp SCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESSSSTTCCEEECCCC------------
T ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCcccEEEecCCCCCCEEEccCccccccCccc--c
Confidence 999999998888899999999999999999999999 9999999999999975 8999999999998764322 2
Q ss_pred eeccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceecccccCCC
Q 039819 345 TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELGSN 424 (534)
Q Consensus 345 ~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 424 (534)
.....||+.|+|||++.+..++.++|||||||++|||+||+.||...... ......+.... . .. ...
T Consensus 207 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~------~~~~~~i~~~~-~-~~-----~~~ 273 (349)
T 2w4o_A 207 MKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGD------QFMFRRILNCE-Y-YF-----ISP 273 (349)
T ss_dssp ------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCH------HHHHHHHHTTC-C-CC-----CTT
T ss_pred cccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCccc------HHHHHHHHhCC-C-cc-----CCc
Confidence 33456999999999999889999999999999999999999999643221 01111111111 0 00 001
Q ss_pred CCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 425 YDRIEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 425 ~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
.....+..+.+++.+|++.||++|||+.|+++
T Consensus 274 ~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 305 (349)
T 2w4o_A 274 WWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQ 305 (349)
T ss_dssp TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred hhhhCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 11123457889999999999999999999986
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-42 Score=348.14 Aligned_cols=235 Identities=26% Similarity=0.364 Sum_probs=194.2
Q ss_pred HHHhCCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEehh-----------------hhhhc-ccCceeeEEEEEeCCCee
Q 039819 199 QATENFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLKD-----------------MISLA-VHRNLLRLIGYCATPTER 259 (534)
Q Consensus 199 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~-----------------~l~~~-~h~niv~l~~~~~~~~~~ 259 (534)
...++|...+.||+|+||.||+|+.. +++.||||+++. ++... .||||+++++++.+....
T Consensus 14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~ 93 (345)
T 1xjd_A 14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENL 93 (345)
T ss_dssp --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEE
Confidence 34578999999999999999999985 689999998852 23333 899999999999999999
Q ss_pred EEEeeccCCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCC
Q 039819 260 LLVYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDH 339 (534)
Q Consensus 260 ~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~ 339 (534)
|+||||+++|+|.+++.....+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 94 ~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 170 (345)
T 1xjd_A 94 FFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENML 170 (345)
T ss_dssp EEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCChhhEEECCCCCEEEeEChhhhhccc
Confidence 99999999999999998877899999999999999999999999 999999999999999999999999999986432
Q ss_pred CCCceeeccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceeccc
Q 039819 340 SDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDR 419 (534)
Q Consensus 340 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 419 (534)
.. ......+||+.|+|||++.+..++.++|||||||++|||++|+.||..... .+....+.... .
T Consensus 171 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~-------~~~~~~i~~~~-------~ 235 (345)
T 1xjd_A 171 GD-AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE-------EELFHSIRMDN-------P 235 (345)
T ss_dssp TT-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHHHHHCC-------C
T ss_pred CC-CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCH-------HHHHHHHHhCC-------C
Confidence 22 224456799999999999998999999999999999999999999974322 11112221111 1
Q ss_pred ccCCCCCHHHHHHHHHHHHHhcccCCCCCCChH-HHH
Q 039819 420 ELGSNYDRIEVGEILQVALLCTQYLPVHRPKMS-EVV 455 (534)
Q Consensus 420 ~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~-ev~ 455 (534)
.. +......+.+++.+|++.+|++||++. ++.
T Consensus 236 ~~----p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~ 268 (345)
T 1xjd_A 236 FY----PRWLEKEAKDLLVKLFVREPEKRLGVRGDIR 268 (345)
T ss_dssp CC----CTTSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred CC----CcccCHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence 11 112245788999999999999999997 554
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-42 Score=347.29 Aligned_cols=239 Identities=25% Similarity=0.405 Sum_probs=190.7
Q ss_pred hCCCcCCeeccCCcEEEEEEEEC-CCc----EEEEEEeh---------------hhhhhcccCceeeEEEEEeCCCeeEE
Q 039819 202 ENFSSKNILGAGGFGNVYKGKLG-DGT----VLAVKRLK---------------DMISLAVHRNLLRLIGYCATPTERLL 261 (534)
Q Consensus 202 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~----~vavK~~~---------------~~l~~~~h~niv~l~~~~~~~~~~~l 261 (534)
++|...+.||+|+||.||+|++. ++. .||+|.+. .++..++||||++++++|.+.. .++
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~ 93 (327)
T 3poz_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL 93 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EEE
T ss_pred HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eEE
Confidence 56888899999999999999864 333 46888764 2677889999999999998764 789
Q ss_pred EeeccCCCChhhhccc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCC
Q 039819 262 VYPYMSNGSVASRLRE-KPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHS 340 (534)
Q Consensus 262 v~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~ 340 (534)
|+||+++|+|.+++.. ...+++..++.|+.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 94 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~ 170 (327)
T 3poz_A 94 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 170 (327)
T ss_dssp EEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTHHHHHTTT
T ss_pred EEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCChheEEECCCCCEEEccCcceeEccCC
Confidence 9999999999999975 46799999999999999999999999 9999999999999999999999999999876543
Q ss_pred CCc-eeeccccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCcCCCccccccchHHHHHHHHhhhcccceecc
Q 039819 341 DSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVD 418 (534)
Q Consensus 341 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 418 (534)
... ......||..|+|||++.+..++.++|||||||++|||+| |+.||...... .+...+. ...
T Consensus 171 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~----~~~~~~~---~~~------- 236 (327)
T 3poz_A 171 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS----EISSILE---KGE------- 236 (327)
T ss_dssp CC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG----GHHHHHH---TTC-------
T ss_pred cccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHH----HHHHHHH---cCC-------
Confidence 321 2233456889999999999999999999999999999999 99999743321 1111111 111
Q ss_pred cccCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhcC
Q 039819 419 RELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLEGD 461 (534)
Q Consensus 419 ~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~~ 461 (534)
....+...+..+.+++.+||+.+|.+||++.|+++.|+..
T Consensus 237 ---~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~ 276 (327)
T 3poz_A 237 ---RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 276 (327)
T ss_dssp ---CCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHH
T ss_pred ---CCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 1111222345789999999999999999999999998764
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=341.58 Aligned_cols=251 Identities=23% Similarity=0.317 Sum_probs=189.9
Q ss_pred HHhCCCcCCeeccCCcEEEEEEEE-CCCcEEEEEEehh-------------------h---hhhcccCceeeEEEEEeCC
Q 039819 200 ATENFSSKNILGAGGFGNVYKGKL-GDGTVLAVKRLKD-------------------M---ISLAVHRNLLRLIGYCATP 256 (534)
Q Consensus 200 ~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~-------------------~---l~~~~h~niv~l~~~~~~~ 256 (534)
..++|...+.||+|+||.||+|+. .+++.||||++.. . +..+.||||++++++|...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 467899999999999999999997 4789999998741 2 3344599999999999875
Q ss_pred C-----eeEEEeeccCCCChhhhcccCCC--CCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEE
Q 039819 257 T-----ERLLVYPYMSNGSVASRLREKPA--LDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVG 329 (534)
Q Consensus 257 ~-----~~~lv~e~~~~gsL~~~l~~~~~--l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~ 329 (534)
. ..++||||+. |+|.+++..... +++..++.|+.|++.||+|||++ +|+||||||+|||++.++.+||+
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl~ 162 (308)
T 3g33_A 87 RTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLA 162 (308)
T ss_dssp CSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCTTTEEECTTSCEEEC
T ss_pred CCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEEe
Confidence 5 4789999997 599999976543 99999999999999999999999 99999999999999999999999
Q ss_pred ecccceecCCCCCceeeccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhh
Q 039819 330 DFGLAKLLDHSDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQ 409 (534)
Q Consensus 330 DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 409 (534)
|||+++...... ......||+.|+|||++.+..++.++|||||||++|||+||+.||...........+.+.......
T Consensus 163 Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~ 240 (308)
T 3g33_A 163 DFGLARIYSYQM--ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPE 240 (308)
T ss_dssp SCSCTTTSTTCC--CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCT
T ss_pred eCccccccCCCc--ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCh
Confidence 999998764332 234567999999999999999999999999999999999999999754432211111111110000
Q ss_pred hccccee--cccccCC--CC-----CHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 410 EKKVEVL--VDRELGS--NY-----DRIEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 410 ~~~~~~~--~d~~l~~--~~-----~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
....... ....... .. .......+.+++.+|++.||++|||+.|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 296 (308)
T 3g33_A 241 DDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ 296 (308)
T ss_dssp TTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence 0000000 0000000 00 0112357889999999999999999999985
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=347.13 Aligned_cols=241 Identities=24% Similarity=0.335 Sum_probs=195.0
Q ss_pred HhCCCcCCeeccCCcEEEEEEEE----CCCcEEEEEEehh------------------hhhhc-ccCceeeEEEEEeCCC
Q 039819 201 TENFSSKNILGAGGFGNVYKGKL----GDGTVLAVKRLKD------------------MISLA-VHRNLLRLIGYCATPT 257 (534)
Q Consensus 201 ~~~~~~~~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~------------------~l~~~-~h~niv~l~~~~~~~~ 257 (534)
.++|...+.||+|+||.||+|+. .+++.||||+++. ++..+ .||||+++++++....
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 132 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 132 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence 36788899999999999999997 4789999998742 45556 5999999999999999
Q ss_pred eeEEEeeccCCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceec
Q 039819 258 ERLLVYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLL 337 (534)
Q Consensus 258 ~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~ 337 (534)
..++||||+++|+|.+++.....+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++..
T Consensus 133 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~ 209 (355)
T 1vzo_A 133 KLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEF 209 (355)
T ss_dssp EEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEEEEC
T ss_pred eEEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCcEEEeeCCCCeec
Confidence 9999999999999999998877899999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCCceeecccccccccccccccc--CCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccce
Q 039819 338 DHSDSHVTTAVRGTVGHIAPEYLST--GQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEV 415 (534)
Q Consensus 338 ~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 415 (534)
............||+.|+|||++.+ ..++.++|||||||++|||+||+.||........ ...+.......
T Consensus 210 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~---~~~~~~~~~~~----- 281 (355)
T 1vzo_A 210 VADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNS---QAEISRRILKS----- 281 (355)
T ss_dssp CGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCC---HHHHHHHHHHC-----
T ss_pred ccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccch---HHHHHHHHhcc-----
Confidence 4433333445679999999999975 3478999999999999999999999975432222 12222221111
Q ss_pred ecccccCCCCCHHHHHHHHHHHHHhcccCCCCCC-----ChHHHHHHh
Q 039819 416 LVDRELGSNYDRIEVGEILQVALLCTQYLPVHRP-----KMSEVVRML 458 (534)
Q Consensus 416 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RP-----t~~ev~~~L 458 (534)
.+. ++......+.+++.+|++.||.+|| ++.|+++..
T Consensus 282 --~~~----~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~ 323 (355)
T 1vzo_A 282 --EPP----YPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL 323 (355)
T ss_dssp --CCC----CCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred --CCC----CCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence 011 1222345788999999999999999 888888643
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=336.53 Aligned_cols=245 Identities=17% Similarity=0.190 Sum_probs=196.9
Q ss_pred hCCCcCCeeccCCcEEEEEEEE-CCCcEEEEEEehh------------hhhhc-ccCceeeEEEEEeCCCeeEEEeeccC
Q 039819 202 ENFSSKNILGAGGFGNVYKGKL-GDGTVLAVKRLKD------------MISLA-VHRNLLRLIGYCATPTERLLVYPYMS 267 (534)
Q Consensus 202 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~------------~l~~~-~h~niv~l~~~~~~~~~~~lv~e~~~ 267 (534)
++|...+.||+|+||.||+|+. .+++.||||.+.. .+..+ .|+|++++++++......++||||+
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~- 88 (298)
T 1csn_A 10 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL- 88 (298)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-
T ss_pred cceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEEec-
Confidence 5688889999999999999996 5789999998752 45555 7999999999999999999999999
Q ss_pred CCChhhhcccC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCc-----EEEEecccceecCCCC
Q 039819 268 NGSVASRLREK-PALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCE-----AIVGDFGLAKLLDHSD 341 (534)
Q Consensus 268 ~gsL~~~l~~~-~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~-----~kl~DFGla~~~~~~~ 341 (534)
+++|.+++... ..+++..+..++.|++.||.|||+. +|+||||||+|||++.++. +||+|||+++......
T Consensus 89 ~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~~ 165 (298)
T 1csn_A 89 GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPV 165 (298)
T ss_dssp CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTT
T ss_pred CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEeccCCCCCCCeEEEEECcccccccccc
Confidence 99999999854 4699999999999999999999998 9999999999999987776 9999999999775432
Q ss_pred Cc------eeeccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccce
Q 039819 342 SH------VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEV 415 (534)
Q Consensus 342 ~~------~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 415 (534)
.. ......||+.|+|||++.+..++.++|||||||++|||+||+.||.................. ......
T Consensus 166 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~-~~~~~~-- 242 (298)
T 1csn_A 166 TKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEK-KQSTPL-- 242 (298)
T ss_dssp TCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHH-HHHSCH--
T ss_pred ccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhh-ccCccH--
Confidence 21 234567999999999999989999999999999999999999999754322211111111111 000000
Q ss_pred ecccccCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhc
Q 039819 416 LVDRELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLEG 460 (534)
Q Consensus 416 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~ 460 (534)
+.+... .+..+.+++.+|++.+|.+||++.+|++.|+.
T Consensus 243 ---~~~~~~----~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~ 280 (298)
T 1csn_A 243 ---RELCAG----FPEEFYKYMHYARNLAFDATPDYDYLQGLFSK 280 (298)
T ss_dssp ---HHHTTT----SCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHH
T ss_pred ---HHHHhh----CcHHHHHHHHHHhcCCcccCCCHHHHHHHHHH
Confidence 011111 23588999999999999999999999999875
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=346.72 Aligned_cols=239 Identities=21% Similarity=0.282 Sum_probs=196.7
Q ss_pred HHHhCCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEehh----------------hhhhcccCceeeEEEEEeCCCeeEE
Q 039819 199 QATENFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLKD----------------MISLAVHRNLLRLIGYCATPTERLL 261 (534)
Q Consensus 199 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~----------------~l~~~~h~niv~l~~~~~~~~~~~l 261 (534)
...++|...+.||+|+||.||+|... ++..||||++.. ++..++||||+++++++.+....++
T Consensus 26 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~l 105 (362)
T 2bdw_A 26 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL 105 (362)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred CcccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence 34578999999999999999999975 689999998741 5677899999999999999999999
Q ss_pred EeeccCCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCC---CcEEEEecccceecC
Q 039819 262 VYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDF---CEAIVGDFGLAKLLD 338 (534)
Q Consensus 262 v~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~---~~~kl~DFGla~~~~ 338 (534)
||||+++|+|.+.+.....+++..+..++.||+.||.|||+. +|+||||||+|||++.+ +.+||+|||+++...
T Consensus 106 v~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~ 182 (362)
T 2bdw_A 106 VFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN 182 (362)
T ss_dssp EECCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCT
T ss_pred EEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEeecCcceEec
Confidence 999999999999998888899999999999999999999999 99999999999999865 459999999998765
Q ss_pred CCCCceeeccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceecc
Q 039819 339 HSDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVD 418 (534)
Q Consensus 339 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 418 (534)
... ......||+.|+|||++.+..++.++|||||||++|||+||+.||..... .+....+.... .. .
T Consensus 183 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~-------~~~~~~i~~~~-~~-~-- 249 (362)
T 2bdw_A 183 DSE--AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ-------HRLYAQIKAGA-YD-Y-- 249 (362)
T ss_dssp TCC--SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHHHHHTC-CC-C--
T ss_pred CCc--ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH-------HHHHHHHHhCC-CC-C--
Confidence 432 23446799999999999988999999999999999999999999974321 11222221111 00 0
Q ss_pred cccCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 419 RELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 419 ~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
........+..+.+++.+|++.||.+||++.|+++
T Consensus 250 ---~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 284 (362)
T 2bdw_A 250 ---PSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALK 284 (362)
T ss_dssp ---CTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred ---CcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 00000112457889999999999999999999975
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=344.47 Aligned_cols=236 Identities=23% Similarity=0.318 Sum_probs=190.2
Q ss_pred hCCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEehh-----------------hhhhc-ccCceeeEEEEEeCCCeeEEE
Q 039819 202 ENFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLKD-----------------MISLA-VHRNLLRLIGYCATPTERLLV 262 (534)
Q Consensus 202 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~-----------------~l~~~-~h~niv~l~~~~~~~~~~~lv 262 (534)
++|...+.||+|+||.||+|+.. +++.||||++.. ++..+ +||||+++++++.+....++|
T Consensus 9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv 88 (345)
T 3a8x_A 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 88 (345)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence 57888899999999999999985 588999998852 34444 799999999999999999999
Q ss_pred eeccCCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCC
Q 039819 263 YPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDS 342 (534)
Q Consensus 263 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~ 342 (534)
|||+++|+|.+++.....+++..++.++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++......
T Consensus 89 ~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~~- 164 (345)
T 3a8x_A 89 IEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG- 164 (345)
T ss_dssp ECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCTT-
T ss_pred EeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEEeccccccccCCC-
Confidence 99999999999998877899999999999999999999999 99999999999999999999999999998643222
Q ss_pred ceeeccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCcccccc-chHHHHHHHHhhhcccceeccccc
Q 039819 343 HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQK-GAMLEWVKKIQQEKKVEVLVDREL 421 (534)
Q Consensus 343 ~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~d~~l 421 (534)
......+||+.|+|||++.+..++.++|||||||++|||++|+.||......... ................ .
T Consensus 165 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~------~- 237 (345)
T 3a8x_A 165 DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI------R- 237 (345)
T ss_dssp CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCC------C-
T ss_pred CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCC------C-
Confidence 2344567999999999999989999999999999999999999999742211110 0011111111111110 1
Q ss_pred CCCCCHHHHHHHHHHHHHhcccCCCCCCCh
Q 039819 422 GSNYDRIEVGEILQVALLCTQYLPVHRPKM 451 (534)
Q Consensus 422 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~ 451 (534)
++...+..+.+++.+|++.+|.+||++
T Consensus 238 ---~p~~~s~~~~~li~~lL~~dP~~R~~~ 264 (345)
T 3a8x_A 238 ---IPRSLSVKAASVLKSFLNKDPKERLGC 264 (345)
T ss_dssp ---CCTTSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred ---CCCCCCHHHHHHHHHHhcCCHhHCCCC
Confidence 122234578899999999999999996
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-41 Score=354.14 Aligned_cols=240 Identities=19% Similarity=0.246 Sum_probs=196.5
Q ss_pred HHHhCCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEeh----------------hhhhhcccCceeeEEEEEeCCCeeEE
Q 039819 199 QATENFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLK----------------DMISLAVHRNLLRLIGYCATPTERLL 261 (534)
Q Consensus 199 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~----------------~~l~~~~h~niv~l~~~~~~~~~~~l 261 (534)
...++|...+.||+|+||.||+|... +++.||+|.+. +++..++|||||++++++.+....++
T Consensus 8 ~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 87 (444)
T 3soa_A 8 RFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYL 87 (444)
T ss_dssp HHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEE
T ss_pred cccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEE
Confidence 34678999999999999999999874 78999999874 26778899999999999999999999
Q ss_pred EeeccCCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeC---CCCcEEEEecccceecC
Q 039819 262 VYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLD---DFCEAIVGDFGLAKLLD 338 (534)
Q Consensus 262 v~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~---~~~~~kl~DFGla~~~~ 338 (534)
||||+++|+|.+.+.....+++..+..++.|++.||.|||++ +|+||||||+|||++ .++.+||+|||+++...
T Consensus 88 v~E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~---givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~ 164 (444)
T 3soa_A 88 IFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVE 164 (444)
T ss_dssp EECCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCC
T ss_pred EEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEeccCCCCcEEEccCceeEEec
Confidence 999999999999998888899999999999999999999999 999999999999998 56889999999998765
Q ss_pred CCCCceeeccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceecc
Q 039819 339 HSDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVD 418 (534)
Q Consensus 339 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 418 (534)
... .......||+.|+|||++.+..++.++|||||||++|||++|+.||..... .+....+.... . ....
T Consensus 165 ~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~-------~~~~~~i~~~~-~-~~~~ 234 (444)
T 3soa_A 165 GEQ-QAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQ-------HRLYQQIKAGA-Y-DFPS 234 (444)
T ss_dssp TTC-CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSH-------HHHHHHHHHTC-C-CCCT
T ss_pred CCC-ceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccH-------HHHHHHHHhCC-C-CCCc
Confidence 432 223456799999999999988999999999999999999999999964321 11122221111 0 0000
Q ss_pred cccCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 419 RELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 419 ~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
+ . ....+..+.+++.+|++.||.+|||+.|+++
T Consensus 235 ~-~----~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~ 267 (444)
T 3soa_A 235 P-E----WDTVTPEAKDLINKMLTINPSKRITAAEALK 267 (444)
T ss_dssp T-T----TTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred c-c----cccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 0 0 0112457889999999999999999999986
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-42 Score=341.87 Aligned_cols=246 Identities=24% Similarity=0.387 Sum_probs=190.9
Q ss_pred hCCCcCCeeccCCcEEEEEEEE-----CCCcEEEEEEehh--------------hhhhcccCceeeEEEEEeCC--CeeE
Q 039819 202 ENFSSKNILGAGGFGNVYKGKL-----GDGTVLAVKRLKD--------------MISLAVHRNLLRLIGYCATP--TERL 260 (534)
Q Consensus 202 ~~~~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~--------------~l~~~~h~niv~l~~~~~~~--~~~~ 260 (534)
++|+..+.||+|+||.||+|++ .+++.||||++.. ++..++||||+++++++... ...+
T Consensus 10 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 89 (295)
T 3ugc_A 10 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK 89 (295)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSCE
T ss_pred HHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCceE
Confidence 5788889999999999999985 3688999998752 67888999999999998654 4579
Q ss_pred EEeeccCCCChhhhcccC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCC
Q 039819 261 LVYPYMSNGSVASRLREK-PALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDH 339 (534)
Q Consensus 261 lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~ 339 (534)
+||||+++|+|.+++... ..+++..++.++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 90 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 166 (295)
T 3ugc_A 90 LIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQ 166 (295)
T ss_dssp EEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCSCC----
T ss_pred EEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHhhEEEcCCCeEEEccCcccccccC
Confidence 999999999999999764 3599999999999999999999998 999999999999999999999999999987654
Q ss_pred CCC--ceeeccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccc-------c-ccchHH-HHHHHHh
Q 039819 340 SDS--HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSI-------N-QKGAML-EWVKKIQ 408 (534)
Q Consensus 340 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~-------~-~~~~~~-~~~~~~~ 408 (534)
... .......+|..|+|||++.+..++.++|||||||++|||+||..|+...... . ...... .......
T Consensus 167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (295)
T 3ugc_A 167 DKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLK 246 (295)
T ss_dssp ---------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHHHHH
T ss_pred CcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHHHHh
Confidence 322 1223345778899999999999999999999999999999999998632110 0 000000 1111111
Q ss_pred hhcccceecccccCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhc
Q 039819 409 QEKKVEVLVDRELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLEG 460 (534)
Q Consensus 409 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~ 460 (534)
. ......+...+..+.+++.+||+.+|++|||+.|+++.|+.
T Consensus 247 ~----------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~ 288 (295)
T 3ugc_A 247 N----------NGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQ 288 (295)
T ss_dssp T----------TCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHH
T ss_pred c----------cCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHH
Confidence 1 11111222335689999999999999999999999999875
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-42 Score=335.08 Aligned_cols=238 Identities=26% Similarity=0.413 Sum_probs=185.6
Q ss_pred hCCCcCCeeccCCcEEEEEEEECCCcEEEEEEeh------------------hhhhhcccCceeeEEEEEeCCCeeEEEe
Q 039819 202 ENFSSKNILGAGGFGNVYKGKLGDGTVLAVKRLK------------------DMISLAVHRNLLRLIGYCATPTERLLVY 263 (534)
Q Consensus 202 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~------------------~~l~~~~h~niv~l~~~~~~~~~~~lv~ 263 (534)
++|...+.||+|+||.||+|+.. +..||||++. +++..++||||+++++++.+....++||
T Consensus 7 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 85 (271)
T 3dtc_A 7 AELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVM 85 (271)
T ss_dssp TSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEE
T ss_pred hheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEE
Confidence 57888899999999999999985 7889999864 2567788999999999999999999999
Q ss_pred eccCCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCC--------CCcEEEEecccce
Q 039819 264 PYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDD--------FCEAIVGDFGLAK 335 (534)
Q Consensus 264 e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~--------~~~~kl~DFGla~ 335 (534)
||+++++|.+++.. ..+++..++.++.|++.||.|||++...+|+||||||+|||++. ++.+||+|||+++
T Consensus 86 e~~~~~~L~~~~~~-~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~~~ 164 (271)
T 3dtc_A 86 EFARGGPLNRVLSG-KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR 164 (271)
T ss_dssp ECCTTEEHHHHHTS-SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC--
T ss_pred EcCCCCCHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCCccc
Confidence 99999999998864 46999999999999999999999982222999999999999986 7889999999998
Q ss_pred ecCCCCCceeeccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccce
Q 039819 336 LLDHSDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEV 415 (534)
Q Consensus 336 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 415 (534)
...... .....||+.|+|||++.+..++.++||||||+++|||+||+.||...... ..........
T Consensus 165 ~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-------~~~~~~~~~~---- 230 (271)
T 3dtc_A 165 EWHRTT---KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGL-------AVAYGVAMNK---- 230 (271)
T ss_dssp --------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHH-------HHHHHHHTSC----
T ss_pred cccccc---ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-------HHHHhhhcCC----
Confidence 664332 22456899999999998888999999999999999999999999743211 1111111111
Q ss_pred ecccccCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhc
Q 039819 416 LVDRELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLEG 460 (534)
Q Consensus 416 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~ 460 (534)
.....+...+..+.+++.+|++.+|.+|||+.|+++.|+.
T Consensus 231 -----~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~ 270 (271)
T 3dtc_A 231 -----LALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTT 270 (271)
T ss_dssp -----CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC
T ss_pred -----CCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhc
Confidence 1111222234578999999999999999999999999874
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-41 Score=340.61 Aligned_cols=237 Identities=20% Similarity=0.247 Sum_probs=195.8
Q ss_pred HhCCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEeh-------------hhhhhcccCceeeEEEEEeCCCeeEEEeecc
Q 039819 201 TENFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLK-------------DMISLAVHRNLLRLIGYCATPTERLLVYPYM 266 (534)
Q Consensus 201 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~-------------~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~ 266 (534)
.++|...+.||+|+||.||+|+.. ++..||+|.+. .++..++||||+++++++.+.+..++||||+
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~ 83 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFI 83 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCcccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEeC
Confidence 367888999999999999999986 58899999874 2678889999999999999999999999999
Q ss_pred CCCChhhhcccC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCC--CCcEEEEecccceecCCCCCc
Q 039819 267 SNGSVASRLREK-PALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDD--FCEAIVGDFGLAKLLDHSDSH 343 (534)
Q Consensus 267 ~~gsL~~~l~~~-~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~--~~~~kl~DFGla~~~~~~~~~ 343 (534)
++|+|.+++... ..+++..+..++.|++.||.|||+. +|+||||||+|||++. ++.+||+|||+++......
T Consensus 84 ~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~---givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~-- 158 (321)
T 1tki_A 84 SGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD-- 158 (321)
T ss_dssp CCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC--
T ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCC--
Confidence 999999999765 4799999999999999999999999 9999999999999987 7999999999999875432
Q ss_pred eeeccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceecccccCC
Q 039819 344 VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELGS 423 (534)
Q Consensus 344 ~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 423 (534)
......||+.|+|||++.+..++.++|||||||++|||+||+.||..... .+....+...... .+.....
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-------~~~~~~i~~~~~~---~~~~~~~ 228 (321)
T 1tki_A 159 NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETN-------QQIIENIMNAEYT---FDEEAFK 228 (321)
T ss_dssp EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSH-------HHHHHHHHHTCCC---CCHHHHT
T ss_pred ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCH-------HHHHHHHHcCCCC---CChhhhc
Confidence 23445699999999999888899999999999999999999999974332 1122222111100 0000001
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 424 NYDRIEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 424 ~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
..+.++.+++.+|++.||.+|||+.|+++
T Consensus 229 ----~~s~~~~~li~~~L~~dp~~Rpt~~e~l~ 257 (321)
T 1tki_A 229 ----EISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp ----TSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ----cCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 12357889999999999999999999987
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=355.73 Aligned_cols=240 Identities=29% Similarity=0.420 Sum_probs=194.4
Q ss_pred hCCCcCCeeccCCcEEEEEEEEC------CCcEEEEEEehh---------------hhhhcccCceeeEEEEEeCCCeeE
Q 039819 202 ENFSSKNILGAGGFGNVYKGKLG------DGTVLAVKRLKD---------------MISLAVHRNLLRLIGYCATPTERL 260 (534)
Q Consensus 202 ~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~---------------~l~~~~h~niv~l~~~~~~~~~~~ 260 (534)
++|...+.||+|+||.||+|++. ++..||||++.. ++..++|||||++++++......+
T Consensus 71 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 150 (367)
T 3l9p_A 71 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRF 150 (367)
T ss_dssp GGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred hHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCE
Confidence 56788899999999999999853 467899999742 567789999999999999999999
Q ss_pred EEeeccCCCChhhhcccC-------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCC---cEEEEe
Q 039819 261 LVYPYMSNGSVASRLREK-------PALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFC---EAIVGD 330 (534)
Q Consensus 261 lv~e~~~~gsL~~~l~~~-------~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~---~~kl~D 330 (534)
+||||+++|+|.+++... ..+++..++.|+.|++.||.|||++ +|+||||||+|||++.++ .+||+|
T Consensus 151 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kL~D 227 (367)
T 3l9p_A 151 ILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGD 227 (367)
T ss_dssp EEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECC
T ss_pred EEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEEecCCCCceEEECC
Confidence 999999999999999643 3599999999999999999999999 999999999999999554 599999
Q ss_pred cccceecCCCC-CceeeccccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCcCCCccccccchHHHHHHHHh
Q 039819 331 FGLAKLLDHSD-SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GMRALEFGKSINQKGAMLEWVKKIQ 408 (534)
Q Consensus 331 FGla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~ 408 (534)
||+++...... ........||+.|+|||++.+..++.++|||||||++|||+| |+.||..... .+......
T Consensus 228 FG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~-------~~~~~~i~ 300 (367)
T 3l9p_A 228 FGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN-------QEVLEFVT 300 (367)
T ss_dssp CHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH-------HHHHHHHH
T ss_pred CccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH-------HHHHHHHH
Confidence 99998542211 112334557899999999998999999999999999999998 9999974321 12222222
Q ss_pred hhcccceecccccCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhcC
Q 039819 409 QEKKVEVLVDRELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLEGD 461 (534)
Q Consensus 409 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~~ 461 (534)
.... ...+...+..+.+++.+||+.+|.+||++.+|++.|+..
T Consensus 301 ~~~~----------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~ 343 (367)
T 3l9p_A 301 SGGR----------MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC 343 (367)
T ss_dssp TTCC----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred cCCC----------CCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 2111 011222345789999999999999999999999998763
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-41 Score=345.23 Aligned_cols=229 Identities=25% Similarity=0.325 Sum_probs=190.7
Q ss_pred HhCCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEehh-----------------hhhhc-ccCceeeEEEEEeCCCeeEE
Q 039819 201 TENFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLKD-----------------MISLA-VHRNLLRLIGYCATPTERLL 261 (534)
Q Consensus 201 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~-----------------~l~~~-~h~niv~l~~~~~~~~~~~l 261 (534)
.++|...+.||+|+||.||+|+.. +++.||||++.. ++..+ .||||+++++++.+.+..|+
T Consensus 19 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l 98 (353)
T 2i0e_A 19 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF 98 (353)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEE
Confidence 467889999999999999999986 478999998852 33344 79999999999999999999
Q ss_pred EeeccCCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCC
Q 039819 262 VYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSD 341 (534)
Q Consensus 262 v~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~ 341 (534)
||||+++|+|.+++.....+++..++.++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 99 v~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~ 175 (353)
T 2i0e_A 99 VMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG 175 (353)
T ss_dssp EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT
T ss_pred EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEEcCCCcEEEEeCCcccccccCC
Confidence 999999999999998877899999999999999999999999 99999999999999999999999999998643222
Q ss_pred CceeeccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceeccccc
Q 039819 342 SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDREL 421 (534)
Q Consensus 342 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 421 (534)
......+||+.|+|||++.+..++.++|||||||++|||++|+.||..... .+....+.... ..
T Consensus 176 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~-------~~~~~~i~~~~-------~~- 239 (353)
T 2i0e_A 176 -VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE-------DELFQSIMEHN-------VA- 239 (353)
T ss_dssp -CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHHHHHCC-------CC-
T ss_pred -cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCH-------HHHHHHHHhCC-------CC-
Confidence 234456799999999999988999999999999999999999999974321 11222222111 01
Q ss_pred CCCCCHHHHHHHHHHHHHhcccCCCCCCCh
Q 039819 422 GSNYDRIEVGEILQVALLCTQYLPVHRPKM 451 (534)
Q Consensus 422 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~ 451 (534)
++...+..+.+++.+|++.+|.+||++
T Consensus 240 ---~p~~~s~~~~~li~~lL~~dP~~R~~~ 266 (353)
T 2i0e_A 240 ---YPKSMSKEAVAICKGLMTKHPGKRLGC 266 (353)
T ss_dssp ---CCTTSCHHHHHHHHHHTCSCTTSCTTC
T ss_pred ---CCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence 112234578999999999999999965
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=342.04 Aligned_cols=249 Identities=21% Similarity=0.305 Sum_probs=186.8
Q ss_pred hCCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEeh---------------hhhhhcccCceeeEEEEEeCCCeeEEEeec
Q 039819 202 ENFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLK---------------DMISLAVHRNLLRLIGYCATPTERLLVYPY 265 (534)
Q Consensus 202 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~---------------~~l~~~~h~niv~l~~~~~~~~~~~lv~e~ 265 (534)
++|...+.||+|+||.||+|+.. +++.||||++. +++..++||||+++++++......++||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 46888899999999999999986 78999999874 267788999999999999999999999999
Q ss_pred cCCCChhhhccc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCCce
Q 039819 266 MSNGSVASRLRE-KPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHV 344 (534)
Q Consensus 266 ~~~gsL~~~l~~-~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~ 344 (534)
++ |+|.+++.. ...+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++....... .
T Consensus 82 ~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~-~ 156 (324)
T 3mtl_A 82 LD-KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK-T 156 (324)
T ss_dssp CS-EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCCGGGEEECTTCCEEECSSSEEECC-------
T ss_pred cc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCcCHHHEEECCCCCEEEccCcccccccCCcc-c
Confidence 97 588888875 45699999999999999999999999 999999999999999999999999999986543222 2
Q ss_pred eecccccccccccccccc-CCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceecc-----
Q 039819 345 TTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVD----- 418 (534)
Q Consensus 345 ~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d----- 418 (534)
.....||..|+|||++.+ ..++.++|||||||++|||+||+.||...........+............ .....
T Consensus 157 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~-~~~~~~~~~~ 235 (324)
T 3mtl_A 157 YDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETW-PGILSNEEFK 235 (324)
T ss_dssp ------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTS-TTGGGCHHHH
T ss_pred cccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhc-hhhhcchhhc
Confidence 334568999999999876 56899999999999999999999999754432211111111110000000 00000
Q ss_pred ----cccCCC----CCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 419 ----RELGSN----YDRIEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 419 ----~~l~~~----~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
+..... ........+.+++.+|++.||.+|||++|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 281 (324)
T 3mtl_A 236 TYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK 281 (324)
T ss_dssp HTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred ccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 000000 00112347889999999999999999999985
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-42 Score=338.55 Aligned_cols=240 Identities=23% Similarity=0.368 Sum_probs=183.7
Q ss_pred HhCCCcCCeeccCCcEEEEEEEECC----CcEEEEEEehh---------------hhhhcccCceeeEEEEEeCCCeeEE
Q 039819 201 TENFSSKNILGAGGFGNVYKGKLGD----GTVLAVKRLKD---------------MISLAVHRNLLRLIGYCATPTERLL 261 (534)
Q Consensus 201 ~~~~~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~---------------~l~~~~h~niv~l~~~~~~~~~~~l 261 (534)
.++|...+.||+|+||.||+|.... +..||||.+.. .+..++||||+++++++. .+..++
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~l 92 (281)
T 1mp8_A 14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 92 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEE
Confidence 3578888999999999999998743 45799998652 567788999999999984 466899
Q ss_pred EeeccCCCChhhhcccC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCC
Q 039819 262 VYPYMSNGSVASRLREK-PALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHS 340 (534)
Q Consensus 262 v~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~ 340 (534)
||||+++|+|.+++... ..+++..++.++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 93 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 169 (281)
T 1mp8_A 93 IMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS 169 (281)
T ss_dssp EEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC----------
T ss_pred EEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHEEECCCCCEEECccccccccCcc
Confidence 99999999999999754 4699999999999999999999999 9999999999999999999999999999877543
Q ss_pred CCceeeccccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCcCCCccccccchHHHHHHHHhhhcccceeccc
Q 039819 341 DSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDR 419 (534)
Q Consensus 341 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 419 (534)
.........+|+.|+|||++.+..++.++|||||||++|||++ |+.||...... .... .+..... .
T Consensus 170 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~----~~~~---~i~~~~~------~ 236 (281)
T 1mp8_A 170 TYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN----DVIG---RIENGER------L 236 (281)
T ss_dssp ---------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG----GHHH---HHHTTCC------C
T ss_pred cccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHH----HHHH---HHHcCCC------C
Confidence 3323334457789999999988899999999999999999997 99999753321 1111 1111110 0
Q ss_pred ccCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhcC
Q 039819 420 ELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLEGD 461 (534)
Q Consensus 420 ~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~~ 461 (534)
..+...+..+.+++.+|++.+|.+||++.|+++.|+..
T Consensus 237 ----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~ 274 (281)
T 1mp8_A 237 ----PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 274 (281)
T ss_dssp ----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ----CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 11122345788999999999999999999999998763
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-42 Score=348.59 Aligned_cols=242 Identities=25% Similarity=0.427 Sum_probs=198.1
Q ss_pred HHhCCCcCCeeccCCcEEEEEEEEC------CCcEEEEEEehh---------------hhhhcccCceeeEEEEEeCCCe
Q 039819 200 ATENFSSKNILGAGGFGNVYKGKLG------DGTVLAVKRLKD---------------MISLAVHRNLLRLIGYCATPTE 258 (534)
Q Consensus 200 ~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~---------------~l~~~~h~niv~l~~~~~~~~~ 258 (534)
..++|...+.||+|+||.||+|+.. +++.||||.+.. ++..++||||++++++|.+...
T Consensus 45 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 124 (343)
T 1luf_A 45 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKP 124 (343)
T ss_dssp CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred cHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCc
Confidence 4578999999999999999999974 348899998752 5778899999999999999999
Q ss_pred eEEEeeccCCCChhhhcccC------------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCC
Q 039819 259 RLLVYPYMSNGSVASRLREK------------------------PALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVK 314 (534)
Q Consensus 259 ~~lv~e~~~~gsL~~~l~~~------------------------~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlk 314 (534)
.++||||+++|+|.+++... ..+++.+++.|+.|++.||.|||+. +|+|||||
T Consensus 125 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlk 201 (343)
T 1luf_A 125 MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLA 201 (343)
T ss_dssp CEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCS
T ss_pred eEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCC
Confidence 99999999999999998752 5699999999999999999999999 99999999
Q ss_pred CCcEEeCCCCcEEEEecccceecCCCCC-ceeeccccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCcCCCc
Q 039819 315 AANVLLDDFCEAIVGDFGLAKLLDHSDS-HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GMRALEFGK 392 (534)
Q Consensus 315 p~NiLl~~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~ellt-G~~p~~~~~ 392 (534)
|+|||++.++.+||+|||+++....... .......||..|+|||++.+..++.++|||||||++|||+| |+.||....
T Consensus 202 p~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 281 (343)
T 1luf_A 202 TRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMA 281 (343)
T ss_dssp GGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred cceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCCC
Confidence 9999999999999999999986543221 12234567899999999988899999999999999999999 999996432
Q ss_pred cccccchHHHHHHHHhhhcccceecccccCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhcC
Q 039819 393 SINQKGAMLEWVKKIQQEKKVEVLVDRELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLEGD 461 (534)
Q Consensus 393 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~~ 461 (534)
. .+......... .. ..+...+..+.+++.+||+.+|.+||++.++++.|+..
T Consensus 282 ~-------~~~~~~~~~~~-~~---------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~ 333 (343)
T 1luf_A 282 H-------EEVIYYVRDGN-IL---------ACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRM 333 (343)
T ss_dssp H-------HHHHHHHHTTC-CC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred h-------HHHHHHHhCCC-cC---------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHH
Confidence 1 11222221111 10 11122345789999999999999999999999999874
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-42 Score=362.45 Aligned_cols=240 Identities=27% Similarity=0.385 Sum_probs=192.7
Q ss_pred HhCCCcCCeeccCCcEEEEEEEECCCcEEEEEEehh-------------hhhhcccCceeeEEEEEeCCCeeEEEeeccC
Q 039819 201 TENFSSKNILGAGGFGNVYKGKLGDGTVLAVKRLKD-------------MISLAVHRNLLRLIGYCATPTERLLVYPYMS 267 (534)
Q Consensus 201 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~-------------~l~~~~h~niv~l~~~~~~~~~~~lv~e~~~ 267 (534)
.++|...+.||+|+||.||+|.+.++..||||+++. ++..++||||+++++++.+ ...++||||++
T Consensus 183 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~~ 261 (452)
T 1fmk_A 183 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMS 261 (452)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCT
T ss_pred hhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehhhc
Confidence 356778889999999999999998888899998862 6788899999999999876 67899999999
Q ss_pred CCChhhhccc--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCCcee
Q 039819 268 NGSVASRLRE--KPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVT 345 (534)
Q Consensus 268 ~gsL~~~l~~--~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~ 345 (534)
+|+|.+++.. ...+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++..........
T Consensus 262 ~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~ 338 (452)
T 1fmk_A 262 KGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTAR 338 (452)
T ss_dssp TCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC----------
T ss_pred CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEECCCCCEEECCCccceecCCCceecc
Confidence 9999999974 35699999999999999999999999 999999999999999999999999999987654332223
Q ss_pred eccccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCcCCCccccccchHHHHHHHHhhhcccceecccccCCC
Q 039819 346 TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELGSN 424 (534)
Q Consensus 346 ~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 424 (534)
....+|..|+|||++..+.++.++|||||||++|||+| |+.||..... .+.......... ..
T Consensus 339 ~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~-------~~~~~~i~~~~~----------~~ 401 (452)
T 1fmk_A 339 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN-------REVLDQVERGYR----------MP 401 (452)
T ss_dssp ----CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH-------HHHHHHHHTTCC----------CC
T ss_pred cCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCH-------HHHHHHHHcCCC----------CC
Confidence 34457889999999998999999999999999999999 9999974321 112222211111 11
Q ss_pred CCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhcC
Q 039819 425 YDRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLEGD 461 (534)
Q Consensus 425 ~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~~ 461 (534)
.+...+..+.+++.+||+.+|++|||++++++.|+..
T Consensus 402 ~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~ 438 (452)
T 1fmk_A 402 CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 438 (452)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTT
T ss_pred CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 1223345889999999999999999999999999864
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-42 Score=342.39 Aligned_cols=241 Identities=28% Similarity=0.406 Sum_probs=197.3
Q ss_pred HhCCCcCCeeccCCcEEEEEEEE------CCCcEEEEEEehh---------------hhhhcccCceeeEEEEEeCCCee
Q 039819 201 TENFSSKNILGAGGFGNVYKGKL------GDGTVLAVKRLKD---------------MISLAVHRNLLRLIGYCATPTER 259 (534)
Q Consensus 201 ~~~~~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~---------------~l~~~~h~niv~l~~~~~~~~~~ 259 (534)
.++|...+.||+|+||.||+|+. .++..||||.+.. ++..++||||+++++++.+....
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 101 (314)
T 2ivs_A 22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPL 101 (314)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCce
Confidence 46788889999999999999986 3458899998752 56778999999999999999999
Q ss_pred EEEeeccCCCChhhhcccCC------------------------CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCC
Q 039819 260 LLVYPYMSNGSVASRLREKP------------------------ALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKA 315 (534)
Q Consensus 260 ~lv~e~~~~gsL~~~l~~~~------------------------~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp 315 (534)
++||||+++|+|.+++.... .+++..++.++.|++.||.|||+. +|+||||||
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dikp 178 (314)
T 2ivs_A 102 LLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM---KLVHRDLAA 178 (314)
T ss_dssp EEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHT---TEECCCCSG
T ss_pred EEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHC---CCcccccch
Confidence 99999999999999997543 389999999999999999999999 999999999
Q ss_pred CcEEeCCCCcEEEEecccceecCCCCCc-eeeccccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCcCCCcc
Q 039819 316 ANVLLDDFCEAIVGDFGLAKLLDHSDSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GMRALEFGKS 393 (534)
Q Consensus 316 ~NiLl~~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~ellt-G~~p~~~~~~ 393 (534)
+|||++.++.+||+|||+++........ ......+|..|+|||++.+..++.++|||||||++|||+| |+.||.....
T Consensus 179 ~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~ 258 (314)
T 2ivs_A 179 RNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPP 258 (314)
T ss_dssp GGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCG
T ss_pred heEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 9999999999999999999877543322 1223457889999999988889999999999999999999 9999974332
Q ss_pred ccccchHHHHHHHHhhhcccceecccccCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhcC
Q 039819 394 INQKGAMLEWVKKIQQEKKVEVLVDRELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLEGD 461 (534)
Q Consensus 394 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~~ 461 (534)
. .+...+ ..... ...+...+..+.+++.+|++.+|.+||++.|+++.|+..
T Consensus 259 ~----~~~~~~---~~~~~----------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~ 309 (314)
T 2ivs_A 259 E----RLFNLL---KTGHR----------MERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKM 309 (314)
T ss_dssp G----GHHHHH---HTTCC----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred H----HHHHHh---hcCCc----------CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 1 111111 11110 011122345789999999999999999999999998763
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=358.74 Aligned_cols=235 Identities=27% Similarity=0.392 Sum_probs=193.6
Q ss_pred HhCCCcCCeeccCCcEEEEEEEECCCcEEEEEEehh------------hhhhcccCceeeEEEEEeCCC-eeEEEeeccC
Q 039819 201 TENFSSKNILGAGGFGNVYKGKLGDGTVLAVKRLKD------------MISLAVHRNLLRLIGYCATPT-ERLLVYPYMS 267 (534)
Q Consensus 201 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~------------~l~~~~h~niv~l~~~~~~~~-~~~lv~e~~~ 267 (534)
.++|...+.||+|+||.||+|++. ++.||||.++. ++..++|||||++++++.+.. ..++|||||+
T Consensus 192 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~~ 270 (450)
T 1k9a_A 192 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMA 270 (450)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCTTSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEECCT
T ss_pred hHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCchHHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEecC
Confidence 356788899999999999999985 67999998862 678889999999999987765 6899999999
Q ss_pred CCChhhhcccCC--CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCCcee
Q 039819 268 NGSVASRLREKP--ALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVT 345 (534)
Q Consensus 268 ~gsL~~~l~~~~--~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~ 345 (534)
+|+|.+++.... .+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++..... .
T Consensus 271 ~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~----~ 343 (450)
T 1k9a_A 271 KGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST----Q 343 (450)
T ss_dssp TCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTSCEEECCCTTCEECC-------
T ss_pred CCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEECCCCCEEEeeCCCccccccc----c
Confidence 999999997543 479999999999999999999999 9999999999999999999999999999865332 1
Q ss_pred eccccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCcCCCccccccchHHHHHHHHhhhcccceecccccCCC
Q 039819 346 TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELGSN 424 (534)
Q Consensus 346 ~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 424 (534)
....++..|+|||++.+..++.++|||||||++|||+| |+.||...... .+. ..+..... ..
T Consensus 344 ~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~----~~~---~~i~~~~~----------~~ 406 (450)
T 1k9a_A 344 DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK----DVV---PRVEKGYK----------MD 406 (450)
T ss_dssp ---CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTT----THH---HHHHTTCC----------CC
T ss_pred cCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH----HHH---HHHHcCCC----------CC
Confidence 22357889999999999999999999999999999999 99999743321 111 11111111 11
Q ss_pred CCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhc
Q 039819 425 YDRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLEG 460 (534)
Q Consensus 425 ~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~ 460 (534)
.+...+..+.+++.+||+.+|.+|||+.++++.|+.
T Consensus 407 ~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~ 442 (450)
T 1k9a_A 407 APDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEH 442 (450)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 222335688999999999999999999999999875
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=346.74 Aligned_cols=242 Identities=28% Similarity=0.424 Sum_probs=197.0
Q ss_pred HhCCCcCCeeccCCcEEEEEEEE------CCCcEEEEEEehh---------------hhhhc-ccCceeeEEEEEeCCCe
Q 039819 201 TENFSSKNILGAGGFGNVYKGKL------GDGTVLAVKRLKD---------------MISLA-VHRNLLRLIGYCATPTE 258 (534)
Q Consensus 201 ~~~~~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~---------------~l~~~-~h~niv~l~~~~~~~~~ 258 (534)
.++|...+.||+|+||.||+|+. .++..||||.+.. ++..+ .||||+++++++...+.
T Consensus 44 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~ 123 (344)
T 1rjb_A 44 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP 123 (344)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCCc
Confidence 46788889999999999999986 2456899998752 56677 89999999999999999
Q ss_pred eEEEeeccCCCChhhhcccCC-----------------------CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCC
Q 039819 259 RLLVYPYMSNGSVASRLREKP-----------------------ALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKA 315 (534)
Q Consensus 259 ~~lv~e~~~~gsL~~~l~~~~-----------------------~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp 315 (534)
.++||||+++|+|.+++.... .+++..++.++.|++.||.|||+. +|+||||||
T Consensus 124 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp 200 (344)
T 1rjb_A 124 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAA 200 (344)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTCSG
T ss_pred cEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCh
Confidence 999999999999999997542 379999999999999999999999 999999999
Q ss_pred CcEEeCCCCcEEEEecccceecCCCCC-ceeeccccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCcCCCcc
Q 039819 316 ANVLLDDFCEAIVGDFGLAKLLDHSDS-HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GMRALEFGKS 393 (534)
Q Consensus 316 ~NiLl~~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~ellt-G~~p~~~~~~ 393 (534)
+|||++.++.+||+|||+++....... .......||+.|+|||++.+..++.++|||||||++|||+| |+.||.....
T Consensus 201 ~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~ 280 (344)
T 1rjb_A 201 RNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV 280 (344)
T ss_dssp GGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred hhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCCc
Confidence 999999999999999999987644332 22334557889999999988899999999999999999998 9999975332
Q ss_pred ccccchHHHHHHHHhhhcccceecccccCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhcC
Q 039819 394 INQKGAMLEWVKKIQQEKKVEVLVDRELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLEGD 461 (534)
Q Consensus 394 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~~ 461 (534)
. ..+...+ .. . .....+...+..+.+++.+||+.+|.+||++.++++.|+..
T Consensus 281 ~---~~~~~~~---~~-~---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~ 332 (344)
T 1rjb_A 281 D---ANFYKLI---QN-G---------FKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQ 332 (344)
T ss_dssp S---HHHHHHH---HT-T---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred H---HHHHHHH---hc-C---------CCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHH
Confidence 1 1111111 11 1 01111222345889999999999999999999999998763
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=348.93 Aligned_cols=260 Identities=20% Similarity=0.269 Sum_probs=198.4
Q ss_pred ccccCHHHHHHHHhCCCcCCeeccCCcEEEEEEEE-CCCcEEEEEEehh-------------hhhhcc-----cCceeeE
Q 039819 189 LRNFTFRELQQATENFSSKNILGAGGFGNVYKGKL-GDGTVLAVKRLKD-------------MISLAV-----HRNLLRL 249 (534)
Q Consensus 189 ~~~~~~~~l~~~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~-------------~l~~~~-----h~niv~l 249 (534)
...+++.+.....++|...+.||+|+||.||+|+. .+++.||||++.. ++..+. ||||+++
T Consensus 22 ~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~ 101 (360)
T 3llt_A 22 IVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIVKY 101 (360)
T ss_dssp GGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCHHHHHHHHHHHHHHHHTCCCSTTGGGBCCE
T ss_pred ceeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccchhhhhhhHHHHHHHHHhcccCCCCCCeecc
Confidence 34455555555678999999999999999999998 4689999999852 445554 9999999
Q ss_pred EEEEeCCCeeEEEeeccCCCChhhhcccCC--CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCC-----
Q 039819 250 IGYCATPTERLLVYPYMSNGSVASRLREKP--ALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDD----- 322 (534)
Q Consensus 250 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~--~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~----- 322 (534)
++++...+..++||||+ +++|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+|||++.
T Consensus 102 ~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~ 177 (360)
T 3llt_A 102 HGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKM---SLTHTDLKPENILLDDPYFEK 177 (360)
T ss_dssp EEEEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCTTCCE
T ss_pred cceeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCcccEEEccccccc
Confidence 99999999999999999 999999997543 599999999999999999999999 9999999999999975
Q ss_pred --------------------CCcEEEEecccceecCCCCCceeeccccccccccccccccCCCCcchhHHHHHHHHHHHH
Q 039819 323 --------------------FCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELI 382 (534)
Q Consensus 323 --------------------~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~ell 382 (534)
++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||+
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell 253 (360)
T 3llt_A 178 SLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY----HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELY 253 (360)
T ss_dssp EEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHH
T ss_pred cccchhcccccccccccccCCCCEEEEeccCceecCCC----CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHH
Confidence 789999999999875432 23456899999999999999999999999999999999
Q ss_pred hCCCCcCCCccccccchHHH--------HHHHHhhhcccceeccccc----CCCCC----------------HHHHHHHH
Q 039819 383 TGMRALEFGKSINQKGAMLE--------WVKKIQQEKKVEVLVDREL----GSNYD----------------RIEVGEIL 434 (534)
Q Consensus 383 tG~~p~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~d~~l----~~~~~----------------~~~~~~l~ 434 (534)
||+.||...........+.. +.................. ..... ......+.
T Consensus 254 ~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 333 (360)
T 3llt_A 254 TGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFC 333 (360)
T ss_dssp HSSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHH
T ss_pred HCCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHH
Confidence 99999975432211111111 0000000000000000000 00000 00114678
Q ss_pred HHHHHhcccCCCCCCChHHHHH
Q 039819 435 QVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 435 ~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
+++.+|++.||++|||+.|+++
T Consensus 334 ~li~~~L~~dP~~Rpta~elL~ 355 (360)
T 3llt_A 334 DFLYSILQIDPTLRPSPAELLK 355 (360)
T ss_dssp HHHHHHCCSSGGGSCCHHHHTT
T ss_pred HHHHHHhcCChhhCCCHHHHhc
Confidence 9999999999999999999974
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-41 Score=354.94 Aligned_cols=234 Identities=23% Similarity=0.284 Sum_probs=194.7
Q ss_pred HhCCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEehh-----------------hhhhcccCceeeEEEEEeCCCeeEEE
Q 039819 201 TENFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLKD-----------------MISLAVHRNLLRLIGYCATPTERLLV 262 (534)
Q Consensus 201 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~-----------------~l~~~~h~niv~l~~~~~~~~~~~lv 262 (534)
.++|...+.||+|+||.||+|+.. +++.||||++.. ++..++||||++++++|...+..++|
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 226 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV 226 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence 367888999999999999999975 689999998752 46677899999999999999999999
Q ss_pred eeccCCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCC
Q 039819 263 YPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHE-QCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSD 341 (534)
Q Consensus 263 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~-~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~ 341 (534)
|||+++|+|.+++.....+++..+..++.|++.||+|||+ . +||||||||+|||++.++.+||+|||+++......
T Consensus 227 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 303 (446)
T 4ejn_A 227 MEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG 303 (446)
T ss_dssp ECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC--
T ss_pred EeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcC---CEEECCCCHHHEEECCCCCEEEccCCCceeccCCC
Confidence 9999999999999888889999999999999999999998 7 89999999999999999999999999998643322
Q ss_pred CceeeccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceeccccc
Q 039819 342 SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDREL 421 (534)
Q Consensus 342 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 421 (534)
......+||+.|+|||++.+..++.++|||||||++|||+||+.||..... .+....+.... ..
T Consensus 304 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~-------~~~~~~i~~~~-------~~- 367 (446)
T 4ejn_A 304 -ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-------EKLFELILMEE-------IR- 367 (446)
T ss_dssp ----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHHHHHCC-------CC-
T ss_pred -cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH-------HHHHHHHHhCC-------CC-
Confidence 233456799999999999999999999999999999999999999974321 11111111111 01
Q ss_pred CCCCCHHHHHHHHHHHHHhcccCCCCCC-----ChHHHHH
Q 039819 422 GSNYDRIEVGEILQVALLCTQYLPVHRP-----KMSEVVR 456 (534)
Q Consensus 422 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RP-----t~~ev~~ 456 (534)
++......+.+++.+|++.||.+|| +++|+++
T Consensus 368 ---~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~ 404 (446)
T 4ejn_A 368 ---FPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ 404 (446)
T ss_dssp ---CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred ---CCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence 1122345789999999999999999 9999886
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=335.36 Aligned_cols=232 Identities=29% Similarity=0.424 Sum_probs=192.0
Q ss_pred HhCCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEeh-----------------hhhhhcccCceeeEEEEEeCCCeeEEE
Q 039819 201 TENFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLK-----------------DMISLAVHRNLLRLIGYCATPTERLLV 262 (534)
Q Consensus 201 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~-----------------~~l~~~~h~niv~l~~~~~~~~~~~lv 262 (534)
.++|...+.||+|+||.||+|+.. ++..||||++. .++..++||||+++++++.+....++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 87 (279)
T 3fdn_A 8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 87 (279)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence 467888999999999999999875 57799999874 256778899999999999999999999
Q ss_pred eeccCCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCC
Q 039819 263 YPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDS 342 (534)
Q Consensus 263 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~ 342 (534)
|||+++|+|.+++.....+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++......
T Consensus 88 ~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~-- 162 (279)
T 3fdn_A 88 LEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS-- 162 (279)
T ss_dssp ECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTT---TCEECCCCGGGEEECTTSCEEECSCCEESCC-----
T ss_pred EecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHhEEEcCCCCEEEEeccccccCCcc--
Confidence 99999999999998878899999999999999999999998 9999999999999999999999999998654332
Q ss_pred ceeeccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceecccccC
Q 039819 343 HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELG 422 (534)
Q Consensus 343 ~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 422 (534)
......||..|+|||++.+..++.++||||||+++|||++|+.||..... .+......... .
T Consensus 163 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-------~~~~~~~~~~~-------~--- 224 (279)
T 3fdn_A 163 -RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY-------QETYKRISRVE-------F--- 224 (279)
T ss_dssp ------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSH-------HHHHHHHHHTC-------C---
T ss_pred -cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcH-------HHHHHHHHhCC-------C---
Confidence 23345689999999999988899999999999999999999999974321 11111111110 0
Q ss_pred CCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 423 SNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 423 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
..+...+..+.+++.+|++.+|.+||++.|+++
T Consensus 225 -~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~ 257 (279)
T 3fdn_A 225 -TFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 257 (279)
T ss_dssp -CCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred -CCCCcCCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 111223457889999999999999999999986
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-41 Score=347.34 Aligned_cols=237 Identities=22% Similarity=0.302 Sum_probs=195.3
Q ss_pred HhCCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEeh--------------hhhhhcccCceeeEEEEEeCCCeeEEEeec
Q 039819 201 TENFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLK--------------DMISLAVHRNLLRLIGYCATPTERLLVYPY 265 (534)
Q Consensus 201 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~--------------~~l~~~~h~niv~l~~~~~~~~~~~lv~e~ 265 (534)
.++|...+.||+|+||.||+|... +++.||+|.+. +++..++||||+++++++.+....++||||
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~ 129 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 129 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence 367889999999999999999985 68899999874 267788999999999999999999999999
Q ss_pred cCCCChhhhcccC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeC--CCCcEEEEecccceecCCCCC
Q 039819 266 MSNGSVASRLREK-PALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLD--DFCEAIVGDFGLAKLLDHSDS 342 (534)
Q Consensus 266 ~~~gsL~~~l~~~-~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~--~~~~~kl~DFGla~~~~~~~~ 342 (534)
+++|+|.+++... ..+++..+..++.|++.||.|||+. +|+||||||+|||++ ..+.+||+|||+++......
T Consensus 130 ~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~- 205 (387)
T 1kob_A 130 LSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE- 205 (387)
T ss_dssp CCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS-
T ss_pred CCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccchHHeEEecCCCCceEEEecccceecCCCc-
Confidence 9999999999754 4799999999999999999999999 999999999999997 45789999999999875432
Q ss_pred ceeeccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceecccccC
Q 039819 343 HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELG 422 (534)
Q Consensus 343 ~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 422 (534)
......||+.|+|||++.+..++.++|||||||++|||+||+.||..... .+.+..+..... ..+....
T Consensus 206 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~-------~~~~~~i~~~~~---~~~~~~~ 274 (387)
T 1kob_A 206 -IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDD-------LETLQNVKRCDW---EFDEDAF 274 (387)
T ss_dssp -CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH-------HHHHHHHHHCCC---CCCSSTT
T ss_pred -ceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCH-------HHHHHHHHhCCC---CCCcccc
Confidence 23345699999999999988999999999999999999999999974322 111222111110 0111111
Q ss_pred CCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 423 SNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 423 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
. ..+..+.+++.+|++.||.+|||+.|+++
T Consensus 275 ~----~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 304 (387)
T 1kob_A 275 S----SVSPEAKDFIKNLLQKEPRKRLTVHDALE 304 (387)
T ss_dssp T----TSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred c----cCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence 1 22457899999999999999999999986
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=340.52 Aligned_cols=252 Identities=21% Similarity=0.279 Sum_probs=191.0
Q ss_pred HhCCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEeh----------------hhhhhcccCceeeEEEEEeCCCeeEEEe
Q 039819 201 TENFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLK----------------DMISLAVHRNLLRLIGYCATPTERLLVY 263 (534)
Q Consensus 201 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~----------------~~l~~~~h~niv~l~~~~~~~~~~~lv~ 263 (534)
.++|...+.||+|+||.||+|+.. +++.||||++. +++..++||||+++++++......++||
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVF 81 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEE
Confidence 357888999999999999999986 58999999873 2677889999999999999999999999
Q ss_pred eccCCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCCc
Q 039819 264 PYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSH 343 (534)
Q Consensus 264 e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~ 343 (534)
||+++++|.+++.....+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 82 e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~- 157 (311)
T 4agu_A 82 EYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSD- 157 (311)
T ss_dssp ECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred EeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCChhhEEEcCCCCEEEeeCCCchhccCccc-
Confidence 9999999999998888899999999999999999999999 999999999999999999999999999987653322
Q ss_pred eeecccccccccccccccc-CCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHH--------HHHhhhcccc
Q 039819 344 VTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWV--------KKIQQEKKVE 414 (534)
Q Consensus 344 ~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~--------~~~~~~~~~~ 414 (534)
......||..|+|||++.+ ..++.++|||||||++|||+||+.||...........+.... ..........
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (311)
T 4agu_A 158 YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFS 237 (311)
T ss_dssp --------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGT
T ss_pred ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccccc
Confidence 2334568999999999875 568999999999999999999999997544322211111110 0000000000
Q ss_pred --eecccccCCCC---CHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 415 --VLVDRELGSNY---DRIEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 415 --~~~d~~l~~~~---~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
.+.++...... ....+..+.+++.+|++.||.+|||++|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 284 (311)
T 4agu_A 238 GVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH 284 (311)
T ss_dssp TCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT
T ss_pred cCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 00000000000 0112346889999999999999999999985
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-41 Score=339.62 Aligned_cols=254 Identities=23% Similarity=0.341 Sum_probs=193.7
Q ss_pred HHHHhCCCcCCeeccCCcEEEEEEEECCCcEEEEEEehh-----------h--hhhcccCceeeEEEEEeCC----CeeE
Q 039819 198 QQATENFSSKNILGAGGFGNVYKGKLGDGTVLAVKRLKD-----------M--ISLAVHRNLLRLIGYCATP----TERL 260 (534)
Q Consensus 198 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~-----------~--l~~~~h~niv~l~~~~~~~----~~~~ 260 (534)
....++|...+.||+|+||.||+|+.. ++.||||++.. + ...++||||+++++++... ...+
T Consensus 33 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 111 (337)
T 3mdy_A 33 RTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTEEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLY 111 (337)
T ss_dssp TTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEEE
T ss_pred cccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEeccccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCceE
Confidence 345678999999999999999999985 88999998752 2 2234899999999999877 6789
Q ss_pred EEeeccCCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcC-----CCCeEeccCCCCcEEeCCCCcEEEEecccce
Q 039819 261 LVYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQC-----DPKIIHRDVKAANVLLDDFCEAIVGDFGLAK 335 (534)
Q Consensus 261 lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~-----~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~ 335 (534)
+||||+++|+|.++++.. .+++..++.++.|++.||.|||+.+ .++|+||||||+|||++.++.+||+|||+++
T Consensus 112 lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~ 190 (337)
T 3mdy_A 112 LITDYHENGSLYDYLKST-TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 190 (337)
T ss_dssp EEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred EEEeccCCCcHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEeCCCce
Confidence 999999999999999755 5999999999999999999999752 3489999999999999999999999999998
Q ss_pred ecCCCCCce---eeccccccccccccccccCCCCcc------hhHHHHHHHHHHHHhC----------CCCcCCCccccc
Q 039819 336 LLDHSDSHV---TTAVRGTVGHIAPEYLSTGQSSEK------TDVFGFGILLLELITG----------MRALEFGKSINQ 396 (534)
Q Consensus 336 ~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~k------~Dv~S~Gvvl~elltG----------~~p~~~~~~~~~ 396 (534)
......... .....||+.|+|||++.+...+.+ +|||||||++|||+|| +.||........
T Consensus 191 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~ 270 (337)
T 3mdy_A 191 KFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDP 270 (337)
T ss_dssp ECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred eeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhcCCCC
Confidence 764432211 124579999999999987666554 9999999999999999 555543221111
Q ss_pred cchHHHHHHHHhhhcccceecccccCCCC-CHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhc
Q 039819 397 KGAMLEWVKKIQQEKKVEVLVDRELGSNY-DRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLEG 460 (534)
Q Consensus 397 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~-~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~ 460 (534)
....+.... .... ..+...... ....+..+.+++.+||+.+|.+|||+.||++.|+.
T Consensus 271 --~~~~~~~~~-~~~~----~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~ 328 (337)
T 3mdy_A 271 --SYEDMREIV-CIKK----LRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAK 328 (337)
T ss_dssp --CHHHHHHHH-TTSC----CCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHH
T ss_pred --chhhhHHHH-hhhc----cCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHH
Confidence 111111111 1111 111111111 12456789999999999999999999999999875
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-42 Score=334.78 Aligned_cols=239 Identities=26% Similarity=0.411 Sum_probs=198.1
Q ss_pred hCCCcCCeeccCCcEEEEEEEECCCcEEEEEEehh-------------hhhhcccCceeeEEEEEeCCCeeEEEeeccCC
Q 039819 202 ENFSSKNILGAGGFGNVYKGKLGDGTVLAVKRLKD-------------MISLAVHRNLLRLIGYCATPTERLLVYPYMSN 268 (534)
Q Consensus 202 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~-------------~l~~~~h~niv~l~~~~~~~~~~~lv~e~~~~ 268 (534)
++|...+.||+|+||.||+|...++..||||.+.. .+..++||||+++++++.+....++||||+++
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 87 (267)
T 3t9t_A 8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEH 87 (267)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCTT
T ss_pred hheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCCCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCCC
Confidence 56778899999999999999998889999998862 57788999999999999999999999999999
Q ss_pred CChhhhcccC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCCceeec
Q 039819 269 GSVASRLREK-PALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTA 347 (534)
Q Consensus 269 gsL~~~l~~~-~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~ 347 (534)
++|.+++... ..+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||+++............
T Consensus 88 ~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~ 164 (267)
T 3t9t_A 88 GCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTG 164 (267)
T ss_dssp CBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHHSTTS
T ss_pred CcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEECCCCCEEEccccccccccccccccccc
Confidence 9999999754 5689999999999999999999999 99999999999999999999999999998764322112233
Q ss_pred cccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCcCCCccccccchHHHHHHHHhhhcccceecccccCCCCC
Q 039819 348 VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELGSNYD 426 (534)
Q Consensus 348 ~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 426 (534)
..+|..|+|||++.+..++.++||||||+++|||+| |+.||..... .+.......... . ..+
T Consensus 165 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~-------~~~~~~i~~~~~------~----~~~ 227 (267)
T 3t9t_A 165 TKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN-------SEVVEDISTGFR------L----YKP 227 (267)
T ss_dssp TTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH-------HHHHHHHHTTCC------C----CCC
T ss_pred ccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCH-------HHHHHHHhcCCc------C----CCC
Confidence 457789999999988889999999999999999999 8999874321 112222211110 0 111
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhc
Q 039819 427 RIEVGEILQVALLCTQYLPVHRPKMSEVVRMLEG 460 (534)
Q Consensus 427 ~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~ 460 (534)
...+..+.+++.+|++.+|.+||++.++++.|+.
T Consensus 228 ~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~ 261 (267)
T 3t9t_A 228 RLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAE 261 (267)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 1224578999999999999999999999999875
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=335.27 Aligned_cols=239 Identities=30% Similarity=0.459 Sum_probs=197.1
Q ss_pred HhCCCcCCeeccCCcEEEEEEEECCCcEEEEEEehh-------------hhhhcccCceeeEEEEEeCCCeeEEEeeccC
Q 039819 201 TENFSSKNILGAGGFGNVYKGKLGDGTVLAVKRLKD-------------MISLAVHRNLLRLIGYCATPTERLLVYPYMS 267 (534)
Q Consensus 201 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~-------------~l~~~~h~niv~l~~~~~~~~~~~lv~e~~~ 267 (534)
.++|...+.||+|+||.||+|+..++..||||.+.. ++..++||||+++++++.. +..++||||++
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~ 90 (279)
T 1qpc_A 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYME 90 (279)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCT
T ss_pred HHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCcccHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEEEecCC
Confidence 357888899999999999999998888999998852 6778899999999999864 56899999999
Q ss_pred CCChhhhcccCC--CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCCcee
Q 039819 268 NGSVASRLREKP--ALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVT 345 (534)
Q Consensus 268 ~gsL~~~l~~~~--~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~ 345 (534)
+++|.+++.... .+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||+++..........
T Consensus 91 ~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 167 (279)
T 1qpc_A 91 NGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAR 167 (279)
T ss_dssp TCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEECC
T ss_pred CCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHhhEEEcCCCCEEECCCcccccccCcccccc
Confidence 999999997543 699999999999999999999999 999999999999999999999999999998754432223
Q ss_pred eccccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCcCCCccccccchHHHHHHHHhhhcccceecccccCCC
Q 039819 346 TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELGSN 424 (534)
Q Consensus 346 ~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 424 (534)
....++..|+|||++.+..++.++|||||||++|||+| |+.||..... .+.......... . .
T Consensus 168 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~-------~~~~~~~~~~~~------~----~ 230 (279)
T 1qpc_A 168 EGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN-------PEVIQNLERGYR------M----V 230 (279)
T ss_dssp TTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCH-------HHHHHHHHTTCC------C----C
T ss_pred cCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCH-------HHHHHHHhcccC------C----C
Confidence 34457889999999988889999999999999999999 9999974321 111222211110 0 1
Q ss_pred CCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhc
Q 039819 425 YDRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLEG 460 (534)
Q Consensus 425 ~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~ 460 (534)
.+...+..+.+++.+|++.+|++|||+.++++.|+.
T Consensus 231 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~ 266 (279)
T 1qpc_A 231 RPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLED 266 (279)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHH
Confidence 111234588999999999999999999999999876
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=341.23 Aligned_cols=240 Identities=27% Similarity=0.412 Sum_probs=196.4
Q ss_pred hCCCcCCeeccCCcEEEEEEEE------CCCcEEEEEEehh---------------hhhhc-ccCceeeEEEEEeCCCee
Q 039819 202 ENFSSKNILGAGGFGNVYKGKL------GDGTVLAVKRLKD---------------MISLA-VHRNLLRLIGYCATPTER 259 (534)
Q Consensus 202 ~~~~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~---------------~l~~~-~h~niv~l~~~~~~~~~~ 259 (534)
++|...+.||+|+||.||+|+. .+++.||||++.. .+..+ +||||+++++++...+..
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~ 102 (313)
T 1t46_A 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPT 102 (313)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred hhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCCc
Confidence 5788889999999999999985 3568899998752 56666 899999999999999999
Q ss_pred EEEeeccCCCChhhhcccCC------------------CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeC
Q 039819 260 LLVYPYMSNGSVASRLREKP------------------ALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLD 321 (534)
Q Consensus 260 ~lv~e~~~~gsL~~~l~~~~------------------~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~ 321 (534)
++||||+++|+|.+++.... .+++..++.++.|++.||.|||+. +|+||||||+|||++
T Consensus 103 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~ 179 (313)
T 1t46_A 103 LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLT 179 (313)
T ss_dssp EEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEE
T ss_pred EEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEc
Confidence 99999999999999997543 489999999999999999999999 999999999999999
Q ss_pred CCCcEEEEecccceecCCCCCc-eeeccccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCcCCCccccccch
Q 039819 322 DFCEAIVGDFGLAKLLDHSDSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GMRALEFGKSINQKGA 399 (534)
Q Consensus 322 ~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~ellt-G~~p~~~~~~~~~~~~ 399 (534)
.++.+||+|||+++........ ......||..|+|||++.+..++.++|||||||++|||+| |+.||...... ..
T Consensus 180 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~---~~ 256 (313)
T 1t46_A 180 HGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD---SK 256 (313)
T ss_dssp TTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS---HH
T ss_pred CCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccch---hH
Confidence 9999999999999877544322 2234457889999999988899999999999999999999 99999743321 11
Q ss_pred HHHHHHHHhhhcccceecccccCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhc
Q 039819 400 MLEWVKKIQQEKKVEVLVDRELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLEG 460 (534)
Q Consensus 400 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~ 460 (534)
....+ .... .. ..+...+..+.+++.+|++.+|.+|||+.|+++.|+.
T Consensus 257 ~~~~~---~~~~------~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~ 304 (313)
T 1t46_A 257 FYKMI---KEGF------RM----LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEK 304 (313)
T ss_dssp HHHHH---HHTC------CC----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHHh---ccCC------CC----CCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHH
Confidence 11111 1110 00 1111224578999999999999999999999999875
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=341.83 Aligned_cols=235 Identities=20% Similarity=0.333 Sum_probs=186.8
Q ss_pred HHhCCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEeh---------------hhhhhcccCceeeEEEEEeCCC------
Q 039819 200 ATENFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLK---------------DMISLAVHRNLLRLIGYCATPT------ 257 (534)
Q Consensus 200 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~---------------~~l~~~~h~niv~l~~~~~~~~------ 257 (534)
..++|+..+.||+|+||.||+|+.. +++.||||++. +++..++||||++++++|.+..
T Consensus 4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 83 (332)
T 3qd2_B 4 YLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQE 83 (332)
T ss_dssp HHHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHH
T ss_pred hhhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhh
Confidence 4567899999999999999999986 78999999875 2678889999999999986543
Q ss_pred ---------------------------------------------------eeEEEeeccCCCChhhhcccCC---CCCH
Q 039819 258 ---------------------------------------------------ERLLVYPYMSNGSVASRLREKP---ALDW 283 (534)
Q Consensus 258 ---------------------------------------------------~~~lv~e~~~~gsL~~~l~~~~---~l~~ 283 (534)
..++||||+++|+|.+++.... ..++
T Consensus 84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~ 163 (332)
T 3qd2_B 84 EMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREH 163 (332)
T ss_dssp HHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCH
T ss_pred hhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhh
Confidence 2799999999999999997543 3567
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCC-----------ceeecccccc
Q 039819 284 NTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDS-----------HVTTAVRGTV 352 (534)
Q Consensus 284 ~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~-----------~~~~~~~gt~ 352 (534)
..++.++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++....... .......||+
T Consensus 164 ~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 240 (332)
T 3qd2_B 164 GVCLHIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTK 240 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CG
T ss_pred HHHHHHHHHHHHHHHHHHhC---CeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCc
Confidence 78999999999999999999 999999999999999999999999999998754321 1223456999
Q ss_pred ccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceecccccCCCCCHHHHHH
Q 039819 353 GHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELGSNYDRIEVGE 432 (534)
Q Consensus 353 ~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~ 432 (534)
.|+|||++.+..++.++|||||||++|||++|..|+.. ........... .. ..........
T Consensus 241 ~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~---------~~~~~~~~~~~-~~---------~~~~~~~~~~ 301 (332)
T 3qd2_B 241 LYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME---------RVRIITDVRNL-KF---------PLLFTQKYPQ 301 (332)
T ss_dssp GGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHH---------HHHHHHHHHTT-CC---------CHHHHHHCHH
T ss_pred CccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhH---------HHHHHHHhhcc-CC---------CcccccCChh
Confidence 99999999998999999999999999999999776531 01111111110 00 0011222356
Q ss_pred HHHHHHHhcccCCCCCCChHHHHH
Q 039819 433 ILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 433 l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
+.+++.+|++.+|.+|||+.|+++
T Consensus 302 ~~~li~~~l~~~p~~Rps~~~~l~ 325 (332)
T 3qd2_B 302 EHMMVQDMLSPSPTERPEATDIIE 325 (332)
T ss_dssp HHHHHHHHHCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHccCCCCcCCCHHHHhh
Confidence 789999999999999999999986
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=346.95 Aligned_cols=239 Identities=23% Similarity=0.268 Sum_probs=185.2
Q ss_pred HhCCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEehh-------------hhhhcccCceeeEEEEEeCCCeeEEEeecc
Q 039819 201 TENFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLKD-------------MISLAVHRNLLRLIGYCATPTERLLVYPYM 266 (534)
Q Consensus 201 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~-------------~l~~~~h~niv~l~~~~~~~~~~~lv~e~~ 266 (534)
.++|...+.||+|+||.||+++.. +++.||||++.. .+..++||||+++++++.+....++||||+
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 98 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYA 98 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEeC
Confidence 357888899999999999999986 789999998852 577889999999999999999999999999
Q ss_pred CCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCc--EEEEecccceecCCCCCce
Q 039819 267 SNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCE--AIVGDFGLAKLLDHSDSHV 344 (534)
Q Consensus 267 ~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~--~kl~DFGla~~~~~~~~~~ 344 (534)
++|+|.+++...+.+++..++.++.|++.||.|||+. +|+||||||+|||++.++. +||+|||+++...... .
T Consensus 99 ~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~---~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~--~ 173 (361)
T 3uc3_A 99 SGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSM---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS--Q 173 (361)
T ss_dssp CSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCSCCCCGGGEEECSSSSCCEEECCCCCC----------
T ss_pred CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCceEEEeecCccccccccC--C
Confidence 9999999998877899999999999999999999998 9999999999999987765 9999999998543221 2
Q ss_pred eeccccccccccccccccCCCCcc-hhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceecccccCC
Q 039819 345 TTAVRGTVGHIAPEYLSTGQSSEK-TDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELGS 423 (534)
Q Consensus 345 ~~~~~gt~~y~aPE~~~~~~~~~k-~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 423 (534)
.....||+.|+|||++.+..++.+ +|||||||++|||++|+.||........ ............. ....
T Consensus 174 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~---~~~~~~~~~~~~~-------~~~~ 243 (361)
T 3uc3_A 174 PKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRD---YRKTIQRILSVKY-------SIPD 243 (361)
T ss_dssp -------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCC---HHHHHHHHHTTCC-------CCCT
T ss_pred CCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHH---HHHHHHHHhcCCC-------CCCC
Confidence 334569999999999988777655 8999999999999999999975433221 1122222111110 0000
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 424 NYDRIEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 424 ~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
....+..+.+++.+|++.+|.+|||+.|+++
T Consensus 244 --~~~~s~~~~~li~~~L~~dP~~Rps~~ell~ 274 (361)
T 3uc3_A 244 --DIRISPECCHLISRIFVADPATRISIPEIKT 274 (361)
T ss_dssp --TSCCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred --cCCCCHHHHHHHHHHccCChhHCcCHHHHHh
Confidence 0012347889999999999999999999986
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=341.99 Aligned_cols=233 Identities=25% Similarity=0.329 Sum_probs=190.2
Q ss_pred hCCCcCCeeccCCcEEEEEEEE----CCCcEEEEEEehh------------------hhhhcccCceeeEEEEEeCCCee
Q 039819 202 ENFSSKNILGAGGFGNVYKGKL----GDGTVLAVKRLKD------------------MISLAVHRNLLRLIGYCATPTER 259 (534)
Q Consensus 202 ~~~~~~~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~------------------~l~~~~h~niv~l~~~~~~~~~~ 259 (534)
++|...+.||+|+||.||+|+. .+++.||||+++. ++..++||||+++++++...+..
T Consensus 17 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 96 (327)
T 3a62_A 17 ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKL 96 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSCE
T ss_pred HHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCEE
Confidence 5788899999999999999987 4789999998742 57788999999999999999999
Q ss_pred EEEeeccCCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCC
Q 039819 260 LLVYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDH 339 (534)
Q Consensus 260 ~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~ 339 (534)
++||||+++|+|.+++.....+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 97 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 173 (327)
T 3a62_A 97 YLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCKESIH 173 (327)
T ss_dssp EEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTSCEEECCCSCC-----
T ss_pred EEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEcccCCHHHeEECCCCcEEEEeCCccccccc
Confidence 99999999999999998878899999999999999999999999 999999999999999999999999999986433
Q ss_pred CCCceeeccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceeccc
Q 039819 340 SDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDR 419 (534)
Q Consensus 340 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 419 (534)
.. .......||+.|+|||++.+..++.++|||||||++|||++|+.||..... .+....+.... .
T Consensus 174 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-------~~~~~~i~~~~-------~ 238 (327)
T 3a62_A 174 DG-TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENR-------KKTIDKILKCK-------L 238 (327)
T ss_dssp ------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-------HHHHHHHHHTC-------C
T ss_pred CC-ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCH-------HHHHHHHHhCC-------C
Confidence 22 223456799999999999988899999999999999999999999974332 11112111110 0
Q ss_pred ccCCCCCHHHHHHHHHHHHHhcccCCCCCC-----ChHHHHH
Q 039819 420 ELGSNYDRIEVGEILQVALLCTQYLPVHRP-----KMSEVVR 456 (534)
Q Consensus 420 ~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RP-----t~~ev~~ 456 (534)
. .+......+.+++.+|++.+|.+|| ++.|+++
T Consensus 239 ~----~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~ 276 (327)
T 3a62_A 239 N----LPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA 276 (327)
T ss_dssp C----CCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred C----CCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence 1 1112245789999999999999999 5667665
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-42 Score=348.67 Aligned_cols=235 Identities=22% Similarity=0.313 Sum_probs=186.0
Q ss_pred hCCCcCCeeccCCcEEEEEEEECCCcEEEEEEeh----------------hhhhhccc--CceeeEEEEEeCCCeeEEEe
Q 039819 202 ENFSSKNILGAGGFGNVYKGKLGDGTVLAVKRLK----------------DMISLAVH--RNLLRLIGYCATPTERLLVY 263 (534)
Q Consensus 202 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~----------------~~l~~~~h--~niv~l~~~~~~~~~~~lv~ 263 (534)
++|...+.||+|+||.||+|...+++.||||++. .++..+.| +||+++++++......++||
T Consensus 9 ~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~ 88 (343)
T 3dbq_A 9 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 88 (343)
T ss_dssp CEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred CEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEEE
Confidence 4688889999999999999999899999999874 14566666 99999999999999999999
Q ss_pred eccCCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCC-
Q 039819 264 PYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDS- 342 (534)
Q Consensus 264 e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~- 342 (534)
| +.+|+|.+++.....+++.++..|+.|++.||.|||+. +|+||||||+|||++ ++.+||+|||+++.......
T Consensus 89 e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~---~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~~~ 163 (343)
T 3dbq_A 89 E-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTS 163 (343)
T ss_dssp C-CCSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEE-TTEEEECCCSSSCCC------
T ss_pred e-CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEE-CCcEEEeecccccccCccccc
Confidence 9 56889999999888899999999999999999999999 999999999999997 57899999999987654322
Q ss_pred ceeecccccccccccccccc-----------CCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhc
Q 039819 343 HVTTAVRGTVGHIAPEYLST-----------GQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEK 411 (534)
Q Consensus 343 ~~~~~~~gt~~y~aPE~~~~-----------~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 411 (534)
.......||+.|+|||++.+ ..++.++|||||||++|||+||+.||..... ..... ...
T Consensus 164 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-----~~~~~-~~~---- 233 (343)
T 3dbq_A 164 VVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN-----QISKL-HAI---- 233 (343)
T ss_dssp ------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCS-----HHHHH-HHH----
T ss_pred ccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhh-----HHHHH-HHH----
Confidence 12335679999999999864 6789999999999999999999999963221 11111 111
Q ss_pred ccceecccccCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 412 KVEVLVDRELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 412 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
+++.....++......+.+++.+||+.+|.+|||+.|+++
T Consensus 234 -----~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~ 273 (343)
T 3dbq_A 234 -----IDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA 273 (343)
T ss_dssp -----HCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred -----hcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHh
Confidence 1111111222222357889999999999999999999986
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-41 Score=349.69 Aligned_cols=240 Identities=20% Similarity=0.276 Sum_probs=184.5
Q ss_pred hCCCcC-CeeccCCcEEEEEEEEC-CCcEEEEEEehh----------hhhhcccCceeeEEEEEeC----CCeeEEEeec
Q 039819 202 ENFSSK-NILGAGGFGNVYKGKLG-DGTVLAVKRLKD----------MISLAVHRNLLRLIGYCAT----PTERLLVYPY 265 (534)
Q Consensus 202 ~~~~~~-~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~----------~l~~~~h~niv~l~~~~~~----~~~~~lv~e~ 265 (534)
++|... +.||+|+||.||+|... +++.||||++.. .....+||||+++++++.. ....++||||
T Consensus 61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~lv~E~ 140 (400)
T 1nxk_A 61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMEC 140 (400)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEEC
T ss_pred ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcchhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEEEEEe
Confidence 456555 68999999999999975 689999999852 2345689999999999865 5568999999
Q ss_pred cCCCChhhhcccC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCC---CCcEEEEecccceecCCC
Q 039819 266 MSNGSVASRLREK--PALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDD---FCEAIVGDFGLAKLLDHS 340 (534)
Q Consensus 266 ~~~gsL~~~l~~~--~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~---~~~~kl~DFGla~~~~~~ 340 (534)
|++|+|.+++... ..+++..+..|+.||+.||.|||+. +|+||||||+|||++. ++.+||+|||+++.....
T Consensus 141 ~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~~ 217 (400)
T 1nxk_A 141 LDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH 217 (400)
T ss_dssp CCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSTTCCEEECCCTTCEECC--
T ss_pred CCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCcceEEEecCCCCccEEEEecccccccCCC
Confidence 9999999999764 3599999999999999999999998 9999999999999997 789999999999876432
Q ss_pred CCceeeccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceecccc
Q 039819 341 DSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRE 420 (534)
Q Consensus 341 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 420 (534)
. .....+||+.|+|||++.+..++.++|||||||++|||+||+.||...........+...+. . .... +..+
T Consensus 218 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~---~-~~~~-~~~~- 289 (400)
T 1nxk_A 218 N--SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIR---M-GQYE-FPNP- 289 (400)
T ss_dssp -----------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHH---H-TCCC-CCTT-
T ss_pred C--ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHH---c-Cccc-CCCc-
Confidence 2 23456789999999999999999999999999999999999999975433221111211111 1 1000 0000
Q ss_pred cCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 421 LGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 421 l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
.......++.+++.+||+.||.+|||+.|+++
T Consensus 290 ----~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 321 (400)
T 1nxk_A 290 ----EWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 321 (400)
T ss_dssp ----TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ----ccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 00112457899999999999999999999987
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=344.66 Aligned_cols=242 Identities=21% Similarity=0.292 Sum_probs=195.4
Q ss_pred HHhCCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEehh----------hhhhc-ccCceeeEEEEEeCCCeeEEEeeccC
Q 039819 200 ATENFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLKD----------MISLA-VHRNLLRLIGYCATPTERLLVYPYMS 267 (534)
Q Consensus 200 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~----------~l~~~-~h~niv~l~~~~~~~~~~~lv~e~~~ 267 (534)
..++|...+.||+|+||.||+|+.. +++.||||++.+ ++.++ .||||+++++++.+....++||||++
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~ 99 (342)
T 2qr7_A 20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMK 99 (342)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCCCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCC
T ss_pred ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEeCCC
Confidence 4577999999999999999999985 688999999853 34444 79999999999999999999999999
Q ss_pred CCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCC----CcEEEEecccceecCCCCCc
Q 039819 268 NGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDF----CEAIVGDFGLAKLLDHSDSH 343 (534)
Q Consensus 268 ~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~----~~~kl~DFGla~~~~~~~~~ 343 (534)
+|+|.+++.....+++..+..++.||+.||.|||+. +|+||||||+|||+... +.+||+|||+++.......
T Consensus 100 gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~---givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~~- 175 (342)
T 2qr7_A 100 GGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENG- 175 (342)
T ss_dssp SCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCTTC-
T ss_pred CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCCCC-
Confidence 999999998888899999999999999999999999 99999999999998433 3599999999997654332
Q ss_pred eeeccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceecccccCC
Q 039819 344 VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELGS 423 (534)
Q Consensus 344 ~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 423 (534)
.....+||+.|+|||++.+..++.++|||||||++|||++|+.||...... ...+....+.... . ....
T Consensus 176 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~----~~~~~~~~i~~~~-~------~~~~ 244 (342)
T 2qr7_A 176 LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDD----TPEEILARIGSGK-F------SLSG 244 (342)
T ss_dssp CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTS----CHHHHHHHHHHCC-C------CCCS
T ss_pred ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcC----CHHHHHHHHccCC-c------ccCc
Confidence 234567899999999998878899999999999999999999999743221 1122222222211 0 0111
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 424 NYDRIEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 424 ~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
......+..+.+++.+|++.||++||++.|+++
T Consensus 245 ~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~ 277 (342)
T 2qr7_A 245 GYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLR 277 (342)
T ss_dssp TTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred cccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 111223457889999999999999999999875
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=344.97 Aligned_cols=250 Identities=18% Similarity=0.181 Sum_probs=189.7
Q ss_pred hCCCcCCeeccCCcEEEEEEEEC----CCcEEEEEEehh-------------------------hhhhcccCceeeEEEE
Q 039819 202 ENFSSKNILGAGGFGNVYKGKLG----DGTVLAVKRLKD-------------------------MISLAVHRNLLRLIGY 252 (534)
Q Consensus 202 ~~~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~-------------------------~l~~~~h~niv~l~~~ 252 (534)
++|...+.||+|+||.||+|+.. .+..||||.+.. .+..+.||||++++++
T Consensus 37 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~ 116 (345)
T 2v62_A 37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGS 116 (345)
T ss_dssp CEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEE
T ss_pred ceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecc
Confidence 56788899999999999999985 578899998742 2455689999999999
Q ss_pred EeC----CCeeEEEeeccCCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCC--cE
Q 039819 253 CAT----PTERLLVYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFC--EA 326 (534)
Q Consensus 253 ~~~----~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~--~~ 326 (534)
+.. ....++||||+ +++|.+++.....+++..++.|+.|++.||.|||+. +|+||||||+|||++.++ .+
T Consensus 117 ~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~ 192 (345)
T 2v62_A 117 GLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHEN---EYVHGDIKAANLLLGYKNPDQV 192 (345)
T ss_dssp EEEESSSCEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEESSSTTSE
T ss_pred cccccCCCcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCcCHHHEEEccCCCCcE
Confidence 987 67889999999 999999998777899999999999999999999999 999999999999999877 99
Q ss_pred EEEecccceecCCCCC------ceeeccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchH
Q 039819 327 IVGDFGLAKLLDHSDS------HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAM 400 (534)
Q Consensus 327 kl~DFGla~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~ 400 (534)
||+|||+++.+..... .......||..|+|||++.+..++.++|||||||++|||+||+.||...... ....
T Consensus 193 kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~--~~~~ 270 (345)
T 2v62_A 193 YLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKD--PVAV 270 (345)
T ss_dssp EECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTC--HHHH
T ss_pred EEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccc--cHHH
Confidence 9999999987643211 1113457999999999999888999999999999999999999999632111 0011
Q ss_pred HHHHHHHhhhcccceecccccCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhcCC
Q 039819 401 LEWVKKIQQEKKVEVLVDRELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLEGDG 462 (534)
Q Consensus 401 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~~~ 462 (534)
......... .....+..... ....+..+.+++.+|++.+|++||++.+|++.|+...
T Consensus 271 ~~~~~~~~~--~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~ 327 (345)
T 2v62_A 271 QTAKTNLLD--ELPQSVLKWAP---SGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHG 327 (345)
T ss_dssp HHHHHHHHH--TTTHHHHHHSC---TTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTC
T ss_pred HHHHHhhcc--cccHHHHhhcc---ccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccC
Confidence 111111110 00000000000 0012348899999999999999999999999998744
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-41 Score=362.12 Aligned_cols=237 Identities=24% Similarity=0.331 Sum_probs=195.6
Q ss_pred HhCCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEehh-----------------hhhhcccCceeeEEEEEeCCCeeEEE
Q 039819 201 TENFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLKD-----------------MISLAVHRNLLRLIGYCATPTERLLV 262 (534)
Q Consensus 201 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~-----------------~l~~~~h~niv~l~~~~~~~~~~~lv 262 (534)
.++|...+.||+|+||.||+|+.. +|+.||||++.. ++..++|||||++++++.+.+..++|
T Consensus 183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 262 (576)
T 2acx_A 183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV 262 (576)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence 467888999999999999999985 689999998742 57788999999999999999999999
Q ss_pred eeccCCCChhhhcccCC--CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCC
Q 039819 263 YPYMSNGSVASRLREKP--ALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHS 340 (534)
Q Consensus 263 ~e~~~~gsL~~~l~~~~--~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~ 340 (534)
|||+++|+|.+++.... .+++..++.++.||+.||.|||++ +||||||||+|||++.++.+||+|||+++.....
T Consensus 263 mEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~---gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~ 339 (576)
T 2acx_A 263 LTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG 339 (576)
T ss_dssp ECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred EEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCchheEEEeCCCCeEEEecccceecccC
Confidence 99999999999987543 499999999999999999999999 9999999999999999999999999999877543
Q ss_pred CCceeeccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceecccc
Q 039819 341 DSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRE 420 (534)
Q Consensus 341 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 420 (534)
. .....+||+.|+|||++.+..++.++|||||||++|||++|+.||...........+...+ ... . .
T Consensus 340 ~--~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i---~~~-~------~- 406 (576)
T 2acx_A 340 Q--TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLV---KEV-P------E- 406 (576)
T ss_dssp C--CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHH---HHC-C------C-
T ss_pred c--cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHh---hcc-c------c-
Confidence 2 2344579999999999998889999999999999999999999997543221111111111 110 0 1
Q ss_pred cCCCCCHHHHHHHHHHHHHhcccCCCCCC-----ChHHHHH
Q 039819 421 LGSNYDRIEVGEILQVALLCTQYLPVHRP-----KMSEVVR 456 (534)
Q Consensus 421 l~~~~~~~~~~~l~~l~~~Cl~~~P~~RP-----t~~ev~~ 456 (534)
.++...+..+.+++.+|++.||.+|| +++||++
T Consensus 407 ---~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~ 444 (576)
T 2acx_A 407 ---EYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE 444 (576)
T ss_dssp ---CCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred ---cCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence 11122345889999999999999999 5677764
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-41 Score=348.05 Aligned_cols=253 Identities=18% Similarity=0.224 Sum_probs=191.8
Q ss_pred HhCCCcCCeeccC--CcEEEEEEEEC-CCcEEEEEEehh----------------hhhhcccCceeeEEEEEeCCCeeEE
Q 039819 201 TENFSSKNILGAG--GFGNVYKGKLG-DGTVLAVKRLKD----------------MISLAVHRNLLRLIGYCATPTERLL 261 (534)
Q Consensus 201 ~~~~~~~~~lG~G--~~g~Vy~~~~~-~~~~vavK~~~~----------------~l~~~~h~niv~l~~~~~~~~~~~l 261 (534)
.++|...+.||+| +||.||+|+.. +++.||||++.. +++.++|||||++++++.+....++
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 103 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV 103 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence 3578889999999 99999999986 689999998852 5778899999999999999999999
Q ss_pred EeeccCCCChhhhcccC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCC
Q 039819 262 VYPYMSNGSVASRLREK--PALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDH 339 (534)
Q Consensus 262 v~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~ 339 (534)
|||||++|+|.+++... ..+++..+..|+.|++.||.|||+. +|+||||||+|||++.++.+||+|||.+.....
T Consensus 104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~ 180 (389)
T 3gni_B 104 VTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMIS 180 (389)
T ss_dssp EEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCGGGCEECEE
T ss_pred EEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccccceeecc
Confidence 99999999999999754 6799999999999999999999999 999999999999999999999999999875422
Q ss_pred CC------Cceeecccccccccccccccc--CCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHH-HHHHHhh-
Q 039819 340 SD------SHVTTAVRGTVGHIAPEYLST--GQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLE-WVKKIQQ- 409 (534)
Q Consensus 340 ~~------~~~~~~~~gt~~y~aPE~~~~--~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~-~~~~~~~- 409 (534)
.. ........||..|+|||++.+ ..++.++|||||||++|||+||+.||.............. .......
T Consensus 181 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 260 (389)
T 3gni_B 181 HGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDT 260 (389)
T ss_dssp TTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC-----------
T ss_pred ccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCccccc
Confidence 11 111223468999999999977 5789999999999999999999999975432211100000 0000000
Q ss_pred -----h------------cccceecc---cc------cCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 410 -----E------------KKVEVLVD---RE------LGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 410 -----~------------~~~~~~~d---~~------l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
. ......+. +. ............+.+++.+||+.||++|||+.|+++
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~ 333 (389)
T 3gni_B 261 STIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLN 333 (389)
T ss_dssp ---------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred cccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 0 00000000 00 000111223457899999999999999999999985
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=337.93 Aligned_cols=242 Identities=26% Similarity=0.416 Sum_probs=201.7
Q ss_pred HhCCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEeh-------------hhhhhcccCceeeEEEEEeCCCeeEEEeecc
Q 039819 201 TENFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLK-------------DMISLAVHRNLLRLIGYCATPTERLLVYPYM 266 (534)
Q Consensus 201 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~-------------~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~ 266 (534)
.++|...+.||+|+||.||+|... ++..||||.+. +++..++||||+++++++.+....++||||+
T Consensus 12 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 91 (288)
T 3kfa_A 12 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 91 (288)
T ss_dssp GGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCSTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred ccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEEcC
Confidence 467888899999999999999986 48889999875 2678889999999999999999999999999
Q ss_pred CCCChhhhccc--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCCce
Q 039819 267 SNGSVASRLRE--KPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHV 344 (534)
Q Consensus 267 ~~gsL~~~l~~--~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~ 344 (534)
++++|.+++.. ...+++..++.++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++..........
T Consensus 92 ~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~ 168 (288)
T 3kfa_A 92 TYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTA 168 (288)
T ss_dssp TTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHH---TCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSSSEE
T ss_pred CCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHC---CccCCCCCcceEEEcCCCCEEEccCccceeccCCcccc
Confidence 99999999975 34599999999999999999999999 99999999999999999999999999998776544444
Q ss_pred eeccccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCcCCCccccccchHHHHHHHHhhhcccceecccccCC
Q 039819 345 TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELGS 423 (534)
Q Consensus 345 ~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 423 (534)
.....+|..|+|||++.+..++.++||||||+++|||++ |+.||...... .+.+.+ ... ...
T Consensus 169 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~----~~~~~~---~~~----------~~~ 231 (288)
T 3kfa_A 169 HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS----QVYELL---EKD----------YRM 231 (288)
T ss_dssp ETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG----GHHHHH---HTT----------CCC
T ss_pred ccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH----HHHHHH---hcc----------CCC
Confidence 445567889999999998899999999999999999999 99999743321 111111 111 011
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhcCC
Q 039819 424 NYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLEGDG 462 (534)
Q Consensus 424 ~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~~~ 462 (534)
..+...+..+.+++.+|++.+|.+||++.++++.|+...
T Consensus 232 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~ 270 (288)
T 3kfa_A 232 ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 270 (288)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHH
Confidence 112223457899999999999999999999999988643
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-41 Score=330.69 Aligned_cols=233 Identities=23% Similarity=0.351 Sum_probs=190.7
Q ss_pred hCCCcCCeeccCCcEEEEEEEECCCcEEEEEEeh----------------hhhhhcccCceeeEEEEEeCC--CeeEEEe
Q 039819 202 ENFSSKNILGAGGFGNVYKGKLGDGTVLAVKRLK----------------DMISLAVHRNLLRLIGYCATP--TERLLVY 263 (534)
Q Consensus 202 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~----------------~~l~~~~h~niv~l~~~~~~~--~~~~lv~ 263 (534)
++|...+.||+|+||.||+|+.. +..||||++. .++..++||||+++++++.+. ...++||
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 88 (271)
T 3kmu_A 10 KQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLIT 88 (271)
T ss_dssp GGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEE
T ss_pred HHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeee
Confidence 57888899999999999999985 8889999875 256778899999999999887 6789999
Q ss_pred eccCCCChhhhcccCC--CCCHHHHHHHHHHHHHHHHHHHhcCCCC--eEeccCCCCcEEeCCCCcEEEEecccceecCC
Q 039819 264 PYMSNGSVASRLREKP--ALDWNTRKRIAIGAARGLLYLHEQCDPK--IIHRDVKAANVLLDDFCEAIVGDFGLAKLLDH 339 (534)
Q Consensus 264 e~~~~gsL~~~l~~~~--~l~~~~~~~i~~~i~~~l~yLH~~~~~~--ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~ 339 (534)
||+++|+|.+++.... .+++..++.|+.|++.||.|||+. + |+||||||+|||++.++.++|+|||++.....
T Consensus 89 e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~ 165 (271)
T 3kmu_A 89 HWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTL---EPLIPRHALNSRSVMIDEDMTARISMADVKFSFQS 165 (271)
T ss_dssp ECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTS---SSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSC
T ss_pred cccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcC---CCceecCCCccceEEEcCCcceeEEeccceeeecc
Confidence 9999999999998654 589999999999999999999998 7 99999999999999999999999998764322
Q ss_pred CCCceeeccccccccccccccccCCCCc---chhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhccccee
Q 039819 340 SDSHVTTAVRGTVGHIAPEYLSTGQSSE---KTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVL 416 (534)
Q Consensus 340 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~---k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 416 (534)
....||+.|+|||++.+..++. ++|||||||++|||+||+.||...... +..........
T Consensus 166 ------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-------~~~~~~~~~~~---- 228 (271)
T 3kmu_A 166 ------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNM-------EIGMKVALEGL---- 228 (271)
T ss_dssp ------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHH-------HHHHHHHHSCC----
T ss_pred ------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChH-------HHHHHHHhcCC----
Confidence 2345899999999997765544 899999999999999999999743211 11111111110
Q ss_pred cccccCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhc
Q 039819 417 VDRELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLEG 460 (534)
Q Consensus 417 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~ 460 (534)
.+. .+...+..+.+++.+|++.+|++|||+.|+++.|+.
T Consensus 229 -~~~----~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~ 267 (271)
T 3kmu_A 229 -RPT----IPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEK 267 (271)
T ss_dssp -CCC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred -CCC----CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 111 122234578999999999999999999999999875
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=342.11 Aligned_cols=235 Identities=16% Similarity=0.175 Sum_probs=190.9
Q ss_pred HhCCCcCCeeccCCcEEEEEEE------ECCCcEEEEEEehh-----------hhhhc---ccCceeeEEEEEeCCCeeE
Q 039819 201 TENFSSKNILGAGGFGNVYKGK------LGDGTVLAVKRLKD-----------MISLA---VHRNLLRLIGYCATPTERL 260 (534)
Q Consensus 201 ~~~~~~~~~lG~G~~g~Vy~~~------~~~~~~vavK~~~~-----------~l~~~---~h~niv~l~~~~~~~~~~~ 260 (534)
.++|...+.||+|+||.||+|. ..+++.||||++.. .+..+ .|+||+++++++...+..+
T Consensus 64 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~~~~ 143 (365)
T 3e7e_A 64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSV 143 (365)
T ss_dssp SSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCCHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSSCEE
T ss_pred CEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCChhHHHHHHHHHHHhhhhhhhhhhhhheeeecCCCcE
Confidence 3678888999999999999994 45688999999862 33333 4999999999999999999
Q ss_pred EEeeccCCCChhhhcc-----cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCC-----------CC
Q 039819 261 LVYPYMSNGSVASRLR-----EKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDD-----------FC 324 (534)
Q Consensus 261 lv~e~~~~gsL~~~l~-----~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~-----------~~ 324 (534)
+|||||++|+|.+++. ....+++..++.|+.|++.||+|||+. +||||||||+|||++. ++
T Consensus 144 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~---~ivHrDiKp~NIll~~~~~~~~~~~~~~~ 220 (365)
T 3e7e_A 144 LVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQDDEDDLSA 220 (365)
T ss_dssp EEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECGGGTCC------CT
T ss_pred EEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEecccccCccccccccC
Confidence 9999999999999996 356799999999999999999999998 9999999999999998 89
Q ss_pred cEEEEecccceecCC-CCCceeeccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHH
Q 039819 325 EAIVGDFGLAKLLDH-SDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEW 403 (534)
Q Consensus 325 ~~kl~DFGla~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~ 403 (534)
.+||+|||+++.+.. .........+||++|+|||++.+..++.++|||||||++|||+||+.||.......
T Consensus 221 ~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~-------- 292 (365)
T 3e7e_A 221 GLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGE-------- 292 (365)
T ss_dssp TEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTE--------
T ss_pred CEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCc--------
Confidence 999999999986542 22334456779999999999999899999999999999999999999986322110
Q ss_pred HHHHhhhcccceecccccCCCCCHHHHHHHHHHHHHhcccCCCCC-CChHHHHHHhhc
Q 039819 404 VKKIQQEKKVEVLVDRELGSNYDRIEVGEILQVALLCTQYLPVHR-PKMSEVVRMLEG 460 (534)
Q Consensus 404 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~R-Pt~~ev~~~L~~ 460 (534)
. .....+.... ....+.+++..|++.+|.+| |+++++.+.|+.
T Consensus 293 -------~----~~~~~~~~~~---~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~ 336 (365)
T 3e7e_A 293 -------C----KPEGLFRRLP---HLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKK 336 (365)
T ss_dssp -------E----EECSCCTTCS---SHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHH
T ss_pred -------e----eechhccccC---cHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHH
Confidence 0 0111111111 24467789999999999998 567777777764
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-41 Score=339.71 Aligned_cols=229 Identities=21% Similarity=0.290 Sum_probs=194.4
Q ss_pred HHhCCCcCCeeccCCcEEEEEEEE-CCCcEEEEEEeh----------------------hhhhhcccCceeeEEEEEeCC
Q 039819 200 ATENFSSKNILGAGGFGNVYKGKL-GDGTVLAVKRLK----------------------DMISLAVHRNLLRLIGYCATP 256 (534)
Q Consensus 200 ~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~----------------------~~l~~~~h~niv~l~~~~~~~ 256 (534)
..++|...+.||+|+||.||+|+. .+++.||||++. .++..++||||+++++++.+.
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 101 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ 101 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence 457899999999999999999986 468899999764 256778999999999999999
Q ss_pred CeeEEEeeccCCC-ChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccce
Q 039819 257 TERLLVYPYMSNG-SVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAK 335 (534)
Q Consensus 257 ~~~~lv~e~~~~g-sL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~ 335 (534)
...++||||+.+| +|.+++.....+++..+..|+.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus 102 ~~~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~ 178 (335)
T 3dls_A 102 GFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDFGSAA 178 (335)
T ss_dssp SEEEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCE
T ss_pred CEEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEEeccCHHHEEEcCCCcEEEeecccce
Confidence 9999999999777 9999999888899999999999999999999999 99999999999999999999999999999
Q ss_pred ecCCCCCceeeccccccccccccccccCCC-CcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccc
Q 039819 336 LLDHSDSHVTTAVRGTVGHIAPEYLSTGQS-SEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVE 414 (534)
Q Consensus 336 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 414 (534)
....... .....||+.|+|||++.+..+ +.++|||||||++|||++|+.||...... .
T Consensus 179 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~------------------~- 237 (335)
T 3dls_A 179 YLERGKL--FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET------------------V- 237 (335)
T ss_dssp ECCTTCC--BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG------------------T-
T ss_pred ECCCCCc--eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH------------------H-
Confidence 8754332 334569999999999988776 88999999999999999999999631110 0
Q ss_pred eecccccCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHH
Q 039819 415 VLVDRELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRM 457 (534)
Q Consensus 415 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~ 457 (534)
..... .+...+..+.+++.+|++.+|.+|||+.|+++.
T Consensus 238 ---~~~~~--~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 238 ---EAAIH--PPYLVSKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp ---TTCCC--CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred ---hhccC--CCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00000 011123478999999999999999999999873
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-41 Score=333.89 Aligned_cols=234 Identities=24% Similarity=0.339 Sum_probs=187.0
Q ss_pred hCCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEeh----------------------------------------hhhhh
Q 039819 202 ENFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLK----------------------------------------DMISL 240 (534)
Q Consensus 202 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~----------------------------------------~~l~~ 240 (534)
++|...+.||+|+||.||+|+.. +++.||||++. +++..
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 92 (298)
T 2zv2_A 13 NQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKK 92 (298)
T ss_dssp TTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHT
T ss_pred cceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHh
Confidence 57888899999999999999975 68899999862 25677
Q ss_pred cccCceeeEEEEEeC--CCeeEEEeeccCCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcE
Q 039819 241 AVHRNLLRLIGYCAT--PTERLLVYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANV 318 (534)
Q Consensus 241 ~~h~niv~l~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~Ni 318 (534)
++||||+++++++.+ ....++||||+++|+|.+++.. ..+++..++.++.|++.||.|||+. +|+||||||+||
T Consensus 93 l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Ni 168 (298)
T 2zv2_A 93 LDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL-KPLSEDQARFYFQDLIKGIEYLHYQ---KIIHRDIKPSNL 168 (298)
T ss_dssp CCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS-SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGE
T ss_pred CCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHE
Confidence 889999999999987 5678999999999999887654 4699999999999999999999999 999999999999
Q ss_pred EeCCCCcEEEEecccceecCCCCCceeeccccccccccccccccCC---CCcchhHHHHHHHHHHHHhCCCCcCCCcccc
Q 039819 319 LLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGHIAPEYLSTGQ---SSEKTDVFGFGILLLELITGMRALEFGKSIN 395 (534)
Q Consensus 319 Ll~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~ 395 (534)
|++.++.+||+|||+++....... ......||+.|+|||++.+.. ++.++|||||||++|||++|+.||....
T Consensus 169 l~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~--- 244 (298)
T 2zv2_A 169 LVGEDGHIKIADFGVSNEFKGSDA-LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDER--- 244 (298)
T ss_dssp EECTTSCEEECCCTTCEECSSSSC-EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSS---
T ss_pred EECCCCCEEEecCCCccccccccc-cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCcc---
Confidence 999999999999999987754332 234457999999999997655 3788999999999999999999996432
Q ss_pred ccchHHHHHHHHhhhcccceecccccCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 396 QKGAMLEWVKKIQQEKKVEVLVDRELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 396 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
...+....... ... . + . ....+..+.+++.+|++.||++||++.|+++
T Consensus 245 ----~~~~~~~~~~~-~~~-~--~-~----~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 245 ----IMCLHSKIKSQ-ALE-F--P-D----QPDIAEDLKDLITRMLDKNPESRIVVPEIKL 292 (298)
T ss_dssp ----HHHHHHHHHHC-CCC-C--C-S----SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred ----HHHHHHHHhcc-cCC-C--C-C----ccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence 11222222111 100 0 0 0 0112347899999999999999999999874
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=339.92 Aligned_cols=237 Identities=22% Similarity=0.288 Sum_probs=192.1
Q ss_pred HhCCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEeh-------------------hhhhhcccCceeeEEEEEeCCCeeE
Q 039819 201 TENFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLK-------------------DMISLAVHRNLLRLIGYCATPTERL 260 (534)
Q Consensus 201 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~-------------------~~l~~~~h~niv~l~~~~~~~~~~~ 260 (534)
.+.|...+.||+|+||.||+|... +++.||||++. .++..++||||+++++++.+....+
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 102 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY 102 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 457889999999999999999875 68999999873 1567788999999999999999999
Q ss_pred EEeeccCCCChhhhccc----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCc---EEEEeccc
Q 039819 261 LVYPYMSNGSVASRLRE----KPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCE---AIVGDFGL 333 (534)
Q Consensus 261 lv~e~~~~gsL~~~l~~----~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~---~kl~DFGl 333 (534)
+||||+++|+|.+.+.. ...+++..+..++.|++.||.|||++ +|+||||||+|||++.++. +||+|||+
T Consensus 103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~ 179 (351)
T 3c0i_A 103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGV 179 (351)
T ss_dssp EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChHHeEEecCCCCCcEEEecCcc
Confidence 99999999999887753 34589999999999999999999999 9999999999999986554 99999999
Q ss_pred ceecCCCCCceeeccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhccc
Q 039819 334 AKLLDHSDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKV 413 (534)
Q Consensus 334 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 413 (534)
++...... .......||+.|+|||++.+..++.++|||||||++|||+||+.||..... +....+.....
T Consensus 180 a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~--------~~~~~i~~~~~- 249 (351)
T 3c0i_A 180 AIQLGESG-LVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE--------RLFEGIIKGKY- 249 (351)
T ss_dssp CEECCTTS-CBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHH--------HHHHHHHHTCC-
T ss_pred eeEecCCC-eeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHH--------HHHHHHHcCCC-
Confidence 98875432 223445799999999999988999999999999999999999999974321 11111111110
Q ss_pred ceecccccCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 414 EVLVDRELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 414 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
. ..+..... .+..+.+++.+|++.||++|||+.|+++
T Consensus 250 ~--~~~~~~~~----~s~~~~~li~~~L~~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 250 K--MNPRQWSH----ISESAKDLVRRMLMLDPAERITVYEALN 286 (351)
T ss_dssp C--CCHHHHTT----SCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred C--CCcccccc----CCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 0 00000011 2357889999999999999999999986
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=343.23 Aligned_cols=248 Identities=19% Similarity=0.284 Sum_probs=187.4
Q ss_pred HhCCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEeh----------------hhhhhcccCceeeEEEEEeCCCeeEEEe
Q 039819 201 TENFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLK----------------DMISLAVHRNLLRLIGYCATPTERLLVY 263 (534)
Q Consensus 201 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~----------------~~l~~~~h~niv~l~~~~~~~~~~~lv~ 263 (534)
.++|...+.||+|+||.||+|+.. +++.||||++. +++..++||||+++++++.+....++||
T Consensus 33 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 112 (329)
T 3gbz_A 33 IDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIF 112 (329)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEEE
Confidence 467889999999999999999865 78999999874 2678889999999999999999999999
Q ss_pred eccCCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEe-----CCCCcEEEEecccceecC
Q 039819 264 PYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLL-----DDFCEAIVGDFGLAKLLD 338 (534)
Q Consensus 264 e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl-----~~~~~~kl~DFGla~~~~ 338 (534)
||++ |+|.+++.....+++..++.|+.|++.||.|||+. +|+||||||+|||+ +..+.+||+|||+++...
T Consensus 113 e~~~-~~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~ 188 (329)
T 3gbz_A 113 EYAE-NDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFG 188 (329)
T ss_dssp ECCS-EEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC
T ss_pred ecCC-CCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhC---CEECCCCCHHHEEEecCCCCccceEEECcCCCccccC
Confidence 9998 49999998888899999999999999999999999 99999999999999 455669999999998765
Q ss_pred CCCCceeeccccccccccccccccC-CCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhc--cc--
Q 039819 339 HSDSHVTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEK--KV-- 413 (534)
Q Consensus 339 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~-- 413 (534)
.... ......||..|+|||++.+. .++.++|||||||++|||++|+.||........ +........... ..
T Consensus 189 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~---~~~~~~~~~~~~~~~~~~ 264 (329)
T 3gbz_A 189 IPIR-QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQ---LFKIFEVLGLPDDTTWPG 264 (329)
T ss_dssp ------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHHHHHHCCCCTTTSTT
T ss_pred Cccc-ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHH---HHHHHHHhCCCchhhhhh
Confidence 3322 23345689999999999764 489999999999999999999999975433211 111111110000 00
Q ss_pred ----ceec--ccccCCCC-----CHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 414 ----EVLV--DRELGSNY-----DRIEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 414 ----~~~~--d~~l~~~~-----~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
.... .+...... .......+.+++.+|++.||.+|||+.|+++
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 318 (329)
T 3gbz_A 265 VTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE 318 (329)
T ss_dssp GGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence 0000 00000000 0112357889999999999999999999985
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-41 Score=342.02 Aligned_cols=241 Identities=29% Similarity=0.435 Sum_probs=195.6
Q ss_pred HhCCCcCCeeccCCcEEEEEEEEC--------CCcEEEEEEehh---------------hhhhc-ccCceeeEEEEEeCC
Q 039819 201 TENFSSKNILGAGGFGNVYKGKLG--------DGTVLAVKRLKD---------------MISLA-VHRNLLRLIGYCATP 256 (534)
Q Consensus 201 ~~~~~~~~~lG~G~~g~Vy~~~~~--------~~~~vavK~~~~---------------~l~~~-~h~niv~l~~~~~~~ 256 (534)
.++|...+.||+|+||.||+|+.. ++..||||++.. ++..+ +||||+++++++...
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 113 (334)
T 2pvf_A 34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 113 (334)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccC
Confidence 367888899999999999999863 467899998852 45566 899999999999999
Q ss_pred CeeEEEeeccCCCChhhhcccCC----------------CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEe
Q 039819 257 TERLLVYPYMSNGSVASRLREKP----------------ALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLL 320 (534)
Q Consensus 257 ~~~~lv~e~~~~gsL~~~l~~~~----------------~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl 320 (534)
...++||||+++|+|.+++.... .+++..++.++.|++.||.|||+. +|+||||||+|||+
T Consensus 114 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll 190 (334)
T 2pvf_A 114 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLV 190 (334)
T ss_dssp SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEE
T ss_pred CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCccceEEE
Confidence 99999999999999999997543 389999999999999999999999 99999999999999
Q ss_pred CCCCcEEEEecccceecCCCCCc-eeeccccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCcCCCccccccc
Q 039819 321 DDFCEAIVGDFGLAKLLDHSDSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GMRALEFGKSINQKG 398 (534)
Q Consensus 321 ~~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~ellt-G~~p~~~~~~~~~~~ 398 (534)
+.++.+||+|||+++........ ......+|..|+|||++.+..++.++|||||||++|||+| |+.||.....
T Consensus 191 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~----- 265 (334)
T 2pvf_A 191 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV----- 265 (334)
T ss_dssp CTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCH-----
T ss_pred cCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCH-----
Confidence 99999999999999877543321 1223457889999999988889999999999999999999 9999974321
Q ss_pred hHHHHHHHHhhhcccceecccccCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhcC
Q 039819 399 AMLEWVKKIQQEKKVEVLVDRELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLEGD 461 (534)
Q Consensus 399 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~~ 461 (534)
.+.......... .. .+...+..+.+++.+|++.+|.+||++.|+++.|+..
T Consensus 266 --~~~~~~~~~~~~------~~----~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l 316 (334)
T 2pvf_A 266 --EELFKLLKEGHR------MD----KPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 316 (334)
T ss_dssp --HHHHHHHHHTCC------CC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --HHHHHHHhcCCC------CC----CCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 112222211111 01 1122345789999999999999999999999998863
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-41 Score=341.00 Aligned_cols=255 Identities=26% Similarity=0.396 Sum_probs=191.6
Q ss_pred HhCCCcCCeeccCCcEEEEEEEECCCcEEEEEEehh-------------hhhhcccCceeeEEEEEeC-----CCeeEEE
Q 039819 201 TENFSSKNILGAGGFGNVYKGKLGDGTVLAVKRLKD-------------MISLAVHRNLLRLIGYCAT-----PTERLLV 262 (534)
Q Consensus 201 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~-------------~l~~~~h~niv~l~~~~~~-----~~~~~lv 262 (534)
.++|...+.||+|+||.||+|+. +++.||||++.. .+..+.||||+++++++.. ....++|
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~lv 90 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLV 90 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEEEE
T ss_pred hHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccchhhHHHHHHHHHHHhccCcchhhheecccccccCCCceEEEE
Confidence 35788889999999999999987 678999999852 2345789999999986532 2356899
Q ss_pred eeccCCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcC------CCCeEeccCCCCcEEeCCCCcEEEEeccccee
Q 039819 263 YPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQC------DPKIIHRDVKAANVLLDDFCEAIVGDFGLAKL 336 (534)
Q Consensus 263 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~------~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~ 336 (534)
|||+++|+|.+++.... .++..+..|+.|++.||.|||+.+ .++|+||||||+|||++.++.+||+|||+++.
T Consensus 91 ~e~~~~g~L~~~l~~~~-~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DFG~a~~ 169 (336)
T 3g2f_A 91 MEYYPNGSLXKYLSLHT-SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMR 169 (336)
T ss_dssp ECCCTTCBHHHHHHHCC-BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECCCTTCEE
T ss_pred EecCCCCcHHHHHhhcc-cchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEeeccceee
Confidence 99999999999997654 589999999999999999999863 23899999999999999999999999999987
Q ss_pred cCCCC-------Cceeecccccccccccccccc-------CCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHH-
Q 039819 337 LDHSD-------SHVTTAVRGTVGHIAPEYLST-------GQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAML- 401 (534)
Q Consensus 337 ~~~~~-------~~~~~~~~gt~~y~aPE~~~~-------~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~- 401 (534)
+.... ........||+.|+|||++.+ ..++.++|||||||++|||+||+.||.............
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~ 249 (336)
T 3g2f_A 170 LTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQ 249 (336)
T ss_dssp CSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCCCTTH
T ss_pred cccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHHHHhhh
Confidence 65321 112234569999999999876 456789999999999999999988875433322111110
Q ss_pred ---------HHHHHHhhhcccceecccccCCC--CCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhcC
Q 039819 402 ---------EWVKKIQQEKKVEVLVDRELGSN--YDRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLEGD 461 (534)
Q Consensus 402 ---------~~~~~~~~~~~~~~~~d~~l~~~--~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~~ 461 (534)
........... ..+.+... .....+..+.+++.+||+.+|++|||+.|+++.|+..
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~l 316 (336)
T 3g2f_A 250 TEVGNHPTFEDMQVLVSREK----QRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAEL 316 (336)
T ss_dssp HHHCSSCCHHHHHHHHTTSC----CCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred cccCCCchHHHHHhhhcccc----cCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHH
Confidence 01111111111 11111111 1223566899999999999999999999999998863
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=339.54 Aligned_cols=238 Identities=22% Similarity=0.309 Sum_probs=184.6
Q ss_pred hCCCcCCeeccCCcEEEEEEEE-CCCcEEEEEEehh-----------------hhhhcccCceeeEEEEEeCCCe----e
Q 039819 202 ENFSSKNILGAGGFGNVYKGKL-GDGTVLAVKRLKD-----------------MISLAVHRNLLRLIGYCATPTE----R 259 (534)
Q Consensus 202 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~-----------------~l~~~~h~niv~l~~~~~~~~~----~ 259 (534)
++|...+.||+|+||.||+|+. .+++.||||++.. .+..++||||+++++++..... .
T Consensus 12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 91 (311)
T 3ork_A 12 DRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLP 91 (311)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred CcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCccc
Confidence 5788899999999999999997 5789999998852 4566789999999999876543 3
Q ss_pred EEEeeccCCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCC
Q 039819 260 LLVYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDH 339 (534)
Q Consensus 260 ~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~ 339 (534)
++||||+++|+|.+++.....+++..++.++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 92 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~ 168 (311)
T 3ork_A 92 YIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIAD 168 (311)
T ss_dssp EEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEETTSCEEECCCSCC-----
T ss_pred EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEcCCCCEEEeeccCcccccc
Confidence 99999999999999998878899999999999999999999999 999999999999999999999999999987654
Q ss_pred CCC--ceeeccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceec
Q 039819 340 SDS--HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLV 417 (534)
Q Consensus 340 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 417 (534)
... .......||+.|+|||++.+..++.++|||||||++|||+||+.||...... +............
T Consensus 169 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~-------~~~~~~~~~~~~~--- 238 (311)
T 3ork_A 169 SGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPV-------SVAYQHVREDPIP--- 238 (311)
T ss_dssp -------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH-------HHHHHHHHCCCCC---
T ss_pred cccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH-------HHHHHHhcCCCCC---
Confidence 322 1223456899999999999989999999999999999999999999753321 1111111111000
Q ss_pred ccccCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 418 DRELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 418 d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
...... ..+..+.+++.+|++.||.+||++.+++.
T Consensus 239 ~~~~~~----~~~~~l~~li~~~l~~dP~~R~~~~~~l~ 273 (311)
T 3ork_A 239 PSARHE----GLSADLDAVVLKALAKNPENRYQTAAEMR 273 (311)
T ss_dssp HHHHST----TCCHHHHHHHHHHTCSSGGGSCSSHHHHH
T ss_pred cccccC----CCCHHHHHHHHHHHhcCHhhChhhHHHHH
Confidence 000001 12347889999999999999998887765
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-41 Score=357.18 Aligned_cols=248 Identities=20% Similarity=0.265 Sum_probs=185.1
Q ss_pred HhCCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEehh----------------hhhhcccCceeeEEEEEeCC------C
Q 039819 201 TENFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLKD----------------MISLAVHRNLLRLIGYCATP------T 257 (534)
Q Consensus 201 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~----------------~l~~~~h~niv~l~~~~~~~------~ 257 (534)
.++|...+.||+|+||.||+|... +++.||||++.. +++.++|||||++++++... .
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 467888999999999999999875 689999998842 67788999999999999655 3
Q ss_pred eeEEEeeccCCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceec
Q 039819 258 ERLLVYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLL 337 (534)
Q Consensus 258 ~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~ 337 (534)
..|+|||||+++ |.+.+.. .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++..
T Consensus 141 ~~~lv~E~~~~~-l~~~~~~--~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~ 214 (464)
T 3ttj_A 141 DVYLVMELMDAN-LCQVIQM--ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA 214 (464)
T ss_dssp EEEEEEECCSEE-HHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCCC---
T ss_pred eEEEEEeCCCCC-HHHHHhh--cCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChHhEEEeCCCCEEEEEEEeeeec
Confidence 569999999864 6565543 489999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCCceeeccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHH----------
Q 039819 338 DHSDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKI---------- 407 (534)
Q Consensus 338 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~---------- 407 (534)
... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||......++...+.+.....
T Consensus 215 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~ 292 (464)
T 3ttj_A 215 GTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP 292 (464)
T ss_dssp --C--CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSCH
T ss_pred CCC--cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcch
Confidence 543 22445679999999999999999999999999999999999999998654332222222111000
Q ss_pred -----hhh-cccc-----eecccccCCC---CCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 408 -----QQE-KKVE-----VLVDRELGSN---YDRIEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 408 -----~~~-~~~~-----~~~d~~l~~~---~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
... .... ..+...+... ........+.+++.+|++.||++|||++|+++
T Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 355 (464)
T 3ttj_A 293 TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 355 (464)
T ss_dssp HHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred hhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 000 0000 0000000000 01122567899999999999999999999985
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=333.74 Aligned_cols=243 Identities=17% Similarity=0.191 Sum_probs=188.7
Q ss_pred HhCCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEehh-----------------hhhhcccCceeeEEEEEeCCCeeEEE
Q 039819 201 TENFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLKD-----------------MISLAVHRNLLRLIGYCATPTERLLV 262 (534)
Q Consensus 201 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~-----------------~l~~~~h~niv~l~~~~~~~~~~~lv 262 (534)
.++|...+.||+|+||.||+|+.. +++.||||.+.. .+..++||||+++++++......++|
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD 112 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence 468889999999999999999975 688999998752 56778899999999999999999999
Q ss_pred eeccCCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCC
Q 039819 263 YPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDS 342 (534)
Q Consensus 263 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~ 342 (534)
|||+++++|.+++.....+++..++.++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++........
T Consensus 113 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~ 189 (309)
T 2h34_A 113 MRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAA---GATHRDVKPENILVSADDFAYLVDFGIASATTDEKL 189 (309)
T ss_dssp EECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSCCC---------
T ss_pred EEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---cCCcCCCChHHEEEcCCCCEEEecCccCcccccccc
Confidence 99999999999998878899999999999999999999999 999999999999999999999999999987654333
Q ss_pred ceeeccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceecccccC
Q 039819 343 HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELG 422 (534)
Q Consensus 343 ~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 422 (534)
.......||..|+|||++.+..++.++||||||+++|||+||+.||..... .......... ... ....
T Consensus 190 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~--------~~~~~~~~~~-~~~--~~~~- 257 (309)
T 2h34_A 190 TQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQL--------SVMGAHINQA-IPR--PSTV- 257 (309)
T ss_dssp -------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHH--------HHHHHHHHSC-CCC--GGGT-
T ss_pred ccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchH--------HHHHHHhccC-CCC--cccc-
Confidence 333455689999999999988999999999999999999999999974321 1111111110 000 0011
Q ss_pred CCCCHHHHHHHHHHHHHhcccCCCCCC-ChHHHHHHhhcC
Q 039819 423 SNYDRIEVGEILQVALLCTQYLPVHRP-KMSEVVRMLEGD 461 (534)
Q Consensus 423 ~~~~~~~~~~l~~l~~~Cl~~~P~~RP-t~~ev~~~L~~~ 461 (534)
....+..+.+++.+|++.+|++|| +++++++.|+..
T Consensus 258 ---~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~ 294 (309)
T 2h34_A 258 ---RPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAA 294 (309)
T ss_dssp ---STTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHT
T ss_pred ---CCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHH
Confidence 112234788999999999999999 999999998864
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-41 Score=347.60 Aligned_cols=251 Identities=19% Similarity=0.265 Sum_probs=199.1
Q ss_pred hCCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEehh---------------hhhhcccCceeeEEEEEeCCC--eeEEEe
Q 039819 202 ENFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLKD---------------MISLAVHRNLLRLIGYCATPT--ERLLVY 263 (534)
Q Consensus 202 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~---------------~l~~~~h~niv~l~~~~~~~~--~~~lv~ 263 (534)
++|...+.||+|+||.||+|+.. +++.||||++.. ++..++||||+++++++.... ..++||
T Consensus 9 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~ 88 (396)
T 4eut_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM 88 (396)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred CceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEE
Confidence 46788899999999999999986 489999998752 677889999999999998765 679999
Q ss_pred eccCCCChhhhcccCC---CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEe----CCCCcEEEEeccccee
Q 039819 264 PYMSNGSVASRLREKP---ALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLL----DDFCEAIVGDFGLAKL 336 (534)
Q Consensus 264 e~~~~gsL~~~l~~~~---~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl----~~~~~~kl~DFGla~~ 336 (534)
||+++|+|.+++.... .+++..++.|+.|++.||.|||+. +|+||||||+|||+ +.++.+||+|||+++.
T Consensus 89 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~ 165 (396)
T 4eut_A 89 EFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE 165 (396)
T ss_dssp CCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEECTTSCEEEEECCGGGCEE
T ss_pred ecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCcCHHHEEEeecCCCceeEEEecCCCceE
Confidence 9999999999997543 399999999999999999999999 99999999999999 7888899999999987
Q ss_pred cCCCCCceeecccccccccccccccc--------CCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHh
Q 039819 337 LDHSDSHVTTAVRGTVGHIAPEYLST--------GQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQ 408 (534)
Q Consensus 337 ~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~ 408 (534)
..... ......||..|+|||++.+ ..++.++|||||||++|||+||+.||.......... +......
T Consensus 166 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~---~~~~~~~ 240 (396)
T 4eut_A 166 LEDDE--QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNK---EVMYKII 240 (396)
T ss_dssp CCCGG--GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCH---HHHHHHH
T ss_pred ccCCC--ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchH---HHHHHHh
Confidence 65432 2334569999999999864 567889999999999999999999997433222111 1111111
Q ss_pred hhc---cccee---------cccc--cCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhc
Q 039819 409 QEK---KVEVL---------VDRE--LGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLEG 460 (534)
Q Consensus 409 ~~~---~~~~~---------~d~~--l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~ 460 (534)
... ....+ +... ............+.+++.+|++.||++||++.|+++.++.
T Consensus 241 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~ 306 (396)
T 4eut_A 241 TGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSD 306 (396)
T ss_dssp HSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHH
T ss_pred cCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHH
Confidence 111 00000 0111 1223456777889999999999999999999999988764
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-40 Score=347.11 Aligned_cols=184 Identities=24% Similarity=0.370 Sum_probs=157.1
Q ss_pred HhCCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEehh----------------hhhhcccCceeeEEEEEeCC-----Ce
Q 039819 201 TENFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLKD----------------MISLAVHRNLLRLIGYCATP-----TE 258 (534)
Q Consensus 201 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~----------------~l~~~~h~niv~l~~~~~~~-----~~ 258 (534)
.++|...+.||+|+||.||+|+.. +++.||||++.. ++..++||||+++++++... ..
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 357888999999999999999975 578999998842 67788999999999999766 56
Q ss_pred eEEEeeccCCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecC
Q 039819 259 RLLVYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLD 338 (534)
Q Consensus 259 ~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~ 338 (534)
.|+||||+. |+|.+++.....+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 105 ~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~---givHrDlkp~NILl~~~~~~kL~DFGla~~~~ 180 (432)
T 3n9x_A 105 LYIVLEIAD-SDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLARTIN 180 (432)
T ss_dssp EEEEEECCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEEC-
T ss_pred EEEEEecCC-cCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHeEECCCCCEEEccCCCccccc
Confidence 899999997 59999999888899999999999999999999999 99999999999999999999999999999764
Q ss_pred CCCC---------------------ceeecccccccccccccc-ccCCCCcchhHHHHHHHHHHHHhCCCCc
Q 039819 339 HSDS---------------------HVTTAVRGTVGHIAPEYL-STGQSSEKTDVFGFGILLLELITGMRAL 388 (534)
Q Consensus 339 ~~~~---------------------~~~~~~~gt~~y~aPE~~-~~~~~~~k~Dv~S~Gvvl~elltG~~p~ 388 (534)
.... ......+||+.|+|||++ ....++.++|||||||++|||++|..||
T Consensus 181 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~ 252 (432)
T 3n9x_A 181 SEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSH 252 (432)
T ss_dssp ------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTT
T ss_pred ccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccc
Confidence 3221 123556799999999986 5566999999999999999999865544
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=333.97 Aligned_cols=237 Identities=23% Similarity=0.277 Sum_probs=196.2
Q ss_pred HhCCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEehh--------------------hhhhcccCceeeEEEEEeCCCee
Q 039819 201 TENFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLKD--------------------MISLAVHRNLLRLIGYCATPTER 259 (534)
Q Consensus 201 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~--------------------~l~~~~h~niv~l~~~~~~~~~~ 259 (534)
.++|...+.||+|+||.||+|+.. +++.||||.+.. ++..+.||||+++++++.+....
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 467889999999999999999985 689999998741 56788899999999999999999
Q ss_pred EEEeeccCCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCC----cEEEEecccce
Q 039819 260 LLVYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFC----EAIVGDFGLAK 335 (534)
Q Consensus 260 ~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~----~~kl~DFGla~ 335 (534)
++||||+++++|.+++.....+++..+..++.|++.||.|||+. +|+||||||+|||++.++ .+||+|||+++
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~---~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~ 167 (321)
T 2a2a_A 91 VLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH 167 (321)
T ss_dssp EEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCCTTCE
T ss_pred EEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChHHEEEecCCCCcCCEEEccCccce
Confidence 99999999999999998888899999999999999999999999 999999999999999888 79999999998
Q ss_pred ecCCCCCceeeccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccce
Q 039819 336 LLDHSDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEV 415 (534)
Q Consensus 336 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 415 (534)
...... ......||+.|+|||++.+..++.++|||||||++|||+||+.||..... .+..........
T Consensus 168 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-------~~~~~~i~~~~~--- 235 (321)
T 2a2a_A 168 EIEDGV--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK-------QETLANITSVSY--- 235 (321)
T ss_dssp ECCTTC--CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH-------HHHHHHHHTTCC---
T ss_pred ecCccc--cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCH-------HHHHHHHHhccc---
Confidence 775432 23345699999999999988999999999999999999999999974321 111111111100
Q ss_pred ecccccCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 416 LVDRELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 416 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
..++..... .+..+.+++.+|++.+|.+|||+.|+++
T Consensus 236 ~~~~~~~~~----~~~~~~~li~~~l~~dp~~Rps~~e~l~ 272 (321)
T 2a2a_A 236 DFDEEFFSH----TSELAKDFIRKLLVKETRKRLTIQEALR 272 (321)
T ss_dssp CCCHHHHTT----CCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred ccChhhhcc----cCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 001111111 2347889999999999999999999986
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-41 Score=340.33 Aligned_cols=251 Identities=26% Similarity=0.350 Sum_probs=194.0
Q ss_pred CCcCCeeccCCcEEEEEEEEC-----CCcEEEEEEehh---------------hhhhcccCceeeEEEEEeCC--CeeEE
Q 039819 204 FSSKNILGAGGFGNVYKGKLG-----DGTVLAVKRLKD---------------MISLAVHRNLLRLIGYCATP--TERLL 261 (534)
Q Consensus 204 ~~~~~~lG~G~~g~Vy~~~~~-----~~~~vavK~~~~---------------~l~~~~h~niv~l~~~~~~~--~~~~l 261 (534)
|...+.||+|+||.||++.+. +++.||||++.. ++..++||||+++++++.+. ...++
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 112 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL 112 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence 377889999999999998753 678999998852 57788999999999999874 56799
Q ss_pred EeeccCCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCC
Q 039819 262 VYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSD 341 (534)
Q Consensus 262 v~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~ 341 (534)
||||+++|+|.+++.... +++..++.++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 113 v~e~~~~~~L~~~l~~~~-~~~~~~~~i~~~l~~~l~~LH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~ 188 (318)
T 3lxp_A 113 VMEYVPLGSLRDYLPRHS-IGLAQLLLFAQQICEGMAYLHAQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGH 188 (318)
T ss_dssp EECCCTTCBHHHHGGGSC-CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEECCTTC
T ss_pred EEecccCCcHHHHHhhCC-CCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEEcCCCCEEECCccccccccccc
Confidence 999999999999997654 99999999999999999999999 99999999999999999999999999999876543
Q ss_pred Cc--eeeccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceeccc
Q 039819 342 SH--VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDR 419 (534)
Q Consensus 342 ~~--~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 419 (534)
.. ......||..|+|||++.+..++.++|||||||++|||+||+.||........ ....+.............++.
T Consensus 189 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 266 (318)
T 3lxp_A 189 EYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFL--ELIGIAQGQMTVLRLTELLER 266 (318)
T ss_dssp SEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHH--HHHCSCCHHHHHHHHHHHHHT
T ss_pred cccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhh--hhhcccccchhHHHHHHHHhc
Confidence 21 22344578899999999888899999999999999999999999864221000 000000000000000111111
Q ss_pred ccCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhc
Q 039819 420 ELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLEG 460 (534)
Q Consensus 420 ~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~ 460 (534)
......+...+..+.+++.+|++.+|.+|||+.|+++.|+.
T Consensus 267 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~ 307 (318)
T 3lxp_A 267 GERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKT 307 (318)
T ss_dssp TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHH
Confidence 11112223345689999999999999999999999999975
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-41 Score=331.76 Aligned_cols=236 Identities=28% Similarity=0.499 Sum_probs=190.6
Q ss_pred hCCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEeh---------------------hhhhhcccCceeeEEEEEeCCCee
Q 039819 202 ENFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLK---------------------DMISLAVHRNLLRLIGYCATPTER 259 (534)
Q Consensus 202 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~---------------------~~l~~~~h~niv~l~~~~~~~~~~ 259 (534)
++|...+.||+|+||.||+|+.. +++.||||++. +++..++||||+++++++.+..
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-- 96 (287)
T 4f0f_A 19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP-- 96 (287)
T ss_dssp TTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT--
T ss_pred ccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC--
Confidence 56788899999999999999984 78999999873 1567788999999999997655
Q ss_pred EEEeeccCCCChhhhccc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCC--eEeccCCCCcEEeCCCCc-----EEEEec
Q 039819 260 LLVYPYMSNGSVASRLRE-KPALDWNTRKRIAIGAARGLLYLHEQCDPK--IIHRDVKAANVLLDDFCE-----AIVGDF 331 (534)
Q Consensus 260 ~lv~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~--ivH~Dlkp~NiLl~~~~~-----~kl~DF 331 (534)
++||||+++|+|.+.+.. ...+++..++.++.|++.||+|||+. + |+||||||+|||++.++. +||+||
T Consensus 97 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~ivH~dikp~Nil~~~~~~~~~~~~kl~Df 173 (287)
T 4f0f_A 97 RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQ---NPPIVHRDLRSPNIFLQSLDENAPVCAKVADF 173 (287)
T ss_dssp EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCSCCSGGGEEESCCCTTCSCCEEECCC
T ss_pred eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhC---CCCeecCCCCcceEEEeccCCCCceeEEeCCC
Confidence 799999999999888864 45799999999999999999999998 7 999999999999988776 999999
Q ss_pred ccceecCCCCCceeeccccccccccccccc--cCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhh
Q 039819 332 GLAKLLDHSDSHVTTAVRGTVGHIAPEYLS--TGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQ 409 (534)
Q Consensus 332 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 409 (534)
|+++.... ......||+.|+|||++. ...++.++|||||||++|||++|+.||...... ...+......
T Consensus 174 g~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~-----~~~~~~~~~~ 244 (287)
T 4f0f_A 174 GLSQQSVH----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYG-----KIKFINMIRE 244 (287)
T ss_dssp TTCBCCSS----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCC-----HHHHHHHHHH
T ss_pred Cccccccc----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCcccccc-----HHHHHHHHhc
Confidence 99985433 234467999999999983 455789999999999999999999999743321 1111111111
Q ss_pred hcccceecccccCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhc
Q 039819 410 EKKVEVLVDRELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLEG 460 (534)
Q Consensus 410 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~ 460 (534)
.. .....+...+..+.+++.+|++.+|.+||++.|+++.|+.
T Consensus 245 ~~---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ 286 (287)
T 4f0f_A 245 EG---------LRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSE 286 (287)
T ss_dssp SC---------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred cC---------CCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHh
Confidence 11 1111222334588999999999999999999999999875
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=351.52 Aligned_cols=235 Identities=22% Similarity=0.295 Sum_probs=186.3
Q ss_pred hCCCcCCeeccCCcEEEEEEEECCCcEEEEEEehh----------------hhhhcc--cCceeeEEEEEeCCCeeEEEe
Q 039819 202 ENFSSKNILGAGGFGNVYKGKLGDGTVLAVKRLKD----------------MISLAV--HRNLLRLIGYCATPTERLLVY 263 (534)
Q Consensus 202 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~----------------~l~~~~--h~niv~l~~~~~~~~~~~lv~ 263 (534)
.+|...+.||+|+||.||+|...+++.||||++.. ++..+. ||||+++++++...+..++||
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~ 135 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 135 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence 35888899999999999999998899999998741 455665 599999999999999999999
Q ss_pred eccCCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCC-
Q 039819 264 PYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDS- 342 (534)
Q Consensus 264 e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~- 342 (534)
| +.+++|.+++.....+++..+..|+.||+.||.|||+. +|+||||||+|||++ ++.+||+|||+++.......
T Consensus 136 E-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~~ 210 (390)
T 2zmd_A 136 E-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTS 210 (390)
T ss_dssp E-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCCGGGEEES-SSCEEECCCSSSCCC------
T ss_pred e-cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEEE-CCeEEEEecCccccccCCCcc
Confidence 9 56889999998888899999999999999999999998 999999999999996 58999999999987653322
Q ss_pred ceeecccccccccccccccc-----------CCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhc
Q 039819 343 HVTTAVRGTVGHIAPEYLST-----------GQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEK 411 (534)
Q Consensus 343 ~~~~~~~gt~~y~aPE~~~~-----------~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 411 (534)
......+||+.|+|||++.+ ..++.++|||||||++|||++|+.||..... ....+....
T Consensus 211 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~------~~~~~~~~~--- 281 (390)
T 2zmd_A 211 VVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN------QISKLHAII--- 281 (390)
T ss_dssp ---CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCC------HHHHHHHHH---
T ss_pred ccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhH------HHHHHHHHh---
Confidence 12345679999999999864 4688999999999999999999999964221 111111111
Q ss_pred ccceecccccCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 412 KVEVLVDRELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 412 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
++.....++......+.+++.+||+.+|.+||++.|+++
T Consensus 282 ------~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 320 (390)
T 2zmd_A 282 ------DPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA 320 (390)
T ss_dssp ------CTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ------CccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhh
Confidence 111111112222457889999999999999999999986
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-40 Score=327.58 Aligned_cols=247 Identities=19% Similarity=0.253 Sum_probs=194.1
Q ss_pred HHhCCCcCCeeccCCcEEEEEEEE-CCCcEEEEEEeh------------hhhhhcccCceeeEEEEE-eCCCeeEEEeec
Q 039819 200 ATENFSSKNILGAGGFGNVYKGKL-GDGTVLAVKRLK------------DMISLAVHRNLLRLIGYC-ATPTERLLVYPY 265 (534)
Q Consensus 200 ~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~------------~~l~~~~h~niv~l~~~~-~~~~~~~lv~e~ 265 (534)
..++|...+.||+|+||.||+|+. .+++.||||.+. +++..+.|++++..+.++ ......++||||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~ 86 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL 86 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEEc
Confidence 457899999999999999999997 578999999754 267777888877776666 566778999999
Q ss_pred cCCCChhhhccc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEe---CCCCcEEEEecccceecCCCC
Q 039819 266 MSNGSVASRLRE-KPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLL---DDFCEAIVGDFGLAKLLDHSD 341 (534)
Q Consensus 266 ~~~gsL~~~l~~-~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl---~~~~~~kl~DFGla~~~~~~~ 341 (534)
+ +++|.+++.. ...+++..++.++.|++.||.|||+. +|+||||||+|||+ +.++.+||+|||+++......
T Consensus 87 ~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~ 162 (296)
T 4hgt_A 87 L-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR 162 (296)
T ss_dssp C-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCTT
T ss_pred c-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeeeeccCCCCeEEEecCccceeccCcc
Confidence 9 9999999974 55799999999999999999999999 99999999999999 789999999999999775432
Q ss_pred C------ceeeccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccce
Q 039819 342 S------HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEV 415 (534)
Q Consensus 342 ~------~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 415 (534)
. .......||..|+|||++.+..++.++|||||||++|||+||+.||...........+......... ...
T Consensus 163 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~~-- 239 (296)
T 4hgt_A 163 THQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMS-TPI-- 239 (296)
T ss_dssp TCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHH-SCH--
T ss_pred cCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhccccc-chh--
Confidence 2 1223457999999999999989999999999999999999999999754433222222222111111 000
Q ss_pred ecccccCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhc
Q 039819 416 LVDRELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLEG 460 (534)
Q Consensus 416 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~ 460 (534)
+.....+ +..+.+++.+|++.+|++||++.+|++.|+.
T Consensus 240 ---~~~~~~~----~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~ 277 (296)
T 4hgt_A 240 ---EVLCKGY----PSEFATYLNFCRSLRFDDKPDYSYLRQLFRN 277 (296)
T ss_dssp ---HHHTTTS----CHHHHHHHHHHHTSCTTCCCCHHHHHHHHHH
T ss_pred ---hhhhccC----CHHHHHHHHHHHhcCCCCCCCHHHHHHHHHH
Confidence 0001111 3478999999999999999999999999875
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=352.59 Aligned_cols=232 Identities=25% Similarity=0.402 Sum_probs=195.7
Q ss_pred hCCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEehh-----------------hhhhcccCceeeEEEEEeCCCeeEEEe
Q 039819 202 ENFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLKD-----------------MISLAVHRNLLRLIGYCATPTERLLVY 263 (534)
Q Consensus 202 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~-----------------~l~~~~h~niv~l~~~~~~~~~~~lv~ 263 (534)
++|...+.||+|+||.||+|+.. +|+.||||++.. +++.++||||+++++++......++||
T Consensus 16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~ 95 (476)
T 2y94_A 16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVM 95 (476)
T ss_dssp TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 56888899999999999999986 789999998742 567788999999999999999999999
Q ss_pred eccCCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCCc
Q 039819 264 PYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSH 343 (534)
Q Consensus 264 e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~ 343 (534)
||+++|+|.+++...+.+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 96 E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~-- 170 (476)
T 2y94_A 96 EYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE-- 170 (476)
T ss_dssp ECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEECTTCCEEECCCSSCEECCTTC--
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcccccHHHEEEecCCCeEEEeccchhhccccc--
Confidence 9999999999999888899999999999999999999998 99999999999999999999999999999775432
Q ss_pred eeeccccccccccccccccCCC-CcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceecccccC
Q 039819 344 VTTAVRGTVGHIAPEYLSTGQS-SEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELG 422 (534)
Q Consensus 344 ~~~~~~gt~~y~aPE~~~~~~~-~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 422 (534)
.....+||+.|+|||++.+..+ +.++|||||||++|||++|+.||+.... ......+.... . .
T Consensus 171 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~-------~~~~~~i~~~~-~------~-- 234 (476)
T 2y94_A 171 FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHV-------PTLFKKICDGI-F------Y-- 234 (476)
T ss_dssp CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSS-------HHHHHHHHTTC-C------C--
T ss_pred cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCH-------HHHHHHHhcCC-c------C--
Confidence 2345679999999999987765 7899999999999999999999974321 11222221111 0 0
Q ss_pred CCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 423 SNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 423 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
.+......+.+++.+|++.||.+|||+.|+++
T Consensus 235 --~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~ 266 (476)
T 2y94_A 235 --TPQYLNPSVISLLKHMLQVDPMKRATIKDIRE 266 (476)
T ss_dssp --CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred --CCccCCHHHHHHHHHHcCCCchhCcCHHHHHh
Confidence 11112347889999999999999999999986
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-41 Score=349.84 Aligned_cols=250 Identities=20% Similarity=0.268 Sum_probs=188.1
Q ss_pred hCCCcCCeeccCCcEEEEEEEECCCcEEEEEEeh----------hhhhhcccCceeeEEEEEeCCC------eeEEEeec
Q 039819 202 ENFSSKNILGAGGFGNVYKGKLGDGTVLAVKRLK----------DMISLAVHRNLLRLIGYCATPT------ERLLVYPY 265 (534)
Q Consensus 202 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~----------~~l~~~~h~niv~l~~~~~~~~------~~~lv~e~ 265 (534)
.+|...+.||+|+||.||+|+...+..||+|++. +++..++||||++++++|.... ..++||||
T Consensus 40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~lv~e~ 119 (394)
T 4e7w_A 40 IAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEY 119 (394)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTSCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEEEEEC
T ss_pred ceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcchHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEEEeec
Confidence 4678889999999999999999877779999874 3788899999999999996433 37899999
Q ss_pred cCCCChhhhc---ccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeC-CCCcEEEEecccceecCCCC
Q 039819 266 MSNGSVASRL---REKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLD-DFCEAIVGDFGLAKLLDHSD 341 (534)
Q Consensus 266 ~~~gsL~~~l---~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~-~~~~~kl~DFGla~~~~~~~ 341 (534)
++++.+.... .....+++..++.++.|++.||+|||+. +|+||||||+|||++ .++.+||+|||+++......
T Consensus 120 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~~~~ 196 (394)
T 4e7w_A 120 VPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGE 196 (394)
T ss_dssp CSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCEECCTTC
T ss_pred cCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEcCCCCcEEEeeCCCcccccCCC
Confidence 9875443332 2356799999999999999999999999 999999999999999 79999999999998764432
Q ss_pred CceeeccccccccccccccccC-CCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhh------hcccc
Q 039819 342 SHVTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQ------EKKVE 414 (534)
Q Consensus 342 ~~~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~------~~~~~ 414 (534)
. .....||+.|+|||++.+. .++.++|||||||++|||++|+.||...........+......... .....
T Consensus 197 ~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~ 274 (394)
T 4e7w_A 197 P--NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNPNYM 274 (394)
T ss_dssp C--CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCGGGS
T ss_pred C--CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhhh
Confidence 2 3345689999999998664 5899999999999999999999999865433222222211100000 00000
Q ss_pred eecccccCC-----CCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 415 VLVDRELGS-----NYDRIEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 415 ~~~d~~l~~-----~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
...-+.... .+....+..+.+++.+|++.||.+|||+.|+++
T Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 321 (394)
T 4e7w_A 275 EHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALC 321 (394)
T ss_dssp SSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred hhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhc
Confidence 000000000 011113458999999999999999999999985
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-41 Score=333.36 Aligned_cols=246 Identities=24% Similarity=0.381 Sum_probs=195.2
Q ss_pred hCCCcCCeeccCCcEEEEEEEE-----CCCcEEEEEEehh---------------hhhhcccCceeeEEEEEeCC--Cee
Q 039819 202 ENFSSKNILGAGGFGNVYKGKL-----GDGTVLAVKRLKD---------------MISLAVHRNLLRLIGYCATP--TER 259 (534)
Q Consensus 202 ~~~~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~---------------~l~~~~h~niv~l~~~~~~~--~~~ 259 (534)
..|+..+.||+|+||.||+|++ .+++.||||++.. ++..++||||+++++++... ...
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 100 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 100 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence 4577788999999999999984 4688999998752 57788999999999999877 667
Q ss_pred EEEeeccCCCChhhhcc-cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecC
Q 039819 260 LLVYPYMSNGSVASRLR-EKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLD 338 (534)
Q Consensus 260 ~lv~e~~~~gsL~~~l~-~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~ 338 (534)
++||||+++|+|.+++. ....+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 101 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 177 (302)
T 4e5w_A 101 KLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIE 177 (302)
T ss_dssp EEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECC
T ss_pred EEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcC---CcccCCCchheEEEcCCCCEEECccccccccc
Confidence 99999999999999995 456799999999999999999999999 99999999999999999999999999999875
Q ss_pred CCCCc--eeeccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCcc--------ccccchHHHHHHHHh
Q 039819 339 HSDSH--VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKS--------INQKGAMLEWVKKIQ 408 (534)
Q Consensus 339 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~--------~~~~~~~~~~~~~~~ 408 (534)
..... ......||..|+|||++.+..++.++|||||||++|||+||+.|+..... ...............
T Consensus 178 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (302)
T 4e5w_A 178 TDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLK 257 (302)
T ss_dssp TTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHHHH
T ss_pred CCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHHHh
Confidence 54321 22345688899999999888899999999999999999999998642110 000001111111111
Q ss_pred hhcccceecccccCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhc
Q 039819 409 QEKKVEVLVDRELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLEG 460 (534)
Q Consensus 409 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~ 460 (534)
.. .....+...+..+.+++.+|++.+|.+|||+.++++.|+.
T Consensus 258 ~~----------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ 299 (302)
T 4e5w_A 258 EG----------KRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEA 299 (302)
T ss_dssp TT----------CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred cc----------CCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHH
Confidence 11 1111222334588999999999999999999999999874
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-41 Score=340.56 Aligned_cols=240 Identities=25% Similarity=0.383 Sum_probs=181.5
Q ss_pred HhCCCcCCeeccCCcEEEEEEEECCC----cEEEEEEehh----------------hhhhcccCceeeEEEEEeCCCee-
Q 039819 201 TENFSSKNILGAGGFGNVYKGKLGDG----TVLAVKRLKD----------------MISLAVHRNLLRLIGYCATPTER- 259 (534)
Q Consensus 201 ~~~~~~~~~lG~G~~g~Vy~~~~~~~----~~vavK~~~~----------------~l~~~~h~niv~l~~~~~~~~~~- 259 (534)
.++|...+.||+|+||.||+|+.... ..||||.+.. ++..++||||+++++++......
T Consensus 22 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 101 (323)
T 3qup_A 22 EQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKG 101 (323)
T ss_dssp ---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC----
T ss_pred hhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecccccc
Confidence 46789999999999999999987543 3799998752 57778999999999999887655
Q ss_pred -----EEEeeccCCCChhhhcccC------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEE
Q 039819 260 -----LLVYPYMSNGSVASRLREK------PALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIV 328 (534)
Q Consensus 260 -----~lv~e~~~~gsL~~~l~~~------~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl 328 (534)
++||||+++|+|.+++... ..+++..++.|+.|++.||.|||++ +|+||||||+|||++.++.+||
T Consensus 102 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~Dikp~NIli~~~~~~kl 178 (323)
T 3qup_A 102 RLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSR---NFIHRDLAARNCMLAEDMTVCV 178 (323)
T ss_dssp ---CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEE
T ss_pred CCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcC---CcccCCCCcceEEEcCCCCEEE
Confidence 9999999999999998532 2599999999999999999999999 9999999999999999999999
Q ss_pred EecccceecCCCCC-ceeeccccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCcCCCccccccchHHHHHHH
Q 039819 329 GDFGLAKLLDHSDS-HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GMRALEFGKSINQKGAMLEWVKK 406 (534)
Q Consensus 329 ~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~ 406 (534)
+|||+++....... .......+|+.|+|||.+.+..++.++|||||||++|||+| |+.||....... +. ..
T Consensus 179 ~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~----~~---~~ 251 (323)
T 3qup_A 179 ADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAE----IY---NY 251 (323)
T ss_dssp CCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG----HH---HH
T ss_pred eeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHH----HH---HH
Confidence 99999987644322 12223446789999999999899999999999999999999 999997533211 11 11
Q ss_pred HhhhcccceecccccCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhc
Q 039819 407 IQQEKKVEVLVDRELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLEG 460 (534)
Q Consensus 407 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~ 460 (534)
...... ...+...+..+.+++.+|++.+|++|||+.++++.|+.
T Consensus 252 ~~~~~~----------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~ 295 (323)
T 3qup_A 252 LIGGNR----------LKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELEN 295 (323)
T ss_dssp HHTTCC----------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred HhcCCC----------CCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 111111 01112234578999999999999999999999999876
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=327.34 Aligned_cols=239 Identities=24% Similarity=0.348 Sum_probs=195.1
Q ss_pred HHhCCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEeh---------------hhhhhcccCceeeEEEEEeCCCeeEEEe
Q 039819 200 ATENFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLK---------------DMISLAVHRNLLRLIGYCATPTERLLVY 263 (534)
Q Consensus 200 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~---------------~~l~~~~h~niv~l~~~~~~~~~~~lv~ 263 (534)
..++|...+.||+|+||.||+|+.. +++.||||.+. .++..++||||+++++++.+....++||
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 84 (276)
T 2yex_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL 84 (276)
T ss_dssp HHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred eecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEE
Confidence 3567889999999999999999986 68999999874 1567788999999999999999999999
Q ss_pred eccCCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCC-
Q 039819 264 PYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDS- 342 (534)
Q Consensus 264 e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~- 342 (534)
||+++++|.+++.....+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++........
T Consensus 85 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~ 161 (276)
T 2yex_A 85 EYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 161 (276)
T ss_dssp ECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred EecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCChHHEEEccCCCEEEeeCCCccccCCCcch
Confidence 9999999999998888899999999999999999999998 999999999999999999999999999986543221
Q ss_pred ceeeccccccccccccccccCCC-CcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceeccccc
Q 039819 343 HVTTAVRGTVGHIAPEYLSTGQS-SEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDREL 421 (534)
Q Consensus 343 ~~~~~~~gt~~y~aPE~~~~~~~-~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 421 (534)
.......||..|+|||++.+..+ +.++|||||||++|||+||+.||........ ....|.. .... .
T Consensus 162 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--~~~~~~~----~~~~-------~ 228 (276)
T 2yex_A 162 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ--EYSDWKE----KKTY-------L 228 (276)
T ss_dssp CCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSH--HHHHHHT----TCTT-------S
T ss_pred hcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHH--HHHHhhh----cccc-------c
Confidence 12334568999999999987665 7899999999999999999999975432111 1112211 1000 0
Q ss_pred CCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 422 GSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 422 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
......+..+.+++.+|++.+|.+|||+.|+++
T Consensus 229 --~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (276)
T 2yex_A 229 --NPWKKIDSAPLALLHKILVENPSARITIPDIKK 261 (276)
T ss_dssp --TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred --CchhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence 001112347889999999999999999999874
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-40 Score=349.27 Aligned_cols=178 Identities=24% Similarity=0.406 Sum_probs=144.4
Q ss_pred hCCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEehh----------------hhhhcccCceeeEEEEEeCC-----Cee
Q 039819 202 ENFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLKD----------------MISLAVHRNLLRLIGYCATP-----TER 259 (534)
Q Consensus 202 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~----------------~l~~~~h~niv~l~~~~~~~-----~~~ 259 (534)
++|...+.||+|+||.||+|+.. +++.||||++.. ++..++|||||++++++... ...
T Consensus 53 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 132 (458)
T 3rp9_A 53 DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDEL 132 (458)
T ss_dssp TTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCE
T ss_pred CCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceE
Confidence 67899999999999999999875 689999998742 67788999999999999543 568
Q ss_pred EEEeeccCCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCC
Q 039819 260 LLVYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDH 339 (534)
Q Consensus 260 ~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~ 339 (534)
|+||||+ +|+|.+++.....+++..+..|+.||+.||+|||+. +||||||||+|||++.++.+||+|||+++....
T Consensus 133 ~lv~e~~-~~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~ 208 (458)
T 3rp9_A 133 YVVLEIA-DSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLARTVDY 208 (458)
T ss_dssp EEEECCC-SEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTCBCTTS
T ss_pred EEEEecc-ccchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhC---CcCCCCCChhhEEECCCCCEeecccccchhccC
Confidence 9999998 479999998888899999999999999999999999 999999999999999999999999999987642
Q ss_pred CCC--------------------------ceeecccccccccccccc-ccCCCCcchhHHHHHHHHHHHHh
Q 039819 340 SDS--------------------------HVTTAVRGTVGHIAPEYL-STGQSSEKTDVFGFGILLLELIT 383 (534)
Q Consensus 340 ~~~--------------------------~~~~~~~gt~~y~aPE~~-~~~~~~~k~Dv~S~Gvvl~ellt 383 (534)
... ......+||+.|+|||++ ....++.++|||||||++|||+|
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~ellt 279 (458)
T 3rp9_A 209 PENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLN 279 (458)
T ss_dssp CTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHT
T ss_pred ccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHH
Confidence 211 123445789999999976 45679999999999999999999
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-41 Score=332.36 Aligned_cols=235 Identities=23% Similarity=0.359 Sum_probs=189.6
Q ss_pred hCCCcCCeeccCCcEEEEEEEECC-C-------cEEEEEEehh--------------hhhhcccCceeeEEEEEeCCCee
Q 039819 202 ENFSSKNILGAGGFGNVYKGKLGD-G-------TVLAVKRLKD--------------MISLAVHRNLLRLIGYCATPTER 259 (534)
Q Consensus 202 ~~~~~~~~lG~G~~g~Vy~~~~~~-~-------~~vavK~~~~--------------~l~~~~h~niv~l~~~~~~~~~~ 259 (534)
++|...+.||+|+||.||+|+... + ..||+|.+.. ++..++||||+++++++.+.+..
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 87 (289)
T 4fvq_A 8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDEN 87 (289)
T ss_dssp GGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTCC
T ss_pred hHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCCC
Confidence 578888999999999999998643 2 5799998742 57788999999999999999999
Q ss_pred EEEeeccCCCChhhhcccCCC-CCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCc--------EEEEe
Q 039819 260 LLVYPYMSNGSVASRLREKPA-LDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCE--------AIVGD 330 (534)
Q Consensus 260 ~lv~e~~~~gsL~~~l~~~~~-l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~--------~kl~D 330 (534)
++||||+++|+|.+++..... +++..++.++.|++.||.|||++ +|+||||||+|||++.++. +||+|
T Consensus 88 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~D 164 (289)
T 4fvq_A 88 ILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEEN---TLIHGNVCAKNILLIREEDRKTGNPPFIKLSD 164 (289)
T ss_dssp EEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEEECCBGGGTBCCEEEECC
T ss_pred EEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhC---CeECCCcCcceEEEecCCcccccccceeeecc
Confidence 999999999999999986544 99999999999999999999999 9999999999999998887 99999
Q ss_pred cccceecCCCCCceeecccccccccccccccc-CCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhh
Q 039819 331 FGLAKLLDHSDSHVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQ 409 (534)
Q Consensus 331 FGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 409 (534)
||++..... .....||..|+|||++.+ ..++.++|||||||++|||+||..|+...... .........
T Consensus 165 fg~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~------~~~~~~~~~ 233 (289)
T 4fvq_A 165 PGISITVLP-----KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDS------QRKLQFYED 233 (289)
T ss_dssp CCSCTTTSC-----HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH------HHHHHHHHT
T ss_pred CcccccccC-----ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccch------HHHHHHhhc
Confidence 999875432 223458899999999977 67899999999999999999965554322111 111111111
Q ss_pred hcccceecccccCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhcCC
Q 039819 410 EKKVEVLVDRELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLEGDG 462 (534)
Q Consensus 410 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~~~ 462 (534)
.. .+... .+..+.+++.+|++.+|.+|||+.|+++.|+..-
T Consensus 234 ~~--------~~~~~----~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~ 274 (289)
T 4fvq_A 234 RH--------QLPAP----KAAELANLINNCMDYEPDHRPSFRAIIRDLNSLF 274 (289)
T ss_dssp TC--------CCCCC----SSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC
T ss_pred cC--------CCCCC----CCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 11 01111 1236789999999999999999999999998754
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=327.78 Aligned_cols=234 Identities=26% Similarity=0.411 Sum_probs=173.2
Q ss_pred HhCCCcCCeeccCCcEEEEEEEE-CCCcEEEEEEehh-----------------hhhhcccCceeeEEEEEeCCCeeEEE
Q 039819 201 TENFSSKNILGAGGFGNVYKGKL-GDGTVLAVKRLKD-----------------MISLAVHRNLLRLIGYCATPTERLLV 262 (534)
Q Consensus 201 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~-----------------~l~~~~h~niv~l~~~~~~~~~~~lv 262 (534)
.++|...+.||+|+||.||+|+. .+++.||||.+.. ++..++||||+++++++.+....++|
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV 89 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence 36788899999999999999997 4789999998742 56678899999999999999999999
Q ss_pred eeccCCCChhhhcccC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCC
Q 039819 263 YPYMSNGSVASRLREK-PALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSD 341 (534)
Q Consensus 263 ~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~ 341 (534)
|||+++++|.+++... ..+++..++.++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++.......
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~ 166 (278)
T 3cok_A 90 LEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPH 166 (278)
T ss_dssp EECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSSCCGGGEEECTTCCEEECCCTTCEECC---
T ss_pred EecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEEeecceeeccCCC
Confidence 9999999999999764 6799999999999999999999999 99999999999999999999999999998765322
Q ss_pred CceeeccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceeccccc
Q 039819 342 SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDREL 421 (534)
Q Consensus 342 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 421 (534)
. ......||+.|+|||++.+..++.++|||||||++|||+||+.||........ ..... ..+...
T Consensus 167 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-------~~~~~-------~~~~~~ 231 (278)
T 3cok_A 167 E-KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNT-------LNKVV-------LADYEM 231 (278)
T ss_dssp --------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC------------CC-------SSCCCC
T ss_pred C-cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHH-------HHHHh-------hcccCC
Confidence 2 22345689999999999888899999999999999999999999974332110 00000 001111
Q ss_pred CCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 422 GSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 422 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
+...+..+.+++.+|++.+|++||++.++++
T Consensus 232 ----~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 232 ----PSFLSIEAKDLIHQLLRRNPADRLSLSSVLD 262 (278)
T ss_dssp ----CTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred ----ccccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence 1223457889999999999999999999974
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-40 Score=325.79 Aligned_cols=237 Identities=20% Similarity=0.283 Sum_probs=195.0
Q ss_pred HhCCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEehh----------------hhhhcccCceeeEEEEEeCCCeeEEEe
Q 039819 201 TENFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLKD----------------MISLAVHRNLLRLIGYCATPTERLLVY 263 (534)
Q Consensus 201 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~----------------~l~~~~h~niv~l~~~~~~~~~~~lv~ 263 (534)
.++|...+.||+|+||.||+|... ++..||+|++.. ++..++||||+++++++.+....++||
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 84 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 84 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence 467889999999999999999975 589999998742 567889999999999999999999999
Q ss_pred eccCCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCc---EEEEecccceecCCC
Q 039819 264 PYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCE---AIVGDFGLAKLLDHS 340 (534)
Q Consensus 264 e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~---~kl~DFGla~~~~~~ 340 (534)
||+++|+|.+.+.....+++..+..++.|++.||.|||+. +|+||||||+||+++.++. +||+|||++......
T Consensus 85 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~ 161 (284)
T 3kk8_A 85 DLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS 161 (284)
T ss_dssp CCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSS
T ss_pred ecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccC
Confidence 9999999999998878899999999999999999999999 9999999999999986655 999999999876543
Q ss_pred CCceeeccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceecccc
Q 039819 341 DSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRE 420 (534)
Q Consensus 341 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 420 (534)
. ......||+.|+|||++.+..++.++||||||+++|||++|+.||..... .+.......... . ...+
T Consensus 162 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~-------~~~~~~~~~~~~-~-~~~~- 229 (284)
T 3kk8_A 162 E--AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ-------HRLYAQIKAGAY-D-YPSP- 229 (284)
T ss_dssp C--BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHHHHHTCC-C-CCTT-
T ss_pred c--cccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCch-------hHHHHHHHhccc-c-CCch-
Confidence 2 23345699999999999998999999999999999999999999964322 111111111110 0 0000
Q ss_pred cCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 421 LGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 421 l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
.....+..+.+++.+|++.+|++|||+.|+++
T Consensus 230 ----~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (284)
T 3kk8_A 230 ----EWDTVTPEAKSLIDSMLTVNPKKRITADQALK 261 (284)
T ss_dssp ----TTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ----hhcccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 01112357889999999999999999999985
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=365.74 Aligned_cols=240 Identities=27% Similarity=0.385 Sum_probs=197.4
Q ss_pred HhCCCcCCeeccCCcEEEEEEEECCCcEEEEEEehh-------------hhhhcccCceeeEEEEEeCCCeeEEEeeccC
Q 039819 201 TENFSSKNILGAGGFGNVYKGKLGDGTVLAVKRLKD-------------MISLAVHRNLLRLIGYCATPTERLLVYPYMS 267 (534)
Q Consensus 201 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~-------------~l~~~~h~niv~l~~~~~~~~~~~lv~e~~~ 267 (534)
.++|...+.||+|+||.||+|++.++..||||+++. ++..++|+|||++++++.+ ...++|||||+
T Consensus 266 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~~~ 344 (535)
T 2h8h_A 266 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMS 344 (535)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCT
T ss_pred hhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeehhc
Confidence 456778889999999999999998888899998862 6788899999999999876 67899999999
Q ss_pred CCChhhhccc--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCCcee
Q 039819 268 NGSVASRLRE--KPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVT 345 (534)
Q Consensus 268 ~gsL~~~l~~--~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~ 345 (534)
+|+|.+++.. ...+++..++.|+.||+.||+|||++ +||||||||+|||++.++.+||+|||+++..........
T Consensus 345 ~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~ 421 (535)
T 2h8h_A 345 KGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTAR 421 (535)
T ss_dssp TEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHHHTT
T ss_pred CCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEEcCCCcEEEcccccceecCCCceecc
Confidence 9999999974 35699999999999999999999999 999999999999999999999999999986643211112
Q ss_pred eccccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCcCCCccccccchHHHHHHHHhhhcccceecccccCCC
Q 039819 346 TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELGSN 424 (534)
Q Consensus 346 ~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 424 (534)
....++..|+|||++....++.++|||||||++|||+| |+.||..... .+....+..... ..
T Consensus 422 ~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~-------~~~~~~i~~~~~----------~~ 484 (535)
T 2h8h_A 422 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN-------REVLDQVERGYR----------MP 484 (535)
T ss_dssp CSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCH-------HHHHHHHHTTCC----------CC
T ss_pred cCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH-------HHHHHHHHcCCC----------CC
Confidence 23446789999999998899999999999999999999 9999974321 122222221111 11
Q ss_pred CCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhcC
Q 039819 425 YDRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLEGD 461 (534)
Q Consensus 425 ~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~~ 461 (534)
.+...+..+.+++.+||+.+|++|||+.+|+++|+..
T Consensus 485 ~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~ 521 (535)
T 2h8h_A 485 CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 521 (535)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 1222345789999999999999999999999999864
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=342.54 Aligned_cols=248 Identities=24% Similarity=0.323 Sum_probs=197.7
Q ss_pred hCCCcCCeeccCCcEEEEEEEE-----CCCcEEEEEEeh--------------hhhhhcccCceeeEEEEEe--CCCeeE
Q 039819 202 ENFSSKNILGAGGFGNVYKGKL-----GDGTVLAVKRLK--------------DMISLAVHRNLLRLIGYCA--TPTERL 260 (534)
Q Consensus 202 ~~~~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~--------------~~l~~~~h~niv~l~~~~~--~~~~~~ 260 (534)
++|...+.||+|+||.||+|++ .++..||||++. +++..++||||+++++++. +....+
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 102 (327)
T 3lxl_A 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLR 102 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEE
T ss_pred hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEE
Confidence 5788889999999999999984 468899999875 2677889999999999987 445688
Q ss_pred EEeeccCCCChhhhccc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCC
Q 039819 261 LVYPYMSNGSVASRLRE-KPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDH 339 (534)
Q Consensus 261 lv~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~ 339 (534)
+||||+++|+|.+++.. ...+++..++.|+.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 103 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~ 179 (327)
T 3lxl_A 103 LVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSR---RCVHRDLAARNILVESEAHVKIADFGLAKLLPL 179 (327)
T ss_dssp EEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCGGGCEECCT
T ss_pred EEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChhhEEECCCCCEEEcccccceeccc
Confidence 99999999999999975 45699999999999999999999998 999999999999999999999999999998754
Q ss_pred CCCc--eeeccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCcccc--------ccchHHHHHHHHhh
Q 039819 340 SDSH--VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSIN--------QKGAMLEWVKKIQQ 409 (534)
Q Consensus 340 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~--------~~~~~~~~~~~~~~ 409 (534)
.... ......||..|+|||++.+..++.++|||||||++|||+||+.||....... ...........
T Consensus 180 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~--- 256 (327)
T 3lxl_A 180 DKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLEL--- 256 (327)
T ss_dssp TCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHH---
T ss_pred CCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHH---
Confidence 3322 2233457888999999988889999999999999999999999986322110 00000011111
Q ss_pred hcccceecccccCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhcCC
Q 039819 410 EKKVEVLVDRELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLEGDG 462 (534)
Q Consensus 410 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~~~ 462 (534)
+........+...+..+.+++.+|++.+|.+|||+.|+++.|+...
T Consensus 257 -------~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~ 302 (327)
T 3lxl_A 257 -------LEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLW 302 (327)
T ss_dssp -------HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC-
T ss_pred -------hhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 1111111222334568999999999999999999999999998754
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-40 Score=327.46 Aligned_cols=246 Identities=19% Similarity=0.248 Sum_probs=195.2
Q ss_pred HhCCCcCCeeccCCcEEEEEEEE-CCCcEEEEEEeh------------hhhhhcccCceeeEEEEE-eCCCeeEEEeecc
Q 039819 201 TENFSSKNILGAGGFGNVYKGKL-GDGTVLAVKRLK------------DMISLAVHRNLLRLIGYC-ATPTERLLVYPYM 266 (534)
Q Consensus 201 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~------------~~l~~~~h~niv~l~~~~-~~~~~~~lv~e~~ 266 (534)
.++|...+.||+|+||.||+|+. .+++.||||++. .++..+.|++++..+.++ ......++||||+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~ 87 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL 87 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcchhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEEec
Confidence 36788899999999999999997 578999999864 267778888877666665 5567789999999
Q ss_pred CCCChhhhcc-cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEe---CCCCcEEEEecccceecCCCCC
Q 039819 267 SNGSVASRLR-EKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLL---DDFCEAIVGDFGLAKLLDHSDS 342 (534)
Q Consensus 267 ~~gsL~~~l~-~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl---~~~~~~kl~DFGla~~~~~~~~ 342 (534)
+++|.+++. ....+++..++.++.|++.||.|||++ +|+||||||+|||+ +.++.+||+|||+++.......
T Consensus 88 -~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~ 163 (296)
T 3uzp_A 88 -GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDART 163 (296)
T ss_dssp -CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTT
T ss_pred -CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHeEEecCCCCCeEEEeeCCCccccccccc
Confidence 999999997 455799999999999999999999999 99999999999999 4889999999999997754332
Q ss_pred c------eeeccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhccccee
Q 039819 343 H------VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVL 416 (534)
Q Consensus 343 ~------~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 416 (534)
. ......||..|+|||++.+..++.++|||||||++|||+||+.||...........+......... ...
T Consensus 164 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~~--- 239 (296)
T 3uzp_A 164 HQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMS-TPI--- 239 (296)
T ss_dssp CCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHH-SCH---
T ss_pred ccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccC-Cch---
Confidence 1 124457999999999999989999999999999999999999999854332222222222111111 000
Q ss_pred cccccCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhc
Q 039819 417 VDRELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLEG 460 (534)
Q Consensus 417 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~ 460 (534)
+.+... .+..+.+++.+|++.+|.+||++.+|++.|+.
T Consensus 240 --~~~~~~----~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~ 277 (296)
T 3uzp_A 240 --EVLCKG----YPSEFATYLNFCRSLRFDDKPDYSYLRQLFRN 277 (296)
T ss_dssp --HHHTTT----SCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHH
T ss_pred --HHHHhh----CCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHH
Confidence 001111 23478999999999999999999999999875
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=336.02 Aligned_cols=244 Identities=22% Similarity=0.287 Sum_probs=191.5
Q ss_pred HHHHHHHHhCCCcC-CeeccCCcEEEEEEEEC-CCcEEEEEEehh----------------hhhhc-ccCceeeEEEEEe
Q 039819 194 FRELQQATENFSSK-NILGAGGFGNVYKGKLG-DGTVLAVKRLKD----------------MISLA-VHRNLLRLIGYCA 254 (534)
Q Consensus 194 ~~~l~~~~~~~~~~-~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~----------------~l~~~-~h~niv~l~~~~~ 254 (534)
+.......+.|... +.||+|+||.||+|+.. +++.||||++.. ++..+ .||||+++++++.
T Consensus 20 ~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~ 99 (327)
T 3lm5_A 20 FQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYE 99 (327)
T ss_dssp SBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEE
T ss_pred HHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEE
Confidence 33444556677776 88999999999999986 689999998752 34444 4799999999999
Q ss_pred CCCeeEEEeeccCCCChhhhccc--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCC---CCcEEEE
Q 039819 255 TPTERLLVYPYMSNGSVASRLRE--KPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDD---FCEAIVG 329 (534)
Q Consensus 255 ~~~~~~lv~e~~~~gsL~~~l~~--~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~---~~~~kl~ 329 (534)
+....++||||+++|+|.+++.. ...+++..++.++.|++.||+|||+. +|+||||||+|||++. ++.+||+
T Consensus 100 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~---givH~Dikp~NIl~~~~~~~~~~kL~ 176 (327)
T 3lm5_A 100 NTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQN---NIVHLDLKPQNILLSSIYPLGDIKIV 176 (327)
T ss_dssp CSSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESCBTTBCCEEEC
T ss_pred eCCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCChHHEEEecCCCCCcEEEe
Confidence 99999999999999999999864 36799999999999999999999999 9999999999999998 7899999
Q ss_pred ecccceecCCCCCceeeccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhh
Q 039819 330 DFGLAKLLDHSDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQ 409 (534)
Q Consensus 330 DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 409 (534)
|||+++...... ......||+.|+|||++.+..++.++|||||||++|||+||+.||...... +.......
T Consensus 177 Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-------~~~~~i~~ 247 (327)
T 3lm5_A 177 DFGMSRKIGHAC--ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQ-------ETYLNISQ 247 (327)
T ss_dssp CGGGCEEC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHHHHHH
T ss_pred eCccccccCCcc--ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCch-------HHHHHHHh
Confidence 999999775432 233456999999999999899999999999999999999999999753321 11111111
Q ss_pred hcccceecccccCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 410 EKKVEVLVDRELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 410 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
.. ..............+.+++.+|++.+|.+|||++|+++
T Consensus 248 ~~-------~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~ 287 (327)
T 3lm5_A 248 VN-------VDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLS 287 (327)
T ss_dssp TC-------CCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred cc-------cccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhC
Confidence 10 00011111123457889999999999999999999874
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-41 Score=331.72 Aligned_cols=240 Identities=22% Similarity=0.385 Sum_probs=190.9
Q ss_pred HhCCCcCCeeccCCcEEEEEEEECC----CcEEEEEEehh---------------hhhhcccCceeeEEEEEeCCCeeEE
Q 039819 201 TENFSSKNILGAGGFGNVYKGKLGD----GTVLAVKRLKD---------------MISLAVHRNLLRLIGYCATPTERLL 261 (534)
Q Consensus 201 ~~~~~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~---------------~l~~~~h~niv~l~~~~~~~~~~~l 261 (534)
.++|...+.||+|+||.||+|+..+ +..||||.+.. .+..++||||+++++++.+ +..++
T Consensus 11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~ 89 (281)
T 3cc6_A 11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTWI 89 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCEE
T ss_pred ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCEE
Confidence 4678888999999999999998643 34699998752 5777899999999999865 45689
Q ss_pred EeeccCCCChhhhccc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCC
Q 039819 262 VYPYMSNGSVASRLRE-KPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHS 340 (534)
Q Consensus 262 v~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~ 340 (534)
||||+++++|.+++.. ...+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 90 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 166 (281)
T 3cc6_A 90 IMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESI---NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDE 166 (281)
T ss_dssp EEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEEETTEEEECCCCGGGCC---
T ss_pred EEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEECCCCcEEeCccCCCcccccc
Confidence 9999999999999975 35699999999999999999999999 9999999999999999999999999999876544
Q ss_pred CCceeeccccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCcCCCccccccchHHHHHHHHhhhcccceeccc
Q 039819 341 DSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDR 419 (534)
Q Consensus 341 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 419 (534)
.........+|..|+|||++.+..++.++|||||||++|||+| |+.||...... ..... .......
T Consensus 167 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~----~~~~~---~~~~~~~------ 233 (281)
T 3cc6_A 167 DYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENK----DVIGV---LEKGDRL------ 233 (281)
T ss_dssp ------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGG----GHHHH---HHHTCCC------
T ss_pred cccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChH----HHHHH---HhcCCCC------
Confidence 3333344557889999999988899999999999999999998 99999743321 11111 1111110
Q ss_pred ccCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhcC
Q 039819 420 ELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLEGD 461 (534)
Q Consensus 420 ~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~~ 461 (534)
..+...+..+.+++.+|++.+|.+||++.|+++.|+..
T Consensus 234 ----~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~ 271 (281)
T 3cc6_A 234 ----PKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDV 271 (281)
T ss_dssp ----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ----CCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHH
Confidence 01112245789999999999999999999999998864
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-41 Score=338.93 Aligned_cols=248 Identities=26% Similarity=0.404 Sum_probs=198.0
Q ss_pred HHHHHHHhCCCcCCeeccCCcEEEEEEEE------CCCcEEEEEEehh---------------hhhhc-ccCceeeEEEE
Q 039819 195 RELQQATENFSSKNILGAGGFGNVYKGKL------GDGTVLAVKRLKD---------------MISLA-VHRNLLRLIGY 252 (534)
Q Consensus 195 ~~l~~~~~~~~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~---------------~l~~~-~h~niv~l~~~ 252 (534)
.+.....++|...+.||+|+||.||+|+. .+++.||||++.. ++..+ +||||++++++
T Consensus 20 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~ 99 (316)
T 2xir_A 20 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGA 99 (316)
T ss_dssp HHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEE
Confidence 33444467899999999999999999984 3568899998752 45555 69999999999
Q ss_pred EeCCC-eeEEEeeccCCCChhhhcccCCC----------------CCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCC
Q 039819 253 CATPT-ERLLVYPYMSNGSVASRLREKPA----------------LDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKA 315 (534)
Q Consensus 253 ~~~~~-~~~lv~e~~~~gsL~~~l~~~~~----------------l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp 315 (534)
+...+ ..++||||+++|+|.+++..... +++..++.++.|++.||.|||+. +|+||||||
T Consensus 100 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp 176 (316)
T 2xir_A 100 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAA 176 (316)
T ss_dssp ECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSG
T ss_pred EecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhC---CcccccCcc
Confidence 98765 48999999999999999975443 89999999999999999999999 999999999
Q ss_pred CcEEeCCCCcEEEEecccceecCCCCC-ceeeccccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCcCCCcc
Q 039819 316 ANVLLDDFCEAIVGDFGLAKLLDHSDS-HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GMRALEFGKS 393 (534)
Q Consensus 316 ~NiLl~~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~ellt-G~~p~~~~~~ 393 (534)
+||+++.++.+||+|||+++....... .......||+.|+|||++.+..++.++|||||||++|||+| |+.||.....
T Consensus 177 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~ 256 (316)
T 2xir_A 177 RNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI 256 (316)
T ss_dssp GGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCC
T ss_pred ceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccch
Confidence 999999999999999999987654332 22334567899999999998899999999999999999998 9999974332
Q ss_pred ccccchHHHHHHHHhhhcccceecccccCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhcC
Q 039819 394 INQKGAMLEWVKKIQQEKKVEVLVDRELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLEGD 461 (534)
Q Consensus 394 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~~ 461 (534)
.. ........... .. .+...+..+.+++.+|++.+|.+|||+.|+++.|+..
T Consensus 257 ~~------~~~~~~~~~~~------~~----~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 308 (316)
T 2xir_A 257 DE------EFCRRLKEGTR------MR----APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 308 (316)
T ss_dssp SH------HHHHHHHHTCC------CC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred hH------HHHHHhccCcc------CC----CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 11 11111111111 01 1112245789999999999999999999999998753
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-40 Score=335.90 Aligned_cols=243 Identities=21% Similarity=0.219 Sum_probs=189.8
Q ss_pred HHHHHhCCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEeh-------------------hhhhhcccCceeeEEEEEeCC
Q 039819 197 LQQATENFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLK-------------------DMISLAVHRNLLRLIGYCATP 256 (534)
Q Consensus 197 l~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~-------------------~~l~~~~h~niv~l~~~~~~~ 256 (534)
+....++|...+.||+|+||.||+|... ++..||||++. +++..++||||+++++++.+.
T Consensus 21 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 100 (345)
T 3hko_A 21 LLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDE 100 (345)
T ss_dssp HHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred hhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccC
Confidence 4566788999999999999999999974 68899999874 157788999999999999999
Q ss_pred CeeEEEeeccCCCChhhhccc----------------------------------------CCCCCHHHHHHHHHHHHHH
Q 039819 257 TERLLVYPYMSNGSVASRLRE----------------------------------------KPALDWNTRKRIAIGAARG 296 (534)
Q Consensus 257 ~~~~lv~e~~~~gsL~~~l~~----------------------------------------~~~l~~~~~~~i~~~i~~~ 296 (534)
...++||||+++|+|.+++.. ...+++..++.|+.|++.|
T Consensus 101 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~ 180 (345)
T 3hko_A 101 QYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSA 180 (345)
T ss_dssp SEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHH
T ss_pred CeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHH
Confidence 999999999999999998852 1123577788999999999
Q ss_pred HHHHHhcCCCCeEeccCCCCcEEeCCCC--cEEEEecccceecCCCC---Cceeecccccccccccccccc--CCCCcch
Q 039819 297 LLYLHEQCDPKIIHRDVKAANVLLDDFC--EAIVGDFGLAKLLDHSD---SHVTTAVRGTVGHIAPEYLST--GQSSEKT 369 (534)
Q Consensus 297 l~yLH~~~~~~ivH~Dlkp~NiLl~~~~--~~kl~DFGla~~~~~~~---~~~~~~~~gt~~y~aPE~~~~--~~~~~k~ 369 (534)
|.|||+. +|+||||||+|||++.++ .+||+|||+++...... ........||+.|+|||++.+ ..++.++
T Consensus 181 l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~ 257 (345)
T 3hko_A 181 LHYLHNQ---GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKC 257 (345)
T ss_dssp HHHHHHT---TEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHH
T ss_pred HHHHHHC---CccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHH
Confidence 9999999 999999999999998766 89999999998764321 112345669999999999865 6789999
Q ss_pred hHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceecccccCCCCCHHHHHHHHHHHHHhcccCCCCCC
Q 039819 370 DVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELGSNYDRIEVGEILQVALLCTQYLPVHRP 449 (534)
Q Consensus 370 Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RP 449 (534)
|||||||++|||+||+.||...... +.......... .. ...........+.+++.+|++.+|.+||
T Consensus 258 DiwslG~il~el~~g~~pf~~~~~~-------~~~~~~~~~~~--~~-----~~~~~~~~~~~~~~li~~~l~~~p~~Rp 323 (345)
T 3hko_A 258 DAWSAGVLLHLLLMGAVPFPGVNDA-------DTISQVLNKKL--CF-----ENPNYNVLSPLARDLLSNLLNRNVDERF 323 (345)
T ss_dssp HHHHHHHHHHHHHHSSCSSCCSSHH-------HHHHHHHHCCC--CT-----TSGGGGGSCHHHHHHHHHHSCSCTTTSC
T ss_pred HHHHHHHHHHHHHHCCCCCCCCChH-------HHHHHHHhccc--cc-----CCcccccCCHHHHHHHHHHcCCChhHCC
Confidence 9999999999999999999743321 11111111110 00 0000011235788999999999999999
Q ss_pred ChHHHHH
Q 039819 450 KMSEVVR 456 (534)
Q Consensus 450 t~~ev~~ 456 (534)
++.|+++
T Consensus 324 s~~~~l~ 330 (345)
T 3hko_A 324 DAMRALQ 330 (345)
T ss_dssp CHHHHHH
T ss_pred CHHHHhc
Confidence 9999986
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-41 Score=342.69 Aligned_cols=256 Identities=24% Similarity=0.293 Sum_probs=182.0
Q ss_pred HHHHHHHhCCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEehh-------------hhhhcccCceeeEEEEEeCCCe--
Q 039819 195 RELQQATENFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLKD-------------MISLAVHRNLLRLIGYCATPTE-- 258 (534)
Q Consensus 195 ~~l~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~-------------~l~~~~h~niv~l~~~~~~~~~-- 258 (534)
++.....++|...+.||+|+||.||+|+.. ++..||||++.. .+..++||||++++++|.....
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~ 95 (360)
T 3e3p_A 16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERD 95 (360)
T ss_dssp HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSC
T ss_pred hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccccHHHHHHHHHHHhcCCCCcccHHHhhhcccccc
Confidence 455677889999999999999999999985 689999998742 4566789999999999965433
Q ss_pred -----eEEEeeccCCCChhhh----cccCCCCCHHHHHHHHHHHHHHHHHHH--hcCCCCeEeccCCCCcEEeCC-CCcE
Q 039819 259 -----RLLVYPYMSNGSVASR----LREKPALDWNTRKRIAIGAARGLLYLH--EQCDPKIIHRDVKAANVLLDD-FCEA 326 (534)
Q Consensus 259 -----~~lv~e~~~~gsL~~~----l~~~~~l~~~~~~~i~~~i~~~l~yLH--~~~~~~ivH~Dlkp~NiLl~~-~~~~ 326 (534)
.++||||++++ |.+. ......+++..+..++.|++.||.||| +. +|+||||||+|||++. ++.+
T Consensus 96 ~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~---~ivH~Dlkp~NIll~~~~~~~ 171 (360)
T 3e3p_A 96 RRDIYLNVVMEYVPDT-LHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSV---NVCHRDIKPHNVLVNEADGTL 171 (360)
T ss_dssp TTCEEEEEEEECCSCB-HHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTT---CCBCSCCCGGGEEEETTTTEE
T ss_pred ccceeEEEEeeccccc-HHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCC---CeecCcCCHHHEEEeCCCCcE
Confidence 78999999874 4333 345667999999999999999999999 77 9999999999999996 8999
Q ss_pred EEEecccceecCCCCCceeeccccccccccccccccCC-CCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHH--
Q 039819 327 IVGDFGLAKLLDHSDSHVTTAVRGTVGHIAPEYLSTGQ-SSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEW-- 403 (534)
Q Consensus 327 kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~-- 403 (534)
||+|||+++...... ......||+.|+|||++.+.. ++.++|||||||++|||+||+.||...........+...
T Consensus 172 kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~ 249 (360)
T 3e3p_A 172 KLCDFGSAKKLSPSE--PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLG 249 (360)
T ss_dssp EECCCTTCBCCCTTS--CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHC
T ss_pred EEeeCCCceecCCCC--CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcC
Confidence 999999998765432 233456899999999986544 899999999999999999999999764432221111111
Q ss_pred ------HHHHhhhcccceeccc------ccCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 404 ------VKKIQQEKKVEVLVDR------ELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 404 ------~~~~~~~~~~~~~~d~------~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
..............+. .............+.+++.+|++.||.+|||+.|+++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 314 (360)
T 3e3p_A 250 CPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALC 314 (360)
T ss_dssp CCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhc
Confidence 0111000000000000 0001111123568999999999999999999999974
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=332.15 Aligned_cols=241 Identities=20% Similarity=0.263 Sum_probs=185.7
Q ss_pred hCCCcC-CeeccCCcEEEEEEEEC-CCcEEEEEEehh--------------hhhh-cccCceeeEEEEEeCCCeeEEEee
Q 039819 202 ENFSSK-NILGAGGFGNVYKGKLG-DGTVLAVKRLKD--------------MISL-AVHRNLLRLIGYCATPTERLLVYP 264 (534)
Q Consensus 202 ~~~~~~-~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~--------------~l~~-~~h~niv~l~~~~~~~~~~~lv~e 264 (534)
+.|... +.||+|+||.||+|+.. +++.||||++.. ++.+ .+||||+++++++.+.+..++|||
T Consensus 12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e 91 (316)
T 2ac3_A 12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFE 91 (316)
T ss_dssp TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEE
Confidence 456663 78999999999999964 789999998842 3444 579999999999999999999999
Q ss_pred ccCCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCc---EEEEecccceecCCCC
Q 039819 265 YMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCE---AIVGDFGLAKLLDHSD 341 (534)
Q Consensus 265 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~---~kl~DFGla~~~~~~~ 341 (534)
|+++|+|.+++.....+++..+..++.|++.||+|||+. +|+||||||+|||++.++. +||+|||+++......
T Consensus 92 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~ 168 (316)
T 2ac3_A 92 KMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNK---GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNG 168 (316)
T ss_dssp CCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESCSSSSCSEEECCTTCCC------
T ss_pred cCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEEccCCCcCceEEEEccCccccccCC
Confidence 999999999998878899999999999999999999999 9999999999999998776 9999999998653221
Q ss_pred C------ceeecccccccccccccccc-----CCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccch--------HHH
Q 039819 342 S------HVTTAVRGTVGHIAPEYLST-----GQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGA--------MLE 402 (534)
Q Consensus 342 ~------~~~~~~~gt~~y~aPE~~~~-----~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~--------~~~ 402 (534)
. .......||+.|+|||++.. ..++.++|||||||++|||+||+.||........... ...
T Consensus 169 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 248 (316)
T 2ac3_A 169 DCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNM 248 (316)
T ss_dssp -------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHHH
T ss_pred ccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHHHH
Confidence 1 11223459999999999865 5578999999999999999999999975432211100 001
Q ss_pred HHHHHhhhcccceecccccCCCCCH----HHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 403 WVKKIQQEKKVEVLVDRELGSNYDR----IEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 403 ~~~~~~~~~~~~~~~d~~l~~~~~~----~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
....+... .. .++. ..+..+.+++.+|++.||.+|||+.|+++
T Consensus 249 ~~~~i~~~-~~----------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 295 (316)
T 2ac3_A 249 LFESIQEG-KY----------EFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQ 295 (316)
T ss_dssp HHHHHHHC-CC----------CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHHHHhcc-Cc----------ccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence 11111111 00 1111 12357899999999999999999999986
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=338.69 Aligned_cols=250 Identities=23% Similarity=0.330 Sum_probs=189.3
Q ss_pred HHHhCCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEeh-------------------hhhhhcccCceeeEEEEEeCCCe
Q 039819 199 QATENFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLK-------------------DMISLAVHRNLLRLIGYCATPTE 258 (534)
Q Consensus 199 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~-------------------~~l~~~~h~niv~l~~~~~~~~~ 258 (534)
...++|...+.||+|+||.||+|+.. +++.||||++. +++..++||||+++++++.....
T Consensus 7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (346)
T 1ua2_A 7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSN 86 (346)
T ss_dssp ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTC
T ss_pred HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCc
Confidence 44578999999999999999999985 58999999874 15677889999999999999999
Q ss_pred eEEEeeccCCCChhhhcccC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceec
Q 039819 259 RLLVYPYMSNGSVASRLREK-PALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLL 337 (534)
Q Consensus 259 ~~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~ 337 (534)
.++||||+++ +|.+++... ..+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++..
T Consensus 87 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~ 162 (346)
T 1ua2_A 87 ISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSF 162 (346)
T ss_dssp CEEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGSTT
T ss_pred eEEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHEEEcCCCCEEEEecccceec
Confidence 9999999986 888887654 4689999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCCceeeccccccccccccccccC-CCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhh---hccc
Q 039819 338 DHSDSHVTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQ---EKKV 413 (534)
Q Consensus 338 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~ 413 (534)
.... .......||+.|+|||++.+. .++.++|||||||++|||++|++||........ +......... ....
T Consensus 163 ~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~---~~~i~~~~~~~~~~~~~ 238 (346)
T 1ua2_A 163 GSPN-RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQ---LTRIFETLGTPTEEQWP 238 (346)
T ss_dssp TSCC-CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHHHHHHCCCCTTTSS
T ss_pred cCCc-ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHH---HHHHHHHcCCCChhhhh
Confidence 5332 223445689999999998654 488999999999999999999999975433211 1111111100 0000
Q ss_pred --ceeccc---ccCCCCC-----HHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 414 --EVLVDR---ELGSNYD-----RIEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 414 --~~~~d~---~l~~~~~-----~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
....+. ......+ ......+.+++.+|++.||.+|||+.|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 291 (346)
T 1ua2_A 239 DMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 291 (346)
T ss_dssp STTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred hhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhc
Confidence 000000 0000001 112357899999999999999999999986
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-41 Score=335.95 Aligned_cols=238 Identities=26% Similarity=0.390 Sum_probs=185.3
Q ss_pred hCCCcCCeeccCCcEEEEEEEECCCcEEEEEEehh------------hhhhcccCceeeEEEEEeCCCeeEEEeeccCCC
Q 039819 202 ENFSSKNILGAGGFGNVYKGKLGDGTVLAVKRLKD------------MISLAVHRNLLRLIGYCATPTERLLVYPYMSNG 269 (534)
Q Consensus 202 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~------------~l~~~~h~niv~l~~~~~~~~~~~lv~e~~~~g 269 (534)
++|...+.||+|+||.||+|+.. ++.||||++.. .+..++||||+++++++.+ ..++||||+++|
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~~~~~ 84 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESESERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYAEGG 84 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSSTTHHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEECCTTC
T ss_pred hHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecChhHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEcCCCC
Confidence 56778899999999999999985 68899998852 6778899999999998874 479999999999
Q ss_pred ChhhhcccCC---CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCc-EEEEecccceecCCCCCcee
Q 039819 270 SVASRLREKP---ALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCE-AIVGDFGLAKLLDHSDSHVT 345 (534)
Q Consensus 270 sL~~~l~~~~---~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~-~kl~DFGla~~~~~~~~~~~ 345 (534)
+|.+++.... .+++..++.++.|+++||.|||+....+|+||||||+|||++.++. +||+|||++...... .
T Consensus 85 ~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~----~ 160 (307)
T 2eva_A 85 SLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH----M 160 (307)
T ss_dssp BHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC------------
T ss_pred CHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc----c
Confidence 9999997654 4789999999999999999999932238999999999999998886 799999999765432 2
Q ss_pred eccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceecccccCCCC
Q 039819 346 TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELGSNY 425 (534)
Q Consensus 346 ~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 425 (534)
....||..|+|||++.+..++.++|||||||++|||+||+.||...... ............. +....
T Consensus 161 ~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-----~~~~~~~~~~~~~------~~~~~-- 227 (307)
T 2eva_A 161 TNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGP-----AFRIMWAVHNGTR------PPLIK-- 227 (307)
T ss_dssp ----CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSS-----HHHHHHHHHTTCC------CCCBT--
T ss_pred ccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCcc-----HHHHHHHHhcCCC------CCccc--
Confidence 2345899999999999889999999999999999999999999743211 1111111111110 11111
Q ss_pred CHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhcC
Q 039819 426 DRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLEGD 461 (534)
Q Consensus 426 ~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~~ 461 (534)
..+..+.+++.+|++.+|.+|||+.++++.|+..
T Consensus 228 --~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 261 (307)
T 2eva_A 228 --NLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHL 261 (307)
T ss_dssp --TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --ccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence 2234788999999999999999999999998763
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-40 Score=345.41 Aligned_cols=239 Identities=21% Similarity=0.316 Sum_probs=185.2
Q ss_pred HHHhCCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEeh----------------------hhhhhcccCceeeEEEEEeC
Q 039819 199 QATENFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLK----------------------DMISLAVHRNLLRLIGYCAT 255 (534)
Q Consensus 199 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~----------------------~~l~~~~h~niv~l~~~~~~ 255 (534)
...++|...+.||+|+||.||+|... +++.||||++. +++..++||||+++++++..
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~ 211 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA 211 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES
T ss_pred hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence 34678999999999999999999875 57999999864 15678899999999999864
Q ss_pred CCeeEEEeeccCCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCC---CcEEEEecc
Q 039819 256 PTERLLVYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDF---CEAIVGDFG 332 (534)
Q Consensus 256 ~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~---~~~kl~DFG 332 (534)
...++||||+++|+|.+++.....+++..+..++.|++.||+|||+. +|+||||||+|||++.+ +.+||+|||
T Consensus 212 -~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kl~DFG 287 (419)
T 3i6u_A 212 -EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFG 287 (419)
T ss_dssp -SEEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSSSCCEEECCSS
T ss_pred -CceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCCCcceEEEeecc
Confidence 45799999999999999999888899999999999999999999999 99999999999999654 459999999
Q ss_pred cceecCCCCCceeecccccccccccccccc---CCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhh
Q 039819 333 LAKLLDHSDSHVTTAVRGTVGHIAPEYLST---GQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQ 409 (534)
Q Consensus 333 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 409 (534)
+++..... .......||+.|+|||++.+ ..++.++|||||||++|||+||+.||....... .+...+ ..
T Consensus 288 ~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~---~~~~~i---~~ 359 (419)
T 3i6u_A 288 HSKILGET--SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV---SLKDQI---TS 359 (419)
T ss_dssp TTTSCC-------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSC---CHHHHH---HT
T ss_pred cceecCCC--ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchH---HHHHHH---hc
Confidence 99876532 22345679999999999853 567889999999999999999999997433211 111111 11
Q ss_pred hcccceecccccCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 410 EKKVEVLVDRELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 410 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
..... .+.... ..+..+.+++.+|++.+|.+||++.|+++
T Consensus 360 -~~~~~--~~~~~~----~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 399 (419)
T 3i6u_A 360 -GKYNF--IPEVWA----EVSEKALDLVKKLLVVDPKARFTTEEALR 399 (419)
T ss_dssp -TCCCC--CHHHHT----TSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred -CCCCC--Cchhhc----ccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 10000 000000 12357899999999999999999999986
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=329.31 Aligned_cols=233 Identities=23% Similarity=0.333 Sum_probs=194.8
Q ss_pred hCCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEehh-----------------hhhhcccCceeeEEEEEeCCCeeEEEe
Q 039819 202 ENFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLKD-----------------MISLAVHRNLLRLIGYCATPTERLLVY 263 (534)
Q Consensus 202 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~-----------------~l~~~~h~niv~l~~~~~~~~~~~lv~ 263 (534)
++|...+.||+|+||.||+|+.. +++.||+|.+.. ++..+.||||+++++++.+.+..++||
T Consensus 15 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 94 (294)
T 2rku_A 15 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVL 94 (294)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEEE
Confidence 56788899999999999999986 578999998641 567788999999999999999999999
Q ss_pred eccCCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCCc
Q 039819 264 PYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSH 343 (534)
Q Consensus 264 e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~ 343 (534)
||+++++|.+++.....+++..++.++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 95 e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~- 170 (294)
T 2rku_A 95 ELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE- 170 (294)
T ss_dssp ECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCSTTC-
T ss_pred ecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEcCCCCEEEEeccCceecccCcc-
Confidence 9999999999998878899999999999999999999999 999999999999999999999999999987653222
Q ss_pred eeeccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceecccccCC
Q 039819 344 VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELGS 423 (534)
Q Consensus 344 ~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 423 (534)
......||..|+|||++.+..++.++||||||+++|||+||+.||..... .+......... ..+
T Consensus 171 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~-------~~~~~~~~~~~-------~~~-- 234 (294)
T 2rku_A 171 RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCL-------KETYLRIKKNE-------YSI-- 234 (294)
T ss_dssp CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSH-------HHHHHHHHTTC-------CCC--
T ss_pred ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-------HHHHHHHhhcc-------CCC--
Confidence 23345689999999999888899999999999999999999999974331 11111111110 011
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 424 NYDRIEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 424 ~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
+......+.+++.+|++.+|++||++.|+++
T Consensus 235 --~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~ 265 (294)
T 2rku_A 235 --PKHINPVAASLIQKMLQTDPTARPTINELLN 265 (294)
T ss_dssp --CTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred --ccccCHHHHHHHHHHcccChhhCcCHHHHhh
Confidence 1122347889999999999999999999875
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-41 Score=339.19 Aligned_cols=240 Identities=29% Similarity=0.444 Sum_probs=188.2
Q ss_pred hCCCcCCeeccCCcEEEEEEEECC-----CcEEEEEEehh---------------hhhhcccCceeeEEEEEeCCCeeEE
Q 039819 202 ENFSSKNILGAGGFGNVYKGKLGD-----GTVLAVKRLKD---------------MISLAVHRNLLRLIGYCATPTERLL 261 (534)
Q Consensus 202 ~~~~~~~~lG~G~~g~Vy~~~~~~-----~~~vavK~~~~---------------~l~~~~h~niv~l~~~~~~~~~~~l 261 (534)
++|...+.||+|+||.||+|.... +..||||.+.. ++..++||||+++++++......++
T Consensus 44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 123 (333)
T 1mqb_A 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 123 (333)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEE
Confidence 355667899999999999998642 24699998752 5677899999999999999999999
Q ss_pred EeeccCCCChhhhcccC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCC
Q 039819 262 VYPYMSNGSVASRLREK-PALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHS 340 (534)
Q Consensus 262 v~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~ 340 (534)
||||+++|+|.+++... ..+++..++.++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 124 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~ 200 (333)
T 1mqb_A 124 ITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 200 (333)
T ss_dssp EEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC-------
T ss_pred EEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChheEEECCCCcEEECCCCcchhhccc
Confidence 99999999999999754 6799999999999999999999999 9999999999999999999999999999876543
Q ss_pred CCc--eeeccccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCcCCCccccccchHHHHHHHHhhhcccceec
Q 039819 341 DSH--VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLV 417 (534)
Q Consensus 341 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 417 (534)
... ......+|..|+|||++.+..++.++|||||||++|||+| |+.||..... .+....+.....
T Consensus 201 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~-------~~~~~~~~~~~~----- 268 (333)
T 1mqb_A 201 PEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN-------HEVMKAINDGFR----- 268 (333)
T ss_dssp ----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH-------HHHHHHHHTTCC-----
T ss_pred cccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCH-------HHHHHHHHCCCc-----
Confidence 211 1222346788999999988899999999999999999999 9999964321 111222211111
Q ss_pred ccccCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhcC
Q 039819 418 DRELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLEGD 461 (534)
Q Consensus 418 d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~~ 461 (534)
...+...+..+.+++.+||+.+|.+||++.++++.|+..
T Consensus 269 -----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~ 307 (333)
T 1mqb_A 269 -----LPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKL 307 (333)
T ss_dssp -----CCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred -----CCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 011122345789999999999999999999999998764
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-41 Score=334.66 Aligned_cols=240 Identities=27% Similarity=0.367 Sum_probs=194.3
Q ss_pred HhCCCcCC-eeccCCcEEEEEEEE---CCCcEEEEEEehh----------------hhhhcccCceeeEEEEEeCCCeeE
Q 039819 201 TENFSSKN-ILGAGGFGNVYKGKL---GDGTVLAVKRLKD----------------MISLAVHRNLLRLIGYCATPTERL 260 (534)
Q Consensus 201 ~~~~~~~~-~lG~G~~g~Vy~~~~---~~~~~vavK~~~~----------------~l~~~~h~niv~l~~~~~~~~~~~ 260 (534)
.++|...+ .||+|+||.||+|.+ ..++.||||++.. ++..++||||+++++++ ..+..+
T Consensus 15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~ 93 (291)
T 1xbb_A 15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWM 93 (291)
T ss_dssp GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEE
T ss_pred chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcE
Confidence 35666666 899999999999965 2468899998752 56778999999999999 556789
Q ss_pred EEeeccCCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCC
Q 039819 261 LVYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHS 340 (534)
Q Consensus 261 lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~ 340 (534)
+||||+++++|.+++.....+++..++.++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 94 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 170 (291)
T 1xbb_A 94 LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRAD 170 (291)
T ss_dssp EEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCTT
T ss_pred EEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhC---CeEcCCCCcceEEEeCCCcEEEccCCcceeeccC
Confidence 9999999999999999888899999999999999999999999 9999999999999999999999999999877544
Q ss_pred CCcee--eccccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCcCCCccccccchHHHHHHHHhhhcccceec
Q 039819 341 DSHVT--TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLV 417 (534)
Q Consensus 341 ~~~~~--~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 417 (534)
..... ....+|..|+|||.+.+..++.++||||||+++|||+| |+.||...... +..........
T Consensus 171 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~-------~~~~~~~~~~~----- 238 (291)
T 1xbb_A 171 ENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS-------EVTAMLEKGER----- 238 (291)
T ss_dssp CSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH-------HHHHHHHTTCC-----
T ss_pred CCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHH-------HHHHHHHcCCC-----
Confidence 33221 22346789999999988889999999999999999999 99999743221 11111111110
Q ss_pred ccccCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhcC
Q 039819 418 DRELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLEGD 461 (534)
Q Consensus 418 d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~~ 461 (534)
. ..+...+..+.+++.+|++.+|.+||++.++++.|+..
T Consensus 239 -~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~ 277 (291)
T 1xbb_A 239 -M----GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 277 (291)
T ss_dssp -C----CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred -C----CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 1 11222345899999999999999999999999999864
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=341.02 Aligned_cols=248 Identities=17% Similarity=0.191 Sum_probs=194.6
Q ss_pred hCCCcCCeeccCCcEEEEEEEECC---------CcEEEEEEeh---------hhhhhcccCceee---------------
Q 039819 202 ENFSSKNILGAGGFGNVYKGKLGD---------GTVLAVKRLK---------DMISLAVHRNLLR--------------- 248 (534)
Q Consensus 202 ~~~~~~~~lG~G~~g~Vy~~~~~~---------~~~vavK~~~---------~~l~~~~h~niv~--------------- 248 (534)
++|...+.||+|+||.||+|+... ++.||||.+. +++..++||||++
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~i~~ 121 (352)
T 2jii_A 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLAIPT 121 (352)
T ss_dssp CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETTSTHHHHHHHHHHHCCHHHHHHHHHHTTCTTCSCCC
T ss_pred CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEecccchHHHHHHHHHHhcccchhhhhhhhccCCccCccc
Confidence 568888999999999999999864 7899999885 2678888999887
Q ss_pred EEEEEeC-CCeeEEEeeccCCCChhhhcccC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCC-
Q 039819 249 LIGYCAT-PTERLLVYPYMSNGSVASRLREK--PALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFC- 324 (534)
Q Consensus 249 l~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~- 324 (534)
+++++.. ....++||||+ +++|.+++... ..+++..++.|+.|++.||.|||++ +|+||||||+|||++.++
T Consensus 122 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIl~~~~~~ 197 (352)
T 2jii_A 122 CMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHEN---EYVHGNVTAENIFVDPEDQ 197 (352)
T ss_dssp CCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCGGGEEEETTEE
T ss_pred hhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEEcCCCC
Confidence 6777765 67889999999 99999999865 7799999999999999999999999 999999999999999998
Q ss_pred -cEEEEecccceecCCCCCc------eeeccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCcccccc
Q 039819 325 -EAIVGDFGLAKLLDHSDSH------VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQK 397 (534)
Q Consensus 325 -~~kl~DFGla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~ 397 (534)
.+||+|||+++........ ......||+.|+|||++.+..++.++|||||||++|||+||+.||...... .
T Consensus 198 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~--~ 275 (352)
T 2jii_A 198 SQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCLPN--T 275 (352)
T ss_dssp EEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTC--H
T ss_pred ceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCCcC--H
Confidence 9999999999876432211 123457999999999999889999999999999999999999999743211 1
Q ss_pred chHHHHHHHHhhhcccceecccccCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhc
Q 039819 398 GAMLEWVKKIQQEKKVEVLVDRELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLEG 460 (534)
Q Consensus 398 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~ 460 (534)
..+......... ....+.+..... ...+..+.+++.+|++.+|.+||++.+|++.|+.
T Consensus 276 ~~~~~~~~~~~~--~~~~~~~~~~~~---~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~ 333 (352)
T 2jii_A 276 EDIMKQKQKFVD--KPGPFVGPCGHW---IRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEA 333 (352)
T ss_dssp HHHHHHHHHHHH--SCCCEECTTSCE---ECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHH
T ss_pred HHHHHHHHhccC--Chhhhhhhcccc---CCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHH
Confidence 112222221111 111111111100 0113578999999999999999999999999876
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-40 Score=332.84 Aligned_cols=252 Identities=22% Similarity=0.307 Sum_probs=198.2
Q ss_pred HHHHhCCCcCCeeccCCcEEEEEEEECCCcEEEEEEehh-----------hhhh--cccCceeeEEEEEeCCC----eeE
Q 039819 198 QQATENFSSKNILGAGGFGNVYKGKLGDGTVLAVKRLKD-----------MISL--AVHRNLLRLIGYCATPT----ERL 260 (534)
Q Consensus 198 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~-----------~l~~--~~h~niv~l~~~~~~~~----~~~ 260 (534)
....++|...+.||+|+||.||+|+. +++.||||++.. ++.. ++||||+++++++.... ..+
T Consensus 38 ~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~ 116 (342)
T 1b6c_B 38 RTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLW 116 (342)
T ss_dssp HHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGGGHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCCEE
T ss_pred ccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCchhHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccceeE
Confidence 44567899999999999999999998 588999999852 3333 78999999999998876 789
Q ss_pred EEeeccCCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHH--------hcCCCCeEeccCCCCcEEeCCCCcEEEEecc
Q 039819 261 LVYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLH--------EQCDPKIIHRDVKAANVLLDDFCEAIVGDFG 332 (534)
Q Consensus 261 lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH--------~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFG 332 (534)
+||||+++|+|.+++... .+++..++.++.|++.||.||| +. +|+||||||+|||++.++.+||+|||
T Consensus 117 lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg 192 (342)
T 1b6c_B 117 LVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKP---AIAHRDLKSKNILVKKNGTCCIADLG 192 (342)
T ss_dssp EEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBC---EEECSCCSGGGEEECTTSCEEECCCT
T ss_pred EEEeecCCCcHHHHHhcc-CccHHHHHHHHHHHHHHHHHHHHHHhhhcccC---CeeeCCCCHHHEEECCCCCEEEEECC
Confidence 999999999999999764 5899999999999999999999 66 99999999999999999999999999
Q ss_pred cceecCCCCCc---eeeccccccccccccccccC------CCCcchhHHHHHHHHHHHHhC----------CCCcCCCcc
Q 039819 333 LAKLLDHSDSH---VTTAVRGTVGHIAPEYLSTG------QSSEKTDVFGFGILLLELITG----------MRALEFGKS 393 (534)
Q Consensus 333 la~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~------~~~~k~Dv~S~Gvvl~elltG----------~~p~~~~~~ 393 (534)
+++........ ......||+.|+|||++.+. .++.++|||||||++|||+|| +.||.....
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~~ 272 (342)
T 1b6c_B 193 LAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVP 272 (342)
T ss_dssp TCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSC
T ss_pred CceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccCc
Confidence 99876544322 12345699999999998765 234789999999999999999 667753322
Q ss_pred ccccchHHHHHHHHhhhcccceecccccCCC-CCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhcC
Q 039819 394 INQKGAMLEWVKKIQQEKKVEVLVDRELGSN-YDRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLEGD 461 (534)
Q Consensus 394 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~-~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~~ 461 (534)
.. .....+........ ..+.+... ........+.+++.+||+.+|++|||+.||++.|+..
T Consensus 273 ~~--~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i 334 (342)
T 1b6c_B 273 SD--PSVEEMRKVVCEQK-----LRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 334 (342)
T ss_dssp SS--CCHHHHHHHHTTSC-----CCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred Cc--ccHHHHHHHHHHHH-----hCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHH
Confidence 11 11222222221111 11111111 1234567899999999999999999999999999863
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=328.10 Aligned_cols=235 Identities=23% Similarity=0.399 Sum_probs=195.3
Q ss_pred HHhCCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEeh----------hhhhhcccCceeeEEEEEeC-------------
Q 039819 200 ATENFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLK----------DMISLAVHRNLLRLIGYCAT------------- 255 (534)
Q Consensus 200 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~----------~~l~~~~h~niv~l~~~~~~------------- 255 (534)
...+|...+.||+|+||.||+|+.. +++.||||++. +++..++||||+++++++..
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~ 88 (284)
T 2a19_B 9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSS 88 (284)
T ss_dssp HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCSGGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC---------
T ss_pred hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEeccccHHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccccccc
Confidence 4467889999999999999999986 78999999885 26788899999999998854
Q ss_pred ---CCeeEEEeeccCCCChhhhccc--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEe
Q 039819 256 ---PTERLLVYPYMSNGSVASRLRE--KPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGD 330 (534)
Q Consensus 256 ---~~~~~lv~e~~~~gsL~~~l~~--~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~D 330 (534)
....++||||+++|+|.+++.. ...+++..++.++.|++.||.|||+. +|+||||||+|||++.++.+||+|
T Consensus 89 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~D 165 (284)
T 2a19_B 89 RSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGD 165 (284)
T ss_dssp CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECC
T ss_pred ccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHEEEcCCCCEEECc
Confidence 3457999999999999999964 35799999999999999999999999 999999999999999999999999
Q ss_pred cccceecCCCCCceeeccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhh
Q 039819 331 FGLAKLLDHSDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQE 410 (534)
Q Consensus 331 FGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 410 (534)
||+++...... ......||+.|+|||++.+..++.++|||||||++|||+||..|+... ..+......
T Consensus 166 fg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~---------~~~~~~~~~- 233 (284)
T 2a19_B 166 FGLVTSLKNDG--KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET---------SKFFTDLRD- 233 (284)
T ss_dssp CTTCEESSCCS--CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH---------HHHHHHHHT-
T ss_pred chhheeccccc--cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH---------HHHHHHhhc-
Confidence 99998775432 233456899999999999888999999999999999999999887411 111111111
Q ss_pred cccceecccccCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhcC
Q 039819 411 KKVEVLVDRELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLEGD 461 (534)
Q Consensus 411 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~~ 461 (534)
..+...+ +..+.+++.+|++.+|.+||++.|+++.|+..
T Consensus 234 --------~~~~~~~----~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~ 272 (284)
T 2a19_B 234 --------GIISDIF----DKKEKTLLQKLLSKKPEDRPNTSEILRTLTVW 272 (284)
T ss_dssp --------TCCCTTS----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --------ccccccC----CHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 1111122 34688999999999999999999999998754
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-41 Score=340.46 Aligned_cols=246 Identities=24% Similarity=0.376 Sum_probs=198.7
Q ss_pred HHHHHHhCCCcCCeeccCCcEEEEEEEEC------CCcEEEEEEehh---------------hhhhcccCceeeEEEEEe
Q 039819 196 ELQQATENFSSKNILGAGGFGNVYKGKLG------DGTVLAVKRLKD---------------MISLAVHRNLLRLIGYCA 254 (534)
Q Consensus 196 ~l~~~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~---------------~l~~~~h~niv~l~~~~~ 254 (534)
+.....++|...+.||+|+||.||+|+.. .++.||||.+.. ++..++||||+++++++.
T Consensus 19 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 98 (322)
T 1p4o_A 19 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVS 98 (322)
T ss_dssp TTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEEC
T ss_pred hhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEc
Confidence 33445678889999999999999999864 367899998752 577889999999999999
Q ss_pred CCCeeEEEeeccCCCChhhhcccC----------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCC
Q 039819 255 TPTERLLVYPYMSNGSVASRLREK----------PALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFC 324 (534)
Q Consensus 255 ~~~~~~lv~e~~~~gsL~~~l~~~----------~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~ 324 (534)
+....++||||+++|+|.+++... ..+++..++.++.|++.||.|||++ +|+||||||+|||++.++
T Consensus 99 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~NIli~~~~ 175 (322)
T 1p4o_A 99 QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDF 175 (322)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTC
T ss_pred cCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CCccCCCccceEEEcCCC
Confidence 999999999999999999998642 4579999999999999999999999 999999999999999999
Q ss_pred cEEEEecccceecCCCCCc-eeeccccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCcCCCccccccchHHH
Q 039819 325 EAIVGDFGLAKLLDHSDSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GMRALEFGKSINQKGAMLE 402 (534)
Q Consensus 325 ~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~ 402 (534)
.+||+|||+++........ ......||+.|+|||++.+..++.++|||||||++|||+| |+.||..... .+
T Consensus 176 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~-------~~ 248 (322)
T 1p4o_A 176 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN-------EQ 248 (322)
T ss_dssp CEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH-------HH
T ss_pred eEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCH-------HH
Confidence 9999999999865432211 1223346889999999988899999999999999999999 8899864321 11
Q ss_pred HHHHHhhhcccceecccccCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhcC
Q 039819 403 WVKKIQQEKKVEVLVDRELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLEGD 461 (534)
Q Consensus 403 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~~ 461 (534)
.......... . ..+...+..+.+++.+|++.+|.+||++.|+++.|+..
T Consensus 249 ~~~~~~~~~~-~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~ 297 (322)
T 1p4o_A 249 VLRFVMEGGL-L---------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEE 297 (322)
T ss_dssp HHHHHHTTCC-C---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGG
T ss_pred HHHHHHcCCc-C---------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHh
Confidence 1222111110 0 11122345789999999999999999999999999874
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=342.46 Aligned_cols=245 Identities=22% Similarity=0.342 Sum_probs=184.7
Q ss_pred hCCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEeh----------------hhhhhcccCceeeEEEEEeCCC------e
Q 039819 202 ENFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLK----------------DMISLAVHRNLLRLIGYCATPT------E 258 (534)
Q Consensus 202 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~----------------~~l~~~~h~niv~l~~~~~~~~------~ 258 (534)
++|...+.||+|+||.||+|... +|+.||||++. +++..++||||+++++++.... .
T Consensus 25 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~ 104 (367)
T 1cm8_A 25 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTD 104 (367)
T ss_dssp SSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCC
T ss_pred ceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCce
Confidence 57888899999999999999984 68999999883 2577889999999999997653 4
Q ss_pred eEEEeeccCCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecC
Q 039819 259 RLLVYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLD 338 (534)
Q Consensus 259 ~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~ 338 (534)
.|+||||+ +++|.+++.. ..+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 105 ~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 179 (367)
T 1cm8_A 105 FYLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQAD 179 (367)
T ss_dssp CEEEEECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCHHHEEEcCCCCEEEEeeecccccc
Confidence 59999999 8899998876 4699999999999999999999999 99999999999999999999999999998764
Q ss_pred CCCCceeecccccccccccccccc-CCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHH--------Hhh
Q 039819 339 HSDSHVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKK--------IQQ 409 (534)
Q Consensus 339 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~--------~~~ 409 (534)
.. .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||...........+...... ...
T Consensus 180 ~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~ 255 (367)
T 1cm8_A 180 SE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQS 255 (367)
T ss_dssp SS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSC
T ss_pred cc----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhh
Confidence 32 334578999999999876 67899999999999999999999999865432222111111100 000
Q ss_pred h------cccceecccccCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 410 E------KKVEVLVDRELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 410 ~------~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
. ..........+. .........+.+++.+|++.||.+|||++|+++
T Consensus 256 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~ 307 (367)
T 1cm8_A 256 DEAKNYMKGLPELEKKDFA-SILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 307 (367)
T ss_dssp HHHHHHHHHSCCCCCCCGG-GTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHHHHHHHhCCCCCCCCHH-HHCCCCCHHHHHHHHHHccCChhHCCCHHHHhc
Confidence 0 000000000000 011122457899999999999999999999986
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=349.80 Aligned_cols=184 Identities=20% Similarity=0.272 Sum_probs=161.3
Q ss_pred hCCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEehh-------------hhhhc------ccCceeeEEEEEeCCCeeEE
Q 039819 202 ENFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLKD-------------MISLA------VHRNLLRLIGYCATPTERLL 261 (534)
Q Consensus 202 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~-------------~l~~~------~h~niv~l~~~~~~~~~~~l 261 (534)
.+|...+.||+|+||.||+|... +++.||||++.. ++..+ .|+||+++++++......++
T Consensus 97 ~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~l 176 (429)
T 3kvw_A 97 YRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICM 176 (429)
T ss_dssp TTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEEEE
T ss_pred CcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeEEE
Confidence 56888899999999999999875 588999999852 23333 57899999999999999999
Q ss_pred EeeccCCCChhhhcccC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCc--EEEEecccceec
Q 039819 262 VYPYMSNGSVASRLREK--PALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCE--AIVGDFGLAKLL 337 (534)
Q Consensus 262 v~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~--~kl~DFGla~~~ 337 (534)
||||+. ++|.+++... ..+++..++.|+.||+.||.|||+. +||||||||+|||++.++. +||+|||+++..
T Consensus 177 v~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~~ 252 (429)
T 3kvw_A 177 TFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKN---RIIHCDLKPENILLKQQGRSGIKVIDFGSSCYE 252 (429)
T ss_dssp EECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHH---TEECSCCSGGGEEESSTTSCCEEECCCTTCEET
T ss_pred EEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEccCCCcceEEeecccceec
Confidence 999996 6999988754 3599999999999999999999999 9999999999999999887 999999999865
Q ss_pred CCCCCceeeccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCcc
Q 039819 338 DHSDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKS 393 (534)
Q Consensus 338 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~ 393 (534)
... .....||+.|+|||++.+..++.++|||||||++|||+||+.||.....
T Consensus 253 ~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~ 304 (429)
T 3kvw_A 253 HQR----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDE 304 (429)
T ss_dssp TCC----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred CCc----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCH
Confidence 432 2345789999999999999999999999999999999999999986543
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=329.27 Aligned_cols=242 Identities=29% Similarity=0.445 Sum_probs=182.0
Q ss_pred hCCCcCCeeccCCcEEEEEEEECCCcEEEEEEeh----------------hhhhhcccCceeeEEEEEeCCCeeEEEeec
Q 039819 202 ENFSSKNILGAGGFGNVYKGKLGDGTVLAVKRLK----------------DMISLAVHRNLLRLIGYCATPTERLLVYPY 265 (534)
Q Consensus 202 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~----------------~~l~~~~h~niv~l~~~~~~~~~~~lv~e~ 265 (534)
++|...+.||+|+||.||+|+... .||||.++ +++..++||||+++++++ .....++||||
T Consensus 24 ~~y~~~~~lG~G~~g~Vy~~~~~~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e~ 100 (289)
T 3og7_A 24 GQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQW 100 (289)
T ss_dssp TSCEEEEEEEECSSEEEEEEESSS--EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEEC
T ss_pred cceeeeeEecCCCCeEEEEEEEcC--ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEEe
Confidence 578888999999999999998754 49999875 267788999999999965 45568999999
Q ss_pred cCCCChhhhccc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCC-Cc
Q 039819 266 MSNGSVASRLRE-KPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSD-SH 343 (534)
Q Consensus 266 ~~~gsL~~~l~~-~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~-~~ 343 (534)
+++++|.+++.. ...+++..++.++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++...... ..
T Consensus 101 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 177 (289)
T 3og7_A 101 CEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSH 177 (289)
T ss_dssp CCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEEECCCC------------
T ss_pred cCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEECCCCCEEEccceeccccccccccc
Confidence 999999999964 45699999999999999999999999 99999999999999999999999999998654321 22
Q ss_pred eeeccccccccccccccc---cCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceecccc
Q 039819 344 VTTAVRGTVGHIAPEYLS---TGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRE 420 (534)
Q Consensus 344 ~~~~~~gt~~y~aPE~~~---~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 420 (534)
......||+.|+|||++. ...++.++|||||||++|||+||+.||...... ..+.+.+. . .... +.
T Consensus 178 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~---~~~~~~~~---~-~~~~----~~ 246 (289)
T 3og7_A 178 QFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR---DQIIEMVG---R-GSLS----PD 246 (289)
T ss_dssp ------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCH---HHHHHHHH---H-TSCC----CC
T ss_pred cccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchH---HHHHHHhc---c-cccC----cc
Confidence 233456999999999986 567888999999999999999999999743321 11112111 1 1111 00
Q ss_pred cCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhcC
Q 039819 421 LGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLEGD 461 (534)
Q Consensus 421 l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~~ 461 (534)
+ .......+..+.+++.+|++.+|.+||++.++++.|+..
T Consensus 247 ~-~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l 286 (289)
T 3og7_A 247 L-SKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEEL 286 (289)
T ss_dssp T-TSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred h-hhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHH
Confidence 0 011122345899999999999999999999999999864
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-40 Score=344.76 Aligned_cols=246 Identities=24% Similarity=0.333 Sum_probs=186.8
Q ss_pred hCCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEeh----------hhhhhcccCceeeEEEEEeCC----C--eeEEEee
Q 039819 202 ENFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLK----------DMISLAVHRNLLRLIGYCATP----T--ERLLVYP 264 (534)
Q Consensus 202 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~----------~~l~~~~h~niv~l~~~~~~~----~--~~~lv~e 264 (534)
.+|...+.||+|+||.||+|+.. +++.||||++. +++..++|||||+++++|... + ..++|||
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~e 133 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLD 133 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTTSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEEEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEeehh
Confidence 35778899999999999999985 58999999874 278888999999999998532 2 3579999
Q ss_pred ccCCCChhhhcc----cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCC-CcEEEEecccceecCC
Q 039819 265 YMSNGSVASRLR----EKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDF-CEAIVGDFGLAKLLDH 339 (534)
Q Consensus 265 ~~~~gsL~~~l~----~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~-~~~kl~DFGla~~~~~ 339 (534)
|+++ +|.+.+. ....+++..++.++.||++||.|||+. +|+||||||+|||++.+ +.+||+|||+++....
T Consensus 134 ~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~~~ 209 (420)
T 1j1b_A 134 YVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR 209 (420)
T ss_dssp CCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEEETTTTEEEECCCTTCEECCT
T ss_pred cccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChhhEEEeCCCCeEEeccchhhhhccc
Confidence 9986 5555543 356799999999999999999999998 99999999999999965 6789999999997654
Q ss_pred CCCceeeccccccccccccccccC-CCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhh---------
Q 039819 340 SDSHVTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQ--------- 409 (534)
Q Consensus 340 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~--------- 409 (534)
... .....||+.|+|||++.+. .++.++|||||||++|||++|+.||......+. +.+.++....
T Consensus 210 ~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~---l~~i~~~lg~p~~~~~~~~ 284 (420)
T 1j1b_A 210 GEP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQ---LVEIIKVLGTPTREQIREM 284 (420)
T ss_dssp TCC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHHHHHHCSCCHHHHHHH
T ss_pred CCC--ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHhCCCCHHHHHhh
Confidence 322 3345689999999998764 689999999999999999999999986443222 2222221100
Q ss_pred hcccceecccccCCC-----CCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 410 EKKVEVLVDRELGSN-----YDRIEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 410 ~~~~~~~~d~~l~~~-----~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
.........+.+... +....+.++.+++.+|++.||.+||++.|+++
T Consensus 285 ~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~ 336 (420)
T 1j1b_A 285 NPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 336 (420)
T ss_dssp CSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhC
Confidence 000111111111100 11122458899999999999999999999985
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-40 Score=352.40 Aligned_cols=233 Identities=26% Similarity=0.343 Sum_probs=192.7
Q ss_pred hCCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEehh-----------------hhhhcccCceeeEEEEEeCCCeeEEEe
Q 039819 202 ENFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLKD-----------------MISLAVHRNLLRLIGYCATPTERLLVY 263 (534)
Q Consensus 202 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~-----------------~l~~~~h~niv~l~~~~~~~~~~~lv~ 263 (534)
++|...+.||+|+||.||+|+.. +++.||||++.. ++..++||||+++++++.+....|+||
T Consensus 185 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVm 264 (543)
T 3c4z_A 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVM 264 (543)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEE
Confidence 67888899999999999999985 689999999842 567889999999999999999999999
Q ss_pred eccCCCChhhhccc----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCC
Q 039819 264 PYMSNGSVASRLRE----KPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDH 339 (534)
Q Consensus 264 e~~~~gsL~~~l~~----~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~ 339 (534)
||+++|+|.+++.. ...+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 265 E~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~---gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~ 341 (543)
T 3c4z_A 265 TIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKA 341 (543)
T ss_dssp CCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHc---CCcccCCChHHEEEeCCCCEEEeecceeeeccC
Confidence 99999999998864 34699999999999999999999999 999999999999999999999999999997754
Q ss_pred CCCceeeccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceeccc
Q 039819 340 SDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDR 419 (534)
Q Consensus 340 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 419 (534)
... .....+||+.|+|||++.+..++.++|||||||++|||+||+.||........ ..++...+... . .
T Consensus 342 ~~~-~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~---~~~~~~~i~~~-~------~ 410 (543)
T 3c4z_A 342 GQT-KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE---NKELKQRVLEQ-A------V 410 (543)
T ss_dssp TCC-CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCC---HHHHHHHHHHC-C------C
T ss_pred CCc-ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchh---HHHHHHHHhhc-c------c
Confidence 322 23445799999999999998999999999999999999999999975432111 11222222111 0 0
Q ss_pred ccCCCCCHHHHHHHHHHHHHhcccCCCCCCChH
Q 039819 420 ELGSNYDRIEVGEILQVALLCTQYLPVHRPKMS 452 (534)
Q Consensus 420 ~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ 452 (534)
.++...+..+.+++.+|++.+|.+||++.
T Consensus 411 ----~~p~~~s~~~~~li~~lL~~dP~~R~~~~ 439 (543)
T 3c4z_A 411 ----TYPDKFSPASKDFCEALLQKDPEKRLGFR 439 (543)
T ss_dssp ----CCCTTSCHHHHHHHHHHSCSSGGGSCCCB
T ss_pred ----CCCcccCHHHHHHHHHhccCCHhHCCCCc
Confidence 11222345788999999999999999864
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-41 Score=339.36 Aligned_cols=242 Identities=28% Similarity=0.406 Sum_probs=195.3
Q ss_pred HhCCCcCCeeccCCcEEEEEEEECC------CcEEEEEEehh---------------hhhhc-ccCceeeEEEEEeCCCe
Q 039819 201 TENFSSKNILGAGGFGNVYKGKLGD------GTVLAVKRLKD---------------MISLA-VHRNLLRLIGYCATPTE 258 (534)
Q Consensus 201 ~~~~~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~---------------~l~~~-~h~niv~l~~~~~~~~~ 258 (534)
.++|...+.||+|+||.||+|.... ...||||.+.. ++..+ +||||+++++++.....
T Consensus 45 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 124 (333)
T 2i1m_A 45 RNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGP 124 (333)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCCc
Confidence 3678888999999999999998742 24799998752 56667 89999999999999999
Q ss_pred eEEEeeccCCCChhhhccc--------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCC
Q 039819 259 RLLVYPYMSNGSVASRLRE--------------KPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFC 324 (534)
Q Consensus 259 ~~lv~e~~~~gsL~~~l~~--------------~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~ 324 (534)
.++||||+++|+|.+++.. ...+++..++.++.|++.||.|||+. +|+||||||+|||++.++
T Consensus 125 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~ 201 (333)
T 2i1m_A 125 VLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK---NCIHRDVAARNVLLTNGH 201 (333)
T ss_dssp CEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGCEEEGGG
T ss_pred eEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCcccceEEECCCC
Confidence 9999999999999999863 34589999999999999999999999 999999999999999999
Q ss_pred cEEEEecccceecCCCCC-ceeeccccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCcCCCccccccchHHH
Q 039819 325 EAIVGDFGLAKLLDHSDS-HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GMRALEFGKSINQKGAMLE 402 (534)
Q Consensus 325 ~~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~ 402 (534)
.+||+|||+++....... .......||..|+|||++.+..++.++|||||||++|||+| |+.||...... .....
T Consensus 202 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~---~~~~~ 278 (333)
T 2i1m_A 202 VAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVN---SKFYK 278 (333)
T ss_dssp EEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSS---HHHHH
T ss_pred eEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchh---HHHHH
Confidence 999999999986643322 22334457889999999988899999999999999999999 99999743221 11111
Q ss_pred HHHHHhhhcccceecccccCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhcC
Q 039819 403 WVKKIQQEKKVEVLVDRELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLEGD 461 (534)
Q Consensus 403 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~~ 461 (534)
.+. ... ....+...+..+.+++.+|++.+|.+|||+.||++.|+..
T Consensus 279 ~~~----~~~---------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~ 324 (333)
T 2i1m_A 279 LVK----DGY---------QMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQ 324 (333)
T ss_dssp HHH----HTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHh----cCC---------CCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHH
Confidence 111 110 0011112245789999999999999999999999999864
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-40 Score=335.47 Aligned_cols=233 Identities=23% Similarity=0.328 Sum_probs=195.0
Q ss_pred hCCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEehh-----------------hhhhcccCceeeEEEEEeCCCeeEEEe
Q 039819 202 ENFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLKD-----------------MISLAVHRNLLRLIGYCATPTERLLVY 263 (534)
Q Consensus 202 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~-----------------~l~~~~h~niv~l~~~~~~~~~~~lv~ 263 (534)
++|...+.||+|+||.||+++.. +++.||+|.+.. ++..++||||+++++++.+.+..++||
T Consensus 41 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 120 (335)
T 2owb_A 41 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVL 120 (335)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEE
Confidence 57888899999999999999986 578999998741 567788999999999999999999999
Q ss_pred eccCCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCCc
Q 039819 264 PYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSH 343 (534)
Q Consensus 264 e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~ 343 (534)
||+++++|.+++.....+++..++.++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 121 e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~- 196 (335)
T 2owb_A 121 ELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE- 196 (335)
T ss_dssp CCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECCSTTC-
T ss_pred ecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CCEecCCCchhEEEcCCCCEEEeeccCceecccCcc-
Confidence 9999999999998878899999999999999999999999 999999999999999999999999999987653322
Q ss_pred eeeccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceecccccCC
Q 039819 344 VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELGS 423 (534)
Q Consensus 344 ~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 423 (534)
......||..|+|||++.+..++.++|||||||++|||+||+.||..... .+......... ..+..
T Consensus 197 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-------~~~~~~~~~~~-------~~~~~ 262 (335)
T 2owb_A 197 RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCL-------KETYLRIKKNE-------YSIPK 262 (335)
T ss_dssp CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSH-------HHHHHHHHHTC-------CCCCT
T ss_pred cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCH-------HHHHHHHhcCC-------CCCCc
Confidence 23445699999999999888899999999999999999999999974321 11111111111 01111
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 424 NYDRIEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 424 ~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
.....+.+++.+|++.||++||++.|+++
T Consensus 263 ----~~~~~~~~li~~~l~~dp~~Rps~~ell~ 291 (335)
T 2owb_A 263 ----HINPVAASLIQKMLQTDPTARPTINELLN 291 (335)
T ss_dssp ----TSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred ----cCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 22347889999999999999999999975
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-41 Score=345.70 Aligned_cols=253 Identities=21% Similarity=0.251 Sum_probs=189.8
Q ss_pred HHHHhCCCcCCeeccCCcEEEEEEEE-CCCcEEEEEEeh----------hhhhhcccCceeeEEEEEeCC----------
Q 039819 198 QQATENFSSKNILGAGGFGNVYKGKL-GDGTVLAVKRLK----------DMISLAVHRNLLRLIGYCATP---------- 256 (534)
Q Consensus 198 ~~~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~----------~~l~~~~h~niv~l~~~~~~~---------- 256 (534)
....++|...+.||+|+||.||+|+. .+++.||||++. ++++.++|||||+++++|...
T Consensus 3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~ 82 (383)
T 3eb0_A 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQP 82 (383)
T ss_dssp ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTSCCHHHHHHTTCCCTTBCCEEEEEEEC----------
T ss_pred ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcchHHHHHHHHHHcCCCCccchhheeeecCccccccccc
Confidence 34567899999999999999999987 578999999875 378888999999999998443
Q ss_pred ----------------------------CeeEEEeeccCCCChhhhcc----cCCCCCHHHHHHHHHHHHHHHHHHHhcC
Q 039819 257 ----------------------------TERLLVYPYMSNGSVASRLR----EKPALDWNTRKRIAIGAARGLLYLHEQC 304 (534)
Q Consensus 257 ----------------------------~~~~lv~e~~~~gsL~~~l~----~~~~l~~~~~~~i~~~i~~~l~yLH~~~ 304 (534)
...++||||++ |+|.+.+. ....+++..+..++.|+++||.|||+.
T Consensus 83 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~- 160 (383)
T 3eb0_A 83 PDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSL- 160 (383)
T ss_dssp ---------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT-
T ss_pred ccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC-
Confidence 34789999998 47766664 457799999999999999999999998
Q ss_pred CCCeEeccCCCCcEEeC-CCCcEEEEecccceecCCCCCceeeccccccccccccccccC-CCCcchhHHHHHHHHHHHH
Q 039819 305 DPKIIHRDVKAANVLLD-DFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELI 382 (534)
Q Consensus 305 ~~~ivH~Dlkp~NiLl~-~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~S~Gvvl~ell 382 (534)
+|+||||||+|||++ .++.+||+|||+++...... ......||+.|+|||++.+. .++.++|||||||++|||+
T Consensus 161 --gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell 236 (383)
T 3eb0_A 161 --GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE--PSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELI 236 (383)
T ss_dssp --TEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS--CCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHH
T ss_pred --cCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC--CCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHH
Confidence 999999999999997 68999999999999765433 23345689999999998764 4899999999999999999
Q ss_pred hCCCCcCCCccccccchHHHHHHHHhh------hcccceecccccCC-----CCCHHHHHHHHHHHHHhcccCCCCCCCh
Q 039819 383 TGMRALEFGKSINQKGAMLEWVKKIQQ------EKKVEVLVDRELGS-----NYDRIEVGEILQVALLCTQYLPVHRPKM 451 (534)
Q Consensus 383 tG~~p~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~d~~l~~-----~~~~~~~~~l~~l~~~Cl~~~P~~RPt~ 451 (534)
+|+.||......+....+......... ........-+.... .++...+..+.+++.+|++.+|.+|||+
T Consensus 237 ~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~ 316 (383)
T 3eb0_A 237 LGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINP 316 (383)
T ss_dssp HSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCH
T ss_pred hCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCCH
Confidence 999999865433222212111100000 00000000001100 0122234578999999999999999999
Q ss_pred HHHHH
Q 039819 452 SEVVR 456 (534)
Q Consensus 452 ~ev~~ 456 (534)
.|+++
T Consensus 317 ~e~l~ 321 (383)
T 3eb0_A 317 YEAMA 321 (383)
T ss_dssp HHHHT
T ss_pred HHHhc
Confidence 99985
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=335.62 Aligned_cols=263 Identities=22% Similarity=0.355 Sum_probs=196.9
Q ss_pred HhCCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEeh----------------hhhhhcccCceeeEEEEEeCCCeeEEEe
Q 039819 201 TENFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLK----------------DMISLAVHRNLLRLIGYCATPTERLLVY 263 (534)
Q Consensus 201 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~----------------~~l~~~~h~niv~l~~~~~~~~~~~lv~ 263 (534)
.++|...+.||+|+||.||+|+.. +++.||||++. +++..++||||+++++++.+....++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 103 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF 103 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence 357888899999999999999986 58999999873 2577889999999999999999999999
Q ss_pred eccCCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCCc
Q 039819 264 PYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSH 343 (534)
Q Consensus 264 e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~ 343 (534)
||+++++|.+++.....+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 104 e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~- 179 (331)
T 4aaa_A 104 EFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE- 179 (331)
T ss_dssp ECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCTTC---------
T ss_pred ecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHC---CEEccCcChheEEEcCCCcEEEEeCCCceeecCCcc-
Confidence 9999999999888777899999999999999999999999 999999999999999999999999999987643322
Q ss_pred eeeccccccccccccccccC-CCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHH--------HHHHhhhcccc
Q 039819 344 VTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEW--------VKKIQQEKKVE 414 (534)
Q Consensus 344 ~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~--------~~~~~~~~~~~ 414 (534)
......||..|+|||++.+. .++.++|||||||++|||+||+.||...........+... ...........
T Consensus 180 ~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (331)
T 4aaa_A 180 VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFA 259 (331)
T ss_dssp ----CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGGT
T ss_pred ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhccccc
Confidence 23345689999999998765 6899999999999999999999999765432211111110 00001111111
Q ss_pred eecccccCCCCCH-----HHHHHHHHHHHHhcccCCCCCCChHHHHH--HhhcCCchhhH
Q 039819 415 VLVDRELGSNYDR-----IEVGEILQVALLCTQYLPVHRPKMSEVVR--MLEGDGLAEKW 467 (534)
Q Consensus 415 ~~~d~~l~~~~~~-----~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~--~L~~~~~~~~~ 467 (534)
....+.+...... ..+..+.+++.+|++.||.+|||+.|+++ .++..+..+++
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~~ 319 (331)
T 4aaa_A 260 GVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMDGFAERF 319 (331)
T ss_dssp TCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHGGGHHHHH
T ss_pred cccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhccCChhhhh
Confidence 1111111111111 12457899999999999999999999986 34444434433
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-40 Score=325.51 Aligned_cols=235 Identities=22% Similarity=0.304 Sum_probs=185.9
Q ss_pred HhCCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEehh---------------hhhhcccCceeeEEEEEeCCCeeEEEee
Q 039819 201 TENFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLKD---------------MISLAVHRNLLRLIGYCATPTERLLVYP 264 (534)
Q Consensus 201 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~---------------~l~~~~h~niv~l~~~~~~~~~~~lv~e 264 (534)
.++|...+.||+|+||.||+|+.. ++..||+|++.. ++..++||||+++++++.+....++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 100 (285)
T 3is5_A 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVME 100 (285)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEE
Confidence 357888899999999999999975 688999998752 5778899999999999999999999999
Q ss_pred ccCCCChhhhccc----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEe---CCCCcEEEEecccceec
Q 039819 265 YMSNGSVASRLRE----KPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLL---DDFCEAIVGDFGLAKLL 337 (534)
Q Consensus 265 ~~~~gsL~~~l~~----~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl---~~~~~~kl~DFGla~~~ 337 (534)
|+++|+|.+.+.. ...+++..+..|+.|++.||.|||+. +|+||||||+|||+ +.++.+||+|||+++..
T Consensus 101 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~ 177 (285)
T 3is5_A 101 TCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELF 177 (285)
T ss_dssp CCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-
T ss_pred eCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCCCHHHEEEecCCCCCCEEEEeeecceec
Confidence 9999999998853 46799999999999999999999999 99999999999999 55688999999999876
Q ss_pred CCCCCceeeccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceec
Q 039819 338 DHSDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLV 417 (534)
Q Consensus 338 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 417 (534)
.... ......||..|+|||++. +.++.++|||||||++|||++|+.||..... .+............
T Consensus 178 ~~~~--~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~-------~~~~~~~~~~~~~~--- 244 (285)
T 3is5_A 178 KSDE--HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSL-------EEVQQKATYKEPNY--- 244 (285)
T ss_dssp -----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHHHHHCCCCC---
T ss_pred CCcc--cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCH-------HHHHhhhccCCccc---
Confidence 4332 234456899999999885 5689999999999999999999999974321 11111111111000
Q ss_pred ccccCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 418 DRELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 418 d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
... ... ....+.+++.+|++.+|++|||+.|+++
T Consensus 245 ~~~-~~~----~~~~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 245 AVE-CRP----LTPQAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp CC---CC----CCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred ccc-cCc----CCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 000 001 2347889999999999999999999985
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=328.69 Aligned_cols=229 Identities=23% Similarity=0.385 Sum_probs=187.3
Q ss_pred HHhCCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEehh----------------hhhhc-ccCceeeEEEEEeCCCeeEE
Q 039819 200 ATENFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLKD----------------MISLA-VHRNLLRLIGYCATPTERLL 261 (534)
Q Consensus 200 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~----------------~l~~~-~h~niv~l~~~~~~~~~~~l 261 (534)
..++|...+.||+|+||.||+|+.. +++.||||++.. .+..+ .||||+++++++.+.+..++
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~l 88 (289)
T 1x8b_A 9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLI 88 (289)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEE
T ss_pred ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence 4578999999999999999999986 789999998752 33444 89999999999999999999
Q ss_pred EeeccCCCChhhhcccC----CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCC---------------
Q 039819 262 VYPYMSNGSVASRLREK----PALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDD--------------- 322 (534)
Q Consensus 262 v~e~~~~gsL~~~l~~~----~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~--------------- 322 (534)
||||+++|+|.+++... ..+++..++.|+.|++.||.|||++ +|+||||||+|||++.
T Consensus 89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~ 165 (289)
T 1x8b_A 89 QNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDD 165 (289)
T ss_dssp EEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC----------------
T ss_pred EEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeecCCCHHHEEEcCCCCCccccccccccc
Confidence 99999999999999753 6799999999999999999999999 9999999999999984
Q ss_pred ----CCcEEEEecccceecCCCCCceeeccccccccccccccccC-CCCcchhHHHHHHHHHHHHhCCCCcCCCcccccc
Q 039819 323 ----FCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELITGMRALEFGKSINQK 397 (534)
Q Consensus 323 ----~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~ 397 (534)
...+||+|||.+....... ...||..|+|||++.+. .++.++|||||||++|||++|++++....
T Consensus 166 ~~~~~~~~kl~Dfg~~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~----- 235 (289)
T 1x8b_A 166 WASNKVMFKIGDLGHVTRISSPQ-----VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD----- 235 (289)
T ss_dssp ----CCCEEECCCTTCEETTCSC-----CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSH-----
T ss_pred ccCCceEEEEcccccccccCCcc-----ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchh-----
Confidence 4479999999998775432 23589999999999765 56789999999999999999988764221
Q ss_pred chHHHHHHHHhhhcccceecccccCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 398 GAMLEWVKKIQQEKKVEVLVDRELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 398 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
.+. .... ... +.+... .+..+.+++.+|++.+|.+|||+.|+++
T Consensus 236 ----~~~-~~~~-~~~-----~~~~~~----~~~~~~~li~~~l~~dp~~Rps~~~ll~ 279 (289)
T 1x8b_A 236 ----QWH-EIRQ-GRL-----PRIPQV----LSQEFTELLKVMIHPDPERRPSAMALVK 279 (289)
T ss_dssp ----HHH-HHHT-TCC-----CCCSSC----CCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ----HHH-HHHc-CCC-----CCCCcc----cCHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence 111 1111 111 111112 2357899999999999999999999985
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=337.14 Aligned_cols=239 Identities=25% Similarity=0.397 Sum_probs=186.6
Q ss_pred hCCCcCCeeccCCcEEEEEEEEC-CCc----EEEEEEeh---------------hhhhhcccCceeeEEEEEeCCCeeEE
Q 039819 202 ENFSSKNILGAGGFGNVYKGKLG-DGT----VLAVKRLK---------------DMISLAVHRNLLRLIGYCATPTERLL 261 (534)
Q Consensus 202 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~----~vavK~~~---------------~~l~~~~h~niv~l~~~~~~~~~~~l 261 (534)
++|...+.||+|+||.||+|+.. ++. .||+|.+. .++..++||||++++++|.... .++
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~ 93 (327)
T 3lzb_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL 93 (327)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EEE
T ss_pred hHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ceE
Confidence 57888899999999999999964 343 36788763 2677889999999999998765 789
Q ss_pred EeeccCCCChhhhccc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCC
Q 039819 262 VYPYMSNGSVASRLRE-KPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHS 340 (534)
Q Consensus 262 v~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~ 340 (534)
|+||+++|+|.+++.. ...+++..++.|+.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 94 v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~~ 170 (327)
T 3lzb_A 94 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 170 (327)
T ss_dssp EECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTC-------
T ss_pred EEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhC---CCcCCCCCHHHEEEcCCCCEEEccCcceeEccCc
Confidence 9999999999999975 45799999999999999999999999 9999999999999999999999999999876433
Q ss_pred CC-ceeeccccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCcCCCccccccchHHHHHHHHhhhcccceecc
Q 039819 341 DS-HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVD 418 (534)
Q Consensus 341 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 418 (534)
.. .......+|..|+|||++.+..++.++|||||||++|||+| |+.||...... .+...+ ....
T Consensus 171 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~----~~~~~~---~~~~------- 236 (327)
T 3lzb_A 171 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS----EISSIL---EKGE------- 236 (327)
T ss_dssp ---------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG----GHHHHH---HTTC-------
T ss_pred cccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHH----HHHHHH---HcCC-------
Confidence 22 12233456889999999999999999999999999999999 99999753321 111111 1111
Q ss_pred cccCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhcC
Q 039819 419 RELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLEGD 461 (534)
Q Consensus 419 ~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~~ 461 (534)
....+...+..+.+++.+||+.+|.+||++.|+++.|+..
T Consensus 237 ---~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 276 (327)
T 3lzb_A 237 ---RLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKM 276 (327)
T ss_dssp ---CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 1111222345789999999999999999999999998864
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-40 Score=322.04 Aligned_cols=232 Identities=19% Similarity=0.263 Sum_probs=193.2
Q ss_pred HhCCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEehh--------------hhhhcccCceeeEEEEEeCCCeeEEEeec
Q 039819 201 TENFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLKD--------------MISLAVHRNLLRLIGYCATPTERLLVYPY 265 (534)
Q Consensus 201 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~--------------~l~~~~h~niv~l~~~~~~~~~~~lv~e~ 265 (534)
.++|...+.||+|+||.||+|... ++..||+|++.. ++..++||||+++++++.+....++||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMEL 87 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEec
Confidence 467889999999999999999986 477899998752 57788999999999999999999999999
Q ss_pred cCCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEe---CCCCcEEEEecccceecCCCCC
Q 039819 266 MSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLL---DDFCEAIVGDFGLAKLLDHSDS 342 (534)
Q Consensus 266 ~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl---~~~~~~kl~DFGla~~~~~~~~ 342 (534)
+++++|.+++.....+++..+..++.|++.||.|||+. +|+||||||+|||+ +.++.+||+|||++.......
T Consensus 88 ~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~- 163 (277)
T 3f3z_A 88 CTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK- 163 (277)
T ss_dssp CCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTS-
T ss_pred cCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEecCCCCCcEEEEecccceeccCcc-
Confidence 99999999998888899999999999999999999999 99999999999999 888999999999998765432
Q ss_pred ceeeccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceecccccC
Q 039819 343 HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELG 422 (534)
Q Consensus 343 ~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 422 (534)
......||+.|+|||++.+ .++.++||||||+++|||+||+.||...... +..........
T Consensus 164 -~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-------~~~~~~~~~~~---------- 224 (277)
T 3f3z_A 164 -MMRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPTDS-------EVMLKIREGTF---------- 224 (277)
T ss_dssp -CBCCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHHHHHHCCC----------
T ss_pred -chhccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHHCCCCCCCCCHH-------HHHHHHHhCCC----------
Confidence 2334569999999998855 5899999999999999999999999743321 11111111110
Q ss_pred CCCCH----HHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 423 SNYDR----IEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 423 ~~~~~----~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
..+. ..+..+.+++.+|++.+|.+||++.++++
T Consensus 225 -~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~ 261 (277)
T 3f3z_A 225 -TFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALE 261 (277)
T ss_dssp -CCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred -CCCchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0111 12357889999999999999999999875
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=330.01 Aligned_cols=239 Identities=26% Similarity=0.377 Sum_probs=193.3
Q ss_pred hCCCcCC-eeccCCcEEEEEEEEC---CCcEEEEEEehh---------------hhhhcccCceeeEEEEEeCCCeeEEE
Q 039819 202 ENFSSKN-ILGAGGFGNVYKGKLG---DGTVLAVKRLKD---------------MISLAVHRNLLRLIGYCATPTERLLV 262 (534)
Q Consensus 202 ~~~~~~~-~lG~G~~g~Vy~~~~~---~~~~vavK~~~~---------------~l~~~~h~niv~l~~~~~~~~~~~lv 262 (534)
++|...+ .||+|+||.||+|.+. ++..||||.+.. ++..++||||+++++++. .+..++|
T Consensus 9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~lv 87 (287)
T 1u59_A 9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQ-AEALMLV 87 (287)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-SSSEEEE
T ss_pred HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEec-CCCcEEE
Confidence 4455555 8999999999999864 578899999852 567789999999999994 5568999
Q ss_pred eeccCCCChhhhccc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCC
Q 039819 263 YPYMSNGSVASRLRE-KPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSD 341 (534)
Q Consensus 263 ~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~ 341 (534)
|||+++++|.+++.. ...+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~ 164 (287)
T 1u59_A 88 MEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADD 164 (287)
T ss_dssp EECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEECTTCS
T ss_pred EEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCchheEEEcCCCCEEECcccceeeeccCc
Confidence 999999999999864 45699999999999999999999999 99999999999999999999999999999875433
Q ss_pred Cce--eeccccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCcCCCccccccchHHHHHHHHhhhcccceecc
Q 039819 342 SHV--TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVD 418 (534)
Q Consensus 342 ~~~--~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 418 (534)
... .....||..|+|||++.+..++.++|||||||++|||+| |+.||...... +....+.....
T Consensus 165 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~-------~~~~~i~~~~~------ 231 (287)
T 1u59_A 165 SYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP-------EVMAFIEQGKR------ 231 (287)
T ss_dssp CEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH-------HHHHHHHTTCC------
T ss_pred ceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH-------HHHHHHhcCCc------
Confidence 221 223346889999999988889999999999999999999 99999743221 11111111110
Q ss_pred cccCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhcC
Q 039819 419 RELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLEGD 461 (534)
Q Consensus 419 ~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~~ 461 (534)
...+...+..+.+++.+|++.+|.+||++.++++.|+..
T Consensus 232 ----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~ 270 (287)
T 1u59_A 232 ----MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 270 (287)
T ss_dssp ----CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred ----CCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 111222345899999999999999999999999998864
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-40 Score=339.04 Aligned_cols=231 Identities=24% Similarity=0.285 Sum_probs=184.5
Q ss_pred CCeeccCCcEEEEEEEEC-CCcEEEEEEeh--------------hhhhhcccCceeeEEEEEeCCCeeEEEeeccCCCCh
Q 039819 207 KNILGAGGFGNVYKGKLG-DGTVLAVKRLK--------------DMISLAVHRNLLRLIGYCATPTERLLVYPYMSNGSV 271 (534)
Q Consensus 207 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~--------------~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 271 (534)
.+.||+|+||.||+|+.. +++.||||++. +++..++||||+++++++.+.+..++||||+++|+|
T Consensus 94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L 173 (373)
T 2x4f_A 94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGEL 173 (373)
T ss_dssp EEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEE
T ss_pred ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcH
Confidence 567999999999999974 68999999875 267788999999999999999999999999999999
Q ss_pred hhhcccC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEe--CCCCcEEEEecccceecCCCCCceeecc
Q 039819 272 ASRLREK-PALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLL--DDFCEAIVGDFGLAKLLDHSDSHVTTAV 348 (534)
Q Consensus 272 ~~~l~~~-~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl--~~~~~~kl~DFGla~~~~~~~~~~~~~~ 348 (534)
.+++... ..+++..++.++.|++.||.|||+. +|+||||||+|||+ +.++.+||+|||+++...... .....
T Consensus 174 ~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~--~~~~~ 248 (373)
T 2x4f_A 174 FDRIIDESYNLTELDTILFMKQICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE--KLKVN 248 (373)
T ss_dssp HHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC--BCCCC
T ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc--ccccc
Confidence 9988643 4699999999999999999999999 99999999999999 677899999999999775432 23345
Q ss_pred ccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceecccccCCCCCHH
Q 039819 349 RGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELGSNYDRI 428 (534)
Q Consensus 349 ~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 428 (534)
.||+.|+|||++.+..++.++|||||||++|||+||+.||...... +....+..... . ........
T Consensus 249 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~-------~~~~~i~~~~~--~-~~~~~~~~---- 314 (373)
T 2x4f_A 249 FGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDA-------ETLNNILACRW--D-LEDEEFQD---- 314 (373)
T ss_dssp CSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHH-------HHHHHHHHTCC--C-SCSGGGTT----
T ss_pred cCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH-------HHHHHHHhccC--C-CChhhhcc----
Confidence 6999999999998888999999999999999999999999754321 11111111110 0 00111111
Q ss_pred HHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 429 EVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 429 ~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
....+.+++.+|++.+|.+||++.|+++
T Consensus 315 ~~~~~~~li~~~L~~dp~~Rps~~e~l~ 342 (373)
T 2x4f_A 315 ISEEAKEFISKLLIKEKSWRISASEALK 342 (373)
T ss_dssp SCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 2357899999999999999999999987
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=339.75 Aligned_cols=231 Identities=29% Similarity=0.412 Sum_probs=189.4
Q ss_pred HhCCCcCCeeccCCcEEEEEEEE-CCCcEEEEEEeh-----------------hhhhhcccCceeeEEEEEeCCCeeEEE
Q 039819 201 TENFSSKNILGAGGFGNVYKGKL-GDGTVLAVKRLK-----------------DMISLAVHRNLLRLIGYCATPTERLLV 262 (534)
Q Consensus 201 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~-----------------~~l~~~~h~niv~l~~~~~~~~~~~lv 262 (534)
.+.|...+.||+|+||.||+|+. .+++.||||++. +++..++||||+++++++......++|
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 132 (348)
T 1u5q_A 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 132 (348)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEE
Confidence 35588889999999999999997 578999999874 157788999999999999999999999
Q ss_pred eeccCCCChhhhcc-cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCC
Q 039819 263 YPYMSNGSVASRLR-EKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSD 341 (534)
Q Consensus 263 ~e~~~~gsL~~~l~-~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~ 341 (534)
|||+. |+|.+.+. ....+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 133 ~e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~- 207 (348)
T 1u5q_A 133 MEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA- 207 (348)
T ss_dssp EECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB-
T ss_pred EecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEeeccCceecCCC-
Confidence 99997 67877775 456799999999999999999999999 9999999999999999999999999999876432
Q ss_pred Cceeeccccccccccccccc---cCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceecc
Q 039819 342 SHVTTAVRGTVGHIAPEYLS---TGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVD 418 (534)
Q Consensus 342 ~~~~~~~~gt~~y~aPE~~~---~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 418 (534)
....||+.|+|||++. .+.++.++|||||||++|||+||+.||..... ............
T Consensus 208 ----~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~-------~~~~~~~~~~~~------ 270 (348)
T 1u5q_A 208 ----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-------MSALYHIAQNES------ 270 (348)
T ss_dssp ----CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH-------HHHHHHHHHSCC------
T ss_pred ----CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh-------HHHHHHHHhcCC------
Confidence 2356999999999984 56789999999999999999999999964321 111122211111
Q ss_pred cccCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 419 RELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 419 ~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
+... ....+..+.+++.+||+.+|++|||++++++
T Consensus 271 ~~~~---~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~ 305 (348)
T 1u5q_A 271 PALQ---SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 305 (348)
T ss_dssp CCCC---CTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CCCC---CCCCCHHHHHHHHHHcccChhhCcCHHHHhh
Confidence 1111 1112347889999999999999999999985
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=365.34 Aligned_cols=232 Identities=28% Similarity=0.388 Sum_probs=187.6
Q ss_pred CeeccCCcEEEEEEEEC---CCcEEEEEEehh----------------hhhhcccCceeeEEEEEeCCCeeEEEeeccCC
Q 039819 208 NILGAGGFGNVYKGKLG---DGTVLAVKRLKD----------------MISLAVHRNLLRLIGYCATPTERLLVYPYMSN 268 (534)
Q Consensus 208 ~~lG~G~~g~Vy~~~~~---~~~~vavK~~~~----------------~l~~~~h~niv~l~~~~~~~~~~~lv~e~~~~ 268 (534)
+.||+|+||.||+|.+. .++.||||+++. ++..++|||||+++++|.. +..++|||||++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence 47999999999999763 467899998862 5778899999999999975 457899999999
Q ss_pred CChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCC--ceee
Q 039819 269 GSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDS--HVTT 346 (534)
Q Consensus 269 gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~--~~~~ 346 (534)
|+|.+++.....+++..++.|+.||+.||+|||++ +||||||||+|||++.++.+||+|||+++....... ....
T Consensus 454 g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~---~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~ 530 (635)
T 4fl3_A 454 GPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQT 530 (635)
T ss_dssp EEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC---------
T ss_pred CCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeCCCCChHhEEEeCCCCEEEEEcCCccccccCcccccccc
Confidence 99999999888899999999999999999999999 999999999999999999999999999987654322 1223
Q ss_pred ccccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCcCCCccccccchHHHHHHHHhhhcccceecccccCCCC
Q 039819 347 AVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELGSNY 425 (534)
Q Consensus 347 ~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 425 (534)
...+|..|+|||++.+..++.++|||||||++|||+| |+.||...... +....+..... ...
T Consensus 531 ~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~-------~~~~~i~~~~~----------~~~ 593 (635)
T 4fl3_A 531 HGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS-------EVTAMLEKGER----------MGC 593 (635)
T ss_dssp ----CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH-------HHHHHHHTTCC----------CCC
T ss_pred CCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH-------HHHHHHHcCCC----------CCC
Confidence 3456789999999999999999999999999999999 99999743321 11122211111 111
Q ss_pred CHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhc
Q 039819 426 DRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLEG 460 (534)
Q Consensus 426 ~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~ 460 (534)
+...+..+.+++.+||+.+|++||++.+|++.|+.
T Consensus 594 p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~ 628 (635)
T 4fl3_A 594 PAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN 628 (635)
T ss_dssp CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred CCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 22334689999999999999999999999999875
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=334.60 Aligned_cols=243 Identities=26% Similarity=0.357 Sum_probs=189.7
Q ss_pred hCCCcCCeeccCCcEEEEEEEE-CCCcEEEEEEeh--------------hhhhhcccCceeeEEEEEe----CCCeeEEE
Q 039819 202 ENFSSKNILGAGGFGNVYKGKL-GDGTVLAVKRLK--------------DMISLAVHRNLLRLIGYCA----TPTERLLV 262 (534)
Q Consensus 202 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~--------------~~l~~~~h~niv~l~~~~~----~~~~~~lv 262 (534)
++|...+.||+|+||.||+|+. .+++.||||++. +++..++||||+++++++. .....++|
T Consensus 29 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv 108 (317)
T 2buj_A 29 KHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLL 108 (317)
T ss_dssp EEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEEE
T ss_pred eEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEEE
Confidence 5788889999999999999997 578999999873 2677889999999999987 34467999
Q ss_pred eeccCCCChhhhccc----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecC
Q 039819 263 YPYMSNGSVASRLRE----KPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLD 338 (534)
Q Consensus 263 ~e~~~~gsL~~~l~~----~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~ 338 (534)
|||+++|+|.+++.. ...+++..++.++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++....
T Consensus 109 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~~ 185 (317)
T 2buj_A 109 LPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAK---GYAHRDLKPTNILLGDEGQPVLMDLGSMNQAC 185 (317)
T ss_dssp EECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCSSCEESC
T ss_pred EEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCCEEEEecCcchhcc
Confidence 999999999998864 56799999999999999999999999 99999999999999999999999999988653
Q ss_pred CCCCc--------eeeccccccccccccccccCC---CCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHH
Q 039819 339 HSDSH--------VTTAVRGTVGHIAPEYLSTGQ---SSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKI 407 (534)
Q Consensus 339 ~~~~~--------~~~~~~gt~~y~aPE~~~~~~---~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~ 407 (534)
..... ......||+.|+|||++.+.. ++.++|||||||++|||++|+.||+....... ......
T Consensus 186 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~--~~~~~~--- 260 (317)
T 2buj_A 186 IHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGD--SVALAV--- 260 (317)
T ss_dssp EEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTS--CHHHHH---
T ss_pred cccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccc--hhhHHh---
Confidence 21100 012345799999999986543 68899999999999999999999963111000 011100
Q ss_pred hhhcccceecccccCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhcCC
Q 039819 408 QQEKKVEVLVDRELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLEGDG 462 (534)
Q Consensus 408 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~~~ 462 (534)
.. ..........+..+.+++.+|++.+|.+||++.++++.|+...
T Consensus 261 ~~----------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~ 305 (317)
T 2buj_A 261 QN----------QLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQ 305 (317)
T ss_dssp HC----------C--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTC
T ss_pred hc----------cCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcC
Confidence 00 0000111122457899999999999999999999999998643
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-40 Score=325.82 Aligned_cols=231 Identities=25% Similarity=0.386 Sum_probs=194.6
Q ss_pred hCCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEeh-----------------hhhhhcccCceeeEEEEEeCCCeeEEEe
Q 039819 202 ENFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLK-----------------DMISLAVHRNLLRLIGYCATPTERLLVY 263 (534)
Q Consensus 202 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~-----------------~~l~~~~h~niv~l~~~~~~~~~~~lv~ 263 (534)
++|...+.||+|+||.||+|+.. ++..||||.+. +++..++||||+++++++.+....++||
T Consensus 14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 93 (284)
T 2vgo_A 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLML 93 (284)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEE
Confidence 67888999999999999999986 57889999873 1567788999999999999999999999
Q ss_pred eccCCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCCc
Q 039819 264 PYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSH 343 (534)
Q Consensus 264 e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~ 343 (534)
||+++|+|.+++.....+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++.......
T Consensus 94 e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~-- 168 (284)
T 2vgo_A 94 EFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLR-- 168 (284)
T ss_dssp CCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTCCEEECCCTTCEECSSSC--
T ss_pred EeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEEcCCCCEEEecccccccCcccc--
Confidence 9999999999998877899999999999999999999998 99999999999999999999999999997664322
Q ss_pred eeeccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceecccccCC
Q 039819 344 VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELGS 423 (534)
Q Consensus 344 ~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 423 (534)
.....||..|+|||++.+..++.++||||||+++|||++|+.||...... +........ +...
T Consensus 169 -~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-------~~~~~~~~~-------~~~~-- 231 (284)
T 2vgo_A 169 -RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHT-------ETHRRIVNV-------DLKF-- 231 (284)
T ss_dssp -BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH-------HHHHHHHTT-------CCCC--
T ss_pred -cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHh-------HHHHHHhcc-------ccCC--
Confidence 23456899999999999888999999999999999999999999743221 111111111 1111
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 424 NYDRIEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 424 ~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
+...+..+.+++.+|++.+|.+||++.++++
T Consensus 232 --~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~ 262 (284)
T 2vgo_A 232 --PPFLSDGSKDLISKLLRYHPPQRLPLKGVME 262 (284)
T ss_dssp --CTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred --CCcCCHHHHHHHHHHhhcCHhhCCCHHHHhh
Confidence 1222457889999999999999999999985
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-40 Score=328.75 Aligned_cols=238 Identities=29% Similarity=0.392 Sum_probs=189.1
Q ss_pred CCcCCeeccCCcEEEEEEEEC-C---CcEEEEEEehh---------------hhhhcccCceeeEEEEEeCCCee-EEEe
Q 039819 204 FSSKNILGAGGFGNVYKGKLG-D---GTVLAVKRLKD---------------MISLAVHRNLLRLIGYCATPTER-LLVY 263 (534)
Q Consensus 204 ~~~~~~lG~G~~g~Vy~~~~~-~---~~~vavK~~~~---------------~l~~~~h~niv~l~~~~~~~~~~-~lv~ 263 (534)
|...+.||+|+||.||+|++. + +..||+|.+.. ++..++||||+++++++.+.+.. ++||
T Consensus 23 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~ 102 (298)
T 3pls_A 23 THSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLL 102 (298)
T ss_dssp EEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEE
T ss_pred EccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEEE
Confidence 445688999999999999863 2 23799998752 56778999999999999877665 9999
Q ss_pred eccCCCChhhhccc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCC-
Q 039819 264 PYMSNGSVASRLRE-KPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSD- 341 (534)
Q Consensus 264 e~~~~gsL~~~l~~-~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~- 341 (534)
||+.+|+|.+++.. ...+++..++.|+.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 103 e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 179 (298)
T 3pls_A 103 PYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQ---KFVHRDLAARNCMLDESFTVKVADFGLARDILDREY 179 (298)
T ss_dssp CCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGGG
T ss_pred ecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEeCcCCCcccccCCcc
Confidence 99999999999976 45689999999999999999999999 99999999999999999999999999998654321
Q ss_pred --CceeeccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceeccc
Q 039819 342 --SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDR 419 (534)
Q Consensus 342 --~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 419 (534)
........+|..|+|||.+.+..++.++|||||||++|||+||..|+...... ..+.... .....
T Consensus 180 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~---~~~~~~~---~~~~~------- 246 (298)
T 3pls_A 180 YSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDP---FDLTHFL---AQGRR------- 246 (298)
T ss_dssp GCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCG---GGHHHHH---HTTCC-------
T ss_pred cccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCH---HHHHHHh---hcCCC-------
Confidence 11223456789999999999989999999999999999999966665432211 1111111 11110
Q ss_pred ccCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhc
Q 039819 420 ELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLEG 460 (534)
Q Consensus 420 ~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~ 460 (534)
...+...+..+.+++.+|++.+|.+|||+.++++.|+.
T Consensus 247 ---~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~ 284 (298)
T 3pls_A 247 ---LPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQ 284 (298)
T ss_dssp ---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ---CCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 01111224578999999999999999999999999875
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=342.87 Aligned_cols=238 Identities=30% Similarity=0.472 Sum_probs=180.3
Q ss_pred CCCcCCeeccCCcEEEEEEEEC--CC--cEEEEEEehh---------------hhhhcccCceeeEEEEEeC-CCeeEEE
Q 039819 203 NFSSKNILGAGGFGNVYKGKLG--DG--TVLAVKRLKD---------------MISLAVHRNLLRLIGYCAT-PTERLLV 262 (534)
Q Consensus 203 ~~~~~~~lG~G~~g~Vy~~~~~--~~--~~vavK~~~~---------------~l~~~~h~niv~l~~~~~~-~~~~~lv 262 (534)
.|...+.||+|+||.||+|++. ++ ..||||.+.. ++..++||||++++++|.. ....++|
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv 169 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV 169 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence 3556678999999999999863 22 4689998752 5677889999999999765 4577999
Q ss_pred eeccCCCChhhhcccC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCC
Q 039819 263 YPYMSNGSVASRLREK-PALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSD 341 (534)
Q Consensus 263 ~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~ 341 (534)
|||+++|+|.+++... ..+++..++.++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 170 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~ 246 (373)
T 3c1x_A 170 LPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 246 (373)
T ss_dssp EECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred EECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCccchheEEECCCCCEEEeeccccccccccc
Confidence 9999999999999754 4689999999999999999999999 99999999999999999999999999998664322
Q ss_pred C---ceeeccccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCcCCCccccccchHHHHHHHHhhhcccceec
Q 039819 342 S---HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLV 417 (534)
Q Consensus 342 ~---~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 417 (534)
. .......+|..|+|||++.+..++.++|||||||++|||+| |.+||....... +...+ ..... .
T Consensus 247 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~----~~~~~---~~~~~---~- 315 (373)
T 3c1x_A 247 FDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD----ITVYL---LQGRR---L- 315 (373)
T ss_dssp -----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSC----HHHHH---HTTCC---C-
T ss_pred cccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHH----HHHHH---HcCCC---C-
Confidence 1 11233457889999999999999999999999999999999 677776432211 11111 11110 0
Q ss_pred ccccCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhc
Q 039819 418 DRELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLEG 460 (534)
Q Consensus 418 d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~ 460 (534)
..+...+..+.+++.+||+.+|.+||++.|+++.|+.
T Consensus 316 ------~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~ 352 (373)
T 3c1x_A 316 ------LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISA 352 (373)
T ss_dssp ------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 0112234578999999999999999999999999875
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=328.60 Aligned_cols=235 Identities=27% Similarity=0.388 Sum_probs=187.2
Q ss_pred HhCCCcCCeeccCCcEEEEEEEECCCcEEEEEEehh------------hhhhcccCceeeEEEEEeCC-CeeEEEeeccC
Q 039819 201 TENFSSKNILGAGGFGNVYKGKLGDGTVLAVKRLKD------------MISLAVHRNLLRLIGYCATP-TERLLVYPYMS 267 (534)
Q Consensus 201 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~------------~l~~~~h~niv~l~~~~~~~-~~~~lv~e~~~ 267 (534)
.++|...+.||+|+||.||+|+.. ++.||||.+.. .+..++||||+++++++.+. ...++||||++
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 98 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMA 98 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCT
T ss_pred hhhceEEeEEecCCCceEEEEEEc-CCEEEEEEecchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEecCC
Confidence 357888899999999999999984 78999998752 67788999999999997655 46899999999
Q ss_pred CCChhhhcccCC--CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCCcee
Q 039819 268 NGSVASRLREKP--ALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVT 345 (534)
Q Consensus 268 ~gsL~~~l~~~~--~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~ 345 (534)
+|+|.+++.... .+++..++.++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++...... .
T Consensus 99 ~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~----~ 171 (278)
T 1byg_A 99 KGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST----Q 171 (278)
T ss_dssp TEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC------------
T ss_pred CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhC---CccccCCCcceEEEeCCCcEEEeecccccccccc----c
Confidence 999999997543 389999999999999999999999 9999999999999999999999999999865432 2
Q ss_pred eccccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCcCCCccccccchHHHHHHHHhhhcccceecccccCCC
Q 039819 346 TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELGSN 424 (534)
Q Consensus 346 ~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 424 (534)
....++..|+|||.+.+..++.++||||||+++|||+| |+.||...... .+ ........ .. .
T Consensus 172 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~----~~---~~~~~~~~------~~----~ 234 (278)
T 1byg_A 172 DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK----DV---VPRVEKGY------KM----D 234 (278)
T ss_dssp ----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG----GH---HHHHTTTC------CC----C
T ss_pred cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHH----HH---HHHHhcCC------CC----C
Confidence 23357889999999988899999999999999999998 99999743221 11 11111110 01 1
Q ss_pred CCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhc
Q 039819 425 YDRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLEG 460 (534)
Q Consensus 425 ~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~ 460 (534)
.+...+..+.+++.+|++.+|.+||++.|+++.|+.
T Consensus 235 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~ 270 (278)
T 1byg_A 235 APDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEH 270 (278)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHH
Confidence 122234588999999999999999999999999876
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=340.78 Aligned_cols=258 Identities=20% Similarity=0.246 Sum_probs=189.5
Q ss_pred CHHHHHHHHhCCCcCCeeccCCcEEEEEEEECCCcEEEEEEeh-------------------------hhhhhcccCcee
Q 039819 193 TFRELQQATENFSSKNILGAGGFGNVYKGKLGDGTVLAVKRLK-------------------------DMISLAVHRNLL 247 (534)
Q Consensus 193 ~~~~l~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~-------------------------~~l~~~~h~niv 247 (534)
...++....++|...+.||+|+||.||+|...++..||||++. +++..++||||+
T Consensus 13 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv 92 (362)
T 3pg1_A 13 LIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNIL 92 (362)
T ss_dssp HHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred HHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCcc
Confidence 4567888899999999999999999999999889999999772 257788999999
Q ss_pred eEEEEEeC-----CCeeEEEeeccCCCChhhhccc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeC
Q 039819 248 RLIGYCAT-----PTERLLVYPYMSNGSVASRLRE-KPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLD 321 (534)
Q Consensus 248 ~l~~~~~~-----~~~~~lv~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~ 321 (534)
++++++.. ....++||||++ |+|.+.+.. ...+++..+..|+.|++.||.|||+. +|+||||||+|||++
T Consensus 93 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~ 168 (362)
T 3pg1_A 93 GLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEA---GVVHRDLHPGNILLA 168 (362)
T ss_dssp CCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEC
T ss_pred ceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---cCEecCCChHHEEEc
Confidence 99999843 345799999998 578777764 44799999999999999999999999 999999999999999
Q ss_pred CCCcEEEEecccceecCCCCCceeecccccccccccccccc-CCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchH
Q 039819 322 DFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAM 400 (534)
Q Consensus 322 ~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~ 400 (534)
.++.+||+|||+++...... ......||+.|+|||++.+ ..++.++|||||||++|||+||+.||...........+
T Consensus 169 ~~~~~kl~Dfg~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i 246 (362)
T 3pg1_A 169 DNNDITICDFNLAREDTADA--NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKI 246 (362)
T ss_dssp TTCCEEECCTTC-----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH
T ss_pred CCCCEEEEecCccccccccc--ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 99999999999998554322 2334568999999999876 67899999999999999999999999754432221111
Q ss_pred HHHHHHHhhh-------cccceecccccCC-------CCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 401 LEWVKKIQQE-------KKVEVLVDRELGS-------NYDRIEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 401 ~~~~~~~~~~-------~~~~~~~d~~l~~-------~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
.+........ ......+...... .........+.+++.+|++.+|.+|||+.|+++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 316 (362)
T 3pg1_A 247 VEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALR 316 (362)
T ss_dssp HHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHc
Confidence 1111000000 0000000000000 001112347889999999999999999999985
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-40 Score=362.21 Aligned_cols=230 Identities=25% Similarity=0.324 Sum_probs=192.3
Q ss_pred HHhCCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEehh-----------------hhhhc-ccCceeeEEEEEeCCCeeE
Q 039819 200 ATENFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLKD-----------------MISLA-VHRNLLRLIGYCATPTERL 260 (534)
Q Consensus 200 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~-----------------~l~~~-~h~niv~l~~~~~~~~~~~ 260 (534)
..++|...+.||+|+||.||+|+.. +++.||||++++ ++..+ .||+|+++++++.+.+..|
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~ 418 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 418 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence 3467899999999999999999975 688999999863 23333 6999999999999999999
Q ss_pred EEeeccCCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCC
Q 039819 261 LVYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHS 340 (534)
Q Consensus 261 lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~ 340 (534)
+||||+++|+|.+++.....+++..++.|+.||+.||.|||+. +||||||||+|||++.++.+||+|||+++.....
T Consensus 419 lV~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~ 495 (674)
T 3pfq_A 419 FVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWD 495 (674)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---SEECCCCCSTTEEECSSSCEEECCCTTCEECCCT
T ss_pred EEEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeccCChhhEEEcCCCcEEEeecceeeccccC
Confidence 9999999999999999878899999999999999999999999 9999999999999999999999999999864332
Q ss_pred CCceeeccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceecccc
Q 039819 341 DSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRE 420 (534)
Q Consensus 341 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 420 (534)
. ......+||+.|+|||++.+..++.++|||||||++|||+||+.||..... .+....+....
T Consensus 496 ~-~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~-------~~~~~~i~~~~--------- 558 (674)
T 3pfq_A 496 G-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE-------DELFQSIMEHN--------- 558 (674)
T ss_dssp T-CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHHHHSSC---------
T ss_pred C-cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCH-------HHHHHHHHhCC---------
Confidence 2 234557899999999999999999999999999999999999999975332 12222222111
Q ss_pred cCCCCCHHHHHHHHHHHHHhcccCCCCCCCh
Q 039819 421 LGSNYDRIEVGEILQVALLCTQYLPVHRPKM 451 (534)
Q Consensus 421 l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~ 451 (534)
..++.....++.+++.+|++.||.+||++
T Consensus 559 --~~~p~~~s~~~~~li~~lL~~dP~~R~~~ 587 (674)
T 3pfq_A 559 --VAYPKSMSKEAVAICKGLMTKHPGKRLGC 587 (674)
T ss_dssp --CCCCTTSCHHHHHHHHHHSCSSSTTCTTC
T ss_pred --CCCCccCCHHHHHHHHHHccCCHHHCCCC
Confidence 01222234588999999999999999998
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=332.99 Aligned_cols=244 Identities=22% Similarity=0.356 Sum_probs=196.9
Q ss_pred HHHHHHHHhCCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEehh----------------------hhhhc-ccCceeeE
Q 039819 194 FRELQQATENFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLKD----------------------MISLA-VHRNLLRL 249 (534)
Q Consensus 194 ~~~l~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~----------------------~l~~~-~h~niv~l 249 (534)
+.......++|...+.||+|+||.||+|+.. +|+.||||++.. ++..+ .||||+++
T Consensus 86 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~ 165 (365)
T 2y7j_A 86 WAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITL 165 (365)
T ss_dssp HHHHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCE
T ss_pred chhhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEE
Confidence 3444556688999999999999999999985 799999997631 34455 79999999
Q ss_pred EEEEeCCCeeEEEeeccCCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEE
Q 039819 250 IGYCATPTERLLVYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVG 329 (534)
Q Consensus 250 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~ 329 (534)
++++......++||||+++++|.+++.....+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+
T Consensus 166 ~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~---gi~H~Dlkp~NIl~~~~~~ikl~ 242 (365)
T 2y7j_A 166 IDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHAN---NIVHRDLKPENILLDDNMQIRLS 242 (365)
T ss_dssp EEEEEBSSEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEEC
T ss_pred EEEEeeCCEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEE
Confidence 999999999999999999999999998877899999999999999999999998 99999999999999999999999
Q ss_pred ecccceecCCCCCceeecccccccccccccccc------CCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHH
Q 039819 330 DFGLAKLLDHSDSHVTTAVRGTVGHIAPEYLST------GQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEW 403 (534)
Q Consensus 330 DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~ 403 (534)
|||++....... ......||+.|+|||++.+ ..++.++|||||||++|||+||+.||..... ...
T Consensus 243 DfG~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~-------~~~ 313 (365)
T 2y7j_A 243 DFGFSCHLEPGE--KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQ-------ILM 313 (365)
T ss_dssp CCTTCEECCTTC--CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH-------HHH
T ss_pred ecCcccccCCCc--ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCH-------HHH
Confidence 999998775432 2344679999999999853 3578899999999999999999999964321 111
Q ss_pred HHHHhhhcccceecccccCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 404 VKKIQQEKKVEVLVDRELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 404 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
...+.... .. ...+.. . ..+..+.+++.+|++.+|++||++.|+++
T Consensus 314 ~~~i~~~~-~~-~~~~~~-~----~~~~~~~~li~~~L~~dP~~Rps~~ell~ 359 (365)
T 2y7j_A 314 LRMIMEGQ-YQ-FSSPEW-D----DRSSTVKDLISRLLQVDPEARLTAEQALQ 359 (365)
T ss_dssp HHHHHHTC-CC-CCHHHH-S----SSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHHHHhCC-CC-CCCccc-c----cCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 11111110 00 000000 0 11346889999999999999999999986
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=322.45 Aligned_cols=237 Identities=22% Similarity=0.285 Sum_probs=192.1
Q ss_pred HhCCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEeh--------------------hhhhhcccCceeeEEEEEeCCCee
Q 039819 201 TENFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLK--------------------DMISLAVHRNLLRLIGYCATPTER 259 (534)
Q Consensus 201 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~--------------------~~l~~~~h~niv~l~~~~~~~~~~ 259 (534)
.++|...+.||+|+||.||+|+.. +++.||||.+. .++..++||||+++++++.+....
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T 3bhy_A 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV 83 (283)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence 356888999999999999999986 68999999864 156788899999999999999999
Q ss_pred EEEeeccCCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCC----cEEEEecccce
Q 039819 260 LLVYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFC----EAIVGDFGLAK 335 (534)
Q Consensus 260 ~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~----~~kl~DFGla~ 335 (534)
++||||+++++|.+++.....+++..+..++.|++.||.|||+. +|+||||||+||+++.++ .+||+|||++.
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~ 160 (283)
T 3bhy_A 84 VLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAH 160 (283)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred EEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChHHEEEecCCCCCCceEEEecccce
Confidence 99999999999999998877899999999999999999999999 999999999999998877 89999999998
Q ss_pred ecCCCCCceeeccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccce
Q 039819 336 LLDHSDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEV 415 (534)
Q Consensus 336 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 415 (534)
...... ......||+.|+|||++.+..++.++||||||+++|||+||+.||..... .+..........
T Consensus 161 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-------~~~~~~~~~~~~--- 228 (283)
T 3bhy_A 161 KIEAGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETK-------QETLTNISAVNY--- 228 (283)
T ss_dssp ECC----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSH-------HHHHHHHHTTCC---
T ss_pred eccCCC--cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcch-------HHHHHHhHhccc---
Confidence 765432 22345689999999999888999999999999999999999999974321 111111111100
Q ss_pred ecccccCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 416 LVDRELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 416 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
..+..... ..+..+.+++.+|++.+|.+||++.|+++
T Consensus 229 ~~~~~~~~----~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 265 (283)
T 3bhy_A 229 DFDEEYFS----NTSELAKDFIRRLLVKDPKRRMTIAQSLE 265 (283)
T ss_dssp CCCHHHHT----TCCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CCcchhcc----cCCHHHHHHHHHHccCCHhHCcCHHHHHh
Confidence 00000001 12347889999999999999999999986
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=363.42 Aligned_cols=231 Identities=26% Similarity=0.382 Sum_probs=185.8
Q ss_pred eeccCCcEEEEEEEEC---CCcEEEEEEehh---------------hhhhcccCceeeEEEEEeCCCeeEEEeeccCCCC
Q 039819 209 ILGAGGFGNVYKGKLG---DGTVLAVKRLKD---------------MISLAVHRNLLRLIGYCATPTERLLVYPYMSNGS 270 (534)
Q Consensus 209 ~lG~G~~g~Vy~~~~~---~~~~vavK~~~~---------------~l~~~~h~niv~l~~~~~~~~~~~lv~e~~~~gs 270 (534)
.||+|+||.||+|.+. ++..||||+++. ++..++|||||+++++|.. +..++|||||++|+
T Consensus 343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~ 421 (613)
T 2ozo_A 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP 421 (613)
T ss_dssp EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCB
T ss_pred EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCc
Confidence 6999999999999874 467799998852 6778899999999999986 56899999999999
Q ss_pred hhhhccc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCCce--eec
Q 039819 271 VASRLRE-KPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHV--TTA 347 (534)
Q Consensus 271 L~~~l~~-~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~--~~~ 347 (534)
|.+++.. ...+++..++.|+.||+.||+|||++ +||||||||+|||++.++.+||+|||+++......... ...
T Consensus 422 L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~ 498 (613)
T 2ozo_A 422 LHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSA 498 (613)
T ss_dssp HHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCSTTTTCC-----------
T ss_pred HHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeeeccC
Confidence 9999974 45699999999999999999999999 99999999999999999999999999998764332211 122
Q ss_pred cccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCcCCCccccccchHHHHHHHHhhhcccceecccccCCCCC
Q 039819 348 VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELGSNYD 426 (534)
Q Consensus 348 ~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 426 (534)
..+|..|+|||++.+..++.++|||||||++|||+| |+.||...... +....+..... ...+
T Consensus 499 ~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~-------~~~~~i~~~~~----------~~~p 561 (613)
T 2ozo_A 499 GKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP-------EVMAFIEQGKR----------MECP 561 (613)
T ss_dssp ---CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSH-------HHHHHHHTTCC----------CCCC
T ss_pred CCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHH-------HHHHHHHcCCC----------CCCC
Confidence 335689999999998999999999999999999998 99999753321 11122221111 1122
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhc
Q 039819 427 RIEVGEILQVALLCTQYLPVHRPKMSEVVRMLEG 460 (534)
Q Consensus 427 ~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~ 460 (534)
...+..+.+++.+||+.+|++||++.+|++.|+.
T Consensus 562 ~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~ 595 (613)
T 2ozo_A 562 PECPPELYALMSDCWIYKWEDRPDFLTVEQRMRA 595 (613)
T ss_dssp TTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHH
T ss_pred CcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 2345689999999999999999999999999875
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-41 Score=344.86 Aligned_cols=224 Identities=12% Similarity=0.134 Sum_probs=179.3
Q ss_pred hCCCcCCeeccCCcEEEEEEEE-CCCcEEEEEEeh--------------------hhhhhcccCceeeEE-------EEE
Q 039819 202 ENFSSKNILGAGGFGNVYKGKL-GDGTVLAVKRLK--------------------DMISLAVHRNLLRLI-------GYC 253 (534)
Q Consensus 202 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~--------------------~~l~~~~h~niv~l~-------~~~ 253 (534)
++|...+.||+|+||.||+|+. .+++.||||++. +.++.++|||||+++ +++
T Consensus 73 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~ 152 (377)
T 3byv_A 73 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV 152 (377)
T ss_dssp EEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEE
T ss_pred ceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhhh
Confidence 5677789999999999999996 568999999974 135556899999998 666
Q ss_pred eCCCe-----------------eEEEeeccCCCChhhhcccCCCC-------CHHHHHHHHHHHHHHHHHHHhcCCCCeE
Q 039819 254 ATPTE-----------------RLLVYPYMSNGSVASRLREKPAL-------DWNTRKRIAIGAARGLLYLHEQCDPKII 309 (534)
Q Consensus 254 ~~~~~-----------------~~lv~e~~~~gsL~~~l~~~~~l-------~~~~~~~i~~~i~~~l~yLH~~~~~~iv 309 (534)
.+++. .++||||+ +|+|.+++.....+ ++..++.|+.|++.||+|||++ +|+
T Consensus 153 ~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~iv 228 (377)
T 3byv_A 153 KDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GLV 228 (377)
T ss_dssp ECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHT---TEE
T ss_pred hccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhC---Cee
Confidence 65532 78999999 68999999754333 3588899999999999999999 999
Q ss_pred eccCCCCcEEeCCCCcEEEEecccceecCCCCCceeeccccccccccccccccC-----------CCCcchhHHHHHHHH
Q 039819 310 HRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGHIAPEYLSTG-----------QSSEKTDVFGFGILL 378 (534)
Q Consensus 310 H~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~k~Dv~S~Gvvl 378 (534)
||||||+|||++.++.+||+|||+++.... ......| +.|+|||++.+. .++.++|||||||++
T Consensus 229 HrDikp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il 303 (377)
T 3byv_A 229 HTYLRPVDIVLDQRGGVFLTGFEHLVRDGA----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVI 303 (377)
T ss_dssp CSCCCGGGEEECTTCCEEECCGGGCEETTC----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHH
T ss_pred cCCCCHHHEEEcCCCCEEEEechhheecCC----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHH
Confidence 999999999999999999999999986432 3445668 999999999877 899999999999999
Q ss_pred HHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceecccccCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 379 LELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 379 ~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
|||+||+.||......... ..+.. . .... +..+.+++.+||+.||.+||++.|+++
T Consensus 304 ~elltg~~Pf~~~~~~~~~----------------~~~~~-~-~~~~----~~~~~~li~~~L~~dp~~Rpt~~e~l~ 359 (377)
T 3byv_A 304 YWIWCADLPITKDAALGGS----------------EWIFR-S-CKNI----PQPVRALLEGFLRYPKEDRLLPLQAME 359 (377)
T ss_dssp HHHHHSSCCC------CCS----------------GGGGS-S-CCCC----CHHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred HHHHHCCCCCcccccccch----------------hhhhh-h-ccCC----CHHHHHHHHHHcCCCchhCCCHHHHhh
Confidence 9999999999643221110 00000 0 0112 347889999999999999999999986
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=329.28 Aligned_cols=245 Identities=19% Similarity=0.230 Sum_probs=189.7
Q ss_pred hCCCcCCeeccCCcEEEEEEEE-CCCcEEEEEEehh-----------hhhhcc-cCceeeEEEEEeC--CCeeEEEeecc
Q 039819 202 ENFSSKNILGAGGFGNVYKGKL-GDGTVLAVKRLKD-----------MISLAV-HRNLLRLIGYCAT--PTERLLVYPYM 266 (534)
Q Consensus 202 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~-----------~l~~~~-h~niv~l~~~~~~--~~~~~lv~e~~ 266 (534)
++|...+.||+|+||.||+|+. .+++.||||++.. ++..++ ||||+++++++.+ ....++||||+
T Consensus 36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~e~~ 115 (330)
T 3nsz_A 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHV 115 (330)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEEECC
T ss_pred CceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccchHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEEecc
Confidence 5788889999999999999987 5789999999862 566776 9999999999988 56789999999
Q ss_pred CCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCC-cEEEEecccceecCCCCCcee
Q 039819 267 SNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFC-EAIVGDFGLAKLLDHSDSHVT 345 (534)
Q Consensus 267 ~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~-~~kl~DFGla~~~~~~~~~~~ 345 (534)
++++|.+++.. +++..+..++.|++.||.|||+. +|+||||||+|||++.++ .+||+|||+++....... .
T Consensus 116 ~~~~l~~~~~~---~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~--~ 187 (330)
T 3nsz_A 116 NNTDFKQLYQT---LTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE--Y 187 (330)
T ss_dssp CCCCHHHHGGG---CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCCTTCEECCTTCC--C
T ss_pred CchhHHHHHHh---CCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCCc--c
Confidence 99999998853 89999999999999999999999 999999999999999776 899999999987654332 3
Q ss_pred ecccccccccccccccc-CCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhh--------cc----
Q 039819 346 TAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQE--------KK---- 412 (534)
Q Consensus 346 ~~~~gt~~y~aPE~~~~-~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~--------~~---- 412 (534)
....||..|+|||++.+ ..++.++|||||||++|||+||+.||..+.... ..+.......... ..
T Consensus 188 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~--~~l~~~~~~~~~~~~~~~~~~~~~~~~ 265 (330)
T 3nsz_A 188 NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNY--DQLVRIAKVLGTEDLYDYIDKYNIELD 265 (330)
T ss_dssp CSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHH--HHHHHHHHHHCHHHHHHHHHHTTCCCC
T ss_pred ccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchH--HHHHHHHHhcCCchhhhHHHHhccccc
Confidence 34568999999999876 668999999999999999999999996433211 1111111110000 00
Q ss_pred ----------cceecccccCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 413 ----------VEVLVDRELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 413 ----------~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
....................+.+++.+|++.||.+|||++|+++
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~ 319 (330)
T 3nsz_A 266 PRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 319 (330)
T ss_dssp THHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred cchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 00000001111111223568899999999999999999999985
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-40 Score=328.40 Aligned_cols=244 Identities=23% Similarity=0.348 Sum_probs=186.9
Q ss_pred HhCCCcCCeeccCCcEEEEEEEE-CCCcEEEEEEeh-----------------hhhhhcccCceeeEEEEEeCCCeeEEE
Q 039819 201 TENFSSKNILGAGGFGNVYKGKL-GDGTVLAVKRLK-----------------DMISLAVHRNLLRLIGYCATPTERLLV 262 (534)
Q Consensus 201 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~-----------------~~l~~~~h~niv~l~~~~~~~~~~~lv 262 (534)
.++|...+.||+|+||.||+|.. .+++.||||++. ..+..++||||+++++++...+..++|
T Consensus 31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 110 (310)
T 2wqm_A 31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV 110 (310)
T ss_dssp GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEE
Confidence 35788889999999999999997 478999999874 156778899999999999999999999
Q ss_pred eeccCCCChhhhccc----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecC
Q 039819 263 YPYMSNGSVASRLRE----KPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLD 338 (534)
Q Consensus 263 ~e~~~~gsL~~~l~~----~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~ 338 (534)
|||+++|+|.+++.. ...+++..++.++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++....
T Consensus 111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~ 187 (310)
T 2wqm_A 111 LELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFS 187 (310)
T ss_dssp EECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred EecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence 999999999998863 56699999999999999999999999 99999999999999999999999999998764
Q ss_pred CCCCceeeccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceecc
Q 039819 339 HSDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVD 418 (534)
Q Consensus 339 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 418 (534)
.... ......||..|+|||++.+..++.++|||||||++|||++|+.||..... ....+......... .
T Consensus 188 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-----~~~~~~~~~~~~~~-~---- 256 (310)
T 2wqm_A 188 SKTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM-----NLYSLCKKIEQCDY-P---- 256 (310)
T ss_dssp ------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---C-----CHHHHHHHHHTTCS-C----
T ss_pred CCCc-cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccch-----hHHHHHHHhhcccC-C----
Confidence 3321 22345689999999999988999999999999999999999999964321 11222222222111 0
Q ss_pred cccCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhcCC
Q 039819 419 RELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLEGDG 462 (534)
Q Consensus 419 ~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~~~ 462 (534)
.. .....+..+.+++.+|++.||.+||++.+|++.|+...
T Consensus 257 -~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~ 296 (310)
T 2wqm_A 257 -PL---PSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMH 296 (310)
T ss_dssp -CC---CTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -CC---cccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 00 01122347899999999999999999999999998643
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-40 Score=328.92 Aligned_cols=239 Identities=30% Similarity=0.443 Sum_probs=187.5
Q ss_pred hCCCcCCeeccCCcEEEEEEEECC----CcEEEEEEehh---------------hhhhcccCceeeEEEEEeC-CCeeEE
Q 039819 202 ENFSSKNILGAGGFGNVYKGKLGD----GTVLAVKRLKD---------------MISLAVHRNLLRLIGYCAT-PTERLL 261 (534)
Q Consensus 202 ~~~~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~---------------~l~~~~h~niv~l~~~~~~-~~~~~l 261 (534)
.+|...+.||+|+||.||+|+..+ ...||||.+.. ++..++||||++++++|.. ....++
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 104 (298)
T 3f66_A 25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 104 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEE
Confidence 356777899999999999998643 23689998752 6778899999999999654 557799
Q ss_pred EeeccCCCChhhhccc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCC
Q 039819 262 VYPYMSNGSVASRLRE-KPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHS 340 (534)
Q Consensus 262 v~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~ 340 (534)
||||+++|+|.+++.. ...+++..++.|+.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 105 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~ 181 (298)
T 3f66_A 105 VLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK 181 (298)
T ss_dssp EEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSCGGGCCCSCG
T ss_pred EEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEECCCCCEEECccccccccccc
Confidence 9999999999999975 45689999999999999999999999 9999999999999999999999999999876432
Q ss_pred CC---ceeeccccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCcCCCccccccchHHHHHHHHhhhccccee
Q 039819 341 DS---HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GMRALEFGKSINQKGAMLEWVKKIQQEKKVEVL 416 (534)
Q Consensus 341 ~~---~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 416 (534)
.. .......||+.|+|||.+.+..++.++|||||||++|||+| |.+||....... ... .......
T Consensus 182 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~----~~~---~~~~~~~---- 250 (298)
T 3f66_A 182 EYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD----ITV---YLLQGRR---- 250 (298)
T ss_dssp GGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTT----HHH---HHHTTCC----
T ss_pred chhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHH----HHH---HHhcCCC----
Confidence 21 12234457889999999988899999999999999999999 555554322111 111 1111110
Q ss_pred cccccCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhc
Q 039819 417 VDRELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLEG 460 (534)
Q Consensus 417 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~ 460 (534)
...+...+..+.+++.+|++.+|.+||++.|+++.|+.
T Consensus 251 ------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~ 288 (298)
T 3f66_A 251 ------LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISA 288 (298)
T ss_dssp ------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ------CCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 00111223578999999999999999999999999875
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=341.58 Aligned_cols=250 Identities=22% Similarity=0.308 Sum_probs=192.5
Q ss_pred hCCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEeh---------------hhhhhcccCceeeEEEEEeCCCeeEEEeec
Q 039819 202 ENFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLK---------------DMISLAVHRNLLRLIGYCATPTERLLVYPY 265 (534)
Q Consensus 202 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~---------------~~l~~~~h~niv~l~~~~~~~~~~~lv~e~ 265 (534)
++|...+.||+|+||.||+|+.. ++..||+|++. .++..++||||+++++++......++||||
T Consensus 33 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 112 (360)
T 3eqc_A 33 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH 112 (360)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEEC
Confidence 57888899999999999999986 68999999874 267788999999999999999999999999
Q ss_pred cCCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCCcee
Q 039819 266 MSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVT 345 (534)
Q Consensus 266 ~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~ 345 (534)
+++|+|.+++.....+++..+..++.+++.||.|||+.. +|+||||||+|||++.++.+||+|||++...... ..
T Consensus 113 ~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~---~~ 187 (360)
T 3eqc_A 113 MDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---MA 187 (360)
T ss_dssp CTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHH--CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH---C-
T ss_pred CCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhC--CEEcCCccHHHEEECCCCCEEEEECCCCcccccc---cc
Confidence 999999999988778999999999999999999999842 7999999999999999999999999999755321 12
Q ss_pred eccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHH-HHHHHHh----------------
Q 039819 346 TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAML-EWVKKIQ---------------- 408 (534)
Q Consensus 346 ~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~-~~~~~~~---------------- 408 (534)
....||+.|+|||++.+..++.++|||||||++|||+||+.||...........+. .......
T Consensus 188 ~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (360)
T 3eqc_A 188 NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKF 267 (360)
T ss_dssp ---CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC------------------------
T ss_pred cCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCccccc
Confidence 34568999999999999899999999999999999999999997533211000000 0000000
Q ss_pred -----hhcc----cceecccccCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 409 -----QEKK----VEVLVDRELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 409 -----~~~~----~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
.... ...+.............+..+.+++.+|++.+|.+|||++|+++
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 324 (360)
T 3eqc_A 268 GMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 324 (360)
T ss_dssp ------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred ccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 0000 00000000000011112447899999999999999999999985
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=334.50 Aligned_cols=237 Identities=27% Similarity=0.418 Sum_probs=191.7
Q ss_pred hCCCcCCeeccCCcEEEEEEEEC-CCcE--EEEEEehh---------------hhhhc-ccCceeeEEEEEeCCCeeEEE
Q 039819 202 ENFSSKNILGAGGFGNVYKGKLG-DGTV--LAVKRLKD---------------MISLA-VHRNLLRLIGYCATPTERLLV 262 (534)
Q Consensus 202 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~--vavK~~~~---------------~l~~~-~h~niv~l~~~~~~~~~~~lv 262 (534)
++|...+.||+|+||.||+|+.. ++.. ||||++.. ++..+ .||||+++++++.+.+..++|
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 104 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 104 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence 57888899999999999999874 4554 48998752 56677 899999999999999999999
Q ss_pred eeccCCCChhhhcccCC----------------CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcE
Q 039819 263 YPYMSNGSVASRLREKP----------------ALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEA 326 (534)
Q Consensus 263 ~e~~~~gsL~~~l~~~~----------------~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~ 326 (534)
|||+++|+|.+++.... .+++..++.++.|++.||.|||+. +|+||||||+|||++.++.+
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~ 181 (327)
T 1fvr_A 105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVA 181 (327)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCE
T ss_pred EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCccceEEEcCCCeE
Confidence 99999999999997543 699999999999999999999999 99999999999999999999
Q ss_pred EEEecccceecCCCCCceeeccccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCcCCCccccccchHHHHHH
Q 039819 327 IVGDFGLAKLLDHSDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GMRALEFGKSINQKGAMLEWVK 405 (534)
Q Consensus 327 kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~ 405 (534)
||+|||+++...... ......++..|+|||++.+..++.++|||||||++|||+| |+.||..... .+...
T Consensus 182 kL~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~-------~~~~~ 252 (327)
T 1fvr_A 182 KIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC-------AELYE 252 (327)
T ss_dssp EECCTTCEESSCEEC--CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCH-------HHHHH
T ss_pred EEcccCcCccccccc--cccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcH-------HHHHH
Confidence 999999997443211 1223446889999999988889999999999999999998 9999974321 12222
Q ss_pred HHhhhcccceecccccCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhc
Q 039819 406 KIQQEKKVEVLVDRELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLEG 460 (534)
Q Consensus 406 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~ 460 (534)
....... . ..+...+..+.+++.+|++.+|.+||++.|+++.|..
T Consensus 253 ~~~~~~~------~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~ 297 (327)
T 1fvr_A 253 KLPQGYR------L----EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNR 297 (327)
T ss_dssp HGGGTCC------C----CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HhhcCCC------C----CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 2211110 1 1112234578999999999999999999999998875
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=328.04 Aligned_cols=236 Identities=22% Similarity=0.314 Sum_probs=179.4
Q ss_pred HhCCCcCCeeccCCcEEEEEEEE-CCCcEEEEEEehh----------------hhhhcccCceeeEEEEEeCCCeeEEEe
Q 039819 201 TENFSSKNILGAGGFGNVYKGKL-GDGTVLAVKRLKD----------------MISLAVHRNLLRLIGYCATPTERLLVY 263 (534)
Q Consensus 201 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~----------------~l~~~~h~niv~l~~~~~~~~~~~lv~ 263 (534)
.++|+..+.||+|+||.||+|+. .+++.||||++.. .+....||||+++++++.+....++||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~ 85 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM 85 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence 46788899999999999999997 4789999998852 366788999999999999999999999
Q ss_pred eccCCCChhhhcc----cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCC
Q 039819 264 PYMSNGSVASRLR----EKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDH 339 (534)
Q Consensus 264 e~~~~gsL~~~l~----~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~ 339 (534)
||+++ +|.+++. ....+++..++.|+.|++.||.|||+++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 86 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 162 (290)
T 3fme_A 86 ELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKL--SVIHRDVKPSNVLINALGQVKMCDFGISGYLVD 162 (290)
T ss_dssp ECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHS--CCCCCCCSGGGCEECTTCCEEBCCC--------
T ss_pred ehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecCCcccccc
Confidence 99974 8877764 4567999999999999999999999853 899999999999999999999999999987654
Q ss_pred CCCceeecccccccccccccc----ccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccce
Q 039819 340 SDSHVTTAVRGTVGHIAPEYL----STGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEV 415 (534)
Q Consensus 340 ~~~~~~~~~~gt~~y~aPE~~----~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 415 (534)
.. ......||+.|+|||++ .+..++.++|||||||++|||+||+.||+..... ...+ ........
T Consensus 163 ~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-----~~~~-~~~~~~~~--- 231 (290)
T 3fme_A 163 DV--AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTP-----FQQL-KQVVEEPS--- 231 (290)
T ss_dssp ---------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCH-----HHHH-HHHHHSCC---
T ss_pred cc--cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCch-----HHHH-HHHhccCC---
Confidence 32 22334689999999996 4567899999999999999999999999742211 1111 11111111
Q ss_pred ecccccCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 416 LVDRELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 416 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
+.. .....+..+.+++.+|++.+|++|||+.|+++
T Consensus 232 ---~~~---~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 232 ---PQL---PADKFSAEFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp ---CCC---CTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred ---CCc---ccccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence 000 11122457899999999999999999999975
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=331.95 Aligned_cols=240 Identities=27% Similarity=0.423 Sum_probs=184.0
Q ss_pred HhCCCcCCeeccCCcEEEEEEEEC----CCcEEEEEEeh----------------hhhhhcccCceeeEEEEEeCCCe--
Q 039819 201 TENFSSKNILGAGGFGNVYKGKLG----DGTVLAVKRLK----------------DMISLAVHRNLLRLIGYCATPTE-- 258 (534)
Q Consensus 201 ~~~~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~----------------~~l~~~~h~niv~l~~~~~~~~~-- 258 (534)
.++|...+.||+|+||.||+|... .+..||||++. ..+..++||||+++++++.+...
T Consensus 33 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 112 (313)
T 3brb_A 33 RNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQG 112 (313)
T ss_dssp GGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-----
T ss_pred HHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccccC
Confidence 467888899999999999999864 34589999875 15678889999999999987653
Q ss_pred ---eEEEeeccCCCChhhhcc------cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEE
Q 039819 259 ---RLLVYPYMSNGSVASRLR------EKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVG 329 (534)
Q Consensus 259 ---~~lv~e~~~~gsL~~~l~------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~ 329 (534)
.++||||+++|+|.+++. ....+++..++.|+.|++.||.|||+. +|+||||||+|||++.++.+||+
T Consensus 113 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kl~ 189 (313)
T 3brb_A 113 IPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNR---NFLHRDLAARNCMLRDDMTVCVA 189 (313)
T ss_dssp --CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCSGGGEEECTTSCEEEC
T ss_pred CcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEEe
Confidence 499999999999999983 345699999999999999999999998 99999999999999999999999
Q ss_pred ecccceecCCCCC-ceeeccccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCcCCCccccccchHHHHHHHH
Q 039819 330 DFGLAKLLDHSDS-HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GMRALEFGKSINQKGAMLEWVKKI 407 (534)
Q Consensus 330 DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~ 407 (534)
|||+++....... .......+++.|+|||.+.+..++.++|||||||++|||+| |+.||...... .+.. ..
T Consensus 190 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~----~~~~---~~ 262 (313)
T 3brb_A 190 DFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNH----EMYD---YL 262 (313)
T ss_dssp SCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG----GHHH---HH
T ss_pred ecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHH----HHHH---HH
Confidence 9999987643321 12233457889999999999899999999999999999999 88898743321 1111 11
Q ss_pred hhhcccceecccccCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhc
Q 039819 408 QQEKKVEVLVDRELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLEG 460 (534)
Q Consensus 408 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~ 460 (534)
..... .. .+...+..+.+++.+|++.+|.+||++.++++.|+.
T Consensus 263 ~~~~~------~~----~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~ 305 (313)
T 3brb_A 263 LHGHR------LK----QPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEK 305 (313)
T ss_dssp HTTCC------CC----CBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred HcCCC------CC----CCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 11110 01 112234578999999999999999999999999875
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-40 Score=325.51 Aligned_cols=231 Identities=25% Similarity=0.391 Sum_probs=186.8
Q ss_pred CCcCCeeccCCcEEEEEEEEC-CCcEEEEEEehh----------------hhhhcccCceeeEEEEEeC----CCeeEEE
Q 039819 204 FSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLKD----------------MISLAVHRNLLRLIGYCAT----PTERLLV 262 (534)
Q Consensus 204 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~----------------~l~~~~h~niv~l~~~~~~----~~~~~lv 262 (534)
|...+.||+|+||.||+|... ++..||+|.+.. ++..++||||+++++++.. ....++|
T Consensus 28 ~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv 107 (290)
T 1t4h_A 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 107 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred EEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEEE
Confidence 556678999999999999875 678999998742 5778899999999999865 3457999
Q ss_pred eeccCCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC--eEeccCCCCcEEeC-CCCcEEEEecccceecCC
Q 039819 263 YPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPK--IIHRDVKAANVLLD-DFCEAIVGDFGLAKLLDH 339 (534)
Q Consensus 263 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~--ivH~Dlkp~NiLl~-~~~~~kl~DFGla~~~~~ 339 (534)
|||+++|+|.+++.....+++..++.|+.|++.||.|||+. + |+||||||+|||++ .++.+||+|||++.....
T Consensus 108 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~~ 184 (290)
T 1t4h_A 108 TELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 184 (290)
T ss_dssp EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred EEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcC---CCCEEECCCCHHHEEEECCCCCEEEeeCCCcccccc
Confidence 99999999999998878899999999999999999999998 7 99999999999998 789999999999976543
Q ss_pred CCCceeeccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceeccc
Q 039819 340 SDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDR 419 (534)
Q Consensus 340 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 419 (534)
. ......||+.|+|||++. +.++.++|||||||++|||+||+.||..... .............. .
T Consensus 185 ~---~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~------~~~~~~~~~~~~~~-----~ 249 (290)
T 1t4h_A 185 S---FAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQN------AAQIYRRVTSGVKP-----A 249 (290)
T ss_dssp T---SBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSS------HHHHHHHHTTTCCC-----G
T ss_pred c---ccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCc------HHHHHHHHhccCCc-----c
Confidence 2 233456999999999886 5689999999999999999999999974322 11222222111110 0
Q ss_pred ccCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 420 ELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 420 ~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
. .+......+.+++.+|++.+|.+|||+.|+++
T Consensus 250 ~----~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 282 (290)
T 1t4h_A 250 S----FDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp G----GGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred c----cCCCCCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 0 11112347899999999999999999999985
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=320.59 Aligned_cols=232 Identities=24% Similarity=0.388 Sum_probs=185.9
Q ss_pred hCCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEehh-----------------hhhhcccCceeeEEEEEeCCCeeEEEe
Q 039819 202 ENFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLKD-----------------MISLAVHRNLLRLIGYCATPTERLLVY 263 (534)
Q Consensus 202 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~-----------------~l~~~~h~niv~l~~~~~~~~~~~lv~ 263 (534)
++|...+.||+|+||.||+|+.. +++.||||.+.. .+..++||||+++++++......++||
T Consensus 11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 90 (276)
T 2h6d_A 11 GHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVM 90 (276)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEE
Confidence 57888899999999999999986 789999998742 467788999999999999999999999
Q ss_pred eccCCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCCc
Q 039819 264 PYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSH 343 (534)
Q Consensus 264 e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~ 343 (534)
||+++++|.+++.....+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++.......
T Consensus 91 e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~-- 165 (276)
T 2h6d_A 91 EYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE-- 165 (276)
T ss_dssp ECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHH---CSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC----
T ss_pred eccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChhhEEECCCCCEEEeecccccccCCCc--
Confidence 9999999999998777899999999999999999999999 99999999999999999999999999998765432
Q ss_pred eeeccccccccccccccccCCC-CcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceecccccC
Q 039819 344 VTTAVRGTVGHIAPEYLSTGQS-SEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELG 422 (534)
Q Consensus 344 ~~~~~~gt~~y~aPE~~~~~~~-~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 422 (534)
......||+.|+|||.+.+..+ +.++||||||+++|||++|+.||..... ........... ..+
T Consensus 166 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~-------~~~~~~~~~~~-------~~~- 230 (276)
T 2h6d_A 166 FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHV-------PTLFKKIRGGV-------FYI- 230 (276)
T ss_dssp -----------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHHHHHCC-------CCC-
T ss_pred ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcH-------HHHHHHhhcCc-------ccC-
Confidence 2234568999999999987665 6899999999999999999999974321 11112111110 001
Q ss_pred CCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 423 SNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 423 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
+......+.+++.+|++.+|.+|||+.|+++
T Consensus 231 ---~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~ 261 (276)
T 2h6d_A 231 ---PEYLNRSVATLLMHMLQVDPLKRATIKDIRE 261 (276)
T ss_dssp ---CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---chhcCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence 1112347889999999999999999999986
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-40 Score=331.01 Aligned_cols=251 Identities=22% Similarity=0.361 Sum_probs=190.7
Q ss_pred HHhCCCcCCeeccCCcEEEEEEEE--CCCcEEEEEEehh----------------hhh---hcccCceeeEEEEEe----
Q 039819 200 ATENFSSKNILGAGGFGNVYKGKL--GDGTVLAVKRLKD----------------MIS---LAVHRNLLRLIGYCA---- 254 (534)
Q Consensus 200 ~~~~~~~~~~lG~G~~g~Vy~~~~--~~~~~vavK~~~~----------------~l~---~~~h~niv~l~~~~~---- 254 (534)
+.++|...+.||+|+||.||+|+. .+++.||||++.. .+. .+.||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 457899999999999999999998 4688999998741 233 348999999999987
Q ss_pred -CCCeeEEEeeccCCCChhhhcccC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEec
Q 039819 255 -TPTERLLVYPYMSNGSVASRLREK--PALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDF 331 (534)
Q Consensus 255 -~~~~~~lv~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DF 331 (534)
.....++||||++ |+|.+++... ..+++..++.++.|++.||.|||+. +|+||||||+|||++.++.+||+||
T Consensus 89 ~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---gi~H~dlkp~Nili~~~~~~kl~Df 164 (326)
T 1blx_A 89 DRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADF 164 (326)
T ss_dssp SSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECSC
T ss_pred CCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHHHeEEcCCCCEEEecC
Confidence 5567899999998 6999998754 3499999999999999999999999 9999999999999999999999999
Q ss_pred ccceecCCCCCceeeccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhc
Q 039819 332 GLAKLLDHSDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEK 411 (534)
Q Consensus 332 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 411 (534)
|+++..... .......||..|+|||++.+..++.++|||||||++|||+||+.||...........+...........
T Consensus 165 g~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 242 (326)
T 1blx_A 165 GLARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED 242 (326)
T ss_dssp CSCCCCCGG--GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGG
T ss_pred cccccccCC--CCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCccc
Confidence 999865432 123345689999999999988999999999999999999999999975443221111111100000000
Q ss_pred cccee------ccc---ccCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 412 KVEVL------VDR---ELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 412 ~~~~~------~d~---~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
..... +.. ..........+..+.+++.+|++.+|.+||++.|+++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 296 (326)
T 1blx_A 243 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 296 (326)
T ss_dssp SCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 00000 000 0000111123457889999999999999999999985
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-40 Score=337.11 Aligned_cols=245 Identities=23% Similarity=0.313 Sum_probs=172.4
Q ss_pred hCCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEeh----------------hhhhhcccCceeeEEEEEeCC------Ce
Q 039819 202 ENFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLK----------------DMISLAVHRNLLRLIGYCATP------TE 258 (534)
Q Consensus 202 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~----------------~~l~~~~h~niv~l~~~~~~~------~~ 258 (534)
++|...+.||+|+||.||+|... +|+.||||++. +++..++||||+++++++... ..
T Consensus 29 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~ 108 (367)
T 2fst_X 29 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND 108 (367)
T ss_dssp TTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred CceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCe
Confidence 67888999999999999999864 68999999874 267788999999999999754 55
Q ss_pred eEEEeeccCCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecC
Q 039819 259 RLLVYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLD 338 (534)
Q Consensus 259 ~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~ 338 (534)
.++||||+ +++|.+++.. ..+++..+..++.|+++||.|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 109 ~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kL~DFG~a~~~~ 183 (367)
T 2fst_X 109 VYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTA 183 (367)
T ss_dssp CEEEEECC-CEECC------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC--------
T ss_pred EEEEeccc-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHhhEEECCCCCEEEeecccccccc
Confidence 79999999 6899988875 5699999999999999999999998 99999999999999999999999999998654
Q ss_pred CCCCceeecccccccccccccccc-CCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhh--ccc--
Q 039819 339 HSDSHVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQE--KKV-- 413 (534)
Q Consensus 339 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~-- 413 (534)
.. .....||+.|+|||++.+ ..++.++|||||||++|||+||+.||...........+...+.....+ ..+
T Consensus 184 ~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~ 259 (367)
T 2fst_X 184 DE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 259 (367)
T ss_dssp -----------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCCC
T ss_pred cc----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhh
Confidence 32 334578999999999876 678999999999999999999999998654332222222111100000 000
Q ss_pred ---ceecccccC--CCCCH-----HHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 414 ---EVLVDRELG--SNYDR-----IEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 414 ---~~~~d~~l~--~~~~~-----~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
...+. .+. ..... .....+.+++.+|++.||.+|||+.|+++
T Consensus 260 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~ 311 (367)
T 2fst_X 260 ESARNYIQ-SLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 311 (367)
T ss_dssp HHHHHHHH-TSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHHHHh-ccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhc
Confidence 00000 000 00000 11347889999999999999999999985
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=332.61 Aligned_cols=250 Identities=20% Similarity=0.323 Sum_probs=190.2
Q ss_pred HhCCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEeh---------------hhhhhcccCceeeEEEEEeCC-----Cee
Q 039819 201 TENFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLK---------------DMISLAVHRNLLRLIGYCATP-----TER 259 (534)
Q Consensus 201 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~---------------~~l~~~~h~niv~l~~~~~~~-----~~~ 259 (534)
.++|...+.||+|+||.||+|... ++..||||++. +++..++||||+++++++... ...
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 105 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 105 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence 457888999999999999999975 68889999885 267788999999999999765 367
Q ss_pred EEEeeccCCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCC
Q 039819 260 LLVYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDH 339 (534)
Q Consensus 260 ~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~ 339 (534)
++||||+. |+|.+++... .+++..+..|+.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 106 ~iv~e~~~-~~L~~~l~~~-~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~ 180 (364)
T 3qyz_A 106 YIVQDLME-TDLYKLLKTQ-HLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADP 180 (364)
T ss_dssp EEEEECCS-EEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCG
T ss_pred EEEEcccC-cCHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChHhEEECCCCCEEEEeCcceEecCC
Confidence 99999997 5899888754 599999999999999999999999 999999999999999999999999999987653
Q ss_pred CCCc--eeecccccccccccccccc-CCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhccccee
Q 039819 340 SDSH--VTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVL 416 (534)
Q Consensus 340 ~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 416 (534)
.... ......||+.|+|||++.+ ..++.++|||||||++|||+||+.||...........+........... ....
T Consensus 181 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~-~~~~ 259 (364)
T 3qyz_A 181 DHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQED-LNCI 259 (364)
T ss_dssp GGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHH-HHTC
T ss_pred CCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHH-HHHh
Confidence 2211 1234579999999998754 4589999999999999999999999976543332222211110000000 0000
Q ss_pred ---------cccccCCCCC-----HHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 417 ---------VDRELGSNYD-----RIEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 417 ---------~d~~l~~~~~-----~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
.........+ ......+.+++.+|++.||.+|||+.|+++
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 313 (364)
T 3qyz_A 260 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 313 (364)
T ss_dssp CCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 0000000000 112347889999999999999999999985
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-40 Score=334.42 Aligned_cols=236 Identities=25% Similarity=0.313 Sum_probs=172.2
Q ss_pred hCCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEeh--------------hhhhhcc-cCceeeEEEEEe--------CCC
Q 039819 202 ENFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLK--------------DMISLAV-HRNLLRLIGYCA--------TPT 257 (534)
Q Consensus 202 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~--------------~~l~~~~-h~niv~l~~~~~--------~~~ 257 (534)
.+|...+.||+|+||.||+|+.. +++.||||++. ..+..+. ||||+++++++. ...
T Consensus 28 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~ 107 (337)
T 3ll6_A 28 LRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQA 107 (337)
T ss_dssp EEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSSE
T ss_pred ceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCCc
Confidence 46788899999999999999975 78999999873 1455664 999999999994 334
Q ss_pred eeEEEeeccCCCChhhhccc---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCC--eEeccCCCCcEEeCCCCcEEEEecc
Q 039819 258 ERLLVYPYMSNGSVASRLRE---KPALDWNTRKRIAIGAARGLLYLHEQCDPK--IIHRDVKAANVLLDDFCEAIVGDFG 332 (534)
Q Consensus 258 ~~~lv~e~~~~gsL~~~l~~---~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~--ivH~Dlkp~NiLl~~~~~~kl~DFG 332 (534)
..++||||+. |+|.+++.. ...+++..++.|+.|++.||.|||+. + |+||||||+|||++.++.+||+|||
T Consensus 108 ~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg 183 (337)
T 3ll6_A 108 EFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQ---KPPIIHRDLKVENLLLSNQGTIKLCDFG 183 (337)
T ss_dssp EEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCCCCCGGGCEECTTSCEEBCCCT
T ss_pred eEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCEEEccCCcccEEECCCCCEEEecCc
Confidence 5789999996 799888863 56799999999999999999999998 7 9999999999999999999999999
Q ss_pred cceecCCCCCc-----------eeecccccccccccccc---ccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccc
Q 039819 333 LAKLLDHSDSH-----------VTTAVRGTVGHIAPEYL---STGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKG 398 (534)
Q Consensus 333 la~~~~~~~~~-----------~~~~~~gt~~y~aPE~~---~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~ 398 (534)
+++........ ......||+.|+|||++ .+..++.++|||||||++|||+||+.||......
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~---- 259 (337)
T 3ll6_A 184 SATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKL---- 259 (337)
T ss_dssp TCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC----------
T ss_pred cceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHH----
Confidence 99876543211 11134589999999998 5667899999999999999999999999642211
Q ss_pred hHHHHHHHHhhhcccceecccccCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhcC
Q 039819 399 AMLEWVKKIQQEKKVEVLVDRELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLEGD 461 (534)
Q Consensus 399 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~~ 461 (534)
.... ..............+.+++.+|++.+|.+||++.|+++.|+..
T Consensus 260 ---~~~~-------------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~ 306 (337)
T 3ll6_A 260 ---RIVN-------------GKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEI 306 (337)
T ss_dssp ----------------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred ---Hhhc-------------CcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 0000 0000001111123578999999999999999999999998753
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=344.99 Aligned_cols=237 Identities=24% Similarity=0.361 Sum_probs=193.4
Q ss_pred HHhCCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEeh----------------hhhhhcccCceeeEEEEEeCCCeeEEE
Q 039819 200 ATENFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLK----------------DMISLAVHRNLLRLIGYCATPTERLLV 262 (534)
Q Consensus 200 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~----------------~~l~~~~h~niv~l~~~~~~~~~~~lv 262 (534)
..++|...+.||+|+||.||+|+.. +++.||||++. +++..++||||+++++++.+....++|
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 99 (486)
T 3mwu_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV 99 (486)
T ss_dssp HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEE
Confidence 3467999999999999999999985 78999999974 267888999999999999999999999
Q ss_pred eeccCCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeC---CCCcEEEEecccceecCC
Q 039819 263 YPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLD---DFCEAIVGDFGLAKLLDH 339 (534)
Q Consensus 263 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~---~~~~~kl~DFGla~~~~~ 339 (534)
|||+++|+|.+.+.....+++..+..|+.|++.||.|||+. +|+||||||+|||++ .++.+||+|||+++....
T Consensus 100 ~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~ 176 (486)
T 3mwu_A 100 GELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ 176 (486)
T ss_dssp ECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCC
T ss_pred EEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEEECCcCeECCC
Confidence 99999999999998778899999999999999999999999 999999999999995 567899999999987644
Q ss_pred CCCceeeccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceeccc
Q 039819 340 SDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDR 419 (534)
Q Consensus 340 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 419 (534)
.. ......||+.|+|||++.+ .++.++|||||||++|||++|+.||..... .+....+....... +.
T Consensus 177 ~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~-------~~~~~~i~~~~~~~---~~ 243 (486)
T 3mwu_A 177 NT--KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNE-------YDILKRVETGKYAF---DL 243 (486)
T ss_dssp C------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHHHHHTCCCS---CS
T ss_pred CC--ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCH-------HHHHHHHHhCCCCC---CC
Confidence 32 2344579999999999865 689999999999999999999999974332 12222222111100 00
Q ss_pred ccCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 420 ELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 420 ~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
. .....+..+.+++.+|++.+|.+|||+.|+++
T Consensus 244 ~----~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~ 276 (486)
T 3mwu_A 244 P----QWRTISDDAKDLIRKMLTFHPSLRITATQCLE 276 (486)
T ss_dssp G----GGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred c----ccCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 0 00112357889999999999999999999986
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=325.30 Aligned_cols=236 Identities=22% Similarity=0.347 Sum_probs=195.5
Q ss_pred HhCCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEeh--------------hhhhhcccCceeeEEEEEeCCCeeEEEeec
Q 039819 201 TENFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLK--------------DMISLAVHRNLLRLIGYCATPTERLLVYPY 265 (534)
Q Consensus 201 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~--------------~~l~~~~h~niv~l~~~~~~~~~~~lv~e~ 265 (534)
.++|...+.||+|+||.||+|+.. +++.||||.+. .++..++||||+++++++.+....++||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQL 87 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEc
Confidence 467888999999999999999985 78999999874 257788999999999999999999999999
Q ss_pred cCCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEe---CCCCcEEEEecccceecCCCCC
Q 039819 266 MSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLL---DDFCEAIVGDFGLAKLLDHSDS 342 (534)
Q Consensus 266 ~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl---~~~~~~kl~DFGla~~~~~~~~ 342 (534)
+++++|.+++.....+++..+..++.|++.||.|||+. +|+||||||+||++ +.++.+||+|||+++.....
T Consensus 88 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~-- 162 (304)
T 2jam_A 88 VSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG-- 162 (304)
T ss_dssp CCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCB--
T ss_pred CCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEecCCCCCCEEEccCCcceecCCC--
Confidence 99999999998777899999999999999999999999 99999999999999 78899999999999765432
Q ss_pred ceeeccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceecccccC
Q 039819 343 HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELG 422 (534)
Q Consensus 343 ~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 422 (534)
......||+.|+|||++.+..++.++|||||||++|||++|+.||..... .+....+.... . . ...
T Consensus 163 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-------~~~~~~i~~~~-~-~-~~~--- 228 (304)
T 2jam_A 163 -IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETE-------SKLFEKIKEGY-Y-E-FES--- 228 (304)
T ss_dssp -TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCH-------HHHHHHHHHCC-C-C-CCT---
T ss_pred -ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH-------HHHHHHHHcCC-C-C-CCc---
Confidence 12334689999999999988999999999999999999999999974321 11112211111 0 0 011
Q ss_pred CCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 423 SNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 423 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
......+..+.+++.+|++.+|.+||++.|+++
T Consensus 229 -~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (304)
T 2jam_A 229 -PFWDDISESAKDFICHLLEKDPNERYTCEKALS 261 (304)
T ss_dssp -TTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred -cccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 111123457899999999999999999999985
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-41 Score=329.70 Aligned_cols=239 Identities=28% Similarity=0.394 Sum_probs=191.4
Q ss_pred HhCCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEeh----------------hhhhhcccCceeeEEEEEe--CCCeeEE
Q 039819 201 TENFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLK----------------DMISLAVHRNLLRLIGYCA--TPTERLL 261 (534)
Q Consensus 201 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~----------------~~l~~~~h~niv~l~~~~~--~~~~~~l 261 (534)
.++|...+.||+|+||.||+|+.. +++.||+|.+. +.+..++||||+++++++. .....++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 367888999999999999999985 68999999874 1577889999999999885 4567899
Q ss_pred EeeccCCCChhhhccc----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCC-----eEeccCCCCcEEeCCCCcEEEEecc
Q 039819 262 VYPYMSNGSVASRLRE----KPALDWNTRKRIAIGAARGLLYLHEQCDPK-----IIHRDVKAANVLLDDFCEAIVGDFG 332 (534)
Q Consensus 262 v~e~~~~gsL~~~l~~----~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~-----ivH~Dlkp~NiLl~~~~~~kl~DFG 332 (534)
||||+++|+|.+++.. ...+++..++.++.|++.||.|||+. + |+||||||+|||++.++.+||+|||
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg 161 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR---SDGGHTVLHRDLKPANVFLDGKQNVKLGDFG 161 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH---C------CCCCCSGGGEEECSSSCEEECCCC
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcc---cCCCCeeEEeccchhhEEEcCCCCEEEecCc
Confidence 9999999999999864 34599999999999999999999998 6 9999999999999999999999999
Q ss_pred cceecCCCCCceeeccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcc
Q 039819 333 LAKLLDHSDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKK 412 (534)
Q Consensus 333 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 412 (534)
+++....... ......||..|+|||++.+..++.++||||||+++|||+||+.||..... .+....+....
T Consensus 162 ~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-------~~~~~~i~~~~- 232 (279)
T 2w5a_A 162 LARILNHDTS-FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ-------KELAGKIREGK- 232 (279)
T ss_dssp HHHHC---CH-HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHHHHHTC-
T ss_pred hheeeccccc-cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCH-------HHHHHHHhhcc-
Confidence 9987653321 22345689999999999888899999999999999999999999974321 11112221111
Q ss_pred cceecccccCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhc
Q 039819 413 VEVLVDRELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLEG 460 (534)
Q Consensus 413 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~ 460 (534)
. +.+ +...+..+.+++.+|++.+|.+||++.|+++.+..
T Consensus 233 ~-----~~~----~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~ 271 (279)
T 2w5a_A 233 F-----RRI----PYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 271 (279)
T ss_dssp C-----CCC----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred c-----ccC----CcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhh
Confidence 1 011 11234578999999999999999999999986543
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=337.18 Aligned_cols=248 Identities=20% Similarity=0.241 Sum_probs=188.7
Q ss_pred hCCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEehh-------------hhhhcc--------cCceeeEEEEEe----C
Q 039819 202 ENFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLKD-------------MISLAV--------HRNLLRLIGYCA----T 255 (534)
Q Consensus 202 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~-------------~l~~~~--------h~niv~l~~~~~----~ 255 (534)
++|...+.||+|+||.||+|+.. +++.||||++.. ++..++ |+||+++++++. .
T Consensus 37 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~~~ 116 (397)
T 1wak_A 37 GRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGVN 116 (397)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEETT
T ss_pred CeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecCCC
Confidence 67888999999999999999874 688999998852 344443 888999999987 5
Q ss_pred CCeeEEEeeccCCCChhhhcccC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCC---------
Q 039819 256 PTERLLVYPYMSNGSVASRLREK--PALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFC--------- 324 (534)
Q Consensus 256 ~~~~~lv~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~--------- 324 (534)
....++||||+ +++|.+.+... ..+++..++.|+.||+.||.|||+++ +|+||||||+|||++.++
T Consensus 117 ~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~--givHrDikp~NIll~~~~~~~~~~~~~ 193 (397)
T 1wak_A 117 GTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKC--RIIHTDIKPENILLSVNEQYIRRLAAE 193 (397)
T ss_dssp EEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECCCCSGGGEEECCCHHHHHHHHHH
T ss_pred CceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhC--CEecCCCCHHHeeEeccchhhhhhhhh
Confidence 56789999999 55666666432 56999999999999999999999864 799999999999999775
Q ss_pred ----------------------------------------cEEEEecccceecCCCCCceeeccccccccccccccccCC
Q 039819 325 ----------------------------------------EAIVGDFGLAKLLDHSDSHVTTAVRGTVGHIAPEYLSTGQ 364 (534)
Q Consensus 325 ----------------------------------------~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 364 (534)
.+||+|||+++..... .....||..|+|||++.+..
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~----~~~~~gt~~y~aPE~~~~~~ 269 (397)
T 1wak_A 194 ATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH----FTEDIQTRQYRSLEVLIGSG 269 (397)
T ss_dssp HC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC----SCSCCSCGGGCCHHHHHTSC
T ss_pred hHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc----CccCCCCCcccCChhhcCCC
Confidence 7999999999876532 23456899999999999989
Q ss_pred CCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHH---HHHHHHhh--------hcccceecccc--c----------
Q 039819 365 SSEKTDVFGFGILLLELITGMRALEFGKSINQKGAML---EWVKKIQQ--------EKKVEVLVDRE--L---------- 421 (534)
Q Consensus 365 ~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~---~~~~~~~~--------~~~~~~~~d~~--l---------- 421 (534)
++.++|||||||++|||+||+.||............. ........ .......+... +
T Consensus 270 ~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 349 (397)
T 1wak_A 270 YNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWG 349 (397)
T ss_dssp CCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCCCC
T ss_pred CCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCCcc
Confidence 9999999999999999999999997543222111111 11110000 00000000000 0
Q ss_pred -------CCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 422 -------GSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 422 -------~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
....+......+.+++.+||+.||++|||++|+++
T Consensus 350 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 391 (397)
T 1wak_A 350 LFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391 (397)
T ss_dssp HHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred hhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence 01234566778999999999999999999999985
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-40 Score=335.13 Aligned_cols=251 Identities=25% Similarity=0.343 Sum_probs=188.4
Q ss_pred hCCCcCCeeccCCcEEEEEEEE-CCCcEEEEEEeh----------------hhhhhcccCceeeEEEEEeCC--------
Q 039819 202 ENFSSKNILGAGGFGNVYKGKL-GDGTVLAVKRLK----------------DMISLAVHRNLLRLIGYCATP-------- 256 (534)
Q Consensus 202 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~----------------~~l~~~~h~niv~l~~~~~~~-------- 256 (534)
++|...+.||+|+||.||+|+. .+++.||||++. +++..++||||+++++++...
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 96 (351)
T 3mi9_A 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 96 (351)
T ss_dssp GGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------
T ss_pred cceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCC
Confidence 5788899999999999999998 478999999773 267788999999999999763
Q ss_pred CeeEEEeeccCCCChhhhccc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccce
Q 039819 257 TERLLVYPYMSNGSVASRLRE-KPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAK 335 (534)
Q Consensus 257 ~~~~lv~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~ 335 (534)
...++||||+++ +|.+.+.. ...+++..++.|+.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus 97 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~ 172 (351)
T 3mi9_A 97 GSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLAR 172 (351)
T ss_dssp CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred ceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCCEEEccchhcc
Confidence 467999999986 66666654 46799999999999999999999999 99999999999999999999999999998
Q ss_pred ecCCCC---Cceeecccccccccccccccc-CCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhc
Q 039819 336 LLDHSD---SHVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEK 411 (534)
Q Consensus 336 ~~~~~~---~~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 411 (534)
...... ........||+.|+|||++.+ ..++.++|||||||++|||+||+.||...........+...........
T Consensus 173 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 252 (351)
T 3mi9_A 173 AFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEV 252 (351)
T ss_dssp ECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTT
T ss_pred cccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhh
Confidence 764322 122344568999999998876 4579999999999999999999999975433221111111111000000
Q ss_pred c--c--ceeccc-cc--CCCCCH-H------HHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 412 K--V--EVLVDR-EL--GSNYDR-I------EVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 412 ~--~--~~~~d~-~l--~~~~~~-~------~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
. . ....+. .. ...... . ....+.+++.+|++.||++|||+.|+++
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 311 (351)
T 3mi9_A 253 WPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 311 (351)
T ss_dssp STTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhC
Confidence 0 0 000000 00 000000 0 1246889999999999999999999985
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-40 Score=333.78 Aligned_cols=241 Identities=29% Similarity=0.413 Sum_probs=190.9
Q ss_pred HhCCCcCCeeccCCcEEEEEEEE------CCCcEEEEEEehh---------------hhhhcccCceeeEEEEEeCCCee
Q 039819 201 TENFSSKNILGAGGFGNVYKGKL------GDGTVLAVKRLKD---------------MISLAVHRNLLRLIGYCATPTER 259 (534)
Q Consensus 201 ~~~~~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~---------------~l~~~~h~niv~l~~~~~~~~~~ 259 (534)
.++|...+.||+|+||.||+|++ .++..||||.+.. ++..++||||+++++++......
T Consensus 29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 108 (327)
T 2yfx_A 29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 108 (327)
T ss_dssp GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCc
Confidence 36788899999999999999984 3567899998741 56778999999999999999999
Q ss_pred EEEeeccCCCChhhhcccC-------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCC---CCcEEEE
Q 039819 260 LLVYPYMSNGSVASRLREK-------PALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDD---FCEAIVG 329 (534)
Q Consensus 260 ~lv~e~~~~gsL~~~l~~~-------~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~---~~~~kl~ 329 (534)
++||||+++|+|.+++... ..+++..++.++.|++.||.|||+. +|+||||||+|||++. +..+||+
T Consensus 109 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~i~H~dlkp~NIli~~~~~~~~~kl~ 185 (327)
T 2yfx_A 109 FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIG 185 (327)
T ss_dssp EEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeecCcCCHhHEEEecCCCcceEEEC
Confidence 9999999999999999754 3489999999999999999999999 9999999999999984 4569999
Q ss_pred ecccceecCCCCC-ceeeccccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCcCCCccccccchHHHHHHHH
Q 039819 330 DFGLAKLLDHSDS-HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GMRALEFGKSINQKGAMLEWVKKI 407 (534)
Q Consensus 330 DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~ 407 (534)
|||+++....... .......||..|+|||++.+..++.++|||||||++|||+| |+.||..... .+.....
T Consensus 186 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~-------~~~~~~~ 258 (327)
T 2yfx_A 186 DFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN-------QEVLEFV 258 (327)
T ss_dssp CCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH-------HHHHHHH
T ss_pred ccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCH-------HHHHHHH
Confidence 9999986533221 12234557899999999988899999999999999999998 9999874321 1122222
Q ss_pred hhhcccceecccccCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhcC
Q 039819 408 QQEKKVEVLVDRELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLEGD 461 (534)
Q Consensus 408 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~~ 461 (534)
..... ...+...+..+.+++.+|++.+|.+||++.++++.|+..
T Consensus 259 ~~~~~----------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~ 302 (327)
T 2yfx_A 259 TSGGR----------MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC 302 (327)
T ss_dssp HTTCC----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred hcCCC----------CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence 11111 011122345789999999999999999999999998753
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-40 Score=330.98 Aligned_cols=246 Identities=23% Similarity=0.378 Sum_probs=193.8
Q ss_pred hCCCcCCeeccCCcEEEEEEEE-----CCCcEEEEEEehh--------------hhhhcccCceeeEEEEEeCCC--eeE
Q 039819 202 ENFSSKNILGAGGFGNVYKGKL-----GDGTVLAVKRLKD--------------MISLAVHRNLLRLIGYCATPT--ERL 260 (534)
Q Consensus 202 ~~~~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~--------------~l~~~~h~niv~l~~~~~~~~--~~~ 260 (534)
++|...+.||+|+||.||+|++ .+++.||||++.. .+..++||||+++++++.... ..+
T Consensus 41 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 120 (326)
T 2w1i_A 41 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK 120 (326)
T ss_dssp GGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CCE
T ss_pred HHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCceE
Confidence 5677889999999999999984 3688999998752 577889999999999987654 679
Q ss_pred EEeeccCCCChhhhcccC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCC
Q 039819 261 LVYPYMSNGSVASRLREK-PALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDH 339 (534)
Q Consensus 261 lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~ 339 (534)
+||||+++|+|.+++... ..+++..++.++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 121 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~~ 197 (326)
T 2w1i_A 121 LIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQ 197 (326)
T ss_dssp EEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEECCS
T ss_pred EEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEEcCCCcEEEecCcchhhccc
Confidence 999999999999999764 4699999999999999999999998 999999999999999999999999999998754
Q ss_pred CCCce--eeccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccc-------ccc-chHH-HHHHHHh
Q 039819 340 SDSHV--TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSI-------NQK-GAML-EWVKKIQ 408 (534)
Q Consensus 340 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~-------~~~-~~~~-~~~~~~~ 408 (534)
..... .....++..|+|||.+.+..++.++|||||||++|||+||+.|+...... ... .... .......
T Consensus 198 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (326)
T 2w1i_A 198 DKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLK 277 (326)
T ss_dssp SCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHHHHH
T ss_pred cccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHHHhh
Confidence 43221 22345678899999998888999999999999999999999998632100 000 0000 1111111
Q ss_pred hhcccceecccccCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhc
Q 039819 409 QEKKVEVLVDRELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLEG 460 (534)
Q Consensus 409 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~ 460 (534)
. ......+...+..+.+++.+||+.+|.+||++.||++.|+.
T Consensus 278 ~----------~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~ 319 (326)
T 2w1i_A 278 N----------NGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQ 319 (326)
T ss_dssp T----------TCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHH
T ss_pred c----------CCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 1 11111122334689999999999999999999999999875
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-40 Score=337.18 Aligned_cols=251 Identities=20% Similarity=0.305 Sum_probs=187.4
Q ss_pred HhCCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEeh---------------hhhhhcccCceeeEEEEEeCC-----Cee
Q 039819 201 TENFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLK---------------DMISLAVHRNLLRLIGYCATP-----TER 259 (534)
Q Consensus 201 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~---------------~~l~~~~h~niv~l~~~~~~~-----~~~ 259 (534)
.++|...+.||+|+||.||+|+.. +++.||||++. +++..++||||+++++++... ...
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 89 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV 89 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence 367888999999999999999985 68999999874 267788999999999998754 678
Q ss_pred EEEeeccCCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCC
Q 039819 260 LLVYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDH 339 (534)
Q Consensus 260 ~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~ 339 (534)
++||||+. |+|.+++.. ..+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 90 ~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~ 164 (353)
T 2b9h_A 90 YIIQELMQ-TDLHRVIST-QMLSDDHIQYFIYQTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDE 164 (353)
T ss_dssp EEEECCCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred EEEEeccC-ccHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEcCCCcEEEEeccccccccc
Confidence 99999997 589888876 4699999999999999999999999 999999999999999999999999999987653
Q ss_pred CCCc---------eeecccccccccccccccc-CCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhh
Q 039819 340 SDSH---------VTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQ 409 (534)
Q Consensus 340 ~~~~---------~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 409 (534)
.... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||...........+.........
T Consensus 165 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 244 (353)
T 2b9h_A 165 SAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHS 244 (353)
T ss_dssp ---------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCS
T ss_pred ccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCch
Confidence 2211 1223568999999998754 67899999999999999999999999754321111111100000000
Q ss_pred hcccceecc-------cccC--CCC-----CHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 410 EKKVEVLVD-------RELG--SNY-----DRIEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 410 ~~~~~~~~d-------~~l~--~~~-----~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
......+.. ..+. ... ....+..+.+++.+|++.||++|||+.|+++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (353)
T 2b9h_A 245 DNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE 305 (353)
T ss_dssp TTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 000000000 0000 000 0112357889999999999999999999985
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-39 Score=345.18 Aligned_cols=236 Identities=22% Similarity=0.334 Sum_probs=190.9
Q ss_pred HhCCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEeh----------------hhhhhcccCceeeEEEEEeCCCeeEEEe
Q 039819 201 TENFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLK----------------DMISLAVHRNLLRLIGYCATPTERLLVY 263 (534)
Q Consensus 201 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~----------------~~l~~~~h~niv~l~~~~~~~~~~~lv~ 263 (534)
.+.|...+.||+|+||.||+|+.. ++..||||++. .++..+.|||||+++++|.+....++||
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 115 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM 115 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 457888999999999999999986 68899999875 2678889999999999999999999999
Q ss_pred eccCCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCC---CCcEEEEecccceecCCC
Q 039819 264 PYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDD---FCEAIVGDFGLAKLLDHS 340 (534)
Q Consensus 264 e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~---~~~~kl~DFGla~~~~~~ 340 (534)
||+++|+|.+.+.....+++..+..|+.|++.||.|||+. +|+||||||+|||++. ++.+||+|||+++.....
T Consensus 116 e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~ 192 (494)
T 3lij_A 116 ECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQ 192 (494)
T ss_dssp ECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTT
T ss_pred ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCC
Confidence 9999999999998878899999999999999999999999 9999999999999976 455999999999877543
Q ss_pred CCceeeccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceecccc
Q 039819 341 DSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRE 420 (534)
Q Consensus 341 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 420 (534)
. ......||+.|+|||++. +.++.++|||||||++|||++|+.||..... .+....+...... .+..
T Consensus 193 ~--~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-------~~~~~~i~~~~~~---~~~~ 259 (494)
T 3lij_A 193 K--KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTD-------QEILRKVEKGKYT---FDSP 259 (494)
T ss_dssp B--CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHHHHHTCCC---CCSG
T ss_pred c--cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCH-------HHHHHHHHhCCCC---CCch
Confidence 2 234467999999999885 5789999999999999999999999975332 1222222221110 0111
Q ss_pred cCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 421 LGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 421 l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
... ..+..+.+++.+|++.+|.+|||+.|+++
T Consensus 260 ~~~----~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 291 (494)
T 3lij_A 260 EWK----NVSEGAKDLIKQMLQFDSQRRISAQQALE 291 (494)
T ss_dssp GGT----TSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hcc----cCCHHHHHHHHHHCCCChhhCccHHHHhc
Confidence 111 12347889999999999999999999985
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=343.52 Aligned_cols=245 Identities=19% Similarity=0.260 Sum_probs=194.0
Q ss_pred hCCCcCCeeccCCcEEEEEEEE-CCCcEEEEEEeh------------hhhhhccc-CceeeEEEEEeCCCeeEEEeeccC
Q 039819 202 ENFSSKNILGAGGFGNVYKGKL-GDGTVLAVKRLK------------DMISLAVH-RNLLRLIGYCATPTERLLVYPYMS 267 (534)
Q Consensus 202 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~------------~~l~~~~h-~niv~l~~~~~~~~~~~lv~e~~~ 267 (534)
++|...+.||+|+||.||+|+. .+++.||||++. +++..+.| +++..+..++......++||||+
T Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~~- 85 (483)
T 3sv0_A 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDLL- 85 (483)
T ss_dssp TTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSSCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEECC-
T ss_pred CcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccccHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEECC-
Confidence 6788999999999999999997 578999999765 25666666 55666666777888889999999
Q ss_pred CCChhhhccc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEe---CCCCcEEEEecccceecCCCCCc
Q 039819 268 NGSVASRLRE-KPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLL---DDFCEAIVGDFGLAKLLDHSDSH 343 (534)
Q Consensus 268 ~gsL~~~l~~-~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl---~~~~~~kl~DFGla~~~~~~~~~ 343 (534)
+++|.+++.. ...+++..++.|+.||+.||.|||++ +||||||||+|||+ +.++.+||+|||+++........
T Consensus 86 g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~ 162 (483)
T 3sv0_A 86 GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK---SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTH 162 (483)
T ss_dssp CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTC
T ss_pred CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCcceEEEecCCCCCeEEEEeCCcceeccCCccc
Confidence 9999999974 56799999999999999999999999 99999999999999 68899999999999987543321
Q ss_pred ------eeeccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceec
Q 039819 344 ------VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLV 417 (534)
Q Consensus 344 ------~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 417 (534)
......||..|+|||++.+..++.++||||||||+|||++|+.||...........+..+..... ......
T Consensus 163 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~-~~~~~~-- 239 (483)
T 3sv0_A 163 QHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV-ATSIEA-- 239 (483)
T ss_dssp CBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHH-HSCHHH--
T ss_pred cccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccc-cccHHH--
Confidence 12256799999999999999999999999999999999999999975433221111111111110 011000
Q ss_pred ccccCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhc
Q 039819 418 DRELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLEG 460 (534)
Q Consensus 418 d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~ 460 (534)
+...+ +.++.+++..|++.+|++||++.+|++.|+.
T Consensus 240 ---l~~~~----p~~l~~li~~cl~~dP~~RPs~~el~~~L~~ 275 (483)
T 3sv0_A 240 ---LCRGY----PTEFASYFHYCRSLRFDDKPDYSYLKRLFRD 275 (483)
T ss_dssp ---HHTTS----CHHHHHHHHHHHTCCTTCCCCHHHHHHHHHH
T ss_pred ---HhcCC----cHHHHHHHHHHhcCChhhCcCHHHHHHHHHH
Confidence 00111 3478999999999999999999999998875
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=335.71 Aligned_cols=247 Identities=21% Similarity=0.275 Sum_probs=180.8
Q ss_pred hCCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEeh----------------hhhhhcccCceeeEEEEEeCCC------e
Q 039819 202 ENFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLK----------------DMISLAVHRNLLRLIGYCATPT------E 258 (534)
Q Consensus 202 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~----------------~~l~~~~h~niv~l~~~~~~~~------~ 258 (534)
++|...+.||+|+||.||+|... +++.||||++. .+++.++||||+++++++.... .
T Consensus 25 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 104 (371)
T 2xrw_A 25 KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQD 104 (371)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCE
T ss_pred hheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccccc
Confidence 57888999999999999999875 68899999874 1567889999999999997665 6
Q ss_pred eEEEeeccCCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecC
Q 039819 259 RLLVYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLD 338 (534)
Q Consensus 259 ~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~ 338 (534)
.++||||+++ +|.+.+. ..+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 105 ~~lv~e~~~~-~l~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~ 178 (371)
T 2xrw_A 105 VYIVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 178 (371)
T ss_dssp EEEEEECCSE-EHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCCCC-----
T ss_pred eEEEEEcCCC-CHHHHHh--hccCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEEEeecccccc
Confidence 7999999975 7877775 3489999999999999999999999 99999999999999999999999999998764
Q ss_pred CCCCceeeccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHH--------HH------
Q 039819 339 HSDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLE--------WV------ 404 (534)
Q Consensus 339 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~--------~~------ 404 (534)
... ......||+.|+|||++.+..++.++|||||||++|||+||+.||...........+.+ +.
T Consensus 179 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 256 (371)
T 2xrw_A 179 TSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPT 256 (371)
T ss_dssp -------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSCHH
T ss_pred ccc--ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhH
Confidence 321 23345789999999999988999999999999999999999999975432211110000 00
Q ss_pred -HHHhhh-ccc-----ceecccccCCC---CCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 405 -KKIQQE-KKV-----EVLVDRELGSN---YDRIEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 405 -~~~~~~-~~~-----~~~~d~~l~~~---~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
...... ... ...+....... ........+.+++.+|++.||.+|||++|+++
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 318 (371)
T 2xrw_A 257 VRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ 318 (371)
T ss_dssp HHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhC
Confidence 000000 000 00000000000 01223568899999999999999999999986
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=346.26 Aligned_cols=236 Identities=24% Similarity=0.353 Sum_probs=195.2
Q ss_pred HhCCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEeh-----------------hhhhhcccCceeeEEEEEeCCCeeEEE
Q 039819 201 TENFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLK-----------------DMISLAVHRNLLRLIGYCATPTERLLV 262 (534)
Q Consensus 201 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~-----------------~~l~~~~h~niv~l~~~~~~~~~~~lv 262 (534)
.++|...+.||+|+||.||+|+.. +++.||||++. .++..++||||+++++++.+....++|
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 104 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV 104 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 467888999999999999999986 78999999873 267788999999999999999999999
Q ss_pred eeccCCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEe---CCCCcEEEEecccceecCC
Q 039819 263 YPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLL---DDFCEAIVGDFGLAKLLDH 339 (534)
Q Consensus 263 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl---~~~~~~kl~DFGla~~~~~ 339 (534)
|||+.+|+|.+.+.....+++..+..|+.|++.||.|||++ +|+||||||+|||+ +.++.+||+|||+++....
T Consensus 105 ~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~ 181 (484)
T 3nyv_A 105 GEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA 181 (484)
T ss_dssp ECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCC
T ss_pred EecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEccc
Confidence 99999999999998888899999999999999999999999 99999999999999 5678999999999987654
Q ss_pred CCCceeeccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceeccc
Q 039819 340 SDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDR 419 (534)
Q Consensus 340 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 419 (534)
.. ......||+.|+|||++.+ .++.++|||||||++|||++|+.||..... .+....+....... .
T Consensus 182 ~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~-------~~~~~~i~~~~~~~---~- 247 (484)
T 3nyv_A 182 SK--KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANE-------YDILKKVEKGKYTF---E- 247 (484)
T ss_dssp CC--SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHHHHHCCCCC---C-
T ss_pred cc--ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCH-------HHHHHHHHcCCCCC---C-
Confidence 33 2344569999999999865 789999999999999999999999975332 11122222111000 0
Q ss_pred ccCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 420 ELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 420 ~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
.......+..+.+++.+|++.+|.+|||+.|+++
T Consensus 248 ---~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 281 (484)
T 3nyv_A 248 ---LPQWKKVSESAKDLIRKMLTYVPSMRISARDALD 281 (484)
T ss_dssp ---SGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ---CcccccCCHHHHHHHHHHCCCChhHCcCHHHHhh
Confidence 0000122457889999999999999999999985
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-39 Score=331.17 Aligned_cols=245 Identities=20% Similarity=0.315 Sum_probs=183.8
Q ss_pred hCCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEehh----------------hhhhcccCceeeEEEEEeCCCee-----
Q 039819 202 ENFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLKD----------------MISLAVHRNLLRLIGYCATPTER----- 259 (534)
Q Consensus 202 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~----------------~l~~~~h~niv~l~~~~~~~~~~----- 259 (534)
++|...+.||+|+||.||+|... +++.||||++.. ++..++||||+++++++......
T Consensus 42 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 121 (371)
T 4exu_A 42 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD 121 (371)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCC
T ss_pred ccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCccccee
Confidence 57888899999999999999875 689999998852 57788999999999999877655
Q ss_pred -EEEeeccCCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecC
Q 039819 260 -LLVYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLD 338 (534)
Q Consensus 260 -~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~ 338 (534)
++||||+. ++|.+.+.. .+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 122 ~~lv~e~~~-~~l~~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~ 195 (371)
T 4exu_A 122 FYLVMPFMQ-TDLQKIMGM--EFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLARHAD 195 (371)
T ss_dssp CEEEEECCC-EEHHHHTTS--CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECSTTCC----
T ss_pred EEEEEcccc-ccHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCcCHHHeEECCCCCEEEEecCcccccc
Confidence 99999997 588887743 499999999999999999999999 99999999999999999999999999998654
Q ss_pred CCCCceeecccccccccccccccc-CCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhh--ccc--
Q 039819 339 HSDSHVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQE--KKV-- 413 (534)
Q Consensus 339 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~-- 413 (534)
.. .....||+.|+|||++.+ ..++.++|||||||++|||+||+.||...........+.......... ...
T Consensus 196 ~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 271 (371)
T 4exu_A 196 AE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLND 271 (371)
T ss_dssp --------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCSC
T ss_pred cC----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhhh
Confidence 32 334568999999999877 678999999999999999999999997543221111111100000000 000
Q ss_pred ---cee---cccccCCCC---CHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 414 ---EVL---VDRELGSNY---DRIEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 414 ---~~~---~d~~l~~~~---~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
... +.......+ .......+.+++.+|++.+|++|||+.|+++
T Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 323 (371)
T 4exu_A 272 KAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT 323 (371)
T ss_dssp HHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred hhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhc
Confidence 000 000000000 0112457899999999999999999999985
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-39 Score=319.80 Aligned_cols=234 Identities=21% Similarity=0.288 Sum_probs=186.4
Q ss_pred HhCCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEehh------------------hhhhcccCceeeEEEEEe--CCCee
Q 039819 201 TENFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLKD------------------MISLAVHRNLLRLIGYCA--TPTER 259 (534)
Q Consensus 201 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~------------------~l~~~~h~niv~l~~~~~--~~~~~ 259 (534)
.++|...+.||+|+||.||+|... +++.||||.+.. ++..++||||+++++++. +....
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 478999999999999999999975 688999998742 567788999999999984 44578
Q ss_pred EEEeeccCCCChhhhccc--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceec
Q 039819 260 LLVYPYMSNGSVASRLRE--KPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLL 337 (534)
Q Consensus 260 ~lv~e~~~~gsL~~~l~~--~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~ 337 (534)
++||||++++ |.+++.. ...+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||++...
T Consensus 84 ~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~ 159 (305)
T 2wtk_C 84 YMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAEAL 159 (305)
T ss_dssp EEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEcCCCcEEeecccccccc
Confidence 9999999887 6666653 45699999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCC-CceeeccccccccccccccccCC--CCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccc
Q 039819 338 DHSD-SHVTTAVRGTVGHIAPEYLSTGQ--SSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVE 414 (534)
Q Consensus 338 ~~~~-~~~~~~~~gt~~y~aPE~~~~~~--~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 414 (534)
.... ........||..|+|||++.+.. ++.++|||||||++|||++|+.||..... .+....+....
T Consensus 160 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-------~~~~~~i~~~~--- 229 (305)
T 2wtk_C 160 HPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNI-------YKLFENIGKGS--- 229 (305)
T ss_dssp CTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSH-------HHHHHHHHHCC---
T ss_pred CccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchH-------HHHHHHHhcCC---
Confidence 5322 22334556899999999987644 37899999999999999999999974321 12222221111
Q ss_pred eecccccCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 415 VLVDRELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 415 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
..+... ....+.+++.+|++.||.+||++.|+++
T Consensus 230 ----~~~~~~----~~~~l~~li~~~l~~dp~~Rps~~~ll~ 263 (305)
T 2wtk_C 230 ----YAIPGD----CGPPLSDLLKGMLEYEPAKRFSIRQIRQ 263 (305)
T ss_dssp ----CCCCSS----SCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred ----CCCCCc----cCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 011112 2347889999999999999999999986
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=325.42 Aligned_cols=243 Identities=28% Similarity=0.420 Sum_probs=183.3
Q ss_pred HhCCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEeh---------------hhhhhcccCceeeEEEEEeCCCeeEEEee
Q 039819 201 TENFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLK---------------DMISLAVHRNLLRLIGYCATPTERLLVYP 264 (534)
Q Consensus 201 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~---------------~~l~~~~h~niv~l~~~~~~~~~~~lv~e 264 (534)
.++|...+.||+|+||.||+|... +++.||||++. ..+..++||||+++++++...+..++|||
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 93 (303)
T 2vwi_A 14 RDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMK 93 (303)
T ss_dssp CCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEEE
T ss_pred hhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEeh
Confidence 467888999999999999999864 68899999764 15667789999999999999999999999
Q ss_pred ccCCCChhhhccc--------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEeccccee
Q 039819 265 YMSNGSVASRLRE--------KPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKL 336 (534)
Q Consensus 265 ~~~~gsL~~~l~~--------~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~ 336 (534)
|+++++|.+++.. ...+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++..
T Consensus 94 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~ 170 (303)
T 2vwi_A 94 LLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAF 170 (303)
T ss_dssp CCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECCCHHHHH
T ss_pred hccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCCChhhEEEcCCCCEEEEeccchhe
Confidence 9999999999863 45699999999999999999999999 999999999999999999999999999986
Q ss_pred cCCCCC----ceeecccccccccccccccc-CCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhc
Q 039819 337 LDHSDS----HVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEK 411 (534)
Q Consensus 337 ~~~~~~----~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 411 (534)
...... .......||+.|+|||++.+ ..++.++|||||||++|||+||+.||....... .. ........
T Consensus 171 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~----~~--~~~~~~~~ 244 (303)
T 2vwi_A 171 LATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMK----VL--MLTLQNDP 244 (303)
T ss_dssp CC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGG----HH--HHHHTSSC
T ss_pred eccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhh----HH--HHHhccCC
Confidence 643221 12234568999999999865 568999999999999999999999997543211 11 11111100
Q ss_pred -cc-ceecccccCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 412 -KV-EVLVDRELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 412 -~~-~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
.. ....+......+ +..+.+++.+|++.+|.+||++.|+++
T Consensus 245 ~~~~~~~~~~~~~~~~----~~~~~~li~~~l~~dp~~Rps~~~ll~ 287 (303)
T 2vwi_A 245 PSLETGVQDKEMLKKY----GKSFRKMISLCLQKDPEKRPTAAELLR 287 (303)
T ss_dssp CCTTC-----CCCCCC----CHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred Cccccccccchhhhhh----hHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 00 111111122222 347889999999999999999999985
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=325.29 Aligned_cols=233 Identities=28% Similarity=0.420 Sum_probs=193.6
Q ss_pred hCCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEeh---------------hhhhhcccCceeeEEEEEeCCCeeEEEeec
Q 039819 202 ENFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLK---------------DMISLAVHRNLLRLIGYCATPTERLLVYPY 265 (534)
Q Consensus 202 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~---------------~~l~~~~h~niv~l~~~~~~~~~~~lv~e~ 265 (534)
+.|...+.||+|+||.||+|+.. +++.||||.+. .++..+.||||+++++++.+....++||||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 101 (303)
T 3a7i_A 22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY 101 (303)
T ss_dssp GTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred HHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEe
Confidence 46888899999999999999874 68999999874 256778999999999999999999999999
Q ss_pred cCCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCCcee
Q 039819 266 MSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVT 345 (534)
Q Consensus 266 ~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~ 345 (534)
+++++|.+++.. ..+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++....... ...
T Consensus 102 ~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~ 176 (303)
T 3a7i_A 102 LGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ-IKR 176 (303)
T ss_dssp CTTEEHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECBTTB-CCB
T ss_pred CCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChheEEECCCCCEEEeecccceecCccc-ccc
Confidence 999999999875 4699999999999999999999999 99999999999999999999999999998765432 123
Q ss_pred eccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceecccccCCCC
Q 039819 346 TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELGSNY 425 (534)
Q Consensus 346 ~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 425 (534)
....||..|+|||++.+..++.++|||||||++|||+||+.||..... ........... .+.+...+
T Consensus 177 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-------~~~~~~~~~~~------~~~~~~~~ 243 (303)
T 3a7i_A 177 NTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHP-------MKVLFLIPKNN------PPTLEGNY 243 (303)
T ss_dssp CCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH-------HHHHHHHHHSC------CCCCCSSC
T ss_pred CccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCH-------HHHHHHhhcCC------CCCCcccc
Confidence 345689999999999988999999999999999999999999964321 11111111111 11122222
Q ss_pred CHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 426 DRIEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 426 ~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
+..+.+++.+|++.+|.+|||+.|+++
T Consensus 244 ----~~~l~~li~~~l~~dp~~Rps~~~ll~ 270 (303)
T 3a7i_A 244 ----SKPLKEFVEACLNKEPSFRPTAKELLK 270 (303)
T ss_dssp ----CHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred ----CHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 347899999999999999999999986
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-39 Score=330.76 Aligned_cols=187 Identities=23% Similarity=0.307 Sum_probs=160.1
Q ss_pred HHhCCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEehh-------------hhhhcc-cC-----ceeeEEEEEeCCCee
Q 039819 200 ATENFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLKD-------------MISLAV-HR-----NLLRLIGYCATPTER 259 (534)
Q Consensus 200 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~-------------~l~~~~-h~-----niv~l~~~~~~~~~~ 259 (534)
..++|...+.||+|+||.||+|+.. +++.||||++.. ++..+. |+ +|+++++++......
T Consensus 52 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~ 131 (382)
T 2vx3_A 52 WMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHL 131 (382)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEE
T ss_pred eeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCce
Confidence 3578899999999999999999975 678999999852 333333 44 599999999999999
Q ss_pred EEEeeccCCCChhhhcccC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeC--CCCcEEEEecccce
Q 039819 260 LLVYPYMSNGSVASRLREK--PALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLD--DFCEAIVGDFGLAK 335 (534)
Q Consensus 260 ~lv~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~--~~~~~kl~DFGla~ 335 (534)
++||||++ |+|.+++... ..+++..+..++.|++.||.|||+. ..+||||||||+|||++ .++.+||+|||+++
T Consensus 132 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a~ 209 (382)
T 2vx3_A 132 CLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSC 209 (382)
T ss_dssp EEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECCCTTCE
T ss_pred EEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEeccCce
Confidence 99999996 5999998754 4699999999999999999999952 22899999999999994 57889999999998
Q ss_pred ecCCCCCceeeccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCc
Q 039819 336 LLDHSDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGK 392 (534)
Q Consensus 336 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~ 392 (534)
..... .....||+.|+|||++.+..++.++|||||||++|||+||+.||....
T Consensus 210 ~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~ 262 (382)
T 2vx3_A 210 QLGQR----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGAN 262 (382)
T ss_dssp ETTCC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ecccc----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 77532 234568999999999999899999999999999999999999998544
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-39 Score=323.28 Aligned_cols=240 Identities=24% Similarity=0.405 Sum_probs=188.4
Q ss_pred HhCCCcCCeeccCCcEEEEEEEECCCcEEEEEEeh----------------hhhhhcccCceeeEEEEEeCCCeeEEEee
Q 039819 201 TENFSSKNILGAGGFGNVYKGKLGDGTVLAVKRLK----------------DMISLAVHRNLLRLIGYCATPTERLLVYP 264 (534)
Q Consensus 201 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~----------------~~l~~~~h~niv~l~~~~~~~~~~~lv~e 264 (534)
.++|...+.||+|+||.||+|+... .||||.+. ..+..++||||+++++++.+....++|||
T Consensus 32 ~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e 109 (319)
T 2y4i_B 32 FEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITS 109 (319)
T ss_dssp CSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEECB
T ss_pred HHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEee
Confidence 4678888999999999999999865 38888774 26778899999999999999999999999
Q ss_pred ccCCCChhhhcccCC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCC--
Q 039819 265 YMSNGSVASRLREKP-ALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSD-- 341 (534)
Q Consensus 265 ~~~~gsL~~~l~~~~-~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~-- 341 (534)
|+++++|.+++.... .+++..++.++.|++.||.|||+. +|+||||||+|||++ ++.+||+|||+++......
T Consensus 110 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~~ 185 (319)
T 2y4i_B 110 LCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAK---GILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAG 185 (319)
T ss_dssp CCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHT---TCCCCCCCSTTEEEC---CCEECCCSCCC--------
T ss_pred cccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChhhEEEe-CCCEEEeecCCcccccccccc
Confidence 999999999998654 699999999999999999999999 999999999999998 6899999999987653211
Q ss_pred --Cceeecccccccccccccccc---------CCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhh
Q 039819 342 --SHVTTAVRGTVGHIAPEYLST---------GQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQE 410 (534)
Q Consensus 342 --~~~~~~~~gt~~y~aPE~~~~---------~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 410 (534)
........||..|+|||++.. ..++.++|||||||++|||+||+.||..... ..........
T Consensus 186 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-------~~~~~~~~~~ 258 (319)
T 2y4i_B 186 RREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPA-------EAIIWQMGTG 258 (319)
T ss_dssp --CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCH-------HHHHHHHHTT
T ss_pred ccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-------HHHHHHhccC
Confidence 112233458999999999864 4578899999999999999999999974321 1111111111
Q ss_pred cccceecccccCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhcCC
Q 039819 411 KKVEVLVDRELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLEGDG 462 (534)
Q Consensus 411 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~~~ 462 (534)
. .+.... ...+..+.+++.+|++.+|.+|||+.+++++|+...
T Consensus 259 ~------~~~~~~---~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~ 301 (319)
T 2y4i_B 259 M------KPNLSQ---IGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLP 301 (319)
T ss_dssp C------CCCCCC---SSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC-
T ss_pred C------CCCCCc---CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHH
Confidence 1 011110 012236889999999999999999999999998754
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-40 Score=337.98 Aligned_cols=238 Identities=11% Similarity=0.040 Sum_probs=171.7
Q ss_pred hCCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEehh-----------------hhhhc--ccCceeeEE-------EEEe
Q 039819 202 ENFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLKD-----------------MISLA--VHRNLLRLI-------GYCA 254 (534)
Q Consensus 202 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~-----------------~l~~~--~h~niv~l~-------~~~~ 254 (534)
.+|...+.||+|+||.||+|+.. +++.||||++.. .+..+ .||||++++ +++.
T Consensus 62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~ 141 (371)
T 3q60_A 62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVA 141 (371)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEE
T ss_pred eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhee
Confidence 34777889999999999999975 789999998752 12333 599988755 4443
Q ss_pred CC-----------------CeeEEEeeccCCCChhhhccc-CCCCCHHHH------HHHHHHHHHHHHHHHhcCCCCeEe
Q 039819 255 TP-----------------TERLLVYPYMSNGSVASRLRE-KPALDWNTR------KRIAIGAARGLLYLHEQCDPKIIH 310 (534)
Q Consensus 255 ~~-----------------~~~~lv~e~~~~gsL~~~l~~-~~~l~~~~~------~~i~~~i~~~l~yLH~~~~~~ivH 310 (534)
.+ ...++|||||+ |+|.+++.. ...+.+..+ ..++.|++.||+|||++ +|||
T Consensus 142 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~---~ivH 217 (371)
T 3q60_A 142 VQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSK---GLVH 217 (371)
T ss_dssp ETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHT---TEEE
T ss_pred cCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHC---CCcc
Confidence 32 33799999999 899999975 334566666 78889999999999999 9999
Q ss_pred ccCCCCcEEeCCCCcEEEEecccceecCCCCCceeecccccccccccccccc--CCCCcchhHHHHHHHHHHHHhCCCCc
Q 039819 311 RDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGHIAPEYLST--GQSSEKTDVFGFGILLLELITGMRAL 388 (534)
Q Consensus 311 ~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~k~Dv~S~Gvvl~elltG~~p~ 388 (534)
|||||+|||++.++.+||+|||+++..... .....+|+.|+|||++.+ ..++.++|||||||++|||+||+.||
T Consensus 218 rDikp~NIll~~~~~~kL~DFG~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf 293 (371)
T 3q60_A 218 GHFTPDNLFIMPDGRLMLGDVSALWKVGTR----GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPF 293 (371)
T ss_dssp TTCSGGGEEECTTSCEEECCGGGEEETTCE----EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCST
T ss_pred CcCCHHHEEECCCCCEEEEecceeeecCCC----ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCC
Confidence 999999999999999999999999976431 224457799999999977 67899999999999999999999999
Q ss_pred CCCccccccchHHHHHHHHhhhcccceecccccCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 389 EFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 389 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
......... .| .....................+..+.+++.+||+.||++|||+.|+++
T Consensus 294 ~~~~~~~~~----~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 294 GLVTPGIKG----SW-----KRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352 (371)
T ss_dssp TBCCTTCTT----CC-----CBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred CCcCccccc----ch-----hhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 754221100 00 000000000011111111123458899999999999999999999975
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-39 Score=321.72 Aligned_cols=238 Identities=24% Similarity=0.360 Sum_probs=190.3
Q ss_pred HHhCCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEeh------------hhhhhcccCceeeEEEEEeCCCeeEEEeecc
Q 039819 200 ATENFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLK------------DMISLAVHRNLLRLIGYCATPTERLLVYPYM 266 (534)
Q Consensus 200 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~------------~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~ 266 (534)
..++|...+.||+|+||.||+|... +++.||||.+. .++..+.||||+++++++......++||||+
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 106 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYC 106 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSCCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEeecC
Confidence 3467888999999999999999986 58999999875 2677889999999999999999999999999
Q ss_pred CCCChhhhcc-cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCCcee
Q 039819 267 SNGSVASRLR-EKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVT 345 (534)
Q Consensus 267 ~~gsL~~~l~-~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~ 345 (534)
++|+|.+++. ....+++..+..++.+++.||.|||+. +|+||||||+||+++.++.+||+|||++........ ..
T Consensus 107 ~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~-~~ 182 (314)
T 3com_A 107 GAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMA-KR 182 (314)
T ss_dssp TTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECBTTBS-CB
T ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCcCHHHEEECCCCCEEEeecccchhhhhhcc-cc
Confidence 9999999987 456799999999999999999999999 999999999999999999999999999987654321 23
Q ss_pred eccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceecccccCCCC
Q 039819 346 TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELGSNY 425 (534)
Q Consensus 346 ~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 425 (534)
....||..|+|||++.+..++.++|||||||++|||++|+.||...... .......... .... ..
T Consensus 183 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-------~~~~~~~~~~-~~~~-------~~ 247 (314)
T 3com_A 183 NTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPM-------RAIFMIPTNP-PPTF-------RK 247 (314)
T ss_dssp CCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHH-------HHHHHHHHSC-CCCC-------SS
T ss_pred CccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChH-------HHHHHHhcCC-Cccc-------CC
Confidence 3456899999999999888999999999999999999999999743211 1111111111 0000 01
Q ss_pred CHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 426 DRIEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 426 ~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
+...+..+.+++.+|++.+|.+|||+.++++
T Consensus 248 ~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~ 278 (314)
T 3com_A 248 PELWSDNFTDFVKQCLVKSPEQRATATQLLQ 278 (314)
T ss_dssp GGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred cccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 1122457899999999999999999999985
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=323.50 Aligned_cols=237 Identities=23% Similarity=0.312 Sum_probs=188.0
Q ss_pred HhCCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEeh--------------hhhhhcccCceeeEEEEEeCCCeeEEEeec
Q 039819 201 TENFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLK--------------DMISLAVHRNLLRLIGYCATPTERLLVYPY 265 (534)
Q Consensus 201 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~--------------~~l~~~~h~niv~l~~~~~~~~~~~lv~e~ 265 (534)
.++|+..+.||+|+||.||+|+.. ++..||+|.+. +++..++||||+++++++......++||||
T Consensus 18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 97 (302)
T 2j7t_A 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEF 97 (302)
T ss_dssp GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEEC
T ss_pred ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEe
Confidence 467888999999999999999986 58999999874 257788999999999999999999999999
Q ss_pred cCCCChhhhccc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCCce
Q 039819 266 MSNGSVASRLRE-KPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHV 344 (534)
Q Consensus 266 ~~~gsL~~~l~~-~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~ 344 (534)
+++++|.+++.. ...+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++...... ...
T Consensus 98 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~~ 173 (302)
T 2j7t_A 98 CPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKT-LQK 173 (302)
T ss_dssp CTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHH-HHC
T ss_pred CCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEECCCCCEEEEECCCCcccccc-ccc
Confidence 999999998864 56799999999999999999999999 9999999999999999999999999997643211 011
Q ss_pred eecccccccccccccc-----ccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceeccc
Q 039819 345 TTAVRGTVGHIAPEYL-----STGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDR 419 (534)
Q Consensus 345 ~~~~~gt~~y~aPE~~-----~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 419 (534)
.....||..|+|||++ ....++.++|||||||++|||+||+.||..... .............. .
T Consensus 174 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-------~~~~~~~~~~~~~~-~--- 242 (302)
T 2j7t_A 174 RDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP-------MRVLLKIAKSDPPT-L--- 242 (302)
T ss_dssp -----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCH-------HHHHHHHHHSCCCC-C---
T ss_pred cccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCH-------HHHHHHHhccCCcc-c---
Confidence 2234689999999998 356789999999999999999999999974321 11111111111100 0
Q ss_pred ccCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 420 ELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 420 ~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
..+...+..+.+++.+|++.+|.+|||+.++++
T Consensus 243 ----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 243 ----LTPSKWSVEFRDFLKIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp ----SSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred ----CCccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 011122357889999999999999999999874
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-39 Score=326.97 Aligned_cols=247 Identities=20% Similarity=0.293 Sum_probs=190.3
Q ss_pred hCCCcCCeeccCCcEEEEEEEE--CCCcEEEEEEehh-------------hhhhcccC------ceeeEEEEEeCCCeeE
Q 039819 202 ENFSSKNILGAGGFGNVYKGKL--GDGTVLAVKRLKD-------------MISLAVHR------NLLRLIGYCATPTERL 260 (534)
Q Consensus 202 ~~~~~~~~lG~G~~g~Vy~~~~--~~~~~vavK~~~~-------------~l~~~~h~------niv~l~~~~~~~~~~~ 260 (534)
++|...+.||+|+||.||+|.. .+++.||||++.. ++..+.|+ +++++++++...+..+
T Consensus 14 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~~~ 93 (339)
T 1z57_A 14 ARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHIC 93 (339)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTEEE
T ss_pred CceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCCchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCcEE
Confidence 5788899999999999999987 3688999998852 45555555 4999999999999999
Q ss_pred EEeeccCCCChhhhcccCC--CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCC----------------
Q 039819 261 LVYPYMSNGSVASRLREKP--ALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDD---------------- 322 (534)
Q Consensus 261 lv~e~~~~gsL~~~l~~~~--~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~---------------- 322 (534)
+||||+ +++|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+|||++.
T Consensus 94 lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~~ 169 (339)
T 1z57_A 94 IVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSN---KLTHTDLKPENILFVQSDYTEAYNPKIKRDER 169 (339)
T ss_dssp EEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCCCEEEEEC----CEEE
T ss_pred EEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeccccccccCCccccccc
Confidence 999999 889999997654 689999999999999999999999 9999999999999987
Q ss_pred ---CCcEEEEecccceecCCCCCceeeccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccch
Q 039819 323 ---FCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGA 399 (534)
Q Consensus 323 ---~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~ 399 (534)
++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||+||+.||...........
T Consensus 170 ~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~ 245 (339)
T 1z57_A 170 TLINPDIKVVDFGSATYDDEH----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAM 245 (339)
T ss_dssp EESCCCEEECCCSSCEETTSC----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHHHHH
T ss_pred cccCCCceEeeCcccccCccc----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHH
Confidence 678999999999875432 2345689999999999988999999999999999999999999975433211111
Q ss_pred HHHHHHHHh----hhcc-cceecccc-------------------c--CCCCCHHHHHHHHHHHHHhcccCCCCCCChHH
Q 039819 400 MLEWVKKIQ----QEKK-VEVLVDRE-------------------L--GSNYDRIEVGEILQVALLCTQYLPVHRPKMSE 453 (534)
Q Consensus 400 ~~~~~~~~~----~~~~-~~~~~d~~-------------------l--~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~e 453 (534)
+........ .... ........ + ...........+.+++.+|++.||.+|||+.|
T Consensus 246 ~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e 325 (339)
T 1z57_A 246 MERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLRE 325 (339)
T ss_dssp HHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred HHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccCHHH
Confidence 111000000 0000 00000000 0 01112344678999999999999999999999
Q ss_pred HHH
Q 039819 454 VVR 456 (534)
Q Consensus 454 v~~ 456 (534)
+++
T Consensus 326 ll~ 328 (339)
T 1z57_A 326 ALK 328 (339)
T ss_dssp HTT
T ss_pred Hhc
Confidence 874
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=330.73 Aligned_cols=240 Identities=20% Similarity=0.269 Sum_probs=169.3
Q ss_pred HhCCCcC-CeeccCCcEEEEEEEEC-CCcEEEEEEehh----------hhhhcccCceeeEEEEEeC----CCeeEEEee
Q 039819 201 TENFSSK-NILGAGGFGNVYKGKLG-DGTVLAVKRLKD----------MISLAVHRNLLRLIGYCAT----PTERLLVYP 264 (534)
Q Consensus 201 ~~~~~~~-~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~----------~l~~~~h~niv~l~~~~~~----~~~~~lv~e 264 (534)
.++|... ++||+|+||.||+|+.. +++.||||++.. .+....||||+++++++.. ....++|||
T Consensus 27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e 106 (336)
T 3fhr_A 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIME 106 (336)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEE
T ss_pred cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcHHHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEEEEEe
Confidence 4677774 47999999999999986 689999998852 4567789999999999876 445799999
Q ss_pred ccCCCChhhhcccC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCC---CCcEEEEecccceecCC
Q 039819 265 YMSNGSVASRLREK--PALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDD---FCEAIVGDFGLAKLLDH 339 (534)
Q Consensus 265 ~~~~gsL~~~l~~~--~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~---~~~~kl~DFGla~~~~~ 339 (534)
|+++|+|.+++... ..+++..++.++.|++.||.|||+. +|+||||||+|||++. ++.+||+|||+++....
T Consensus 107 ~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~---~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~~ 183 (336)
T 3fhr_A 107 CMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQ 183 (336)
T ss_dssp CCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC--
T ss_pred ccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEEecCCCceEEEeccccceeccc
Confidence 99999999999764 3699999999999999999999999 9999999999999976 45699999999987643
Q ss_pred CCCceeeccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceeccc
Q 039819 340 SDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDR 419 (534)
Q Consensus 340 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 419 (534)
. ......||+.|+|||++.+..++.++|||||||++|||+||+.||............. ..... .. .
T Consensus 184 ~---~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~---~~~~~-~~------~ 250 (336)
T 3fhr_A 184 N---ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMK---RRIRL-GQ------Y 250 (336)
T ss_dssp -----------------------CHHHHHHHHHHHHHHHHHHHHSSCCC-------------------------------
T ss_pred c---ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHH---Hhhhc-cc------c
Confidence 2 2234568999999999988889999999999999999999999996433211100000 00000 00 0
Q ss_pred ccCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 420 ELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 420 ~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
..........+..+.+++.+|++.+|.+|||+.|+++
T Consensus 251 ~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 287 (336)
T 3fhr_A 251 GFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMN 287 (336)
T ss_dssp CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred ccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 0000011123457899999999999999999999986
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-39 Score=323.94 Aligned_cols=238 Identities=22% Similarity=0.304 Sum_probs=191.0
Q ss_pred HHhCCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEeh----------------------hhhhhcccCceeeEEEEEeCC
Q 039819 200 ATENFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLK----------------------DMISLAVHRNLLRLIGYCATP 256 (534)
Q Consensus 200 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~----------------------~~l~~~~h~niv~l~~~~~~~ 256 (534)
..++|...+.||+|+||.||+|+.. +++.||||.+. +++..++||||+++++++...
T Consensus 8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 87 (322)
T 2ycf_A 8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE 87 (322)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence 3567999999999999999999975 57899999763 257788999999999999766
Q ss_pred CeeEEEeeccCCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCc---EEEEeccc
Q 039819 257 TERLLVYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCE---AIVGDFGL 333 (534)
Q Consensus 257 ~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~---~kl~DFGl 333 (534)
. .++||||+++|+|.+++.....+++..+..++.|++.||.|||+. +|+||||||+|||++.++. +||+|||+
T Consensus 88 ~-~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~ 163 (322)
T 2ycf_A 88 D-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGH 163 (322)
T ss_dssp S-EEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSSSCCEEECCCTT
T ss_pred c-eEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEecCCCCCeEEEccCcc
Confidence 5 899999999999999998888899999999999999999999999 9999999999999987654 99999999
Q ss_pred ceecCCCCCceeeccccccccccccccc---cCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhh
Q 039819 334 AKLLDHSDSHVTTAVRGTVGHIAPEYLS---TGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQE 410 (534)
Q Consensus 334 a~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 410 (534)
++..... .......||+.|+|||++. ...++.++|||||||++|||+||+.||....... .+...+. .
T Consensus 164 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~~~~~~~---~- 234 (322)
T 2ycf_A 164 SKILGET--SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV---SLKDQIT---S- 234 (322)
T ss_dssp CEECCCC--HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSS---CHHHHHH---H-
T ss_pred ceecccc--cccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHH---HHHHHHH---h-
Confidence 9876532 2223456899999999873 5678999999999999999999999997433211 1111111 1
Q ss_pred cccceecccccCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 411 KKVEVLVDRELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 411 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
.... ..+.... ..+..+.+++.+|++.+|.+||++.++++
T Consensus 235 ~~~~--~~~~~~~----~~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 235 GKYN--FIPEVWA----EVSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp TCCC--CCHHHHT----TSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred Cccc--cCchhhh----hcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 1000 0000001 12357899999999999999999999986
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-39 Score=335.62 Aligned_cols=186 Identities=24% Similarity=0.363 Sum_probs=144.9
Q ss_pred hCCCc-CCeeccCCcEEEEEEEEC---CCcEEEEEEeh------------hhhhhcccCceeeEEEEEe--CCCeeEEEe
Q 039819 202 ENFSS-KNILGAGGFGNVYKGKLG---DGTVLAVKRLK------------DMISLAVHRNLLRLIGYCA--TPTERLLVY 263 (534)
Q Consensus 202 ~~~~~-~~~lG~G~~g~Vy~~~~~---~~~~vavK~~~------------~~l~~~~h~niv~l~~~~~--~~~~~~lv~ 263 (534)
+.|.. .++||+|+||.||+|+.. ++..||||++. .++..++|||||++++++. .....++||
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~ 99 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLF 99 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEE
T ss_pred hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEE
Confidence 44554 458999999999999975 57889999875 2678889999999999995 467889999
Q ss_pred eccCCCChhhhccc---------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEe----CCCCcEEEEe
Q 039819 264 PYMSNGSVASRLRE---------KPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLL----DDFCEAIVGD 330 (534)
Q Consensus 264 e~~~~gsL~~~l~~---------~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl----~~~~~~kl~D 330 (534)
||+.+ +|.+++.. ...+++..++.|+.||+.||.|||+. +|+||||||+|||+ +.++.+||+|
T Consensus 100 e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~D 175 (405)
T 3rgf_A 100 DYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIAD 175 (405)
T ss_dssp ECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECCSSTTTTCEEECC
T ss_pred eCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeCCCcCHHHeEEecCCCCCCcEEEEE
Confidence 99974 78777742 12499999999999999999999999 99999999999999 7789999999
Q ss_pred cccceecCCCCC--ceeeccccccccccccccccC-CCCcchhHHHHHHHHHHHHhCCCCcCCC
Q 039819 331 FGLAKLLDHSDS--HVTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELITGMRALEFG 391 (534)
Q Consensus 331 FGla~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~S~Gvvl~elltG~~p~~~~ 391 (534)
||+++....... .......||+.|+|||++.+. .++.++|||||||++|||+||+.||...
T Consensus 176 fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~ 239 (405)
T 3rgf_A 176 MGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 239 (405)
T ss_dssp TTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCC
T ss_pred CCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCc
Confidence 999987653211 223446799999999998774 5899999999999999999999999754
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-39 Score=342.28 Aligned_cols=236 Identities=24% Similarity=0.335 Sum_probs=191.9
Q ss_pred HhCCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEeh---------------------------hhhhhcccCceeeEEEE
Q 039819 201 TENFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLK---------------------------DMISLAVHRNLLRLIGY 252 (534)
Q Consensus 201 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~---------------------------~~l~~~~h~niv~l~~~ 252 (534)
.++|...+.||+|+||.||+|+.. ++..||||++. .++..++||||++++++
T Consensus 35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~ 114 (504)
T 3q5i_A 35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV 114 (504)
T ss_dssp GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 467889999999999999999985 57899999864 15677889999999999
Q ss_pred EeCCCeeEEEeeccCCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCC---cEEEE
Q 039819 253 CATPTERLLVYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFC---EAIVG 329 (534)
Q Consensus 253 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~---~~kl~ 329 (534)
|.+....++|||||++|+|.+.+.....+++..+..|+.|++.||.|||+. +|+||||||+|||++.++ .+||+
T Consensus 115 ~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~ 191 (504)
T 3q5i_A 115 FEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKH---NIVHRDIKPENILLENKNSLLNIKIV 191 (504)
T ss_dssp EECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESSTTCCSSEEEC
T ss_pred EEcCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCcHHHEEEecCCCCccEEEE
Confidence 999999999999999999999998878899999999999999999999999 999999999999998775 69999
Q ss_pred ecccceecCCCCCceeeccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhh
Q 039819 330 DFGLAKLLDHSDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQ 409 (534)
Q Consensus 330 DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 409 (534)
|||+++...... ......||+.|+|||++. +.++.++|||||||++|||++|+.||..... .+....+..
T Consensus 192 Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-------~~~~~~i~~ 261 (504)
T 3q5i_A 192 DFGLSSFFSKDY--KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQND-------QDIIKKVEK 261 (504)
T ss_dssp CCTTCEECCTTS--CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHHHHH
T ss_pred ECCCCEEcCCCC--ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCH-------HHHHHHHHc
Confidence 999998775432 234456999999999986 5689999999999999999999999975332 122222221
Q ss_pred hcccceecccccCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 410 EKKVEVLVDRELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 410 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
.... .+..... ..+..+.+++.+|++.+|.+|||+.|+++
T Consensus 262 ~~~~---~~~~~~~----~~s~~~~~li~~~L~~dp~~R~t~~e~l~ 301 (504)
T 3q5i_A 262 GKYY---FDFNDWK----NISDEAKELIKLMLTYDYNKRCTAEEALN 301 (504)
T ss_dssp CCCC---CCHHHHT----TSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CCCC---CCccccC----CCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 1100 0000001 12357899999999999999999999985
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=321.69 Aligned_cols=235 Identities=24% Similarity=0.348 Sum_probs=186.8
Q ss_pred CCCcCCeeccCCcEEEEEEEE-CCCcEEEEEEeh--------------hhhhhcccCceeeEEEEEeCCCeeEEEeeccC
Q 039819 203 NFSSKNILGAGGFGNVYKGKL-GDGTVLAVKRLK--------------DMISLAVHRNLLRLIGYCATPTERLLVYPYMS 267 (534)
Q Consensus 203 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~--------------~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~~ 267 (534)
+|....+||+|+||.||+|+. .+++.||||.+. .++..++||||+++++++......++||||++
T Consensus 23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 102 (295)
T 2clq_A 23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVP 102 (295)
T ss_dssp TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCC
Confidence 455566899999999999997 468899999864 26778899999999999999999999999999
Q ss_pred CCChhhhcccC---CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCC-CCcEEEEecccceecCCCCCc
Q 039819 268 NGSVASRLREK---PALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDD-FCEAIVGDFGLAKLLDHSDSH 343 (534)
Q Consensus 268 ~gsL~~~l~~~---~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~-~~~~kl~DFGla~~~~~~~~~ 343 (534)
+++|.+++... ..+++..+..++.|++.||.|||+. +|+||||||+||+++. ++.+||+|||+++.......
T Consensus 103 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~- 178 (295)
T 2clq_A 103 GGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP- 178 (295)
T ss_dssp EEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTCCEEECCTTTCEESCC----
T ss_pred CCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhC---CEEccCCChhhEEEECCCCCEEEeecccccccCCCCC-
Confidence 99999999754 3567899999999999999999999 9999999999999987 89999999999987654221
Q ss_pred eeeccccccccccccccccCC--CCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceeccccc
Q 039819 344 VTTAVRGTVGHIAPEYLSTGQ--SSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDREL 421 (534)
Q Consensus 344 ~~~~~~gt~~y~aPE~~~~~~--~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 421 (534)
......||..|+|||++.+.. ++.++|||||||++|||+||+.||...... .......... . ..+.+
T Consensus 179 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-----~~~~~~~~~~-~-----~~~~~ 247 (295)
T 2clq_A 179 CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEP-----QAAMFKVGMF-K-----VHPEI 247 (295)
T ss_dssp --CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSH-----HHHHHHHHHH-C-----CCCCC
T ss_pred cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCch-----hHHHHhhccc-c-----ccccc
Confidence 233456899999999987644 789999999999999999999999632211 0011110000 0 01112
Q ss_pred CCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 422 GSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 422 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
+...+..+.+++.+|++.+|++||++.|+++
T Consensus 248 ----~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 278 (295)
T 2clq_A 248 ----PESMSAEAKAFILKCFEPDPDKRACANDLLV 278 (295)
T ss_dssp ----CTTSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred ----cccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 2223457889999999999999999999985
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-40 Score=331.79 Aligned_cols=245 Identities=25% Similarity=0.377 Sum_probs=186.9
Q ss_pred cCHHHHHHHHhCCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEeh-------------hhhhhc-ccCceeeEEEEEeC-
Q 039819 192 FTFRELQQATENFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLK-------------DMISLA-VHRNLLRLIGYCAT- 255 (534)
Q Consensus 192 ~~~~~l~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~-------------~~l~~~-~h~niv~l~~~~~~- 255 (534)
+++.++....++|...+.||+|+||.||+|+.. +++.||||++. ..+..+ .||||+++++++..
T Consensus 14 ~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 93 (326)
T 2x7f_A 14 IDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKK 93 (326)
T ss_dssp --CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEEC
T ss_pred ccchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcccHHHHHHHHHHHHhccCCCCeeeeeeEEeec
Confidence 344444455688999999999999999999984 78999999874 145555 79999999999976
Q ss_pred -----CCeeEEEeeccCCCChhhhcccC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEE
Q 039819 256 -----PTERLLVYPYMSNGSVASRLREK--PALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIV 328 (534)
Q Consensus 256 -----~~~~~lv~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl 328 (534)
....++||||+++|+|.+++... ..+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||
T Consensus 94 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~kl 170 (326)
T 2x7f_A 94 NPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKL 170 (326)
T ss_dssp C--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEE
T ss_pred cCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCcHHHEEEcCCCCEEE
Confidence 45789999999999999999753 5799999999999999999999999 9999999999999999999999
Q ss_pred EecccceecCCCCCceeeccccccccccccccc-----cCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHH
Q 039819 329 GDFGLAKLLDHSDSHVTTAVRGTVGHIAPEYLS-----TGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEW 403 (534)
Q Consensus 329 ~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~ 403 (534)
+|||++........ ......||..|+|||++. +..++.++|||||||++|||+||+.||...... ..
T Consensus 171 ~Dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-------~~ 242 (326)
T 2x7f_A 171 VDFGVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM-------RA 242 (326)
T ss_dssp CCCTTTC--------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHH-------HH
T ss_pred eeCcCceecCcCcc-ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHH-------HH
Confidence 99999987643221 223456899999999986 566899999999999999999999999643211 11
Q ss_pred HHHHhhhcccceecccccCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 404 VKKIQQEKKVEVLVDRELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 404 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
........ . +... ....+..+.+++.+|++.+|.+||++.++++
T Consensus 243 ~~~~~~~~-~-----~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 286 (326)
T 2x7f_A 243 LFLIPRNP-A-----PRLK---SKKWSKKFQSFIESCLVKNHSQRPATEQLMK 286 (326)
T ss_dssp HHHHHHSC-C-----CCCS---CSCSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred HHHhhcCc-c-----ccCC---ccccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 11111111 0 0110 1112347889999999999999999999986
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-40 Score=325.07 Aligned_cols=240 Identities=31% Similarity=0.419 Sum_probs=186.3
Q ss_pred hCCCcCCeeccCCcEEEEEEEEC--CCc--EEEEEEeh-----------------hhhhhcccCceeeEEEEEeCCCeeE
Q 039819 202 ENFSSKNILGAGGFGNVYKGKLG--DGT--VLAVKRLK-----------------DMISLAVHRNLLRLIGYCATPTERL 260 (534)
Q Consensus 202 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~--~vavK~~~-----------------~~l~~~~h~niv~l~~~~~~~~~~~ 260 (534)
++|...+.||+|+||.||+|++. ++. .||||++. +.+..++||||+++++++.... .+
T Consensus 18 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~ 96 (291)
T 1u46_A 18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MK 96 (291)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-CE
T ss_pred hHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-ce
Confidence 56888899999999999999863 333 68999774 1567788999999999998765 88
Q ss_pred EEeeccCCCChhhhccc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCC
Q 039819 261 LVYPYMSNGSVASRLRE-KPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDH 339 (534)
Q Consensus 261 lv~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~ 339 (534)
+||||+++|+|.+++.. ...+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 97 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 173 (291)
T 1u46_A 97 MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQ 173 (291)
T ss_dssp EEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEECCC
T ss_pred eeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEEcCCCCEEEccccccccccc
Confidence 99999999999999975 35699999999999999999999999 999999999999999999999999999988754
Q ss_pred CCCce--eeccccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCcCCCccccccchHHHHHHHHhhhccccee
Q 039819 340 SDSHV--TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GMRALEFGKSINQKGAMLEWVKKIQQEKKVEVL 416 (534)
Q Consensus 340 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 416 (534)
..... .....+|..|+|||++.+..++.++||||||+++|||++ |+.||..... .+...........
T Consensus 174 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~-------~~~~~~~~~~~~~--- 243 (291)
T 1u46_A 174 NDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG-------SQILHKIDKEGER--- 243 (291)
T ss_dssp -CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCH-------HHHHHHHHTSCCC---
T ss_pred cccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCH-------HHHHHHHHccCCC---
Confidence 33221 223457889999999988889999999999999999999 9999974321 1222222111110
Q ss_pred cccccCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhcC
Q 039819 417 VDRELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLEGD 461 (534)
Q Consensus 417 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~~ 461 (534)
...+...+..+.+++.+|++.+|.+||++.++++.|+..
T Consensus 244 ------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~ 282 (291)
T 1u46_A 244 ------LPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 282 (291)
T ss_dssp ------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ------CCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHh
Confidence 011122345789999999999999999999999998763
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-39 Score=328.76 Aligned_cols=244 Identities=19% Similarity=0.314 Sum_probs=184.2
Q ss_pred hCCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEeh----------------hhhhhcccCceeeEEEEEeCCCe------
Q 039819 202 ENFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLK----------------DMISLAVHRNLLRLIGYCATPTE------ 258 (534)
Q Consensus 202 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~----------------~~l~~~~h~niv~l~~~~~~~~~------ 258 (534)
++|...+.||+|+||.||+|+.. +|+.||||++. .++..++||||+++++++.....
T Consensus 24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 103 (353)
T 3coi_A 24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD 103 (353)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred ceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEeccccccccee
Confidence 56888899999999999999975 68999999874 15677889999999999987654
Q ss_pred eEEEeeccCCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecC
Q 039819 259 RLLVYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLD 338 (534)
Q Consensus 259 ~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~ 338 (534)
.++||||+. |+|.+++.. .+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 104 ~~lv~e~~~-~~l~~~~~~--~~~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 177 (353)
T 3coi_A 104 FYLVMPFMQ-TDLQKIMGL--KFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLARHAD 177 (353)
T ss_dssp CEEEEECCS-EEGGGTTTS--CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTCCEEECSTTCTTC--
T ss_pred EEEEecccc-CCHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEeECCCCcEEEeecccccCCC
Confidence 499999997 588888754 499999999999999999999999 99999999999999999999999999998654
Q ss_pred CCCCceeecccccccccccccccc-CCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHH--------HHHhh
Q 039819 339 HSDSHVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWV--------KKIQQ 409 (534)
Q Consensus 339 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~--------~~~~~ 409 (534)
.. .....||+.|+|||++.+ ..++.++|||||||++|||+||+.||...........+.... .....
T Consensus 178 ~~----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 253 (353)
T 3coi_A 178 AE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLND 253 (353)
T ss_dssp ----------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCSC
T ss_pred CC----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHhh
Confidence 32 234568999999999876 678999999999999999999999997543221111111100 00000
Q ss_pred h------cccceecccccCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 410 E------KKVEVLVDRELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 410 ~------~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
. ........+.+. .........+.+++.+|++.||.+|||+.|+++
T Consensus 254 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 305 (353)
T 3coi_A 254 KAAKSYIQSLPQTPRKDFT-QLFPRASPQAADLLEKMLELDVDKRLTAAQALT 305 (353)
T ss_dssp HHHHHHHHTSCBCSSCCTT-TTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred HHHHHHHHhCcCCCCccHH-HhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 0 000000000000 111223458899999999999999999999985
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-39 Score=319.20 Aligned_cols=237 Identities=25% Similarity=0.324 Sum_probs=193.2
Q ss_pred HhCCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEeh-----------------------hhhhhcc-cCceeeEEEEEeC
Q 039819 201 TENFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLK-----------------------DMISLAV-HRNLLRLIGYCAT 255 (534)
Q Consensus 201 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~-----------------------~~l~~~~-h~niv~l~~~~~~ 255 (534)
.++|...+.||+|+||.||+|+.. +++.||||.+. +++..+. ||||+++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 95 (298)
T 1phk_A 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 95 (298)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred hhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeecc
Confidence 467888999999999999999985 68999999873 1455564 9999999999999
Q ss_pred CCeeEEEeeccCCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccce
Q 039819 256 PTERLLVYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAK 335 (534)
Q Consensus 256 ~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~ 335 (534)
....++||||+++++|.+++.....+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++.
T Consensus 96 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~ 172 (298)
T 1phk_A 96 NTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSC 172 (298)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred CCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEcCCCcEEEecccchh
Confidence 999999999999999999998878899999999999999999999999 99999999999999999999999999998
Q ss_pred ecCCCCCceeeccccccccccccccc------cCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhh
Q 039819 336 LLDHSDSHVTTAVRGTVGHIAPEYLS------TGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQ 409 (534)
Q Consensus 336 ~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 409 (534)
...... ......||..|+|||++. ...++.++||||||+++|||++|+.||..... .........
T Consensus 173 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~-------~~~~~~~~~ 243 (298)
T 1phk_A 173 QLDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ-------MLMLRMIMS 243 (298)
T ss_dssp ECCTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHHHHH
T ss_pred hcCCCc--ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccH-------HHHHHHHhc
Confidence 765432 233456899999999884 45678999999999999999999999964321 111111111
Q ss_pred hcccceecccccCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 410 EKKVEVLVDRELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 410 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
... . .........+..+.+++.+|++.+|.+||++.|+++
T Consensus 244 ~~~-~------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 244 GNY-Q------FGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp TCC-C------CCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred CCc-c------cCcccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 110 0 000011123457899999999999999999999975
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-39 Score=325.63 Aligned_cols=242 Identities=21% Similarity=0.333 Sum_probs=193.9
Q ss_pred HhCCCcCCeeccCCcEEEEEEEECCCcEEEEEEeh-------------------------------hhhhhcccCceeeE
Q 039819 201 TENFSSKNILGAGGFGNVYKGKLGDGTVLAVKRLK-------------------------------DMISLAVHRNLLRL 249 (534)
Q Consensus 201 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~-------------------------------~~l~~~~h~niv~l 249 (534)
.++|...+.||+|+||.||+|+. +++.||||++. .++..++||||+++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 36788899999999999999999 99999999863 14667789999999
Q ss_pred EEEEeCCCeeEEEeeccCCCChhhh------ccc--CCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEeccCCCCcEEe
Q 039819 250 IGYCATPTERLLVYPYMSNGSVASR------LRE--KPALDWNTRKRIAIGAARGLLYLHE-QCDPKIIHRDVKAANVLL 320 (534)
Q Consensus 250 ~~~~~~~~~~~lv~e~~~~gsL~~~------l~~--~~~l~~~~~~~i~~~i~~~l~yLH~-~~~~~ivH~Dlkp~NiLl 320 (534)
++++.+.+..++||||+++|+|.++ +.. ...+++..++.++.|++.||.|||+ . +|+||||||+||++
T Consensus 109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---~i~H~dl~p~Nil~ 185 (348)
T 2pml_X 109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEK---NICHRDVKPSNILM 185 (348)
T ss_dssp SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTS---CEECCCCCGGGEEE
T ss_pred EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccC---CEeecCCChHhEEE
Confidence 9999999999999999999999998 665 5679999999999999999999998 7 99999999999999
Q ss_pred CCCCcEEEEecccceecCCCCCceeeccccccccccccccccC-CCCc-chhHHHHHHHHHHHHhCCCCcCCCccccccc
Q 039819 321 DDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGHIAPEYLSTG-QSSE-KTDVFGFGILLLELITGMRALEFGKSINQKG 398 (534)
Q Consensus 321 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~ 398 (534)
+.++.+||+|||++...... ......||..|+|||++.+. .++. ++|||||||++|||+||+.||......
T Consensus 186 ~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---- 258 (348)
T 2pml_X 186 DKNGRVKLSDFGESEYMVDK---KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISL---- 258 (348)
T ss_dssp CTTSCEEECCCTTCEECBTT---EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCS----
T ss_pred cCCCcEEEeccccccccccc---cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcH----
Confidence 99999999999999876443 34456799999999999877 5666 999999999999999999999754321
Q ss_pred hHHHHHHHHhhhccccee------cccccC---CCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 399 AMLEWVKKIQQEKKVEVL------VDRELG---SNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 399 ~~~~~~~~~~~~~~~~~~------~d~~l~---~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
.+....+.... .... ..+... .......+..+.+++.+|++.+|.+||++.|+++
T Consensus 259 --~~~~~~i~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~ 322 (348)
T 2pml_X 259 --VELFNNIRTKN-IEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK 322 (348)
T ss_dssp --HHHHHHHTSCC-CCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred --HHHHHHHhccC-cCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 11222221111 0000 000000 0001223458899999999999999999999986
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-39 Score=323.89 Aligned_cols=229 Identities=24% Similarity=0.364 Sum_probs=183.3
Q ss_pred HHHHhCCCcCCeeccCCcEEEEEEEE-CCCcEEEEEEehh--------------------hhhhc----ccCceeeEEEE
Q 039819 198 QQATENFSSKNILGAGGFGNVYKGKL-GDGTVLAVKRLKD--------------------MISLA----VHRNLLRLIGY 252 (534)
Q Consensus 198 ~~~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~--------------------~l~~~----~h~niv~l~~~ 252 (534)
....++|...+.||+|+||.||+|+. .+++.||||++.. .+..+ +|+||++++++
T Consensus 27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~ 106 (312)
T 2iwi_A 27 EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDW 106 (312)
T ss_dssp ------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEE
T ss_pred hhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEE
Confidence 34467899999999999999999987 4688999998731 34444 79999999999
Q ss_pred EeCCCeeEEEeec-cCCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeC-CCCcEEEEe
Q 039819 253 CATPTERLLVYPY-MSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLD-DFCEAIVGD 330 (534)
Q Consensus 253 ~~~~~~~~lv~e~-~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~-~~~~~kl~D 330 (534)
+...+..++|||| +.+++|.+++.....+++..++.++.|++.||.|||+. +|+||||||+||+++ .++.+||+|
T Consensus 107 ~~~~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~kl~d 183 (312)
T 2iwi_A 107 FETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSR---GVVHRDIKDENILIDLRRGCAKLID 183 (312)
T ss_dssp C-----CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHH---TEECCCCSGGGEEEETTTTEEEECC
T ss_pred EecCCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChhhEEEeCCCCeEEEEE
Confidence 9999999999999 78999999998877899999999999999999999999 999999999999999 889999999
Q ss_pred cccceecCCCCCceeeccccccccccccccccCCC-CcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhh
Q 039819 331 FGLAKLLDHSDSHVTTAVRGTVGHIAPEYLSTGQS-SEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQ 409 (534)
Q Consensus 331 FGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 409 (534)
||+++...... .....||..|+|||++.+..+ +.++|||||||++|||++|+.||.... +.. .
T Consensus 184 fg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~---------~~~----~ 247 (312)
T 2iwi_A 184 FGSGALLHDEP---YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ---------EIL----E 247 (312)
T ss_dssp CSSCEECCSSC---BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH---------HHH----H
T ss_pred cchhhhcccCc---ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH---------HHh----h
Confidence 99998775432 334568999999999877666 458999999999999999999996321 000 0
Q ss_pred hcccceecccccCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 410 EKKVEVLVDRELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 410 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
.. .. .+......+.+++.+|++.+|++||++.|+++
T Consensus 248 -~~------~~----~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~ 283 (312)
T 2iwi_A 248 -AE------LH----FPAHVSPDCCALIRRCLAPKPSSRPSLEEILL 283 (312)
T ss_dssp -TC------CC----CCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred -hc------cC----CcccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00 01 11122347889999999999999999999986
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=326.08 Aligned_cols=236 Identities=22% Similarity=0.313 Sum_probs=184.8
Q ss_pred HhCCCcCCeeccCCcEEEEEEEECCCcEEEEEEeh----------------hhhhhcc--cCceeeEEEEEeCCCeeEEE
Q 039819 201 TENFSSKNILGAGGFGNVYKGKLGDGTVLAVKRLK----------------DMISLAV--HRNLLRLIGYCATPTERLLV 262 (534)
Q Consensus 201 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~----------------~~l~~~~--h~niv~l~~~~~~~~~~~lv 262 (534)
.++|...+.||+|+||.||+|+..+++.||||.+. +.+..+. |+||+++++++......++|
T Consensus 27 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 106 (313)
T 3cek_A 27 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 106 (313)
T ss_dssp TEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEEE
T ss_pred cceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEEE
Confidence 46788889999999999999999889999999874 1455665 59999999999999999999
Q ss_pred eeccCCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCC
Q 039819 263 YPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDS 342 (534)
Q Consensus 263 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~ 342 (534)
|| +.+++|.+++.....+++..++.++.|++.||.|||+. +|+||||||+|||+++ +.+||+|||+++.......
T Consensus 107 ~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~~~~~ 181 (313)
T 3cek_A 107 ME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTT 181 (313)
T ss_dssp EC-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEET-TEEEECCCSSSCC------
T ss_pred Ee-cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEEEC-CeEEEeeccccccccCccc
Confidence 99 56889999998888899999999999999999999999 9999999999999975 8999999999987643322
Q ss_pred -ceeecccccccccccccccc-----------CCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhh
Q 039819 343 -HVTTAVRGTVGHIAPEYLST-----------GQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQE 410 (534)
Q Consensus 343 -~~~~~~~gt~~y~aPE~~~~-----------~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 410 (534)
.......||+.|+|||++.+ ..++.++|||||||++|||+||+.||..... .........
T Consensus 182 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~------~~~~~~~~~-- 253 (313)
T 3cek_A 182 SVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN------QISKLHAII-- 253 (313)
T ss_dssp --------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCS------HHHHHHHHH--
T ss_pred cccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHH------HHHHHHHHH--
Confidence 12234568999999999865 4688899999999999999999999964321 111111111
Q ss_pred cccceecccccCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 411 KKVEVLVDRELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 411 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
++.....++......+.+++.+|++.+|.+||++.|+++
T Consensus 254 -------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 292 (313)
T 3cek_A 254 -------DPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA 292 (313)
T ss_dssp -------CTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred -------hcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhc
Confidence 111111111122457889999999999999999999985
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=327.97 Aligned_cols=248 Identities=21% Similarity=0.276 Sum_probs=186.3
Q ss_pred hCCCcCCeeccCCcEEEEEEEE-CCCcEEEEEEehh-------------hhhhcc-----------cCceeeEEEEEeCC
Q 039819 202 ENFSSKNILGAGGFGNVYKGKL-GDGTVLAVKRLKD-------------MISLAV-----------HRNLLRLIGYCATP 256 (534)
Q Consensus 202 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~-------------~l~~~~-----------h~niv~l~~~~~~~ 256 (534)
++|...+.||+|+||.||+|+. .+++.||||++.. ++..+. |+||+++++++...
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~~ 98 (373)
T 1q8y_A 19 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK 98 (373)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred CeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhcc
Confidence 5788889999999999999997 4789999998851 333333 89999999999764
Q ss_pred C----eeEEEeeccCCCChhhhccc--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeC------CCC
Q 039819 257 T----ERLLVYPYMSNGSVASRLRE--KPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLD------DFC 324 (534)
Q Consensus 257 ~----~~~lv~e~~~~gsL~~~l~~--~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~------~~~ 324 (534)
. ..++||||+ +++|.+++.. ...+++..+..|+.||+.||.|||+++ +|+||||||+|||++ ..+
T Consensus 99 ~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~--~ivH~Dikp~NIll~~~~~~~~~~ 175 (373)
T 1q8y_A 99 GPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLI 175 (373)
T ss_dssp ETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECSCCSGGGEEEEEEETTTTEE
T ss_pred CCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChHHeEEeccCCCcCcc
Confidence 4 679999999 8899999875 345999999999999999999999853 799999999999994 455
Q ss_pred cEEEEecccceecCCCCCceeeccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccc---hHH
Q 039819 325 EAIVGDFGLAKLLDHSDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKG---AML 401 (534)
Q Consensus 325 ~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~---~~~ 401 (534)
.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||+||+.||.......... .+.
T Consensus 176 ~~kl~Dfg~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~ 251 (373)
T 1q8y_A 176 QIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIA 251 (373)
T ss_dssp EEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHH
T ss_pred eEEEcccccccccCCC----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHHH
Confidence 8999999999876532 233468999999999999899999999999999999999999997543211111 111
Q ss_pred HHHHHHhhh------------------cccceeccc---------ccCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHH
Q 039819 402 EWVKKIQQE------------------KKVEVLVDR---------ELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEV 454 (534)
Q Consensus 402 ~~~~~~~~~------------------~~~~~~~d~---------~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev 454 (534)
......... .....+... .-...++......+.+++.+|++.||.+|||++|+
T Consensus 252 ~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~el 331 (373)
T 1q8y_A 252 QIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGL 331 (373)
T ss_dssp HHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHH
T ss_pred HHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHHHH
Confidence 111110000 000000000 00112445667889999999999999999999999
Q ss_pred HH
Q 039819 455 VR 456 (534)
Q Consensus 455 ~~ 456 (534)
++
T Consensus 332 l~ 333 (373)
T 1q8y_A 332 VN 333 (373)
T ss_dssp HT
T ss_pred hh
Confidence 85
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-39 Score=326.43 Aligned_cols=238 Identities=25% Similarity=0.333 Sum_probs=169.6
Q ss_pred hCCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEehh----------------hhhhcccCceeeEEEEEeCCCeeEEEee
Q 039819 202 ENFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLKD----------------MISLAVHRNLLRLIGYCATPTERLLVYP 264 (534)
Q Consensus 202 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~----------------~l~~~~h~niv~l~~~~~~~~~~~lv~e 264 (534)
++|...+.||+|+||.||+|... +++.||||++.. ++..+.||||+++++++...+..++|||
T Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e 101 (327)
T 3aln_A 22 EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICME 101 (327)
T ss_dssp CSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred HHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEe
Confidence 57888899999999999999985 689999998852 4566789999999999999999999999
Q ss_pred ccCCCChhhhccc-----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCC
Q 039819 265 YMSNGSVASRLRE-----KPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDH 339 (534)
Q Consensus 265 ~~~~gsL~~~l~~-----~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~ 339 (534)
|+++ +|.+++.. ...+++..+..++.|++.||.|||+.. +|+||||||+|||++.++.+||+|||+++....
T Consensus 102 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 178 (327)
T 3aln_A 102 LMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENL--KIIHRDIKPSNILLDRSGNIKLCDFGISGQLVD 178 (327)
T ss_dssp CCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHH--SCCCSCCCGGGEEEETTTEEEECCCSSSCC---
T ss_pred ecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccC--CEeECCCCHHHEEEcCCCCEEEccCCCceeccc
Confidence 9985 77777652 567999999999999999999999853 799999999999999999999999999987643
Q ss_pred CCCceeecccccccccccccc----ccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccce
Q 039819 340 SDSHVTTAVRGTVGHIAPEYL----STGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEV 415 (534)
Q Consensus 340 ~~~~~~~~~~gt~~y~aPE~~----~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 415 (534)
.. ......||..|+|||++ .+..++.++|||||||++|||+||+.||....... +... ....
T Consensus 179 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~------~~~~------~~~~ 244 (327)
T 3aln_A 179 SI--AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVF------DQLT------QVVK 244 (327)
T ss_dssp -----------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------------C------CCCC
T ss_pred cc--ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHH------HHHH------HHhc
Confidence 32 22334689999999998 45678999999999999999999999997422110 0000 0000
Q ss_pred ecccccCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 416 LVDRELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 416 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
...+.+...........+.+++.+|++.+|.+||++.++++
T Consensus 245 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 245 GDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK 285 (327)
T ss_dssp SCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence 00111111111123457899999999999999999999975
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=356.53 Aligned_cols=240 Identities=23% Similarity=0.372 Sum_probs=191.5
Q ss_pred HhCCCcCCeeccCCcEEEEEEEECC----CcEEEEEEehh---------------hhhhcccCceeeEEEEEeCCCeeEE
Q 039819 201 TENFSSKNILGAGGFGNVYKGKLGD----GTVLAVKRLKD---------------MISLAVHRNLLRLIGYCATPTERLL 261 (534)
Q Consensus 201 ~~~~~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~---------------~l~~~~h~niv~l~~~~~~~~~~~l 261 (534)
.++|...+.||+|+||.||+|.+.. +..||||++.. ++..++||||+++++++. .+..++
T Consensus 389 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~l 467 (656)
T 2j0j_A 389 RERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 467 (656)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEE
T ss_pred cccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCceEE
Confidence 4678888999999999999998742 46799998752 567789999999999985 456899
Q ss_pred EeeccCCCChhhhcccC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCC
Q 039819 262 VYPYMSNGSVASRLREK-PALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHS 340 (534)
Q Consensus 262 v~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~ 340 (534)
||||+++|+|.+++... ..+++..++.++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 468 v~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDikp~NILl~~~~~vkL~DFG~a~~~~~~ 544 (656)
T 2j0j_A 468 IMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS 544 (656)
T ss_dssp EEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCCCCSCCC-
T ss_pred EEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchHhEEEeCCCCEEEEecCCCeecCCC
Confidence 99999999999999754 4699999999999999999999999 9999999999999999999999999999877544
Q ss_pred CCceeeccccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCcCCCccccccchHHHHHHHHhhhcccceeccc
Q 039819 341 DSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDR 419 (534)
Q Consensus 341 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 419 (534)
.........+|+.|+|||++.+..++.++|||||||++|||++ |+.||...... +....+......
T Consensus 545 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~-------~~~~~i~~~~~~------ 611 (656)
T 2j0j_A 545 TYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN-------DVIGRIENGERL------ 611 (656)
T ss_dssp ---------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-------HHHHHHHHTCCC------
T ss_pred cceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHH-------HHHHHHHcCCCC------
Confidence 3333334457889999999988899999999999999999997 99999743221 112222111110
Q ss_pred ccCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhcC
Q 039819 420 ELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLEGD 461 (534)
Q Consensus 420 ~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~~ 461 (534)
..+...+..+.+++.+||+.+|.+||++.++++.|+..
T Consensus 612 ----~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~i 649 (656)
T 2j0j_A 612 ----PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 649 (656)
T ss_dssp ----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ----CCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 11122345889999999999999999999999998763
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=316.43 Aligned_cols=238 Identities=25% Similarity=0.410 Sum_probs=183.3
Q ss_pred HHhCCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEehh-------------hhhhcccCceeeEEEEEeC----------
Q 039819 200 ATENFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLKD-------------MISLAVHRNLLRLIGYCAT---------- 255 (534)
Q Consensus 200 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~-------------~l~~~~h~niv~l~~~~~~---------- 255 (534)
..++|...+.||+|+||.||+|+.. +++.||||++.. ++..++||||+++++++.+
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (303)
T 1zy4_A 4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTA 83 (303)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC----
T ss_pred ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcc
Confidence 4567899999999999999999974 789999998752 5778899999999998865
Q ss_pred ---CCeeEEEeeccCCCChhhhcccC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEec
Q 039819 256 ---PTERLLVYPYMSNGSVASRLREK-PALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDF 331 (534)
Q Consensus 256 ---~~~~~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DF 331 (534)
....++||||+++|+|.+++... ..+++..++.++.|++.||.|||+. +|+||||||+|||++.++.+||+||
T Consensus 84 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dlkp~Nil~~~~~~~kl~df 160 (303)
T 1zy4_A 84 VKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRNVKIGDF 160 (303)
T ss_dssp --CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCC
T ss_pred cccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhC---CeecccCCHHhEEEcCCCCEEEeeC
Confidence 34678999999999999999743 4688999999999999999999999 9999999999999999999999999
Q ss_pred ccceecCCCC-------------CceeeccccccccccccccccC-CCCcchhHHHHHHHHHHHHhCCCCcCCCcccccc
Q 039819 332 GLAKLLDHSD-------------SHVTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELITGMRALEFGKSINQK 397 (534)
Q Consensus 332 Gla~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~ 397 (534)
|+++...... ........||..|+|||++.+. .++.++|||||||++|||++ ||....
T Consensus 161 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~----- 232 (303)
T 1zy4_A 161 GLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGM----- 232 (303)
T ss_dssp CCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHH-----
T ss_pred cchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCch-----
Confidence 9998764321 1122345689999999998754 68999999999999999998 443211
Q ss_pred chHHHHHHHHhhhcccceecccccCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 398 GAMLEWVKKIQQEKKVEVLVDRELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 398 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
............ ............+..+.+++.+|++.||.+|||+.++++
T Consensus 233 -~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 283 (303)
T 1zy4_A 233 -ERVNILKKLRSV-------SIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN 283 (303)
T ss_dssp -HHHHHHHHHHST-------TCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -hHHHHHHhcccc-------ccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence 111222221111 111122233334457889999999999999999999986
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=321.01 Aligned_cols=227 Identities=23% Similarity=0.398 Sum_probs=189.6
Q ss_pred HHhCCCcCCeeccCCcEEEEEEEE-CCCcEEEEEEehh--------------------hhhhcc--cCceeeEEEEEeCC
Q 039819 200 ATENFSSKNILGAGGFGNVYKGKL-GDGTVLAVKRLKD--------------------MISLAV--HRNLLRLIGYCATP 256 (534)
Q Consensus 200 ~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~--------------------~l~~~~--h~niv~l~~~~~~~ 256 (534)
..++|...+.||+|+||.||+|+. .+++.||||++.. ++..+. |+||+++++++...
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~ 120 (320)
T 3a99_A 41 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP 120 (320)
T ss_dssp CTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS
T ss_pred ccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecC
Confidence 346788899999999999999986 4689999998742 445554 69999999999999
Q ss_pred CeeEEEeeccCC-CChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeC-CCCcEEEEecccc
Q 039819 257 TERLLVYPYMSN-GSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLD-DFCEAIVGDFGLA 334 (534)
Q Consensus 257 ~~~~lv~e~~~~-gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~-~~~~~kl~DFGla 334 (534)
+..++||||+.+ ++|.+++.....+++..++.++.|++.||.|||+. +|+||||||+|||++ .++.+||+|||++
T Consensus 121 ~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~kL~Dfg~~ 197 (320)
T 3a99_A 121 DSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSG 197 (320)
T ss_dssp SEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCCTTC
T ss_pred CcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CcEeCCCCHHHEEEeCCCCCEEEeeCccc
Confidence 999999999986 89999998888899999999999999999999999 999999999999999 7899999999999
Q ss_pred eecCCCCCceeeccccccccccccccccCCC-CcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhccc
Q 039819 335 KLLDHSDSHVTTAVRGTVGHIAPEYLSTGQS-SEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKV 413 (534)
Q Consensus 335 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 413 (534)
+..... ......||+.|+|||++.+..+ +.++|||||||++|||+||+.||..... . .. ...
T Consensus 198 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~---------~----~~-~~~ 260 (320)
T 3a99_A 198 ALLKDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE---------I----IR-GQV 260 (320)
T ss_dssp EECCSS---CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH---------H----HH-CCC
T ss_pred cccccc---cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh---------h----hc-ccc
Confidence 877543 2334569999999999877665 6889999999999999999999963210 0 00 000
Q ss_pred ceecccccCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 414 EVLVDRELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 414 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
..... .+..+.+++.+|++.+|.+||++.|+++
T Consensus 261 ------~~~~~----~~~~~~~li~~~l~~dp~~Rps~~~ll~ 293 (320)
T 3a99_A 261 ------FFRQR----VSSECQHLIRWCLALRPSDRPTFEEIQN 293 (320)
T ss_dssp ------CCSSC----CCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ------ccccc----CCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 01111 2347889999999999999999999986
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-38 Score=311.95 Aligned_cols=237 Identities=23% Similarity=0.366 Sum_probs=192.4
Q ss_pred HHhCCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEeh----------------hhhhhcccCceeeEEEEEeCCCeeEEE
Q 039819 200 ATENFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLK----------------DMISLAVHRNLLRLIGYCATPTERLLV 262 (534)
Q Consensus 200 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~----------------~~l~~~~h~niv~l~~~~~~~~~~~lv 262 (534)
..++|...+.||+|+||.||+|+.. +++.||||++. +.+..++||||+++++++......++|
T Consensus 20 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 99 (287)
T 2wei_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV 99 (287)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred HhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEE
Confidence 4578999999999999999999986 68999999874 256788999999999999999999999
Q ss_pred eeccCCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCC---CcEEEEecccceecCC
Q 039819 263 YPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDF---CEAIVGDFGLAKLLDH 339 (534)
Q Consensus 263 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~---~~~kl~DFGla~~~~~ 339 (534)
|||+++++|.+.+.....+++..++.++.|++.||.|||+. +|+||||||+||+++.+ +.+||+|||++.....
T Consensus 100 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~ 176 (287)
T 2wei_A 100 GELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ 176 (287)
T ss_dssp ECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCC
T ss_pred EEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChhhEEEecCCCcccEEEeccCcceeecC
Confidence 99999999999998777899999999999999999999999 99999999999999754 4799999999987643
Q ss_pred CCCceeeccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceeccc
Q 039819 340 SDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDR 419 (534)
Q Consensus 340 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 419 (534)
... .....||..|+|||.+.+ .++.++||||||+++|||++|+.||..... .+....+...... .+.
T Consensus 177 ~~~--~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~-------~~~~~~~~~~~~~---~~~ 243 (287)
T 2wei_A 177 NTK--MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNE-------YDILKRVETGKYA---FDL 243 (287)
T ss_dssp CSS--CSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHHHHHCCCC---CCS
T ss_pred CCc--cccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCH-------HHHHHHHHcCCCC---CCc
Confidence 321 233458999999998865 589999999999999999999999974321 1122222211100 000
Q ss_pred ccCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 420 ELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 420 ~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
.... ..+..+.+++.+|++.+|.+|||+.|+++
T Consensus 244 ~~~~----~~~~~~~~li~~~l~~dp~~Rps~~ell~ 276 (287)
T 2wei_A 244 PQWR----TISDDAKDLIRKMLTFHPSLRITATQCLE 276 (287)
T ss_dssp GGGT----TSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hhhh----hcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence 0001 12347899999999999999999999986
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=319.70 Aligned_cols=247 Identities=21% Similarity=0.297 Sum_probs=180.2
Q ss_pred hCCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEeh--------------hhhhhcccCceeeEEEEEe------------
Q 039819 202 ENFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLK--------------DMISLAVHRNLLRLIGYCA------------ 254 (534)
Q Consensus 202 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~--------------~~l~~~~h~niv~l~~~~~------------ 254 (534)
++|...+.||+|+||.||+|... +++.||||++. +++..++||||+++++++.
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 90 (320)
T 2i6l_A 11 SRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGS 90 (320)
T ss_dssp TTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----
T ss_pred CceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccccccc
Confidence 57888899999999999999986 48999999874 2677889999999999874
Q ss_pred --CCCeeEEEeeccCCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeC-CCCcEEEEec
Q 039819 255 --TPTERLLVYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLD-DFCEAIVGDF 331 (534)
Q Consensus 255 --~~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~-~~~~~kl~DF 331 (534)
+....++||||++ |+|.+++.. ..+++..++.++.|++.||+|||+. +|+||||||+|||++ +++.+||+||
T Consensus 91 ~~~~~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~kl~Df 165 (320)
T 2i6l_A 91 LTELNSVYIVQEYME-TDLANVLEQ-GPLLEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANLFINTEDLVLKIGDF 165 (320)
T ss_dssp CCSCSEEEEEEECCS-EEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTTEEEECCC
T ss_pred ccccCceeEEeeccC-CCHHHHhhc-CCccHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCeEEEccC
Confidence 3467799999998 699998865 4689999999999999999999999 999999999999997 5679999999
Q ss_pred ccceecCCCCC--ceeecccccccccccccccc-CCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHh
Q 039819 332 GLAKLLDHSDS--HVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQ 408 (534)
Q Consensus 332 Gla~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~ 408 (534)
|+++....... .......+|..|+|||.+.+ ..++.++|||||||++|||+||+.||.......... .......
T Consensus 166 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~---~~~~~~~ 242 (320)
T 2i6l_A 166 GLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQ---LILESIP 242 (320)
T ss_dssp TTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH---HHHHHSC
T ss_pred ccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHH---HHHHhcC
Confidence 99987643211 12233457899999998865 678999999999999999999999997544221111 1111000
Q ss_pred h---------hcccceecccccCC-CC-----CHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 409 Q---------EKKVEVLVDRELGS-NY-----DRIEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 409 ~---------~~~~~~~~d~~l~~-~~-----~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
. .......+...... .. ....+..+.+++.+|++.||.+|||+.|+++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (320)
T 2i6l_A 243 VVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS 305 (320)
T ss_dssp CCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred CCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence 0 00000000000000 00 0112457899999999999999999999985
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-38 Score=316.02 Aligned_cols=236 Identities=24% Similarity=0.365 Sum_probs=171.9
Q ss_pred HhCCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEehh----------------hhhhcccCceeeEEEEEeCCCeeEEEe
Q 039819 201 TENFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLKD----------------MISLAVHRNLLRLIGYCATPTERLLVY 263 (534)
Q Consensus 201 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~----------------~l~~~~h~niv~l~~~~~~~~~~~lv~ 263 (534)
.++|...+.||+|+||.||+|+.. +++.||||++.. ++....||||+++++++.+.+..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~ 103 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM 103 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence 357888899999999999999985 689999998852 456678999999999999999999999
Q ss_pred eccCCCChhhhcc-cCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCC
Q 039819 264 PYMSNGSVASRLR-EKPALDWNTRKRIAIGAARGLLYLHE-QCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSD 341 (534)
Q Consensus 264 e~~~~gsL~~~l~-~~~~l~~~~~~~i~~~i~~~l~yLH~-~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~ 341 (534)
||+ ++.+..+.. ....+++..+..++.|++.||.|||+ . +|+||||||+|||++.++.+||+|||++.......
T Consensus 104 e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~ 179 (318)
T 2dyl_A 104 ELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKH---GVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDK 179 (318)
T ss_dssp CCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHH---CCCCCCCCGGGEEECTTSCEEECCCTTC-------
T ss_pred ecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhC---CEEeCCCCHHHEEECCCCCEEEEECCCchhccCCc
Confidence 999 445544443 25679999999999999999999998 5 89999999999999999999999999998664332
Q ss_pred Cceeeccccccccccccccc-----cCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhccccee
Q 039819 342 SHVTTAVRGTVGHIAPEYLS-----TGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVL 416 (534)
Q Consensus 342 ~~~~~~~~gt~~y~aPE~~~-----~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 416 (534)
......||+.|+|||++. ...++.++|||||||++|||+||+.||..... ..+..........
T Consensus 180 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~------~~~~~~~~~~~~~---- 247 (318)
T 2dyl_A 180 --AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKT------DFEVLTKVLQEEP---- 247 (318)
T ss_dssp ---------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCS------HHHHHHHHHHSCC----
T ss_pred --cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCc------cHHHHHHHhccCC----
Confidence 223456899999999984 45688999999999999999999999974221 1111122211111
Q ss_pred cccccCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 417 VDRELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 417 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
+.+.. ....+..+.+++.+|++.+|.+||++.++++
T Consensus 248 --~~~~~--~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (318)
T 2dyl_A 248 --PLLPG--HMGFSGDFQSFVKDCLTKDHRKRPKYNKLLE 283 (318)
T ss_dssp --CCCCS--SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred --CCCCc--cCCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 01110 0112347889999999999999999999975
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-38 Score=321.32 Aligned_cols=247 Identities=18% Similarity=0.266 Sum_probs=187.7
Q ss_pred hCCCcCCeeccCCcEEEEEEEEC-CC-cEEEEEEehh-------------hhhhcccCc------eeeEEEEEeCCCeeE
Q 039819 202 ENFSSKNILGAGGFGNVYKGKLG-DG-TVLAVKRLKD-------------MISLAVHRN------LLRLIGYCATPTERL 260 (534)
Q Consensus 202 ~~~~~~~~lG~G~~g~Vy~~~~~-~~-~~vavK~~~~-------------~l~~~~h~n------iv~l~~~~~~~~~~~ 260 (534)
++|...+.||+|+||.||+|... ++ ..||||++.. ++..+.|++ ++.+.+++......+
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 98 (355)
T 2eu9_A 19 ERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHMC 98 (355)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTEEE
T ss_pred ccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCeEE
Confidence 67888999999999999999974 34 7899999852 456666665 999999999999999
Q ss_pred EEeeccCCCChhhhcccC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEe------------------
Q 039819 261 LVYPYMSNGSVASRLREK--PALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLL------------------ 320 (534)
Q Consensus 261 lv~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl------------------ 320 (534)
+||||+ +++|.+.+... ..+++..++.|+.|++.||.|||+. +|+||||||+|||+
T Consensus 99 lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~~ 174 (355)
T 2eu9_A 99 IAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHEN---QLTHTDLKPENILFVNSEFETLYNEHKSCEEK 174 (355)
T ss_dssp EEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEESCCCEEEEECCC-CCCEE
T ss_pred EEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeccccccccccccccccc
Confidence 999999 66777777543 4699999999999999999999998 99999999999999
Q ss_pred -CCCCcEEEEecccceecCCCCCceeeccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccch
Q 039819 321 -DDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGA 399 (534)
Q Consensus 321 -~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~ 399 (534)
+.++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||+||+.||...........
T Consensus 175 ~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~ 250 (355)
T 2eu9_A 175 SVKNTSIRVADFGSATFDHEH----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVM 250 (355)
T ss_dssp EESCCCEEECCCTTCEETTSC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH
T ss_pred ccCCCcEEEeecCcccccccc----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 56889999999999875432 2345699999999999998999999999999999999999999975432211111
Q ss_pred HHHHHHHHh-----hhcccceecccc---------------------cCCCCCHHHHHHHHHHHHHhcccCCCCCCChHH
Q 039819 400 MLEWVKKIQ-----QEKKVEVLVDRE---------------------LGSNYDRIEVGEILQVALLCTQYLPVHRPKMSE 453 (534)
Q Consensus 400 ~~~~~~~~~-----~~~~~~~~~d~~---------------------l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~e 453 (534)
+........ ............ ............+.+++.+|++.||.+|||+.|
T Consensus 251 ~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e 330 (355)
T 2eu9_A 251 MEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAE 330 (355)
T ss_dssp HHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred HHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcCHHH
Confidence 111000000 000000000000 000112234568899999999999999999999
Q ss_pred HHH
Q 039819 454 VVR 456 (534)
Q Consensus 454 v~~ 456 (534)
+++
T Consensus 331 ~l~ 333 (355)
T 2eu9_A 331 ALL 333 (355)
T ss_dssp HTT
T ss_pred Hhc
Confidence 974
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=332.54 Aligned_cols=236 Identities=25% Similarity=0.305 Sum_probs=176.8
Q ss_pred CCcCCeeccCCcEEEEEEEECCCcEEEEEEehh-----------hhhhc-ccCceeeEEEEEeCCCeeEEEeeccCCCCh
Q 039819 204 FSSKNILGAGGFGNVYKGKLGDGTVLAVKRLKD-----------MISLA-VHRNLLRLIGYCATPTERLLVYPYMSNGSV 271 (534)
Q Consensus 204 ~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~-----------~l~~~-~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 271 (534)
|...+.||+|+||+||.+...+|+.||||++.. ++..+ +|||||++++++.+....++||||+. |+|
T Consensus 17 ~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~-gsL 95 (434)
T 2rio_A 17 VVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN-LNL 95 (434)
T ss_dssp EEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGGGHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS-EEH
T ss_pred eeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHHHHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC-CCH
Confidence 344678999999999877777899999998742 44444 79999999999999999999999996 699
Q ss_pred hhhcccCCCC-------CHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCC-------------CcEEEEec
Q 039819 272 ASRLREKPAL-------DWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDF-------------CEAIVGDF 331 (534)
Q Consensus 272 ~~~l~~~~~l-------~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~-------------~~~kl~DF 331 (534)
.+++...... ++..++.|+.||+.||.|||+. +|+||||||+|||++.+ +.+||+||
T Consensus 96 ~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~DF 172 (434)
T 2rio_A 96 QDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDF 172 (434)
T ss_dssp HHHHHTC------------CCHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEECCC
T ss_pred HHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCcccccccccCCCceEEEEccc
Confidence 9999754332 2334578999999999999999 99999999999999654 58999999
Q ss_pred ccceecCCCCCc---eeecccccccccccccccc-------CCCCcchhHHHHHHHHHHHHh-CCCCcCCCccccccchH
Q 039819 332 GLAKLLDHSDSH---VTTAVRGTVGHIAPEYLST-------GQSSEKTDVFGFGILLLELIT-GMRALEFGKSINQKGAM 400 (534)
Q Consensus 332 Gla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~-------~~~~~k~Dv~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~ 400 (534)
|+++........ ......||+.|+|||++.+ ..++.++|||||||++|||+| |+.||...... .
T Consensus 173 G~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~-----~ 247 (434)
T 2rio_A 173 GLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSR-----E 247 (434)
T ss_dssp TTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTH-----H
T ss_pred ccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhh-----H
Confidence 999987543221 1234579999999999865 568999999999999999999 99999643211 0
Q ss_pred HHHHHHHhhhcccceecccccCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 401 LEWVKKIQQEKKVEVLVDRELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 401 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
..... ..... +..........+.++.+++.+|++.+|.+|||+.||++
T Consensus 248 ~~i~~---~~~~~-----~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 248 SNIIR---GIFSL-----DEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp HHHHH---TCCCC-----CCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHhc---CCCCc-----ccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 11111 00000 11112224455678999999999999999999999986
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-38 Score=331.36 Aligned_cols=236 Identities=23% Similarity=0.309 Sum_probs=177.8
Q ss_pred hCCCcCCeeccCCcEEEEEEEECCCcEEEEEEehh-----------hhhhc-ccCceeeEEEEEeCCCeeEEEeeccCCC
Q 039819 202 ENFSSKNILGAGGFGNVYKGKLGDGTVLAVKRLKD-----------MISLA-VHRNLLRLIGYCATPTERLLVYPYMSNG 269 (534)
Q Consensus 202 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~-----------~l~~~-~h~niv~l~~~~~~~~~~~lv~e~~~~g 269 (534)
.+|...+.||+|+||+||.....+++.||||++.. ++..+ +|||||++++++.+....++|||||. |
T Consensus 24 ~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~-g 102 (432)
T 3p23_A 24 ISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA-A 102 (432)
T ss_dssp EEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTEEECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECCS-E
T ss_pred EEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHHHHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECCC-C
Confidence 35777889999999997666666889999998852 56666 79999999999999999999999996 5
Q ss_pred ChhhhcccCC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCC-----CCcEEEEecccceecCCCCC-
Q 039819 270 SVASRLREKP-ALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDD-----FCEAIVGDFGLAKLLDHSDS- 342 (534)
Q Consensus 270 sL~~~l~~~~-~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~-----~~~~kl~DFGla~~~~~~~~- 342 (534)
+|.+++.... .+.+..+..|+.||+.||.|||+. +|+||||||+|||++. ...+||+|||+++.......
T Consensus 103 ~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~~~ 179 (432)
T 3p23_A 103 TLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSL---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHS 179 (432)
T ss_dssp EHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHT---TCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC------
T ss_pred CHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHC---cCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCCCcc
Confidence 9999987543 456667789999999999999999 9999999999999943 34688999999987653321
Q ss_pred -ceeeccccccccccccccc---cCCCCcchhHHHHHHHHHHHHh-CCCCcCCCccccccchHHHHHHHHhhhcccceec
Q 039819 343 -HVTTAVRGTVGHIAPEYLS---TGQSSEKTDVFGFGILLLELIT-GMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLV 417 (534)
Q Consensus 343 -~~~~~~~gt~~y~aPE~~~---~~~~~~k~Dv~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 417 (534)
.......||+.|+|||++. ...++.++|||||||++|||+| |+.||..... .............
T Consensus 180 ~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~--------~~~~~~~~~~~~~--- 248 (432)
T 3p23_A 180 FSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQ--------RQANILLGACSLD--- 248 (432)
T ss_dssp ------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTT--------HHHHHHTTCCCCT---
T ss_pred eeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhH--------HHHHHHhccCCcc---
Confidence 2234467999999999997 4567889999999999999999 9999853211 1111111110000
Q ss_pred ccccCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 418 DRELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 418 d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
.. .........+.+++.+|++.+|.+|||+.||++
T Consensus 249 --~~--~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 249 --CL--HPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp --TS--CTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred --cc--CccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 00 111233456789999999999999999999985
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-37 Score=339.83 Aligned_cols=223 Identities=19% Similarity=0.264 Sum_probs=180.5
Q ss_pred hCCCcCCeeccCCcEEEEEEEEC--CCcEEEEEEeh---------------hhhhhcccCceeeEEEEEeCCCe-----e
Q 039819 202 ENFSSKNILGAGGFGNVYKGKLG--DGTVLAVKRLK---------------DMISLAVHRNLLRLIGYCATPTE-----R 259 (534)
Q Consensus 202 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~~vavK~~~---------------~~l~~~~h~niv~l~~~~~~~~~-----~ 259 (534)
++|...+.||+|+||.||+|.+. +++.||||++. +++..++|||||++++++...+. .
T Consensus 80 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~ 159 (681)
T 2pzi_A 80 GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVG 159 (681)
T ss_dssp TTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred CceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCcee
Confidence 67889999999999999999985 58999999874 25788899999999999987655 6
Q ss_pred EEEeeccCCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCC
Q 039819 260 LLVYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDH 339 (534)
Q Consensus 260 ~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~ 339 (534)
|+||||+++++|.+++.. .+++..++.|+.||+.||.|||++ +||||||||+|||++.+ .+||+|||+++....
T Consensus 160 ~lv~E~~~g~~L~~~~~~--~l~~~~~~~~~~qi~~aL~~lH~~---giiHrDlkp~NIll~~~-~~kl~DFG~a~~~~~ 233 (681)
T 2pzi_A 160 YIVMEYVGGQSLKRSKGQ--KLPVAEAIAYLLEILPALSYLHSI---GLVYNDLKPENIMLTEE-QLKLIDLGAVSRINS 233 (681)
T ss_dssp EEEEECCCCEECC----C--CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSS-CEEECCCTTCEETTC
T ss_pred EEEEEeCCCCcHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHC---CCeecccChHHeEEeCC-cEEEEecccchhccc
Confidence 999999999999988765 699999999999999999999999 99999999999999985 999999999987654
Q ss_pred CCCceeeccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceeccc
Q 039819 340 SDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDR 419 (534)
Q Consensus 340 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 419 (534)
. ....||++|+|||++.++. +.++|||||||++|||++|..||....... +
T Consensus 234 ~-----~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~--------------------~--- 284 (681)
T 2pzi_A 234 F-----GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDG--------------------L--- 284 (681)
T ss_dssp C-----SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSS--------------------C---
T ss_pred C-----CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCccccccc--------------------c---
Confidence 3 3456999999999987654 889999999999999999998876311000 0
Q ss_pred ccCCCCCHHHHHHHHHHHHHhcccCCCCCCC-hHHHHHHhhc
Q 039819 420 ELGSNYDRIEVGEILQVALLCTQYLPVHRPK-MSEVVRMLEG 460 (534)
Q Consensus 420 ~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt-~~ev~~~L~~ 460 (534)
............+.+++.+|++.+|.+||+ ++++...|.+
T Consensus 285 -~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~ 325 (681)
T 2pzi_A 285 -PEDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTG 325 (681)
T ss_dssp -CTTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred -cccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHH
Confidence 000001112357889999999999999996 5555555553
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=338.52 Aligned_cols=243 Identities=25% Similarity=0.356 Sum_probs=186.9
Q ss_pred HhCCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEeh---------------hhhhhcccCceeeEEEEEeC------CCe
Q 039819 201 TENFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLK---------------DMISLAVHRNLLRLIGYCAT------PTE 258 (534)
Q Consensus 201 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~---------------~~l~~~~h~niv~l~~~~~~------~~~ 258 (534)
.++|...+.||+|+||.||+|... +++.||||++. +++..++||||+++++++.. ...
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~ 92 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL 92 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence 368999999999999999999874 68999999864 26788899999999999765 667
Q ss_pred eEEEeeccCCCChhhhcccCC---CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCc---EEEEecc
Q 039819 259 RLLVYPYMSNGSVASRLREKP---ALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCE---AIVGDFG 332 (534)
Q Consensus 259 ~~lv~e~~~~gsL~~~l~~~~---~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~---~kl~DFG 332 (534)
.++||||+++|+|.+++.... .+++..++.|+.+++.||.|||+. +|+||||||+|||++.++. +||+|||
T Consensus 93 ~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~---gIVHrDLKP~NILl~~~g~~~~vKL~DFG 169 (676)
T 3qa8_A 93 PLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLG 169 (676)
T ss_dssp CCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHT---TBCCCCCCSTTEEEECCSSSCEEEECSCC
T ss_pred EEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEeecCCCceeEEEcccc
Confidence 799999999999999997543 699999999999999999999998 9999999999999997665 9999999
Q ss_pred cceecCCCCCceeeccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcc
Q 039819 333 LAKLLDHSDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKK 412 (534)
Q Consensus 333 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 412 (534)
++....... ......||..|+|||++.+..++.++|||||||++|||+||+.||..... ...|.........
T Consensus 170 ~a~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~------~~~~~~~i~~~~~ 241 (676)
T 3qa8_A 170 YAKELDQGE--LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQ------PVQWHGKVREKSN 241 (676)
T ss_dssp CCCBTTSCC--CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCH------HHHSSTTCC----
T ss_pred ccccccccc--ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccc------hhhhhhhhhcccc
Confidence 998765432 23446799999999999999999999999999999999999999974321 1122111111110
Q ss_pred cceecc----------cc--cCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHH
Q 039819 413 VEVLVD----------RE--LGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEV 454 (534)
Q Consensus 413 ~~~~~d----------~~--l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev 454 (534)
...... .. .........+..+.+++.+|++.||++|||+.|+
T Consensus 242 ~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~el 295 (676)
T 3qa8_A 242 EHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQN 295 (676)
T ss_dssp --CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTC
T ss_pred hhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHH
Confidence 000000 00 1112334467789999999999999999999875
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-36 Score=298.38 Aligned_cols=215 Identities=19% Similarity=0.285 Sum_probs=169.8
Q ss_pred hCCCcC-CeeccCCcEEEEEEEE-CCCcEEEEEEehh----------hhhhcccCceeeEEEEEeC----CCeeEEEeec
Q 039819 202 ENFSSK-NILGAGGFGNVYKGKL-GDGTVLAVKRLKD----------MISLAVHRNLLRLIGYCAT----PTERLLVYPY 265 (534)
Q Consensus 202 ~~~~~~-~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~----------~l~~~~h~niv~l~~~~~~----~~~~~lv~e~ 265 (534)
++|... +.||+|+||.||+|.. .+++.||||++.. +.....||||+++++++.. ....++||||
T Consensus 17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~ 96 (299)
T 3m2w_A 17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMEC 96 (299)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEECC
T ss_pred cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecccHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEEEEee
Confidence 456665 7899999999999997 4689999999863 3366689999999999876 6678999999
Q ss_pred cCCCChhhhcccC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCC---CCcEEEEecccceecCCC
Q 039819 266 MSNGSVASRLREK--PALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDD---FCEAIVGDFGLAKLLDHS 340 (534)
Q Consensus 266 ~~~gsL~~~l~~~--~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~---~~~~kl~DFGla~~~~~~ 340 (534)
+++|+|.+++... ..+++..++.++.|++.||.|||+. +|+||||||+|||++. ++.+||+|||++....
T Consensus 97 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~-- 171 (299)
T 3m2w_A 97 LDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT-- 171 (299)
T ss_dssp CCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTCEECT--
T ss_pred cCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEecCCCCCcEEEeccccccccc--
Confidence 9999999999754 3699999999999999999999999 9999999999999998 7899999999987542
Q ss_pred CCceeeccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceecccc
Q 039819 341 DSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRE 420 (534)
Q Consensus 341 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 420 (534)
+..++.++|||||||++|||+||+.||......... ......+....
T Consensus 172 ---------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~------------~~~~~~~~~~~ 218 (299)
T 3m2w_A 172 ---------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS------------PGMKTRIRMGQ 218 (299)
T ss_dssp ---------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------------------CCSCCSSCTTC
T ss_pred ---------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhh------------HHHHHHHhhcc
Confidence 234678999999999999999999999643211100 00000000000
Q ss_pred cCCCCCH----HHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 421 LGSNYDR----IEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 421 l~~~~~~----~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
...+. ..+..+.+++.+|++.+|.+|||+.|+++
T Consensus 219 --~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~ 256 (299)
T 3m2w_A 219 --YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 256 (299)
T ss_dssp --CSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred --ccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 01111 12457899999999999999999999985
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=294.69 Aligned_cols=213 Identities=13% Similarity=0.028 Sum_probs=170.1
Q ss_pred hCCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEehh-----------------hhhhcccCceeeEEEEEeCCCeeEEEe
Q 039819 202 ENFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLKD-----------------MISLAVHRNLLRLIGYCATPTERLLVY 263 (534)
Q Consensus 202 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~-----------------~l~~~~h~niv~l~~~~~~~~~~~lv~ 263 (534)
++|...+.||+|+||.||+|+.. +++.||||.+.. .+..+.||||+++++++...+..|+||
T Consensus 31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 110 (286)
T 3uqc_A 31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVA 110 (286)
T ss_dssp TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEE
Confidence 56888899999999999999986 489999998852 467788999999999999999999999
Q ss_pred eccCCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCCc
Q 039819 264 PYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSH 343 (534)
Q Consensus 264 e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~ 343 (534)
||+++++|.+++... ....++.+|+.|++.||.|||++ +|+||||||+|||++.++.+||+++
T Consensus 111 e~~~g~~L~~~l~~~--~~~~~~~~i~~ql~~aL~~lH~~---givH~Dikp~NIll~~~g~~kl~~~------------ 173 (286)
T 3uqc_A 111 EWIRGGSLQEVADTS--PSPVGAIRAMQSLAAAADAAHRA---GVALSIDHPSRVRVSIDGDVVLAYP------------ 173 (286)
T ss_dssp ECCCEEEHHHHHTTC--CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEETTSCEEECSC------------
T ss_pred EecCCCCHHHHHhcC--CChHHHHHHHHHHHHHHHHHHHC---CCccCCCCcccEEEcCCCCEEEEec------------
Confidence 999999999999654 35667889999999999999999 9999999999999999999999743
Q ss_pred eeeccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceecccccCC
Q 039819 344 VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELGS 423 (534)
Q Consensus 344 ~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 423 (534)
+|++ .++.++|||||||++|||+||+.||........... ....+......
T Consensus 174 ---------~~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~-------------~~~~~~~~~~~ 224 (286)
T 3uqc_A 174 ---------ATMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAP-------------AERDTAGQPIE 224 (286)
T ss_dssp ---------CCCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEE-------------CCBCTTSCBCC
T ss_pred ---------cccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHH-------------HHHHhccCCCC
Confidence 3444 368899999999999999999999985433211000 00000000000
Q ss_pred --CCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhcC
Q 039819 424 --NYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLEGD 461 (534)
Q Consensus 424 --~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~~ 461 (534)
......+..+.+++.+||+.||.+| |+.|+++.|+..
T Consensus 225 ~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~ 263 (286)
T 3uqc_A 225 PADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQA 263 (286)
T ss_dssp HHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHH
T ss_pred hhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHH
Confidence 0011124578999999999999999 999999999863
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-37 Score=309.67 Aligned_cols=228 Identities=14% Similarity=0.165 Sum_probs=172.9
Q ss_pred HhCCCcCCeeccCCcEEEEEEEECCCcEEEEEEehh----------------------hhhhcc---------cCceeeE
Q 039819 201 TENFSSKNILGAGGFGNVYKGKLGDGTVLAVKRLKD----------------------MISLAV---------HRNLLRL 249 (534)
Q Consensus 201 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~----------------------~l~~~~---------h~niv~l 249 (534)
.++|...+.||+|+||.||+|+. +++.||||++.. +++.++ |||||++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l 97 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL 97 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence 35688889999999999999998 789999998751 234443 7777777
Q ss_pred EEEEe------------------------------CCCeeEEEeeccCCCChhhhcccCCCCCHHHHHHHHHHHHHHHHH
Q 039819 250 IGYCA------------------------------TPTERLLVYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLY 299 (534)
Q Consensus 250 ~~~~~------------------------------~~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~y 299 (534)
.+.+. .....++||||+++|++.+.+.+ ..+++..++.|+.||+.||.|
T Consensus 98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-~~~~~~~~~~i~~qi~~aL~~ 176 (336)
T 2vuw_A 98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-KLSSLATAKSILHQLTASLAV 176 (336)
T ss_dssp EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-TCCCHHHHHHHHHHHHHHHHH
T ss_pred cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-cCCCHHHHHHHHHHHHHHHHH
Confidence 76642 26788999999999987777754 568999999999999999999
Q ss_pred HH-hcCCCCeEeccCCCCcEEeCCCC--------------------cEEEEecccceecCCCCCceeecccccccccccc
Q 039819 300 LH-EQCDPKIIHRDVKAANVLLDDFC--------------------EAIVGDFGLAKLLDHSDSHVTTAVRGTVGHIAPE 358 (534)
Q Consensus 300 LH-~~~~~~ivH~Dlkp~NiLl~~~~--------------------~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE 358 (534)
|| +. +||||||||+|||++.++ .+||+|||+|+..... ...||+.|+|||
T Consensus 177 lH~~~---~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~------~~~gt~~y~aPE 247 (336)
T 2vuw_A 177 AEASL---RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG------IVVFCDVSMDED 247 (336)
T ss_dssp HHHHH---CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT------EEECCCCTTCSG
T ss_pred HHHhC---CEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC------cEEEeecccChh
Confidence 99 88 999999999999999887 8999999999976532 246999999999
Q ss_pred ccccCCCCcchhHHHHHHH-HHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceecccccCCCCCHHHHHHHHHHH
Q 039819 359 YLSTGQSSEKTDVFGFGIL-LLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELGSNYDRIEVGEILQVA 437 (534)
Q Consensus 359 ~~~~~~~~~k~Dv~S~Gvv-l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~ 437 (534)
++.+.. +.++||||+|++ .+++++|..||.. ..|.......-..................+.++.+++
T Consensus 248 ~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli 316 (336)
T 2vuw_A 248 LFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSN----------VLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFH 316 (336)
T ss_dssp GGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHH----------HHHHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHH
T ss_pred hhcCCC-ccceehhhhhCCCCcccccccCCCcc----------hhhhhHHHHhhhhhhccCcccchhhhhhcCHHHHHHH
Confidence 997665 899999998777 7889999999851 1222211111000000011111111234567899999
Q ss_pred HHhcccCCCCCCChHHHH
Q 039819 438 LLCTQYLPVHRPKMSEVV 455 (534)
Q Consensus 438 ~~Cl~~~P~~RPt~~ev~ 455 (534)
.+|++.+ |++|++
T Consensus 317 ~~~L~~d-----sa~e~l 329 (336)
T 2vuw_A 317 RTMLNFS-----SATDLL 329 (336)
T ss_dssp HHGGGSS-----SHHHHH
T ss_pred HHHhccC-----CHHHHH
Confidence 9999976 888887
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-36 Score=314.80 Aligned_cols=224 Identities=14% Similarity=0.145 Sum_probs=166.0
Q ss_pred hCCCcCCeeccCCcEEEEEEEE-CCCcEEEEEEehh-----------------hhhhccc-Cc---------ee------
Q 039819 202 ENFSSKNILGAGGFGNVYKGKL-GDGTVLAVKRLKD-----------------MISLAVH-RN---------LL------ 247 (534)
Q Consensus 202 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~-----------------~l~~~~h-~n---------iv------ 247 (534)
.+|...+.||+|+||.||+|+. .+|+.||||++.. ++..+.| +| ++
T Consensus 78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 157 (413)
T 3dzo_A 78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV 157 (413)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEE
T ss_pred eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhc
Confidence 3455678999999999999996 4789999998861 3444544 11 11
Q ss_pred e------EEEEEeC-----CCeeEEEeeccCCCChhhhcc-------cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeE
Q 039819 248 R------LIGYCAT-----PTERLLVYPYMSNGSVASRLR-------EKPALDWNTRKRIAIGAARGLLYLHEQCDPKII 309 (534)
Q Consensus 248 ~------l~~~~~~-----~~~~~lv~e~~~~gsL~~~l~-------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iv 309 (534)
. +..++.. ....+++|+++ +++|.+++. ....+++..++.|+.|+++||+|||++ +||
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ii 233 (413)
T 3dzo_A 158 KDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GLV 233 (413)
T ss_dssp ECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEE
T ss_pred ccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC---Ccc
Confidence 1 1111111 12346666665 679998884 134588899999999999999999999 999
Q ss_pred eccCCCCcEEeCCCCcEEEEecccceecCCCCCceeecccccccccccccc----------ccCCCCcchhHHHHHHHHH
Q 039819 310 HRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGHIAPEYL----------STGQSSEKTDVFGFGILLL 379 (534)
Q Consensus 310 H~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~k~Dv~S~Gvvl~ 379 (534)
||||||+|||++.++.+||+|||+++..... .....| +.|+|||++ ....++.++|||||||++|
T Consensus 234 HrDiKp~NILl~~~~~~kL~DFG~a~~~~~~----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~ 308 (413)
T 3dzo_A 234 HTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIY 308 (413)
T ss_dssp CSCCCGGGEEECTTCCEEECCGGGCEETTEE----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHH
T ss_pred cCCcccceEEEecCCeEEEEeccceeecCCc----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHH
Confidence 9999999999999999999999999875432 445567 999999999 5556888999999999999
Q ss_pred HHHhCCCCcCCCccccccchHHHHHHHHhhhcccceecccccCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 380 ELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 380 elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
||+||+.||......... ..++... ... +..+.+++.+||+.+|++||++.++++
T Consensus 309 elltg~~Pf~~~~~~~~~----------------~~~~~~~--~~~----~~~~~~li~~~l~~dP~~Rpt~~~~l~ 363 (413)
T 3dzo_A 309 WIWCADLPNTDDAALGGS----------------EWIFRSC--KNI----PQPVRALLEGFLRYPKEDRLLPLQAME 363 (413)
T ss_dssp HHHHSSCCCCTTGGGSCS----------------GGGGSSC--CCC----CHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHHHCCCCCCCcchhhhH----------------HHHHhhc--ccC----CHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 999999999743321110 0011100 112 357899999999999999999988865
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=8.6e-30 Score=275.57 Aligned_cols=171 Identities=16% Similarity=0.056 Sum_probs=121.4
Q ss_pred eccCCcEEEEEEE-ECCCcEEEEEEehh------------------------hhhhc-ccCceeeEEEEEeCCCeeEEEe
Q 039819 210 LGAGGFGNVYKGK-LGDGTVLAVKRLKD------------------------MISLA-VHRNLLRLIGYCATPTERLLVY 263 (534)
Q Consensus 210 lG~G~~g~Vy~~~-~~~~~~vavK~~~~------------------------~l~~~-~h~niv~l~~~~~~~~~~~lv~ 263 (534)
.+.|+.|.+..++ .-.|+.+|||.+.. ++.++ .|+||+++++++++....||||
T Consensus 242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVM 321 (569)
T 4azs_A 242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVM 321 (569)
T ss_dssp -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEE
T ss_pred cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEE
Confidence 4566666666543 33577899998841 45665 6999999999999999999999
Q ss_pred eccCCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCCc
Q 039819 264 PYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSH 343 (534)
Q Consensus 264 e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~ 343 (534)
||++|++|.+++...+.++.. +|+.||+.||+|+|++ +||||||||+|||++.++.+||+|||+|+.......
T Consensus 322 Eyv~G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~~---GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~~- 394 (569)
T 4azs_A 322 EKLPGRLLSDMLAAGEEIDRE---KILGSLLRSLAALEKQ---GFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDCS- 394 (569)
T ss_dssp ECCCSEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHHHT---TCEESCCCGGGEEECTTSCEEECCCTTEESCC---C-
T ss_pred ecCCCCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHHHC---CceeccCchHhEEECCCCCEEEeecccCeeCCCCCc-
Confidence 999999999999988888764 5889999999999999 999999999999999999999999999997654322
Q ss_pred eeeccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCc
Q 039819 344 VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRAL 388 (534)
Q Consensus 344 ~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~ 388 (534)
.....+||++|||||++.+ .+..++|+||+|++++++.++..++
T Consensus 395 ~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~~ 438 (569)
T 4azs_A 395 WPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSNW 438 (569)
T ss_dssp CSHHHHHHHHHHHHHHC------------------CCCCTTHHHH
T ss_pred cccCceechhhccHHHhCC-CCCCcccccccccchhhhccccchh
Confidence 3345679999999999864 5677899999999998887765543
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=7.8e-27 Score=250.99 Aligned_cols=170 Identities=15% Similarity=0.203 Sum_probs=136.9
Q ss_pred CcCCeeccCCcEEEEEEEECCCcEEEEEEeh----------------------hhhhhcccCceeeEEEEEeCCCeeEEE
Q 039819 205 SSKNILGAGGFGNVYKGKLGDGTVLAVKRLK----------------------DMISLAVHRNLLRLIGYCATPTERLLV 262 (534)
Q Consensus 205 ~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~----------------------~~l~~~~h~niv~l~~~~~~~~~~~lv 262 (534)
...+.||+|+||.||+|+. .+..+|+|+.. +++.+++||||+++..++...+..++|
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV 417 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM 417 (540)
T ss_dssp ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence 4467899999999999954 56788888742 257788999999777777777888999
Q ss_pred eeccCCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCC
Q 039819 263 YPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDS 342 (534)
Q Consensus 263 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~ 342 (534)
|||+++|+|.+++.. +..|+.|+++||.|||++ +|+||||||+|||++. .+||+|||+++.......
T Consensus 418 mE~~~ggsL~~~l~~--------~~~i~~qi~~aL~~LH~~---gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~ 484 (540)
T 3en9_A 418 MSYINGKLAKDVIED--------NLDIAYKIGEIVGKLHKN---DVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDED 484 (540)
T ss_dssp EECCCSEEHHHHSTT--------CTHHHHHHHHHHHHHHHT---TEECTTCCTTSEEESS--SEEECCCTTCEECCCHHH
T ss_pred EECCCCCCHHHHHHH--------HHHHHHHHHHHHHHHHHC---cCccCCCCHHHEEECC--eEEEEECccCEECCCccc
Confidence 999999999999976 568999999999999999 9999999999999999 999999999998754322
Q ss_pred ce------eecccccccccccccccc--CCCCcchhHHHHHHHHHHHHhCCCCc
Q 039819 343 HV------TTAVRGTVGHIAPEYLST--GQSSEKTDVFGFGILLLELITGMRAL 388 (534)
Q Consensus 343 ~~------~~~~~gt~~y~aPE~~~~--~~~~~k~Dv~S~Gvvl~elltG~~p~ 388 (534)
.. .....||+.|||||++.. ..|+..+|+||..+-.++.+.++.+|
T Consensus 485 ~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 485 KAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp HHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred cccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 11 235679999999999976 56788899999999999998887765
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=1e-22 Score=201.03 Aligned_cols=138 Identities=14% Similarity=0.054 Sum_probs=109.9
Q ss_pred HHHHHHHhCCCcCCeeccCCcEEEEEEEECCCcEEEEEEehh--------------------------------hhhhcc
Q 039819 195 RELQQATENFSSKNILGAGGFGNVYKGKLGDGTVLAVKRLKD--------------------------------MISLAV 242 (534)
Q Consensus 195 ~~l~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~--------------------------------~l~~~~ 242 (534)
..+......|...+.||+|+||.||+|+..+|+.||||.+.. ++..+.
T Consensus 83 ~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~ 162 (282)
T 1zar_A 83 HRLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ 162 (282)
T ss_dssp HHHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc
Confidence 344444455666799999999999999997799999998831 344444
Q ss_pred cCceeeEEEEEeCCCeeEEEeeccCCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCC
Q 039819 243 HRNLLRLIGYCATPTERLLVYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDD 322 (534)
Q Consensus 243 h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~ 322 (534)
| +++.+++.. +..++||||+++|+|.+ +.. .....++.|++.||.|||+. +|+||||||+|||++
T Consensus 163 --~-~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~------~~~~~i~~qi~~~l~~lH~~---giiHrDlkp~NILl~- 227 (282)
T 1zar_A 163 --G-LAVPKVYAW-EGNAVLMELIDAKELYR-VRV------ENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVS- 227 (282)
T ss_dssp --T-SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC------SCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEE-
T ss_pred --C-CCcCeEEec-cceEEEEEecCCCcHHH-cch------hhHHHHHHHHHHHHHHHHHC---CCEeCCCCHHHEEEE-
Confidence 4 666665533 55699999999999998 532 23457999999999999998 999999999999999
Q ss_pred CCcEEEEecccceecCCCCCceeeccccccccccccccc
Q 039819 323 FCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGHIAPEYLS 361 (534)
Q Consensus 323 ~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~ 361 (534)
++.+||+|||+++. +..|+|||++.
T Consensus 228 ~~~vkl~DFG~a~~--------------~~~~~a~e~l~ 252 (282)
T 1zar_A 228 EEGIWIIDFPQSVE--------------VGEEGWREILE 252 (282)
T ss_dssp TTEEEECCCTTCEE--------------TTSTTHHHHHH
T ss_pred CCcEEEEECCCCeE--------------CCCCCHHHHHH
Confidence 99999999999973 34578999874
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.79 E-value=4e-19 Score=168.75 Aligned_cols=131 Identities=24% Similarity=0.301 Sum_probs=118.1
Q ss_pred CcEEEEEecCCCceeecccccccCCCCCEEEccCCccCcCCCCCCCCCCCCCEEEcCCCcCccccCchhhhcccCccccc
Q 039819 8 NLVIGLGAPSQSLSGTLSGSIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFLSIWLPRKWD 87 (534)
Q Consensus 8 ~~l~~L~l~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~P~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~l~~~~~ 87 (534)
..++.|+|++|+|++..+..|..+++|++|+|++|+|++..|..|.++++|++|+|++|+|+...+..|..++
T Consensus 32 ~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~------- 104 (220)
T 2v9t_B 32 ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKITELPKSLFEGLF------- 104 (220)
T ss_dssp TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCT-------
T ss_pred cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCCcCCccCHhHccCCC-------
Confidence 4799999999999987778999999999999999999988899999999999999999999966666677777
Q ss_pred ccccCCccccceeCCCCcCcccCChhhhcccccccccccCCCCCCCCCCCCC-----ccccccCCcceec
Q 039819 88 KRKCSGVDQGLLRLNNNSLSGAFPVFLAKISELAFLDLSYNNLSGPVPKFPA-----RTFNVAGNPLICG 152 (534)
Q Consensus 88 ~~~~~~~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~-----~~~~~~~N~~~cg 152 (534)
+|+.|+|++|+|++..|..|..+++|+.|+|++|+|++..+..+. +.+.+.+|||.|.
T Consensus 105 -------~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~ 167 (220)
T 2v9t_B 105 -------SLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFICD 167 (220)
T ss_dssp -------TCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCEECS
T ss_pred -------CCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCCCcCCC
Confidence 889999999999988899999999999999999999977665443 5678999999984
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.77 E-value=9e-19 Score=167.32 Aligned_cols=131 Identities=22% Similarity=0.240 Sum_probs=115.7
Q ss_pred CcEEEEEecCCCceeecccccccCCCCCEEEccCCccCcCCCCCCCCCCCCCEEEcCCCcCccccCchhhhcccCccccc
Q 039819 8 NLVIGLGAPSQSLSGTLSGSIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFLSIWLPRKWD 87 (534)
Q Consensus 8 ~~l~~L~l~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~P~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~l~~~~~ 87 (534)
.+++.|+|++|+|++..|..|.++++|++|+|++|+|++..+..|.++++|++|+|++|+|++..+..|..++
T Consensus 40 ~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~------- 112 (229)
T 3e6j_A 40 TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTNQLTVLPSAVFDRLV------- 112 (229)
T ss_dssp TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCT-------
T ss_pred CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcccCCCcCEEECCCCcCCccChhHhCcch-------
Confidence 4799999999999998899999999999999999999855556689999999999999999977777777777
Q ss_pred ccccCCccccceeCCCCcCcccCChhhhcccccccccccCCCCCCCCCCCCC-----ccccccCCcceecC
Q 039819 88 KRKCSGVDQGLLRLNNNSLSGAFPVFLAKISELAFLDLSYNNLSGPVPKFPA-----RTFNVAGNPLICGS 153 (534)
Q Consensus 88 ~~~~~~~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~-----~~~~~~~N~~~cg~ 153 (534)
+|+.|+|++|+|+ .+|..+..+++|+.|+|++|+|++..+..+. +.+.+.+|||.|..
T Consensus 113 -------~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c 175 (229)
T 3e6j_A 113 -------HLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGNPWDCEC 175 (229)
T ss_dssp -------TCCEEECCSSCCC-SCCTTGGGCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCBCTTB
T ss_pred -------hhCeEeccCCccc-ccCcccccCCCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCCccCCc
Confidence 8899999999999 8999999999999999999999966554443 56789999998853
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.76 E-value=1.4e-18 Score=164.95 Aligned_cols=131 Identities=20% Similarity=0.222 Sum_probs=117.9
Q ss_pred cEEEEEecCCCceeecc-cccccCCCCCEEEccCCccCcCCCCCCCCCCCCCEEEcCCCcCccccCchhhhcccCccccc
Q 039819 9 LVIGLGAPSQSLSGTLS-GSIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFLSIWLPRKWD 87 (534)
Q Consensus 9 ~l~~L~l~~n~l~g~~p-~~~~~l~~L~~L~L~~N~l~g~~P~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~l~~~~~ 87 (534)
.++.|+|++|+|++..| ..|+.+++|++|+|++|+|++..|.+|.++++|++|+|++|+|++..|..|..++
T Consensus 33 ~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~------- 105 (220)
T 2v70_A 33 YTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLENVQHKMFKGLE------- 105 (220)
T ss_dssp TCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCCCCGGGGTTCS-------
T ss_pred CCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCCCccCccCHhHhcCCc-------
Confidence 57899999999998765 4689999999999999999987777999999999999999999988888888887
Q ss_pred ccccCCccccceeCCCCcCcccCChhhhcccccccccccCCCCCCCCCCCCC-----ccccccCCcceecC
Q 039819 88 KRKCSGVDQGLLRLNNNSLSGAFPVFLAKISELAFLDLSYNNLSGPVPKFPA-----RTFNVAGNPLICGS 153 (534)
Q Consensus 88 ~~~~~~~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~-----~~~~~~~N~~~cg~ 153 (534)
+|+.|+|++|+|++..|..|..+++|+.|+|++|+|++..|..+. +.+.+.+|||.|..
T Consensus 106 -------~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c 169 (220)
T 2v70_A 106 -------SLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFNCNC 169 (220)
T ss_dssp -------SCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEECSG
T ss_pred -------CCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCCcCCC
Confidence 889999999999988899999999999999999999987786654 56789999999853
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=99.76 E-value=5.7e-19 Score=198.27 Aligned_cols=134 Identities=31% Similarity=0.478 Sum_probs=123.0
Q ss_pred EEecCCCceeecccccccCCCCCEEEccCCccCcCCCCCCCCCCCCCEEEcCCCcCccccCchhhhcccCcccccccccC
Q 039819 13 LGAPSQSLSGTLSGSIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFLSIWLPRKWDKRKCS 92 (534)
Q Consensus 13 L~l~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~P~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~l~~~~~~~~~~ 92 (534)
++++.|.++|.+|..|+++++|++|+|++|+|+|.+|.+|++|++|+.|+|++|+|+|.+|..++.+.
T Consensus 613 ~~l~~~~~~g~~~~~~~~l~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~------------ 680 (768)
T 3rgz_A 613 CNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLR------------ 680 (768)
T ss_dssp SCTTSCEEEEECCCSCSSSBCCCEEECCSSCCBSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCT------------
T ss_pred cccccceecccCchhhhccccccEEECcCCcccccCCHHHhccccCCEEeCcCCccCCCCChHHhCCC------------
Confidence 45667999999999999999999999999999999999999999999999999999999999999998
Q ss_pred CccccceeCCCCcCcccCChhhhcccccccccccCCCCCCCCCCCCC----ccccccCCcceecCCCCCcccC
Q 039819 93 GVDQGLLRLNNNSLSGAFPVFLAKISELAFLDLSYNNLSGPVPKFPA----RTFNVAGNPLICGSSSTNVCSG 161 (534)
Q Consensus 93 ~~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~----~~~~~~~N~~~cg~~~~~~~~~ 161 (534)
+|+.|+|++|+|+|.+|..|+.+++|+.|||++|+|+|.+|.... ....+.|||..||.+.. .|..
T Consensus 681 --~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~ls~N~l~g~iP~~~~~~~~~~~~~~gN~~Lcg~~l~-~C~~ 750 (768)
T 3rgz_A 681 --GLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGLCGYPLP-RCDP 750 (768)
T ss_dssp --TCCEEECCSSCCEECCCGGGGGCCCCSEEECCSSEEEEECCSSSSGGGSCGGGGCSCTEEESTTSC-CCCS
T ss_pred --CCCEEECCCCcccCcCChHHhCCCCCCEEECcCCcccccCCCchhhccCCHHHhcCCchhcCCCCc-CCCC
Confidence 889999999999999999999999999999999999999997532 45578899999997654 6754
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=99.76 E-value=5.2e-19 Score=177.17 Aligned_cols=135 Identities=26% Similarity=0.438 Sum_probs=120.9
Q ss_pred CceecCC---CcEEEEEecCCCcee--ecccccccCCCCCEEEccC-CccCcCCCCCCCCCCCCCEEEcCCCcCccccCc
Q 039819 1 MITCSPE---NLVIGLGAPSQSLSG--TLSGSIGNLTNLRQVLLQN-NNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPA 74 (534)
Q Consensus 1 ~v~c~~~---~~l~~L~l~~n~l~g--~~p~~~~~l~~L~~L~L~~-N~l~g~~P~~~~~l~~L~~L~Ls~N~l~g~~p~ 74 (534)
||+|... ++|+.|+|++|+|+| .+|..|+++++|++|+|++ |++++.+|.+|+++++|++|+|++|+|++.+|.
T Consensus 40 gv~C~~~~~~~~l~~L~L~~~~l~~~~~~~~~l~~l~~L~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~ 119 (313)
T 1ogq_A 40 GVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPD 119 (313)
T ss_dssp TEEECCSSSCCCEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCG
T ss_pred ceEeCCCCCCceEEEEECCCCCccCCcccChhHhCCCCCCeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCH
Confidence 7999843 799999999999999 9999999999999999994 999999999999999999999999999999999
Q ss_pred hhhhcccCcccccccccCCccccceeCCCCcCcccCChhhhcccccccccccCCCCCCCCCCCCC------ccccccCCc
Q 039819 75 LLFLSIWLPRKWDKRKCSGVDQGLLRLNNNSLSGAFPVFLAKISELAFLDLSYNNLSGPVPKFPA------RTFNVAGNP 148 (534)
Q Consensus 75 ~~~~l~~l~~~~~~~~~~~~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~------~~~~~~~N~ 148 (534)
.+..++ +|++|+|++|.+++.+|..|..+++|+.|+|++|+++|.+|..+. +.+.+.+|.
T Consensus 120 ~~~~l~--------------~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~~L~~L~L~~N~ 185 (313)
T 1ogq_A 120 FLSQIK--------------TLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNR 185 (313)
T ss_dssp GGGGCT--------------TCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSE
T ss_pred HHhCCC--------------CCCEEeCCCCccCCcCChHHhcCCCCCeEECcCCcccCcCCHHHhhhhhcCcEEECcCCe
Confidence 999888 888899999999999999999999999999999999988886443 345666665
Q ss_pred c
Q 039819 149 L 149 (534)
Q Consensus 149 ~ 149 (534)
+
T Consensus 186 l 186 (313)
T 1ogq_A 186 L 186 (313)
T ss_dssp E
T ss_pred e
Confidence 5
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.74 E-value=2.2e-18 Score=167.71 Aligned_cols=123 Identities=20% Similarity=0.248 Sum_probs=95.4
Q ss_pred CCcCCeeccCCcEEEEEEEE-CCCcE--EEEEEeh--------------------------------------hhhhhcc
Q 039819 204 FSSKNILGAGGFGNVYKGKL-GDGTV--LAVKRLK--------------------------------------DMISLAV 242 (534)
Q Consensus 204 ~~~~~~lG~G~~g~Vy~~~~-~~~~~--vavK~~~--------------------------------------~~l~~~~ 242 (534)
|...+.||+|+||.||+|.. .+|+. ||||.++ ..+..+.
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 45678899999999999998 68888 9999742 1345556
Q ss_pred cCce--eeEEEEEeCCCeeEEEeeccCC-C----ChhhhcccCCCCCHHHHHHHHHHHHHHHHHHH-hcCCCCeEeccCC
Q 039819 243 HRNL--LRLIGYCATPTERLLVYPYMSN-G----SVASRLREKPALDWNTRKRIAIGAARGLLYLH-EQCDPKIIHRDVK 314 (534)
Q Consensus 243 h~ni--v~l~~~~~~~~~~~lv~e~~~~-g----sL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH-~~~~~~ivH~Dlk 314 (534)
|+++ ..++++ ...+|||||+.+ | +|.+.... .++..+..++.|++.||.||| +. +|||||||
T Consensus 129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~---givHrDlk 198 (258)
T 1zth_A 129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE---LKELDVEGIFNDVVENVKRLYQEA---ELVHADLS 198 (258)
T ss_dssp HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG---GGGSCHHHHHHHHHHHHHHHHHTS---CEECSSCS
T ss_pred hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc---cChHHHHHHHHHHHHHHHHHHHHC---CEEeCCCC
Confidence 6653 334432 356899999952 4 56555432 234567889999999999999 77 99999999
Q ss_pred CCcEEeCCCCcEEEEecccceecC
Q 039819 315 AANVLLDDFCEAIVGDFGLAKLLD 338 (534)
Q Consensus 315 p~NiLl~~~~~~kl~DFGla~~~~ 338 (534)
|+|||++. .++|+|||+|....
T Consensus 199 p~NILl~~--~~~liDFG~a~~~~ 220 (258)
T 1zth_A 199 EYNIMYID--KVYFIDMGQAVTLR 220 (258)
T ss_dssp TTSEEESS--SEEECCCTTCEETT
T ss_pred HHHEEEcC--cEEEEECcccccCC
Confidence 99999998 99999999998653
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=99.74 E-value=2.9e-18 Score=171.76 Aligned_cols=151 Identities=31% Similarity=0.453 Sum_probs=105.4
Q ss_pred CcEEEEEecCCCceeecccccccCCCCCEEEccCCccCcCCCCCCCCCC-CCCEEEcCCCcCccccCchhhhc-------
Q 039819 8 NLVIGLGAPSQSLSGTLSGSIGNLTNLRQVLLQNNNISGGIPPQLGSLP-KLQTLDLSNNRLSGVIPALLFLS------- 79 (534)
Q Consensus 8 ~~l~~L~l~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~P~~~~~l~-~L~~L~Ls~N~l~g~~p~~~~~l------- 79 (534)
.+++.|+|++|+|++.+|..|+.+++|++|+|++|+|+|.+|..|+.++ +|++|+|++|+|+|.+|..+..+
T Consensus 125 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~~L~~L~L~~N~l~~~~~~~~~~l~L~~L~L 204 (313)
T 1ogq_A 125 KTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDL 204 (313)
T ss_dssp TTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCSEEEC
T ss_pred CCCCEEeCCCCccCCcCChHHhcCCCCCeEECcCCcccCcCCHHHhhhhhcCcEEECcCCeeeccCChHHhCCcccEEEC
Confidence 3566666666666666666666666666666666666666666666665 66666666666666666555443
Q ss_pred ----------------ccCcccccccc-c--------CCccccceeCCCCcCcccCChhhhcccccccccccCCCCCCCC
Q 039819 80 ----------------IWLPRKWDKRK-C--------SGVDQGLLRLNNNSLSGAFPVFLAKISELAFLDLSYNNLSGPV 134 (534)
Q Consensus 80 ----------------~~l~~~~~~~~-~--------~~~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~ 134 (534)
+.|..+..+.+ . ...+|+.|+|++|+|++.+|..|..+++|+.|+|++|+|+|.+
T Consensus 205 s~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~i 284 (313)
T 1ogq_A 205 SRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEI 284 (313)
T ss_dssp CSSEEEECCGGGCCTTSCCSEEECCSSEECCBGGGCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEEC
T ss_pred cCCcccCcCCHHHhcCCCCCEEECCCCceeeecCcccccCCCCEEECcCCcccCcCChHHhcCcCCCEEECcCCcccccC
Confidence 33332221111 0 1137899999999999999999999999999999999999999
Q ss_pred CCCCC----ccccccCCcceecCCCCCcc
Q 039819 135 PKFPA----RTFNVAGNPLICGSSSTNVC 159 (534)
Q Consensus 135 p~~~~----~~~~~~~N~~~cg~~~~~~~ 159 (534)
|.... +.+.+.+||+.|+.+.. .|
T Consensus 285 p~~~~l~~L~~l~l~~N~~lc~~p~~-~C 312 (313)
T 1ogq_A 285 PQGGNLQRFDVSAYANNKCLCGSPLP-AC 312 (313)
T ss_dssp CCSTTGGGSCGGGTCSSSEEESTTSS-CC
T ss_pred CCCccccccChHHhcCCCCccCCCCC-CC
Confidence 97632 56789999999986443 45
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.73 E-value=1e-17 Score=162.26 Aligned_cols=145 Identities=23% Similarity=0.200 Sum_probs=118.5
Q ss_pred CcEEEEEecCCCceeecccccccCCCCCEEEccCCccCcCCCCCCCCCCCCCEEEcCCCcCccccCchhhhcccCccccc
Q 039819 8 NLVIGLGAPSQSLSGTLSGSIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFLSIWLPRKWD 87 (534)
Q Consensus 8 ~~l~~L~l~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~P~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~l~~~~~ 87 (534)
..++.|+|++|+|++..+..|+++++|++|+|++|+|++..|..|..+++|++|+|++|+|++..|..|..++.|..+..
T Consensus 35 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 114 (251)
T 3m19_A 35 ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLASLPLGVFDHLTQLDKLYL 114 (251)
T ss_dssp TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEECCCCcccccChhHhcccCCCCEEEc
Confidence 46899999999999888888999999999999999999877778999999999999999999777777777776665532
Q ss_pred ccc---------c-CCccccceeCCCCcCcccCChhhhcccccccccccCCCCCCCCCCCCC-----ccccccCCcceec
Q 039819 88 KRK---------C-SGVDQGLLRLNNNSLSGAFPVFLAKISELAFLDLSYNNLSGPVPKFPA-----RTFNVAGNPLICG 152 (534)
Q Consensus 88 ~~~---------~-~~~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~-----~~~~~~~N~~~cg 152 (534)
+++ + ...+|+.|+|++|+|++..|..|..+++|+.|+|++|+|++..|..+. +.+.+.+|+|.|.
T Consensus 115 ~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~ 194 (251)
T 3m19_A 115 GGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQFDCS 194 (251)
T ss_dssp CSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCTT
T ss_pred CCCcCCCcChhHhccCCcccEEECcCCcCCccCHHHcCcCcCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCceeCC
Confidence 221 1 123788999999999977677899999999999999999976665443 5678899999875
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.72 E-value=1.6e-17 Score=155.86 Aligned_cols=132 Identities=23% Similarity=0.221 Sum_probs=114.1
Q ss_pred CcEEEEEecCCCceeecccccccCCCCCEEEccCCccCcCCCCCCCCCCCCCEEEcCCCcCccccCchhhhcccCccccc
Q 039819 8 NLVIGLGAPSQSLSGTLSGSIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFLSIWLPRKWD 87 (534)
Q Consensus 8 ~~l~~L~l~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~P~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~l~~~~~ 87 (534)
.+++.|+|++|+|++..+..|+++++|++|+|++|+|++..+..|..+++|++|+|++|+|++..+..+..++
T Consensus 28 ~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~------- 100 (208)
T 2o6s_A 28 AQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQSLPNGVFDKLT------- 100 (208)
T ss_dssp TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCT-------
T ss_pred CCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEECCCCcCCccCHhHhcCcc-------
Confidence 3699999999999977777799999999999999999965556689999999999999999977666677777
Q ss_pred ccccCCccccceeCCCCcCcccCChhhhcccccccccccCCCCCCCCCCCCC-----ccccccCCcceecC
Q 039819 88 KRKCSGVDQGLLRLNNNSLSGAFPVFLAKISELAFLDLSYNNLSGPVPKFPA-----RTFNVAGNPLICGS 153 (534)
Q Consensus 88 ~~~~~~~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~-----~~~~~~~N~~~cg~ 153 (534)
+|+.|+|++|+|++..+..|..+++|+.|+|++|++++..+..+. +.+.+.+|+|.|..
T Consensus 101 -------~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~ 164 (208)
T 2o6s_A 101 -------QLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCTC 164 (208)
T ss_dssp -------TCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCCCT
T ss_pred -------CCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCccceeCHHHhccCCCccEEEecCCCeecCC
Confidence 889999999999977777899999999999999999976654433 56788999998754
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.70 E-value=5.3e-17 Score=150.58 Aligned_cols=113 Identities=20% Similarity=0.273 Sum_probs=67.8
Q ss_pred cEEEEEecCCCceeeccc-ccccCCCCCEEEccCCccCcCCCCCCCCCCCCCEEEcCCCcCccccCchhhhcccCccccc
Q 039819 9 LVIGLGAPSQSLSGTLSG-SIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFLSIWLPRKWD 87 (534)
Q Consensus 9 ~l~~L~l~~n~l~g~~p~-~~~~l~~L~~L~L~~N~l~g~~P~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~l~~~~~ 87 (534)
.++.|+|++|+|++..+. .|+.+++|++|+|++|+|++..|..|.++++|++|+|++|+|++..|..|..++
T Consensus 30 ~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~------- 102 (192)
T 1w8a_A 30 HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLH------- 102 (192)
T ss_dssp TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCT-------
T ss_pred CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCCCcCCccCHHHhcCCC-------
Confidence 455666666666544433 356666666666666666655566666666666666666666655555555554
Q ss_pred ccccCCccccceeCCCCcCcccCChhhhcccccccccccCCCCCCCCC
Q 039819 88 KRKCSGVDQGLLRLNNNSLSGAFPVFLAKISELAFLDLSYNNLSGPVP 135 (534)
Q Consensus 88 ~~~~~~~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p 135 (534)
+|+.|+|++|+|++..|..|..+++|+.|+|++|.+++..+
T Consensus 103 -------~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~ 143 (192)
T 1w8a_A 103 -------QLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCH 143 (192)
T ss_dssp -------TCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGG
T ss_pred -------CCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcCc
Confidence 55566666666666666666666666666666666665443
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=99.70 E-value=6.9e-18 Score=185.38 Aligned_cols=120 Identities=23% Similarity=0.310 Sum_probs=97.5
Q ss_pred CceecCCCcEEEEEecCCCceeecccccccCCCCCEEEccCC--------------------------------------
Q 039819 1 MITCSPENLVIGLGAPSQSLSGTLSGSIGNLTNLRQVLLQNN-------------------------------------- 42 (534)
Q Consensus 1 ~v~c~~~~~l~~L~l~~n~l~g~~p~~~~~l~~L~~L~L~~N-------------------------------------- 42 (534)
||+|+..++|+.|+|++|+|+|.+|++|++|++|++|+|++|
T Consensus 74 GV~C~~~~~V~~L~L~~~~l~g~lp~~l~~L~~L~~L~Ls~N~~~~~~~~~~~~~~~~~~~~~~~~~l~l~l~~~~l~~~ 153 (636)
T 4eco_A 74 GVSLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYD 153 (636)
T ss_dssp TEEECTTCCEEEEECTTSCCEEEECGGGGGCTTCCEEESCCGGGGGTCCSBSTTSBCTTCCHHHHHHHHTHHHHHHTCCC
T ss_pred CeEEcCCCCEEEEEecCcccCCcCChHHhcCccceEEECcCCccccCCccccccccccCchHHHHHHHHhhHHHhhhccC
Confidence 899987789999999999999999999999999999999988
Q ss_pred ----------------------------------------ccCcCCCCCCCCCCCCCEEEcCCCcCccc-----------
Q 039819 43 ----------------------------------------NISGGIPPQLGSLPKLQTLDLSNNRLSGV----------- 71 (534)
Q Consensus 43 ----------------------------------------~l~g~~P~~~~~l~~L~~L~Ls~N~l~g~----------- 71 (534)
+|+| +|.+|++|++|++|+|++|+|+|.
T Consensus 154 ~~~~~~~~~~~l~~~~l~~~~~~~~~~~~l~~l~l~~~~n~l~~-ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~ 232 (636)
T 4eco_A 154 PREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENS 232 (636)
T ss_dssp GGGGSCHHHHHHHHHCTTSCCCCCCCCCCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTS
T ss_pred chhhHHHHHHHHhhcCccccccccccccchhhhhhccccCCCcc-CCHHHhcccCCCEEECcCCcccccccccccccccc
Confidence 4556 899999999999999999999986
Q ss_pred ------cCchhh--hcccCcccccccccCCccccceeCCCCcCcccCChhhhcccccccccccCCC-CCC-CCC
Q 039819 72 ------IPALLF--LSIWLPRKWDKRKCSGVDQGLLRLNNNSLSGAFPVFLAKISELAFLDLSYNN-LSG-PVP 135 (534)
Q Consensus 72 ------~p~~~~--~l~~l~~~~~~~~~~~~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~-l~g-~~p 135 (534)
+|..++ .++ +|++|+|++|++.|.+|..|+++++|+.|+|++|+ ++| .+|
T Consensus 233 ~~~~~~ip~~l~~~~l~--------------~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~~l~~~~lp 292 (636)
T 4eco_A 233 EYAQQYKTEDLKWDNLK--------------DLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLK 292 (636)
T ss_dssp HHHHHHTTSCCCGGGCT--------------TCCEEEEECCTTCSSCCTTTTTCSSCCEEECTTCTTSCHHHHH
T ss_pred chhcccCchhhhhcccC--------------CCCEEEecCCcCCccChHHHhcCCCCCEEECcCCCCCccccch
Confidence 898888 888 55556666666655666666666666666666665 555 444
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.70 E-value=2e-17 Score=153.48 Aligned_cols=126 Identities=23% Similarity=0.352 Sum_probs=111.9
Q ss_pred EEEEecCCCceeecccccccCCCCCEEEccCCccCcCCCC-CCCCCCCCCEEEcCCCcCccccCchhhhcccCccccccc
Q 039819 11 IGLGAPSQSLSGTLSGSIGNLTNLRQVLLQNNNISGGIPP-QLGSLPKLQTLDLSNNRLSGVIPALLFLSIWLPRKWDKR 89 (534)
Q Consensus 11 ~~L~l~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~P~-~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~l~~~~~~~ 89 (534)
+.|++++|+|+ .+|..+.. +|++|+|++|+|++..|. .|+.+++|++|+|++|+|++.+|..|..+.
T Consensus 11 ~~l~~s~~~l~-~ip~~~~~--~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~--------- 78 (192)
T 1w8a_A 11 TTVDCTGRGLK-EIPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGAS--------- 78 (192)
T ss_dssp TEEECTTSCCS-SCCSCCCT--TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCT---------
T ss_pred CEEEcCCCCcC-cCccCCCC--CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcc---------
Confidence 57999999997 78887754 999999999999965554 489999999999999999999899998888
Q ss_pred ccCCccccceeCCCCcCcccCChhhhcccccccccccCCCCCCCCCCCCC-----ccccccCCcceecC
Q 039819 90 KCSGVDQGLLRLNNNSLSGAFPVFLAKISELAFLDLSYNNLSGPVPKFPA-----RTFNVAGNPLICGS 153 (534)
Q Consensus 90 ~~~~~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~-----~~~~~~~N~~~cg~ 153 (534)
+|+.|+|++|+|++..|..|..+++|+.|+|++|+|++.+|..+. +.+.+.+|+|.|..
T Consensus 79 -----~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c 142 (192)
T 1w8a_A 79 -----HIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNC 142 (192)
T ss_dssp -----TCCEEECCSCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSG
T ss_pred -----cCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcC
Confidence 889999999999998889999999999999999999988887654 56789999998853
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.69 E-value=5.6e-17 Score=160.54 Aligned_cols=141 Identities=26% Similarity=0.247 Sum_probs=92.1
Q ss_pred CcEEEEEecCCCceeecccccccCCCCCEEEccCCccCcCCCCCCCCCCCCCEEEcCCCcCccccCchhhhcccCccccc
Q 039819 8 NLVIGLGAPSQSLSGTLSGSIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFLSIWLPRKWD 87 (534)
Q Consensus 8 ~~l~~L~l~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~P~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~l~~~~~ 87 (534)
.+|+.|+|++|+|++..+ . +.+++|++|+|++|+|+ .+|..+..+++|++|+|++|+|++..|..|..++.|..+..
T Consensus 55 ~~L~~L~L~~n~l~~~~~-~-~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L 131 (290)
T 1p9a_G 55 TRLTQLNLDRAELTKLQV-D-GTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYL 131 (290)
T ss_dssp TTCCEEECTTSCCCEEEC-C-SCCTTCCEEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEEC
T ss_pred CCCCEEECCCCccCcccC-C-CCCCcCCEEECCCCcCC-cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEEC
Confidence 356666666666664322 2 55666666666666666 55666666666666666666666555555555554444322
Q ss_pred ccc---------c-CCccccceeCCCCcCcccCChhhhcccccccccccCCCCCCCCCCCCC-----ccccccCCcceec
Q 039819 88 KRK---------C-SGVDQGLLRLNNNSLSGAFPVFLAKISELAFLDLSYNNLSGPVPKFPA-----RTFNVAGNPLICG 152 (534)
Q Consensus 88 ~~~---------~-~~~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~-----~~~~~~~N~~~cg 152 (534)
+++ + ...+|+.|+|++|+|++..+..|..+++|+.|+|++|+|+ .+|..+. +.+.+.+|||.|.
T Consensus 132 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~-~ip~~~~~~~~L~~l~L~~Np~~C~ 210 (290)
T 1p9a_G 132 KGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLCN 210 (290)
T ss_dssp TTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBCCS
T ss_pred CCCCCCccChhhcccccCCCEEECCCCcCCccCHHHhcCcCCCCEEECCCCcCC-ccChhhcccccCCeEEeCCCCccCc
Confidence 111 0 1127889999999999666667788999999999999999 5665443 4577899999985
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.69 E-value=7.8e-17 Score=157.93 Aligned_cols=145 Identities=20% Similarity=0.150 Sum_probs=103.4
Q ss_pred CcEEEEEecCCCceeecccccccCCCCCEEEccCCccCcCCCCCCCCCCCCCEEEcCCCcCccccCchhhhcccCccccc
Q 039819 8 NLVIGLGAPSQSLSGTLSGSIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFLSIWLPRKWD 87 (534)
Q Consensus 8 ~~l~~L~l~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~P~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~l~~~~~ 87 (534)
.+|+.|+|++|+|++ + +.++.+++|++|+|++|+|++..|..|+++++|++|+|++|+|++..|..+..++.|..+..
T Consensus 63 ~~L~~L~l~~n~l~~-~-~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 140 (272)
T 3rfs_A 63 PNVRYLALGGNKLHD-I-SALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNL 140 (272)
T ss_dssp TTCCEEECTTSCCCC-C-GGGTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCCcEEECCCCCCCC-c-hhhcCCCCCCEEECCCCccCccChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCCEEEC
Confidence 457777777777775 3 36777777777777777777555555677777777777777777666665666665544432
Q ss_pred ccc---------c-CCccccceeCCCCcCcccCChhhhcccccccccccCCCCCCCCCCCCC-----ccccccCCcceec
Q 039819 88 KRK---------C-SGVDQGLLRLNNNSLSGAFPVFLAKISELAFLDLSYNNLSGPVPKFPA-----RTFNVAGNPLICG 152 (534)
Q Consensus 88 ~~~---------~-~~~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~-----~~~~~~~N~~~cg 152 (534)
+.+ + ...+|+.|+|++|+|++..|..|+.+++|+.|+|++|++++.+|..+. +.+.+.+|||.|.
T Consensus 141 ~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~ 220 (272)
T 3rfs_A 141 AHNQLQSLPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCT 220 (272)
T ss_dssp CSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCC
T ss_pred CCCccCccCHHHhccCccCCEEECCCCCcCccCHHHhcCCccCCEEECCCCcCCccCHHHHhCCcCCCEEEccCCCcccc
Confidence 211 0 113789999999999977777889999999999999999987775443 5678899999875
Q ss_pred CC
Q 039819 153 SS 154 (534)
Q Consensus 153 ~~ 154 (534)
..
T Consensus 221 ~~ 222 (272)
T 3rfs_A 221 CP 222 (272)
T ss_dssp TT
T ss_pred Cc
Confidence 43
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.69 E-value=6.4e-17 Score=150.22 Aligned_cols=125 Identities=23% Similarity=0.296 Sum_probs=107.9
Q ss_pred EEEEecCCCceeecccccccCCCCCEEEccCCccCcCCCCCCCCCCCCCEEEcCCCcCccccCchhhhcccCcccccccc
Q 039819 11 IGLGAPSQSLSGTLSGSIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFLSIWLPRKWDKRK 90 (534)
Q Consensus 11 ~~L~l~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~P~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~l~~~~~~~~ 90 (534)
+.+++++|+|+ .+|..+. ++|++|+|++|+|+ .+|..|.++++|+.|+|++|+|++..|..|..+.
T Consensus 13 ~~l~~~~~~l~-~ip~~~~--~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~---------- 78 (193)
T 2wfh_A 13 TVVRCSNKGLK-VLPKGIP--RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMT---------- 78 (193)
T ss_dssp TEEECTTSCCS-SCCSCCC--TTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCT----------
T ss_pred CEEEcCCCCCC-cCCCCCC--CCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCC----------
Confidence 46889999998 6787654 68999999999999 7999999999999999999999988888888887
Q ss_pred cCCccccceeCCCCcCcccCChhhhcccccccccccCCCCCCCCCCCCC-----ccccccCCcceecC
Q 039819 91 CSGVDQGLLRLNNNSLSGAFPVFLAKISELAFLDLSYNNLSGPVPKFPA-----RTFNVAGNPLICGS 153 (534)
Q Consensus 91 ~~~~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~-----~~~~~~~N~~~cg~ 153 (534)
+|+.|+|++|+|++..|..|..+++|+.|+|++|+|++..+..+. +.+.+.+|||.|..
T Consensus 79 ----~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C~c 142 (193)
T 2wfh_A 79 ----QLLTLILSYNRLRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLYCDC 142 (193)
T ss_dssp ----TCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEECSG
T ss_pred ----CCCEEECCCCccCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCeecCC
Confidence 888999999999988888999999999999999999965554333 56788999999853
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=99.68 E-value=4.4e-17 Score=182.94 Aligned_cols=142 Identities=30% Similarity=0.387 Sum_probs=105.0
Q ss_pred CcEEEEEecCCCceeecccccccCCCCCEEEccCCccCcCCCCCCCCCCCCCEEEcCCCcCccccCchhhhcccCccccc
Q 039819 8 NLVIGLGAPSQSLSGTLSGSIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFLSIWLPRKWD 87 (534)
Q Consensus 8 ~~l~~L~l~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~P~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~l~~~~~ 87 (534)
.+++.|+|++|+++|.+|..|+.+++|++|+|++|+|+|.+|..|+.+++|+.|+|++|+|+|.+|..++....+.....
T Consensus 490 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~~~~~~~~~ 569 (768)
T 3rgz_A 490 TNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANF 569 (768)
T ss_dssp TTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEEECCGGGGGCTTCCEEECCSSEEESBCCGGGGTTTTCBCCST
T ss_pred CCCCEEEccCCccCCcCChHHhcCCCCCEEECCCCcccCcCCHHHcCCCCCCEEECCCCccCCcCChHHhcccchhhhhc
Confidence 47899999999999999999999999999999999999999999999999999999999999999987765432211000
Q ss_pred c-----------------------------------------------c---------ccCCccccceeCCCCcCcccCC
Q 039819 88 K-----------------------------------------------R---------KCSGVDQGLLRLNNNSLSGAFP 111 (534)
Q Consensus 88 ~-----------------------------------------------~---------~~~~~~L~~L~L~~N~l~g~~p 111 (534)
. + .....+|+.|+|++|+|+|.+|
T Consensus 570 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~g~~~~~~~~l~~L~~LdLs~N~l~g~ip 649 (768)
T 3rgz_A 570 IAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIP 649 (768)
T ss_dssp TCSCEEEEEECCSCCTTCCSSEEEEECTTCCGGGGGGGGGTCCSCTTSCEEEEECCCSCSSSBCCCEEECCSSCCBSCCC
T ss_pred cccccccccccccccccccccccccccccccchhhhccccccccccccceecccCchhhhccccccEEECcCCcccccCC
Confidence 0 0 0011256667777777777777
Q ss_pred hhhhcccccccccccCCCCCCCCCCCCC-----ccccccCCcc
Q 039819 112 VFLAKISELAFLDLSYNNLSGPVPKFPA-----RTFNVAGNPL 149 (534)
Q Consensus 112 ~~~~~l~~L~~L~ls~N~l~g~~p~~~~-----~~~~~~~N~~ 149 (534)
..|+.+++|+.|+|++|+|+|.+|..+. +.+++++|.+
T Consensus 650 ~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~l 692 (768)
T 3rgz_A 650 KEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKL 692 (768)
T ss_dssp GGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCC
T ss_pred HHHhccccCCEEeCcCCccCCCCChHHhCCCCCCEEECCCCcc
Confidence 7777777777777777777776665543 3455566654
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.67 E-value=2.1e-16 Score=152.87 Aligned_cols=115 Identities=22% Similarity=0.222 Sum_probs=86.3
Q ss_pred CceecCCCcEEEEEecCCCceeecccccccCCCCCEEEccCCccCcCCCCCCCCCCCCCEEEcCCCcCccccCchhhhcc
Q 039819 1 MITCSPENLVIGLGAPSQSLSGTLSGSIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFLSI 80 (534)
Q Consensus 1 ~v~c~~~~~l~~L~l~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~P~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~ 80 (534)
|++|.. ..+.+++++++|+ .+|..+. ++|+.|+|++|+|++..|..|.++++|++|+|++|+|++..|..|..++
T Consensus 9 gC~C~~--~~~~l~~~~~~l~-~~p~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~ 83 (251)
T 3m19_A 9 GCTCNE--GKKEVDCQGKSLD-SVPSGIP--ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLT 83 (251)
T ss_dssp SSEEEG--GGTEEECTTCCCS-SCCSCCC--TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCT
T ss_pred ceEcCC--CCeEEecCCCCcc-ccCCCCC--CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhccCC
Confidence 567742 3557999999999 6887776 6999999999999988888899999999999999999988888888887
Q ss_pred cCcccccccccCCccccceeCCCCcCcccCChhhhcccccccccccCCCCCCCC
Q 039819 81 WLPRKWDKRKCSGVDQGLLRLNNNSLSGAFPVFLAKISELAFLDLSYNNLSGPV 134 (534)
Q Consensus 81 ~l~~~~~~~~~~~~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~ 134 (534)
+|+.|+|++|+|++..|..|..+++|+.|+|++|+|++..
T Consensus 84 --------------~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~ 123 (251)
T 3m19_A 84 --------------ELGTLGLANNQLASLPLGVFDHLTQLDKLYLGGNQLKSLP 123 (251)
T ss_dssp --------------TCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCC
T ss_pred --------------cCCEEECCCCcccccChhHhcccCCCCEEEcCCCcCCCcC
Confidence 4555555555555444445555555555555555555433
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.67 E-value=1.9e-16 Score=154.97 Aligned_cols=146 Identities=21% Similarity=0.162 Sum_probs=111.6
Q ss_pred CcEEEEEecCCCceeecccccccCCCCCEEEccCCccCcCCCCCCCCCCCCCEEEcCCCcCccccCchhhhcccCccccc
Q 039819 8 NLVIGLGAPSQSLSGTLSGSIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFLSIWLPRKWD 87 (534)
Q Consensus 8 ~~l~~L~l~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~P~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~l~~~~~ 87 (534)
.+|+.|+|++|+|+...+..|.++++|++|+|++|+|++..+..|.++++|++|+|++|+|++..|..|..++.|..+..
T Consensus 61 ~~L~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L 140 (270)
T 2o6q_A 61 TKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTDNKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSL 140 (270)
T ss_dssp TTCCEEECCSSCCSCCCTTTTSSCTTCCEEECCSSCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCCCEEECCCCccCeeChhhhcCCCCCCEEECCCCcCCcCCHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCEEEC
Confidence 46888889989888655556788888999999988888655566788888888888888888777777777776655433
Q ss_pred ccc---------c-CCccccceeCCCCcCcccCChhhhcccccccccccCCCCCCCCCCCCC-----ccccccCCcceec
Q 039819 88 KRK---------C-SGVDQGLLRLNNNSLSGAFPVFLAKISELAFLDLSYNNLSGPVPKFPA-----RTFNVAGNPLICG 152 (534)
Q Consensus 88 ~~~---------~-~~~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~-----~~~~~~~N~~~cg 152 (534)
+.+ + ...+|+.|+|++|++++..|..|..+++|+.|+|++|++++..+..+. +.+.+.+|||.|.
T Consensus 141 s~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~ 220 (270)
T 2o6q_A 141 GYNELQSLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQENPWDCT 220 (270)
T ss_dssp CSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCS
T ss_pred CCCcCCccCHhHccCCcccceeEecCCcCcEeChhHhccCCCcCEEECCCCcCCcCCHHHhccccCCCEEEecCCCeeCC
Confidence 221 1 113788999999999977777788999999999999999965554332 5678899999885
Q ss_pred C
Q 039819 153 S 153 (534)
Q Consensus 153 ~ 153 (534)
.
T Consensus 221 c 221 (270)
T 2o6q_A 221 C 221 (270)
T ss_dssp S
T ss_pred C
Confidence 4
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.66 E-value=3e-17 Score=166.80 Aligned_cols=126 Identities=13% Similarity=0.112 Sum_probs=96.5
Q ss_pred CCcCCeeccCCcEEEEEEEECCCcEEEEEEehh----------------------------hhhhcccCceeeEEEEEeC
Q 039819 204 FSSKNILGAGGFGNVYKGKLGDGTVLAVKRLKD----------------------------MISLAVHRNLLRLIGYCAT 255 (534)
Q Consensus 204 ~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~----------------------------~l~~~~h~niv~l~~~~~~ 255 (534)
|++.+.||+|+||.||+|...+|+.||||+++. +.....|+|+++++.....
T Consensus 97 Y~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv~ 176 (397)
T 4gyi_A 97 YSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGFP 176 (397)
T ss_dssp SEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTCS
T ss_pred EEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCCC
Confidence 788899999999999999999999999997641 0011236666655432211
Q ss_pred C------CeeEEEeeccCCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCC-----
Q 039819 256 P------TERLLVYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFC----- 324 (534)
Q Consensus 256 ~------~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~----- 324 (534)
. ...+|||||++++.|.+.... +....++.|++.+|.|||+. +||||||||.|||+++++
T Consensus 177 vp~p~~~~~~~LVME~i~G~~L~~l~~~------~~~~~l~~qll~~l~~lH~~---gIVHrDLKp~NILl~~dgd~~d~ 247 (397)
T 4gyi_A 177 VPEPIAQSRHTIVMSLVDALPMRQVSSV------PDPASLYADLIALILRLAKH---GLIHGDFNEFNILIREEKDAEDP 247 (397)
T ss_dssp CCCEEEEETTEEEEECCSCEEGGGCCCC------SCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEEEEECSSCT
T ss_pred CCeeeeccCceEEEEecCCccHhhhccc------HHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeCCCCcccc
Confidence 1 123799999999988766532 23356889999999999998 999999999999998776
Q ss_pred -----cEEEEecccceecC
Q 039819 325 -----EAIVGDFGLAKLLD 338 (534)
Q Consensus 325 -----~~kl~DFGla~~~~ 338 (534)
.+.|+||+-+....
T Consensus 248 ~~~~~~~~iID~~Q~V~~~ 266 (397)
T 4gyi_A 248 SSITLTPIIIXFPQMVSMD 266 (397)
T ss_dssp TSEEEEEEECCCTTCEETT
T ss_pred cccccceEEEEeCCcccCC
Confidence 38999999877543
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.66 E-value=3.1e-17 Score=184.59 Aligned_cols=121 Identities=23% Similarity=0.292 Sum_probs=95.9
Q ss_pred CceecCCCcEEEEEecCCCceeecccccccCCCCCEEEc-cCCccCcC--------------------------------
Q 039819 1 MITCSPENLVIGLGAPSQSLSGTLSGSIGNLTNLRQVLL-QNNNISGG-------------------------------- 47 (534)
Q Consensus 1 ~v~c~~~~~l~~L~l~~n~l~g~~p~~~~~l~~L~~L~L-~~N~l~g~-------------------------------- 47 (534)
||+|+..++|+.|+|++|+|+|.+|++|++|++|++|+| ++|.|+|.
T Consensus 316 GV~C~~~~~V~~L~Ls~~~L~G~ip~~l~~L~~L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~~l~~~ 395 (876)
T 4ecn_A 316 GVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYD 395 (876)
T ss_dssp TEEECTTSCEEEEECTTTCCEEEECGGGGGCTTCCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHHHHTCCC
T ss_pred ceEecCCCCEEEEECccCCCCCcCchHHhccccceEeeecccccccccccccccccccccchhHHHHHHHhhhhhhhccC
Confidence 799987789999999999999999999999999999999 88876554
Q ss_pred --------------------------------------------CCCCCCCCCCCCEEEcCCCcCcc-------------
Q 039819 48 --------------------------------------------IPPQLGSLPKLQTLDLSNNRLSG------------- 70 (534)
Q Consensus 48 --------------------------------------------~P~~~~~l~~L~~L~Ls~N~l~g------------- 70 (534)
+|.+|++|++|++|+|++|+|+|
T Consensus 396 ~~~~~s~l~~~~l~~~~~~~~i~~~~~l~l~~l~l~~~~N~L~~IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n 475 (876)
T 4ecn_A 396 QRLNLSDLLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRITFISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSD 475 (876)
T ss_dssp GGGGSCHHHHHHHHTCTTSCCCCCCCCCCCCTTTTTCCSCEEEEECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSH
T ss_pred cchhhhHHHHHHhhhCccccccccccccchhhceeccccCcccchhHHHhcCCCCCEEECcCCcCCCCcccccccccccc
Confidence 88899999999999999999998
Q ss_pred ----ccCchhh--hcccCcccccccccCCccccceeCCCCcCcccCChhhhcccccccccccCCC-CCC-CCC
Q 039819 71 ----VIPALLF--LSIWLPRKWDKRKCSGVDQGLLRLNNNSLSGAFPVFLAKISELAFLDLSYNN-LSG-PVP 135 (534)
Q Consensus 71 ----~~p~~~~--~l~~l~~~~~~~~~~~~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~-l~g-~~p 135 (534)
.+|..++ .++ +|+.|+|++|++.|.+|..|+.+++|+.|+|++|+ |+| .+|
T Consensus 476 ~~~g~iP~~l~f~~L~--------------~L~~L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N~~lsg~~iP 534 (876)
T 4ecn_A 476 YAKQYENEELSWSNLK--------------DLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLK 534 (876)
T ss_dssp HHHHHTTSCCCGGGCT--------------TCCEEEEESCTTCCSCCGGGGGCSSCCEEECTTCTTSCHHHHH
T ss_pred cccccCChhhhhccCC--------------CCCEEECcCCCCCccChHHHhCCCCCCEEECcCCCCcccccch
Confidence 3888876 777 55555555555555555555555555555555555 554 444
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.65 E-value=1.2e-16 Score=163.32 Aligned_cols=145 Identities=25% Similarity=0.197 Sum_probs=104.5
Q ss_pred CcEEEEEecCCCceeecccccc-cCCCCCEEEccCCccCcCCCCCCCCCCCCCEEEcCCCcCccccCchhhhcccCcccc
Q 039819 8 NLVIGLGAPSQSLSGTLSGSIG-NLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFLSIWLPRKW 86 (534)
Q Consensus 8 ~~l~~L~l~~n~l~g~~p~~~~-~l~~L~~L~L~~N~l~g~~P~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~l~~~~ 86 (534)
..++.|+|++|+|++..+..|. ++++|++|+|++|+|++..|..|.++++|++|+|++|+|++..+..|..+..|..+.
T Consensus 39 ~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 118 (361)
T 2xot_A 39 SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSNHLHTLDEFLFSDLQALEVLL 118 (361)
T ss_dssp TTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEE
T ss_pred CCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCCCcCCcCCHHHhCCCcCCCEEE
Confidence 3578899999999987777787 899999999999999976777899999999999999999877777777777655543
Q ss_pred ccccc----------CCccccceeCCCCcCcccCChhh---hcccccccccccCCCCCCCCCCCC-------CccccccC
Q 039819 87 DKRKC----------SGVDQGLLRLNNNSLSGAFPVFL---AKISELAFLDLSYNNLSGPVPKFP-------ARTFNVAG 146 (534)
Q Consensus 87 ~~~~~----------~~~~L~~L~L~~N~l~g~~p~~~---~~l~~L~~L~ls~N~l~g~~p~~~-------~~~~~~~~ 146 (534)
.+++. ...+|+.|+|++|+|++..+..| ..+++|+.|+|++|+|++..+..+ .+.+.+.+
T Consensus 119 L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~~~l~~l~l~~ 198 (361)
T 2xot_A 119 LYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHN 198 (361)
T ss_dssp CCSSCCCEECTTTTTTCTTCCEEECCSSCCCSCCGGGTC----CTTCCEEECCSSCCCCCCHHHHHHSCHHHHTTEECCS
T ss_pred CCCCcccEECHHHhCCcccCCEEECCCCcCCeeCHHHhcCcccCCcCCEEECCCCCCCccCHHHhhhccHhhcceEEecC
Confidence 22211 11367788888888874333334 567788888888888884332211 14578889
Q ss_pred Ccceec
Q 039819 147 NPLICG 152 (534)
Q Consensus 147 N~~~cg 152 (534)
|||.|.
T Consensus 199 N~~~C~ 204 (361)
T 2xot_A 199 NPLECD 204 (361)
T ss_dssp SCEECC
T ss_pred CCccCC
Confidence 999884
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.65 E-value=1.6e-16 Score=150.61 Aligned_cols=114 Identities=18% Similarity=0.221 Sum_probs=106.2
Q ss_pred CcEEEEEecCCCceeecccccccCCCCCEEEccCCccCcCCCCCCCCCCCCCEEEcCCCcCccccCchhhhcccCccccc
Q 039819 8 NLVIGLGAPSQSLSGTLSGSIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFLSIWLPRKWD 87 (534)
Q Consensus 8 ~~l~~L~l~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~P~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~l~~~~~ 87 (534)
.+|+.|+|++|+|++..+.+|+++++|++|+|++|+|++..|..|.++++|++|+|++|+|++..|..|..+.
T Consensus 57 ~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~------- 129 (220)
T 2v70_A 57 PQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLS------- 129 (220)
T ss_dssp TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCT-------
T ss_pred CCCCEEECCCCcCCEECHHHhCCCCCCCEEECCCCccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCc-------
Confidence 4799999999999988888999999999999999999977777799999999999999999998898888887
Q ss_pred ccccCCccccceeCCCCcCcccCChhhhcccccccccccCCCCCCCCC
Q 039819 88 KRKCSGVDQGLLRLNNNSLSGAFPVFLAKISELAFLDLSYNNLSGPVP 135 (534)
Q Consensus 88 ~~~~~~~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p 135 (534)
+|+.|+|++|+|++..|..|..+++|+.|+|++|.+++..+
T Consensus 130 -------~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~ 170 (220)
T 2v70_A 130 -------SVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFNCNCY 170 (220)
T ss_dssp -------TCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEECSGG
T ss_pred -------cCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCCcCCCc
Confidence 88999999999998889999999999999999999997654
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.65 E-value=1.9e-16 Score=156.09 Aligned_cols=146 Identities=21% Similarity=0.185 Sum_probs=112.7
Q ss_pred CcEEEEEecCCC-ceeecccccccCCCCCEEEccCCccCcCCCCCCCCCCCCCEEEcCCCcCccccCchhhhcccCcccc
Q 039819 8 NLVIGLGAPSQS-LSGTLSGSIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFLSIWLPRKW 86 (534)
Q Consensus 8 ~~l~~L~l~~n~-l~g~~p~~~~~l~~L~~L~L~~N~l~g~~P~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~l~~~~ 86 (534)
.+|+.|+|++|+ ++...|..|..+++|++|+|++|+|++..|..|.++++|++|+|++|+|++..+..+..+++|..+.
T Consensus 80 ~~L~~L~l~~n~~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ 159 (285)
T 1ozn_A 80 ALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLF 159 (285)
T ss_dssp TTCCEEECCSCTTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred cCCCEEeCCCCCCccccCHHHhcCCcCCCEEECCCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEEE
Confidence 468888888887 7765577888888888888888888877777788888888888888888866666677776665543
Q ss_pred cccc---------c-CCccccceeCCCCcCcccCChhhhcccccccccccCCCCCCCCCCCCC-----ccccccCCccee
Q 039819 87 DKRK---------C-SGVDQGLLRLNNNSLSGAFPVFLAKISELAFLDLSYNNLSGPVPKFPA-----RTFNVAGNPLIC 151 (534)
Q Consensus 87 ~~~~---------~-~~~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~-----~~~~~~~N~~~c 151 (534)
.+++ + ...+|+.|+|++|.+++..|..|..+++|+.|+|++|++++..+..+. +.+.+.+|||.|
T Consensus 160 l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c 239 (285)
T 1ozn_A 160 LHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVC 239 (285)
T ss_dssp CCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEEC
T ss_pred CCCCcccccCHHHhcCccccCEEECCCCcccccCHhHccCcccccEeeCCCCcCCcCCHHHcccCcccCEEeccCCCccC
Confidence 2221 1 113788999999999988899999999999999999999975554222 567889999988
Q ss_pred cC
Q 039819 152 GS 153 (534)
Q Consensus 152 g~ 153 (534)
..
T Consensus 240 ~~ 241 (285)
T 1ozn_A 240 DC 241 (285)
T ss_dssp SG
T ss_pred CC
Confidence 53
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=99.64 E-value=3.8e-16 Score=164.15 Aligned_cols=133 Identities=20% Similarity=0.161 Sum_probs=120.5
Q ss_pred CcEEEEEecCCCceeecccccccCCCCCEEEccCCccCcCCCCCCCCCCCCCEEEcCCCcCccccCchhhhcccCccccc
Q 039819 8 NLVIGLGAPSQSLSGTLSGSIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFLSIWLPRKWD 87 (534)
Q Consensus 8 ~~l~~L~l~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~P~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~l~~~~~ 87 (534)
..++.|+|++|++++.+|..|+.+++|++|+|++|+|++..|..|.++++|++|+|++|+|++..|..+..++
T Consensus 275 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~------- 347 (455)
T 3v47_A 275 SGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLD------- 347 (455)
T ss_dssp SCCCEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGGTTCT-------
T ss_pred cCceEEEecCccccccchhhcccCCCCCEEECCCCcccccChhHhcCcccCCEEECCCCccCCcChhHhcCcc-------
Confidence 4799999999999999999999999999999999999988898999999999999999999988888888887
Q ss_pred ccccCCccccceeCCCCcCcccCChhhhcccccccccccCCCCCCCCCCCCC-----ccccccCCcceecCC
Q 039819 88 KRKCSGVDQGLLRLNNNSLSGAFPVFLAKISELAFLDLSYNNLSGPVPKFPA-----RTFNVAGNPLICGSS 154 (534)
Q Consensus 88 ~~~~~~~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~-----~~~~~~~N~~~cg~~ 154 (534)
+|+.|+|++|++++..|..|..+++|+.|+|++|+|++..+..+. +.+.+.+||+.|...
T Consensus 348 -------~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~ 412 (455)
T 3v47_A 348 -------KLEVLDLSYNHIRALGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 412 (455)
T ss_dssp -------TCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTT
T ss_pred -------cCCEEECCCCcccccChhhccccccccEEECCCCccccCCHhHhccCCcccEEEccCCCcccCCC
Confidence 889999999999988899999999999999999999976554433 567899999988643
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.64 E-value=3.7e-16 Score=155.54 Aligned_cols=130 Identities=19% Similarity=0.231 Sum_probs=88.9
Q ss_pred cEEEEEecCCCceeecccccccCCCCCEEEccCCccCc-CCCCCCCCCCCCCEEEcCCCcCccccCchhhhcccCccccc
Q 039819 9 LVIGLGAPSQSLSGTLSGSIGNLTNLRQVLLQNNNISG-GIPPQLGSLPKLQTLDLSNNRLSGVIPALLFLSIWLPRKWD 87 (534)
Q Consensus 9 ~l~~L~l~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g-~~P~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~l~~~~~ 87 (534)
+++.|+|++|++++..+..|+++++|++|+|++|.+++ .+|..|..+++|++|+|++|+|++..|..+..++
T Consensus 127 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~------- 199 (306)
T 2z66_A 127 NLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLS------- 199 (306)
T ss_dssp TCCEEECTTSCCEECSTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCT-------
T ss_pred CCCEEECCCCcCCccchhhcccCcCCCEEECCCCccccccchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCC-------
Confidence 45555555555555555555555555555555555554 3555555555555555555555555555555444
Q ss_pred ccccCCccccceeCCCCcCcccCChhhhcccccccccccCCCCCCCCCCCCC------ccccccCCcceec
Q 039819 88 KRKCSGVDQGLLRLNNNSLSGAFPVFLAKISELAFLDLSYNNLSGPVPKFPA------RTFNVAGNPLICG 152 (534)
Q Consensus 88 ~~~~~~~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~------~~~~~~~N~~~cg 152 (534)
+|+.|+|++|++++..+..|..+++|+.|+|++|++++..|..+. +.+.+.+|++.|.
T Consensus 200 -------~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~L~~N~~~~~ 263 (306)
T 2z66_A 200 -------SLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACT 263 (306)
T ss_dssp -------TCCEEECTTSCCSBCCSGGGTTCTTCCEEECTTSCCCBCSSSSCCCCCTTCCEEECTTCCEECS
T ss_pred -------CCCEEECCCCccCccChhhccCcccCCEeECCCCCCcccCHHHHHhhhccCCEEEccCCCeecc
Confidence 788999999999977777889999999999999999987775433 4578899999885
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.64 E-value=3.5e-16 Score=142.90 Aligned_cols=125 Identities=19% Similarity=0.239 Sum_probs=76.1
Q ss_pred EEEEecCCCceeecccccccCCCCCEEEccCCccCcCCCCCCCCCCCCCEEEcCCCcCccccCchhhhcccCcccccccc
Q 039819 11 IGLGAPSQSLSGTLSGSIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFLSIWLPRKWDKRK 90 (534)
Q Consensus 11 ~~L~l~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~P~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~l~~~~~~~~ 90 (534)
+.|++++|+++ .+|..+. ++|++|+|++|+|++..|..|..+++|++|+|++|+|++..+..+..+.
T Consensus 10 ~~l~~~~~~l~-~~p~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~---------- 76 (177)
T 2o6r_A 10 TEIRCNSKGLT-SVPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLT---------- 76 (177)
T ss_dssp TEEECCSSCCS-SCCTTCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCT----------
T ss_pred CEEEecCCCCc-cCCCCCC--CCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCC----------
Confidence 45666666666 4554332 5667777777777654444566667777777777777655555555555
Q ss_pred cCCccccceeCCCCcCcccCChhhhcccccccccccCCCCCCCCCCCCC-----ccccccCCcceec
Q 039819 91 CSGVDQGLLRLNNNSLSGAFPVFLAKISELAFLDLSYNNLSGPVPKFPA-----RTFNVAGNPLICG 152 (534)
Q Consensus 91 ~~~~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~-----~~~~~~~N~~~cg 152 (534)
+|+.|+|++|+|++..+..|..+++|+.|+|++|+|++..+..+. +.+.+.+|++.|.
T Consensus 77 ----~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~ 139 (177)
T 2o6r_A 77 ----KLTILYLHENKLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCS 139 (177)
T ss_dssp ----TCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCC
T ss_pred ----ccCEEECCCCCccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeecc
Confidence 566677777777655555566666777777777777644433222 3456666666653
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=99.64 E-value=3.3e-16 Score=171.13 Aligned_cols=128 Identities=16% Similarity=0.099 Sum_probs=100.3
Q ss_pred CcEEEEEecCCCceeecccccccCCCCCEEEccCCccCcCCCCCCCCCCCCCEEEcCCCcCccccCchhhhcccCccccc
Q 039819 8 NLVIGLGAPSQSLSGTLSGSIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFLSIWLPRKWD 87 (534)
Q Consensus 8 ~~l~~L~l~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~P~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~l~~~~~ 87 (534)
..++.|+|++|+|++..|.+|.++++|++|+|++|+|++..|.+|.+|++|++|+|++|+|++..|..|..+.
T Consensus 52 ~~~~~LdLs~N~i~~l~~~~f~~l~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~~l~~~~f~~L~------- 124 (635)
T 4g8a_A 52 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLS------- 124 (635)
T ss_dssp TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECGGGGTTCT-------
T ss_pred cCCCEEEeeCCCCCCCCHHHHhCCCCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCcCCCCCHHHhcCCC-------
Confidence 4799999999999987778999999999999999999977777899999999999999999977777888888
Q ss_pred ccccCCccccceeCCCCcCcccCChhhhcccccccccccCCCCCCC-CCCCCC-----ccccccCCcc
Q 039819 88 KRKCSGVDQGLLRLNNNSLSGAFPVFLAKISELAFLDLSYNNLSGP-VPKFPA-----RTFNVAGNPL 149 (534)
Q Consensus 88 ~~~~~~~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~-~p~~~~-----~~~~~~~N~~ 149 (534)
+|++|+|++|+|++..+..|+.+++|+.|+|++|++++. +|..+. +.+.+.+|.+
T Consensus 125 -------~L~~L~Ls~N~l~~l~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l 185 (635)
T 4g8a_A 125 -------SLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKI 185 (635)
T ss_dssp -------TCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCC
T ss_pred -------CCCEEECCCCcCCCCChhhhhcCcccCeeccccCccccCCCchhhccchhhhhhcccCccc
Confidence 666677777777655555667777777777777776642 333322 3445555554
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.63 E-value=5.2e-16 Score=144.02 Aligned_cols=111 Identities=25% Similarity=0.214 Sum_probs=102.3
Q ss_pred CcEEEEEecCCCceeecccccccCCCCCEEEccCCccCcCCCCCCCCCCCCCEEEcCCCcCccccCchhhhcccCccccc
Q 039819 8 NLVIGLGAPSQSLSGTLSGSIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFLSIWLPRKWD 87 (534)
Q Consensus 8 ~~l~~L~l~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~P~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~l~~~~~ 87 (534)
..++.|+|++|+|+ .+|..|.++++|++|+|++|+|++..|..|.+|++|++|+|++|+|++..|..|..++
T Consensus 31 ~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~------- 102 (193)
T 2wfh_A 31 RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLRCIPPRTFDGLK------- 102 (193)
T ss_dssp TTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCT-------
T ss_pred CCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCCccCEeCHHHhCCCC-------
Confidence 47999999999998 7889999999999999999999987778899999999999999999988888888888
Q ss_pred ccccCCccccceeCCCCcCcccCChhhhcccccccccccCCCCCCC
Q 039819 88 KRKCSGVDQGLLRLNNNSLSGAFPVFLAKISELAFLDLSYNNLSGP 133 (534)
Q Consensus 88 ~~~~~~~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~ 133 (534)
+|+.|+|++|+|++..+..|..+++|+.|+|++|.+...
T Consensus 103 -------~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C~ 141 (193)
T 2wfh_A 103 -------SLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLYCD 141 (193)
T ss_dssp -------TCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEECS
T ss_pred -------CCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCeecC
Confidence 889999999999966667899999999999999999753
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.63 E-value=9.8e-16 Score=139.89 Aligned_cols=114 Identities=22% Similarity=0.217 Sum_probs=101.9
Q ss_pred CcEEEEEecCCCceeecccccccCCCCCEEEccCCccCcCCCCCCCCCCCCCEEEcCCCcCccccCchhhhcccCccccc
Q 039819 8 NLVIGLGAPSQSLSGTLSGSIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFLSIWLPRKWD 87 (534)
Q Consensus 8 ~~l~~L~l~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~P~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~l~~~~~ 87 (534)
..++.|+|++|+|++..+..|+++++|++|+|++|+|++..|..|..+++|++|+|++|+|++.++..+..++
T Consensus 28 ~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~------- 100 (177)
T 2o6r_A 28 SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHENKLQSLPNGVFDKLT------- 100 (177)
T ss_dssp TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCT-------
T ss_pred CCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCCCCccccCHHHhhCCc-------
Confidence 4799999999999977777889999999999999999966666689999999999999999977777777777
Q ss_pred ccccCCccccceeCCCCcCcccCChhhhcccccccccccCCCCCCCCC
Q 039819 88 KRKCSGVDQGLLRLNNNSLSGAFPVFLAKISELAFLDLSYNNLSGPVP 135 (534)
Q Consensus 88 ~~~~~~~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p 135 (534)
+|+.|+|++|+|++..+..|..+++|+.|+|++|.+++..|
T Consensus 101 -------~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 141 (177)
T 2o6r_A 101 -------QLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 141 (177)
T ss_dssp -------TCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred -------ccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeeccCc
Confidence 88999999999996666678999999999999999998766
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.62 E-value=8.8e-16 Score=145.54 Aligned_cols=111 Identities=17% Similarity=0.160 Sum_probs=102.2
Q ss_pred CcEEEEEecCCCceeecccccccCCCCCEEEccCCccCcCCCCCCCCCCCCCEEEcCCCcCccccCchhhhcccCccccc
Q 039819 8 NLVIGLGAPSQSLSGTLSGSIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFLSIWLPRKWD 87 (534)
Q Consensus 8 ~~l~~L~l~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~P~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~l~~~~~ 87 (534)
.+|+.|+|++|+|++..|..|.++++|++|+|++|+|++..+..|.++++|++|+|++|+|++..|..|..++
T Consensus 56 ~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~------- 128 (220)
T 2v9t_B 56 KKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLH------- 128 (220)
T ss_dssp TTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCT-------
T ss_pred CCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCCcCCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCC-------
Confidence 5799999999999998899999999999999999999954445589999999999999999988888888887
Q ss_pred ccccCCccccceeCCCCcCcccCChhhhcccccccccccCCCCCC
Q 039819 88 KRKCSGVDQGLLRLNNNSLSGAFPVFLAKISELAFLDLSYNNLSG 132 (534)
Q Consensus 88 ~~~~~~~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g 132 (534)
+|+.|+|++|+|++..+..|..+++|+.|+|++|.++.
T Consensus 129 -------~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c 166 (220)
T 2v9t_B 129 -------NLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFIC 166 (220)
T ss_dssp -------TCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCEEC
T ss_pred -------CCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCCCcCC
Confidence 88999999999998888889999999999999999974
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.62 E-value=9.1e-16 Score=139.34 Aligned_cols=109 Identities=22% Similarity=0.229 Sum_probs=97.6
Q ss_pred EEEEEecCCCceeecccccccCCCCCEEEccCCccCcCCCCCCCCCCCCCEEEcCCCcCccccCchhhhcccCccccccc
Q 039819 10 VIGLGAPSQSLSGTLSGSIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFLSIWLPRKWDKR 89 (534)
Q Consensus 10 l~~L~l~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~P~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~l~~~~~~~ 89 (534)
.+.|++++|+|+ .+|..+. ++|++|+|++|+|++..|..|.++++|++|+|++|+|++..|..|..++
T Consensus 11 ~~~l~~s~n~l~-~ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~--------- 78 (170)
T 3g39_A 11 GTTVDCSGKSLA-SVPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLT--------- 78 (170)
T ss_dssp TTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCT---------
T ss_pred CCEEEeCCCCcC-ccCccCC--CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCC---------
Confidence 457999999999 5887764 8999999999999988888999999999999999999977777777777
Q ss_pred ccCCccccceeCCCCcCcccCChhhhcccccccccccCCCCCCCCC
Q 039819 90 KCSGVDQGLLRLNNNSLSGAFPVFLAKISELAFLDLSYNNLSGPVP 135 (534)
Q Consensus 90 ~~~~~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p 135 (534)
+|+.|+|++|+|++..|..|..+++|+.|+|++|.++...+
T Consensus 79 -----~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c~ 119 (170)
T 3g39_A 79 -----QLTQLSLNDNQLKSIPRGAFDNLKSLTHIWLLNNPWDCACS 119 (170)
T ss_dssp -----TCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCBCTTBG
T ss_pred -----CCCEEECCCCccCEeCHHHhcCCCCCCEEEeCCCCCCCCch
Confidence 88999999999997777789999999999999999996654
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=99.61 E-value=9.7e-16 Score=167.43 Aligned_cols=132 Identities=19% Similarity=0.231 Sum_probs=120.0
Q ss_pred CcEEEEEecCCCceeecccccccCCCCCEEEccCCccC-cCCCCCCCCCCCCCEEEcCCCcCccccCchhhhcccCcccc
Q 039819 8 NLVIGLGAPSQSLSGTLSGSIGNLTNLRQVLLQNNNIS-GGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFLSIWLPRKW 86 (534)
Q Consensus 8 ~~l~~L~l~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~-g~~P~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~l~~~~ 86 (534)
..++.++++.|++++..+..+..++.|+.|+|++|++. +.+|..|..+++|++|||++|+|++.+|..|..++
T Consensus 445 ~~l~~l~ls~n~l~~~~~~~~~~~~~L~~L~Ls~N~~~~~~~~~~~~~l~~L~~L~Ls~N~L~~l~~~~f~~l~------ 518 (635)
T 4g8a_A 445 RNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLS------ 518 (635)
T ss_dssp TTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCT------
T ss_pred cccccccccccccccccccccccchhhhhhhhhhcccccccCchhhhhccccCEEECCCCccCCcChHHHcCCC------
Confidence 46889999999999999999999999999999999854 56888999999999999999999999999999888
Q ss_pred cccccCCccccceeCCCCcCcccCChhhhcccccccccccCCCCCCCCCCCCC------ccccccCCcceecC
Q 039819 87 DKRKCSGVDQGLLRLNNNSLSGAFPVFLAKISELAFLDLSYNNLSGPVPKFPA------RTFNVAGNPLICGS 153 (534)
Q Consensus 87 ~~~~~~~~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~------~~~~~~~N~~~cg~ 153 (534)
+|+.|+|++|+|++..|..|..+++|+.|+|++|+|++.+|..+. +.+.+++|||.|..
T Consensus 519 --------~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~~L~~L~L~~Np~~C~C 583 (635)
T 4g8a_A 519 --------SLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTC 583 (635)
T ss_dssp --------TCCEEECTTSCCCBCCCGGGTTCTTCCEEECTTSCCCBCCSSCTTCCCTTCCEEECTTCCBCCSG
T ss_pred --------CCCEEECCCCcCCCCChhHHhCCCCCCEEECCCCcCCCCCHHHHHhhhCcCCEEEeeCCCCcccC
Confidence 899999999999988899999999999999999999998887553 45789999999953
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.60 E-value=7.4e-16 Score=136.45 Aligned_cols=113 Identities=25% Similarity=0.230 Sum_probs=102.0
Q ss_pred CCcEEEEEecCCCce-eecccccccCCCCCEEEccCCccCcCCCCCCCCCCCCCEEEcCCCcCccccCchhhhcccCccc
Q 039819 7 ENLVIGLGAPSQSLS-GTLSGSIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFLSIWLPRK 85 (534)
Q Consensus 7 ~~~l~~L~l~~n~l~-g~~p~~~~~l~~L~~L~L~~N~l~g~~P~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~l~~~ 85 (534)
..+++.|+|++|+++ +.+|..++.+++|++|+|++|+|++. ..|+.+++|++|+|++|+|++.+|..+..++
T Consensus 16 ~~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~----- 88 (149)
T 2je0_A 16 PSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCP----- 88 (149)
T ss_dssp GGGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCT-----
T ss_pred CccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCC-----
Confidence 357999999999999 88999999999999999999999965 7899999999999999999987888887787
Q ss_pred ccccccCCccccceeCCCCcCccc-CChhhhcccccccccccCCCCCCCCC
Q 039819 86 WDKRKCSGVDQGLLRLNNNSLSGA-FPVFLAKISELAFLDLSYNNLSGPVP 135 (534)
Q Consensus 86 ~~~~~~~~~~L~~L~L~~N~l~g~-~p~~~~~l~~L~~L~ls~N~l~g~~p 135 (534)
+|+.|+|++|.+++. .|..+..+++|+.|++++|++++..+
T Consensus 89 ---------~L~~L~ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~ 130 (149)
T 2je0_A 89 ---------NLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLND 130 (149)
T ss_dssp ---------TCCEEECTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTT
T ss_pred ---------CCCEEECCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHH
Confidence 889999999999963 45889999999999999999996543
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.60 E-value=1.6e-15 Score=154.77 Aligned_cols=108 Identities=21% Similarity=0.155 Sum_probs=79.6
Q ss_pred EEEEecCCCceeecccccccCCCCCEEEccCCccCcCCCCCCC-CCCCCCEEEcCCCcCccccCchhhhcccCccccccc
Q 039819 11 IGLGAPSQSLSGTLSGSIGNLTNLRQVLLQNNNISGGIPPQLG-SLPKLQTLDLSNNRLSGVIPALLFLSIWLPRKWDKR 89 (534)
Q Consensus 11 ~~L~l~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~P~~~~-~l~~L~~L~Ls~N~l~g~~p~~~~~l~~l~~~~~~~ 89 (534)
..+++++|+|+ .+|..+. ..|+.|+|++|+|++..+..|. ++++|+.|+|++|+|++..|..|..++
T Consensus 21 ~~l~c~~~~l~-~iP~~~~--~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~--------- 88 (361)
T 2xot_A 21 NILSCSKQQLP-NVPQSLP--SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVP--------- 88 (361)
T ss_dssp TEEECCSSCCS-SCCSSCC--TTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCT---------
T ss_pred CEEEeCCCCcC-ccCccCC--CCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCC---------
Confidence 36899999999 5887665 5699999999999977777787 999999999999999988888888888
Q ss_pred ccCCccccceeCCCCcCcccCChhhhcccccccccccCCCCCCCCC
Q 039819 90 KCSGVDQGLLRLNNNSLSGAFPVFLAKISELAFLDLSYNNLSGPVP 135 (534)
Q Consensus 90 ~~~~~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p 135 (534)
+|+.|+|++|+|++..+..|..+++|+.|+|++|+|++..|
T Consensus 89 -----~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~ 129 (361)
T 2xot_A 89 -----NLRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIVVVDR 129 (361)
T ss_dssp -----TCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECT
T ss_pred -----CCCEEECCCCcCCcCCHHHhCCCcCCCEEECCCCcccEECH
Confidence 45555555555554444445555555555555555554333
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.60 E-value=2.8e-15 Score=157.71 Aligned_cols=65 Identities=20% Similarity=0.167 Sum_probs=36.7
Q ss_pred cEEEEEecCCCceeecccccccCCCCCEEEccCCccCcCCCCCCCCCCCCCEEEcCCCcCccccC
Q 039819 9 LVIGLGAPSQSLSGTLSGSIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIP 73 (534)
Q Consensus 9 ~l~~L~l~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~P~~~~~l~~L~~L~Ls~N~l~g~~p 73 (534)
+++.|+|++|+|++..|..|+++++|++|+|++|+|++..|..|.++++|++|+|++|+|++..+
T Consensus 76 ~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~ 140 (452)
T 3zyi_A 76 NTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWLTVIPS 140 (452)
T ss_dssp TCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSBCCT
T ss_pred CccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECCCCcCCccCh
Confidence 45566666666665555555556666666665555555444555555555555555555554333
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=99.59 E-value=1.1e-15 Score=166.57 Aligned_cols=131 Identities=19% Similarity=0.218 Sum_probs=89.4
Q ss_pred cEEEEEecCCCceeecccccccCCCCCEEEccCCccCc-CCCCCCCCCCCCCEEEcCCCcCccccCchhhhcccCccccc
Q 039819 9 LVIGLGAPSQSLSGTLSGSIGNLTNLRQVLLQNNNISG-GIPPQLGSLPKLQTLDLSNNRLSGVIPALLFLSIWLPRKWD 87 (534)
Q Consensus 9 ~l~~L~l~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g-~~P~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~l~~~~~ 87 (534)
+++.|+|++|++++.+|..|+++++|++|+|++|++++ .+|..|+.+++|++|+|++|+|++.+|..+..++
T Consensus 425 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~------- 497 (606)
T 3vq2_A 425 KLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLH------- 497 (606)
T ss_dssp TCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCT-------
T ss_pred cCCEEECcCCCCCccchhhhcCCCCCCEEECCCCcCCCcchHHhhccCCCCCEEECCCCcCCccChhhhcccc-------
Confidence 45555555555555555555555555555555555554 2455555555555555555555555555555444
Q ss_pred ccccCCccccceeCCCCcCcccCChhhhcccccccccccCCCCCCCCCCCCC------ccccccCCcceecCC
Q 039819 88 KRKCSGVDQGLLRLNNNSLSGAFPVFLAKISELAFLDLSYNNLSGPVPKFPA------RTFNVAGNPLICGSS 154 (534)
Q Consensus 88 ~~~~~~~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~------~~~~~~~N~~~cg~~ 154 (534)
+|+.|+|++|++++.+|..|..+++|+.|+|++|+|+ .+|..+. +.+.+.+|||.|...
T Consensus 498 -------~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~-~~p~~~~~l~~~L~~l~l~~N~~~c~c~ 562 (606)
T 3vq2_A 498 -------RLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIE-TSKGILQHFPKSLAFFNLTNNSVACICE 562 (606)
T ss_dssp -------TCCEEECCSSCCSCEEGGGTTTCTTCCEEECTTSCCC-CEESCGGGSCTTCCEEECCSCCCCCSST
T ss_pred -------cCCEEECCCCcCCCcCHHHccCCCcCCEEECCCCcCc-ccCHhHhhhcccCcEEEccCCCcccCCc
Confidence 8899999999999888999999999999999999999 5665432 456889999998543
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.59 E-value=2.6e-15 Score=136.89 Aligned_cols=108 Identities=20% Similarity=0.224 Sum_probs=95.8
Q ss_pred EEEEecCCCceeecccccccCCCCCEEEccCCccCcCCCCCCCCCCCCCEEEcCCCcCccccCchhhhcccCcccccccc
Q 039819 11 IGLGAPSQSLSGTLSGSIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFLSIWLPRKWDKRK 90 (534)
Q Consensus 11 ~~L~l~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~P~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~l~~~~~~~~ 90 (534)
+.|++++|+|+ .+|..+. ++|++|+|++|+|++..|..|.++++|++|+|++|+|++..+..|..++
T Consensus 15 ~~l~~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~---------- 81 (174)
T 2r9u_A 15 TLVNCQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLT---------- 81 (174)
T ss_dssp SEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCT----------
T ss_pred cEEEeCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcc----------
Confidence 57999999997 7888775 8999999999999988888999999999999999999976666677777
Q ss_pred cCCccccceeCCCCcCcccCChhhhcccccccccccCCCCCCCCC
Q 039819 91 CSGVDQGLLRLNNNSLSGAFPVFLAKISELAFLDLSYNNLSGPVP 135 (534)
Q Consensus 91 ~~~~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p 135 (534)
+|+.|+|++|+|++..+..|..+++|+.|+|++|.++...+
T Consensus 82 ----~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L~~N~~~c~~~ 122 (174)
T 2r9u_A 82 ----QLTQLDLNDNHLKSIPRGAFDNLKSLTHIYLYNNPWDCECR 122 (174)
T ss_dssp ----TCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCBCTTBG
T ss_pred ----hhhEEECCCCccceeCHHHhccccCCCEEEeCCCCcccccc
Confidence 88999999999996666679999999999999999995443
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.59 E-value=1.2e-15 Score=153.76 Aligned_cols=115 Identities=19% Similarity=0.197 Sum_probs=79.9
Q ss_pred CcEEEEEecCCCceeeccccccc---------CCCCCEEEccCCccCcCCCCCCCCCCCCCEEEcCCCcCccccCchhhh
Q 039819 8 NLVIGLGAPSQSLSGTLSGSIGN---------LTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFL 78 (534)
Q Consensus 8 ~~l~~L~l~~n~l~g~~p~~~~~---------l~~L~~L~L~~N~l~g~~P~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~ 78 (534)
.+++.|+|++|++.+.+|..++. +++|++|+|++|+|+ .+|..|+++++|++|+|++|+|++ +|..+..
T Consensus 150 ~~L~~L~L~~n~~~~~~p~~~~~~~~~~~~~~l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~~-l~~~l~~ 227 (328)
T 4fcg_A 150 NRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSA-LGPAIHH 227 (328)
T ss_dssp TTCCEEEEEEETTCCCCCSCSEEEC-CCCEEESTTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSCCCC-CCGGGGG
T ss_pred cCCCEEECCCCCCccccChhHhhccchhhhccCCCCCEEECcCCCcC-cchHhhcCCCCCCEEEccCCCCCc-Cchhhcc
Confidence 46778888887777777776654 788888888888887 777778888888888888888884 5556666
Q ss_pred cccCcccccccccCCccccceeCCCCcCcccCChhhhcccccccccccCCCCCCCCCCCC
Q 039819 79 SIWLPRKWDKRKCSGVDQGLLRLNNNSLSGAFPVFLAKISELAFLDLSYNNLSGPVPKFP 138 (534)
Q Consensus 79 l~~l~~~~~~~~~~~~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~ 138 (534)
++ +|+.|+|++|.+.+.+|..|+.+++|+.|+|++|++.+.+|..+
T Consensus 228 l~--------------~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~~p~~~ 273 (328)
T 4fcg_A 228 LP--------------KLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDI 273 (328)
T ss_dssp CT--------------TCCEEECTTCTTCCBCCCCTTCCCCCCEEECTTCTTCCBCCTTG
T ss_pred CC--------------CCCEEECcCCcchhhhHHHhcCCCCCCEEECCCCCchhhcchhh
Confidence 66 55556666666655666666666666666666666655555443
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.58 E-value=3.7e-15 Score=139.70 Aligned_cols=115 Identities=20% Similarity=0.214 Sum_probs=102.1
Q ss_pred CcEEEEEecCCCceeecccccccCCCCCEEEccCCccCcCCCCCCCCCCCCCEEEcCCCcCccccCchhhhcccCccccc
Q 039819 8 NLVIGLGAPSQSLSGTLSGSIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFLSIWLPRKWD 87 (534)
Q Consensus 8 ~~l~~L~l~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~P~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~l~~~~~ 87 (534)
.+|+.|+|++|+|++..+..|.++++|++|+|++|+|++..+..|..+++|++|+|++|+|++..+..+..++
T Consensus 52 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~------- 124 (208)
T 2o6s_A 52 TSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLT------- 124 (208)
T ss_dssp TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCT-------
T ss_pred ccCcEEECCCCccCccChhhcCCCCCcCEEECCCCcCCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCC-------
Confidence 5799999999999976667789999999999999999966666689999999999999999977777777777
Q ss_pred ccccCCccccceeCCCCcCcccCChhhhcccccccccccCCCCCCCCCC
Q 039819 88 KRKCSGVDQGLLRLNNNSLSGAFPVFLAKISELAFLDLSYNNLSGPVPK 136 (534)
Q Consensus 88 ~~~~~~~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~ 136 (534)
+|+.|+|++|+|++..+..|..+++|+.|+|++|.+.+..|.
T Consensus 125 -------~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~ 166 (208)
T 2o6s_A 125 -------QLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCTCPG 166 (208)
T ss_dssp -------TCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCCCTTT
T ss_pred -------cCCEEECCCCccceeCHHHhccCCCccEEEecCCCeecCCCC
Confidence 889999999999977777799999999999999999987764
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.58 E-value=1.1e-15 Score=162.34 Aligned_cols=128 Identities=19% Similarity=0.185 Sum_probs=82.8
Q ss_pred CcEEEEEecCCCceeecccccccCCCCCEEEccCCccCcCCCCCCC-CCCCCCEEEcCCCcCccccCchhhhcccCcccc
Q 039819 8 NLVIGLGAPSQSLSGTLSGSIGNLTNLRQVLLQNNNISGGIPPQLG-SLPKLQTLDLSNNRLSGVIPALLFLSIWLPRKW 86 (534)
Q Consensus 8 ~~l~~L~l~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~P~~~~-~l~~L~~L~Ls~N~l~g~~p~~~~~l~~l~~~~ 86 (534)
.+|+.|+|++|+|++..|..|+++++|++|+|++|+|++.+|..|. .+++|++|+|++|.|++..+.. .+
T Consensus 120 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l~~~~~~~--~l------- 190 (487)
T 3oja_A 120 QGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDVKGQV--VF------- 190 (487)
T ss_dssp SSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEEECCC--CC-------
T ss_pred CCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEecCCCccccccccc--cC-------
Confidence 3455555555555554455555555555555555555554444443 4555555555555555432111 12
Q ss_pred cccccCCccccceeCCCCcCcccCChhhhcccccccccccCCCCCCCCCCCCC-----ccccccCCcceecC
Q 039819 87 DKRKCSGVDQGLLRLNNNSLSGAFPVFLAKISELAFLDLSYNNLSGPVPKFPA-----RTFNVAGNPLICGS 153 (534)
Q Consensus 87 ~~~~~~~~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~-----~~~~~~~N~~~cg~ 153 (534)
.+|+.|+|++|.|++ +|..|..+++|+.|+|++|+|++ +|..+. ..+.+.+|++.|+.
T Consensus 191 -------~~L~~L~Ls~N~l~~-~~~~~~~l~~L~~L~Ls~N~l~~-lp~~l~~l~~L~~L~l~~N~l~c~~ 253 (487)
T 3oja_A 191 -------AKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFHCGT 253 (487)
T ss_dssp -------TTCCEEECCSSCCCE-ECGGGGGGTTCSEEECTTSCCCE-ECTTCCCCTTCCEEECTTCCBCHHH
T ss_pred -------CCCCEEECCCCCCCC-CCHhHcCCCCccEEEecCCcCcc-cchhhccCCCCCEEEcCCCCCcCcc
Confidence 288999999999995 55569999999999999999996 565443 56789999999864
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.58 E-value=6.4e-15 Score=144.35 Aligned_cols=73 Identities=16% Similarity=0.106 Sum_probs=47.8
Q ss_pred CcEEEEEecCCCceeecccccccCCCCCEEEccCCccCcCCCCCCCCCCCCCEEEcCCCcCccccCchhhhcc
Q 039819 8 NLVIGLGAPSQSLSGTLSGSIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFLSI 80 (534)
Q Consensus 8 ~~l~~L~l~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~P~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~ 80 (534)
.+++.|+|++|+|++..+..|+++++|++|+|++|+|++..|..|.++++|++|+|++|++++..+..+..++
T Consensus 52 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~ 124 (276)
T 2z62_A 52 PELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLK 124 (276)
T ss_dssp TTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTSCCCCSTTCCCTTCT
T ss_pred cCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEEECCCCCccccCchhcccCC
Confidence 3566777777777765555677777777777777777665556666667777777777766655544555555
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.57 E-value=2.7e-15 Score=135.69 Aligned_cols=113 Identities=27% Similarity=0.236 Sum_probs=101.0
Q ss_pred CCcEEEEEecCCCce-eecccccccCCCCCEEEccCCccCcCCCCCCCCCCCCCEEEcCCCcCccccCchhhhcccCccc
Q 039819 7 ENLVIGLGAPSQSLS-GTLSGSIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFLSIWLPRK 85 (534)
Q Consensus 7 ~~~l~~L~l~~n~l~-g~~p~~~~~l~~L~~L~L~~N~l~g~~P~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~l~~~ 85 (534)
..+|+.|+|++|+|+ +.+|..|..+++|++|+|++|.|++. ..|..+++|++|+|++|+|++.+|..+..++
T Consensus 23 ~~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~----- 95 (168)
T 2ell_A 23 PAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLP----- 95 (168)
T ss_dssp TTSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCT-----
T ss_pred cccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCC-----
Confidence 467999999999998 78999999999999999999999964 7899999999999999999988888887788
Q ss_pred ccccccCCccccceeCCCCcCcccC-ChhhhcccccccccccCCCCCCCCC
Q 039819 86 WDKRKCSGVDQGLLRLNNNSLSGAF-PVFLAKISELAFLDLSYNNLSGPVP 135 (534)
Q Consensus 86 ~~~~~~~~~~L~~L~L~~N~l~g~~-p~~~~~l~~L~~L~ls~N~l~g~~p 135 (534)
+|+.|+|++|.|++.. +..+..+++|+.|++++|.+++..+
T Consensus 96 ---------~L~~L~Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~ 137 (168)
T 2ell_A 96 ---------NLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLND 137 (168)
T ss_dssp ---------TCCEEECBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTT
T ss_pred ---------CCCEEeccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHH
Confidence 8889999999998532 2789999999999999999996544
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.57 E-value=5.6e-15 Score=154.87 Aligned_cols=144 Identities=17% Similarity=0.119 Sum_probs=94.6
Q ss_pred CcEEEEEecCCCceeecccccccCCCCCEEEccCC-ccCcCCCCCCCCCCCCCEEEcCCCcCccccCchhhhcccCcccc
Q 039819 8 NLVIGLGAPSQSLSGTLSGSIGNLTNLRQVLLQNN-NISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFLSIWLPRKW 86 (534)
Q Consensus 8 ~~l~~L~l~~n~l~g~~p~~~~~l~~L~~L~L~~N-~l~g~~P~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~l~~~~ 86 (534)
.+|+.|+|++|+|++..+..|.++++|++|+|++| .++...+..|.++++|++|+|++|+|+ .+|. +..+..|..+.
T Consensus 136 ~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~-~~~~-~~~l~~L~~L~ 213 (440)
T 3zyj_A 136 SKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EIPN-LTPLIKLDELD 213 (440)
T ss_dssp SSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCCEEECTTSCCS-SCCC-CTTCSSCCEEE
T ss_pred ccCceeeCCCCcccccCHHHhhhCcccCEeCCCCCCCcceeCcchhhcccccCeecCCCCcCc-cccc-cCCCcccCEEE
Confidence 46777777777777655556666666666666663 333222234556666666666666655 3342 33333333322
Q ss_pred cccc---------c-CCccccceeCCCCcCcccCChhhhcccccccccccCCCCCCCCCCCCC-----ccccccCCccee
Q 039819 87 DKRK---------C-SGVDQGLLRLNNNSLSGAFPVFLAKISELAFLDLSYNNLSGPVPKFPA-----RTFNVAGNPLIC 151 (534)
Q Consensus 87 ~~~~---------~-~~~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~-----~~~~~~~N~~~c 151 (534)
.+++ + ...+|+.|+|++|+|++..|..|..+++|+.|+|++|+|++..+..+. +.+.+.+|||.|
T Consensus 214 Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~C 293 (440)
T 3zyj_A 214 LSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPWNC 293 (440)
T ss_dssp CTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTSSTTCTTCCEEECTTSCCCCCCTTTTSSCTTCCEEECCSSCEEC
T ss_pred CCCCccCccChhhhccCccCCEEECCCCceeEEChhhhcCCCCCCEEECCCCCCCccChhHhccccCCCEEEcCCCCccC
Confidence 1111 0 112789999999999988899999999999999999999966655443 567899999999
Q ss_pred cC
Q 039819 152 GS 153 (534)
Q Consensus 152 g~ 153 (534)
..
T Consensus 294 dC 295 (440)
T 3zyj_A 294 NC 295 (440)
T ss_dssp SS
T ss_pred CC
Confidence 54
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.57 E-value=7.9e-15 Score=144.39 Aligned_cols=128 Identities=22% Similarity=0.183 Sum_probs=105.4
Q ss_pred CcEEEEEecCCCceeecccccccCCCCCEEEccCCccCcCCCCCCCCCCCCCEEEcCCCc-CccccCchhhhcccCcccc
Q 039819 8 NLVIGLGAPSQSLSGTLSGSIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNR-LSGVIPALLFLSIWLPRKW 86 (534)
Q Consensus 8 ~~l~~L~l~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~P~~~~~l~~L~~L~Ls~N~-l~g~~p~~~~~l~~l~~~~ 86 (534)
.+++.|+|++|+|++..+..|+++++|++|+|++|+|++..|..|.++++|++|+|++|+ ++...|..+..++
T Consensus 32 ~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~l~~~~~~~~~~l~------ 105 (285)
T 1ozn_A 32 AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLG------ 105 (285)
T ss_dssp TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCT------
T ss_pred CCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCCCCCccccCHHHhcCCc------
Confidence 468999999999998777889999999999999999998778899999999999999997 8866678887777
Q ss_pred cccccCCccccceeCCCCcCcccCChhhhcccccccccccCCCCCCCCCCCCC-----ccccccCCcc
Q 039819 87 DKRKCSGVDQGLLRLNNNSLSGAFPVFLAKISELAFLDLSYNNLSGPVPKFPA-----RTFNVAGNPL 149 (534)
Q Consensus 87 ~~~~~~~~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~-----~~~~~~~N~~ 149 (534)
+|+.|+|++|.+++..|..|..+++|+.|+|++|++++..+..+. +.+.+.+|.+
T Consensus 106 --------~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l 165 (285)
T 1ozn_A 106 --------RLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRI 165 (285)
T ss_dssp --------TCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCC
T ss_pred --------CCCEEECCCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEEECCCCcc
Confidence 778888888888877788888888888888888888865554332 4456666654
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.57 E-value=6.1e-15 Score=140.63 Aligned_cols=114 Identities=20% Similarity=0.111 Sum_probs=102.3
Q ss_pred CCcEEEEEecCCCceeecccccccCCCCCEEEccCCccCcCCCCCCCCCCCCCEEEcCCCcCccccCchhhhcccCcccc
Q 039819 7 ENLVIGLGAPSQSLSGTLSGSIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFLSIWLPRKW 86 (534)
Q Consensus 7 ~~~l~~L~l~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~P~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~l~~~~ 86 (534)
..+|+.|+|++|+|++..+..|.++++|++|+|++|+|++..|..|..+++|++|+|++|+|+ .+|..+..++
T Consensus 63 l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~------ 135 (229)
T 3e6j_A 63 LINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTNQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLT------ 135 (229)
T ss_dssp CTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCT------
T ss_pred ccCCcEEECCCCCCCCcChhhcccCCCcCEEECCCCcCCccChhHhCcchhhCeEeccCCccc-ccCcccccCC------
Confidence 357999999999998666677899999999999999999766667899999999999999999 8888888777
Q ss_pred cccccCCccccceeCCCCcCcccCChhhhcccccccccccCCCCCCCCC
Q 039819 87 DKRKCSGVDQGLLRLNNNSLSGAFPVFLAKISELAFLDLSYNNLSGPVP 135 (534)
Q Consensus 87 ~~~~~~~~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p 135 (534)
+|+.|+|++|+|++..+..|..+++|+.|+|++|.+++..+
T Consensus 136 --------~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~ 176 (229)
T 3e6j_A 136 --------HLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGNPWDCECR 176 (229)
T ss_dssp --------TCSEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCBCTTBG
T ss_pred --------CCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCCccCCcc
Confidence 88999999999997777889999999999999999997655
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.57 E-value=6.1e-15 Score=144.49 Aligned_cols=111 Identities=17% Similarity=0.046 Sum_probs=87.7
Q ss_pred CcEEEEEecCCCceeecccccccCCCCCEEEccCCccCcCCCCCCCCCCCCCEEEcCCCcCccccCchhhhcccCccccc
Q 039819 8 NLVIGLGAPSQSLSGTLSGSIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFLSIWLPRKWD 87 (534)
Q Consensus 8 ~~l~~L~l~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~P~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~l~~~~~ 87 (534)
..++.|+|++|+|++..+..|.++++|++|+|++|+|++..|..|.++++|++|+|++|+|++..|..+..++
T Consensus 28 ~~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~------- 100 (276)
T 2z62_A 28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLS------- 100 (276)
T ss_dssp TTCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCT-------
T ss_pred CCccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcCCc-------
Confidence 3699999999999987777999999999999999999977777899999999999999999988888888887
Q ss_pred ccccCCccccceeCCCCcCcccCChhhhcccccccccccCCCCCC
Q 039819 88 KRKCSGVDQGLLRLNNNSLSGAFPVFLAKISELAFLDLSYNNLSG 132 (534)
Q Consensus 88 ~~~~~~~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g 132 (534)
+|+.|+|++|.+++..+..++.+++|+.|+|++|++++
T Consensus 101 -------~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~ 138 (276)
T 2z62_A 101 -------SLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQS 138 (276)
T ss_dssp -------TCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCC
T ss_pred -------cccEEECCCCCccccCchhcccCCCCCEEECcCCccce
Confidence 45555555555554444455555555555555555553
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.57 E-value=6.6e-15 Score=144.14 Aligned_cols=129 Identities=19% Similarity=0.171 Sum_probs=104.0
Q ss_pred CcEEEEEecCCCceeecccccccCCCCCEEEccCCccCcCCCCCCCCCCCCCEEEcCCCcCccccCchhhhcccCccccc
Q 039819 8 NLVIGLGAPSQSLSGTLSGSIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFLSIWLPRKWD 87 (534)
Q Consensus 8 ~~l~~L~l~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~P~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~l~~~~~ 87 (534)
.+++.|+|++|+|++..+..|+++++|++|+|++|+|++..|..|+.+++|++|+|++|+|++..|..+..++.|..+..
T Consensus 85 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l 164 (272)
T 3rfs_A 85 TNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDL 164 (272)
T ss_dssp TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCCCEEECCCCccCccChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEEEC
Confidence 46888888888888777777888888888888888888666666888888888888888888777766777766665543
Q ss_pred ccc-c---------CCccccceeCCCCcCcccCChhhhcccccccccccCCCCCCCCCC
Q 039819 88 KRK-C---------SGVDQGLLRLNNNSLSGAFPVFLAKISELAFLDLSYNNLSGPVPK 136 (534)
Q Consensus 88 ~~~-~---------~~~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~ 136 (534)
+.+ . ...+|+.|+|++|+|++..|..|..+++|+.|+|++|.+++..|.
T Consensus 165 ~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~ 223 (272)
T 3rfs_A 165 SYNQLQSLPEGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCTCPG 223 (272)
T ss_dssp CSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTTT
T ss_pred CCCCcCccCHHHhcCCccCCEEECCCCcCCccCHHHHhCCcCCCEEEccCCCccccCcH
Confidence 221 1 113799999999999988888899999999999999999988775
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.56 E-value=2.5e-15 Score=151.33 Aligned_cols=125 Identities=22% Similarity=0.238 Sum_probs=111.8
Q ss_pred CcEEEEEecCCCceeecccccccCCCCCEEEccCCccCcCCCCCCCC---------CCCCCEEEcCCCcCccccCchhhh
Q 039819 8 NLVIGLGAPSQSLSGTLSGSIGNLTNLRQVLLQNNNISGGIPPQLGS---------LPKLQTLDLSNNRLSGVIPALLFL 78 (534)
Q Consensus 8 ~~l~~L~l~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~P~~~~~---------l~~L~~L~Ls~N~l~g~~p~~~~~ 78 (534)
.+++.|+|++|+|+ .+|..|+++++|++|+|++|++.+.+|..++. +++|++|+|++|+|+ .+|..+..
T Consensus 127 ~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~L~~n~~~~~~p~~~~~~~~~~~~~~l~~L~~L~L~~n~l~-~lp~~l~~ 204 (328)
T 4fcg_A 127 AGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIAN 204 (328)
T ss_dssp TTCSEEEEESCCCC-CCCGGGGGCTTCCEEEEEEETTCCCCCSCSEEEC-CCCEEESTTCCEEEEEEECCC-CCCGGGGG
T ss_pred CCCCEEECCCCccc-cCcHHHhcCcCCCEEECCCCCCccccChhHhhccchhhhccCCCCCEEECcCCCcC-cchHhhcC
Confidence 47999999999999 88999999999999999999999999998875 999999999999999 88988888
Q ss_pred cccCcccccccccCCccccceeCCCCcCcccCChhhhcccccccccccCCCCCCCCCCCCC-----ccccccCCcc
Q 039819 79 SIWLPRKWDKRKCSGVDQGLLRLNNNSLSGAFPVFLAKISELAFLDLSYNNLSGPVPKFPA-----RTFNVAGNPL 149 (534)
Q Consensus 79 l~~l~~~~~~~~~~~~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~-----~~~~~~~N~~ 149 (534)
++ +|+.|+|++|+++ .+|..|+.+++|+.|+|++|++.+.+|..+. +.+.+.+|..
T Consensus 205 l~--------------~L~~L~L~~N~l~-~l~~~l~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~~ 265 (328)
T 4fcg_A 205 LQ--------------NLKSLKIRNSPLS-ALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSN 265 (328)
T ss_dssp CT--------------TCCEEEEESSCCC-CCCGGGGGCTTCCEEECTTCTTCCBCCCCTTCCCCCCEEECTTCTT
T ss_pred CC--------------CCCEEEccCCCCC-cCchhhccCCCCCEEECcCCcchhhhHHHhcCCCCCCEEECCCCCc
Confidence 87 8899999999999 5777899999999999999999999997654 4567777654
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.56 E-value=1e-14 Score=142.52 Aligned_cols=112 Identities=26% Similarity=0.331 Sum_probs=86.3
Q ss_pred CcEEEEEecCCCceeecccccccCCCCCEEEccCCccCcCCCCCCCCCCCCCEEEcCCCcCccccCchhhhcccCccccc
Q 039819 8 NLVIGLGAPSQSLSGTLSGSIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFLSIWLPRKWD 87 (534)
Q Consensus 8 ~~l~~L~l~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~P~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~l~~~~~ 87 (534)
..++.|+|++|+|++..+..|+++++|++|+|++|+|+...+..|.++++|++|+|++|+|++..+..+..++
T Consensus 37 ~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~------- 109 (270)
T 2o6q_A 37 ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTDNKLQALPIGVFDQLV------- 109 (270)
T ss_dssp TTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCCTTTTSSCTTCCEEECCSSCCCCCCTTTTTTCS-------
T ss_pred CCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeChhhhcCCCCCCEEECCCCcCCcCCHhHccccc-------
Confidence 4689999999999977777999999999999999999955455578999999999999999977777777777
Q ss_pred ccccCCccccceeCCCCcCcccCChhhhcccccccccccCCCCCCC
Q 039819 88 KRKCSGVDQGLLRLNNNSLSGAFPVFLAKISELAFLDLSYNNLSGP 133 (534)
Q Consensus 88 ~~~~~~~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~ 133 (534)
+|+.|+|++|++++..|..|..+++|+.|+|++|++++.
T Consensus 110 -------~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~ 148 (270)
T 2o6q_A 110 -------NLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQSL 148 (270)
T ss_dssp -------SCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCC
T ss_pred -------CCCEEECCCCccCeeCHHHhCcCcCCCEEECCCCcCCcc
Confidence 555566666666555555555555666666666655543
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.55 E-value=1.4e-14 Score=143.27 Aligned_cols=125 Identities=26% Similarity=0.238 Sum_probs=99.1
Q ss_pred CcEEEEEecCCCceeecccccccCCCCCEEEccCCccCcCCCCCCCCCCCCCEEEcCCCcCccccCchhhhcccCccccc
Q 039819 8 NLVIGLGAPSQSLSGTLSGSIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFLSIWLPRKWD 87 (534)
Q Consensus 8 ~~l~~L~l~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~P~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~l~~~~~ 87 (534)
..++.|+|++|+|++..|..|.++++|++|+|++|+|++ +|.. +.+++|++|+|++|+|+ .+|..+..++
T Consensus 31 ~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~-~~~~-~~l~~L~~L~Ls~N~l~-~l~~~~~~l~------- 100 (290)
T 1p9a_G 31 KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTK-LQVD-GTLPVLGTLDLSHNQLQ-SLPLLGQTLP------- 100 (290)
T ss_dssp TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCE-EECC-SCCTTCCEEECCSSCCS-SCCCCTTTCT-------
T ss_pred CCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCc-ccCC-CCCCcCCEEECCCCcCC-cCchhhccCC-------
Confidence 579999999999999888999999999999999999995 5543 88999999999999999 7888777777
Q ss_pred ccccCCccccceeCCCCcCcccCChhhhcccccccccccCCCCCCCCCCCCC-----ccccccCCcc
Q 039819 88 KRKCSGVDQGLLRLNNNSLSGAFPVFLAKISELAFLDLSYNNLSGPVPKFPA-----RTFNVAGNPL 149 (534)
Q Consensus 88 ~~~~~~~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~-----~~~~~~~N~~ 149 (534)
+|+.|+|++|+|++..|..|..+++|+.|+|++|+|++..+..+. +.+.+++|.+
T Consensus 101 -------~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l 160 (290)
T 1p9a_G 101 -------ALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNL 160 (290)
T ss_dssp -------TCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCC
T ss_pred -------CCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEEECCCCcC
Confidence 667777777777766666777777777777777777754443322 3455666654
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=99.55 E-value=2.9e-15 Score=164.51 Aligned_cols=127 Identities=24% Similarity=0.355 Sum_probs=108.9
Q ss_pred CcEEEEEecCCCceee-----------------cccccc--cCCCCCEEEccCCccCcCCCCCCCCCCCCCEEEcCCCc-
Q 039819 8 NLVIGLGAPSQSLSGT-----------------LSGSIG--NLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNR- 67 (534)
Q Consensus 8 ~~l~~L~l~~n~l~g~-----------------~p~~~~--~l~~L~~L~L~~N~l~g~~P~~~~~l~~L~~L~Ls~N~- 67 (534)
.+++.|+|++|+|+|. +|..|+ ++++|++|+|++|+++|.+|.+|++|++|++|+|++|+
T Consensus 206 ~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~~ 285 (636)
T 4eco_A 206 TKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRG 285 (636)
T ss_dssp TTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEECCTTCSSCCTTTTTCSSCCEEECTTCTT
T ss_pred cCCCEEECcCCccccccccccccccccchhcccCchhhhhcccCCCCEEEecCCcCCccChHHHhcCCCCCEEECcCCCC
Confidence 5799999999999986 999999 99999999999999999999999999999999999999
Q ss_pred Ccc-ccCchhhhc------ccCcccccccccCCccccceeCCCCcCcccCCh--hhhcccccccccccCCCCCCCCCCCC
Q 039819 68 LSG-VIPALLFLS------IWLPRKWDKRKCSGVDQGLLRLNNNSLSGAFPV--FLAKISELAFLDLSYNNLSGPVPKFP 138 (534)
Q Consensus 68 l~g-~~p~~~~~l------~~l~~~~~~~~~~~~~L~~L~L~~N~l~g~~p~--~~~~l~~L~~L~ls~N~l~g~~p~~~ 138 (534)
|+| .+|..++.+ + +|+.|+|++|+++ .+|. .|+.+++|+.|+|++|+++|.+| .+
T Consensus 286 l~~~~lp~~~~~L~~~~~l~--------------~L~~L~L~~n~l~-~ip~~~~l~~l~~L~~L~L~~N~l~g~ip-~~ 349 (636)
T 4eco_A 286 ISGEQLKDDWQALADAPVGE--------------KIQIIYIGYNNLK-TFPVETSLQKMKKLGMLECLYNQLEGKLP-AF 349 (636)
T ss_dssp SCHHHHHHHHHHHHHSGGGG--------------TCCEEECCSSCCS-SCCCHHHHTTCTTCCEEECCSCCCEEECC-CC
T ss_pred CccccchHHHHhhhccccCC--------------CCCEEECCCCcCC-ccCchhhhccCCCCCEEeCcCCcCccchh-hh
Confidence 999 899988876 5 6777888888888 7777 78888888888888888887777 33
Q ss_pred C-----ccccccCCcce
Q 039819 139 A-----RTFNVAGNPLI 150 (534)
Q Consensus 139 ~-----~~~~~~~N~~~ 150 (534)
. +.+.+.+|.+.
T Consensus 350 ~~l~~L~~L~L~~N~l~ 366 (636)
T 4eco_A 350 GSEIKLASLNLAYNQIT 366 (636)
T ss_dssp EEEEEESEEECCSSEEE
T ss_pred CCCCCCCEEECCCCccc
Confidence 2 45566666554
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=99.55 E-value=9.2e-15 Score=159.39 Aligned_cols=143 Identities=17% Similarity=0.164 Sum_probs=114.7
Q ss_pred CcEEEEEecCCCceeecccccccCCCCCEEEccCCccCcCCCCCCCCCCCCCEEEcCCCcCccccCchhhhcccCccccc
Q 039819 8 NLVIGLGAPSQSLSGTLSGSIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFLSIWLPRKWD 87 (534)
Q Consensus 8 ~~l~~L~l~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~P~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~l~~~~~ 87 (534)
..++.|+|++|+|++..+..|+++++|++|+|++|+|++..|.+|.++++|++|+|++|+|++..|..|..+.+|..+..
T Consensus 32 ~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L 111 (606)
T 3vq2_A 32 SSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVA 111 (606)
T ss_dssp TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCCCCTTSSTTCTTCCEEEC
T ss_pred CCcCEEECCCCCcCEeChhhccCCccCcEEeCCCCcccccCHHHhhchhhcCEeECCCCcccccChhhcCCcccCCEEEc
Confidence 57999999999999888889999999999999999999888889999999999999999999888999988887665533
Q ss_pred ccc-c---------CCccccceeCCCCcCcc-cCChhhhcccccccccccCCCCCCCCCCCCC---------ccccccCC
Q 039819 88 KRK-C---------SGVDQGLLRLNNNSLSG-AFPVFLAKISELAFLDLSYNNLSGPVPKFPA---------RTFNVAGN 147 (534)
Q Consensus 88 ~~~-~---------~~~~L~~L~L~~N~l~g-~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~---------~~~~~~~N 147 (534)
+.. . ...+|+.|+|++|.+++ .+|..|+++++|+.|+|++|++++..|..+. ..+.+.+|
T Consensus 112 ~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~~l~~L~l~~n 191 (606)
T 3vq2_A 112 VETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLN 191 (606)
T ss_dssp TTSCCCCSSSSCCTTCTTCCEEECCSSCCCCCCCCGGGGTCTTCCEEECCSSCCCEECTTTTHHHHHCTTCCCEEECTTC
T ss_pred cCCccccccccccCCCCCCCEEeCCCCcccceechHhHhhcCCCCEEEccCCcceecChhhhhhhhccccccceeeccCC
Confidence 221 1 11367888888888875 5688888888888888888888876665443 14566677
Q ss_pred cce
Q 039819 148 PLI 150 (534)
Q Consensus 148 ~~~ 150 (534)
.+.
T Consensus 192 ~l~ 194 (606)
T 3vq2_A 192 PID 194 (606)
T ss_dssp CCC
T ss_pred Ccc
Confidence 654
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.54 E-value=1e-14 Score=154.40 Aligned_cols=128 Identities=16% Similarity=0.149 Sum_probs=101.6
Q ss_pred CcEEEEEecCCCceeecccccccCCCCCEEEccCCccCcCCCCCCCCCCCCCEEEcCCCcCccccCchhhhcccCccccc
Q 039819 8 NLVIGLGAPSQSLSGTLSGSIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFLSIWLPRKWD 87 (534)
Q Consensus 8 ~~l~~L~l~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~P~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~l~~~~~ 87 (534)
..++.|+|++|+|++..|..|.++++|++|+|++|+|++..|.+|.+|++|++|+|++|+|++..+..|..++
T Consensus 32 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~------- 104 (477)
T 2id5_A 32 TETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRLKLIPLGVFTGLS------- 104 (477)
T ss_dssp TTCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCSCCTTSSTTCT-------
T ss_pred CCCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCCCcCCccCcccccCCC-------
Confidence 4789999999999988889999999999999999999988899999999999999999999966666677777
Q ss_pred ccccCCccccceeCCCCcCcccCChhhhcccccccccccCCCCCCCCCCCCC-----ccccccCCcc
Q 039819 88 KRKCSGVDQGLLRLNNNSLSGAFPVFLAKISELAFLDLSYNNLSGPVPKFPA-----RTFNVAGNPL 149 (534)
Q Consensus 88 ~~~~~~~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~-----~~~~~~~N~~ 149 (534)
+|+.|+|++|++++..|..|..+++|+.|+|++|++++..|..+. +.+.+.+|.+
T Consensus 105 -------~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l 164 (477)
T 2id5_A 105 -------NLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNL 164 (477)
T ss_dssp -------TCCEEECTTSCCCEECTTTTTTCTTCCEEEECCTTCCEECTTSSTTCTTCCEEEEESCCC
T ss_pred -------CCCEEECCCCccccCChhHccccccCCEEECCCCccceeChhhccCCCCCCEEECCCCcC
Confidence 666777777777766677777777777777777777655544332 3344555543
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=99.53 E-value=1.4e-14 Score=157.85 Aligned_cols=111 Identities=22% Similarity=0.063 Sum_probs=92.4
Q ss_pred CcEEEEEecCCCceeecccccccCCCCCEEEccCCccCcCCCCCCCCCCCCCEEEcCCCcCccccCchhhhcccCccccc
Q 039819 8 NLVIGLGAPSQSLSGTLSGSIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFLSIWLPRKWD 87 (534)
Q Consensus 8 ~~l~~L~l~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~P~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~l~~~~~ 87 (534)
..++.|+|++|+|++..|.+|+++++|++|+|++|+|++..|.+|.++++|++|+|++|++++..|..|..++
T Consensus 33 ~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~------- 105 (606)
T 3t6q_A 33 NSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPK------- 105 (606)
T ss_dssp TTCCEEECTTCCCSEECTTTSTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCSEECTTTTSSCT-------
T ss_pred CcCcEEEccCCccCcCChhHhccCccceEEECCCCccceeChhhccCccccCeeeCCCCcccccChhhhcccc-------
Confidence 5799999999999988899999999999999999999988899999999999999999999999899998888
Q ss_pred ccccCCccccceeCCCCcCcccCChhhhcccccccccccCCCCCC
Q 039819 88 KRKCSGVDQGLLRLNNNSLSGAFPVFLAKISELAFLDLSYNNLSG 132 (534)
Q Consensus 88 ~~~~~~~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g 132 (534)
+|++|+|++|++++..|..|+.+++|++|+|++|++++
T Consensus 106 -------~L~~L~L~~n~i~~l~~~~~~~l~~L~~L~L~~n~l~~ 143 (606)
T 3t6q_A 106 -------ALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISS 143 (606)
T ss_dssp -------TCCEEECTTSCCSCGGGSCCTTCTTCCEEECCSSCCCC
T ss_pred -------cccEeeccccCcccCCcchhccCCcccEEECCCCcccc
Confidence 55566666666665445556666666666666666654
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.53 E-value=6.6e-15 Score=158.97 Aligned_cols=109 Identities=25% Similarity=0.218 Sum_probs=100.4
Q ss_pred cEEEEEecCCCceeecccccccCCCCCEEEccCCccCcCCCCCCCCCCCCCEEEcCCCcCccccCchhhhcccCcccccc
Q 039819 9 LVIGLGAPSQSLSGTLSGSIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFLSIWLPRKWDK 88 (534)
Q Consensus 9 ~l~~L~l~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~P~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~l~~~~~~ 88 (534)
.++.|+|++|+|++ +|. |++|++|+.|+|++|+|+ .+|..|++|++|+.|+|++|+|++ +| .+..++
T Consensus 442 ~L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~-lp-~l~~l~-------- 508 (567)
T 1dce_A 442 DVRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLP-------- 508 (567)
T ss_dssp TCSEEECTTSCCSS-CCC-GGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCS--------
T ss_pred CceEEEecCCCCCC-CcC-ccccccCcEeecCccccc-ccchhhhcCCCCCEEECCCCCCCC-Cc-ccCCCC--------
Confidence 57889999999996 776 999999999999999999 899999999999999999999996 67 777777
Q ss_pred cccCCccccceeCCCCcCcccC-ChhhhcccccccccccCCCCCCCCCC
Q 039819 89 RKCSGVDQGLLRLNNNSLSGAF-PVFLAKISELAFLDLSYNNLSGPVPK 136 (534)
Q Consensus 89 ~~~~~~~L~~L~L~~N~l~g~~-p~~~~~l~~L~~L~ls~N~l~g~~p~ 136 (534)
+|+.|+|++|+|++.. |..|+.+++|+.|+|++|+|++.+|.
T Consensus 509 ------~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~ 551 (567)
T 1dce_A 509 ------RLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGI 551 (567)
T ss_dssp ------SCCEEECCSSCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSSC
T ss_pred ------CCcEEECCCCCCCCCCCcHHHhcCCCCCEEEecCCcCCCCccH
Confidence 8899999999999877 99999999999999999999976653
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=99.53 E-value=6.7e-15 Score=160.50 Aligned_cols=144 Identities=23% Similarity=0.178 Sum_probs=112.2
Q ss_pred CcEEEEEecCCCceeecccc-cccCCCCCEEEccCCccCcCCCCCCCCCCCCCEEEcCCCcCccc---cCchhhhcccCc
Q 039819 8 NLVIGLGAPSQSLSGTLSGS-IGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGV---IPALLFLSIWLP 83 (534)
Q Consensus 8 ~~l~~L~l~~n~l~g~~p~~-~~~l~~L~~L~L~~N~l~g~~P~~~~~l~~L~~L~Ls~N~l~g~---~p~~~~~l~~l~ 83 (534)
.+++.|+|++|++++..|.. |.++++|++|+|++|.+++..|..|..+++|++|+|++|+|++. .+..+..++.|.
T Consensus 400 ~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~L~ 479 (606)
T 3t6q_A 400 PQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLE 479 (606)
T ss_dssp TTCSEEECTTCCEECCTTCCTTTTCTTCCEEECTTCCCBTTCTTTTTTCTTCCEEECTTCBCGGGEECSSCGGGGCTTCC
T ss_pred ccCCeEECCCCcCCCcccchhhhCcccCCEEECCCCccCCcCHHHHhCCCCCCEEECCCCCCCccccccchhhccCCCcc
Confidence 46888899999988776654 88888999999999998887888888888999999999988862 224566666655
Q ss_pred ccccccc---------c-CCccccceeCCCCcCcccCChhhhcccccccccccCCCCCCCCCCCCC-----ccccccCCc
Q 039819 84 RKWDKRK---------C-SGVDQGLLRLNNNSLSGAFPVFLAKISELAFLDLSYNNLSGPVPKFPA-----RTFNVAGNP 148 (534)
Q Consensus 84 ~~~~~~~---------~-~~~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~-----~~~~~~~N~ 148 (534)
.+..+.+ + ...+|+.|+|++|++++..|..|..++.| .|+|++|++++.+|..+. +.+.+.+||
T Consensus 480 ~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L-~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~ 558 (606)
T 3t6q_A 480 ILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHISIILPSLLPILSQQRTINLRQNP 558 (606)
T ss_dssp EEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCGGGGGGGTTCCSC-EEECCSSCCCCCCGGGHHHHHTSSEEECTTCC
T ss_pred EEECCCCccCccChhhhccccCCCEEECCCCccCcCChhHhCccccc-EEECcCCcccccCHhhcccCCCCCEEeCCCCC
Confidence 5432211 1 11378899999999998899999999999 999999999987776433 678899999
Q ss_pred ceec
Q 039819 149 LICG 152 (534)
Q Consensus 149 ~~cg 152 (534)
|.|.
T Consensus 559 ~~c~ 562 (606)
T 3t6q_A 559 LDCT 562 (606)
T ss_dssp EECS
T ss_pred cccc
Confidence 9884
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.52 E-value=1.6e-14 Score=156.23 Aligned_cols=144 Identities=19% Similarity=0.196 Sum_probs=117.1
Q ss_pred CCcEEEEEecCCCceeecccccccCCCCCEEEccCCccCc--CCCCCCCCCCCCCEEEcCCCcCccccCc-hhhhcccCc
Q 039819 7 ENLVIGLGAPSQSLSGTLSGSIGNLTNLRQVLLQNNNISG--GIPPQLGSLPKLQTLDLSNNRLSGVIPA-LLFLSIWLP 83 (534)
Q Consensus 7 ~~~l~~L~l~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g--~~P~~~~~l~~L~~L~Ls~N~l~g~~p~-~~~~l~~l~ 83 (534)
..+++.|+|++|++++.+|..|+++++|++|+|++|+|++ .+|..|.++++|++|+|++|+|++.+|. .+..++.|.
T Consensus 352 l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~L~ 431 (562)
T 3a79_B 352 PSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESIL 431 (562)
T ss_dssp CCCCCEEECCSSCCCTTTTTTCCSCSSCCEEECCSSCCCBTTHHHHTTTTCTTCCEEECTTSCCBSCCSSCCCCCCTTCC
T ss_pred CCCceEEECCCCccccchhhhhcccCCCCEEECCCCCcCCcccchhhhcCCCCCCEEECCCCcCCCccChhhhcCcccCC
Confidence 4579999999999999899999999999999999999996 3457899999999999999999985665 455666655
Q ss_pred ccccccc-cC-----C--ccccceeCCCCcCcccCChhhhcccccccccccCCCCCCCCCCC-CC-----ccccccCCcc
Q 039819 84 RKWDKRK-CS-----G--VDQGLLRLNNNSLSGAFPVFLAKISELAFLDLSYNNLSGPVPKF-PA-----RTFNVAGNPL 149 (534)
Q Consensus 84 ~~~~~~~-~~-----~--~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~-~~-----~~~~~~~N~~ 149 (534)
.+..+++ .. . .+|+.|+|++|+|+ .+|..+..+++|+.|+|++|+|+ .+|.. +. +.+.+++|||
T Consensus 432 ~L~l~~n~l~~~~~~~l~~~L~~L~L~~N~l~-~ip~~~~~l~~L~~L~L~~N~l~-~l~~~~~~~l~~L~~L~l~~N~~ 509 (562)
T 3a79_B 432 VLNLSSNMLTGSVFRCLPPKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLK-SVPDGVFDRLTSLQYIWLHDNPW 509 (562)
T ss_dssp EEECCSSCCCGGGGSSCCTTCSEEECCSSCCC-CCCTTTTSSCCCSEEECCSSCCC-CCCTTSTTTCTTCCCEECCSCCB
T ss_pred EEECCCCCCCcchhhhhcCcCCEEECCCCcCc-ccChhhcCCCCCCEEECCCCCCC-CCCHHHHhcCCCCCEEEecCCCc
Confidence 5433221 11 1 38999999999999 88888889999999999999999 45554 32 5678999999
Q ss_pred eec
Q 039819 150 ICG 152 (534)
Q Consensus 150 ~cg 152 (534)
.|.
T Consensus 510 ~c~ 512 (562)
T 3a79_B 510 DCT 512 (562)
T ss_dssp CCC
T ss_pred CCC
Confidence 884
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.52 E-value=1.4e-14 Score=156.67 Aligned_cols=145 Identities=17% Similarity=0.112 Sum_probs=111.7
Q ss_pred CcEEEEEecCCCceeecccccccCCCCCEEEccCCccCcCCC-CCCCCCCCCCEEEcCCCcCccccCchhhhcccCcccc
Q 039819 8 NLVIGLGAPSQSLSGTLSGSIGNLTNLRQVLLQNNNISGGIP-PQLGSLPKLQTLDLSNNRLSGVIPALLFLSIWLPRKW 86 (534)
Q Consensus 8 ~~l~~L~l~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~P-~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~l~~~~ 86 (534)
.+++.|+|++|++++..+ .|+.+++|++|+|++|++++..| ..|.++++|++|+|++|++++.+|..+..++.|..+.
T Consensus 373 ~~L~~L~l~~n~l~~~~~-~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ 451 (570)
T 2z63_A 373 TSLKYLDLSFNGVITMSS-NFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLK 451 (570)
T ss_dssp SCCCEEECCSCSEEEEEE-EEETCTTCCEEECTTSEEESCTTSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEE
T ss_pred CccCEEECCCCccccccc-cccccCCCCEEEccCCccccccchhhhhcCCCCCEEeCcCCcccccchhhhhcCCcCcEEE
Confidence 467888888888885444 48888888888888888886555 4577888888888888888877777777776665543
Q ss_pred cccc-c----------CCccccceeCCCCcCcccCChhhhcccccccccccCCCCCCCCCCCCC-----ccccccCCcce
Q 039819 87 DKRK-C----------SGVDQGLLRLNNNSLSGAFPVFLAKISELAFLDLSYNNLSGPVPKFPA-----RTFNVAGNPLI 150 (534)
Q Consensus 87 ~~~~-~----------~~~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~-----~~~~~~~N~~~ 150 (534)
.++. . ...+|+.|+|++|++++..|..|..+++|+.|+|++|++++.+|..+. +.+.+.+|||.
T Consensus 452 l~~n~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~ 531 (570)
T 2z63_A 452 MAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWD 531 (570)
T ss_dssp CTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBC
T ss_pred CcCCcCccccchhhhhcccCCCEEECCCCccccCChhhhhcccCCCEEeCCCCcCCCCCHHHhhcccCCcEEEecCCccc
Confidence 2221 0 113789999999999988899999999999999999999987776543 56788999998
Q ss_pred ecC
Q 039819 151 CGS 153 (534)
Q Consensus 151 cg~ 153 (534)
|..
T Consensus 532 ~~~ 534 (570)
T 2z63_A 532 CSC 534 (570)
T ss_dssp CCT
T ss_pred CCC
Confidence 853
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.52 E-value=1.3e-14 Score=155.15 Aligned_cols=144 Identities=23% Similarity=0.237 Sum_probs=116.5
Q ss_pred CCcEEEEEecCCCceeecccccccCCCCCEEEccCCccCc--CCCCCCCCCCCCCEEEcCCCcCccccCch-hhhcccCc
Q 039819 7 ENLVIGLGAPSQSLSGTLSGSIGNLTNLRQVLLQNNNISG--GIPPQLGSLPKLQTLDLSNNRLSGVIPAL-LFLSIWLP 83 (534)
Q Consensus 7 ~~~l~~L~l~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g--~~P~~~~~l~~L~~L~Ls~N~l~g~~p~~-~~~l~~l~ 83 (534)
..+++.|+|++|++++.+|..|+.+++|++|+|++|+|++ .+|..|+.+++|++|+|++|++++.+|.. +..++.|.
T Consensus 323 l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~ 402 (520)
T 2z7x_B 323 ISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLL 402 (520)
T ss_dssp CCCCCEEECCSSCCCTTTTTTCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGGGCSCCCCTTCC
T ss_pred CCcccEEEeECCccChhhhhhhccCCCCCEEEccCCccCccccchHHHhhCCCCCEEECCCCcCCcccccchhccCccCC
Confidence 3578999999999998889999999999999999999996 56778999999999999999999856654 55555555
Q ss_pred ccccccc-cC-------CccccceeCCCCcCcccCChhhhcccccccccccCCCCCCCCCCC-CC-----ccccccCCcc
Q 039819 84 RKWDKRK-CS-------GVDQGLLRLNNNSLSGAFPVFLAKISELAFLDLSYNNLSGPVPKF-PA-----RTFNVAGNPL 149 (534)
Q Consensus 84 ~~~~~~~-~~-------~~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~-~~-----~~~~~~~N~~ 149 (534)
.+..+++ .. ..+|+.|+|++|+|+ .+|..+..+++|+.|+|++|+|+ .+|.. +. +.+.+.+|||
T Consensus 403 ~L~Ls~N~l~~~~~~~l~~~L~~L~Ls~N~l~-~ip~~~~~l~~L~~L~L~~N~l~-~l~~~~~~~l~~L~~L~l~~N~~ 480 (520)
T 2z7x_B 403 SLNMSSNILTDTIFRCLPPRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLK-SVPDGIFDRLTSLQKIWLHTNPW 480 (520)
T ss_dssp EEECCSSCCCGGGGGSCCTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCB
T ss_pred EEECcCCCCCcchhhhhcccCCEEECCCCccc-ccchhhhcCCCCCEEECCCCcCC-ccCHHHhccCCcccEEECcCCCC
Confidence 5432221 11 148999999999999 89998889999999999999999 46653 32 5678999999
Q ss_pred eec
Q 039819 150 ICG 152 (534)
Q Consensus 150 ~cg 152 (534)
.|.
T Consensus 481 ~c~ 483 (520)
T 2z7x_B 481 DCS 483 (520)
T ss_dssp CCC
T ss_pred ccc
Confidence 884
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=99.51 E-value=2.1e-14 Score=150.89 Aligned_cols=115 Identities=19% Similarity=0.169 Sum_probs=107.9
Q ss_pred CcEEEEEecCCCceeecccccccCCCCCEEEccCCccCcCCCCCCCCCCCCCEEEcCCCcCccccCchhhhcccCccccc
Q 039819 8 NLVIGLGAPSQSLSGTLSGSIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFLSIWLPRKWD 87 (534)
Q Consensus 8 ~~l~~L~l~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~P~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~l~~~~~ 87 (534)
.+++.|+|++|+|++..|..|+++++|++|+|++|+|++..|..|.++++|++|+|++|+|++..|..+..++
T Consensus 299 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~------- 371 (455)
T 3v47_A 299 TDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLP------- 371 (455)
T ss_dssp TTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGGTTCTTCCEEECCSSCCCEECTTTTTTCT-------
T ss_pred CCCCEEECCCCcccccChhHhcCcccCCEEECCCCccCCcChhHhcCcccCCEEECCCCcccccChhhccccc-------
Confidence 5799999999999998899999999999999999999988888999999999999999999988899998888
Q ss_pred ccccCCccccceeCCCCcCcccCChhhhcccccccccccCCCCCCCCCC
Q 039819 88 KRKCSGVDQGLLRLNNNSLSGAFPVFLAKISELAFLDLSYNNLSGPVPK 136 (534)
Q Consensus 88 ~~~~~~~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~ 136 (534)
+|+.|+|++|+|++..+..|..+++|+.|+|++|++++..|.
T Consensus 372 -------~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~ 413 (455)
T 3v47_A 372 -------NLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPR 413 (455)
T ss_dssp -------TCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTTT
T ss_pred -------cccEEECCCCccccCCHhHhccCCcccEEEccCCCcccCCCc
Confidence 899999999999977777889999999999999999998885
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.50 E-value=2e-14 Score=143.63 Aligned_cols=142 Identities=18% Similarity=0.083 Sum_probs=84.9
Q ss_pred CcEEEEEecCCCceeeccccc--ccCCCCCEEEccCCccCcCCCCCCCCC-----CCCCEEEcCCCcCccccCchhhhcc
Q 039819 8 NLVIGLGAPSQSLSGTLSGSI--GNLTNLRQVLLQNNNISGGIPPQLGSL-----PKLQTLDLSNNRLSGVIPALLFLSI 80 (534)
Q Consensus 8 ~~l~~L~l~~n~l~g~~p~~~--~~l~~L~~L~L~~N~l~g~~P~~~~~l-----~~L~~L~Ls~N~l~g~~p~~~~~l~ 80 (534)
.+++.|+|++|+|++.+|..+ +.+++|++|+|++|+|++. |..|+.+ ++|++|+|++|+|++..|..+..++
T Consensus 95 ~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~ 173 (312)
T 1wwl_A 95 SGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFP 173 (312)
T ss_dssp SCCCEEEEEEEBCBSCCCCCSSSCCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCS
T ss_pred CCccEEEccCCcccchhHHHHHHhcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCC
Confidence 356666666666666666654 6666666666666666644 5555555 6666666666666655556665555
Q ss_pred cCccccccccc--------------CCccccceeCCCCcCcc--cCC-hhhhcccccccccccCCCCCCCCCCC-C----
Q 039819 81 WLPRKWDKRKC--------------SGVDQGLLRLNNNSLSG--AFP-VFLAKISELAFLDLSYNNLSGPVPKF-P---- 138 (534)
Q Consensus 81 ~l~~~~~~~~~--------------~~~~L~~L~L~~N~l~g--~~p-~~~~~l~~L~~L~ls~N~l~g~~p~~-~---- 138 (534)
.|..+..+++. ...+|+.|+|++|+|++ .++ ..+..+++|+.|+|++|++++.+|.. .
T Consensus 174 ~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~ 253 (312)
T 1wwl_A 174 ALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPS 253 (312)
T ss_dssp SCCEEECCSCTTCHHHHHHHHSCTTSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCCSCCCCCT
T ss_pred CCCEEECCCCCcCcchHHHHHHHhccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccchhhhhhcC
Confidence 55444322111 11267778888887772 222 33456677888888888887765421 1
Q ss_pred -CccccccCCcce
Q 039819 139 -ARTFNVAGNPLI 150 (534)
Q Consensus 139 -~~~~~~~~N~~~ 150 (534)
-+.+.+++|.+.
T Consensus 254 ~L~~L~Ls~N~l~ 266 (312)
T 1wwl_A 254 QLNSLNLSFTGLK 266 (312)
T ss_dssp TCCEEECTTSCCS
T ss_pred CCCEEECCCCccC
Confidence 145566666653
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.50 E-value=4.2e-14 Score=154.14 Aligned_cols=124 Identities=15% Similarity=0.053 Sum_probs=62.8
Q ss_pred cEEEEEecCCCceeecccccccCCCCCEEEccCCccCcCCCCCCCCCCCCCEEEcCCCcCccccCchhhhcccCcccccc
Q 039819 9 LVIGLGAPSQSLSGTLSGSIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFLSIWLPRKWDK 88 (534)
Q Consensus 9 ~l~~L~l~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~P~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~l~~~~~~ 88 (534)
+++.|++++|.++...+..|+++++|++|+|++|.|++..|..|+.+++|++|+|++|.|++.+|..|..++.|..+..+
T Consensus 52 ~l~~l~l~~~~l~~lp~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 131 (597)
T 3oja_B 52 NQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLE 131 (597)
T ss_dssp CCSEEEESSCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred CceEEEeeCCCCCCcCHHHHccCCCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEEee
Confidence 34555555555554333345555555555555555554444455555555555555555555555445544421111000
Q ss_pred cc---------c-CCccccceeCCCCcCcccCChhhhcccccccccccCCCCCC
Q 039819 89 RK---------C-SGVDQGLLRLNNNSLSGAFPVFLAKISELAFLDLSYNNLSG 132 (534)
Q Consensus 89 ~~---------~-~~~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g 132 (534)
++ + ...+|+.|+|++|.|++..|..|+.+++|+.|+|++|+|++
T Consensus 132 ~n~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 185 (597)
T 3oja_B 132 RNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTH 185 (597)
T ss_dssp SSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECTTSCCSB
T ss_pred CCCCCCCCHHHhccCCCCCEEEeeCCcCCCCChhhhhcCCcCcEEECcCCCCCC
Confidence 00 0 00155566666666665555556666666666666666654
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.50 E-value=4.1e-14 Score=148.84 Aligned_cols=107 Identities=21% Similarity=0.134 Sum_probs=80.7
Q ss_pred EEEEEecCCCceeecccccccCCCCCEEEccCCccCcCCCCCCCCCCCCCEEEcCCCcCccccCchhhhcccCccccccc
Q 039819 10 VIGLGAPSQSLSGTLSGSIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFLSIWLPRKWDKR 89 (534)
Q Consensus 10 l~~L~l~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~P~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~l~~~~~~~ 89 (534)
...++.++++|+ .+|..+. ++|++|+|++|+|++..|..|.++++|+.|+|++|+|++..|..|..++
T Consensus 56 ~~~v~c~~~~l~-~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~--------- 123 (452)
T 3zyi_A 56 FSKVVCTRRGLS-EVPQGIP--SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLA--------- 123 (452)
T ss_dssp SCEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCT---------
T ss_pred CcEEEECCCCcC-ccCCCCC--CCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcc---------
Confidence 456777888887 5776554 6888888888888877778888888888888888888877777777777
Q ss_pred ccCCccccceeCCCCcCcccCChhhhcccccccccccCCCCCCC
Q 039819 90 KCSGVDQGLLRLNNNSLSGAFPVFLAKISELAFLDLSYNNLSGP 133 (534)
Q Consensus 90 ~~~~~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~ 133 (534)
+|+.|+|++|+|++..+..|..+++|+.|+|++|+++..
T Consensus 124 -----~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~ 162 (452)
T 3zyi_A 124 -----SLNTLELFDNWLTVIPSGAFEYLSKLRELWLRNNPIESI 162 (452)
T ss_dssp -----TCCEEECCSSCCSBCCTTTSSSCTTCCEEECCSCCCCEE
T ss_pred -----cCCEEECCCCcCCccChhhhcccCCCCEEECCCCCccee
Confidence 667777777777755556677777777777777777743
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.49 E-value=2.4e-14 Score=142.37 Aligned_cols=125 Identities=19% Similarity=0.122 Sum_probs=89.7
Q ss_pred CcEEEEEecCCCceeecccccccCCCCCEEEccCCccCcCCC-CCCCCCCCCCEEEcCCCcCccccCchhhhcccCcccc
Q 039819 8 NLVIGLGAPSQSLSGTLSGSIGNLTNLRQVLLQNNNISGGIP-PQLGSLPKLQTLDLSNNRLSGVIPALLFLSIWLPRKW 86 (534)
Q Consensus 8 ~~l~~L~l~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~P-~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~l~~~~ 86 (534)
.+++.|+|++|+++ .+|..|..+++|++|+|++|+|++..+ ..|..+++|++|+|++|.+++.+|..+..++.|..+.
T Consensus 78 ~~L~~L~Ls~n~i~-~l~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ 156 (306)
T 2z66_A 78 TSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLK 156 (306)
T ss_dssp SCCCEEECCSCSEE-EEEEEEETCTTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTCTTCCEEE
T ss_pred cccCEEECCCCccc-cChhhcCCCCCCCEEECCCCcccccccchhhhhccCCCEEECCCCcCCccchhhcccCcCCCEEE
Confidence 57899999999998 578889999999999999999995444 5799999999999999999988888887777444332
Q ss_pred cccc----------c-CCccccceeCCCCcCcccCChhhhcccccccccccCCCCCCC
Q 039819 87 DKRK----------C-SGVDQGLLRLNNNSLSGAFPVFLAKISELAFLDLSYNNLSGP 133 (534)
Q Consensus 87 ~~~~----------~-~~~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~ 133 (534)
.+++ + ...+|+.|+|++|++++..|..|..+++|+.|+|++|++++.
T Consensus 157 l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~ 214 (306)
T 2z66_A 157 MAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSL 214 (306)
T ss_dssp CTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCSBC
T ss_pred CCCCccccccchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEECCCCccCcc
Confidence 1110 0 012455666666666655555666666666666666666543
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.49 E-value=4.9e-14 Score=130.96 Aligned_cols=103 Identities=15% Similarity=0.203 Sum_probs=69.9
Q ss_pred cEEEEEecCCCceeecccccccCCCCCEEEccCCccCcCCCCCCCCCCCCCEEEcCCCcCccccCchhhhcccCcccccc
Q 039819 9 LVIGLGAPSQSLSGTLSGSIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFLSIWLPRKWDK 88 (534)
Q Consensus 9 ~l~~L~l~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~P~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~l~~~~~~ 88 (534)
+++.|+|++|+|+ .+| .+..+++|++|+|++|.++ .++.|..+++|++|+|++|+|++..|..+..++
T Consensus 45 ~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~n~~~--~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~-------- 112 (197)
T 4ezg_A 45 SLTYITLANINVT-DLT-GIEYAHNIKDLTINNIHAT--NYNPISGLSNLERLRIMGKDVTSDKIPNLSGLT-------- 112 (197)
T ss_dssp TCCEEEEESSCCS-CCT-TGGGCTTCSEEEEESCCCS--CCGGGTTCTTCCEEEEECTTCBGGGSCCCTTCT--------
T ss_pred CccEEeccCCCcc-ChH-HHhcCCCCCEEEccCCCCC--cchhhhcCCCCCEEEeECCccCcccChhhcCCC--------
Confidence 5677777777777 555 5777777777777777665 233677777777777777777766666666665
Q ss_pred cccCCccccceeCCCCcCcccCChhhhcccccccccccCCC
Q 039819 89 RKCSGVDQGLLRLNNNSLSGAFPVFLAKISELAFLDLSYNN 129 (534)
Q Consensus 89 ~~~~~~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~ 129 (534)
+|+.|+|++|++++..|..|+.+++|+.|+|++|+
T Consensus 113 ------~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~ 147 (197)
T 4ezg_A 113 ------SLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNG 147 (197)
T ss_dssp ------TCCEEECCSSBCBGGGHHHHTTCSSCCEEECCSCT
T ss_pred ------CCCEEEecCCccCcHhHHHHhhCCCCCEEEccCCC
Confidence 56666666666666566666666666666666666
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.49 E-value=7.6e-14 Score=146.23 Aligned_cols=139 Identities=22% Similarity=0.129 Sum_probs=77.2
Q ss_pred cEEEEEecCCCceeecccccccCCCCCEEEccCCccCcCCCCCCCCCCCCCEEEcCCCcCccccCchhhhcccCcccccc
Q 039819 9 LVIGLGAPSQSLSGTLSGSIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFLSIWLPRKWDK 88 (534)
Q Consensus 9 ~l~~L~l~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~P~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~l~~~~~~ 88 (534)
+|+.|+|++|+|++..+..|.++++|++|+|++|+|++..+..|..+++|++|+|++|+|+...+..|..++.|..+...
T Consensus 89 ~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~ 168 (440)
T 3zyj_A 89 HLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLG 168 (440)
T ss_dssp SCCEEECCSSCCCEECGGGGTTCSSCCEEECCSSCCSSCCTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEECC
T ss_pred CCCEEECCCCcCCccChhhccCCccCCEEECCCCcCCeeCHhHhhccccCceeeCCCCcccccCHHHhhhCcccCEeCCC
Confidence 45566666666665555566666666666666666664334456666666666666666665544455555544443222
Q ss_pred c----------ccC-CccccceeCCCCcCcccCChhhhcccccccccccCCCCCCCCCCCCC-----ccccccCCcc
Q 039819 89 R----------KCS-GVDQGLLRLNNNSLSGAFPVFLAKISELAFLDLSYNNLSGPVPKFPA-----RTFNVAGNPL 149 (534)
Q Consensus 89 ~----------~~~-~~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~-----~~~~~~~N~~ 149 (534)
. .+. ..+|+.|+|++|+|+ .+| .+..+++|+.|+|++|+|++..|..+. +.+.+.+|.+
T Consensus 169 ~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~-~~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l 243 (440)
T 3zyj_A 169 ELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EIP-NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQI 243 (440)
T ss_dssp CCTTCCEECTTTTTTCSSCCEEECTTSCCS-SCC-CCTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCC
T ss_pred CCCCcceeCcchhhcccccCeecCCCCcCc-ccc-ccCCCcccCEEECCCCccCccChhhhccCccCCEEECCCCce
Confidence 1 011 125666666666666 444 355666666666666666655444332 3344455543
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=99.49 E-value=2.4e-14 Score=158.34 Aligned_cols=145 Identities=22% Similarity=0.169 Sum_probs=96.8
Q ss_pred cEEEEEecCCCce--eecccccccCCCCCEEEccCCccCcCCCCCCCCCCCCCEEEcCCCcCccccCc--------hhhh
Q 039819 9 LVIGLGAPSQSLS--GTLSGSIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPA--------LLFL 78 (534)
Q Consensus 9 ~l~~L~l~~n~l~--g~~p~~~~~l~~L~~L~L~~N~l~g~~P~~~~~l~~L~~L~Ls~N~l~g~~p~--------~~~~ 78 (534)
.++.|+|++|.++ +.+|..|+++++|++|+|++|+|++..|..|.++++|++|+|++|+|++..+. .+..
T Consensus 455 ~L~~L~l~~n~l~~~~~~p~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~~~~ 534 (680)
T 1ziw_A 455 SLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKG 534 (680)
T ss_dssp TCCEEECTTSCCBCTTCSSCTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCGGGGSTTSTTSCCCTTTT
T ss_pred ccccchhccccccccccCCcccccCCCCCEEECCCCCCCcCChhhhccccccCEEeCCCCCccccchhhccCCcchhhcC
Confidence 5667777777765 45666677777777777777777755555567777777777777777643221 1344
Q ss_pred cccCcccccccc---------cC-CccccceeCCCCcCcccCChhhhcccccccccccCCCCCCCCCCCC------Cccc
Q 039819 79 SIWLPRKWDKRK---------CS-GVDQGLLRLNNNSLSGAFPVFLAKISELAFLDLSYNNLSGPVPKFP------ARTF 142 (534)
Q Consensus 79 l~~l~~~~~~~~---------~~-~~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~------~~~~ 142 (534)
++.|..+..+.+ +. ..+|+.|+|++|+|++..+..|..+++|+.|+|++|+|++..|..+ .+.+
T Consensus 535 l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~l 614 (680)
T 1ziw_A 535 LSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTEL 614 (680)
T ss_dssp CTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCCCBCCHHHHHHHHTTCSEE
T ss_pred CCCCCEEECCCCCCCCCCHHHcccccCcceeECCCCCCCcCCHhHhCCCCCCCEEECCCCcCCccChhHhcccccccCEE
Confidence 444333221110 11 1278889999999996666778889999999999999997666422 1567
Q ss_pred cccCCcceecC
Q 039819 143 NVAGNPLICGS 153 (534)
Q Consensus 143 ~~~~N~~~cg~ 153 (534)
.+.+|||.|..
T Consensus 615 ~l~~N~~~c~c 625 (680)
T 1ziw_A 615 DMRFNPFDCTC 625 (680)
T ss_dssp ECTTCCCCBCC
T ss_pred EccCCCcccCC
Confidence 89999999964
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.48 E-value=1.3e-14 Score=161.39 Aligned_cols=113 Identities=25% Similarity=0.367 Sum_probs=95.0
Q ss_pred CcEEEEEecCCCceeecccccccCCCCCEEEccCCccCcCCCCCCCCCCCCCEEEcCCCcCccccCchhhhcccCccccc
Q 039819 8 NLVIGLGAPSQSLSGTLSGSIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFLSIWLPRKWD 87 (534)
Q Consensus 8 ~~l~~L~l~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~P~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~l~~~~~ 87 (534)
..|+.|+|++|+|. .+|..+.+|++|++|+|++|+|+ .+|..|++|++|++|+|++|+|+ .+|..|+.+.
T Consensus 224 ~~L~~L~Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~------- 293 (727)
T 4b8c_D 224 QLWHALDLSNLQIF-NISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT-SLPAELGSCF------- 293 (727)
T ss_dssp CCCCEEECTTSCCS-CCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS-SCCSSGGGGT-------
T ss_pred CCCcEEECCCCCCC-CCChhhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC-ccChhhcCCC-------
Confidence 56888999999988 78888888999999999999998 78888999999999999999998 7788888887
Q ss_pred ccccCCccccceeCCCCcCcccCChhhhcccccccccccCCCCCCCCCCCC
Q 039819 88 KRKCSGVDQGLLRLNNNSLSGAFPVFLAKISELAFLDLSYNNLSGPVPKFP 138 (534)
Q Consensus 88 ~~~~~~~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~ 138 (534)
+|+.|+|++|.|+ .+|..|+.+++|+.|+|++|+|++.+|..+
T Consensus 294 -------~L~~L~L~~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~ 336 (727)
T 4b8c_D 294 -------QLKYFYFFDNMVT-TLPWEFGNLCNLQFLGVEGNPLEKQFLKIL 336 (727)
T ss_dssp -------TCSEEECCSSCCC-CCCSSTTSCTTCCCEECTTSCCCSHHHHHH
T ss_pred -------CCCEEECCCCCCC-ccChhhhcCCCccEEeCCCCccCCCChHHH
Confidence 7778888888887 778778888888888888888887766543
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.48 E-value=1.9e-14 Score=144.12 Aligned_cols=139 Identities=22% Similarity=0.190 Sum_probs=92.7
Q ss_pred cEEEEEecCCCceeecccccccCCCCCEEEccCCccCcCCCCCCCCCCCCCEEEcCCCcCccccCchhh-hcccCccccc
Q 039819 9 LVIGLGAPSQSLSGTLSGSIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLF-LSIWLPRKWD 87 (534)
Q Consensus 9 ~l~~L~l~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~P~~~~~l~~L~~L~Ls~N~l~g~~p~~~~-~l~~l~~~~~ 87 (534)
.++.|+|++|+|++..+.. +++|++|+|++|+|++..|..|+.+++|++|+|++|+|++..|..+. .++.|..+..
T Consensus 100 ~L~~L~l~~n~l~~~~~~~---~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L 176 (317)
T 3o53_A 100 SIETLHAANNNISRVSCSR---GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNL 176 (317)
T ss_dssp TCCEEECCSSCCSEEEECC---CSSCEEEECCSSCCCSGGGBCTGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEEC
T ss_pred CcCEEECCCCccCCcCccc---cCCCCEEECCCCCCCCccchhhhccCCCCEEECCCCCCCcccHHHHhhccCcCCEEEC
Confidence 4556666666666544332 45666666666666655555666666666666666666665555443 3444443322
Q ss_pred cccc--------CCccccceeCCCCcCcccCChhhhcccccccccccCCCCCCCCCCCCC-----ccccccCCcceec
Q 039819 88 KRKC--------SGVDQGLLRLNNNSLSGAFPVFLAKISELAFLDLSYNNLSGPVPKFPA-----RTFNVAGNPLICG 152 (534)
Q Consensus 88 ~~~~--------~~~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~-----~~~~~~~N~~~cg 152 (534)
+++. ...+|+.|+|++|+|+ .+|..|..+++|+.|+|++|+|+ .+|..+. +.+.+.+|++.|+
T Consensus 177 ~~N~l~~~~~~~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~L~~L~L~~N~l~-~l~~~~~~l~~L~~L~l~~N~~~~~ 252 (317)
T 3o53_A 177 QYNFIYDVKGQVVFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCG 252 (317)
T ss_dssp TTSCCCEEECCCCCTTCCEEECCSSCCC-EECGGGGGGTTCSEEECTTSCCC-EECTTCCCCTTCCEEECTTCCCBHH
T ss_pred CCCcCcccccccccccCCEEECCCCcCC-cchhhhcccCcccEEECcCCccc-chhhHhhcCCCCCEEEccCCCccCc
Confidence 1111 1238999999999999 56667999999999999999999 4665443 5678999999875
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.48 E-value=1.9e-14 Score=137.87 Aligned_cols=124 Identities=15% Similarity=0.089 Sum_probs=86.0
Q ss_pred CcEEEEEecCCCceeecccccccCCCCCEEEccCCc-cCcCCCCCCCCCCCCCEEEcCC-CcCccccCchhhhcccCccc
Q 039819 8 NLVIGLGAPSQSLSGTLSGSIGNLTNLRQVLLQNNN-ISGGIPPQLGSLPKLQTLDLSN-NRLSGVIPALLFLSIWLPRK 85 (534)
Q Consensus 8 ~~l~~L~l~~n~l~g~~p~~~~~l~~L~~L~L~~N~-l~g~~P~~~~~l~~L~~L~Ls~-N~l~g~~p~~~~~l~~l~~~ 85 (534)
..++.|+|++|+|++..+..|+++++|++|+|++|+ |++..|..|.++++|++|+|++ |+|++..|..|..++.|..+
T Consensus 31 ~~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L 110 (239)
T 2xwt_C 31 PSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFL 110 (239)
T ss_dssp TTCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEE
T ss_pred CcccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEE
Confidence 479999999999998777789999999999999997 8865566899999999999998 99997777778777744332
Q ss_pred ccccc-c-------CCcccc---ceeCCCC-cCcccCChhhhcccccc-cccccCCCCC
Q 039819 86 WDKRK-C-------SGVDQG---LLRLNNN-SLSGAFPVFLAKISELA-FLDLSYNNLS 131 (534)
Q Consensus 86 ~~~~~-~-------~~~~L~---~L~L~~N-~l~g~~p~~~~~l~~L~-~L~ls~N~l~ 131 (534)
..+++ . ...+|+ .|+|++| .+++..+..|..+++|+ .|++++|+++
T Consensus 111 ~l~~n~l~~lp~~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~ 169 (239)
T 2xwt_C 111 GIFNTGLKMFPDLTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT 169 (239)
T ss_dssp EEEEECCCSCCCCTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCCC
T ss_pred eCCCCCCccccccccccccccccEEECCCCcchhhcCcccccchhcceeEEEcCCCCCc
Confidence 21110 0 001233 5555555 55544444455555555 5555555555
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.48 E-value=2.4e-14 Score=129.41 Aligned_cols=112 Identities=22% Similarity=0.224 Sum_probs=97.7
Q ss_pred CcEEEEEecCCCceeecccccccCCCCCEEEccCCccCcCCCCCCCCCCCCCEEEcCCCcCccccC-chhhhcccCcccc
Q 039819 8 NLVIGLGAPSQSLSGTLSGSIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIP-ALLFLSIWLPRKW 86 (534)
Q Consensus 8 ~~l~~L~l~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~P~~~~~l~~L~~L~Ls~N~l~g~~p-~~~~~l~~l~~~~ 86 (534)
.+++.|+|++|+|++. ..|+.+++|++|+|++|+|++.+|..+..+++|++|+|++|+|++..+ ..+..++
T Consensus 49 ~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~l~~l~------ 120 (168)
T 2ell_A 49 VNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLE------ 120 (168)
T ss_dssp GGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEECBSSSCCSSGGGGGGSSCS------
T ss_pred CCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEeccCCccCcchhHHHHhcCC------
Confidence 4799999999999965 789999999999999999997788888889999999999999996432 5666666
Q ss_pred cccccCCccccceeCCCCcCcccCC---hhhhcccccccccccCCCCCCCCCC
Q 039819 87 DKRKCSGVDQGLLRLNNNSLSGAFP---VFLAKISELAFLDLSYNNLSGPVPK 136 (534)
Q Consensus 87 ~~~~~~~~~L~~L~L~~N~l~g~~p---~~~~~l~~L~~L~ls~N~l~g~~p~ 136 (534)
+|+.|+|++|.+++..+ ..|..+++|+.|++++|.+. .+|.
T Consensus 121 --------~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~-~~~~ 164 (168)
T 2ell_A 121 --------CLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQ-EAPD 164 (168)
T ss_dssp --------CCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTSC-BCCS
T ss_pred --------CCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCChh-hccc
Confidence 88999999999995555 48999999999999999998 4554
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=99.48 E-value=4e-14 Score=156.51 Aligned_cols=115 Identities=24% Similarity=0.205 Sum_probs=85.2
Q ss_pred CcEEEEEecCCCceeecccccccCCCCCEEEccCCccCcCCCCCCCCCCCCCEEEcCCCcCccccCchhhhcccCccccc
Q 039819 8 NLVIGLGAPSQSLSGTLSGSIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFLSIWLPRKWD 87 (534)
Q Consensus 8 ~~l~~L~l~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~P~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~l~~~~~ 87 (534)
.+|+.|+|++|+|++..+..|+++++|++|+|++|+|++..|..|++|++|++|+|++|+|++..+..|..+.
T Consensus 25 ~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~------- 97 (680)
T 1ziw_A 25 TNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCT------- 97 (680)
T ss_dssp TTCSEEECCSSCCCCCCGGGGGGGTTCSEEECCSSCCCCCCTTHHHHCTTCCEEECCSSCCCCCCTTTTTTCT-------
T ss_pred CCCcEEECCCCCCCCcCHHHHhCCCcCcEEECCCCccCccCHHHHhcccCcCEEECCCCccCccChhhhccCC-------
Confidence 4789999999999987777899999999999999999988888899999999999999999965555788777
Q ss_pred ccccCCccccceeCCCCcCcccCChhhhcccccccccccCCCCCCCCCC
Q 039819 88 KRKCSGVDQGLLRLNNNSLSGAFPVFLAKISELAFLDLSYNNLSGPVPK 136 (534)
Q Consensus 88 ~~~~~~~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~ 136 (534)
+|++|+|++|++++..|..|+.+++|++|+|++|++++..|.
T Consensus 98 -------~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~ 139 (680)
T 1ziw_A 98 -------NLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLG 139 (680)
T ss_dssp -------TCSEEECCSSCCCCCCSCTTTTCTTCCEEECCSSCCSCCCCC
T ss_pred -------CCCEEECCCCccCccChhHccccCCCCEEECCCCcccccCch
Confidence 455555555555544444555555555555555555544443
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.47 E-value=7.7e-14 Score=150.73 Aligned_cols=129 Identities=19% Similarity=0.107 Sum_probs=102.0
Q ss_pred CcEEEEEecCCCceeecccccccCCCCCEEEccCCccCcCCCCCCCCCCCCCEEEcCCCcCccccCchhhhcccCccccc
Q 039819 8 NLVIGLGAPSQSLSGTLSGSIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFLSIWLPRKWD 87 (534)
Q Consensus 8 ~~l~~L~l~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~P~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~l~~~~~ 87 (534)
..++.|+|++|+|++..+.+|.++++|++|+|++|+|++..|..|.++++|++|+|++|++++..|..|..+.+|..+..
T Consensus 28 ~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 107 (570)
T 2z63_A 28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVA 107 (570)
T ss_dssp SSCCEEECCSCCCCEECTTTTTTCSSCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEEC
T ss_pred ccccEEEccCCccCccChhHhhCCCCceEEECCCCcCCccCcccccCchhCCEEeCcCCcCCccCHhhhcCccccccccc
Confidence 46899999999999888889999999999999999999877888999999999999999999888888888886655432
Q ss_pred ccc---------c-CCccccceeCCCCcCcc-cCChhhhcccccccccccCCCCCCCCCC
Q 039819 88 KRK---------C-SGVDQGLLRLNNNSLSG-AFPVFLAKISELAFLDLSYNNLSGPVPK 136 (534)
Q Consensus 88 ~~~---------~-~~~~L~~L~L~~N~l~g-~~p~~~~~l~~L~~L~ls~N~l~g~~p~ 136 (534)
... + ...+|+.|+|++|.+++ .+|..|+++++|+.|++++|++++..|.
T Consensus 108 ~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~l~~n~l~~~~~~ 167 (570)
T 2z63_A 108 VETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCT 167 (570)
T ss_dssp TTSCCCCSTTCSCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECTTSCCCEECGG
T ss_pred cccccccCCCccccccccccEEecCCCccceecChhhhcccCCCCEEeCcCCccceecHH
Confidence 211 1 11267777777777765 4677777777777777777777755443
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=99.47 E-value=1.1e-13 Score=139.06 Aligned_cols=107 Identities=28% Similarity=0.303 Sum_probs=77.1
Q ss_pred CcEEEEEecCCCcee--ecccccccCCCCCEEEccCCccCcCCCCCCCCCCCCCEEEcCCCcCccccCchhhhcccCccc
Q 039819 8 NLVIGLGAPSQSLSG--TLSGSIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFLSIWLPRK 85 (534)
Q Consensus 8 ~~l~~L~l~~n~l~g--~~p~~~~~l~~L~~L~L~~N~l~g~~P~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~l~~~ 85 (534)
.+++.|+|++|.++. ..+..|.++++|++|+|++|+|+ .+|..+. ++|++|+|++|+|++..|..+..++
T Consensus 145 ~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~-~l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~----- 216 (330)
T 1xku_A 145 NQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGLP--PSLTELHLDGNKITKVDAASLKGLN----- 216 (330)
T ss_dssp TTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCC-SCCSSCC--TTCSEEECTTSCCCEECTGGGTTCT-----
T ss_pred ccccEEECCCCcCCccCcChhhccCCCCcCEEECCCCccc-cCCcccc--ccCCEEECCCCcCCccCHHHhcCCC-----
Confidence 478889999999863 67788899999999999999988 5777665 7888888888888877787777777
Q ss_pred ccccccCCccccceeCCCCcCcccCChhhhcccccccccccCCCCC
Q 039819 86 WDKRKCSGVDQGLLRLNNNSLSGAFPVFLAKISELAFLDLSYNNLS 131 (534)
Q Consensus 86 ~~~~~~~~~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~ 131 (534)
+|+.|+|++|.+++..|..|..+++|+.|+|++|+++
T Consensus 217 ---------~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~ 253 (330)
T 1xku_A 217 ---------NLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV 253 (330)
T ss_dssp ---------TCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS
T ss_pred ---------CCCEEECCCCcCceeChhhccCCCCCCEEECCCCcCc
Confidence 4455555555555444445555555555555555555
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=99.47 E-value=4.6e-14 Score=151.91 Aligned_cols=109 Identities=19% Similarity=0.205 Sum_probs=86.1
Q ss_pred CcEEEEEecCCCceeecccccccCCCCCEEEccCCccCcCCCCCCCCCCCCCEEEcCCCcCccccCchhhhcccCccccc
Q 039819 8 NLVIGLGAPSQSLSGTLSGSIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFLSIWLPRKWD 87 (534)
Q Consensus 8 ~~l~~L~l~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~P~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~l~~~~~ 87 (534)
..++.|+|++|+|++..|.+|+++++|++|+|++|+|++..|.+|+++++|++|+|++|+|++.+|..|..++
T Consensus 26 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~------- 98 (549)
T 2z81_A 26 AAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLS------- 98 (549)
T ss_dssp TTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCSCCHHHHTTCT-------
T ss_pred CCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccChhhccccccCCEEECCCCccCccCHHHhccCC-------
Confidence 4799999999999988899999999999999999999988888999999999999999999988777788888
Q ss_pred ccccCCccccceeCCCCcCcc-cCChhhhcccccccccccCCCC
Q 039819 88 KRKCSGVDQGLLRLNNNSLSG-AFPVFLAKISELAFLDLSYNNL 130 (534)
Q Consensus 88 ~~~~~~~~L~~L~L~~N~l~g-~~p~~~~~l~~L~~L~ls~N~l 130 (534)
+|++|+|++|.+++ .+|..|+.+++|+.|++++|++
T Consensus 99 -------~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~~ 135 (549)
T 2z81_A 99 -------SLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVET 135 (549)
T ss_dssp -------TCCEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSS
T ss_pred -------CCcEEECCCCcccccchhhhhhccCCccEEECCCCcc
Confidence 45555555555543 2344455555555555555553
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.47 E-value=2.2e-14 Score=143.28 Aligned_cols=140 Identities=24% Similarity=0.162 Sum_probs=85.1
Q ss_pred CcEEEEEecCCCceeecccccccC-----CCCCEEEccCCccCcCCCCCCCCCCCCCEEEcCCCcCccc--cCchh--hh
Q 039819 8 NLVIGLGAPSQSLSGTLSGSIGNL-----TNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGV--IPALL--FL 78 (534)
Q Consensus 8 ~~l~~L~l~~n~l~g~~p~~~~~l-----~~L~~L~L~~N~l~g~~P~~~~~l~~L~~L~Ls~N~l~g~--~p~~~--~~ 78 (534)
.+++.|+|++|+|++. |..|+.+ ++|++|+|++|+|++..|..|+++++|++|+|++|++.|. +|..+ ..
T Consensus 121 ~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~ 199 (312)
T 1wwl_A 121 PDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLK 199 (312)
T ss_dssp CCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSSCCEEECCSCTTCHHHHHHHHSCTTS
T ss_pred CCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCCCCEEECCCCCcCcchHHHHHHHhcc
Confidence 4567777777777765 6666666 6777777777777765556777777777777777776654 22233 44
Q ss_pred cccCcccccccc-cC------------CccccceeCCCCcCcccCC-hhhhcccccccccccCCCCCCCCCCCCC---cc
Q 039819 79 SIWLPRKWDKRK-CS------------GVDQGLLRLNNNSLSGAFP-VFLAKISELAFLDLSYNNLSGPVPKFPA---RT 141 (534)
Q Consensus 79 l~~l~~~~~~~~-~~------------~~~L~~L~L~~N~l~g~~p-~~~~~l~~L~~L~ls~N~l~g~~p~~~~---~~ 141 (534)
++.|..+..+++ .. ..+|+.|+|++|+|++..| ..+..+++|+.|+|++|+|+ .+|..+. +.
T Consensus 200 l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~-~ip~~~~~~L~~ 278 (312)
T 1wwl_A 200 FPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGLPAKLSV 278 (312)
T ss_dssp CTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCCSCCCCCTTCCEEECTTSCCS-SCCSSCCSEEEE
T ss_pred CCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccchhhhhhcCCCCEEECCCCccC-hhhhhccCCceE
Confidence 444444332211 11 0266777777777776554 34555677777777777777 5555433 34
Q ss_pred ccccCCcc
Q 039819 142 FNVAGNPL 149 (534)
Q Consensus 142 ~~~~~N~~ 149 (534)
+.+++|.+
T Consensus 279 L~Ls~N~l 286 (312)
T 1wwl_A 279 LDLSYNRL 286 (312)
T ss_dssp EECCSSCC
T ss_pred EECCCCCC
Confidence 45566654
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.46 E-value=6.5e-14 Score=141.90 Aligned_cols=105 Identities=24% Similarity=0.245 Sum_probs=93.8
Q ss_pred EEEecCC-CceeecccccccCCCCCEEEccC-CccCcCCCCCCCCCCCCCEEEcCCCcCccccCchhhhcccCccccccc
Q 039819 12 GLGAPSQ-SLSGTLSGSIGNLTNLRQVLLQN-NNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFLSIWLPRKWDKR 89 (534)
Q Consensus 12 ~L~l~~n-~l~g~~p~~~~~l~~L~~L~L~~-N~l~g~~P~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~l~~~~~~~ 89 (534)
.++++++ +|+ .+|. |..+++|++|+|++ |+|++..|..|++|++|+.|+|++|+|++.+|..|..++
T Consensus 12 ~v~~~~~n~l~-~ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~--------- 80 (347)
T 2ifg_A 12 GLRCTRDGALD-SLHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTP--------- 80 (347)
T ss_dssp CEECCSSCCCT-TTTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCS---------
T ss_pred EEEcCCCCCCC-ccCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCc---------
Confidence 4588888 999 5888 99999999999996 999977778899999999999999999999999999888
Q ss_pred ccCCccccceeCCCCcCcccCChhhhcccccccccccCCCCCCC
Q 039819 90 KCSGVDQGLLRLNNNSLSGAFPVFLAKISELAFLDLSYNNLSGP 133 (534)
Q Consensus 90 ~~~~~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~ 133 (534)
+|+.|+|++|+|++..|..|..++ |+.|+|++|.|+..
T Consensus 81 -----~L~~L~l~~N~l~~~~~~~~~~~~-L~~l~l~~N~~~c~ 118 (347)
T 2ifg_A 81 -----RLSRLNLSFNALESLSWKTVQGLS-LQELVLSGNPLHCS 118 (347)
T ss_dssp -----CCCEEECCSSCCSCCCSTTTCSCC-CCEEECCSSCCCCC
T ss_pred -----CCCEEeCCCCccceeCHHHcccCC-ceEEEeeCCCccCC
Confidence 889999999999976666777666 99999999999853
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.46 E-value=4.9e-14 Score=149.15 Aligned_cols=113 Identities=21% Similarity=0.186 Sum_probs=95.5
Q ss_pred CcEEEEEecCCCceeecccccccCCCCCEEEccCCccCcCCCCCCCCCCCCCEEEcCCCcCccccCchhhhcccCccccc
Q 039819 8 NLVIGLGAPSQSLSGTLSGSIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFLSIWLPRKWD 87 (534)
Q Consensus 8 ~~l~~L~l~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~P~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~l~~~~~ 87 (534)
.+|+.|+|++|+|++..|.+|+++++|++|+|++|+|++..+..|.++++|++|+|++|++++.+|..|..++
T Consensus 56 ~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~------- 128 (477)
T 2id5_A 56 PHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLY------- 128 (477)
T ss_dssp TTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCSCCTTSSTTCTTCCEEECTTSCCCEECTTTTTTCT-------
T ss_pred CCCCEEECCCCccCEeChhhhhCCccCCEEECCCCcCCccCcccccCCCCCCEEECCCCccccCChhHccccc-------
Confidence 4799999999999998899999999999999999999965555689999999999999999998898888887
Q ss_pred ccccCCccccceeCCCCcCcccCChhhhcccccccccccCCCCCCCC
Q 039819 88 KRKCSGVDQGLLRLNNNSLSGAFPVFLAKISELAFLDLSYNNLSGPV 134 (534)
Q Consensus 88 ~~~~~~~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~ 134 (534)
+|+.|+|++|.+++..|..|..+++|+.|+|++|++++..
T Consensus 129 -------~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~ 168 (477)
T 2id5_A 129 -------NLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSIP 168 (477)
T ss_dssp -------TCCEEEECCTTCCEECTTSSTTCTTCCEEEEESCCCSSCC
T ss_pred -------cCCEEECCCCccceeChhhccCCCCCCEEECCCCcCcccC
Confidence 6667777777777666777777777777777777777543
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.46 E-value=1.3e-13 Score=141.98 Aligned_cols=128 Identities=16% Similarity=0.090 Sum_probs=82.8
Q ss_pred CcEEEEEecCCCceeecccccccCCCCCEEEccCCccCcCCCCCCCCCCCCCEEEcCCCcCccccCchhhhcccCccccc
Q 039819 8 NLVIGLGAPSQSLSGTLSGSIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFLSIWLPRKWD 87 (534)
Q Consensus 8 ~~l~~L~l~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~P~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~l~~~~~ 87 (534)
.+++.|++++|.++...+..|..+++|++|+|++|+|++..|..|..+++|++|+|++|++++..|..+..++
T Consensus 45 ~~l~~l~l~~~~l~~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~------- 117 (390)
T 3o6n_A 45 NNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVP------- 117 (390)
T ss_dssp CCCSEEEEESCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCT-------
T ss_pred CCceEEEecCCchhhCChhHhcccccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCC-------
Confidence 4577777777777744334467778888888888888766666777788888888888888776666676666
Q ss_pred ccccCCccccceeCCCCcCcccCChhhhcccccccccccCCCCCCCCCCCCC-----ccccccCCcc
Q 039819 88 KRKCSGVDQGLLRLNNNSLSGAFPVFLAKISELAFLDLSYNNLSGPVPKFPA-----RTFNVAGNPL 149 (534)
Q Consensus 88 ~~~~~~~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~-----~~~~~~~N~~ 149 (534)
+|+.|+|++|+++...+..|..+++|+.|+|++|++++..|..+. +.+.+.+|.+
T Consensus 118 -------~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l 177 (390)
T 3o6n_A 118 -------LLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRL 177 (390)
T ss_dssp -------TCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTSSCTTCCEEECCSSCC
T ss_pred -------CCCEEECCCCccCcCCHHHhcCCCCCcEEECCCCccCccChhhccCCCCCCEEECCCCcC
Confidence 556666666666633333346666666666666666654444332 3344555543
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.46 E-value=1.5e-13 Score=124.58 Aligned_cols=104 Identities=20% Similarity=0.225 Sum_probs=91.4
Q ss_pred CCCEEEccCCccCcCCCCCCCCCCCCCEEEcCCCcCccccCchhhhcccCcccccccccCCccccceeCCCCcCcccCCh
Q 039819 33 NLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFLSIWLPRKWDKRKCSGVDQGLLRLNNNSLSGAFPV 112 (534)
Q Consensus 33 ~L~~L~L~~N~l~g~~P~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~l~~~~~~~~~~~~~L~~L~L~~N~l~g~~p~ 112 (534)
..+.|++++|+|+ .+|..+. ++|++|+|++|+|++..|..|..+. +|+.|+|++|+|++..|.
T Consensus 10 ~~~~l~~s~n~l~-~ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~--------------~L~~L~Ls~N~l~~l~~~ 72 (170)
T 3g39_A 10 SGTTVDCSGKSLA-SVPTGIP--TTTQVLYLYDNQITKLEPGVFDRLT--------------QLTRLDLDNNQLTVLPAG 72 (170)
T ss_dssp ETTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCT--------------TCSEEECCSSCCCCCCTT
T ss_pred CCCEEEeCCCCcC-ccCccCC--CCCcEEEcCCCcCCccChhhhcCcc--------------cCCEEECCCCCcCccChh
Confidence 4579999999999 6998775 7999999999999988898888888 889999999999977777
Q ss_pred hhhcccccccccccCCCCCCCCCCCCC-----ccccccCCcceecC
Q 039819 113 FLAKISELAFLDLSYNNLSGPVPKFPA-----RTFNVAGNPLICGS 153 (534)
Q Consensus 113 ~~~~l~~L~~L~ls~N~l~g~~p~~~~-----~~~~~~~N~~~cg~ 153 (534)
.|..+++|+.|+|++|+|++..|..+. +.+.+.+|||.|..
T Consensus 73 ~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c 118 (170)
T 3g39_A 73 VFDKLTQLTQLSLNDNQLKSIPRGAFDNLKSLTHIWLLNNPWDCAC 118 (170)
T ss_dssp TTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCBCTTB
T ss_pred hccCCCCCCEEECCCCccCEeCHHHhcCCCCCCEEEeCCCCCCCCc
Confidence 889999999999999999976665443 57789999998864
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.46 E-value=4.7e-14 Score=158.83 Aligned_cols=131 Identities=22% Similarity=0.239 Sum_probs=102.5
Q ss_pred CcEEEEEecCCCcee-----------------ecccccc--cCCCCCEEEccCCccCcCCCCCCCCCCCCCEEEcCCCc-
Q 039819 8 NLVIGLGAPSQSLSG-----------------TLSGSIG--NLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNR- 67 (534)
Q Consensus 8 ~~l~~L~l~~n~l~g-----------------~~p~~~~--~l~~L~~L~L~~N~l~g~~P~~~~~l~~L~~L~Ls~N~- 67 (534)
.+|+.|+|++|+|+| .+|..++ +|++|++|+|++|++.|.+|..|++|++|+.|+|++|+
T Consensus 448 ~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L~~L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N~~ 527 (876)
T 4ecn_A 448 TKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRG 527 (876)
T ss_dssp TTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEESCTTCCSCCGGGGGCSSCCEEECTTCTT
T ss_pred CCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccCCCCCEEECcCCCCCccChHHHhCCCCCCEEECcCCCC
Confidence 579999999999998 4999988 99999999999999999999999999999999999998
Q ss_pred Ccc-ccCchhhhcc-cCcccccccccCCccccceeCCCCcCcccCCh--hhhcccccccccccCCCCCCCCCCCCC----
Q 039819 68 LSG-VIPALLFLSI-WLPRKWDKRKCSGVDQGLLRLNNNSLSGAFPV--FLAKISELAFLDLSYNNLSGPVPKFPA---- 139 (534)
Q Consensus 68 l~g-~~p~~~~~l~-~l~~~~~~~~~~~~~L~~L~L~~N~l~g~~p~--~~~~l~~L~~L~ls~N~l~g~~p~~~~---- 139 (534)
|+| .+|..++.+. .+. ...+|+.|+|++|+|+ .+|. .|+.+++|+.|+|++|+++ .+| .+.
T Consensus 528 lsg~~iP~~i~~L~~~~~--------~l~~L~~L~Ls~N~L~-~ip~~~~l~~L~~L~~L~Ls~N~l~-~lp-~~~~L~~ 596 (876)
T 4ecn_A 528 ISAAQLKADWTRLADDED--------TGPKIQIFYMGYNNLE-EFPASASLQKMVKLGLLDCVHNKVR-HLE-AFGTNVK 596 (876)
T ss_dssp SCHHHHHHHHHHHHHCTT--------TTTTCCEEECCSSCCC-BCCCHHHHTTCTTCCEEECTTSCCC-BCC-CCCTTSE
T ss_pred cccccchHHHHhhhhccc--------ccCCccEEEeeCCcCC-ccCChhhhhcCCCCCEEECCCCCcc-cch-hhcCCCc
Confidence 999 8998887765 110 0115667777777777 6666 6777777777777777777 566 222
Q ss_pred -ccccccCCcc
Q 039819 140 -RTFNVAGNPL 149 (534)
Q Consensus 140 -~~~~~~~N~~ 149 (534)
+.+.+.+|.+
T Consensus 597 L~~L~Ls~N~l 607 (876)
T 4ecn_A 597 LTDLKLDYNQI 607 (876)
T ss_dssp ESEEECCSSCC
T ss_pred ceEEECcCCcc
Confidence 3455555554
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.45 E-value=8.7e-14 Score=129.27 Aligned_cols=124 Identities=15% Similarity=0.201 Sum_probs=103.7
Q ss_pred CcEEEEEecCCCceeecccccccCCCCCEEEccCCccCcCCCCCCCCCCCCCEEEcCCCcCccccCchhhhcccCccccc
Q 039819 8 NLVIGLGAPSQSLSGTLSGSIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFLSIWLPRKWD 87 (534)
Q Consensus 8 ~~l~~L~l~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~P~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~l~~~~~ 87 (534)
.+++.|+|++|.++ .++.|..+++|++|+|++|+|++..|..|+.|++|++|+|++|++++..|..+..++
T Consensus 66 ~~L~~L~l~~n~~~--~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~~l~~l~------- 136 (197)
T 4ezg_A 66 HNIKDLTINNIHAT--NYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLP------- 136 (197)
T ss_dssp TTCSEEEEESCCCS--CCGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCEEECCSSBCBGGGHHHHTTCS-------
T ss_pred CCCCEEEccCCCCC--cchhhhcCCCCCEEEeECCccCcccChhhcCCCCCCEEEecCCccCcHhHHHHhhCC-------
Confidence 47999999999876 345899999999999999999988899999999999999999999988888888887
Q ss_pred ccccCCccccceeCCCCcCcccCChhhhcccccccccccCCCCCCCCCCCC----CccccccCCcc
Q 039819 88 KRKCSGVDQGLLRLNNNSLSGAFPVFLAKISELAFLDLSYNNLSGPVPKFP----ARTFNVAGNPL 149 (534)
Q Consensus 88 ~~~~~~~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~----~~~~~~~~N~~ 149 (534)
+|+.|+|++|.+.+.+| .+..+++|+.|++++|++++ ++... -+.+.+.+|+.
T Consensus 137 -------~L~~L~L~~n~~i~~~~-~l~~l~~L~~L~l~~n~i~~-~~~l~~l~~L~~L~l~~N~i 193 (197)
T 4ezg_A 137 -------KVNSIDLSYNGAITDIM-PLKTLPELKSLNIQFDGVHD-YRGIEDFPKLNQLYAFSQTI 193 (197)
T ss_dssp -------SCCEEECCSCTBCCCCG-GGGGCSSCCEEECTTBCCCC-CTTGGGCSSCCEEEECBC--
T ss_pred -------CCCEEEccCCCCccccH-hhcCCCCCCEEECCCCCCcC-hHHhccCCCCCEEEeeCccc
Confidence 88999999998433676 79999999999999999996 33211 14566677764
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.45 E-value=4.9e-14 Score=140.63 Aligned_cols=141 Identities=23% Similarity=0.172 Sum_probs=85.8
Q ss_pred CcEEEEEecCCCceeecc----cccccCCCCCEEEccCCccCcCCCCCCCCCCCCCEEEcCCCcCccc--cC--chhhhc
Q 039819 8 NLVIGLGAPSQSLSGTLS----GSIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGV--IP--ALLFLS 79 (534)
Q Consensus 8 ~~l~~L~l~~n~l~g~~p----~~~~~l~~L~~L~L~~N~l~g~~P~~~~~l~~L~~L~Ls~N~l~g~--~p--~~~~~l 79 (534)
.+++.|+|++|++++..+ ..+..+++|++|+|++|+|++..|..|+++++|++|||++|++.+. ++ ..+..+
T Consensus 117 ~~L~~L~Ls~n~i~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l 196 (310)
T 4glp_A 117 LALSSLRLRNVSWATGRSWLAELQQWLKPGLKVLSIAQAHSPAFSCEQVRAFPALTSLDLSDNPGLGERGLMAALCPHKF 196 (310)
T ss_dssp BCCSSCEEESCCCSSTTSSHHHHHTTBCSCCCEEEEECCSSCCCCTTSCCCCTTCCEEECCSCTTCHHHHHHTTSCTTSS
T ss_pred CCCCEEEeecccccchhhhhHHHHhhhccCCCEEEeeCCCcchhhHHHhccCCCCCEEECCCCCCccchhhhHHHhhhcC
Confidence 467888888888887555 3456788888888888888877777888888888888888887652 22 112344
Q ss_pred ccCcccccccc-c------------CCccccceeCCCCcCcccCChhhhcc---cccccccccCCCCCCCCCCCCC---c
Q 039819 80 IWLPRKWDKRK-C------------SGVDQGLLRLNNNSLSGAFPVFLAKI---SELAFLDLSYNNLSGPVPKFPA---R 140 (534)
Q Consensus 80 ~~l~~~~~~~~-~------------~~~~L~~L~L~~N~l~g~~p~~~~~l---~~L~~L~ls~N~l~g~~p~~~~---~ 140 (534)
+.|..+..+++ . ...+|+.|+|++|+|++..|..+..+ ++|+.|+|++|+|+ .+|..+. +
T Consensus 197 ~~L~~L~Ls~N~l~~l~~~~~~l~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~l~-~lp~~~~~~L~ 275 (310)
T 4glp_A 197 PAIQNLALRNTGMETPTGVCAALAAAGVQPHSLDLSHNSLRATVNPSAPRCMWSSALNSLNLSFAGLE-QVPKGLPAKLR 275 (310)
T ss_dssp CCCCSCBCCSSCCCCHHHHHHHHHHHTCCCSSEECTTSCCCCCCCSCCSSCCCCTTCCCEECCSSCCC-SCCSCCCSCCS
T ss_pred CCCCEEECCCCCCCchHHHHHHHHhcCCCCCEEECCCCCCCccchhhHHhccCcCcCCEEECCCCCCC-chhhhhcCCCC
Confidence 43332221110 0 00255666666666665556555554 46666666666666 4444332 3
Q ss_pred cccccCCcc
Q 039819 141 TFNVAGNPL 149 (534)
Q Consensus 141 ~~~~~~N~~ 149 (534)
.+++++|.+
T Consensus 276 ~L~Ls~N~l 284 (310)
T 4glp_A 276 VLDLSSNRL 284 (310)
T ss_dssp CEECCSCCC
T ss_pred EEECCCCcC
Confidence 445555544
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.45 E-value=8.9e-14 Score=141.28 Aligned_cols=126 Identities=20% Similarity=0.227 Sum_probs=88.6
Q ss_pred cEEEEEecCCCceeecccccccCCCCCEEEccCCccCcCCCCCCCCCCCCCEEEcCCCcCccccCchhhhcccCcccccc
Q 039819 9 LVIGLGAPSQSLSGTLSGSIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFLSIWLPRKWDK 88 (534)
Q Consensus 9 ~l~~L~l~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~P~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~l~~~~~~ 88 (534)
+++.|+|++|+|++..+..|.++++|++|+|++|+|++..|..|.++++|++|+|++|+|++..+..+..++
T Consensus 53 ~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~-------- 124 (353)
T 2z80_A 53 AVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLS-------- 124 (353)
T ss_dssp TCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSSCCHHHHTTCT--------
T ss_pred cCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccCHhhcCCCCCCCEEECCCCcCCcCCHhHhCCCc--------
Confidence 678888888888866666788888888888888888876677788888888888888888854444466666
Q ss_pred cccCCccccceeCCCCcCcccCCh--hhhcccccccccccCCC-CCCCCCCCCC-----ccccccCCcc
Q 039819 89 RKCSGVDQGLLRLNNNSLSGAFPV--FLAKISELAFLDLSYNN-LSGPVPKFPA-----RTFNVAGNPL 149 (534)
Q Consensus 89 ~~~~~~~L~~L~L~~N~l~g~~p~--~~~~l~~L~~L~ls~N~-l~g~~p~~~~-----~~~~~~~N~~ 149 (534)
+|+.|+|++|+++ .+|. .|..+++|+.|++++|+ +++..|..+. +.+.+.+|.+
T Consensus 125 ------~L~~L~L~~n~l~-~l~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l 186 (353)
T 2z80_A 125 ------SLTFLNLLGNPYK-TLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDL 186 (353)
T ss_dssp ------TCSEEECTTCCCS-SSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTC
T ss_pred ------cCCEEECCCCCCc-ccCchhhhccCCCCcEEECCCCccccccCHHHccCCCCCCEEECCCCCc
Confidence 6777777777777 4444 67777777777777774 5433333332 3345555543
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.45 E-value=1e-13 Score=157.23 Aligned_cols=143 Identities=19% Similarity=0.114 Sum_probs=111.0
Q ss_pred CCcEEEEEecCCCceeecccccccCCCCCEEEccCCccCcCC-CCCCCCCCCCCEEEcCCCcCccccCchhhhcccCccc
Q 039819 7 ENLVIGLGAPSQSLSGTLSGSIGNLTNLRQVLLQNNNISGGI-PPQLGSLPKLQTLDLSNNRLSGVIPALLFLSIWLPRK 85 (534)
Q Consensus 7 ~~~l~~L~l~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~-P~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~l~~~ 85 (534)
..+++.|+|++|+|++..|..|+++++|++|+|++|.+.+.+ |.+|.+|++|++|+|++|+|++..|..|..+.+|..+
T Consensus 23 p~~l~~LdLs~N~i~~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 102 (844)
T 3j0a_A 23 LNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFEL 102 (844)
T ss_dssp CTTCCEEEEESCCCCEECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCCCCEECTTSSCSCSSCCCE
T ss_pred CCCcCEEECCCCcCCccChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCcCcccCHhHccCCcccCEe
Confidence 467999999999999988999999999999999999776666 7789999999999999999998889999888866554
Q ss_pred ccccc-----------c-CCccccceeCCCCcCcccCC-hhhhcccccccccccCCCCCCCCCCCCC-------cccccc
Q 039819 86 WDKRK-----------C-SGVDQGLLRLNNNSLSGAFP-VFLAKISELAFLDLSYNNLSGPVPKFPA-------RTFNVA 145 (534)
Q Consensus 86 ~~~~~-----------~-~~~~L~~L~L~~N~l~g~~p-~~~~~l~~L~~L~ls~N~l~g~~p~~~~-------~~~~~~ 145 (534)
..+.+ + ...+|+.|+|++|.+++..| ..|+++++|+.|+|++|++++..|..+. +.+.+.
T Consensus 103 ~Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i~~~~~~~l~~l~~~~L~~L~L~ 182 (844)
T 3j0a_A 103 RLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLA 182 (844)
T ss_dssp ECTTCCCSSCCSTTCCCSSCSSCCEEEEESCCCCCCCCCGGGGTCSSCCEEEEESSCCCCCCSGGGHHHHHCSSCCCEEC
T ss_pred eCcCCCCCcccccCccccccCCCCEEECCCCcccccccchhHhhCCCCCEEECCCCcCCeeCHHHcccccCCccceEECC
Confidence 32211 1 11367788888888876554 5678888888888888888776665432 345666
Q ss_pred CCcc
Q 039819 146 GNPL 149 (534)
Q Consensus 146 ~N~~ 149 (534)
+|.+
T Consensus 183 ~n~l 186 (844)
T 3j0a_A 183 ANSL 186 (844)
T ss_dssp CSBS
T ss_pred CCcc
Confidence 6655
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.44 E-value=2e-13 Score=124.34 Aligned_cols=110 Identities=22% Similarity=0.195 Sum_probs=94.5
Q ss_pred CCcEEEEEecCCCceeecccccccCC-CCCEEEccCCccCcCCCCCCCCCCCCCEEEcCCCcCccccCchhhhcccCccc
Q 039819 7 ENLVIGLGAPSQSLSGTLSGSIGNLT-NLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFLSIWLPRK 85 (534)
Q Consensus 7 ~~~l~~L~l~~n~l~g~~p~~~~~l~-~L~~L~L~~N~l~g~~P~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~l~~~ 85 (534)
..+++.|+|++|+|+ .+|. +..+. +|++|+|++|+|++. ..|..+++|++|+|++|+|++..|..+..++
T Consensus 18 ~~~L~~L~l~~n~l~-~i~~-~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~----- 88 (176)
T 1a9n_A 18 AVRDRELDLRGYKIP-VIEN-LGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALP----- 88 (176)
T ss_dssp TTSCEEEECTTSCCC-SCCC-GGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCT-----
T ss_pred cCCceEEEeeCCCCc-hhHH-hhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCC-----
Confidence 457999999999999 4554 55655 999999999999964 6899999999999999999976666668887
Q ss_pred ccccccCCccccceeCCCCcCcccCCh--hhhcccccccccccCCCCCCCCCC
Q 039819 86 WDKRKCSGVDQGLLRLNNNSLSGAFPV--FLAKISELAFLDLSYNNLSGPVPK 136 (534)
Q Consensus 86 ~~~~~~~~~~L~~L~L~~N~l~g~~p~--~~~~l~~L~~L~ls~N~l~g~~p~ 136 (534)
+|+.|+|++|+|+ .+|. .+..+++|+.|++++|.++ .+|.
T Consensus 89 ---------~L~~L~L~~N~i~-~~~~~~~l~~l~~L~~L~l~~N~i~-~~~~ 130 (176)
T 1a9n_A 89 ---------DLTELILTNNSLV-ELGDLDPLASLKSLTYLCILRNPVT-NKKH 130 (176)
T ss_dssp ---------TCCEEECCSCCCC-CGGGGGGGGGCTTCCEEECCSSGGG-GSTT
T ss_pred ---------CCCEEECCCCcCC-cchhhHhhhcCCCCCEEEecCCCCC-CcHh
Confidence 8899999999997 6776 8999999999999999998 4443
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.44 E-value=1.3e-13 Score=150.35 Aligned_cols=107 Identities=18% Similarity=0.153 Sum_probs=69.1
Q ss_pred cCCCCCEEEccCCccCcCCCCCCCCCCCCCEEEcCCCcCccccCchhhhcccCcccccccc-c---------CCccccce
Q 039819 30 NLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFLSIWLPRKWDKRK-C---------SGVDQGLL 99 (534)
Q Consensus 30 ~l~~L~~L~L~~N~l~g~~P~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~l~~~~~~~~-~---------~~~~L~~L 99 (534)
.+.+|+.|+|++|.++...|..|.++++|++|+|++|.|++..|..|..++.|..+..+.+ . ...+|+.|
T Consensus 49 ~l~~l~~l~l~~~~l~~lp~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 128 (597)
T 3oja_B 49 TLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVL 128 (597)
T ss_dssp GGCCCSEEEESSCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEE
T ss_pred cCCCceEEEeeCCCCCCcCHHHHccCCCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEE
Confidence 4789999999999999544444788999999999999999888888988884443322110 0 01245555
Q ss_pred eCCCCcCcccCChhhhcccccccccccCCCCCCCCCC
Q 039819 100 RLNNNSLSGAFPVFLAKISELAFLDLSYNNLSGPVPK 136 (534)
Q Consensus 100 ~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~ 136 (534)
+|++|.|++..|..|+.+++|+.|+|++|++++.+|.
T Consensus 129 ~L~~n~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~ 165 (597)
T 3oja_B 129 VLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDD 165 (597)
T ss_dssp ECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTT
T ss_pred EeeCCCCCCCCHHHhccCCCCCEEEeeCCcCCCCChh
Confidence 5555555533333345555555555555555544443
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=99.44 E-value=3.6e-13 Score=135.53 Aligned_cols=64 Identities=30% Similarity=0.295 Sum_probs=47.9
Q ss_pred cEEEEEecCCCceeecccccccCCCCCEEEccCCccCcCCCCCCCCCCCCCEEEcCCCcCccccC
Q 039819 9 LVIGLGAPSQSLSGTLSGSIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIP 73 (534)
Q Consensus 9 ~l~~L~l~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~P~~~~~l~~L~~L~Ls~N~l~g~~p 73 (534)
.++.|+|++|+|++..|..|+++++|++|+|++|+|++..|.+|+++++|++|+|++|+|+ .+|
T Consensus 55 ~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~l~ 118 (332)
T 2ft3_A 55 DTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNHLV-EIP 118 (332)
T ss_dssp TCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEECCSSCCC-SCC
T ss_pred CCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEECCCCcCC-ccC
Confidence 5777788888877666667777778888888877777666777777777777777777776 444
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.44 E-value=4.5e-14 Score=124.87 Aligned_cols=105 Identities=21% Similarity=0.240 Sum_probs=93.1
Q ss_pred CCcEEEEEecCCCceeecccccccCCCCCEEEccCCccCcCCCCCCCCCCCCCEEEcCCCcCccc-cCchhhhcccCccc
Q 039819 7 ENLVIGLGAPSQSLSGTLSGSIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGV-IPALLFLSIWLPRK 85 (534)
Q Consensus 7 ~~~l~~L~l~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~P~~~~~l~~L~~L~Ls~N~l~g~-~p~~~~~l~~l~~~ 85 (534)
..+++.|+|++|+|++. ..|+++++|++|+|++|+|++.+|..+..+++|++|+|++|+|++. .|..+..++
T Consensus 41 l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~ls~N~i~~~~~~~~~~~l~----- 113 (149)
T 2je0_A 41 FEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLE----- 113 (149)
T ss_dssp CTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEECTTSCCCSHHHHGGGGGCT-----
T ss_pred cCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEECCCCcCCChHHHHHHhhCC-----
Confidence 35799999999999975 7899999999999999999977898888899999999999999964 347777777
Q ss_pred ccccccCCccccceeCCCCcCcccCC---hhhhcccccccccccC
Q 039819 86 WDKRKCSGVDQGLLRLNNNSLSGAFP---VFLAKISELAFLDLSY 127 (534)
Q Consensus 86 ~~~~~~~~~~L~~L~L~~N~l~g~~p---~~~~~l~~L~~L~ls~ 127 (534)
+|+.|+|++|.+++..+ ..+..+++|+.|++++
T Consensus 114 ---------~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~d 149 (149)
T 2je0_A 114 ---------NLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGYD 149 (149)
T ss_dssp ---------TCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTBC
T ss_pred ---------CCCEEeCcCCcccchHHHHHHHHHHCCCcccccCCC
Confidence 88999999999996665 5899999999999874
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.44 E-value=2.6e-13 Score=123.52 Aligned_cols=103 Identities=23% Similarity=0.273 Sum_probs=89.9
Q ss_pred CCEEEccCCccCcCCCCCCCCCCCCCEEEcCCCcCccccCchhhhcccCcccccccccCCccccceeCCCCcCcccCChh
Q 039819 34 LRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFLSIWLPRKWDKRKCSGVDQGLLRLNNNSLSGAFPVF 113 (534)
Q Consensus 34 L~~L~L~~N~l~g~~P~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~l~~~~~~~~~~~~~L~~L~L~~N~l~g~~p~~ 113 (534)
-+.|++++|+|+ .+|..+. ++|++|+|++|+|++.+|..|..++ +|+.|+|++|+|++..+..
T Consensus 14 ~~~l~~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~--------------~L~~L~Ls~N~l~~i~~~~ 76 (174)
T 2r9u_A 14 QTLVNCQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLV--------------NLQQLYFNSNKLTAIPTGV 76 (174)
T ss_dssp SSEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCT--------------TCCEEECCSSCCCCCCTTT
T ss_pred CcEEEeCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCHHHhcCCc--------------CCCEEECCCCCCCccChhH
Confidence 478999999998 7998876 7999999999999988898888888 8899999999999766667
Q ss_pred hhcccccccccccCCCCCCCCCCCCC-----ccccccCCcceecC
Q 039819 114 LAKISELAFLDLSYNNLSGPVPKFPA-----RTFNVAGNPLICGS 153 (534)
Q Consensus 114 ~~~l~~L~~L~ls~N~l~g~~p~~~~-----~~~~~~~N~~~cg~ 153 (534)
|..+++|+.|+|++|+|++..+..+. +.+.+.+|||.|..
T Consensus 77 ~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L~~N~~~c~~ 121 (174)
T 2r9u_A 77 FDKLTQLTQLDLNDNHLKSIPRGAFDNLKSLTHIYLYNNPWDCEC 121 (174)
T ss_dssp TTTCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCBCTTB
T ss_pred hCCcchhhEEECCCCccceeCHHHhccccCCCEEEeCCCCccccc
Confidence 89999999999999999976655343 56789999998854
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.42 E-value=7.1e-14 Score=142.00 Aligned_cols=126 Identities=18% Similarity=0.164 Sum_probs=102.4
Q ss_pred CcEEEEEecCCCceeecccccccCCCCCEEEccCCccCcCCCCC-CCCCCCCCEEEcCCCcCccccC-chhhhcccCccc
Q 039819 8 NLVIGLGAPSQSLSGTLSGSIGNLTNLRQVLLQNNNISGGIPPQ-LGSLPKLQTLDLSNNRLSGVIP-ALLFLSIWLPRK 85 (534)
Q Consensus 8 ~~l~~L~l~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~P~~-~~~l~~L~~L~Ls~N~l~g~~p-~~~~~l~~l~~~ 85 (534)
.+++.|+|++|+|++..|..|+++++|++|+|++|+|++ +|.. |+++++|++|+|++|+|++..+ ..+..++
T Consensus 76 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~-~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~~l~----- 149 (353)
T 2z80_A 76 VNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSN-LSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLT----- 149 (353)
T ss_dssp TTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSS-CCHHHHTTCTTCSEEECTTCCCSSSCSSCSCTTCT-----
T ss_pred CCCCEEECCCCccCccCHhhcCCCCCCCEEECCCCcCCc-CCHhHhCCCccCCEEECCCCCCcccCchhhhccCC-----
Confidence 579999999999998888899999999999999999995 5554 9999999999999999995433 3677777
Q ss_pred ccccccCCccccceeCCCC-cCcccCChhhhcccccccccccCCCCCCCCCCCCC-----ccccccCCc
Q 039819 86 WDKRKCSGVDQGLLRLNNN-SLSGAFPVFLAKISELAFLDLSYNNLSGPVPKFPA-----RTFNVAGNP 148 (534)
Q Consensus 86 ~~~~~~~~~~L~~L~L~~N-~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~-----~~~~~~~N~ 148 (534)
+|+.|+|++| .+++..|..|+.+++|+.|++++|++++..|..+. +.+.+.+|.
T Consensus 150 ---------~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~ 209 (353)
T 2z80_A 150 ---------KLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQ 209 (353)
T ss_dssp ---------TCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSC
T ss_pred ---------CCcEEECCCCccccccCHHHccCCCCCCEEECCCCCcCccCHHHHhccccCCeecCCCCc
Confidence 7888888888 46766677888888888888888888877666554 334455554
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=99.42 E-value=3.4e-13 Score=135.70 Aligned_cols=120 Identities=18% Similarity=0.167 Sum_probs=87.2
Q ss_pred cEEEEEecCCCceeecccccccCCCCCEEEccCCccCcCCCCCCCCCCCCCEEEcCCCcCccccCchhhhcccCcccccc
Q 039819 9 LVIGLGAPSQSLSGTLSGSIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFLSIWLPRKWDK 88 (534)
Q Consensus 9 ~l~~L~l~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~P~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~l~~~~~~ 88 (534)
.++.|++++|+++ .+|..+. ++|++|+|++|+|++..|..|.++++|++|+|++|+|++..|..+..++.|..+..+
T Consensus 34 ~l~~l~~~~~~l~-~ip~~~~--~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 110 (332)
T 2ft3_A 34 HLRVVQCSDLGLK-AVPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYIS 110 (332)
T ss_dssp ETTEEECCSSCCS-SCCSCCC--TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEECC
T ss_pred cCCEEECCCCCcc-ccCCCCC--CCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEECC
Confidence 4778999999998 7887774 799999999999997777899999999999999999998889889888855443222
Q ss_pred cc-cC------CccccceeCCCCcCcccCChhhhcccccccccccCCCCC
Q 039819 89 RK-CS------GVDQGLLRLNNNSLSGAFPVFLAKISELAFLDLSYNNLS 131 (534)
Q Consensus 89 ~~-~~------~~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~ 131 (534)
.+ .. ..+|+.|+|++|++++..+..|..+++|+.|++++|.++
T Consensus 111 ~n~l~~l~~~~~~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~ 160 (332)
T 2ft3_A 111 KNHLVEIPPNLPSSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLE 160 (332)
T ss_dssp SSCCCSCCSSCCTTCCEEECCSSCCCCCCSGGGSSCSSCCEEECCSCCCB
T ss_pred CCcCCccCccccccCCEEECCCCccCccCHhHhCCCccCCEEECCCCccc
Confidence 11 10 124555666666665444445556666666666666654
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.42 E-value=1.4e-13 Score=137.24 Aligned_cols=141 Identities=18% Similarity=0.037 Sum_probs=111.2
Q ss_pred cEEEEEecCCCceeeccccc--ccCCCCCEEEccCCccCcCCC----CCCCCCCCCCEEEcCCCcCccccCchhhhcccC
Q 039819 9 LVIGLGAPSQSLSGTLSGSI--GNLTNLRQVLLQNNNISGGIP----PQLGSLPKLQTLDLSNNRLSGVIPALLFLSIWL 82 (534)
Q Consensus 9 ~l~~L~l~~n~l~g~~p~~~--~~l~~L~~L~L~~N~l~g~~P----~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~l 82 (534)
+++.|+|++|++++.+|..+ +.+++|++|+|++|+|++..| ..+..+++|++|+|++|+|++.+|..+..++.|
T Consensus 92 ~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L 171 (310)
T 4glp_A 92 RLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWLKPGLKVLSIAQAHSPAFSCEQVRAFPAL 171 (310)
T ss_dssp CCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTBCSCCCEEEEECCSSCCCCTTSCCCCTTC
T ss_pred ceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhhccCCCEEEeeCCCcchhhHHHhccCCCC
Confidence 59999999999999999998 999999999999999998666 446789999999999999998888888888876
Q ss_pred ccccccccc--------------CCccccceeCCCCcCcccCCh----hhhcccccccccccCCCCCCCCCCCCC-----
Q 039819 83 PRKWDKRKC--------------SGVDQGLLRLNNNSLSGAFPV----FLAKISELAFLDLSYNNLSGPVPKFPA----- 139 (534)
Q Consensus 83 ~~~~~~~~~--------------~~~~L~~L~L~~N~l~g~~p~----~~~~l~~L~~L~ls~N~l~g~~p~~~~----- 139 (534)
..+..+.+. ...+|+.|+|++|+|+ .+|. .++.+++|+.|+|++|+|++..|..+.
T Consensus 172 ~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~ 250 (310)
T 4glp_A 172 TSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGME-TPTGVCAALAAAGVQPHSLDLSHNSLRATVNPSAPRCMWS 250 (310)
T ss_dssp CEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCC-CHHHHHHHHHHHTCCCSSEECTTSCCCCCCCSCCSSCCCC
T ss_pred CEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCC-chHHHHHHHHhcCCCCCEEECCCCCCCccchhhHHhccCc
Confidence 665432221 1236888999999987 4443 357788999999999999987664332
Q ss_pred ---ccccccCCcce
Q 039819 140 ---RTFNVAGNPLI 150 (534)
Q Consensus 140 ---~~~~~~~N~~~ 150 (534)
+.+++++|.+.
T Consensus 251 ~~L~~L~Ls~N~l~ 264 (310)
T 4glp_A 251 SALNSLNLSFAGLE 264 (310)
T ss_dssp TTCCCEECCSSCCC
T ss_pred CcCCEEECCCCCCC
Confidence 45567777664
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.42 E-value=2.4e-13 Score=139.94 Aligned_cols=128 Identities=20% Similarity=0.133 Sum_probs=108.3
Q ss_pred CcEEEEEecCCCceeecccccccCCCCCEEEccCCccCcCCCCCCCCCCCCCEEEcCCCcCccccCchhhhcccCccccc
Q 039819 8 NLVIGLGAPSQSLSGTLSGSIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFLSIWLPRKWD 87 (534)
Q Consensus 8 ~~l~~L~l~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~P~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~l~~~~~ 87 (534)
.+|+.|+|++|+|++..+..|+.+++|++|+|++|+|++..|..|+++++|++|+|++|+|+...+..|..++
T Consensus 69 ~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~------- 141 (390)
T 3o6n_A 69 RQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTP------- 141 (390)
T ss_dssp CCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCT-------
T ss_pred ccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEECCCCccCcCCHHHhcCCC-------
Confidence 4799999999999988788999999999999999999987788899999999999999999954444567777
Q ss_pred ccccCCccccceeCCCCcCcccCChhhhcccccccccccCCCCCCCCCCCCC--ccccccCCcc
Q 039819 88 KRKCSGVDQGLLRLNNNSLSGAFPVFLAKISELAFLDLSYNNLSGPVPKFPA--RTFNVAGNPL 149 (534)
Q Consensus 88 ~~~~~~~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~--~~~~~~~N~~ 149 (534)
+|+.|+|++|.+++..|..|..+++|+.|++++|++++.....+. +.+.+.+|..
T Consensus 142 -------~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~L~~L~l~~n~l 198 (390)
T 3o6n_A 142 -------KLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVDLSLIPSLFHANVSYNLL 198 (390)
T ss_dssp -------TCCEEECCSSCCCBCCTTTTSSCTTCCEEECCSSCCSBCCGGGCTTCSEEECCSSCC
T ss_pred -------CCcEEECCCCccCccChhhccCCCCCCEEECCCCcCCccccccccccceeecccccc
Confidence 889999999999988888999999999999999999964322222 3455566644
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.42 E-value=1.2e-13 Score=132.39 Aligned_cols=140 Identities=19% Similarity=0.127 Sum_probs=102.3
Q ss_pred CcEEEEEecCCC-ceeecccccccCCCCCEEEccC-CccCcCCCCCCCCCCCCCEEEcCCCcCccccCchhhhcccCc--
Q 039819 8 NLVIGLGAPSQS-LSGTLSGSIGNLTNLRQVLLQN-NNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFLSIWLP-- 83 (534)
Q Consensus 8 ~~l~~L~l~~n~-l~g~~p~~~~~l~~L~~L~L~~-N~l~g~~P~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~l~-- 83 (534)
.+++.|+|++|+ +++..+..|+++++|++|+|++ |+|++..|..|.++++|++|+|++|+|++ +|. +..+..+.
T Consensus 55 ~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L~l~~n~l~~-lp~-~~~l~~L~~L 132 (239)
T 2xwt_C 55 PNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLKM-FPD-LTKVYSTDIF 132 (239)
T ss_dssp TTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEEEEEEECCCS-CCC-CTTCCBCCSE
T ss_pred CCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEEeCCCCCCcc-ccc-cccccccccc
Confidence 478899999997 8866666899999999999998 99986666778899999999999999985 665 66666655
Q ss_pred -ccccccc----------cC-Ccccc-ceeCCCCcCcccCChhhhcccccccccccCCC-CCCCCCCCCC------cccc
Q 039819 84 -RKWDKRK----------CS-GVDQG-LLRLNNNSLSGAFPVFLAKISELAFLDLSYNN-LSGPVPKFPA------RTFN 143 (534)
Q Consensus 84 -~~~~~~~----------~~-~~~L~-~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~-l~g~~p~~~~------~~~~ 143 (534)
.+..+.+ +. ..+|+ .|+|++|+++ .+|......++|+.|+|++|+ +++..+..+. +.+.
T Consensus 133 ~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~-~i~~~~~~~~~L~~L~L~~n~~l~~i~~~~~~~l~~~L~~L~ 211 (239)
T 2xwt_C 133 FILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLD 211 (239)
T ss_dssp EEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCCC-EECTTTTTTCEEEEEECTTCTTCCEECTTTTTTCSBCCSEEE
T ss_pred cEEECCCCcchhhcCcccccchhcceeEEEcCCCCCc-ccCHhhcCCCCCCEEEcCCCCCcccCCHHHhhccccCCcEEE
Confidence 2221111 11 23788 9999999999 666544344899999999995 9854444332 3456
Q ss_pred ccCCcce
Q 039819 144 VAGNPLI 150 (534)
Q Consensus 144 ~~~N~~~ 150 (534)
+.+|++.
T Consensus 212 l~~N~l~ 218 (239)
T 2xwt_C 212 VSQTSVT 218 (239)
T ss_dssp CTTCCCC
T ss_pred CCCCccc
Confidence 6667653
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.41 E-value=1.7e-13 Score=145.57 Aligned_cols=121 Identities=22% Similarity=0.221 Sum_probs=87.7
Q ss_pred cEEEEEecCCCceeecccccccCCCCCEEEccCCccCcCCCCCCCCCCCCCEEEcCCCcCccccCchhhhcccCcccccc
Q 039819 9 LVIGLGAPSQSLSGTLSGSIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFLSIWLPRKWDK 88 (534)
Q Consensus 9 ~l~~L~l~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~P~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~l~~~~~~ 88 (534)
+|+.|+|++|+|++..|..|+.+++|++|+|++|.|++..| |+.+++|++|+|++|.|++..+. +.|..+..+
T Consensus 35 ~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~l~~~-----~~L~~L~L~ 107 (487)
T 3oja_A 35 NVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELLVG-----PSIETLHAA 107 (487)
T ss_dssp GCCEEECCSSCCCCCCGGGGTTCTTCCEEECTTSCCEEEEE--CTTCTTCCEEECCSSEEEEEEEC-----TTCCEEECC
T ss_pred CccEEEeeCCcCCCCCHHHHhCCCCCCEEEeeCCCCCCCcc--cccCCCCCEEEecCCcCCCCCCC-----CCcCEEECc
Confidence 79999999999998888899999999999999999997665 99999999999999999865432 122222111
Q ss_pred cc-c------CCccccceeCCCCcCcccCChhhhcccccccccccCCCCCCCCCC
Q 039819 89 RK-C------SGVDQGLLRLNNNSLSGAFPVFLAKISELAFLDLSYNNLSGPVPK 136 (534)
Q Consensus 89 ~~-~------~~~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~ 136 (534)
++ . ...+|+.|+|++|.|++..|..|+.+++|+.|+|++|+|++.+|.
T Consensus 108 ~N~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~ 162 (487)
T 3oja_A 108 NNNISRVSCSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFA 162 (487)
T ss_dssp SSCCCCEEECCCSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGG
T ss_pred CCcCCCCCccccCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChH
Confidence 10 0 112566666666666666666666666666666666666665443
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=99.40 E-value=7.7e-13 Score=132.95 Aligned_cols=126 Identities=21% Similarity=0.253 Sum_probs=102.4
Q ss_pred CcEEEEEecCCCceeecccccccCCCCCEEEccCCccC--cCCCCCCCCCCCCCEEEcCCCcCccccCchhhhcccCccc
Q 039819 8 NLVIGLGAPSQSLSGTLSGSIGNLTNLRQVLLQNNNIS--GGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFLSIWLPRK 85 (534)
Q Consensus 8 ~~l~~L~l~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~--g~~P~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~l~~~ 85 (534)
.+++.|+|++|++++..+..|.++++|++|+|++|.++ +..|..|.++++|++|+|++|+++ .+|..+. +
T Consensus 121 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~-~l~~~~~--~----- 192 (330)
T 1xku_A 121 KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGLP--P----- 192 (330)
T ss_dssp TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCC-SCCSSCC--T-----
T ss_pred ccccEEECCCCcccccCHhHhcCCccccEEECCCCcCCccCcChhhccCCCCcCEEECCCCccc-cCCcccc--c-----
Confidence 46889999999999777778899999999999999996 367788899999999999999998 4565432 2
Q ss_pred ccccccCCccccceeCCCCcCcccCChhhhcccccccccccCCCCCCCCCCCCC-----ccccccCCcce
Q 039819 86 WDKRKCSGVDQGLLRLNNNSLSGAFPVFLAKISELAFLDLSYNNLSGPVPKFPA-----RTFNVAGNPLI 150 (534)
Q Consensus 86 ~~~~~~~~~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~-----~~~~~~~N~~~ 150 (534)
+|+.|+|++|++++..|..|..+++|+.|+|++|++++..|..+. +.+.+.+|.+.
T Consensus 193 ---------~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~ 253 (330)
T 1xku_A 193 ---------SLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV 253 (330)
T ss_dssp ---------TCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS
T ss_pred ---------cCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCceeChhhccCCCCCCEEECCCCcCc
Confidence 788899999999988888999999999999999999876654433 45677777664
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.40 E-value=2.4e-13 Score=151.19 Aligned_cols=110 Identities=24% Similarity=0.228 Sum_probs=94.0
Q ss_pred ecccccccCCCCCEEEccCCccCcCCCCCCCCCCCCCEEEcCCCcCccccCchhhhcccCcccccccccCCccccceeCC
Q 039819 23 TLSGSIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFLSIWLPRKWDKRKCSGVDQGLLRLN 102 (534)
Q Consensus 23 ~~p~~~~~l~~L~~L~L~~N~l~g~~P~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~l~~~~~~~~~~~~~L~~L~L~ 102 (534)
..|..|..+++|+.|+|++|+|+ .+|..+++|++|++|+|++|.|+ .+|..|..+. +|+.|+|+
T Consensus 215 ~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~--------------~L~~L~Ls 278 (727)
T 4b8c_D 215 MPKDSKYDDQLWHALDLSNLQIF-NISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLS--------------NLRVLDLS 278 (727)
T ss_dssp -------CCCCCCEEECTTSCCS-CCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGT--------------TCCEEECT
T ss_pred cChhhhccCCCCcEEECCCCCCC-CCChhhcCCCCCCEEEeeCCcCc-ccChhhhCCC--------------CCCEEeCc
Confidence 44778999999999999999999 89998889999999999999999 8999998888 89999999
Q ss_pred CCcCcccCChhhhcccccccccccCCCCCCCCCCCCC-----ccccccCCcce
Q 039819 103 NNSLSGAFPVFLAKISELAFLDLSYNNLSGPVPKFPA-----RTFNVAGNPLI 150 (534)
Q Consensus 103 ~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~-----~~~~~~~N~~~ 150 (534)
+|.|+ .+|..|+.|++|+.|+|++|.|+ .+|..+. +.+.+++|++.
T Consensus 279 ~N~l~-~lp~~~~~l~~L~~L~L~~N~l~-~lp~~~~~l~~L~~L~L~~N~l~ 329 (727)
T 4b8c_D 279 HNRLT-SLPAELGSCFQLKYFYFFDNMVT-TLPWEFGNLCNLQFLGVEGNPLE 329 (727)
T ss_dssp TSCCS-SCCSSGGGGTTCSEEECCSSCCC-CCCSSTTSCTTCCCEECTTSCCC
T ss_pred CCcCC-ccChhhcCCCCCCEEECCCCCCC-ccChhhhcCCCccEEeCCCCccC
Confidence 99999 88999999999999999999998 7776554 56788888874
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.40 E-value=3.2e-13 Score=145.94 Aligned_cols=108 Identities=24% Similarity=0.186 Sum_probs=80.8
Q ss_pred CcEEEEEecCCCceeecccccccCCCCCEEEccCCccCcCCCCCCCCCCCCCEEEcCCCcCccccCchhhhcccCccccc
Q 039819 8 NLVIGLGAPSQSLSGTLSGSIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFLSIWLPRKWD 87 (534)
Q Consensus 8 ~~l~~L~l~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~P~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~l~~~~~ 87 (534)
.+++.|+|++|+|++..|.+|+++++|++|+|++|+|++..|.+|.++++|++|||++|+|+ .+|.. .+.
T Consensus 52 ~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~--~l~------- 121 (562)
T 3a79_B 52 PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHNRLQ-NISCC--PMA------- 121 (562)
T ss_dssp TTCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECTTSCCC-EECSC--CCT-------
T ss_pred CCcCEEECCCCCccccChhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEECCCCcCC-ccCcc--ccc-------
Confidence 45777777777777666667777777777777777777666777777777777777777777 45544 344
Q ss_pred ccccCCccccceeCCCCcCcc-cCChhhhcccccccccccCCCCCC
Q 039819 88 KRKCSGVDQGLLRLNNNSLSG-AFPVFLAKISELAFLDLSYNNLSG 132 (534)
Q Consensus 88 ~~~~~~~~L~~L~L~~N~l~g-~~p~~~~~l~~L~~L~ls~N~l~g 132 (534)
+|+.|+|++|++++ .+|..|+.+++|+.|+|++|++++
T Consensus 122 -------~L~~L~Ls~N~l~~l~~p~~~~~l~~L~~L~L~~n~l~~ 160 (562)
T 3a79_B 122 -------SLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQ 160 (562)
T ss_dssp -------TCSEEECCSSCCSBCCCCGGGGGCTTCCEEEEECSBCCT
T ss_pred -------cCCEEECCCCCccccCchHhhcccCcccEEecCCCcccc
Confidence 78888888888886 456788888888888888888875
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=99.40 E-value=1.2e-13 Score=148.77 Aligned_cols=118 Identities=18% Similarity=0.142 Sum_probs=96.1
Q ss_pred CcEEEEEecCCCceeecccccccCCCCCEEEccCCccCcCCCCCCCCCCCCCEEEcCCCcCcc-ccCchhhhcccCcccc
Q 039819 8 NLVIGLGAPSQSLSGTLSGSIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSG-VIPALLFLSIWLPRKW 86 (534)
Q Consensus 8 ~~l~~L~l~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~P~~~~~l~~L~~L~Ls~N~l~g-~~p~~~~~l~~l~~~~ 86 (534)
.+++.|+|++|+|++..|.+|+++++|++|+|++|+|++..|..|+++++|++|+|++|+|++ .+|..+..++
T Consensus 50 ~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~------ 123 (549)
T 2z81_A 50 ANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLT------ 123 (549)
T ss_dssp TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCSCCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCT------
T ss_pred CcccEEECCCCCcCccChhhccccccCCEEECCCCccCccCHHHhccCCCCcEEECCCCcccccchhhhhhccC------
Confidence 579999999999999888999999999999999999997666679999999999999999996 3567777777
Q ss_pred cccccCCccccceeCCCCcCcccCC-hhhhcccccccccccCCCCCCCCCCCCC
Q 039819 87 DKRKCSGVDQGLLRLNNNSLSGAFP-VFLAKISELAFLDLSYNNLSGPVPKFPA 139 (534)
Q Consensus 87 ~~~~~~~~~L~~L~L~~N~l~g~~p-~~~~~l~~L~~L~ls~N~l~g~~p~~~~ 139 (534)
+|+.|+|++|.+.+.+| ..|+.+++|+.|++++|++++.+|..+.
T Consensus 124 --------~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~ 169 (549)
T 2z81_A 124 --------NLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLK 169 (549)
T ss_dssp --------TCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECTTTTT
T ss_pred --------CccEEECCCCccccccCHhhhhcccccCeeeccCCcccccChhhhh
Confidence 66777777777444444 5677777777777777777766665543
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.39 E-value=1.3e-13 Score=147.48 Aligned_cols=108 Identities=24% Similarity=0.255 Sum_probs=92.4
Q ss_pred CcEEEEEecCCCceeecccccccCCCCCEEEccCCccCcCCCCCCCCCCCCCEEEcCCCcCccccCchhhhcccCccccc
Q 039819 8 NLVIGLGAPSQSLSGTLSGSIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFLSIWLPRKWD 87 (534)
Q Consensus 8 ~~l~~L~l~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~P~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~l~~~~~ 87 (534)
.+++.|+|++|+|++..|..|+++++|++|+|++|+|++..|..|+++++|++|||++|+|+ .+|.. .+.
T Consensus 21 ~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~--~l~------- 90 (520)
T 2z7x_B 21 QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLV-KISCH--PTV------- 90 (520)
T ss_dssp TTCSEEECCSSCCCCCCHHHHTTCTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSSCCC-EEECC--CCC-------
T ss_pred ccccEEECCCCcccccChhhccccccccEEecCCCccCCcChHHhhcccCCCEEecCCCcee-ecCcc--ccC-------
Confidence 46888999999998777788999999999999999998777888999999999999999998 56654 444
Q ss_pred ccccCCccccceeCCCCcCcc-cCChhhhcccccccccccCCCCCC
Q 039819 88 KRKCSGVDQGLLRLNNNSLSG-AFPVFLAKISELAFLDLSYNNLSG 132 (534)
Q Consensus 88 ~~~~~~~~L~~L~L~~N~l~g-~~p~~~~~l~~L~~L~ls~N~l~g 132 (534)
+|++|+|++|++++ .+|..|+.+++|+.|+|++|++++
T Consensus 91 -------~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~ 129 (520)
T 2z7x_B 91 -------NLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEK 129 (520)
T ss_dssp -------CCSEEECCSSCCSSCCCCGGGGGCTTCCEEEEEESSCCG
T ss_pred -------CccEEeccCCccccccchhhhccCCcceEEEecCcccch
Confidence 88899999999987 578999999999999999999875
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.39 E-value=1.8e-13 Score=124.67 Aligned_cols=104 Identities=21% Similarity=0.239 Sum_probs=91.8
Q ss_pred cEEEEEecCCCceeecccccccCCCCCEEEccCCccCcCCCCC-CCCCCCCCEEEcCCCcCccccCc--hhhhcccCccc
Q 039819 9 LVIGLGAPSQSLSGTLSGSIGNLTNLRQVLLQNNNISGGIPPQ-LGSLPKLQTLDLSNNRLSGVIPA--LLFLSIWLPRK 85 (534)
Q Consensus 9 ~l~~L~l~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~P~~-~~~l~~L~~L~Ls~N~l~g~~p~--~~~~l~~l~~~ 85 (534)
+++.|+|++|+|++. +.|+.+++|++|+|++|+|++ +|+. |..+++|++|+|++|+|+ .+|. .+..++
T Consensus 43 ~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~-~~~~~~~~l~~L~~L~L~~N~i~-~~~~~~~l~~l~----- 113 (176)
T 1a9n_A 43 QFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICR-IGEGLDQALPDLTELILTNNSLV-ELGDLDPLASLK----- 113 (176)
T ss_dssp CCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCE-ECSCHHHHCTTCCEEECCSCCCC-CGGGGGGGGGCT-----
T ss_pred CCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccc-cCcchhhcCCCCCEEECCCCcCC-cchhhHhhhcCC-----
Confidence 799999999999975 689999999999999999995 5554 599999999999999997 6665 666666
Q ss_pred ccccccCCccccceeCCCCcCcccCChh----hhcccccccccccCCCCC
Q 039819 86 WDKRKCSGVDQGLLRLNNNSLSGAFPVF----LAKISELAFLDLSYNNLS 131 (534)
Q Consensus 86 ~~~~~~~~~~L~~L~L~~N~l~g~~p~~----~~~l~~L~~L~ls~N~l~ 131 (534)
+|+.|+|++|.++ .+|.. +..+++|+.||+++|.+.
T Consensus 114 ---------~L~~L~l~~N~i~-~~~~~~~~~~~~l~~L~~Ld~~~n~~~ 153 (176)
T 1a9n_A 114 ---------SLTYLCILRNPVT-NKKHYRLYVIYKVPQVRVLDFQKVKLK 153 (176)
T ss_dssp ---------TCCEEECCSSGGG-GSTTHHHHHHHHCTTCSEETTEECCHH
T ss_pred ---------CCCEEEecCCCCC-CcHhHHHHHHHHCCccceeCCCcCCHH
Confidence 8899999999998 67774 999999999999999875
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.37 E-value=1.3e-12 Score=127.24 Aligned_cols=135 Identities=24% Similarity=0.369 Sum_probs=81.5
Q ss_pred CcEEEEEecCCCceeecccccccCCCCCEEEccCCccCcCCCCCCCCCCCCCEEEcCCCcCccccCchhhhcccCccccc
Q 039819 8 NLVIGLGAPSQSLSGTLSGSIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFLSIWLPRKWD 87 (534)
Q Consensus 8 ~~l~~L~l~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~P~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~l~~~~~ 87 (534)
.+|+.|+|++|+|+ .+| .++.+++|++|+|++|+|++ +|+ |..+++|++|+|++|+|++ +|.... ..|..+..
T Consensus 41 ~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~L~~N~i~~-~~~-l~~l~~L~~L~L~~N~l~~-l~~~~~--~~L~~L~L 113 (263)
T 1xeu_A 41 SGVQNFNGDNSNIQ-SLA-GMQFFTNLKELHLSHNQISD-LSP-LKDLTKLEELSVNRNRLKN-LNGIPS--ACLSRLFL 113 (263)
T ss_dssp TTCSEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCC-CGG-GTTCSSCCEEECCSSCCSC-CTTCCC--SSCCEEEC
T ss_pred CcCcEEECcCCCcc-cch-HHhhCCCCCEEECCCCccCC-Chh-hccCCCCCEEECCCCccCC-cCcccc--CcccEEEc
Confidence 35777888888887 455 67778888888888888874 444 7788888888888888874 343221 32222111
Q ss_pred ccc-c-------CCccccceeCCCCcCcccCChhhhcccccccccccCCCCCCCCCCCCC----ccccccCCcceec
Q 039819 88 KRK-C-------SGVDQGLLRLNNNSLSGAFPVFLAKISELAFLDLSYNNLSGPVPKFPA----RTFNVAGNPLICG 152 (534)
Q Consensus 88 ~~~-~-------~~~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~----~~~~~~~N~~~cg 152 (534)
+++ . ...+|+.|+|++|+|++ +| .+..+++|+.|+|++|++++. +.... +.+.+.+|++.+.
T Consensus 114 ~~N~l~~~~~l~~l~~L~~L~Ls~N~i~~-~~-~l~~l~~L~~L~L~~N~i~~~-~~l~~l~~L~~L~l~~N~~~~~ 187 (263)
T 1xeu_A 114 DNNELRDTDSLIHLKNLEILSIRNNKLKS-IV-MLGFLSKLEVLDLHGNEITNT-GGLTRLKKVNWIDLTGQKCVNE 187 (263)
T ss_dssp CSSCCSBSGGGTTCTTCCEEECTTSCCCB-CG-GGGGCTTCCEEECTTSCCCBC-TTSTTCCCCCEEEEEEEEEECC
T ss_pred cCCccCCChhhcCcccccEEECCCCcCCC-Ch-HHccCCCCCEEECCCCcCcch-HHhccCCCCCEEeCCCCcccCC
Confidence 110 0 11256677777777764 33 566677777777777777654 21111 3455666666543
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.35 E-value=1.7e-12 Score=128.28 Aligned_cols=117 Identities=22% Similarity=0.263 Sum_probs=55.6
Q ss_pred cEEEEEecCCCceeecccccccCCCCCEEEccCCccCcCCCCCCCCCCCCCEEEcCCCcCccccCchhhhcccCcccccc
Q 039819 9 LVIGLGAPSQSLSGTLSGSIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFLSIWLPRKWDK 88 (534)
Q Consensus 9 ~l~~L~l~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~P~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~l~~~~~~ 88 (534)
+|+.|++++|+++. ++ .++.+++|++|+|++|+|++ +|+ +.++++|++|+|++|+|++ +|. +..++.|..+..+
T Consensus 47 ~L~~L~l~~~~i~~-~~-~~~~l~~L~~L~L~~n~l~~-~~~-l~~l~~L~~L~l~~n~l~~-~~~-l~~l~~L~~L~L~ 120 (291)
T 1h6t_A 47 SIDQIIANNSDIKS-VQ-GIQYLPNVTKLFLNGNKLTD-IKP-LANLKNLGWLFLDENKVKD-LSS-LKDLKKLKSLSLE 120 (291)
T ss_dssp TCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCC-CGG-GTTCTTCCEEECCSSCCCC-GGG-GTTCTTCCEEECT
T ss_pred cccEEEccCCCccc-Ch-hHhcCCCCCEEEccCCccCC-Ccc-cccCCCCCEEECCCCcCCC-Chh-hccCCCCCEEECC
Confidence 35555666665553 33 35555666666666666653 333 5555566666666665553 222 4444422221110
Q ss_pred cc-c-------CCccccceeCCCCcCcccCChhhhcccccccccccCCCCCCC
Q 039819 89 RK-C-------SGVDQGLLRLNNNSLSGAFPVFLAKISELAFLDLSYNNLSGP 133 (534)
Q Consensus 89 ~~-~-------~~~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~ 133 (534)
.+ . ...+|+.|+|++|++++. ..+..+++|+.|+|++|++++.
T Consensus 121 ~n~i~~~~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~N~l~~~ 171 (291)
T 1h6t_A 121 HNGISDINGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDI 171 (291)
T ss_dssp TSCCCCCGGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCC
T ss_pred CCcCCCChhhcCCCCCCEEEccCCcCCcc--hhhccCCCCCEEEccCCccccc
Confidence 00 0 001455555555555532 3455555555555555555543
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.35 E-value=1.2e-12 Score=132.60 Aligned_cols=102 Identities=21% Similarity=0.191 Sum_probs=90.2
Q ss_pred CEEEccCC-ccCcCCCCCCCCCCCCCEEEcCC-CcCccccCchhhhcccCcccccccccCCccccceeCCCCcCcccCCh
Q 039819 35 RQVLLQNN-NISGGIPPQLGSLPKLQTLDLSN-NRLSGVIPALLFLSIWLPRKWDKRKCSGVDQGLLRLNNNSLSGAFPV 112 (534)
Q Consensus 35 ~~L~L~~N-~l~g~~P~~~~~l~~L~~L~Ls~-N~l~g~~p~~~~~l~~l~~~~~~~~~~~~~L~~L~L~~N~l~g~~p~ 112 (534)
..+++++| +|+ .+|. |..+++|+.|+|++ |+|++.+|..|..+. +|+.|+|++|+|++..|.
T Consensus 11 ~~v~~~~~n~l~-~ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~--------------~L~~L~l~~N~l~~~~~~ 74 (347)
T 2ifg_A 11 SGLRCTRDGALD-SLHH-LPGAENLTELYIENQQHLQHLELRDLRGLG--------------ELRNLTIVKSGLRFVAPD 74 (347)
T ss_dssp SCEECCSSCCCT-TTTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCC--------------CCSEEECCSSCCCEECTT
T ss_pred CEEEcCCCCCCC-ccCC-CCCCCCeeEEEccCCCCCCCcChhHhcccc--------------CCCEEECCCCccceeCHH
Confidence 35799998 999 6999 99999999999996 999988888888888 899999999999999999
Q ss_pred hhhcccccccccccCCCCCCCCCCCCC----ccccccCCcceec
Q 039819 113 FLAKISELAFLDLSYNNLSGPVPKFPA----RTFNVAGNPLICG 152 (534)
Q Consensus 113 ~~~~l~~L~~L~ls~N~l~g~~p~~~~----~~~~~~~N~~~cg 152 (534)
.|..+++|+.|+|++|+|++.+|..+. +.+.+.+|+|.|.
T Consensus 75 ~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~L~~l~l~~N~~~c~ 118 (347)
T 2ifg_A 75 AFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCS 118 (347)
T ss_dssp GGGSCSCCCEEECCSSCCSCCCSTTTCSCCCCEEECCSSCCCCC
T ss_pred HhcCCcCCCEEeCCCCccceeCHHHcccCCceEEEeeCCCccCC
Confidence 999999999999999999976555432 5678999999885
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.33 E-value=1.9e-12 Score=146.71 Aligned_cols=127 Identities=22% Similarity=0.201 Sum_probs=108.2
Q ss_pred CcEEEEEecCCCceeecccccccCCCCCEEEccCCccCcCCCCCCCCCCCCCEEEcCCCcCccccCchhhhcccCccccc
Q 039819 8 NLVIGLGAPSQSLSGTLSGSIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFLSIWLPRKWD 87 (534)
Q Consensus 8 ~~l~~L~l~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~P~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~l~~~~~ 87 (534)
.+++.|+|++|.+++..|..|+.+++|+.|+|++|+|++..|..|.++++|++|+|++|+|++..|..|..++
T Consensus 266 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~------- 338 (844)
T 3j0a_A 266 SSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLP------- 338 (844)
T ss_dssp SCCCEEECTTCCCCEECSCCSSSCCCCCEEEEESCCCCEECTTTTTTCSSCCEEEEESCCCSCCCSCSCSSCT-------
T ss_pred CCccEEECCCCcccccChhhhhcCCCCCEEECCCCcCCCCChHHhcCCCCCCEEECCCCCCCccCHHHhcCCC-------
Confidence 4799999999999998899999999999999999999988899999999999999999999988898888887
Q ss_pred ccccCCccccceeCCCCcCcccCChhhhcccccccccccCCCCCCCCCCCC-CccccccCCcc
Q 039819 88 KRKCSGVDQGLLRLNNNSLSGAFPVFLAKISELAFLDLSYNNLSGPVPKFP-ARTFNVAGNPL 149 (534)
Q Consensus 88 ~~~~~~~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~-~~~~~~~~N~~ 149 (534)
+|+.|+|++|.+++..|..|..+++|+.|+|++|.+++ ++... .+.+.+.+|.+
T Consensus 339 -------~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~-i~~~~~L~~L~l~~N~l 393 (844)
T 3j0a_A 339 -------KVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALTT-IHFIPSIPDIFLSGNKL 393 (844)
T ss_dssp -------TCCEEECCSCCCCCCCSSCSCSCCCCCEEEEETCCSCC-CSSCCSCSEEEEESCCC
T ss_pred -------CCCEEECCCCCCCccChhhhcCCCCCCEEECCCCCCCc-ccCCCCcchhccCCCCc
Confidence 78889999999987777788889999999999999884 33221 13445555544
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.33 E-value=1.4e-12 Score=130.06 Aligned_cols=136 Identities=21% Similarity=0.268 Sum_probs=91.7
Q ss_pred CcEEEEEecCCCceeecccccccCCCCCEEEccCCccCcCCCCCCCCCCCCCEEEcCCCcCccccCchhhhcccCccccc
Q 039819 8 NLVIGLGAPSQSLSGTLSGSIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFLSIWLPRKWD 87 (534)
Q Consensus 8 ~~l~~L~l~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~P~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~l~~~~~ 87 (534)
.+++.|+|++|+|++ ++ .|..+++|++|+|++|+|++ +|. |..+++|++|+|++|+|++..+ +..++.|..+..
T Consensus 85 ~~L~~L~L~~n~l~~-~~-~~~~l~~L~~L~l~~n~l~~-~~~-l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l 158 (308)
T 1h6u_A 85 TKITELELSGNPLKN-VS-AIAGLQSIKTLDLTSTQITD-VTP-LAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSI 158 (308)
T ss_dssp CSCCEEECCSCCCSC-CG-GGTTCTTCCEEECTTSCCCC-CGG-GTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEEC
T ss_pred CCCCEEEccCCcCCC-ch-hhcCCCCCCEEECCCCCCCC-chh-hcCCCCCCEEECCCCccCcCcc--ccCCCCccEEEc
Confidence 478899999999985 44 68899999999999999985 554 8899999999999999986544 666664444322
Q ss_pred ccc-c-------CCccccceeCCCCcCcccCChhhhcccccccccccCCCCCCCCCCCC---CccccccCCccee
Q 039819 88 KRK-C-------SGVDQGLLRLNNNSLSGAFPVFLAKISELAFLDLSYNNLSGPVPKFP---ARTFNVAGNPLIC 151 (534)
Q Consensus 88 ~~~-~-------~~~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~---~~~~~~~~N~~~c 151 (534)
+++ . ...+|+.|+|++|++++..| +..+++|+.|+|++|++++..|-.. .+.+.+.+|++.+
T Consensus 159 ~~n~l~~~~~l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~L~~N~l~~~~~l~~l~~L~~L~l~~N~i~~ 231 (308)
T 1h6u_A 159 GNAQVSDLTPLANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSPLANTSNLFIVTLTNQTITN 231 (308)
T ss_dssp CSSCCCCCGGGTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECTTSCCCBCGGGTTCTTCCEEEEEEEEEEC
T ss_pred cCCcCCCChhhcCCCCCCEEECCCCccCcChh--hcCCCCCCEEEccCCccCccccccCCCCCCEEEccCCeeec
Confidence 111 0 11256677777777764332 6677777777777777775443111 1445666676644
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.32 E-value=2.3e-12 Score=125.36 Aligned_cols=134 Identities=22% Similarity=0.231 Sum_probs=98.0
Q ss_pred cEEEEEecCCCceeecccccccCCCCCEEEccCCccCcCCCCCCCCCCCCCEEEcCCCcCccccCchhhhcccCcccccc
Q 039819 9 LVIGLGAPSQSLSGTLSGSIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFLSIWLPRKWDK 88 (534)
Q Consensus 9 ~l~~L~l~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~P~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~l~~~~~~ 88 (534)
+++.|+|++|++++. + .+..+++|++|+|++|+|+ .+| .+..+++|+.|+|++|+|++..| +..++.|..+..+
T Consensus 20 ~l~~l~l~~~~i~~~-~-~~~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~L~~N~i~~~~~--l~~l~~L~~L~L~ 93 (263)
T 1xeu_A 20 NAVKQNLGKQSVTDL-V-SQKELSGVQNFNGDNSNIQ-SLA-GMQFFTNLKELHLSHNQISDLSP--LKDLTKLEELSVN 93 (263)
T ss_dssp HHHHHHHTCSCTTSE-E-CHHHHTTCSEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCCGG--GTTCSSCCEEECC
T ss_pred HHHHHHhcCCCcccc-c-chhhcCcCcEEECcCCCcc-cch-HHhhCCCCCEEECCCCccCCChh--hccCCCCCEEECC
Confidence 355678899999854 4 6899999999999999999 677 79999999999999999996554 7777766554322
Q ss_pred cc-c------CCccccceeCCCCcCcccCChhhhcccccccccccCCCCCCCCCCCC----CccccccCCccee
Q 039819 89 RK-C------SGVDQGLLRLNNNSLSGAFPVFLAKISELAFLDLSYNNLSGPVPKFP----ARTFNVAGNPLIC 151 (534)
Q Consensus 89 ~~-~------~~~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~----~~~~~~~~N~~~c 151 (534)
++ . ...+|+.|+|++|++++ +| .+..+++|+.|+|++|++++. |... -+.+.+++|.+..
T Consensus 94 ~N~l~~l~~~~~~~L~~L~L~~N~l~~-~~-~l~~l~~L~~L~Ls~N~i~~~-~~l~~l~~L~~L~L~~N~i~~ 164 (263)
T 1xeu_A 94 RNRLKNLNGIPSACLSRLFLDNNELRD-TD-SLIHLKNLEILSIRNNKLKSI-VMLGFLSKLEVLDLHGNEITN 164 (263)
T ss_dssp SSCCSCCTTCCCSSCCEEECCSSCCSB-SG-GGTTCTTCCEEECTTSCCCBC-GGGGGCTTCCEEECTTSCCCB
T ss_pred CCccCCcCccccCcccEEEccCCccCC-Ch-hhcCcccccEEECCCCcCCCC-hHHccCCCCCEEECCCCcCcc
Confidence 21 1 11467888888888874 33 578888888888888888853 3211 1455666776533
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.32 E-value=7e-15 Score=136.84 Aligned_cols=127 Identities=23% Similarity=0.296 Sum_probs=106.1
Q ss_pred CCcEEEEEecCCCceeeccc------ccccCCCCCEEEccCCccCcCCCCCCCCCCCCCEEEcCCCcCccccCchhhhcc
Q 039819 7 ENLVIGLGAPSQSLSGTLSG------SIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFLSI 80 (534)
Q Consensus 7 ~~~l~~L~l~~n~l~g~~p~------~~~~l~~L~~L~L~~N~l~g~~P~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~ 80 (534)
...++.++|+.++|+|.+|. .|+.+++|++|+|++|+|++ +| .|.++++|++|+|++|+|+ .+|..+..++
T Consensus 17 ~~~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~~~~ 93 (198)
T 1ds9_A 17 RKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVAD 93 (198)
T ss_dssp TTCCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHHHHH
T ss_pred cccccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhhcCC
Confidence 35678888899999988887 89999999999999999995 88 8999999999999999999 7888877777
Q ss_pred cCcccccccccCCccccceeCCCCcCcccCChhhhcccccccccccCCCCCCCCC-CCC-----CccccccCCcceec
Q 039819 81 WLPRKWDKRKCSGVDQGLLRLNNNSLSGAFPVFLAKISELAFLDLSYNNLSGPVP-KFP-----ARTFNVAGNPLICG 152 (534)
Q Consensus 81 ~l~~~~~~~~~~~~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p-~~~-----~~~~~~~~N~~~cg 152 (534)
+|+.|+|++|+|++ +| .+..+++|+.|+|++|++++..+ ..+ .+.+.+.+|++.+.
T Consensus 94 --------------~L~~L~L~~N~l~~-l~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~~~ 155 (198)
T 1ds9_A 94 --------------TLEELWISYNQIAS-LS-GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYND 155 (198)
T ss_dssp --------------HCSEEEEEEEECCC-HH-HHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSCHHHHH
T ss_pred --------------cCCEEECcCCcCCc-CC-ccccCCCCCEEECCCCcCCchhHHHHHhcCCCCCEEEecCCccccc
Confidence 88899999999995 56 68899999999999999985322 111 15678888887553
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.31 E-value=2.3e-12 Score=127.34 Aligned_cols=135 Identities=24% Similarity=0.290 Sum_probs=104.0
Q ss_pred CcEEEEEecCCCceeecccccccCCCCCEEEccCCccCcCCCCCCCCCCCCCEEEcCCCcCccccCchhhhcccCccccc
Q 039819 8 NLVIGLGAPSQSLSGTLSGSIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFLSIWLPRKWD 87 (534)
Q Consensus 8 ~~l~~L~l~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~P~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~l~~~~~ 87 (534)
.+|+.|+|++|+|++..+ ++++++|++|+|++|+|++ +| .+..+++|++|+|++|+|++ + ..+..++.|..+..
T Consensus 68 ~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~-~~-~l~~l~~L~~L~L~~n~i~~-~-~~l~~l~~L~~L~l 141 (291)
T 1h6t_A 68 PNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVKD-LS-SLKDLKKLKSLSLEHNGISD-I-NGLVHLPQLESLYL 141 (291)
T ss_dssp TTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-GG-GGTTCTTCCEEECTTSCCCC-C-GGGGGCTTCCEEEC
T ss_pred CCCCEEEccCCccCCCcc--cccCCCCCEEECCCCcCCC-Ch-hhccCCCCCEEECCCCcCCC-C-hhhcCCCCCCEEEc
Confidence 578999999999996444 9999999999999999984 55 48999999999999999985 3 35666666665543
Q ss_pred ccc-c-------CCccccceeCCCCcCcccCChhhhcccccccccccCCCCCCCCCCCCC----ccccccCCccee
Q 039819 88 KRK-C-------SGVDQGLLRLNNNSLSGAFPVFLAKISELAFLDLSYNNLSGPVPKFPA----RTFNVAGNPLIC 151 (534)
Q Consensus 88 ~~~-~-------~~~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~----~~~~~~~N~~~c 151 (534)
+++ . ...+|+.|+|++|++++..| +..+++|+.|+|++|++++ +|.... +.+.+.+|++.+
T Consensus 142 ~~n~l~~~~~l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~L~~N~i~~-l~~l~~l~~L~~L~l~~n~i~~ 214 (291)
T 1h6t_A 142 GNNKITDITVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHISD-LRALAGLKNLDVLELFSQECLN 214 (291)
T ss_dssp CSSCCCCCGGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCB-CGGGTTCTTCSEEEEEEEEEEC
T ss_pred cCCcCCcchhhccCCCCCEEEccCCccccchh--hcCCCccCEEECCCCcCCC-ChhhccCCCCCEEECcCCcccC
Confidence 322 1 12379999999999996555 9999999999999999995 443211 556778887644
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.30 E-value=5.2e-12 Score=137.18 Aligned_cols=134 Identities=25% Similarity=0.283 Sum_probs=93.6
Q ss_pred CcEEEEEecCCCceeecccccccCCCCCEEEccCCccCcCCCCCCCCCCCCCEEEcCCCcCccccCchhhhcccCccccc
Q 039819 8 NLVIGLGAPSQSLSGTLSGSIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFLSIWLPRKWD 87 (534)
Q Consensus 8 ~~l~~L~l~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~P~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~l~~~~~ 87 (534)
.+|+.|+|++|+|++..| |+.|++|+.|+|++|+|++ +| .|..|++|+.|+|++|+|++ +| .+..++.|..+..
T Consensus 65 ~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~-l~-~l~~l~~L~~L~Ls~N~l~~-l~-~l~~l~~L~~L~L 138 (605)
T 1m9s_A 65 PNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLDENKIKD-LS-SLKDLKKLKSLSLEHNGISD-IN-GLVHLPQLESLYL 138 (605)
T ss_dssp TTCCEEECTTSCCCCCGG--GGGCTTCCEEECCSSCCCC-CT-TSTTCTTCCEEECTTSCCCC-CG-GGGGCTTCSEEEC
T ss_pred CCCCEEEeeCCCCCCChh--hccCCCCCEEECcCCCCCC-Ch-hhccCCCCCEEEecCCCCCC-Cc-cccCCCccCEEEC
Confidence 478899999999986544 8899999999999999984 55 78899999999999999985 33 4666665554432
Q ss_pred ccc-c-------CCccccceeCCCCcCcccCChhhhcccccccccccCCCCCCCCCCCCC----ccccccCCcce
Q 039819 88 KRK-C-------SGVDQGLLRLNNNSLSGAFPVFLAKISELAFLDLSYNNLSGPVPKFPA----RTFNVAGNPLI 150 (534)
Q Consensus 88 ~~~-~-------~~~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~----~~~~~~~N~~~ 150 (534)
+.+ . ...+|+.|+|++|+|++..| +..+++|+.|+|++|+|++. |.... +.+.+.+|++.
T Consensus 139 s~N~l~~l~~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~i~~l-~~l~~l~~L~~L~L~~N~l~ 210 (605)
T 1m9s_A 139 GNNKITDITVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHISDL-RALAGLKNLDVLELFSQECL 210 (605)
T ss_dssp CSSCCCCCGGGGSCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCBC-GGGTTCTTCSEEECCSEEEE
T ss_pred CCCccCCchhhcccCCCCEEECcCCcCCCchh--hccCCCCCEEECcCCCCCCC-hHHccCCCCCEEEccCCcCc
Confidence 221 1 11367777777777775555 77777777777777777753 32111 44566666653
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.30 E-value=4.2e-12 Score=126.45 Aligned_cols=66 Identities=27% Similarity=0.385 Sum_probs=41.2
Q ss_pred cEEEEEecCCCceeecccccccCCCCCEEEccCCccCcCCCCCCCCCCCCCEEEcCCCcCccccCchhhhcc
Q 039819 9 LVIGLGAPSQSLSGTLSGSIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFLSI 80 (534)
Q Consensus 9 ~l~~L~l~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~P~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~ 80 (534)
+|+.|++++|+++ .+| .+..+++|++|+|++|+|++ +|. |..+++|++|+|++|+|++ +| .+..++
T Consensus 42 ~L~~L~l~~~~i~-~l~-~~~~l~~L~~L~L~~n~i~~-~~~-~~~l~~L~~L~L~~n~l~~-~~-~~~~l~ 107 (308)
T 1h6u_A 42 GITTLSAFGTGVT-TIE-GVQYLNNLIGLELKDNQITD-LAP-LKNLTKITELELSGNPLKN-VS-AIAGLQ 107 (308)
T ss_dssp TCCEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCC-CGG-GTTCCSCCEEECCSCCCSC-CG-GGTTCT
T ss_pred CcCEEEeeCCCcc-Cch-hhhccCCCCEEEccCCcCCC-Chh-HccCCCCCEEEccCCcCCC-ch-hhcCCC
Confidence 4666777777766 344 46667777777777777763 444 6667777777777777664 33 344444
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.30 E-value=2.8e-12 Score=138.38 Aligned_cols=101 Identities=25% Similarity=0.277 Sum_probs=90.3
Q ss_pred CcEEEEEecCCCceeecccccccCCCCCEEEccCCccCcCCCCCCCCCCCCCEEEcCCCcCcccc-CchhhhcccCcccc
Q 039819 8 NLVIGLGAPSQSLSGTLSGSIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVI-PALLFLSIWLPRKW 86 (534)
Q Consensus 8 ~~l~~L~l~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~P~~~~~l~~L~~L~Ls~N~l~g~~-p~~~~~l~~l~~~~ 86 (534)
.+|+.|+|++|+|+ .+|..|++|++|++|+|++|+|++ +| .|++|++|++|+|++|+|++.+ |..+..++
T Consensus 463 ~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~------ 533 (567)
T 1dce_A 463 LLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCP------ 533 (567)
T ss_dssp TTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCT------
T ss_pred ccCcEeecCccccc-ccchhhhcCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECCCCCCCCCCCcHHHhcCC------
Confidence 47999999999999 899999999999999999999996 88 8999999999999999999887 99999888
Q ss_pred cccccCCccccceeCCCCcCcccCCh---hhhcccccccccc
Q 039819 87 DKRKCSGVDQGLLRLNNNSLSGAFPV---FLAKISELAFLDL 125 (534)
Q Consensus 87 ~~~~~~~~~L~~L~L~~N~l~g~~p~---~~~~l~~L~~L~l 125 (534)
+|+.|+|++|.|++..|. .+..+++|+.|++
T Consensus 534 --------~L~~L~L~~N~l~~~~~~~~~l~~~lp~L~~L~l 567 (567)
T 1dce_A 534 --------RLVLLNLQGNSLCQEEGIQERLAEMLPSVSSILT 567 (567)
T ss_dssp --------TCCEEECTTSGGGGSSSCTTHHHHHCTTCSEEEC
T ss_pred --------CCCEEEecCCcCCCCccHHHHHHHHCcccCccCC
Confidence 889999999999976553 2445788888864
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.29 E-value=5.3e-12 Score=126.22 Aligned_cols=111 Identities=24% Similarity=0.230 Sum_probs=75.2
Q ss_pred cEEEEEecCCCceeeccccc-ccCCCCCEEEccCCccCcCCCCCCCCCCCCCEEEcCCCcCccccCchhhhcccCccccc
Q 039819 9 LVIGLGAPSQSLSGTLSGSI-GNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFLSIWLPRKWD 87 (534)
Q Consensus 9 ~l~~L~l~~n~l~g~~p~~~-~~l~~L~~L~L~~N~l~g~~P~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~l~~~~~ 87 (534)
+++.|+|++|+|++..+..+ ..+++|++|+|++|+|++ +|. ...+++|++|+|++|+|++ +|..+..++
T Consensus 145 ~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~-~~~-~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~------- 214 (317)
T 3o53_A 145 RVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYD-VKG-QVVFAKLKTLDLSSNKLAF-MGPEFQSAA------- 214 (317)
T ss_dssp SEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCE-EEC-CCCCTTCCEEECCSSCCCE-ECGGGGGGT-------
T ss_pred CCCEEECCCCCCCcccHHHHhhccCcCCEEECCCCcCcc-ccc-ccccccCCEEECCCCcCCc-chhhhcccC-------
Confidence 45666666666665555544 245666666666666653 232 2236666666666666663 333355554
Q ss_pred ccccCCccccceeCCCCcCcccCChhhhcccccccccccCCCCC-CCCCCC
Q 039819 88 KRKCSGVDQGLLRLNNNSLSGAFPVFLAKISELAFLDLSYNNLS-GPVPKF 137 (534)
Q Consensus 88 ~~~~~~~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~-g~~p~~ 137 (534)
+|+.|+|++|+|+ .+|..+..+++|+.|+|++|.++ +.+|.+
T Consensus 215 -------~L~~L~L~~N~l~-~l~~~~~~l~~L~~L~l~~N~~~~~~~~~~ 257 (317)
T 3o53_A 215 -------GVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDF 257 (317)
T ss_dssp -------TCSEEECTTSCCC-EECTTCCCCTTCCEEECTTCCCBHHHHHHH
T ss_pred -------cccEEECcCCccc-chhhHhhcCCCCCEEEccCCCccCcCHHHH
Confidence 8999999999999 68999999999999999999998 555543
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.29 E-value=2.7e-12 Score=138.07 Aligned_cols=100 Identities=25% Similarity=0.349 Sum_probs=71.2
Q ss_pred eecCCCcEEEEEecCCCceeecccccccCCCCCEEEccCCccCcCCCCCCCCCCCCCEEEcCCCcCccccCchhhhcccC
Q 039819 3 TCSPENLVIGLGAPSQSLSGTLSGSIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFLSIWL 82 (534)
Q Consensus 3 ~c~~~~~l~~L~l~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~P~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~l 82 (534)
.|. .++|+.|+|++|+|++ +|..+. ++|++|+|++|+|+ .+| ..+++|++|+|++|+|++ +|. +..
T Consensus 55 ~C~-~~~L~~L~Ls~n~L~~-lp~~l~--~~L~~L~Ls~N~l~-~ip---~~l~~L~~L~Ls~N~l~~-ip~-l~~---- 120 (571)
T 3cvr_A 55 ECL-INQFSELQLNRLNLSS-LPDNLP--PQITVLEITQNALI-SLP---ELPASLEYLDACDNRLST-LPE-LPA---- 120 (571)
T ss_dssp HHH-HTTCSEEECCSSCCSC-CCSCCC--TTCSEEECCSSCCS-CCC---CCCTTCCEEECCSSCCSC-CCC-CCT----
T ss_pred ccc-cCCccEEEeCCCCCCc-cCHhHc--CCCCEEECcCCCCc-ccc---cccCCCCEEEccCCCCCC-cch-hhc----
Confidence 455 4579999999999996 887664 88999999999999 788 457899999999999996 676 432
Q ss_pred cccccccccCCccccceeCCCCcCcccCChhhhcccccccccccCCCCCC
Q 039819 83 PRKWDKRKCSGVDQGLLRLNNNSLSGAFPVFLAKISELAFLDLSYNNLSG 132 (534)
Q Consensus 83 ~~~~~~~~~~~~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g 132 (534)
+|+.|+|++|+|++ +|. .+++|+.|+|++|+|++
T Consensus 121 ------------~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~l~~ 154 (571)
T 3cvr_A 121 ------------SLKHLDVDNNQLTM-LPE---LPALLEYINADNNQLTM 154 (571)
T ss_dssp ------------TCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC
T ss_pred ------------CCCEEECCCCcCCC-CCC---cCccccEEeCCCCccCc
Confidence 34455555555553 444 34555555555555553
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=99.29 E-value=4.4e-12 Score=128.14 Aligned_cols=135 Identities=21% Similarity=0.215 Sum_probs=76.6
Q ss_pred cEEEEEecCCCceeecccccccCCCCCEEEccCCccCcCCCCCCCCCCCCCEEEcCCCcCccccCchhhhcccCcccccc
Q 039819 9 LVIGLGAPSQSLSGTLSGSIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFLSIWLPRKWDK 88 (534)
Q Consensus 9 ~l~~L~l~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~P~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~l~~~~~~ 88 (534)
.++.|++++|++++..+ +..+++|++|+|++|++++ +|. +..+++|++|+|++|.+++ ++ .+..++.|..+..+
T Consensus 200 ~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~n~l~~-~~~-~~~l~~L~~L~l~~n~l~~-~~-~~~~l~~L~~L~l~ 273 (347)
T 4fmz_A 200 SLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITD-LSP-LANLSQLTWLEIGTNQISD-IN-AVKDLTKLKMLNVG 273 (347)
T ss_dssp TCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCC-CGG-GTTCTTCCEEECCSSCCCC-CG-GGTTCTTCCEEECC
T ss_pred ccceeecccCCCCCCch--hhcCCcCCEEEccCCccCC-Ccc-hhcCCCCCEEECCCCccCC-Ch-hHhcCCCcCEEEcc
Confidence 45556666666654332 5556666666666666653 333 5556666666666666553 22 23333333222111
Q ss_pred cc-c-------CCccccceeCCCCcCcccCChhhhcccccccccccCCCCCCCCCCC-CC--ccccccCCcc
Q 039819 89 RK-C-------SGVDQGLLRLNNNSLSGAFPVFLAKISELAFLDLSYNNLSGPVPKF-PA--RTFNVAGNPL 149 (534)
Q Consensus 89 ~~-~-------~~~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~-~~--~~~~~~~N~~ 149 (534)
++ . ...+|+.|+|++|++++..|..|+.+++|+.|+|++|++++..|-. +. +.+.+.+|++
T Consensus 274 ~n~l~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~l~~L~~L~l~~N~i 345 (347)
T 4fmz_A 274 SNQISDISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRPLASLSKMDSADFANQVI 345 (347)
T ss_dssp SSCCCCCGGGGGCTTCSEEECCSSCCCGGGHHHHHTCTTCSEEECCSSSCCCCGGGGGCTTCSEESSSCC--
T ss_pred CCccCCChhhcCCCCCCEEECcCCcCCCcChhHhhccccCCEEEccCCccccccChhhhhccceeehhhhcc
Confidence 10 0 0126778888888888777788888888888888888888765511 11 4556666654
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.27 E-value=4.9e-12 Score=136.11 Aligned_cols=98 Identities=29% Similarity=0.394 Sum_probs=70.2
Q ss_pred CcEEEEEecCCCceeecccccccCCCCCEEEccCCccCcCCCCCCCCCCCCCEEEcCCCcCccccCchhhhcccCccccc
Q 039819 8 NLVIGLGAPSQSLSGTLSGSIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFLSIWLPRKWD 87 (534)
Q Consensus 8 ~~l~~L~l~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~P~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~l~~~~~ 87 (534)
.+|+.|+|++|+|++ +|. |.+ +|++|+|++|+|++ +|. .+++|+.|+|++|+|++ +|. .++
T Consensus 100 ~~L~~L~Ls~N~l~~-ip~-l~~--~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~l~~-lp~---~l~------- 160 (571)
T 3cvr_A 100 ASLEYLDACDNRLST-LPE-LPA--SLKHLDVDNNQLTM-LPE---LPALLEYINADNNQLTM-LPE---LPT------- 160 (571)
T ss_dssp TTCCEEECCSSCCSC-CCC-CCT--TCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC---CCT-------
T ss_pred CCCCEEEccCCCCCC-cch-hhc--CCCEEECCCCcCCC-CCC---cCccccEEeCCCCccCc-CCC---cCC-------
Confidence 468888888888886 776 665 88888999888885 776 67888888888888885 565 233
Q ss_pred ccccCCccccceeCCCCcCcccCChhhhcccccccccccCCCCCCCCCC
Q 039819 88 KRKCSGVDQGLLRLNNNSLSGAFPVFLAKISELAFLDLSYNNLSGPVPK 136 (534)
Q Consensus 88 ~~~~~~~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~ 136 (534)
+|+.|+|++|+|++ +|. |. ++|+.|+|++|+|+ .+|.
T Consensus 161 -------~L~~L~Ls~N~L~~-lp~-l~--~~L~~L~Ls~N~L~-~lp~ 197 (571)
T 3cvr_A 161 -------SLEVLSVRNNQLTF-LPE-LP--ESLEALDVSTNLLE-SLPA 197 (571)
T ss_dssp -------TCCEEECCSSCCSC-CCC-CC--TTCCEEECCSSCCS-SCCC
T ss_pred -------CcCEEECCCCCCCC-cch-hh--CCCCEEECcCCCCC-chhh
Confidence 55666666666664 555 44 56666666666666 4444
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.23 E-value=9e-12 Score=135.32 Aligned_cols=119 Identities=25% Similarity=0.254 Sum_probs=79.6
Q ss_pred CcEEEEEecCCCceeecccccccCCCCCEEEccCCccCcCCCCCCCCCCCCCEEEcCCCcCccccCchhhhcccCccccc
Q 039819 8 NLVIGLGAPSQSLSGTLSGSIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFLSIWLPRKWD 87 (534)
Q Consensus 8 ~~l~~L~l~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~P~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~l~~~~~ 87 (534)
.+|+.|+|++|+|++ +| .|+.|++|+.|+|++|+|++ +| .|..|++|+.|+|++|+|++. ..+..++.|..+..
T Consensus 87 ~~L~~L~Ls~N~l~~-l~-~l~~l~~L~~L~Ls~N~l~~-l~-~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~L 160 (605)
T 1m9s_A 87 KNLGWLFLDENKIKD-LS-SLKDLKKLKSLSLEHNGISD-IN-GLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSL 160 (605)
T ss_dssp TTCCEEECCSSCCCC-CT-TSTTCTTCCEEECTTSCCCC-CG-GGGGCTTCSEEECCSSCCCCC--GGGGSCTTCSEEEC
T ss_pred CCCCEEECcCCCCCC-Ch-hhccCCCCCEEEecCCCCCC-Cc-cccCCCccCEEECCCCccCCc--hhhcccCCCCEEEC
Confidence 356677777777764 33 56667777777777777763 33 466666677777777666643 34555555544432
Q ss_pred ccc-c-------CCccccceeCCCCcCcccCChhhhcccccccccccCCCCCCCC
Q 039819 88 KRK-C-------SGVDQGLLRLNNNSLSGAFPVFLAKISELAFLDLSYNNLSGPV 134 (534)
Q Consensus 88 ~~~-~-------~~~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~ 134 (534)
+.+ . ...+|+.|+|++|+|++ +| .|..+++|+.|+|++|++++..
T Consensus 161 s~N~l~~~~~l~~l~~L~~L~Ls~N~i~~-l~-~l~~l~~L~~L~L~~N~l~~~p 213 (605)
T 1m9s_A 161 EDNQISDIVPLAGLTKLQNLYLSKNHISD-LR-ALAGLKNLDVLELFSQECLNKP 213 (605)
T ss_dssp CSSCCCCCGGGTTCTTCCEEECCSSCCCB-CG-GGTTCTTCSEEECCSEEEECCC
T ss_pred cCCcCCCchhhccCCCCCEEECcCCCCCC-Ch-HHccCCCCCEEEccCCcCcCCc
Confidence 211 1 11289999999999995 44 6999999999999999999643
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=99.23 E-value=1.1e-11 Score=130.88 Aligned_cols=136 Identities=23% Similarity=0.253 Sum_probs=90.7
Q ss_pred CcEEEEEecCCCceeecccccccCCCCCEEEccCCccCcCCCCCCCCCCCCCEEEcCCCcCccccCchhhhcccCccccc
Q 039819 8 NLVIGLGAPSQSLSGTLSGSIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFLSIWLPRKWD 87 (534)
Q Consensus 8 ~~l~~L~l~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~P~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~l~~~~~ 87 (534)
.+++.|+|++|++++..| ++.+++|++|+|++|+|++ +|. +..+++|+.|+|++|++++..| +..++.|..+..
T Consensus 243 ~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~-~~~-~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~L 316 (466)
T 1o6v_A 243 TNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISN-ISP-LAGLTALTNLELNENQLEDISP--ISNLKNLTYLTL 316 (466)
T ss_dssp TTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCC-CGG-GTTCTTCSEEECCSSCCSCCGG--GGGCTTCSEEEC
T ss_pred CCCCEEECCCCccccchh--hhcCCCCCEEECCCCccCc-ccc-ccCCCccCeEEcCCCcccCchh--hcCCCCCCEEEC
Confidence 468888888888886544 7888888888888888885 444 7788888888888888886544 555554443322
Q ss_pred ccc-c-------CCccccceeCCCCcCcccCChhhhcccccccccccCCCCCCCCCCCCC---ccccccCCccee
Q 039819 88 KRK-C-------SGVDQGLLRLNNNSLSGAFPVFLAKISELAFLDLSYNNLSGPVPKFPA---RTFNVAGNPLIC 151 (534)
Q Consensus 88 ~~~-~-------~~~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~---~~~~~~~N~~~c 151 (534)
+.+ . ...+|+.|+|++|.+++. ..+..+++|+.|++++|++++.+|-... +.+.+.+|+|..
T Consensus 317 ~~n~l~~~~~~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~~~~l~~L~~L~l~~n~~~~ 389 (466)
T 1o6v_A 317 YFNNISDISPVSSLTKLQRLFFYNNKVSDV--SSLANLTNINWLSAGHNQISDLTPLANLTRITQLGLNDQAWTN 389 (466)
T ss_dssp CSSCCSCCGGGGGCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCBCGGGTTCTTCCEEECCCEEEEC
T ss_pred cCCcCCCchhhccCccCCEeECCCCccCCc--hhhccCCCCCEEeCCCCccCccchhhcCCCCCEEeccCCcccC
Confidence 111 1 112677777777777754 4577777777777777777776662111 455667777755
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.22 E-value=5.6e-14 Score=130.69 Aligned_cols=110 Identities=22% Similarity=0.196 Sum_probs=97.0
Q ss_pred CcEEEEEecCCCceeecccccccCCCCCEEEccCCccCcCCCCCCCCCCCCCEEEcCCCcCccccCchhhhcccCccccc
Q 039819 8 NLVIGLGAPSQSLSGTLSGSIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFLSIWLPRKWD 87 (534)
Q Consensus 8 ~~l~~L~l~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~P~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~l~~~~~ 87 (534)
.+++.|+|++|+|++ +| .|+++++|++|+|++|+|+ .+|..+..+++|++|+|++|+|++ +| .+..++
T Consensus 48 ~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~~~~~L~~L~L~~N~l~~-l~-~~~~l~------- 115 (198)
T 1ds9_A 48 KACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIAS-LS-GIEKLV------- 115 (198)
T ss_dssp TTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHHHHHHCSEEEEEEEECCC-HH-HHHHHH-------
T ss_pred CCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhhcCCcCCEEECcCCcCCc-CC-ccccCC-------
Confidence 479999999999996 77 9999999999999999999 799888888999999999999996 55 577777
Q ss_pred ccccCCccccceeCCCCcCcccCC-hhhhcccccccccccCCCCCCCCCC
Q 039819 88 KRKCSGVDQGLLRLNNNSLSGAFP-VFLAKISELAFLDLSYNNLSGPVPK 136 (534)
Q Consensus 88 ~~~~~~~~L~~L~L~~N~l~g~~p-~~~~~l~~L~~L~ls~N~l~g~~p~ 136 (534)
+|+.|+|++|++++..+ ..+..+++|+.|++++|.+++.+|.
T Consensus 116 -------~L~~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~ 158 (198)
T 1ds9_A 116 -------NLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKE 158 (198)
T ss_dssp -------HSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSCHHHHHHHT
T ss_pred -------CCCEEECCCCcCCchhHHHHHhcCCCCCEEEecCCcccccccc
Confidence 88999999999994332 4789999999999999999877654
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=99.20 E-value=2.2e-12 Score=135.63 Aligned_cols=136 Identities=21% Similarity=0.256 Sum_probs=75.3
Q ss_pred CCcEEEEEecCCCceeecccccccCCCCCEEEccCCccCcCCCCCCCCCCCC-------------CEEEcCCCcCccc--
Q 039819 7 ENLVIGLGAPSQSLSGTLSGSIGNLTNLRQVLLQNNNISGGIPPQLGSLPKL-------------QTLDLSNNRLSGV-- 71 (534)
Q Consensus 7 ~~~l~~L~l~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~P~~~~~l~~L-------------~~L~Ls~N~l~g~-- 71 (534)
...++.|++++|+| |.+|.+|++|++|++|+|++|+++|.+|.+++.+.+| ++|+|++|.|++.
T Consensus 10 ~~~L~~L~l~~n~l-~~iP~~i~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~c~~~~l~~L~l~~~~l~~lp~ 88 (454)
T 1jl5_A 10 NTFLQEPLRHSSNL-TEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLSSLPE 88 (454)
T ss_dssp -------------------------CCHHHHHHHHHHHHHTSCTTSCCCHHHHHHHHHHHHHHTCSEEECTTSCCSCCCS
T ss_pred cccchhhhcccCch-hhCChhHhcccchhhhhccCCcccccCCcccccchhcchhhhhhhhccCCCEEEecCCccccCCC
Confidence 45789999999999 7999999999999999999999999999999887643 5555555555531
Q ss_pred -----------------cCchhhhcccCccccc-ccccCC-----ccccceeCCCCcCcccCChhhhcccccccccccCC
Q 039819 72 -----------------IPALLFLSIWLPRKWD-KRKCSG-----VDQGLLRLNNNSLSGAFPVFLAKISELAFLDLSYN 128 (534)
Q Consensus 72 -----------------~p~~~~~l~~l~~~~~-~~~~~~-----~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N 128 (534)
+|..+. .+..+.. .+.... .+|+.|+|++|++++ +| .|+.+++|++|++++|
T Consensus 89 ~~~~L~~L~l~~n~l~~lp~~~~---~L~~L~l~~n~l~~l~~~~~~L~~L~L~~n~l~~-lp-~~~~l~~L~~L~l~~N 163 (454)
T 1jl5_A 89 LPPHLESLVASCNSLTELPELPQ---SLKSLLVDNNNLKALSDLPPLLEYLGVSNNQLEK-LP-ELQNSSFLKIIDVDNN 163 (454)
T ss_dssp CCTTCSEEECCSSCCSSCCCCCT---TCCEEECCSSCCSCCCSCCTTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSS
T ss_pred CcCCCCEEEccCCcCCccccccC---CCcEEECCCCccCcccCCCCCCCEEECcCCCCCC-Cc-ccCCCCCCCEEECCCC
Confidence 332221 1111111 111111 378889999999885 77 5889999999999999
Q ss_pred CCCCCCCCCCC--ccccccCCcc
Q 039819 129 NLSGPVPKFPA--RTFNVAGNPL 149 (534)
Q Consensus 129 ~l~g~~p~~~~--~~~~~~~N~~ 149 (534)
++++ +|..+. +.+.+.+|.+
T Consensus 164 ~l~~-lp~~~~~L~~L~L~~n~l 185 (454)
T 1jl5_A 164 SLKK-LPDLPPSLEFIAAGNNQL 185 (454)
T ss_dssp CCSC-CCCCCTTCCEEECCSSCC
T ss_pred cCcc-cCCCcccccEEECcCCcC
Confidence 9985 665443 5566667755
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=99.20 E-value=4.2e-11 Score=125.84 Aligned_cols=130 Identities=25% Similarity=0.352 Sum_probs=74.4
Q ss_pred cEEEEEecCCCceeecccccccCCCCCEEEccCCccCcCCCCCCCCCCCCCEEEcCCCcCccccCchhhhcccCcccccc
Q 039819 9 LVIGLGAPSQSLSGTLSGSIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFLSIWLPRKWDK 88 (534)
Q Consensus 9 ~l~~L~l~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~P~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~l~~~~~~ 88 (534)
+++.|+|++|+|++ +| +|+++++|++|+|++|+|++ +|..+ .+|++|+|++|++++ +| .+..++.|..+..+
T Consensus 132 ~L~~L~L~~n~l~~-lp-~~~~l~~L~~L~l~~N~l~~-lp~~~---~~L~~L~L~~n~l~~-l~-~~~~l~~L~~L~l~ 203 (454)
T 1jl5_A 132 LLEYLGVSNNQLEK-LP-ELQNSSFLKIIDVDNNSLKK-LPDLP---PSLEFIAAGNNQLEE-LP-ELQNLPFLTAIYAD 203 (454)
T ss_dssp TCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSC-CCCCC---TTCCEEECCSSCCSS-CC-CCTTCTTCCEEECC
T ss_pred CCCEEECcCCCCCC-Cc-ccCCCCCCCEEECCCCcCcc-cCCCc---ccccEEECcCCcCCc-Cc-cccCCCCCCEEECC
Confidence 56666666666664 55 46666666666666666663 55433 366666666666664 44 35555544443222
Q ss_pred cc-cCC-----ccccceeCCCCcCcccCChhhhcccccccccccCCCCCCCCCCCCC--ccccccCCcc
Q 039819 89 RK-CSG-----VDQGLLRLNNNSLSGAFPVFLAKISELAFLDLSYNNLSGPVPKFPA--RTFNVAGNPL 149 (534)
Q Consensus 89 ~~-~~~-----~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~--~~~~~~~N~~ 149 (534)
++ ..+ .+|+.|+|++|.++ .+|. |+.+++|+.|++++|++++ +|..+. +.+.+++|.+
T Consensus 204 ~N~l~~l~~~~~~L~~L~l~~n~l~-~lp~-~~~l~~L~~L~l~~N~l~~-l~~~~~~L~~L~l~~N~l 269 (454)
T 1jl5_A 204 NNSLKKLPDLPLSLESIVAGNNILE-ELPE-LQNLPFLTTIYADNNLLKT-LPDLPPSLEALNVRDNYL 269 (454)
T ss_dssp SSCCSSCCCCCTTCCEEECCSSCCS-SCCC-CTTCTTCCEEECCSSCCSS-CCSCCTTCCEEECCSSCC
T ss_pred CCcCCcCCCCcCcccEEECcCCcCC-cccc-cCCCCCCCEEECCCCcCCc-ccccccccCEEECCCCcc
Confidence 11 111 25667777777776 5663 6677777777777777774 443322 3445555543
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=99.20 E-value=1.5e-11 Score=124.19 Aligned_cols=116 Identities=22% Similarity=0.271 Sum_probs=75.3
Q ss_pred CcEEEEEecCCCceeecccccccCCCCCEEEccCCccCcCCCCCCCCCCCCCEEEcCCCcCccccCchhhhcccCccccc
Q 039819 8 NLVIGLGAPSQSLSGTLSGSIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFLSIWLPRKWD 87 (534)
Q Consensus 8 ~~l~~L~l~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~P~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~l~~~~~ 87 (534)
.+++.|+|++|++++. +. +..+++|++|+|++|.+++ + +.+..+++|++|+|++|++++. | .+..++.|..+..
T Consensus 221 ~~L~~L~l~~n~l~~~-~~-~~~l~~L~~L~l~~n~l~~-~-~~~~~l~~L~~L~l~~n~l~~~-~-~~~~l~~L~~L~L 294 (347)
T 4fmz_A 221 TRLNSLKIGNNKITDL-SP-LANLSQLTWLEIGTNQISD-I-NAVKDLTKLKMLNVGSNQISDI-S-VLNNLSQLNSLFL 294 (347)
T ss_dssp TTCCEEECCSSCCCCC-GG-GTTCTTCCEEECCSSCCCC-C-GGGTTCTTCCEEECCSSCCCCC-G-GGGGCTTCSEEEC
T ss_pred CcCCEEEccCCccCCC-cc-hhcCCCCCEEECCCCccCC-C-hhHhcCCCcCEEEccCCccCCC-h-hhcCCCCCCEEEC
Confidence 3566777777777643 33 6667777777777777763 3 3466666777777777766643 2 3444444444332
Q ss_pred cccc----------CCccccceeCCCCcCcccCChhhhcccccccccccCCCCC
Q 039819 88 KRKC----------SGVDQGLLRLNNNSLSGAFPVFLAKISELAFLDLSYNNLS 131 (534)
Q Consensus 88 ~~~~----------~~~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~ 131 (534)
+++. ...+|+.|+|++|.+++..| +..+++|+.|++++|.|+
T Consensus 295 ~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~N~i~ 346 (347)
T 4fmz_A 295 NNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQVIK 346 (347)
T ss_dssp CSSCCCGGGHHHHHTCTTCSEEECCSSSCCCCGG--GGGCTTCSEESSSCC---
T ss_pred cCCcCCCcChhHhhccccCCEEEccCCccccccC--hhhhhccceeehhhhccc
Confidence 2211 11389999999999997666 889999999999999986
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.18 E-value=4.9e-11 Score=125.46 Aligned_cols=100 Identities=21% Similarity=0.339 Sum_probs=83.3
Q ss_pred CcEEEEEecCCCceeecccccccCCCCCEEEccCCccCcCCCCCCCCCCCCCEEEcCCCcCccccCchhhhcccCccccc
Q 039819 8 NLVIGLGAPSQSLSGTLSGSIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFLSIWLPRKWD 87 (534)
Q Consensus 8 ~~l~~L~l~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~P~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~l~~~~~ 87 (534)
.+++.|+|++|+|++ +| .|+.+++|++|+|++|+|++ +| |+.+++|++|+|++|+|++. | +..++
T Consensus 42 ~~L~~L~Ls~n~l~~-~~-~l~~l~~L~~L~Ls~n~l~~-~~--~~~l~~L~~L~Ls~N~l~~~-~--~~~l~------- 106 (457)
T 3bz5_A 42 ATLTSLDCHNSSITD-MT-GIEKLTGLTKLICTSNNITT-LD--LSQNTNLTYLACDSNKLTNL-D--VTPLT------- 106 (457)
T ss_dssp TTCCEEECCSSCCCC-CT-TGGGCTTCSEEECCSSCCSC-CC--CTTCTTCSEEECCSSCCSCC-C--CTTCT-------
T ss_pred CCCCEEEccCCCccc-Ch-hhcccCCCCEEEccCCcCCe-Ec--cccCCCCCEEECcCCCCcee-e--cCCCC-------
Confidence 478999999999997 45 79999999999999999996 55 99999999999999999964 4 66666
Q ss_pred ccccCCccccceeCCCCcCcccCChhhhcccccccccccCCCCCC
Q 039819 88 KRKCSGVDQGLLRLNNNSLSGAFPVFLAKISELAFLDLSYNNLSG 132 (534)
Q Consensus 88 ~~~~~~~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g 132 (534)
+|+.|+|++|+|++ +| ++.+++|+.|++++|+|++
T Consensus 107 -------~L~~L~L~~N~l~~-l~--~~~l~~L~~L~l~~N~l~~ 141 (457)
T 3bz5_A 107 -------KLTYLNCDTNKLTK-LD--VSQNPLLTYLNCARNTLTE 141 (457)
T ss_dssp -------TCCEEECCSSCCSC-CC--CTTCTTCCEEECTTSCCSC
T ss_pred -------cCCEEECCCCcCCe-ec--CCCCCcCCEEECCCCccce
Confidence 67778888888875 44 7777788888888888776
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=99.17 E-value=3.7e-11 Score=126.70 Aligned_cols=106 Identities=34% Similarity=0.491 Sum_probs=80.4
Q ss_pred CcEEEEEecCCCceeecccccccCCCCCEEEccCCccCcCCCCCCCCCCCCCEEEcCCCcCccccCchhhhcccCccccc
Q 039819 8 NLVIGLGAPSQSLSGTLSGSIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFLSIWLPRKWD 87 (534)
Q Consensus 8 ~~l~~L~l~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~P~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~l~~~~~ 87 (534)
.+++.|+|++|++++ + +.+..+++|++|+|++|++++..| +..+++|+.|+|++|++++..| +..++
T Consensus 221 ~~L~~L~l~~n~l~~-~-~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~------- 287 (466)
T 1o6v_A 221 TNLDELSLNGNQLKD-I-GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLT------- 287 (466)
T ss_dssp TTCCEEECCSSCCCC-C-GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCGG--GTTCT-------
T ss_pred CCCCEEECCCCCccc-c-hhhhcCCCCCEEECCCCccccchh--hhcCCCCCEEECCCCccCcccc--ccCCC-------
Confidence 479999999999996 4 478999999999999999996544 9999999999999999996554 66666
Q ss_pred ccccCCccccceeCCCCcCcccCChhhhcccccccccccCCCCCCCCC
Q 039819 88 KRKCSGVDQGLLRLNNNSLSGAFPVFLAKISELAFLDLSYNNLSGPVP 135 (534)
Q Consensus 88 ~~~~~~~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p 135 (534)
+|+.|+|++|++++..| +..+++|+.|+|++|++++..|
T Consensus 288 -------~L~~L~L~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~ 326 (466)
T 1o6v_A 288 -------ALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP 326 (466)
T ss_dssp -------TCSEEECCSSCCSCCGG--GGGCTTCSEEECCSSCCSCCGG
T ss_pred -------ccCeEEcCCCcccCchh--hcCCCCCCEEECcCCcCCCchh
Confidence 55566666666664333 5566666666666666665444
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.16 E-value=2.3e-11 Score=123.34 Aligned_cols=107 Identities=12% Similarity=0.100 Sum_probs=75.0
Q ss_pred EEEecCCCceeecccccccCCCCCEEEccCCccCcCCCCCCCCCCCCCEEEcCCCcCccccCc-hhhhcccCcccccccc
Q 039819 12 GLGAPSQSLSGTLSGSIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPA-LLFLSIWLPRKWDKRK 90 (534)
Q Consensus 12 ~L~l~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~P~~~~~l~~L~~L~Ls~N~l~g~~p~-~~~~l~~l~~~~~~~~ 90 (534)
.++.++|+|+ .+|..| .++|++|+|++|+|+..-+.+|.+|++|++|+|++|++.+.+|. .|..++
T Consensus 13 ~v~C~~~~Lt-~iP~~l--~~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~---------- 79 (350)
T 4ay9_X 13 VFLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLP---------- 79 (350)
T ss_dssp EEEEESTTCC-SCCTTC--CTTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCT----------
T ss_pred EEEecCCCCC-ccCcCc--CCCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcch----------
Confidence 3566788887 677665 36788888888888843334688888888888888887666664 444554
Q ss_pred cCCcccc-ceeCCCCcCcccCChhhhcccccccccccCCCCCCCCC
Q 039819 91 CSGVDQG-LLRLNNNSLSGAFPVFLAKISELAFLDLSYNNLSGPVP 135 (534)
Q Consensus 91 ~~~~~L~-~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p 135 (534)
+|. .+.+++|+|+...|..|..+++|+.|++++|+|++..+
T Consensus 80 ----~l~~~l~~~~N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~ 121 (350)
T 4ay9_X 80 ----KLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPD 121 (350)
T ss_dssp ----TCCEEEEEEETTCCEECTTSBCCCTTCCEEEEEEECCSSCCC
T ss_pred ----hhhhhhcccCCcccccCchhhhhccccccccccccccccCCc
Confidence 332 46667778876667777888888888888888875444
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.15 E-value=7e-11 Score=124.25 Aligned_cols=104 Identities=18% Similarity=0.225 Sum_probs=80.1
Q ss_pred CcEEEEEecCCCceeecccccccCCCCCEEEccCCccCcCCCCCCCCCCCCCEEEcCCCcCccccCchhhhcccCccccc
Q 039819 8 NLVIGLGAPSQSLSGTLSGSIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFLSIWLPRKWD 87 (534)
Q Consensus 8 ~~l~~L~l~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~P~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~l~~~~~ 87 (534)
.+++.|+|++|+..+.+ .++.+++|++|+|++|+|++ +| ++.+++|+.|+|++|+|++. + +..++
T Consensus 148 ~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~ls~n~l~~-l~--l~~l~~L~~L~l~~N~l~~~-~--l~~l~------- 212 (457)
T 3bz5_A 148 TQLTELDCHLNKKITKL--DVTPQTQLTTLDCSFNKITE-LD--VSQNKLLNRLNCDTNNITKL-D--LNQNI------- 212 (457)
T ss_dssp TTCCEEECTTCSCCCCC--CCTTCTTCCEEECCSSCCCC-CC--CTTCTTCCEEECCSSCCSCC-C--CTTCT-------
T ss_pred CcCCEEECCCCCccccc--ccccCCcCCEEECCCCccce-ec--cccCCCCCEEECcCCcCCee-c--cccCC-------
Confidence 46888888888666666 47888888888888888885 66 78888888888888888864 2 55555
Q ss_pred ccccCCccccceeCCCCcCcccCChhhhcccccccccccCCCCCCCCCC
Q 039819 88 KRKCSGVDQGLLRLNNNSLSGAFPVFLAKISELAFLDLSYNNLSGPVPK 136 (534)
Q Consensus 88 ~~~~~~~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~ 136 (534)
+|+.|+|++|+|++ +| ++.+++|+.|++++|+|++..+.
T Consensus 213 -------~L~~L~Ls~N~l~~-ip--~~~l~~L~~L~l~~N~l~~~~~~ 251 (457)
T 3bz5_A 213 -------QLTFLDCSSNKLTE-ID--VTPLTQLTYFDCSVNPLTELDVS 251 (457)
T ss_dssp -------TCSEEECCSSCCSC-CC--CTTCTTCSEEECCSSCCSCCCCT
T ss_pred -------CCCEEECcCCcccc-cC--ccccCCCCEEEeeCCcCCCcCHH
Confidence 77788888888885 56 77788888888888888875443
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.14 E-value=2.3e-12 Score=132.46 Aligned_cols=128 Identities=21% Similarity=0.217 Sum_probs=82.0
Q ss_pred CcEEEEEecCCCce-eecc---cccccCCCCCEEEccCCccC--c---CCCCCCCCCCCCCEEEcCCCcCc----cccCc
Q 039819 8 NLVIGLGAPSQSLS-GTLS---GSIGNLTNLRQVLLQNNNIS--G---GIPPQLGSLPKLQTLDLSNNRLS----GVIPA 74 (534)
Q Consensus 8 ~~l~~L~l~~n~l~-g~~p---~~~~~l~~L~~L~L~~N~l~--g---~~P~~~~~l~~L~~L~Ls~N~l~----g~~p~ 74 (534)
.+|+.|+|++|+|+ +.+| ..|..+++|++|+|++|+|+ | .+|..+..+++|+.|+|++|.|+ +.+|.
T Consensus 159 ~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~ 238 (386)
T 2ca6_A 159 PPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAI 238 (386)
T ss_dssp CCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHH
T ss_pred CCCcEEECCCCCCCcHHHHHHHHHHHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHH
Confidence 46777777777776 3344 45667777777777777776 3 34546777777777777777775 45666
Q ss_pred hhhhcccCcccccccccCCccccceeCCCCcCccc----CChhhhc--ccccccccccCCCCCC----CCCCCC------
Q 039819 75 LLFLSIWLPRKWDKRKCSGVDQGLLRLNNNSLSGA----FPVFLAK--ISELAFLDLSYNNLSG----PVPKFP------ 138 (534)
Q Consensus 75 ~~~~l~~l~~~~~~~~~~~~~L~~L~L~~N~l~g~----~p~~~~~--l~~L~~L~ls~N~l~g----~~p~~~------ 138 (534)
.+..++ +|+.|+|++|.|++. +|..+.. +++|+.|+|++|++++ .+|..+
T Consensus 239 ~l~~~~--------------~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~~L~~L~L~~n~i~~~g~~~l~~~l~~~l~~ 304 (386)
T 2ca6_A 239 ALKSWP--------------NLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPD 304 (386)
T ss_dssp HGGGCT--------------TCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTT
T ss_pred HHccCC--------------CcCEEECCCCCCchhhHHHHHHHHhhccCCCeEEEECcCCcCCHHHHHHHHHHHHhcCCC
Confidence 666555 666777777777654 4555533 6777777777777775 244322
Q ss_pred CccccccCCcc
Q 039819 139 ARTFNVAGNPL 149 (534)
Q Consensus 139 ~~~~~~~~N~~ 149 (534)
.+.+.+.+|++
T Consensus 305 L~~L~l~~N~l 315 (386)
T 2ca6_A 305 LLFLELNGNRF 315 (386)
T ss_dssp CCEEECTTSBS
T ss_pred ceEEEccCCcC
Confidence 14455666655
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.14 E-value=5.1e-12 Score=129.87 Aligned_cols=114 Identities=24% Similarity=0.323 Sum_probs=98.1
Q ss_pred CcEEEEEecCCCce--e---ecccccccCCCCCEEEccCCccC----cCCCCCCCCCCCCCEEEcCCCcCccc----cCc
Q 039819 8 NLVIGLGAPSQSLS--G---TLSGSIGNLTNLRQVLLQNNNIS----GGIPPQLGSLPKLQTLDLSNNRLSGV----IPA 74 (534)
Q Consensus 8 ~~l~~L~l~~n~l~--g---~~p~~~~~l~~L~~L~L~~N~l~----g~~P~~~~~l~~L~~L~Ls~N~l~g~----~p~ 74 (534)
.+++.|+|++|+|+ | .+|..|..+++|++|+|++|.|+ +.+|..|..+++|+.|+|++|+|++. +|.
T Consensus 187 ~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~ 266 (386)
T 2ca6_A 187 RLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVD 266 (386)
T ss_dssp TTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHH
T ss_pred CCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHccCCCcCEEECCCCCCchhhHHHHHH
Confidence 47999999999998 3 45558999999999999999996 67899999999999999999999976 455
Q ss_pred hhhh--cccCcccccccccCCccccceeCCCCcCcc----cCChhh-hcccccccccccCCCCCCCCC
Q 039819 75 LLFL--SIWLPRKWDKRKCSGVDQGLLRLNNNSLSG----AFPVFL-AKISELAFLDLSYNNLSGPVP 135 (534)
Q Consensus 75 ~~~~--l~~l~~~~~~~~~~~~~L~~L~L~~N~l~g----~~p~~~-~~l~~L~~L~ls~N~l~g~~p 135 (534)
.+.. ++ +|+.|+|++|.|++ .+|..+ .++++|+.|+|++|++++..|
T Consensus 267 ~l~~~~~~--------------~L~~L~L~~n~i~~~g~~~l~~~l~~~l~~L~~L~l~~N~l~~~~~ 320 (386)
T 2ca6_A 267 AFSKLENI--------------GLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEEDD 320 (386)
T ss_dssp HHHTCSSC--------------CCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCTTSH
T ss_pred HHhhccCC--------------CeEEEECcCCcCCHHHHHHHHHHHHhcCCCceEEEccCCcCCcchh
Confidence 4432 44 88999999999997 588888 678999999999999997654
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.10 E-value=3e-10 Score=109.94 Aligned_cols=134 Identities=14% Similarity=0.070 Sum_probs=103.3
Q ss_pred HHHHHHhCCCcCCeeccCCcEEEEEEEECCCcEEEEEEehh--------------hhhhc-ccCceeeEEEEEeCCCeeE
Q 039819 196 ELQQATENFSSKNILGAGGFGNVYKGKLGDGTVLAVKRLKD--------------MISLA-VHRNLLRLIGYCATPTERL 260 (534)
Q Consensus 196 ~l~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~--------------~l~~~-~h~niv~l~~~~~~~~~~~ 260 (534)
.+......|.....++.|+.+.||++... +..+++|+... .+..+ .+..+.++++++......|
T Consensus 8 ~l~~~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~ 86 (263)
T 3tm0_A 8 ELKKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSN 86 (263)
T ss_dssp HHHHHHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEE
T ss_pred HHHHHhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceE
Confidence 44556678887778888889999999864 67899998741 33333 2567888999998888899
Q ss_pred EEeeccCCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcC------------------------------------
Q 039819 261 LVYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQC------------------------------------ 304 (534)
Q Consensus 261 lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~------------------------------------ 304 (534)
+||||++|.+|.+.+.. ......++.+++++|..||+..
T Consensus 87 lv~e~i~G~~l~~~~~~-----~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (263)
T 3tm0_A 87 LLMSEADGVLCSEEYED-----EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEED 161 (263)
T ss_dssp EEEECCSSEEHHHHCCT-----TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTT
T ss_pred EEEEecCCeehhhccCC-----cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccccc
Confidence 99999999998876421 1233578889999999999810
Q ss_pred --------------------CCCeEeccCCCCcEEeCCCCcEEEEecccce
Q 039819 305 --------------------DPKIIHRDVKAANVLLDDFCEAIVGDFGLAK 335 (534)
Q Consensus 305 --------------------~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~ 335 (534)
.+.++|+|++|.|||+++...+.|+||+.+.
T Consensus 162 ~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 162 TPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp CSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred ccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 1358999999999999876666799998775
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.10 E-value=2.7e-11 Score=123.36 Aligned_cols=113 Identities=20% Similarity=0.127 Sum_probs=68.8
Q ss_pred EEecCCCceeecccccccCCCCCEEEccCCccCcCCC----CCCCCCC-CCCEEEcCCCcCccccCchhhhcccCccccc
Q 039819 13 LGAPSQSLSGTLSGSIGNLTNLRQVLLQNNNISGGIP----PQLGSLP-KLQTLDLSNNRLSGVIPALLFLSIWLPRKWD 87 (534)
Q Consensus 13 L~l~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~P----~~~~~l~-~L~~L~Ls~N~l~g~~p~~~~~l~~l~~~~~ 87 (534)
+.|+.|+++|.+|..+...++|++|+|++|+|++..+ ..|.+++ +|++|+|++|+|++..+..+..+..-.
T Consensus 3 ~~ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~---- 78 (362)
T 3goz_A 3 YKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAI---- 78 (362)
T ss_dssp EECCCCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTS----
T ss_pred cccccccchHHHHHHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhcc----
Confidence 5667777777666666655667777777777774444 5566666 677777777777766565555431000
Q ss_pred ccccCCccccceeCCCCcCcccCChhhhcc-----cccccccccCCCCCCCC
Q 039819 88 KRKCSGVDQGLLRLNNNSLSGAFPVFLAKI-----SELAFLDLSYNNLSGPV 134 (534)
Q Consensus 88 ~~~~~~~~L~~L~L~~N~l~g~~p~~~~~l-----~~L~~L~ls~N~l~g~~ 134 (534)
..+|+.|+|++|++++..+..++.. ++|+.|+|++|++++..
T Consensus 79 -----~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~ 125 (362)
T 3goz_A 79 -----PANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKS 125 (362)
T ss_dssp -----CTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSC
T ss_pred -----CCCccEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHH
Confidence 0056667777777765555544433 56777777777766443
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.08 E-value=7.5e-11 Score=119.52 Aligned_cols=113 Identities=18% Similarity=0.172 Sum_probs=95.2
Q ss_pred CcEEEEEecCCCceeecccccccCCCCCEEEccCCccCcCCCC-CCCCCCCCCE-EEcCCCcCccccCchhhhcccCccc
Q 039819 8 NLVIGLGAPSQSLSGTLSGSIGNLTNLRQVLLQNNNISGGIPP-QLGSLPKLQT-LDLSNNRLSGVIPALLFLSIWLPRK 85 (534)
Q Consensus 8 ~~l~~L~l~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~P~-~~~~l~~L~~-L~Ls~N~l~g~~p~~~~~l~~l~~~ 85 (534)
.+++.|+|++|+|+...+.+|.+|++|++|+|++|++.+.+|. +|.+|++|.. ++++.|+|+...|..|..++
T Consensus 30 ~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~~~N~l~~l~~~~f~~l~----- 104 (350)
T 4ay9_X 30 RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLP----- 104 (350)
T ss_dssp TTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEEEETTCCEECTTSBCCCT-----
T ss_pred CCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhcccCCcccccCchhhhhcc-----
Confidence 4689999999999965556899999999999999999777775 5899999875 77788999988888888888
Q ss_pred ccccccCCccccceeCCCCcCcccCChhhhcccccccccccC-CCCCCCCC
Q 039819 86 WDKRKCSGVDQGLLRLNNNSLSGAFPVFLAKISELAFLDLSY-NNLSGPVP 135 (534)
Q Consensus 86 ~~~~~~~~~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~-N~l~g~~p 135 (534)
+|+.|++++|+|++..+..+....++..|++.+ |+++ .+|
T Consensus 105 ---------~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~-~l~ 145 (350)
T 4ay9_X 105 ---------NLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIH-TIE 145 (350)
T ss_dssp ---------TCCEEEEEEECCSSCCCCTTCCBSSCEEEEEESCTTCC-EEC
T ss_pred ---------ccccccccccccccCCchhhcccchhhhhhhccccccc-ccc
Confidence 889999999999977777777888888999866 5666 444
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.05 E-value=2.6e-11 Score=121.79 Aligned_cols=102 Identities=24% Similarity=0.159 Sum_probs=54.0
Q ss_pred cEEEEEecCCCceeecccccccC--CCCCEEEccCCccCcCCCCCCCCCCCCCEEEcCCCcCccc-cCchhhhcccCccc
Q 039819 9 LVIGLGAPSQSLSGTLSGSIGNL--TNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGV-IPALLFLSIWLPRK 85 (534)
Q Consensus 9 ~l~~L~l~~n~l~g~~p~~~~~l--~~L~~L~L~~N~l~g~~P~~~~~l~~L~~L~Ls~N~l~g~-~p~~~~~l~~l~~~ 85 (534)
.++.|+|++|++. |..+..+ ++|+.|+|++|.+++..|. +..+++|++|+|++|.+++. +|..+..++
T Consensus 48 ~~~~l~l~~~~~~---~~~~~~~~~~~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~~~~~~~~~~~~----- 118 (336)
T 2ast_B 48 LWQTLDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVSTLHGILSQCS----- 118 (336)
T ss_dssp TSSEEECTTCBCC---HHHHHHHHHTTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECHHHHHHHHTTBC-----
T ss_pred hheeeccccccCC---HHHHHhhhhccceEEEcCCccccccchh-hccCCCCCEEEccCCCcCHHHHHHHHhhCC-----
Confidence 3555666655554 3444544 5566666666666543333 44555666666666655543 555554444
Q ss_pred ccccccCCccccceeCCCCcCcccCChhhhcccccccccccCC
Q 039819 86 WDKRKCSGVDQGLLRLNNNSLSGAFPVFLAKISELAFLDLSYN 128 (534)
Q Consensus 86 ~~~~~~~~~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N 128 (534)
+|+.|+|++|.+++..|..++.+++|+.|+|++|
T Consensus 119 ---------~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~L~~~ 152 (336)
T 2ast_B 119 ---------KLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGC 152 (336)
T ss_dssp ---------CCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTC
T ss_pred ---------CCCEEeCcCcccCHHHHHHHhcCCCCCEEECCCC
Confidence 4445555555555445555555555555555555
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.05 E-value=1.4e-10 Score=126.16 Aligned_cols=113 Identities=27% Similarity=0.377 Sum_probs=55.3
Q ss_pred cEEEEEecCCCceeecccccccCCCCCEEEccCCccCcCCCCCCCC-----------------CCCCCEEEcCCCcCccc
Q 039819 9 LVIGLGAPSQSLSGTLSGSIGNLTNLRQVLLQNNNISGGIPPQLGS-----------------LPKLQTLDLSNNRLSGV 71 (534)
Q Consensus 9 ~l~~L~l~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~P~~~~~-----------------l~~L~~L~Ls~N~l~g~ 71 (534)
+++.|+|++|+|++ +| ..+++|+.|+|++|+|++ +|..+.+ +++|+.|+|++|+|++
T Consensus 162 ~L~~L~L~~N~l~~-l~---~~~~~L~~L~Ls~N~l~~-l~~~~~~L~~L~L~~N~l~~l~~~~~~L~~L~Ls~N~L~~- 235 (622)
T 3g06_A 162 ELCKLWAYNNQLTS-LP---MLPSGLQELSVSDNQLAS-LPTLPSELYKLWAYNNRLTSLPALPSGLKELIVSGNRLTS- 235 (622)
T ss_dssp TCCEEECCSSCCSC-CC---CCCTTCCEEECCSSCCSC-CCCCCTTCCEEECCSSCCSSCCCCCTTCCEEECCSSCCSC-
T ss_pred CCCEEECCCCCCCC-Cc---ccCCCCcEEECCCCCCCC-CCCccchhhEEECcCCcccccCCCCCCCCEEEccCCccCc-
Confidence 34455555555542 33 234667777777777663 4443211 1345555555555553
Q ss_pred cCchhhhcccCcccccccccCCccccceeCCCCcCcccCChhhhcccccccccccCCCCCCCCCCCCC-----ccccccC
Q 039819 72 IPALLFLSIWLPRKWDKRKCSGVDQGLLRLNNNSLSGAFPVFLAKISELAFLDLSYNNLSGPVPKFPA-----RTFNVAG 146 (534)
Q Consensus 72 ~p~~~~~l~~l~~~~~~~~~~~~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~-----~~~~~~~ 146 (534)
+|..+ + +|+.|+|++|+|+ .+|. .+++|+.|+|++|+|+ .+|..+. +.+++.+
T Consensus 236 lp~~l---~--------------~L~~L~Ls~N~L~-~lp~---~~~~L~~L~Ls~N~L~-~lp~~l~~l~~L~~L~L~~ 293 (622)
T 3g06_A 236 LPVLP---S--------------ELKELMVSGNRLT-SLPM---LPSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEG 293 (622)
T ss_dssp CCCCC---T--------------TCCEEECCSSCCS-CCCC---CCTTCCEEECCSSCCC-SCCGGGGGSCTTCEEECCS
T ss_pred CCCCC---C--------------cCcEEECCCCCCC-cCCc---ccccCcEEeCCCCCCC-cCCHHHhhccccCEEEecC
Confidence 33211 1 4555555555555 3444 3455555555555555 4443322 3344555
Q ss_pred Ccc
Q 039819 147 NPL 149 (534)
Q Consensus 147 N~~ 149 (534)
|++
T Consensus 294 N~l 296 (622)
T 3g06_A 294 NPL 296 (622)
T ss_dssp CCC
T ss_pred CCC
Confidence 554
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.05 E-value=1.9e-11 Score=122.77 Aligned_cols=110 Identities=25% Similarity=0.251 Sum_probs=80.9
Q ss_pred CcEEEEEecCCCceeecccccccCCCCCEEEccCCccCcC-CCCCCCCCCCCCEEEcCCCcCccccCchhhhcccCcccc
Q 039819 8 NLVIGLGAPSQSLSGTLSGSIGNLTNLRQVLLQNNNISGG-IPPQLGSLPKLQTLDLSNNRLSGVIPALLFLSIWLPRKW 86 (534)
Q Consensus 8 ~~l~~L~l~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~-~P~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~l~~~~ 86 (534)
.+++.|++++|.+++.++. +..+++|++|+|++|.+++. +|..+..+++|++|+|++|.+++..|..+..++
T Consensus 70 ~~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~~------ 142 (336)
T 2ast_B 70 QGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNS------ 142 (336)
T ss_dssp TTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCT------
T ss_pred ccceEEEcCCccccccchh-hccCCCCCEEEccCCCcCHHHHHHHHhhCCCCCEEeCcCcccCHHHHHHHhcCC------
Confidence 4677888888888876554 55688888888888888765 777788888888888888888877777777666
Q ss_pred cccccCCccccceeCCCC-cCcc-cCChhhhcccccccccccCC-CCCC
Q 039819 87 DKRKCSGVDQGLLRLNNN-SLSG-AFPVFLAKISELAFLDLSYN-NLSG 132 (534)
Q Consensus 87 ~~~~~~~~~L~~L~L~~N-~l~g-~~p~~~~~l~~L~~L~ls~N-~l~g 132 (534)
+|+.|+|++| .+++ .+|..+..+++|+.|+|++| ++++
T Consensus 143 --------~L~~L~L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~ 183 (336)
T 2ast_B 143 --------NLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTE 183 (336)
T ss_dssp --------TCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCH
T ss_pred --------CCCEEECCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcCh
Confidence 6666777776 5654 25566666667777777766 6653
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.04 E-value=3.3e-11 Score=122.76 Aligned_cols=115 Identities=20% Similarity=0.177 Sum_probs=92.1
Q ss_pred CcEEEEEecCCCceeecc----cccccCC-CCCEEEccCCccCcCCCCCCCCC-----CCCCEEEcCCCcCccccCchhh
Q 039819 8 NLVIGLGAPSQSLSGTLS----GSIGNLT-NLRQVLLQNNNISGGIPPQLGSL-----PKLQTLDLSNNRLSGVIPALLF 77 (534)
Q Consensus 8 ~~l~~L~l~~n~l~g~~p----~~~~~l~-~L~~L~L~~N~l~g~~P~~~~~l-----~~L~~L~Ls~N~l~g~~p~~~~ 77 (534)
..++.|+|++|+|++..+ ..|.+++ +|++|+|++|+|++..+..|..+ ++|++|+|++|+|++..+..+.
T Consensus 22 ~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~~~~~~l~ 101 (362)
T 3goz_A 22 HGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANVTSLNLSGNFLSYKSSDELV 101 (362)
T ss_dssp TTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHH
T ss_pred CCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCCccEEECcCCcCChHHHHHHH
Confidence 459999999999997666 7788898 99999999999998777777775 9999999999999987777665
Q ss_pred hc-ccCcccccccccCCccccceeCCCCcCcccCChhhhc-----ccccccccccCCCCCC
Q 039819 78 LS-IWLPRKWDKRKCSGVDQGLLRLNNNSLSGAFPVFLAK-----ISELAFLDLSYNNLSG 132 (534)
Q Consensus 78 ~l-~~l~~~~~~~~~~~~~L~~L~L~~N~l~g~~p~~~~~-----l~~L~~L~ls~N~l~g 132 (534)
.. .... .+|+.|+|++|+|++..+..++. ..+|+.|+|++|+++.
T Consensus 102 ~~l~~~~----------~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~ 152 (362)
T 3goz_A 102 KTLAAIP----------FTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGI 152 (362)
T ss_dssp HHHHTSC----------TTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGG
T ss_pred HHHHhCC----------CCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCH
Confidence 43 1110 17888999999998666655544 2589999999998884
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.03 E-value=4.6e-10 Score=108.09 Aligned_cols=118 Identities=14% Similarity=0.052 Sum_probs=87.7
Q ss_pred ccCCcEEEEEEEECCCcEEEEEEehh-----------hhhhcccCc--eeeEEEEEeCCCeeEEEeeccCCCChhhhccc
Q 039819 211 GAGGFGNVYKGKLGDGTVLAVKRLKD-----------MISLAVHRN--LLRLIGYCATPTERLLVYPYMSNGSVASRLRE 277 (534)
Q Consensus 211 G~G~~g~Vy~~~~~~~~~vavK~~~~-----------~l~~~~h~n--iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~ 277 (534)
+.|..+.||++...+|..+++|.... .+..+.+.+ +.+++++....+..++||||++|.+|. ...
T Consensus 29 ~gg~~~~v~~~~~~~g~~~vlK~~~~~~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l~--~~~ 106 (264)
T 1nd4_A 29 IGCSDAAVFRLSAQGRPVLFVKTDLSGALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL--SSH 106 (264)
T ss_dssp CTTSSCEEEEEECTTSCCEEEEEECSCTTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT--TSC
T ss_pred cCCCCceEEEEecCCCCeEEEEeCCcccchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcccC--cCc
Confidence 45566999999887788899997542 344444434 456888888877889999999998884 211
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHHhcC-----------------------------------------------------
Q 039819 278 KPALDWNTRKRIAIGAARGLLYLHEQC----------------------------------------------------- 304 (534)
Q Consensus 278 ~~~l~~~~~~~i~~~i~~~l~yLH~~~----------------------------------------------------- 304 (534)
.+ ...++.++++.|..||+..
T Consensus 107 ---~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 180 (264)
T 1nd4_A 107 ---LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMPD 180 (264)
T ss_dssp ---CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCCS
T ss_pred ---CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHHHHHHhcCC
Confidence 12 2367788888888888742
Q ss_pred --CCCeEeccCCCCcEEeCCCCcEEEEeccccee
Q 039819 305 --DPKIIHRDVKAANVLLDDFCEAIVGDFGLAKL 336 (534)
Q Consensus 305 --~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~ 336 (534)
...++|+|++|.|||++++..+.|+|||.+..
T Consensus 181 ~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 181 GEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp SCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred CCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 11299999999999998876677999998753
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.02 E-value=2.9e-10 Score=123.71 Aligned_cols=126 Identities=25% Similarity=0.339 Sum_probs=80.8
Q ss_pred CcEEEEEecCCCceeecccccccCCCCCEEEccCCccCcCCCCCCCCCCCCCEEEcCCCcCccccCchhhhcccCccccc
Q 039819 8 NLVIGLGAPSQSLSGTLSGSIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFLSIWLPRKWD 87 (534)
Q Consensus 8 ~~l~~L~l~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~P~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~l~~~~~ 87 (534)
.+++.|++++|+|+ .+|..+. ++|++|+|++|+|+ .+|. .+++|++|+|++|+|+ .+|.. +++|..+..
T Consensus 40 ~~l~~L~ls~n~L~-~lp~~l~--~~L~~L~L~~N~l~-~lp~---~l~~L~~L~Ls~N~l~-~lp~~---l~~L~~L~L 108 (622)
T 3g06_A 40 NGNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPA---LPPELRTLEVSGNQLT-SLPVL---PPGLLELSI 108 (622)
T ss_dssp HCCCEEECCSSCCS-CCCSCCC--TTCSEEEECSCCCS-CCCC---CCTTCCEEEECSCCCS-CCCCC---CTTCCEEEE
T ss_pred CCCcEEEecCCCcC-ccChhhC--CCCcEEEecCCCCC-CCCC---cCCCCCEEEcCCCcCC-cCCCC---CCCCCEEEC
Confidence 35788888888888 7787665 78888888888888 5776 5678888888888888 45653 232222211
Q ss_pred cc-cc-----CCccccceeCCCCcCcccCChhhhcccccccccccCCCCCCCCCCCCC--ccccccCCcc
Q 039819 88 KR-KC-----SGVDQGLLRLNNNSLSGAFPVFLAKISELAFLDLSYNNLSGPVPKFPA--RTFNVAGNPL 149 (534)
Q Consensus 88 ~~-~~-----~~~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~--~~~~~~~N~~ 149 (534)
+. .. ...+|+.|+|++|+|+ .+|.. +++|+.|+|++|++++ +|..+. ..+.+.+|.+
T Consensus 109 s~N~l~~l~~~l~~L~~L~L~~N~l~-~lp~~---l~~L~~L~Ls~N~l~~-l~~~~~~L~~L~L~~N~l 173 (622)
T 3g06_A 109 FSNPLTHLPALPSGLCKLWIFGNQLT-SLPVL---PPGLQELSVSDNQLAS-LPALPSELCKLWAYNNQL 173 (622)
T ss_dssp CSCCCCCCCCCCTTCCEEECCSSCCS-CCCCC---CTTCCEEECCSSCCSC-CCCCCTTCCEEECCSSCC
T ss_pred cCCcCCCCCCCCCCcCEEECCCCCCC-cCCCC---CCCCCEEECcCCcCCC-cCCccCCCCEEECCCCCC
Confidence 11 11 1125677777777777 35553 3677777777777774 343332 3344555544
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.85 E-value=1.2e-08 Score=103.57 Aligned_cols=128 Identities=14% Similarity=0.183 Sum_probs=97.4
Q ss_pred cCCeeccCCcEEEEEEEECCCcEEEEEEeh--h---------------hhhhcc--cCceeeEEEEEeCC---CeeEEEe
Q 039819 206 SKNILGAGGFGNVYKGKLGDGTVLAVKRLK--D---------------MISLAV--HRNLLRLIGYCATP---TERLLVY 263 (534)
Q Consensus 206 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~--~---------------~l~~~~--h~niv~l~~~~~~~---~~~~lv~ 263 (534)
..+.|+.|.++.||+....+ ..+++|+.. . ++..+. +..+.+++.++.+. +..++||
T Consensus 42 ~~~~l~~G~sn~~y~v~~~~-~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vm 120 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTPG-QTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIM 120 (359)
T ss_dssp EEEECCC-CCSCEEEEECSS-CEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEE
T ss_pred eEEEcCCcccceEEEEEECC-ceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEE
Confidence 34678999999999998765 467777664 1 333443 45678889988776 3479999
Q ss_pred eccCCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcC---------------------------------------
Q 039819 264 PYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQC--------------------------------------- 304 (534)
Q Consensus 264 e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~--------------------------------------- 304 (534)
||++|..+.+... ..++...+..++.++++.|+.||+..
T Consensus 121 e~v~G~~l~~~~~--~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 198 (359)
T 3dxp_A 121 EFVSGRVLWDQSL--PGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAMD 198 (359)
T ss_dssp ECCCCBCCCCTTC--TTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHHH
T ss_pred EecCCeecCCCcc--ccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHHH
Confidence 9999988754222 24778889999999999999999731
Q ss_pred ----------------CCCeEeccCCCCcEEeCCCCc--EEEEeccccee
Q 039819 305 ----------------DPKIIHRDVKAANVLLDDFCE--AIVGDFGLAKL 336 (534)
Q Consensus 305 ----------------~~~ivH~Dlkp~NiLl~~~~~--~kl~DFGla~~ 336 (534)
.+.++|+|+++.|||++.++. +.|.||+.+..
T Consensus 199 ~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 199 SLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 247999999999999997653 68999998875
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=98.83 E-value=2.3e-10 Score=119.95 Aligned_cols=110 Identities=18% Similarity=0.086 Sum_probs=74.9
Q ss_pred CcEEEEEecCCCceee----cccccccCCCCCEEEccCCccCcCCCCCCC-----CCCCCCEEEcCCCcCccc----cCc
Q 039819 8 NLVIGLGAPSQSLSGT----LSGSIGNLTNLRQVLLQNNNISGGIPPQLG-----SLPKLQTLDLSNNRLSGV----IPA 74 (534)
Q Consensus 8 ~~l~~L~l~~n~l~g~----~p~~~~~l~~L~~L~L~~N~l~g~~P~~~~-----~l~~L~~L~Ls~N~l~g~----~p~ 74 (534)
.+++.|+|++|+|+.. ++..+..+++|++|+|++|.|++..+..+. ..++|+.|+|++|.|++. +|.
T Consensus 256 ~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~ 335 (461)
T 1z7x_W 256 SRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSS 335 (461)
T ss_dssp CCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHH
T ss_pred CCceEEECcCCCCCHHHHHHHHHHHhhCCCcceEECCCCCCchHHHHHHHHHhccCCccceeeEcCCCCCchHHHHHHHH
Confidence 5799999999999865 677888899999999999998754333332 236899999999998865 455
Q ss_pred hhhhcccCcccccccccCCccccceeCCCCcCcccCChhhhc-----ccccccccccCCCCC
Q 039819 75 LLFLSIWLPRKWDKRKCSGVDQGLLRLNNNSLSGAFPVFLAK-----ISELAFLDLSYNNLS 131 (534)
Q Consensus 75 ~~~~l~~l~~~~~~~~~~~~~L~~L~L~~N~l~g~~p~~~~~-----l~~L~~L~ls~N~l~ 131 (534)
.+..++ +|+.|+|++|.+++..+..+.. .++|+.|+|++|+++
T Consensus 336 ~l~~~~--------------~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~ 383 (461)
T 1z7x_W 336 VLAQNR--------------FLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVS 383 (461)
T ss_dssp HHHHCS--------------SCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCC
T ss_pred HHhhCC--------------CccEEEccCCccccccHHHHHHHHcCCCCceEEEECCCCCCC
Confidence 555556 5555666666555443433332 345556666666555
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=98.83 E-value=7.3e-11 Score=123.86 Aligned_cols=133 Identities=22% Similarity=0.200 Sum_probs=100.7
Q ss_pred CcEEEEEecCCCceeec-----ccccccCCCCCEEEccCCccCcC----CCCCCCCCCCCCEEEcCCCcCccccCchhhh
Q 039819 8 NLVIGLGAPSQSLSGTL-----SGSIGNLTNLRQVLLQNNNISGG----IPPQLGSLPKLQTLDLSNNRLSGVIPALLFL 78 (534)
Q Consensus 8 ~~l~~L~l~~n~l~g~~-----p~~~~~l~~L~~L~L~~N~l~g~----~P~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~ 78 (534)
.+++.|+|++|+|++.- +..+..+++|++|+|++|+|+.. +|..+..+++|++|+|++|.|++..+..+..
T Consensus 227 ~~L~~L~Ls~n~l~~~~~~~l~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~ 306 (461)
T 1z7x_W 227 ASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCE 306 (461)
T ss_dssp TTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHH
T ss_pred CCccEEeccCCcCChHHHHHHHHHHhcCCCCceEEECcCCCCCHHHHHHHHHHHhhCCCcceEECCCCCCchHHHHHHHH
Confidence 57999999999998643 22334689999999999999953 7888888999999999999998765555544
Q ss_pred cccCcccccccccCCccccceeCCCCcCccc----CChhhhcccccccccccCCCCCCCCCCC----------CCccccc
Q 039819 79 SIWLPRKWDKRKCSGVDQGLLRLNNNSLSGA----FPVFLAKISELAFLDLSYNNLSGPVPKF----------PARTFNV 144 (534)
Q Consensus 79 l~~l~~~~~~~~~~~~~L~~L~L~~N~l~g~----~p~~~~~l~~L~~L~ls~N~l~g~~p~~----------~~~~~~~ 144 (534)
...- ...+|+.|+|++|.+++. +|..+..+++|+.|+|++|++++..+.. --+.+.+
T Consensus 307 ~l~~---------~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L 377 (461)
T 1z7x_W 307 TLLE---------PGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWL 377 (461)
T ss_dssp HHTS---------TTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEEC
T ss_pred Hhcc---------CCccceeeEcCCCCCchHHHHHHHHHHhhCCCccEEEccCCccccccHHHHHHHHcCCCCceEEEEC
Confidence 3100 001789999999999865 6778888999999999999998542211 1245677
Q ss_pred cCCcc
Q 039819 145 AGNPL 149 (534)
Q Consensus 145 ~~N~~ 149 (534)
.+|.+
T Consensus 378 ~~n~i 382 (461)
T 1z7x_W 378 ADCDV 382 (461)
T ss_dssp TTSCC
T ss_pred CCCCC
Confidence 77755
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.74 E-value=2.1e-09 Score=103.92 Aligned_cols=98 Identities=26% Similarity=0.239 Sum_probs=71.3
Q ss_pred EEecCCCce---eecccccccCCCCCEEEccCCccCc--CCCCCCCCCCCCCEEEcCCCcCccccCchhhhcccCccccc
Q 039819 13 LGAPSQSLS---GTLSGSIGNLTNLRQVLLQNNNISG--GIPPQLGSLPKLQTLDLSNNRLSGVIPALLFLSIWLPRKWD 87 (534)
Q Consensus 13 L~l~~n~l~---g~~p~~~~~l~~L~~L~L~~N~l~g--~~P~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~l~~~~~ 87 (534)
++++.|+.. +.++-...++++|+.|+|++|+|++ .+|..+..+++|+.|+|++|+|++. ..+..+..
T Consensus 148 l~l~~N~~~~~~~~l~i~~~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l~~l~~------ 219 (267)
T 3rw6_A 148 IDVVLNRRSCMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RELDKIKG------ 219 (267)
T ss_dssp CCCCTTSHHHHHHHHHHHHHHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGGGGGTT------
T ss_pred ccccCCHHHHHHHHHHHHHhhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhhhhccc------
Confidence 455666433 2222233568899999999999997 5567777899999999999999954 33333331
Q ss_pred ccccCCccccceeCCCCcCcccCCh-------hhhccccccccc
Q 039819 88 KRKCSGVDQGLLRLNNNSLSGAFPV-------FLAKISELAFLD 124 (534)
Q Consensus 88 ~~~~~~~~L~~L~L~~N~l~g~~p~-------~~~~l~~L~~L~ 124 (534)
.+|+.|+|++|.+++.+|. .+..+++|+.||
T Consensus 220 ------l~L~~L~L~~Npl~~~~~~~~~y~~~il~~~P~L~~LD 257 (267)
T 3rw6_A 220 ------LKLEELWLDGNSLCDTFRDQSTYISAIRERFPKLLRLD 257 (267)
T ss_dssp ------SCCSEEECTTSTTGGGCSSHHHHHHHHHHHCTTCCEES
T ss_pred ------CCcceEEccCCcCccccCcchhHHHHHHHHCcccCeEC
Confidence 1688899999999887773 467888888887
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.73 E-value=7.8e-09 Score=102.38 Aligned_cols=174 Identities=18% Similarity=0.172 Sum_probs=111.3
Q ss_pred CCeeccCCcEEEEEEEECCCcEEEEEEehh------------hhhhc-ccCc--eeeEEEEEeCCC---eeEEEeeccCC
Q 039819 207 KNILGAGGFGNVYKGKLGDGTVLAVKRLKD------------MISLA-VHRN--LLRLIGYCATPT---ERLLVYPYMSN 268 (534)
Q Consensus 207 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~------------~l~~~-~h~n--iv~l~~~~~~~~---~~~lv~e~~~~ 268 (534)
.+.++.|.+..||+.. ..+++|.... .+..+ .+.. +.+++.+..... ..|+||||++|
T Consensus 25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~G 100 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----RDFIFKFPKHSRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIKG 100 (304)
T ss_dssp CCEEEECSSEEEEEST----TSEEEEEESSHHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCCC
T ss_pred eEecCCCCcceEEEEC----CEEEEEecCCcchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccCC
Confidence 4678999999999864 3477886531 34343 2222 344555443333 34899999999
Q ss_pred CChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhc---------------------------------------------
Q 039819 269 GSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQ--------------------------------------------- 303 (534)
Q Consensus 269 gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~--------------------------------------------- 303 (534)
.++.+... ..++..++..++.++++.++.||+.
T Consensus 101 ~~l~~~~~--~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 178 (304)
T 3sg8_A 101 VPLTPLLL--NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDDFYR 178 (304)
T ss_dssp EECCHHHH--HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHHHHH
T ss_pred eECCcccc--ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHHHHH
Confidence 88865432 2467788888999999999999861
Q ss_pred ----------CCCCeEeccCCCCcEEeCC--CCcEEEEecccceecCCCCCceeec-------------ccccccccc-c
Q 039819 304 ----------CDPKIIHRDVKAANVLLDD--FCEAIVGDFGLAKLLDHSDSHVTTA-------------VRGTVGHIA-P 357 (534)
Q Consensus 304 ----------~~~~ivH~Dlkp~NiLl~~--~~~~kl~DFGla~~~~~~~~~~~~~-------------~~gt~~y~a-P 357 (534)
..+.++|+|++|.||++++ ...+.|+||+.+............. .....++.. |
T Consensus 179 ~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~~~~~~ 258 (304)
T 3sg8_A 179 DILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYKHKDIP 258 (304)
T ss_dssp HHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHTCSCHH
T ss_pred HHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcCCCCcH
Confidence 1135899999999999998 5567899999987543210000000 000011112 2
Q ss_pred cccccCCCCcchhHHHHHHHHHHHHhCCCCc
Q 039819 358 EYLSTGQSSEKTDVFGFGILLLELITGMRAL 388 (534)
Q Consensus 358 E~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~ 388 (534)
+.... .....+.|++|.++|.+.+|..+|
T Consensus 259 ~~~~r--~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 259 TVLEK--YRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HHHHH--HHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred HHHHH--HHHHHHHHHHHHHHHHHHcCCHHH
Confidence 22211 122368999999999999998776
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.71 E-value=1.8e-09 Score=110.33 Aligned_cols=128 Identities=20% Similarity=0.165 Sum_probs=88.4
Q ss_pred CcEEEEEecCCCceeeccccc-ccCCCCCEEEccCCccCcCCCCCC-----CCCCCCCEEEcCCCcCccc----cCchhh
Q 039819 8 NLVIGLGAPSQSLSGTLSGSI-GNLTNLRQVLLQNNNISGGIPPQL-----GSLPKLQTLDLSNNRLSGV----IPALLF 77 (534)
Q Consensus 8 ~~l~~L~l~~n~l~g~~p~~~-~~l~~L~~L~L~~N~l~g~~P~~~-----~~l~~L~~L~Ls~N~l~g~----~p~~~~ 77 (534)
..|+.|+|++|+|+..-...+ ..+++|+.|+|++|+|+..-...+ ...++|++|+|++|.|+.. ++..+.
T Consensus 101 ~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~ 180 (372)
T 3un9_A 101 HALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLA 180 (372)
T ss_dssp SCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHHHSTTCCCCEEECCSSCCHHHHHHHHHHHHH
T ss_pred CCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHHHhcCCccceeeCCCCCCChHHHHHHHHHHh
Confidence 479999999999975544443 346789999999999974333333 3467899999999999743 223333
Q ss_pred hcccCcccccccccCCccccceeCCCCcCcc----cCChhhhcccccccccccCCCCCCC----CCCC-----CCccccc
Q 039819 78 LSIWLPRKWDKRKCSGVDQGLLRLNNNSLSG----AFPVFLAKISELAFLDLSYNNLSGP----VPKF-----PARTFNV 144 (534)
Q Consensus 78 ~l~~l~~~~~~~~~~~~~L~~L~L~~N~l~g----~~p~~~~~l~~L~~L~ls~N~l~g~----~p~~-----~~~~~~~ 144 (534)
..+ +|+.|+|++|.|+. .++..+...++|+.|+|++|.|+.. ++.. --+.+++
T Consensus 181 ~~~--------------~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~~g~~~l~~~L~~~~~L~~L~L 246 (372)
T 3un9_A 181 GNT--------------SVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALALARAAREHPSLELLHL 246 (372)
T ss_dssp TCS--------------SCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCHHHHHHHHHHHHHCSSCCEEEC
T ss_pred cCC--------------CcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCHHHHHHHHHHHHhCCCCCEEec
Confidence 344 78888999988864 3456677778888899998888732 1110 1256677
Q ss_pred cCCcc
Q 039819 145 AGNPL 149 (534)
Q Consensus 145 ~~N~~ 149 (534)
++|++
T Consensus 247 s~N~i 251 (372)
T 3un9_A 247 YFNEL 251 (372)
T ss_dssp TTSSC
T ss_pred cCCCC
Confidence 77765
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.58 E-value=5.2e-09 Score=106.79 Aligned_cols=116 Identities=18% Similarity=0.115 Sum_probs=84.8
Q ss_pred CcEEEEEecCCCceeecccccccC-----CCCCEEEccCCccCcCCCCCC-CCCCCCCEEEcCCCcCccccCchhhhccc
Q 039819 8 NLVIGLGAPSQSLSGTLSGSIGNL-----TNLRQVLLQNNNISGGIPPQL-GSLPKLQTLDLSNNRLSGVIPALLFLSIW 81 (534)
Q Consensus 8 ~~l~~L~l~~n~l~g~~p~~~~~l-----~~L~~L~L~~N~l~g~~P~~~-~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~ 81 (534)
..++.|+|++|+|+......|..+ ++|++|+|++|.|+..-...+ ..+++|+.|+|++|+|+..-...+.....
T Consensus 72 ~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L~ 151 (372)
T 3un9_A 72 SSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLL 151 (372)
T ss_dssp TTCCEEECTTSCCCHHHHHHHHHHHSSCSSCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHHH
T ss_pred hhCCEEEecCCCCCHHHHHHHHHHHhhCCCCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHHH
Confidence 468899999999986555555444 799999999999975333333 34678999999999998554444432210
Q ss_pred CcccccccccCCccccceeCCCCcCcc----cCChhhhcccccccccccCCCCCC
Q 039819 82 LPRKWDKRKCSGVDQGLLRLNNNSLSG----AFPVFLAKISELAFLDLSYNNLSG 132 (534)
Q Consensus 82 l~~~~~~~~~~~~~L~~L~L~~N~l~g----~~p~~~~~l~~L~~L~ls~N~l~g 132 (534)
- ...+|+.|+|++|.|+. .++..+..+++|+.|+|++|.|+.
T Consensus 152 ~---------~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~ 197 (372)
T 3un9_A 152 H---------DQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGD 197 (372)
T ss_dssp S---------TTCCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHH
T ss_pred h---------cCCccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCc
Confidence 0 00178999999999964 356667888999999999999873
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=98.52 E-value=1.1e-07 Score=95.20 Aligned_cols=100 Identities=8% Similarity=0.040 Sum_probs=50.1
Q ss_pred cEEEEEecCCCceeecccccccCCCCCEEEccCCccCcCCCCCCCCCCCCC-EEEcCCCcCccccCchhhhcccCccccc
Q 039819 9 LVIGLGAPSQSLSGTLSGSIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQ-TLDLSNNRLSGVIPALLFLSIWLPRKWD 87 (534)
Q Consensus 9 ~l~~L~l~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~P~~~~~l~~L~-~L~Ls~N~l~g~~p~~~~~l~~l~~~~~ 87 (534)
+++.|+|++|+++...+.+|.++++|+.|+|.+| ++..-+.+|.+|.+|+ .|+|.+ +++..-+.+|..+.
T Consensus 227 ~L~~l~L~~n~i~~I~~~aF~~~~~L~~l~l~~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~------- 297 (329)
T 3sb4_A 227 NLVSLDISKTNATTIPDFTFAQKKYLLKIKLPHN-LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCD------- 297 (329)
T ss_dssp TCCEEECTTBCCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCT-------
T ss_pred CCeEEECCCCCcceecHhhhhCCCCCCEEECCcc-cceehHHHhhCChhccEEEEEcc-cceEEchhhhhCCc-------
Confidence 4555555555555333344555555555555555 4433333455555555 555555 44433334444444
Q ss_pred ccccCCccccceeCCCCcCcccCChhhhccccccccc
Q 039819 88 KRKCSGVDQGLLRLNNNSLSGAFPVFLAKISELAFLD 124 (534)
Q Consensus 88 ~~~~~~~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ 124 (534)
+|+.|+|++|+++..-+.+|.++++|+.++
T Consensus 298 -------~L~~l~l~~n~i~~I~~~aF~~~~~L~~ly 327 (329)
T 3sb4_A 298 -------NLRYVLATGDKITTLGDELFGNGVPSKLIY 327 (329)
T ss_dssp -------TEEEEEECSSCCCEECTTTTCTTCCCCEEE
T ss_pred -------cCCEEEeCCCccCccchhhhcCCcchhhhc
Confidence 455555555555534444555555555543
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=98.44 E-value=4.4e-07 Score=90.71 Aligned_cols=37 Identities=5% Similarity=0.074 Sum_probs=28.2
Q ss_pred CcEEEEEecCCCceeecccccccCCCCCEEEccCCccC
Q 039819 8 NLVIGLGAPSQSLSGTLSGSIGNLTNLRQVLLQNNNIS 45 (534)
Q Consensus 8 ~~l~~L~l~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~ 45 (534)
.+|+.|+|++ +++.+-+.+|.++++|+.|+|++|.++
T Consensus 101 ~~L~~l~L~~-~i~~I~~~aF~~~~~L~~l~l~~n~i~ 137 (329)
T 3sb4_A 101 QTLEKVILSE-KIKNIEDAAFKGCDNLKICQIRKKTAP 137 (329)
T ss_dssp TTCCC-CBCT-TCCEECTTTTTTCTTCCEEEBCCSSCC
T ss_pred CCCcEEECCc-cccchhHHHhhcCcccceEEcCCCCcc
Confidence 3788888888 888555667888888888888888764
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.42 E-value=1.2e-07 Score=91.60 Aligned_cols=65 Identities=22% Similarity=0.306 Sum_probs=55.5
Q ss_pred CcEEEEEecCCCcee--ecccccccCCCCCEEEccCCccCcCCCCCCCCCC--CCCEEEcCCCcCccccCc
Q 039819 8 NLVIGLGAPSQSLSG--TLSGSIGNLTNLRQVLLQNNNISGGIPPQLGSLP--KLQTLDLSNNRLSGVIPA 74 (534)
Q Consensus 8 ~~l~~L~l~~n~l~g--~~p~~~~~l~~L~~L~L~~N~l~g~~P~~~~~l~--~L~~L~Ls~N~l~g~~p~ 74 (534)
.+|+.|+|++|+|++ .+|..++.+++|+.|+|++|+|++. .++..+. +|++|+|++|.|++.+|.
T Consensus 170 ~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l~~l~~l~L~~L~L~~Npl~~~~~~ 238 (267)
T 3rw6_A 170 PELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RELDKIKGLKLEELWLDGNSLCDTFRD 238 (267)
T ss_dssp TTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGGGGGTTSCCSEEECTTSTTGGGCSS
T ss_pred CCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhhhhcccCCcceEEccCCcCccccCc
Confidence 479999999999998 4567889999999999999999964 3344444 999999999999988873
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.42 E-value=2.3e-08 Score=91.50 Aligned_cols=110 Identities=13% Similarity=0.130 Sum_probs=72.6
Q ss_pred CcEEEEEecCC-Cceee----cccccccCCCCCEEEccCCccCc----CCCCCCCCCCCCCEEEcCCCcCcccc----Cc
Q 039819 8 NLVIGLGAPSQ-SLSGT----LSGSIGNLTNLRQVLLQNNNISG----GIPPQLGSLPKLQTLDLSNNRLSGVI----PA 74 (534)
Q Consensus 8 ~~l~~L~l~~n-~l~g~----~p~~~~~l~~L~~L~L~~N~l~g----~~P~~~~~l~~L~~L~Ls~N~l~g~~----p~ 74 (534)
..++.|+|++| +|... +...+...++|++|+|++|+|+. .+...+...++|++|+|++|.|+..- ..
T Consensus 36 ~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~~g~~~l~~ 115 (185)
T 1io0_A 36 PDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALVE 115 (185)
T ss_dssp TTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHHH
T ss_pred CCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCHHHHHHHHH
Confidence 46788888888 77643 34556667788888888888863 24444555677888888888887431 12
Q ss_pred hhhhcccCcccccccccCCccccceeC--CCCcCccc----CChhhhcccccccccccCCCCC
Q 039819 75 LLFLSIWLPRKWDKRKCSGVDQGLLRL--NNNSLSGA----FPVFLAKISELAFLDLSYNNLS 131 (534)
Q Consensus 75 ~~~~l~~l~~~~~~~~~~~~~L~~L~L--~~N~l~g~----~p~~~~~l~~L~~L~ls~N~l~ 131 (534)
.+.... .|+.|+| ++|.|... +...+...++|+.|+|++|.+.
T Consensus 116 ~L~~n~--------------~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i~ 164 (185)
T 1io0_A 116 ALQSNT--------------SLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG 164 (185)
T ss_dssp GGGGCS--------------SCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred HHHhCC--------------CceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCCC
Confidence 222222 6778888 77888643 3445556677888888888764
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=98.34 E-value=3.3e-08 Score=106.99 Aligned_cols=110 Identities=17% Similarity=0.097 Sum_probs=67.5
Q ss_pred CcEEEEEecCCCceeeccccccc-CCCCCEEEcc----CCccCcC-----CCCCCCCCCCCCEEEcCCC--cCccccCch
Q 039819 8 NLVIGLGAPSQSLSGTLSGSIGN-LTNLRQVLLQ----NNNISGG-----IPPQLGSLPKLQTLDLSNN--RLSGVIPAL 75 (534)
Q Consensus 8 ~~l~~L~l~~n~l~g~~p~~~~~-l~~L~~L~L~----~N~l~g~-----~P~~~~~l~~L~~L~Ls~N--~l~g~~p~~ 75 (534)
.+++.|+|+.|++++..+..++. +++|+.|+|+ .|++++. ++..+.++++|+.|+|+++ .+++..+..
T Consensus 378 ~~L~~L~l~~~~l~~~~~~~l~~~~~~L~~L~l~~~~~~n~l~~~p~~~~~~~~~~~~~~L~~L~L~~~~~~l~~~~~~~ 457 (592)
T 3ogk_B 378 QELEYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDREERITDLPLDNGVRSLLIGCKKLRRFAFYLRQGGLTDLGLSY 457 (592)
T ss_dssp TTCSEEEEEESCCCHHHHHHHHHHCCSCCEEEEEECSCCSCCSSCCCHHHHHHHHHHCTTCCEEEEECCGGGCCHHHHHH
T ss_pred ccCeEEEeecCCccHHHHHHHHhhCCCCcEEEEeecCCCccccCchHHHHHHHHHHhCCCCCEEEEecCCCCccHHHHHH
Confidence 36778888888888777777765 7888888885 6777742 3333556777777877643 355554444
Q ss_pred hhh-cccCcccccccccCCccccceeCCCCcCcc-cCChhhhcccccccccccCCCCC
Q 039819 76 LFL-SIWLPRKWDKRKCSGVDQGLLRLNNNSLSG-AFPVFLAKISELAFLDLSYNNLS 131 (534)
Q Consensus 76 ~~~-l~~l~~~~~~~~~~~~~L~~L~L~~N~l~g-~~p~~~~~l~~L~~L~ls~N~l~ 131 (534)
+.. ++ +|+.|+|++|++++ .++..+..+++|+.|+|++|.++
T Consensus 458 ~~~~~~--------------~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~l~~n~l~ 501 (592)
T 3ogk_B 458 IGQYSP--------------NVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCFS 501 (592)
T ss_dssp HHHSCT--------------TCCEEEECSCCSSHHHHHHHHTCCTTCCEEEEESCCCB
T ss_pred HHHhCc--------------cceEeeccCCCCCHHHHHHHHhcCcccCeeeccCCCCc
Confidence 432 33 45556666665554 33444455555666666666554
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=98.27 E-value=1.8e-07 Score=101.21 Aligned_cols=121 Identities=13% Similarity=0.081 Sum_probs=60.7
Q ss_pred cEEEEEecCCCceee----cccccccCCCCCEEEccCCccC----cCCCCCCCCCCCCCEEEcCCCcCccccCchhhhcc
Q 039819 9 LVIGLGAPSQSLSGT----LSGSIGNLTNLRQVLLQNNNIS----GGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFLSI 80 (534)
Q Consensus 9 ~l~~L~l~~n~l~g~----~p~~~~~l~~L~~L~L~~N~l~----g~~P~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~ 80 (534)
+++.|+|++|.+++. ++..+.++++|++|+|++|.++ +.++..+.++++|+.|+|++|.+.+ +|..+..++
T Consensus 165 ~L~~L~L~~~~~~~~~~~~l~~~~~~~~~L~~L~L~~n~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~-l~~~~~~~~ 243 (592)
T 3ogk_B 165 KIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDFEILE-LVGFFKAAA 243 (592)
T ss_dssp TCSEEECTTCEEECCCSHHHHHHHHHCCCCCEEECTTCCCSSCCHHHHHHHHHHCTTCCEEECSSCBGGG-GHHHHHHCT
T ss_pred CCCEEECccccccCcchhHHHHHHhcCCCccEEEeeccCCCccCHHHHHHHHhhCCCCcEEeccCccHHH-HHHHHhhhh
Confidence 455666666655544 3334445566666666666665 2233334455666666666666663 445555554
Q ss_pred cCcccccccc-------------cCCccccceeCCCCcCcccCChhhhcccccccccccCCCCC
Q 039819 81 WLPRKWDKRK-------------CSGVDQGLLRLNNNSLSGAFPVFLAKISELAFLDLSYNNLS 131 (534)
Q Consensus 81 ~l~~~~~~~~-------------~~~~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~ 131 (534)
.|..+..... ....+|+.|+++++.. +.+|..+..+++|+.|+|++|.++
T Consensus 244 ~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~~~-~~l~~~~~~~~~L~~L~Ls~~~l~ 306 (592)
T 3ogk_B 244 NLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGLSYMGP-NEMPILFPFAAQIRKLDLLYALLE 306 (592)
T ss_dssp TCCEEEECBCCCCTTCTTSSSCCCCCTTCCEEEETTCCT-TTGGGGGGGGGGCCEEEETTCCCC
T ss_pred HHHhhcccccccccchHHHHHHhhccccccccCccccch-hHHHHHHhhcCCCcEEecCCCcCC
Confidence 4333221100 0001444455554322 245555556666666666666554
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=98.04 E-value=1.4e-06 Score=88.33 Aligned_cols=113 Identities=15% Similarity=0.135 Sum_probs=60.4
Q ss_pred CcEEEEEecCCC-ceeecccccccCCCCCEEEccCCccCcCCCCCCC--CCCCCCEEEcCC--CcCcccc-Cchhhhccc
Q 039819 8 NLVIGLGAPSQS-LSGTLSGSIGNLTNLRQVLLQNNNISGGIPPQLG--SLPKLQTLDLSN--NRLSGVI-PALLFLSIW 81 (534)
Q Consensus 8 ~~l~~L~l~~n~-l~g~~p~~~~~l~~L~~L~L~~N~l~g~~P~~~~--~l~~L~~L~Ls~--N~l~g~~-p~~~~~l~~ 81 (534)
.+|+.|+|++|. ++ ++. +. +++|+.|+|..+.|+...-..+. .+++|+.|+|+. |...|.. ...+..+
T Consensus 172 P~L~~L~L~g~~~l~--l~~-~~-~~~L~~L~L~~~~l~~~~l~~l~~~~lp~L~~L~L~~~~~~~~~~~~~~~l~~~-- 245 (362)
T 2ra8_A 172 PLLNNLKIKGTNNLS--IGK-KP-RPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPL-- 245 (362)
T ss_dssp TTCCEEEEECCBTCB--CCS-CB-CTTCSEEEEECSBCCHHHHHHHHHSBCTTCCEEEEECBCGGGTCCSCGGGTGGG--
T ss_pred CCCcEEEEeCCCCce--ecc-cc-CCCCcEEEEecCCCChHHHHHHHHccCCCCcEEEEeccccccccchhHHHHHHH--
Confidence 468888887763 32 333 43 77888888877776532222232 577788887753 2221110 0011100
Q ss_pred CcccccccccCCccccceeCCCCcCcccCChhhh---cccccccccccCCCCCC
Q 039819 82 LPRKWDKRKCSGVDQGLLRLNNNSLSGAFPVFLA---KISELAFLDLSYNNLSG 132 (534)
Q Consensus 82 l~~~~~~~~~~~~~L~~L~L~~N~l~g~~p~~~~---~l~~L~~L~ls~N~l~g 132 (534)
+... ...+|+.|+|++|.+....+..+. .+++|+.|+|+.|.|+.
T Consensus 246 ----l~~~--~~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d 293 (362)
T 2ra8_A 246 ----FSKD--RFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTD 293 (362)
T ss_dssp ----SCTT--TCTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBH
T ss_pred ----HhcC--CCCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCCh
Confidence 0000 012677777777777644443443 35677777777777664
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=97.98 E-value=4.5e-07 Score=97.99 Aligned_cols=109 Identities=13% Similarity=0.050 Sum_probs=80.5
Q ss_pred CcEEEEEecCCCceeecccccc-cCCCCCEEEcc--C----CccCcCCCC------CCCCCCCCCEEEcCCCcCccccCc
Q 039819 8 NLVIGLGAPSQSLSGTLSGSIG-NLTNLRQVLLQ--N----NNISGGIPP------QLGSLPKLQTLDLSNNRLSGVIPA 74 (534)
Q Consensus 8 ~~l~~L~l~~n~l~g~~p~~~~-~l~~L~~L~L~--~----N~l~g~~P~------~~~~l~~L~~L~Ls~N~l~g~~p~ 74 (534)
.+++.|.+..|++++.....+. .+++|+.|+|+ + |+++ ..|. .+.++++|+.|+|++ .+++..+.
T Consensus 372 ~~L~~L~~~~~~l~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~-~~~~~~~~~~l~~~~~~L~~L~L~~-~l~~~~~~ 449 (594)
T 2p1m_B 372 PKLESVLYFCRQMTNAALITIARNRPNMTRFRLCIIEPKAPDYLT-LEPLDIGFGAIVEHCKDLRRLSLSG-LLTDKVFE 449 (594)
T ss_dssp TTCCEEEEEESCCCHHHHHHHHHHCTTCCEEEEEESSTTCCCTTT-CCCTHHHHHHHHHHCTTCCEEECCS-SCCHHHHH
T ss_pred hhHHHHHHhcCCcCHHHHHHHHhhCCCcceeEeecccCCCccccc-CCchhhHHHHHHhhCCCccEEeecC-cccHHHHH
Confidence 3688888999999887777776 58999999999 4 6676 2332 256788999999977 67665555
Q ss_pred hhhh-cccCcccccccccCCccccceeCCCCcCcccCChhh-hcccccccccccCCCCCC
Q 039819 75 LLFL-SIWLPRKWDKRKCSGVDQGLLRLNNNSLSGAFPVFL-AKISELAFLDLSYNNLSG 132 (534)
Q Consensus 75 ~~~~-l~~l~~~~~~~~~~~~~L~~L~L~~N~l~g~~p~~~-~~l~~L~~L~ls~N~l~g 132 (534)
.+.. ++ +|+.|+|++|.+++..+..+ ..+++|+.|+|++|.+++
T Consensus 450 ~l~~~~~--------------~L~~L~L~~~~i~~~~~~~l~~~~~~L~~L~L~~n~~~~ 495 (594)
T 2p1m_B 450 YIGTYAK--------------KMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFGD 495 (594)
T ss_dssp HHHHHCT--------------TCCEEEEESCCSSHHHHHHHHHHCTTCCEEEEESCSCCH
T ss_pred HHHHhch--------------hccEeeccCCCCcHHHHHHHHhcCCCcCEEECcCCCCcH
Confidence 5544 44 77888888888876555555 668888888888888853
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=97.94 E-value=1.4e-06 Score=79.46 Aligned_cols=97 Identities=21% Similarity=0.210 Sum_probs=74.2
Q ss_pred eecccccccCCCCCEEEccCC-ccCc----CCCCCCCCCCCCCEEEcCCCcCccccC----chhhhcccCcccccccccC
Q 039819 22 GTLSGSIGNLTNLRQVLLQNN-NISG----GIPPQLGSLPKLQTLDLSNNRLSGVIP----ALLFLSIWLPRKWDKRKCS 92 (534)
Q Consensus 22 g~~p~~~~~l~~L~~L~L~~N-~l~g----~~P~~~~~l~~L~~L~Ls~N~l~g~~p----~~~~~l~~l~~~~~~~~~~ 92 (534)
..+...+...+.|++|+|++| .|+. .+...+...++|++|+|++|+|...-. ..+....
T Consensus 26 ~~l~~~l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~------------ 93 (185)
T 1io0_A 26 ETLKRIQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNN------------ 93 (185)
T ss_dssp HHHHHHHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCS------------
T ss_pred HHHHHHHhcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCC------------
Confidence 334556778899999999999 9873 355667778999999999999974322 2222222
Q ss_pred CccccceeCCCCcCccc----CChhhhcccccccccc--cCCCCCC
Q 039819 93 GVDQGLLRLNNNSLSGA----FPVFLAKISELAFLDL--SYNNLSG 132 (534)
Q Consensus 93 ~~~L~~L~L~~N~l~g~----~p~~~~~l~~L~~L~l--s~N~l~g 132 (534)
.|+.|+|++|.|... +..++...+.|+.|+| ++|.++.
T Consensus 94 --~L~~L~L~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~~~N~i~~ 137 (185)
T 1io0_A 94 --TLKSLNVESNFISGSGILALVEALQSNTSLIELRIDNQSQPLGN 137 (185)
T ss_dssp --SCCEEECCSSCCCHHHHHHHHHGGGGCSSCCEEECCCCSSCCCH
T ss_pred --CcCEEECcCCcCCHHHHHHHHHHHHhCCCceEEEecCCCCCCCH
Confidence 789999999999743 5667778889999999 8899873
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=97.94 E-value=4.8e-05 Score=75.07 Aligned_cols=125 Identities=18% Similarity=0.152 Sum_probs=83.0
Q ss_pred CCeeccCCcEEEEEEEECCCcEEEEEEehh------------hhhhcccC---ceeeEEEEEe-CCCeeEEEeeccCCCC
Q 039819 207 KNILGAGGFGNVYKGKLGDGTVLAVKRLKD------------MISLAVHR---NLLRLIGYCA-TPTERLLVYPYMSNGS 270 (534)
Q Consensus 207 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~------------~l~~~~h~---niv~l~~~~~-~~~~~~lv~e~~~~gs 270 (534)
.+.++.|....||+. +..+++|.-.. .+..+.+. .+.+++.++. ..+..++||||++|..
T Consensus 24 v~~l~~G~~n~v~~v----g~~~VlR~~~~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~~ 99 (306)
T 3tdw_A 24 VESLGEGFRNYAILV----NGDWVFRFPKSQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQI 99 (306)
T ss_dssp EEEEEECSSEEEEEE----TTTEEEEEESSHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSEE
T ss_pred eeecCCCcceeEEEE----CCEEEEEecCCchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCeE
Confidence 356888999999988 45577776531 34444432 3556676664 4455789999999988
Q ss_pred hhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhc-----------------------------------------------
Q 039819 271 VASRLREKPALDWNTRKRIAIGAARGLLYLHEQ----------------------------------------------- 303 (534)
Q Consensus 271 L~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~----------------------------------------------- 303 (534)
+.+... ..++...+..++.++++.|+.||+.
T Consensus 100 l~~~~~--~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~ 177 (306)
T 3tdw_A 100 LGEDGM--AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTLRFQ 177 (306)
T ss_dssp CHHHHH--TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHHHHH
T ss_pred Cchhhh--hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHHHHH
Confidence 765321 1234455555555666665555542
Q ss_pred ----------CCCCeEeccCCCCcEEeCC---CCc-EEEEecccceec
Q 039819 304 ----------CDPKIIHRDVKAANVLLDD---FCE-AIVGDFGLAKLL 337 (534)
Q Consensus 304 ----------~~~~ivH~Dlkp~NiLl~~---~~~-~kl~DFGla~~~ 337 (534)
..+.++|+|+++.|||++. ++. ..|+||+.+...
T Consensus 178 ~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g 225 (306)
T 3tdw_A 178 SYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS 225 (306)
T ss_dssp HHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred HHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence 2235699999999999987 455 489999988653
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=97.87 E-value=1.8e-06 Score=93.16 Aligned_cols=127 Identities=15% Similarity=0.179 Sum_probs=89.2
Q ss_pred CcEEEEEe---------cCCCceeecccccc-cCCCCCEEEccCCccCcCCCCCCC-CCCCCCEEEcC--C----CcCcc
Q 039819 8 NLVIGLGA---------PSQSLSGTLSGSIG-NLTNLRQVLLQNNNISGGIPPQLG-SLPKLQTLDLS--N----NRLSG 70 (534)
Q Consensus 8 ~~l~~L~l---------~~n~l~g~~p~~~~-~l~~L~~L~L~~N~l~g~~P~~~~-~l~~L~~L~Ls--~----N~l~g 70 (534)
.+++.|+| +.+.+++.....+. ++++|++|.++.|++++..+..+. .+++|+.|+|+ + |.+++
T Consensus 338 ~~L~~L~L~~~~~~g~~~~~~l~~~~l~~l~~~~~~L~~L~~~~~~l~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~ 417 (594)
T 2p1m_B 338 KDLRELRVFPSEPFVMEPNVALTEQGLVSVSMGCPKLESVLYFCRQMTNAALITIARNRPNMTRFRLCIIEPKAPDYLTL 417 (594)
T ss_dssp TTCCEEEEECSCTTCSSCSSCCCHHHHHHHHHHCTTCCEEEEEESCCCHHHHHHHHHHCTTCCEEEEEESSTTCCCTTTC
T ss_pred CCCCEEEEecCcccccccCCCCCHHHHHHHHHhchhHHHHHHhcCCcCHHHHHHHHhhCCCcceeEeecccCCCcccccC
Confidence 46888988 44677655444444 489999999999999876555555 58999999999 4 66763
Q ss_pred cc-----CchhhhcccCcccccccccCCccccceeCCCCcCcccCChhhhc-ccccccccccCCCCCCCCCCCC------
Q 039819 71 VI-----PALLFLSIWLPRKWDKRKCSGVDQGLLRLNNNSLSGAFPVFLAK-ISELAFLDLSYNNLSGPVPKFP------ 138 (534)
Q Consensus 71 ~~-----p~~~~~l~~l~~~~~~~~~~~~~L~~L~L~~N~l~g~~p~~~~~-l~~L~~L~ls~N~l~g~~p~~~------ 138 (534)
.. +..+..++ +|+.|+|++ .+++..+..++. +++|+.|+|++|.+++..+..+
T Consensus 418 ~~~~~~~~~l~~~~~--------------~L~~L~L~~-~l~~~~~~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~ 482 (594)
T 2p1m_B 418 EPLDIGFGAIVEHCK--------------DLRRLSLSG-LLTDKVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDS 482 (594)
T ss_dssp CCTHHHHHHHHHHCT--------------TCCEEECCS-SCCHHHHHHHHHHCTTCCEEEEESCCSSHHHHHHHHHHCTT
T ss_pred CchhhHHHHHHhhCC--------------CccEEeecC-cccHHHHHHHHHhchhccEeeccCCCCcHHHHHHHHhcCCC
Confidence 21 12234444 788999977 777666666666 8899999999999875322111
Q ss_pred CccccccCCcc
Q 039819 139 ARTFNVAGNPL 149 (534)
Q Consensus 139 ~~~~~~~~N~~ 149 (534)
-+.+.+.+|+.
T Consensus 483 L~~L~L~~n~~ 493 (594)
T 2p1m_B 483 LRKLEIRDCPF 493 (594)
T ss_dssp CCEEEEESCSC
T ss_pred cCEEECcCCCC
Confidence 15667777765
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=97.83 E-value=6.2e-05 Score=72.51 Aligned_cols=124 Identities=19% Similarity=0.150 Sum_probs=84.9
Q ss_pred eeccCCcE-EEEEEEEC-CCcEEEEEEehh-----------hhhhcc-cCceeeEEEEEeCCCeeEEEeeccCCCChhhh
Q 039819 209 ILGAGGFG-NVYKGKLG-DGTVLAVKRLKD-----------MISLAV-HRNLLRLIGYCATPTERLLVYPYMSNGSVASR 274 (534)
Q Consensus 209 ~lG~G~~g-~Vy~~~~~-~~~~vavK~~~~-----------~l~~~~-h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~ 274 (534)
.+..|..| .||+.... ++..+.+|+-.. .+..+. +--+.++++++.+.+..++|||++++.++.+.
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~~~~ 110 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGSVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAFQV 110 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEETHHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEHHHH
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCCCCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCcccccc
Confidence 45556665 69988765 456788887541 222221 22366788899888999999999999887665
Q ss_pred cccCCCCCHHHHHHHHHHHHHHHHHHHhcC--------------------------------------------------
Q 039819 275 LREKPALDWNTRKRIAIGAARGLLYLHEQC-------------------------------------------------- 304 (534)
Q Consensus 275 l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~-------------------------------------------------- 304 (534)
.... ......+..++++.|.-||...
T Consensus 111 ~~~~----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 186 (272)
T 4gkh_A 111 LEEY----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKEMHKL 186 (272)
T ss_dssp HHHC----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHHHHTT
T ss_pred ccCC----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHHHHhc
Confidence 4321 1223455666666666666421
Q ss_pred -----CCCeEeccCCCCcEEeCCCCcEEEEeccccee
Q 039819 305 -----DPKIIHRDVKAANVLLDDFCEAIVGDFGLAKL 336 (534)
Q Consensus 305 -----~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~ 336 (534)
.+.++|+|+.+.|||++..+.+-|+||+.+..
T Consensus 187 ~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 187 LPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp CCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred ccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 11379999999999999877777999988753
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=97.79 E-value=6.6e-05 Score=75.57 Aligned_cols=66 Identities=11% Similarity=-0.027 Sum_probs=44.1
Q ss_pred Cee-ccCCcEEEEEEEEC-------CCcEEEEEEehh-----------------hhhhcc-c--CceeeEEEEEeCC---
Q 039819 208 NIL-GAGGFGNVYKGKLG-------DGTVLAVKRLKD-----------------MISLAV-H--RNLLRLIGYCATP--- 256 (534)
Q Consensus 208 ~~l-G~G~~g~Vy~~~~~-------~~~~vavK~~~~-----------------~l~~~~-h--~niv~l~~~~~~~--- 256 (534)
+.| +.|....+|+.... ++..+++|+... .+..+. + -.+.+++.++.+.
T Consensus 26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~ 105 (357)
T 3ats_A 26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL 105 (357)
T ss_dssp EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence 456 88889999998764 256788886431 222222 2 2466778877665
Q ss_pred CeeEEEeeccCCCChhh
Q 039819 257 TERLLVYPYMSNGSVAS 273 (534)
Q Consensus 257 ~~~~lv~e~~~~gsL~~ 273 (534)
...++||||++|..+.+
T Consensus 106 g~~~~v~e~l~G~~l~~ 122 (357)
T 3ats_A 106 GTPFFLMDYVEGVVPPD 122 (357)
T ss_dssp SSCEEEEECCCCBCCCB
T ss_pred CCceEEEEecCCCChhh
Confidence 34689999999877654
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=97.77 E-value=4.3e-05 Score=78.48 Aligned_cols=69 Identities=13% Similarity=0.110 Sum_probs=38.2
Q ss_pred cEEEEEecCCCceeecccccccCCCCCEEEccCCccCcCCCCCCCCCCCCCEEEcCCCcCc-----cccCchhhhcc
Q 039819 9 LVIGLGAPSQSLSGTLSGSIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLS-----GVIPALLFLSI 80 (534)
Q Consensus 9 ~l~~L~l~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~P~~~~~l~~L~~L~Ls~N~l~-----g~~p~~~~~l~ 80 (534)
+|+.|+|.+| ++..-..+|.+ .+|+.+.| .|+++..-+.+|.+|++|+.|+|.+|.+. ...+..|..+.
T Consensus 227 ~L~~l~l~~~-l~~I~~~aF~~-~~L~~i~l-p~~i~~I~~~aF~~c~~L~~l~l~~~~~~~~~~~~I~~~aF~~c~ 300 (401)
T 4fdw_A 227 QLKTIEIPEN-VSTIGQEAFRE-SGITTVKL-PNGVTNIASRAFYYCPELAEVTTYGSTFNDDPEAMIHPYCLEGCP 300 (401)
T ss_dssp TCCCEECCTT-CCEECTTTTTT-CCCSEEEE-ETTCCEECTTTTTTCTTCCEEEEESSCCCCCTTCEECTTTTTTCT
T ss_pred CCCEEecCCC-ccCcccccccc-CCccEEEe-CCCccEEChhHhhCCCCCCEEEeCCccccCCcccEECHHHhhCCc
Confidence 5666666653 55344445665 56666666 34455333455666666666666666554 23334455554
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=97.59 E-value=0.00013 Score=74.83 Aligned_cols=118 Identities=14% Similarity=0.070 Sum_probs=48.3
Q ss_pred EEEEEecCCCceeecccccccCCCCCEEEccCCccCcCCCCCCCCCCCCCEEEcCCCcCccccCchhhhcccCccccc--
Q 039819 10 VIGLGAPSQSLSGTLSGSIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFLSIWLPRKWD-- 87 (534)
Q Consensus 10 l~~L~l~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~P~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~l~~~~~-- 87 (534)
|+.|.|.+ +++..-+.+|.++++|+.|+|++|+++ .+|.....+.+|+.+.|.+| ++..-..+|..+.+|.....
T Consensus 159 L~~i~lp~-~l~~I~~~aF~~c~~L~~l~l~~n~l~-~I~~~aF~~~~L~~l~lp~~-l~~I~~~aF~~~~~L~~l~l~~ 235 (401)
T 4fdw_A 159 VQEIVFPS-TLEQLKEDIFYYCYNLKKADLSKTKIT-KLPASTFVYAGIEEVLLPVT-LKEIGSQAFLKTSQLKTIEIPE 235 (401)
T ss_dssp CCEEECCT-TCCEECSSTTTTCTTCCEEECTTSCCS-EECTTTTTTCCCSEEECCTT-CCEECTTTTTTCTTCCCEECCT
T ss_pred ceEEEeCC-CccEehHHHhhCcccCCeeecCCCcce-EechhhEeecccCEEEeCCc-hheehhhHhhCCCCCCEEecCC
Confidence 44444443 444333344555555555555555554 23332222345555555422 44233334444433222111
Q ss_pred ------ccccCCccccceeCCCCcCcccCChhhhcccccccccccCCCCC
Q 039819 88 ------KRKCSGVDQGLLRLNNNSLSGAFPVFLAKISELAFLDLSYNNLS 131 (534)
Q Consensus 88 ------~~~~~~~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~ 131 (534)
...+.+.+|+.+.| .|.++..-+.+|.+|.+|+.+++.+|.+.
T Consensus 236 ~l~~I~~~aF~~~~L~~i~l-p~~i~~I~~~aF~~c~~L~~l~l~~~~~~ 284 (401)
T 4fdw_A 236 NVSTIGQEAFRESGITTVKL-PNGVTNIASRAFYYCPELAEVTTYGSTFN 284 (401)
T ss_dssp TCCEECTTTTTTCCCSEEEE-ETTCCEECTTTTTTCTTCCEEEEESSCCC
T ss_pred CccCccccccccCCccEEEe-CCCccEEChhHhhCCCCCCEEEeCCcccc
Confidence 11111223444444 23333233445555555555555555443
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.54 E-value=7.4e-05 Score=77.17 Aligned_cols=79 Identities=13% Similarity=-0.021 Sum_probs=48.9
Q ss_pred CCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCCceeeccccccccccccccccC---CCCcchhHHHHHHHHHHH
Q 039819 305 DPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGHIAPEYLSTG---QSSEKTDVFGFGILLLEL 381 (534)
Q Consensus 305 ~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~k~Dv~S~Gvvl~el 381 (534)
.+.++|+|++|.|||++.++ ++|+||+.+..-............-...|++|+..... ......++.+....+|+.
T Consensus 231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWNL 309 (420)
T ss_dssp CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHHH
T ss_pred CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHHH
Confidence 34799999999999999876 99999998875431100000000012346777655321 112235566888888888
Q ss_pred HhC
Q 039819 382 ITG 384 (534)
Q Consensus 382 ltG 384 (534)
+++
T Consensus 310 y~~ 312 (420)
T 2pyw_A 310 FNK 312 (420)
T ss_dssp HHH
T ss_pred HHH
Confidence 765
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.48 E-value=0.00032 Score=69.69 Aligned_cols=31 Identities=26% Similarity=0.366 Sum_probs=27.6
Q ss_pred CCCeEeccCCCCcEEeCCCCcEEEEecccce
Q 039819 305 DPKIIHRDVKAANVLLDDFCEAIVGDFGLAK 335 (534)
Q Consensus 305 ~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~ 335 (534)
...++|+|+++.|||++.++.+.|+||+.+.
T Consensus 221 ~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 221 SPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp SCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred cCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 4589999999999999888899999999775
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=97.43 E-value=8.6e-05 Score=75.03 Aligned_cols=107 Identities=15% Similarity=0.160 Sum_probs=69.0
Q ss_pred CcEEEEEecCCCc---------eeecccccccCCCCCEEEccCCc-cCcCCCCCCCCCCCCCEEEcCCCcCccccCchhh
Q 039819 8 NLVIGLGAPSQSL---------SGTLSGSIGNLTNLRQVLLQNNN-ISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLF 77 (534)
Q Consensus 8 ~~l~~L~l~~n~l---------~g~~p~~~~~l~~L~~L~L~~N~-l~g~~P~~~~~l~~L~~L~Ls~N~l~g~~p~~~~ 77 (534)
.+|+.|.+..+.. .+.++..+..+++|+.|+|++|. + .+|. +. +++|+.|+|..|.++...-..+.
T Consensus 139 ~~L~~L~l~~~~~e~~~is~~~~~~L~~ll~~~P~L~~L~L~g~~~l--~l~~-~~-~~~L~~L~L~~~~l~~~~l~~l~ 214 (362)
T 2ra8_A 139 AHFEGLFWGDIDFEEQEISWIEQVDLSPVLDAMPLLNNLKIKGTNNL--SIGK-KP-RPNLKSLEIISGGLPDSVVEDIL 214 (362)
T ss_dssp TTCSEEEECCCCTTTCCGGGCBCCBCHHHHHTCTTCCEEEEECCBTC--BCCS-CB-CTTCSEEEEECSBCCHHHHHHHH
T ss_pred chhhheeecCcchhhcccccccccCHHHHHhcCCCCcEEEEeCCCCc--eecc-cc-CCCCcEEEEecCCCChHHHHHHH
Confidence 4678888876543 12355566778899999998873 3 3444 43 78999999988887643333333
Q ss_pred --hcccCcccccccccCCccccceeCCC--CcCccc-----CChhh--hcccccccccccCCCCCC
Q 039819 78 --LSIWLPRKWDKRKCSGVDQGLLRLNN--NSLSGA-----FPVFL--AKISELAFLDLSYNNLSG 132 (534)
Q Consensus 78 --~l~~l~~~~~~~~~~~~~L~~L~L~~--N~l~g~-----~p~~~--~~l~~L~~L~ls~N~l~g 132 (534)
.++ +|+.|+|+. |...|. +...+ ..+++|+.|+|++|.++.
T Consensus 215 ~~~lp--------------~L~~L~L~~~~~~~~~~~~~~~l~~~l~~~~~p~Lr~L~L~~~~i~~ 266 (362)
T 2ra8_A 215 GSDLP--------------NLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQN 266 (362)
T ss_dssp HSBCT--------------TCCEEEEECBCGGGTCCSCGGGTGGGSCTTTCTTCCEEEEESCTTHH
T ss_pred HccCC--------------CCcEEEEeccccccccchhHHHHHHHHhcCCCCCcCEEeCCCCCCch
Confidence 334 788888853 322111 11222 357899999999999874
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.33 E-value=0.00067 Score=69.24 Aligned_cols=31 Identities=23% Similarity=0.274 Sum_probs=26.1
Q ss_pred CCeEeccCCCCcEEeCCCCcEEEEecccceec
Q 039819 306 PKIIHRDVKAANVLLDDFCEAIVGDFGLAKLL 337 (534)
Q Consensus 306 ~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~ 337 (534)
+.++|+|+.+.|||++.+ .++|.||..+...
T Consensus 227 ~~L~HGDl~~~Nil~~~~-~~~lID~e~a~~G 257 (397)
T 2olc_A 227 ETLIHGDLHTGSIFASEH-ETKVIDPEFAFYG 257 (397)
T ss_dssp CEEECSCCSGGGEEECSS-CEEECCCTTCEEE
T ss_pred CceeeCCCCcCcEEEeCC-CeEEEeCcccccC
Confidence 479999999999999875 4889999877643
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=97.29 E-value=0.00025 Score=60.42 Aligned_cols=56 Identities=23% Similarity=0.354 Sum_probs=38.0
Q ss_pred EEEecCCCce-eecccccccCCCCCEEEccCCccCcCCCCCCCCCCCCCEEEcCCCcCc
Q 039819 12 GLGAPSQSLS-GTLSGSIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLS 69 (534)
Q Consensus 12 ~L~l~~n~l~-g~~p~~~~~l~~L~~L~L~~N~l~g~~P~~~~~l~~L~~L~Ls~N~l~ 69 (534)
.++.++++|+ ..+|..|. .+|++|+|++|+|+..-+..|..+++|+.|+|++|.+.
T Consensus 12 ~v~Cs~~~L~~~~vP~~lp--~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~ 68 (130)
T 3rfe_A 12 LVDCGRRGLTWASLPTAFP--VDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWR 68 (130)
T ss_dssp EEECCSSCCCTTTSCSCCC--TTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCB
T ss_pred EEEeCCCCCccccCCCCCC--cCCCEEECCCCcCCccChhhhhhccccCEEEecCCCee
Confidence 5677778776 24564432 46788888888887433445677788888888888765
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.26 E-value=0.0015 Score=64.42 Aligned_cols=124 Identities=16% Similarity=0.140 Sum_probs=79.0
Q ss_pred CCeeccCCcEEEEEEEECCCcEEEEEEehh-----------hhhhcc---cCceeeEEEEEeCCCeeEEEeeccCCCChh
Q 039819 207 KNILGAGGFGNVYKGKLGDGTVLAVKRLKD-----------MISLAV---HRNLLRLIGYCATPTERLLVYPYMSNGSVA 272 (534)
Q Consensus 207 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~-----------~l~~~~---h~niv~l~~~~~~~~~~~lv~e~~~~gsL~ 272 (534)
.+.|+.|....+|+... ++..+++|+... .+..+. ...+.+++.++...+..++||||+++..+.
T Consensus 41 ~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~~~~ 119 (312)
T 3jr1_A 41 KEKLYSGEMNEIWLIND-EVQTVFVKINERSYRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKSKNK 119 (312)
T ss_dssp EEEECCSSSSEEEEEES-SSCEEEEEEEEGGGHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCCCCC
T ss_pred eEEeCCccceeeeEEEE-CCCeEEEEeCCcccHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCCCCC
Confidence 45789999999999987 456778887531 233322 356788888888888899999999987642
Q ss_pred h-----------hcccC---C-------------------CCCHHHHH---HHH----------------HHHHHH-HHH
Q 039819 273 S-----------RLREK---P-------------------ALDWNTRK---RIA----------------IGAARG-LLY 299 (534)
Q Consensus 273 ~-----------~l~~~---~-------------------~l~~~~~~---~i~----------------~~i~~~-l~y 299 (534)
. .++.. . .-+|.... ++. ..+++. ...
T Consensus 120 ~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~l~~~ 199 (312)
T 3jr1_A 120 QSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQIVADT 199 (312)
T ss_dssp TTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHHHHHH
T ss_pred chhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHHHHHH
Confidence 1 11111 1 01454321 111 111111 123
Q ss_pred HHh-cCCCCeEeccCCCCcEEeCCCCcEEEEecc
Q 039819 300 LHE-QCDPKIIHRDVKAANVLLDDFCEAIVGDFG 332 (534)
Q Consensus 300 LH~-~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFG 332 (534)
|.. ...+.+||+|+.+.|++++.++ +.|.||.
T Consensus 200 L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 200 LSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred hccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 321 2356899999999999999887 8888974
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=97.03 E-value=0.0011 Score=56.30 Aligned_cols=57 Identities=19% Similarity=0.200 Sum_probs=39.1
Q ss_pred CEEEccCCccC-cCCCCCCCCCCCCCEEEcCCCcCccccCchhhhcccCcccccccccCCccccceeCCCCcCc
Q 039819 35 RQVLLQNNNIS-GGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFLSIWLPRKWDKRKCSGVDQGLLRLNNNSLS 107 (534)
Q Consensus 35 ~~L~L~~N~l~-g~~P~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~l~~~~~~~~~~~~~L~~L~L~~N~l~ 107 (534)
..++.++++|+ ..+|..+. ++|+.|+|++|+|+...+..|..+. +|+.|+|++|.+.
T Consensus 11 ~~v~Cs~~~L~~~~vP~~lp--~~l~~L~Ls~N~l~~l~~~~f~~l~--------------~L~~L~L~~NP~~ 68 (130)
T 3rfe_A 11 TLVDCGRRGLTWASLPTAFP--VDTTELVLTGNNLTALPPGLLDALP--------------ALRTAHLGANPWR 68 (130)
T ss_dssp TEEECCSSCCCTTTSCSCCC--TTCSEEECTTSCCSSCCTTTGGGCT--------------TCCEEECCSSCCB
T ss_pred CEEEeCCCCCccccCCCCCC--cCCCEEECCCCcCCccChhhhhhcc--------------ccCEEEecCCCee
Confidence 47788888886 35775543 3688888888888854445555555 6677788777764
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=96.98 E-value=0.00014 Score=66.39 Aligned_cols=113 Identities=18% Similarity=0.206 Sum_probs=60.6
Q ss_pred CCcEEEEEecCC-Cceee----cccccccCCCCCEEEccCCccCc----CCCCCCCCCCCCCEEEcCCCcCccccCchhh
Q 039819 7 ENLVIGLGAPSQ-SLSGT----LSGSIGNLTNLRQVLLQNNNISG----GIPPQLGSLPKLQTLDLSNNRLSGVIPALLF 77 (534)
Q Consensus 7 ~~~l~~L~l~~n-~l~g~----~p~~~~~l~~L~~L~L~~N~l~g----~~P~~~~~l~~L~~L~Ls~N~l~g~~p~~~~ 77 (534)
...++.|+|++| +|... +-..+..-+.|+.|+|++|+|.. .|-..+..-+.|+.|+|++|+|...=-..+.
T Consensus 40 n~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga~ala 119 (197)
T 1pgv_A 40 DTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLL 119 (197)
T ss_dssp CSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHH
T ss_pred CCCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHHHHHH
Confidence 345777777764 66422 33445555677777777777762 2333333456777777777777632111121
Q ss_pred hcccCcccccccccCCccccceeCCCC---cCcc----cCChhhhcccccccccccCCC
Q 039819 78 LSIWLPRKWDKRKCSGVDQGLLRLNNN---SLSG----AFPVFLAKISELAFLDLSYNN 129 (534)
Q Consensus 78 ~l~~l~~~~~~~~~~~~~L~~L~L~~N---~l~g----~~p~~~~~l~~L~~L~ls~N~ 129 (534)
... .. ...|+.|+|++| .+.. .+-..+..-+.|+.|+++.|.
T Consensus 120 ~aL--~~--------N~tL~~L~L~n~~~~~ig~~g~~~ia~aL~~N~tL~~L~l~~~~ 168 (197)
T 1pgv_A 120 RST--LV--------TQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFAS 168 (197)
T ss_dssp HHT--TT--------TCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCC
T ss_pred HHH--hh--------CCceeEEECCCCcCcCcCHHHHHHHHHHHHhCCCcCeEeccCCC
Confidence 111 00 115677777654 3321 233344455667777776554
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=96.89 E-value=0.004 Score=60.38 Aligned_cols=63 Identities=22% Similarity=0.299 Sum_probs=42.8
Q ss_pred CCcCCeeccCCcEEEEEEEECCCcEEEEEEehh--------------hhhhccc---CceeeEEEEEeCCCeeEEEeecc
Q 039819 204 FSSKNILGAGGFGNVYKGKLGDGTVLAVKRLKD--------------MISLAVH---RNLLRLIGYCATPTERLLVYPYM 266 (534)
Q Consensus 204 ~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~--------------~l~~~~h---~niv~l~~~~~~~~~~~lv~e~~ 266 (534)
....+.+|.|..+.||+.++.||+.|.||+-.. .++.+.. --+.+++++. ..++||||+
T Consensus 17 v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~e~l 92 (288)
T 3f7w_A 17 VAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAMEWV 92 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEEECC
T ss_pred eEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEEEee
Confidence 344567899999999999999999999997431 2222221 1234445442 347999999
Q ss_pred CCCC
Q 039819 267 SNGS 270 (534)
Q Consensus 267 ~~gs 270 (534)
+++.
T Consensus 93 ~~~~ 96 (288)
T 3f7w_A 93 DERP 96 (288)
T ss_dssp CCCC
T ss_pred cccC
Confidence 8764
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.83 E-value=0.003 Score=62.16 Aligned_cols=145 Identities=12% Similarity=0.067 Sum_probs=81.7
Q ss_pred cccCHHHHHHHHhCCCcC-----CeeccCCcEEEEEEEECCCcEEEEEEehh------------hhhhcccCc--eeeEE
Q 039819 190 RNFTFRELQQATENFSSK-----NILGAGGFGNVYKGKLGDGTVLAVKRLKD------------MISLAVHRN--LLRLI 250 (534)
Q Consensus 190 ~~~~~~~l~~~~~~~~~~-----~~lG~G~~g~Vy~~~~~~~~~vavK~~~~------------~l~~~~h~n--iv~l~ 250 (534)
..++.+++......|... +.|+.|....+|+....++ .+++|.... .+..+.... +.+++
T Consensus 5 ~~~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~~~~~l~~e~~~l~~L~~~g~~vP~~~ 83 (322)
T 2ppq_A 5 TDITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRVEKNDLPFFLGLMQHLAAKGLSCPLPL 83 (322)
T ss_dssp CCCCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC---CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred ccCCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCCCCHHHHHHHHHHHHHHHHCCCCCCccc
Confidence 456777888777777652 3466788899999988766 467886542 222222111 22232
Q ss_pred EE------EeCCCeeEEEeeccCCCChhh--------------hccc---C---C---C---CCHHHHHH----------
Q 039819 251 GY------CATPTERLLVYPYMSNGSVAS--------------RLRE---K---P---A---LDWNTRKR---------- 288 (534)
Q Consensus 251 ~~------~~~~~~~~lv~e~~~~gsL~~--------------~l~~---~---~---~---l~~~~~~~---------- 288 (534)
.. ....+..++||+|++|..+.. .++. . . . ..|.....
T Consensus 84 ~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~ 163 (322)
T 2ppq_A 84 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE 163 (322)
T ss_dssp CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred CCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhh
Confidence 21 112345689999998865321 0110 0 0 0 12332111
Q ss_pred --HHHHHHHHHHHHHhc----CCCCeEeccCCCCcEEeCCCCcEEEEecccce
Q 039819 289 --IAIGAARGLLYLHEQ----CDPKIIHRDVKAANVLLDDFCEAIVGDFGLAK 335 (534)
Q Consensus 289 --i~~~i~~~l~yLH~~----~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~ 335 (534)
+...+.+.+.+++.. ....++|+|+.+.|||++.+..+.|+||+.+.
T Consensus 164 ~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 164 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 011244455666532 13478999999999999987666899998775
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=96.74 E-value=0.0063 Score=55.98 Aligned_cols=97 Identities=14% Similarity=0.102 Sum_probs=63.7
Q ss_pred Chhhhcc-cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCCceeecc
Q 039819 270 SVASRLR-EKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAV 348 (534)
Q Consensus 270 sL~~~l~-~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~~ 348 (534)
+|.+.|. ...++++++++.++.|.+.+|.-+-.+.. + ..+=+-|..|++..+|.+...+ +.+.
T Consensus 34 SL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~-~-~~~i~~~~~i~l~~dG~V~f~~-~~s~------------- 97 (229)
T 2yle_A 34 SLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQ-P-RHRVRSAAQIRVWRDGAVTLAP-AADD------------- 97 (229)
T ss_dssp EHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTC-C-CCCCCSGGGEEEETTSCEEECC-C----------------
T ss_pred cHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhccc-C-CceecCCcceEEecCCceeccc-cccc-------------
Confidence 7888887 46789999999999999999877622111 1 1223446889999999887653 1110
Q ss_pred ccccccccccccccCCCCcchhHHHHHHHHHHHHh
Q 039819 349 RGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT 383 (534)
Q Consensus 349 ~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~ellt 383 (534)
.....+.|||... ...+.+.=|||+|+++|..+-
T Consensus 98 ~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALD 131 (229)
T 2yle_A 98 AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALD 131 (229)
T ss_dssp ---------CCSS-SSSCHHHHHHHHHHHHHHHHT
T ss_pred ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhh
Confidence 0123466888763 345788899999999999885
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=96.60 E-value=0.00055 Score=61.31 Aligned_cols=96 Identities=11% Similarity=-0.008 Sum_probs=60.4
Q ss_pred cccccccCCCCCEEEccCCccCcCCCCCCCCCCCCCEEEcCCCc-CccccCchhhhcccCcccccccccCCccccceeCC
Q 039819 24 LSGSIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNR-LSGVIPALLFLSIWLPRKWDKRKCSGVDQGLLRLN 102 (534)
Q Consensus 24 ~p~~~~~l~~L~~L~L~~N~l~g~~P~~~~~l~~L~~L~Ls~N~-l~g~~p~~~~~l~~l~~~~~~~~~~~~~L~~L~L~ 102 (534)
+|.....--+|+.|+|+++.|+..==..+.+|++|+.|+|+++. |+.. .+..+..+.. . ..+|+.|+|+
T Consensus 53 LP~~~~~~~~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~---gL~~L~~~~~-----~--~~~L~~L~Ls 122 (176)
T 3e4g_A 53 LPTGPLDKYKIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDG---CLERLSQLEN-----L--QKSMLEMEII 122 (176)
T ss_dssp SCCCSTTCCCEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHH---HHHHHHTCHH-----H--HHHCCEEEEE
T ss_pred CCcccCCCceEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHH---HHHHHHhccc-----c--cCCCCEEEcC
Confidence 45433223478999999998874322346789999999999985 6532 2222221100 0 0058889999
Q ss_pred CC-cCcccCChhhhcccccccccccCCC
Q 039819 103 NN-SLSGAFPVFLAKISELAFLDLSYNN 129 (534)
Q Consensus 103 ~N-~l~g~~p~~~~~l~~L~~L~ls~N~ 129 (534)
++ +++..==..+..+++|+.|+|++..
T Consensus 123 ~C~~ITD~Gl~~L~~~~~L~~L~L~~c~ 150 (176)
T 3e4g_A 123 SCGNVTDKGIIALHHFRNLKYLFLSDLP 150 (176)
T ss_dssp SCTTCCHHHHHHGGGCTTCCEEEEESCT
T ss_pred CCCcCCHHHHHHHhcCCCCCEEECCCCC
Confidence 87 4764323456788999999998754
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=96.59 E-value=0.0087 Score=58.36 Aligned_cols=30 Identities=20% Similarity=0.145 Sum_probs=25.2
Q ss_pred CCeEeccCCCCcEEeCCCCcEEEEeccccee
Q 039819 306 PKIIHRDVKAANVLLDDFCEAIVGDFGLAKL 336 (534)
Q Consensus 306 ~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~ 336 (534)
..++|+|+.+.||+ ..++.+.|+||..+..
T Consensus 173 ~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~ 202 (301)
T 3dxq_A 173 LAACHCDPLCENFL-DTGERMWIVDWEYSGM 202 (301)
T ss_dssp CEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred ceeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence 35899999999999 5567789999988764
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=96.46 E-value=0.0069 Score=61.60 Aligned_cols=38 Identities=18% Similarity=0.211 Sum_probs=18.7
Q ss_pred cccccCCCCCEEEccCCccCcCCCCCCCCCCCCCEEEcC
Q 039819 26 GSIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLS 64 (534)
Q Consensus 26 ~~~~~l~~L~~L~L~~N~l~g~~P~~~~~l~~L~~L~Ls 64 (534)
.+|.++.+|+.+.+.++..+ .-..+|.++.+|+.+.+.
T Consensus 259 ~aF~~c~~L~~i~lp~~~~~-I~~~aF~~c~~L~~i~l~ 296 (394)
T 4gt6_A 259 HAFDSCAYLASVKMPDSVVS-IGTGAFMNCPALQDIEFS 296 (394)
T ss_dssp TTTTTCSSCCEEECCTTCCE-ECTTTTTTCTTCCEEECC
T ss_pred ceeeecccccEEecccccce-ecCcccccccccccccCC
Confidence 34555555555555444333 333345555555555553
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=96.46 E-value=0.0073 Score=60.93 Aligned_cols=86 Identities=15% Similarity=0.162 Sum_probs=38.3
Q ss_pred ccccccCCCCCEEEccCCccCcCCCCCCCCCCCCCEEEcCCCcCccccCchhhhcccCcccccccccCCccccceeCCCC
Q 039819 25 SGSIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFLSIWLPRKWDKRKCSGVDQGLLRLNNN 104 (534)
Q Consensus 25 p~~~~~l~~L~~L~L~~N~l~g~~P~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~l~~~~~~~~~~~~~L~~L~L~~N 104 (534)
..+|.++.+|+.+.+..+ ++..-..+|.++.+|+.+.+..+ ++..-...|..+. +|+.+.+.+|
T Consensus 233 ~~~f~~~~~L~~i~lp~~-v~~I~~~aF~~~~~l~~i~l~~~-i~~i~~~aF~~c~--------------~L~~i~l~~~ 296 (379)
T 4h09_A 233 DGAFYGMKALDEIAIPKN-VTSIGSFLLQNCTALKTLNFYAK-VKTVPYLLCSGCS--------------NLTKVVMDNS 296 (379)
T ss_dssp TTTTTTCSSCCEEEECTT-CCEECTTTTTTCTTCCEEEECCC-CSEECTTTTTTCT--------------TCCEEEECCT
T ss_pred cccccCCccceEEEcCCC-ccEeCccccceeehhcccccccc-ceecccccccccc--------------cccccccccc
Confidence 344555555555555443 33223334555555555555432 3312223333333 4444455444
Q ss_pred cCcccCChhhhccccccccccc
Q 039819 105 SLSGAFPVFLAKISELAFLDLS 126 (534)
Q Consensus 105 ~l~g~~p~~~~~l~~L~~L~ls 126 (534)
.++..-..+|.++.+|+.+.|.
T Consensus 297 ~i~~I~~~aF~~c~~L~~i~lp 318 (379)
T 4h09_A 297 AIETLEPRVFMDCVKLSSVTLP 318 (379)
T ss_dssp TCCEECTTTTTTCTTCCEEECC
T ss_pred ccceehhhhhcCCCCCCEEEcC
Confidence 4442333444455555555443
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.28 E-value=0.013 Score=57.77 Aligned_cols=144 Identities=13% Similarity=0.140 Sum_probs=80.0
Q ss_pred cccCHHHHHHHHhCCCc-----CCeeccCCcEEEEEEEECCCcEEEEEEehh-------------hhhhcccC--ceeeE
Q 039819 190 RNFTFRELQQATENFSS-----KNILGAGGFGNVYKGKLGDGTVLAVKRLKD-------------MISLAVHR--NLLRL 249 (534)
Q Consensus 190 ~~~~~~~l~~~~~~~~~-----~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~-------------~l~~~~h~--niv~l 249 (534)
...+.+++..+...|.. ...++ |....||+....+|..+++|.... .+..+... .++++
T Consensus 9 ~~l~~~~i~~~l~~~g~~~~~~~~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~~~~~~~~E~~~~~~L~~~g~~vp~~ 87 (328)
T 1zyl_A 9 QTLHPDTIMDALFEHGIRVDSGLTPLN-SYENRVYQFQDEDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAP 87 (328)
T ss_dssp CCCCHHHHHHHHHHTTCCCCSCCEEEC-CSSSEEEEECCTTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCC
T ss_pred CCCCHHHHHHHHHHcCCCCCceEEeec-CcccceEEEEcCCCCEEEEEEcCCCCCCHHHHHHHHHHHHHHHHcCCeecce
Confidence 34566667666665543 23466 888899998887787788998741 12222211 13334
Q ss_pred EEE-----EeCCCeeEEEeeccCCCChhh-----------h---cc----c-----CCCCCHHHH----HHH--------
Q 039819 250 IGY-----CATPTERLLVYPYMSNGSVAS-----------R---LR----E-----KPALDWNTR----KRI-------- 289 (534)
Q Consensus 250 ~~~-----~~~~~~~~lv~e~~~~gsL~~-----------~---l~----~-----~~~l~~~~~----~~i-------- 289 (534)
+.. ....+..++||+|++|..+.. . ++ . ....++... ..+
T Consensus 88 ~~~~g~~~~~~~g~~~~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 167 (328)
T 1zyl_A 88 VAFNGQTLLNHQGFYFAVFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIP 167 (328)
T ss_dssp CCBTTBSCEEETTEEEEEEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSC
T ss_pred eecCCcEEEEECCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCC
Confidence 332 112345578999998754321 0 11 0 011222211 001
Q ss_pred -------HHHHHHHHHHHHhc----CCCCeEeccCCCCcEEeCCCCcEEEEeccccee
Q 039819 290 -------AIGAARGLLYLHEQ----CDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKL 336 (534)
Q Consensus 290 -------~~~i~~~l~yLH~~----~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~ 336 (534)
...+.+.+..+... ....++|+|+++.|||++ + .+.|+||+.+..
T Consensus 168 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 168 SGLKAAFLKATDELIAAVTAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp TTTHHHHHHHHHHHHHHHHHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred HHHHHHHHHHHHHHHHHHHHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 11111223333321 234689999999999999 4 899999987754
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=96.25 E-value=0.00079 Score=60.25 Aligned_cols=86 Identities=12% Similarity=0.110 Sum_probs=60.6
Q ss_pred CcEEEEEecCCCceeecccccccCCCCCEEEccCCc-cCcCCCCCCCCC----CCCCEEEcCCCc-CccccCchhhhccc
Q 039819 8 NLVIGLGAPSQSLSGTLSGSIGNLTNLRQVLLQNNN-ISGGIPPQLGSL----PKLQTLDLSNNR-LSGVIPALLFLSIW 81 (534)
Q Consensus 8 ~~l~~L~l~~n~l~g~~p~~~~~l~~L~~L~L~~N~-l~g~~P~~~~~l----~~L~~L~Ls~N~-l~g~~p~~~~~l~~ 81 (534)
-+|+.|||+++.|+..--..+.++++|+.|+|+++. |+..-=..+..+ ++|+.|+|+++. ++..==..+..++
T Consensus 61 ~~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~- 139 (176)
T 3e4g_A 61 YKIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFR- 139 (176)
T ss_dssp CCEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCT-
T ss_pred ceEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCC-
Confidence 369999999999886545668899999999999985 763211223443 479999999974 7632112233333
Q ss_pred CcccccccccCCccccceeCCCCc-Cc
Q 039819 82 LPRKWDKRKCSGVDQGLLRLNNNS-LS 107 (534)
Q Consensus 82 l~~~~~~~~~~~~~L~~L~L~~N~-l~ 107 (534)
+|+.|+|++.. ++
T Consensus 140 -------------~L~~L~L~~c~~It 153 (176)
T 3e4g_A 140 -------------NLKYLFLSDLPGVK 153 (176)
T ss_dssp -------------TCCEEEEESCTTCC
T ss_pred -------------CCCEEECCCCCCCC
Confidence 88999999874 44
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=96.17 E-value=0.019 Score=56.78 Aligned_cols=33 Identities=39% Similarity=0.311 Sum_probs=28.1
Q ss_pred CCCeEeccCCCCcEEeCCC----CcEEEEecccceec
Q 039819 305 DPKIIHRDVKAANVLLDDF----CEAIVGDFGLAKLL 337 (534)
Q Consensus 305 ~~~ivH~Dlkp~NiLl~~~----~~~kl~DFGla~~~ 337 (534)
.+.++|||+.+.|||++.+ ..+.|+||+.+..-
T Consensus 182 ~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 182 DMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp CCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred CCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 3479999999999999874 67899999988754
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=96.03 E-value=0.0082 Score=61.03 Aligned_cols=104 Identities=10% Similarity=0.143 Sum_probs=78.8
Q ss_pred cEEEEEecCCCceeecccccccCCCCCEEEccCCccCcCCCCCCCCCCCCCEEEcCCCcCccccCchhhhcccCcccccc
Q 039819 9 LVIGLGAPSQSLSGTLSGSIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFLSIWLPRKWDK 88 (534)
Q Consensus 9 ~l~~L~l~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~P~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~l~~~~~~ 88 (534)
.++.+.+.++-.+ .-..+|.++++|+.+.+. +.++..-..+|.++.+|+.++|..| ++-.-..+|..+.
T Consensus 266 ~L~~i~lp~~~~~-I~~~aF~~c~~L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~C~-------- 334 (394)
T 4gt6_A 266 YLASVKMPDSVVS-IGTGAFMNCPALQDIEFS-SRITELPESVFAGCISLKSIDIPEG-ITQILDDAFAGCE-------- 334 (394)
T ss_dssp SCCEEECCTTCCE-ECTTTTTTCTTCCEEECC-TTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCT--------
T ss_pred cccEEecccccce-ecCcccccccccccccCC-CcccccCceeecCCCCcCEEEeCCc-ccEehHhHhhCCC--------
Confidence 6788888766554 556789999999999996 5676444557999999999999865 6634456677777
Q ss_pred cccCCccccceeCCCCcCcccCChhhhcccccccccccCCCC
Q 039819 89 RKCSGVDQGLLRLNNNSLSGAFPVFLAKISELAFLDLSYNNL 130 (534)
Q Consensus 89 ~~~~~~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l 130 (534)
+|+.+.|..+ ++..-..+|.+|.+|+.+++.+|..
T Consensus 335 ------~L~~i~ip~s-v~~I~~~aF~~C~~L~~i~~~~~~~ 369 (394)
T 4gt6_A 335 ------QLERIAIPSS-VTKIPESAFSNCTALNNIEYSGSRS 369 (394)
T ss_dssp ------TCCEEEECTT-CCBCCGGGGTTCTTCCEEEESSCHH
T ss_pred ------CCCEEEECcc-cCEEhHhHhhCCCCCCEEEECCcee
Confidence 7888888655 6634457899999999999887753
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=95.97 E-value=0.03 Score=58.11 Aligned_cols=61 Identities=10% Similarity=0.097 Sum_probs=38.3
Q ss_pred CCeeccCCcEEEEEEEECC-CcEEEEEEehh-------------hhhhcccCce-eeEEEEEeCCCeeEEEeeccCCCCh
Q 039819 207 KNILGAGGFGNVYKGKLGD-GTVLAVKRLKD-------------MISLAVHRNL-LRLIGYCATPTERLLVYPYMSNGSV 271 (534)
Q Consensus 207 ~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~-------------~l~~~~h~ni-v~l~~~~~~~~~~~lv~e~~~~gsL 271 (534)
.+.|+.|-...+|+....+ +..+.+|+... .+..+...++ .++++++. + .+||||+++..|
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~l 188 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEIINREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYAL 188 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCSCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEEC
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhcCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCccC
Confidence 3467888899999999875 46778886521 2333333333 46777663 2 359999987544
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=95.93 E-value=0.0077 Score=61.23 Aligned_cols=100 Identities=11% Similarity=-0.050 Sum_probs=69.8
Q ss_pred cEEEEEecCCCceeecccccccCCCCCEEEccCCccCcCCCCCCCCCCCCCEEEcCCCcCccccCchhhhcccCcccccc
Q 039819 9 LVIGLGAPSQSLSGTLSGSIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFLSIWLPRKWDK 88 (534)
Q Consensus 9 ~l~~L~l~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~P~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~l~~~~~~ 88 (534)
.+..+.+..+. .....|..+.+|+.+.+.+| ++..-..+|.++.+|+.++|.++ ++-.-..+|..+.
T Consensus 277 ~l~~~~~~~~~---i~~~~F~~~~~L~~i~l~~~-i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~c~-------- 343 (394)
T 4fs7_A 277 GLKKVIYGSVI---VPEKTFYGCSSLTEVKLLDS-VKFIGEEAFESCTSLVSIDLPYL-VEEIGKRSFRGCT-------- 343 (394)
T ss_dssp TCCEEEECSSE---ECTTTTTTCTTCCEEEECTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCT--------
T ss_pred ccceeccCcee---eccccccccccccccccccc-cceechhhhcCCCCCCEEEeCCc-ccEEhHHhccCCC--------
Confidence 34444444432 23457888899999998765 66444567889999999999754 6634456677776
Q ss_pred cccCCccccceeCCCCcCcccCChhhhcccccccccccCC
Q 039819 89 RKCSGVDQGLLRLNNNSLSGAFPVFLAKISELAFLDLSYN 128 (534)
Q Consensus 89 ~~~~~~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N 128 (534)
+|+.+.|..| ++..-..+|.+|.+|+.++|..|
T Consensus 344 ------~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~lp~~ 376 (394)
T 4fs7_A 344 ------SLSNINFPLS-LRKIGANAFQGCINLKKVELPKR 376 (394)
T ss_dssp ------TCCEECCCTT-CCEECTTTBTTCTTCCEEEEEGG
T ss_pred ------CCCEEEECcc-ccEehHHHhhCCCCCCEEEECCC
Confidence 7778888776 66455678888999998888654
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=95.86 E-value=0.038 Score=54.91 Aligned_cols=32 Identities=25% Similarity=0.283 Sum_probs=28.0
Q ss_pred CCeEeccCCCCcEEeCCCCcEEEEecccceec
Q 039819 306 PKIIHRDVKAANVLLDDFCEAIVGDFGLAKLL 337 (534)
Q Consensus 306 ~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~ 337 (534)
..++|+|+.+.||+++.++.+.|+||+.+...
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~ 237 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPMLA 237 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCeeC
Confidence 46999999999999998888999999877643
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=95.80 E-value=0.021 Score=58.88 Aligned_cols=61 Identities=13% Similarity=0.218 Sum_probs=39.1
Q ss_pred CCeeccCCcEEEEEEEECC--------CcEEEEEEehh------------hhhhcccCce-eeEEEEEeCCCeeEEEeec
Q 039819 207 KNILGAGGFGNVYKGKLGD--------GTVLAVKRLKD------------MISLAVHRNL-LRLIGYCATPTERLLVYPY 265 (534)
Q Consensus 207 ~~~lG~G~~g~Vy~~~~~~--------~~~vavK~~~~------------~l~~~~h~ni-v~l~~~~~~~~~~~lv~e~ 265 (534)
.+.|+.|....||+....+ +..+.+|+... .+..+...++ .++++.+.+ .+||||
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~e~ 153 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEEY 153 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEECC
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCCcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEEEE
Confidence 3467888899999998763 47788887622 1222222223 566666543 389999
Q ss_pred cCCCCh
Q 039819 266 MSNGSV 271 (534)
Q Consensus 266 ~~~gsL 271 (534)
++|.++
T Consensus 154 l~G~~l 159 (429)
T 1nw1_A 154 IPSRPL 159 (429)
T ss_dssp CCEEEC
T ss_pred eCCccc
Confidence 986444
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=95.73 E-value=0.025 Score=56.76 Aligned_cols=29 Identities=21% Similarity=0.361 Sum_probs=24.3
Q ss_pred CCeEeccCCCCcEEeCCCCcEEEEecccce
Q 039819 306 PKIIHRDVKAANVLLDDFCEAIVGDFGLAK 335 (534)
Q Consensus 306 ~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~ 335 (534)
..++|+|+.+.|||++.+. +.|+||..+.
T Consensus 212 ~~l~HgDl~~~Nil~~~~~-~~lID~e~a~ 240 (369)
T 3c5i_A 212 IVFCHNDLQENNIINTNKC-LRLIDFEYSG 240 (369)
T ss_dssp EEEECSCCCGGGEEECC-C-EEECCCTTCE
T ss_pred eEEEeCCCCcccEEecCCc-EEEEEecCCC
Confidence 3689999999999998655 8999998775
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=95.72 E-value=0.0021 Score=58.52 Aligned_cols=93 Identities=14% Similarity=0.092 Sum_probs=62.8
Q ss_pred cccCCCCCEEEccCC-ccCc----CCCCCCCCCCCCCEEEcCCCcCccccCchhhhcccCcccccccccCCccccceeCC
Q 039819 28 IGNLTNLRQVLLQNN-NISG----GIPPQLGSLPKLQTLDLSNNRLSGVIPALLFLSIWLPRKWDKRKCSGVDQGLLRLN 102 (534)
Q Consensus 28 ~~~l~~L~~L~L~~N-~l~g----~~P~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~l~~~~~~~~~~~~~L~~L~L~ 102 (534)
+.+-+.|+.|+|++| +|.. .+-.++..-..|+.|+|++|+|...--..+.....- ...|+.|+|+
T Consensus 37 l~~n~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~----------N~tL~~L~L~ 106 (197)
T 1pgv_A 37 REDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIET----------SPSLRVLNVE 106 (197)
T ss_dssp HTTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHH----------CSSCCEEECC
T ss_pred HhcCCCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhc----------CCccCeEecC
Confidence 445578999999986 8862 244556667899999999999974322223221100 1178999999
Q ss_pred CCcCccc----CChhhhcccccccccccCCCC
Q 039819 103 NNSLSGA----FPVFLAKISELAFLDLSYNNL 130 (534)
Q Consensus 103 ~N~l~g~----~p~~~~~l~~L~~L~ls~N~l 130 (534)
+|.|... +-.++..-..|+.|+|++|..
T Consensus 107 ~N~Ig~~Ga~ala~aL~~N~tL~~L~L~n~~~ 138 (197)
T 1pgv_A 107 SNFLTPELLARLLRSTLVTQSIVEFKADNQRQ 138 (197)
T ss_dssp SSBCCHHHHHHHHHHTTTTCCCSEEECCCCSS
T ss_pred CCcCCHHHHHHHHHHHhhCCceeEEECCCCcC
Confidence 9999642 233445556799999987643
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=95.33 E-value=0.055 Score=54.64 Aligned_cols=124 Identities=14% Similarity=0.155 Sum_probs=70.8
Q ss_pred CeeccCCcEEEEEEEECC--------CcEEEEEEehh-------------hhhhcc-cCceeeEEEEEeCCCeeEEEeec
Q 039819 208 NILGAGGFGNVYKGKLGD--------GTVLAVKRLKD-------------MISLAV-HRNLLRLIGYCATPTERLLVYPY 265 (534)
Q Consensus 208 ~~lG~G~~g~Vy~~~~~~--------~~~vavK~~~~-------------~l~~~~-h~niv~l~~~~~~~~~~~lv~e~ 265 (534)
+.|..|....+|+....+ +..+.+|+.-. ++..+. +.-..++++++.+ .+||||
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e~ 131 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAILQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQY 131 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC---CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEEC
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCccchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEEE
Confidence 457778888999998753 46788887521 122222 1112566666654 299999
Q ss_pred cCCCChhhh-----------------cccC-----CCCC--HHHHHHHHHHHHH-------------------HHHHHHh
Q 039819 266 MSNGSVASR-----------------LREK-----PALD--WNTRKRIAIGAAR-------------------GLLYLHE 302 (534)
Q Consensus 266 ~~~gsL~~~-----------------l~~~-----~~l~--~~~~~~i~~~i~~-------------------~l~yLH~ 302 (534)
++|..|... ++.. .... |.++.++..++.. .+..|..
T Consensus 132 i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~ 211 (379)
T 3feg_A 132 IPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLRK 211 (379)
T ss_dssp CSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHHH
T ss_pred ecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHHH
Confidence 998655311 0111 1122 4555555544322 2333322
Q ss_pred ----c-CCCCeEeccCCCCcEEeCCC----CcEEEEecccce
Q 039819 303 ----Q-CDPKIIHRDVKAANVLLDDF----CEAIVGDFGLAK 335 (534)
Q Consensus 303 ----~-~~~~ivH~Dlkp~NiLl~~~----~~~kl~DFGla~ 335 (534)
. ....++|+|+.+.|||++.+ +.+.|+||..+.
T Consensus 212 ~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 212 LLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp HHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred HHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 1 12368999999999999876 788999998775
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=95.26 E-value=0.038 Score=55.99 Aligned_cols=54 Identities=13% Similarity=0.075 Sum_probs=23.6
Q ss_pred cEEEEEecCCCceeecccccccCCCCCEEEccCCccCcCCCCCCCCCCCCCEEEcC
Q 039819 9 LVIGLGAPSQSLSGTLSGSIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLS 64 (534)
Q Consensus 9 ~l~~L~l~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~P~~~~~l~~L~~L~Ls 64 (534)
+|+.+.|++ +++.+-..+|.++++|+.++|.+| ++..-..+|.++.+|+.+.+.
T Consensus 72 ~L~~i~lp~-~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~c~~L~~i~~p 125 (394)
T 4fs7_A 72 KVTEIKIPS-TVREIGEFAFENCSKLEIINIPDS-VKMIGRCTFSGCYALKSILLP 125 (394)
T ss_dssp TEEEEECCT-TCCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCCCCCC
T ss_pred CceEEEeCC-CccCcchhHhhCCCCCcEEEeCCC-ceEccchhhcccccchhhccc
Confidence 455555542 244222334555555555555433 332222334455555544444
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=94.88 E-value=0.055 Score=54.36 Aligned_cols=106 Identities=10% Similarity=0.105 Sum_probs=82.9
Q ss_pred CcEEEEEecCCCceeecccccccCCCCCEEEccCCccCcCCCCCCCCCCCCCEEEcCCCcCccccCchhhhcccCccccc
Q 039819 8 NLVIGLGAPSQSLSGTLSGSIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFLSIWLPRKWD 87 (534)
Q Consensus 8 ~~l~~L~l~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~P~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~l~~~~~ 87 (534)
..++.+.+..+ ++..-..+|.++.+|+.+.+..+ ++..-..+|.++.+|+.+.|.+|.++..-..+|..+.
T Consensus 240 ~~L~~i~lp~~-v~~I~~~aF~~~~~l~~i~l~~~-i~~i~~~aF~~c~~L~~i~l~~~~i~~I~~~aF~~c~------- 310 (379)
T 4h09_A 240 KALDEIAIPKN-VTSIGSFLLQNCTALKTLNFYAK-VKTVPYLLCSGCSNLTKVVMDNSAIETLEPRVFMDCV------- 310 (379)
T ss_dssp SSCCEEEECTT-CCEECTTTTTTCTTCCEEEECCC-CSEECTTTTTTCTTCCEEEECCTTCCEECTTTTTTCT-------
T ss_pred ccceEEEcCCC-ccEeCccccceeehhcccccccc-ceeccccccccccccccccccccccceehhhhhcCCC-------
Confidence 36888888765 77555678999999999999755 6634455799999999999999999855556777777
Q ss_pred ccccCCccccceeCCCCcCcccCChhhhcccccccccccCCCCC
Q 039819 88 KRKCSGVDQGLLRLNNNSLSGAFPVFLAKISELAFLDLSYNNLS 131 (534)
Q Consensus 88 ~~~~~~~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~ 131 (534)
+|+.+.|.++ ++..-..+|.+|.+|+.+.+..| ++
T Consensus 311 -------~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~ip~~-v~ 345 (379)
T 4h09_A 311 -------KLSSVTLPTA-LKTIQVYAFKNCKALSTISYPKS-IT 345 (379)
T ss_dssp -------TCCEEECCTT-CCEECTTTTTTCTTCCCCCCCTT-CC
T ss_pred -------CCCEEEcCcc-ccEEHHHHhhCCCCCCEEEECCc-cC
Confidence 7888999765 66344578999999999988654 44
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=89.43 E-value=1.3 Score=45.15 Aligned_cols=29 Identities=17% Similarity=0.299 Sum_probs=25.8
Q ss_pred CeEeccCCCCcEEeCCCCcEEEEeccccee
Q 039819 307 KIIHRDVKAANVLLDDFCEAIVGDFGLAKL 336 (534)
Q Consensus 307 ~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~ 336 (534)
.++|+|+.+.||+ +.++.+.|+||..+..
T Consensus 263 ~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~ 291 (424)
T 3mes_A 263 VFAHNDLQENNLL-QTQNNIRMIDYEYSAI 291 (424)
T ss_dssp EEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred eEECCCCCcccee-cCCCcEEEEecccCCc
Confidence 5899999999999 7888999999988763
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=87.10 E-value=2.2 Score=38.93 Aligned_cols=117 Identities=9% Similarity=0.060 Sum_probs=79.5
Q ss_pred cccCceeeEEEEEeCCCeeEEEeeccCCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEe
Q 039819 241 AVHRNLLRLIGYCATPTERLLVYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLL 320 (534)
Q Consensus 241 ~~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl 320 (534)
..||+++.. .+-.+.+...+.|+.-+.+.=...+ ..++...+++++.+|+....+++.. +|--|.|+||++
T Consensus 42 ~~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~i---k~~~~~eKlr~l~ni~~l~~~~~~r-----~tf~L~P~NL~f 112 (215)
T 4ann_A 42 QHSPYFIDA-ELTELRDSFQIHYDINDNHTPFDNI---KSFTKNEKLRYLLNIKNLEEVNRTR-----YTFVLAPDELFF 112 (215)
T ss_dssp SCCTTBCCE-EEEECSSEEEEEECCCTTSEEGGGG---GGSCHHHHHHHHHHGGGGGGGGGSS-----EECCCSGGGEEE
T ss_pred ccCCcccce-EEEEcccEEEEEEEcCcccCCHHHH---HhcCHHHHHHHHHHHHHHHHHhcCc-----eEEEEecceEEE
Confidence 348888866 4555666666666654433222223 2467889999999999988666643 788899999999
Q ss_pred CCCCcEEEEecccceecCCCCCceeeccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcC
Q 039819 321 DDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALE 389 (534)
Q Consensus 321 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~ 389 (534)
+.++.+++.-.|+... ++|. ..+...=.-.+=+++..+++++..|+
T Consensus 113 ~~~~~p~i~~RGik~~------------------l~P~-----~~~ee~fL~qyKAliiall~~K~~Fe 158 (215)
T 4ann_A 113 TRDGLPIAKTRGLQNV------------------VDPL-----PVSEAEFLTRYKALVICAFNEKQSFD 158 (215)
T ss_dssp CTTSCEEESCCEETTT------------------BSCC-----CCCHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred cCCCCEEEEEccCccC------------------CCCC-----CCCHHHHHHHHHHHHHHHHcCCCCHH
Confidence 9999999976665322 2222 11222234467888999999998885
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=81.01 E-value=2.7 Score=38.47 Aligned_cols=116 Identities=14% Similarity=0.078 Sum_probs=78.4
Q ss_pred cccCceeeEEEEEeCCCeeEEEeeccCCCChhhhcccCCCCCHHHHHHHHHHHHHHHH-HHHhcCCCCeEeccCCCCcEE
Q 039819 241 AVHRNLLRLIGYCATPTERLLVYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLL-YLHEQCDPKIIHRDVKAANVL 319 (534)
Q Consensus 241 ~~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~-yLH~~~~~~ivH~Dlkp~NiL 319 (534)
..||.+ -...-.+.+...+.|+.-+++.=...+ ..++...+++++.+|+.... +++. -+|--+.|+||+
T Consensus 47 ~~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i---~~~~~~eKlrll~nl~~L~~~~~~~-----r~tf~l~P~NL~ 116 (219)
T 4ano_A 47 EVDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAI---RKTTLLSRIRAAIHLVSKVKHHSAR-----RLIFIVCPENLM 116 (219)
T ss_dssp GSCSSS--EEEEEECSSEEEEEEECCTTCEEHHHH---HTSCHHHHHHHHHHHHHHHSSCCSS-----SEECCCCGGGEE
T ss_pred ccCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHH---HhcCHHHHHHHHHHHHHHHHHhhhC-----ceeEEEeCceEE
Confidence 347777 344446677777777765444323333 34788899999999988777 6664 478889999999
Q ss_pred eCCCCcEEEEecccceecCCCCCceeeccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcC
Q 039819 320 LDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALE 389 (534)
Q Consensus 320 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~ 389 (534)
++.++.++|.-.|+-. -++|.-+ +..-=.-.+=+++..++.++..|+
T Consensus 117 f~~~~~p~i~hRGi~~------------------~lpP~e~-----~ee~fl~qyKali~all~~K~~Fe 163 (219)
T 4ano_A 117 FNRALEPFFLHVGVKE------------------SLPPDEW-----DDERLLREVKATVLALTEGEYRFD 163 (219)
T ss_dssp ECTTCCEEESCCEETT------------------TBSSCSC-----CHHHHHHHHHHHHHHHTTCSSCHH
T ss_pred EeCCCcEEEEEcCCcc------------------cCCCCCC-----CHHHHHHHHHHHHHHHHcCCCCHH
Confidence 9999999997666532 2333321 222223367788899999988775
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 534 | ||||
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 2e-59 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 2e-57 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 2e-56 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 5e-56 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 3e-55 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 4e-54 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 7e-54 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 1e-53 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 9e-53 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 1e-52 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 1e-52 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 1e-52 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 1e-51 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 1e-51 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 2e-51 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 2e-51 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 3e-51 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 7e-51 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 5e-50 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 4e-49 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 2e-47 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 2e-47 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 3e-47 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 5e-47 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 9e-46 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 3e-45 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 8e-45 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 3e-44 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 4e-44 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 1e-42 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 2e-41 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 5e-41 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 4e-40 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 6e-39 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 4e-38 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 8e-38 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 1e-37 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 1e-37 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 2e-37 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 2e-36 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 2e-36 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 3e-36 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 6e-36 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 1e-35 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 2e-35 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 1e-34 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 2e-34 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 6e-34 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 2e-33 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 3e-32 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 2e-31 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 6e-31 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 2e-30 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 1e-29 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 5e-29 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 4e-28 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 6e-28 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 8e-28 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 1e-26 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 1e-22 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 1e-22 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 1e-20 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 1e-17 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 7e-11 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 1e-09 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 1e-08 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 8e-05 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 2e-10 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 2e-05 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 3e-10 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 1e-09 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 2e-09 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 0.003 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 1e-08 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 2e-07 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 1e-04 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 1e-04 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 2e-04 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 2e-06 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 3e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 3e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 8e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 9e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-04 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 3e-06 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 6e-06 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 1e-05 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 0.001 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 3e-05 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 7e-04 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 4e-05 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 4e-05 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 2e-04 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 2e-04 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 5e-04 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 8e-04 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 0.002 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 0.003 |
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (498), Expect = 2e-59
Identities = 74/273 (27%), Positives = 119/273 (43%), Gaps = 35/273 (12%)
Query: 202 ENFSSKNILGAGGFGNVYKGKLGDGTVLAVKRLK-------------DMISLAVHRNLLR 248
E LGAG FG V+ G T +AVK LK +++ H+ L+R
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVR 72
Query: 249 LIGYCATPTERLLVYPYMSNGSVASRLREKPA--LDWNTRKRIAIGAARGLLYLHEQCDP 306
L T ++ YM NGS+ L+ L N +A A G+ ++ E+
Sbjct: 73 LYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN-- 129
Query: 307 KIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGHIAPEYLSTGQSS 366
IHRD++AAN+L+ D + DFGLA+L++ ++ + + APE ++ G +
Sbjct: 130 -YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFT 188
Query: 367 EKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELGSNYD 426
K+DV+ FGILL E++T R G + + LE ++ +
Sbjct: 189 IKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCP------------ 236
Query: 427 RIEVGEILQVALLCTQYLPVHRPKMSEVVRMLE 459
E+ Q+ LC + P RP + +LE
Sbjct: 237 ----EELYQLMRLCWKERPEDRPTFDYLRSVLE 265
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (484), Expect = 2e-57
Identities = 70/279 (25%), Positives = 120/279 (43%), Gaps = 39/279 (13%)
Query: 202 ENFSSKNILGAGGFGNVYKGKLGDGTVLAVKRLK----------------DMISLAVHRN 245
+ +G+G FG VYKGK +AVK L ++ H N
Sbjct: 8 GQITVGQRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 65
Query: 246 LLRLIGYCATPTERLLVYPYMSNGSVASRLR-EKPALDWNTRKRIAIGAARGLLYLHEQC 304
+L +GY T + +V + S+ L + + IA A+G+ YLH +
Sbjct: 66 ILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS 124
Query: 305 DPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDH-SDSHVTTAVRGTVGHIAPEYLSTG 363
IIHRD+K+ N+ L + +GDFGLA + S SH + G++ +APE +
Sbjct: 125 ---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 181
Query: 364 QS---SEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRE 420
S ++DV+ FGI+L EL+TG +IN + ++ V + + +
Sbjct: 182 DKNPYSFQSDVYAFGIVLYELMTGQLPYS---NINNRDQIIFMVGRGYLSPDL-----SK 233
Query: 421 LGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLE 459
+ SN + + ++ C + RP +++ +E
Sbjct: 234 VRSNCPK----AMKRLMAECLKKKRDERPLFPQILASIE 268
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (476), Expect = 2e-56
Identities = 63/272 (23%), Positives = 115/272 (42%), Gaps = 33/272 (12%)
Query: 202 ENFSSKNILGAGGFGNVYKGKLGDGTVLAVKRLKD-------------MISLAVHRNLLR 248
+ +G+G FG V+ G + +A+K +++ ++ H L++
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQ 64
Query: 249 LIGYCATPTERLLVYPYMSNGSVASRLREKPAL-DWNTRKRIAIGAARGLLYLHEQCDPK 307
L G C LV+ +M +G ++ LR + L T + + G+ YL E C
Sbjct: 65 LYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC--- 121
Query: 308 IIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGHIAPEYLSTGQSSE 367
+IHRD+ A N L+ + V DFG+ + + +T + V +PE S + S
Sbjct: 122 VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSS 181
Query: 368 KTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELGSNYDR 427
K+DV+ FG+L+ E+ + + +S + E V+ I ++ R
Sbjct: 182 KSDVWSFGVLMWEVFSEGKIPYENRSNS------EVVEDISTGFRLY----------KPR 225
Query: 428 IEVGEILQVALLCTQYLPVHRPKMSEVVRMLE 459
+ + Q+ C + P RP S ++R L
Sbjct: 226 LASTHVYQIMNHCWKERPEDRPAFSRLLRQLA 257
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 187 bits (476), Expect = 5e-56
Identities = 70/301 (23%), Positives = 126/301 (41%), Gaps = 52/301 (17%)
Query: 192 FTFRELQQATENFSSK---------NILGAGGFGNVYKGKL----GDGTVLAVKRLK--- 235
FTF + +A F+ + ++GAG FG V G L +A+K LK
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66
Query: 236 ------------DMISLAVHRNLLRLIGYCATPTERLLVYPYMSNGSVASRLREK-PALD 282
++ H N++ L G T +++ +M NGS+ S LR+
Sbjct: 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFT 126
Query: 283 WNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDS 342
+ G A G+ YL + +HRD+ A N+L++ V DFGL++ L+ S
Sbjct: 127 VIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTS 183
Query: 343 HVTT----AVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKG 398
T + + APE + + + +DV+ +GI++ E+++ +G+
Sbjct: 184 DPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMS------YGERPYWDM 237
Query: 399 AMLEWVKKIQQEKKVEVLVDRELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRML 458
+ + I+Q+ ++ +D + Q+ L C Q HRPK ++V L
Sbjct: 238 TNQDVINAIEQDYRLPPPMD----------CPSALHQLMLDCWQKDRNHRPKFGQIVNTL 287
Query: 459 E 459
+
Sbjct: 288 D 288
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (471), Expect = 3e-55
Identities = 58/288 (20%), Positives = 105/288 (36%), Gaps = 37/288 (12%)
Query: 207 KNILGAGGFGNVYKGKLGDGTVLAVKRLKD-------------MISLAVHRNLLRLIGYC 253
+ +G G FG V++GK G +AVK + H N+L I
Sbjct: 8 QESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAAD 66
Query: 254 ----ATPTERLLVYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQC----- 304
T T+ LV Y +GS+ L + ++A+ A GL +LH +
Sbjct: 67 NKDNGTWTQLWLVSDYHEHGSLFDYLNRYT-VTVEGMIKLALSTASGLAHLHMEIVGTQG 125
Query: 305 DPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHV---TTAVRGTVGHIAPEYLS 361
P I HRD+K+ N+L+ + D GLA D + + GT ++APE L
Sbjct: 126 KPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLD 185
Query: 362 T------GQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAML---EWVKKIQQEKK 412
+S ++ D++ G++ E+ + L + + ++
Sbjct: 186 DSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVV 245
Query: 413 VEVLVDRELGSNYDRIEV-GEILQVALLCTQYLPVHRPKMSEVVRMLE 459
E + + + + E + ++ C R + + L
Sbjct: 246 CEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS 293
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (460), Expect = 4e-54
Identities = 55/272 (20%), Positives = 105/272 (38%), Gaps = 33/272 (12%)
Query: 202 ENFSSKNILGAGGFGNVYKGKLGDGTVLAVKRLKD-------------MISLAVHRNLLR 248
++ + LG G FG V GK +A+K +K+ ++ H L++
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQ 63
Query: 249 LIGYCATPTERLLVYPYMSNGSVASRLR-EKPALDWNTRKRIAIGAARGLLYLHEQCDPK 307
L G C ++ YM+NG + + LR + + + YL +
Sbjct: 64 LYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ--- 120
Query: 308 IIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGHIAPEYLSTGQSSE 367
+HRD+ A N L++D V DFGL++ + + + + V PE L + S
Sbjct: 121 FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSS 180
Query: 368 KTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELGSNYDR 427
K+D++ FG+L+ E+ + GK ++ E + I Q ++
Sbjct: 181 KSDIWAFGVLMWEIYS------LGKMPYERFTNSETAEHIAQGLRLY----------RPH 224
Query: 428 IEVGEILQVALLCTQYLPVHRPKMSEVVRMLE 459
+ ++ + C RP ++ +
Sbjct: 225 LASEKVYTIMYSCWHEKADERPTFKILLSNIL 256
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (461), Expect = 7e-54
Identities = 73/303 (24%), Positives = 126/303 (41%), Gaps = 44/303 (14%)
Query: 195 RELQQATENFSSKNI-LGAGGFGNVYKGKL---GDGTVLAVKRLK--------------- 235
++L +N +I LG G FG+V +G +A+K LK
Sbjct: 1 KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREA 60
Query: 236 DMISLAVHRNLLRLIGYCATPTERLLVYPYMSNGSVASRLREK-PALDWNTRKRIAIGAA 294
++ + ++RLIG C +LV G + L K + + + +
Sbjct: 61 QIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVS 119
Query: 295 RGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVT--TAVRGTV 352
G+ YL E+ +HRD+ A NVLL + A + DFGL+K L DS+ T +A + +
Sbjct: 120 MGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPL 176
Query: 353 GHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKK 412
APE ++ + S ++DV+ +G+ + E ++ +G+ +K E + I+Q K+
Sbjct: 177 KWYAPECINFRKFSSRSDVWSYGVTMWEALS------YGQKPYKKMKGPEVMAFIEQGKR 230
Query: 413 VEVLVDRELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLEG--DGLAEKWAAA 470
+ E E+ + C Y RP V + + LA K
Sbjct: 231 M------ECPPECPP----ELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVEGH 280
Query: 471 HNH 473
H+H
Sbjct: 281 HHH 283
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (459), Expect = 1e-53
Identities = 66/273 (24%), Positives = 110/273 (40%), Gaps = 35/273 (12%)
Query: 202 ENFSSKNILGAGGFGNVYKGKLGDGTVLAVKRLK-------------DMISLAVHRNLLR 248
E+ + LG G FG V+ G T +A+K LK ++ H L++
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQ 76
Query: 249 LIGYCATPTERLLVYPYMSNGSVAS--RLREKPALDWNTRKRIAIGAARGLLYLHEQCDP 306
L + +V YMS GS+ + L +A A G+ Y+
Sbjct: 77 LYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN-- 133
Query: 307 KIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGHIAPEYLSTGQSS 366
+HRD++AAN+L+ + V DFGLA+L++ ++ + + APE G+ +
Sbjct: 134 -YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFT 192
Query: 367 EKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELGSNYD 426
K+DV+ FGILL EL T R G + +L+ V++ + +
Sbjct: 193 IKSDVWSFGILLTELTTKGRVPYPGMVNRE---VLDQVERGYRMPCPPECPE-------- 241
Query: 427 RIEVGEILQVALLCTQYLPVHRPKMSEVVRMLE 459
+ + C + P RP + LE
Sbjct: 242 -----SLHDLMCQCWRKEPEERPTFEYLQAFLE 269
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (451), Expect = 9e-53
Identities = 65/273 (23%), Positives = 109/273 (39%), Gaps = 39/273 (14%)
Query: 202 ENFSSKNILGAGGFGNVYKGKLGDGTVLAVKRLKD------------MISLAVHRNLLRL 249
+ +G G FG+V G G +AVK +K+ +++ H NL++L
Sbjct: 7 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQL 65
Query: 250 IGYCATPTERL-LVYPYMSNGSVASRLREK--PALDWNTRKRIAIGAARGLLYLHEQCDP 306
+G L +V YM+ GS+ LR + L + + ++ + YL
Sbjct: 66 LGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN--- 122
Query: 307 KIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGHIAPEYLSTGQSS 366
+HRD+ A NVL+ + A V DFGL K + + V APE L + S
Sbjct: 123 NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST----QDTGKLPVKWTAPEALREKKFS 178
Query: 367 EKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELGSNYD 426
K+DV+ FGILL E+ + R + + V ++++ K+ +
Sbjct: 179 TKSDVWSFGILLWEIYSFGRVPYPRIPLK------DVVPRVEKGYKM------DAPDGCP 226
Query: 427 RIEVGEILQVALLCTQYLPVHRPKMSEVVRMLE 459
+ +V C RP ++ LE
Sbjct: 227 P----AVYEVMKNCWHLDAAMRPSFLQLREQLE 255
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (454), Expect = 1e-52
Identities = 71/281 (25%), Positives = 112/281 (39%), Gaps = 45/281 (16%)
Query: 203 NFSSKNILGAGGFGNVYKGKL----GDGTVLAVKRLK---------------DMISLAVH 243
+F ++G G FG VY G L G AVK L ++ H
Sbjct: 30 HF--NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 87
Query: 244 RNLLRLIGYCA-TPTERLLVYPYMSNGSVAS-RLREKPALDWNTRKRIAIGAARGLLYLH 301
N+L L+G C + L+V PYM +G + + E + A+G+
Sbjct: 88 PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGM---K 144
Query: 302 EQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDS---HVTTAVRGTVGHIAPE 358
K +HRD+ A N +LD+ V DFGLA+ + + H T + V +A E
Sbjct: 145 FLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALE 204
Query: 359 YLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVD 418
L T + + K+DV+ FG+LL EL+T + + + Q ++ L+
Sbjct: 205 SLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT------FDITVYLLQGRR---LLQ 255
Query: 419 RELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLE 459
E + + +V L C RP SE+V +
Sbjct: 256 PEYCPD-------PLYEVMLKCWHPKAEMRPSFSELVSRIS 289
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 178 bits (453), Expect = 1e-52
Identities = 64/315 (20%), Positives = 120/315 (38%), Gaps = 65/315 (20%)
Query: 191 NFTFRELQQATENFSSKNILGAGGFGNVYKGKL------GDGTVLAVKRLK--------- 235
N L+ N +G G FG V++ + T++AVK LK
Sbjct: 2 NPKLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQA 61
Query: 236 ------DMISLAVHRNLLRLIGYCATPTERLLVYPYMSNGSVASRLRE------------ 277
+++ + N+++L+G CA L++ YM+ G + LR
Sbjct: 62 DFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHS 121
Query: 278 ------------KPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCE 325
P L + IA A G+ YL E+ K +HRD+ N L+ +
Sbjct: 122 DLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMV 178
Query: 326 AIVGDFGLAKLLDHSD-SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITG 384
+ DFGL++ + +D + + PE + + + ++DV+ +G++L E+ +
Sbjct: 179 VKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSY 238
Query: 385 MRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELGSNYDRIEVGEILQVALLCTQYL 444
+G + + ++ +V+ E E+ + LC L
Sbjct: 239 GLQPYYGMAHEE---VIYYVRDGNILACPENCPL-------------ELYNLMRLCWSKL 282
Query: 445 PVHRPKMSEVVRMLE 459
P RP + R+L+
Sbjct: 283 PADRPSFCSIHRILQ 297
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (455), Expect = 1e-52
Identities = 59/302 (19%), Positives = 113/302 (37%), Gaps = 47/302 (15%)
Query: 197 LQQATENFSSKNILGAGGFGNVYKGK-LGDGTVLAVKRLK---------------DMISL 240
++ ++F + LGAG G V+K G V+A K + ++
Sbjct: 1 MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 241 AVHRNLLRLIGYCATPTERLLVYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYL 300
++ G + E + +M GS+ L++ + +++I +GL YL
Sbjct: 61 CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYL 120
Query: 301 HEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGHIAPEYL 360
E+ KI+HRDVK +N+L++ E + DFG++ L S + + GT +++PE L
Sbjct: 121 REKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---MANSFVGTRSYMSPERL 175
Query: 361 STGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRE 420
S ++D++ G+ L+E+ G + + + V+ E
Sbjct: 176 QGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGR 235
Query: 421 LGSNYDRIEVGEILQVALL--------------------------CTQYLPVHRPKMSEV 454
S+Y + LL C P R + ++
Sbjct: 236 PLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQL 295
Query: 455 VR 456
+
Sbjct: 296 MV 297
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (447), Expect = 1e-51
Identities = 66/301 (21%), Positives = 110/301 (36%), Gaps = 59/301 (19%)
Query: 202 ENFSSKNILGAGGFGNVYKGKL------GDGTVLAVKRLKD----------------MIS 239
S LGAG FG V + +AVK LK +
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 240 LAVHRNLLRLIGYCATPTERLLVYPYMSNGSVASRLREK------------------PAL 281
L H N++ L+G C L++ Y G + + LR K AL
Sbjct: 83 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 282 DWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSD 341
D + A+G+ +L + IHRD+ A N+LL + DFGLA+ + +
Sbjct: 143 DLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 199
Query: 342 SH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAM 400
++ V R V +APE + + ++DV+ +GI L EL + + G ++
Sbjct: 200 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS---- 255
Query: 401 LEWVKKIQQEKKVEVLVDRELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLEG 460
K ++ E+ + C P+ RP ++V+++E
Sbjct: 256 -----------KFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEK 304
Query: 461 D 461
Sbjct: 305 Q 305
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (448), Expect = 1e-51
Identities = 72/304 (23%), Positives = 111/304 (36%), Gaps = 64/304 (21%)
Query: 202 ENFSSKNILGAGGFGNVYKG------KLGDGTVLAVKRLKD----------------MIS 239
EN +LG+G FG V K G +AVK LK+ M
Sbjct: 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 96
Query: 240 LAVHRNLLRLIGYCATPTERLLVYPYMSNGSVASRLREK--------------------- 278
L H N++ L+G C L++ Y G + + LR K
Sbjct: 97 LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 156
Query: 279 --PALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKL 336
L + A A+G+ +L + +HRD+ A NVL+ + DFGLA+
Sbjct: 157 DLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDFGLARD 213
Query: 337 LDHSDSHVT-TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSIN 395
+ ++V R V +APE L G + K+DV+ +GILL E+ + G ++
Sbjct: 214 IMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD 273
Query: 396 QKGAMLEWVKKIQQEKKVEVLVDRELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVV 455
+ K IQ K++ EI + C + RP +
Sbjct: 274 A-----NFYKLIQNGFKMD----------QPFYATEEIYIIMQSCWAFDSRKRPSFPNLT 318
Query: 456 RMLE 459
L
Sbjct: 319 SFLG 322
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (444), Expect = 2e-51
Identities = 71/282 (25%), Positives = 126/282 (44%), Gaps = 42/282 (14%)
Query: 202 ENFSSKNILGAGGFGNVYKGKLGDGT-----VLAVKRLK---------------DMISLA 241
+ + ++GAG FG VYKG L + +A+K LK ++
Sbjct: 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 66
Query: 242 VHRNLLRLIGYCATPTERLLVYPYMSNGSVASRLREK-PALDWNTRKRIAIGAARGLLYL 300
H N++RL G + +++ YM NG++ LREK + G A G+ YL
Sbjct: 67 SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYL 126
Query: 301 HEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLL--DHSDSHVTTAVRGTVGHIAPE 358
+HRD+ A N+L++ V DFGL+++L D ++ T+ + + APE
Sbjct: 127 AN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPE 183
Query: 359 YLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVD 418
+S + + +DV+ FGI++ E++T G+ + + E +K I ++ +D
Sbjct: 184 AISYRKFTSASDVWSFGIVMWEVMTY------GERPYWELSNHEVMKAINDGFRLPTPMD 237
Query: 419 RELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLEG 460
I Q+ + C Q RPK +++V +L+
Sbjct: 238 ----------CPSAIYQLMMQCWQQERARRPKFADIVSILDK 269
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (445), Expect = 2e-51
Identities = 64/293 (21%), Positives = 116/293 (39%), Gaps = 56/293 (19%)
Query: 202 ENFSSKNILGAGGFGNVYKGKL---GDGTVLAVKRLKD----------------MISLAV 242
+ ++++G G FG V K ++ G A+KR+K+ + L
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69
Query: 243 HRNLLRLIGYCATPTERLLVYPYMSNGSVASRLREKP----------------ALDWNTR 286
H N++ L+G C L Y +G++ LR+ L
Sbjct: 70 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129
Query: 287 KRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTT 346
A ARG+ YL + + IHRD+ A N+L+ + A + DFGL++ T
Sbjct: 130 LHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSR--GQEVYVKKT 184
Query: 347 AVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKK 406
R V +A E L+ + +DV+ +G+LL E+++ G + E +K
Sbjct: 185 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA------ELYEK 238
Query: 407 IQQEKKVEVLVDRELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLE 459
+ Q ++E ++ E+ + C + P RP ++++ L
Sbjct: 239 LPQGYRLEKPLN----------CDDEVYDLMRQCWREKPYERPSFAQILVSLN 281
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 174 bits (443), Expect = 3e-51
Identities = 63/274 (22%), Positives = 115/274 (41%), Gaps = 35/274 (12%)
Query: 202 ENFSSKNILGAGGFGNVYKGKL-GDGTVLAVKRLK-------------DMISLAVHRNLL 247
+ + K+ LG G +G VY+G +AVK LK ++ H NL+
Sbjct: 17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLV 76
Query: 248 RLIGYCATPTERLLVYPYMSNGSVASRL--REKPALDWNTRKRIAIGAARGLLYLHEQCD 305
+L+G C ++ +M+ G++ L + + +A + + YL +
Sbjct: 77 QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK--- 133
Query: 306 PKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGHIAPEYLSTGQS 365
IHRD+ A N L+ + V DFGL++L+ + + APE L+ +
Sbjct: 134 KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKF 193
Query: 366 SEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELGSNY 425
S K+DV+ FG+LL E+ T + G ++Q V L++++
Sbjct: 194 SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ----------------VYELLEKDYRMER 237
Query: 426 DRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLE 459
++ ++ C Q+ P RP +E+ + E
Sbjct: 238 PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFE 271
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (440), Expect = 7e-51
Identities = 65/273 (23%), Positives = 110/273 (40%), Gaps = 41/273 (15%)
Query: 208 NILGAGGFGNVYKGKL---GDGTVLAVKRLK----------------DMISLAVHRNLLR 248
LG+G FG V KG +AVK LK +++ + ++R
Sbjct: 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 72
Query: 249 LIGYCATPTERLLVYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKI 308
+IG C + +LV G + L++ + + + G+ YL E
Sbjct: 73 MIGICEAES-WMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEES---NF 128
Query: 309 IHRDVKAANVLLDDFCEAIVGDFGLAKLL--DHSDSHVTTAVRGTVGHIAPEYLSTGQSS 366
+HRD+ A NVLL A + DFGL+K L D + T + V APE ++ + S
Sbjct: 129 VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFS 188
Query: 367 EKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELGSNYD 426
K+DV+ FG+L+ E + + G + E +++ +++ +
Sbjct: 189 SKSDVWSFGVLMWEAFSYGQKPYRGMKGS------EVTAMLEKGERM------GCPAGCP 236
Query: 427 RIEVGEILQVALLCTQYLPVHRPKMSEVVRMLE 459
R E+ + LC Y +RP + V L
Sbjct: 237 R----EMYDLMNLCWTYDVENRPGFAAVELRLR 265
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (433), Expect = 5e-50
Identities = 70/280 (25%), Positives = 113/280 (40%), Gaps = 43/280 (15%)
Query: 202 ENFSSKNILGAGGFGNVYKGK-LGDGTVLAVKRLK----------------DMISLAVHR 244
E++ +G G +G K + DG +L K L +++ H
Sbjct: 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 63
Query: 245 NLLRLIGYCATPTERLL--VYPYMSNGSVASRL----REKPALDWNTRKRIAIGAARGLL 298
N++R T L V Y G +AS + +E+ LD R+ L
Sbjct: 64 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 123
Query: 299 YLHEQ--CDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGHIA 356
H + ++HRD+K ANV LD +GDFGLA++L+H D+ A GT +++
Sbjct: 124 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNH-DTSFAKAFVGTPYYMS 182
Query: 357 PEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVL 416
PE ++ +EK+D++ G LL EL M S E KI++ K
Sbjct: 183 PEQMNRMSYNEKSDIWSLGCLLYELCALMPPFT-AFSQK------ELAGKIREGK----- 230
Query: 417 VDRELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVR 456
R + Y E+ ++ HRP + E++
Sbjct: 231 -FRRIPYRYSD----ELNEIITRMLNLKDYHRPSVEEILE 265
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (427), Expect = 4e-49
Identities = 58/272 (21%), Positives = 111/272 (40%), Gaps = 42/272 (15%)
Query: 207 KNILGAGGFGNVYKGKL-GDGTVLAVKRLKD----------------MISLAVHRNLLRL 249
+G G F VYKG +A L+D M+ H N++R
Sbjct: 14 DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 73
Query: 250 IGYCATPTER----LLVYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCD 305
+ + +LV M++G++ + L+ + + +GL +LH +
Sbjct: 74 YDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRT- 132
Query: 306 PKIIHRDVKAANVLLDDFCEAI-VGDFGLAKLLDHSDSHVTTAVRGTVGHIAPEYLSTGQ 364
P IIHRD+K N+ + ++ +GD GLA L + AV GT +APE +
Sbjct: 133 PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK---RASFAKAVIGTPEFMAPEMYE-EK 188
Query: 365 SSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELGSN 424
E DV+ FG+ +LE+ T + + N + +++ K ++
Sbjct: 189 YDESVDVYAFGMCMLEMATSEYP--YSECQNAA----QIYRRVTSGVKP---------AS 233
Query: 425 YDRIEVGEILQVALLCTQYLPVHRPKMSEVVR 456
+D++ + E+ ++ C + R + +++
Sbjct: 234 FDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (415), Expect = 2e-47
Identities = 55/273 (20%), Positives = 102/273 (37%), Gaps = 36/273 (13%)
Query: 202 ENFSSKNILGAGGFGNVYKGK-LGDGTVLAVKRLK---------------DMISLAVHRN 245
E++ LG G +G V +AVK + + + H N
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64
Query: 246 LLRLIGYCATPTERLLVYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCD 305
+++ G+ + L Y S G + R+ + +R G++YLH
Sbjct: 65 VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG- 123
Query: 306 PKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLD-HSDSHVTTAVRGTVGHIAPEYLSTGQ 364
I HRD+K N+LLD+ + DFGLA + ++ + + GT+ ++APE L +
Sbjct: 124 --ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 181
Query: 365 -SSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELGS 423
+E DV+ GI+L ++ G + Q+ +W +K + +
Sbjct: 182 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE--YSDWKEKKTYLNPWKKIDS----- 234
Query: 424 NYDRIEVGEILQVALLCTQYLPVHRPKMSEVVR 456
L + P R + ++ +
Sbjct: 235 --------APLALLHKILVENPSARITIPDIKK 259
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (415), Expect = 2e-47
Identities = 58/278 (20%), Positives = 117/278 (42%), Gaps = 40/278 (14%)
Query: 202 ENFSSKNILGAGGFGNVYKGKL----GDGTVLAVKRLKDMISLAV--------------- 242
E +G G FG+V++G +A+K K+ S +V
Sbjct: 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 66
Query: 243 HRNLLRLIGYCATPTERLLVYPYMSNGSVASRLREKP-ALDWNTRKRIAIGAARGLLYLH 301
H ++++LIG T ++ + G + S L+ + +LD + A + L YL
Sbjct: 67 HPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE 125
Query: 302 EQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGHIAPEYLS 361
+ + +HRD+ A NVL+ +GDFGL++ ++ S + + + + +APE ++
Sbjct: 126 SK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESIN 182
Query: 362 TGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDREL 421
+ + +DV+ FG+ + E++ G N + + +I+ +++ +
Sbjct: 183 FRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN------DVIGRIENGERL------PM 230
Query: 422 GSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLE 459
N + + C Y P RP+ +E+ L
Sbjct: 231 PPNCPP----TLYSLMTKCWAYDPSRRPRFTELKAQLS 264
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (413), Expect = 3e-47
Identities = 72/282 (25%), Positives = 112/282 (39%), Gaps = 43/282 (15%)
Query: 202 ENFSSKNILGAGGFGNVYKGKL----GDGTVLAVKRLK-----------------DMISL 240
++ LG G FG V +G+ G +AVK LK + +
Sbjct: 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67
Query: 241 AVHRNLLRLIGYCATPTERLLVYPYMSNGSVASR-LREKPALDWNTRKRIAIGAARGLLY 299
HRNL+RL G TP + +V GS+ R + + T R A+ A G+ Y
Sbjct: 68 LDHRNLIRLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGY 126
Query: 300 LHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSH--VTTAVRGTVGHIAP 357
L + IHRD+ A N+LL +GDFGL + L +D H + + AP
Sbjct: 127 LESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAP 183
Query: 358 EYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLV 417
E L T S +D + FG+ L E+ T + G + + + + KI +E +
Sbjct: 184 ESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS------QILHKIDKEGE----- 232
Query: 418 DRELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLE 459
+ + +I V + C + P RP + L
Sbjct: 233 RLPRPEDCPQ----DIYNVMVQCWAHKPEDRPTFVALRDFLL 270
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (412), Expect = 5e-47
Identities = 69/273 (25%), Positives = 106/273 (38%), Gaps = 42/273 (15%)
Query: 202 ENFSSKNILGAGGFGNVYKGKL-GDGTVLAVKRLK-----------------DMISLAVH 243
E+F LG G FGNVY + +LA+K L ++ S H
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 244 RNLLRLIGYCATPTERLLVYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQ 303
N+LRL GY T L+ Y G+V L++ D A L Y H +
Sbjct: 66 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK 125
Query: 304 CDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGHIAPEYLSTG 363
++IHRD+K N+LL E + DFG + H+ S T + GT+ ++ PE +
Sbjct: 126 ---RVIHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRTTLCGTLDYLPPEMIEGR 179
Query: 364 QSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELGS 423
EK D++ G+L E + G E + E K+I + V+
Sbjct: 180 MHDEKVDLWSLGVLCYEFLVGKPPFE-ANT------YQETYKRISR-------VEFTFPD 225
Query: 424 NYDRIEVGEILQVALLCTQYLPVHRPKMSEVVR 456
+ ++ P RP + EV+
Sbjct: 226 FVTE----GARDLISRLLKHNPSQRPMLREVLE 254
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 160 bits (407), Expect = 9e-46
Identities = 65/277 (23%), Positives = 102/277 (36%), Gaps = 45/277 (16%)
Query: 201 TENFSSKNILGAGGFGNVYKGK-LGDGTVLAVKRLK-----------------DMISLAV 242
+ FS +G G FG VY + + + V+A+K++ +
Sbjct: 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73
Query: 243 HRNLLRLIGYCATPTERLLVYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHE 302
H N ++ G LV Y + K L + GA +GL YLH
Sbjct: 74 HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHS 133
Query: 303 QCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGHIAPEYLST 362
+IHRDVKA N+LL + +GDFG A ++ ++S V GT +APE +
Sbjct: 134 H---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFV-----GTPYWMAPEVILA 185
Query: 363 ---GQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDR 419
GQ K DV+ GI +EL L ++ + I Q +
Sbjct: 186 MDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-------SALYHIAQNES-----PA 233
Query: 420 ELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVR 456
++ C Q +P RP +++
Sbjct: 234 LQSGHWSE----YFRNFVDSCLQKIPQDRPTSEVLLK 266
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (403), Expect = 3e-45
Identities = 67/338 (19%), Positives = 128/338 (37%), Gaps = 53/338 (15%)
Query: 202 ENFSSKNILGAGGFGNVYKGK-LGDGTVL----AVKRLKD---------------MISLA 241
F +LG+G FG VYKG + +G + A+K L++ +++
Sbjct: 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 68
Query: 242 VHRNLLRLIGYCATPTERLLVYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLH 301
+ ++ RL+G C T T +L+ + K + + A+G+ YL
Sbjct: 69 DNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 128
Query: 302 EQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDS-HVTTAVRGTVGHIAPEYL 360
++ +++HRD+ A NVL+ + DFGLAKLL + + + + +A E +
Sbjct: 129 DR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 185
Query: 361 STGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRE 420
+ ++DV+ +G+ + EL+T FG E +++ +++
Sbjct: 186 LHRIYTHQSDVWSYGVTVWELMT------FGSKPYDGIPASEISSILEKGERLP------ 233
Query: 421 LGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLEGDGLAEKWAAAHNHTNPTMNN 480
I ++ + + C RPK E++ K A +
Sbjct: 234 ----QPPICTIDVYMIMVKCWMIDADSRPKFRELIIEF------SKMARDPQRYLVIQGD 283
Query: 481 FHTNTKKSTSCPTSAPKHDHEEKNDQSSMFGTAVDEDD 518
+ T D E+ +D VD D+
Sbjct: 284 ERMHLPSPTDSNFYRALMDEEDMDD-------VVDADE 314
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (399), Expect = 8e-45
Identities = 63/292 (21%), Positives = 115/292 (39%), Gaps = 51/292 (17%)
Query: 202 ENFSSKNILGAGGFGNVYKGKL------GDGTVLAVKRLK---------------DMISL 240
E + LG G FG VY+G T +A+K + ++
Sbjct: 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79
Query: 241 AVHRNLLRLIGYCATPTERLLVYPYMSNGSVASRLR----------EKPALDWNTRKRIA 290
+++RL+G + L++ M+ G + S LR + ++A
Sbjct: 80 FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 139
Query: 291 IGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDS-HVTTAVR 349
A G+ YL+ K +HRD+ A N ++ + +GDFG+ + + +D
Sbjct: 140 GEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGL 196
Query: 350 GTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQ 409
V ++PE L G + +DV+ FG++L E+ T G S Q +L +V +
Sbjct: 197 LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ---VLRFVMEGGL 253
Query: 410 EKKVEVLVDRELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLEGD 461
K + D + ++ +C QY P RP E++ ++ +
Sbjct: 254 LDKPDNCPD-------------MLFELMRMCWQYNPKMRPSFLEIISSIKEE 292
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (394), Expect = 3e-44
Identities = 70/299 (23%), Positives = 114/299 (38%), Gaps = 60/299 (20%)
Query: 202 ENFSSKNILGAGGFGNVYKGKL--------GDGTVLAVKRLKD----------------M 237
+ LG G FG V + T +AVK LK M
Sbjct: 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72
Query: 238 ISLAVHRNLLRLIGYCATPTERLLVYPYMSNGSVASRLR----------------EKPAL 281
+ H+N++ L+G C ++ Y S G++ L+ + L
Sbjct: 73 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132
Query: 282 DWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSD 341
A ARG+ YL K IHRD+ A NVL+ + + DFGLA+ + H D
Sbjct: 133 SSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 189
Query: 342 SHVTTAV-RGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAM 400
+ T R V +APE L + ++DV+ FG+LL E+ T + G + + +
Sbjct: 190 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE---L 246
Query: 401 LEWVKKIQQEKKVEVLVDRELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLE 459
+ +K+ + K + E+ + C +P RP ++V L+
Sbjct: 247 FKLLKEGHRMDKPSNCTN-------------ELYMMMRDCWHAVPSQRPTFKQLVEDLD 292
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (394), Expect = 4e-44
Identities = 68/298 (22%), Positives = 119/298 (39%), Gaps = 58/298 (19%)
Query: 202 ENFSSKNILGAGGFGNVYKG------KLGDGTVLAVKRLKD----------------MIS 239
+ LG G FG V + K +AVK LK+ +I
Sbjct: 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72
Query: 240 LAVHRNLLRLIGYCATPTERL-LVYPYMSNGSVASRLREK----------------PALD 282
+ H N++ L+G C P L ++ + G++++ LR K L
Sbjct: 73 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132
Query: 283 WNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDS 342
+ A+G+ +L + K IHRD+ A N+LL + + DFGLA+ +
Sbjct: 133 LEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 189
Query: 343 HV-TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAML 401
+V R + +APE + + ++DV+ FG+LL E+ + + G I++
Sbjct: 190 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE----- 244
Query: 402 EWVKKIQQEKKVEVLVDRELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLE 459
E+ +++++ ++ E+ Q L C P RP SE+V L
Sbjct: 245 EFCRRLKEGTRMR----------APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLG 292
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (383), Expect = 1e-42
Identities = 54/277 (19%), Positives = 104/277 (37%), Gaps = 40/277 (14%)
Query: 201 TENFSSKNILGAGGFGNVYKGK-LGDGTVLAVKRLK--------------DMISLAVHRN 245
+ + LG G FG VYK + + A K + D+++ H N
Sbjct: 11 EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPN 70
Query: 246 LLRLIGYCATPTERLLVYPYMSNGSVASRLREKP-ALDWNTRKRIAIGAARGLLYLHEQC 304
+++L+ ++ + + G+V + + E L + + + L YLH+
Sbjct: 71 IVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDN- 129
Query: 305 DPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGHIAPEYLSTGQ 364
KIIHRD+KA N+L + + DFG++ + + + GT +APE +
Sbjct: 130 --KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI-GTPYWMAPEVVMCET 186
Query: 365 S-----SEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDR 419
S K DV+ GI L+E+ + + + + + KI + + +
Sbjct: 187 SKDRPYDYKADVWSLGITLIEMAE-------IEPPHHELNPMRVLLKIAKSEPPTLAQPS 239
Query: 420 ELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVR 456
S C + R S++++
Sbjct: 240 RWSS--------NFKDFLKKCLEKNVDARWTTSQLLQ 268
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (375), Expect = 2e-41
Identities = 51/271 (18%), Positives = 100/271 (36%), Gaps = 35/271 (12%)
Query: 201 TENFSSKNILGAGGFGNVYKGK-LGDGTVLAVKRLK--------------DMISLAVHRN 245
+ ++ +G G G VY + G +A++++ ++ + N
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78
Query: 246 LLRLIGYCATPTERLLVYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCD 305
++ + E +V Y++ GS+ + E D + + L +LH
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCM-DEGQIAAVCRECLQALEFLHSN-- 135
Query: 306 PKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGHIAPEYLSTGQS 365
++IHRD+K+ N+LL + DFG + S +T V GT +APE ++
Sbjct: 136 -QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAY 193
Query: 366 SEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELGSNY 425
K D++ GI+ +E+I G ++ L + I E+ +L +
Sbjct: 194 GPKVDIWSLGIMAIEMIEG-EPPYLNENP------LRALYLIATNGTPELQNPEKLSA-- 244
Query: 426 DRIEVGEILQVALLCTQYLPVHRPKMSEVVR 456
C R E+++
Sbjct: 245 ------IFRDFLNRCLDMDVEKRGSAKELLQ 269
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (372), Expect = 5e-41
Identities = 50/206 (24%), Positives = 87/206 (42%), Gaps = 22/206 (10%)
Query: 198 QQATENFSSKNILGAGGFGNVYKGK-LGDGTVLAVKRLK-----------------DMIS 239
++ E+F ILG G F V + L A+K L+ D++S
Sbjct: 4 KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMS 63
Query: 240 LAVHRNLLRLIGYCATPTERLLVYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLY 299
H ++L + Y NG + +R+ + D + L Y
Sbjct: 64 RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEY 123
Query: 300 LHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDH-SDSHVTTAVRGTVGHIAPE 358
LH + IIHRD+K N+LL++ + DFG AK+L S + GT +++PE
Sbjct: 124 LHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPE 180
Query: 359 YLSTGQSSEKTDVFGFGILLLELITG 384
L+ + + +D++ G ++ +L+ G
Sbjct: 181 LLTEKSACKSSDLWALGCIIYQLVAG 206
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 144 bits (364), Expect = 4e-40
Identities = 57/284 (20%), Positives = 98/284 (34%), Gaps = 50/284 (17%)
Query: 202 ENFSSKNILGAGGFGNVYKGK-LGDGTVLAVKRLKD------------------------ 236
EN+ K ILG G V + AVK +
Sbjct: 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62
Query: 237 MISLAVHRNLLRLIGYCATPTERLLVYPYMSNGSVASRLREKPALDWNTRKRIAIGAARG 296
+ ++ H N+++L T T LV+ M G + L EK L ++I
Sbjct: 63 LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEV 122
Query: 297 LLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGHIA 356
+ LH+ I+HRD+K N+LLDD + DFG + LD + V GT ++A
Sbjct: 123 ICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK--LREVCGTPSYLA 177
Query: 357 PEYLSTGQS------SEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQE 410
PE + + ++ D++ G+++ L+ G + + + ++ I
Sbjct: 178 PEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG-SPPFWHRKQ------MLMLRMIMSG 230
Query: 411 KKVEVLVDRELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEV 454
+Y + + P R E
Sbjct: 231 N---YQFGSPEWDDYSD----TVKDLVSRFLVVQPQKRYTAEEA 267
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 143 bits (361), Expect = 6e-39
Identities = 53/271 (19%), Positives = 96/271 (35%), Gaps = 37/271 (13%)
Query: 202 ENFSSKNILGAGGFGNVYKGK-LGDGTVLAVKRLK--------------DMISLAVHRNL 246
+++ LG G FG V++ G A K + +S+ H L
Sbjct: 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 85
Query: 247 LRLIGYCATPTERLLVYPYMSNGSVASRL-REKPALDWNTRKRIAIGAARGLLYLHEQCD 305
+ L E +++Y +MS G + ++ E + + +GL ++HE
Sbjct: 86 VNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN- 144
Query: 306 PKIIHRDVKAANVLL--DDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGHIAPEYLSTG 363
+H D+K N++ E + DFGL LD S T GT APE
Sbjct: 145 --YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVT--TGTAEFAAPEVAEGK 200
Query: 364 QSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELGS 423
TD++ G+L L++G+ G++ ++ ++ K + +D S
Sbjct: 201 PVGYYTDMWSVGVLSYILLSGLSPFG-GENDDE---------TLRNVKSCDWNMDDSAFS 250
Query: 424 NYDRIEVGEILQVALLCTQYLPVHRPKMSEV 454
+ P R + +
Sbjct: 251 GISE----DGKDFIRKLLLADPNTRMTIHQA 277
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 141 bits (357), Expect = 4e-38
Identities = 51/205 (24%), Positives = 84/205 (40%), Gaps = 28/205 (13%)
Query: 202 ENFSSKNILGAGGFGNVYKGK-LGDGTVLAVKRLK--------------------DMISL 240
+FS I+G GGFG VY + G + A+K L ++S
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 241 AVHRNLLRLIGYCATPTERLLVYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYL 300
++ + TP + + M+ G + L + + A GL ++
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHM 123
Query: 301 HEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGHIAPEYL 360
H + +++RD+K AN+LLD+ + D GLA H + GT G++APE L
Sbjct: 124 HNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS---VGTHGYMAPEVL 177
Query: 361 STGQS-SEKTDVFGFGILLLELITG 384
G + D F G +L +L+ G
Sbjct: 178 QKGVAYDSSADWFSLGCMLFKLLRG 202
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (351), Expect = 8e-38
Identities = 52/202 (25%), Positives = 81/202 (40%), Gaps = 23/202 (11%)
Query: 202 ENFSSKNILGAGGFGNVYKGK-LGDGTVLAVKRLKD------------------MISLAV 242
E+F +LG G FG V+ + A+K LK +
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 243 HRNLLRLIGYCATPTERLLVYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHE 302
H L + T V Y++ G + ++ D + A GL +LH
Sbjct: 62 HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHS 121
Query: 303 QCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGHIAPEYLST 362
+ I++RD+K N+LLD + DFG+ K D+ T GT +IAPE L
Sbjct: 122 K---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFC-GTPDYIAPEILLG 177
Query: 363 GQSSEKTDVFGFGILLLELITG 384
+ + D + FG+LL E++ G
Sbjct: 178 QKYNHSVDWWSFGVLLYEMLIG 199
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 139 bits (350), Expect = 1e-37
Identities = 47/279 (16%), Positives = 100/279 (35%), Gaps = 32/279 (11%)
Query: 194 FRELQQATENFSSKNILGAGGFGNVYKGK-LGDGTVLAVKRLK---------------DM 237
+++ + + + +++LG G F V + ++A+K + +
Sbjct: 1 WKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAV 60
Query: 238 ISLAVHRNLLRLIGYCATPTERLLVYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGL 297
+ H N++ L + L+ +S G + R+ EK R+ +
Sbjct: 61 LHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAV 120
Query: 298 LYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGHIAP 357
YLH+ + LD+ + ++ DFGL+K+ D V + GT G++AP
Sbjct: 121 KYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMED--PGSVLSTACGTPGYVAP 178
Query: 358 EYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLV 417
E L+ S+ D + G++ L+ G + ++ + ++I K E
Sbjct: 179 EVLAQKPYSKAVDCWSIGVIAYILLCG-YPPFYDENDA------KLFEQI---LKAEYEF 228
Query: 418 DRELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVR 456
D + + P R + ++
Sbjct: 229 DSPYWDDISD----SAKDFIRHLMEKDPEKRFTCEQALQ 263
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 138 bits (347), Expect = 1e-37
Identities = 41/283 (14%), Positives = 87/283 (30%), Gaps = 38/283 (13%)
Query: 202 ENFSSKNILGAGGFGNVYKGK-LGDGTVLAVKRLKD-------------MISLAVHRNLL 247
++ +G G FG +++G L + +A+K LA +
Sbjct: 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIP 64
Query: 248 RLIGYCATPTERLLVYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPK 307
+ + +LV + T A + +HE+
Sbjct: 65 NVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEK---S 121
Query: 308 IIHRDVKAANVLLDDFCEAIVG-----DFGLAKLLD------HSDSHVTTAVRGTVGHIA 356
+++RD+K N L+ DFG+ K H + GT +++
Sbjct: 122 LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMS 181
Query: 357 PEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVL 416
+ S + D+ G + + + G + K+ + ++I ++K+ L
Sbjct: 182 INTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATN----KQKYERIGEKKQSTPL 237
Query: 417 VDRELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLE 459
REL + + E + P + +
Sbjct: 238 --RELCAGFPE----EFYKYMHYARNLAFDATPDYDYLQGLFS 274
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 139 bits (351), Expect = 2e-37
Identities = 52/273 (19%), Positives = 95/273 (34%), Gaps = 37/273 (13%)
Query: 202 ENFSSKNILGAGGFGNVYKGK-LGDGTVLAVKRLK--------------DMISLAVHRNL 246
+ + LG+G FG V++ G V K + +++ H L
Sbjct: 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKL 88
Query: 247 LRLIGYCATPTERLLVYPYMSNGSVASRL-REKPALDWNTRKRIAIGAARGLLYLHEQCD 305
+ L E +L+ ++S G + R+ E + A GL ++HE
Sbjct: 89 INLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEH-- 146
Query: 306 PKIIHRDVKAANVLLD--DFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGHIAPEYLSTG 363
I+H D+K N++ + + DFGLA L+ + T APE +
Sbjct: 147 -SIVHLDIKPENIMCETKKASSVKIIDFGLATKLN--PDEIVKVTTATAEFAAPEIVDRE 203
Query: 364 QSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELGS 423
TD++ G+L L++G+ + +Q K+ + D + S
Sbjct: 204 PVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLET----------LQNVKRCDWEFDEDAFS 253
Query: 424 NYDRIEVGEILQVALLCTQYLPVHRPKMSEVVR 456
+ E Q P R + + +
Sbjct: 254 SVSP----EAKDFIKNLLQKEPRKRLTVHDALE 282
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 134 bits (339), Expect = 2e-36
Identities = 59/284 (20%), Positives = 107/284 (37%), Gaps = 42/284 (14%)
Query: 201 TENFSSKNILGAGGFGNVYKGK-LGDGTVLAVKRLK-----------------DMISLAV 242
++ + ILG GG V+ + L +AVK L+ +
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65
Query: 243 HRNLLRLIGYCATPTERL----LVYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLL 298
H ++ + T +V Y+ ++ + + + + A + L
Sbjct: 66 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALN 125
Query: 299 YLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHV--TTAVRGTVGHIA 356
+ H+ IIHRDVK AN+++ V DFG+A+ + S + V T AV GT +++
Sbjct: 126 FSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLS 182
Query: 357 PEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVL 416
PE ++DV+ G +L E++TG G S + + +E +
Sbjct: 183 PEQARGDSVDARSDVYSLGCVLYEVLTGEPPFT-GDS------PVSVAYQHVREDPIPPS 235
Query: 417 VDRELGSNYDRIEVGEILQVALLCTQYLPVHRPK-MSEVVRMLE 459
E S ++ V L P +R + +E+ L
Sbjct: 236 ARHEGLSA-------DLDAVVLKALAKNPENRYQTAAEMRADLV 272
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 134 bits (338), Expect = 2e-36
Identities = 46/282 (16%), Positives = 98/282 (34%), Gaps = 30/282 (10%)
Query: 202 ENFSSKNILGAGGFGNVYKGKLGDGTVLAVKRLK----------------DMISLAVHRN 245
E + +G G +G VYK + G A+K+++ ++ H N
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 246 LLRLIGYCATPTERLLVYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCD 305
+++L T +LV+ ++ + L+ T K + G+ Y H++
Sbjct: 62 IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDR-- 119
Query: 306 PKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGHIAPEYLSTGQS 365
+++HRD+K N+L++ E + DFGLA+ T + + + +
Sbjct: 120 -RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKY 178
Query: 366 SEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELGSNY 425
S D++ G + E++ G +Q + + + V + N+
Sbjct: 179 STTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNF 238
Query: 426 DRIEVG-----------EILQVALLCTQYLPVHRPKMSEVVR 456
E + + + P R + +
Sbjct: 239 TVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 134 bits (338), Expect = 3e-36
Identities = 46/273 (16%), Positives = 84/273 (30%), Gaps = 36/273 (13%)
Query: 210 LGAGGFGNVYKGK-LGDGTVLAVKRLK------------DMISLAVHRNLLRLIGYCATP 256
+G+G FG++Y G + G +A+K + + + I +C
Sbjct: 15 IGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAE 74
Query: 257 TERL-LVYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKA 315
+ +V + T +A + Y+H + IHRDVK
Sbjct: 75 GDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKP 131
Query: 316 ANVL---LDDFCEAIVGDFGLAKLLDHSDSHV------TTAVRGTVGHIAPEYLSTGQSS 366
N L + DFGLAK + +H + GT + + + S
Sbjct: 132 DNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQS 191
Query: 367 EKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELGSNYD 426
+ D+ G +L+ G + K+ ++ +K L Y
Sbjct: 192 RRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMS------TPIEVLCKGYP 245
Query: 427 RIEVGEILQVALLCTQYLPVHRPKMSEVVRMLE 459
E C +P S + ++
Sbjct: 246 S----EFATYLNFCRSLRFDDKPDYSYLRQLFR 274
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (337), Expect = 6e-36
Identities = 53/294 (18%), Positives = 103/294 (35%), Gaps = 41/294 (13%)
Query: 197 LQQATENFSSKNILGAGGFGNVYKGK--LGDGTVLAVKRLKD------------------ 236
L +A + + +G G +G V+K + G +A+KR++
Sbjct: 2 LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVL 61
Query: 237 -MISLAVHRNLLRLIGYCATPTERLLVYPYMSNGSVAS------RLREKPALDWNTRKRI 289
+ H N++RL C + V +P + T K +
Sbjct: 62 RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDM 121
Query: 290 AIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVR 349
RGL +LH +++HRD+K N+L+ + + DFGLA++ + + V
Sbjct: 122 MFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTS--VV 176
Query: 350 GTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLE------- 402
T+ + APE L + D++ G + E+ ++Q G +L+
Sbjct: 177 VTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGE 236
Query: 403 --WVKKIQQEKKVEVLVDRELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEV 454
W + + ++ + + + L C + P R
Sbjct: 237 EDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA 290
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (336), Expect = 1e-35
Identities = 59/316 (18%), Positives = 103/316 (32%), Gaps = 42/316 (13%)
Query: 202 ENFSSKNILGAGGFGNVYKGK-LGDGTVLAVKRLK-------------DMISLAVHRNLL 247
E + LG G FG V++ K +K ++++A HRN+L
Sbjct: 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNIL 64
Query: 248 RLIGYCATPTERLLVYPYMSNGSVASRLREKP-ALDWNTRKRIAIGAARGLLYLHEQCDP 306
L + E ++++ ++S + R+ L+ L +LH
Sbjct: 65 HLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSH--- 121
Query: 307 KIIHRDVKAANVLLD--DFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGHIAPEYLSTGQ 364
I H D++ N++ + +FG A+ L D+ + APE
Sbjct: 122 NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLL--FTAPEYYAPEVHQHDV 179
Query: 365 SSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELGSN 424
S TD++ G L+ L++G+ + I+ E D E
Sbjct: 180 VSTATDMWSLGTLVYVLLSGINPFLAETNQQI----------IENIMNAEYTFDEEAFKE 229
Query: 425 YDRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLEGDGLAEKWAAAHNHTNPTM---NNF 481
E + R SE L+ L +K T+ +
Sbjct: 230 ISI----EAMDFVDRLLVKERKSRMTASEA---LQHPWLKQKIERVSTKVIRTLKHRRYY 282
Query: 482 HTNTKKSTSCPTSAPK 497
HT KK + SA +
Sbjct: 283 HTLIKKDLNMVVSAAR 298
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (334), Expect = 2e-35
Identities = 52/268 (19%), Positives = 92/268 (34%), Gaps = 35/268 (13%)
Query: 209 ILGAGGFGNVYKGK-LGDGTVLAVKRLKD----------MISLAVHRNLLRLIGYCATPT 257
+LG G G V + A+K L+D + +++R++
Sbjct: 19 VLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLY 78
Query: 258 ER----LLVYPYMSNGSVASRLREKP--ALDWNTRKRIAIGAARGLLYLHEQCDPKIIHR 311
L+V + G + SR++++ A I + YLH I HR
Sbjct: 79 AGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHR 135
Query: 312 DVKAANVLLDDFCE---AIVGDFGLAKLLDHSDSHVTTAVRGTVGHIAPEYLSTGQSSEK 368
DVK N+L + DFG AK +S T T ++APE L + +
Sbjct: 136 DVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTT--PCYTPYYVAPEVLGPEKYDKS 193
Query: 369 TDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELGSNYDRI 428
D++ G+++ L+ G + M ++ Q E S
Sbjct: 194 CDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYE------FPNPEWSEVSE- 246
Query: 429 EVGEILQVALLCTQYLPVHRPKMSEVVR 456
E+ + + P R ++E +
Sbjct: 247 ---EVKMLIRNLLKTEPTQRMTITEFMN 271
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 130 bits (328), Expect = 1e-34
Identities = 57/201 (28%), Positives = 89/201 (44%), Gaps = 25/201 (12%)
Query: 202 ENFSSKNILGAGGFGNVYKGK-LGDGTVLAVKRLK-----------------DMISLAVH 243
++F LG G FG V+ + +G A+K LK M+S+ H
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63
Query: 244 RNLLRLIGYCATPTERLLVYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQ 303
++R+ G + ++ Y+ G + S LR+ K A L YLH +
Sbjct: 64 PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSK 123
Query: 304 CDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGHIAPEYLSTG 363
II+RD+K N+LLD + DFG AK + + GT +IAPE +ST
Sbjct: 124 D---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT----YTLCGTPDYIAPEVVSTK 176
Query: 364 QSSEKTDVFGFGILLLELITG 384
++ D + FGIL+ E++ G
Sbjct: 177 PYNKSIDWWSFGILIYEMLAG 197
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (324), Expect = 2e-34
Identities = 51/282 (18%), Positives = 96/282 (34%), Gaps = 32/282 (11%)
Query: 202 ENFSSKNILGAGGFGNVYKGK-LGDGTVLAVKRLK----------------DMISLAVHR 244
ENF +G G +G VYK + G V+A+K+++ ++ H
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 245 NLLRLIGYCATPTERLLVYPYMSNGSVAS-RLREKPALDWNTRKRIAIGAARGLLYLHEQ 303
N+++L+ T + LV+ ++ + K +GL + H
Sbjct: 62 NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 121
Query: 304 CDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGHIAPEYLSTG 363
++HRD+K N+L++ + DFGLA+ T V L
Sbjct: 122 R---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCK 178
Query: 364 QSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELGS 423
S D++ G + E++T I+Q + + + V +
Sbjct: 179 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 238
Query: 424 NYDRIEVGEILQV---------ALL--CTQYLPVHRPKMSEV 454
++ + + +V +LL Y P R
Sbjct: 239 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 280
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (321), Expect = 6e-34
Identities = 63/281 (22%), Positives = 110/281 (39%), Gaps = 35/281 (12%)
Query: 208 NILGAGGFGNVYKGK-LGDGTVLAVKRLK-------------------DMISLAVHRNLL 247
+ LG G F VYK + ++A+K++K ++ H N++
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 248 RLIGYCATPTERLLVYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPK 307
L+ + LV+ +M L + K + +GL YLH+
Sbjct: 64 GLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW--- 120
Query: 308 IIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGHIAPEYLSTGQS-S 366
I+HRD+K N+LLD+ + DFGLAK + T V T + APE L +
Sbjct: 121 ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQV-VTRWYRAPELLFGARMYG 179
Query: 367 EKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQE--KKVEVLVDRELGSN 424
D++ G +L EL+ + L ++Q + E + +E + L D +
Sbjct: 180 VGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKS 239
Query: 425 YDRIEVGEILQVA------LL--CTQYLPVHRPKMSEVVRM 457
+ I + I A L+ + P R ++ ++M
Sbjct: 240 FPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 280
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (321), Expect = 2e-33
Identities = 49/292 (16%), Positives = 107/292 (36%), Gaps = 40/292 (13%)
Query: 201 TENFSSKNILGAGGFGNVYKGK-LGDGTVLAVKRLK---------------DMISLAVHR 244
+++ + +G G +G V + +A+K++ ++ H
Sbjct: 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66
Query: 245 NLLRLIGYCATPTERLLVYPYM----SNGSVASRLREKPALDWNTRKRIAIGAARGLLYL 300
N++ + PT + Y+ + L+ + L + RGL Y+
Sbjct: 67 NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQH-LSNDHICYFLYQILRGLKYI 125
Query: 301 HEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVT--TAVRGTVGHIAPE 358
H ++HRD+K +N+LL+ C+ + DFGLA++ D H T T + APE
Sbjct: 126 HSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 182
Query: 359 YLSTGQ-SSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLV 417
+ + ++ D++ G +L E+++ ++Q +L + QE ++
Sbjct: 183 IMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIIN 242
Query: 418 DRELGSNYDRIEVG-------------EILQVALLCTQYLPVHRPKMSEVVR 456
+ + L + + P R ++ + +
Sbjct: 243 LKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 294
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (313), Expect = 3e-32
Identities = 59/284 (20%), Positives = 98/284 (34%), Gaps = 36/284 (12%)
Query: 203 NFSSKNILGAGGFGNVYKGKL-GDGTVLAVKRLK----------DMISLAVHRNLLRLIG 251
+++ ++G G FG VY+ KL G ++A+K++ ++ H N++RL
Sbjct: 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRY 80
Query: 252 YCATPTER------LLVYPYMSNG---SVASRLREKPALDWNTRKRIAIGAARGLLYLHE 302
+ + E+ LV Y+ R K L K R L Y+H
Sbjct: 81 FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS 140
Query: 303 QCDPKIIHRDVKAANVLLD-DFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGHIAPEYLS 361
I HRD+K N+LLD D + DFG AK L + +V+ +
Sbjct: 141 F---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY-ICSRYYRAPELIFG 196
Query: 362 TGQSSEKTDVFGFGILLLELITGMRALE-------FGKSINQKGAMLEWVKKIQQEKKVE 414
+ DV+ G +L EL+ G + I G + E
Sbjct: 197 ATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTE 256
Query: 415 VLVDRELGSNYDRIEVGEILQVAL----LCTQYLPVHRPKMSEV 454
+ + ++ A+ +Y P R E
Sbjct: 257 FKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEA 300
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (302), Expect = 2e-31
Identities = 54/274 (19%), Positives = 99/274 (36%), Gaps = 56/274 (20%)
Query: 209 ILGAGGFGNVYKGK-LGDGTVLAVKRLK-----DMISLAV-----------------HRN 245
+LG+GGFG+VY G + D +A+K ++ D L
Sbjct: 11 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 246 LLRLIGYCATPTERLLVYPYMSNGS-VASRLREKPALDWNTRKRIAIGAARGLLYLHEQC 304
++RL+ + P +L+ + + E+ AL + + + H
Sbjct: 71 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNC- 129
Query: 305 DPKIIHRDVKAANVLLD-DFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGHIAPEYLSTG 363
++HRD+K N+L+D + E + DFG LL + T GT + PE++
Sbjct: 130 --GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV---YTDFDGTRVYSPPEWIRYH 184
Query: 364 Q-SSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELG 422
+ V+ GILL +++ G E + I + + + +++
Sbjct: 185 RYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIR--GQVFFRQRVSS------------- 229
Query: 423 SNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVR 456
E + C P RP E+
Sbjct: 230 ---------ECQHLIRWCLALRPSDRPTFEEIQN 254
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (299), Expect = 6e-31
Identities = 48/284 (16%), Positives = 95/284 (33%), Gaps = 32/284 (11%)
Query: 202 ENFSSKNILGAGGFGNVYKGK-LGDGTVLAVKRLK----------------DMISLAVHR 244
+ + +G G +G V+K K ++A+KR++ ++ H+
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 245 NLLRLIGYCATPTERLLVYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQC 304
N++RL + + LV+ + LD K +GL + H +
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN 121
Query: 305 DPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGHIAPEYLSTGQ 364
++HRD+K N+L++ E + +FGLA+ + V
Sbjct: 122 ---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKL 178
Query: 365 SSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELGSN 424
S D++ G + EL R L G ++ + + + E++ +
Sbjct: 179 YSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKP 238
Query: 425 YDRIEVGEILQVALL------------CTQYLPVHRPKMSEVVR 456
Y L + + PV R E ++
Sbjct: 239 YPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (296), Expect = 2e-30
Identities = 54/287 (18%), Positives = 94/287 (32%), Gaps = 53/287 (18%)
Query: 204 FSSKNI---------LGAGGFGNVYKGK-LGDGTVLAVKRLK------------------ 235
F +N+ LG+G F V K + G A K +K
Sbjct: 3 FRQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIER 62
Query: 236 --DMISLAVHRNLLRLIGYCATPTERLLVYPYMSNGSVASRLREKPALDWNTRKRIAIGA 293
++ H N++ L T+ +L+ ++ G + L EK +L
Sbjct: 63 EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI 122
Query: 294 ARGLLYLHEQCDPKIIHRDVKAANVLLDDF----CEAIVGDFGLAKLLDHSDSHVTTAVR 349
G+ YLH I H D+K N++L D + DFGLA +D + +
Sbjct: 123 LNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE--FKNIF 177
Query: 350 GTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQ 409
GT +APE ++ + D++ G++ L++G +
Sbjct: 178 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET----------LAN 227
Query: 410 EKKVEVLVDRELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVR 456
V + E SN P R + + ++
Sbjct: 228 VSAVNYEFEDEYFSNTSA----LAKDFIRRLLVKDPKKRMTIQDSLQ 270
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (294), Expect = 1e-29
Identities = 60/303 (19%), Positives = 116/303 (38%), Gaps = 48/303 (15%)
Query: 192 FTFRELQQATENFSSK----NILGAGGFGNVYKGK-LGDGTVLAVKRLK----------- 235
F +E+ + + +G+G +G V G +A+K+L
Sbjct: 4 FYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKR 63
Query: 236 -----DMISLAVHRNLLRLIGYCATP------TERLLVYPYMSNGSVASRLREKPALDWN 284
++ H N++ L+ T+ LV P+M G+ +L + L +
Sbjct: 64 AYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHEKLGED 121
Query: 285 TRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHV 344
+ + +GL Y+H IIHRD+K N+ +++ CE + DFGLA+ +DS +
Sbjct: 122 RIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLAR---QADSEM 175
Query: 345 TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWV 404
T V L+ + ++ D++ G ++ E+ITG + ++Q +++
Sbjct: 176 TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVT 235
Query: 405 KK-----IQQEKKVEVLVDRELGSNYDRIEVGEILQ------VALL--CTQYLPVHRPKM 451
+Q+ + E + ++ + IL V LL R
Sbjct: 236 GTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTA 295
Query: 452 SEV 454
E
Sbjct: 296 GEA 298
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (288), Expect = 5e-29
Identities = 45/201 (22%), Positives = 72/201 (35%), Gaps = 22/201 (10%)
Query: 202 ENFSSKNILGAGGFGNVYKGK-LGDGTVLAVKRLK-----------------DMISLAVH 243
+F +LG G FG V + G A+K L+ ++ H
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 244 RNLLRLIGYCATPTERLLVYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQ 303
L L T V Y + G + L + + A + L
Sbjct: 65 PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYG---AEIVSALEYL 121
Query: 304 CDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGHIAPEYLSTG 363
+++RD+K N++LD + DFGL K SD GT ++APE L
Sbjct: 122 HSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEG-ISDGATMKTFCGTPEYLAPEVLEDN 180
Query: 364 QSSEKTDVFGFGILLLELITG 384
D +G G+++ E++ G
Sbjct: 181 DYGRAVDWWGLGVVMYEMMCG 201
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 112 bits (282), Expect = 4e-28
Identities = 48/203 (23%), Positives = 75/203 (36%), Gaps = 25/203 (12%)
Query: 202 ENFSSKNILGAGGFGNVYKGK-LGDGTVLAVKRLK-----------------DMISLAVH 243
+ F LG G FG V K G A+K L ++
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 244 RNLLRLIGYCATPTERLLVYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQ 303
L++L + +V Y++ G + S LR + A YLH
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL 160
Query: 304 CDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGHIAPEYLSTG 363
+I+RD+K N+L+D V DFG AK T + GT +APE + +
Sbjct: 161 ---DLIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWTLCGTPEALAPEIILSK 213
Query: 364 QSSEKTDVFGFGILLLELITGMR 386
++ D + G+L+ E+ G
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYP 236
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 112 bits (280), Expect = 6e-28
Identities = 46/244 (18%), Positives = 86/244 (35%), Gaps = 25/244 (10%)
Query: 202 ENFSSKNILGAGGFGNVYKGK-LGDGTVLAVKRLKD------------MISLAVHRNLLR 248
+++ LG G + V++ + + + VK LK + +L N++
Sbjct: 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIIT 94
Query: 249 LIGYCATPTERL--LVYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDP 306
L P R LV+ +++N + L + + L Y H
Sbjct: 95 LADIVKDPVSRTPALVFEHVNNTDFKQLYQ---TLTDYDIRFYMYEILKALDYCHSMG-- 149
Query: 307 KIIHRDVKAANVLLD-DFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGHIAPEYLSTGQS 365
I+HRDVK NV++D + + + D+GLA+ + + PE L Q
Sbjct: 150 -IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY--NVRVASRYFKGPELLVDYQM 206
Query: 366 -SEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELGSN 424
D++ G +L +I G + + V + + EL
Sbjct: 207 YDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPR 266
Query: 425 YDRI 428
++ I
Sbjct: 267 FNDI 270
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 111 bits (278), Expect = 8e-28
Identities = 49/212 (23%), Positives = 82/212 (38%), Gaps = 32/212 (15%)
Query: 202 ENFSSKNILGAGGFGNVYKGK-LGDGTVLAVKRLK----------------DMISLAVHR 244
+ +G G FG V+K + G +A+K++ ++ L H
Sbjct: 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69
Query: 245 NLLRLIGYCATPTER--------LLVYPYMSNGSVASRLREKPALDWNTRKRIAIGAARG 296
N++ LI C T LV+ + + + KR+ G
Sbjct: 70 NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNG 129
Query: 297 LLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLD---HSDSHVTTAVRGTVG 353
L + KI+HRD+KAANVL+ + DFGLA+ +S + T T+
Sbjct: 130 L---YYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLW 186
Query: 354 HIAPEYLSTGQS-SEKTDVFGFGILLLELITG 384
+ PE L + D++G G ++ E+ T
Sbjct: 187 YRPPELLLGERDYGPPIDLWGAGCIMAEMWTR 218
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 108 bits (270), Expect = 1e-26
Identities = 53/230 (23%), Positives = 93/230 (40%), Gaps = 28/230 (12%)
Query: 202 ENFSSKNILGAGGFGNVYKGKL----GDGTVLAVKRLKD-------------------MI 238
ENF +LG G +G V+ + G + A+K LK +
Sbjct: 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83
Query: 239 SLAVHRNLLRLIGYCATPTERLLVYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLL 298
+ L+ L T T+ L+ Y++ G + + L ++ + I +L
Sbjct: 84 HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTE---HEVQIYVGEIVL 140
Query: 299 YLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGHIAPE 358
L II+RD+K N+LLD ++ DFGL+K ++ GT+ ++AP+
Sbjct: 141 ALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPD 200
Query: 359 YLSTGQS--SEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKK 406
+ G S + D + G+L+ EL+TG N + + + K
Sbjct: 201 IVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILK 250
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 96.9 bits (240), Expect = 1e-22
Identities = 52/245 (21%), Positives = 100/245 (40%), Gaps = 33/245 (13%)
Query: 192 FTFRELQQA----TENFSSKNILGAGGFGNVYKGK-LGDGTVLAVKRLK----------- 235
F +EL + E + + + +G+G +G+V G +AVK+L
Sbjct: 4 FYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR 63
Query: 236 -----DMISLAVHRNLLRLIGYCATPT-----ERLLVYPYMSNGSVASRLREKPALDWNT 285
++ H N++ L+ + + ++ + + ++ + L +
Sbjct: 64 TYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK-LTDDH 122
Query: 286 RKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVT 345
+ + RGL Y+H IIHRD+K +N+ +++ CE + DFGLA H+D +T
Sbjct: 123 VQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDEMT 176
Query: 346 TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVK 405
V L+ ++ D++ G ++ EL+TG I+Q +L V
Sbjct: 177 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVG 236
Query: 406 KIQQE 410
E
Sbjct: 237 TPGAE 241
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 96.9 bits (240), Expect = 1e-22
Identities = 40/206 (19%), Positives = 74/206 (35%), Gaps = 31/206 (15%)
Query: 202 ENFSSKNILGAGGFGNVYKGK-LGDGTVLAVKRLK----------------DMISLAVHR 244
+ + + +G+G G V +A+K+L ++ H+
Sbjct: 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 76
Query: 245 NLLRLIGYCATP------TERLLVYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLL 298
N++ L+ + LV M E + G+
Sbjct: 77 NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELD---HERMSYLLYQMLCGIK 133
Query: 299 YLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTAVRGTVGHIAPE 358
+LH IIHRD+K +N+++ C + DFGLA+ S + T T + APE
Sbjct: 134 HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMTPYVVTRYYRAPE 188
Query: 359 YLSTGQSSEKTDVFGFGILLLELITG 384
+ E D++ G ++ E++
Sbjct: 189 VILGMGYKENVDIWSVGCIMGEMVRH 214
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 90.9 bits (224), Expect = 1e-20
Identities = 43/232 (18%), Positives = 79/232 (34%), Gaps = 35/232 (15%)
Query: 210 LGAGGFGNVYKGK-LGDGTVLAVKRLK------------------------DMISLAVHR 244
LG G F V+ K + + T +A+K ++
Sbjct: 21 LGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGAN 80
Query: 245 NLLRLIGYCATPTERLLVYPYMS-----NGSVASRLREKPALDWNTRKRIAIGAARGLLY 299
++L+L+ + + + N + E + K+I+ GL Y
Sbjct: 81 HILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDY 140
Query: 300 LHEQCDPKIIHRDVKAANVLLD-DFCEAIVGDFGLAKLLDHSDSHVTTA-VRGTVGHIAP 357
+H +C IIH D+K NVL++ + +A L + T + +P
Sbjct: 141 MHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYRSP 198
Query: 358 EYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQ 409
E L D++ L+ ELITG L + + + +I +
Sbjct: 199 EVLLGAPWGCGADIWSTACLIFELITG-DFLFEPDEGHSYTKDDDHIAQIIE 249
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 79.1 bits (194), Expect = 1e-17
Identities = 19/163 (11%), Positives = 39/163 (23%), Gaps = 39/163 (23%)
Query: 208 NILGAGGFGNVYKGKLGDGTVLAVKRLKDMIS------------------------LAVH 243
++G G V+ VK K +
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 244 RNLLRLIGYCATPT----ERLLVYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLY 299
R L +L G ++ + + + +
Sbjct: 66 RALQKLQGLAVPKVYAWEGNAVLMELIDAKELYRV-------RVENPDEVLDMILEEVAK 118
Query: 300 LHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDS 342
+ + I+H D+ NVL+ + I+ DF + +
Sbjct: 119 FYHRG---IVHGDLSQYNVLVSEEGIWII-DFPQSVEVGEEGW 157
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 61.6 bits (148), Expect = 7e-11
Identities = 30/133 (22%), Positives = 53/133 (39%), Gaps = 13/133 (9%)
Query: 26 GSIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFLSIWLPRK 85
G++ +LTNL + L NN IS P L L KL L L N++S + P ++
Sbjct: 235 GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISPLAGLTALTNLEL 292
Query: 86 WDKRKCSGVDQG------LLRLNNNSLSGAFPVFLAKISELAFLDLSYNNLSGP--VPKF 137
+ + L L N++S P ++ +++L L + N +S +
Sbjct: 293 NENQLEDISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSDVSSLANL 350
Query: 138 PA-RTFNVAGNPL 149
+ N +
Sbjct: 351 TNINWLSAGHNQI 363
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 57.7 bits (138), Expect = 1e-09
Identities = 12/47 (25%), Positives = 24/47 (51%), Gaps = 2/47 (4%)
Query: 27 SIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIP 73
+ +LT L+++ NN +S L +L + L +N++S + P
Sbjct: 324 PVSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGHNQISDLTP 368
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 54.6 bits (130), Expect = 1e-08
Identities = 29/101 (28%), Positives = 44/101 (43%), Gaps = 24/101 (23%)
Query: 30 NLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFLSIWLPRKWDKR 89
NL NL + L NNIS P + SL KLQ L +NN++S + +L L+
Sbjct: 305 NLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD-VSSLANLT---------- 351
Query: 90 KCSGVDQGL--LRLNNNSLSGAFPVFLAKISELAFLDLSYN 128
+ L +N +S P LA ++ + L L+
Sbjct: 352 -------NINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 42.7 bits (99), Expect = 8e-05
Identities = 10/47 (21%), Positives = 19/47 (40%), Gaps = 2/47 (4%)
Query: 27 SIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIP 73
S +L + + I + L L ++ SNN+L+ + P
Sbjct: 39 SQTDLDQVTTLQADRLGIKS--IDGVEYLNNLTQINFSNNQLTDITP 83
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 56.6 bits (136), Expect = 2e-10
Identities = 28/106 (26%), Positives = 42/106 (39%), Gaps = 11/106 (10%)
Query: 36 QVL-LQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFL-------SIWLPRKWD 87
+VL L + +++ + L L + LDLS+NRL + PAL L + +
Sbjct: 1 RVLHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALENV 58
Query: 88 KRKCSGVDQGLLRLNNNSL-SGAFPVFLAKISELAFLDLSYNNLSG 132
+ L L NN L A L L L+L N+L
Sbjct: 59 DGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 42.4 bits (99), Expect = 2e-05
Identities = 16/51 (31%), Positives = 23/51 (45%), Gaps = 1/51 (1%)
Query: 35 RQVLLQNNNISGGIPPQ-LGSLPKLQTLDLSNNRLSGVIPALLFLSIWLPR 84
+++LL NN + Q L S P+L L+L N L L+ LP
Sbjct: 68 QELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPS 118
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 59.4 bits (142), Expect = 3e-10
Identities = 19/48 (39%), Positives = 25/48 (52%)
Query: 32 TNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFLS 79
NL + L+NN I G +P L L L +L++S N L G IP L
Sbjct: 244 KNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQ 291
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 57.5 bits (137), Expect = 1e-09
Identities = 19/57 (33%), Positives = 28/57 (49%), Gaps = 4/57 (7%)
Query: 101 LNNNSLSGAFPVFLAKISELAFLDLSYNNLSGPVPKFPA----RTFNVAGNPLICGS 153
L NN + G P L ++ L L++S+NNL G +P+ A N +CGS
Sbjct: 251 LRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGS 307
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 56.7 bits (135), Expect = 2e-09
Identities = 15/50 (30%), Positives = 24/50 (48%), Gaps = 1/50 (2%)
Query: 19 SLSGTLSGSIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRL 68
+ GTL + L L + + NN+ G I PQ G+L + +NN+
Sbjct: 255 RIYGTLPQGLTQLKFLHSLNVSFNNLCGEI-PQGGNLQRFDVSAYANNKC 303
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 37.4 bits (85), Expect = 0.003
Identities = 32/148 (21%), Positives = 54/148 (36%), Gaps = 20/148 (13%)
Query: 2 ITCSPENL---VIGLGAPSQSLSG--TLSGSIGNLTNLRQVLLQNN-NISGGIPPQLGSL 55
+ C + V L +L + S+ NL L + + N+ G IPP + L
Sbjct: 41 VLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKL 100
Query: 56 PKLQTLDLSNNRLSGVIPALLFLSIWLPRKWDKRKCSGVDQGLLRLNNNSLSGAFPVFLA 115
+L L +++ +SG IP L L + N+LSG P ++
Sbjct: 101 TQLHYLYITHTNVSGAIPDFLSQIKTLVTLDF--------------SYNALSGTLPPSIS 146
Query: 116 KISELAFLDLSYNNLSGPVPKFPARTFN 143
+ L + N +SG +P
Sbjct: 147 SLPNLVGITFDGNRISGAIPDSYGSFSK 174
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 54.3 bits (129), Expect = 1e-08
Identities = 29/149 (19%), Positives = 56/149 (37%), Gaps = 11/149 (7%)
Query: 19 SLSGTLSGSIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFL 78
++ G NL NL ++L NN IS P L KL+ L LS N+L + +
Sbjct: 42 KITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLKELPEKMPKT 101
Query: 79 SIWLPRKWDK---------RKCSGVDQGLLRLNNNSLSGAFPVFLAKISELAFLDLSYNN 129
L ++ + + L N SG + +L+++ ++ N
Sbjct: 102 LQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTN 161
Query: 130 LSGPVPKFPA--RTFNVAGNPLICGSSST 156
++ P ++ GN + +++
Sbjct: 162 ITTIPQGLPPSLTELHLDGNKITKVDAAS 190
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 50.0 bits (118), Expect = 2e-07
Identities = 34/167 (20%), Positives = 52/167 (31%), Gaps = 16/167 (9%)
Query: 4 CSPENLVIGLGAPSQSLSGTLSGSIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDL 63
+ +V+ LG SG +G+ + L + + + NI+ IP G P L L L
Sbjct: 122 GLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQ--GLPPSLTELHL 178
Query: 64 SNNRLSGVIPALLFLSIWLPRKWDKRKCSGVDQGLLRLNNNSLS---------GAFPVFL 114
N+++ V A L L + N L P L
Sbjct: 179 DGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGL 238
Query: 115 AKISELAFLDLSYNNLSGPVPKFPARTFNVAGNPLICGSSSTNVCSG 161
A + + L NN+S + F G S S
Sbjct: 239 ADHKYIQVVYLHNNNISA----IGSNDFCPPGYNTKKASYSGVSLFS 281
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 41.9 bits (97), Expect = 1e-04
Identities = 22/99 (22%), Positives = 34/99 (34%), Gaps = 14/99 (14%)
Query: 32 TNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFLSIWLPRKWDKRKC 91
+ + LQNN I+ +L L TL L NN++S + P + L R
Sbjct: 31 PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLER------- 83
Query: 92 SGVDQGLLRLNNNSLSGAFPVFLAKISELAFLDLSYNNL 130
L L+ N L + EL + +
Sbjct: 84 -------LYLSKNQLKELPEKMPKTLQELRVHENEITKV 115
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 41.9 bits (97), Expect = 1e-04
Identities = 25/118 (21%), Positives = 41/118 (34%), Gaps = 15/118 (12%)
Query: 29 GNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFLSIWLPRKWDK 88
G +L ++ L N I+ L L L L LS N +S V L + L
Sbjct: 168 GLPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLN 227
Query: 89 RKCSGVDQG---------LLRLNNNSLSG------AFPVFLAKISELAFLDLSYNNLS 131
G ++ L+NN++S P + K + + + L N +
Sbjct: 228 NNKLVKVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQ 285
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 41.6 bits (96), Expect = 2e-04
Identities = 19/127 (14%), Positives = 42/127 (33%), Gaps = 12/127 (9%)
Query: 18 QSLSGTLSGSIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLF 77
+S G+ L L ++ L N + +L +L+ + ++ + L
Sbjct: 65 NKISKISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLN 124
Query: 78 LSIWLPRKWDKRKCSGVDQGLL---------RLNNNSLSGAFPVFLAKISELAFLDLSYN 128
I + + K SG++ G R+ + +++ L L L N
Sbjct: 125 QMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTIPQGLP---PSLTELHLDGN 181
Query: 129 NLSGPVP 135
++
Sbjct: 182 KITKVDA 188
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 46.9 bits (110), Expect = 2e-06
Identities = 14/39 (35%), Positives = 21/39 (53%), Gaps = 2/39 (5%)
Query: 27 SIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSN 65
+ +L NL +V L+NN IS P L + L + L+N
Sbjct: 190 PLASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTN 226
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 46.2 bits (108), Expect = 3e-06
Identities = 18/46 (39%), Positives = 25/46 (54%), Gaps = 2/46 (4%)
Query: 28 IGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIP 73
+ NL+ L + +N IS P L SLP L + L NN++S V P
Sbjct: 169 LANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP 212
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 47.3 bits (110), Expect = 3e-06
Identities = 20/94 (21%), Positives = 34/94 (36%), Gaps = 13/94 (13%)
Query: 30 NLTNLRQVLLQNNNISG----GIPPQLGSLPKLQTLDLSNNRLSGVIPALLFLSIWLPRK 85
+ LR + L + ++S + L + L+ LDLSNN L L S+ P
Sbjct: 367 PGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGC 426
Query: 86 WDKRKCSGVDQGLLRLNNNSLSGAFPVFLAKISE 119
++ L L + S L + +
Sbjct: 427 LLEQ---------LVLYDIYWSEEMEDRLQALEK 451
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.1 bits (107), Expect = 8e-06
Identities = 12/58 (20%), Positives = 21/58 (36%), Gaps = 4/58 (6%)
Query: 24 LSGSIGNLTNLRQVLLQNNNISG----GIPPQLGSLPKLQTLDLSNNRLSGVIPALLF 77
+ + L + V L + ++ I L P L L+L +N L V +
Sbjct: 19 WAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVL 76
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.7 bits (106), Expect = 9e-06
Identities = 13/101 (12%), Positives = 34/101 (33%), Gaps = 11/101 (10%)
Query: 33 NLRQVLLQNNNIS-GGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFLSIWLPRKWDKRKC 91
+++ + +Q +S L L + Q + L + L+ + ++ R
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSAL--------RVN 54
Query: 92 SGVDQGLLRLNNNSLSGAFPVFLAKISELAFLDLSYNNLSG 132
+ + L L +N L + + + + +L
Sbjct: 55 PALAE--LNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQN 93
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.3 bits (97), Expect = 1e-04
Identities = 13/58 (22%), Positives = 23/58 (39%), Gaps = 5/58 (8%)
Query: 24 LSGSIGNLTNLRQVLLQNNNISGGIPPQLGS-----LPKLQTLDLSNNRLSGVIPALL 76
L+ ++ +LR++ L NN + QL L+ L L + S + L
Sbjct: 389 LAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSEEMEDRL 446
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.3 bits (106), Expect = 3e-06
Identities = 15/98 (15%), Positives = 33/98 (33%), Gaps = 1/98 (1%)
Query: 25 SGSIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFLSIWLPR 84
+ N R++ L+ I I +L + +D S+N + + L +
Sbjct: 11 AAQYTNAVRDRELDLRGYKIPV-IENLGATLDQFDAIDFSDNEIRKLDGFPLLRRLKTLL 69
Query: 85 KWDKRKCSGVDQGLLRLNNNSLSGAFPVFLAKISELAF 122
+ R C + L + + L ++ +L
Sbjct: 70 VNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDP 107
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.0 bits (107), Expect = 6e-06
Identities = 23/144 (15%), Positives = 44/144 (30%), Gaps = 42/144 (29%)
Query: 13 LGAPSQSLSGTLSGSIGNLTNLRQVLLQNNNISGGIPPQLGSLP---------------- 56
L +S + L +L ++LL N ++ P L
Sbjct: 158 LFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALP 217
Query: 57 --------KLQTLDLSNNRLSGVIPALLFLSIWLPRKWDKRKCSGVDQGLLRLNNNSLSG 108
LQ L L++N A + WL + R +++ +
Sbjct: 218 TEALAPLRALQYLRLNDNPWVCDCRARPLWA-WLQK--------------FRGSSSEVPC 262
Query: 109 AFPVFLAKISELAFLDLSYNNLSG 132
+ P +++ L+ N+L G
Sbjct: 263 SLP---QRLAGRDLKRLAANDLQG 283
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.7 bits (104), Expect = 1e-05
Identities = 25/99 (25%), Positives = 37/99 (37%), Gaps = 8/99 (8%)
Query: 21 SGTLSGSIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFLSI 80
+ +G + L NL +LLQ N++ IP L L N +L+
Sbjct: 161 TELPAGLLNGLENLDTLLLQENSLYT-IPKGFFGSHLLPFAFLHGNPWLCN-CEILYFRR 218
Query: 81 WLPRKWDKRKC--SGVDQGLLRLNNNSL----SGAFPVF 113
WL + GVD + N S+ S FPV+
Sbjct: 219 WLQDNAENVYVWKQGVDVKAMTSNVASVQCDNSDKFPVY 257
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.9 bits (89), Expect = 0.001
Identities = 7/60 (11%), Positives = 16/60 (26%)
Query: 32 TNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFLSIWLPRKWDKRKC 91
+ + L N + L +L L+L L+ + + +
Sbjct: 31 KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVDGTLPVLGTLDLSHNQLQ 90
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 42.7 bits (99), Expect = 3e-05
Identities = 12/39 (30%), Positives = 18/39 (46%), Gaps = 2/39 (5%)
Query: 27 SIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSN 65
+ LT L+ + L N+IS L L L L+L +
Sbjct: 173 PLAGLTKLQNLYLSKNHISD--LRALAGLKNLDVLELFS 209
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 38.8 bits (89), Expect = 7e-04
Identities = 10/44 (22%), Positives = 22/44 (50%), Gaps = 2/44 (4%)
Query: 27 SIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSG 70
+ L ++ Q++ N++I + LP + L L+ N+L+
Sbjct: 41 TQNELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLNGNKLTD 82
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.0 bits (99), Expect = 4e-05
Identities = 8/50 (16%), Positives = 15/50 (30%), Gaps = 3/50 (6%)
Query: 26 GSIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPAL 75
+ + + I L +L KL+ N + +P L
Sbjct: 195 DVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK---KLPTL 241
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 43.3 bits (100), Expect = 4e-05
Identities = 18/91 (19%), Positives = 30/91 (32%), Gaps = 23/91 (25%)
Query: 30 NLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFLSIWLPRKWDKR 89
+L ++ + NN + +P P+L+ L S N L+ V L
Sbjct: 282 LPPSLEELNVSNNKLIE-LPA---LPPRLERLIASFNHLAEVPELPQNLKQ--------- 328
Query: 90 KCSGVDQGLLRLNNNSLSGAFPVFLAKISEL 120
L + N L FP + +L
Sbjct: 329 ---------LHVEYNPLRE-FPDIPESVEDL 349
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 41.3 bits (95), Expect = 2e-04
Identities = 22/100 (22%), Positives = 30/100 (30%), Gaps = 23/100 (23%)
Query: 39 LQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFLSIWLPRKWDKRKCSGVDQGL 98
N S I P L+ L++SNN+L + L
Sbjct: 267 YYLNASSNEIRSLCDLPPSLEELNVSNNKLIELPALPPRLER------------------ 308
Query: 99 LRLNNNSLSGAFPVFLAKISELAFLDLSYNNLSGPVPKFP 138
L + N L+ P L L + YN L P P
Sbjct: 309 LIASFNHLA-EVPELP---QNLKQLHVEYNPLRE-FPDIP 343
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 41.3 bits (95), Expect = 2e-04
Identities = 10/54 (18%), Positives = 18/54 (33%), Gaps = 8/54 (14%)
Query: 23 TLSGSIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALL 76
L L L N+++ +P + L+ L + N L P +
Sbjct: 298 ELPALPPRLERLI---ASFNHLA-EVPELPQN---LKQLHVEYNPLRE-FPDIP 343
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 40.2 bits (92), Expect = 5e-04
Identities = 14/48 (29%), Positives = 20/48 (41%), Gaps = 5/48 (10%)
Query: 27 SIGNLTNLRQVLLQNNNISGGIPPQLGS-----LPKLQTLDLSNNRLS 69
S L+ + LQ N I L + +P L L+L+ NR S
Sbjct: 268 SKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFS 315
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 39.5 bits (90), Expect = 8e-04
Identities = 9/69 (13%), Positives = 24/69 (34%), Gaps = 4/69 (5%)
Query: 24 LSGSIGNLTNLRQVLLQNNNISG----GIPPQLGSLPKLQTLDLSNNRLSGVIPALLFLS 79
+ + ++++++L N I + + S L+ + S+ V +
Sbjct: 23 VFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEAL 82
Query: 80 IWLPRKWDK 88
L + K
Sbjct: 83 RLLLQALLK 91
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.8 bits (86), Expect = 0.002
Identities = 14/89 (15%), Positives = 28/89 (31%), Gaps = 3/89 (3%)
Query: 20 LSGT--LSGSIGNLTNLRQVLLQ-NNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALL 76
L+G G L + + + + + S ++Q +DLSN+ + +
Sbjct: 7 LTGKNLHPDVTGRLLSQGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVSTLHGI 66
Query: 77 FLSIWLPRKWDKRKCSGVDQGLLRLNNNS 105
+ D + L NS
Sbjct: 67 LSQCSKLQNLSLEGLRLSDPIVNTLAKNS 95
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 36.6 bits (83), Expect = 0.003
Identities = 10/35 (28%), Positives = 18/35 (51%), Gaps = 2/35 (5%)
Query: 27 SIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTL 61
+ NLT L ++ + +N +S L L L++L
Sbjct: 167 PLANLTTLERLDISSNKVSD--ISVLAKLTNLESL 199
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 534 | |||
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.88 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.83 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.71 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.69 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.68 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.57 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.57 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.48 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.45 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.41 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.37 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.35 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.35 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.33 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.3 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.29 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.2 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.13 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.1 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.1 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.06 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.06 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.02 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.02 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 98.94 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 98.93 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 98.87 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 98.81 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 98.81 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 98.78 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 98.49 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.36 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.23 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 98.2 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 98.11 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 98.05 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.02 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 97.93 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 97.82 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 97.62 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.62 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 97.55 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.07 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 96.86 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 96.54 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 95.62 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 94.75 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 94.53 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 94.38 |
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-52 Score=407.16 Aligned_cols=240 Identities=25% Similarity=0.405 Sum_probs=188.3
Q ss_pred hCCCcCCeeccCCcEEEEEEEECCCcEEEEEEehh-------------hhhhcccCceeeEEEEEeCCCeeEEEeeccCC
Q 039819 202 ENFSSKNILGAGGFGNVYKGKLGDGTVLAVKRLKD-------------MISLAVHRNLLRLIGYCATPTERLLVYPYMSN 268 (534)
Q Consensus 202 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~-------------~l~~~~h~niv~l~~~~~~~~~~~lv~e~~~~ 268 (534)
++|+..+.||+|+||.||+|++.++..||||++.. ++..++|||||+++|+|...+..++|||||++
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~~ 84 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEH 84 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTT
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCcCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecCC
Confidence 46777889999999999999999899999998862 67889999999999999999999999999999
Q ss_pred CChhhhccc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCCceeec
Q 039819 269 GSVASRLRE-KPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTA 347 (534)
Q Consensus 269 gsL~~~l~~-~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~ 347 (534)
|+|.+++.. ...++|..++.|+.|+|.||+|||+. +|+||||||+|||++.++.+||+|||+++............
T Consensus 85 g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~ 161 (263)
T d1sm2a_ 85 GCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTG 161 (263)
T ss_dssp CBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCTTCSGGGEEECGGGCEEECSCC---------------
T ss_pred CcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhcc---ceeecccchhheeecCCCCeEecccchheeccCCCceeecc
Confidence 999999864 45689999999999999999999998 99999999999999999999999999998776544334445
Q ss_pred cccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceecccccCCCCCH
Q 039819 348 VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELGSNYDR 427 (534)
Q Consensus 348 ~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 427 (534)
..||..|+|||++.+..++.++|||||||++|||+|+..|+..... ..+....+..... ...+.
T Consensus 162 ~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~------~~~~~~~i~~~~~----------~~~p~ 225 (263)
T d1sm2a_ 162 TKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS------NSEVVEDISTGFR----------LYKPR 225 (263)
T ss_dssp ---CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCC------HHHHHHHHHHTCC----------CCCCT
T ss_pred eecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCC------HHHHHHHHHhcCC----------CCCcc
Confidence 6789999999999999999999999999999999996444432211 1122222222111 11122
Q ss_pred HHHHHHHHHHHHhcccCCCCCCChHHHHHHhhc
Q 039819 428 IEVGEILQVALLCTQYLPVHRPKMSEVVRMLEG 460 (534)
Q Consensus 428 ~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~ 460 (534)
..+.++.+++.+||+.+|++||||+||++.|+.
T Consensus 226 ~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~ 258 (263)
T d1sm2a_ 226 LASTHVYQIMNHCWKERPEDRPAFSRLLRQLAE 258 (263)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHH
Confidence 234588999999999999999999999999875
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-51 Score=403.74 Aligned_cols=238 Identities=24% Similarity=0.338 Sum_probs=196.4
Q ss_pred HhCCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEeh---------------hhhhhcccCceeeEEEEEeCCCeeEEEee
Q 039819 201 TENFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLK---------------DMISLAVHRNLLRLIGYCATPTERLLVYP 264 (534)
Q Consensus 201 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~---------------~~l~~~~h~niv~l~~~~~~~~~~~lv~e 264 (534)
.++|+..+.||+|+||+||+|+.. +|+.||||++. ++++.++|||||++++++.+.+..|+|||
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE 83 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 83 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEe
Confidence 357888999999999999999985 68999999874 26788899999999999999999999999
Q ss_pred ccCCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCC-Cc
Q 039819 265 YMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSD-SH 343 (534)
Q Consensus 265 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~-~~ 343 (534)
||++|+|.+++.....+++.+++.|+.|++.||+|||++ +||||||||+|||+++++.+||+|||+|+...... ..
T Consensus 84 y~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~---~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~ 160 (271)
T d1nvra_ 84 YCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER 160 (271)
T ss_dssp CCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEEC
T ss_pred ccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHc---CCccCcccHHHEEECCCCCEEEccchhheeeccCCccc
Confidence 999999999999888899999999999999999999999 99999999999999999999999999999765332 22
Q ss_pred eeeccccccccccccccccCCC-CcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceecccccC
Q 039819 344 VTTAVRGTVGHIAPEYLSTGQS-SEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELG 422 (534)
Q Consensus 344 ~~~~~~gt~~y~aPE~~~~~~~-~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 422 (534)
.....+||+.|||||++.+..+ +.++|||||||++|||+||+.||........ .+ .........
T Consensus 161 ~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~-----~~-~~~~~~~~~--------- 225 (271)
T d1nvra_ 161 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ-----EY-SDWKEKKTY--------- 225 (271)
T ss_dssp CBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSH-----HH-HHHHTTCTT---------
T ss_pred cccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHH-----HH-HHHhcCCCC---------
Confidence 2345679999999999988776 6789999999999999999999975432111 11 111111100
Q ss_pred CCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 423 SNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 423 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
.......+.++.+++.+|++.||++|||++|+++
T Consensus 226 ~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 226 LNPWKKIDSAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CCccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 0001112357889999999999999999999863
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.3e-52 Score=405.49 Aligned_cols=239 Identities=30% Similarity=0.456 Sum_probs=197.2
Q ss_pred hCCCcCCeeccCCcEEEEEEEECCCcEEEEEEehh-------------hhhhcccCceeeEEEEEeCCCeeEEEeeccCC
Q 039819 202 ENFSSKNILGAGGFGNVYKGKLGDGTVLAVKRLKD-------------MISLAVHRNLLRLIGYCATPTERLLVYPYMSN 268 (534)
Q Consensus 202 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~-------------~l~~~~h~niv~l~~~~~~~~~~~lv~e~~~~ 268 (534)
++|+..+.||+|+||.||+|++++++.||||++.. ++.+++|||||+++|++.+ +..++||||+++
T Consensus 13 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~~~ 91 (272)
T d1qpca_ 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMEN 91 (272)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCTT
T ss_pred HHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCcCCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeCCC
Confidence 56778889999999999999999889999999862 6788999999999998855 567999999999
Q ss_pred CChhhhcccC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCCceee
Q 039819 269 GSVASRLREK--PALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTT 346 (534)
Q Consensus 269 gsL~~~l~~~--~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~ 346 (534)
|+|.+++... ..++|..+++|+.||++||.|||++ +|+||||||+||||++++.+||+|||+|+.+.........
T Consensus 92 g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~---~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~~~~ 168 (272)
T d1qpca_ 92 GSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTARE 168 (272)
T ss_dssp CBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEECCT
T ss_pred CcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccchhheeeecccceeeccccceEEccCCcccccc
Confidence 9999987643 3699999999999999999999998 9999999999999999999999999999988655444445
Q ss_pred ccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceecccccCCCCC
Q 039819 347 AVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELGSNYD 426 (534)
Q Consensus 347 ~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 426 (534)
...||+.|||||++.++.++.++|||||||++|||+||..|+..... ..+....+..... +. .+
T Consensus 169 ~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~------~~~~~~~i~~~~~------~~----~p 232 (272)
T d1qpca_ 169 GAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT------NPEVIQNLERGYR------MV----RP 232 (272)
T ss_dssp TCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCC------HHHHHHHHHTTCC------CC----CC
T ss_pred ccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCC------HHHHHHHHHhcCC------CC----Cc
Confidence 56789999999999989999999999999999999997666543221 1112222221111 11 11
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhc
Q 039819 427 RIEVGEILQVALLCTQYLPVHRPKMSEVVRMLEG 460 (534)
Q Consensus 427 ~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~ 460 (534)
...+.++.+++.+||+.+|++||||.||++.|+.
T Consensus 233 ~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~ 266 (272)
T d1qpca_ 233 DNCPEELYQLMRLCWKERPEDRPTFDYLRSVLED 266 (272)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhh
Confidence 2234578999999999999999999999999875
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.4e-51 Score=409.25 Aligned_cols=251 Identities=28% Similarity=0.445 Sum_probs=193.5
Q ss_pred cccCHHHHHHHHhCCC---------cCCeeccCCcEEEEEEEECC-C---cEEEEEEeh---------------hhhhhc
Q 039819 190 RNFTFRELQQATENFS---------SKNILGAGGFGNVYKGKLGD-G---TVLAVKRLK---------------DMISLA 241 (534)
Q Consensus 190 ~~~~~~~l~~~~~~~~---------~~~~lG~G~~g~Vy~~~~~~-~---~~vavK~~~---------------~~l~~~ 241 (534)
..+|++++.+++.+|. ..+.||+|+||+||+|++.. + ..||||++. ++++++
T Consensus 5 d~~t~~d~~~a~~~f~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l 84 (299)
T d1jpaa_ 5 DPFTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQF 84 (299)
T ss_dssp CGGGSSSHHHHHHHHSCBCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTC
T ss_pred CCCCHHHHHHHHhhhchhhChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhC
Confidence 3567777777776553 45789999999999999742 2 368999874 267889
Q ss_pred ccCceeeEEEEEeCCCeeEEEeeccCCCChhhhccc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEe
Q 039819 242 VHRNLLRLIGYCATPTERLLVYPYMSNGSVASRLRE-KPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLL 320 (534)
Q Consensus 242 ~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl 320 (534)
+|||||+++|+|.+.+..++|||||++|+|.+++.. .+.++|.+++.|+.|||+||.|||++ +||||||||+|||+
T Consensus 85 ~HpnIv~l~g~~~~~~~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHrDlKp~NILl 161 (299)
T d1jpaa_ 85 DHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILV 161 (299)
T ss_dssp CCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEE
T ss_pred CCCCCccEEEEEeeCCEEEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhC---CCccCccccceEEE
Confidence 999999999999999999999999999999998875 45799999999999999999999998 99999999999999
Q ss_pred CCCCcEEEEecccceecCCCCCc----eeeccccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCcCCCcccc
Q 039819 321 DDFCEAIVGDFGLAKLLDHSDSH----VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GMRALEFGKSIN 395 (534)
Q Consensus 321 ~~~~~~kl~DFGla~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~ellt-G~~p~~~~~~~~ 395 (534)
+.++.+||+|||+++.+...... ......||+.|||||++.++.++.++|||||||++|||+| |+.||.....
T Consensus 162 ~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~-- 239 (299)
T d1jpaa_ 162 NSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTN-- 239 (299)
T ss_dssp CTTCCEEECCC-----------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH--
T ss_pred CCCCcEEECCcccceEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCH--
Confidence 99999999999999977543221 1122457899999999999999999999999999999998 8999964321
Q ss_pred ccchHHHHHHHHhhhcccceecccccCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhc
Q 039819 396 QKGAMLEWVKKIQQEKKVEVLVDRELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLEG 460 (534)
Q Consensus 396 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~ 460 (534)
.+.+..+..... ...+...+..+.+++.+||+.+|.+||||.||++.|+.
T Consensus 240 -----~~~~~~i~~~~~----------~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~ 289 (299)
T d1jpaa_ 240 -----QDVINAIEQDYR----------LPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDK 289 (299)
T ss_dssp -----HHHHHHHHTTCC----------CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred -----HHHHHHHHcCCC----------CCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 122222222111 11222345688999999999999999999999999874
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-51 Score=397.94 Aligned_cols=231 Identities=29% Similarity=0.431 Sum_probs=197.6
Q ss_pred hCCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEeh-----------------hhhhhcccCceeeEEEEEeCCCeeEEEe
Q 039819 202 ENFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLK-----------------DMISLAVHRNLLRLIGYCATPTERLLVY 263 (534)
Q Consensus 202 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~-----------------~~l~~~~h~niv~l~~~~~~~~~~~lv~ 263 (534)
++|+..+.||+|+||.||+|+.. +++.||||++. +++..++|||||++++++.+++..++||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 57888999999999999999985 68999999874 2677889999999999999999999999
Q ss_pred eccCCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCCc
Q 039819 264 PYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSH 343 (534)
Q Consensus 264 e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~ 343 (534)
|||++|+|.+++.....+++..+..|+.||+.||+|||++ +||||||||+|||++.++.+||+|||+|+......
T Consensus 86 Ey~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~-- 160 (263)
T d2j4za1 86 EYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR-- 160 (263)
T ss_dssp ECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCC--
T ss_pred eecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeeeeccccceecCCCCEeecccceeeecCCCc--
Confidence 9999999999999888899999999999999999999999 99999999999999999999999999998765432
Q ss_pred eeeccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceecccccCC
Q 039819 344 VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELGS 423 (534)
Q Consensus 344 ~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 423 (534)
.....||+.|||||++.+..++.++|||||||++|||+||+.||..... .+....+.... ..
T Consensus 161 -~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~-------~~~~~~i~~~~-------~~--- 222 (263)
T d2j4za1 161 -RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY-------QETYKRISRVE-------FT--- 222 (263)
T ss_dssp -CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSH-------HHHHHHHHTTC-------CC---
T ss_pred -ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCH-------HHHHHHHHcCC-------CC---
Confidence 3456799999999999999999999999999999999999999974321 11222221111 11
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 424 NYDRIEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 424 ~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
++...+.++.+++.+|++.||++|||++|+++
T Consensus 223 -~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 223 -FPDFVTEGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp -CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -CCccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence 12223457889999999999999999999975
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.4e-51 Score=406.77 Aligned_cols=241 Identities=26% Similarity=0.409 Sum_probs=201.5
Q ss_pred hCCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEehh-------------hhhhcccCceeeEEEEEeCCCeeEEEeeccC
Q 039819 202 ENFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLKD-------------MISLAVHRNLLRLIGYCATPTERLLVYPYMS 267 (534)
Q Consensus 202 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~-------------~l~~~~h~niv~l~~~~~~~~~~~lv~e~~~ 267 (534)
++|+..+.||+|+||+||+|++. +++.||||+++. +++.++|||||+++++|.+.+..++|||||+
T Consensus 17 ~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~ 96 (287)
T d1opja_ 17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMT 96 (287)
T ss_dssp GGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred HHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccchHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeeccc
Confidence 56777889999999999999986 588999999852 7888999999999999999999999999999
Q ss_pred CCChhhhccc--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCCcee
Q 039819 268 NGSVASRLRE--KPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVT 345 (534)
Q Consensus 268 ~gsL~~~l~~--~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~ 345 (534)
+|+|.+++.. ...+++..++.|+.||+.||+|||++ +||||||||+|||++.++.+||+|||+|+..........
T Consensus 97 ~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~~~~ 173 (287)
T d1opja_ 97 YGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAH 173 (287)
T ss_dssp TCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSSEEE
T ss_pred CcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHC---CcccCccccCeEEECCCCcEEEccccceeecCCCCceee
Confidence 9999999864 35799999999999999999999998 999999999999999999999999999998765544445
Q ss_pred eccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceecccccCCCC
Q 039819 346 TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELGSNY 425 (534)
Q Consensus 346 ~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 425 (534)
....||..|+|||++.++.++.++|||||||++|||+||..|+...... .+....+... .....
T Consensus 174 ~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~------~~~~~~i~~~----------~~~~~ 237 (287)
T d1opja_ 174 AGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL------SQVYELLEKD----------YRMER 237 (287)
T ss_dssp TTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCH------HHHHHHHHTT----------CCCCC
T ss_pred ccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchH------HHHHHHHhcC----------CCCCC
Confidence 5566899999999999999999999999999999999987776533221 1111111111 11112
Q ss_pred CHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhcC
Q 039819 426 DRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLEGD 461 (534)
Q Consensus 426 ~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~~ 461 (534)
+...+..+.+++.+||+.||++||||+||++.|+..
T Consensus 238 ~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~ 273 (287)
T d1opja_ 238 PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 273 (287)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred CccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 223345899999999999999999999999988754
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.8e-51 Score=398.64 Aligned_cols=241 Identities=27% Similarity=0.424 Sum_probs=189.1
Q ss_pred hCCCcCCeeccCCcEEEEEEEECCCcEEEEEEeh----------------hhhhhcccCceeeEEEEEeCCCeeEEEeec
Q 039819 202 ENFSSKNILGAGGFGNVYKGKLGDGTVLAVKRLK----------------DMISLAVHRNLLRLIGYCATPTERLLVYPY 265 (534)
Q Consensus 202 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~----------------~~l~~~~h~niv~l~~~~~~~~~~~lv~e~ 265 (534)
++|...+.||+|+||+||+|+++. .||||+++ +++.+++|||||++++++.+ +..++||||
T Consensus 8 ~~~~~~~~lG~G~fg~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~Ey 84 (276)
T d1uwha_ 8 GQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQW 84 (276)
T ss_dssp TCCCCCSEEEECSSCEEEEEESSS--EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred ccEEEEEEEeeCCCcEEEEEEECC--EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEec
Confidence 578889999999999999998754 59999875 26788899999999998865 567999999
Q ss_pred cCCCChhhhccc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCC-Cc
Q 039819 266 MSNGSVASRLRE-KPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSD-SH 343 (534)
Q Consensus 266 ~~~gsL~~~l~~-~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~-~~ 343 (534)
|++|+|.+++.. ...+++..++.|+.||++||+|||++ +||||||||+|||++.++.+||+|||+|+...... ..
T Consensus 85 ~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~---~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~~ 161 (276)
T d1uwha_ 85 CEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSH 161 (276)
T ss_dssp CCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTSSEEECCCCCSCC--------
T ss_pred CCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcC---CEeccccCHHHEEEcCCCCEEEccccceeeccccCCcc
Confidence 999999999964 45699999999999999999999998 99999999999999999999999999998765432 22
Q ss_pred eeecccccccccccccccc---CCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceecccc
Q 039819 344 VTTAVRGTVGHIAPEYLST---GQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRE 420 (534)
Q Consensus 344 ~~~~~~gt~~y~aPE~~~~---~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 420 (534)
......||+.|||||++.+ +.++.++|||||||++|||+||+.||....... .+... ... ... .+.
T Consensus 162 ~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~---~~~~~---~~~-~~~----~p~ 230 (276)
T d1uwha_ 162 QFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD---QIIFM---VGR-GYL----SPD 230 (276)
T ss_dssp ----CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH---HHHHH---HHH-TSC----CCC
T ss_pred cccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHH---HHHHH---Hhc-CCC----CCc
Confidence 3445679999999999864 458999999999999999999999997432211 11111 111 110 111
Q ss_pred cCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhc
Q 039819 421 LGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLEG 460 (534)
Q Consensus 421 l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~ 460 (534)
+ .......+..+.+++.+||+.+|.+||||+||++.|+.
T Consensus 231 ~-~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~ 269 (276)
T d1uwha_ 231 L-SKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIEL 269 (276)
T ss_dssp G-GGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred c-hhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 1 01122234588999999999999999999999999874
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-50 Score=394.00 Aligned_cols=239 Identities=23% Similarity=0.371 Sum_probs=202.6
Q ss_pred hCCCcCCeeccCCcEEEEEEEECCCcEEEEEEehh-------------hhhhcccCceeeEEEEEeCCCeeEEEeeccCC
Q 039819 202 ENFSSKNILGAGGFGNVYKGKLGDGTVLAVKRLKD-------------MISLAVHRNLLRLIGYCATPTERLLVYPYMSN 268 (534)
Q Consensus 202 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~-------------~l~~~~h~niv~l~~~~~~~~~~~lv~e~~~~ 268 (534)
++|+..+.||+|+||+||+|+++++..||||+++. ++.+++|||||+++|+|.+....++||||+++
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~~ 83 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMAN 83 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSSCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCTT
T ss_pred HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcCCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccCC
Confidence 57888999999999999999999899999998862 78889999999999999999999999999999
Q ss_pred CChhhhcc-cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCCceeec
Q 039819 269 GSVASRLR-EKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTTA 347 (534)
Q Consensus 269 gsL~~~l~-~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~ 347 (534)
|+|.+++. ....+++..+++|+.|+++||+|||+. +|+||||||+|||++.++.+||+|||+++............
T Consensus 84 g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~---~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~ 160 (258)
T d1k2pa_ 84 GCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVG 160 (258)
T ss_dssp EEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHT---TBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCCCCC
T ss_pred CcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhc---CcccccccceeEEEcCCCcEEECcchhheeccCCCceeecc
Confidence 99999865 456799999999999999999999998 99999999999999999999999999998776544444445
Q ss_pred cccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCcCCCccccccchHHHHHHHHhhhcccceecccccCCCCC
Q 039819 348 VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELGSNYD 426 (534)
Q Consensus 348 ~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 426 (534)
..||..|+|||++.+..++.++|||||||++|||+| |+.||..... .+....+..... ...+
T Consensus 161 ~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~-------~~~~~~i~~~~~----------~~~p 223 (258)
T d1k2pa_ 161 SKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTN-------SETAEHIAQGLR----------LYRP 223 (258)
T ss_dssp SCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCH-------HHHHHHHHTTCC----------CCCC
T ss_pred cCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCH-------HHHHHHHHhCCC----------CCCc
Confidence 678999999999999999999999999999999998 8999974332 122222222111 1112
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhc
Q 039819 427 RIEVGEILQVALLCTQYLPVHRPKMSEVVRMLEG 460 (534)
Q Consensus 427 ~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~ 460 (534)
...+.++.+++.+||+.+|++|||++++++.|.+
T Consensus 224 ~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d 257 (258)
T d1k2pa_ 224 HLASEKVYTIMYSCWHEKADERPTFKILLSNILD 257 (258)
T ss_dssp TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred ccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence 2334588999999999999999999999999864
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-49 Score=392.05 Aligned_cols=235 Identities=20% Similarity=0.325 Sum_probs=196.2
Q ss_pred hCCCcCCeeccCCcEEEEEEEE-CCCcEEEEEEeh--------------hhhhhcccCceeeEEEEEeCCCeeEEEeecc
Q 039819 202 ENFSSKNILGAGGFGNVYKGKL-GDGTVLAVKRLK--------------DMISLAVHRNLLRLIGYCATPTERLLVYPYM 266 (534)
Q Consensus 202 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~--------------~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~ 266 (534)
++|...+.||+|+||.||+|+. .+|+.||||++. ++++.++|||||++++++.+.+..|+|||||
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~ 99 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence 4699999999999999999997 468999999875 2678899999999999999999999999999
Q ss_pred CCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCCceee
Q 039819 267 SNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTT 346 (534)
Q Consensus 267 ~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~ 346 (534)
++|+|.+++..+ .+++.+++.|+.||+.||.|||++ +||||||||+|||++.++.+||+|||+|+....... ...
T Consensus 100 ~gg~L~~~~~~~-~l~~~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~-~~~ 174 (293)
T d1yhwa1 100 AGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-KRS 174 (293)
T ss_dssp TTCBHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC-CBC
T ss_pred CCCcHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCcHHHeEECCCCcEeeccchhheeeccccc-ccc
Confidence 999999887654 599999999999999999999999 999999999999999999999999999998754332 334
Q ss_pred ccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceecccccCCCCC
Q 039819 347 AVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELGSNYD 426 (534)
Q Consensus 347 ~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 426 (534)
..+||+.|+|||++.+..++.++|||||||++|||+||+.||...... +.+.......... + ..+
T Consensus 175 ~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~-------~~~~~~~~~~~~~------~--~~~ 239 (293)
T d1yhwa1 175 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL-------RALYLIATNGTPE------L--QNP 239 (293)
T ss_dssp CCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH-------HHHHHHHHHCSCC------C--SSG
T ss_pred ccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHH-------HHHHHHHhCCCCC------C--CCc
Confidence 567999999999999999999999999999999999999999743321 1111111111110 0 111
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 427 RIEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 427 ~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
...+..+.+++.+|++.||.+|||+.|+++
T Consensus 240 ~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 240 EKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp GGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred ccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 223457889999999999999999999863
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-50 Score=396.12 Aligned_cols=237 Identities=28% Similarity=0.416 Sum_probs=182.5
Q ss_pred hCCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEeh----------------hhhhhcccCceeeEEEEEeC--CCeeEEE
Q 039819 202 ENFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLK----------------DMISLAVHRNLLRLIGYCAT--PTERLLV 262 (534)
Q Consensus 202 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~----------------~~l~~~~h~niv~l~~~~~~--~~~~~lv 262 (534)
++|+..+.||+|+||.||+|+.. +|+.||||.+. +++..++|||||++++++.+ ....|+|
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 67889999999999999999875 68999999874 26778899999999999965 3557999
Q ss_pred eeccCCCChhhhcc----cCCCCCHHHHHHHHHHHHHHHHHHHhcC--CCCeEeccCCCCcEEeCCCCcEEEEeccccee
Q 039819 263 YPYMSNGSVASRLR----EKPALDWNTRKRIAIGAARGLLYLHEQC--DPKIIHRDVKAANVLLDDFCEAIVGDFGLAKL 336 (534)
Q Consensus 263 ~e~~~~gsL~~~l~----~~~~l~~~~~~~i~~~i~~~l~yLH~~~--~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~ 336 (534)
||||++|+|.+++. ....+++..++.|+.|++.||.|||++. ..+||||||||+|||++.++.+||+|||+|+.
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~ 163 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence 99999999999885 3567999999999999999999999872 12499999999999999999999999999998
Q ss_pred cCCCCCceeeccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhccccee
Q 039819 337 LDHSDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVL 416 (534)
Q Consensus 337 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 416 (534)
...... ......||+.|||||++.+..++.++|||||||++|||+||+.||..... .+....+... ..
T Consensus 164 ~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~-------~~~~~~i~~~-~~--- 231 (269)
T d2java1 164 LNHDTS-FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ-------KELAGKIREG-KF--- 231 (269)
T ss_dssp C------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH-------HHHHHHHHHT-CC---
T ss_pred cccCCC-ccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCH-------HHHHHHHHcC-CC---
Confidence 754322 33456799999999999999999999999999999999999999974321 1222222211 11
Q ss_pred cccccCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 417 VDRELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 417 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
+.+... .+.++.+++.+||+.||.+|||+.|+++
T Consensus 232 --~~~~~~----~s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 232 --RRIPYR----YSDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp --CCCCTT----SCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred --CCCCcc----cCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 111122 2347899999999999999999999974
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-50 Score=398.18 Aligned_cols=234 Identities=22% Similarity=0.327 Sum_probs=195.3
Q ss_pred hCCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEehh-----------------hhhhcccCceeeEEEEEeCCCeeEEEe
Q 039819 202 ENFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLKD-----------------MISLAVHRNLLRLIGYCATPTERLLVY 263 (534)
Q Consensus 202 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~-----------------~l~~~~h~niv~l~~~~~~~~~~~lv~ 263 (534)
++|+..+.||+|+||.||+|+.. +++.||||++.. ++++++|||||++++++.+.+..|+||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 57889999999999999999984 689999998752 678889999999999999999999999
Q ss_pred eccCCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCC-C
Q 039819 264 PYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSD-S 342 (534)
Q Consensus 264 e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~-~ 342 (534)
|||++|+|.+++...+.+++..++.++.|++.||+|||++ +||||||||+|||+++++.+||+|||+|+.+.... .
T Consensus 88 Ey~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~ 164 (288)
T d1uu3a_ 88 SYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ 164 (288)
T ss_dssp CCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred EccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccc---cEEcCcCCccccccCCCceEEecccccceecccCCcc
Confidence 9999999999999888899999999999999999999999 99999999999999999999999999999875432 2
Q ss_pred ceeeccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceecccccC
Q 039819 343 HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELG 422 (534)
Q Consensus 343 ~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 422 (534)
......+||+.|||||++.+..++.++|||||||++|||+||+.||..... .+....+.... ..
T Consensus 165 ~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~-------~~~~~~i~~~~-------~~-- 228 (288)
T d1uu3a_ 165 ARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE-------YLIFQKIIKLE-------YD-- 228 (288)
T ss_dssp -----CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHHHHTTC-------CC--
T ss_pred cccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCH-------HHHHHHHHcCC-------CC--
Confidence 233456799999999999999999999999999999999999999975332 11112221111 11
Q ss_pred CCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 423 SNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 423 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
++...+.++.+++.+|++.||.+|||++|++.
T Consensus 229 --~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~ 260 (288)
T d1uu3a_ 229 --FPEKFFPKARDLVEKLLVLDATKRLGCEEMEG 260 (288)
T ss_dssp --CCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTC
T ss_pred --CCccCCHHHHHHHHHHccCCHhHCcCHHHHcC
Confidence 11223457889999999999999999999754
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-50 Score=404.40 Aligned_cols=239 Identities=28% Similarity=0.421 Sum_probs=194.7
Q ss_pred hCCCcCCeeccCCcEEEEEEEECC------CcEEEEEEehh---------------hhhhc-ccCceeeEEEEEeCCCee
Q 039819 202 ENFSSKNILGAGGFGNVYKGKLGD------GTVLAVKRLKD---------------MISLA-VHRNLLRLIGYCATPTER 259 (534)
Q Consensus 202 ~~~~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~---------------~l~~~-~h~niv~l~~~~~~~~~~ 259 (534)
++|...+.||+|+||+||+|++.. ...||||++.. ++.++ +|||||+++++|.+.+..
T Consensus 37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~ 116 (325)
T d1rjba_ 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPI 116 (325)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeE
Confidence 568888999999999999998642 23699998742 45555 899999999999999999
Q ss_pred EEEeeccCCCChhhhcccC-----------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCC
Q 039819 260 LLVYPYMSNGSVASRLREK-----------------------PALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAA 316 (534)
Q Consensus 260 ~lv~e~~~~gsL~~~l~~~-----------------------~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~ 316 (534)
++|||||++|+|.++++.. ..+++..++.|+.||+.||+|||++ +||||||||+
T Consensus 117 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~---~IiHRDlKp~ 193 (325)
T d1rjba_ 117 YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAAR 193 (325)
T ss_dssp EEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTCSGG
T ss_pred EEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCchh
Confidence 9999999999999999643 2489999999999999999999999 9999999999
Q ss_pred cEEeCCCCcEEEEecccceecCCCCCc-eeeccccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCcCCCccc
Q 039819 317 NVLLDDFCEAIVGDFGLAKLLDHSDSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GMRALEFGKSI 394 (534)
Q Consensus 317 NiLl~~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~ellt-G~~p~~~~~~~ 394 (534)
|||++.++.+||+|||+|+........ ......||+.|||||++.++.++.++|||||||++|||+| |+.||......
T Consensus 194 Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~ 273 (325)
T d1rjba_ 194 NVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD 273 (325)
T ss_dssp GEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS
T ss_pred ccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCHH
Confidence 999999999999999999876544332 3345668999999999999999999999999999999998 89999743321
Q ss_pred cccchHHHHHHHHhhhcccceecccccCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhh
Q 039819 395 NQKGAMLEWVKKIQQEKKVEVLVDRELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLE 459 (534)
Q Consensus 395 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~ 459 (534)
..+...+ ... .....+...+.++.+++.+||+.+|++||||+||+++|.
T Consensus 274 ---~~~~~~~---~~~----------~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 274 ---ANFYKLI---QNG----------FKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp ---HHHHHHH---HTT----------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred ---HHHHHHH---hcC----------CCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 1111111 111 111122233458999999999999999999999999885
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-50 Score=393.57 Aligned_cols=232 Identities=28% Similarity=0.381 Sum_probs=190.6
Q ss_pred CeeccCCcEEEEEEEECC---CcEEEEEEehh----------------hhhhcccCceeeEEEEEeCCCeeEEEeeccCC
Q 039819 208 NILGAGGFGNVYKGKLGD---GTVLAVKRLKD----------------MISLAVHRNLLRLIGYCATPTERLLVYPYMSN 268 (534)
Q Consensus 208 ~~lG~G~~g~Vy~~~~~~---~~~vavK~~~~----------------~l~~~~h~niv~l~~~~~~~~~~~lv~e~~~~ 268 (534)
+.||+|+||.||+|.+.+ ++.||||+++. ++.+++|||||+++|+|..+ ..++|||||++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~-~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS-SEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC-CEEEEEEcCCC
Confidence 469999999999998643 46899998852 67888999999999999654 57899999999
Q ss_pred CChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCCce--ee
Q 039819 269 GSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHV--TT 346 (534)
Q Consensus 269 gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~--~~ 346 (534)
|+|.++++....+++..++.|+.||+.||+|||+. +||||||||+|||++.++.+||+|||+++......... ..
T Consensus 92 g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~---~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~ 168 (277)
T d1xbba_ 92 GPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQT 168 (277)
T ss_dssp EEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC--
T ss_pred CcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhC---CcccCCCcchhhcccccCcccccchhhhhhcccccccccccc
Confidence 99999999888899999999999999999999998 99999999999999999999999999999875443322 23
Q ss_pred ccccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCcCCCccccccchHHHHHHHHhhhcccceecccccCCCC
Q 039819 347 AVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELGSNY 425 (534)
Q Consensus 347 ~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 425 (534)
...||+.|||||.+.+..++.++|||||||++|||+| |+.||..... .+....+..... ...
T Consensus 169 ~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~-------~~~~~~i~~~~~----------~~~ 231 (277)
T d1xbba_ 169 HGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG-------SEVTAMLEKGER----------MGC 231 (277)
T ss_dssp --CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH-------HHHHHHHHTTCC----------CCC
T ss_pred ccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCH-------HHHHHHHHcCCC----------CCC
Confidence 4568999999999999999999999999999999998 8999974321 111222222111 112
Q ss_pred CHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhc
Q 039819 426 DRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLEG 460 (534)
Q Consensus 426 ~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~ 460 (534)
+...+.++.+++.+||+.+|++||||++|++.|+.
T Consensus 232 p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~ 266 (277)
T d1xbba_ 232 PAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN 266 (277)
T ss_dssp CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred CcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhC
Confidence 22334588999999999999999999999998875
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-50 Score=394.85 Aligned_cols=240 Identities=28% Similarity=0.427 Sum_probs=189.2
Q ss_pred hCCCcCCeeccCCcEEEEEEEECCC-----cEEEEEEeh---------------hhhhhcccCceeeEEEEEeCCCeeEE
Q 039819 202 ENFSSKNILGAGGFGNVYKGKLGDG-----TVLAVKRLK---------------DMISLAVHRNLLRLIGYCATPTERLL 261 (534)
Q Consensus 202 ~~~~~~~~lG~G~~g~Vy~~~~~~~-----~~vavK~~~---------------~~l~~~~h~niv~l~~~~~~~~~~~l 261 (534)
+.|+..++||+|+||.||+|.+... ..||||++. +++..++|||||+++|+|.+.+..++
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~ 86 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 86 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence 4577788999999999999987532 479999875 26788899999999999999999999
Q ss_pred EeeccCCCChhhhccc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCC
Q 039819 262 VYPYMSNGSVASRLRE-KPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHS 340 (534)
Q Consensus 262 v~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~ 340 (534)
|||||.+|++.+.+.. ...++|.++++|+.|++.||+|||+. +||||||||+||||+.++.+||+|||+++.+...
T Consensus 87 v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~ 163 (283)
T d1mqba_ 87 ITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 163 (283)
T ss_dssp EEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC-------
T ss_pred EEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhcccc---ccccCccccceEEECCCCeEEEcccchhhcccCC
Confidence 9999999999988864 46799999999999999999999998 9999999999999999999999999999976543
Q ss_pred CC--ceeeccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceecc
Q 039819 341 DS--HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVD 418 (534)
Q Consensus 341 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 418 (534)
.. .......||+.|||||++.++.++.++|||||||++|||+||..|+...... .+....+....
T Consensus 164 ~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~------~~~~~~i~~~~------- 230 (283)
T d1mqba_ 164 PEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN------HEVMKAINDGF------- 230 (283)
T ss_dssp ----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH------HHHHHHHHTTC-------
T ss_pred CccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCH------HHHHHHHhccC-------
Confidence 22 2233456899999999999999999999999999999999977666533221 12222222211
Q ss_pred cccCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhc
Q 039819 419 RELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLEG 460 (534)
Q Consensus 419 ~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~ 460 (534)
....+...+..+.+++.+||+.+|++||||.||+++|+.
T Consensus 231 ---~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~ 269 (283)
T d1mqba_ 231 ---RLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDK 269 (283)
T ss_dssp ---CCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred ---CCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHH
Confidence 111222345689999999999999999999999998875
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-50 Score=404.53 Aligned_cols=251 Identities=22% Similarity=0.310 Sum_probs=195.1
Q ss_pred HhCCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEeh---------------hhhhhcccCceeeEEEEEeCCCeeEEEee
Q 039819 201 TENFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLK---------------DMISLAVHRNLLRLIGYCATPTERLLVYP 264 (534)
Q Consensus 201 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~---------------~~l~~~~h~niv~l~~~~~~~~~~~lv~e 264 (534)
.++|+..+.||+|+||+||+|+.. +|+.||||+++ ++++.++|||||+++++|.+....++|||
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE 84 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 84 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 468999999999999999999975 68999999874 26888999999999999999999999999
Q ss_pred ccCCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCCce
Q 039819 265 YMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHV 344 (534)
Q Consensus 265 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~ 344 (534)
||++|+|.+++.+.+.+++..+..++.|++.||.|||+++ +|+||||||+|||++.++.+||+|||+|+..... .
T Consensus 85 y~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~--~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~---~ 159 (322)
T d1s9ja_ 85 HMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---M 159 (322)
T ss_dssp CCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHH--CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH---T
T ss_pred cCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhC--CEEccccCHHHeeECCCCCEEEeeCCCccccCCC---c
Confidence 9999999999988888999999999999999999999732 7999999999999999999999999999876432 2
Q ss_pred eeccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHH-HHHHHHh-------------hh
Q 039819 345 TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAML-EWVKKIQ-------------QE 410 (534)
Q Consensus 345 ~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~-~~~~~~~-------------~~ 410 (534)
....+||+.|||||++.+.+|+.++||||+||++|||+||+.||............. ....... ..
T Consensus 160 ~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (322)
T d1s9ja_ 160 ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSS 239 (322)
T ss_dssp C---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC------------------------
T ss_pred cccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccccccccc
Confidence 335679999999999999999999999999999999999999997543221100000 0000000 00
Q ss_pred ----c----c----cceecccccCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 411 ----K----K----VEVLVDRELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 411 ----~----~----~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
. . ...+.............+.++.+++.+|++.||.+|||++|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~ 297 (322)
T d1s9ja_ 240 YGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 297 (322)
T ss_dssp ------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence 0 0 00000000000000112347889999999999999999999986
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.2e-50 Score=393.77 Aligned_cols=238 Identities=27% Similarity=0.394 Sum_probs=194.1
Q ss_pred hCCCcCCe-eccCCcEEEEEEEEC---CCcEEEEEEehh---------------hhhhcccCceeeEEEEEeCCCeeEEE
Q 039819 202 ENFSSKNI-LGAGGFGNVYKGKLG---DGTVLAVKRLKD---------------MISLAVHRNLLRLIGYCATPTERLLV 262 (534)
Q Consensus 202 ~~~~~~~~-lG~G~~g~Vy~~~~~---~~~~vavK~~~~---------------~l~~~~h~niv~l~~~~~~~~~~~lv 262 (534)
++|...+. ||+|+||.||+|.+. ++..||||+++. ++.+++|||||+++|+|.+ +..++|
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lv 86 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV 86 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEE
Confidence 34555564 999999999999864 456799998852 6788999999999999975 457999
Q ss_pred eeccCCCChhhhccc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCC
Q 039819 263 YPYMSNGSVASRLRE-KPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSD 341 (534)
Q Consensus 263 ~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~ 341 (534)
||||++|+|.+++.. +..+++..+++|+.||+.||+|||++ +||||||||+|||++.++.+||+|||+++.+....
T Consensus 87 mE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~ 163 (285)
T d1u59a_ 87 MEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADD 163 (285)
T ss_dssp EECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEECTTCS
T ss_pred EEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCcCchhheeeccCCceeeccchhhhcccccc
Confidence 999999999998764 46799999999999999999999998 99999999999999999999999999999876543
Q ss_pred Cc--eeeccccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCcCCCccccccchHHHHHHHHhhhcccceecc
Q 039819 342 SH--VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVD 418 (534)
Q Consensus 342 ~~--~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 418 (534)
.. ......||+.|+|||++.++.++.++|||||||++|||+| |+.||..... .+....+.....
T Consensus 164 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~-------~~~~~~i~~~~~------ 230 (285)
T d1u59a_ 164 SYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG-------PEVMAFIEQGKR------ 230 (285)
T ss_dssp CEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT-------HHHHHHHHTTCC------
T ss_pred cccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCH-------HHHHHHHHcCCC------
Confidence 22 2234568999999999999999999999999999999998 9999974322 122222222111
Q ss_pred cccCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhc
Q 039819 419 RELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLEG 460 (534)
Q Consensus 419 ~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~ 460 (534)
+ ..+...+.++.+++.+||+.+|++||||.+|++.|+.
T Consensus 231 ~----~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~ 268 (285)
T d1u59a_ 231 M----ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRA 268 (285)
T ss_dssp C----CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred C----CCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 1 1222334688999999999999999999999998875
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-50 Score=394.63 Aligned_cols=239 Identities=28% Similarity=0.391 Sum_probs=191.7
Q ss_pred hCCCcCCeeccCCcEEEEEEEECCCcEEEEEEehh-------------hhhhcccCceeeEEEEEeCCCeeEEEeeccCC
Q 039819 202 ENFSSKNILGAGGFGNVYKGKLGDGTVLAVKRLKD-------------MISLAVHRNLLRLIGYCATPTERLLVYPYMSN 268 (534)
Q Consensus 202 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~-------------~l~~~~h~niv~l~~~~~~~~~~~lv~e~~~~ 268 (534)
++|+..+.||+|+||.||+|+++++..||||++.. ++.+++|||||+++|+|.+ +..++|||||++
T Consensus 17 ~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~~~ 95 (285)
T d1fmka3 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSK 95 (285)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTT
T ss_pred HHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccCCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEecCC
Confidence 56888899999999999999999888999999862 6888999999999999854 568999999999
Q ss_pred CChhhhccc--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCCceee
Q 039819 269 GSVASRLRE--KPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTT 346 (534)
Q Consensus 269 gsL~~~l~~--~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~ 346 (534)
|+|..++.. .+.++|.+++.|+.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++...........
T Consensus 96 g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~---~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 172 (285)
T d1fmka3 96 GSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQ 172 (285)
T ss_dssp CBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC-----------
T ss_pred CchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhh---heecccccceEEEECCCCcEEEcccchhhhccCCCceeec
Confidence 999988864 35699999999999999999999999 9999999999999999999999999999877554443444
Q ss_pred ccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceecccccCCCCC
Q 039819 347 AVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELGSNYD 426 (534)
Q Consensus 347 ~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 426 (534)
...||+.|+|||++..+.++.++|||||||++|||+||..|+..... ..+.+..+..... ...+
T Consensus 173 ~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~------~~~~~~~i~~~~~----------~~~~ 236 (285)
T d1fmka3 173 GAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV------NREVLDQVERGYR----------MPCP 236 (285)
T ss_dssp ---CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC------HHHHHHHHHTTCC----------CCCC
T ss_pred cccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCC------HHHHHHHHHhcCC----------CCCC
Confidence 56799999999999999999999999999999999997777653322 1122222222111 1122
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhc
Q 039819 427 RIEVGEILQVALLCTQYLPVHRPKMSEVVRMLEG 460 (534)
Q Consensus 427 ~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~ 460 (534)
...+.++.+++.+||+.+|++||+|.+|+++|+.
T Consensus 237 ~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~ 270 (285)
T d1fmka3 237 PECPESLHDLMCQCWRKEPEERPTFEYLQAFLED 270 (285)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred cccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhh
Confidence 2334588999999999999999999999999876
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-49 Score=389.15 Aligned_cols=232 Identities=25% Similarity=0.397 Sum_probs=186.4
Q ss_pred CcCCeeccCCcEEEEEEEEC-CCcEEEEEEehh----------------hhhhcccCceeeEEEEEeC----CCeeEEEe
Q 039819 205 SSKNILGAGGFGNVYKGKLG-DGTVLAVKRLKD----------------MISLAVHRNLLRLIGYCAT----PTERLLVY 263 (534)
Q Consensus 205 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~----------------~l~~~~h~niv~l~~~~~~----~~~~~lv~ 263 (534)
+..+.||+|+||+||+|+.. +++.||+|.+.. +++.++|||||+++++|.+ ....++||
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm 91 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 91 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence 34457999999999999985 688999998752 6788999999999999864 34578999
Q ss_pred eccCCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeC-CCCcEEEEecccceecCCCCC
Q 039819 264 PYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLD-DFCEAIVGDFGLAKLLDHSDS 342 (534)
Q Consensus 264 e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~-~~~~~kl~DFGla~~~~~~~~ 342 (534)
||+++|+|.+++.+...+++..++.|+.||++||+|||++ .++||||||||+|||++ +++.+||+|||+|+.....
T Consensus 92 E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~-~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~~-- 168 (270)
T d1t4ha_ 92 ELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS-- 168 (270)
T ss_dssp ECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTT--
T ss_pred eCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHC-CCCEEeCCcChhhceeeCCCCCEEEeecCcceeccCC--
Confidence 9999999999999888899999999999999999999998 11399999999999996 5899999999999865432
Q ss_pred ceeeccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceecccccC
Q 039819 343 HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELG 422 (534)
Q Consensus 343 ~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 422 (534)
.....+||+.|||||++.+ +++.++|||||||++|||+||+.||..... ..+....+...... ..
T Consensus 169 -~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~------~~~~~~~i~~~~~~-----~~-- 233 (270)
T d1t4ha_ 169 -FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQN------AAQIYRRVTSGVKP-----AS-- 233 (270)
T ss_dssp -SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS------HHHHHHHHTTTCCC-----GG--
T ss_pred -ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCccc------HHHHHHHHHcCCCC-----cc--
Confidence 2345679999999998864 699999999999999999999999964321 11222222211110 01
Q ss_pred CCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 423 SNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 423 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
.+.....++.+++.+||+.||++|||++|+++
T Consensus 234 --~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 234 --FDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp --GGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred --cCccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence 11112346889999999999999999999975
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.1e-49 Score=396.70 Aligned_cols=237 Identities=22% Similarity=0.333 Sum_probs=186.0
Q ss_pred HhCCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEeh---------------hhhhhcccCceeeEEEEEeCCCeeEEEee
Q 039819 201 TENFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLK---------------DMISLAVHRNLLRLIGYCATPTERLLVYP 264 (534)
Q Consensus 201 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~---------------~~l~~~~h~niv~l~~~~~~~~~~~lv~e 264 (534)
.+.|...+.||+|+||+||+|+.. +++.||||++. ++++.++|||||++++++.+.+..|+|||
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE 87 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ 87 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 356888999999999999999985 68999999874 26788899999999999999999999999
Q ss_pred ccCCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeC---CCCcEEEEecccceecCCCC
Q 039819 265 YMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLD---DFCEAIVGDFGLAKLLDHSD 341 (534)
Q Consensus 265 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~---~~~~~kl~DFGla~~~~~~~ 341 (534)
||++|+|.+++...+.+++..+..++.|++.||+|||++ +||||||||+|||+. +++.+||+|||+|+......
T Consensus 88 ~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~ 164 (307)
T d1a06a_ 88 LVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDL---GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS 164 (307)
T ss_dssp CCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCC----------
T ss_pred ccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhc---eeeeEEecccceeecccCCCceEEEeccceeEEccCCC
Confidence 999999999999888899999999999999999999999 999999999999994 57899999999998764332
Q ss_pred CceeeccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceeccccc
Q 039819 342 SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDREL 421 (534)
Q Consensus 342 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 421 (534)
.....+||+.|||||++.+..++.++|||||||++|||+||+.||...... +....+.... ...
T Consensus 165 --~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~-------~~~~~i~~~~-------~~~ 228 (307)
T d1a06a_ 165 --VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDA-------KLFEQILKAE-------YEF 228 (307)
T ss_dssp ----------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-------HHHHHHHTTC-------CCC
T ss_pred --eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHH-------HHHHHHhccC-------CCC
Confidence 234567999999999999999999999999999999999999999743221 1111111111 011
Q ss_pred CCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 422 GSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 422 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
........+..+.+++.+|++.||++|||++|+++
T Consensus 229 ~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 263 (307)
T d1a06a_ 229 DSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQ 263 (307)
T ss_dssp CTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred CCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 11111223457899999999999999999999986
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-49 Score=389.63 Aligned_cols=236 Identities=22% Similarity=0.302 Sum_probs=192.9
Q ss_pred hCCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEeh--------------hhhhhcccCceeeEEEEEeCCCeeEEEeecc
Q 039819 202 ENFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLK--------------DMISLAVHRNLLRLIGYCATPTERLLVYPYM 266 (534)
Q Consensus 202 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~--------------~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~ 266 (534)
+.|+..+.||+|+||.||+|+.. +++.||||++. ++++.++|||||++++++.+.+..++|||||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence 45788899999999999999975 68999999875 2678899999999999999999999999999
Q ss_pred CCCChhhhccc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCCcee
Q 039819 267 SNGSVASRLRE-KPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVT 345 (534)
Q Consensus 267 ~~gsL~~~l~~-~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~ 345 (534)
++|+|.+++.+ ...+++..+..|+.||+.||.|||++ +||||||||+|||++.++.+||+|||+|+...... ...
T Consensus 92 ~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~---~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~-~~~ 167 (288)
T d2jfla1 92 AGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-QRR 167 (288)
T ss_dssp TTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECHHHH-HHH
T ss_pred CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEEeecChhheeECCCCCEEEEechhhhccCCCc-ccc
Confidence 99999998764 56799999999999999999999999 99999999999999999999999999998653221 123
Q ss_pred eccccccccccccccc-----cCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceecccc
Q 039819 346 TAVRGTVGHIAPEYLS-----TGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRE 420 (534)
Q Consensus 346 ~~~~gt~~y~aPE~~~-----~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 420 (534)
....||+.|||||++. ...|+.++|||||||++|||+||+.||....... + +..+..... . .
T Consensus 168 ~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~----~---~~~i~~~~~-~-----~ 234 (288)
T d2jfla1 168 DSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMR----V---LLKIAKSEP-P-----T 234 (288)
T ss_dssp TCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGG----H---HHHHHHSCC-C-----C
T ss_pred cccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHH----H---HHHHHcCCC-C-----C
Confidence 3467999999999984 4568999999999999999999999997543211 1 111111111 0 0
Q ss_pred cCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 421 LGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 421 l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
+ ..+...+.++.+++.+||+.||++|||++|+++
T Consensus 235 ~--~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 235 L--AQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp C--SSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred C--CccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0 111223457899999999999999999999864
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-48 Score=386.30 Aligned_cols=236 Identities=22% Similarity=0.288 Sum_probs=195.9
Q ss_pred hCCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEeh--------------------hhhhhcccCceeeEEEEEeCCCeeE
Q 039819 202 ENFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLK--------------------DMISLAVHRNLLRLIGYCATPTERL 260 (534)
Q Consensus 202 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~--------------------~~l~~~~h~niv~l~~~~~~~~~~~ 260 (534)
++|...+.||+|+||+||+|+.. +|+.||||++. ++++.++|||||+++++|.+....|
T Consensus 10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 89 (293)
T d1jksa_ 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 89 (293)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 57899999999999999999984 78999999874 1577889999999999999999999
Q ss_pred EEeeccCCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCC----cEEEEeccccee
Q 039819 261 LVYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFC----EAIVGDFGLAKL 336 (534)
Q Consensus 261 lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~----~~kl~DFGla~~ 336 (534)
+|||||++|+|.+++...+.+++..++.++.|++.||+|||++ +||||||||+|||++.++ .+||+|||+|+.
T Consensus 90 iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~---~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~ 166 (293)
T d1jksa_ 90 LILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK 166 (293)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSSSSCCEEECCCTTCEE
T ss_pred EEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhc---ceeecccccceEEEecCCCcccceEecchhhhhh
Confidence 9999999999999998888899999999999999999999999 999999999999998776 599999999998
Q ss_pred cCCCCCceeeccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhccccee
Q 039819 337 LDHSDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVL 416 (534)
Q Consensus 337 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 416 (534)
..... ......||+.|+|||++.+..++.++|||||||++|||+||+.||...... +....+..... .
T Consensus 167 ~~~~~--~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~-------~~~~~i~~~~~-~-- 234 (293)
T d1jksa_ 167 IDFGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ-------ETLANVSAVNY-E-- 234 (293)
T ss_dssp CTTSC--BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHHHHHTTCC-C--
T ss_pred cCCCc--cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHH-------HHHHHHHhcCC-C--
Confidence 75432 234567999999999999989999999999999999999999999743321 11122211110 0
Q ss_pred cccccCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 417 VDRELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 417 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
...... ...+..+.+++.+||+.||.+|||++|+++
T Consensus 235 ~~~~~~----~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 235 FEDEYF----SNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp CCHHHH----TTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CCchhc----CCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000000 112347889999999999999999999975
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=1e-48 Score=396.33 Aligned_cols=237 Identities=21% Similarity=0.279 Sum_probs=196.7
Q ss_pred HhCCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEeh--------------hhhhhcccCceeeEEEEEeCCCeeEEEeec
Q 039819 201 TENFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLK--------------DMISLAVHRNLLRLIGYCATPTERLLVYPY 265 (534)
Q Consensus 201 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~--------------~~l~~~~h~niv~l~~~~~~~~~~~lv~e~ 265 (534)
.++|...+.||+|+||.||+|+.. +|+.||||++. +++..++|||||++++++.+.+..|+||||
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 104 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 104 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 357999999999999999999974 68999999875 267888999999999999999999999999
Q ss_pred cCCCChhhhcc-cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeC--CCCcEEEEecccceecCCCCC
Q 039819 266 MSNGSVASRLR-EKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLD--DFCEAIVGDFGLAKLLDHSDS 342 (534)
Q Consensus 266 ~~~gsL~~~l~-~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~--~~~~~kl~DFGla~~~~~~~~ 342 (534)
|++|+|.+++. ....+++..+..|+.||+.||.|||++ +||||||||+|||++ .++.+||+|||+|+......
T Consensus 105 ~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~- 180 (350)
T d1koaa2 105 MSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ- 180 (350)
T ss_dssp CCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTS-
T ss_pred CCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhc---CCeeeeechhHeeeccCCCCeEEEeecchheeccccc-
Confidence 99999999985 456799999999999999999999999 999999999999995 46889999999999875433
Q ss_pred ceeeccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceecccccC
Q 039819 343 HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELG 422 (534)
Q Consensus 343 ~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 422 (534)
......||+.|||||++.+..++.++|||||||++|||+||+.||..... .+.+..+...... .+...
T Consensus 181 -~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~-------~~~~~~i~~~~~~---~~~~~- 248 (350)
T d1koaa2 181 -SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEND-------DETLRNVKSCDWN---MDDSA- 248 (350)
T ss_dssp -CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHHHHHTCCC---SCCGG-
T ss_pred -ccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCH-------HHHHHHHHhCCCC---CCccc-
Confidence 34456799999999999999999999999999999999999999974322 1222222221110 01111
Q ss_pred CCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 423 SNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 423 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
....+.++.+++.+|++.||++|||++|+++
T Consensus 249 ---~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 279 (350)
T d1koaa2 249 ---FSGISEDGKDFIRKLLLADPNTRMTIHQALE 279 (350)
T ss_dssp ---GGGCCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred ---ccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1112357889999999999999999999986
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.7e-49 Score=395.41 Aligned_cols=231 Identities=28% Similarity=0.378 Sum_probs=192.4
Q ss_pred hCCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEeh-----------------hhhhhcccCceeeEEEEEeCCCeeEEEe
Q 039819 202 ENFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLK-----------------DMISLAVHRNLLRLIGYCATPTERLLVY 263 (534)
Q Consensus 202 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~-----------------~~l~~~~h~niv~l~~~~~~~~~~~lv~ 263 (534)
+.|+..+.||+|+||.||+|+.. +++.||||++. +++..++|||||++++++.+.+..|+||
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~ 94 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence 45888899999999999999874 68899999874 2678899999999999999999999999
Q ss_pred eccCCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCCc
Q 039819 264 PYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSH 343 (534)
Q Consensus 264 e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~ 343 (534)
|||++|+|..++.....+++..++.|+.||+.||.|||++ +||||||||+|||++.++.+||+|||+|+....
T Consensus 95 E~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~---- 167 (309)
T d1u5ra_ 95 EYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP---- 167 (309)
T ss_dssp ECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS----
T ss_pred EecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEECCCCCEEEeecccccccCC----
Confidence 9999999988877778899999999999999999999999 999999999999999999999999999987643
Q ss_pred eeecccccccccccccccc---CCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceecccc
Q 039819 344 VTTAVRGTVGHIAPEYLST---GQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRE 420 (534)
Q Consensus 344 ~~~~~~gt~~y~aPE~~~~---~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 420 (534)
.....||+.|||||++.+ +.|+.++|||||||++|||++|+.||..... .+.......... +.
T Consensus 168 -~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~-------~~~~~~i~~~~~------~~ 233 (309)
T d1u5ra_ 168 -ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-------MSALYHIAQNES------PA 233 (309)
T ss_dssp -BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH-------HHHHHHHHHSCC------CC
T ss_pred -CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCH-------HHHHHHHHhCCC------CC
Confidence 234579999999999853 4689999999999999999999999964321 111111111111 11
Q ss_pred cCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 421 LGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 421 l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
. .+...+..+.+++.+||+.||.+|||++|+++
T Consensus 234 ~---~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 234 L---QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp C---SCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred C---CCCCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence 1 11122357899999999999999999999975
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=4e-48 Score=392.31 Aligned_cols=236 Identities=21% Similarity=0.308 Sum_probs=196.3
Q ss_pred hCCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEeh--------------hhhhhcccCceeeEEEEEeCCCeeEEEeecc
Q 039819 202 ENFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLK--------------DMISLAVHRNLLRLIGYCATPTERLLVYPYM 266 (534)
Q Consensus 202 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~--------------~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~ 266 (534)
++|+..+.||+|+||.||+|+.. +|+.||||++. ++++.++|||||++++++.+.+..|+|||||
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~ 108 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL 108 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 57889999999999999999974 79999999874 2678889999999999999999999999999
Q ss_pred CCCChhhhcccC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeC--CCCcEEEEecccceecCCCCCc
Q 039819 267 SNGSVASRLREK-PALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLD--DFCEAIVGDFGLAKLLDHSDSH 343 (534)
Q Consensus 267 ~~gsL~~~l~~~-~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~--~~~~~kl~DFGla~~~~~~~~~ 343 (534)
++|+|.+.+... ..+++.+++.|+.||+.||.|||++ +||||||||+|||++ .++.+||+|||+|+......
T Consensus 109 ~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~-- 183 (352)
T d1koba_ 109 SGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE-- 183 (352)
T ss_dssp CCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS--
T ss_pred CCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccccccccccccCCCeEEEeecccceecCCCC--
Confidence 999999887654 4699999999999999999999998 999999999999998 67899999999999876432
Q ss_pred eeeccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceecccccCC
Q 039819 344 VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELGS 423 (534)
Q Consensus 344 ~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 423 (534)
......||+.|+|||++.+..++.++|||||||++|||+||+.||...... +....+.... .....
T Consensus 184 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~-------~~~~~i~~~~-------~~~~~ 249 (352)
T d1koba_ 184 IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL-------ETLQNVKRCD-------WEFDE 249 (352)
T ss_dssp CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH-------HHHHHHHHCC-------CCCCS
T ss_pred ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH-------HHHHHHHhCC-------CCCCc
Confidence 344567999999999999999999999999999999999999999743321 1122221111 00111
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 424 NYDRIEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 424 ~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
......+.++.+++.+|++.||.+|||+.|+++
T Consensus 250 ~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 282 (352)
T d1koba_ 250 DAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE 282 (352)
T ss_dssp STTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred ccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 111122457889999999999999999999975
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=6.2e-48 Score=392.86 Aligned_cols=234 Identities=25% Similarity=0.316 Sum_probs=192.9
Q ss_pred hCCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEehh--------------------hhhhcccCceeeEEEEEeCCCeeE
Q 039819 202 ENFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLKD--------------------MISLAVHRNLLRLIGYCATPTERL 260 (534)
Q Consensus 202 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~--------------------~l~~~~h~niv~l~~~~~~~~~~~ 260 (534)
++|...+.||+|+||.||+|+.. +|+.||||++.. +++.+.|||||++++++.+.+..|
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ 83 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 83 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence 57889999999999999999975 689999998741 345567999999999999999999
Q ss_pred EEeeccCCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCC
Q 039819 261 LVYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHS 340 (534)
Q Consensus 261 lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~ 340 (534)
+|||||++|+|.+++.....+++..++.|+.||+.||+|||++ +||||||||+|||++.++.+||+|||+|+.....
T Consensus 84 ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~---~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~ 160 (364)
T d1omwa3 84 FILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKK 160 (364)
T ss_dssp EEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSSSCEEECCCTTCEECSSS
T ss_pred EEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHC---CccceeeccceeEEcCCCcEEEeeeceeeecCCC
Confidence 9999999999999999888899999999999999999999999 9999999999999999999999999999977543
Q ss_pred CCceeecccccccccccccccc-CCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceeccc
Q 039819 341 DSHVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDR 419 (534)
Q Consensus 341 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 419 (534)
. .....||+.|+|||++.. ..++.++|||||||++|||+||+.||....... ........ ... ..
T Consensus 161 ~---~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~----~~~~~~~~-~~~------~~ 226 (364)
T d1omwa3 161 K---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD----KHEIDRMT-LTM------AV 226 (364)
T ss_dssp C---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSC----HHHHHHHS-SSC------CC
T ss_pred c---ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHH----HHHHHHhc-ccC------CC
Confidence 2 344579999999999865 468999999999999999999999997543221 11111111 000 01
Q ss_pred ccCCCCCHHHHHHHHHHHHHhcccCCCCCCC-----hHHHHH
Q 039819 420 ELGSNYDRIEVGEILQVALLCTQYLPVHRPK-----MSEVVR 456 (534)
Q Consensus 420 ~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt-----~~ev~~ 456 (534)
.. +...+.++.+++.+||+.||.+||| ++|+++
T Consensus 227 ~~----~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 227 EL----PDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp CC----CSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred CC----CCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence 11 1122347899999999999999999 466654
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=3.1e-47 Score=380.46 Aligned_cols=230 Identities=27% Similarity=0.386 Sum_probs=196.5
Q ss_pred hCCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEehh-----------------hhhhcccCceeeEEEEEeCCCeeEEEe
Q 039819 202 ENFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLKD-----------------MISLAVHRNLLRLIGYCATPTERLLVY 263 (534)
Q Consensus 202 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~-----------------~l~~~~h~niv~l~~~~~~~~~~~lv~ 263 (534)
++|+..+.||+|+||+||+|+.. +|+.||||++.+ +++.++|||||++++++.+.+..|+||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 57889999999999999999984 689999999852 678889999999999999999999999
Q ss_pred eccCCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCCc
Q 039819 264 PYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSH 343 (534)
Q Consensus 264 e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~ 343 (534)
|||++|+|..++.....+++..+..++.||+.||+|||++ +||||||||+|||++.++.+||+|||+|+.....
T Consensus 84 E~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~--- 157 (316)
T d1fota_ 84 DYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV--- 157 (316)
T ss_dssp CCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSSC---
T ss_pred eecCCccccccccccccccccHHHHHHHHHHHhhhhhccC---cEEccccCchheeEcCCCCEEEecCccceEeccc---
Confidence 9999999999999888899999999999999999999999 9999999999999999999999999999987543
Q ss_pred eeeccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceecccccCC
Q 039819 344 VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELGS 423 (534)
Q Consensus 344 ~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 423 (534)
....+||+.|||||++.+..++.++|||||||++|||+||+.||..... .+....+.... ..
T Consensus 158 -~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~-------~~~~~~i~~~~-------~~--- 219 (316)
T d1fota_ 158 -TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT-------MKTYEKILNAE-------LR--- 219 (316)
T ss_dssp -BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH-------HHHHHHHHHCC-------CC---
T ss_pred -cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCH-------HHHHHHHHcCC-------CC---
Confidence 3456799999999999999999999999999999999999999975332 12222221111 01
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCC-----ChHHHHH
Q 039819 424 NYDRIEVGEILQVALLCTQYLPVHRP-----KMSEVVR 456 (534)
Q Consensus 424 ~~~~~~~~~l~~l~~~Cl~~~P~~RP-----t~~ev~~ 456 (534)
++...+.++.+++.+|++.+|.+|| |++|+++
T Consensus 220 -~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~ 256 (316)
T d1fota_ 220 -FPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 256 (316)
T ss_dssp -CCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred -CCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence 1112235788999999999999996 7888875
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-48 Score=380.55 Aligned_cols=234 Identities=27% Similarity=0.388 Sum_probs=187.3
Q ss_pred hCCCcCCeeccCCcEEEEEEEECCCcEEEEEEehh------------hhhhcccCceeeEEEEEeCC-CeeEEEeeccCC
Q 039819 202 ENFSSKNILGAGGFGNVYKGKLGDGTVLAVKRLKD------------MISLAVHRNLLRLIGYCATP-TERLLVYPYMSN 268 (534)
Q Consensus 202 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~------------~l~~~~h~niv~l~~~~~~~-~~~~lv~e~~~~ 268 (534)
++|+..+.||+|+||.||+|++ .|+.||||++++ ++++++|||||+++|+|.+. +..++||||+++
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~i~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~~~ 85 (262)
T d1byga_ 7 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAK 85 (262)
T ss_dssp GGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCCC--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTT
T ss_pred HHeEEeEEEecCCCeEEEEEEE-CCeEEEEEEECcHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEeccCC
Confidence 4577788999999999999999 477899999863 78889999999999999654 567999999999
Q ss_pred CChhhhcccC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCCceee
Q 039819 269 GSVASRLREK--PALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTT 346 (534)
Q Consensus 269 gsL~~~l~~~--~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~ 346 (534)
|+|.+++... ..++|..+++|+.||+.||.|||+. +||||||||+|||++.++.+||+|||+++..... ..
T Consensus 86 g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~----~~ 158 (262)
T d1byga_ 86 GSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST----QD 158 (262)
T ss_dssp EEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC-------------
T ss_pred CCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccC---ceeccccchHhheecCCCCEeecccccceecCCC----Cc
Confidence 9999999653 3589999999999999999999998 9999999999999999999999999999876432 23
Q ss_pred ccccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCcCCCccccccchHHHHHHHHhhhcccceecccccCCCC
Q 039819 347 AVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELGSNY 425 (534)
Q Consensus 347 ~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 425 (534)
...+|..|+|||++.++.++.++|||||||++|||+| |+.||..... ..+..++ .... .+ ..
T Consensus 159 ~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~----~~~~~~i---~~~~------~~----~~ 221 (262)
T d1byga_ 159 TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL----KDVVPRV---EKGY------KM----DA 221 (262)
T ss_dssp ---CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCG----GGHHHHH---TTTC------CC----CC
T ss_pred cccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCH----HHHHHHH---HcCC------CC----CC
Confidence 3458899999999999999999999999999999999 6777764322 1222222 1111 11 12
Q ss_pred CHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhc
Q 039819 426 DRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLEG 460 (534)
Q Consensus 426 ~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~ 460 (534)
+...+.++.+++.+||+.||.+||||.|++++|+.
T Consensus 222 ~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~ 256 (262)
T d1byga_ 222 PDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEH 256 (262)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHH
Confidence 22334588999999999999999999999999875
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=8.1e-49 Score=390.02 Aligned_cols=245 Identities=25% Similarity=0.398 Sum_probs=198.5
Q ss_pred HHHHHhCCCcCCeeccCCcEEEEEEEEC------CCcEEEEEEehh---------------hhhhcccCceeeEEEEEeC
Q 039819 197 LQQATENFSSKNILGAGGFGNVYKGKLG------DGTVLAVKRLKD---------------MISLAVHRNLLRLIGYCAT 255 (534)
Q Consensus 197 l~~~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~---------------~l~~~~h~niv~l~~~~~~ 255 (534)
++...++|+..+.||+|+||.||+|+.. +++.||||++.. +++.++||||++++++|.+
T Consensus 8 ~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~ 87 (301)
T d1lufa_ 8 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAV 87 (301)
T ss_dssp TBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred ccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeecc
Confidence 3334578999999999999999999863 457899999852 6788899999999999999
Q ss_pred CCeeEEEeeccCCCChhhhcccC------------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEec
Q 039819 256 PTERLLVYPYMSNGSVASRLREK------------------------PALDWNTRKRIAIGAARGLLYLHEQCDPKIIHR 311 (534)
Q Consensus 256 ~~~~~lv~e~~~~gsL~~~l~~~------------------------~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~ 311 (534)
....++||||+++|+|.+++... ..+++..++.|+.|++.||+|||++ +||||
T Consensus 88 ~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~---~ivHr 164 (301)
T d1lufa_ 88 GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHR 164 (301)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCS
T ss_pred CCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccC---CeEee
Confidence 99999999999999999988532 2489999999999999999999999 99999
Q ss_pred cCCCCcEEeCCCCcEEEEecccceecCCCC-CceeeccccccccccccccccCCCCcchhHHHHHHHHHHHHhCC-CCcC
Q 039819 312 DVKAANVLLDDFCEAIVGDFGLAKLLDHSD-SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGM-RALE 389 (534)
Q Consensus 312 Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~-~p~~ 389 (534)
||||+|||++.++.+||+|||+|+.+.... ........||+.|+|||++.+..++.++|||||||++|||+||. +||.
T Consensus 165 DlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~ 244 (301)
T d1lufa_ 165 DLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYY 244 (301)
T ss_dssp CCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred EEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCC
Confidence 999999999999999999999998764332 22334567899999999999999999999999999999999996 4665
Q ss_pred CCccccccchHHHHHHHHhhhcccceecccccCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhcC
Q 039819 390 FGKSINQKGAMLEWVKKIQQEKKVEVLVDRELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLEGD 461 (534)
Q Consensus 390 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~~ 461 (534)
.... .+....+..... + ..+...+.++.+|+.+||+.+|++||||.||+++|+..
T Consensus 245 ~~~~-------~e~~~~v~~~~~------~----~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i 299 (301)
T d1lufa_ 245 GMAH-------EEVIYYVRDGNI------L----ACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRM 299 (301)
T ss_dssp TSCH-------HHHHHHHHTTCC------C----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred CCCH-------HHHHHHHHcCCC------C----CCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 3221 122222222111 1 11222345789999999999999999999999999864
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-48 Score=381.76 Aligned_cols=238 Identities=23% Similarity=0.383 Sum_probs=184.1
Q ss_pred hCCCcCCeeccCCcEEEEEEEECC----CcEEEEEEehh---------------hhhhcccCceeeEEEEEeCCCeeEEE
Q 039819 202 ENFSSKNILGAGGFGNVYKGKLGD----GTVLAVKRLKD---------------MISLAVHRNLLRLIGYCATPTERLLV 262 (534)
Q Consensus 202 ~~~~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~---------------~l~~~~h~niv~l~~~~~~~~~~~lv 262 (534)
++|+..+.||+|+||.||+|++.. +..||||.++. +++.++|||||+++++|. .+..++|
T Consensus 7 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~iv 85 (273)
T d1mp8a_ 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWII 85 (273)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEE
T ss_pred HHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEEE
Confidence 578888999999999999998742 45799998752 678889999999999996 4678999
Q ss_pred eeccCCCChhhhccc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCC
Q 039819 263 YPYMSNGSVASRLRE-KPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSD 341 (534)
Q Consensus 263 ~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~ 341 (534)
|||+++|+|.+++.. ...+++..++.++.||++||.|||++ +||||||||+||+++.++.+||+|||+|+......
T Consensus 86 ~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~~ 162 (273)
T d1mp8a_ 86 MELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST 162 (273)
T ss_dssp EECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC-----------
T ss_pred EEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhccc---CeeccccchhheeecCCCcEEEccchhheeccCCc
Confidence 999999999998764 45799999999999999999999999 99999999999999999999999999999876544
Q ss_pred CceeeccccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCcCCCccccccchHHHHHHHHhhhcccceecccc
Q 039819 342 SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRE 420 (534)
Q Consensus 342 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 420 (534)
........||+.|+|||++.+..++.++|||||||++|||+| |++||...... .+.. .+......
T Consensus 163 ~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~----~~~~---~i~~~~~~------- 228 (273)
T d1mp8a_ 163 YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN----DVIG---RIENGERL------- 228 (273)
T ss_dssp --------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG----GHHH---HHHTTCCC-------
T ss_pred ceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHH----HHHH---HHHcCCCC-------
Confidence 444555678999999999999999999999999999999998 89998754321 1221 11111111
Q ss_pred cCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhc
Q 039819 421 LGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLEG 460 (534)
Q Consensus 421 l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~ 460 (534)
..+...+..+.+++.+||+.||++|||+.||++.|+.
T Consensus 229 ---~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~ 265 (273)
T d1mp8a_ 229 ---PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLST 265 (273)
T ss_dssp ---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ---CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 1122234589999999999999999999999998875
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-47 Score=385.32 Aligned_cols=234 Identities=23% Similarity=0.286 Sum_probs=197.6
Q ss_pred HhCCCcCCeeccCCcEEEEEEEE-CCCcEEEEEEehh-----------------hhhhcccCceeeEEEEEeCCCeeEEE
Q 039819 201 TENFSSKNILGAGGFGNVYKGKL-GDGTVLAVKRLKD-----------------MISLAVHRNLLRLIGYCATPTERLLV 262 (534)
Q Consensus 201 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~-----------------~l~~~~h~niv~l~~~~~~~~~~~lv 262 (534)
.++|...+.||+|+||.||+|+. .+++.||||++.+ +++.++|||||++++++.+.+..|+|
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv 83 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccc
Confidence 36789999999999999999997 4789999998852 67788999999999999999999999
Q ss_pred eeccCCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCC
Q 039819 263 YPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDS 342 (534)
Q Consensus 263 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~ 342 (534)
||||++|+|.+++.....+++..++.++.|++.||+|||++ +||||||||+|||++.+|.+||+|||+|+......
T Consensus 84 ~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~- 159 (337)
T d1o6la_ 84 MEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG- 159 (337)
T ss_dssp EECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT-
T ss_pred eeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhc---CccccccCHHHeEecCCCCEEEeecccccccccCC-
Confidence 99999999999999888899999999999999999999999 99999999999999999999999999999764332
Q ss_pred ceeeccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceecccccC
Q 039819 343 HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELG 422 (534)
Q Consensus 343 ~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 422 (534)
......+||+.|+|||++.+..|+.++||||+||++|||+||+.||..... .+........ . ..
T Consensus 160 ~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~-------~~~~~~i~~~-~------~~-- 223 (337)
T d1o6la_ 160 ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-------ERLFELILME-E------IR-- 223 (337)
T ss_dssp CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHHHHHC-C------CC--
T ss_pred cccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCH-------HHHHHHHhcC-C------CC--
Confidence 234456799999999999999999999999999999999999999975432 1122222111 1 11
Q ss_pred CCCCHHHHHHHHHHHHHhcccCCCCCCC-----hHHHHH
Q 039819 423 SNYDRIEVGEILQVALLCTQYLPVHRPK-----MSEVVR 456 (534)
Q Consensus 423 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPt-----~~ev~~ 456 (534)
++...+.++.+++.+|++.||.+||+ ++|+++
T Consensus 224 --~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~ 260 (337)
T d1o6la_ 224 --FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp --CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred --CCccCCHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence 12223457889999999999999995 666654
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=8.2e-48 Score=377.43 Aligned_cols=236 Identities=25% Similarity=0.318 Sum_probs=194.1
Q ss_pred hCCCcCCeeccCCcEEEEEEEE-CCCcEEEEEEehh-----------------------hhhhcc-cCceeeEEEEEeCC
Q 039819 202 ENFSSKNILGAGGFGNVYKGKL-GDGTVLAVKRLKD-----------------------MISLAV-HRNLLRLIGYCATP 256 (534)
Q Consensus 202 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~-----------------------~l~~~~-h~niv~l~~~~~~~ 256 (534)
++|+..+.||+|+||+||+|+. .+++.||||++.. +++++. |||||++++++.++
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence 5788899999999999999997 4789999998741 455665 99999999999999
Q ss_pred CeeEEEeeccCCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEeccccee
Q 039819 257 TERLLVYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKL 336 (534)
Q Consensus 257 ~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~ 336 (534)
+..|+|||||++|+|.++++.+..+++..++.++.||+.||+|||++ +||||||||+|||++.++.+||+|||+++.
T Consensus 83 ~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~a~~ 159 (277)
T d1phka_ 83 TFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQ 159 (277)
T ss_dssp SEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred cceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHc---CCcccccccceEEEcCCCCeEEccchheeE
Confidence 99999999999999999998888899999999999999999999998 999999999999999999999999999998
Q ss_pred cCCCCCceeecccccccccccccccc------CCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhh
Q 039819 337 LDHSDSHVTTAVRGTVGHIAPEYLST------GQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQE 410 (534)
Q Consensus 337 ~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 410 (534)
..... ......||..|+|||++.+ ..++.++||||+||++|||+||+.||...... .....+...
T Consensus 160 ~~~~~--~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~-------~~~~~i~~~ 230 (277)
T d1phka_ 160 LDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQM-------LMLRMIMSG 230 (277)
T ss_dssp CCTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHHHHHHT
T ss_pred ccCCC--ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHH-------HHHHHHHhC
Confidence 75432 2345679999999999853 34688999999999999999999999754321 111111111
Q ss_pred cccceecccccCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 411 KKVEVLVDRELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 411 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
. .. .........+.++.+++.+|++.+|++|||++||++
T Consensus 231 ~-~~------~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~ 269 (277)
T d1phka_ 231 N-YQ------FGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269 (277)
T ss_dssp C-CC------CCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred C-CC------CCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 1 10 111111123458899999999999999999999864
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-48 Score=386.19 Aligned_cols=240 Identities=27% Similarity=0.404 Sum_probs=185.0
Q ss_pred hCCCcCCeeccCCcEEEEEEEEC------CCcEEEEEEehh----------------hhhhcccCceeeEEEEEeCCC-e
Q 039819 202 ENFSSKNILGAGGFGNVYKGKLG------DGTVLAVKRLKD----------------MISLAVHRNLLRLIGYCATPT-E 258 (534)
Q Consensus 202 ~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~----------------~l~~~~h~niv~l~~~~~~~~-~ 258 (534)
++|+..+.||+|+||.||+|++. +++.||||+++. +....+|+|||.+++++.+.+ .
T Consensus 13 ~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~ 92 (299)
T d1ywna1 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP 92 (299)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSC
T ss_pred HHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCCe
Confidence 67888999999999999999863 346899999852 233446999999999987654 5
Q ss_pred eEEEeeccCCCChhhhcccC----------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCC
Q 039819 259 RLLVYPYMSNGSVASRLREK----------------PALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDD 322 (534)
Q Consensus 259 ~~lv~e~~~~gsL~~~l~~~----------------~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~ 322 (534)
.++|||||++|+|.++++.. ..+++..++.|+.||++||+|||++ +||||||||+|||++.
T Consensus 93 ~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~ivHrDlKp~NILl~~ 169 (299)
T d1ywna1 93 LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSE 169 (299)
T ss_dssp CEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECG
T ss_pred EEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC---CCcCCcCCccceeECC
Confidence 79999999999999998632 3489999999999999999999999 9999999999999999
Q ss_pred CCcEEEEecccceecCCCCC-ceeeccccccccccccccccCCCCcchhHHHHHHHHHHHHhCC-CCcCCCccccccchH
Q 039819 323 FCEAIVGDFGLAKLLDHSDS-HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGM-RALEFGKSINQKGAM 400 (534)
Q Consensus 323 ~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~-~p~~~~~~~~~~~~~ 400 (534)
++.+||+|||+|+....... .......||+.|+|||++.+..++.++|||||||++|||+||. .||...... .
T Consensus 170 ~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~---~-- 244 (299)
T d1ywna1 170 KNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID---E-- 244 (299)
T ss_dssp GGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCS---H--
T ss_pred CCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHH---H--
Confidence 99999999999987654332 2334567999999999999999999999999999999999975 566533211 1
Q ss_pred HHHHHHHhhhcccceecccccCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhc
Q 039819 401 LEWVKKIQQEKKVEVLVDRELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLEG 460 (534)
Q Consensus 401 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~ 460 (534)
........... +. .+...+.++.+++.+||+.||++||||.||+++|+.
T Consensus 245 -~~~~~~~~~~~------~~----~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ 293 (299)
T d1ywna1 245 -EFCRRLKEGTR------MR----APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGN 293 (299)
T ss_dssp -HHHHHHHHTCC------CC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred -HHHHHHhcCCC------CC----CCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 11111111111 11 122234578999999999999999999999999875
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-48 Score=384.09 Aligned_cols=254 Identities=22% Similarity=0.330 Sum_probs=193.6
Q ss_pred hCCCcCCeeccCCcEEEEEEEECCCcEEEEEEehh-------------hhhhcccCceeeEEEEEeCCC----eeEEEee
Q 039819 202 ENFSSKNILGAGGFGNVYKGKLGDGTVLAVKRLKD-------------MISLAVHRNLLRLIGYCATPT----ERLLVYP 264 (534)
Q Consensus 202 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~-------------~l~~~~h~niv~l~~~~~~~~----~~~lv~e 264 (534)
.+|...+.||+|+||.||+|++ +|+.||||++.. .+..++|||||+++++|.+.+ ..++|||
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~E 81 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSD 81 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEEe
Confidence 3456677899999999999997 678999999852 345678999999999997654 5789999
Q ss_pred ccCCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcC-----CCCeEeccCCCCcEEeCCCCcEEEEecccceecCC
Q 039819 265 YMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQC-----DPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDH 339 (534)
Q Consensus 265 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~-----~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~ 339 (534)
||++|+|.+++++. .++|..+++++.|+|.||.|+|+.+ .++||||||||+||||+.++.+||+|||+++....
T Consensus 82 y~~~g~L~~~l~~~-~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~~~ 160 (303)
T d1vjya_ 82 YHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDS 160 (303)
T ss_dssp CCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEEET
T ss_pred cccCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccccccC
Confidence 99999999999865 5999999999999999999999731 34899999999999999999999999999998754
Q ss_pred CCCc---eeeccccccccccccccccC------CCCcchhHHHHHHHHHHHHhCCCCcCCCcccccc-------chHHHH
Q 039819 340 SDSH---VTTAVRGTVGHIAPEYLSTG------QSSEKTDVFGFGILLLELITGMRALEFGKSINQK-------GAMLEW 403 (534)
Q Consensus 340 ~~~~---~~~~~~gt~~y~aPE~~~~~------~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~-------~~~~~~ 403 (534)
.... ......||+.|+|||++.+. .++.++|||||||++|||+||+.|+......... ....+.
T Consensus 161 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (303)
T d1vjya_ 161 ATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEE 240 (303)
T ss_dssp TTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHH
T ss_pred CCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccchHHH
Confidence 4322 23346799999999998654 2577999999999999999999887543221110 011122
Q ss_pred HHHHhhhcccceecccccCCCC-CHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhcC
Q 039819 404 VKKIQQEKKVEVLVDRELGSNY-DRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLEGD 461 (534)
Q Consensus 404 ~~~~~~~~~~~~~~d~~l~~~~-~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~~ 461 (534)
........ ..++.+.... +......+.+++.+||+.||++||||.||++.|+..
T Consensus 241 ~~~~~~~~----~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i 295 (303)
T d1vjya_ 241 MRKVVCEQ----KLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 295 (303)
T ss_dssp HHHHHTTS----CCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHhcc----ccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence 22211111 1122222211 223456799999999999999999999999998753
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-47 Score=383.66 Aligned_cols=233 Identities=25% Similarity=0.357 Sum_probs=195.9
Q ss_pred hCCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEehh------------------hhhhcccCceeeEEEEEeCCCeeEEE
Q 039819 202 ENFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLKD------------------MISLAVHRNLLRLIGYCATPTERLLV 262 (534)
Q Consensus 202 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~------------------~l~~~~h~niv~l~~~~~~~~~~~lv 262 (534)
++|...+.||+|+||+||+|+.. +++.||||++.+ +...++|||||++++++.+++..|+|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 57888999999999999999985 689999999852 23467899999999999999999999
Q ss_pred eeccCCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCC
Q 039819 263 YPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDS 342 (534)
Q Consensus 263 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~ 342 (534)
||||++|+|.+++.....+++.+++.++.||+.||+|||++ +||||||||+|||++.++.+||+|||+++......
T Consensus 82 mEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~---~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~- 157 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD- 157 (320)
T ss_dssp EECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT-
T ss_pred EeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCcccceeecCCCceeccccchhhhccccc-
Confidence 99999999999999888899999999999999999999999 99999999999999999999999999998765432
Q ss_pred ceeeccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceecccccC
Q 039819 343 HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELG 422 (534)
Q Consensus 343 ~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 422 (534)
.......||+.|+|||++.+..++.++|||||||++|||+||+.||..... .+....+... . +.
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~-------~~~~~~i~~~-~------~~-- 221 (320)
T d1xjda_ 158 AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE-------EELFHSIRMD-N------PF-- 221 (320)
T ss_dssp CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHHHHHC-C------CC--
T ss_pred ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCH-------HHHHHHHHcC-C------CC--
Confidence 234456799999999999999999999999999999999999999975332 1111222111 1 11
Q ss_pred CCCCHHHHHHHHHHHHHhcccCCCCCCChH-HHHH
Q 039819 423 SNYDRIEVGEILQVALLCTQYLPVHRPKMS-EVVR 456 (534)
Q Consensus 423 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~-ev~~ 456 (534)
++...+.++.+++.+|++.||.+||++. |+++
T Consensus 222 --~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 222 --YPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp --CCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred --CCccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 1222345789999999999999999996 6653
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.2e-46 Score=379.38 Aligned_cols=230 Identities=23% Similarity=0.301 Sum_probs=196.1
Q ss_pred hCCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEehh-----------------hhhhcccCceeeEEEEEeCCCeeEEEe
Q 039819 202 ENFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLKD-----------------MISLAVHRNLLRLIGYCATPTERLLVY 263 (534)
Q Consensus 202 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~-----------------~l~~~~h~niv~l~~~~~~~~~~~lv~ 263 (534)
++|+..+.||+|+||.||+|+.. +|+.||||++.. ++..++|||||++++++.+....++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 57889999999999999999985 799999998742 578889999999999999999999999
Q ss_pred eccCCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCCc
Q 039819 264 PYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSH 343 (534)
Q Consensus 264 e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~ 343 (534)
||+.+|+|.+++...+.+++..++.|+.||+.||.|||++ +||||||||+|||++.++.+||+|||+|+.....
T Consensus 121 e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~--- 194 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR--- 194 (350)
T ss_dssp ECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSSC---
T ss_pred ccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCcCCHHHcccCCCCCEEeeeceeeeecccc---
Confidence 9999999999998888899999999999999999999999 9999999999999999999999999999987532
Q ss_pred eeeccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceecccccCC
Q 039819 344 VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELGS 423 (534)
Q Consensus 344 ~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 423 (534)
.....||+.|||||++.+..++.++|||||||++|||+||+.||..... ......+.... ..
T Consensus 195 -~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~-------~~~~~~i~~~~-------~~--- 256 (350)
T d1rdqe_ 195 -TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP-------IQIYEKIVSGK-------VR--- 256 (350)
T ss_dssp -BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHHHHHCC-------CC---
T ss_pred -cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCH-------HHHHHHHhcCC-------CC---
Confidence 3346799999999999999999999999999999999999999974321 12222221111 01
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCC-----ChHHHHH
Q 039819 424 NYDRIEVGEILQVALLCTQYLPVHRP-----KMSEVVR 456 (534)
Q Consensus 424 ~~~~~~~~~l~~l~~~Cl~~~P~~RP-----t~~ev~~ 456 (534)
.+...+.++.+++.+|++.||.+|+ |++|+++
T Consensus 257 -~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 257 -FPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp -CCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred -CCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence 1112345789999999999999994 8888875
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-47 Score=384.73 Aligned_cols=238 Identities=25% Similarity=0.413 Sum_probs=190.3
Q ss_pred hCCCcCCeeccCCcEEEEEEEEC-CCc----EEEEEEeh---------------hhhhhcccCceeeEEEEEeCCCeeEE
Q 039819 202 ENFSSKNILGAGGFGNVYKGKLG-DGT----VLAVKRLK---------------DMISLAVHRNLLRLIGYCATPTERLL 261 (534)
Q Consensus 202 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~----~vavK~~~---------------~~l~~~~h~niv~l~~~~~~~~~~~l 261 (534)
.+|+..+.||+|+||+||+|++. +|+ .||||+++ +++++++|||||+++|+|.++ ..++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence 46888999999999999999874 343 68999875 267888999999999999875 5678
Q ss_pred EeeccCCCChhhhccc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCC
Q 039819 262 VYPYMSNGSVASRLRE-KPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHS 340 (534)
Q Consensus 262 v~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~ 340 (534)
++||+.+|+|.+.+.. ...+++..+++|+.|||.||+|||++ +||||||||+|||++.++.+||+|||+|+.....
T Consensus 88 v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~---~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~ 164 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 164 (317)
T ss_dssp EEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTT
T ss_pred EEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHc---CcccCcchhhcceeCCCCCeEeeccccceecccc
Confidence 8999999999988764 46799999999999999999999998 9999999999999999999999999999987543
Q ss_pred CCc-eeeccccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCcCCCccccccchHHHHHHHHhhhcccceecc
Q 039819 341 DSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVD 418 (534)
Q Consensus 341 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 418 (534)
... ......||+.|+|||++.++.++.++|||||||++|||+| |+.||+..... .+...+ .....
T Consensus 165 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~----~~~~~i---~~~~~------ 231 (317)
T d1xkka_ 165 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS----EISSIL---EKGER------ 231 (317)
T ss_dssp CC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGG----GHHHHH---HHTCC------
T ss_pred cccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHH----HHHHHH---HcCCC------
Confidence 322 2334568999999999999999999999999999999999 78888643321 122221 11111
Q ss_pred cccCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhc
Q 039819 419 RELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLEG 460 (534)
Q Consensus 419 ~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~ 460 (534)
...+...+..+.+++.+||+.+|.+|||+.||++.|+.
T Consensus 232 ----~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~ 269 (317)
T d1xkka_ 232 ----LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSK 269 (317)
T ss_dssp ----CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ----CCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHH
Confidence 11122334578999999999999999999999998865
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=4.5e-47 Score=372.93 Aligned_cols=242 Identities=22% Similarity=0.284 Sum_probs=190.3
Q ss_pred hCCCcCCeeccCCcEEEEEEEE-CCCcEEEEEEehh-----------------hhhhcccCceeeEEEEEeCCC----ee
Q 039819 202 ENFSSKNILGAGGFGNVYKGKL-GDGTVLAVKRLKD-----------------MISLAVHRNLLRLIGYCATPT----ER 259 (534)
Q Consensus 202 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~-----------------~l~~~~h~niv~l~~~~~~~~----~~ 259 (534)
++|...+.||+|+||.||+|+. .+++.||||++.. +++.++|||||++++++...+ ..
T Consensus 7 drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~ 86 (277)
T d1o6ya_ 7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLP 86 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred ceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceE
Confidence 5788999999999999999997 4789999998841 577889999999999987654 37
Q ss_pred EEEeeccCCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCC
Q 039819 260 LLVYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDH 339 (534)
Q Consensus 260 ~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~ 339 (534)
|+||||+++|+|.+++...+.+++.+++.|+.|++.||+|||++ +||||||||+|||++.++..+|+|||.++....
T Consensus 87 ~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~ 163 (277)
T d1o6ya_ 87 YIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIAD 163 (277)
T ss_dssp EEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTSCEEECCCTTCEECC-
T ss_pred EEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CccCccccCcccccCccccceeehhhhhhhhcc
Confidence 89999999999999998888899999999999999999999998 999999999999999999999999999986643
Q ss_pred CC--CceeeccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceec
Q 039819 340 SD--SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLV 417 (534)
Q Consensus 340 ~~--~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 417 (534)
.. .......+||+.|+|||++.+..++.++|||||||++|||+||+.||..... .+............
T Consensus 164 ~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~-------~~~~~~~~~~~~~~--- 233 (277)
T d1o6ya_ 164 SGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP-------VSVAYQHVREDPIP--- 233 (277)
T ss_dssp ---------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH-------HHHHHHHHHCCCCC---
T ss_pred ccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCH-------HHHHHHHHhcCCCC---
Confidence 32 2233456799999999999999999999999999999999999999974332 11122221111110
Q ss_pred ccccCCCCCHHHHHHHHHHHHHhcccCCCCCC-ChHHHHHHhhc
Q 039819 418 DRELGSNYDRIEVGEILQVALLCTQYLPVHRP-KMSEVVRMLEG 460 (534)
Q Consensus 418 d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RP-t~~ev~~~L~~ 460 (534)
....... .+..+.+++.+|++.||.+|| |++++.+.|..
T Consensus 234 ~~~~~~~----~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r 273 (277)
T d1o6ya_ 234 PSARHEG----LSADLDAVVLKALAKNPENRYQTAAEMRADLVR 273 (277)
T ss_dssp GGGTSSS----CCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred CchhccC----CCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHH
Confidence 0011111 235788999999999999999 89999887754
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-47 Score=377.76 Aligned_cols=246 Identities=24% Similarity=0.301 Sum_probs=190.9
Q ss_pred CCeeccCCcEEEEEEEEC-CCcEEEEEEeh-------------------hhhhhcccCceeeEEEEEeCCCeeEEEeecc
Q 039819 207 KNILGAGGFGNVYKGKLG-DGTVLAVKRLK-------------------DMISLAVHRNLLRLIGYCATPTERLLVYPYM 266 (534)
Q Consensus 207 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~-------------------~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~ 266 (534)
+++||+|+||+||+|+.. +|+.||||++. ++++.++|||||++++++.+.+..++||||+
T Consensus 3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~ 82 (299)
T d1ua2a_ 3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM 82 (299)
T ss_dssp EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhh
Confidence 468999999999999975 68999999874 2678889999999999999999999999999
Q ss_pred CCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCCceee
Q 039819 267 SNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVTT 346 (534)
Q Consensus 267 ~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~ 346 (534)
.++++.........+++..+..|+.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+....... ...
T Consensus 83 ~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~-~~~ 158 (299)
T d1ua2a_ 83 ETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR-AYT 158 (299)
T ss_dssp SEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC-CCC
T ss_pred cchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcc---ceecccCCcceEEecCCCccccccCccccccCCCcc-ccc
Confidence 9998888887778899999999999999999999999 999999999999999999999999999987654332 233
Q ss_pred ccccccccccccccccC-CCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcc--cceecccc-c-
Q 039819 347 AVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKK--VEVLVDRE-L- 421 (534)
Q Consensus 347 ~~~gt~~y~aPE~~~~~-~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~d~~-l- 421 (534)
..+||+.|+|||++... .++.++|||||||++|||+||+.||......+....+.+.......... ........ .
T Consensus 159 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (299)
T d1ua2a_ 159 HQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFK 238 (299)
T ss_dssp CSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCC
T ss_pred ceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhhhc
Confidence 45799999999998654 5799999999999999999999999765433222112111110000000 00000000 0
Q ss_pred -CCCCCH-----HHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 422 -GSNYDR-----IEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 422 -~~~~~~-----~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
....+. .....+.+++.+|++.||++|||++|+++
T Consensus 239 ~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~ 279 (299)
T d1ua2a_ 239 SFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279 (299)
T ss_dssp CCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred cCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence 000111 12357899999999999999999999874
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-47 Score=382.17 Aligned_cols=240 Identities=27% Similarity=0.409 Sum_probs=195.0
Q ss_pred hCCCcCCeeccCCcEEEEEEEE------CCCcEEEEEEehh---------------hhhhc-ccCceeeEEEEEeCCCee
Q 039819 202 ENFSSKNILGAGGFGNVYKGKL------GDGTVLAVKRLKD---------------MISLA-VHRNLLRLIGYCATPTER 259 (534)
Q Consensus 202 ~~~~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~---------------~l~~~-~h~niv~l~~~~~~~~~~ 259 (534)
++|+..+.||+|+||.||+|++ .+++.||||+++. ++..+ +|||||+++++|.+.+..
T Consensus 23 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~~ 102 (311)
T d1t46a_ 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPT 102 (311)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCEE
Confidence 5677788999999999999985 3467899999862 44555 699999999999999999
Q ss_pred EEEeeccCCCChhhhcccC------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeC
Q 039819 260 LLVYPYMSNGSVASRLREK------------------PALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLD 321 (534)
Q Consensus 260 ~lv~e~~~~gsL~~~l~~~------------------~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~ 321 (534)
++|||||++|+|.++++.. ..+++..+++|+.||++||+|||++ +||||||||+|||++
T Consensus 103 ~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~---~ivHrDLKp~NIl~~ 179 (311)
T d1t46a_ 103 LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLT 179 (311)
T ss_dssp EEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEE
T ss_pred EEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---Ceeeccccccccccc
Confidence 9999999999999998643 2589999999999999999999999 999999999999999
Q ss_pred CCCcEEEEecccceecCCCCC-ceeeccccccccccccccccCCCCcchhHHHHHHHHHHHHhC-CCCcCCCccccccch
Q 039819 322 DFCEAIVGDFGLAKLLDHSDS-HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITG-MRALEFGKSINQKGA 399 (534)
Q Consensus 322 ~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG-~~p~~~~~~~~~~~~ 399 (534)
.++.+||+|||+++....... .......||+.|+|||++.++.++.++|||||||++|||+|+ ++||..... ...
T Consensus 180 ~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~---~~~ 256 (311)
T d1t46a_ 180 HGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPV---DSK 256 (311)
T ss_dssp TTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCS---SHH
T ss_pred ccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCH---HHH
Confidence 999999999999998765433 333456789999999999999999999999999999999995 444543221 111
Q ss_pred HHHHHHHHhhhcccceecccccCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhc
Q 039819 400 MLEWVKKIQQEKKVEVLVDRELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLEG 460 (534)
Q Consensus 400 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~ 460 (534)
+...+.. + .....+...+..+.+|+.+||+.||++||||.||+++|+.
T Consensus 257 ~~~~i~~----~---------~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~ 304 (311)
T d1t46a_ 257 FYKMIKE----G---------FRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEK 304 (311)
T ss_dssp HHHHHHH----T---------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHHHhc----C---------CCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 2222211 1 1111122234588999999999999999999999999975
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.2e-48 Score=376.56 Aligned_cols=239 Identities=31% Similarity=0.411 Sum_probs=185.9
Q ss_pred hCCCcCCeeccCCcEEEEEEEEC--C--CcEEEEEEehh-----------------hhhhcccCceeeEEEEEeCCCeeE
Q 039819 202 ENFSSKNILGAGGFGNVYKGKLG--D--GTVLAVKRLKD-----------------MISLAVHRNLLRLIGYCATPTERL 260 (534)
Q Consensus 202 ~~~~~~~~lG~G~~g~Vy~~~~~--~--~~~vavK~~~~-----------------~l~~~~h~niv~l~~~~~~~~~~~ 260 (534)
++|+..+.||+|+||.||+|++. + ...||||++.. ++..++|||||+++|+|.++ ..+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~-~~~ 86 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP-PMK 86 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-SCE
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeec-chh
Confidence 56888899999999999999863 2 24789998752 57888999999999999764 678
Q ss_pred EEeeccCCCChhhhccc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCC
Q 039819 261 LVYPYMSNGSVASRLRE-KPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDH 339 (534)
Q Consensus 261 lv~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~ 339 (534)
+||||+++|++.+++.. ...+++..++.++.|+|.||.|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 87 lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~ 163 (273)
T d1u46a_ 87 MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQ 163 (273)
T ss_dssp EEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEECCC
T ss_pred eeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhC---CEeeeeecHHHhccccccceeeccchhhhhccc
Confidence 99999999999988764 45699999999999999999999998 999999999999999999999999999998755
Q ss_pred CCCc--eeeccccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCcCCCccccccchHHHHHHHHhhhccccee
Q 039819 340 SDSH--VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GMRALEFGKSINQKGAMLEWVKKIQQEKKVEVL 416 (534)
Q Consensus 340 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 416 (534)
.... ......||..|+|||++.+..++.++|||||||++|||+| |+.||..... .+....+.....
T Consensus 164 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~-------~~~~~~i~~~~~---- 232 (273)
T d1u46a_ 164 NDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG-------SQILHKIDKEGE---- 232 (273)
T ss_dssp -CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCH-------HHHHHHHHTSCC----
T ss_pred CCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCH-------HHHHHHHHhCCC----
Confidence 4332 2234568899999999999999999999999999999998 8999974321 111222222111
Q ss_pred cccccCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhc
Q 039819 417 VDRELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLEG 460 (534)
Q Consensus 417 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~ 460 (534)
....+...+..+.+++.+||+.||++||||.||++.|++
T Consensus 233 -----~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~ 271 (273)
T d1u46a_ 233 -----RLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLE 271 (273)
T ss_dssp -----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred -----CCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHh
Confidence 111122234578999999999999999999999998874
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-47 Score=380.09 Aligned_cols=239 Identities=29% Similarity=0.427 Sum_probs=189.6
Q ss_pred hCCCcCCeeccCCcEEEEEEEEC--------CCcEEEEEEehh---------------hhhhc-ccCceeeEEEEEeCCC
Q 039819 202 ENFSSKNILGAGGFGNVYKGKLG--------DGTVLAVKRLKD---------------MISLA-VHRNLLRLIGYCATPT 257 (534)
Q Consensus 202 ~~~~~~~~lG~G~~g~Vy~~~~~--------~~~~vavK~~~~---------------~l~~~-~h~niv~l~~~~~~~~ 257 (534)
++|...+.||+|+||.||+|+.. ++..||||+++. .+.++ +|||||+++++|.+..
T Consensus 13 ~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~ 92 (299)
T d1fgka_ 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG 92 (299)
T ss_dssp GGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred HHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccCC
Confidence 56778899999999999999852 235799998852 34444 7999999999999999
Q ss_pred eeEEEeeccCCCChhhhcccC----------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeC
Q 039819 258 ERLLVYPYMSNGSVASRLREK----------------PALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLD 321 (534)
Q Consensus 258 ~~~lv~e~~~~gsL~~~l~~~----------------~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~ 321 (534)
..++|||||++|+|.+++... ..+++.+++.++.|++.||+|||+. +||||||||+|||++
T Consensus 93 ~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~---~ivHrDiKp~NiLl~ 169 (299)
T d1fgka_ 93 PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVT 169 (299)
T ss_dssp SCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEC
T ss_pred eEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhC---CEEeeeecccceeec
Confidence 999999999999999999643 3589999999999999999999999 999999999999999
Q ss_pred CCCcEEEEecccceecCCCCC-ceeeccccccccccccccccCCCCcchhHHHHHHHHHHHHh-CCCCcCCCccccccch
Q 039819 322 DFCEAIVGDFGLAKLLDHSDS-HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GMRALEFGKSINQKGA 399 (534)
Q Consensus 322 ~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~ellt-G~~p~~~~~~~~~~~~ 399 (534)
.++.+||+|||+++....... .......||+.|+|||.+.++.++.++||||||||+|||+| |+.||..... ..
T Consensus 170 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~----~~ 245 (299)
T d1fgka_ 170 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV----EE 245 (299)
T ss_dssp TTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH----HH
T ss_pred CCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCH----HH
Confidence 999999999999997754332 22344668999999999999999999999999999999998 6888763321 11
Q ss_pred HHHHHHHHhhhcccceecccccCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhc
Q 039819 400 MLEWVKKIQQEKKVEVLVDRELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLEG 460 (534)
Q Consensus 400 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~ 460 (534)
+.+ .+..... +. .+...+..+.+++.+||+.+|++||||.||++.|+.
T Consensus 246 ~~~---~i~~~~~------~~----~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~ 293 (299)
T d1fgka_ 246 LFK---LLKEGHR------MD----KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDR 293 (299)
T ss_dssp HHH---HHHTTCC------CC----CCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHH---HHHcCCC------CC----CCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHH
Confidence 112 1111111 11 112234578999999999999999999999999975
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-47 Score=381.17 Aligned_cols=237 Identities=26% Similarity=0.394 Sum_probs=191.6
Q ss_pred hCCCcCCeeccCCcEEEEEEEECC-Cc--EEEEEEehh---------------hhhhc-ccCceeeEEEEEeCCCeeEEE
Q 039819 202 ENFSSKNILGAGGFGNVYKGKLGD-GT--VLAVKRLKD---------------MISLA-VHRNLLRLIGYCATPTERLLV 262 (534)
Q Consensus 202 ~~~~~~~~lG~G~~g~Vy~~~~~~-~~--~vavK~~~~---------------~l~~~-~h~niv~l~~~~~~~~~~~lv 262 (534)
++|+..+.||+|+||.||+|++.+ +. .||||++.. ++.++ +|||||+++|+|.+.+..++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 567788999999999999998753 33 578888742 56676 799999999999999999999
Q ss_pred eeccCCCChhhhcccC----------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcE
Q 039819 263 YPYMSNGSVASRLREK----------------PALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEA 326 (534)
Q Consensus 263 ~e~~~~gsL~~~l~~~----------------~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~ 326 (534)
|||+++|+|.++++.. ..++|..+.+++.|||+||.|||+. +||||||||+|||++.++.+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~---~iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVA 166 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCE
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcC---CccccccccceEEEcCCCce
Confidence 9999999999998643 5799999999999999999999999 99999999999999999999
Q ss_pred EEEecccceecCCCCCceeeccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCC-CcCCCccccccchHHHHHH
Q 039819 327 IVGDFGLAKLLDHSDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMR-ALEFGKSINQKGAMLEWVK 405 (534)
Q Consensus 327 kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~-p~~~~~~~~~~~~~~~~~~ 405 (534)
||+|||+++...... ......||..|+|||.+.++.++.++|||||||++|||++|.. ||.... ..+...
T Consensus 167 kl~DfG~a~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~-------~~~~~~ 237 (309)
T d1fvra_ 167 KIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT-------CAELYE 237 (309)
T ss_dssp EECCTTCEESSCEEC--CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC-------HHHHHH
T ss_pred EEccccccccccccc--cccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCC-------HHHHHH
Confidence 999999998654322 1234568999999999999999999999999999999999765 554321 112222
Q ss_pred HHhhhcccceecccccCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhc
Q 039819 406 KIQQEKKVEVLVDRELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLEG 460 (534)
Q Consensus 406 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~ 460 (534)
.+..... + ..+...+.++.+++.+||+.+|++||||.||++.|+.
T Consensus 238 ~i~~~~~------~----~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~ 282 (309)
T d1fvra_ 238 KLPQGYR------L----EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNR 282 (309)
T ss_dssp HGGGTCC------C----CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHhcCC------C----CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 2222111 1 1222234589999999999999999999999998875
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.1e-47 Score=380.47 Aligned_cols=239 Identities=20% Similarity=0.267 Sum_probs=189.6
Q ss_pred HhCCCcC-CeeccCCcEEEEEEEE-CCCcEEEEEEehh---------h-hhhcccCceeeEEEEEeC----CCeeEEEee
Q 039819 201 TENFSSK-NILGAGGFGNVYKGKL-GDGTVLAVKRLKD---------M-ISLAVHRNLLRLIGYCAT----PTERLLVYP 264 (534)
Q Consensus 201 ~~~~~~~-~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~---------~-l~~~~h~niv~l~~~~~~----~~~~~lv~e 264 (534)
.++|.+. ++||+|+||.||+|+. .+++.||||++.+ + +...+|||||+++++|.+ ....|+|||
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ivmE 89 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVME 89 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECSHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCcHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEEEEEE
Confidence 3678765 4699999999999997 5789999999863 3 345579999999999865 356799999
Q ss_pred ccCCCChhhhcccC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCC---CCcEEEEecccceecCC
Q 039819 265 YMSNGSVASRLREK--PALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDD---FCEAIVGDFGLAKLLDH 339 (534)
Q Consensus 265 ~~~~gsL~~~l~~~--~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~---~~~~kl~DFGla~~~~~ 339 (534)
||++|+|.+++... ..+++.+++.|+.|++.||+|||++ +|+||||||+|||++. .+.+||+|||+|+....
T Consensus 90 y~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~---~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~~ 166 (335)
T d2ozaa1 90 CLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTS 166 (335)
T ss_dssp CCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSTTCCEEECCCTTCEECCC
T ss_pred CCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHc---CCccccccccccccccccccccccccccceeeeccC
Confidence 99999999999753 4699999999999999999999999 9999999999999985 56799999999997754
Q ss_pred CCCceeeccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceeccc
Q 039819 340 SDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDR 419 (534)
Q Consensus 340 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 419 (534)
.. ......||+.|||||++.+..|+.++|||||||++|||+||+.||......... ..... .+...
T Consensus 167 ~~--~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~----~~~~~--------~i~~~ 232 (335)
T d2ozaa1 167 HN--SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS----PGMKT--------RIRMG 232 (335)
T ss_dssp CC--CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------------------CCCSC
T ss_pred CC--ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHH----HHHHH--------HHhcC
Confidence 33 234567999999999999999999999999999999999999999743321110 00000 00000
Q ss_pred c--cCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 420 E--LGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 420 ~--l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
. .........+.++.+++.+|++.||++|||+.|+++
T Consensus 233 ~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 271 (335)
T d2ozaa1 233 QYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 271 (335)
T ss_dssp SSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred CCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 0 111111223467899999999999999999999986
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.9e-47 Score=376.40 Aligned_cols=236 Identities=29% Similarity=0.436 Sum_probs=189.3
Q ss_pred CCeeccCCcEEEEEEEECCC----cEEEEEEehh---------------hhhhcccCceeeEEEEEeC-CCeeEEEeecc
Q 039819 207 KNILGAGGFGNVYKGKLGDG----TVLAVKRLKD---------------MISLAVHRNLLRLIGYCAT-PTERLLVYPYM 266 (534)
Q Consensus 207 ~~~lG~G~~g~Vy~~~~~~~----~~vavK~~~~---------------~l~~~~h~niv~l~~~~~~-~~~~~lv~e~~ 266 (534)
.++||+|+||+||+|++.++ ..||||++.+ ++++++|||||+++|+|.+ +...++|||||
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 36799999999999997532 3689998852 6788899999999999875 45789999999
Q ss_pred CCCChhhhccc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCC---
Q 039819 267 SNGSVASRLRE-KPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDS--- 342 (534)
Q Consensus 267 ~~gsL~~~l~~-~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~--- 342 (534)
++|+|.+++.. ...+++..+++++.|++.||.|||+. +|+||||||+|||+++++.+||+|||+++.......
T Consensus 112 ~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~---~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~~ 188 (311)
T d1r0pa_ 112 KHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSV 188 (311)
T ss_dssp TTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCCT
T ss_pred ecCchhhhhccccccchHHHHHHHHHHHHHhhhhhccc---CcccCCccHHhEeECCCCCEEEecccchhhccccccccc
Confidence 99999998874 45688999999999999999999999 999999999999999999999999999997654322
Q ss_pred ceeeccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceecccccC
Q 039819 343 HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELG 422 (534)
Q Consensus 343 ~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 422 (534)
.......||..|+|||.+.++.++.++|||||||++|||+||+.||...... .++...+......
T Consensus 189 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~------~~~~~~i~~g~~~--------- 253 (311)
T d1r0pa_ 189 HNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT------FDITVYLLQGRRL--------- 253 (311)
T ss_dssp TCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------------CHHHHHTTCCC---------
T ss_pred eecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCH------HHHHHHHHcCCCC---------
Confidence 1223356899999999999999999999999999999999988887643221 1122222221111
Q ss_pred CCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhcC
Q 039819 423 SNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLEGD 461 (534)
Q Consensus 423 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~~ 461 (534)
..+...+..+.+++.+||+.+|++||+|.||++.|+..
T Consensus 254 -~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i 291 (311)
T d1r0pa_ 254 -LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 291 (311)
T ss_dssp -CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -CCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 11122345789999999999999999999999998753
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-46 Score=367.69 Aligned_cols=225 Identities=23% Similarity=0.388 Sum_probs=187.7
Q ss_pred hCCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEehh--------------------hhhhcc--cCceeeEEEEEeCCCe
Q 039819 202 ENFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLKD--------------------MISLAV--HRNLLRLIGYCATPTE 258 (534)
Q Consensus 202 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~--------------------~l~~~~--h~niv~l~~~~~~~~~ 258 (534)
++|...+.||+|+||.||+|+.. +++.||||++.. +++.+. |||||++++++.+++.
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~ 83 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 83 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence 57888999999999999999974 789999998742 445554 8999999999999999
Q ss_pred eEEEeeccCC-CChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCC-CCcEEEEeccccee
Q 039819 259 RLLVYPYMSN-GSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDD-FCEAIVGDFGLAKL 336 (534)
Q Consensus 259 ~~lv~e~~~~-gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~-~~~~kl~DFGla~~ 336 (534)
.++||||+.+ +++.+++.....+++.+++.++.|++.||+|||++ +||||||||+|||++. ++.+||+|||+|+.
T Consensus 84 ~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~ 160 (273)
T d1xwsa_ 84 FVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSGAL 160 (273)
T ss_dssp EEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CCccccCcccceEEecCCCeEEECcccccee
Confidence 9999999975 68888888888899999999999999999999999 9999999999999985 47999999999987
Q ss_pred cCCCCCceeeccccccccccccccccCCC-CcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccce
Q 039819 337 LDHSDSHVTTAVRGTVGHIAPEYLSTGQS-SEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEV 415 (534)
Q Consensus 337 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 415 (534)
.... ......||+.|+|||++.+..+ +.++|||||||++|||+||+.||..... + .. ..
T Consensus 161 ~~~~---~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~------i-------~~-~~--- 220 (273)
T d1xwsa_ 161 LKDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------I-------IR-GQ--- 220 (273)
T ss_dssp CCSS---CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------H-------HH-CC---
T ss_pred cccc---cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchH------H-------hh-cc---
Confidence 6433 2345679999999999987765 6779999999999999999999973210 0 00 00
Q ss_pred ecccccCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 416 LVDRELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 416 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
....... +.++.+++.+|++.||++|||++|+++
T Consensus 221 ---~~~~~~~----s~~~~~li~~~L~~dp~~R~s~~eil~ 254 (273)
T d1xwsa_ 221 ---VFFRQRV----SSECQHLIRWCLALRPSDRPTFEEIQN 254 (273)
T ss_dssp ---CCCSSCC----CHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ---cCCCCCC----CHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 0111122 357899999999999999999999975
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-46 Score=372.00 Aligned_cols=237 Identities=20% Similarity=0.256 Sum_probs=195.9
Q ss_pred HhCCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEeh-------------hhhhhcccCceeeEEEEEeCCCeeEEEeecc
Q 039819 201 TENFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLK-------------DMISLAVHRNLLRLIGYCATPTERLLVYPYM 266 (534)
Q Consensus 201 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~-------------~~l~~~~h~niv~l~~~~~~~~~~~lv~e~~ 266 (534)
.++|...+.||+|+||+||+|... +++.||||.+. ++++.++|||||++++++.+....|+|||||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~ 83 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFI 83 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecC
Confidence 467889999999999999999985 68899999885 2688999999999999999999999999999
Q ss_pred CCCChhhhcccCC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCC--CCcEEEEecccceecCCCCCc
Q 039819 267 SNGSVASRLREKP-ALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDD--FCEAIVGDFGLAKLLDHSDSH 343 (534)
Q Consensus 267 ~~gsL~~~l~~~~-~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~--~~~~kl~DFGla~~~~~~~~~ 343 (534)
++|+|.+++...+ .+++.+++.|+.||+.||.|||++ +|+||||||+|||++. ...+||+|||+++......
T Consensus 84 ~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~---~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~-- 158 (321)
T d1tkia_ 84 SGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD-- 158 (321)
T ss_dssp CCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC--
T ss_pred CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHc---CCCcccccccceeecCCCceEEEEcccchhhccccCC--
Confidence 9999999998654 799999999999999999999999 9999999999999984 4589999999999775432
Q ss_pred eeeccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceecccccCC
Q 039819 344 VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLVDRELGS 423 (534)
Q Consensus 344 ~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 423 (534)
......||+.|+|||.+.+..++.++||||+||++|||+||+.||..... .+....+..... .++.....
T Consensus 159 ~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~-------~~~~~~i~~~~~---~~~~~~~~ 228 (321)
T d1tkia_ 159 NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETN-------QQIIENIMNAEY---TFDEEAFK 228 (321)
T ss_dssp EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSH-------HHHHHHHHHTCC---CCCHHHHT
T ss_pred cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCH-------HHHHHHHHhCCC---CCChhhcc
Confidence 34445689999999999999999999999999999999999999975432 112222221110 00000001
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 424 NYDRIEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 424 ~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
. .+.++.+++.+|++.||.+|||+.|+++
T Consensus 229 ~----~s~~~~~li~~~L~~dp~~R~s~~eil~ 257 (321)
T d1tkia_ 229 E----ISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp T----SCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred C----CCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1 2347889999999999999999999986
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-46 Score=371.33 Aligned_cols=248 Identities=21% Similarity=0.308 Sum_probs=190.2
Q ss_pred hCCCcCCeeccCCcEEEEEEEE-CCCcEEEEEEeh----------------hhhhhcccCceeeEEEEEeCCCeeEEEee
Q 039819 202 ENFSSKNILGAGGFGNVYKGKL-GDGTVLAVKRLK----------------DMISLAVHRNLLRLIGYCATPTERLLVYP 264 (534)
Q Consensus 202 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~----------------~~l~~~~h~niv~l~~~~~~~~~~~lv~e 264 (534)
++|+..+.||+|+||.||+|+. .+++.||||+++ ++++.++|||||++++++.++...|+|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 5788999999999999999997 478999999874 26788999999999999999999999999
Q ss_pred ccCCCChhhhcc-cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCCc
Q 039819 265 YMSNGSVASRLR-EKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSH 343 (534)
Q Consensus 265 ~~~~gsL~~~l~-~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~ 343 (534)
|+.++.+..... ....+++..+..++.|++.||.|||++ +||||||||+|||++.++.+||+|||+|+...... .
T Consensus 82 ~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~---~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~-~ 157 (298)
T d1gz8a_ 82 FLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-R 157 (298)
T ss_dssp CCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS-B
T ss_pred ecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcC---CEEccccCchheeecccCcceeccCCcceeccCCc-c
Confidence 997654443333 355699999999999999999999999 99999999999999999999999999998775432 2
Q ss_pred eeeccccccccccccccccCC-CCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhc---c--cceec
Q 039819 344 VTTAVRGTVGHIAPEYLSTGQ-SSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEK---K--VEVLV 417 (534)
Q Consensus 344 ~~~~~~gt~~y~aPE~~~~~~-~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~---~--~~~~~ 417 (534)
......||+.|+|||.+.... ++.++|||||||++|||++|+.||........ +........... . .....
T Consensus 158 ~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~---~~~i~~~~~~~~~~~~~~~~~~~ 234 (298)
T d1gz8a_ 158 TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQ---LFRIFRTLGTPDEVVWPGVTSMP 234 (298)
T ss_dssp CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHHHHCCCCTTTSTTGGGST
T ss_pred cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHH---HHHHHHhcCCCchhhcccccccc
Confidence 334457999999999876655 57899999999999999999999975432211 111111100000 0 00000
Q ss_pred c--cccCC--CCC-----HHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 418 D--RELGS--NYD-----RIEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 418 d--~~l~~--~~~-----~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
+ ..... ... .....++.+++.+|++.||++|||+.|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~ 282 (298)
T d1gz8a_ 235 DYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 282 (298)
T ss_dssp TCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 0 00000 000 012357889999999999999999999974
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-46 Score=373.26 Aligned_cols=240 Identities=23% Similarity=0.375 Sum_probs=196.4
Q ss_pred hCCCcCCeeccCCcEEEEEEEEC------CCcEEEEEEehh---------------hhhhcccCceeeEEEEEeCCCeeE
Q 039819 202 ENFSSKNILGAGGFGNVYKGKLG------DGTVLAVKRLKD---------------MISLAVHRNLLRLIGYCATPTERL 260 (534)
Q Consensus 202 ~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~---------------~l~~~~h~niv~l~~~~~~~~~~~ 260 (534)
++|...+.||+|+||.||+|.+. +++.||||+++. ++.++.|||||+++++|......+
T Consensus 20 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~ 99 (308)
T d1p4oa_ 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTL 99 (308)
T ss_dssp GGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCE
T ss_pred HHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCcee
Confidence 56777889999999999999863 357899998862 678889999999999999999999
Q ss_pred EEeeccCCCChhhhcccC----------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEe
Q 039819 261 LVYPYMSNGSVASRLREK----------PALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGD 330 (534)
Q Consensus 261 lv~e~~~~gsL~~~l~~~----------~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~D 330 (534)
+|||||++|+|.+++... ..+++..+.+++.|+|+||.|||++ +|+||||||+|||+++++++||+|
T Consensus 100 lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~---~ivHrDlk~~NiLld~~~~~Kl~D 176 (308)
T d1p4oa_ 100 VIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGD 176 (308)
T ss_dssp EEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTCCEEECC
T ss_pred EEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeeceEcCCceeecCCceEEEee
Confidence 999999999999988521 3579999999999999999999998 999999999999999999999999
Q ss_pred cccceecCCCCCc-eeeccccccccccccccccCCCCcchhHHHHHHHHHHHHhCC-CCcCCCccccccchHHHHHHHHh
Q 039819 331 FGLAKLLDHSDSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGM-RALEFGKSINQKGAMLEWVKKIQ 408 (534)
Q Consensus 331 FGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~-~p~~~~~~~~~~~~~~~~~~~~~ 408 (534)
||+|+.+...... ......||+.|+|||.+.++.++.++|||||||++|||+||+ .||.... ..++...+.
T Consensus 177 FGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~-------~~~~~~~i~ 249 (308)
T d1p4oa_ 177 FGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS-------NEQVLRFVM 249 (308)
T ss_dssp TTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC-------HHHHHHHHH
T ss_pred cccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCC-------HHHHHHHHH
Confidence 9999876543322 223345899999999999999999999999999999999995 5564321 123333322
Q ss_pred hhcccceecccccCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhcC
Q 039819 409 QEKKVEVLVDRELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLEGD 461 (534)
Q Consensus 409 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~~ 461 (534)
..... ..+...+..+.+++.+||+.+|.+||||.+|+++|+..
T Consensus 250 ~~~~~----------~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~ 292 (308)
T d1p4oa_ 250 EGGLL----------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEE 292 (308)
T ss_dssp TTCCC----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGG
T ss_pred hCCCC----------CCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 22111 11122345899999999999999999999999999864
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=6.3e-46 Score=366.49 Aligned_cols=251 Identities=20% Similarity=0.281 Sum_probs=192.7
Q ss_pred hCCCcCCeeccCCcEEEEEEEECCCcEEEEEEeh----------------hhhhhcccCceeeEEEEEeCCCeeEEEeec
Q 039819 202 ENFSSKNILGAGGFGNVYKGKLGDGTVLAVKRLK----------------DMISLAVHRNLLRLIGYCATPTERLLVYPY 265 (534)
Q Consensus 202 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~----------------~~l~~~~h~niv~l~~~~~~~~~~~lv~e~ 265 (534)
++|...+.||+|+||+||+|+..+|+.||||++. ++++.++|||||++++++......+++|||
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 5788899999999999999999999999999974 267889999999999999999999999999
Q ss_pred cCCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCCcee
Q 039819 266 MSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHVT 345 (534)
Q Consensus 266 ~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~ 345 (534)
+.++.+..+....+.+++..+..|+.||+.||+|||+. +||||||||+|||++.++.+||+|||.+........ ..
T Consensus 82 ~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~-~~ 157 (286)
T d1ob3a_ 82 LDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR-KY 157 (286)
T ss_dssp CSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC------
T ss_pred ehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccC---cEEecCCCCceeeEcCCCCEEecccccceecccCcc-cc
Confidence 99988888888788899999999999999999999998 999999999999999999999999999987654322 23
Q ss_pred ecccccccccccccccc-CCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcc--ccee--cccc
Q 039819 346 TAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKK--VEVL--VDRE 420 (534)
Q Consensus 346 ~~~~gt~~y~aPE~~~~-~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~--~d~~ 420 (534)
....|++.|+|||.+.+ ..++.++|||||||++|||++|+.||......+....+............ .... .+..
T Consensus 158 ~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 237 (286)
T d1ob3a_ 158 THEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPN 237 (286)
T ss_dssp ----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTT
T ss_pred ceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhcccc
Confidence 34468999999999865 45689999999999999999999999754322211111110000000000 0000 0000
Q ss_pred cC-------CCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 421 LG-------SNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 421 l~-------~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
.. ..........+.+++.+|++.||++|||++|+++
T Consensus 238 ~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 238 FTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp CCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00 0011112357889999999999999999999974
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-46 Score=370.11 Aligned_cols=251 Identities=22% Similarity=0.337 Sum_probs=188.9
Q ss_pred HhCCCcCCeeccCCcEEEEEEEEC-C-CcEEEEEEehh----------------h---hhhcccCceeeEEEEEeC----
Q 039819 201 TENFSSKNILGAGGFGNVYKGKLG-D-GTVLAVKRLKD----------------M---ISLAVHRNLLRLIGYCAT---- 255 (534)
Q Consensus 201 ~~~~~~~~~lG~G~~g~Vy~~~~~-~-~~~vavK~~~~----------------~---l~~~~h~niv~l~~~~~~---- 255 (534)
.++|+..+.||+|+||+||+|+.. + ++.||||+++. + ++..+||||++++++|..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 368999999999999999999973 3 67899998741 2 344479999999999853
Q ss_pred -CCeeEEEeeccCCCChhhhcc-cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEeccc
Q 039819 256 -PTERLLVYPYMSNGSVASRLR-EKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGL 333 (534)
Q Consensus 256 -~~~~~lv~e~~~~gsL~~~l~-~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGl 333 (534)
....+++|||++++++..... ....+++..++.++.|++.||+|||++ +||||||||+|||++.++.+||+|||+
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~---~ivHrDiKp~NILi~~~~~~kl~dfg~ 162 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGL 162 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECSCCS
T ss_pred cCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecCCCccEEEEcCCCCeeecchhh
Confidence 346789999999887754443 456799999999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCCceeeccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhccc
Q 039819 334 AKLLDHSDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKV 413 (534)
Q Consensus 334 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 413 (534)
++..... .......||+.|+|||++.+..++.++||||+||++|||+||+.||...........+.............
T Consensus 163 ~~~~~~~--~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 240 (305)
T d1blxa_ 163 ARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP 240 (305)
T ss_dssp CCCCCGG--GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSC
T ss_pred hhhhccc--ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhccc
Confidence 9865432 23445679999999999999999999999999999999999999998554322221221111110000000
Q ss_pred ce------eccccc---CCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 414 EV------LVDREL---GSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 414 ~~------~~d~~l---~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
.. ...... ...........+.+++.+|++.||++|||+.|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~ 292 (305)
T d1blxa_ 241 RDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292 (305)
T ss_dssp TTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred ccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 00 000000 00011122347889999999999999999999874
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-44 Score=367.43 Aligned_cols=249 Identities=23% Similarity=0.308 Sum_probs=186.4
Q ss_pred CCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEehh----------hhhhcccCceeeEEEEEeCC------CeeEEEeec
Q 039819 203 NFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLKD----------MISLAVHRNLLRLIGYCATP------TERLLVYPY 265 (534)
Q Consensus 203 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~----------~l~~~~h~niv~l~~~~~~~------~~~~lv~e~ 265 (534)
+|+..++||+|+||+||+|+.. +|+.||||++.. +++.++|||||+++++|... ...++||||
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~Ey 100 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDY 100 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSSCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEEEEC
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchHHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEEEec
Confidence 4667789999999999999985 689999998852 78889999999999998543 346899999
Q ss_pred cCCCChhhhc---ccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCC-cEEEEecccceecCCCC
Q 039819 266 MSNGSVASRL---REKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFC-EAIVGDFGLAKLLDHSD 341 (534)
Q Consensus 266 ~~~gsL~~~l---~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~-~~kl~DFGla~~~~~~~ 341 (534)
|+++.+.... .....+++..++.|+.||+.||+|||++ +||||||||+|||++.++ .+||+|||+++......
T Consensus 101 ~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~---~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~~~ 177 (350)
T d1q5ka_ 101 VPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE 177 (350)
T ss_dssp CSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTTCCEEECCCTTCEECCTTS
T ss_pred cCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhc---CCcccCCCcceEEEecCCCceeEecccchhhccCCc
Confidence 9876544333 3556799999999999999999999998 999999999999999775 89999999998775433
Q ss_pred Cceeecccccccccccccccc-CCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHH--------HHHHhhhc-
Q 039819 342 SHVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEW--------VKKIQQEK- 411 (534)
Q Consensus 342 ~~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~--------~~~~~~~~- 411 (534)
......||..|+|||.+.+ ..++.++||||+||++|||++|+.||......+....+... ........
T Consensus 178 --~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~ 255 (350)
T d1q5ka_ 178 --PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYT 255 (350)
T ss_dssp --CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC---
T ss_pred --ccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhccchh
Confidence 2344579999999998765 56899999999999999999999999755432221111111 11100000
Q ss_pred --ccceecccccCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 412 --KVEVLVDRELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 412 --~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
.....................+.+++.+|++.||++|||+.|+++
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 302 (350)
T d1q5ka_ 256 EFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 302 (350)
T ss_dssp CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000000000000011123457889999999999999999999875
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9e-44 Score=356.35 Aligned_cols=252 Identities=23% Similarity=0.301 Sum_probs=190.2
Q ss_pred HhCCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEeh----------------hhhhhcccCceeeEEEEEeCC-------
Q 039819 201 TENFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLK----------------DMISLAVHRNLLRLIGYCATP------- 256 (534)
Q Consensus 201 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~----------------~~l~~~~h~niv~l~~~~~~~------- 256 (534)
.++|+..+.||+|+||+||+|+.. +|+.||||++. ++++.++||||+++++++...
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 368889999999999999999974 79999999874 267889999999999998653
Q ss_pred -CeeEEEeeccCCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccce
Q 039819 257 -TERLLVYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAK 335 (534)
Q Consensus 257 -~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~ 335 (534)
...++||||+.++.+.........++...++.|+.|++.||.|||++ +||||||||+|||++.++.+||+|||+++
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~---~ivHrDlKp~NILl~~~~~~kl~dfg~~~ 165 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLAR 165 (318)
T ss_dssp --CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCE
T ss_pred CceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccC---CEEecCcCchheeecCCCcEEeeecceee
Confidence 45789999999988877777777899999999999999999999999 99999999999999999999999999998
Q ss_pred ecCCCCC---ceeeccccccccccccccccC-CCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhc
Q 039819 336 LLDHSDS---HVTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEK 411 (534)
Q Consensus 336 ~~~~~~~---~~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 411 (534)
....... .......||+.|+|||++.+. .++.++|||||||++|||+||+.||...........+..........
T Consensus 166 ~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~- 244 (318)
T d3blha1 166 AFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPE- 244 (318)
T ss_dssp ECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTT-
T ss_pred ecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChh-
Confidence 7653221 122345699999999998765 68999999999999999999999997543222111111111100000
Q ss_pred ccceeccc--------ccCCCCCH-------HHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 412 KVEVLVDR--------ELGSNYDR-------IEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 412 ~~~~~~d~--------~l~~~~~~-------~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
........ ........ .....+.+++.+|++.||++|||++|+++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~ 304 (318)
T d3blha1 245 VWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 304 (318)
T ss_dssp TSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred hccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHc
Confidence 00000000 00000111 11236678999999999999999999985
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-44 Score=358.05 Aligned_cols=238 Identities=24% Similarity=0.349 Sum_probs=193.6
Q ss_pred hCCCcCCeeccCCcEEEEEEEE----CCCcEEEEEEeh------------------hhhhhccc-CceeeEEEEEeCCCe
Q 039819 202 ENFSSKNILGAGGFGNVYKGKL----GDGTVLAVKRLK------------------DMISLAVH-RNLLRLIGYCATPTE 258 (534)
Q Consensus 202 ~~~~~~~~lG~G~~g~Vy~~~~----~~~~~vavK~~~------------------~~l~~~~h-~niv~l~~~~~~~~~ 258 (534)
++|+..+.||+|+||+||+|+. .+|+.||||.++ +++.+++| |||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 6699999999999999999986 247899999874 25677777 799999999999999
Q ss_pred eEEEeeccCCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecC
Q 039819 259 RLLVYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLD 338 (534)
Q Consensus 259 ~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~ 338 (534)
.++||||+.+|+|.+++.....++......++.|++.||.|||++ +||||||||+|||++.++.+||+|||+++.+.
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~ 180 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFV 180 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEEEECC
T ss_pred eeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcC---CEEeccCCccceeecCCCCEEEeeccchhhhc
Confidence 999999999999999999888899999999999999999999999 99999999999999999999999999998775
Q ss_pred CCCCceeeccccccccccccccccC--CCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhccccee
Q 039819 339 HSDSHVTTAVRGTVGHIAPEYLSTG--QSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVL 416 (534)
Q Consensus 339 ~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 416 (534)
...........|++.|+|||.+.+. .++.++|||||||+||||+||+.||...........+ ...... ..
T Consensus 181 ~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i---~~~~~~-~~---- 252 (322)
T d1vzoa_ 181 ADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEI---SRRILK-SE---- 252 (322)
T ss_dssp GGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHH---HHHHHH-CC----
T ss_pred ccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH---HHhccc-CC----
Confidence 4444444556799999999998654 4688999999999999999999999765433222111 111111 00
Q ss_pred cccccCCCCCHHHHHHHHHHHHHhcccCCCCCCC-----hHHHHH
Q 039819 417 VDRELGSNYDRIEVGEILQVALLCTQYLPVHRPK-----MSEVVR 456 (534)
Q Consensus 417 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt-----~~ev~~ 456 (534)
+ .++...+.++.+++.+|++.||.+||+ ++|+++
T Consensus 253 --~----~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 253 --P----PYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp --C----CCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred --C----CCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence 1 112223458899999999999999995 667653
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-43 Score=350.24 Aligned_cols=248 Identities=21% Similarity=0.275 Sum_probs=194.3
Q ss_pred hCCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEeh----------------hhhhhcccCceeeEEEEEeCCCeeEEEee
Q 039819 202 ENFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLK----------------DMISLAVHRNLLRLIGYCATPTERLLVYP 264 (534)
Q Consensus 202 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~----------------~~l~~~~h~niv~l~~~~~~~~~~~lv~e 264 (534)
++|+..+.||+|+||+||+|+.. +++.||||+++ .+++.++|||||+++++|.+....++|+|
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 57889999999999999999974 78999999874 15788899999999999999999999999
Q ss_pred ccCCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCCCce
Q 039819 265 YMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSDSHV 344 (534)
Q Consensus 265 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~ 344 (534)
|+.+++|..++...+.+++..+..++.|++.||+|||++ +||||||||+|||++.++.+||+|||.++....... .
T Consensus 82 ~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~---~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~-~ 157 (292)
T d1unla_ 82 FCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR-C 157 (292)
T ss_dssp CCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCS-C
T ss_pred eccccccccccccccccchhHHHHHHHHHHHHHHHhhcC---CEeeecccCcccccccCCceeeeecchhhcccCCCc-c
Confidence 999999999888888899999999999999999999998 999999999999999999999999999998754332 2
Q ss_pred eeccccccccccccccccCC-CCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhh---ccc---ceec
Q 039819 345 TTAVRGTVGHIAPEYLSTGQ-SSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQE---KKV---EVLV 417 (534)
Q Consensus 345 ~~~~~gt~~y~aPE~~~~~~-~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~---~~~~ 417 (534)
.....++..|+|||.+.... ++.++|||||||++|||++|+.||..+....+. ..-+...... ... ....
T Consensus 158 ~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~ 234 (292)
T d1unla_ 158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQ---LKRIFRLLGTPTEEQWPSMTKLP 234 (292)
T ss_dssp CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHH---HHHHHHHHCCCCTTTCTTGGGST
T ss_pred ceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHH---HHHHHhhcCCCChhhhhhhhhcc
Confidence 33445788999999987655 689999999999999999999997543322111 1111110000 000 0000
Q ss_pred c---------cccCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 418 D---------RELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 418 d---------~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
+ ..-...........+.+++.+|++.||.+|||++|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~ 282 (292)
T d1unla_ 235 DYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp TCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred cccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0 00000111222357889999999999999999999874
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=6.5e-43 Score=346.99 Aligned_cols=245 Identities=18% Similarity=0.199 Sum_probs=186.5
Q ss_pred hCCCcCCeeccCCcEEEEEEEE-CCCcEEEEEEeh------------hhhhhcccCceeeE-EEEEeCCCeeEEEeeccC
Q 039819 202 ENFSSKNILGAGGFGNVYKGKL-GDGTVLAVKRLK------------DMISLAVHRNLLRL-IGYCATPTERLLVYPYMS 267 (534)
Q Consensus 202 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~------------~~l~~~~h~niv~l-~~~~~~~~~~~lv~e~~~ 267 (534)
++|+..+.||+|+||.||+|+. .+++.||||.+. ++++.+.|+|++.. .+++.+.+..++||||+.
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~~ 86 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLG 86 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECCC
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEEcC
Confidence 4688899999999999999997 468999999865 26777777765555 555577788899999995
Q ss_pred CCChhhhc-ccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeC---CCCcEEEEecccceecCCCCCc
Q 039819 268 NGSVASRL-REKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLD---DFCEAIVGDFGLAKLLDHSDSH 343 (534)
Q Consensus 268 ~gsL~~~l-~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~---~~~~~kl~DFGla~~~~~~~~~ 343 (534)
|++.+.+ .....+++..+..++.|++.||+|||++ +||||||||+|||++ .+..+||+|||+|+........
T Consensus 87 -~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~~ 162 (299)
T d1ckia_ 87 -PSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTH 162 (299)
T ss_dssp -CBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTTC
T ss_pred -CchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHhhccccccCCCceeeeeccCcceeccccccc
Confidence 4555554 4566799999999999999999999999 999999999999975 4567999999999987543321
Q ss_pred ------eeeccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccceec
Q 039819 344 ------VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEVLV 417 (534)
Q Consensus 344 ------~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 417 (534)
......||+.|||||.+.+..++.++|||||||++|||+||+.||..............+...... ..
T Consensus 163 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~-~~----- 236 (299)
T d1ckia_ 163 QHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMS-TP----- 236 (299)
T ss_dssp CBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHH-SC-----
T ss_pred cceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCC-CC-----
Confidence 234567999999999999999999999999999999999999999754332222212122111100 00
Q ss_pred ccccCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhc
Q 039819 418 DRELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLEG 460 (534)
Q Consensus 418 d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~ 460 (534)
.+.+... .+.++.+++..|++.+|++||++.++.+.|+.
T Consensus 237 ~~~~~~~----~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 275 (299)
T d1ckia_ 237 IEVLCKG----YPSEFATYLNFCRSLRFDDKPDYSYLRQLFRN 275 (299)
T ss_dssp HHHHTTT----SCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHH
T ss_pred hhHhccC----CCHHHHHHHHHHccCChhHCcCHHHHHHHHHH
Confidence 0111111 23478999999999999999999999888764
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-43 Score=354.89 Aligned_cols=251 Identities=20% Similarity=0.305 Sum_probs=184.4
Q ss_pred hCCCcCCeeccCCcEEEEEEEE-CCCcEEEEEEeh---------------hhhhhcccCceeeEEEEEeCCC----eeEE
Q 039819 202 ENFSSKNILGAGGFGNVYKGKL-GDGTVLAVKRLK---------------DMISLAVHRNLLRLIGYCATPT----ERLL 261 (534)
Q Consensus 202 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~---------------~~l~~~~h~niv~l~~~~~~~~----~~~l 261 (534)
++|...+.||+|+||+||+|+. .+|+.||||++. .++..++||||+++++++.... ..++
T Consensus 8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~ 87 (345)
T d1pmea_ 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVY 87 (345)
T ss_dssp TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEE
T ss_pred CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEE
Confidence 5688899999999999999987 479999999985 2678889999999999997653 3355
Q ss_pred EeeccCCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecCCCC
Q 039819 262 VYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLDHSD 341 (534)
Q Consensus 262 v~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~~~~ 341 (534)
+++|+.+|+|.+++..+ .+++..++.++.|++.||+|||++ +||||||||+|||++.++.+||+|||+++......
T Consensus 88 l~~~~~~g~L~~~l~~~-~l~~~~i~~i~~qil~al~yLH~~---~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~ 163 (345)
T d1pmea_ 88 LVTHLMGADLYKLLKTQ-HLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH 163 (345)
T ss_dssp EEEECCCEEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCGGG
T ss_pred EEEeecCCchhhhhhcC-CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCcceEEECCCCCEEEcccCceeeccCCC
Confidence 66677799999999754 599999999999999999999999 99999999999999999999999999998764322
Q ss_pred C--ceeecccccccccccccccc-CCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhc-------
Q 039819 342 S--HVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEK------- 411 (534)
Q Consensus 342 ~--~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~------- 411 (534)
. .......||+.|+|||++.. ..++.++||||+||++|||++|+.||......+................
T Consensus 164 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (345)
T d1pmea_ 164 DHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL 243 (345)
T ss_dssp CBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCCH
T ss_pred ccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhhhh
Confidence 1 12344669999999999854 4578999999999999999999999975443221111110000000000
Q ss_pred ccce-ecccccCCCCCH-----HHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 412 KVEV-LVDRELGSNYDR-----IEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 412 ~~~~-~~d~~l~~~~~~-----~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
.... ..........+. ....++.+++.+|++.||.+|||+.|+++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~ 294 (345)
T d1pmea_ 244 KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 294 (345)
T ss_dssp HHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred hhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0000 000000000010 11246889999999999999999999984
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.2e-43 Score=353.48 Aligned_cols=245 Identities=22% Similarity=0.342 Sum_probs=181.3
Q ss_pred hCCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEehh----------------hhhhcccCceeeEEEEEeCCC------e
Q 039819 202 ENFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLKD----------------MISLAVHRNLLRLIGYCATPT------E 258 (534)
Q Consensus 202 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~----------------~l~~~~h~niv~l~~~~~~~~------~ 258 (534)
++|+..+.||+|+||+||+|... +|+.||||++.. +++.++|||||+++++|...+ .
T Consensus 18 ~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~ 97 (346)
T d1cm8a_ 18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTD 97 (346)
T ss_dssp SSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCC
T ss_pred CcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccce
Confidence 57888999999999999999975 699999999852 678889999999999997654 4
Q ss_pred eEEEeeccCCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecC
Q 039819 259 RLLVYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLD 338 (534)
Q Consensus 259 ~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~ 338 (534)
.++||||+ +.+|....+ ...+++..++.++.|++.||.|||++ +||||||||+|||++.++.+|++|||+|+...
T Consensus 98 ~~lv~e~~-~~~l~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~---~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~ 172 (346)
T d1cm8a_ 98 FYLVMPFM-GTDLGKLMK-HEKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQAD 172 (346)
T ss_dssp CEEEEECC-SEEHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEEEEecc-cccHHHHHH-hccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCcchhhcccccccccccccceeccC
Confidence 69999999 556766654 45699999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCceeeccccccccccccccccC-CCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHH--------HHHhh
Q 039819 339 HSDSHVTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWV--------KKIQQ 409 (534)
Q Consensus 339 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~--------~~~~~ 409 (534)
.. .+...||+.|+|||++.+. .++.++||||+||++|||++|+.||...........+.... .....
T Consensus 173 ~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (346)
T d1cm8a_ 173 SE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQS 248 (346)
T ss_dssp SS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSC
T ss_pred Cc----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcc
Confidence 32 3456799999999998764 56899999999999999999999997543221111111000 00000
Q ss_pred ------hcccceecccccCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 410 ------EKKVEVLVDRELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 410 ------~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
...........+. .........+.+++.+|++.||.+|||+.|+++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~-~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~ 300 (346)
T d1cm8a_ 249 DEAKNYMKGLPELEKKDFA-SILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 300 (346)
T ss_dssp HHHHHHHHHSCCCCCCCGG-GTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred hhhhhhhccCCcccccchH-HhccCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 0000000000000 011112346789999999999999999999986
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=2.3e-42 Score=341.82 Aligned_cols=245 Identities=17% Similarity=0.216 Sum_probs=193.9
Q ss_pred hCCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEehh------------hhhhccc-CceeeEEEEEeCCCeeEEEeeccC
Q 039819 202 ENFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLKD------------MISLAVH-RNLLRLIGYCATPTERLLVYPYMS 267 (534)
Q Consensus 202 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~------------~l~~~~h-~niv~l~~~~~~~~~~~lv~e~~~ 267 (534)
++|...+.||+|+||.||+|+.. +|+.||||.+.. .+..+.| +|++.+++++......++||||+
T Consensus 5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~~- 83 (293)
T d1csna_ 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL- 83 (293)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-
T ss_pred CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEec-
Confidence 57888999999999999999975 689999998742 4555554 89999999999999999999999
Q ss_pred CCChhhhccc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCC-----CCcEEEEecccceecCCCC
Q 039819 268 NGSVASRLRE-KPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDD-----FCEAIVGDFGLAKLLDHSD 341 (534)
Q Consensus 268 ~gsL~~~l~~-~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~-----~~~~kl~DFGla~~~~~~~ 341 (534)
+|+|.+++.. ...+++.++..++.|++.||+|||++ +||||||||+|||++. ++.+||+|||+|+......
T Consensus 84 ~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~---giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~~ 160 (293)
T d1csna_ 84 GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPV 160 (293)
T ss_dssp CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTT
T ss_pred CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHC---CceeccCCccceeecCcccccCCceEEcccceeEEcccCc
Confidence 6899988875 45799999999999999999999999 9999999999999974 5789999999999875432
Q ss_pred C------ceeeccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhhcccce
Q 039819 342 S------HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQEKKVEV 415 (534)
Q Consensus 342 ~------~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 415 (534)
. ......+||+.|||||++.+..++.++|||||||++|||+||+.||............ ..+.........
T Consensus 161 ~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~-~~i~~~~~~~~~-- 237 (293)
T d1csna_ 161 TKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKY-ERIGEKKQSTPL-- 237 (293)
T ss_dssp TCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHH-HHHHHHHHHSCH--
T ss_pred cccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHH-HHHHhccCCCCh--
Confidence 1 1233567999999999999999999999999999999999999999754432221111 111111110110
Q ss_pred ecccccCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHHHhhc
Q 039819 416 LVDRELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVRMLEG 460 (534)
Q Consensus 416 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~~L~~ 460 (534)
+.+.... +.++.+++..|++.+|++||+++.+.+.|+.
T Consensus 238 ---~~l~~~~----p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~ 275 (293)
T d1csna_ 238 ---RELCAGF----PEEFYKYMHYARNLAFDATPDYDYLQGLFSK 275 (293)
T ss_dssp ---HHHTTTS----CHHHHHHHHHHHHCCTTCCCCHHHHHHHHHH
T ss_pred ---HHhcCCC----CHHHHHHHHHHhcCCcccCcCHHHHHHHHHH
Confidence 1111122 3478899999999999999999998887764
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=2.3e-42 Score=347.58 Aligned_cols=247 Identities=20% Similarity=0.242 Sum_probs=187.5
Q ss_pred hCCCcCCeeccCCcEEEEEEEE-CCCcEEEEEEehh-----------hhhhcc-cCceeeEEEEEeCC--CeeEEEeecc
Q 039819 202 ENFSSKNILGAGGFGNVYKGKL-GDGTVLAVKRLKD-----------MISLAV-HRNLLRLIGYCATP--TERLLVYPYM 266 (534)
Q Consensus 202 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~-----------~l~~~~-h~niv~l~~~~~~~--~~~~lv~e~~ 266 (534)
++|+..+.||+|+||+||+|+. .+++.||||+++. ++..+. ||||+++++++... ...++|||||
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e~~ 114 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHV 114 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEECC
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHHHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEEeec
Confidence 5789999999999999999997 4789999998762 566764 99999999999754 4689999999
Q ss_pred CCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCC-cEEEEecccceecCCCCCcee
Q 039819 267 SNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFC-EAIVGDFGLAKLLDHSDSHVT 345 (534)
Q Consensus 267 ~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~-~~kl~DFGla~~~~~~~~~~~ 345 (534)
.+++|.... +.+++..++.++.||+.||.|||++ +||||||||+|||++.++ .+||+|||+|+...... ..
T Consensus 115 ~~~~L~~~~---~~l~e~~i~~i~~qil~aL~~LH~~---gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~--~~ 186 (328)
T d3bqca1 115 NNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ--EY 186 (328)
T ss_dssp CSCBGGGTT---TSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCGGGCEECCTTC--CC
T ss_pred CCCcHHHHh---cCCCHHHHHHHHHHHHHHHHHHhhc---ccccccccccceEEcCCCCeeeecccccceeccCCC--cc
Confidence 999998764 3599999999999999999999999 999999999999998655 68999999999775432 23
Q ss_pred eccccccccccccccccCC-CCcchhHHHHHHHHHHHHhCCCCcCCCcccccc-chHHHH---------HHHHhhhc--c
Q 039819 346 TAVRGTVGHIAPEYLSTGQ-SSEKTDVFGFGILLLELITGMRALEFGKSINQK-GAMLEW---------VKKIQQEK--K 412 (534)
Q Consensus 346 ~~~~gt~~y~aPE~~~~~~-~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~-~~~~~~---------~~~~~~~~--~ 412 (534)
....||+.|+|||.+.+.. ++.++||||+||++|||++|+.||......... ..+... ........ .
T Consensus 187 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~ 266 (328)
T d3bqca1 187 NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPR 266 (328)
T ss_dssp CSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCGG
T ss_pred cccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccccCcc
Confidence 4567899999999987654 799999999999999999999999754432111 111111 11000000 0
Q ss_pred cceeccc--------ccCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 413 VEVLVDR--------ELGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 413 ~~~~~d~--------~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
....... ............++.+++.+|++.||++|||++|+++
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 267 FNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp GGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0000000 0001111223457889999999999999999999974
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-42 Score=352.61 Aligned_cols=247 Identities=20% Similarity=0.279 Sum_probs=179.1
Q ss_pred hCCCcCCeeccCCcEEEEEEEEC-CCcEEEEEEeh----------------hhhhhcccCceeeEEEEEeCC------Ce
Q 039819 202 ENFSSKNILGAGGFGNVYKGKLG-DGTVLAVKRLK----------------DMISLAVHRNLLRLIGYCATP------TE 258 (534)
Q Consensus 202 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~----------------~~l~~~~h~niv~l~~~~~~~------~~ 258 (534)
++|+..+.||+|+||+||+|+.. +|+.||||++. .+++.++|||||+++++|... ..
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 57888999999999999999975 69999999985 266788999999999999643 57
Q ss_pred eEEEeeccCCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecC
Q 039819 259 RLLVYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLD 338 (534)
Q Consensus 259 ~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~ 338 (534)
.|+|||||.++.+.. +. ..+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+|++|||+++...
T Consensus 97 ~~iv~Ey~~~~l~~~-~~--~~~~~~~i~~~~~qil~gl~~LH~~---giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~ 170 (355)
T d2b1pa1 97 VYLVMELMDANLCQV-IQ--MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 170 (355)
T ss_dssp EEEEEECCSEEHHHH-HT--SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred eEEEEeccchHHHHh-hh--cCCCHHHHHHHHHHHHHHHHHhhhc---ccccccCCccccccccccceeeechhhhhccc
Confidence 799999997765543 33 4589999999999999999999999 99999999999999999999999999988664
Q ss_pred CCCCceeeccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHH--------H-------
Q 039819 339 HSDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLE--------W------- 403 (534)
Q Consensus 339 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~--------~------- 403 (534)
... ......||+.|+|||++.+..++.++||||+||+++||++|+.||...........+.. +
T Consensus 171 ~~~--~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 248 (355)
T d2b1pa1 171 TSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPT 248 (355)
T ss_dssp ------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHH
T ss_pred ccc--ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhh
Confidence 332 33455789999999999999999999999999999999999999975432211111110 0
Q ss_pred HHHHhhhc-cc-----ceecccccCC-C--CCHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 404 VKKIQQEK-KV-----EVLVDRELGS-N--YDRIEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 404 ~~~~~~~~-~~-----~~~~d~~l~~-~--~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
........ .. .......... . ........+.+++.+|++.||++|||++|+++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~ 310 (355)
T d2b1pa1 249 VRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 310 (355)
T ss_dssp HHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 00000000 00 0000001111 1 12234568899999999999999999999984
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-41 Score=345.26 Aligned_cols=248 Identities=21% Similarity=0.289 Sum_probs=184.4
Q ss_pred HhCCCcCCeeccCCcEEEEEEEE-CCCcEEEEEEeh----------------hhhhhcccCceeeEEEEEeCC-----Ce
Q 039819 201 TENFSSKNILGAGGFGNVYKGKL-GDGTVLAVKRLK----------------DMISLAVHRNLLRLIGYCATP-----TE 258 (534)
Q Consensus 201 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~----------------~~l~~~~h~niv~l~~~~~~~-----~~ 258 (534)
.++|+..+.||+|+||+||+|+. .+|+.||||++. ++++.++|||||++++++... ..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 35789999999999999999997 479999999874 267889999999999998643 34
Q ss_pred eEEEeeccCCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEecccceecC
Q 039819 259 RLLVYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGLAKLLD 338 (534)
Q Consensus 259 ~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~~~ 338 (534)
.++|++|+.+|+|.+++..+ .+++.+++.++.||+.||+|||++ +|+||||||+|||++.++.+|++|||++....
T Consensus 97 ~~~i~~~~~gg~L~~~~~~~-~l~e~~~~~i~~qil~aL~~LH~~---giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~ 172 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTD 172 (348)
T ss_dssp CCEEEEECCSEEHHHHHTTC-CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCC----CCT
T ss_pred eEEEEEeecCCchhhhcccc-cccHHHHHHHHHHHHHHHHHHHhC---CCcccccCCccccccccccccccccchhcccC
Confidence 57778888999999998654 699999999999999999999999 99999999999999999999999999997653
Q ss_pred CCCCceeeccccccccccccccccC-CCCcchhHHHHHHHHHHHHhCCCCcCCCccccccchHHHHHHHHhhh----c--
Q 039819 339 HSDSHVTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELITGMRALEFGKSINQKGAMLEWVKKIQQE----K-- 411 (534)
Q Consensus 339 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~----~-- 411 (534)
. ......||..|+|||...+. .++.++|||||||++|||++|+.||...........+.......... .
T Consensus 173 ~----~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 248 (348)
T d2gfsa1 173 D----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 248 (348)
T ss_dssp G----GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCC
T ss_pred c----ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccc
Confidence 2 23445689999999987665 46899999999999999999999998654322211111110000000 0
Q ss_pred -ccceecc--cccCC-CC---CHHHHHHHHHHHHHhcccCCCCCCChHHHHH
Q 039819 412 -KVEVLVD--RELGS-NY---DRIEVGEILQVALLCTQYLPVHRPKMSEVVR 456 (534)
Q Consensus 412 -~~~~~~d--~~l~~-~~---~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~~ 456 (534)
....... ..... .. .......+.+++.+|++.||.+|||+.|+++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~ 300 (348)
T d2gfsa1 249 ESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 300 (348)
T ss_dssp HHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhc
Confidence 0000000 00000 00 0012346889999999999999999999984
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=4.3e-37 Score=312.96 Aligned_cols=247 Identities=23% Similarity=0.253 Sum_probs=178.0
Q ss_pred CCCcCCeeccCCcEEEEEEEE-CCCcEEEEEEehh-------------hhhh-----------cccCceeeEEEEEeC--
Q 039819 203 NFSSKNILGAGGFGNVYKGKL-GDGTVLAVKRLKD-------------MISL-----------AVHRNLLRLIGYCAT-- 255 (534)
Q Consensus 203 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~-------------~l~~-----------~~h~niv~l~~~~~~-- 255 (534)
+|...+.||+|+||+||+|+. .+|+.||||+++. +++. ..|+|||++++++..
T Consensus 14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~~ 93 (362)
T d1q8ya_ 14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKG 93 (362)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEE
T ss_pred cEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeecc
Confidence 488899999999999999997 4789999999752 2233 247899999998864
Q ss_pred CCeeEEEeeccCCCChhhhc---ccCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEeccCCCCcEEeCCCCc------
Q 039819 256 PTERLLVYPYMSNGSVASRL---REKPALDWNTRKRIAIGAARGLLYLHE-QCDPKIIHRDVKAANVLLDDFCE------ 325 (534)
Q Consensus 256 ~~~~~lv~e~~~~gsL~~~l---~~~~~l~~~~~~~i~~~i~~~l~yLH~-~~~~~ivH~Dlkp~NiLl~~~~~------ 325 (534)
....+++|+++..+...... .....+++..+..++.|++.||+|||+ . +|+||||||+|||++.++.
T Consensus 94 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~---~IvHrDlKp~NIll~~~~~~~~~~~ 170 (362)
T d1q8ya_ 94 PNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRC---GIIHTDIKPENVLMEIVDSPENLIQ 170 (362)
T ss_dssp TTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT---CEECSCCSGGGEEEEEEETTTTEEE
T ss_pred ccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhc---CcccccCChhHeeeeccCcccccce
Confidence 35567777776555432222 245678999999999999999999998 5 8999999999999986553
Q ss_pred EEEEecccceecCCCCCceeeccccccccccccccccCCCCcchhHHHHHHHHHHHHhCCCCcCCCccccccc---hHHH
Q 039819 326 AIVGDFGLAKLLDHSDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSINQKG---AMLE 402 (534)
Q Consensus 326 ~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl~elltG~~p~~~~~~~~~~~---~~~~ 402 (534)
++++|||.+...... .....||+.|+|||++....++.++||||+||+++||++|+.||.......... .+..
T Consensus 171 ~kl~dfg~s~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~ 246 (362)
T d1q8ya_ 171 IKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQ 246 (362)
T ss_dssp EEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHH
T ss_pred eeEeecccccccccc----cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHH
Confidence 899999999865432 234569999999999999999999999999999999999999997533221111 1111
Q ss_pred HHHHHhh--------hcccceecc-----cc--------------cCCCCCHHHHHHHHHHHHHhcccCCCCCCChHHHH
Q 039819 403 WVKKIQQ--------EKKVEVLVD-----RE--------------LGSNYDRIEVGEILQVALLCTQYLPVHRPKMSEVV 455 (534)
Q Consensus 403 ~~~~~~~--------~~~~~~~~d-----~~--------------l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPt~~ev~ 455 (534)
.+..... ........+ .. ............+.+++.+|++.||.+|||++|++
T Consensus 247 ~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L 326 (362)
T d1q8ya_ 247 IIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLV 326 (362)
T ss_dssp HHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHH
T ss_pred HHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHHh
Confidence 1111100 000000000 00 01123455677899999999999999999999987
Q ss_pred H
Q 039819 456 R 456 (534)
Q Consensus 456 ~ 456 (534)
+
T Consensus 327 ~ 327 (362)
T d1q8ya_ 327 N 327 (362)
T ss_dssp T
T ss_pred c
Confidence 4
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.88 E-value=2.2e-23 Score=191.53 Aligned_cols=154 Identities=11% Similarity=0.076 Sum_probs=112.3
Q ss_pred cCCeeccCCcEEEEEEEECCCcEEEEEEeh--------------------------------hhhhhcccCceeeEEEEE
Q 039819 206 SKNILGAGGFGNVYKGKLGDGTVLAVKRLK--------------------------------DMISLAVHRNLLRLIGYC 253 (534)
Q Consensus 206 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~--------------------------------~~l~~~~h~niv~l~~~~ 253 (534)
..+.||+|+||.||+|+..+|+.||||.++ ..+.++.|.+++..+++.
T Consensus 4 vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~~ 83 (191)
T d1zara2 4 IGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAWE 83 (191)
T ss_dssp EEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEEE
T ss_pred hCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEec
Confidence 457899999999999999999999999753 134566788888877653
Q ss_pred eCCCeeEEEeeccCCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCcEEeCCCCcEEEEeccc
Q 039819 254 ATPTERLLVYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANVLLDDFCEAIVGDFGL 333 (534)
Q Consensus 254 ~~~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH~Dlkp~NiLl~~~~~~kl~DFGl 333 (534)
..++||||+++..+.+ ++......++.|++.+|.|||+. +|+||||||+|||++++ .++|+|||+
T Consensus 84 ----~~~lvme~~~~~~~~~-------l~~~~~~~i~~ql~~~l~~lH~~---giiHrDiKP~NILv~~~-~~~liDFG~ 148 (191)
T d1zara2 84 ----GNAVLMELIDAKELYR-------VRVENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVSEE-GIWIIDFPQ 148 (191)
T ss_dssp ----TTEEEEECCCCEEGGG-------CCCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEETT-EEEECCCTT
T ss_pred ----CCEEEEEeeccccccc-------hhhHHHHHHHHHHHHHHHHHhhC---CEEEccCChhheeeeCC-CEEEEECCC
Confidence 2479999998866543 33445678999999999999998 99999999999999975 588999999
Q ss_pred ceecCCCCCceeeccccccccccccccccCCCCcchhHHHHHHHH
Q 039819 334 AKLLDHSDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILL 378 (534)
Q Consensus 334 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvvl 378 (534)
|+.......... ...+... -.+++ ...|+.++||||..--+
T Consensus 149 a~~~~~~~~~~~--l~rd~~~-~~~~f-~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 149 SVEVGEEGWREI--LERDVRN-IITYF-SRTYRTEKDINSAIDRI 189 (191)
T ss_dssp CEETTSTTHHHH--HHHHHHH-HHHHH-HHHHCCCCCHHHHHHHH
T ss_pred cccCCCCCcHHH--HHHHHHH-HHHHH-cCCCCCcccHHHHHHHH
Confidence 987654321110 0000000 01222 35678899999975443
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.83 E-value=2.9e-21 Score=191.09 Aligned_cols=158 Identities=28% Similarity=0.409 Sum_probs=125.6
Q ss_pred CceecCC---CcEEEEEecCCCcee--ecccccccCCCCCEEEccC-CccCcCCCCCCCCCCCCCEEEcCCCcCccccCc
Q 039819 1 MITCSPE---NLVIGLGAPSQSLSG--TLSGSIGNLTNLRQVLLQN-NNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPA 74 (534)
Q Consensus 1 ~v~c~~~---~~l~~L~l~~n~l~g--~~p~~~~~l~~L~~L~L~~-N~l~g~~P~~~~~l~~L~~L~Ls~N~l~g~~p~ 74 (534)
||+|+.. .+|+.|+|++|+++| .+|++|++|++|++|+|++ |+|+|.+|.+|++|++|++|+|++|+|++..|.
T Consensus 40 gv~C~~~~~~~~v~~L~L~~~~l~g~~~lp~~l~~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~ 119 (313)
T d1ogqa_ 40 GVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPD 119 (313)
T ss_dssp TEEECCSSSCCCEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCG
T ss_pred CeEEeCCCCcEEEEEEECCCCCCCCCCCCChHHhcCccccccccccccccccccccccccccccchhhhccccccccccc
Confidence 8999853 379999999999998 5899999999999999986 899999999999999999999999999887665
Q ss_pred hhhhccc------------------------Cccccc-------------------------c-c---------------
Q 039819 75 LLFLSIW------------------------LPRKWD-------------------------K-R--------------- 89 (534)
Q Consensus 75 ~~~~l~~------------------------l~~~~~-------------------------~-~--------------- 89 (534)
.+..+.. +..... . +
T Consensus 120 ~~~~~~~L~~l~l~~N~~~~~~p~~l~~l~~L~~l~l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~ 199 (313)
T d1ogqa_ 120 FLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNL 199 (313)
T ss_dssp GGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCC
T ss_pred cccchhhhcccccccccccccCchhhccCcccceeecccccccccccccccccccccccccccccccccccccccccccc
Confidence 4332211 100000 0 0
Q ss_pred --------------------------------cc--------CCccccceeCCCCcCcccCChhhhcccccccccccCCC
Q 039819 90 --------------------------------KC--------SGVDQGLLRLNNNSLSGAFPVFLAKISELAFLDLSYNN 129 (534)
Q Consensus 90 --------------------------------~~--------~~~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~ 129 (534)
.. ...+|+.|+|++|+|+|.+|..|+.+++|++|+|++|+
T Consensus 200 ~~l~l~~~~~~~~~~~~~~~~~~l~~l~~~~~~l~~~~~~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~ 279 (313)
T d1ogqa_ 200 AFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNN 279 (313)
T ss_dssp SEEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGGGCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSE
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccCccCeecccCChHHhCCCCCCEEECcCCc
Confidence 00 00257889999999999999999999999999999999
Q ss_pred CCCCCCCCCC----ccccccCCcceecCCCCCcc
Q 039819 130 LSGPVPKFPA----RTFNVAGNPLICGSSSTNVC 159 (534)
Q Consensus 130 l~g~~p~~~~----~~~~~~~N~~~cg~~~~~~~ 159 (534)
|+|.+|.... +.+.+.+|+..||.+. .+|
T Consensus 280 l~g~iP~~~~L~~L~~l~l~~N~~l~g~pl-p~c 312 (313)
T d1ogqa_ 280 LCGEIPQGGNLQRFDVSAYANNKCLCGSPL-PAC 312 (313)
T ss_dssp EEEECCCSTTGGGSCGGGTCSSSEEESTTS-SCC
T ss_pred ccccCCCcccCCCCCHHHhCCCccccCCCC-CCC
Confidence 9999997532 5678899999998643 355
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.71 E-value=1.4e-17 Score=160.35 Aligned_cols=141 Identities=26% Similarity=0.202 Sum_probs=112.7
Q ss_pred CcEEEEEecCCCceeecccccccCCCCCEEEccCCccCcCCCCCCCCCCCCCEEEcCCCcCccccCchhhhcccCccccc
Q 039819 8 NLVIGLGAPSQSLSGTLSGSIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFLSIWLPRKWD 87 (534)
Q Consensus 8 ~~l~~L~l~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~P~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~l~~~~~ 87 (534)
..++.|+|++|+|++..+.+|.++++|++|+|++|+|+ .+| .++.+++|++|+|++|+|++ +|..+..++.|..+..
T Consensus 31 ~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~-~l~-~~~~l~~L~~L~Ls~N~l~~-~~~~~~~l~~L~~L~l 107 (266)
T d1p9ag_ 31 KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQ-VDGTLPVLGTLDLSHNQLQS-LPLLGQTLPALTVLDV 107 (266)
T ss_dssp TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCC-EEE-CCSCCTTCCEEECCSSCCSS-CCCCTTTCTTCCEEEC
T ss_pred cCCCEEECcCCcCCCcCHHHhhcccccccccccccccc-ccc-cccccccccccccccccccc-cccccccccccccccc
Confidence 46999999999999777788999999999999999999 566 46889999999999999984 4555555554433211
Q ss_pred cc---------------------------------cc-CCccccceeCCCCcCcccCChhhhcccccccccccCCCCCCC
Q 039819 88 KR---------------------------------KC-SGVDQGLLRLNNNSLSGAFPVFLAKISELAFLDLSYNNLSGP 133 (534)
Q Consensus 88 ~~---------------------------------~~-~~~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~ 133 (534)
+. .+ ...+|+.|++++|+|++..|..|..+++|+.|+|++|+|+ .
T Consensus 108 ~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~-~ 186 (266)
T d1p9ag_ 108 SFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-T 186 (266)
T ss_dssp CSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-C
T ss_pred cccccceeeccccccccccccccccccccceeccccccccccchhcccccccccccCccccccccccceeecccCCCc-c
Confidence 00 00 1136888999999999888888999999999999999999 7
Q ss_pred CCCCCC-----ccccccCCcceec
Q 039819 134 VPKFPA-----RTFNVAGNPLICG 152 (534)
Q Consensus 134 ~p~~~~-----~~~~~~~N~~~cg 152 (534)
+|..+. +.+.+.+|||.|.
T Consensus 187 lp~~~~~~~~L~~L~L~~Np~~Cd 210 (266)
T d1p9ag_ 187 IPKGFFGSHLLPFAFLHGNPWLCN 210 (266)
T ss_dssp CCTTTTTTCCCSEEECCSCCBCCS
T ss_pred cChhHCCCCCCCEEEecCCCCCCC
Confidence 776543 5688999999995
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.69 E-value=3.9e-17 Score=149.29 Aligned_cols=109 Identities=21% Similarity=0.310 Sum_probs=50.9
Q ss_pred cEEEEEecCCCceeec-ccccccCCCCCEEEccCCccCcCCCCCCCCCCCCCEEEcCCCcCccccCchhhhcccCccccc
Q 039819 9 LVIGLGAPSQSLSGTL-SGSIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFLSIWLPRKWD 87 (534)
Q Consensus 9 ~l~~L~l~~n~l~g~~-p~~~~~l~~L~~L~L~~N~l~g~~P~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~l~~~~~ 87 (534)
.++.|+|++|+|++.+ +..|+++++|+.|+|++|+|++..+..|..+++|++|+|++|+|++..|..|..++
T Consensus 30 ~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~N~l~~l~~~~F~~l~------- 102 (192)
T d1w8aa_ 30 HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLH------- 102 (192)
T ss_dssp TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCT-------
T ss_pred CCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeeccccccccCHHHHhCCC-------
Confidence 3444444444444322 23344444444444444444444444444444444444444444444444444444
Q ss_pred ccccCCccccceeCCCCcCcccCChhhhcccccccccccCCCCC
Q 039819 88 KRKCSGVDQGLLRLNNNSLSGAFPVFLAKISELAFLDLSYNNLS 131 (534)
Q Consensus 88 ~~~~~~~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~ 131 (534)
+|+.|+|++|+|++..|.+|..+++|++|+|++|.+.
T Consensus 103 -------~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~ 139 (192)
T d1w8aa_ 103 -------QLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFN 139 (192)
T ss_dssp -------TCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBC
T ss_pred -------cccccccCCccccccCHHHhcCCcccccccccccccc
Confidence 4444444444444444444444444444444444444
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.68 E-value=1.8e-17 Score=151.57 Aligned_cols=126 Identities=23% Similarity=0.351 Sum_probs=110.2
Q ss_pred EEEEecCCCceeecccccccCCCCCEEEccCCccCcCC-CCCCCCCCCCCEEEcCCCcCccccCchhhhcccCccccccc
Q 039819 11 IGLGAPSQSLSGTLSGSIGNLTNLRQVLLQNNNISGGI-PPQLGSLPKLQTLDLSNNRLSGVIPALLFLSIWLPRKWDKR 89 (534)
Q Consensus 11 ~~L~l~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~-P~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~l~~~~~~~ 89 (534)
+.++.++|+|+ .+|..+. ++|++|+|++|+|++.+ +..|.++++|+.|+|++|++++.++..+..+.
T Consensus 11 ~~v~Cs~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~--------- 78 (192)
T d1w8aa_ 11 TTVDCTGRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGAS--------- 78 (192)
T ss_dssp TEEECTTSCCS-SCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCT---------
T ss_pred CEEEEeCCCcC-ccCCCCC--CCCCEEEeCCCCCcccccccccCCCceEeeeecccccccccccccccccc---------
Confidence 36889999999 7887764 79999999999998755 45689999999999999999988888888887
Q ss_pred ccCCccccceeCCCCcCcccCChhhhcccccccccccCCCCCCCCCCCCC-----ccccccCCcceecC
Q 039819 90 KCSGVDQGLLRLNNNSLSGAFPVFLAKISELAFLDLSYNNLSGPVPKFPA-----RTFNVAGNPLICGS 153 (534)
Q Consensus 90 ~~~~~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~-----~~~~~~~N~~~cg~ 153 (534)
+|+.|+|++|+|++..|.+|.++++|+.|+|++|+|++..|..+. +.+.+.+|||.|..
T Consensus 79 -----~L~~L~Ls~N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~ 142 (192)
T d1w8aa_ 79 -----HIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNC 142 (192)
T ss_dssp -----TCCEEECCSCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSG
T ss_pred -----ccceeeeccccccccCHHHHhCCCcccccccCCccccccCHHHhcCCccccccccccccccccc
Confidence 889999999999988888999999999999999999976666543 57789999998853
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.57 E-value=1.5e-15 Score=147.30 Aligned_cols=131 Identities=24% Similarity=0.226 Sum_probs=105.8
Q ss_pred CcEEEEEecCCCceeecccccccCCCCCEEEccCCccCcCCCCCCCCCCCCCEEEcCCCcCccccCchhhhcccCccccc
Q 039819 8 NLVIGLGAPSQSLSGTLSGSIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFLSIWLPRKWD 87 (534)
Q Consensus 8 ~~l~~L~l~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~P~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~l~~~~~ 87 (534)
.+++.|+|++|++.+..+..+..+.+|+.|++++|+|++..|..|..+++|+.|+|++|+|++..|..|..++
T Consensus 105 ~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~f~~l~------- 177 (284)
T d1ozna_ 105 GRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLH------- 177 (284)
T ss_dssp TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCT-------
T ss_pred ccCCEEecCCcccccccccccchhcccchhhhccccccccChhHhccccchhhcccccCcccccchhhhcccc-------
Confidence 4677788888887766666777777888888888888755556677777888888888888766666776666
Q ss_pred ccccCCccccceeCCCCcCcccCChhhhcccccccccccCCCCCCCCCCCCC-----ccccccCCcceec
Q 039819 88 KRKCSGVDQGLLRLNNNSLSGAFPVFLAKISELAFLDLSYNNLSGPVPKFPA-----RTFNVAGNPLICG 152 (534)
Q Consensus 88 ~~~~~~~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~-----~~~~~~~N~~~cg 152 (534)
+|+.|++++|++++..|..|..+++|+.|++++|++++..|..+. +.+.+.+|||.|.
T Consensus 178 -------~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C~ 240 (284)
T d1ozna_ 178 -------SLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCD 240 (284)
T ss_dssp -------TCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECS
T ss_pred -------ccchhhhhhccccccChhHhhhhhhcccccccccccccccccccccccccCEEEecCCCCCCC
Confidence 888999999999999999999999999999999999977665432 6778999999984
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.57 E-value=1.8e-15 Score=127.62 Aligned_cols=102 Identities=25% Similarity=0.285 Sum_probs=89.5
Q ss_pred EEEecCCCceeecccccccCCCCCEEEccCCccCcCCCCCCCCCCCCCEEEcCCCcCccccCchhhhcccCccccccccc
Q 039819 12 GLGAPSQSLSGTLSGSIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFLSIWLPRKWDKRKC 91 (534)
Q Consensus 12 ~L~l~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~P~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~l~~~~~~~~~ 91 (534)
.|+|++|+|+ .++ .++.+++|++|+|++|+|+ .+|+.|+.+++|++|+|++|+|+ .+|+ +..++
T Consensus 2 ~L~Ls~n~l~-~l~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~-~l~~-~~~l~----------- 65 (124)
T d1dcea3 2 VLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVDG-VANLP----------- 65 (124)
T ss_dssp EEECTTSCCS-SCC-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCC-CCGG-GTTCS-----------
T ss_pred EEEcCCCCCC-CCc-ccccCCCCCEEECCCCccC-cchhhhhhhhccccccccccccc-ccCc-ccccc-----------
Confidence 6999999999 566 4999999999999999999 78989999999999999999999 4553 66666
Q ss_pred CCccccceeCCCCcCcccC-ChhhhcccccccccccCCCCCC
Q 039819 92 SGVDQGLLRLNNNSLSGAF-PVFLAKISELAFLDLSYNNLSG 132 (534)
Q Consensus 92 ~~~~L~~L~L~~N~l~g~~-p~~~~~l~~L~~L~ls~N~l~g 132 (534)
+|+.|++++|+|+... +..+..+++|+.|++++|+++.
T Consensus 66 ---~L~~L~l~~N~i~~~~~~~~l~~~~~L~~L~l~~N~i~~ 104 (124)
T d1dcea3 66 ---RLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104 (124)
T ss_dssp ---SCCEEECCSSCCCSSSTTGGGGGCTTCCEEECTTSGGGG
T ss_pred ---ccCeEECCCCccCCCCCchhhcCCCCCCEEECCCCcCCc
Confidence 8899999999998432 2578999999999999999984
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.48 E-value=3.2e-14 Score=125.79 Aligned_cols=106 Identities=23% Similarity=0.208 Sum_probs=91.7
Q ss_pred CcEEEEEecCCCceeecccccccCCCCCEEEccCCccCcCCCCCCCCCCCCCEEEcCCCcCccccCchhhhcccCccccc
Q 039819 8 NLVIGLGAPSQSLSGTLSGSIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFLSIWLPRKWD 87 (534)
Q Consensus 8 ~~l~~L~l~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~P~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~l~~~~~ 87 (534)
.+++.|+|++|+|+ .++..+..+++|++|+|++|+|+ .++ .|..+++|++|+|++|+|+...+..+..++
T Consensus 18 ~~lr~L~L~~n~I~-~i~~~~~~l~~L~~L~Ls~N~i~-~l~-~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~------- 87 (162)
T d1a9na_ 18 VRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KLD-GFPLLRRLKTLLVNNNRICRIGEGLDQALP------- 87 (162)
T ss_dssp TSCEEEECTTSCCC-SCCCGGGGTTCCSEEECCSSCCC-EEC-CCCCCSSCCEEECCSSCCCEECSCHHHHCT-------
T ss_pred CcCcEEECCCCCCC-ccCccccccccCCEEECCCCCCC-ccC-CcccCcchhhhhcccccccCCCcccccccc-------
Confidence 47899999999998 56877788999999999999999 565 589999999999999999966566666777
Q ss_pred ccccCCccccceeCCCCcCcccCC--hhhhcccccccccccCCCCC
Q 039819 88 KRKCSGVDQGLLRLNNNSLSGAFP--VFLAKISELAFLDLSYNNLS 131 (534)
Q Consensus 88 ~~~~~~~~L~~L~L~~N~l~g~~p--~~~~~l~~L~~L~ls~N~l~ 131 (534)
+|+.|+|++|+|+ .++ ..+..+++|+.|++++|.++
T Consensus 88 -------~L~~L~L~~N~i~-~~~~l~~l~~l~~L~~L~l~~N~i~ 125 (162)
T d1a9na_ 88 -------DLTELILTNNSLV-ELGDLDPLASLKSLTYLCILRNPVT 125 (162)
T ss_dssp -------TCCEEECCSCCCC-CGGGGGGGGGCTTCCEEECCSSGGG
T ss_pred -------ccccceecccccc-ccccccccccccccchhhcCCCccc
Confidence 8889999999998 444 46889999999999999987
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.45 E-value=3.1e-14 Score=139.72 Aligned_cols=110 Identities=25% Similarity=0.328 Sum_probs=98.3
Q ss_pred EEEEEecCCCceeecccccccCCCCCEEEccCCccCcCCCCCCCCCCCCCEEEcCCCcCccccCchhhhcccCccccccc
Q 039819 10 VIGLGAPSQSLSGTLSGSIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFLSIWLPRKWDKR 89 (534)
Q Consensus 10 l~~L~l~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~P~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~l~~~~~~~ 89 (534)
...|+++++.+.|.+|..++.+++|+.|++++|.+++.+| .++.+++|+.|+|++|+|+|.+|..+..++
T Consensus 199 ~~~l~l~~~~~~~~~~~~~~~~~~l~~l~~~~~~l~~~~~-~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~--------- 268 (313)
T d1ogqa_ 199 LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLK--------- 268 (313)
T ss_dssp CSEEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGG-GCCCCTTCCEEECCSSCCEECCCGGGGGCT---------
T ss_pred cccccccccccccccccccccccccccccccccccccccc-ccccccccccccCccCeecccCChHHhCCC---------
Confidence 3468888888888888889999999999999999997655 799999999999999999999999999988
Q ss_pred ccCCccccceeCCCCcCcccCChhhhcccccccccccCCC-CCCC-CC
Q 039819 90 KCSGVDQGLLRLNNNSLSGAFPVFLAKISELAFLDLSYNN-LSGP-VP 135 (534)
Q Consensus 90 ~~~~~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~-l~g~-~p 135 (534)
+|+.|+|++|+|+|.+|. ++++++|+.+++++|+ +.|. +|
T Consensus 269 -----~L~~L~Ls~N~l~g~iP~-~~~L~~L~~l~l~~N~~l~g~plp 310 (313)
T d1ogqa_ 269 -----FLHSLNVSFNNLCGEIPQ-GGNLQRFDVSAYANNKCLCGSPLP 310 (313)
T ss_dssp -----TCCEEECCSSEEEEECCC-STTGGGSCGGGTCSSSEEESTTSS
T ss_pred -----CCCEEECcCCcccccCCC-cccCCCCCHHHhCCCccccCCCCC
Confidence 889999999999999995 6889999999999998 6775 44
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.41 E-value=1.2e-13 Score=133.69 Aligned_cols=114 Identities=25% Similarity=0.180 Sum_probs=105.3
Q ss_pred CCcEEEEEecCCCceeecccccccCCCCCEEEccCCccCcCCCCCCCCCCCCCEEEcCCCcCccccCchhhhcccCcccc
Q 039819 7 ENLVIGLGAPSQSLSGTLSGSIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFLSIWLPRKW 86 (534)
Q Consensus 7 ~~~l~~L~l~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~P~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~l~~~~ 86 (534)
..++..|++++|+|++..+..|..+++|+.|+|++|+|++..|.+|.++++|+.|+|++|++++..|..|..++
T Consensus 128 ~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~------ 201 (284)
T d1ozna_ 128 LAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLG------ 201 (284)
T ss_dssp CTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCT------
T ss_pred hcccchhhhccccccccChhHhccccchhhcccccCcccccchhhhccccccchhhhhhccccccChhHhhhhh------
Confidence 35689999999999977778899999999999999999987788899999999999999999999999998888
Q ss_pred cccccCCccccceeCCCCcCcccCChhhhcccccccccccCCCCCCCC
Q 039819 87 DKRKCSGVDQGLLRLNNNSLSGAFPVFLAKISELAFLDLSYNNLSGPV 134 (534)
Q Consensus 87 ~~~~~~~~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~ 134 (534)
+|+.|++++|.+++..|..|..+++|+.|+|++|.+...-
T Consensus 202 --------~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C~C 241 (284)
T d1ozna_ 202 --------RLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDC 241 (284)
T ss_dssp --------TCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSG
T ss_pred --------hcccccccccccccccccccccccccCEEEecCCCCCCCc
Confidence 8889999999999888899999999999999999998653
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.37 E-value=6.2e-13 Score=129.70 Aligned_cols=127 Identities=24% Similarity=0.206 Sum_probs=105.7
Q ss_pred CcEEEEEecCCCceeecccccccCCCCCEEEccCCccCcCCCCCCCCCCCCCEEEcCCCcCccccCchhhhcccCccccc
Q 039819 8 NLVIGLGAPSQSLSGTLSGSIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFLSIWLPRKWD 87 (534)
Q Consensus 8 ~~l~~L~l~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~P~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~l~~~~~ 87 (534)
..++.|++++|+++ .+|..+ +++|+.|+|++|.+++..|..|.+++.++.|++++|.+++..|..+..++
T Consensus 150 ~~L~~l~l~~n~l~-~l~~~~--~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~------- 219 (305)
T d1xkua_ 150 KKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTP------- 219 (305)
T ss_dssp TTCCEEECCSSCCC-SCCSSC--CTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGST-------
T ss_pred cccCccccccCCcc-ccCccc--CCccCEEECCCCcCCCCChhHhhccccccccccccccccccccccccccc-------
Confidence 46788999999988 566543 67899999999999988888899999999999999999987788777777
Q ss_pred ccccCCccccceeCCCCcCcccCChhhhcccccccccccCCCCCCCCCC-CC-----------CccccccCCcceecC
Q 039819 88 KRKCSGVDQGLLRLNNNSLSGAFPVFLAKISELAFLDLSYNNLSGPVPK-FP-----------ARTFNVAGNPLICGS 153 (534)
Q Consensus 88 ~~~~~~~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~-~~-----------~~~~~~~~N~~~cg~ 153 (534)
+|+.|+|++|+|+ .+|.+|..+++|+.|+|++|+|+. ++. .+ .+.+.+.+|||.++.
T Consensus 220 -------~L~~L~L~~N~L~-~lp~~l~~l~~L~~L~Ls~N~i~~-i~~~~f~~~~~~~~~~~L~~L~L~~N~~~~~~ 288 (305)
T d1xkua_ 220 -------HLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISA-IGSNDFCPPGYNTKKASYSGVSLFSNPVQYWE 288 (305)
T ss_dssp -------TCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCCC-CCTTSSSCSSCCTTSCCCSEEECCSSSSCGGG
T ss_pred -------cceeeeccccccc-ccccccccccCCCEEECCCCccCc-cChhhccCcchhcccCCCCEEECCCCcCccCc
Confidence 8899999999999 789999999999999999999994 442 11 145678999997754
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.35 E-value=5.5e-13 Score=116.89 Aligned_cols=105 Identities=21% Similarity=0.182 Sum_probs=84.5
Q ss_pred EEEEecCCCceeecccccccCCCCCEEEccCC-ccCcCCCCCCCCCCCCCEEEcCCCcCccccCchhhhcccCccccccc
Q 039819 11 IGLGAPSQSLSGTLSGSIGNLTNLRQVLLQNN-NISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFLSIWLPRKWDKR 89 (534)
Q Consensus 11 ~~L~l~~n~l~g~~p~~~~~l~~L~~L~L~~N-~l~g~~P~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~l~~~~~~~ 89 (534)
..++++++++. .+|..|..+++|++|+|++| .|+..-+.+|.+|++|+.|+|++|+|+...|..|..++
T Consensus 11 ~~l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~--------- 80 (156)
T d2ifga3 11 SGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTP--------- 80 (156)
T ss_dssp SCEECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCS---------
T ss_pred CeEEecCCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccc---------
Confidence 35788888888 67888889999999999766 58855556799999999999999999977788888887
Q ss_pred ccCCccccceeCCCCcCcccCChhhhcccccccccccCCCCC
Q 039819 90 KCSGVDQGLLRLNNNSLSGAFPVFLAKISELAFLDLSYNNLS 131 (534)
Q Consensus 90 ~~~~~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~ 131 (534)
+|+.|+|++|+|+ .+|..+-...+|+.|+|++|.+.
T Consensus 81 -----~L~~L~Ls~N~l~-~l~~~~~~~~~l~~L~L~~Np~~ 116 (156)
T d2ifga3 81 -----RLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLH 116 (156)
T ss_dssp -----CCCEEECCSSCCS-CCCSTTTCSCCCCEEECCSSCCC
T ss_pred -----cccceeccCCCCc-ccChhhhccccccccccCCCccc
Confidence 8889999999999 55544434446888888888775
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.35 E-value=6.8e-13 Score=111.55 Aligned_cols=96 Identities=27% Similarity=0.305 Sum_probs=81.0
Q ss_pred CEEEccCCccCcCCCCCCCCCCCCCEEEcCCCcCccccCchhhhcccCcccccccccCCccccceeCCCCcCcccCChhh
Q 039819 35 RQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFLSIWLPRKWDKRKCSGVDQGLLRLNNNSLSGAFPVFL 114 (534)
Q Consensus 35 ~~L~L~~N~l~g~~P~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~l~~~~~~~~~~~~~L~~L~L~~N~l~g~~p~~~ 114 (534)
++|+|++|+|+ .+| .+.++++|++|||++|+|+ .+|..+..++ +|+.|+|++|+|+ .+| .+
T Consensus 1 R~L~Ls~n~l~-~l~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~--------------~L~~L~l~~N~i~-~l~-~~ 61 (124)
T d1dcea3 1 RVLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLR-ALPPALAALR--------------CLEVLQASDNALE-NVD-GV 61 (124)
T ss_dssp SEEECTTSCCS-SCC-CGGGGTTCCEEECCSSCCC-CCCGGGGGCT--------------TCCEEECCSSCCC-CCG-GG
T ss_pred CEEEcCCCCCC-CCc-ccccCCCCCEEECCCCccC-cchhhhhhhh--------------ccccccccccccc-ccC-cc
Confidence 68999999999 676 4999999999999999999 6788888888 8899999999999 555 58
Q ss_pred hcccccccccccCCCCCCCCCC--CCC-----ccccccCCcce
Q 039819 115 AKISELAFLDLSYNNLSGPVPK--FPA-----RTFNVAGNPLI 150 (534)
Q Consensus 115 ~~l~~L~~L~ls~N~l~g~~p~--~~~-----~~~~~~~N~~~ 150 (534)
+.+++|+.|++++|+++. +|. .+. +.+.+.+|++.
T Consensus 62 ~~l~~L~~L~l~~N~i~~-~~~~~~l~~~~~L~~L~l~~N~i~ 103 (124)
T d1dcea3 62 ANLPRLQELLLCNNRLQQ-SAAIQPLVSCPRLVLLNLQGNSLC 103 (124)
T ss_dssp TTCSSCCEEECCSSCCCS-SSTTGGGGGCTTCCEEECTTSGGG
T ss_pred ccccccCeEECCCCccCC-CCCchhhcCCCCCCEEECCCCcCC
Confidence 999999999999999984 332 111 56778889873
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.33 E-value=1.3e-12 Score=114.37 Aligned_cols=109 Identities=19% Similarity=0.122 Sum_probs=91.4
Q ss_pred ccCCCCCEEEccCCccCcCCCCCCCCCCCCCEEEcCCC-cCccccCchhhhcccCcccccccccCCccccceeCCCCcCc
Q 039819 29 GNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNN-RLSGVIPALLFLSIWLPRKWDKRKCSGVDQGLLRLNNNSLS 107 (534)
Q Consensus 29 ~~l~~L~~L~L~~N~l~g~~P~~~~~l~~L~~L~Ls~N-~l~g~~p~~~~~l~~l~~~~~~~~~~~~~L~~L~L~~N~l~ 107 (534)
......+.++++++++. .+|..+..+++|+.|+|++| .|+...+..|..++ +|+.|+|++|+|+
T Consensus 5 C~c~~~~~l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~--------------~L~~L~Ls~N~l~ 69 (156)
T d2ifga3 5 CCPHGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLG--------------ELRNLTIVKSGLR 69 (156)
T ss_dssp SCCSSSSCEECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCC--------------CCSEEECCSSCCC
T ss_pred CCcCCCCeEEecCCCCc-cCcccccCccccCeeecCCCccccccCchhhcccc--------------ccCcceeeccccC
Confidence 34456678999999998 78999999999999999766 59966667788777 8899999999999
Q ss_pred ccCChhhhcccccccccccCCCCCCCCCCCCC----ccccccCCcceec
Q 039819 108 GAFPVFLAKISELAFLDLSYNNLSGPVPKFPA----RTFNVAGNPLICG 152 (534)
Q Consensus 108 g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~----~~~~~~~N~~~cg 152 (534)
...|.+|..+++|+.|+|++|+|+...+..+. ..+.+.+|||.|.
T Consensus 70 ~i~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~~~l~~L~L~~Np~~C~ 118 (156)
T d2ifga3 70 FVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCS 118 (156)
T ss_dssp EECTTGGGSCSCCCEEECCSSCCSCCCSTTTCSCCCCEEECCSSCCCCC
T ss_pred CcccccccccccccceeccCCCCcccChhhhccccccccccCCCcccCC
Confidence 88889999999999999999999943333332 5778999999884
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.30 E-value=2.4e-12 Score=123.04 Aligned_cols=123 Identities=23% Similarity=0.105 Sum_probs=90.2
Q ss_pred CcEEEEEecCCCceeecccccccCCCCCEEEccCCccCcCCCCCCCCCCCCCEEEcCCCcCccccCchhhhcccCccccc
Q 039819 8 NLVIGLGAPSQSLSGTLSGSIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFLSIWLPRKWD 87 (534)
Q Consensus 8 ~~l~~L~l~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~P~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~l~~~~~ 87 (534)
.+|+.|+|++|+|+ .++..+.++++|++|+|++|.+.+..+..+..+.+|++|++++|.++...+..+..+..+..+..
T Consensus 77 ~~L~~L~Ls~N~l~-~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l 155 (266)
T d1p9ag_ 77 PVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSL 155 (266)
T ss_dssp TTCCEEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEEC
T ss_pred cccccccccccccc-ccccccccccccccccccccccceeeccccccccccccccccccccceeccccccccccchhccc
Confidence 46788888888887 45667778888888888888877656666777777777777777777555555555554443322
Q ss_pred ccc---------cC-CccccceeCCCCcCcccCChhhhcccccccccccCCCCCC
Q 039819 88 KRK---------CS-GVDQGLLRLNNNSLSGAFPVFLAKISELAFLDLSYNNLSG 132 (534)
Q Consensus 88 ~~~---------~~-~~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g 132 (534)
+++ +. ..+|+.|+|++|+|+ .+|..+..+++|+.|+|++|.+.-
T Consensus 156 ~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~L~~L~L~~Np~~C 209 (266)
T d1p9ag_ 156 ANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLC 209 (266)
T ss_dssp TTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBCC
T ss_pred ccccccccCccccccccccceeecccCCCc-ccChhHCCCCCCCEEEecCCCCCC
Confidence 111 11 137999999999999 899999999999999999998863
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.29 E-value=1e-12 Score=115.91 Aligned_cols=106 Identities=20% Similarity=0.184 Sum_probs=86.9
Q ss_pred cccccCCCCCEEEccCCccCcCCCCCCCCCCCCCEEEcCCCcCccccCchhhhcccCcccccccccCCccccceeCCCCc
Q 039819 26 GSIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFLSIWLPRKWDKRKCSGVDQGLLRLNNNS 105 (534)
Q Consensus 26 ~~~~~l~~L~~L~L~~N~l~g~~P~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~l~~~~~~~~~~~~~L~~L~L~~N~ 105 (534)
+.|.++.+|++|+|++|+|+ .+|..+..+++|+.|||++|+|+ .++. +..++ +|+.|+|++|+
T Consensus 12 ~~~~n~~~lr~L~L~~n~I~-~i~~~~~~l~~L~~L~Ls~N~i~-~l~~-~~~l~--------------~L~~L~ls~N~ 74 (162)
T d1a9na_ 12 AQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KLDG-FPLLR--------------RLKTLLVNNNR 74 (162)
T ss_dssp CEEECTTSCEEEECTTSCCC-SCCCGGGGTTCCSEEECCSSCCC-EECC-CCCCS--------------SCCEEECCSSC
T ss_pred HhccCcCcCcEEECCCCCCC-ccCccccccccCCEEECCCCCCC-ccCC-cccCc--------------chhhhhccccc
Confidence 45788899999999999999 67877788999999999999999 5553 55555 89999999999
Q ss_pred CcccCChhhhcccccccccccCCCCCCCCCC--CC-----CccccccCCcc
Q 039819 106 LSGAFPVFLAKISELAFLDLSYNNLSGPVPK--FP-----ARTFNVAGNPL 149 (534)
Q Consensus 106 l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~--~~-----~~~~~~~~N~~ 149 (534)
++...+..+..+++|+.|++++|+++. ++. .+ -+.+.+.+||+
T Consensus 75 i~~l~~~~~~~l~~L~~L~L~~N~i~~-~~~l~~l~~l~~L~~L~l~~N~i 124 (162)
T d1a9na_ 75 ICRIGEGLDQALPDLTELILTNNSLVE-LGDLDPLASLKSLTYLCILRNPV 124 (162)
T ss_dssp CCEECSCHHHHCTTCCEEECCSCCCCC-GGGGGGGGGCTTCCEEECCSSGG
T ss_pred ccCCCccccccccccccceeccccccc-cccccccccccccchhhcCCCcc
Confidence 996666667889999999999999983 432 11 15667788887
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.20 E-value=1e-11 Score=120.86 Aligned_cols=110 Identities=24% Similarity=0.224 Sum_probs=97.4
Q ss_pred CCcEEEEEecCCCceeecccccccCCCCCEEEccCCccCcCCCCCCCCCCCCCEEEcCCCcCccccCchhhhcccCcccc
Q 039819 7 ENLVIGLGAPSQSLSGTLSGSIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFLSIWLPRKW 86 (534)
Q Consensus 7 ~~~l~~L~l~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~P~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~l~~~~ 86 (534)
..+++.|++++|.+++..+..|.+++.+++|++++|.|++..|..|.++++|++|+|++|+|+ .+|..+..++
T Consensus 170 ~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~-~lp~~l~~l~------ 242 (305)
T d1xkua_ 170 PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHK------ 242 (305)
T ss_dssp CTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCS------
T ss_pred CCccCEEECCCCcCCCCChhHhhccccccccccccccccccccccccccccceeeeccccccc-cccccccccc------
Confidence 357899999999999999999999999999999999999888888999999999999999999 7788888888
Q ss_pred cccccCCccccceeCCCCcCcccCCh------hhhcccccccccccCCCCC
Q 039819 87 DKRKCSGVDQGLLRLNNNSLSGAFPV------FLAKISELAFLDLSYNNLS 131 (534)
Q Consensus 87 ~~~~~~~~~L~~L~L~~N~l~g~~p~------~~~~l~~L~~L~ls~N~l~ 131 (534)
+|+.|+|++|+|+..-.. .+..+.+|+.|+|++|.++
T Consensus 243 --------~L~~L~Ls~N~i~~i~~~~f~~~~~~~~~~~L~~L~L~~N~~~ 285 (305)
T d1xkua_ 243 --------YIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQ 285 (305)
T ss_dssp --------SCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSC
T ss_pred --------CCCEEECCCCccCccChhhccCcchhcccCCCCEEECCCCcCc
Confidence 889999999999843222 3356788999999999986
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.13 E-value=5.9e-11 Score=108.02 Aligned_cols=117 Identities=25% Similarity=0.310 Sum_probs=82.2
Q ss_pred CcEEEEEecCCCceeecccccccCCCCCEEEccCCccCcCCCCCCCCCCCCCEEEcCCCcCccccCchhhhcccCccccc
Q 039819 8 NLVIGLGAPSQSLSGTLSGSIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFLSIWLPRKWD 87 (534)
Q Consensus 8 ~~l~~L~l~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~P~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~l~~~~~ 87 (534)
.+++.|++++|+++ .++ .+..+++|++|+|++|+|++ +++ |++|++|++|++++|.+. .+|. +..+..+..+..
T Consensus 40 ~~l~~L~l~~~~i~-~l~-~l~~l~nL~~L~Ls~N~l~~-~~~-l~~l~~L~~L~l~~n~~~-~~~~-l~~l~~L~~L~l 113 (199)
T d2omxa2 40 DQVTTLQADRLGIK-SID-GVEYLNNLTQINFSNNQLTD-ITP-LKNLTKLVDILMNNNQIA-DITP-LANLTNLTGLTL 113 (199)
T ss_dssp TTCCEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCC-CGG-GTTCTTCCEEECCSSCCC-CCGG-GTTCTTCSEEEC
T ss_pred cCCCEEECCCCCCC-Ccc-ccccCCCcCcCccccccccC-ccc-ccCCcccccccccccccc-cccc-cccccccccccc
Confidence 46889999999998 454 48899999999999999995 554 899999999999999998 4443 556664443321
Q ss_pred ccc--------cCCccccceeCCCCcCcccCChhhhcccccccccccCCCCCC
Q 039819 88 KRK--------CSGVDQGLLRLNNNSLSGAFPVFLAKISELAFLDLSYNNLSG 132 (534)
Q Consensus 88 ~~~--------~~~~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g 132 (534)
+.. ....+|+.|++++|++. .+| .+..+++|+.|++++|++++
T Consensus 114 ~~~~~~~~~~~~~l~~L~~L~l~~n~l~-~~~-~l~~~~~L~~L~l~~n~l~~ 164 (199)
T d2omxa2 114 FNNQITDIDPLKNLTNLNRLELSSNTIS-DIS-ALSGLTSLQQLNFSSNQVTD 164 (199)
T ss_dssp CSSCCCCCGGGTTCTTCSEEECCSSCCC-CCG-GGTTCTTCSEEECCSSCCCC
T ss_pred cccccccccccchhhhhHHhhhhhhhhc-ccc-cccccccccccccccccccC
Confidence 110 01135667777777765 333 46667777777777777764
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.10 E-value=9.1e-11 Score=106.75 Aligned_cols=99 Identities=22% Similarity=0.272 Sum_probs=71.5
Q ss_pred EEEecCCCceeecccccccCCCCCEEEccCCccCcCCCCCCCCCCCCCEEEcCCCcCccccCchhhhcccCccccccccc
Q 039819 12 GLGAPSQSLSGTLSGSIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFLSIWLPRKWDKRKC 91 (534)
Q Consensus 12 ~L~l~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~P~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~l~~~~~~~~~ 91 (534)
.+.++.+++++.++ ...+.+|++|+|++|.|+ .++ .+..+++|++|+|++|+|++..| +..++
T Consensus 22 ~~~l~~~~~~~~~~--~~~l~~l~~L~l~~~~i~-~l~-~l~~l~nL~~L~Ls~N~l~~~~~--l~~l~----------- 84 (199)
T d2omxa2 22 KTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIK-SID-GVEYLNNLTQINFSNNQLTDITP--LKNLT----------- 84 (199)
T ss_dssp HHHTTCSSTTSEEC--HHHHTTCCEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCCGG--GTTCT-----------
T ss_pred HHHhCCCCCCCccC--HHHhcCCCEEECCCCCCC-Ccc-ccccCCCcCcCccccccccCccc--ccCCc-----------
Confidence 34577888887654 356889999999999999 565 48889999999999999996543 67777
Q ss_pred CCccccceeCCCCcCcccCChhhhcccccccccccCCCCCC
Q 039819 92 SGVDQGLLRLNNNSLSGAFPVFLAKISELAFLDLSYNNLSG 132 (534)
Q Consensus 92 ~~~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g 132 (534)
+|+.|++++|.+. .+| .+..++.|+.|++++|.+..
T Consensus 85 ---~L~~L~l~~n~~~-~~~-~l~~l~~L~~L~l~~~~~~~ 120 (199)
T d2omxa2 85 ---KLVDILMNNNQIA-DIT-PLANLTNLTGLTLFNNQITD 120 (199)
T ss_dssp ---TCCEEECCSSCCC-CCG-GGTTCTTCSEEECCSSCCCC
T ss_pred ---ccccccccccccc-ccc-cccccccccccccccccccc
Confidence 5566666666665 333 25566666666666666553
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.10 E-value=5.5e-13 Score=121.77 Aligned_cols=121 Identities=21% Similarity=0.286 Sum_probs=92.3
Q ss_pred EEEEEecCC--CceeecccccccCCCCCEEEccCCccCcCCCCCCCCCCCCCEEEcCCCcCccccCchhhhcccCccccc
Q 039819 10 VIGLGAPSQ--SLSGTLSGSIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFLSIWLPRKWD 87 (534)
Q Consensus 10 l~~L~l~~n--~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~P~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~l~~~~~ 87 (534)
+..++|.++ .+. .+|.+|+.|++|++|+|++|+|+ .++ .|.+|++|+.|+|++|+|+ .+|..+..++
T Consensus 25 ~~~~~l~~~~~~i~-~l~~sl~~L~~L~~L~Ls~n~I~-~i~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~------- 93 (198)
T d1m9la_ 25 AEKVELHGMIPPIE-KMDATLSTLKACKHLALSTNNIE-KIS-SLSGMENLRILSLGRNLIK-KIENLDAVAD------- 93 (198)
T ss_dssp CSCEECCBCCTTCC-CCHHHHHHTTTCCEEECSEEEES-CCC-CHHHHTTCCEEECCEEEEC-SCSSHHHHHH-------
T ss_pred cceeeeecccCchh-hhhhHHhcccccceeECcccCCC-Ccc-cccCCccccChhhcccccc-cccccccccc-------
Confidence 344555543 354 56778999999999999999999 566 5889999999999999998 6776665555
Q ss_pred ccccCCccccceeCCCCcCcccCChhhhcccccccccccCCCCCCCCCC-----CC--CccccccCCccee
Q 039819 88 KRKCSGVDQGLLRLNNNSLSGAFPVFLAKISELAFLDLSYNNLSGPVPK-----FP--ARTFNVAGNPLIC 151 (534)
Q Consensus 88 ~~~~~~~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~-----~~--~~~~~~~~N~~~c 151 (534)
+|+.|++++|+++ .+ ..+..+++|+.|+|++|+++. ++. .+ -+.+.+.+||..+
T Consensus 94 -------~L~~L~l~~N~i~-~l-~~~~~l~~L~~L~L~~N~i~~-~~~~~~l~~l~~L~~L~L~~N~l~~ 154 (198)
T d1m9la_ 94 -------TLEELWISYNQIA-SL-SGIEKLVNLRVLYMSNNKITN-WGEIDKLAALDKLEDLLLAGNPLYN 154 (198)
T ss_dssp -------HCCEEECSEEECC-CH-HHHHHHHHSSEEEESEEECCC-HHHHHHHTTTTTCSEEEECSSHHHH
T ss_pred -------ccccccccccccc-cc-ccccccccccccccccchhcc-ccccccccCCCccceeecCCCcccc
Confidence 6888999999998 44 358888999999999999874 321 11 1567888888744
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.06 E-value=2e-10 Score=105.45 Aligned_cols=116 Identities=22% Similarity=0.236 Sum_probs=71.2
Q ss_pred cEEEEEecCCCceeecccccccCCCCCEEEccCCccCcCCCCCCCCCCCCCEEEcCCCcCccccCchhhhcccCcccccc
Q 039819 9 LVIGLGAPSQSLSGTLSGSIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFLSIWLPRKWDK 88 (534)
Q Consensus 9 ~l~~L~l~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~P~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~l~~~~~~ 88 (534)
.++.|++++|+++. ++ .|..+++|++|+|++|+|++ +| .++.|++|++|+|++|+|++ +| .+..++.+..+...
T Consensus 47 ~L~~L~l~~~~i~~-l~-~l~~l~~L~~L~L~~n~i~~-l~-~~~~l~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~l~ 120 (210)
T d1h6ta2 47 SIDQIIANNSDIKS-VQ-GIQYLPNVTKLFLNGNKLTD-IK-PLANLKNLGWLFLDENKVKD-LS-SLKDLKKLKSLSLE 120 (210)
T ss_dssp TCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCC-CG-GGTTCTTCCEEECCSSCCCC-GG-GGTTCTTCCEEECT
T ss_pred CccEEECcCCCCCC-ch-hHhhCCCCCEEeCCCccccC-cc-ccccCccccccccccccccc-cc-cccccccccccccc
Confidence 57778888888874 44 37788888888888888884 55 36778888888888888884 44 35555544332211
Q ss_pred cc-c-------CCccccceeCCCCcCcccCChhhhcccccccccccCCCCCC
Q 039819 89 RK-C-------SGVDQGLLRLNNNSLSGAFPVFLAKISELAFLDLSYNNLSG 132 (534)
Q Consensus 89 ~~-~-------~~~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g 132 (534)
+. . ....|+.++++.|.+++ +..+..+++|+.+++++|++++
T Consensus 121 ~~~~~~~~~l~~l~~l~~l~~~~n~l~~--~~~~~~l~~L~~l~l~~n~l~~ 170 (210)
T d1h6ta2 121 HNGISDINGLVHLPQLESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQISD 170 (210)
T ss_dssp TSCCCCCGGGGGCTTCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCC
T ss_pred cccccccccccccccccccccccccccc--cccccccccccccccccccccc
Confidence 10 0 01145555555555542 2234455566666666666653
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.06 E-value=2e-12 Score=117.94 Aligned_cols=109 Identities=22% Similarity=0.234 Sum_probs=92.3
Q ss_pred CcEEEEEecCCCceeecccccccCCCCCEEEccCCccCcCCCCCCCCCCCCCEEEcCCCcCccccCchhhhcccCccccc
Q 039819 8 NLVIGLGAPSQSLSGTLSGSIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFLSIWLPRKWD 87 (534)
Q Consensus 8 ~~l~~L~l~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~P~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~l~~~~~ 87 (534)
.+|+.|+|++|+|+ .++ .|.+|++|++|+|++|+|+ .+|..+..+++|++|+|++|+|+. ++ .+..++
T Consensus 48 ~~L~~L~Ls~n~I~-~i~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~~-l~-~~~~l~------- 115 (198)
T d1m9la_ 48 KACKHLALSTNNIE-KIS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIAS-LS-GIEKLV------- 115 (198)
T ss_dssp TTCCEEECSEEEES-CCC-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECCC-HH-HHHHHH-------
T ss_pred cccceeECcccCCC-Ccc-cccCCccccChhhcccccc-cccccccccccccccccccccccc-cc-cccccc-------
Confidence 47899999999999 565 5999999999999999999 688766667899999999999994 44 466666
Q ss_pred ccccCCccccceeCCCCcCcccCC--hhhhcccccccccccCCCCCCCCCC
Q 039819 88 KRKCSGVDQGLLRLNNNSLSGAFP--VFLAKISELAFLDLSYNNLSGPVPK 136 (534)
Q Consensus 88 ~~~~~~~~L~~L~L~~N~l~g~~p--~~~~~l~~L~~L~ls~N~l~g~~p~ 136 (534)
+|+.|+|++|+++ .++ ..|..+++|+.|+|++|.++...+.
T Consensus 116 -------~L~~L~L~~N~i~-~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~ 158 (198)
T d1m9la_ 116 -------NLRVLYMSNNKIT-NWGEIDKLAALDKLEDLLLAGNPLYNDYKE 158 (198)
T ss_dssp -------HSSEEEESEEECC-CHHHHHHHTTTTTCSEEEECSSHHHHHHCT
T ss_pred -------cccccccccchhc-cccccccccCCCccceeecCCCccccCccc
Confidence 8899999999998 444 4689999999999999998854443
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.02 E-value=2.8e-10 Score=104.33 Aligned_cols=98 Identities=22% Similarity=0.369 Sum_probs=78.9
Q ss_pred EEecCCCceeecccccccCCCCCEEEccCCccCcCCCCCCCCCCCCCEEEcCCCcCccccCchhhhcccCcccccccccC
Q 039819 13 LGAPSQSLSGTLSGSIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFLSIWLPRKWDKRKCS 92 (534)
Q Consensus 13 L~l~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~P~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~l~~~~~~~~~~ 92 (534)
.+++.+.+++.++. ..|.+|+.|++++|.|+. ++ .+..+++|++|+|++|+|++. +. +..++
T Consensus 29 ~~l~~~~~~~~~~~--~~L~~L~~L~l~~~~i~~-l~-~l~~l~~L~~L~L~~n~i~~l-~~-~~~l~------------ 90 (210)
T d1h6ta2 29 DNLKKKSVTDAVTQ--NELNSIDQIIANNSDIKS-VQ-GIQYLPNVTKLFLNGNKLTDI-KP-LANLK------------ 90 (210)
T ss_dssp HHTTCSCTTSEECH--HHHHTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCC-GG-GTTCT------------
T ss_pred HHhCcCccCCccCH--HHhcCccEEECcCCCCCC-ch-hHhhCCCCCEEeCCCccccCc-cc-cccCc------------
Confidence 45677888876663 457899999999999994 55 488899999999999999964 42 45565
Q ss_pred CccccceeCCCCcCcccCChhhhcccccccccccCCCCCC
Q 039819 93 GVDQGLLRLNNNSLSGAFPVFLAKISELAFLDLSYNNLSG 132 (534)
Q Consensus 93 ~~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g 132 (534)
+|+.|+|++|+|+ .+| .+..+++|+.|++++|.++.
T Consensus 91 --~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~~~~~~ 126 (210)
T d1h6ta2 91 --NLGWLFLDENKVK-DLS-SLKDLKKLKSLSLEHNGISD 126 (210)
T ss_dssp --TCCEEECCSSCCC-CGG-GGTTCTTCCEEECTTSCCCC
T ss_pred --ccccccccccccc-ccc-cccccccccccccccccccc
Confidence 7888999999998 455 58889999999999998873
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.02 E-value=1.6e-10 Score=115.41 Aligned_cols=133 Identities=26% Similarity=0.306 Sum_probs=91.6
Q ss_pred CcEEEEEecCCCceeecccccccCCCCCEEEccCCccCcCCCCCCCCCCCCCEEEcCCCcCccccCchhhhcccCccccc
Q 039819 8 NLVIGLGAPSQSLSGTLSGSIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFLSIWLPRKWD 87 (534)
Q Consensus 8 ~~l~~L~l~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~P~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~l~~~~~ 87 (534)
.+++.|++++|+++. + +.+..+++|+.|++++|++++ +++ ++.+++|++|++++|++++..| +..+..+.....
T Consensus 219 ~~L~~L~l~~n~l~~-~-~~l~~l~~L~~L~l~~n~l~~-~~~-~~~~~~L~~L~l~~~~l~~~~~--~~~~~~l~~l~~ 292 (384)
T d2omza2 219 TNLDELSLNGNQLKD-I-GTLASLTNLTDLDLANNQISN-LAP-LSGLTKLTELKLGANQISNISP--LAGLTALTNLEL 292 (384)
T ss_dssp TTCCEEECCSSCCCC-C-GGGGGCTTCSEEECCSSCCCC-CGG-GTTCTTCSEEECCSSCCCCCGG--GTTCTTCSEEEC
T ss_pred CCCCEEECCCCCCCC-c-chhhcccccchhccccCccCC-CCc-ccccccCCEeeccCcccCCCCc--cccccccccccc
Confidence 578999999999984 4 468899999999999999995 443 8889999999999999996543 223322222111
Q ss_pred cc-c-------cCCccccceeCCCCcCcccCChhhhcccccccccccCCCCCCCCCCCC----CccccccCCcc
Q 039819 88 KR-K-------CSGVDQGLLRLNNNSLSGAFPVFLAKISELAFLDLSYNNLSGPVPKFP----ARTFNVAGNPL 149 (534)
Q Consensus 88 ~~-~-------~~~~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~----~~~~~~~~N~~ 149 (534)
.. . ....+++.|+|++|++++.. .+..+++|+.|+|++|+|++ +|... -+.+.+.+|.+
T Consensus 293 ~~n~l~~~~~~~~~~~l~~L~ls~n~l~~l~--~l~~l~~L~~L~L~~n~l~~-l~~l~~l~~L~~L~l~~N~l 363 (384)
T d2omza2 293 NENQLEDISPISNLKNLTYLTLYFNNISDIS--PVSSLTKLQRLFFANNKVSD-VSSLANLTNINWLSAGHNQI 363 (384)
T ss_dssp CSSCCSCCGGGGGCTTCSEEECCSSCCSCCG--GGGGCTTCCEEECCSSCCCC-CGGGGGCTTCCEEECCSSCC
T ss_pred cccccccccccchhcccCeEECCCCCCCCCc--ccccCCCCCEEECCCCCCCC-ChhHcCCCCCCEEECCCCcC
Confidence 11 0 11126778888888887543 37778888888888888874 44211 14566666665
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=98.94 E-value=3.8e-10 Score=112.63 Aligned_cols=106 Identities=24% Similarity=0.324 Sum_probs=88.8
Q ss_pred CcEEEEEecCCCceeecccccccCCCCCEEEccCCccCcCCCCCCCCCCCCCEEEcCCCcCccccCchhhhcccCccccc
Q 039819 8 NLVIGLGAPSQSLSGTLSGSIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFLSIWLPRKWD 87 (534)
Q Consensus 8 ~~l~~L~l~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~P~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~l~~~~~ 87 (534)
.+++.|++++|++++.. .+.++..++.+.+++|++++ ++ .+..+++|+.|+|++|+|++..| +..++
T Consensus 263 ~~L~~L~l~~~~l~~~~--~~~~~~~l~~l~~~~n~l~~-~~-~~~~~~~l~~L~ls~n~l~~l~~--l~~l~------- 329 (384)
T d2omza2 263 TKLTELKLGANQISNIS--PLAGLTALTNLELNENQLED-IS-PISNLKNLTYLTLYFNNISDISP--VSSLT------- 329 (384)
T ss_dssp TTCSEEECCSSCCCCCG--GGTTCTTCSEEECCSSCCSC-CG-GGGGCTTCSEEECCSSCCSCCGG--GGGCT-------
T ss_pred ccCCEeeccCcccCCCC--cccccccccccccccccccc-cc-ccchhcccCeEECCCCCCCCCcc--cccCC-------
Confidence 47899999999998643 37889999999999999985 33 58889999999999999996543 56666
Q ss_pred ccccCCccccceeCCCCcCcccCChhhhcccccccccccCCCCCCCCC
Q 039819 88 KRKCSGVDQGLLRLNNNSLSGAFPVFLAKISELAFLDLSYNNLSGPVP 135 (534)
Q Consensus 88 ~~~~~~~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p 135 (534)
+|+.|+|++|+|+ .+| .|+.+++|++|+|++|+|++.+|
T Consensus 330 -------~L~~L~L~~n~l~-~l~-~l~~l~~L~~L~l~~N~l~~l~~ 368 (384)
T d2omza2 330 -------KLQRLFFANNKVS-DVS-SLANLTNINWLSAGHNQISDLTP 368 (384)
T ss_dssp -------TCCEEECCSSCCC-CCG-GGGGCTTCCEEECCSSCCCBCGG
T ss_pred -------CCCEEECCCCCCC-CCh-hHcCCCCCCEEECCCCcCCCChh
Confidence 8889999999998 455 68999999999999999997655
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=98.93 E-value=1.1e-09 Score=101.42 Aligned_cols=132 Identities=23% Similarity=0.242 Sum_probs=85.9
Q ss_pred cEEEEEecCCCceeecccccccCCCCCEEEccCCccCcCCCCCCCCCCCCCEEEcCCCcCccccCchhhhcccCcccccc
Q 039819 9 LVIGLGAPSQSLSGTLSGSIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFLSIWLPRKWDK 88 (534)
Q Consensus 9 ~l~~L~l~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~P~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~l~~~~~~ 88 (534)
+|+.|++.+|+|+ .++ .|..|++|++|+|++|+|++..| |..+++|++|++++|.++ .++. +..++++..+...
T Consensus 42 ~L~~L~l~~~~i~-~l~-~l~~l~~L~~L~ls~n~i~~~~~--l~~l~~l~~l~~~~n~~~-~i~~-l~~l~~L~~l~l~ 115 (227)
T d1h6ua2 42 GITTLSAFGTGVT-TIE-GVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLK-NVSA-IAGLQSIKTLDLT 115 (227)
T ss_dssp TCCEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCS-CCGG-GTTCTTCCEEECT
T ss_pred CcCEEECCCCCCC-cch-hHhcCCCCcEeecCCceeecccc--cccccccccccccccccc-cccc-ccccccccccccc
Confidence 5788888888888 454 58888888888888888885333 788888888888888887 4442 3344333221100
Q ss_pred c------------------------------ccCCccccceeCCCCcCcccCChhhhcccccccccccCCCCCCCCCCCC
Q 039819 89 R------------------------------KCSGVDQGLLRLNNNSLSGAFPVFLAKISELAFLDLSYNNLSGPVPKFP 138 (534)
Q Consensus 89 ~------------------------------~~~~~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~ 138 (534)
. .....+|+.|++++|.+++.. .++.+++|+.|+|++|++++ +|...
T Consensus 116 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~L~~L~l~~n~~~~~~--~l~~l~~L~~L~Ls~n~l~~-l~~l~ 192 (227)
T d1h6ua2 116 STQITDVTPLAGLSNLQVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLT--PLANLSKLTTLKADDNKISD-ISPLA 192 (227)
T ss_dssp TSCCCCCGGGTTCTTCCEEECCSSCCCCCGGGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCC-CGGGG
T ss_pred cccccccchhccccchhhhhchhhhhchhhhhccccccccccccccccccch--hhcccccceecccCCCccCC-Chhhc
Confidence 0 001125778888888876432 37788888888888888875 33211
Q ss_pred ----CccccccCCcc
Q 039819 139 ----ARTFNVAGNPL 149 (534)
Q Consensus 139 ----~~~~~~~~N~~ 149 (534)
-+.+.+++|.+
T Consensus 193 ~l~~L~~L~Ls~N~l 207 (227)
T d1h6ua2 193 SLPNLIEVHLKNNQI 207 (227)
T ss_dssp GCTTCCEEECTTSCC
T ss_pred CCCCCCEEECcCCcC
Confidence 14456666654
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.87 E-value=2.2e-09 Score=100.17 Aligned_cols=77 Identities=19% Similarity=0.217 Sum_probs=53.6
Q ss_pred CcEEEEEecCCCceeecccccccCCCCCEEEccCCccCcCCC-CCCCCCCCCCEEEcC-CCcCccccCchhhhcccCcc
Q 039819 8 NLVIGLGAPSQSLSGTLSGSIGNLTNLRQVLLQNNNISGGIP-PQLGSLPKLQTLDLS-NNRLSGVIPALLFLSIWLPR 84 (534)
Q Consensus 8 ~~l~~L~l~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~P-~~~~~l~~L~~L~Ls-~N~l~g~~p~~~~~l~~l~~ 84 (534)
.+++.|+|++|+|+...+.+|.++++|++|+|++|.+...+| .+|.++++++.|++. .|++....+..|..+++|..
T Consensus 29 ~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~~n~l~~~~~~~~~~l~~L~~ 107 (242)
T d1xwdc1 29 RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQY 107 (242)
T ss_dssp SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEECCTTCCEECTTSEECCTTCCE
T ss_pred CCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeeccccccccccccccccccccccccccccccccccccc
Confidence 368888999999885555678888899999998888875444 356677777777654 35666555555555554443
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=98.81 E-value=2.3e-09 Score=105.19 Aligned_cols=99 Identities=24% Similarity=0.289 Sum_probs=82.1
Q ss_pred CcEEEEEecCCCceeecccccccCCCCCEEEccCCccCcCCCCCCCCCCCCCEEEcCCCcCccccCchhhhcccCccccc
Q 039819 8 NLVIGLGAPSQSLSGTLSGSIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFLSIWLPRKWD 87 (534)
Q Consensus 8 ~~l~~L~l~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~P~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~l~~~~~ 87 (534)
.+++.|+|++|+|+ .+|+. +++|++|+|++|+|+ .+|..+ .+|+.|++++|+++ .++.. + .
T Consensus 38 ~~l~~LdLs~~~L~-~lp~~---~~~L~~L~Ls~N~l~-~lp~~~---~~L~~L~l~~n~l~-~l~~l----p---~--- 98 (353)
T d1jl5a_ 38 RQAHELELNNLGLS-SLPEL---PPHLESLVASCNSLT-ELPELP---QSLKSLLVDNNNLK-ALSDL----P---P--- 98 (353)
T ss_dssp HTCSEEECTTSCCS-CCCSC---CTTCSEEECCSSCCS-SCCCCC---TTCCEEECCSSCCS-CCCSC----C---T---
T ss_pred cCCCEEEeCCCCCC-CCCCC---CCCCCEEECCCCCCc-ccccch---hhhhhhhhhhcccc-hhhhh----c---c---
Confidence 36889999999998 68864 578999999999999 789765 47999999999998 55532 1 1
Q ss_pred ccccCCccccceeCCCCcCcccCChhhhcccccccccccCCCCCCCC
Q 039819 88 KRKCSGVDQGLLRLNNNSLSGAFPVFLAKISELAFLDLSYNNLSGPV 134 (534)
Q Consensus 88 ~~~~~~~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~ 134 (534)
.|++|+|++|.++ .+|. ++.++.|+.|++++|.++...
T Consensus 99 -------~L~~L~L~~n~l~-~lp~-~~~l~~L~~L~l~~~~~~~~~ 136 (353)
T d1jl5a_ 99 -------LLEYLGVSNNQLE-KLPE-LQNSSFLKIIDVDNNSLKKLP 136 (353)
T ss_dssp -------TCCEEECCSSCCS-SCCC-CTTCTTCCEEECCSSCCSCCC
T ss_pred -------ccccccccccccc-cccc-hhhhccceeeccccccccccc
Confidence 6889999999998 6775 678999999999999998543
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.81 E-value=3.1e-09 Score=99.09 Aligned_cols=112 Identities=14% Similarity=0.169 Sum_probs=88.4
Q ss_pred eecCCCcEEEEEecCCCceeecccccccCCCCCEEEccCCccCcCCCCCCCCCCCCCEEEcCCCcCccccCc-hhhhccc
Q 039819 3 TCSPENLVIGLGAPSQSLSGTLSGSIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPA-LLFLSIW 81 (534)
Q Consensus 3 ~c~~~~~l~~L~l~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~P~~~~~l~~L~~L~Ls~N~l~g~~p~-~~~~l~~ 81 (534)
.|+..++ .++.++++|+ .+|+.+- +++++|+|++|+|+...+.+|.++++|++|+|++|.+...+|. .|..+.
T Consensus 5 ~C~C~~~--~i~c~~~~l~-~iP~~l~--~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~- 78 (242)
T d1xwdc1 5 ICHCSNR--VFLCQESKVT-EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLP- 78 (242)
T ss_dssp SEEECSS--EEEEESCSCS-SCCSCSC--SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCT-
T ss_pred cCCCcCC--EEEEeCCCCC-CcCCCCC--CCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeecccccccc-
Confidence 4554444 4777889998 7887653 6899999999999954445799999999999999999876553 555566
Q ss_pred CcccccccccCCccccceeCC-CCcCcccCChhhhcccccccccccCCCCCCC
Q 039819 82 LPRKWDKRKCSGVDQGLLRLN-NNSLSGAFPVFLAKISELAFLDLSYNNLSGP 133 (534)
Q Consensus 82 l~~~~~~~~~~~~~L~~L~L~-~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~ 133 (534)
.++.|.+. .|.+....+..|..+++|+.|++++|+++..
T Consensus 79 -------------~l~~l~~~~~n~l~~~~~~~~~~l~~L~~l~l~~~~l~~~ 118 (242)
T d1xwdc1 79 -------------KLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHL 118 (242)
T ss_dssp -------------TCCEEEEECCTTCCEECTTSEECCTTCCEEEEESCCCCSC
T ss_pred -------------ccccccccccccccccccccccccccccccccchhhhccc
Confidence 66667764 5788878888899999999999999999843
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=98.78 E-value=3.4e-09 Score=98.00 Aligned_cols=104 Identities=25% Similarity=0.337 Sum_probs=72.5
Q ss_pred CcEEEEEecCCCceeecccccccCCCCCEEEccCCccCcCCCCCCCCCCCCCEEEcCCCcCccccCchhhhcccCccccc
Q 039819 8 NLVIGLGAPSQSLSGTLSGSIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFLSIWLPRKWD 87 (534)
Q Consensus 8 ~~l~~L~l~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~P~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~l~~~~~ 87 (534)
..++.|+++++...+.. .+...+.++.|.++++.+.... .+.++++|+.|++++|.++...+ +..++
T Consensus 107 ~~L~~l~l~~~~~~~~~--~~~~~~~~~~l~~~~~~~~~~~--~~~~~~~L~~L~l~~n~~~~~~~--l~~l~------- 173 (227)
T d1h6ua2 107 QSIKTLDLTSTQITDVT--PLAGLSNLQVLYLDLNQITNIS--PLAGLTNLQYLSIGNAQVSDLTP--LANLS------- 173 (227)
T ss_dssp TTCCEEECTTSCCCCCG--GGTTCTTCCEEECCSSCCCCCG--GGGGCTTCCEEECCSSCCCCCGG--GTTCT-------
T ss_pred ccccccccccccccccc--hhccccchhhhhchhhhhchhh--hhccccccccccccccccccchh--hcccc-------
Confidence 45777888888776432 3666778888888888777322 36677788888888888774322 45555
Q ss_pred ccccCCccccceeCCCCcCcccCChhhhcccccccccccCCCCCCC
Q 039819 88 KRKCSGVDQGLLRLNNNSLSGAFPVFLAKISELAFLDLSYNNLSGP 133 (534)
Q Consensus 88 ~~~~~~~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~ 133 (534)
+|+.|+|++|++++ +|. ++.+++|++|+|++|+++..
T Consensus 174 -------~L~~L~Ls~n~l~~-l~~-l~~l~~L~~L~Ls~N~lt~i 210 (227)
T d1h6ua2 174 -------KLTTLKADDNKISD-ISP-LASLPNLIEVHLKNNQISDV 210 (227)
T ss_dssp -------TCCEEECCSSCCCC-CGG-GGGCTTCCEEECTTSCCCBC
T ss_pred -------cceecccCCCccCC-Chh-hcCCCCCCEEECcCCcCCCC
Confidence 67778888888874 443 77788888888888888743
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.49 E-value=7.2e-09 Score=105.15 Aligned_cols=114 Identities=25% Similarity=0.272 Sum_probs=86.9
Q ss_pred cEEEEEecCCCceeec-ccccccCCCCCEEEccCCccCc----CCCCCCCCCCCCCEEEcCCCcCccccCchhhhcccCc
Q 039819 9 LVIGLGAPSQSLSGTL-SGSIGNLTNLRQVLLQNNNISG----GIPPQLGSLPKLQTLDLSNNRLSGVIPALLFLSIWLP 83 (534)
Q Consensus 9 ~l~~L~l~~n~l~g~~-p~~~~~l~~L~~L~L~~N~l~g----~~P~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~l~ 83 (534)
+|+.||+++|+|++.- ..-+..+++|++|+|++|.|+- .++..+..+++|++|||++|.|+..--..+... +.
T Consensus 3 ~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~--l~ 80 (460)
T d1z7xw1 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQG--LQ 80 (460)
T ss_dssp EEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHT--TC
T ss_pred CCCEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHH--Hh
Confidence 6899999999999642 4457788999999999999982 456667889999999999999963211112111 10
Q ss_pred ccccccccCCccccceeCCCCcCccc----CChhhhcccccccccccCCCCC
Q 039819 84 RKWDKRKCSGVDQGLLRLNNNSLSGA----FPVFLAKISELAFLDLSYNNLS 131 (534)
Q Consensus 84 ~~~~~~~~~~~~L~~L~L~~N~l~g~----~p~~~~~l~~L~~L~ls~N~l~ 131 (534)
....+|+.|+|++|+++.. ++..+..+++|+.|+|++|.++
T Consensus 81 -------~~~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~ 125 (460)
T d1z7xw1 81 -------TPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLG 125 (460)
T ss_dssp -------STTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCH
T ss_pred -------cCCCCCCEEECCCCCccccccccccchhhccccccccccccccch
Confidence 0112789999999999743 5677888999999999999987
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.36 E-value=9.1e-09 Score=89.93 Aligned_cols=104 Identities=20% Similarity=0.129 Sum_probs=47.2
Q ss_pred EEEEEecCCCceeecccccccCCCCCEEEccCCccCcCCCCCCCCCCCCCEEEcCCCcCccc--cCchhhhcccCccccc
Q 039819 10 VIGLGAPSQSLSGTLSGSIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGV--IPALLFLSIWLPRKWD 87 (534)
Q Consensus 10 l~~L~l~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~P~~~~~l~~L~~L~Ls~N~l~g~--~p~~~~~l~~l~~~~~ 87 (534)
...|+++++... +.+..+..+..|.+.+|.+. .++..+..+++|++|+|++|+|+.. ++..+..++
T Consensus 24 ~~~Ldls~l~~~----~~l~~~~~~~~l~~~~~~~~-~l~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~------- 91 (162)
T d1koha1 24 QQALDLKGLRSD----PDLVAQNIDVVLNRRSSMAA-TLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAP------- 91 (162)
T ss_dssp SCCBCCCCCSSC----TTTTTTTCCCCTTSHHHHHH-HHHHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHST-------
T ss_pred hCeeecccCCCC----chhhhccchhhcchhhhHhh-hhHHHHHhCCCCCEeeCCCccccCCchhHHHHhhCC-------
Confidence 344555544321 12333444444444444433 3333334455566666666665532 122233333
Q ss_pred ccccCCccccceeCCCCcCcccCChhhhcccccccccccCCCCCC
Q 039819 88 KRKCSGVDQGLLRLNNNSLSGAFPVFLAKISELAFLDLSYNNLSG 132 (534)
Q Consensus 88 ~~~~~~~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g 132 (534)
+|+.|+|++|.++..-+-.+.....|+.|++++|.++.
T Consensus 92 -------~L~~L~Ls~N~i~~l~~l~~l~~~~L~~L~L~~Npl~~ 129 (162)
T d1koha1 92 -------NLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSD 129 (162)
T ss_dssp -------TCCCCCCTTSCCCCGGGHHHHTTCCCSSCCCTTSTTSS
T ss_pred -------cccccccccCccccchhhhhhhccccceeecCCCCcCc
Confidence 55556666666552222122233345556666665553
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.23 E-value=2.5e-08 Score=87.09 Aligned_cols=43 Identities=28% Similarity=0.359 Sum_probs=21.6
Q ss_pred ccccCCCCCEEEccCCccCcC--CCCCCCCCCCCCEEEcCCCcCc
Q 039819 27 SIGNLTNLRQVLLQNNNISGG--IPPQLGSLPKLQTLDLSNNRLS 69 (534)
Q Consensus 27 ~~~~l~~L~~L~L~~N~l~g~--~P~~~~~l~~L~~L~Ls~N~l~ 69 (534)
.+..+++|++|+|++|+|+.. ++..+..+++|+.|||++|+|+
T Consensus 60 ~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~ 104 (162)
T d1koha1 60 IEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELK 104 (162)
T ss_dssp HHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCC
T ss_pred HHHhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccc
Confidence 334455555555555555521 1222344555555555555555
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=98.20 E-value=2.5e-06 Score=82.69 Aligned_cols=76 Identities=32% Similarity=0.402 Sum_probs=60.3
Q ss_pred CcEEEEEecCCCceeecccccccCCCCCEEEccCCccCcCCCCCCCCCCCCCEEEcCCCcCccccCchhhhcccCccccc
Q 039819 8 NLVIGLGAPSQSLSGTLSGSIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGVIPALLFLSIWLPRKWD 87 (534)
Q Consensus 8 ~~l~~L~l~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~P~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~l~~~~~ 87 (534)
..++.|+|++|+|+ .+|..+ .+|+.|++++|+++ .++.-. +.|++|+|++|.|+ .+|. +..+.
T Consensus 58 ~~L~~L~Ls~N~l~-~lp~~~---~~L~~L~l~~n~l~-~l~~lp---~~L~~L~L~~n~l~-~lp~-~~~l~------- 120 (353)
T d1jl5a_ 58 PHLESLVASCNSLT-ELPELP---QSLKSLLVDNNNLK-ALSDLP---PLLEYLGVSNNQLE-KLPE-LQNSS------- 120 (353)
T ss_dssp TTCSEEECCSSCCS-SCCCCC---TTCCEEECCSSCCS-CCCSCC---TTCCEEECCSSCCS-SCCC-CTTCT-------
T ss_pred CCCCEEECCCCCCc-ccccch---hhhhhhhhhhcccc-hhhhhc---cccccccccccccc-cccc-hhhhc-------
Confidence 47899999999999 788654 58999999999999 566421 46999999999999 5664 45566
Q ss_pred ccccCCccccceeCCCCcCc
Q 039819 88 KRKCSGVDQGLLRLNNNSLS 107 (534)
Q Consensus 88 ~~~~~~~~L~~L~L~~N~l~ 107 (534)
+|+.|++++|.++
T Consensus 121 -------~L~~L~l~~~~~~ 133 (353)
T d1jl5a_ 121 -------FLKIIDVDNNSLK 133 (353)
T ss_dssp -------TCCEEECCSSCCS
T ss_pred -------cceeecccccccc
Confidence 6777888777776
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.11 E-value=4.4e-07 Score=86.53 Aligned_cols=63 Identities=21% Similarity=0.251 Sum_probs=47.4
Q ss_pred CCcEEEEEecCCCceee-cccccccCCCCCEEEccCCccCcCCCCCCCCCCCCCEEEcCC-CcCc
Q 039819 7 ENLVIGLGAPSQSLSGT-LSGSIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSN-NRLS 69 (534)
Q Consensus 7 ~~~l~~L~l~~n~l~g~-~p~~~~~l~~L~~L~L~~N~l~g~~P~~~~~l~~L~~L~Ls~-N~l~ 69 (534)
..+++.|+|+++.++.. +...+.++++|++|+|+++.++...+..++.+++|++|+|++ +.++
T Consensus 45 ~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls~c~~it 109 (284)
T d2astb2 45 PFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFS 109 (284)
T ss_dssp CBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCC
T ss_pred CCCCCEEECCCCccCHHHHHHHHHhCCCcccccccccCCCcHHHHHHhcCCCCcCcccccccccc
Confidence 34678888888877644 344577788888888888888877777778888888888888 4555
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=98.05 E-value=3.2e-07 Score=89.84 Aligned_cols=110 Identities=21% Similarity=0.177 Sum_probs=62.6
Q ss_pred CcEEEEEecCCCceee----cccccccCCCCCEEEccCCccCc-----CCCCCCCCCCCCCEEEcCCCcCccc----cCc
Q 039819 8 NLVIGLGAPSQSLSGT----LSGSIGNLTNLRQVLLQNNNISG-----GIPPQLGSLPKLQTLDLSNNRLSGV----IPA 74 (534)
Q Consensus 8 ~~l~~L~l~~n~l~g~----~p~~~~~l~~L~~L~L~~N~l~g-----~~P~~~~~l~~L~~L~Ls~N~l~g~----~p~ 74 (534)
..++.|.+++|+++.. +...+...+.|+.|+|++|+|+. .+...+..+++|+.|+|++|.|+.. +..
T Consensus 158 ~~L~~l~l~~n~i~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~ 237 (344)
T d2ca6a1 158 PPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAI 237 (344)
T ss_dssp CCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHH
T ss_pred cccceeecccccccccccccccchhhhhhhhcccccccccccccccccchhhhhcchhhhcccccccccccccccccccc
Confidence 3566777777776522 33445566777777777777762 1344566677777777777777532 112
Q ss_pred hhhhcccCcccccccccCCccccceeCCCCcCcccCCh----hhhc--ccccccccccCCCCC
Q 039819 75 LLFLSIWLPRKWDKRKCSGVDQGLLRLNNNSLSGAFPV----FLAK--ISELAFLDLSYNNLS 131 (534)
Q Consensus 75 ~~~~l~~l~~~~~~~~~~~~~L~~L~L~~N~l~g~~p~----~~~~--l~~L~~L~ls~N~l~ 131 (534)
.+..++ +|+.|+|++|.|++.-.. .+.. ...|+.|+|++|+++
T Consensus 238 ~l~~~~--------------~L~~L~Ls~n~i~~~g~~~l~~~l~~~~~~~L~~L~ls~N~i~ 286 (344)
T d2ca6a1 238 ALKSWP--------------NLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIE 286 (344)
T ss_dssp HGGGCT--------------TCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCB
T ss_pred cccccc--------------cchhhhhhcCccCchhhHHHHHHhhhccCCCCCEEECCCCcCC
Confidence 222333 566666666666533222 2222 234666666666664
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.02 E-value=2.3e-05 Score=72.82 Aligned_cols=135 Identities=14% Similarity=0.087 Sum_probs=89.6
Q ss_pred HHHHHHHhCCCcCCeeccCCcEEEEEEEECCCcEEEEEEehh--------------hhhhc-ccCceeeEEEEEeCCCee
Q 039819 195 RELQQATENFSSKNILGAGGFGNVYKGKLGDGTVLAVKRLKD--------------MISLA-VHRNLLRLIGYCATPTER 259 (534)
Q Consensus 195 ~~l~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~--------------~l~~~-~h~niv~l~~~~~~~~~~ 259 (534)
.|+....+.|+..+..+-++.+.||+... ++..+.||+... .+..+ .+--+.+++.++..++..
T Consensus 7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~ 85 (263)
T d1j7la_ 7 PELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWS 85 (263)
T ss_dssp HHHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEE
T ss_pred HHHHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCce
Confidence 46777777777655544444578999875 445567787642 12212 122356778888888889
Q ss_pred EEEeeccCCCChhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcC-----------------------------------
Q 039819 260 LLVYPYMSNGSVASRLREKPALDWNTRKRIAIGAARGLLYLHEQC----------------------------------- 304 (534)
Q Consensus 260 ~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~~l~yLH~~~----------------------------------- 304 (534)
++||+++++.++.+...... ....++.++++.++.||+..
T Consensus 86 ~lv~~~l~G~~~~~~~~~~~-----~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (263)
T d1j7la_ 86 NLLMSEADGVLCSEEYEDEQ-----SPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEE 160 (263)
T ss_dssp EEEEECCSSEEHHHHTTTCS-----CHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGST
T ss_pred EEEEEecccccccccccccc-----cHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccc
Confidence 99999999988765543211 12334555666666666431
Q ss_pred ---------------------CCCeEeccCCCCcEEeCCCCcEEEEecccce
Q 039819 305 ---------------------DPKIIHRDVKAANVLLDDFCEAIVGDFGLAK 335 (534)
Q Consensus 305 ---------------------~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~ 335 (534)
...++|+|+.|.|||+++++..-|.||+.+.
T Consensus 161 ~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 161 DTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp TCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred cccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 0137999999999999987767799998775
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=97.93 E-value=8.9e-07 Score=86.59 Aligned_cols=111 Identities=18% Similarity=0.187 Sum_probs=63.9
Q ss_pred CcEEEEEecCCCce----eec---------ccccccCCCCCEEEccCCccCc----CCCCCCCCCCCCCEEEcCCCcCcc
Q 039819 8 NLVIGLGAPSQSLS----GTL---------SGSIGNLTNLRQVLLQNNNISG----GIPPQLGSLPKLQTLDLSNNRLSG 70 (534)
Q Consensus 8 ~~l~~L~l~~n~l~----g~~---------p~~~~~l~~L~~L~L~~N~l~g----~~P~~~~~l~~L~~L~Ls~N~l~g 70 (534)
..++.|+|++|.++ ..+ .......+.|+.|++++|+++. .+...+..++.|+.|+|++|+|+.
T Consensus 121 ~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~~~~~~~~~~L~~l~l~~n~i~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~ 200 (344)
T d2ca6a1 121 TPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRP 200 (344)
T ss_dssp TTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCH
T ss_pred ccchheecccccccccccccccccccccccccccccCcccceeecccccccccccccccchhhhhhhhcccccccccccc
Confidence 35777777777641 011 1112345677777777777752 233334456677777777777752
Q ss_pred c-----cCchhhhcccCcccccccccCCccccceeCCCCcCccc----CChhhhcccccccccccCCCCCC
Q 039819 71 V-----IPALLFLSIWLPRKWDKRKCSGVDQGLLRLNNNSLSGA----FPVFLAKISELAFLDLSYNNLSG 132 (534)
Q Consensus 71 ~-----~p~~~~~l~~l~~~~~~~~~~~~~L~~L~L~~N~l~g~----~p~~~~~l~~L~~L~ls~N~l~g 132 (534)
. +...+..++ +|+.|+|++|.++.. +...+..+++|+.|+|++|.|++
T Consensus 201 ~g~~~~l~~~l~~~~--------------~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~L~~L~Ls~n~i~~ 257 (344)
T d2ca6a1 201 EGIEHLLLEGLAYCQ--------------ELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSA 257 (344)
T ss_dssp HHHHHHHHTTGGGCT--------------TCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCH
T ss_pred cccccchhhhhcchh--------------hhcccccccccccccccccccccccccccchhhhhhcCccCc
Confidence 1 111112222 667777777777432 34556667777777777777763
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.82 E-value=1.5e-06 Score=87.47 Aligned_cols=116 Identities=21% Similarity=0.152 Sum_probs=77.7
Q ss_pred CCcEEEEEecCCCceeeccccc-----ccCCCCCEEEccCCccCcCC----CCCCCCCCCCCEEEcCCCcCccccCchhh
Q 039819 7 ENLVIGLGAPSQSLSGTLSGSI-----GNLTNLRQVLLQNNNISGGI----PPQLGSLPKLQTLDLSNNRLSGVIPALLF 77 (534)
Q Consensus 7 ~~~l~~L~l~~n~l~g~~p~~~-----~~l~~L~~L~L~~N~l~g~~----P~~~~~l~~L~~L~Ls~N~l~g~~p~~~~ 77 (534)
...+..+++++|.++......+ .....|+.+++++|.++..- ...+...++|++|||++|+|+..-...+.
T Consensus 282 ~~~l~~l~l~~n~i~~~~~~~l~~~l~~~~~~L~~l~l~~~~l~~~~~~~l~~~~~~~~~L~~L~Ls~N~i~~~g~~~l~ 361 (460)
T d1z7xw1 282 KESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELC 361 (460)
T ss_dssp CTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHH
T ss_pred cccccccccccccccccccchhhccccccccccccccccccchhhhhhhhcccccccccchhhhheeeecccCcccchhh
Confidence 3467888999999874333222 23468999999999987432 22334567899999999998743211121
Q ss_pred h-cccCcccccccccCCccccceeCCCCcCcc----cCChhhhcccccccccccCCCCCC
Q 039819 78 L-SIWLPRKWDKRKCSGVDQGLLRLNNNSLSG----AFPVFLAKISELAFLDLSYNNLSG 132 (534)
Q Consensus 78 ~-l~~l~~~~~~~~~~~~~L~~L~L~~N~l~g----~~p~~~~~l~~L~~L~ls~N~l~g 132 (534)
. +.. ....|+.|+|++|.|+. .++..+..+++|++|+|++|+|+.
T Consensus 362 ~~l~~----------~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~N~i~~ 411 (460)
T d1z7xw1 362 QGLGQ----------PGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGD 411 (460)
T ss_dssp HHHTS----------TTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSSCCH
T ss_pred hhhhc----------ccCCCCEEECCCCCCChHHHHHHHHHHhcCCCCCEEECCCCcCCH
Confidence 1 100 00168889999999974 355667778899999999999873
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.62 E-value=1.1e-05 Score=76.51 Aligned_cols=100 Identities=22% Similarity=0.170 Sum_probs=56.5
Q ss_pred EEEecCCCceeecccccccCCCCCEEEccCCccCcCCCCCCCCCCCCCEEEcCCCcCccc-cCchhhhcccCcccccccc
Q 039819 12 GLGAPSQSLSGTLSGSIGNLTNLRQVLLQNNNISGGIPPQLGSLPKLQTLDLSNNRLSGV-IPALLFLSIWLPRKWDKRK 90 (534)
Q Consensus 12 ~L~l~~n~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~P~~~~~l~~L~~L~Ls~N~l~g~-~p~~~~~l~~l~~~~~~~~ 90 (534)
.|||+++.+.......+.. ..+..+.++...+...+. ......+|++|||+++.++.. ++..+..++
T Consensus 4 ~lDLs~~~l~~~~l~~l~~-~~~~~lrl~~~~~~~~~~-~~~~~~~L~~LdLs~~~i~~~~l~~l~~~c~---------- 71 (284)
T d2astb2 4 TLDLTGKNLHPDVTGRLLS-QGVIAFRCPRSFMDQPLA-EHFSPFRVQHMDLSNSVIEVSTLHGILSQCS---------- 71 (284)
T ss_dssp EEECTTCBCCHHHHHHHHH-TTCSEEECTTCEECSCCC-SCCCCBCCCEEECTTCEECHHHHHHHHTTBC----------
T ss_pred EEECCCCCCCchHHHHHHh-ccceEeeccccccccchh-hhccCCCCCEEECCCCccCHHHHHHHHHhCC----------
Confidence 5677777665333222221 234566666655553222 333445677777777766532 233334444
Q ss_pred cCCccccceeCCCCcCcccCChhhhcccccccccccC
Q 039819 91 CSGVDQGLLRLNNNSLSGAFPVFLAKISELAFLDLSY 127 (534)
Q Consensus 91 ~~~~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ls~ 127 (534)
+|+.|+|+++.+++..+..++.+++|+.|+|++
T Consensus 72 ----~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls~ 104 (284)
T d2astb2 72 ----KLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSG 104 (284)
T ss_dssp ----CCSEEECTTCBCCHHHHHHHTTCTTCSEEECTT
T ss_pred ----CcccccccccCCCcHHHHHHhcCCCCcCccccc
Confidence 666677777776666666666667777777766
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.62 E-value=0.00011 Score=67.55 Aligned_cols=119 Identities=16% Similarity=0.062 Sum_probs=76.0
Q ss_pred eeccCCc-EEEEEEEECCCcEEEEEEehh-----------hhhhcc--cCceeeEEEEEeCCCeeEEEeeccCCCChhhh
Q 039819 209 ILGAGGF-GNVYKGKLGDGTVLAVKRLKD-----------MISLAV--HRNLLRLIGYCATPTERLLVYPYMSNGSVASR 274 (534)
Q Consensus 209 ~lG~G~~-g~Vy~~~~~~~~~vavK~~~~-----------~l~~~~--h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~ 274 (534)
.+..|.. +.||+...+++..+.+|.-.. .+..+. .-.+.+++.++.+++..++||+|++|.++.+.
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~~~~ 96 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLLSS 96 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCTTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETTTS
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCccCHhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeeccccccc
Confidence 3445554 679999988888888887541 222222 22356678888888888999999988665432
Q ss_pred cccCCCCCHHHHHHHHHHHHHHHHHHHh---------------------------------------------------c
Q 039819 275 LREKPALDWNTRKRIAIGAARGLLYLHE---------------------------------------------------Q 303 (534)
Q Consensus 275 l~~~~~l~~~~~~~i~~~i~~~l~yLH~---------------------------------------------------~ 303 (534)
. ... ..++.++++.|+-||+ .
T Consensus 97 ~-----~~~---~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 168 (255)
T d1nd4a_ 97 H-----LAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKAR 168 (255)
T ss_dssp C-----CCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHT
T ss_pred c-----ccH---HHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHHHHHh
Confidence 1 110 1112233333333332 1
Q ss_pred C----CCCeEeccCCCCcEEeCCCCcEEEEecccce
Q 039819 304 C----DPKIIHRDVKAANVLLDDFCEAIVGDFGLAK 335 (534)
Q Consensus 304 ~----~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~ 335 (534)
. .+.++|+|+.|.|||++.+..+-|+||+.+.
T Consensus 169 ~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~ 204 (255)
T d1nd4a_ 169 MPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 204 (255)
T ss_dssp CCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred CCccCCceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence 1 1237999999999999987777899998775
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=97.55 E-value=8.1e-06 Score=70.92 Aligned_cols=113 Identities=17% Similarity=0.166 Sum_probs=72.9
Q ss_pred CCcEEEEEecCC-Cceee----cccccccCCCCCEEEccCCccCcC----CCCCCCCCCCCCEEEcCCCcCccccCchhh
Q 039819 7 ENLVIGLGAPSQ-SLSGT----LSGSIGNLTNLRQVLLQNNNISGG----IPPQLGSLPKLQTLDLSNNRLSGVIPALLF 77 (534)
Q Consensus 7 ~~~l~~L~l~~n-~l~g~----~p~~~~~l~~L~~L~L~~N~l~g~----~P~~~~~l~~L~~L~Ls~N~l~g~~p~~~~ 77 (534)
...++.|+|+++ .++.. +-..+...+.|++|+|++|.|+.. +...+...+.|+.|+|++|.|+..--..+.
T Consensus 14 ~~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~l~ 93 (167)
T d1pgva_ 14 DTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLL 93 (167)
T ss_dssp CSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHH
T ss_pred CCCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHHHH
Confidence 357899999874 46532 334566778899999999998732 223344568899999999998743222222
Q ss_pred hcccCcccccccccCCccccceeCCCCcCcc-------cCChhhhcccccccccccCCC
Q 039819 78 LSIWLPRKWDKRKCSGVDQGLLRLNNNSLSG-------AFPVFLAKISELAFLDLSYNN 129 (534)
Q Consensus 78 ~l~~l~~~~~~~~~~~~~L~~L~L~~N~l~g-------~~p~~~~~l~~L~~L~ls~N~ 129 (534)
.. +.. ...|+.|+|++|.+.. .+...+...++|+.|+++.+.
T Consensus 94 ~a--L~~--------n~sL~~L~l~~n~~~~~g~~~~~~l~~~L~~n~sL~~l~l~~~~ 142 (167)
T d1pgva_ 94 RS--TLV--------TQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFAS 142 (167)
T ss_dssp HH--TTT--------TCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCC
T ss_pred HH--HHh--------CCcCCEEECCCCcCCCccHHHHHHHHHHHHhCCCccEeeCcCCC
Confidence 11 110 1168889999887652 134455566788888887654
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.07 E-value=0.00079 Score=66.27 Aligned_cols=29 Identities=21% Similarity=0.273 Sum_probs=25.3
Q ss_pred CeEeccCCCCcEEeCCCCcEEEEeccccee
Q 039819 307 KIIHRDVKAANVLLDDFCEAIVGDFGLAKL 336 (534)
Q Consensus 307 ~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~ 336 (534)
.++|+|+.|.|||++++. ++|.||-.+..
T Consensus 224 ~LiHGDl~~gNIlv~~~~-~~vID~E~a~~ 252 (392)
T d2pula1 224 TLIHGDLHTGSIFASEHE-TKVIDPEFAFY 252 (392)
T ss_dssp EEECSCCCGGGEEECSSC-EEECCCTTCEE
T ss_pred ceeccCCcCCceeEcCCc-eEEechhhccc
Confidence 589999999999999764 89999988764
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=96.86 E-value=0.00011 Score=63.39 Aligned_cols=93 Identities=15% Similarity=0.114 Sum_probs=64.3
Q ss_pred ccCCCCCEEEccCC-ccCcC----CCCCCCCCCCCCEEEcCCCcCccccCchhhhcccCcccccccccCCccccceeCCC
Q 039819 29 GNLTNLRQVLLQNN-NISGG----IPPQLGSLPKLQTLDLSNNRLSGVIPALLFLSIWLPRKWDKRKCSGVDQGLLRLNN 103 (534)
Q Consensus 29 ~~l~~L~~L~L~~N-~l~g~----~P~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~l~~~~~~~~~~~~~L~~L~L~~ 103 (534)
.+.+.|+.|+|+++ .++.. +-..+...+.|+.|+|++|.|...-...+..... ....|+.|+|++
T Consensus 12 ~n~~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~----------~n~~L~~L~L~~ 81 (167)
T d1pgva_ 12 EDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIE----------TSPSLRVLNVES 81 (167)
T ss_dssp TTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHH----------HCSSCCEEECCS
T ss_pred hCCCCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHHhhhhh----------hcccccceeeeh
Confidence 45689999999974 57631 3345677889999999999997432222322110 011789999999
Q ss_pred CcCccc----CChhhhcccccccccccCCCCC
Q 039819 104 NSLSGA----FPVFLAKISELAFLDLSYNNLS 131 (534)
Q Consensus 104 N~l~g~----~p~~~~~l~~L~~L~ls~N~l~ 131 (534)
|.|+.. +-.++...++|+.|+|++|.+.
T Consensus 82 n~i~~~g~~~l~~aL~~n~sL~~L~l~~n~~~ 113 (167)
T d1pgva_ 82 NFLTPELLARLLRSTLVTQSIVEFKADNQRQS 113 (167)
T ss_dssp SBCCHHHHHHHHHHTTTTCCCSEEECCCCSSC
T ss_pred hhcchHHHHHHHHHHHhCCcCCEEECCCCcCC
Confidence 999742 2235566688999999999776
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=96.54 E-value=0.00014 Score=62.63 Aligned_cols=114 Identities=11% Similarity=0.105 Sum_probs=70.6
Q ss_pred CCcEEEEEecC-CCceee----cccccccCCCCCEEEccCCccCcC----CCCCCCCCCCCCEEEcCCCcCccccCchhh
Q 039819 7 ENLVIGLGAPS-QSLSGT----LSGSIGNLTNLRQVLLQNNNISGG----IPPQLGSLPKLQTLDLSNNRLSGVIPALLF 77 (534)
Q Consensus 7 ~~~l~~L~l~~-n~l~g~----~p~~~~~l~~L~~L~L~~N~l~g~----~P~~~~~l~~L~~L~Ls~N~l~g~~p~~~~ 77 (534)
...|+.|+|++ +.|+.. +-.++...++|+.|+|++|.|+.. +-..+...++|+.|++++|.++..--..+.
T Consensus 16 ~~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~~l~ 95 (166)
T d1io0a_ 16 DPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALV 95 (166)
T ss_dssp CTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHH
T ss_pred CCCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchhHHHHH
Confidence 45788888887 456432 234456778899999999988732 323445678889999998888633221111
Q ss_pred hcccCcccccccccCCccccc--eeCCCCcCcc----cCChhhhcccccccccccCCCC
Q 039819 78 LSIWLPRKWDKRKCSGVDQGL--LRLNNNSLSG----AFPVFLAKISELAFLDLSYNNL 130 (534)
Q Consensus 78 ~l~~l~~~~~~~~~~~~~L~~--L~L~~N~l~g----~~p~~~~~l~~L~~L~ls~N~l 130 (534)
... .. ..+|+. |++++|.+.. .+...+...+.|+.|+++.|..
T Consensus 96 ~~l--~~--------~~~L~~l~L~l~~n~i~~~~~~~La~~L~~n~~L~~L~l~~~~~ 144 (166)
T d1io0a_ 96 EAL--QS--------NTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQ 144 (166)
T ss_dssp HGG--GG--------CSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSH
T ss_pred HHH--Hh--------CccccEEeeccCCCcCcHHHHHHHHHHHHhCCCcCEEeCcCCCC
Confidence 110 00 014554 4556677743 3555667788888888876654
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=95.62 E-value=0.00077 Score=57.65 Aligned_cols=98 Identities=19% Similarity=0.149 Sum_probs=64.4
Q ss_pred cccccccCCCCCEEEccC-CccCc----CCCCCCCCCCCCCEEEcCCCcCccccCchhhhcccCcccccccccCCccccc
Q 039819 24 LSGSIGNLTNLRQVLLQN-NNISG----GIPPQLGSLPKLQTLDLSNNRLSGVIPALLFLSIWLPRKWDKRKCSGVDQGL 98 (534)
Q Consensus 24 ~p~~~~~l~~L~~L~L~~-N~l~g----~~P~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~l~~~~~~~~~~~~~L~~ 98 (534)
+.....+.++|++|+|++ |.|+. .+-.++...++|+.|+|++|.|+..--..+.....- ...++.
T Consensus 9 l~~~~~~~~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~----------~~~l~~ 78 (166)
T d1io0a_ 9 LKRIQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKV----------NNTLKS 78 (166)
T ss_dssp HHHHHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHH----------CSSCCE
T ss_pred HHHHHhcCCCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHHHHHHHHHHhh----------cccchh
Confidence 334446679999999998 56762 244456678999999999999974433333222100 117889
Q ss_pred eeCCCCcCccc----CChhhhccccccccc--ccCCCCC
Q 039819 99 LRLNNNSLSGA----FPVFLAKISELAFLD--LSYNNLS 131 (534)
Q Consensus 99 L~L~~N~l~g~----~p~~~~~l~~L~~L~--ls~N~l~ 131 (534)
|++++|.+... +-..+...++|+.++ +++|.+.
T Consensus 79 l~l~~~~~~~~g~~~l~~~l~~~~~L~~l~L~l~~n~i~ 117 (166)
T d1io0a_ 79 LNVESNFISGSGILALVEALQSNTSLIELRIDNQSQPLG 117 (166)
T ss_dssp EECCSSCCCHHHHHHHHHGGGGCSSCCEEECCCCSSCCC
T ss_pred hhhccccccchhHHHHHHHHHhCccccEEeeccCCCcCc
Confidence 99999998532 335566778888654 4566664
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=94.75 E-value=0.02 Score=54.08 Aligned_cols=30 Identities=27% Similarity=0.264 Sum_probs=24.2
Q ss_pred CCCeEeccCCCCcEEeCCCCcEEEEeccccee
Q 039819 305 DPKIIHRDVKAANVLLDDFCEAIVGDFGLAKL 336 (534)
Q Consensus 305 ~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~~ 336 (534)
..++||+|+.+.|||++++ ..+.||+-+..
T Consensus 191 p~~liHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 191 TVLRLHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp CCEECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred CceeecCCCCcccEEEeCC--ceEEechhccc
Confidence 3468999999999999753 45889998763
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=94.53 E-value=0.061 Score=50.15 Aligned_cols=31 Identities=26% Similarity=0.151 Sum_probs=27.3
Q ss_pred CCCeEeccCCCCcEEeCCCCcEEEEecccce
Q 039819 305 DPKIIHRDVKAANVLLDDFCEAIVGDFGLAK 335 (534)
Q Consensus 305 ~~~ivH~Dlkp~NiLl~~~~~~kl~DFGla~ 335 (534)
..++||+|+.++||+++.+...-|.||+.+.
T Consensus 182 ~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 182 PAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp CEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred ccccccCCcchhhhhcccccceeEecccccc
Confidence 3479999999999999998777899999875
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=94.38 E-value=0.08 Score=51.22 Aligned_cols=60 Identities=13% Similarity=0.224 Sum_probs=37.5
Q ss_pred CeeccCCcEEEEEEEECCC--------cEEEEEEehh------------hhhhcccCce-eeEEEEEeCCCeeEEEeecc
Q 039819 208 NILGAGGFGNVYKGKLGDG--------TVLAVKRLKD------------MISLAVHRNL-LRLIGYCATPTERLLVYPYM 266 (534)
Q Consensus 208 ~~lG~G~~g~Vy~~~~~~~--------~~vavK~~~~------------~l~~~~h~ni-v~l~~~~~~~~~~~lv~e~~ 266 (534)
+.|+-|-.-.+|+....++ ..|.+++.-. +++.+.-.++ .++++++.+ .+||||+
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~efi 123 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEEYI 123 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEECCC
T ss_pred EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcchhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEEEe
Confidence 4688889999999987543 4566654321 2222222233 467777643 6899999
Q ss_pred CCCCh
Q 039819 267 SNGSV 271 (534)
Q Consensus 267 ~~gsL 271 (534)
++..+
T Consensus 124 ~g~~l 128 (395)
T d1nw1a_ 124 PSRPL 128 (395)
T ss_dssp CEEEC
T ss_pred ccccC
Confidence 87544
|